PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Andrawes, MB; Xu, X; Liu, H; Ficarro, SB; Marto, JA; Aster, JC; Blacklow, SC				Andrawes, Marie Blanke; Xu, Xiang; Liu, Hong; Ficarro, Scott B.; Marto, Jarrod A.; Aster, Jon C.; Blacklow, Stephen C.			Intrinsic Selectivity of Notch 1 for Delta-like 4 Over Delta-like 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIGAND INTERACTIONS; LINKED-N-ACETYLGLUCOSAMINE; INHIBITS TUMOR-GROWTH; LINEAGE COMMITMENT; DROSOPHILA NOTCH; ABRUPTEX DOMAIN; BINDING DOMAIN; O-FUCOSE; B-CELLS; FRINGE	Notch signaling makes critical contributions to cell fate determination in all metazoan organisms, yet remarkably little is known about the binding affinity of the four mammalian Notch receptors for their three Delta-like and two Jagged family ligands. Here, we utilized signaling assays and biochemical studies of purified recombinant ligand and receptor molecules to investigate the differences in signaling behavior and intrinsic affinity between Notch1-Dll1 and Notch1-Dll4 complexes. Systematic deletion mutagenesis of the human Notch1 ectodomain revealed that epidermal growth factor (EGF) repeats 6-15 are sufficient to maintain signaling in a reporter assay at levels comparable with the full-length receptor, and identified important contributions from EGF repeats 8-10 in conveying an activating signal in response to either Dll1 or Dll4. Truncation studies of the Dll1 and Dll4 ectodomains showed that the MNNL-EGF3 region was both necessary and sufficient for full activation. Plate-based and cell binding assays revealed a specific, calcium-dependent interaction between cell-surface and recombinant Notch receptors and ligand molecules. Finally, direct measurement of the binding affinity of Notch1 EGF repeats 6-15 for Dll1 and Dll4 revealed that Dll4 binds with at least an order of magnitude higher affinity than Dll1. Together, these studies give new insights into the features of ligand recognition by Notch1, and highlight how intrinsic differences in the biochemical behavior of receptor-ligand complexes can influence receptor-mediated responses of developmental signaling pathways.	[Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Andrawes, Marie Blanke; Xu, Xiang; Liu, Hong; Ficarro, Scott B.; Marto, Jarrod A.; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02114 USA; [Aster, Jon C.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Blacklow, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Stephen_blacklow@hms.harvard.edu			National Institutes of Health [R01 CA092433, P01 CA119070]; NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA092433 (to S. C. B.) and P01 CA119070.	Abe N, 2010, EUR J IMMUNOL, V40, P2608, DOI 10.1002/eji.200940006; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Askenazi M, 2009, NAT METHODS, V6, P240, DOI 10.1038/nmeth0409-240; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; de Celis JF, 2000, DEVELOPMENT, V127, P1291; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; DECELIS JF, 1994, GENETICS, V136, P183; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; LIEBER T, 1992, NEURON, V9, P847, DOI 10.1016/0896-6273(92)90238-9; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murata A, 2010, J IMMUNOL, V185, P3905, DOI 10.4049/jimmunol.1000195; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Patel NS, 2006, CLIN CANCER RES, V12, P4836, DOI 10.1158/1078-0432.CCR-06-0285; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah DK, 2012, CURR TOP MICROBIOL, V360, P19, DOI 10.1007/82_2012_225; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Van de Walle I, 2013, J EXP MED, V210, P683, DOI 10.1084/jem.20121798; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	67	92	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25477	25489		10.1074/jbc.M113.454850	http://dx.doi.org/10.1074/jbc.M113.454850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839946	hybrid, Green Published			2022-12-25	WOS:000330619000043
J	Fagan, RL; Cryderman, DE; Kopelovich, L; Wallrath, LL; Brenner, C				Fagan, Rebecca L.; Cryderman, Diane E.; Kopelovich, Levy; Wallrath, Lori L.; Brenner, Charles			Laccaic Acid A Is a Direct, DNA-competitive Inhibitor of DNA Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TUMOR-SUPPRESSOR GENES; TRANSCRIPTIONAL REGULATION; EPIGENETIC REGULATION; ENZYMATIC-PROPERTIES; PPAR-GAMMA; METHYLATION; DNMT1; MOUSE; EXPRESSION	Methylation of cytosines in CpG dinucleotides is the predominant epigenetic mark on vertebrate DNA. DNA methylation is associated with transcriptional repression. The pattern of DNA methylation changes during development and with disease. Human DNA methyltransferase 1 (Dnmt1), a 1616-amino acid multidomain enzyme, is essential for maintenance of DNA methylation in proliferating cells and is considered an important cancer drug target. Using a fluorogenic, endonuclease-coupled DNA methylation assay with an activated form of Dnmt1 engineered to lack the replication foci targeting sequence domain, we discovered that laccaic acid A (LCA), a highly substituted anthraquinone natural product, is a direct inhibitor with a 310 nM K-i. LCA is competitive with the DNA substrate in in vitro methylation assays and alters the expression of methylated genes in MCF-7 breast cancer cells synergistically with 5-aza-2'-deoxycytidine. LCA represents a novel class of Dnmt-targeted molecular probes, with biochemical properties that allow it to distinguish between non DNA-bound and DNA-bound Dnmt1.	[Fagan, Rebecca L.; Cryderman, Diane E.; Wallrath, Lori L.; Brenner, Charles] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Kopelovich, Levy] NCI, Canc Prevent Div, Bethesda, MD 20892 USA	University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brenner, C (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Wallrath, Lori/0000-0002-4391-7199; Switzer, Rebecca/0000-0003-0591-2538	National Institutes of Health [R01CA075954]; National Cancer Institute [HHSN261200433000C]; Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center; American Cancer Society postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center; American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA075954, Contract HHSN261200433000C from the National Cancer Institute and a generous gift from the Roy J. Carver Charitable Trust (to C. B.). This work was also supported by Oberley Seed Grants from the University of Iowa Holden Comprehensive Cancer Center (to C. B. and L. L. W.), and an American Cancer Society postdoctoral fellowship (to R. L. F.).	Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Ceccaldi A, 2011, CHEMBIOCHEM, V12, P1337, DOI 10.1002/cbic.201100130; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Eads CA, 2002, CANCER RES, V62, P1296; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Huang J, 2013, ONCOGENE IN PRESS; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Khan SI, 2012, CHEM RES TOXICOL, V25, P61, DOI 10.1021/tx200378c; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Norwood LE, 2004, GENE, V336, P37, DOI 10.1016/j.gene.2004.04.003; Ohno M, 2012, J BIOCHEM MOL TOXIC, V26, P16, DOI 10.1002/jbt.20408; Oleaga C, 2012, EUR J NUTR, V51, P465, DOI 10.1007/s00394-011-0231-2; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Paluszczak J, 2010, TOXICOL LETT, V192, P119, DOI 10.1016/j.toxlet.2009.10.010; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Rao CN, 2003, INT J ONCOL, V22, P843; Rivenbark AG, 2006, EPIGENETICS-US, V1, P32, DOI 10.4161/epi.1.1.2358; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tanaka T, 1997, FOOD ADDIT CONTAM, V14, P373, DOI 10.1080/02652039709374540; Tao YG, 2011, NUCLEIC ACIDS RES, V39, P9508, DOI 10.1093/nar/gkr611; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wiechec E, 2008, GENE CHROMOSOME CANC, V47, P766, DOI 10.1002/gcc.20578; Wood RJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq047; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	59	45	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23858	23867		10.1074/jbc.M113.480517	http://dx.doi.org/10.1074/jbc.M113.480517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839987	Green Published, hybrid			2022-12-25	WOS:000330611400025
J	Karayannis, NV; Smeets, RJEM; van den Hoorn, W; Hodges, PW				Karayannis, Nicholas V.; Smeets, Rob J. E. M.; van den Hoorn, Wolbert; Hodges, Paul W.			Fear of Movement Is Related to Trunk Stiffness in Low Back Pain	PLOS ONE			English	Article							AVOIDANCE BELIEFS; MUSCULOSKELETAL PAIN; POSTURAL CONTROL; LUMBAR SPINE; SCALE; DISABILITY; REDUCTION; STATE	Background: Psychological features have been related to trunk muscle activation patterns in low back pain (LBP). We hypothesised higher pain-related fear would relate to changes in trunk mechanical properties, such as higher trunk stiffness. Objectives: To evaluate the relationship between trunk mechanical properties and psychological features in people with recurrent LBP. Methods: The relationship between pain-related fear (Tampa Scale for Kinesiophobia, TSK; Photograph Series of Daily Activities, PHODA-SeV; Fear Avoidance Beliefs Questionnaire, FABQ; Pain Catastrophizing Scale, PCS) and trunk mechanical properties (estimated from the response of the trunk to a sudden sagittal plane forwards or backwards perturbation by unpredictable release of a load) was explored in a case-controlled study of 14 LBP participants. Regression analysis (r(2)) tested the linear relationships between pain-related fear and trunk mechanical properties (trunk stiffness and damping). Mechanical properties were also compared with t-tests between groups based on stratification according to high/low scores based on median values for each psychological measure. Results: Fear of movement (TSK) was positively associated with trunk stiffness (but not damping) in response to a forward perturbation (r(2) = 0.33, P = 0.03), but not backward perturbation (r(2) = 0.22, P = 0.09). Other pain-related fear constructs (PHODA-SeV, FABQ, PCS) were not associated with trunk stiffness or damping. Trunk stiffness was greater for individuals with high kinesiophobia (TSK) for forward (P = 0.03) perturbations, and greater with forward perturbation for those with high fear avoidance scores (FABQ-W, P = 0.01). Conclusions: Fear of movement is positively (but weakly) associated with trunk stiffness. This provides preliminary support an interaction between biological and psychological features of LBP, suggesting this condition may be best understood if these domains are not considered in isolation.	[Karayannis, Nicholas V.; van den Hoorn, Wolbert; Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia; [Smeets, Rob J. E. M.] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Hoensbroek, Netherlands; [Smeets, Rob J. E. M.] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands	University of Queensland; Maastricht University	Hodges, PW (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Karayannis, Nicholas Vasilis/AAA-2582-2021; van den Hoorn, Wolbert/F-6894-2010; Karayannis, Nicholas Vasilis/E-3346-2010; Hodges, Paul W/B-6578-2008; Smeets, Rob JEM/D-1522-2011	van den Hoorn, Wolbert/0000-0002-9658-2388; Karayannis, Nicholas Vasilis/0000-0003-1215-750X; Hodges, Paul W/0000-0002-1206-9107; Smeets, Rob JEM/0000-0002-9503-366X	CCRE SPINE; University of Queensland International Research Tuition Award; American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award; National Health and Medical Research Council of Australia	CCRE SPINE; University of Queensland International Research Tuition Award; American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NK is supported by a PhD scholarship from The CCRE SPINE, The University of Queensland International Research Tuition Award and the American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award. PH is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia. The authors have no financial or personal relationships with other people or organisations that could inappropriately bias their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma K, 2006, EUR J PAIN, V10, P551, DOI 10.1016/j.ejpain.2005.08.004; Calley D, 2010, J ORTHOP SPORT PHYS, V40, P774, DOI 10.2519/jospt.2010.3381; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; den Hollander M, 2010, EXPERT REV NEUROTHER, V10, P1733, DOI [10.1586/ern.10.115, 10.1586/ERN.10.115]; Elfving B, 2007, PHYSIOTHER RES INT, V12, P14, DOI 10.1002/pri.355; Fordyce WE, 1976, CONTEMP PSYCHOL, V21, P834; GATCHEL RJ, 1999, PSYCHOSOCIAL FACTORS, P412; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; George SZ, 2010, J ORTHOP SPORT PHYS, V40, P197, DOI 10.2519/jospt.2010.3298; Hall AM, PAIN, V5, P1044; Hodges P, 2009, J BIOMECH, V42, P61, DOI 10.1016/j.jbiomech.2008.10.001; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Jensen MP KP, 1992, SELF REPORT SCALES P, P193; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Kori SH., 1990, PAIN MANAG, V3, P35, DOI 10.1007/978-3-540-29805-2_4377; Leeuw M, 2008, PAIN, V138, P192, DOI 10.1016/j.pain.2007.12.009; Leeuw M, 2007, J PAIN, V8, P840, DOI 10.1016/j.jpain.2007.05.013; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Linton SJ, 2011, PHYS THER, V5, P1; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; Nicholas MK, 2008, PAIN, V134, P158, DOI 10.1016/j.pain.2007.04.007; Nicholas MK, 2011, PHYS THER, V91, P1; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Reeves NP, 2008, EXP BRAIN RES, V188, P457, DOI 10.1007/s00221-008-1378-9; Reeves NP, 2009, J BIOMECH, V42, P164, DOI 10.1016/j.jbiomech.2008.10.016; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Smeets RJEM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-5; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Watson PJ, 1997, J MUSCULOSKELET PAIN, V5, P41, DOI 10.1300/J094v05n04_05	36	71	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67779	10.1371/journal.pone.0067779	http://dx.doi.org/10.1371/journal.pone.0067779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826339	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000097
J	Schildgen, V; Malecki, M; Tillmann, RL; Brockmann, M; Schildgen, O				Schildgen, Verena; Malecki, Monika; Tillmann, Ramona-Liza; Brockmann, Michael; Schildgen, Oliver			The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors	PLOS ONE			English	Article							HUMAN PARVOVIRUS; HBV CCCDNA; EXPRESSION; INFECTION; VIRUSES; B19	Human bocavirus is the second autonomous human parvovirus with assumed pathogenic potential. Other parvoviruses are known to persist and even integrate into the host genome, eventually contributing to the multi-step development of cancer. Human bocavirus also persists in an unknown percentage of clinically asymptomatic patients in addition to those with primary infection. The aim of the present study was to analyze the role of Human bocavirus in lung and colorectal cancers. Therefore, formalin-fixed, paraffin-embedded, archived tumor samples were screened for Human bocavirus DNA by PCR, Southern blotting, and sequencing. Positive tissues were further subjected to fluorescence in situ hybridization analysis to specifically detect human bocavirus DNA in the infected cells. In total, 11 of the 60 (18.3%) lung and 9 of the 44 (20.5%) colorectal tumors tested positive for human bocavirus DNA by PCR and were confirmed by sequencing and fluorescence in situ hybridization analysis. Thus, human bocavirus DNA is present in the nuclei of infected cells, in either single or multiple copies, and appears to form concatemers. The occurrence of these human bocavirus DNA structures supports the existence of the postulated sigma- or rolling-hairpin replication mechanism. Moreover, the fluorescence in situ hybridization patterns inspired the hypothesis that human bocavirus DNA either persists as cccDNA or is integrated into the host genome. This finding suggests that this virus may indirectly contribute to the development of some colorectal and lung cancers, as do other DNA viruses, such as the human hepatitis B virus, or may play an active role in cancer by interacting with the host genome.	[Schildgen, Verena; Malecki, Monika; Tillmann, Ramona-Liza; Brockmann, Michael; Schildgen, Oliver] Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany	University of Cologne	Schildgen, O (corresponding author), Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	Else Kroner-Fresenius Stiftung, Germany	Else Kroner-Fresenius Stiftung, Germany	This work was supported by an unrestricted research grant from the Else Kroner-Fresenius Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LA, 2011, THYROID, V21, P411, DOI 10.1089/thy.2010.0307; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Carmichael L, 1999, RECENT ADV CANINE IN; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; Hasan N, 2010, INFECT DIS CLIN N AM, V24, P1019, DOI 10.1016/j.idc.2010.07.009; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Khamrin P, 2012, INFECT GENET EVOL, V12, P565, DOI 10.1016/j.meegid.2012.01.025; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Kuethe F, 2009, CLIN INFECT DIS, V49, P1660, DOI 10.1086/648074; Kupfer B, 2006, EMERG INFECT DIS, V12, P1614, DOI 10.3201/eid1210.060520; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-54; Li YS, 2012, ONCOL LETT, V3, P635, DOI 10.3892/ol.2012.548; Li YF, 2007, AM J GASTROENTEROL, V102, P1489, DOI 10.1111/j.1572-0241.2007.01240.x; Liu HQ, 2011, J VIROL, V85, P9863, DOI 10.1128/JVI.00828-11; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nawaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041346; Oleksiewicz MB, 1997, J VIROL, V71, P1386, DOI 10.1128/JVI.71.2.1386-1396.1997; Op De Beeck A, 1997, Prog Cell Cycle Res, V3, P1; Polcz ME, 2013, J CLIN VIROL; Polcz ME, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.014; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen O, 2010, PEDIATR PULM, V45, P118, DOI 10.1002/ppul.21159; Schildgen V, 2012, PERS MED, V9, P801, DOI [10.2217/PME.12.94, 10.2217/pme.12.94]; Schildgen V, 2010, J VIROL METHODS, V163, P74, DOI 10.1016/j.jviromet.2009.08.024; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Tabata Toshiharu, 2005, Kyobu Geka, V58, P1181; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Wang JH, 2008, BRIT J CANCER, V98, P611, DOI 10.1038/sj.bjc.6604196; Wang JH, 2010, J INFECTION, V60, P360, DOI 10.1016/j.jinf.2010.02.006; Yang Wan-zhu, 2012, Chinese Journal of Virology, V28, P418; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	40	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68020	10.1371/journal.pone.0068020	http://dx.doi.org/10.1371/journal.pone.0068020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826357	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000111
J	van Walraven, C; Musselman, R				van Walraven, Carl; Musselman, Reilly			The Surgical Site Infection Risk Score (SSIRS): A Model to Predict the Risk of Surgical Site Infections	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; SURGERY; INDEX	Background: Surgical site infections (SSI) are an important cause of peri-surgical morbidity with risks that vary extensively between patients and surgeries. Quantifying SSI risk would help identify candidates most likely to benefit from interventions to decrease the risk of SSI. Methods: We randomly divided all surgeries recorded in the National Surgical Quality Improvement Program from 2010 into a derivation and validation population. We used multivariate logistic regression to determine the independent association of patient and surgical covariates with the risk of any SSI (including superficial, deep, and organ space SSI) within 30 days of surgery. To capture factors particular to specific surgeries, we developed a surgical risk score specific to all surgeries having a common first 3 numbers of their CPT code. Results: Derivation (n = 181 894) and validation (n = 181 146) patients were similar for all demographics, past medical history, and surgical factors. Overall SSI risk was 3.9%. The SSI Risk Score (SSIRS) found that risk increased with patient factors (smoking, increased body mass index), certain comorbidities (peripheral vascular disease, metastatic cancer, chronic steroid use, recent sepsis), and operative characteristics (surgical urgency; increased ASA class; longer operation duration; infected wounds; general anaesthesia; performance of more than one procedure; and CPT score). In the validation population, the SSIRS had good discrimination (c-statistic 0.800, 95% CI 0.795-0.805) and calibration. Conclusion: SSIRS can be calculated using patient and surgery information to estimate individual risk of SSI for a broad range of surgery types.	[van Walraven, Carl] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Musselman, Reilly] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [van Walraven, Carl] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [van Walraven, Carl] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto	van Walraven, C (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	carlv@ohri.ca						Bowater RJ, 2009, ANN SURG, V249, P551, DOI 10.1097/SLA.0b013e318199f202; BOYCE JM, 1990, INFECT CONT HOSP EP, V11, P89; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; de Blacam C, 2012, ANN SURG, V255, P551, DOI 10.1097/SLA.0b013e318246c294; Ercole FF, 2007, BRAZ J INFECT DIS, V11, P134, DOI 10.1590/S1413-86702007000100028; Gaynes RP, 2000, INFECT CONT HOSP EP, V21, P184, DOI 10.1086/501740; Gibbons C, 2011, HEALTH TECHNOL ASSES, V15, P1; Gu┬nen M., 2007, ANAL RECEIVER OPERAT, V3, P15; HORAN TC, 1993, INFECT CONT HOSP EP, V14, P73, DOI 10.2307/30147164; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Mu Y, 2011, INFECT CONT HOSP EP, V32, P970, DOI 10.1086/662016; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Raval MV, 2010, J AM COLL SURGEONS, V211, P715, DOI 10.1016/j.jamcollsurg.2010.07.021; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033	19	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67167	10.1371/journal.pone.0067167	http://dx.doi.org/10.1371/journal.pone.0067167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826224	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000038
J	Watterson, DM; Grum-Tokars, VL; Roy, SM; Schavocky, JP; Bradaric, BD; Bachstetter, AD; Xing, B; Dimayuga, E; Saeed, F; Zhang, H; Staniszewski, A; Pelletier, JC; Minasov, G; Anderson, WF; Arancio, O; Van Eldik, LJ				Watterson, D. Martin; Grum-Tokars, Valerie L.; Roy, Saktimayee M.; Schavocky, James P.; Bradaric, Brinda Desai; Bachstetter, Adam D.; Xing, Bin; Dimayuga, Edgardo; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Pelletier, Jeffrey C.; Minasov, George; Anderson, Wayne F.; Arancio, Ottavio; Van Eldik, Linda J.			Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction	PLOS ONE			English	Article							CYTOKINE UP-REGULATION; ALZHEIMERS-DISEASE; BEHAVIORAL DEFICITS; P38-ALPHA MAPK; MOUSE MODEL; INHIBITORS; POTENT; ACTIVATION; DISCOVERY; BINDING	Serine-threonine protein kinases are critical to CNS function, yet there is a dearth of highly selective, CNS-active kinase inhibitors for in vivo investigations. Further, prevailing assumptions raise concerns about whether single kinase inhibitors can show in vivo efficacy for CNS pathologies, and debates over viable approaches to the development of safe and efficacious kinase inhibitors are unsettled. It is critical, therefore, that these scientific challenges be addressed in order to test hypotheses about protein kinases in neuropathology progression and the potential for in vivo modulation of their catalytic activity. Identification of molecular targets whose in vivo modulation can attenuate synaptic dysfunction would provide a foundation for future disease-modifying therapeutic development as well as insight into cellular mechanisms. Clinical and preclinical studies suggest a critical link between synaptic dysfunction in neurodegenerative disorders and the activation of p38 alpha MAPK mediated signaling cascades. Activation in both neurons and glia also offers the unusual potential to generate enhanced responses through targeting a single kinase in two distinct cell types involved in pathology progression. However, target validation has been limited by lack of highly selective inhibitors amenable to in vivo use in the CNS. Therefore, we employed high-resolution co-crystallography and pharmacoinformatics to design and develop a novel synthetic, active site targeted, CNS-active, p38 alpha MAPK inhibitor (MW108). Selectivity was demonstrated by large-scale kinome screens, functional GPCR agonist and antagonist analyses of off-target potential, and evaluation of cellular target engagement. In vitro and in vivo assays demonstrated that MW108 ameliorates beta-amyloid induced synaptic and cognitive dysfunction. A serendipitous discovery during co-crystallographic analyses revised prevailing models about active site targeting of inhibitors, providing insights that will facilitate future kinase inhibitor design. Overall, our studies deliver highly selective in vivo probes appropriate for CNS investigations and demonstrate that modulation of p38 alpha MAPK activity can attenuate synaptic dysfunction.	[Watterson, D. Martin; Grum-Tokars, Valerie L.; Roy, Saktimayee M.; Schavocky, James P.; Bradaric, Brinda Desai; Pelletier, Jeffrey C.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Bachstetter, Adam D.; Xing, Bin; Dimayuga, Edgardo; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Northwestern University; University of Kentucky; Columbia University	Watterson, DM (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	d.m.watterson@gmail.com	arancio, ottavio/AAB-7959-2019	Watterson, Daniel/0000-0001-7605-5866; Bradaric, Brinda/0000-0002-3830-7927; arancio, ottavio/0000-0001-6335-164X; Minasov, George/0000-0001-5460-3462; Saeed, Faisal/0000-0003-1194-2792; Bachstetter, Adam/0000-0003-4646-6757	Thome Memorial Foundation; Alzheimer's Association Zenith award; National Institutes of Health [R01 NS064247, R01 NS056051, R01 AG031311, F32 AG037280, U01AG043415]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047586, R01NS064247, R01NS056051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031311, U01AG043415, F32AG037280] Funding Source: NIH RePORTER	Thome Memorial Foundation; Alzheimer's Association Zenith award(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by funds from the Thome Memorial Foundation (LVE), an Alzheimer's Association Zenith award (LVE) and National Institutes of Health grants R01 NS064247 (LVE), R01 NS056051 (DMW), R01 AG031311 (DMW), F32 AG037280 (ADB), U01AG043415 (DMW, JCP, & OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVDEEF A, 1993, ANAL CHEM, V65, P42, DOI 10.1021/ac00049a010; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2010, AGING DIS, V1, P199; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Chico LK, 2009, DRUG METAB DISPOS, V37, P2204, DOI 10.1124/dmd.109.028134; Clark Andrew R, 2012, Open Rheumatol J, V6, P209, DOI 10.2174/1874312901206010209; Correa SA, 2012, J SIGNAL TRANSDUCTIO; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Devadas B, 2011, BIOORG MED CHEM LETT, V21, P3856, DOI 10.1016/j.bmcl.2011.05.006; Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455; Eastwood P, 2011, BIOORG MED CHEM LETT, V21, P4130, DOI 10.1016/j.bmcl.2011.05.114; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fiorito J, 2013, EUR J MED CHEM, V60, P285, DOI 10.1016/j.ejmech.2012.12.009; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Jerome KD, 2010, BIOORG MED CHEM LETT, V20, P469, DOI 10.1016/j.bmcl.2009.11.114; Kusakabe K, 2012, ACS MED CHEM LETT, V3, P560, DOI 10.1021/ml3000879; Lamba V, 2012, CURR PHARM DESIGN, V18, P2936, DOI 10.2174/138161212800672813; Lumeras W, 2011, J MED CHEM, V54, P7899, DOI 10.1021/jm200975u; Lumeras W, 2009, J MED CHEM, V52, P5531, DOI 10.1021/jm9008604; Martz KE, 2012, J MED CHEM, V55, P7862, DOI 10.1021/jm300951u; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Natarajan SR, 2006, BIOORG MED CHEM LETT, V16, P5809, DOI 10.1016/j.bmcl.2006.08.074; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Patel SB, 2009, ACTA CRYSTALLOGR D, V65, P777, DOI 10.1107/S090744490901600X; Pettus LH, 2010, J MED CHEM, V53, P2973, DOI 10.1021/jm100095x; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sabat M, 2006, BIOORG MED CHEM LETT, V16, P4360, DOI 10.1016/j.bmcl.2006.05.050; Scapin G, 2006, CURR DRUG TARGETS, V7, P1443, DOI 10.2174/1389450110607011443; Selness SR, 2009, BIOORG MED CHEM LETT, V19, P5851, DOI 10.1016/j.bmcl.2009.08.082; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Teich AF, 2012, BIOCHEM J, V446, P165, DOI 10.1042/BJ20120653; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Ul-Haq Z, 2012, J MOL GRAPH MODEL, V36, P48, DOI 10.1016/j.jmgm.2012.02.003; Verkaar F, 2011, CHEM BIOL, V18, P485, DOI 10.1016/j.chembiol.2011.01.015; Vitolo O, 2009, NEUROBIOL AGING, V30, P257, DOI 10.1016/j.neurobiolaging.2007.05.025; Wermuth CG, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P1; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P348, DOI 10.1016/j.drudis.2006.02.006; Xing L, 2009, BIOCHEMISTRY-US, V48, P6402, DOI 10.1021/bi900655f	50	56	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66226	10.1371/journal.pone.0066226	http://dx.doi.org/10.1371/journal.pone.0066226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840427	Green Submitted, gold, Green Published			2022-12-25	WOS:000321424400022
J	Zhang, SH; Wang, CJ; Shi, L; Li, XH; Zhou, J; Song, LB; Liao, WT				Zhang, Shi-Hong; Wang, Chan-Juan; Shi, Ling; Li, Xing-Hua; Zhou, Jing; Song, Li-Bing; Liao, Wen-Ting			High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							REGGIE/FLOTILLIN PROTEINS; CANCER PROGRESSION; ALPHA-FETOPROTEIN; BREAST-CANCER; UP-REGULATION; CELLS; REGGIE-1; MICRODOMAINS; DIAGNOSIS; GENES	Background: The flotillin family member flotillin-1 (FLOT1) encodes a caveolae-associated, integral membrane protein that belongs to lipid raft family and involves in vesicular trafficking and signal transduction. However, the role of FLOT1 in development and progression of cancer remains largely unknown. The present study was aimed to investigate the clinical and prognostic significance of FLOT1 in hepatocellular carcinoma (HCC). Methods: Real-time PCR and western blot analyses were applied to examine FLOT1 expression in fourteen HCC cell lines and one normal hepatic cell line, ten pairs of primary HCC and matched adjacent noncancerous liver tissues from the same patient. Immunohistochemistry (IHC) was performed to examine FLOT1 protein expression in paraffin-embedded tissues from 196 HCC patients. Statistical analyses were applied to evaluate the diagnostic value and associations of FLOT1 expression with clinical parameters. Results: FLOT1 expression was evidently up-regulated in HCC tissues compared with that in the matched adjacent noncancerous liver tissues. In the 196 cases of tested HCC samples, FLOT1 protein level was positively correlated with Tumor size (P = 0.025), clinical stage (P<0.002), CLIP stage (P<0.001), vascular invasion (P<0.001), relapse (P<0.001), and serum AFP levels (P = 0.025). Patients with higher FLOT1 expression had shorter overall survival time, whereas those with lower FLOT1 expression had longer survival time. Conclusions: Our study demonstrated FLOT1 is associated with aggressive characteristics of HCC, and suggested the possibility of its use as a prognostic marker in patients with HCC.	[Zhou, Jing; Liao, Wen-Ting] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Chan-Juan; Shi, Ling; Li, Xing-Hua; Song, Li-Bing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shi-Hong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jing; Liao, Wen-Ting] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Song, LB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	lb.song1@gmail.com; liaowt2002@gmail.com	Song, LB/AAL-1968-2020		Natural Science Foundation of China [30901791, 81172055]; National Program on Key Basic Research Project (973 Program) [2012CB519003]; Guangdong Provincial Natural Science Foundation of China [S2012010009643]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	This study was supported by: the Natural Science Foundation of China (No. 30901791, 81172055), National Program on Key Basic Research Project (973 Program, No. 2012CB519003), and Guangdong Provincial Natural Science Foundation of China (No. S2012010009643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chalasani N, 1999, AM J GASTROENTEROL, V94, P2988, DOI 10.1016/S0002-9270(99)00504-3; Colombo M, 1998, DIGESTION, V59, P70, DOI 10.1159/000051428; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Patra SK, 2007, ONCOL REP, V17, P1279; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pust S., 2012, ONCOGENE; Schulte T, 1997, DEVELOPMENT, V124, P577; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Soresi M, 2003, ANTICANCER RES, V23, P1747; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Thorn CC, 2009, GUT, V58, P404, DOI 10.1136/gut.2008.157255; Vassilieva EV, 2009, BIOCHEM BIOPH RES CO, V379, P460, DOI 10.1016/j.bbrc.2008.12.118; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	31	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e64709	10.1371/journal.pone.0064709	http://dx.doi.org/10.1371/journal.pone.0064709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840303	gold, Green Published, Green Submitted			2022-12-25	WOS:000321424400003
J	Hein, I; Suzuki, T; Kadow, ICG				Hein, Irina; Suzuki, Takashi; Kadow, Ilona C. Grunwald			Gogo Receptor Contributes to Retinotopic Map Formation and Prevents R1-6 Photoreceptor Axon Bundling	PLOS ONE			English	Article							DROSOPHILA VISUAL-SYSTEM; N-CADHERIN; TARGET INTERACTIONS; TYROSINE KINASE; LIPRIN-ALPHA; SPECIFICITY; FLAMINGO; MELANOGASTER; SELECTION; GUIDANCE	Background: Topographic maps form the basis of neural processing in sensory systems of both vertebrate and invertebrate species. In the Drosophila visual system, neighboring R1-R6 photoreceptor axons innervate adjacent positions in the first optic ganglion, the lamina, and thereby represent visual space as a continuous map in the brain. The mechanisms responsible for the establishment of retinotopic maps remain incompletely understood. Results: Here, we show that the receptor Golden goal (Gogo) is required for R axon lamina targeting and cartridge elongation in a partially redundant fashion with local guidance cues provided by neighboring axons. Loss of function of Gogo in large clones of R axons results in aberrant R1-R6 fascicle spacing. Gogo affects target cartridge selection only indirectly as a consequence of the disordered lamina map. Interestingly, small clones of gogo deficient R axons perfectly integrate into a proper retinotopic map suggesting that surrounding R axons of the same or neighboring fascicles provide complementary spatial guidance. Using single photoreceptor type rescue, we show that Gogo expression exclusively in R8 cells is sufficient to mediate targeting of all photoreceptor types in the lamina. Upon lamina targeting and cartridge selection, R axons elongate within their individual cartridges. Interestingly, here Gogo prevents bundling of extending R1-6 axons. Conclusion: Taken together, we propose that Gogo contributes to retinotopic map formation in the Drosophila lamina by controlling the distribution of R1-R6 axon fascicles. In a later developmental step, the regular position of R1-R6 axons along the lamina plexus is crucial for target cartridge selection. During cartridge elongation, Gogo allows R1-R6 axons to extend centrally in the lamina cartridge.	[Hein, Irina; Kadow, Ilona C. Grunwald] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Suzuki, Takashi] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 227, Japan	Max Planck Society; Tokyo Institute of Technology	Suzuki, T (corresponding author), Tokyo Inst Technol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 227, Japan.	suzukit@bio.titech.ac.jp; ikadow@neuro.mpg.de	Suzuki, Takashi/D-3651-2019	Suzuki, Takashi/0000-0001-9093-2562; Grunwald Kadow, Ilona/0000-0002-9085-4274	MPS	MPS	This work was supported by the MPS (to TS and IG-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher D., 2001, NUMERICAL PYTHON; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Gontang AC, 2011, DEVELOPMENT, V138, P4899, DOI 10.1242/dev.069930; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Jones E., 2001, SCIPY OPEN SOURCE SC; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prakash S, 2009, DEV BIOL, V336, P10, DOI 10.1016/j.ydbio.2009.09.016; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Timofeev K, 2012, NEURON, V75, P80, DOI 10.1016/j.neuron.2012.04.037; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; White NM, 2000, DEVELOPMENT, V127, P1681; Wolff T, 1993, DEV DROSOPHILA MELAN; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66868	10.1371/journal.pone.0066868	http://dx.doi.org/10.1371/journal.pone.0066868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826162	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400073
J	Singh, BK; Bockarie, MJ; Gambhir, M; Siba, PM; Tisch, DJ; Kazura, J; Michael, E				Singh, Brajendra K.; Bockarie, Moses J.; Gambhir, Manoj; Siba, Peter M.; Tisch, Daniel J.; Kazura, James; Michael, Edwin			Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI INFECTION; DISEASE TRANSMISSION MODELS; CULEX-QUINQUEFASCIATUS; BIOLOGICAL ROBUSTNESS; MATHEMATICAL-MODELS; SIMULATION-MODELS; GLOBAL PROGRAM; VECTOR CONTROL; ENDEMIC AREA; SOUTH-INDIA	Background: Lymphatic filariasis (LF) has been targeted by the WHO for global eradication leading to the implementation of large scale intervention programs based on annual mass drug administrations (MDA) worldwide. Recent work has indicated that locality-specific bio-ecological complexities affecting parasite transmission may complicate the prediction of LF extinction endpoints, casting uncertainty on the achievement of this initiative. One source of difficulty is the limited quantity and quality of data used to parameterize models of parasite transmission, implying the important need to update initially-derived parameter values. Sequential analysis of longitudinal data following annual MDAs will also be important to gaining new understanding of the persistence dynamics of LF. Here, we apply a Bayesian statistical-dynamical modelling framework that enables assimilation of information in human infection data recorded from communities in Papua New Guinea that underwent annual MDAs, into our previously developed model of parasite transmission, in order to examine these questions in LF ecology and control. Results: Biological parameters underlying transmission obtained by fitting the model to longitudinal data remained stable throughout the study period. This enabled us to reliably reconstruct the observed baseline data in each community. Endpoint estimates also showed little variation. However, the updating procedure showed a shift towards higher and less variable values for worm kill but not for any other drug-related parameters. An intriguing finding is that the stability in key biological parameters could be disrupted by a significant reduction in the vector biting rate prevailing in a locality. Conclusions: Temporal invariance of biological parameters in the face of intervention perturbations indicates a robust adaptation of LF transmission to local ecological conditions. The results imply that understanding the mechanisms that underlie locally adapted transmission dynamics will be integral to identifying points of system fragility, and thus countermeasures to reliably facilitate LF extinction both locally and globally.	[Singh, Brajendra K.; Michael, Edwin] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med & Hyg, Liverpool L69 3BX, Merseyside, England; [Gambhir, Manoj] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Tisch, Daniel J.; Kazura, James] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University of Notre Dame; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; PNG Institute Of Medical Research; Case Western Reserve University	Singh, BK (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	bsingh1@nd.edu	Michael, Edwin/D-3388-2014; Bockarie, Moses/AAW-3130-2021; Singh, Brajendra Kumar/C-3787-2012; Bockarie, Moses/AAV-4578-2020; Tisch, Daniel/Q-5044-2019	Singh, Brajendra Kumar/0000-0001-5847-8750; Gambhir, Manoj/0000-0002-4831-6261	National Institutes of Health [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	EM and BKS acknowledge National Institutes of Health grant no: RO1 AI069387-01A1 for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ELEMENTS COMPUTATION; Beven K., 2004, Hydrology: science and practice for the 21st century, Volume 1. Proceedings of the British Hydrological Society International Conference, Imperial College, London, July 2004, P244; Bockarie MJ, 1998, LANCET, V351, P162, DOI 10.1016/S0140-6736(97)07081-5; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626; Brockarie M, 1996, AM J TROP MED HYG, V54, P577, DOI 10.4269/ajtmh.1996.54.577; Brugnach M, 2008, DEV INTEG ENVIRON, V3, P49, DOI 10.1016/S1574-101X(08)00604-2; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016; Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616; Das PK, 1992, EPIDEMIOL INFECT, V108, P483; de Kraker MEA, 2006, TROP MED INT HEALTH, V11, P718, DOI 10.1111/j.1365-3156.2006.01606.x; Dowd M, 2006, ENVIRONMETRICS, V17, P435, DOI 10.1002/env.780; Dowd M, 2011, ENVIRONMETRICS, V22, P501, DOI 10.1002/env.1083; Dreyer G, 2006, T ROY SOC TROP MED H, V100, P1118, DOI 10.1016/j.trstmh.2006.04.006; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Gambhir M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-22; Gambhir M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002874; HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V38, P935; HO BC, 1967, T ROY SOC TROP MED H, V61, P663, DOI 10.1016/0035-9203(67)90130-7; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; LaDeau SL, 2011, ECOL APPL, V21, P1443, DOI 10.1890/09-1409.1; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; Luo YQ, 2011, ECOL APPL, V21, P1429; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 2007, ADV PARASIT, V65, P191, DOI 10.1016/S0065-308X(07)65003-9; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; Norton JP, 2008, DEV INTEG ENVIRON, V3, P181, DOI 10.1016/S1574-101X(08)00611-X; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Plaisier AP, 1999, PARASITOLOGY, V119, P385, DOI 10.1017/S0031182099004783; Plaisier AP, 2000, PARASITOL TODAY, V16, P298, DOI 10.1016/S0169-4758(00)01691-4; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; RAFTERY AE, 1995, J AM STAT ASSOC, V90, P402, DOI 10.2307/2291048; Rajagopalan P.K., 1980, Proceedings of the Indian National Science Academy Part B Biological Sciences, V46, P745; Ramin M, 2011, ENVIRON MODELL SOFTW, V26, P337, DOI 10.1016/j.envsoft.2010.08.006; Scott BC, 2004, TRENDS ECOL EVOL, V19, P365; Sevcikova H, 2007, TRANSPORT RES B-METH, V41, P652, DOI 10.1016/j.trb.2006.11.001; Spear RC, 2002, ENVIRON HEALTH PERSP, V110, P907, DOI 10.1289/ehp.02110907; Spear RC, 2012, J R SOC INTERFACE, V9, P272, DOI 10.1098/rsif.2011.0285; Spear RC, 2010, ADV EXP MED BIOL, V673, P99; Stolk WA, 2008, PARASITOLOGY, V135, P1583, DOI 10.1017/S0031182008000437; SUBRAMANIAN S, 1994, AM J TROP MED HYG, V51, P244, DOI 10.4269/ajtmh.1994.51.244; SUBRAMANIAN S, 1989, EPIDEMIOL INFECT, V103, P693, DOI 10.1017/S0950268800031095; Subramanian S, 1998, PARASITOLOGY, V116, P243, DOI 10.1017/S0031182097002254; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289; Tisch DJ, 2005, LANCET INFECT DIS, V5, P514, DOI 10.1016/S1473-3099(05)70192-4; Tisch DJ, 2001, J INFECT DIS, V184, P898, DOI 10.1086/323324; VANAMAIL P, 1990, INDIAN J MED RES-A, V91, P293; Vanamail P, 1996, T ROY SOC TROP MED H, V90, P119, DOI 10.1016/S0035-9203(96)90106-6; Waller LA, 2003, ECOL MODEL, V164, P49, DOI 10.1016/S0304-3800(03)00011-5; Weisstein E.W., KOLMOGOROV SMIRNOV T; Whitacre JM, 2012, FRONTIERS GENETICS, V3; Ziadinov I, 2008, INT J PARASITOL, V38, P1179, DOI 10.1016/j.ijpara.2008.01.009; Zimmermann HJ, 2000, EUR J OPER RES, V122, P190, DOI 10.1016/S0377-2217(99)00228-3	69	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67004	10.1371/journal.pone.0067004	http://dx.doi.org/10.1371/journal.pone.0067004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826185	gold, Green Published, Green Accepted			2022-12-25	WOS:000321738400093
J	Teng, IF; Wilson, SA				Teng, I-Fang; Wilson, Stuart A.			Mapping Interactions between mRNA Export Factors in Living Cells	PLOS ONE			English	Article							NUCLEAR SPECKLES; TREX COMPLEX; NXF1; RECRUITMENT; PROTEINS; DYNAMICS; DOMAINS	The TREX complex couples nuclear mRNA processing events with subsequent export to the cytoplasm. TREX also acts as a binding platform for the mRNA export receptor Nxf1. The sites of mRNA transcription and processing within the nucleus have been studied extensively. However, little is known about where TREX assembly takes place and where Nxf1 is recruited to TREX to form the export competent mRNP. Here we have used sensitized emission Forster resonance energy transfer (FRET) and fluorescence lifetime imaging (FLIM)-FRET, to produce a spatial map in living cells of the sites for the interaction of two TREX subunits, Alyref and Chtop, with Nxf1. Prominent assembly sites for export factors are found in the vicinity of nuclear speckles in regions known to be involved in transcription, splicing and exon junction complex formation highlighting the close coupling of mRNA export with mRNP biogenesis.	[Teng, I-Fang; Wilson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Wilson, SA (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, 5th Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	stuart.wilson@sheffield.ac.uk		wilson, stuart/0000-0003-3073-258X	Biotechnology and Biological Sciences Research Council [BB/J015067/1]; BBSRC [BB/J015067/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant number: BB/J015067/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; Coyle JH, 2011, RNA, V17, P1344, DOI 10.1261/rna.2616111; Daguenet E, 2012, MOL BIOL CELL, V23, P1765, DOI 10.1091/mbc.E12-01-0040; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; van Dijk TB, 2010, MOL CELL BIOL, V30, P260, DOI 10.1128/MCB.00645-09; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	29	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67676	10.1371/journal.pone.0067676	http://dx.doi.org/10.1371/journal.pone.0067676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826332	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000321738400165
J	Farr, C; Nomellini, JF; Ailon, E; Shanina, I; Sangsari, S; Cavacini, LA; Smit, J; Horwitz, MS				Farr, Christina; Nomellini, John F.; Ailon, Evan; Shanina, Iryna; Sangsari, Sassan; Cavacini, Lisa A.; Smit, John; Horwitz, Marc S.			Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors	PLOS ONE			English	Article							S-LAYER PROTEIN; C-TERMINAL SECRETION; CYANOVIRIN-N; INACTIVATING PROTEIN; LACTOBACILLUS-JENSENII; SUBTYPE DISTRIBUTION; SURFACE-LAYER; FRESH-WATER; I SECRETION; FUSION	The HIV/AIDS pandemic remains an enormous global health concern. Despite effective prevention options, 2.6 million new infections occur annually, with women in developing countries accounting for more than half of these infections. New prevention strategies that can be used by women are urgently needed. Topical microbicides specific for HIV-1 represent a promising prevention strategy. Conceptually, using harmless bacteria to display peptides or proteins capable of blocking entry provides an inexpensive approach to microbicide development. To avoid the potential pitfalls of engineering commensal bacteria, our strategy is to genetically display infection inhibitors on a non-native bacterium and rely on topical application of stabilized bacteria before potential virus exposure. Due to the high density cell-surface display capabilities and the inherent low toxicity of the bacterium, the S-layer mediated protein display capabilities of the non-pathogenic bacterium Caulobacter crescentus has been exploited for this approach. We have demonstrated that C. crescentus displaying MIP1 alpha or CD4 interfered with the virus entry pathway and provided significant protection from HIV-1 pseudovirus representing clade B in a standard single cycle infection assay. Here we have expanded our C. crescentus based microbicide approach with additional and diverse classes of natural and synthetic inhibitors of the HIV-1 entry pathway. All display constructs provided variable but significant protection from HIV-1 infection; some with protection as high as 70%. Further, we describe protection from infection with additional viral clades. These findings indicate the significant potential for engineering C. crescentus to be an effective and readily adaptable HIV-1 microbicide platform.	[Farr, Christina; Nomellini, John F.; Ailon, Evan; Shanina, Iryna; Sangsari, Sassan; Smit, John; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Cavacini, Lisa A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of British Columbia; Harvard University; Beth Israel Deaconess Medical Center	Horwitz, MS (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@mail.ubc.ca	Farr, Christina/ABG-2688-2021		Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bhatnagar PK, 2006, CANCER BIOL THER, V5, P485, DOI 10.4161/cbt.5.5.2553; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; Bingle WH, 1997, MOL MICROBIOL, V26, P277, DOI 10.1046/j.1365-2958.1997.5711932.x; Bingle WH, 1997, J BACTERIOL, V179, P601, DOI 10.1128/jb.179.3.601-611.1997; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Duval M, 2011, ANTIMICROB AGENTS CH, V55, P5547, DOI 10.1128/AAC.00509-11; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; GILCHRIST A, 1991, J BACTERIOL, V173, P921, DOI 10.1128/jb.173.2.921-925.1991; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Greenberg ML, 2002, ANTIVIRAL THERAPY S1; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Lau JHY, 2010, CAN J MICROBIOL, V56, P501, DOI [10.1139/W10-036, 10.1139/w10-036]; Liu JJ, 2007, CELL MICROBIOL, V9, P120, DOI 10.1111/j.1462-5822.2006.00772.x; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; Maniatis G M, 1982, Prog Clin Biol Res, V102 pt A, P13; Mariner JM, 1998, BIOCHEM BIOPH RES CO, V248, P841, DOI 10.1006/bbrc.1998.9060; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Ndesendo VMK, 2008, AAPS PHARMSCITECH, V9, P505, DOI 10.1208/s12249-008-9073-5; Network MT, 2011, MTN STAT DEC DISC US; Nomellini JF, 1997, J BACTERIOL, V179, P6349, DOI 10.1128/jb.179.20.6349-6354.1997; Nomellini JF, 2007, APPL ENVIRON MICROB, V73, P3245, DOI 10.1128/AEM.02900-06; Nomellini JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010366; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; RAVENSCROFT N, 1991, J BACTERIOL, V173, P5677, DOI 10.1128/jb.173.18.5677-5684.1991; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shahzad-ul-Hussan S, 2011, J BIOL CHEM, V286, P20788, DOI 10.1074/jbc.M111.232678; SMIT J, 1984, J BACTERIOL, V160, P1137, DOI 10.1128/JB.160.3.1137-1145.1984; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Toporowski MC, 2004, J BACTERIOL, V186, P8000, DOI 10.1128/JB.186.23.8000-8009.2004; Turpin JA, 2011, DRUG DELIV TRANSL RE, V1, P194, DOI 10.1007/s13346-011-0034-2; UNAIDS, 2011, UNAIDS DAT TABL 2011; Vangelista L, 2010, ANTIMICROB AGENTS CH, V54, P2994, DOI 10.1128/AAC.01492-09; Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012; WALKER SG, 1992, J BACTERIOL, V174, P1783, DOI 10.1128/jb.174.6.1783-1792.1992; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051	48	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65965	10.1371/journal.pone.0065965	http://dx.doi.org/10.1371/journal.pone.0065965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840383	gold, Green Submitted, Green Published			2022-12-25	WOS:000322361200044
J	van Rijen, MML; Kluytmans-van den Bergh, MFQ; Verkade, EJM; ten Ham, PBG; Feingold, BJ; Kluytmans, JAJW				van Rijen, Miranda M. L.; Kluytmans-van den Bergh, Marjolein F. Q.; Verkade, Erwin J. M.; ten Ham, Peter B. G.; Feingold, Beth J.; Kluytmans, Jan A. J. W.		CAM Study Grp	Lifestyle-Associated Risk Factors for Community-Acquired Methicillin-Resistant Staphylococcus aureus Carriage in the Netherlands: An Exploratory Hospital-Based Case-Control Study	PLOS ONE			English	Article							INFECTIONS; PREVALENCE; EMERGENCE; PRODUCTS; MRSA	Background: Community-acquired MRSA (CA-MRSA) is rapidly increasing. Currently, it is unknown which reservoirs are involved. An exploratory hospital-based case-control study was performed in sixteen Dutch hospitals to identify risk factors for CA-MRSA carriage in patients not belonging to established risk groups. Methods: Cases were in-or outpatients from sixteen Dutch hospitals, colonised or infected with MRSA without healthcare-or livestock-associated risk factors for MRSA carriage. Control subjects were patients not carrying MRSA, and hospitalised on the same ward or visited the same outpatients' clinic as the case. The presence of potential risk factors for CA-MRSA carriage was determined using a standardised questionnaire. Results: Regular consumption of poultry (OR 2.40; 95% CI 1.08-5.33), cattle density per municipality (OR 1.30; 95% CI 1.00-1.70), and sharing of scuba diving equipment (OR 2.93 95% CI 1.19-7.21) were found to be independently associated with CA-MRSA carriage. CA-MRSA carriage was not related to being of foreign origin. Conclusions: The observed association between the consumption of poultry and CA-MRSA carriage suggests that MRSA in the food chain may be a source for MRSA carriage in humans. Although sharing of scuba diving equipment was found to be associated with CA-MRSA carriage, the role played by skin abrasions in divers, the lack of decontamination of diving materials, or the favourable high salt content of sea water is currently unclear. The risk for MRSA MC398 carriage in areas with a high cattle density may be due to environmental contamination with MRSA MC398 or human-to-human transmission. Further studies are warranted to confirm our findings and to determine the absolute risks of MRSA acquisition associated with the factors identified.	[van Rijen, Miranda M. L.; Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [ten Ham, Peter B. G.] Reg Hlth Author, Sect Infect Dis Control, Leiden, Netherlands; [Feingold, Beth J.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Johns Hopkins University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Rijen, MML (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	mvrijen@amphia.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Feingold, Beth/0000-0001-6670-5845	Netherlands Organisation for Health Research and Development (ZonMw) [125020007]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was funded by The Netherlands Organisation for Health Research and Development (ZonMw. grant number 125020007). ZonMw is a non-profit organisation working for the Ministry of Health, Welfare and Sport (VWS) and the Dutch Organisation for Scientific Research (NWO). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Bocher S, 2008, CLIN MICROBIOL INFEC, V14, P942, DOI 10.1111/j.1469-0691.2008.02055.x; Bochet M, 2008, J TRAVEL MED, V15, P378, DOI 10.1111/j.1708-8305.2008.00243.x; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Coronado F, 2007, EPIDEMIOL INFECT, V135, P492, DOI 10.1017/S0950268806006960; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Dutch Workingparty on Infection Prevention, 2007, MRSA HOSP; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Longtin Y, 2009, CLIN MICROBIOL INFEC, V15, P552, DOI 10.1111/j.1469-0691.2009.02715.x; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; Wang J, 2003, UNDERSEA HYPERBAR M, V30, P277; Wendlandt S, 2012, ANN REV FOOD SC 1126; Wulf MW, 2008, EURO SURVEILL, V13	29	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65594	10.1371/journal.pone.0065594	http://dx.doi.org/10.1371/journal.pone.0065594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840344	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200027
J	Gerrard, DT; Fricke, C; Edward, DA; Edwards, DR; Chapman, T				Gerrard, Dave T.; Fricke, Claudia; Edward, Dominic A.; Edwards, Dylan R.; Chapman, Tracey			Genome-Wide Responses of Female Fruit Flies Subjected to Divergent Mating Regimes	PLOS ONE			English	Article							OF-FUNCTION SCREEN; DROSOPHILA-MELANOGASTER; LIFE-SPAN; SEX-PEPTIDE; GENE-EXPRESSION; GERM-LINE; REPRODUCTION; COSTS; PROTEINS; MALES	Elevated rates of mating and reproduction cause decreased female survival and lifetime reproductive success across a wide range of taxa from flies to humans. These costs are fundamentally important to the evolution of life histories. Here we investigate the potential mechanistic basis of this classic life history component. We conducted 4 independent replicated experiments in which female Drosophila melanogaster were subjected to 'high' and 'low' mating regimes, resulting in highly significant differences in lifespan. We sampled females for transcriptomic analysis at day 10 of life, before the visible onset of ageing, and used Tiling expression arrays to detect differential gene expression in two body parts (abdomen versus head+thorax). The divergent mating regimes were associated with significant differential expression in a network of genes showing evidence for interactions with ecdysone receptor. Preliminary experimental manipulation of two genes in that network with roles in post-transcriptional modification (CG11486, eyegone) tended to enhance sensitivity to mating costs. However, the subtle nature of those effects suggests substantial functional redundancy or parallelism in this gene network, which could buffer females against excessive responses. There was also evidence for differential expression in genes involved in germline maintenance, cell proliferation and in gustation / odorant reception. Interestingly, we detected differential expression in three specific genes (EcR, keap1, lbk1) and one class of genes (gustation / odorant receptors) with previously reported roles in determining lifespan. Our results suggest that high and low mating regimes that lead to divergence in lifespan are associated with changes in the expression of genes such as reproductive hormones, that influence resource allocation to the germ line, and that may modify post-translational gene expression. This predicts that the correct signalling of nutrient levels to the reproductive system is important for maintaining organismal integrity.	[Gerrard, Dave T.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Gerrard, Dave T.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Gerrard, Dave T.; Fricke, Claudia; Edward, Dominic A.; Edwards, Dylan R.; Chapman, Tracey] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Fricke, Claudia] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Edward, Dominic A.] Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England	University of Manchester; University of Manchester; University of East Anglia; University of Munster; University of Liverpool	Chapman, T (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	tracey.chapman@uea.ac.uk	Edwards, Dylan R/B-4734-2009; Chapman, Tracey/E-5100-2011; Fricke, Claudia/M-6536-2014; Edward, Dominic/B-4074-2010	Edwards, Dylan R/0000-0002-3292-2064; Fricke, Claudia/0000-0002-0691-6779; Gerrard, Dave/0000-0001-6890-7213	BigC Local Cancer Care; Biotechnology and Biological Sciences Research Council [BB/H008047/1] Funding Source: researchfish; BBSRC [BB/H008047/1] Funding Source: UKRI	BigC Local Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the BigC Local Cancer Care to TC, DTG and DRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; BELL PD, 1986, COST REPROD, P83; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Carney GE, 2000, GENETICS, V154, P1203; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chapman T, 2006, CURR BIOL, V16, pR744, DOI 10.1016/j.cub.2006.08.020; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Crespi BJ, 2006, BIOL REV, V81, P407, DOI 10.1017/S1464793106007056; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Leroi AM, 2001, TRENDS ECOL EVOL, V16, P24, DOI 10.1016/S0169-5347(00)02032-2; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; NARBONNE P, 2006, CELL DIVISION, P29; Parker G.A., 1979, P123; Partridge L, 1987, FUNCT ECOL, V1, P317, DOI 10.2307/2389786; PARTRIDGE L, 1986, J INSECT PHYSIOL, V32, P925, DOI 10.1016/0022-1910(86)90140-X; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Romani P, 2009, GENETICS, V181, P165, DOI 10.1534/genetics.108.096008; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Schwedes CC, 2012, J INSECT PHYSIOL, V58, P293, DOI 10.1016/j.jinsphys.2012.01.013; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	90	5	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68136	10.1371/journal.pone.0068136	http://dx.doi.org/10.1371/journal.pone.0068136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826372	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000126
J	Liu, ZQ; Baker, PJ; Cheng, F; Xue, YP; Zheng, YG; Shen, YC				Liu, Zhi-Qiang; Baker, Peter James; Cheng, Feng; Xue, Ya-Ping; Zheng, Yu-Guo; Shen, Yin-Chu			Screening and Improving the Recombinant Nitrilases and Application in Biotransformation of Iminodiacetonitrile to Iminodiacetic Acid	PLOS ONE			English	Article							ESCHERICHIA-COLI; EPOXIDE HYDROLASE; HYDROLYSIS; GENE; EXPRESSION; CLONING; BIOCATALYSIS; GLYPHOSATE; VERSATILE; FAMILY	In this study, several nitrilase genes from phylogenetically distinct organisms were expressed and purified in E. coli in order to study their ability to mediate the biotransformation of nitriles. We identified three nitrilases: Acidovorax facilis nitrilase (AcN); Alcaligenes fecalis nitrilase (AkN); and Rhodococcus rhodochrous nitrilase (RkN), which catalyzed iminodiacetonitrile (IDAN) to iminodiacetic acid (IDA). AcN demonstrated 8.8-fold higher activity for IDAN degradation as compared to AkN and RkN. Based on homology modeling and previously described 'hot spot' mutations, several AcN mutants were screened for improved activity. One mutant M3 (F168V/L201N/S192F) was identified, which demonstrates a 41% enhancement in the conversion as well as a 2.4-fold higher catalytic efficiency towards IDAN as compared to wild-type AcN.	[Liu, Zhi-Qiang; Baker, Peter James; Cheng, Feng; Xue, Ya-Ping; Zheng, Yu-Guo; Shen, Yin-Chu] Zhejiang Univ Technol, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Zheng, YG (corresponding author), Zhejiang Univ Technol, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China.	zhengyg@zjut.edu.cn		Liu, Zhi-Qiang/0000-0003-3259-6796	National High Technology Research and Development Program of China (863 Program) [2011AA02A210]; Natural Science Foundation of Zhejiang Province [R3110155, Z4090612, Y4110409]; Qianjiang Talent Project of Zhejiang Province	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Qianjiang Talent Project of Zhejiang Province	This work was financially supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA02A210), Natural Science Foundation of Zhejiang Province (No. R3110155, Z4090612 and Y4110409) and Qianjiang Talent Project of Zhejiang Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee A, 2003, BIOTECHNOL APPL BIOC, V37, P289, DOI 10.1042/BA20020106; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan S, 2003, APPL MICROBIOL BIOT, V61, P118, DOI 10.1007/s00253-002-1192-4; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Duan PG, 2007, CHEM ENG TECHNOL, V30, P265, DOI 10.1002/ceat.200600298; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Gavagan JE, 1999, APPL MICROBIOL BIOT, V52, P654, DOI 10.1007/s002530051574; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Hann EC, 2003, ADV SYNTH CATAL, V345, P775, DOI 10.1002/adsc.200303007; Hiromoto T, 2006, J MOL BIOL, V364, P863, DOI 10.1016/j.jmb.2006.08.098; KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1016/0378-1097(94)90474-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin ZJ, 2009, AGROCHEMICALS, V48, P547; Liu ZQ, 2012, J MOL MICROB BIOTECH, V22, P35, DOI 10.1159/000337055; Liu ZQ, 2011, CATAL COMMUN, V16, P133, DOI 10.1016/j.catcom.2011.09.010; Liu ZQ, 2011, J AGR FOOD CHEM, V59, P11560, DOI 10.1021/jf202746a; Liu ZQ, 2011, BIOTECHNOL PROGR, V27, P698, DOI 10.1002/btpr.603; Liu ZQ, 2007, APPL MICROBIOL BIOT, V74, P99, DOI 10.1007/s00253-006-0635-8; Martinkova L, 2003, CURR ORG CHEM, V7, P1279, DOI 10.2174/1385272033486486; Martinkova L, 2010, CURR OPIN CHEM BIOL, V14, P130, DOI 10.1016/j.cbpa.2009.11.018; Martinkova L, 2009, BIOTECHNOL ADV, V27, P661, DOI 10.1016/j.biotechadv.2009.04.027; Nagasawa T, 2000, EUR J BIOCHEM, V267, P138, DOI 10.1046/j.1432-1327.2000.00983.x; Nestl BM, 2011, CURR OPIN CHEM BIOL, V15, P187, DOI 10.1016/j.cbpa.2010.11.019; Olson AJ, 1998, SAR QSAR ENVIRON RES, V8, P273, DOI 10.1080/10629369808039144; PACE CN, 1988, J BIOL CHEM, V263, P11820; Pace HC, 2001, GENOME BIOL, V2; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; Raczynska JE, 2011, J STRUCT BIOL, V173, P294, DOI 10.1016/j.jsb.2010.11.017; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sakai N, 2004, PROTEINS, V57, P869, DOI 10.1002/prot.20259; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thuku RN, 2009, J APPL MICROBIOL, V106, P703, DOI 10.1111/j.1365-2672.2008.03941.x; Vink Mandy K. S., 2006, Biotechnology Journal, V1, P569, DOI 10.1002/biot.200600028; Woodburn AT, 2000, PEST MANAG SCI, V56, P309, DOI 10.1002/(SICI)1526-4998(200004)56:4<309::AID-PS143>3.0.CO;2-C; Wu SJ, 2008, BIOTECHNOL BIOENG, V99, P717, DOI 10.1002/bit.21643; Wu SJ, 2007, BIOTECHNOL BIOENG, V97, P689, DOI 10.1002/bit.21289; YAMAMOTO K, 1991, APPL ENVIRON MICROB, V57, P3028, DOI 10.1128/AEM.57.10.3028-3032.1991; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Zhang JF, 2012, ENG LIFE SCI, V12, P69, DOI 10.1002/elsc.201100090; Zhu D, 2007, ADV SYNTH CATAL, V349, P1667, DOI 10.1002/adsc.200700067	46	22	24	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67197	10.1371/journal.pone.0067197	http://dx.doi.org/10.1371/journal.pone.0067197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826231	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000042
J	Cuypers, K; Leenus, DJF; den Berg, FE; Nitsche, MA; Thijs, H; Wenderoth, N; Meesen, RLJ				Cuypers, Koen; Leenus, Daphnie J. F.; van den Berg, Femke E.; Nitsche, Michael A.; Thijs, Herbert; Wenderoth, Nicole; Meesen, Raf L. J.			Is Motor Learning Mediated by tDCS Intensity?	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE CORTICAL STIMULATION; PARKINSONS-DISEASE; BRAIN POLARIZATION; CHRONIC STROKE; CORTEX; PLASTICITY; EXCITABILITY; CONSOLIDATION; IMPLICIT	Although tDCS has been shown to improve motor learning, previous studies reported rather small effects. Since physiological effects of tDCS depend on intensity, the present study evaluated this parameter in order to enhance the effect of tDCS on skill acquisition. The effect of different stimulation intensities of anodal tDCS (atDCS) was investigated in a double blind, sham controlled crossover design. In each condition, thirteen healthy subjects were instructed to perform a unimanual motor (sequence) learning task. Our results showed (1) a significant increase in the slope of the learning curve and (2) a significant improvement in motor performance at retention for 1.5 mA atDCS as compared to sham tDCS. No significant differences were reported between 1 mA atDCS and sham tDCS; and between 1.5 mA atDCS and 1 mA atDCS.	[Cuypers, Koen; Leenus, Daphnie J. F.; Meesen, Raf L. J.] Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; Leenus, Daphnie J. F.; Thijs, Herbert; Meesen, Raf L. J.] PHL Univ Coll, REVAL Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; van den Berg, Femke E.; Wenderoth, Nicole; Meesen, Raf L. J.] Katholieke Univ Leuven, Dept Biomed Kinesiol, Motor Control Lab, B-3001 Heverlee, Belgium; [Nitsche, Michael A.] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Thijs, Herbert] Hasselt Univ, I BioStat Interuniv Inst Biostat & Stat Bioinfir, Diepenbeek, Belgium; [Thijs, Herbert] Katholieke Univ Leuven, Louvain, Belgium; [Wenderoth, Nicole; Meesen, Raf L. J.] ETH, Neural Control Movement Lab, Dept Hlth Sci & Technol, Zurich, Switzerland	Hasselt University; KU Leuven; University of Gottingen; Hasselt University; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Meesen, RLJ (corresponding author), Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium.	raf.meesen@uhasselt.be	Nitsche, Michael A/B-6755-2012; Wenderoth, Nicole/D-7262-2015; Cuypers, Koen/N-9918-2018; Meesen, Raf L/F-2582-2019	Wenderoth, Nicole/0000-0002-3246-9386; Meesen, Raf L/0000-0002-7938-3758	Flanders Fund for Scientific Research [G075810]; Special Research Fund UHasselt	Flanders Fund for Scientific Research(FWO); Special Research Fund UHasselt	This work was supported by the Flanders Fund for Scientific Research [G075810]. Koen Cuypers is supported by the Special Research Fund UHasselt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-73; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; KARNI A, 1995, NATURE, V377, P155; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091; Teo Florence, 2011, Front Psychiatry, V2, P45, DOI 10.3389/fpsyt.2011.00045; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091	24	65	69	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67344	10.1371/journal.pone.0067344	http://dx.doi.org/10.1371/journal.pone.0067344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826272	Green Published, gold			2022-12-25	WOS:000321738400136
J	Gorman, S; Weeden, CE; Tan, DHW; Scott, NM; Hart, J; Foong, RE; Mok, D; Stephens, N; Zosky, G; Hart, PH				Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Hart, Julie; Foong, Rachel E.; Mok, Danny; Stephens, Nahiid; Zosky, Graeme; Hart, Prue H.			Reversible Control by Vitamin D of Granulocytes and Bacteria in the Lungs of Mice: An Ovalbumin-Induced Model of Allergic Airway Disease	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; ANTIMICROBIAL PEPTIDE; D SUPPLEMENTATION; CHILDHOOD ASTHMA; UV-RADIATION; HOST-DEFENSE; CHILDREN; PREGNANCY	Vitamin D may be essential for restricting the development and severity of allergic diseases and asthma, but a direct causal link between vitamin D deficiency and asthma has yet to be established. We have developed a 'low dose' model of allergic airway disease induced by intraperitoneal injection with ovalbumin (1 mu g) and aluminium hydroxide (0.2 mg) in which characteristics of atopic asthma are recapitulated, including airway hyperresponsiveness, antigen-specific immunoglobulin type-E and lung inflammation. We assessed the effects of vitamin D deficiency throughout life (from conception until adulthood) on the severity of ovalbumin-induced allergic airway disease in vitamin D-replete and -deficient BALB/c mice using this model. Vitamin D had protective effects such that deficiency significantly enhanced eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male but not female mice. Vitamin D also suppressed the proliferation and T helper cell type-2 cytokine-secreting capacity of airway-draining lymph node cells from both male and female mice. Supplementation of initially vitamin D-deficient mice with vitamin D for four weeks returned serum 25-hydroxyvitamin D to levels observed in initially vitamin D-replete mice, and also suppressed eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male mice. Using generic 16 S rRNA primers, increased bacterial levels were detected in the lungs of initially vitamin D-deficient male mice, which were also reduced by vitamin D supplementation. These results indicate that vitamin D controls granulocyte levels in the bronchoalveolar lavage fluid in an allergen-sensitive manner, and may contribute towards the severity of asthma in a gender-specific fashion through regulation of respiratory bacteria.	[Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Foong, Rachel E.; Mok, Danny; Zosky, Graeme; Hart, Prue H.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Foong, Rachel E.; Mok, Danny; Zosky, Graeme; Hart, Prue H.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hart, Julie] Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Microbiol, PathWest Lab Med WA, Nedlands, WA 6009, Australia; [Stephens, Nahiid] Murdoch Univ, Fac Hlth Sci, Sch Vet & Biol Sci, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Murdoch University	Gorman, S (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	shelleyg@ichr.uwa.edu.au	Gorman, Shelley/R-9953-2017; Scott, Naomi/R-9951-2017; Mok, Danny/A-5328-2011; Zosky, Graeme/B-2048-2014; Foong, Rachel/A-4678-2019	Gorman, Shelley/0000-0002-7111-6735; Weeden, Clare/0000-0002-1561-1416; Foong, Rachel/0000-0002-1201-6785; Hart, Prue/0000-0001-7207-6467; Mok, Danny/0000-0001-7425-6891; Zosky, Graeme/0000-0001-9039-0302	National Health and Medical Research Council of Australia [458612]; Cancer Council of Western Australia [1008985]; Asthma Foundation of Western Australia; Raine Medical Research Foundation; BrightSpark Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Asthma Foundation of Western Australia; Raine Medical Research Foundation; BrightSpark Foundation	This work was supported by the National Health and Medical Research Council of Australia (#458612, PHH, SG; http://www.nhmrc.gov.au), the Cancer Council of Western Australia (#1008985, PHH, SG; http://www.cancerwa.asn.au), the Asthma Foundation of Western Australia (SG, PHH; www.asthmawa.org.au), the Raine Medical Research Foundation (SG, PHH; http://www.raine.uwa.edu.au) and the BrightSpark Foundation (SG; http://www.brightsparkfoundation.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2012, EXP MOL PATHOL, V93, P74, DOI 10.1016/j.yexmp.2012.04.004; Akuthota P, 2013, AM J RESP CELL MOL, V48, P758, DOI 10.1165/rcmb.2012-0499OC; Amundsen EK, 2012, AM J CLIN PATHOL, V137, P86, DOI 10.1309/AJCP19BFTHYTMORO; Antunes MA, 2010, J APPL PHYSIOL, V109, P855, DOI 10.1152/japplphysiol.00333.2010; Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Brar T, 2012, CURR OPIN PULM MED, V18, P14, DOI 10.1097/MCP.0b013e32834dccc0; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Calvo C, 2007, PEDIATR INFECT DIS J, V26, P904, DOI 10.1097/INF.0b013e31812e52e6; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chinellato I, 2011, EUR RESPIR J, V37, P1366, DOI 10.1183/09031936.00044710; Chinellato I, 2011, J PEDIATR-US, V158, P437, DOI 10.1016/j.jpeds.2010.08.043; Ciaccio CE, 2010, CURR ALLERGY ASTHM R, V10, P387, DOI 10.1007/s11882-010-0144-9; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; Devereux G, 2010, ALLERGY, V65, P666, DOI 10.1111/j.1398-9995.2009.02220.x; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Erkkola M, 2009, CLIN EXP ALLERGY, V39, P875, DOI 10.1111/j.1365-2222.2009.03234.x; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Gorman Shelley, 2012, Photochem Photobiol Sci, V11, P1788, DOI 10.1039/c2pp25108f; Gorman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046006; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Gorman S, 2010, J INVEST DERMATOL, V130, P2368, DOI 10.1038/jid.2010.167; Gorman S, 2010, IMMUNOLOGY, V130, P181, DOI 10.1111/j.1365-2567.2009.03222.x; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Keet CA, 2011, J ALLERGY CLIN IMMUN, V128, P414, DOI 10.1016/j.jaci.2011.06.011; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Ma J, 2010, INFECT IMMUN, V78, P830, DOI 10.1128/IAI.00914-09; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Scott NM, 2011, PHOTOCH PHOTOBIO SCI, V10, P1894, DOI 10.1039/c1pp05206c; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Van Overtvelt L, 2008, INT ARCH ALLERGY IMM, V145, P152, DOI 10.1159/000108140; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wang P, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-7; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Wjst Matthias, 2009, Allergy Asthma Clin Immunol, V5, P8, DOI 10.1186/1710-1492-5-8; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	72	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67823	10.1371/journal.pone.0067823	http://dx.doi.org/10.1371/journal.pone.0067823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826346	Green Published, gold			2022-12-25	WOS:000321738400172
J	Huang, CJ; Yang, SH; Lee, CL; Cheng, YC; Tai, SY; Chien, CC				Huang, Chi-Jung; Yang, Shung-Haur; Lee, Chia-Long; Cheng, Yu-Che; Tai, Szu-Yun; Chien, Chih-Cheng			Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting Prognoses	PLOS ONE			English	Article							DNA-REPAIR; STAGE-II; P53; REPLICATION; TRANSLATION; ACTIVATION; EXPRESSION; RESISTANCE; MUTATIONS; SURVIVAL	Background: The development and progression of colorectal cancer (CRC) involve a complex process of multiple genetic changes. Tumor suppressor p53 is capable of determining the fate of CRC cells. However, the role of a p53-inducible modulator, ribosomal protein S27-like (RPS27L), in CRC is unknown. Methods: Here, the differential expression of RPS27L was examined in the feces and colonic tissues of CRC patients, to explore its possible correlation with patient survival and to investigate the cellular mechanisms underlying their clinical outcomes. Eighty intermediate-stage CRC patients (42 at stage II and 38 at stage III) were divided into two groups according to their fecal RPS27L mRNA levels. The survival probabilities of the groups were estimated using the Kaplan-Meier method. The RPS27L protein in the colonic tissues of stage III patients with different prognoses was further examined immunohistochemically. RPS27L expression in LoVo cells was manipulated to examine the possible cellular responses in vitro. Results: Elevated RPS27L expression, in either feces or tissues, was related to a better prognosis. In vitro, RPS27L-expressing LoVo cells ceased DNA synthesis and apoptotic activity while the expression of their DNA repair molecules was upregulated. Conclusions: Elevated RPS27L may improve the prognoses of certain CRC patients by enhancing the DNA repair capacity of their colonic cells, and can be determined in feces. By integrating clinical, molecular, and cellular data, our study demonstrates that fecal RPS27L may be a useful index for predicting prognoses and guiding personalized therapeutic strategies, especially in patients with intermediate-stage CRC.	[Huang, Chi-Jung; Cheng, Yu-Che; Tai, Szu-Yun; Chien, Chih-Cheng] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Huang, Chi-Jung; Chien, Chih-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Chi-Jung] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lee, Chia-Long] Hsinchu Cathay Gen Hosp, Dept Internal Med, Hsinchu, Taiwan; [Lee, Chia-Long] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chien, Chih-Cheng] Sijhih Cathay Gen Hosp, Dept Anesthesiol, New Taipei, Taiwan	Cathay General Hospital; Fu Jen Catholic University; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Cathay General Hospital; Taipei Medical University; Cathay General Hospital	Chien, CC (corresponding author), Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan.	chiencmail@yahoo.com.tw		Cheng, Yu-Che/0000-0002-5346-3610; Chien, Chih-Cheng/0000-0002-8368-2005	National Science Council [NSC96-2320-B-281-001-MY3, NSC100-2320-B-281-001]; Cathay General Hospital [CGH-MR-9919]; National Research Program for Genomic Medicine Grants of NSC [NSC 97-3112-B-001-016]	National Science Council(Ministry of Science and Technology, Taiwan); Cathay General Hospital; National Research Program for Genomic Medicine Grants of NSC	This work was supported by NSC96-2320-B-281-001-MY3 and NSC100-2320-B-281-001 from the National Science Council, and CGH-MR-9919 from Cathay General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs. Jen-Kou Lin and Shih-Ching Chang (both from Department of Surgery, Taipei-Veterans General Hospital) who informed us the clinical data of some patients and Dr. Yih-Yiing Wu for his superior support in pathology. We also thank National RNAi Core Facility at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica to provide RNAi reagents which were supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016).	BAKER SJ, 1990, CANCER RES, V50, P7717; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Chen D, 2008, J BIOL CHEM, V283, P15381, DOI 10.1074/jbc.M710296200; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; Chien CC, 2007, TRANSL RES, V149, P96, DOI 10.1016/j.trsl.2006.09.006; Chun Patrick, 2009, Gastrointest Cancer Res, V3, P191; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; Fernandez-Pol JA, 2011, CANCER GENOM PROTEOM, V8, P105; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Hansen LT, 2003, INT J CANCER, V105, P472, DOI 10.1002/ijc.11106; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Huang CJ, 2008, J CELL MOL MED, V12, P1936, DOI 10.1111/j.1582-4934.2008.00253.x; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jass Jeremy R., 2006, Critical Reviews in Oncogenesis, V12, P273; Kapoor NR, 2013, FEBS LETT, V587, P1287, DOI 10.1016/j.febslet.2013.03.004; Katoh H, 2008, ANTICANCER RES, V28, P1933; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosmider S, 2007, WORLD J GASTROENTERO, V13, P3799; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Rousseau B, 2010, CANCER J, V16, P202, DOI 10.1097/PPO.0b013e3181ddc5bf; Svobodova S, 2011, ANTICANCER RES, V31, P373; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Tell G, 2010, CELL MOL LIFE SCI, V67, P3569, DOI 10.1007/s00018-010-0484-6; Thomas EA, 2000, J NEUROCHEM, V74, P2259, DOI 10.1046/j.1471-4159.2000.0742259.x; Tien LT, 2010, FU JEN J MED, V8, P11; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yang SH, 2004, J SURG ONCOL, V87, P167, DOI 10.1002/jso.20109; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	37	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67043	10.1371/journal.pone.0067043	http://dx.doi.org/10.1371/journal.pone.0067043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826192	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400097
J	Keane, C; O'Shea, D; Reiberger, T; Peck-Radosavljevic, M; Farrell, G; Bergin, C; Gardiner, CM				Keane, Ciara; O'Shea, Daire; Reiberger, Thomas; Peck-Radosavljevic, Markus; Farrell, Gillian; Bergin, Colm; Gardiner, Clair M.			Variation in Both IL28B and KIR2DS3 Genes Influence Pegylated Interferon and Ribavirin Hepatitis C Treatment Outcome in HIV-1 Co-Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; NATURAL-KILLER-CELLS; GENOTYPE 1 INFECTION; VIRUS-INFECTION; PLUS RIBAVIRIN; PREDICTION; POLYMORPHISM; INDIVIDUALS; ASSOCIATION; BOCEPREVIR	Pegylated-IFN and ribavirin remains the current treatment for chronic HCV infection in patients co-infected with HIV-1, but this regimen has low efficacy rates, particularly for HCV genotype 1/4 infection, has severe side effects and is extremely costly. Therefore, accurate prediction of treatment response is urgently required. We have recently shown that the NK cell gene, KIR2DS3 and a SNP associated with the IL28B gene synergise to increase the risk of chronic infection in primary HCV mono-infected patients. Identification of SNPs associated with the IL28B gene has also proven very powerful for predicting patient response to treatment. Patients co-infected with HIV-1 are of particular concern given they respond less well to HCV treatment, have more side effects and suffer a more rapid liver disease progression. In this study, we examined both IL28B and KIR2DS3 for their ability to predict treatment response in a cohort of HIV-1/HCV co-infected patients attending two treatment centres in Europe. We found that variation in both host genetic risk factors, IL28B and KIR2DS3, was strongly associated with sustained virological response (SVR) to treatment in our co-infected cohort (n = 149). The majority of patients who achieved a rapid virological response (RVR) achieved a SVR. However, it is currently impossible to predict treatment outcome in patients who fail to achieve an RVR. In our cohort, the presence of host genetic risk factors, IL28B-T and KIR2DS3 alleles, resulted in increased odds of treatment failure in these RVR negative patients (n = 88). Our data suggests that testing for host genetic factors will improve predicting treatment responsiveness in the clinical management of co-infected patients, and provides further evidence of the importance of the innate immune system in the immune response to HCV.	[Keane, Ciara; Gardiner, Clair M.] Trinity Coll Dublin, Sch Biochem & Immunol, Nat Killer Cell Grp, Dublin, Ireland; [O'Shea, Daire; Farrell, Gillian; Bergin, Colm] St James Hosp, Dept GU Med & Infect Dis, Dublin, Ireland; [Reiberger, Thomas; Peck-Radosavljevic, Markus] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria	Trinity College Dublin; Trinity College Dublin; Medical University of Vienna	Gardiner, CM (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Nat Killer Cell Grp, Dublin, Ireland.	clair.gardiner@tcd.ie	Reiberger, Thomas/H-7613-2019; Peck-Radosavljevic, Markus/J-6353-2013	Reiberger, Thomas/0000-0002-4590-3583; Peck-Radosavljevic, Markus/0000-0002-0597-2728; Gardiner, Clair/0000-0001-5643-9432	Irish Health Research Board [HRA_POR/2011/19]; Irish Haemophilia Society	Irish Health Research Board; Irish Haemophilia Society	Funding for this project came from the Irish Health Research Board (HRA_POR/2011/19; www.hrb.ie) and the Irish Haemophilia Society (www.haemophilia.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Asselah T, 2010, J HEPATOL, V52, P452, DOI 10.1016/j.jhep.2009.11.016; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Guinan KJ, 2010, GENES IMMUN, V11, P467, DOI 10.1038/gene.2010.9; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Payer BA, 2012, EUR J CLIN INVEST, V42, P599, DOI 10.1111/j.1365-2362.2011.02623.x; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Shea DO, 2008, J VIRAL HEPATITIS, V15, P482, DOI 10.1111/j.1365-2893.2008.00969.x; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2012, CLIN INFECT DIS, V54, P979, DOI 10.1093/cid/cir882; VandenBussche CJ, 2009, GENES IMMUN, V10, P162, DOI 10.1038/gene.2008.91; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Vogel M, 2012, CLIN INFECT DIS, V54, P556, DOI 10.1093/cid/cir854; Wapner J, 2010, SCIENCE, V330, P579, DOI 10.1126/science.330.6004.579	25	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66831	10.1371/journal.pone.0066831	http://dx.doi.org/10.1371/journal.pone.0066831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826153	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400064
J	Mazumder, N; Lyn, RK; Singaravelu, R; Ridsdale, A; Moffatt, DJ; Hu, CW; Tsai, HR; McLauchlan, J; Stolow, A; Kao, FJ; Pezacki, JP				Mazumder, Nirmal; Lyn, Rodney K.; Singaravelu, Ragunath; Ridsdale, Andrew; Moffatt, Douglas J.; Hu, Chih-Wei; Tsai, Han-Ruei; McLauchlan, John; Stolow, Albert; Kao, Fu-Jen; Pezacki, John Paul			Fluorescence Lifetime Imaging of Alterations to Cellular Metabolism by Domain 2 of the Hepatitis C Virus Core Protein	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID SYNTHASE; LIPID DROPLETS; VIRAL-HEPATITIS; MULTIPHOTON MICROSCOPY; OXIDATIVE STRESS; GENOTYPE-3A CORE; CARS MICROSCOPY; INFECTION; NADH	Hepatitis C virus (HCV) co-opts hepatic lipid pathways to facilitate its pathogenesis. The virus alters cellular lipid biosynthesis and trafficking, and causes an accumulation of lipid droplets (LDs) that gives rise to hepatic steatosis. Little is known about how these changes are controlled at the molecular level, and how they are related to the underlying metabolic states of the infected cell. The HCV core protein has previously been shown to independently induce alterations in hepatic lipid homeostasis. Herein, we demonstrate, using coherent anti-Stokes Raman scattering (CARS) microscopy, that expression of domain 2 of the HCV core protein (D2) fused to GFP is sufficient to induce an accumulation of larger lipid droplets (LDs) in the perinuclear region. Additionally, we performed fluorescence lifetime imaging of endogenous reduced nicotinamide adenine dinucleotides [NAD(P)H], a key coenzyme in cellular metabolic processes, to monitor changes in the cofactor's abundance and conformational state in D2-GFP transfected cells. When expressed in Huh-7 human hepatoma cells, we observed that the D2-GFP induced accumulation of LDs correlated with an increase in total NAD(P)H fluorescence and an increase in the ratio of free to bound NAD(P)H. This is consistent with an approximate 10 fold increase in cellular NAD(P)H levels. Furthermore, the lifetimes of bound and free NAD(P)H were both significantly reduced - indicating viral protein-induced alterations in the cofactors' binding and microenvironment. Interestingly, the D2-expressing cells showed a more diffuse localization of NAD(P)H fluorescence signal, consistent with an accumulation of the co-factor outside the mitochondria. These observations suggest that HCV causes a shift of metabolic control away from the use of the coenzyme in mitochondrial electron transport and towards glycolysis, lipid biosynthesis, and building of new biomass. Overall, our findings demonstrate that HCV induced alterations in hepatic metabolism is tightly linked to alterations in NAD(P)H functional states.	[Mazumder, Nirmal; Hu, Chih-Wei; Tsai, Han-Ruei; Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Lyn, Rodney K.; Singaravelu, Ragunath; Ridsdale, Andrew; Moffatt, Douglas J.; Stolow, Albert; Pezacki, John Paul] Natl Res Council Canada, Ottawa, ON, Canada; [Lyn, Rodney K.; Pezacki, John Paul] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Singaravelu, Ragunath; Pezacki, John Paul] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [McLauchlan, John] Univ Glasgow, Med Res Council, Ctr Virus Res, Glasgow, Lanark, Scotland; [Stolow, Albert] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada	National Yang Ming Chiao Tung University; National Research Council Canada; University of Ottawa; University of Ottawa; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; Queens University - Canada	Kao, FJ (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	fjkao@ym.edu.tw; John.Pezacki@nrc.ca	Mazumder, Nirmal/AAF-5047-2020; Kao, Fu-Jen/GYQ-6902-2022; Stolow, Albert/AAN-5609-2020; Mazumder, Nirmal/B-3913-2010; Kao, Fu-Jen/C-8269-2012	Mazumder, Nirmal/0000-0001-8068-6484; Singaravelu, Ragunath/0000-0002-2692-3650; Kao, Fu-Jen/0000-0001-8361-3942	joint NRC-NSC-ITRI Canada-Taiwan Cooperation project; Taiwan National Science Council; National Research Council of Canada; Ontario Graduate Scholarship; NSERC, in the form of a Vanier Canadian Graduate Scholarship; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC); MRC [MC_U130184143, MC_UU_12014/1] Funding Source: UKRI; Medical Research Council [MC_U130184143, MC_UU_12014/1] Funding Source: researchfish	joint NRC-NSC-ITRI Canada-Taiwan Cooperation project; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Research Council of Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC, in the form of a Vanier Canadian Graduate Scholarship; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC)(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by a joint NRC-NSC-ITRI Canada-Taiwan Cooperation project supported by the Taiwan National Science Council and the National Research Council of Canada. RKL received funding from the Ontario Graduate Scholarship. RS received funding from NSERC, in the form of a Vanier Canadian Graduate Scholarship, and the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Assis DN, 2012, CLIN PHARMACOL THER, V92, P294, DOI 10.1038/clpt.2012.103; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Buryakina TY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101503; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P7591, DOI 10.3748/wjg.v11.i48.7591; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; De Giorgi V, 2009, J EUR ACAD DERMATOL, V23, P314, DOI 10.1111/j.1468-3083.2008.03045.x; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan ZY, 1999, J MED VIROL, V59, P131, DOI 10.1002/(SICI)1096-9071(199910)59:2<131::AID-JMV1>3.3.CO;2-3; Ghukasyan VV, 2009, J PHYS CHEM C, V113, P11532, DOI 10.1021/jp810931u; Guo HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2990752; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jackel-Cram C, 2010, J GEN VIROL, V91, P1388, DOI 10.1099/vir.0.017418-0; Jiang LN, 2012, BIOTECHNOL LETT, V34, P2205, DOI 10.1007/s10529-012-1034-0; Kennedy DC, 2011, J AM CHEM SOC, V133, P17993, DOI 10.1021/ja2083027; Kennedy DC, 2009, J AM CHEM SOC, V131, P2444, DOI 10.1021/ja809451w; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li D, 2008, OPT LETT, V33, P2365, DOI 10.1364/OL.33.002365; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Moriya K, 2009, AM J PATHOL, V175, P1515, DOI 10.2353/ajpath.2009.090102; Nan XL, 2006, CHEMBIOCHEM, V7, P1895, DOI 10.1002/cbic.200600330; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Ogikubo S, 2011, J PHYS CHEM B, V115, P10385, DOI 10.1021/jp2058904; Pegoraro AF, 2009, OPT EXPRESS, V17, P20700, DOI 10.1364/OE.17.020700; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Piccoli C, 2009, BBA-BIOENERGETICS, V1787, P539, DOI 10.1016/j.bbabio.2008.11.008; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimoike T, 1999, J VIROL, V73, P9718, DOI 10.1128/JVI.73.12.9718-9725.1999; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Squirrell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043708; Szaszak M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002108; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Yang MS, 2008, TOXICOLOGY, V247, P6, DOI 10.1016/j.tox.2008.01.021	72	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66738	10.1371/journal.pone.0066738	http://dx.doi.org/10.1371/journal.pone.0066738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826122	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000321738400042
J	Riccitelli, E; Giussani, P; Di Vito, C; Condomitti, G; Tringali, C; Caroli, M; Galli, R; Viani, P; Riboni, L				Riccitelli, Elena; Giussani, Paola; Di Vito, Clara; Condomitti, Giuseppe; Tringali, Cristina; Caroli, Manuela; Galli, Rossella; Viani, Paola; Riboni, Laura			Extracellular Sphingosine-1-Phosphate: A Novel Actor in Human Glioblastoma Stem Cell Survival	PLOS ONE			English	Article							SPHINGOSINE KINASE-1 EXPRESSION; GLIOMA-CELLS; MALIGNANT GLIOMAS; GENE-EXPRESSION; 1-PHOSPHATE; TEMOZOLOMIDE; APOPTOSIS; GROWTH; PROLIFERATION; POPULATION	Glioblastomas are the most frequent and aggressive intracranial neoplasms in humans, and despite advances and the introduction of the alkylating agent temozolomide in therapy have improved patient survival, resistance mechanisms limit benefits. Recent studies support that glioblastoma stem-like cells (GSCs), a cell subpopulation within the tumour, are involved in the aberrant expansion and therapy resistance properties of glioblastomas, through still unclear mechanisms. Emerging evidence suggests that sphingosine-1-phosphate (S1P) a potent onco-promoter able to act as extracellular signal, favours malignant and chemoresistance properties in GSCs. Notwithstanding, the origin of S1P in the GSC environment remains unknown. We investigated S1P metabolism, release, and role in cell survival properties of GSCs isolated from either U87-MG cell line or a primary culture of human glioblastoma. We show that both GSC models, grown as neurospheres and expressing GSC markers, are resistant to temozolomide, despite not expressing the DNA repair protein MGMT, a major contributor to temozolomide-resistance. Pulse experiments with labelled sphingosine revealed that both GSC types are able to rapidly phosphorylate the long-chain base, and that the newly produced S1P is efficiently degraded. Of relevance, we found that S1P was present in GSC extracellular medium, its level being significantly higher than in U87-MG cells, and that the extracellular/intracellular ratio of S1P was about ten-fold higher in GSCs. The activity of sphingosine kinases was undetectable in GSC media, suggesting that mechanisms of S1P transport to the extracellular environment are constitutive in GSCs. In addition we found that an inhibitor of S1P biosynthesis made GSCs sensitive to temozolomide (TMZ), and that exogenous S1P reverted this effect, thus involving extracellular S1P as a GSC survival signal in TMZ resistance. Altogether our data implicate for the first time GSCs as a pivotal source of extracellular S1P, which might act as an autocrine/paracrine signal contributing to their malignant properties.	[Riccitelli, Elena; Giussani, Paola; Di Vito, Clara; Condomitti, Giuseppe; Tringali, Cristina; Viani, Paola; Riboni, Laura] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Caroli, Manuela] Maggiore Policlin Hosp, IRCCS Ca Granda Fdn, Milan, Italy; [Galli, Rossella] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, Neural Stem Cell Biol Unit, I-20132 Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Riboni, L (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	laura.riboni@unimi.it	Caroli, Manuela/AAB-9019-2019; Galli, Rossella/AAI-8028-2020; VIANI, PAOLA/Q-5955-2017; Di Vito, Clara/ABC-3385-2020; Tringali, Cristina Alessandra/Q-7259-2017; Giussani, Paola/R-4268-2017; Riboni, Laura/R-4281-2017	Galli, Rossella/0000-0001-9023-7033; VIANI, PAOLA/0000-0002-5728-6631; Di Vito, Clara/0000-0001-7248-1710; Tringali, Cristina Alessandra/0000-0002-0632-6197; Giussani, Paola/0000-0002-7793-1757; Riboni, Laura/0000-0002-4149-8226; Condomitti, Giuseppe/0000-0003-1374-1038	University of Milan [PUR2009]; Italian Ministry of University and Scientific and Technological Research PRIN [2008PH4SMA]	University of Milan; Italian Ministry of University and Scientific and Technological Research PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the University of Milan PUR2009 and from the Italian Ministry of University and Scientific and Technological Research PRIN prot. 2008PH4SMA to L.R. and P.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaner C, 2008, NEOPLASMA, V55, P369; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Annabi B, 2009, MOL CARCINOGEN, V48, P910, DOI 10.1002/mc.20541; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bektas M, 2009, CANCER CHEMOTH PHARM, V64, P1053, DOI 10.1007/s00280-009-1063-0; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Dell'Albani P, 2008, NEUROCHEM RES, V33, P2407, DOI 10.1007/s11064-008-9723-8; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Estrada-Bernal A, 2012, NEURO-ONCOLOGY, V14, P405, DOI 10.1093/neuonc/nos005; Fu J, 2009, CHINESE MED J-PEKING, V122, P1255, DOI 10.3760/cma.j.issn.0366-6999.2009.11.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giussani P, 2012, CANCER INVEST, V30, P27, DOI 10.3109/07357907.2011.629379; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kim K, 2007, J PHARM PHARMACOL, V59, P1035, DOI 10.1211/jpp.59.7.0017; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mora R, 2010, GLIA, V58, P1364, DOI 10.1002/glia.21013; Mutter N, 2006, EXPERT REV ANTICANC, V6, P1187, DOI 10.1586/14737140.6.8.1187; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Piccirillo SGM, 2009, J MOL MED, V87, P1087, DOI 10.1007/s00109-009-0535-3; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang H, 2012, CELL PROLIFERAT, V45, P167, DOI 10.1111/j.1365-2184.2012.00807.x; Zhang MY, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-85	60	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68229	10.1371/journal.pone.0068229	http://dx.doi.org/10.1371/journal.pone.0068229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826381	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400175
J	Sengupta, A; Ghosh, S; Sharma, S; Sonawat, HM				Sengupta, Arjun; Ghosh, Soumita; Sharma, Shobhona; Sonawat, Haripalsingh M.			H-1 NMR Metabonomics Indicates Continued Metabolic Changes and Sexual Dimorphism Post-Parasite Clearance in Self-Limiting Murine Malaria Model	PLOS ONE			English	Article							PLASMODIUM-CHABAUDI; ACETYLCHOLINE; INFECTION; BRAIN; SERUM; SPECTROSCOPY; MECHANISMS; MYOCLONUS; PLASMA; URINE	Malaria, a mosquito-borne disease caused by Plasmodium spp. is considered to be a global threat, specifically for the developing countries. In human subjects considerable information exists regarding post-malarial physiology. However, most murine malarial models are lethal, and most studies deal with acute phases occurring as disease progresses. Much less is known regarding physiological status post-parasite clearance. We have assessed the physiological changes at the organ levels using H-1 NMR based metabonomics in a non lethal self-clearing murine malarial model of P. chabaudi parasites and Balb/C, far beyond the parasite clearance point. The results showed distinct metabolic states between uninfected and infected mice at the peak parasitemia, as well as three weeks post-parasite clearance. Our data also suggests that the response at the peak infection as well as recovery exhibited distinct sexual dimorphism. Specifically, we observed accumulation of acetylcholine in the brain metabolic profile of both the sexes. This might have important implication in understanding the pathophysiology of the post malarial neurological syndromes. In addition, the female liver showed high levels of glucose, dimethylglycine, methylacetoacetate and histidine after three weeks post-parasite clearance, while the males showed accumulation of branched chain amino acids, lysine, glutamine and bile acids.	[Sengupta, Arjun; Ghosh, Soumita; Sonawat, Haripalsingh M.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in; hms@tifr.res.in	Sengupta, Arjun/AAS-8787-2021; Sengupta, Arjun/R-5802-2019	Sengupta, Arjun/0000-0003-2210-1876; 	Tata Institute of Fundamental Research	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	Sources of funding: In-house funding of Tata Institute of Fundamental Research. url: www.tifr.res.in The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basant A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-110; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Chakravarty A, 2004, NEUROL INDIA, V52, P130; COX B, 1969, BRIT J PHARMACOL, V35, P295, DOI 10.1111/j.1476-5381.1969.tb07988.x; COX J, 1987, PARASITE IMMUNOL, V9, P543, DOI 10.1111/j.1365-3024.1987.tb00529.x; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; de Silva H J, 1986, Ceylon Med J, V31, P147; Doherty CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002133; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Ghosh S, 2012, J PROTEOME RES, V11, P4992, DOI 10.1021/pr300562m; Ghosh S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-330; GILKS CF, 1990, PARASITE IMMUNOL, V12, P45, DOI 10.1111/j.1365-3024.1990.tb00935.x; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Joosen MJA, 2007, EUR J PHARMACOL, V555, P122, DOI 10.1016/j.ejphar.2006.10.006; LALLEMENT G, 1992, NEUROTOXICOLOGY, V13, P557; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Marsala SZ, 2006, NEUROL SCI, V27, P442, DOI 10.1007/s10072-006-0728-2; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; NILSSONEHLE I, 1990, J INTERN MED, V227, P151, DOI 10.1111/j.1365-2796.1990.tb00136.x; Planche T, 2006, CURR MOL MED, V6, P141, DOI 10.2174/156652406776055177; Prendki V, 2008, AM J TROP MED HYG, V78, P699, DOI 10.4269/ajtmh.2008.78.699; Schnorf H, 1998, ARCH NEUROL-CHICAGO, V55, P417, DOI 10.1001/archneur.55.3.417; Sengupta A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-384; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Shih TM, 1997, J APPL TOXICOL, V17, P255, DOI 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.3.CO;2-4; SLATER P, 1982, NEUROSCI LETT, V28, P253, DOI 10.1016/0304-3940(82)90066-0; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Sonawat HM, 2012, CLIN LAB MED, V32, P129, DOI 10.1016/j.cll.2012.04.005; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Wang YL, 2004, P NATL ACAD SCI USA, V101, P12676, DOI 10.1073/pnas.0404878101; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Zimmerman G, 2008, EUR J NEUROSCI, V27, P965, DOI 10.1111/j.1460-9568.2008.06070.x	40	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66954	10.1371/journal.pone.0066954	http://dx.doi.org/10.1371/journal.pone.0066954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826178	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400087
J	White, RL; Nash, G; Kavanagh, DPJ; Savage, COS; Kalia, N				White, Rebecca L.; Nash, Gerard; Kavanagh, Dean P. J.; Savage, Caroline O. S.; Kalia, Neena			Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney	PLOS ONE			English	Article							BONE-MARROW; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; STEM/PROGENITOR CELLS; REPERFUSION INJURY; ENDOTHELIAL-CELLS; CD34(+) CELLS; CD44; EXPRESSION; SDF-1	Introduction: Renal disease affects over 500 million people worldwide and is set to increase as treatment options are predominately supportive. Evidence suggests that exogenous haematopoietic stem cells (HSCs) can be of benefit but due to the rarity and poor homing of these cells, benefits are either minor or transitory. Mechanisms governing HSC recruitment to injured renal microcirculation are poorly understood; therefore this study determined (i) the adhesion molecules responsible for HSC recruitment to the injured kidney, (ii) if cytokine HSC pre-treatment can enhance their homing and (iii) the molecular mechanisms accountable for any enhancement. Methods: Adherent and free-flowing HSCs were determined in an intravital murine model of renal ischaemia-reperfusion injury. Some HSCs and animals were pre-treated prior to HSC infusion with function blocking antibodies, hyaluronidase or cytokines. Changes in surface expression and clustering of HSC adhesion molecules were determined using flow cytometry and confocal microscopy. HSC adhesion to endothelial counter-ligands (VCAM-1, hyaluronan) was determined using static adhesion assays in vitro. Results: CD49d, CD44, VCAM-1 and hyaluronan governed HSC adhesion to the IR-injured kidney. Both KC and SDF-1 alpha pretreatment strategies significantly increased HSC adhesion within injured kidney, whilst SDF-1 alpha also increased numbers continuing to circulate. SDF-1 alpha and KC did not increase CD49d or CD44 expression but increased HSC adhesion to VCAM-1 and hyaluronan respectively. SDF-1 alpha increased CD49d surface clustering, as well as HSC deformability. Conclusion: Increasing HSC adhesive capacity for its endothelial counter-ligands, potentially through surface clustering, may explain their enhanced renal retention in vivo. Furthermore, increasing HSC deformability through SDF-1 alpha treatment could explain the prolonged systemic circulation; the HSC can therefore continue to survey the damaged tissue instead of becoming entrapped within non-injured sites. Therefore manipulating these mechanisms of HSC recruitment outlined may improve the clinical outcome of cellular therapies for kidney disease.	[White, Rebecca L.; Nash, Gerard; Kavanagh, Dean P. J.; Kalia, Neena] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Savage, Caroline O. S.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Kalia, N (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	n.kalia@bham.ac.uk	Nash, Gerard B/E-4182-2010	Nash, Gerard B/0000-0002-5935-2831; KALIA, NEENA/0000-0003-2960-7829	Medical Research Council [G0900175-3/1]; British Heart Foundation [PG/08/043/25067]; British Heart Foundation [PG/11/114/29282] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by the Medical Research Council (RLW, NK): G0900175-3/1; British Heart Foundation (DK, NK): PG/08/043/25067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Agrawal M, 2000, AM FAM PHYSICIAN, V61, P2077; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Alexandre CS, 2009, STEM CELLS, V27, P682, DOI 10.1634/stemcells.2008-0496; Ando T, 2005, INFLAMM BOWEL DIS, V11, P258, DOI 10.1097/01.MIB.0000160807.53858.1c; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Burne MJ, 2001, J LEUKOCYTE BIOL, V70, P192; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Dai W, 2011, AM J TRANSPLANT, V11, P2297, DOI 10.1111/j.1600-6143.2011.03750.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; do O PP, 2001, EXP HEMATOL, V29, P1019, DOI 10.1016/S0301-472X(01)00666-X; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Goransson V, 2004, NEPHROL DIAL TRANSPL, V19, P823, DOI 10.1093/ndt/gfh003; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Holstein-Rathlou NH, 2011, AM J PHYSIOL-RENAL, V300, pF319, DOI 10.1152/ajprenal.00417.2010; Johnsson C, 1996, KIDNEY INT, V50, P1224, DOI 10.1038/ki.1996.431; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kavanagh DPJ, 2010, GUT, V59, P79, DOI 10.1136/gut.2008.168054; Kavanagh DP, 2011, STEM CELL REV; Kavanagh DP, 2012, CELL TRANSPLANT; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li L, 2011, AM J PHYSL RENAL PHY; Li L, 2012, AM J PHYSIOL-RENAL, V302, pF9, DOI 10.1152/ajprenal.00377.2011; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Long DA, 2012, NAT REV NEPHROL, V8, P244, DOI 10.1038/nrneph.2011.219; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Melo NM, 2010, AM J PHYSIOL-RENAL, V299, pF1299, DOI 10.1152/ajprenal.00217.2010; Molls RR, 2006, AM J PHYSIOL-RENAL, V290, pF1187, DOI 10.1152/ajprenal.00342.2005; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Stern JM, 2004, AM J PHYSIOL-RENAL, V286, pF509, DOI 10.1152/ajprenal.00253.2002; Stroo I, 2009, NEPHROL DIAL TRANSPL, V24, P2082, DOI 10.1093/ndt/gfp050; Tang YL, 2005, REGUL PEPTIDES, V125, P1, DOI 10.1016/j.regpep.2004.10.014; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel FE, 2012, AM J KIDNEY DIS, V60, P1012, DOI 10.1053/j.ajkd.2012.08.034; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tse WY, 2005, KIDNEY INT, V67, P130, DOI 10.1111/j.1523-1755.2005.00063.x; TURNER ML, 1995, STEM CELLS, V13, P311, DOI 10.1002/stem.5530130312; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Yuen DA, 2012, SEMIN NEPHROL, V32, P215, DOI 10.1016/j.semnephrol.2012.02.008	62	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66489	10.1371/journal.pone.0066489	http://dx.doi.org/10.1371/journal.pone.0066489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840488	gold, Green Submitted, Green Published			2022-12-25	WOS:000322361200086
J	He, W; Wang, Q; Srinivasan, B; Xu, J; Padilla, MT; Li, Z; Wang, X; Liu, Y; Gou, X; Shen, HM; Xing, C; Lin, Y				He, W.; Wang, Q.; Srinivasan, B.; Xu, J.; Padilla, M. T.; Li, Z.; Wang, X.; Liu, Y.; Gou, X.; Shen, H-M; Xing, C.; Lin, Y.			A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy	ONCOGENE			English	Article						autophagy; necroptosis; RIP1; RIP3; c-IAP; apoptosis	MIXED LINEAGE KINASE; INDUCED CELL-DEATH; PROGRAMMED NECROSIS; CANCER CELLS; DOMAIN-LIKE; APOPTOSIS; RIPOPTOSOME; MECHANISMS; CYTOTOXICITY; DOWNSTREAM	Killing cancer cells through the induction of apoptosis is one of the main mechanisms of chemotherapy. However, numerous cancer cells have primary or acquired apoptosis resistance, resulting in chemoresistance. In this study, using a novel chalcone derivative chalcone-24 (Chal-24), we identified a novel anticancer mechanism through autophagy-mediated necroptosis (RIP1- and RIP3-dependent necrosis). Chal-24 potently killed different cancer cells with induction of necrotic cellular morphology while causing no detectable caspase activation. Blocking the necroptosis pathway with either necrostatin-1 or by knockdown of RIP1 and RIP3 effectively blocked the cytotoxicity of Chal-24, suggesting that Chal-24-induced cell death is associated with necroptosis. Chal-24 robustly activated JNK and ERK and blockage of which effectively suppressed Chal-24-induced cytotoxicity. In addition, Chal-24 strongly induced autophagy that is dependent on JNK-mediated phosphorylation of Bcl-2 and Bcl-xL and dissociation of Bcl-2 or Bcl-xL from Beclin-1. Importantly, suppression of autophagy, with either pharmacological inhibitors or small interfering RNAs targeting the essential autophagy components ATG7 and Beclin-1, effectively attenuated Chal-24-induced cell death. Furthermore, we found that autophagy activation resulted in c-IAP1 and c-IAP2 degradation and formation of the Ripoptosome that contributes to necroptosis. These results thus establish a novel mechanism for killing cancer cells that involves autophagy-mediated necroptosis, which may be employed for overcoming chemoresistance.	[He, W.; Wang, Q.; Xu, J.; Padilla, M. T.; Li, Z.; Liu, Y.; Lin, Y.] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM USA; [He, W.; Gou, X.] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Wang, Q.; Wang, X.] Sichuan Univ, West China Univ Hosp 2, Lab Mol & Translat Med, Chengdu 610064, Peoples R China; [Srinivasan, B.; Xing, C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Shen, H-M] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Lovelace Respiratory Research Institute; Chongqing Medical University; Sichuan University; University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore	Xing, C (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	xingx009@umn.edu; ylin@lrri.org	SHEN, Han-Ming/B-5942-2011; Liu, Yushi/A-1533-2014	SHEN, Han-Ming/0000-0001-7369-5227; Liu, Yushi/0000-0003-4185-4187; Xu, Jennings/0000-0002-3068-0559	NIEHS/NIH [R01ES017328]; NCI/NIH [R03CA156301]; Chongqing Health Bureau [2012-2-001]; NATIONAL CANCER INSTITUTE [R03CA156301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017328] Funding Source: NIH RePORTER	NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chongqing Health Bureau; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was partly supported by grants from NIEHS/NIH (R01ES017328), NCI/NIH (R03CA156301), Chongqing Health Bureau (2012-2-001).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Christofferson DE, 2010, CELL DEATH DIFFER, V17, P1942, DOI 10.1038/cdd.2010.123; Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Imre G, 2011, J MOL CELL BIOL, V3, P324, DOI 10.1093/jmcb/mjr034; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Marquez RT, 2012, AM J CANCER RES, V2, P214; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mor Gil, 2008, V414, P1; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Seve Pascal, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P73, DOI 10.2174/1568011053352604; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shen S, 2011, ONCOGENE, V30, P4544, DOI 10.1038/onc.2011.168; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Srinivasan B, 2009, J MED CHEM, V52, P7228, DOI 10.1021/jm901278z; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Warmka JK, 2012, BIOCHEM BIOPH RES CO, V424, P488, DOI 10.1016/j.bbrc.2012.06.140; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	46	78	85	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3004	3013		10.1038/onc.2013.256	http://dx.doi.org/10.1038/onc.2013.256			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23831571	Green Accepted			2022-12-25	WOS:000337232200007
J	Hedglin, M; Zhang, YR; O'Brien, PJ				Hedglin, Mark; Zhang, Yaru; O'Brien, Patrick J.			Isolating Contributions from Intersegmental Transfer to DNA Searching by Alkyladenine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; RESTRICTION-ENDONUCLEASE; DISORDERED REGIONS; COGNATE SITES; PROTEINS; TRANSLOCATION; MECHANISMS; DIFFUSION; RECOGNITION	Large genomes pose a challenge to DNA repair pathways because rare sites of damage must be efficiently located from among a vast excess of undamaged sites. Human alkyladenine DNA glycosylase (AAG) employs nonspecific DNA binding interactions and facilitated diffusion to conduct a highly redundant search of adjacent sites. This ensures that every site is searched, but could be a detriment if the protein is trapped in a local segment of DNA. Intersegmental transfer between DNA segments that are transiently in close proximity provides an elegant solution that balances global and local searching processes. It has been difficult to detect intersegmental transfer experimentally; therefore, we developed biochemical assays that allowed us to observe and measure the rates of intersegmental transfer by AAG. AAG has a flexible amino terminus that tunes its affinity for nonspecific DNA, but we find that it is not required for intersegmental transfer. As AAG has only a single DNA binding site, this argues against the bridging model for intersegmental transfer. The rates of intersegmental transfer are strongly dependent on the salt concentration, supporting a jumping mechanism that involves microscopic dissociation and capture by a proximal DNA site. As many DNA-binding proteins have only a single binding site, jumping may be a common mechanism for intersegmental transfer.	[O'Brien, Patrick J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu		Hedglin, Mark/0000-0003-2599-1691	National Institutes of Health [RO1 CA122254]; Rackham Graduate School; NATIONAL CANCER INSTITUTE [R01CA122254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham Graduate School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA122254 (to P. J. O.). This work was also supported by in part by an International Fellowship and a Barbour Fellowship from the Rackham Graduate School (to Y. Z.).	Baldwin MR, 2012, NUCLEIC ACIDS RES, V40, P11638, DOI 10.1093/nar/gks952; Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; FRIED MG, 1984, J MOL BIOL, V172, P263, DOI 10.1016/S0022-2836(84)80026-1; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; JELTSCH A, 1994, BIOCHEMISTRY-US, V33, P10215, DOI 10.1021/bi00200a001; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Sheinman M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016003; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wentzell LM, 1998, J MOL BIOL, V281, P433, DOI 10.1006/jmbi.1998.1967; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082	42	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24550	24559		10.1074/jbc.M113.477018	http://dx.doi.org/10.1074/jbc.M113.477018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839988	Green Published, hybrid			2022-12-25	WOS:000330612300023
J	Lundqvist, J; Braumann, I; Kurowska, M; Muller, AH; Hansson, M				Lundqvist, Joakim; Braumann, Ilka; Kurowska, Marzena; Mueller, Andre H.; Hansson, Mats			Catalytic Turnover Triggers Exchange of Subunits of the Magnesium Chelatase AAA plus Motor Unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATIVE HEXAMERIC HELICASE; ATPASE ACTIVITY; CHLOROPHYLL BIOSYNTHESIS; PROTOPORPHYRIN CHELATASE; RHODOBACTER-SPHAEROIDES; SYNECHOCYSTIS PCC6803; ESCHERICHIA-COLI; BARLEY MUTANTS; MG-CHELATASE; H-SUBUNIT	The ATP-dependent insertion of Mg2+ into protoporphyrin IX is the first committed step in the chlorophyll biosynthetic pathway. The reaction is catalyzed by magnesium chelatase, which consists of three gene products: BchI, BchD, and BchH. The BchI and BchD subunits belong to the family of AAA+ proteins (ATPases associated with various cellular activities) and form a two-ring complex with six BchI subunits in one layer and six BchD subunits in the other layer. This BchID complex is a two-layered trimer of dimers with the ATP binding site located at the interface between two neighboring BchI subunits. ATP hydrolysis by the BchID motor unit fuels the insertion of Mg2+ into the porphyrin by the BchH subunit. In the present study, we explored mutations that were originally identified in semidominant barley (Hordeum vulgare L.) mutants. The resulting recombinant BchI proteins have marginal ATPase activity and cannot contribute to magnesium chelatase activity although they apparently form structurally correct complexes with BchD. Mixing experiments with modified and wild-type BchI in various combinations showed that an exchange of BchI subunits in magnesium chelatase occurs during the catalytic cycle, which indicates that dissociation of the complex may be part of the reaction mechanism related to product release. Mixing experiments also showed that more than three functional interfaces in the BchI ring structure are required for magnesium chelatase activity.	[Lundqvist, Joakim; Braumann, Ilka; Kurowska, Marzena; Mueller, Andre H.; Hansson, Mats] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Kurowska, Marzena] Silesian Univ, Fac Biol & Environm Protect, Dept Genet, PL-40032 Katowice, Poland; [Mueller, Andre H.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of Silesia in Katowice; Stanford University	Hansson, M (corresponding author), Carlsberg Lab, Gamle Carlsberg Vej 10, DK-1799 Copenhagen V, Denmark.	mats.hansson@carlsberglab.dk		Kurowska, Marzena/0000-0002-9507-6790; Hansson, Mats/0000-0002-0168-9968	Danish Council for Independent Research; Carlsberg Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Danish Council for Independent Research and the Carlsberg Foundation.	Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Hansson A, 1999, P NATL ACAD SCI USA, V96, P1744, DOI 10.1073/pnas.96.4.1744; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lake V, 2004, EUR J BIOCHEM, V271, P2182, DOI 10.1111/j.1432-1033.2004.04143.x; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1994, BIOCHEM J, V299, P277, DOI 10.1042/bj2990277; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24012	24019		10.1074/jbc.M113.480012	http://dx.doi.org/10.1074/jbc.M113.480012			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836887	hybrid, Green Published			2022-12-25	WOS:000330611400039
J	Lund-Katz, S; Lyssenko, NN; Nickel, M; Nguyen, D; Chetty, PS; Weibel, G; Phillips, MC				Lund-Katz, Sissel; Lyssenko, Nicholas N.; Nickel, Margaret; David Nguyen; Chetty, Palaniappan Sevugan; Weibel, Ginny; Phillips, Michael C.			Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; L-ALPHA-DIMYRISTOYLPHOSPHATIDYLCHOLINE; PLASMA-MEMBRANE MICROSOLUBILIZATION; PRE-BETA-HDL; CELLULAR CHOLESTEROL; APOA-I; UNESTERIFIED CHOLESTEROL; SPHINGOLIPID DOMAINS; PHOSPHOLIPID EFFLUX; MICELLAR COMPLEXES	Apolipoprotein (apo) A-I-containing nascent HDL particles produced by the ATP binding cassette transporter A1 have different sizes and compositions. To understand the molecular basis for this heterogeneity, the HDL particles produced by apoA-I-mediated solubilization of phospholipid (PL)/free (unesterified) cholesterol (FC) bilayer membranes in cell and cell-free systems are compared. Incubation of apoA-I with ATP binding cassette transporter A1-expressing baby hamster kidney cells leads to formation of two populations of FC-containing discoidal nascent HDL particles. The larger 11-nm diameter particles are highly FC-enriched (FC/PL = 1.2/1 mol/mol) relative to the smaller 8 nm particles and the cell plasma membrane (FC/PL = 0.4/1). ApoA-I-mediated spontaneous solubilization of either multilamellar or unilamellar vesicles made of a membrane-PL mixture and FC yields discoidal HDL particles with diameters in the range 9-17 nm and, as found with the cell system, the larger particles are relatively enriched in FC despite the fact that all particles are created by solubilization of a common FC/PL membrane domain. The size-dependent distribution of FC among HDL particles is due to varying amounts of PL being sequestered in a boundary layer by interaction with apoA-I at the disc edge. The presence of a relatively large boundary layer in smaller discoidal HDL promotes preferential distribution of phosphatidylserine to such particles. However, phosphatidylcholine and sphingomyelin which are the primary PL constituents of nascent HDL do not exhibit selective incorporation into HDL discs of different sizes. This understanding of the mechanisms responsible for the heterogeneity in lipid composition of nascent HDL particles may provide a basis for selecting subspecies with preferred cardio-protective properties.	[Lund-Katz, Sissel; Lyssenko, Nicholas N.; Nickel, Margaret; David Nguyen; Chetty, Palaniappan Sevugan; Weibel, Ginny; Phillips, Michael C.] Univ Penn, Perelman Sch Med, Lipid Res Grp, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Phillips, MC (corresponding author), Childrens Hosp Philadelphia, Res Inst, 3615 Civ Ctr Blvd,Ste 1102, Philadelphia, PA 19104 USA.	phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; National Research Service Award Postdoctoral Fellowship [HL107065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL107065, P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Program Project Grant HL22633 (to M. C. P.) and National Research Service Award Postdoctoral Fellowship HL107065 (to N. N. L.).	Alexander ET, 2009, J LIPID RES, V50, P1409, DOI 10.1194/jlr.M800578-JLR200; Auton M, 2013, BIOCHEMISTRY-US, V52, P4324, DOI 10.1021/bi4006732; BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; Bielicki JK, 1999, J LIPID RES, V40, P85; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chetty PS, 2013, J LIPID RES, V54, P1589, DOI 10.1194/jlr.M034785; Chetty PS, 2012, P NATL ACAD SCI USA, V109, P11687, DOI 10.1073/pnas.1209305109; COLLINS JJ, 1982, J LIPID RES, V23, P291; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FORTE TM, 1995, J LIPID RES, V36, P148; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gillotte-Taylor K, 2002, J BIOL CHEM, V277, P11811, DOI 10.1074/jbc.M108268200; HARA H, 1991, J BIOL CHEM, V266, P3080; HAUSER H, 1973, J BIOL CHEM, V248, P8585; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; JANIAK MJ, 1979, J BIOL CHEM, V254, P6068; JONAS A, 1978, J BIOL CHEM, V253, P5758; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KADUCE TL, 1983, J LIPID RES, V24, P1398; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lyssenko NN, 2013, FASEB J, V27, P2880, DOI 10.1096/fj.12-216564; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; PHILLIPS MC, 1986, METHOD ENZYMOL, V128, P387; POWNALL HJ, 1979, BIOCHEMISTRY-US, V18, P574, DOI 10.1021/bi00571a004; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saito H, 1997, J LIPID RES, V38, P287; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1980, J BIOL CHEM, V255, P877; TALL AR, 1977, J BIOL CHEM, V252, P4701; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2010, J BIOL CHEM, V285, P31965, DOI 10.1074/jbc.M110.126292; WETTERAU JR, 1983, J BIOL CHEM, V258, P2637; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhang WW, 1998, J LIPID RES, V39, P1601; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	64	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23150	23160		10.1074/jbc.M113.495523	http://dx.doi.org/10.1074/jbc.M113.495523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23836906	Green Published, hybrid			2022-12-25	WOS:000330598200022
J	Glass, C; Wuertzer, C; Cui, XH; Bi, YT; Davuluri, R; Xiao, YY; Wilson, M; Owens, K; Zhang, Y; Perkins, A				Glass, Carolyn; Wuertzer, Charles; Cui, Xiaohui; Bi, Yingtao; Davuluri, Ramana; Xiao, Ying-Yi; Wilson, Michael; Owens, Kristina; Zhang, Yi; Perkins, Archibald			Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-2; ACUTE MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; ISG15 CONJUGATION SYSTEM; BINDING-PROTEIN EPSILON; ZINC-FINGER GENE; CELL-LINES; TRANSCRIPTION FACTORS; GRANULOCYTIC DIFFERENTIATION; RETINOBLASTOMA PROTEIN	The ecotropic virus integration site 1 (EVI1) transcription factor is associated with human myeloid malignancy of poor prognosis and is overexpressed in 8-10% of adult AML and strikingly up to 27% of pediatric MLL-rearranged leukemias. For the first time, we report comprehensive genomewide EVI1 binding and whole transcriptome gene deregulation in leukemic cells using a combination of ChIP-Seq and RNA-Seq expression profiling. We found disruption of terminal myeloid differentiation and cell cycle regulation to be prominent in EVI-induced leukemogenesis. Specifically, we identified EVI1 directly binds to and downregulates the master myeloid differentiation gene Cebpe and several of its downstream gene targets critical for terminal myeloid differentiation. We also found EVI1 binds to and downregulates Serpinb2 as well as numerous genes involved in the Jak-Stat signaling pathway. Finally, we identified decreased expression of several ATP-dependent P2X purinoreceptors genes involved in apoptosis mechanisms. These findings provide a foundation for future study of potential therapeutic gene targets for EVI1-induced leukemia.	[Glass, Carolyn; Wuertzer, Charles; Cui, Xiaohui; Wilson, Michael; Owens, Kristina; Zhang, Yi; Perkins, Archibald] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Bi, Yingtao; Davuluri, Ramana] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Xiao, Ying-Yi] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	University of Rochester; The Wistar Institute; Yale University	Zhang, Y (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	yi_zhang@urmc.rochester.edu; archibald_perkins@urmc.rochester.edu	Glass, Carolyn/ADD-6348-2022	Zhang, Yi/0000-0003-2785-1780; Glass, Carolyn/0000-0002-8850-9906	National Institutes of Health (NIH) [R01CA120313]; New York State Stem Cell Science (NYSTEM) [C026423]; National Heart Lung Blood Institute; NATIONAL CANCER INSTITUTE [R01CA120313] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science (NYSTEM); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH) (R01CA120313 to ASP), New York State Stem Cell Science (NYSTEM) (C026423 to YZ), and a National Heart Lung Blood Institute T32 post-doctoral fellowship grant under Dr. Thomas Pearson, Director of the University of Rochester Clinical Translational Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Balgobind BV, 2010, LEUKEMIA, V24, P942, DOI 10.1038/leu.2010.47; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Bi Y, 2011, TREE BASED POSITION; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; BORDEREAUX D, 1990, ONCOGENE, V5, P925; BRUCE AJ, 1992, MATER RES SOC SYMP P, V244, P157; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Buonamici S, 2003, BLOOD CELL MOL DIS, V31, P206, DOI 10.1016/S1079-9796(03)00159-1; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Chen AG, 2006, WORLD J GASTROENTERO, V12, P7859, DOI 10.3748/wjg.v12.i48.7859; Cong XL, 2010, BLOOD CELL MOL DIS, V45, P103, DOI 10.1016/j.bcmd.2010.05.009; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; Cuenco GM, 2004, ONCOGENE, V23, P569, DOI 10.1038/sj.onc.1207143; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; De Braekeleer E, 2011, ANTICANCER RES, V31, P3441; De Weer A, 2011, BRIT J HAEMATOL, V154, P337, DOI 10.1111/j.1365-2141.2011.08737.x; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Durfee LA, 2012, METHODS MOL BIOL, V832, P141, DOI 10.1007/978-1-61779-474-2_9; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; FUNABIKI T, 1994, ONCOGENE, V9, P1575; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; GROSS TJ, 1990, J IMMUNOL, V144, P1873; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Hebenstreit D, 2005, DRUG NEWS PERSPECT, V18, P243, DOI 10.1358/dnp.2005.18.4.908658; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P6687, DOI 10.1073/pnas.82.19.6687; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Ihle J, 1984, ADV VIRAL ONCOL, P95; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jazaeri AA, 2010, GYNECOL ONCOL, V118, P189, DOI 10.1016/j.ygyno.2010.04.007; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Khanna-Gupta A, 2005, EXP HEMATOL, V33, P42, DOI 10.1016/j.exphem.2004.09.009; KhannaGupta A, 1996, ONCOGENE, V12, P563; Kilbey A, 2005, BRIT J HAEMATOL, V130, P902, DOI 10.1111/j.1365-2141.2005.05709.x; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; Kim JH, 1998, ONCOGENE, V17, P1527, DOI 10.1038/sj.onc.1202331; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Koos B, 2011, CLIN CANCER RES, V17, P3631, DOI 10.1158/1078-0432.CCR-11-0175; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KREIDER BL, 1993, P NATL ACAD SCI USA, V90, P6454, DOI 10.1073/pnas.90.14.6454; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Levine R, 2011, CURR TOP MICROBIOL I; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mane SP, 2011, METHODS MOL BIOL, V678, P1, DOI 10.1007/978-1-60761-682-5_1; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nakajima H, 2006, J BIOL CHEM, V281, P14494, DOI 10.1074/jbc.M600575200; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Pradhan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025370; Pradhan AK, 2011, BBA-GENE REGUL MECH, V1809, P269, DOI 10.1016/j.bbagrm.2011.04.007; Qiu Y, 2008, BIOCHEMISTRY-US, V47, P3697, DOI 10.1021/bi702524v; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RITCHIE H, 1995, BLOOD, V86, P3428, DOI 10.1182/blood.V86.9.3428.bloodjournal8693428; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; SCHLEUNING WD, 1987, MOL CELL BIOL, V7, P4564, DOI 10.1128/MCB.7.12.4564; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; SHIMAMOTO T, 1994, LEUKEMIA, V8, P1176; Sitailo S, 1999, LEUKEMIA, V13, P1639, DOI 10.1038/sj.leu.2401585; Spiekermann K, 2001, EUR J HAEMATOL, V67, P63, DOI 10.1034/j.1600-0609.2001.t01-1-00385.x; Stringer B, 2012, J BIOL CHEM, V287, P10579, DOI 10.1074/jbc.M111.318758; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Suh BC, 2001, J IMMUNOL, V166, P6754, DOI 10.4049/jimmunol.166.11.6754; Swiatkowski S, 2003, EXP CELL RES, V282, P48, DOI 10.1006/excr.2002.5647; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Witt H, 2007, CHROMATIN IMMUNOPREC; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang XJ, 2009, ACTA BIOCH BIOPH SIN, V41, P362, DOI 10.1093/abbs/gmp016; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P10431, DOI 10.1021/bi200962u; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	107	44	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67134	10.1371/journal.pone.0067134	http://dx.doi.org/10.1371/journal.pone.0067134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826213	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000031
J	Kumar, RD; Chang, LW; Ellis, MJ; Bose, R				Kumar, Runjun D.; Chang, Li-Wei; Ellis, Matthew J.; Bose, Ron			Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INFORMATION-SYSTEM; EXPRESSION; GENES; TPIP	A major goal of cancer genome sequencing is to identify mutations or other somatic alterations that can be targeted by selective and specific drugs. dGene is an annotation tool designed to rapidly identify genes belonging to one of ten druggable classes that are frequently targeted in cancer drug development. These classes were comprehensively populated by combining and manually curating data from multiple specialized and general databases. dGene was used by The Cancer Genome Atlas squamous cell lung cancer project, and here we further demonstrate its utility using recently released breast cancer genome sequencing data. dGene is designed to be usable by any cancer researcher without the need for support from a bioinformatics specialist. A full description of dGene and options for its implementation are provided here.	[Kumar, Runjun D.; Ellis, Matthew J.; Bose, Ron] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Kumar, Runjun D.] Washington Univ, Div Biol & Biomed Sci, Computat & Syst Biol Program, St Louis, MO USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Bose, R (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	rbose@dom.wustl.edu			NIH [R01CA095614, U01HG00651701]; Edward Mallinckrodt, Jr. Foundation; Ohana Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA095614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; Ohana Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by NIH grants R01CA095614 and U01HG00651701 (to MJE), and the Edward Mallinckrodt, Jr. Foundation and the 'Ohana Breast Cancer Research Fund (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Condomines M, 2009, J IMMUNOL, V183, P832, DOI 10.4049/jimmunol.0803298; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Huang DW, 2008, BIOINFORMATION, V2, P428; Kelemen LE, 2009, CANCER EPIDEM BIOMAR, V18, P1864, DOI 10.1158/1055-9965.EPI-08-0486; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mishra RR, 2012, MOL BIOL REP, V39, P7389, DOI 10.1007/s11033-012-1571-6; Mishra RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028433; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vroling B, 2012, NUCLEIC ACIDS RES, V40, pD377, DOI 10.1093/nar/gkr960; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Weber A, 2003, CLIN CANCER RES, V9, P5683	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67980	10.1371/journal.pone.0067980	http://dx.doi.org/10.1371/journal.pone.0067980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826350	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000104
J	Arguello, A; Yang, XY; Vogt, D; Stanco, A; Rubenstein, JLR; Cheyette, BNR				Arguello, Annie; Yang, XiaoYong; Vogt, Daniel; Stanco, Amelia; Rubenstein, John L. R.; Cheyette, Benjamin N. R.			Dapper Antagonist of Catenin-1 Cooperates with Dishevelled-1 during Postsynaptic Development in Mouse Forebrain GABAergic Interneurons	PLOS ONE			English	Article							EXCITATORY SYNAPSE DEVELOPMENT; DIFFERENTIAL GENE-EXPRESSION; GREEN FLUORESCENT PROTEIN; CORTICAL INTERNEURONS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINE; INHIBITORY SYNAPSES; SIGNALING PROMOTES; HOMEOBOX GENES; WNT SIGNALS	Synaptogenesis has been extensively studied along with dendritic spine development in glutamatergic pyramidal neurons, however synapse development in cortical interneurons, which are largely aspiny, is comparatively less well understood. Dact1, one of 3 paralogous Dact (Dapper/Frodo) family members in mammals, is a scaffold protein implicated in both the Wnt/beta-catenin and the Wnt/Planar Cell Polarity pathways. We show here that Dact1 is expressed in immature cortical interneurons. Although Dact1 is first expressed in interneuron precursors during proliferative and migratory stages, constitutive Dact1 mutant mice have no major defects in numbers or migration of these neurons. However, cultured cortical interneurons derived from these mice have reduced numbers of excitatory synapses on their dendrites. We selectively eliminated Dact1 from mouse cortical interneurons using a conditional knock-out strategy with a Dlx-I12b enhancer-Cre allele, and thereby demonstrate a cell-autonomous role for Dact1 during postsynaptic development. Confirming this cell-autonomous role, we show that synapse numbers in Dact1 deficient cortical interneurons are rescued by virally-mediated re-expression of Dact1 specifically targeted to these cells. Synapse numbers in these neurons are also rescued by similarly targeted expression of the Dact1 binding partner Dishevelled-1, and partially rescued by expression of Disrupted in Schizophrenia-1, a synaptic protein genetically implicated in susceptibility to several major mental illnesses. In sum, our results support a novel cell-autonomous postsynaptic role for Dact1, in cooperation with Dishevelled-1 and possibly Disrupted in Schizophrenia-1, in the formation of synapses on cortical interneuron dendrites.	[Arguello, Annie; Rubenstein, John L. R.; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Arguello, Annie; Yang, XiaoYong; Vogt, Daniel; Stanco, Amelia; Rubenstein, John L. R.; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cheyette, BNR (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	bc@lppi.ucsf.edu	Cheyette, Benjamin/K-5535-2014	Cheyette, Benjamin/0000-0001-9934-7941; Vogt, Daniel/0000-0003-1876-5936	US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD) [R25GM56847, T32MH089920, R01MH081880, R37MH049428, R21MH085995]; Simons Foundation Autism Research Initiative; UCSF Department of Psychiatry; UCSF Center for Neurobiology and Psychiatry; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH089920, R01MH081880, R21MH085995, R37MH049428] Funding Source: NIH RePORTER	US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD); Simons Foundation Autism Research Initiative; UCSF Department of Psychiatry; UCSF Center for Neurobiology and Psychiatry; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge funding from the US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD) Grant R25GM56847 (A.A.), T32MH089920 (XY.Y. & A.S.), R01MH081880 (D.V./J.L.R.), R37MH049428 (J.L.R.) and R21MH085995 (B.N.R.C.). In addition, the authors received funding from the Simons Foundation Autism Research Initiative (B.N.R.C.), and from the UCSF Department of Psychiatry and the UCSF Center for Neurobiology and Psychiatry (B.N.R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Antypa M, 2011, EUR J NEUROSCI, V34, P1584, DOI 10.1111/j.1460-9568.2011.07896.x; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Badawy RAB, 2009, J CLIN NEUROSCI, V16, P485, DOI 10.1016/j.jocn.2008.10.001; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dean CaS P, 2009, IMAGING SYNAPTOGENES, P1; DENO RL, 1949, CEREBRAL CORTEX ARCH; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Faux C, 2010, J COMP NEUROL, V518, P1232, DOI 10.1002/cne.22271; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Long JE, 2009, CEREB CORTEX S1, V19, P196; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PARNAVELAS JG, 1984, CEREB CORTEX, P205; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sala C, 2008, ACTA NEUROBIOL EXP, V68, P289; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	71	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67679	10.1371/journal.pone.0067679	http://dx.doi.org/10.1371/journal.pone.0067679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826333	gold, Green Published			2022-12-25	WOS:000321738400166
J	Ayieko, P; Griffiths, UK; Ndiritu, M; Moisi, J; Mugoya, IK; Kamau, T; English, M; Scott, JAG				Ayieko, Philip; Griffiths, Ulla K.; Ndiritu, Moses; Moisi, Jennifer; Mugoya, Isaac K.; Kamau, Tatu; English, Mike; Scott, J. Anthony G.			Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; DEVELOPING-COUNTRIES; DISEASE; PNEUMONIA; CARE; SURVEILLANCE; IMMUNIZATION; STRATEGIES; MORTALITY; EFFICACY	Background: The GAVI Alliance supported10-valent pneumococcal conjugate vaccine (PCV10) introduction in Kenya. We estimated the cost-effectiveness of introducing either PCV10 or the 13-valent vaccine (PCV13) from a societal perspective and explored the incremental impact of including indirect vaccine effects. Methods: The costs and effects of pneumococcal vaccination among infants born in Kenya in 2010 were assessed using a decision analytic model comparing PCV10 or PCV13, in turn, with no vaccination. Direct vaccine effects were estimated as a reduction in the incidence of pneumococcal meningitis, sepsis, bacteraemic pneumonia and non-bacteraemic pneumonia. Pneumococcal disease incidence was extrapolated from a population-based hospital surveillance system in Kilifi and adjustments were made for variable access to care across Kenya. We used vaccine efficacy estimates from a trial in The Gambia and accounted for serotype distribution in Kilifi. We estimated indirect vaccine protection and serotype replacement by extrapolating from the USA. Multivariable sensitivity analysis was conducted using Monte Carlo simulation. We assumed a vaccine price of US$ 3.50 per dose. Findings: The annual cost of delivering PCV10 was approximately US$ 14 million. We projected a 42.7% reduction in pneumococcal disease episodes leading to a US$ 1.97 million reduction in treatment costs and a 6.1% reduction in childhood mortality annually. In the base case analysis, costs per discounted DALY and per death averted by PCV10, amounted to US$ 59 (95% CI 26-103) and US$ 1,958 (95% CI 866-3,425), respectively. PCV13 introduction improved the cost-effectiveness ratios by approximately 20% and inclusion of indirect effects improved cost-effectiveness ratios by 43-56%. The break-even prices for introduction of PCV10 and PCV13 are US$ 0.41 and 0.51, respectively. Conclusions: Introducing either PCV10 or PCV13 in Kenya is highly cost-effective from a societal perspective. Indirect effects, if they occur, would significantly improve the cost-effectiveness.	[Ayieko, Philip; Ndiritu, Moses; Moisi, Jennifer; English, Mike; Scott, J. Anthony G.] Wellcome Trust Programme, Kenya Med Res Inst, Nairobi, Kenya; [Griffiths, Ulla K.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mugoya, Isaac K.; Kamau, Tatu] Minist Publ Hlth & Sanitat, Div Vaccine & immunizat, Nairobi, Kenya; [English, Mike] Univ Oxford, Nuffield Dept Paediat, Oxford, England; [Moisi, Jennifer; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Ayieko, P (corresponding author), Wellcome Trust Programme, Kenya Med Res Inst, Nairobi, Kenya.	payieko@nairobi.kemri-wellcome.org		English, Michael/0000-0002-7427-0826	GAVI Alliance through the PneumoADIP; Wellcome Trust [081835, 076827, 092654/Z/10/A]; GlaxoSmithKline Biologicals	GAVI Alliance through the PneumoADIP; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was supported by the GAVI Alliance through the PneumoADIP and by the Wellcome Trust through research fellowships to JAGS (081835) and ME (076827). The KEMRI-Wellcome Trust Research Programme is supported by core funding from the Wellcome Trust (#092654/Z/10/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAGS has received research funding from GlaxoSmithKline Biologicals and travel/hotel support from Merck to attend a Merck sponsored scientific meeting. The remaining authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; [Anonymous], 2011, GAVI ALL PLEDG C IMM; [Anonymous], 2005, WHO POCK BOOK HOSP C; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Cernuschi T, 2009, LANCET, V374, P684, DOI 10.1016/S0140-6736(09)61556-7; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Gentry B, 2008, GETTING STARTED GUID, pC; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Larson BA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-314; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Moisi JC, 2010, VACCINE, V28, P5725, DOI 10.1016/j.vaccine.2010.06.011; Moszynski P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1075; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Tate JE, 2011, VACCINE, V29, P3329, DOI 10.1016/j.vaccine.2010.12.122; Touray MML, 2011, J PHARM HEALTH SERV, V2, P175, DOI 10.1111/j.1759-8893.2011.00057.x; World Health Organisation, 2008, PROGR PROJ IMM SURV	37	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67324	10.1371/journal.pone.0067324	http://dx.doi.org/10.1371/journal.pone.0067324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826268	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000321738400133
J	Choo, YM; Pelletier, J; Atungulu, E; Leal, WS				Choo, Young-Moo; Pelletier, Julien; Atungulu, Elizabeth; Leal, Walter S.			Identification and Characterization of an Antennae-Specific Aldehyde Oxidase from the Navel Orangeworm	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER ADULTS; SEX-PHEROMONE; ALCOHOL-DEHYDROGENASE; ANTHERAEA-POLYPHEMUS; DIFFERENTIAL INHIBITION; AMYELOIS-TRANSITELLA; VOLATILE ALDEHYDES; MOTH; ACETALDEHYDE; LEPIDOPTERA	Antennae-specific odorant-degrading enzymes (ODEs) are postulated to inactivate odorant molecules after they convey their signal. Different classes of insect ODEs are specific to esters, alcohols, and aldehydes - the major functional groups of female-produced, hydrophobic sex pheromones from moth species. Esterases that rapidly inactive acetate and other esters have been well-studied, but less is known about aldehyde oxidases (AOXs). Here we report cloning of an aldehyde oxidase, AtraAOX2, from the antennae of the navel orangeworm (NOW), Amyelois transitella, and the first activity characterization of a recombinant insect AOX. AtraAOX2 gene spans 3,813 bp and encodes a protein with 1,270 amino acid residues. AtraAOX2 cDNA was expressed in baculovirus-infected insect Sf21 cells as a approximate to 280 kDa homodimer with 140 kDa subunits. Recombinant AtraAOX2 degraded Z11Z13-16Ald and plant volatile aldehydes as substrates. However, as expected for aldehyde oxidases, recombinant AtraAOX2 did not show specificity for Z11Z13-16Ald, the main constituent of the sex pheromone, but showed high activity for plant volatile aldehydes. Our data suggest AtraAOX2 might be involved in degradation of a diversity of aldehydes including sex pheromones, plant-derived semiochemicals, and chemical cues for oviposition sites. Additionally, AtraAOX2 could protect the insect's olfactory system from xenobiotics, including pesticides that might reach the sensillar lymph surrounding the olfactory receptor neurons.	[Choo, Young-Moo; Pelletier, Julien; Atungulu, Elizabeth; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Leal Filho, Walter/0000-0002-1241-5225	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65105-20582]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported in part by Agriculture and Food Research Initiative Competitive Grant 2010-65105-20582 from the USDA National Institute of Food and Agriculture. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaba S, 1999, J BIOCHEM-TOKYO, V126, P395, DOI 10.1093/oxfordjournals.jbchem.a022463; Alfaro JF, 2009, DRUG METAB DISPOS, V37, P2393, DOI 10.1124/dmd.109.029520; ANDERSON SM, 1991, GENETICA, V83, P99, DOI 10.1007/BF00058526; Burks CS, 2008, ENTOMOL EXP APPL, V129, P66, DOI 10.1111/j.1570-7458.2008.00754.x; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chertemps T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-56; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Coleman M, 2002, EUR J BIOCHEM, V269, P768, DOI 10.1046/j.0014-2956.2001.02682.x; DAVID JR, 1984, BIOCHEM GENET, V22, P1015, DOI 10.1007/BF00499628; de Groot P, 1999, NATURWISSENSCHAFTEN, V86, P81, DOI 10.1007/s001140050576; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; DICKINSON WJ, 1975, DEV BIOL, V42, P131, DOI 10.1016/0012-1606(75)90319-X; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Hammond DG, 2000, J AGR FOOD CHEM, V48, P4410, DOI 10.1021/jf000233+; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; HEINSTRA PWH, 1989, BIOCHEM J, V259, P791, DOI 10.1042/bj2590791; Hemingway J, 2000, INSECT MOL BIOL, V9, P93, DOI 10.1046/j.1365-2583.2000.00160.x; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Itoh K, 2007, XENOBIOTICA, V37, P709, DOI 10.1080/00498250701397713; JOHNS DG, 1967, J CLIN INVEST, V46, P1492, DOI 10.1172/JCI105641; KASANG G, 1978, ANGEW CHEM INT EDIT, V17, P60, DOI 10.1002/anie.197800601; KIMMERER TW, 1987, PLANT PHYSIOL, V84, P1204, DOI 10.1104/pp.84.4.1204; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; KOCHANSKY J, 1975, J INSECT PHYSIOL, V21, P1977, DOI 10.1016/0022-1910(75)90230-9; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; Kuenen LPS, 2010, J ECON ENTOMOL, V103, P314, DOI 10.1603/EC09177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAL JFM, 1993, INSECT BIOCHEM MOLEC, V23, P543, DOI 10.1016/0965-1748(93)90027-P; LEAL JFM, 1992, INSECT BIOCHEM MOLEC, V22, P885, DOI 10.1016/0965-1748(92)90115-U; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Moriwaki Y, 1997, HISTOL HISTOPATHOL, V12, P513; Nakamura S, 2002, J AGR FOOD CHEM, V50, P7639, DOI 10.1021/jf025808c; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pelletier J, 2007, GENE, V404, P31, DOI 10.1016/j.gene.2007.08.022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; RAJAGOPALAN KV, 1962, J BIOL CHEM, V237, P922; RAJAGOPALAN KV, 1964, J BIOL CHEM, V239, P2022; RAJAGOPALAN KV, 1964, J BIOL CHEM, V239, P2027; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Rogers ME, 1999, J EXP BIOL, V202, P1625; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; TEBBETS JS, 1978, J ECON ENTOMOL, V71, P875, DOI 10.1093/jee/71.6.875; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Vogt R.G., 2005, P753; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; WILLIAMSON JH, 1978, CAN J GENET CYTOL, V20, P545, DOI 10.1139/g78-064; Yoshihara S, 1997, ARCH BIOCHEM BIOPHYS, V338, P29, DOI 10.1006/abbi.1996.9774; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131	61	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67794	10.1371/journal.pone.0067794	http://dx.doi.org/10.1371/journal.pone.0067794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826341	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400171
J	Kitaoka, S; Morielli, AD; Zhao, FQ				Kitaoka, Shun; Morielli, Anthony D.; Zhao, Feng-Qi			FGT-1 Is a Mammalian GLUT2-Like Facilitative Glucose Transporter in Caenorhabditis elegans Whose Malfunction Induces Fat Accumulation in Intestinal Cells	PLOS ONE			English	Article							SUBSTRATE SPECIFICITIES; TISSUE DISTRIBUTION; XENOPUS OOCYTES; EXPRESSION; GENE; SEQUENCE; ENCODES; FAMILY; RNA	Caenorhabditis elegans (C. elegans) is an attractive animal model for biological and biomedical research because it permits relatively easy genetic dissection of cellular pathways, including insulin/IGF-like signaling (IIS), that are conserved in mammalian cells. To explore C. elegans as a model system to study the regulation of the facilitative glucose transporter (GLUT), we have characterized the GLUT gene homologues in C. elegans: fgt-1, R09B5.11, C35A11.4, F53H8.3, F48E3.2, F13B12.2, Y61A9LA. 1, K08F9.1 and Y37A1A. 3. The exogenous expression of these gene products in Xenopus oocytes showed transport activity to unmetabolized glucose analogue 2-deoxy-D-glucose only in FGT-1. The FGT-1-mediated transport activity was inhibited by the specific GLUT inhibitor phloretin and exhibited a Michaelis constant (K-m) of 2.8 mM. Mannose, galactose, and fructose were able to inhibit FGT-1-mediated 2-deoxy-D-glucose uptake (P < 0.01), indicating that FGT-1 is also able to transport these hexose sugars. A GFP fusion protein of FGT-1 was observed only on the basolateral membrane of digestive tract epithelia in C. elegans, but not in other tissues. FGT-1:: eGFP expression was observed from early embryonic stages. The knockdown or mutation of fgt-1 resulted in increased fat staining in both wild-type and daf-2 (mammalian insulin receptor homologue) mutant animals. Other common phenotypes of IIS mutant animals, including dauer formation and brood size reduction, were not affected by fgt-1 knockdown in wild-type or daf-2 mutants. Our results indicated that in C. elegans, FGT-1 is mainly a mammalian GLUT2-like intestinal glucose transporter and is involved in lipid metabolism.	[Kitaoka, Shun; Zhao, Feng-Qi] Univ Vermont, Dept Anim Sci, Lab Lactat & Metab Physiol, Burlington, VT 05405 USA; [Morielli, Anthony D.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Zhao, FQ (corresponding author), Univ Vermont, Dept Anim Sci, Lab Lactat & Metab Physiol, Burlington, VT 05405 USA.	Feng-Qi.Zhao@uvm.edu			University of Vermont; Developmental Studies Hybridoma Bank; NICHD	University of Vermont; Developmental Studies Hybridoma Bank; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by the University of Vermont. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Michael Koelle (Yale University) for providing us with the pRF4 marker plasmid. We thank Gwyn Gould (University of Glasgow) for providing us with the hGLUT1 construct and pSP64T vector. The MH33 antibody that was developed by Robert H. Waterston was obtained from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the NICHD and maintained by the Department of Biology, University of Iowa. We also thank Ruth Blauwiekel and Yong Shao (both at the University of Vermont) for technical assistance with Xenopus laevis surgery.	Bentley PA, 2012, J DAIRY SCI, V95, P1188, DOI 10.3168/jds.2011-4430; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HABER RS, 1993, ENDOCRINOLOGY, V132, P2538, DOI 10.1210/en.132.6.2538; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; KELLER K, 1990, BIOMED BIOCHIM ACTA, V49, P1201; KELLER K, 1989, J BIOL CHEM, V264, P18884; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; MAENZ DD, 1987, J MEMBRANE BIOL, V97, P259, DOI 10.1007/BF01869228; Mello C, 1995, METHOD CELL BIOL, V48, P451; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; SHEPHERD PR, 1992, BIOCHEM BIOPH RES CO, V188, P149, DOI 10.1016/0006-291X(92)92362-2; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Takashima Y, 2012, GENES GENET SYST, V87, P243, DOI 10.1266/ggs.87.243; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Togo SH, 2000, EUR J BIOCHEM, V267, P1307, DOI 10.1046/j.1432-1327.2000.01091.x; WRIGHT EM, 1992, ACTA PHYSIOL SCAND, V146, P201; Yokota S, 2002, HISTOCHEM CELL BIOL, V118, P329, DOI 10.1007/s00418-002-0450-y; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	32	22	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68475	10.1371/journal.pone.0068475	http://dx.doi.org/10.1371/journal.pone.0068475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826391	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400176
J	Neuhaus, J; Schiffer, E; von Wilcke, P; Bauer, HW; Leung, H; Siwy, J; Ulrici, W; Paasch, U; Horn, LC; Stolzenburg, JU				Neuhaus, Jochen; Schiffer, Eric; von Wilcke, Philine; Bauer, Hartwig W.; Leung, Hing; Siwy, Justyna; Ulrici, Wolfram; Paasch, Uwe; Horn, Lars-Christian; Stolzenburg, Jens-Uwe			Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease	PLOS ONE			English	Article							ENHANCED LASER-DESORPTION/IONIZATION; ELECTRON-TRANSFER DISSOCIATION; URINARY PROTEOME ANALYSIS; MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; RADIATION-THERAPY; SEQUENCE-ANALYSIS; DISCOVERY; DIAGNOSIS; SCORE	Background: Extensive prostate specific antigen screening for prostate cancer generates a high number of unnecessary biopsies and over-treatment due to insufficient differentiation between indolent and aggressive tumours. We hypothesized that seminal plasma is a robust source of novel prostate cancer (PCa) biomarkers with the potential to improve primary diagnosis of and to distinguish advanced from indolent disease. Methodology/Principal Findings: In an open-label case/control study 125 patients (70 PCa, 21 benign prostate hyperplasia, 25 chronic prostatitis, 9 healthy controls) were enrolled in 3 centres. Biomarker panels a) for PCa diagnosis (comparison of PCa patients versus benign controls) and b) for advanced disease (comparison of patients with post surgery Gleason score <7 versus Gleason score >7) were sought. Independent cohorts were used for proteomic biomarker discovery and testing the performance of the identified biomarker profiles. Seminal plasma was profiled using capillary electrophoresis mass spectrometry. Pre-analytical stability and analytical precision of the proteome analysis were determined. Support vector machine learning was used for classification. Stepwise application of two biomarker signatures with 21 and 5 biomarkers provided 83% sensitivity and 67% specificity for PCa detection in a test set of samples. A panel of 11 biomarkers for advanced disease discriminated between patients with Gleason score 7 and organ-confined (<pT3a) or advanced (>= pT3a) disease with 80% sensitivity and 82% specificity in a preliminary validation setting. Seminal profiles showed excellent pre-analytical stability. Eight biomarkers were identified as fragments of N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase, prostatic acid phosphatase, stabilin-2, GTPase IMAP family member 6, semenogelin-1 and -2. Restricted sample size was the major limitation of the study. Conclusions/Significance: Seminal plasma represents a robust source of potential peptide makers for primary PCa diagnosis. Our findings warrant further prospective validation to confirm the diagnostic potential of identified seminal biomarker candidates.	[Neuhaus, Jochen; von Wilcke, Philine; Stolzenburg, Jens-Uwe] Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany; [Schiffer, Eric; Siwy, Justyna] Mosa Diagnost GmbH, Hannover, Germany; [Bauer, Hartwig W.] Univ Munich, Munich, Germany; [Leung, Hing] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Ulrici, Wolfram] Med Practice, Leipzig, Germany; [Paasch, Uwe] Univ Leipzig, Dept Dermatol, D-04109 Leipzig, Germany; [Horn, Lars-Christian] Univ Leipzig, Dept Pathol, D-04109 Leipzig, Germany	Leipzig University; Modular Open Systems Approach (MOSA) Solutions; University of Munich; Beatson Institute; Leipzig University; Leipzig University	Neuhaus, J (corresponding author), Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de		Siwy, Justyna/0000-0003-1407-2534	German Ministry of Economy and Technolgy BMWi [KF0362802MD8, EP110141]	German Ministry of Economy and Technolgy BMWi	This study was funded in part by the German Ministry of Economy and Technolgy BMWi with grant No. KF0362802MD8 to JUS, JN, PW, ES, JS and grant No. EP110141 to ES and JS. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batruch I, 2011, J PROTEOME RES, V10, P941, DOI 10.1021/pr100745u; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bright E, 2010, UROL INT, V84, P180, DOI 10.1159/000277595; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Coon JJ, 2005, J AM SOC MASS SPECTR, V16, P880, DOI 10.1016/j.jasms.2005.01.015; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; DeLeo J. M., 1993, [1993] Proceedings Second International Symposium on Uncertainty Modeling and Analysis, P318, DOI 10.1109/ISUMA.1993.366750; Dudoit S, 2008, SPRINGER SER STAT, P1; Emami N, 2008, J BIOL CHEM, V283, P19561, DOI 10.1074/jbc.M801194200; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; Girolami M, 2007, DRUG DISCOV TODAY TE, V3, P12; Goo YA, 2010, J PROTEOMICS, V73, P1839, DOI 10.1016/j.jprot.2010.04.002; Good DM, 2006, BIOTECHNIQUES, V40, P783, DOI 10.2144/000112194; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim Y, 2012, MOL CELL PROTEOMICS; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Marshall S, 2009, WORLD J UROL, V27, P577, DOI 10.1007/s00345-009-0435-8; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Roach M, 2000, INT J RADIAT ONCOL, V47, P609, DOI 10.1016/S0360-3016(00)00578-2; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Schiffer E, 2012, INT J UROL, V19, P118, DOI 10.1111/j.1442-2042.2011.02901.x; Siddiqui E, 2004, J R SOC PROMO HEALTH, V124, P219, DOI 10.1177/146642400412400518; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2008, PROTEOM CLIN APPL, V2, P556, DOI 10.1002/prca.200780082; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Weissinger EM, 2004, KIDNEY INT, V65, P2426, DOI 10.1111/j.1523-1755.2004.00659.x; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Yang ZR, 2004, BIOINFORMATICS, V20, P735, DOI 10.1093/bioinformatics/btg477; You JJ, 2010, CRIT REV ONCOL HEMAT, V73, P10, DOI 10.1016/j.critrevonc.2009.02.007; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	46	36	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67514	10.1371/journal.pone.0067514	http://dx.doi.org/10.1371/journal.pone.0067514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826311	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000321738400153
J	Sasaki, MM; Nichols, JT; Kimmel, CB				Sasaki, Mark M.; Nichols, James T.; Kimmel, Charles B.			edn1 and hand2 Interact in Early Regulation of Pharyngeal Arch Outgrowth during Zebrafish Development	PLOS ONE			English	Article							BHLH TRANSCRIPTION FACTOR; NEURAL CREST CELLS; A RECEPTOR; CRANIOFACIAL DEVELOPMENT; SIGNALING PATHWAYS; ENDOTHELIN-1; DEFICIENT; CARTILAGE; MUTANTS; ROLES	Endothelin-1 (Edn1) signaling provides a critical input to development of the embryonic pharygneal arches and their skeletal derivatives, particularly the articulating joints and the ventral skeleton including the lower jaw. Previous work in zebrafish has mostly focused on the role of Edn1 in dorsal-ventral (DV) patterning, but Edn1 signaling must also regulate tissue size, for with severe loss of the pathway the ventral skeleton is not only mispatterned, but is also prominently hypoplastic - reduced in size. Here we use mutational analyses to show that in the early pharyngeal arches, ventral-specific edn1-mediated proliferation of neural crest derived cells is required for DV expansion and outgrowth, and that this positive regulation is counterbalanced by a negative one exerted through a pivotal, ventrally expressed Edn1-target gene, hand2. We also describe a new morphogenetic cell movement in the ventral first arch, sweeping cells anterior in the arch to the region where the lower jaw forms. This movement is negatively regulated by hand2 in an apparently edn1-independent fashion. These findings point to complexity of regulation by edn1 and hand2 at the earliest stages of pharyngeal arch development, in which control of growth and morphogenesis can be genetically separated.	[Sasaki, Mark M.; Nichols, James T.; Kimmel, Charles B.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nichols, JT (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	jnichols@uoneuro.uoregon.edu		Nichols, James/0000-0002-7263-1704	National Institutes of Health (NIH) [RO1 DE13834, PO1HD22486, F32-086027, F32-DE019056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) RO1 DE13834 and PO1HD22486, and a NIH postdoctoral fellowships F32-086027 (to JTN) and F32-DE019056 (to MMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, INT J DEV BIOL, V51, P97, DOI 10.1387/ijdb.062237ma; Aiyer AR, 2005, DEV BIOL, V278, P155, DOI 10.1016/j.ydbio.2004.11.001; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Bagnato A, 1997, CANCER RES, V57, P1306; Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bonano M, 2008, DEV BIOL, V323, P114, DOI 10.1016/j.ydbio.2008.08.007; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Clouthier DE, 2000, DEV BIOL, V217, P10, DOI 10.1006/dbio.1999.9527; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Del Bufalo D, 2002, CLIN SCI, V103, p302S, DOI 10.1042/CS103S302S; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Kempf H, 1998, DEVELOPMENT, V125, P4931; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Nichols JT, 2013, DEVELOPMENT IN PRESS; Piotrowski T, 1996, DEVELOPMENT, V123, P345; ROHLF FJ, 2005, TPS DIG VERSION 2 04; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Schilling TF, 1996, DEVELOPMENT, V123, P329; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tavares ALP, 2012, DEV BIOL, V371, P47, DOI 10.1016/j.ydbio.2012.08.003; Thomas T, 1998, DEVELOPMENT, V125, P3005; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zuniga E, 2011, DEVELOPMENT, V138, P5147, DOI 10.1242/dev.067785; Zuniga E, 2010, DEVELOPMENT, V137, P1843, DOI 10.1242/dev.049056	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67522	10.1371/journal.pone.0067522	http://dx.doi.org/10.1371/journal.pone.0067522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826316	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400156
J	Tewari-Singh, N; Jain, AK; Inturi, S; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; White, Carl W.; Agarwal, Rajesh			Clinically-Relevant Cutaneous Lesions by Nitrogen Mustard: Useful Biomarkers of Vesicants Skin Injury in SKH-1 Hairless and C57BL/6 Mice	PLOS ONE			English	Article							SULFIDE-INDUCED SKIN; SULFUR MUSTARD; NONINVASIVE METHODS; IRANIAN VETERANS; DNA-DAMAGE; GUINEA-PIG; MOUSE SKIN; EXPOSURE; MODEL; COMPLICATIONS	A paucity of clinically applicable biomarkers to screen therapies in laboratory is a limitation in the development of countermeasures against cutaneous injuries by chemical weapon, sulfur mustard (SM), and its analog nitrogen mustard (NM). Consequently, we assessed NM-caused progression of clinical cutaneous lesions; notably, skin injury with NM is comparable to SM. Exposure of SKH-1 hairless and C57BL/6 (haired) mice to NM (3.2 mg) for 12-120 h caused clinical sequelae of toxicity, including microblister formation, edema, erythema, altered pigmentation, wounding, xerosis and scaly dry skin. These toxic effects of NM were similar in both mouse strains, except that wounding and altered pigmentation at 12-24 h and appearance of dry skin at 24 and 72 h post-NM exposure were more pronounced in C57BL/6 compared to SKH-1 mice. Conversely, edema, erythema and microblister formation were more prominent in SKH-1 than C57BL/6 mice at 24-72 h after NM exposure. In addition, 40-60% mortality was observed following 120 h of NM exposure in the both mouse strains. Overall, these toxic effects of NM are comparable to those reported in humans and other animal species with SM, and thus represent clinically-relevant cutaneous injury endpoints in screening and optimization of therapies for skin injuries by vesicating agents.	[Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Rajesh] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [White, Carl W.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA.	Rajesh.Agarwal@ucdenver.edu			Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Countermeasures Against Chemical Threats (CounterACT) Program, Office of the Director National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), [Grant Number U54 ES015678]. The study sponsors have no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P297, DOI 10.1111/j.1472-8206.2005.00325.x; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Casillas RP, 2000, J APPL TOXICOL, V21, pS145; Clery-Barraud C, 2013, SKIN RES TECHNOL, V19, pE146, DOI 10.1111/j.1600-0846.2012.00621.x; Dachir S, 2010, SKIN RES TECHNOL, V16, P114, DOI 10.1111/j.1600-0846.2009.00409.x; Dorandeu F, 2011, HUM EXP TOXICOL, V30, P470, DOI 10.1177/0960327110373615; DORR RT, 1988, CANCER CHEMOTH PHARM, V22, P299; Emadi SN, 2012, CUTAN OCUL TOXICOL, V31, P214, DOI 10.3109/15569527.2011.641196; Emadi SN, 2011, CUTAN OCUL TOXICOL, V30, P170, DOI 10.3109/15569527.2010.539585; Evison D, 2002, BRIT MED J, V324, P332, DOI 10.1136/bmj.324.7333.332; Firooz A, 2011, CUTAN OCUL TOXICOL, V30, P64, DOI 10.3109/15569527.2010.529547; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Graham John S, 2005, J Burns Wounds, V4, pe1; Henemyre-Harris Claudia L, 2008, Eplasty, V8, pe16; Jain AK, 2011, TOXICOL LETT, V205, P293, DOI 10.1016/j.toxlet.2011.06.019; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Joseph LB, 2011, EXP MOL PATHOL, V91, P515, DOI 10.1016/j.yexmp.2011.05.010; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Kehe Kai, 2008, Eplasty, V8, pe32; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; Naraghi ZS, 2005, EUR J DERMATOL, V15, P140; Pal A, 2009, FREE RADICAL BIO MED, V47, P1640, DOI 10.1016/j.freeradbiomed.2009.09.011; Panahi Y., 2007, SMJ Singapore Medical Journal, V48, P392; Reid FM, 2007, SKIN RES TECHNOL, V13, P217, DOI 10.1111/j.1600-0846.2007.00204.x; Rowell M, 2009, TOXICOLOGY, V263, P9, DOI 10.1016/j.tox.2009.05.015; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Sharma M, 2010, INT J TOXICOL, V29, P391, DOI 10.1177/1091581810365730; Sharma M, 2009, TOXICOL LETT, V188, P243, DOI 10.1016/j.toxlet.2009.04.015; Shohrati M, 2007, CUTAN OCUL TOXICOL, V26, P249, DOI 10.1080/15569520701212340; Smith KJ, 1997, J DERMATOL SCI, V14, P126, DOI 10.1016/S0923-1811(96)00560-9; Smith KJ, 1998, AM J DERMATOPATH, V20, P22, DOI 10.1097/00000372-199802000-00005; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Vallet V, 2012, CUTAN OCUL TOXICOL, V31, P38, DOI 10.3109/15569527.2011.609206; WAHLBERG JE, 1993, CONTACT DERMATITIS, V28, P141, DOI 10.1111/j.1600-0536.1993.tb03374.x; Wang GQ, 2007, BURNS, V33, P923, DOI 10.1016/j.burns.2006.11.004; Wormser U, 2002, ARCH TOXICOL, V76, P119, DOI 10.1007/s00204-001-0307-5	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67557	10.1371/journal.pone.0067557	http://dx.doi.org/10.1371/journal.pone.0067557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826320	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400158
J	Gefenaite, G; Tacken, M; Bos, J; Stirbu-Wagner, I; Korevaar, JC; Stolk, RP; Wolters, B; Bijl, M; Postma, MJ; Wilschut, J; Nichol, KL; Hak, E				Gefenaite, Giedre; Tacken, Margot; Bos, Jens; Stirbu-Wagner, Irina; Korevaar, Joke C.; Stolk, Ronald P.; Wolters, Bert; Bijl, Marc; Postma, Maarten J.; Wilschut, Jan; Nichol, Kristin L.; Hak, Eelko			Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination	PLOS ONE			English	Article							PANDEMIC INFLUENZA; PRIMARY-CARE; SAFETY; IMMUNOGENICITY; COHORT; RISK; AGE	Introduction: Because of variability in published A(H1N1)pdm09 influenza vaccine effectiveness estimates, we conducted a study in the adults belonging to the risk groups to assess the A(H1N1)pdm09 MF59-adjuvanted influenza vaccine effectiveness. Methods: VE against influenza and/or pneumonia was assessed in the cohort study (n>25000), and vaccine effectiveness against laboratory-confirmed A(H1N1)pdm09 influenza was assessed in a matched case-control study (16 pairs). Odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated by using multivariate logistic regression; vaccine effectiveness was estimated as (1-odds ratio)*100%. Results: Vaccine effectiveness against laboratory-confirmed A(H1N1)pdm09 influenza and influenza and/or pneumonia was 98% (84-100%) and 33% (2-54%) respectively. The vaccine did not prevent influenza and/or pneumonia in 18-59 years old subjects, and was 49% (16-69%) effective in 60 years and older subjects. Conclusions: Even though we cannot entirely rule out that selection bias, residual confounding and/or cross-protection has played a role, the present results indicate that the MF59-adjuvanted A(H1N1)pdm09 influenza vaccine has been effective in preventing laboratory-confirmed A(H1N1)pdm09 influenza and influenza and/or pneumonia, the latter notably in 60 years and older subjects.	[Gefenaite, Giedre; Bos, Jens; Postma, Maarten J.; Hak, Eelko] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Gefenaite, Giedre; Stolk, Ronald P.; Postma, Maarten J.; Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands; [Tacken, Margot] Radboud Univ Nijmegen, Sci Inst Qual Healthcare IQ Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Stirbu-Wagner, Irina; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Wolters, Bert] Community Hlth Serv, Groningen, Netherlands; [Bijl, Marc] Martini Hosp, Dept Internal Med & Rheumatol, Groningen, Netherlands; [Wilschut, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands; [Nichol, Kristin L.] Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA; [Nichol, Kristin L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Groningen; University of Groningen; Radboud University Nijmegen; Netherlands Institute for Health Services Research; Martini Hospital; University of Groningen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Gefenaite, G (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	g.gefenaite@umcg.nl	Tacken, M.A.J.B./L-4679-2015	Postma, Maarten/0000-0002-6306-3653; Stolk, Ronald/0000-0002-0518-1205; Gefenaite, Giedre/0000-0001-9952-9446	University of Groningen, University Medical Center Groningen, the Netherlands	University of Groningen, University Medical Center Groningen, the Netherlands(Netherlands Government)	The work was supported by the University of Groningen, University Medical Center Groningen, the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cheong HJ, 2011, CLIN VACCINE IMMUNOL, V18, P1358, DOI 10.1128/CVI.05111-11; Donker G, 2011, CONTINUOUS MORBIDITY; EMEA, 2010, ANN 1 SUMM PROD CHAR; FluNet Global Influenza Surveillance and Response System (GISRS), 2013, GLOB INFL SURV RESP; Fukase H, 2012, VACCINE, V30, P5030, DOI 10.1016/j.vaccine.2012.03.053; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Groenwold RHH, 2009, EUR RESPIR J, V34, P56, DOI 10.1183/09031936.00190008; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Council of the Netherlands, 2009, VACC TEG PAND INFL A; Health Council of the Netherlands, 2007, GRIEPV HERZ IND; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lamberts H, 1996, INT J BIOMED COMPUT, V42, P35, DOI 10.1016/0020-7101(96)01179-8; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Rahamat-Langendoen JC, 2012, J CLIN VIROL, V54, P135, DOI 10.1016/j.jcv.2012.02.010; Rodriguez-Rieiro C, 2010, VACCINE, V28, P6203, DOI 10.1016/j.vaccine.2010.07.013; Soler JK, 2008, FAM PRACT, V25, P312, DOI 10.1093/fampra/cmn028; Steens A, 2011, EUROSURVEILLANCE, V16, P23; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Tacken M, 2010, MONITORING VACCINATI; Tacken MAJB, 2013, VACCINE, V31, P900, DOI 10.1016/j.vaccine.2012.12.002; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Weiner MG, 2008, PHARMACOEPIDEM DR S, V17, P661, DOI 10.1002/pds.1585; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66125	10.1371/journal.pone.0066125	http://dx.doi.org/10.1371/journal.pone.0066125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840413	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800035
J	Ohnishi, S; Maehara, O; Nakagawa, K; Kameya, A; Otaki, K; Fujita, H; Higashi, R; Takagi, K; Asaka, M; Sakamoto, N; Kobayashi, M; Takeda, H				Ohnishi, Shunsuke; Maehara, Osamu; Nakagawa, Koji; Kameya, Ayano; Otaki, Kanako; Fujita, Hirotoshi; Higashi, Ryosuke; Takagi, Kikuko; Asaka, Masahiro; Sakamoto, Naoya; Kobayashi, Masanobu; Takeda, Hiroshi			Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors	PLOS ONE			English	Article							CANCER STEM-CELLS; TUMOR-GROWTH; HEMATOPOIETIC STEM; PANCREATIC-CANCER; IDENTIFICATION; FACTOR-1-ALPHA; HIF-2-ALPHA; EXPRESSION; PROGNOSIS; EXPANSION	CD133 is a cellular surface protein that has been reported to be a cancer stem cell marker, and thus it is considered to be a potential target for cancer treatment. However, the mechanism regulating CD133 expression is not yet understood. In this study, we analyzed the activity of five putative promoters (P1-P5) of CD133 in human embryonic kidney (HEK) 293 cells and colon cancer cell line WiDr, and found that the activity of promoters, particularly of P5, is elevated by overexpression of hypoxia-inducible factors (HIF-1 alpha and HIF-2 alpha). Deletion and mutation analysis identified one of the two E-twenty six (ETS) binding sites (EBSs) in the P5 region as being essential for its promoter activity induced by HIF-1 alpha and HIF-2 alpha. In addition, a chromatin imunoprecipitation assay demonstrated that HIF-1 alpha and HIF-2 alpha bind to the proximal P5 promoter at the EBSs. The immunoprecipitation assay showed that HIF-1 alpha physically interacts with Elk1; however, HIF-2 alpha did not bind to Elk1 or ETS1. Furthermore, knockdown of both HIF-1 alpha and HIF-2 alpha resulted in a reduction of CD133 expression in WiDr. Taken together, our results revealed that HIF-1 alpha and HIF-2 alpha activate CD133 promoter through ETS proteins.	[Ohnishi, Shunsuke; Takagi, Kikuko; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Maehara, Osamu; Nakagawa, Koji; Kameya, Ayano; Otaki, Kanako; Fujita, Hirotoshi; Higashi, Ryosuke; Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Dept Pathophysiol & Therapeut, Sapporo, Hokkaido 060, Japan; [Asaka, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Canc Prevent Med, Sapporo, Hokkaido, Japan; [Kobayashi, Masanobu] Hlth Sci Univ Hokkaido, Dept Nursing, Ishikari, Hokkaido 06102, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Health Sciences University of Hokkaido	Ohnishi, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.	sonishi@pop.med.hokudai.ac.jp	Nakagawa, Koji/B-2889-2015; Takeda, Hiroshi/C-6551-2015; Ohnishi, Shunsuke/A-5982-2012	Ohnishi, Shunsuke/0000-0003-1194-4149	Japan Society for the Promotion of Science (JSPS); Yasuda Memorial Foundation; Grants-in-Aid for Scientific Research [24390185] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yasuda Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS), and by the Yasuda Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; FISHER RJ, 1991, ONCOGENE, V6, P2249; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Iida H, 2012, INT J ONCOL, V40, P71, DOI 10.3892/ijo.2011.1207; Karapetsas A, 2011, INT J BIOCHEM CELL B, V43, P1582, DOI 10.1016/j.biocel.2011.07.007; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rasheed S, 2009, BRIT J CANCER, V100, P1666, DOI 10.1038/sj.bjc.6605026; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sun C, 2012, J CANC RES CLIN ONCO; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	34	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66255	10.1371/journal.pone.0066255	http://dx.doi.org/10.1371/journal.pone.0066255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840432	Green Published, gold			2022-12-25	WOS:000322342800044
J	Gazdhar, A; Susuri, N; Hostettler, K; Gugger, M; Knudsen, L; Roth, M; Ochs, M; Geiser, T				Gazdhar, Amiq; Susuri, Njomeza; Hostettler, Katrin; Gugger, Mathias; Knudsen, Lars; Roth, Michael; Ochs, Matthias; Geiser, Thomas			HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; PERIPHERAL-BLOOD; FACTOR ACTIVATION; STROMAL CELLS; GENE-TRANSFER; LUNG; PATHOGENESIS; TISSUE; FIBROBLASTS	Background: Pulmonary fibrosis may result from abnormal alveolar wound repair after injury. Hepatocyte growth factor (HGF) improves alveolar epithelial wound repair in the lung. Stem cells were shown to play a major role in lung injury, repair and fibrosis. We studied the presence, origin and antifibrotic properties of HGF-expressing stem cells in usual interstitial pneumonia. Methods: Immunohistochemistry was performed in lung tissue sections and primary alveolar epithelial cells obtained from patients with usual interstitial pneumonia (UIP, n = 7). Bone marrow derived stromal cells (BMSC) from adult male rats were transfected with HGF, instilled intratracheally into bleomycin injured rat lungs and analyzed 7 and 14 days later. Results: In UIP, HGF was expressed in specific cells mainly located in fibrotic areas close to the hyperplastic alveolar epithelium. HGF-positive cells showed strong co-staining for the mesenchymal stem cell markers CD44, CD29, CD105 and CD90, indicating stem cell origin. HGF-positive cells also co-stained for CXCR4 (HGF+/CXCR4+) indicating that they originate from the bone marrow. The stem cell characteristics were confirmed in HGF secreting cells isolated from UIP lung biopsies. In vivo experiments showed that HGF-expressing BMSC attenuated bleomycin induced pulmonary fibrosis in the rat, indicating a beneficial role of bone marrow derived, HGF secreting stem cells in lung fibrosis. Conclusions: HGF-positive stem cells are present in human fibrotic lung tissue (UIP) and originate from the bone marrow. Since HGF-transfected BMSC reduce bleomycin induced lung fibrosis in the bleomycin lung injury and fibrosis model, we assume that HGF-expressing, bone-marrow derived stem cells in UIP have antifibrotic properties.	[Gazdhar, Amiq; Susuri, Njomeza; Geiser, Thomas] Univ Hosp Bern, Dept Pulm Med, CH-3010 Bern, Switzerland; [Gazdhar, Amiq; Susuri, Njomeza; Geiser, Thomas] Univ Bern, Dept Clin Res, Bern, Switzerland; [Gugger, Mathias] Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland; [Hostettler, Katrin; Roth, Michael] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Basel; Hannover Medical School	Geiser, T (corresponding author), Univ Hosp Bern, Dept Pulm Med, CH-3010 Bern, Switzerland.	thomas.geiser@insel.ch	Gazdhar, Amiq/AAJ-6835-2020; Knudsen, Lars/G-3146-2013; Roth, Michael/H-8657-2019; Gazdhar, Amiq/AAN-6024-2020	Gazdhar, Amiq/0000-0002-4807-8785; Knudsen, Lars/0000-0002-7926-3879; Roth, Michael/0000-0002-8139-2821; Hostettler, Katrin/0000-0001-8118-7441	Swiss national science foundation [SNF120-408]	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission)	This work supported by a Swiss national science foundation grant to Thomas Geiser (SNF120-408; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; Crestani B, 2002, LAB INVEST, V82, P1015, DOI 10.1097/01.LAB.0000024361.92500.19; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Galvin JR, 2010, RADIOLOGY, V255, P692, DOI 10.1148/radiol.10090717; Gazdhar A, 2007, AM J PHYSIOL-LUNG C, V292, pL529, DOI 10.1152/ajplung.00082.2006; Geiser T, 2003, SWISS MED WKLY, V133, P586; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Hsia CCW, 2010, RESP PHYSIOL NEUROBI, V171, P72, DOI 10.1016/j.resp.2010.02.016; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Jaffre S, 2002, AM J PHYSIOL-LUNG C, V282, pL310, DOI 10.1152/ajplung.00121.2001; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Karoubi G, 2009, LAB INVEST, V89, P1100, DOI 10.1038/labinvest.2009.73; KATZENSTEIN ALA, 1985, HUM PATHOL, V16, P1015, DOI 10.1016/S0046-8177(85)80279-3; Kim HJ, 1999, CHEST, V116, p94S, DOI 10.1378/chest.116.suppl_1.94S; Knudsen L, 2012, AM J RESP CRIT CARE, pA1987; Knudsen Lars, 2011, Expert Opin Med Diagn, V5, P319, DOI 10.1517/17530059.2011.577414; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; Kucia M, 2006, ARCH IMMUNOL THER EX, V54, P121, DOI 10.1007/s00005-006-0015-1; Kucia M, 2005, BIOL CELL, V97, P133, DOI 10.1042/BC20040069; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Leslie KO, 2011, ARCH PATHOL LAB MED; Leuenberger A, 2012, J APPL PHYSL; Marchand-Adam S, 2003, AM J RESP CRIT CARE, V168, P1156, DOI 10.1164/rccm.200212-1514OC; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nathan SD, 2011, CHEST, V140, P221, DOI 10.1378/chest.10-2572; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ohki Y, 2009, NEONATOLOGY, V95, P332, DOI 10.1159/000187651; Phin S, 2010, AM J RESP CELL MOL, V42, P286, DOI 10.1165/rcmb.2008-0305OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Sakai T, 1997, AM J RESP CELL MOL, V16, P388, DOI 10.1165/ajrcmb.16.4.9115749; SCHERLE W, 1970, Mikroskopie, V26, P57; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; SINGHKAW P, 1995, AM J PHYSIOL-LUNG C, V268, pL1012, DOI 10.1152/ajplung.1995.268.6.L1012; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Tjin EPM, 2005, J IMMUNOL, V175, P2807, DOI 10.4049/jimmunol.175.5.2807; Ueda H, 1997, VIRCHOWS ARCH, V430, P407, DOI 10.1007/s004280050050; Umeda Y, 2004, LAB INVEST, V84, P836, DOI 10.1038/labinvest.3700098; Watanabe M, 2005, MOL THER, V12, P58, DOI 10.1016/j.ymthe.2005.02.019; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wuyts WA, 2012, EUROPEAN RESP J; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	56	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65453	10.1371/journal.pone.0065453	http://dx.doi.org/10.1371/journal.pone.0065453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840329	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200018
J	Grosely, R; Kopanic, JL; Nabors, S; Kieken, F; Spagnol, G; Al-Mugotir, M; Zach, S; Sorgen, PL				Grosely, Rosslyn; Kopanic, Jennifer L.; Nabors, Sarah; Kieken, Fabien; Spagnol, Gaelle; Al-Mugotir, Mona; Zach, Sydney; Sorgen, Paul L.			Effects of Phosphorylation on the Structure and Backbone Dynamics of the Intrinsically Disordered Connexin43 C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNEL; CIRCULAR-DICHROISM SPECTROSCOPY; PROTEIN SECONDARY STRUCTURE; CARBOXYL-TERMINUS; MOLECULAR RECOGNITION; TRANSMEMBRANE DOMAIN; BINDING; COMMUNICATION; EVENT; SRC	Phosphorylation of the connexin43 C-terminal (Cx43CT) domain regulates gap junction intercellular communication. However, an understanding of the mechanisms by which phosphorylation exerts its effects is lacking. Here, we test the hypothesis that phosphorylation regulates Cx43 gap junction intercellular communication by mediating structural changes in the C-terminal domain. Circular dichroism and nuclear magnetic resonance were used to characterize the effects of phosphorylation on the secondary structure and backbone dynamics of soluble and membrane-tethered Cx43CT domains. Cx43CT phospho-mimetic isoforms, which have Asp substitutions at specific Ser/Tyr sites, revealed phosphorylation alters the alpha-helical content of the Cx43CT domain only when attached to the membrane. The changes in secondary structure are due to variations in the conformational preference and backbone flexibility of residues adjacent and distal to the site(s) of modification. In addition to the known direct effects of phosphorylation on molecular partner interactions, the data presented here suggest phosphorylation may also indirectly regulate binding affinity by altering the conformational preference of the Cx43CT domain.	[Grosely, Rosslyn; Kopanic, Jennifer L.; Nabors, Sarah; Kieken, Fabien; Spagnol, Gaelle; Al-Mugotir, Mona; Zach, Sydney; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health Grant from USPHS [GM07263]; Graduate Assistance in Areas of National Need Fellowship; McDonald Fellowship; Regents Tuitions Fellowship; Fred W. Upson grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health Grant from USPHS; Graduate Assistance in Areas of National Need Fellowship; McDonald Fellowship; Regents Tuitions Fellowship; Fred W. Upson grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07263 from USPHS.; Supported by a Graduate Assistance in Areas of National Need Fellowship, McDonald Fellowship, Regents Tuitions Fellowship, and a Fred W. Upson grant.	Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Chen JH, 2012, ARCH BIOCHEM BIOPHYS, V524, P123, DOI 10.1016/j.abb.2012.04.024; Cheng A, 2003, CELL COMMUN ADHES, V10, P187, DOI 10.1080/714040425; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; Chung TH, 2007, J CELL BIOCHEM, V100, P653, DOI 10.1002/jcb.21018; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Dobrowolski R, 2009, ANTIOXID REDOX SIGN, V11, P283, DOI 10.1089/ars.2008.2128; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Grosely R., 2012, BIOMOL NMR IN PRESS; Grosely R, 2010, CELL COMMUN ADHES, V17, P23, DOI 10.3109/15419061.2010.487956; Huang RYC, 2011, J PROTEOME RES, V10, P1098, DOI 10.1021/pr1008702; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellezi A, 2008, PROTEIN EXPRES PURIF, V59, P215, DOI 10.1016/j.pep.2008.01.023; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lau A. F., 2005, SCI STKE 2005, V2005, pe33; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Muratore KE, 2007, ACS CHEM BIOL, V2, P454, DOI 10.1021/cb7001285; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Pancsa R, 2012, IUBMB LIFE, V64, P513, DOI 10.1002/iub.1034; Park DJ, 2006, PROTEIN SCI, V15, P2344, DOI 10.1110/ps.062172506; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Severs NJ, 2007, CIRC RES, V101, P1213, DOI 10.1161/CIRCRESAHA.107.165662; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SMITH CL, 1989, J VIROL, V63, P1569, DOI 10.1128/JVI.63.4.1569-1577.1989; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2002, J BIOMOL NMR, V23, P245, DOI 10.1023/A:1019892719979; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Whitmore L, 2010, STRUCTURE, V18, P1267, DOI 10.1016/j.str.2010.08.008; Wikstrom A, 1999, J MOL BIOL, V289, P963, DOI 10.1006/jmbi.1999.2806; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	65	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24857	24870		10.1074/jbc.M113.454389	http://dx.doi.org/10.1074/jbc.M113.454389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828237	Green Published, hybrid			2022-12-25	WOS:000330612300050
J	d'Avo, AF; Cunha, S; Mingote, A; Lamosa, P; da Costa, MS; Costa, J				d'Avo, Ana Filipa; Cunha, Sofia; Mingote, Ana; Lamosa, Pedro; da Costa, Milton S.; Costa, Joana			A Unique Pool of Compatible Solutes on Rhodopirellula baltica, Member of the Deep-Branching Phylum Planctomycetes	PLOS ONE			English	Article							CYANOBACTERIA; EVOLUTION; GLUCOSYLGLYCERATE; OSMOADAPTATION; MICROORGANISMS; HETEROGENEITY; ACCUMULATION; ENVIRONMENTS; DIVERSITY; PIRELLULA	The intracellular accumulation of small organic solutes was described in the marine bacterium Rhodopirellula baltica, which belongs to the globally distributed phylum Planctomycetes whose members exhibit an intriguing lifestyle and cell morphology. Sucrose, alpha-glutamate, trehalose and mannosylglucosylglycerate (MGG) are the main solutes involved in the osmoadaptation of R. baltica. The ratio and total intracellular organic solutes varied significantly in response to an increase in salinity, temperature and nitrogen content. R. baltica displayed an initial response to both osmotic and thermal stresses that includes alpha-glutamate accumulation. This trend was followed by a rather unique and complex osmoadaptation mechanism characterized by a dual response to sub-optimal and supra-optimal salinities. A reduction in the salinity to suboptimal conditions led primarily to the accumulation of trehalose. In contrast, R. baltica responded to salt stress mostly by increasing the intracellular levels of sucrose. The switch between the accumulation of trehalose and sucrose was by far the most significant effect caused by increasing the salt levels of the medium. Additionally, MGG accumulation was found to be salt- as well as nitrogen-dependent. MGG accumulation was regulated by nitrogen levels replacing alpha-glutamate as a K+ counterion in nitrogen-poor environments. This is the first report of the accumulation of compatible solutes in the phylum Planctomycetes and of the MGG accumulation in a mesophilic organism.	[d'Avo, Ana Filipa; Cunha, Sofia; da Costa, Milton S.; Costa, Joana] Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal; [Mingote, Ana] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Lamosa, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Ctr Ressonancia Magnet Antonio Xavier, P-2780156 Oeiras, Portugal; [da Costa, Milton S.; Costa, Joana] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade de Coimbra	Costa, J (corresponding author), Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal.	jcosta@cnc.uc.pt	Costa, Joana/B-9176-2009	Costa, Joana/0000-0001-7028-2873; Cunha, Sofia/0000-0001-7113-3108; Lamosa, Pedro/0000-0002-3003-1516; da Costa, Milton/0000-0003-4027-4412	Fundacao para a Ciencia e a Tecnologia [PEst-C/SAU/LA0001/2011, PTDC/BIA-MIC/105247/2008]; FCT [SFRH/BD/46212/2008, SFRH/BPD/34007/2006]; POCI [REDE/1517/RMN/2005]; Fundacao para a Ciencia e a Tecnologia	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POCI(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The research was funded by Fundacao para a Ciencia e a Tecnologia under the projects PEst-C/SAU/LA0001/2011 and PTDC/BIA-MIC/105247/2008. SC and JC acknowledge scholarships from FCT (SFRH/BD/46212/2008 and SFRH/BPD/34007/2006). The National NMR Network (REDE/1517/RMN/2005) was supported by POCI 2010 and Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Costa J, 2013, WOODH PUB SER BIOMED, P465, DOI 10.1533/9781908818355.3.465; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Fernandes C, 2010, J BACTERIOL, V192, P1624, DOI 10.1128/JB.01424-09; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Goude R, 2004, APPL ENVIRON MICROB, V70, P6535, DOI 10.1128/AEM.70.11.6535-6541.2004; Jorge CD, 2007, FEBS J, V274, P3120, DOI 10.1111/j.1742-4658.2007.05844.x; Khmelenina VN, 1999, ARCH MICROBIOL, V172, P321, DOI 10.1007/s002030050786; Klahn S, 2011, ENVIRON MICROBIOL, V13, P551, DOI 10.1111/j.1462-2920.2010.02366.x; Klahn S, 2010, ENVIRON MICROBIOL, V12, P83, DOI 10.1111/j.1462-2920.2009.02045.x; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; Lyman J, 1940, J MAR RES, V3, P134; REED RH, 1986, FEMS MICROBIOL LETT, V39, P51; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Santos H, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P86; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Silva Z, 1999, EXTREMOPHILES, V3, P163, DOI 10.1007/s007920050112; STALEY JT, 1968, J BACTERIOL, V95, P1921, DOI 10.1128/JB.95.5.1921-1942.1968; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410	27	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68289	10.1371/journal.pone.0068289	http://dx.doi.org/10.1371/journal.pone.0068289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826385	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000138
J	Li, P; Li, SF; Han, HY; Dong, ZY; Luo, J; Guo, ZH; Xiong, HF; Zang, YF; Li, ZJ				Li Ping; Li Su-Fang; Han Hai-Ying; Dong Zhang-Ye; Luo Jia; Guo Zhi-Hua; Xiong Hong-Fang; Zang Yu-Feng; Li Zhan-Jiang			Abnormal Spontaneous Neural Activity in Obsessive-Compulsive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							REGIONAL HOMOGENEITY; RESPONSE-INHIBITION; COGNITIVE FLEXIBILITY; SYMPTOM IMPROVEMENT; BRAIN ACTIVATION; MOTOR INHIBITION; DEFAULT MODE; CONNECTIVITY; CORTEX; DEPRESSION	Neuroimaging studies of obsessive-compulsive disorder have found abnormalities in orbitofronto-striato-thalamic circuitry, including the orbitofrontal cortex, anterior cingulate cortex, caudate, and thalamus, but few studies have explored abnormal intrinsic or spontaneous brain activity in the resting state. We investigated both intra- and inter-regional synchronized activity in twenty patients with obsessive-compulsive disorder and 20 healthy controls using resting-state functional magnetic resonance imaging. Regional homogeneity (ReHo) and functional connectivity methods were used to analyze the intra- and inter-regional synchronized activity, respectively. Compared with healthy controls, patients with obsessive-compulsive disorder showed significantly increased ReHo in the orbitofrontal cortex, cerebellum, and insula, and decreased ReHo in the ventral anterior cingulate cortex, caudate, and inferior occipital cortex. Based on ReHo results, we determined functional connectivity differences between the orbitofrontal cortex and other brain regions in both patients with obsessive-compulsive disorder and controls. We found abnormal functional connectivity between the orbitofrontal cortex and ventral anterior cingulate cortex in patients with obsessive-compulsive disorder compared with healthy controls. Moreover, ReHo in the orbitofrontal cortex was correlated with the duration of obsessive-compulsive disorder. These findings suggest that increased intra- and inter-regional synchronized activity in the orbitofrontal cortex may have a key role in the pathology of obsessive-compulsive disorder. In addition to orbitofronto-striato-thalamic circuitry, brain regions such as the insula and cerebellum may also be involved in the pathophysiology of obsessive-compulsive disorder.	[Li Ping] Qiqihaer Med Univ, Dept Psychiat, Qiqihar, Heilongjiang, Peoples R China; [Li Ping; Han Hai-Ying; Luo Jia; Guo Zhi-Hua; Xiong Hong-Fang; Li Zhan-Jiang] Capital Med Univ, Beijing Anding Hosp, Dept Psychiat & Clin Psychol, Beijing, Peoples R China; [Li Su-Fang; Dong Zhang-Ye; Zang Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zang Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Qiqihar Medical University; Capital Medical University; Beijing Normal University; Hangzhou Normal University; Hangzhou Normal University	Zang, YF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@gmail.com; Lizhj8@ccmu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Li, Sufang/N-5697-2016	ZANG, Yu-Feng/0000-0003-1833-8010; Li, Sufang/0000-0002-4716-4761	Natural Sciences Foundation of China [81141016]; Beijing Natural Science Foundation [7122082]; National Technology Support Programs [2009BAI77B11]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China [ICBIR_C_0044_001]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Technology Support Programs; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China	This work was supported by the Natural Sciences Foundation of China (81141016); Beijing Natural Science Foundation (7122082); National Technology Support Programs (2009BAI77B11); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, China (ICBIR_C_0044_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chamberlain SR, 2007, AM J PSYCHIAT, V164, P335, DOI 10.1176/appi.ajp.164.2.335; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; DiNardo Brown Barlow, 1994, ANXIETY DISORDERS IN; First MB, 2001, STRUCTURED CLIN INTE; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freyer T, 2010, PSYCHOL MED, V1, P1; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hansen ES, 2002, INT J NEUROPSYCHOPH, V5, P1, DOI [10.1017/S1461145701002681, 10.1017/S14611457011002681]; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Jang JH, 2006, AM J PSYCHIAT, V163, P1202, DOI 10.1176/appi.ajp.163.7.1202; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Kwon JS, 2009, EXPERT REV NEUROTHER, V9, P255, DOI 10.1586/14737175.9.2.255; Lazaro L, 2008, J PSYCHIATR RES, V42, P1051, DOI 10.1016/j.jpsychires.2007.12.007; Li P, 2012, NEUROREPORT, V23, P681, DOI 10.1097/WNR.0b013e328355a5fe; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nabeyama M, 2008, PSYCHIAT RES-NEUROIM, V163, P236, DOI 10.1016/j.pscychresns.2007.11.001; Nakao T, 2005, BIOL PSYCHIAT, V57, P901, DOI 10.1016/j.biopsych.2004.12.039; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Penades R, 2007, EUR PSYCHIAT, V22, P404, DOI 10.1016/j.eurpsy.2006.05.001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Salkovskis P. M., 1995, BEHAV COGN PSYCHOTH, V23, P281, DOI DOI 10.1017/S1352465800015885; Sanematsu H, 2010, J PSYCHIATR RES, V44, P193, DOI 10.1016/j.jpsychires.2009.08.007; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Saxena S, 2001, BIOL PSYCHIAT, V50, P159, DOI 10.1016/S0006-3223(01)01123-4; Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013; Schwartz JM., 1999, J CONSCIOUSNESS STUD, V6, P115; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	58	18	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67262	10.1371/journal.pone.0067262	http://dx.doi.org/10.1371/journal.pone.0067262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826251	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000051
J	Mogren, CL; Walton, WE; Parker, DR; Trumble, JT				Mogren, Christina L.; Walton, William E.; Parker, David R.; Trumble, John T.			Trophic Transfer of Arsenic from an Aquatic Insect to Terrestrial Insect Predators	PLOS ONE			English	Article							CONTAMINANTS; BIOACCUMULATION; WATER; PREY; METHYLMERCURY; ACCUMULATION; ARTHROPODS; TRANSPORT; ABUNDANCE; TOXICITY	The movement of energy and nutrients from aquatic to terrestrial ecosystems can be substantial, and emergent aquatic insects can serve as biovectors not only for nutrients, but also for contaminants present in the aquatic environment. The terrestrial predators Tenodera aridifolia sinensis (Mantodea: Mantidae) and Tidarren haemorrhoidale (Araneae: Theridiidae) and the aquatic predator Buenoa scimitra (Hemiptera: Notonectidae) were chosen to evaluate the efficacy of arsenic transfer between aquatic and terrestrial environments. Culex tarsalis larvae were reared in either control water or water containing 1000 mu g l(-1) arsenic. Adults that emerged from the control and arsenic treatments were fed to the terrestrial predators, and fourth instar larvae were fed to the aquatic predator reared in control or arsenic contaminated water. Tenodera a. sinensis fed arsenic-treated Cx. tarsalis accumulated 658 +/- 130 ng g(-1) of arsenic. There was no significant difference between control and arsenic-fed T. haemorrhoidale (range 142-290 ng g(-1)). Buenoa scimitra accumulated 5120 +/- 406 ng g(-1) of arsenic when exposed to arsenic-fed Cx. tarsalis and reared in water containing 1000 mu g l(-1) arsenic. There was no significant difference between controls or arsenic-fed B. scimitra that were not exposed to water-borne arsenic, indicating that for this species environmental exposure was more important in accumulation than strictly dietary arsenic. These results indicate that transfer to terrestrial predators may play an important role in arsenic cycling, which would be particularly true during periods of mass emergence of potential insect biovectors. Trophic transfer within the aquatic environment may still occur with secondary predation, or in predators with different feeding strategies.	[Mogren, Christina L.; Walton, William E.; Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Parker, David R.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Mogren, CL (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	christina.mogren@email.ucr.edu	Mogren, Christina/W-4699-2019	Mogren, Christina/0000-0002-9164-7197	UCR Entomology Department	UCR Entomology Department	The research in this manuscript was supported in part by the UCR Entomology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Akamatsu F, 2011, ENVIRON POLLUT, V159, P1390, DOI 10.1016/j.envpol.2011.01.005; Albert CA, 2008, ENVIRON TOXICOL CHEM, V27, P605, DOI 10.1897/07-147.1; Andrahennadi R, 2008, ENVIRON CHEM, V5, P413, DOI 10.1071/EN08065; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Burghelea CI, 2011, J ENVIRON MONITOR, V13, P1308, DOI 10.1039/c1em10016e; Chen X., 2003, REGRESSION SAS; Croisetiere L, 2006, ENVIRON SCI TECHNOL, V40, P873, DOI 10.1021/es0516209; Culioli JL, 2009, AQUAT TOXICOL, V94, P286, DOI 10.1016/j.aquatox.2009.07.016; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1002/etc.5620200108, 10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2]; Dreyer J, 2012, OIKOS, V121, P252, DOI 10.1111/j.1600-0706.2011.19588.x; Dutton J, 2011, SCI TOTAL ENVIRON, V409, P3438, DOI 10.1016/j.scitotenv.2011.05.022; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Gade G, 2004, PHYSIOL ENTOMOL, V29, P84, DOI 10.1111/j.0307-6962.2004.0375.x; Gratton C, 2008, ECOSYSTEMS, V11, P764, DOI 10.1007/s10021-008-9158-8; Green K, 2008, ARCT ANTARCT ALP RES, V40, P74, DOI 10.1657/1523-0430(06-100)[GREEN]2.0.CO;2; Green Ken, 2001, Victorian Naturalist (Blackburn), V118, P112; Hazelrigg JE, 1973, THESIS U CALIFORNIA; Hoekman D, 2012, OECOLOGIA, V170, P735, DOI 10.1007/s00442-012-2329-5; Hopkins WA, 2002, ENVIRON TOXICOL CHEM, V21, P906, DOI 10.1897/1551-5028(2002)021<0906:EOCDET>2.0.CO;2; Hughes MF, 2002, ECOPHYSIOLOGY METALS; Jensen PD, 2007, ENVIRON TOXICOL, V22, P287, DOI 10.1002/tox.20254; Kaltenpoth M, 2005, ENTOMOL GEN, V28, P1; Kral K, 2012, EUR J ENTOMOL, V109, P295, DOI 10.14411/eje.2012.039; Lavilla I, 2010, J ENVIRON MONITOR, V12, P724, DOI 10.1039/b920379f; Levi H. W., 1957, Journal of the New York Entomological Society, V63, P59; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Martin S, 2008, LIMNOL OCEANOGR, V53, P411, DOI 10.4319/lo.2008.53.2.0411; Mason RP, 2000, ARCH ENVIRON CON TOX, V38, P283, DOI 10.1007/s002449910038; MENZIE CA, 1980, WATER AIR SOIL POLL, V13, P473, DOI 10.1007/BF02191848; Mogren CL, 2013, ENVIRON POLLUT, V180, P78, DOI 10.1016/j.envpol.2013.05.021; Mogren CL, 2012, SCI TOTAL ENVIRON, V425, P60, DOI 10.1016/j.scitotenv.2012.03.009; Morrissey CA, 2008, ECOL APPL, V18, P172, DOI 10.1890/07-0015.1; Morrissey CA, 2007, ENVIRON SCI TECHNOL, V41, P1494, DOI 10.1021/es061967r; Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008; Nriagu JO, 1994, ARSENIC ENV; NYFFELER M, 1988, SOUTHWEST NAT, V33, P215, DOI 10.2307/3671897; Ortiz JGM, 2009, TOXICOL SCI, V107, P416, DOI 10.1093/toxsci/kfn192; Ravenscroft P., 2009, ARSENIC POLLUTION GL; Ringmann S, 2002, ANAL CHIM ACTA, V452, P207, DOI 10.1016/S0003-2670(01)01477-5; Rodriguez-Castro VA, 2006, J AM MOSQUITO CONTR, V22, P123, DOI 10.2987/8756-971X(2006)22[123:MRAERO]2.0.CO;2; Runck C, 2007, ECOL APPL, V17, P740, DOI 10.1890/05-1026; Schmidt-Rhaesa A, 2001, ZOOL ANZ, V240, P167, DOI 10.1078/0044-5231-00014; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; STEWART KW, 1970, ANN ENTOMOL SOC AM, V63, P139, DOI 10.1093/aesa/63.1.139; Sullivan SMP, 2012, ENVIRON TOXICOL CHEM, V31, P1175, DOI 10.1002/etc.1842; Torres KC, 2001, ENVIRON TOXICOL CHEM, V20, P2617, DOI [10.1002/etc.5620201130, 10.1897/1551-5028(2001)020&lt;2617:BOMIPA&gt;2.0.CO;2]; U.S. EPA, 2006, NAT REC WAT QUAL CRI; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; ZAMAN K, 1995, ARCH INSECT BIOCHEM, V29, P199, DOI 10.1002/arch.940290209; ZHANG ML, 1993, J CHEM ECOL, V19, P1109, DOI 10.1007/BF00987372; Zhang ZM, 2012, FRONT EARTH SCI-PRC, V6, P433, DOI 10.1007/s11707-012-0301-7	53	24	24	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67817	10.1371/journal.pone.0067817	http://dx.doi.org/10.1371/journal.pone.0067817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826344	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000101
J	Muller, BM; Keil, E; Lehmann, A; Winzer, KJ; Richter-Ehrenstein, C; Prinzler, J; Bangemann, N; Reles, A; Stadie, S; Schoenegg, W; Eucker, J; Schmidt, M; Lippek, F; Johrens, K; Pahl, S; Sinn, BV; Budczies, J; Dietel, M; Denkert, C				Mueller, Berit Maria; Keil, Elke; Lehmann, Annika; Winzer, Klaus-Juergen; Richter-Ehrenstein, Christiane; Prinzler, Judith; Bangemann, Nikola; Reles, Angela; Stadie, Sylvia; Schoenegg, Winfried; Eucker, Jan; Schmidt, Marcus; Lippek, Frank; Joehrens, Korinna; Pahl, Stefan; Sinn, Bruno Valentin; Budczies, Jan; Dietel, Manfred; Denkert, Carsten			The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; EARLY BREAST-CANCER; INTERNATIONAL EXPERT CONSENSUS; RECURRENCE SCORE ASSAY; ESTROGEN-RECEPTOR; PRIMARY THERAPY; MESSENGER-RNA; HIGHLIGHTS; EXTRACTION; SURVIVAL	The validated EndoPredict assay is a novel tool to predict the risk of metastases of patients with estrogen receptor positive, HER2 negative breast cancer treated with endocrine therapy alone. It has been designed to integrate genomic and clinical information and includes clinico-pathological factors such as tumor size and nodal status. The test is feasible in a decentral setting in molecular pathology laboratories. In this project, we investigated the performance of this test in clinical practice, and performed a retrospective evaluation of its impact on treatment decisions in breast cancer. During one year, EndoPredict assays from 167 patients could be successfully performed. For retrospective evaluation of treatment decisions, a questionnaire was sent to the clinical partner. Regarding the molecular EP class, samples from 56 patients (33.5%) had a low-risk, whereas 111 patients (66.5%) showed a high-risk gene profile. After integration of the clinicopathological factors the combined clinical and molecular score (EPclin) resulted in a low-risk group of 77 patients (46.4%), while 89 (53.6%) had a high risk EPclin score. The EPclin-based estimated median 10-year-risk for metastases with endocrine therapy alone was 11% for the whole cohort. The median handling time averaged three days (range: 0 to 11 days), 59.3% of the tests could be performed in three or less than three days. Comparison of pre- and post-test therapy decisions showed a change of therapy in 37.7% of patients. 16 patients (12.3%) had a change to an additional chemotherapy while 25.4% of patients (n = 33) changed to an endocrine therapy alone. In 73 patients (56.2%) no change of therapy resulted. In 6.1% of patients (n = 8), the patients did not agree to the recommendation of the tumor board. Our results show that the EndoPredict assay could be routinely performed in decentral molecular pathology laboratories and the results markedly change treatment decisions.	[Mueller, Berit Maria; Lehmann, Annika; Prinzler, Judith; Joehrens, Korinna; Pahl, Stefan; Sinn, Bruno Valentin; Budczies, Jan; Dietel, Manfred; Denkert, Carsten] Charite, Inst Pathol, Berlin, Germany; [Keil, Elke; Stadie, Sylvia] Breast Ctr, Berlin, Germany; [Winzer, Klaus-Juergen; Richter-Ehrenstein, Christiane; Bangemann, Nikola] Charite, Breast Ctr, Berlin, Germany; [Reles, Angela; Schoenegg, Winfried] Gynecol Clin, Berlin, Germany; [Eucker, Jan] Charite, Dept Internal Med, Berlin, Germany; [Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Breast Ctr, D-55122 Mainz, Germany; [Lippek, Frank] Inst Pathol, Neuruppin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz	Muller, BM (corresponding author), Charite, Inst Pathol, Campus Mitte, Berlin, Germany.	berit.mueller@charite.de	Schmidt, Marcus/H-3383-2013; Denkert, Carsten/AHE-2675-2022; Budczies, Jan/AAG-8122-2020	Schmidt, Marcus/0000-0003-1365-2414; Lindner, Judith Lea/0000-0003-2223-4468; Denkert, Carsten/0000-0002-2249-0982; Lehmann, Annika/0000-0001-9424-5882; Eucker, Jan/0000-0002-6714-8056	university research advancement	university research advancement	The project was funded by the university research advancement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 2011, ANN ONCOL, V21, pv9; Albanell J, 2012, ANN ONCOL, V23, P625, DOI 10.1093/annonc/mdr278; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Blohmer JU, 2013, J MED EC; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Curigliano G, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.299; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dietel M, 2013, CANCER GENE THER, V20, P211, DOI 10.1038/cgt.2013.13; Dubsky P, 2013, ANN ONCOL; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Kronenwett R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-456; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2012, ANN ONCOL, V23, P211, DOI 10.1093/annonc/mds323	24	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68252	10.1371/journal.pone.0068252	http://dx.doi.org/10.1371/journal.pone.0068252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826382	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000135
J	Zheng, JS; Arnett, DK; Parnell, LD; Lee, YC; Ma, YY; Smith, CE; Richardson, K; Li, D; Borecki, IB; Tucker, KL; Ordovas, JM; Lai, CQ				Zheng, Ju-Sheng; Arnett, Donna K.; Parnell, Laurence D.; Lee, Yu-Chi; Ma, Yiyi; Smith, Caren E.; Richardson, Kris; Li, Duo; Borecki, Ingrid B.; Tucker, Katherine L.; Ordovas, Jose M.; Lai, Chao-Qiang			Polyunsaturated Fatty Acids Modulate the Association between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; BK CHANNELS; FISH CONSUMPTION; GLUCOSE-HOMEOSTASIS; PUERTO-RICAN; PPAR-GAMMA; SENSITIVITY; RISK; POLYMORPHISM; METAANALYSIS	Background: Neighboring genes PIK3CA and KCNMB3 are both important for insulin signaling and beta-cell function, but their associations with glucose-related traits are unclear. Objective: The objective was to examine associations of PIK3CA-KCNMB3 variants with glucose-related traits and potential interaction with dietary fat. Design: We first investigated genetic associations and their modulation by dietary fat in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study (n = 820). Nine single-nucleotide polymorphisms (SNPs) were selected for analysis, covering more than 80% of the SNPs in the region. We then sought to replicate the findings in the Boston Puerto Rican Health Study (BPRHS) (n = 844). Results: For KCNMB3 missense mutation rs7645550, meta-analysis indicated that homeostasis model assessment of insulin resistance (HOMA-IR) was significantly lower in minor allele T homozygotes compared with major allele C carriers (pooled P-value = 0.004); for another SNP rs1183319, which is in moderate LD with rs7645550, minor allele G carriers had higher HOMA-IR compared with non-carriers in both populations (pooled P-value = 0.028). In GOLDN, rs7645550 T allele homozygotes had lower HOMA-IR only when dietary n-3: n-6 PUFA ratio was low (<= 0.11, P = 0.001), but not when it was high (. 0.11, P-interaction = 0.033). Similar interaction was observed between rs1183319 and n-3: n-6 PUFA ratio on HOMAIR (P-interaction = 0.001) in GOLDN. Variance contribution analyses in GOLDN confirmed the genetic association and gene-diet interaction. In BPRHS, dietary n-3: n-6 PUFA ratio significantly modulated the association between rs1183319 and HbA1c (P-interaction = 0.034). Conclusion: PIK3CA-KCNMB3 variants are associated with insulin resistance in populations of different ancestries, and are modified by dietary PUFA.	[Zheng, Ju-Sheng; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Parnell, Laurence D.; Lee, Yu-Chi; Ma, Yiyi; Smith, Caren E.; Richardson, Kris; Ordovas, Jose M.; Lai, Chao-Qiang] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Tucker, Katherine L.] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA	Zhejiang University; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Northeastern University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	duoli@zju.edu.cn; chaoqiang.lai@ars.usda.gov	Ma, Yiyi/J-5237-2017; Ordovas, Jose/B-8727-2013; Zheng, Ju-Sheng/J-3970-2015; Li, Duo/N-3682-2013	Ma, Yiyi/0000-0002-3609-8877; Lai, Chao-Qiang/0000-0003-1107-8375; Ordovas, Jose/0000-0002-7581-5680; Zheng, Ju-Sheng/0000-0001-6560-4890; Tucker, Katherine/0000-0001-7640-662X; Li, Duo/0000-0001-5227-5565	China Scholarship Council; National Basic Research Program of China (973 Program) [2011CB504002]; National Heart, Lung, and Blood Institute [HL54776, HL078885]; US Department of Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL105185, U01HL072524, R01HL091357] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the China Scholarship Council; by the National Basic Research Program of China (973 Program: 2011CB504002); by National Heart, Lung, and Blood Institute grant number HL54776 and HL078885; by the contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture Research Service. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2008, J HUM NUTR DIET, V21, P591, DOI 10.1111/j.1365-277X.2008.00902.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Corella D, 2006, DIABETES CARE, V29, P1313, DOI 10.2337/dc06-0045; Corella D, 2012, BRIT J NUTR, V107, pS271, DOI 10.1017/S0007114512001651; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dedoussis George V Z, 2007, Rev Diabet Stud, V4, P13, DOI 10.1900/RDS.2007.4.13; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; Houamed KM, 2010, J PHYSIOL-LONDON, V588, P3511, DOI 10.1113/jphysiol.2009.184341; Hu S, 2003, PHYSIOL GENOMICS, V15, P191, DOI 10.1152/physiolgenomics.00110.2003; Kelly G S, 2000, Altern Med Rev, V5, P109; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lee Yu-Chi, 2011, J Data Mining Genomics Proteomics, V2; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Marin C, 2005, AM J CLIN NUTR, V82, P196, DOI 10.1093/ajcn/82.1.196; Marin C, 2011, MOL NUTR FOOD RES, V55, P328, DOI 10.1002/mnfr.201000235; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith CE, 2012, NUTR METAB CARDIOVAS, V22, P449, DOI 10.1016/j.numecd.2010.09.003; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Tucker KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-107; Tucker KL, 1998, AM J EPIDEMIOL, V148, P507, DOI 10.1093/oxfordjournals.aje.a009676; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Watanabe RM, 2010, CURR DIABETES REP, V10, P476, DOI 10.1007/s11892-010-0143-1; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869; Zheng JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044525	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67394	10.1371/journal.pone.0067394	http://dx.doi.org/10.1371/journal.pone.0067394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826284	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000072
J	Saugy, J; Place, N; Millet, GY; Degache, F; Schena, F; Millet, GP				Saugy, Jonas; Place, Nicolas; Millet, Guillaume Y.; Degache, Francis; Schena, Federico; Millet, Gregoire P.			Alterations of Neuromuscular Function after the World's Most Challenging Mountain Ultra-Marathon	PLOS ONE			English	Article							SLEEP-DEPRIVATION; MUSCLE DAMAGE; ECCENTRIC EXERCISE; FATIGUE; PERFORMANCE; DOWNHILL; CONTRACTIONS; RESPONSES; UPHILL; MODEL	We investigated the physiological consequences of the most challenging mountain ultra-marathon (MUM) in the world: a 330-km trail run with 24000 m of positive and negative elevation change. Neuromuscular fatigue (NMF) was assessed before (Pre-), during (Mid-) and after (Post-) the MUM in experienced ultra-marathon runners (n = 15; finish time = 122.43 hours +/- 17.21 hours) and in Pre- and Post-in a control group with a similar level of sleep deprivation (n = 8). Blood markers of muscle inflammation and damage were analyzed at Pre- and Post-. Mean +/- SD maximal voluntary contraction force declined significantly at Mid- (-13 +/- 17% and -10 +/- 16%, P<0.05 for knee extensor, KE, and plantar flexor muscles, PF, respectively), and further decreased at Post- (-24 +/- 13% and -26 +/- 19%, P<0.01) with alteration of the central activation ratio (-24 +/- 24% and -28 +/- 34% between Pre- and Post-, P<0.05) in runners whereas these parameters did not change in the control group. Peripheral NMF markers such as 100 Hz doublet (KE: -18 +/- 18% and PF: -20 +/- 15%, P<0.01) and peak twitch (KE: -33 +/- 12%, P<0.001 and PF: -19 +/- 14%, P<0.01) were also altered in runners but not in controls. Post-MUM blood concentrations of creatine kinase (3719 +/- 3045 Ul.(1)), lactate dehydrogenase (1145 +/- 511 UI.L-1), C-Reactive Protein (13.1 +/- 7.5 mg.L-1) and myoglobin (449.3 +/- 338.2 mu g.L-1) were higher (P<0.001) than at Pre- in runners but not in controls. Our findings revealed less neuromuscular fatigue, muscle damage and inflammation than in shorter MUMs. In conclusion, paradoxically, such extreme exercise seems to induce a relative muscle preservation process due likely to a protective anticipatory pacing strategy during the first half of MUM and sleep deprivation in the second half.	[Saugy, Jonas; Degache, Francis; Millet, Gregoire P.] Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland; [Place, Nicolas] Univ Geneva, Inst Movement Sci & Sports Med, Geneva, Switzerland; [Millet, Guillaume Y.] Univ Lyon, St Etienne, France; [Millet, Guillaume Y.] Univ St Etienne, Exercise Physiol Lab, St Etienne, France; [Schena, Federico] Univ Verona, Fac Motor Sci, I-37100 Verona, Italy	University of Lausanne; University of Geneva; Universite Jean Monnet; University of Verona	Saugy, J (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland.	jonas.saugy@unil.ch	Millet, Guillaume/AAO-6520-2020; Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019; Degache, Francis/Y-8618-2019; Place, Nicolas/B-3416-2018	Millet, Guillaume/0000-0002-6395-0762; Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; Degache, Francis/0000-0002-1620-9330; Place, Nicolas/0000-0001-9044-0621				Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Blumert PA, 2007, J STRENGTH COND RES, V21, P1146; Braun WA, 2012, RES SPORTS MED, V20, P274, DOI 10.1080/15438627.2012.697084; Bulbulian R, 1996, EUR J APPL PHYSIOL O, V73, P273, DOI 10.1007/BF02425487; Burnley M, 2012, J APPL PHYSIOL, V113, P215, DOI 10.1152/japplphysiol.00022.2012; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; Guilhem G, 2011, EUR J APPL PHYSIOL, V111, P2723, DOI 10.1007/s00421-011-1894-3; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hoffman MD, 2012, WILD ENVIRON MED, V23, P56, DOI 10.1016/j.wem.2011.11.001; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Lippi G, 2008, SCAND J CLIN LAB INV, V68, P667, DOI 10.1080/00365510802126844; Lippi G, 2012, BLOOD TRANSFUS-ITALY, V10, P377, DOI 10.2450/2012.0167-11; LOSCHER WN, 1994, ACTA PHYSIOL SCAND, V152, P73, DOI 10.1111/j.1748-1716.1994.tb09786.x; Lucas SJE, 2008, J SPORT SCI, V26, P477, DOI 10.1080/02640410701552872; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; MARTIN BJ, 1981, EUR J APPL PHYSIOL O, V47, P345, DOI 10.1007/BF02332962; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; Millet GP, 2012, J APPL PHYSIOL, V113, P686, DOI 10.1152/japplphysiol.00642.2012; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Mischler I, 2003, MED SCI SPORT EXER, V35, P75, DOI 10.1097/00005768-200301000-00013; MYLES WS, 1985, MED SCI SPORT EXER, V17, P580; Noakes TD, 2007, SPORTS MED, V37, P374, DOI 10.2165/00007256-200737040-00026; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Nosaka K, 2001, EUR J APPL PHYSIOL, V85, P34, DOI 10.1007/s004210100430; Oliver SJ, 2009, EUR J APPL PHYSIOL, V107, P155, DOI 10.1007/s00421-009-1103-9; Place N, 2007, J ELECTROMYOGR KINES, V17, P253, DOI 10.1016/j.jelekin.2006.04.001; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Place N, 2009, CLIN EXP PHARMACOL P, V36, P334, DOI 10.1111/j.1440-1681.2008.05021.x; Robach P, 2012, SCANDINAVIAN J MED S; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; Schutz UHW, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-78; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Snyder KL, 2012, J EXP BIOL, V215, P2283, DOI 10.1242/jeb.066332; SYMONS JD, 1988, CAN J SPORT SCI, V13, P225; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; Tsatalas T, 2013, J SPORT SCI, V31, P288, DOI 10.1080/02640414.2012.729135; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; WARREN GL, 1993, J PHYSIOL-LONDON, V464, P457, DOI 10.1113/jphysiol.1993.sp019645	51	99	99	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65596	10.1371/journal.pone.0065596	http://dx.doi.org/10.1371/journal.pone.0065596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840345	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400008
J	Bolstad, I; Andreassen, OA; Reckless, GE; Sigvartsen, NP; Server, A; Jensen, J				Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Sigvartsen, Niels P.; Server, Andres; Jensen, Jimmy			Aversive Event Anticipation Affects Connectivity between the Ventral Striatum and the Orbitofrontal Cortex in an fMRI Avoidance Task	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; NUCLEUS-ACCUMBENS; COGNITIVE CONTROL; HUMAN AMYGDALA; REWARD; ACTIVATION; SALIENCE; DOPAMINE; VALENCE; SYSTEM	Ability to anticipate aversive events is important for avoiding dangerous or unpleasant situations. The motivation to avoid an event is influenced by the incentive salience of an event-predicting cue. In an avoidance fMRI task we used tone intensities to manipulate salience in order to study the involvement of the orbitofrontal cortex in processing of incentive salience. In the task, cues predicting either aversive or neutral avoidable tones were presented. Ventral striatum, amygdala and anterior insula activations were significantly stronger during presentation of cues for aversive than neutral tones. A psychophysiological interaction analysis showed stronger connectivity between the ventral striatum and the orbitofrontal cortex during aversive than neutral conditions. The present study shows an interaction between the ventral striatum, a structure previously linked to negative incentive salience, and the orbitofrontal cortex supporting a role for this region in processing salience. In addition, this study replicates previous findings suggesting that the task is robust.	[Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Sigvartsen, Niels P.; Jensen, Jimmy] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Jensen, Jimmy] Univ Oslo, Inst Clin Med, Oslo, Norway; [Server, Andres] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Jensen, Jimmy] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden	University of Oslo; University of Oslo; University of Oslo; Kristianstad University	Bolstad, I (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway.	Ingeborg.bolstad@medisin.uio.no	Andreassen, Ole A./AAY-7531-2020; Jensen, Jimmy/H-7517-2014	Jensen, Jimmy/0000-0001-6841-1808; Andreassen, Ole A./0000-0002-4461-3568; Bolstad, Ingeborg/0000-0001-7316-6309; Reckless, Greg/0000-0001-6899-9015	South-East Norway Health Authority; Research Council of Norway [199472]	South-East Norway Health Authority; Research Council of Norway(Research Council of Norway)	This project was funded by South-East Norway Health Authority (http://www.helse-sorost.no/Sider/side.aspx) and The Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906). The study was supported by a grant (#199472) from the Research Council of Norway (http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Cunningham WA, 2012, CURR DIR PSYCHOL SCI, V21, P54, DOI 10.1177/0963721411430832; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Esslinger C, 2012, SCHIZOPHR RES, V140, P114, DOI 10.1016/j.schres.2012.06.025; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; FOX PT, 1994, SCIENCE, V266, P994, DOI 10.1126/science.7973682; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Morrison SE, 2011, ANN NY ACAD SCI, V1239, P59, DOI 10.1111/j.1749-6632.2011.06255.x; Nielsen FA, 2004, ARTIF INTELL MED, V30, P141, DOI 10.1016/S0933-3657(03)00041-1; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Ousdal OT, 2012, NEUROIMAGE, V62, P95, DOI 10.1016/j.neuroimage.2012.04.035; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pohlack ST, 2012, BIOL PSYCHOL, V91, P74, DOI 10.1016/j.biopsycho.2012.04.004; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	47	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68494	10.1371/journal.pone.0068494	http://dx.doi.org/10.1371/journal.pone.0068494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826392	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400177
J	Laursen, TM; Wahlbeck, K; Hallgren, J; Westman, J; Osby, U; Alinaghizadeh, H; Gissler, M; Nordentoft, M				Laursen, Thomas Munk; Wahlbeck, Kristian; Hallgren, Jonas; Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan; Gissler, Mika; Nordentoft, Merete			Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; EXCESS MORTALITY; PREMATURE MORTALITY; MENTAL-DISORDER; ILLNESS; SWEDEN; RISK; CERTIFICATES; STATISTICS; REGISTER	Objective: Excess mortality from diseases and medical conditions (natural death) in persons with psychiatric disorders has been extensively reported. Even in the Nordic countries with well-developed welfare systems, register based studies find evidence of an excess mortality. In recent years, cardiac mortality and death by diseases of the circulatory system has seen a decline in all the Nordic countries, but a recent paper indicates that women and men in Denmark, Finland, and Sweden, who had been hospitalised for a psychotic disorder, had a two to three-fold increased risk of dying from a cardiovascular disease. The aim of this study was to compare the mortality by diseases of the circulatory system among patients with bipolar disorder or schizophrenia in the three Nordic countries Denmark, Sweden, and Finland. Furthermore, the aim was to examine and compare life expectancy among these patients. Cause specific Standardized Mortality Rates (SMRs) were calculated for each specific subgroup of mortality. Life expectancy was calculated using Wiesler's method. Results: The SMR for bipolar disorder for diseases of the circulatory system was approximately 2 in all countries and both sexes. SMR was slightly higher for people with schizophrenia for both genders and in all countries, except for men in Denmark. Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter. Conclusion: Our data show that persons in the Nordic countries with schizophrenia or bipolar disorder have a substantially reduced life expectancy. An evaluation of the reasons for these increased mortality rates should be prioritized when planning healthcare in the coming years.	[Laursen, Thomas Munk] Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark; [Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Laursen, Thomas Munk; Wahlbeck, Kristian; Gissler, Mika; Nordentoft, Merete] Nordic Sch Publ Hlth, Nordic Res Acad Mental Hlth, Gothenburg, Sweden; [Hallgren, Jonas] Karolinska Inst, Dept Med Epidemiol & Biostat MEB, Stockholm, Sweden; [Westman, Jeanette; Osby, Urban; Alinaghizadeh, Hassan] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Family Med, Stockholm, Sweden; [Osby, Urban] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Osby, Urban] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Osby, Urban] Tiohundra AB, Dept Psychiat, Norrtalje, Sweden; [Wahlbeck, Kristian; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare	Laursen, TM (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, iPSYCH, Aarhus, Denmark.	tml@ncrr.dk	Nordentoft, Merete/AAH-3253-2019; Laursen, Thomas Munk/AFQ-8066-2022; Wahlbeck, Kristian/F-8394-2011	Wahlbeck, Kristian/0000-0003-3754-3933; Westman, Jeanette/0000-0001-8701-4226; Laursen, Thomas Munk/0000-0001-6934-1784; Gissler, Mika/0000-0001-8254-7525; Alinaghizadeh, Hassan/0000-0002-9455-0753	Stanley Medical Research Institute; Lundbeck Foundation; MRC [MR/K006525/1] Funding Source: UKRI; Lundbeck Foundation [R155-2012-11280] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Stanley Medical Research Institute; Lundbeck Foundation(Lundbeckfonden); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by The Stanley Medical Research Institute. The Lundbeck Foundation is acknowledged for financial support of TML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2012, INT J PSYCHIAT CLIN, V16, P170, DOI 10.3109/13651501.2011.653377; Angst J, 2002, SCHIZOPHR RES, V57, P5, DOI 10.1016/S0920-9964(02)00328-6; Bradley AJ, 2010, J PSYCHOPHARMACOL, V24, P91, DOI 10.1177/1359786810385491; Breslow NE., 1987, STATISTICAL METHODS, P48; Bushe CJ, 2010, J PSYCHOPHARMACOL, V24, P17, DOI 10.1177/1359786810382468; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; Greenland S, 2008, MODERN EPIDEMIOLOGY, P32; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hills, 1993, STAT MODELS EPIDEMIO; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Juel K, 1999, DAN MED BULL, V46, P354; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Laursen TM, 2010, SCHIZOPHR RES, V121, P234, DOI 10.1016/j.schres.2010.05.018; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Laursen TM, 2011, SCHIZOPHR RES, V131, P101, DOI 10.1016/j.schres.2011.06.008; Laursen TM, 2011, J PSYCHIATR RES, V45, P29, DOI 10.1016/j.jpsychires.2010.04.027; Laursen TM, 2009, ARCH GEN PSYCHIAT, V66, P713, DOI 10.1001/archgenpsychiatry.2009.61; Laursen TM, 2006, THESIS; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Manderbacka K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000831; Mitchell AJ, 2010, J PSYCHOPHARMACOL, V24, P69, DOI 10.1177/1359786810382056; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; MORTENSEN PB, 1993, BRIT J PSYCHIAT, V163, P183, DOI 10.1192/bjp.163.2.183; Munk-Jorgensen P, 2010, INDIAN J MED RES, V132, P353; Murray DP, 2009, CURR PSYCHIAT REP, V11, P475, DOI 10.1007/s11920-009-0072-3; NOMESCO, 2009, HLTH STAT NORD COUNT; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Raedler TJ, 2010, CURR OPIN PSYCHIATR, V23, P574, DOI 10.1097/YCO.0b013e32833f46c9; Sikdar KC, 2010, QUAL LIFE RES, V19, P781, DOI 10.1007/s11136-010-9641-5; Thornicroft G, 2011, BRIT J PSYCHIAT, V199, P441, DOI 10.1192/bjp.bp.111.092718; Uter W, 1999, BIOMETRICAL J, V41, P985; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Weiner M, 2011, ANN CLIN PSYCHIATRY, V23, P40; Westman J, 2012, EUR J PUBLIC HEALTH, V22, P604, DOI 10.1093/eurpub/ckr068; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wiesler H, 1954, P 1 WORLD POP C ROM, V4; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P9, DOI 10.1177/1359786810382149; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8	47	196	196	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67133	10.1371/journal.pone.0067133	http://dx.doi.org/10.1371/journal.pone.0067133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826212	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400109
J	Mente, A; Meyre, D; Lanktree, MB; Heydarpour, M; Davis, AD; Miller, R; Gerstein, H; Hegele, RA; Yusuf, S; Anand, SS				Mente, Andrew; Meyre, David; Lanktree, Matthew B.; Heydarpour, Mahyar; Davis, A. Darlene; Miller, Ruby; Gerstein, Hertzel; Hegele, Robert A.; Yusuf, Salim; Anand, Sonia S.		SHARE Investigator; SHARE-AP Investigator	Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population	PLOS ONE			English	Article							DENSITY LIPOPROTEIN-CHOLESTEROL; GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; ADIPOCYTE-DERIVED PROTEIN; CORONARY-ARTERY-DISEASE; FATTY-ACID OXIDATION; TYPE-2 DIABETES RISK; ETHNIC-GROUPS SHARE; INSULIN-RESISTANCE; PLASMA ADIPONECTIN	Background: Adiponectin, a secretagogue exclusively produced by adipocytes, has been associated with metabolic features, but its role in the development of the metabolic syndrome remains unclear. Objectives: We investigated the association between serum adiponectin level and metabolic traits, using both observational and genetic epidemiologic approaches in a multiethnic population assembled in Canada. Methods: Clinical data and serum adiponectin level were collected in 1,157 participants of the SHARE/SHARE-AP studies. Participants were genotyped for the functional rs266729 and rs1260326 SNPs in ADIPOQ and GCKR genes. Results: Adiponectin level was positively associated with HDL cholesterol and negatively associated with body mass index, waist-to-hip ratio, triglycerides, fasting glucose, fasting insulin, systolic and diastolic pressure (all P<0.002). The rs266729 minor G allele was associated with lower adiponectin and higher HOMA-IR (P = 0.004 and 0.003, respectively). The association between rs266729 SNP and HOMA-IR was no longer significant after adjustment for adiponectin concentration (P = 0.10). The rs266729 SNP was associated with HOMA-IR to an extent that exceeded its effect on adiponectin level (0.15 SD 95% C.I. [0.06, 0.24], P<0.001). There was no significant interaction between rs266729 SNP and ethnicity on adiponectin or HOMA-IR. In contrast, the SNP rs1260326 in GCKR was associated with HOMA-IR (P<0.001), but not with adiponectin level (P = 0.67). Conclusion: The association of the functional promoter polymorphism rs266729 with lower serum adiponectin and increased insulin resistance in diverse ethnic groups may suggest a causal relationship between adiponectin level and insulin resistance.	[Mente, Andrew; Meyre, David; Heydarpour, Mahyar; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Mente, Andrew; Meyre, David; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Lanktree, Matthew B.; Hegele, Robert A.] Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5C1, Canada; [Hegele, Robert A.] Univ Western Ontario, Dept Med, London, ON, Canada; [Davis, A. Darlene; Miller, Ruby] Six Nations Hlth Serv, Ohsweken, ON, Canada; [Lanktree, Matthew B.; Gerstein, Hertzel; Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON, Canada	Population Health Research Institute; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Anand, SS (corresponding author), Populat Hlth Res Inst, Hamilton, ON, Canada.	anands@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Hegele, Robert/AAF-6482-2020; Meyre, David/D-7315-2011; Gerstein, Hertzel C/B-1235-2013; Hegele, Robert/G-3301-2011; Lanktree, Matthew Bruce/I-9790-2019	Gerstein, Hertzel/0000-0001-8072-2836; Hegele, Robert/0000-0003-2861-5325; Meyre, David/0000-0003-4850-7444; Gerstein, Hertzel C/0000-0001-8072-2836; Lanktree, Matthew Bruce/0000-0002-5750-6286; Yusuf, Salim/0000-0003-4776-5601	Early Career Award from Hamilton Health Sciences Foundation; Canada Research Chair in Genetics of Obesity and Diabetes; Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award; University of Western Ontario MD/PhD Program; CIHR [MOP-13430, MOP-79523, CTP-79853]; Heart and Stroke Foundation of Ontario [NA-6059, T-6018, PRG-4854, NA-03785]; Genome Canada through the Ontario Genomics Institute; Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award	Early Career Award from Hamilton Health Sciences Foundation; Canada Research Chair in Genetics of Obesity and Diabetes; Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award; University of Western Ontario MD/PhD Program; CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Genome Canada through the Ontario Genomics Institute(Genome Canada); Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award	A. Mente is supported by an Early Career Award from Hamilton Health Sciences Foundation. D. Meyre is supported by a Canada Research Chair in Genetics of Obesity and Diabetes. M.B. Lanktree was supported by the Canadian Institutes of Health Research (CIHR) MD/PhD Studentship Award and the University of Western Ontario MD/PhD Program and is a CIHR Fellow in Vascular Research. R.A. Hegele is a Career Investigator of the Heart and Stroke Foundation of Ontario and holds the Edith Schulich Vinet Canada Research Chair (Tier I) in Human Genetics, the Martha G. Blackburn Chair in Cardiovascular Research, and the Jacob J. Wolfe Distinguished Medical Research Chair at the University of Western Ontario. H. Gerstein holds a Aventis Population Health Institute Chair in Diabetes Research, McMaster University. S. Yusuf holds an endowed chair in Cardiovascular Research from the Heart and Stroke Foundation of Ontario. S.S. Anand holds the Michael G. DeGroote/Heart and Stroke Foundation of Ontario endowed Chair in Population Health Research, Canada Research Chair in Ethnicity and Cardiovascular Disease, and the Eli Lilly-May Cohen Chair in Women's Health Research. This work was supported by CIHR (MOP-13430, MOP-79523, CTP-79853), the Heart and Stroke Foundation of Ontario (NA-6059, T-6018, PRG-4854, NA-03785), Genome Canada through the Ontario Genomics Institute, and the Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anand SS, 1998, CAN J CARDIOL, V14, P1349; Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Buzzetti R, 2007, INT J OBESITY, V31, P424, DOI 10.1038/sj.ijo.0803419; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Croteau-Chonka DC, 2012, HUM MOL GENET, V21, P463, DOI 10.1093/hmg/ddr480; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Ferguson JF, 2010, AM J CLIN NUTR, V91, P794, DOI 10.3945/ajcn.2009.28255; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Goropashnaya AV, 2009, METABOLISM, V58, P22, DOI 10.1016/j.metabol.2008.09.002; Han LY, 2011, DIABETOLOGIA, V54, P2303; Hanley AG, 2003, DIABETES CARE, V26, P3219, DOI 10.2337/diacare.26.12.3219; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Karinenc I, 2012, ARCH MED RES, V43, P145; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Khoo CM, 2011, DIABETES CARE, V34, P1120, DOI 10.2337/dc10-2097; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Mente A, 2010, DIABETES CARE, V33, P1629, DOI 10.2337/dc09-1392; NEELEY WE, 1972, CLIN CHEM, V18, P509; Ong KL, 2010, EUR J ENDOCRINOL, V163, P251, DOI 10.1530/EJE-10-0251; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Perez-Martinez P, 2008, J NUTR, V138, P1609, DOI 10.1093/jn/138.9.1609; Petrone A, 2006, OBESITY, V14, P1498, DOI 10.1038/oby.2006.172; Povel CM, 2011, MOL GENET METAB, V104, P666, DOI 10.1016/j.ymgme.2011.08.035; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees MG, 2012, DIABETOLOGIA, V55, P114, DOI 10.1007/s00125-011-2348-5; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Robiou-du-Pont S, 2012, INT J OBES IN PRESS; Saito K, 1999, GENE, V229, P67, DOI 10.1016/S0378-1119(99)00041-4; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shetty S, 2012, ENDOCRINOLOGY, V153, P113, DOI 10.1210/en.2011-1339; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Vozarova B, 2002, DIABETES, V51, P2964, DOI 10.2337/diabetes.51.10.2964; Wagner A, 2008, DIABETES METAB, V34, P465, DOI 10.1016/j.diabet.2008.02.006; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; WARNICK GR, 1985, CLIN CHEM, V31, P217; Warren LL, 2012, DIABETES, V61, P1297, DOI 10.2337/db11-0985; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wildman RP, 2008, INT J OBESITY, V32, P740, DOI 10.1038/sj.ijo.0803782; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yamamoto Y, 2002, CLIN SCI, V103, P137, DOI 10.1042/CS20010336; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Y, 2012, THROMB RES, V130, P58, DOI 10.1016/j.thromres.2012.01.018	69	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66808	10.1371/journal.pone.0066808	http://dx.doi.org/10.1371/journal.pone.0066808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826141	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400056
J	Tsai, DC; Chen, SJ; Huang, CC; Chou, P; Chung, CM; Huang, PH; Lin, SJ; Chen, JW; Chen, TJ; Leu, HB; Chan, WL				Tsai, Der-Chong; Chen, Shih-Jen; Huang, Chin-Chou; Chou, Pesus; Chung, Chia-Min; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Chen, Tseng-Ji; Leu, Hsin-Bang; Chan, Wan-Leong			Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001-2006: A Population-based Study	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; PSYCHOLOGICAL STRESS; SLEEP-APNEA; A BEHAVIOR; RISK; UPDATE	Objectives: The epidemiology of idiopathic central serous chorioretinopathy (CSCR) is not well understood in an Asian population. The present study aimed to investigate the incidence and risk factors for corticosteroid-unrelated CSCR using Taiwan's National Health Insurance Research Database. Methods and Results: From 2001 to 2006, a total of 786 patients (500 [63.6%] males) who were newly diagnosed with CSCR, aged from 20 to 64 years and had no history of corticosteroid prescription were identified as incident cases of idiopathic CSCR. 3606 age-, gender-, and enrollment time-matched subjects were randomly selected as the control group. The mean annual incidence was 0.21% (0.27% for males, and 0.15% for females; P<0.001), with a male/female ratio of 1.74. The peak incidence was in the 35-to 39-year-old age group (0.30%), followed by the 40- to 44-year-old age group (0.26%). Males had a significantly higher mean annual incidence than female only in the middle age groups. Conditional logistic regression was used to estimate the odds ratios (ORs) for potential risk factors of idiopathic CSCR. Only exposure to anti-anxiety drugs (OR, 1.63; 95% confidence interval, 1.09-2.44) was found to be independently associated with idiopathic CSCR among males. No risk factors of idiopathic CSCR were found for females. Conclusions: This study provides the nationwide, population-based data on the incidence of idiopathic CSCR in adult Asians, and suggests that exposure to anti-anxiety drugs is an independent risk factor for idiopathic CSCR among males.	[Tsai, Der-Chong; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Tsai, Der-Chong; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Chen, Shih-Jen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chung, Chia-Min] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chen, Tseng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tseng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Leu, HB (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	hbleu@vghtpe.gov.tw			National Yang-Ming University Hospital, Yilan, Taiwan [RD 2010-028, RD2011-020]; Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-013]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055]; UST-UCSD International Center of Excellence in Advanced Bio-engineering [NSC-99-2911-I-009-101]; Taiwan National Science Council I-RiCE Program	National Yang-Ming University Hospital, Yilan, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program	The present study was partly supported by research grants from RD 2010-028 and RD2011-020 from National Yang-Ming University Hospital, Yilan, Taiwan; V99B1-011, V99C1-125, and V100B-013 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055 from the National Science Council, and NSC-99-2911-I-009-101 from the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program. The sponsor or funding organization had no role in the design or conduct of this research.	BOUZAS EA, 1993, ARCH OPHTHALMOL-CHIC, V111, P1229, DOI 10.1001/archopht.1993.01090090081024; Bouzas EA, 2002, SURV OPHTHALMOL, V47, P431, DOI 10.1016/S0039-6257(02)00338-7; Carvalho-Recchia CA, 2002, OPHTHALMOLOGY, V109, P1834, DOI 10.1016/S0161-6420(02)01117-X; Chan WM, 2006, JPN J OPHTHALMOL, V50, P161, DOI 10.1007/s10384-005-0259-z; Chou KT, 2012, AM J OPHTHALMOL, V154, P200, DOI 10.1016/j.ajo.2012.01.011; Conrad R, 2000, OPHTHALMOLOGE, V97, P527, DOI 10.1007/s003470070059; Desai UR, 2003, J NATL MED ASSOC, V95, P553; Fukunaga K, 1969, Nippon Ganka Gakkai Zasshi, V73, P1468; GELBER GS, 1987, AM J PSYCHIAT, V144, P46; Gemenetzi M, 2010, EYE, V24, P1743, DOI 10.1038/eye.2010.130; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; HARBIN TJ, 1989, PSYCHOPHYSIOLOGY, V26, P110, DOI 10.1111/j.1469-8986.1989.tb03138.x; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Karadimas P, 2004, GRAEF ARCH CLIN EXP, V242, P800, DOI 10.1007/s00417-004-0885-z; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kitzmann AS, 2008, OPHTHALMOLOGY, V115, P169, DOI [10.1016/j.ophtha.2007.02.032, 10.1016/j.ophtha.2008.01.009]; Leveque TK, 2007, SLEEP BREATH, V11, P253, DOI 10.1007/s11325-007-0112-3; Quillen DA, 1996, OPHTHALMOLOGY, V103, P72, DOI 10.1016/S0161-6420(96)30730-6; Ross A, 2011, CURR OPIN OPHTHALMOL, V22, P166, DOI 10.1097/ICU.0b013e3283459826; Spaide RF, 1996, OPHTHALMOLOGY, V103, P2070, DOI 10.1016/S0161-6420(96)30386-2; Tittl MK, 1999, AM J OPHTHALMOL, V128, P63, DOI 10.1016/S0002-9394(99)00075-6; Tsai DC, 2012, ACTA OPHTHA IN PRESS; Tsai DC, 2012, BRIT J OPHTHALMOL, V96, P1484, DOI 10.1136/bjophthalmol-2012-301810; WAKAKURA M, 1984, BRIT J OPHTHALMOL, V68, P329, DOI 10.1136/bjo.68.5.329; Wakakura M, 1997, JPN J OPHTHALMOL, V41, P180, DOI 10.1016/S0021-5155(97)00027-0; Wang M, 2008, ACTA OPHTHALMOL, V86, P126, DOI 10.1111/j.1600-0420.2007.00889.x; YANNUZZI LA, 1987, RETINA-J RET VIT DIS, V7, P111, DOI 10.1097/00006982-198700720-00009	28	75	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66858	10.1371/journal.pone.0066858	http://dx.doi.org/10.1371/journal.pone.0066858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826160	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400070
J	Wang, YX; Pan, Z; Zhao, L; You, QS; Xu, L; Jonas, JB				Wang, Ya Xing; Pan, Zhe; Zhao, Liang; You, Qi Sheng; Xu, Liang; Jonas, Jost B.			Retinal Nerve Fiber Layer Thickness. The Beijing Eye Study 2011	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; GLAUCOMATOUS EYES; AGE; POPULATION; COUNT; SIZE; DETERMINANTS; HEAD; DISK	Purpose: To measure retinal nerve fiber layer (RNFL) thickness in a population-based setting. Methods: In the population-based Beijing Eye Study 2011 with 3468 individuals, RNFL thickness was measured in a subgroup of 1654 (47.7%) study participants by spectral domain optical coherence tomography (iVue SD-OCT). Results: Mean RNFL thickness was significantly (P<0.001) higher in the inferior sector (131.4 +/- 20.6 mu m) than the superior sector (126.1 +/- 19.1 mu m), where it was higher than in the temporal sector (79.8 +/- 12.2 mu m;P<0.001), where it was higher than in the nasal sector (75.1 +/- 12.6 mu m;P<0.001). In multivariate analysis, mean global RNFL thickness (103.2 +/- 12.6 mu m) increased significantly with younger age (standardized correlation coefficient beta:-0.30;P<0.001), larger neuroretinal rim area (beta:0.26;P<0.001), shorter axial length (beta:-0.21;P<0.001), thicker subfoveal choroidal thickness (beta:0.15;P<0.001), larger optic disc area (beta:0.10;P<0.001), less refractive lens power (beta:0.10;P<0.001), flatter anterior cornea (beta:0.07;P = 0.01) and female gender (beta:0.05;P = 0.03). In this population with an age of 50+ years, the age-related decline in RNFL thickness was 0.5 mu m per year of life or 0.36% of an original RNFL thickness of 137 mu m at baseline of the study at 50 years of age. Mean global RNFL thickness decreased by 2.4 mu m for each mm enlargement of axial length. Conclusions: The RNFL profile shows a double hump configuration with the thickest part in the inferior sector, followed by the superior sector, temporal sector and nasal sector. Factors influencing global RNFL thickness were younger age, larger neuroretinal rim, shorter axial length, thicker subfoveal choroid, larger optic disc, less refractive lens power, flatter anterior cornea and female gender. Beyond an age of 50+ years, RNFL decreased by about 0.3% per year of life at an age of 50+ years and by 2.4 mu m per mm of axial elongation. These findings may be of interest for the knowledge of the normal anatomy of the eye and may be of help to diagnose diseases affecting the RNFL.	[Wang, Ya Xing; Pan, Zhe; Zhao, Liang; You, Qi Sheng; Xu, Liang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio@yahoo.cn; Jost.Jonas@augen.ma.uni-heidelberg.de	You, Qisheng/A-3619-2014; wang, YA XING/K-9671-2016; You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; [Anonymous], 2007, RTVUE US MAN; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Dichtl A, 1999, GRAEF ARCH CLIN EXP, V237, P474, DOI 10.1007/s004170050264; Eid TM, 1997, J GLAUCOMA, V6, P221; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Hoh ST, 2000, AM J OPHTHALMOL, V129, P129, DOI 10.1016/S0002-9394(99)00294-9; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; JONAS JB, 1993, GRAEF ARCH CLIN EXP, V231, P207, DOI 10.1007/BF00918842; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; TjonFoSang MJ, 1997, AM J OPHTHALMOL, V123, P62, DOI 10.1016/S0002-9394(14)70993-6; Varma R, 1996, OPHTHALMOLOGY, V103, P2114, DOI 10.1016/S0161-6420(96)30381-3; Vogt A, 1913, GRAEFES ARHIV OPHTHA, V84, P293; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	28	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66763	10.1371/journal.pone.0066763	http://dx.doi.org/10.1371/journal.pone.0066763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826129	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400047
J	Haney, S; Zhao, J; Tiwari, S; Eng, K; Guey, LT; Tien, E				Haney, Steven; Zhao, Juan; Tiwari, Shiwani; Eng, Kurt; Guey, Lin T.; Tien, Eric			RNAi Screening in Primary Human Hepatocytes of Genes Implicated in Genome-Wide Association Studies for Roles in Type 2 Diabetes Identifies Roles for CAMK1D and CDKAL1, among Others, in Hepatic Glucose Regulation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; CREB COACTIVATOR TORC2; PANCREATIC BETA-CELLS; CDK5; INSULIN; PHOSPHORYLATION; INHIBITION; NUCLEAR; METABOLISM	Genome-wide association (GWA) studies have described a large number of new candidate genes that contribute to of Type 2 Diabetes (T2D). In some cases, small clusters of genes are implicated, rather than a single gene, and in all cases, the genetic contribution is not defined through the effects on a specific organ, such as the pancreas or liver. There is a significant need to develop and use human cell-based models to examine the effects these genes may have on glucose regulation. We describe the development of a primary human hepatocyte model that adjusts glucose disposition according to hormonal signals. This model was used to determine whether candidate genes identified in GWA studies regulate hepatic glucose disposition through siRNAs corresponding to the list of identified genes. We find that several genes affect the storage of glucose as glycogen (glycolytic response) and/or affect the utilization of pyruvate, the critical step in gluconeogenesis. Of the genes that affect both of these processes, CAMK1D, TSPAN8 and KIF11 affect the localization of a mediator of both gluconeogenesis and glycolysis regulation, CRTC2, to the nucleus in response to glucagon. In addition, the gene CDKAL1 was observed to affect glycogen storage, and molecular experiments using mutant forms of CDK5, a putative target of CDKAL1, in HepG2 cells show that this is mediated by coordinate regulation of CDK5 and PKA on MEK, which ultimately regulates the phosphorylation of ribosomal protein S6, a critical step in the insulin signaling pathway.	[Haney, Steven; Zhao, Juan; Tiwari, Shiwani; Guey, Lin T.; Tien, Eric] Pfizer Res Technol Ctr, Target Generat Unit, Cambridge, MA USA; [Eng, Kurt] Pfizer Res Technol Ctr, Oligonucleotide Therapeut Unit, Cambridge, MA USA	Pfizer; Pfizer	Haney, S (corresponding author), Eli Lilly Pharmaceut, Dept Quantitat Biol, Indianapolis, IN USA.	haney_steven_a@lilly.com						Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Falnikar A, 2011, MOL BIOL CELL, V22, P1561, DOI 10.1091/mbc.E10-11-0905; FANCONI G., 1949, HELVETICA PAEDIATR ACTA, V4, P359; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, P640; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Negash S, 2002, J CELL SCI, V115, P2109; Okamura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049055; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Qiao F, 2008, EXPT CELL RES, V314; Reiter V, 2012, NUCLEIC ACIDS RES, V40, P6235, DOI 10.1093/nar/gks240; Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Santer R, 1997, NATURE GENETICS, V17; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang XJ, 2000, J BIOL CHEM, V275, P31763, DOI 10.1074/jbc.M004358200; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109; Xu JHJ, 2012, METHODS MOL BIOL, V795, P83, DOI 10.1007/978-1-61779-337-0_6; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng YL, 2007, MOL BIOL CELL, V18, P404, DOI 10.1091/mbc.E06-09-0851; Zheng YL, 2007, MOL CELLULAR BIOL, V18	71	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64946	10.1371/journal.pone.0064946	http://dx.doi.org/10.1371/journal.pone.0064946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840313	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800007
J	Santra, M; Bagchi, B				Santra, Mantu; Bagchi, Biman			Kinetic Proofreading at Single Molecular Level: Aminoacylation of tRNA(Ile) and the Role of Water as an Editor	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; MISACTIVATED AMINO-ACIDS; EDITING MECHANISMS; DISCRIMINATION; EVOLUTION; INSIGHTS; COMPLEX; ERRORS; VALINE	Proofreading/editing in protein synthesis is essential for accurate translation of information from the genetic code. In this article we present a theoretical investigation of efficiency of a kinetic proofreading mechanism that employs hydrolysis of the wrong substrate as the discriminatory step in enzyme catalytic reactions. We consider aminoacylation of tRNA(Ile) which is a crucial step in protein synthesis and for which experimental results are now available. We present an augmented kinetic scheme and then employ methods of stochastic simulation algorithm to obtain time dependent concentrations of different substances involved in the reaction and their rates of formation. We obtain the rates of product formation and ATP hydrolysis for both correct and wrong substrates (isoleucine and valine in our case, respectively), in single molecular enzyme as well as ensemble enzyme kinetics. The present theoretical scheme correctly reproduces (i) the amplitude of the discrimination factor in the overall rates between isoleucine and valine which is obtained as (1.8x10(2)).(4.33x10(2)) = 7.8x10(4), (ii) the rates of ATP hydrolysis for both Ile and Val at different substrate concentrations in the aminoacylation of tRNA(Ile). The present study shows a non-michaelis type dependence of rate of reaction on tRNA(Ile) concentration in case of valine. The overall editing in steady state is found to be independent of amino acid concentration. Interestingly, the computed ATP hydrolysis rate for valine at high substrate concentration is same as the rate of formation of Ile-tRNA(Ile) whereas at intermediate substrate concentration the ATP hydrolysis rate is relatively low. We find that the presence of additional editing domain in class I editing enzyme makes the kinetic proofreading more efficient through enhanced hydrolysis of wrong product at the editing CP1 domain.	[Santra, Mantu; Bagchi, Biman] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Bagchi, B (corresponding author), Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India.	bbagchi@sscu.iisc.ernet.in		BAGCHI, BIMAN/0000-0002-7146-5994	DST; CSIR (India)	DST(Department of Science & Technology (India)); CSIR (India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in parts by grants from DST and CSIR (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hussain T, 2010, P NATL ACAD SCI USA, V107, P22117, DOI 10.1073/pnas.1014299107; KIMURA M, 1973, GENETICS, V73, P19; Lehninger A.L., 1970, BIOCH MOL BASIS CELL; LOFTFIELD RB, 1966, BIOCHIM BIOPHYS ACTA, V130, P426, DOI 10.1016/0304-4165(66)90239-X; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Santra M, 2012, J PHYS CHEM B, V116, P11809, DOI 10.1021/jp305045w; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Stoll A., 1958, FESTSCHRIFT A STOLL, P597; Watson J.D., 1970, MOL BIOL GENE; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66112	10.1371/journal.pone.0066112	http://dx.doi.org/10.1371/journal.pone.0066112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840412	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000322342800034
J	Szymanski, CR; Chiha, W; Morellini, N; Cummins, N; Bartlett, CA; Doig, RLO; Savigni, DL; Payne, SC; Harvey, AR; Dunlop, SA; Fitzgerald, M				Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Harvey, Alan R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Paranode Abnormalities and Oxidative Stress in Optic Nerve Vulnerable to Secondary Degeneration: Modulation by 670 nm Light Treatment	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C-OXIDASE; NEAR-INFRARED LIGHT; REACTIVE OXYGEN; ABSORPTION-MEASUREMENTS; OLIGODENDROCYTES; CALCIUM; DEATH	Secondary degeneration of nerve tissue adjacent to a traumatic injury results in further loss of neurons, glia and function, via mechanisms that may involve oxidative stress. However, changes in indicators of oxidative stress have not yet been demonstrated in oligodendrocytes vulnerable to secondary degeneration in vivo. We show increases in the oxidative stress indicator carboxymethyl lysine at days 1 and 3 after injury in oligodendrocytes vulnerable to secondary degeneration. Dihydroethidium staining for superoxide is reduced, indicating endogenous control of this particular reactive species after injury. Concurrently, node of Ranvier/paranode complexes are altered, with significant lengthening of the paranodal gap and paranode as well as paranode disorganisation. Therapeutic administration of 670 nm light is thought to improve oxidative metabolism via mechanisms that may include increased activity of cytochrome c oxidase. Here, we show that light at 670 nm, delivered for 30 minutes per day, results in in vivo increases in cytochrome c oxidase activity co-localised with oligodendrocytes. Short term (1 day) 670 nm light treatment is associated with reductions in reactive species at the injury site. In optic nerve vulnerable to secondary degeneration superoxide in oligodendrocytes is reduced relative to handling controls, and is associated with reduced paranode abnormalities. Long term (3 month) administration of 670 nm light preserves retinal ganglion cells vulnerable to secondary degeneration and maintains visual function, as assessed by the optokinetic nystagmus visual reflex. Light at a wavelength of 670 nm may serve as a therapeutic intervention for treatment of secondary degeneration following neurotrauma.	[Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Dunlop, Sarah A/G-9357-2013; Doig, Ryan O'Hare/AAG-7585-2019	Fitzgerald, Melinda/0000-0002-4823-8179; Dunlop, Sarah/0000-0002-1306-3962; Cummins, Nadia/0000-0002-4494-2345; , Alan/0000-0002-2590-831X	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC), Australia [572550]; NHMRC, Australia [APP1002347]	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Neurotrauma Research Program (Western Australia) and National Health and Medical Research Council (NH&MRC), Australia (Grant ID: 572550). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Back SA, 1998, J NEUROSCI, V18, P6241; Balabanov R, 2005, NAT NEUROSCI, V8, P262, DOI 10.1038/nn0305-262; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chan YC, 2009, J PHARMACOL EXP THER, V329, P450, DOI 10.1124/jpet.108.148353; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DANNENBERG AM, 1994, J LEUKOCYTE BIOL, V56, P436, DOI 10.1002/jlb.56.4.436; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Griselda CM, 2011, NEUROSCI BIOBEHAV R, V35, P1353, DOI 10.1016/j.neubiorev.2011.02.009; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Komel'kova L V, 2004, Patol Fiziol Eksp Ter, P15; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; McLellan ME, 2003, J NEUROSCI, V23, P2212; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nickells RW, 2004, BRAIN RES BULL, V62, P439, DOI 10.1016/j.brainresbull.2003.07.007; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Payne SC, 2012, INVEST OPHTHALMOL VI; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Rinholm JE, 2012, NATURE, V487, P435, DOI 10.1038/487435a; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010; Sharikabad MN, 2001, AM J PHYSIOL-HEART C, V280, pH344, DOI 10.1152/ajpheart.2001.280.1.H344; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	65	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66448	10.1371/journal.pone.0066448	http://dx.doi.org/10.1371/journal.pone.0066448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840470	Green Published, gold			2022-12-25	WOS:000322361200080
J	Yang, J; Zhang, Z; Chen, C; Liu, Y; Si, Q; Chuang, TH; Li, N; Gomez-Cabrero, A; Reisfeld, RA; Xiang, R; Luo, Y				Yang, J.; Zhang, Z.; Chen, C.; Liu, Y.; Si, Q.; Chuang, T-H; Li, N.; Gomez-Cabrero, A.; Reisfeld, R. A.; Xiang, R.; Luo, Y.			MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene	ONCOGENE			English	Article						tumor-associated macrophages; tumor microenvironment; Fra-1; miR-19a-3p	TUMOR; INVASION; MIGRATION; CELLS; INVASIVENESS; DIAGNOSTICS; PROGNOSIS; PROMOTES; IL-6; FOS	One of the hallmarks of malignancy is the polarization of tumor-associated macrophages (TAMs) from a pro-immune (M1-like) phenotype to an immune-suppressive (M2-like) phenotype. However, the molecular basis of the process is still unclear. MicroRNA (miRNA) comprises a group of small, non-coding RNAs that are broadly expressed by a variety of organisms and are involved in cell behaviors such as suppression or promotion of tumorigenesis. Here, we demonstrate that miR-19a-3p, broadly conserved among vertebrates, was downregulated in RAW264.7 macrophage cells of the M2 phenotype in conditoned medium of 4T1 mouse breast tumor cells. This downregulation correlated with an increased expression of the Fra-1 gene, which was reported to act as a pro-oncogene by supporting the invasion and progression of breast tumors. We found significant upregulation of miR-19a-3p in RAW264.7 macrophages after transfection with a miR-19a-3p mimic that resulted in a significant suppression of the expression of this gene. In addition, we could measure the activity of binding between miR-19a-3p and Fra-1 with a psiCHECK luciferase reporter system. Further, transfection of RAW264.7 macrophage cells with the miR-19a-3p mimic decreased the expression of the Fra-1 downstream genes VEGF, STAT3 and pSTAT3. Most importantly, the capacity of 4T1 breast tumor cells to migrate and invade was impaired in vivo by the intratumoral injection of miR-19a-3p. Taken together, these findings indicate that miR-19a-3p is capable of downregulating the M2 phenotype in M2 macrophages and that the low expression of this miRNA has an important role in the upregulation of Fra-1 expression and induction of M2 macrophage polarization.	[Yang, J.; Chen, C.; Liu, Y.; Si, Q.; Luo, Y.] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; [Yang, J.; Chen, C.; Liu, Y.; Si, Q.; Luo, Y.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, J.; Zhang, Z.; Li, N.; Xiang, R.] Nankai Univ, Dept Immunol, Tianjin 300071, Peoples R China; [Chuang, T-H] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan; [Gomez-Cabrero, A.; Reisfeld, R. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nankai University; National Health Research Institutes - Taiwan; Scripps Research Institute	Xiang, R (corresponding author), Nankai Univ, Dept Immunol, Tianjin 300071, Peoples R China.	rxiang@nankai.edu.cn; yunpingluo@hotmail.com	Chuang, Tsung-Hsien/F-9679-2010; Yang, Jian/E-1051-2015		Major State Basic Research Development Program of China (973 program) [2013CB967202]; National Science Foundation of China (NSFC) [91029734, 81071711]; Department of Defense grant [BC097723];  [30830096];  [09ZCZDSF04000]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Department of Defense grant(United States Department of Defense); ; 	This work was supported by grants from the Major State Basic Research Development Program of China (973 program): grant no. 2013CB967202 (to YL); the National Science Foundation of China (NSFC): grant no. 91029734 and 81071711 (to YL); grant nos 30830096 and 09ZCZDSF04000 (to RX); and Department of Defense grant, grant no. BC097723 (to RAR).	Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Cubillos-Ruiz JR, 2012, ONCOIMMUNOLOGY, V1, P968, DOI 10.4161/onci.20020; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Garzon R, 2012, CURR OPIN ONCOL, V24, P655, DOI 10.1097/CCO.0b013e328358522c; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kesari S, 2011, CANCER BIOL THER, V11, P307, DOI 10.4161/cbt.11.3.14718; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Setoyama Tetsuro, 2011, Keio Journal of Medicine, V60, P106; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Singh PK, 2012, NAT REV GASTRO HEPAT, V9, P334, DOI 10.1038/nrgastro.2012.63; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Tai SK, 2012, J IMMUNOL, V188, P2464, DOI 10.4049/jimmunol.1101101; Thomas RM, 2012, CLIN CANCER RES, V18, P4482, DOI 10.1158/1078-0432.CCR-12-2089; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; Valleron W, 2012, BLOOD, V120, P3997, DOI 10.1182/blood-2012-06-438135; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763	39	110	119	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					3014	3023		10.1038/onc.2013.258	http://dx.doi.org/10.1038/onc.2013.258			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23831570				2022-12-25	WOS:000337232200008
J	Vivona, S; Cipriano, DJ; O'Leary, S; Li, YH; Fenn, TD; Brunger, AT				Vivona, Sandro; Cipriano, Daniel J.; O'Leary, Sean; Li, Ye Henry; Fenn, Timothy D.; Brunger, Axel T.			Disassembly of All SNARE Complexes by N-Ethylmaleimide-sensitive Factor (NSF) Is Initiated by a Conserved 1:1 Interaction between alpha-Soluble NSF Attachment Protein (SNAP) and SNARE Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUSION PROTEIN; TERMINAL DOMAIN; EXOCYTOSIS; PARTICLES; TRANSPORT; SYNTAXIN	Vesicle trafficking in eukaryotic cells is facilitated by SNARE-mediated membrane fusion. The ATPase NSF (N-ethylmaleimide- sensitive factor) and the adaptor protein alpha-SNAP (soluble NSF attachment protein) disassemble all SNARE complexes formed throughout different pathways, but the effect of SNARE sequence and domain variation on the poorly understood disassembly mechanism is unknown. By measuring SNARE-stimulated ATP hydrolysis rates, Michaelis-Menten constants for disassembly, and SNAP-SNARE binding constants for four different ternary SNARE complexes and one binary complex, we found a conserved mechanism, not influenced by N-terminal SNARE domains. alpha-SNAP and the ternary SNARE complex form a 1:1 complex as revealed by multiangle light scattering. We propose a model of NSF-mediated disassembly in which the reaction is initiated by a 1:1 interaction between alpha-SNAP and the ternary SNARE complex, followed by NSF binding. Subsequent additional alpha-SNAP binding events may occur as part of a processive disassembly mechanism.	[Vivona, Sandro; Cipriano, Daniel J.; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Vivona, Sandro; O'Leary, Sean; Li, Ye Henry; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Photon Sci, Stanford, CA 94305 USA; [Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Cipriano, Daniel J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	brunger@stanford.edu		Brunger, Axel/0000-0001-5121-2036	National Institutes of Health [R37-MH63105]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-MH63105 (to A. T. B.).	Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swanton E, 2000, J CELL SCI, V113, P1783; Tiwari M, 2008, MOL CELL BIOCHEM, V312, P81, DOI 10.1007/s11010-008-9723-7; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	34	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24984	24991		10.1074/jbc.M113.489807	http://dx.doi.org/10.1074/jbc.M113.489807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836889	Green Published, hybrid			2022-12-25	WOS:000330612300061
J	Brun, M; Glubrecht, DD; Baksh, S; Godbout, R				Brun, Miranda; Glubrecht, Darryl D.; Baksh, Shairaz; Godbout, Roseline			Calcineurin Regulates Nuclear Factor I Dephosphorylation and Activity in Malignant Glioma Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; NEURAL STEM-CELLS; TOOTH ROOT DEVELOPMENT; PHOSPHATASE CALCINEURIN; SUBVENTRICULAR ZONE; REACTIVE ASTROCYTES; MOLECULAR-CLONING; PRECURSOR CELLS; GENE-EXPRESSION; CYCLOSPORINE-A	Malignant gliomas (MG), including grades III and IV astrocytomas, are the most common adult brain tumors. These tumors are highly aggressive with a median survival of less than 2 years. Nuclear factor I (NFI) is a family of transcription factors that regulates the expression of glial genes in the developing brain. We have previously shown that regulation of the brain fatty acid-binding protein (B-FABP; FABP7) and glial fibrillary acidic protein (GFAP) genes in MG cells is dependent on the phosphorylation state of NFI, with hypophosphorylation of NFI correlating with GFAP and B-FABP expression. Importantly, NFI phosphorylation is dependent on phosphatase activity that is enriched in GFAP/B-FABP+ve cells. Using chromatin immunoprecipitation, we show that NFI occupies the GFAP and B-FABP promoters in NFI-hypophosphorylated GFAP/BFABP+ve MG cells. NFI occupancy, NFI-dependent transcriptional activity, and NFI phosphorylation are all modulated by the serine/threonine phosphatase calcineurin. Importantly, a cleaved form of calcineurin, associated with increased phosphatase activity, is specifically expressed in NFI-hypophosphorylated GFAP/B-FABP+ve MG cells. Calcineurin in GFAP/BFABP+ve MG cells localizes to the nucleus. In contrast, calcineurin is primarily found in the cytoplasm of GFAP/BFABP-ve cells, suggesting a dual mechanism for calcineurin activation in MG. Finally, our results demonstrate that calcineurin expression is up-regulated in areas of high infiltration/migration in grade IV astrocytoma tumor tissue. Our data suggest a critical role for calcineurin in NFI transcriptional regulation and in the determination of MG infiltrative properties.	[Brun, Miranda; Glubrecht, Darryl D.; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Baksh, Shairaz] Univ Alberta, Cross Canc Inst, Dept Pediat, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016; Baksh, Shairaz/GRX-2106-2022	Godbout, Roseline/0000-0002-4779-9265; 	Alberta Cancer Foundation; Alberta Innovates-Health Solutions; Alberta Innovates [201201237] Funding Source: researchfish	Alberta Cancer Foundation; Alberta Innovates-Health Solutions; Alberta Innovates	This work was supported by a grant from the Alberta Cancer Foundation and a studentship from Alberta Innovates-Health Solutions (to M. B.).	Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Andrin C, 2012, NUCLEUS-PHILA, V3, P384, DOI 10.4161/nucl.21055; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Baumgartel K, 2012, LEARN MEMORY, V19, P375, DOI 10.1101/lm.027201.112; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bleoo S, 2001, MOL BIOL CELL, V12, P3046, DOI 10.1091/mbc.12.10.3046; BOSHER J, 1992, J VIROL, V66, P3140, DOI 10.1128/JVI.66.5.3140-3150.1992; BOSSER R, 1993, J BIOL CHEM, V268, P15477; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DAWSON TM, 1994, NEUROSCIENCE, V62, P569, DOI 10.1016/0306-4522(94)90389-1; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; DONELLADEANA A, 1994, EUR J BIOCHEM, V219, P109, DOI 10.1111/j.1432-1033.1994.tb19920.x; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; ENG LF, 1978, J HISTOCHEM CYTOCHEM, V26, P513, DOI 10.1177/26.7.357640; ENZ A, 1994, ANAL BIOCHEM, V216, P147, DOI 10.1006/abio.1994.1018; FARBER LH, 1987, J NEUROCHEM, V49, P404, DOI 10.1111/j.1471-4159.1987.tb02880.x; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Matsuda T, 1998, J NEUROCHEM, V70, P2004; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; MURAMATSU T, 1992, P NATL ACAD SCI USA, V89, P529, DOI 10.1073/pnas.89.2.529; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; PUJOL MJ, 1993, J NEUROCHEM, V60, P1422, DOI 10.1111/j.1471-4159.1993.tb03304.x; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Santella L, 1997, FASEB J, V11, P1091, DOI 10.1096/fasebj.11.13.9367344; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; Wang MG, 1996, CYTOGENET CELL GENET, V72, P236, DOI 10.1159/000134198; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093	81	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24104	24115		10.1074/jbc.M113.455832	http://dx.doi.org/10.1074/jbc.M113.455832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839947	hybrid, Green Published			2022-12-25	WOS:000330611400046
J	Pacheco, SA; Hsu, FF; Powers, KM; Purdy, GE				Pacheco, Sophia A.; Hsu, Fong-Fu; Powers, Katelyn M.; Purdy, Georgiana E.			MmpL11 Protein Transports Mycolic Acid-containing Lipids to the Mycobacterial Cell Wall and Contributes to Biofilm Formation in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIDING MOTILITY; OUTER-MEMBRANE; DRUG-TOLERANT; TUBERCULOSIS; GROWTH; IDENTIFICATION; BIOSYNTHESIS; BIOGENESIS; VIRULENCE; RESISTANCE	A growing body of evidence indicates that MmpL (mycobacterial membrane protein large) transporters are dedicated to cell wall biosynthesis and transport mycobacterial lipids. How MmpL transporters function and the identities of their substrates have not been fully elucidated. We report the characterization of Mycobacterium smegmatis MmpL11. We showed previously that M. smegmatis lacking MmpL11 has reduced membrane permeability that results in resistance to host antimicrobial peptides. We report herein the further characterization of the M. smegmatis mmpL11 mutant and identification of the MmpL11 substrates. We found that biofilm formation by the M. smegmatis mmpL11 mutant was distinct from that by wildtype M. smegmatis. Analysis of cell wall lipids revealed that the mmpL11 mutant failed to export the mycolic acid-containing lipids monomeromycolyl diacylglycerol and mycolate ester wax to the bacterial surface. In addition, analysis of total lipids indicated that the mycolic acid-containing precursor molecule mycolyl phospholipid accumulated in the mmpL11 mutant compared with wild-type mycobacteria. MmpL11 is encoded at a chromosomal locus that is conserved across pathogenic and nonpathogenic mycobacteria. Phenotypes of the M. smegmatis mmpL11 mutant are complemented by the expression of M. smegmatis or M. tuberculosis MmpL11, suggesting that MmpL11 plays a conserved role in mycobacterial cell wall biogenesis.	[Pacheco, Sophia A.; Powers, Katelyn M.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Hsu, Fong-Fu] Washington Univ, Sch Med, Mass Spectrometry Resource, Div Endocrinol Diabet Metab & Lipid Res,Dept Inte, St Louis, MO 63110 USA	Oregon Health & Science University; Washington University (WUSTL)	Purdy, GE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd,Mail Code L220, Portland, OR 97239 USA.	purdyg@ohsu.edu		Hsu, Fong-Fu/0000-0001-5368-0183	National Institutes of Health [AI079399, AI087840, P41-GM103422, P60-DK20579, P30-DK56341, P01-HL57278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087840, K22AI079399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Awards AI079399 and AI087840 (to G. E. P.). The Washington University Mass Spectrometry Facility is supported by National Institutes of Health Grants P41-GM103422, P60-DK20579, P30-DK56341, and P01-HL57278.	Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Nguyen KT, 2010, J BACTERIOL, V192, P5134, DOI 10.1128/JB.00650-10; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Pang JM, 2012, J BACTERIOL, V194, P715, DOI 10.1128/JB.06304-11; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Purdy GE, 2013, ANAL BIOANAL CHEM, V405, P7415, DOI 10.1007/s00216-013-7179-4; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Yamazaki Y, 2006, APPL ENVIRON MICROB, V72, P819, DOI 10.1128/AEM.72.1.819-825.2006	42	66	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24213	24222		10.1074/jbc.M113.473371	http://dx.doi.org/10.1074/jbc.M113.473371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836904	hybrid, Green Published			2022-12-25	WOS:000330611400059
J	Yin, T; Cho, SJ; Chen, XB				Yin, Tiffany; Cho, Seong-Jun; Chen, Xinbin			RNPC1, an RNA-binding Protein and a p53 Target, Regulates Macrophage Inhibitory Cytokine-1 (MIC-1) Expression through mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; ACTIVATED GENE NAG-1/GDF15; CELL-GROWTH; CANCER; MEMBER; FAMILY; PATHWAY; SERUM; GDF-15/MIC-1	Macrophage inhibitory cytokine-1 (MIC-1), a secreted cytokine, is a direct target of p53 and known to play a role in cell proliferation, apoptosis, cell metastasis, and angiogenesis through autocrine and paracrine signaling. Previous studies have shown that serum levels of MIC-1 closely parallel cancer progression and are being explored as a diagnostic tool. MIC-1 has also shown potential as a therapeutic agent as it has exhibited several anti-carcinogenic activities. Thus, MIC-1 displays two opposing effects: tumor suppression versus promotion. However, it remains unclear whether MIC-1 is regulated by a mechanism other than transcription and how MIC-1 exerts its tumor suppression. In this study, we show that overexpression of RNA-binding protein RNPC1 can increase, whereas knockdown or knock-out of RNPC1 decreases, MIC-1 transcript and protein levels. Additionally, we demonstrate that RNPC1 can bind to MIC-1 mRNA via an AU-rich element within MIC-1 3'-UTR and then enhances MIC-1 mRNA stability. Finally, to explore the functional significance of MIC-1, we showed that knockdown of MIC-1 can decrease RNPC1-induced cell growth suppression. Altogether, we uncover a novel mechanism by which MIC-1 can be regulated through RNPC1 via mRNA stability.	[Yin, Tiffany; Cho, Seong-Jun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Cho, SJ (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	sjucho@ucdavis.edu; xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		NATIONAL CANCER INSTITUTE [R01CA102188, R01CA121137, R01CA081237] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121137, R01 CA081237, R01 CA102188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cheng JC, 2011, ENDOCRINOLOGY, V152, P2987, DOI 10.1210/en.2011-0059; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Kadowaki M, 2012, INT J CANCER, V130, P267, DOI 10.1002/ijc.26082; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kim IY, 2011, ARCH PHARM RES, V34, P323, DOI 10.1007/s12272-011-0219-8; Kim JS, 2005, MOL CANCER THER, V4, P487; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Qian YJ, 2012, P NATL ACAD SCI USA, V109, P11300, DOI 10.1073/pnas.1203185109; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang H, 2003, MOL CANCER THER, V2, P1023; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	34	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23680	23686		10.1074/jbc.M113.480186	http://dx.doi.org/10.1074/jbc.M113.480186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836903	Green Published, hybrid			2022-12-25	WOS:000330611400008
J	Huang, CJ; Luo, YA; Zhao, JW; Yang, FW; Zhao, HW; Fan, WH; Ge, PF				Huang, Chuanjiang; Luo, Yinan; Zhao, Jingwei; Yang, Fuwei; Zhao, Hongwei; Fan, Wenhai; Ge, Pengfei			Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1	PLOS ONE			English	Article							APOPTOSIS; DEATH; NECROSIS; KINASE; CONTRIBUTES; RESISTANCE; INDUCTION; MECHANISM	Background and Purpose: Shikonin was reported to induce necroptosis in leukemia cells, but apoptosis in glioma cell lines. Thus, it is needed to clarify whether shikonin could cause necroptosis in glioma cells and investigate its underlying mechanisms. Methods: Shikonin and rat C6 glioma cell line and Human U87 glioma cell line were used in this study. The cellular viability was assayed by MTT. Flow cytometry with annexin V-FITC and PI double staining was used to analyze cellular death modes. Morphological alterations in C6 glioma cells treated with shikoinin were evaluated by electronic transmission microscopy and fluorescence microscopy with Hoechst 33342 and PI double staining. The level of reactive oxygen species was assessed by using redox-sensitive dye DCFH-DA. The expressional level of necroptosis associated protein RIP-1 was analyzed by western blotting. Results: Shikonin induced cell death in C6 and U87 glioma cells in a dose and time dependent manner. The cell death in C6 and U87 glioma cells could be inhibited by necroptosis inhibitor necrotatin-1, not by pan-caspase inhibitor z-VAD-fmk. Shikonin treated C6 glioma cells presented electron-lucent cytoplasm, loss of plasma membrane integrity and intact nuclear membrane in morphology. The increased ROS level caused by shikonin was attenuated by necrostatin-1 and blocking ROS by anti-oxidant NAC rescued shikonin-induced cell death in both C6 and U87 glioma cells. Moreover, the expressional level of RIP-1 was up-regulated by shikonin in a dose and time dependent manner as well, but NAC suppressed RIP-1 expression. Conclusions: We demonstrated that the cell death caused by shikonin in C6 and U87 glioma cells was mainly via necroptosis. Moreover, not only RIP-1 pathway, but also oxidative stress participated in the activation of shikonin induced necroptosis.	[Huang, Chuanjiang; Luo, Yinan; Yang, Fuwei; Zhao, Hongwei; Ge, Pengfei] Jilin Univ, Dept Neurosurg, Bethune Hosp 1, Changchun 130023, Peoples R China; [Zhao, Jingwei] Jilin Univ, China Japan Union Hosp, Dept Neurosurg, Changchun 130023, Peoples R China; [Fan, Wenhai] Dlian Univ, Zhongshan Hosp, Dept Neurosurg, Dalian, Peoples R China	Jilin University; Jilin University; Dalian University of Technology	Ge, PF (corresponding author), Jilin Univ, Dept Neurosurg, Bethune Hosp 1, Changchun 130023, Peoples R China.	pengfeige@gmail.com			National Nature and Science Foundation of China [81072071, 81171234]; Nature and Science Foundation of Jilin province [201115068, 20121809]; Bethune project of Jilin University [2012203]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Jilin province; Bethune project of Jilin University	This work was supported by National Nature and Science Foundation of China (81072071) and (81171234), Nature and Science Foundation of Jilin province (201115068, 20121809), and Bethune project of Jilin University (No. 2012203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Chandrasekher G, 2004, INVEST OPHTH VIS SCI, V45, P3577, DOI 10.1167/iovs.04-0279; Chang IC, 2010, BIOL PHARM BULL, V33, P816, DOI 10.1248/bpb.33.816; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Cho KS, 1999, INVEST OPHTH VIS SCI, V40, P911; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Ge PF, 2010, NEUROL RES, V32, P94, DOI 10.1179/016164109X12518779082273; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; He SP, 2011, KAOHSIUNG J MED SCI, V27, P477, DOI 10.1016/j.kjms.2011.06.010; Horita H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003909; Hsu TS, 2009, TOXICOL APPL PHARM, V235, P153, DOI 10.1016/j.taap.2008.12.012; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Khan MJ, 2012, J BIOL CHEM, V287, P21110, DOI 10.1074/jbc.M111.319129; Kim SK, 2012, ATHEROSCLEROSIS, V225, P315, DOI 10.1016/j.atherosclerosis.2012.09.021; Kim Sunja, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P137; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Li N, 2011, J CELL BIOCHEM, V112, P3834, DOI 10.1002/jcb.23314; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Nehs MA, 2011, SURGERY, V150, P1032, DOI 10.1016/j.surg.2011.09.012; Ouyang ZZ, 2012, PHARMAZIE, V67, P725, DOI 10.1691/ph.2012.1837; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Ye YC, 2012, INT IMMUNOPHARMACOL, V14, P674, DOI 10.1016/j.intimp.2012.08.003	37	100	106	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66326	10.1371/journal.pone.0066326	http://dx.doi.org/10.1371/journal.pone.0066326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840441	Green Published, gold, Green Submitted			2022-12-25	WOS:000321148400012
J	Akhtar, S; Yousif, MHM; Dhaunsi, GS; Sarkhouh, F; Chandrasekhar, B; Attur, S; Benter, IF				Akhtar, Saghir; Yousif, Mariam H. M.; Dhaunsi, Gursev S.; Sarkhouh, Fatma; Chandrasekhar, Bindu; Attur, Sreeja; Benter, Ibrahim F.			Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; ANGIOTENSIN-II; OXIDATIVE STRESS; TYROSINE KINASE; TRANSACTIVATION; EGFR; INHIBITION; MECHANISMS; CARDIOTOXICITY	Diabetes mellitus leads to vascular complications but the underlying signalling mechanisms are not fully understood. Here, we examined the role of ErbB2 (HER2/Neu), a transmembrane receptor tyrosine kinase of the ErbB/EGFR (epidermal growth factor receptor) family, in mediating diabetes-induced vascular dysfunction in an experimental model of type 1 diabetes. Chronic treatment of streptozotocin-induced diabetic rats (1 mg/kg/alt diem) or acute, ex-vivo (10(-6), 10(-5) M) administration of AG825, a specific inhibitor of ErbB2, significantly corrected the diabetes-induced hyper-reactivity of the perfused mesenteric vascular bed (MVB) to the vasoconstrictor, norephinephrine (NE) and the attenuated responsiveness to the vasodilator, carbachol. Diabetes led to enhanced phosphorylation of ErbB2 at multiple tyrosine (Y) residues (Y1221/1222, Y1248 and Y877) in the MVB that could be attenuated by chronic AG825 treatment. Diabetes-or high glucose-mediated upregulation of ErbB2 phosphorylation was coupled with activation of Rho kinases (ROCKs) and ERK1/2 in MVB and in cultured vascular smooth muscle cells (VSMC) that were attenuated upon treatment with either chronic or acute AG825 or with anti-ErbB2 siRNA. ErbB2 likley heterodimerizes with EGFR, as evidenced by increased co-association in diabetic MVB, and further supported by our finding that ERK1/2 and ROCKs are common downstream effectors since their activation could also be blocked by AG1478. Our results show for the first time that ErbB2 is an upstream effector of ROCKs and ERK1/2 in mediating diabetes-induced vascular dysfunction. Thus, potential strategies aimed at modifying actions of signal transduction pathways involving ErbB2 pathway may prove to be beneficial in treatment of diabetes-induced vascular complications.	[Akhtar, Saghir; Yousif, Mariam H. M.; Sarkhouh, Fatma; Chandrasekhar, Bindu; Attur, Sreeja; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait; [Dhaunsi, Gursev S.] Kuwait Univ, Fac Med, Dept Pediat, Safat, Kuwait	Kuwait University; Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University Research Sector [MR 05/09]	Kuwait University Research Sector	This study was supported by a grant from Kuwait University Research Sector (Project number MR 05/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, BIOIMPACTS, V3, P5, DOI 10.5681/bi.2013.008; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Anand-Apte B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013444; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Cai Z, 2010, SEMIN CELL DEV BIOL, V21, P961, DOI 10.1016/j.semcdb.2010.09.005; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Giusti VC, 2011, HYPERTENSION, V58, P912, DOI 10.1161/HYPERTENSIONAHA.111.176024; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Dong M, 2010, DRUG DISCOV TODAY, V15, P622, DOI 10.1016/j.drudis.2010.06.011; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Galan M, 2012, HYPERTENSION, V60, P71, DOI 10.1161/HYPERTENSIONAHA.112.192500; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hervent AS, 2012, INT J MOL SCI, V13, P12268, DOI 10.3390/ijms131012268; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Izzo JL, 2011, J CLIN HYPERTENS, V13, P290, DOI 10.1111/j.1751-7176.2011.00447.x; Kobayashi T, 2012, HYPERTENSION, V60, P20, DOI 10.1161/HYPERTENSIONAHA.112.197038; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu B, 2012, INTERNAL MED, V51, P1177, DOI 10.2169/internalmedicine.51.6771; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Mandavia CH, 2012, LIFE SCI; Matsumoto T, 2008, PEPTIDES, V29, P1338, DOI 10.1016/j.peptides.2008.04.001; Montezano AC, 2012, ANN MED, V44, pS2, DOI 10.3109/07853890.2011.653393; Moon JY, 2011, AM J PHYSL RENAL PHY; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Schinzari F, 2012, AM J PHYSIOL-ENDOC M, V303, pE806, DOI 10.1152/ajpendo.00206.2012; Schneider JW, 2001, SEMIN ONCOL, V28, P18, DOI 10.1053/sonc.2001.28546; Scully Tony, 2012, Nature, V485, pS2; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Suzuki K, 2012, J SURG RES, V178, P352, DOI 10.1016/j.jss.2012.01.043; Von Lueder TG, 2012, CARDIOVASC DRUGS THE; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yousif M. H. M., 2005, Autonomic & Autacoid Pharmacology, V25, P69, DOI 10.1111/j.1474-8673.2004.00333.x; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67813	10.1371/journal.pone.0067813	http://dx.doi.org/10.1371/journal.pone.0067813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826343	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000100
J	Ayieko, C; Maue, AC; Jura, WGZO; Noland, GS; Ayodo, G; Rochford, R; John, CC				Ayieko, Cyrus; Maue, Alexander C.; Jura, Walter G. Z. O.; Noland, Gregory S.; Ayodo, George; Rochford, Rosemary; John, Chandy C.			Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GERMINAL CENTER; ANTIBODY-RESPONSES; MALARIA INFECTION; BONE-MARROW; ANTIGEN; INDIVIDUALS; CHILDREN; TERM; IGM	Clinical immunity to malaria declines in the absence of repeated parasite exposure. However, little is known about how B cell populations and antigen-specific memory B cells change in the absence of P. falciparum infection. A successful indoor residual insecticide spraying campaign in a highland area of western Kenya, led to an absence of blood-stage P. falciparum infection between March 2007 and April 2008. We assessed memory B cell responses in 45 adults at the beginning (April 2008) and end (April 2009) of a subsequent 12-month period during which none of the adults had evidence of asymptomatic parasitemia or clinical disease. Antibodies and memory B cells to the 42-kDa portion of the merozoite surface protein-1 (MSP-1(42)) were measured using ELISA and ELISPOT assays, respectively. B cell populations were characterized by flow cytometry. From 2008 to 2009, the prevalence of MSP-1(42)-specific memory B cells (45% vs. 55%, respectively, P = 0.32) or antibodies (91% vs. 82%, respectively, P = 0.32) did not differ significantly, although specific individuals did change from positive to negative and vice versa, particularly for memory B cells, suggesting possible low-level undetected parasitemia may have occurred in some individuals. The magnitude of MSP-1(42)-specific memory B cells and levels of antibodies to MSP-1(42) also did not differ from 2008 to 2009 (P > 0.10 for both). However, from 2008 to 2009 the proportions of both class-switched atypical (CD19+IgD-CD27-CD21-IgM-) and class-switched activated (CD19+IgD-CD27+CD21-IgM-) memory B cells decreased (both P < 0.001). In contrast, class-switched resting classical memory B cells (CD19+IgD-CD27+CD21+IgM-) increased (P < 0.001). In this area of seasonal malaria transmission, a one-year absence of detectable P. falciparum infection was not associated with changes in the prevalence or level of MSP-1(42) specific memory B cells, but was associated with major changes in overall memory B cell subsets.	[Ayieko, Cyrus; Jura, Walter G. Z. O.] Maseno Univ, Maseno, Kenya; [Maue, Alexander C.; Rochford, Rosemary] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Noland, Gregory S.; John, Chandy C.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Ayodo, George] Kenya Govt Med Res Ctr, Kisian, Kenya	Maseno University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Kenya Medical Research Institute	Ayieko, C (corresponding author), Maseno Univ, Maseno, Kenya.	cxayk@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Noland, Gregory/0000-0003-1332-4832	National Institute of Allergy and Infectious Diseases [U01 AI067854]; NIH/FIC [D43 TW008085]; FOGARTY INTERNATIONAL CENTER [D43TW008085] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA102667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	1. National Institute of Allergy and Infectious Diseases Grant U01 AI067854; 2. NIH/FIC D43 TW008085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asito AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-362; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bockstal Viki, 2011, J Parasitol Res, V2011, P534697, DOI 10.1155/2011/534697; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Carvalho LJM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-59; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; FACCHETTI F, 1995, J IMMUNOL, V154, P6624; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Gatto D, 2007, J IMMUNOL, V178, P67, DOI 10.4049/jimmunol.178.1.67; GREENWOOD BM, 1974, LANCET, V1, P435; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Hui G, 2007, VACCINE, V25, P948, DOI 10.1016/j.vaccine.2006.08.041; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; John CC, 2005, T ROY SOC TROP MED H, V99, P780, DOI 10.1016/j.trstmh.2005.04.012; John CC, 2009, EMERG INFECT DIS, V15, P1917, DOI 10.3201/eid1512.090627; Kassa D, 2006, CLIN VACCINE IMMUNOL, V13, P376, DOI 10.1128/CVI.13.3.376-379.2006; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Korir JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-66; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Lang B, 2005, J INFECT DIS, V191, P117, DOI 10.1086/426512; Menge DM, 2008, AM J TROP MED HYG, V79, P173, DOI 10.4269/ajtmh.2008.79.173; Migot F, 1995, CLIN EXP IMMUNOL, V102, P529; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J ALLERGY CLIN IMMUN, V122, P12, DOI 10.1016/j.jaci.2008.04.034; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Stephens R, 2009, PARASITE IMMUNOL, V31, P20, DOI 10.1111/j.1365-3024.2008.01066.x; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510	51	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67230	10.1371/journal.pone.0067230	http://dx.doi.org/10.1371/journal.pone.0067230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826242	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000046
J	Ferguson, LR; Dominguez, JM; Balaiya, S; Grover, S; Chalam, KV				Ferguson, Lee R.; Dominguez, James M., II; Balaiya, Sankarathi; Grover, Sandeep; Chalam, Kakarla V.			Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MOUSE MODEL; DEGENERATION; RETINOPATHY; GENE	Objective: To report normative data for retinal thickness in wild-type C57BL/6 mouse utilizing a miniature SD-OCT system. Methods: Thirty adult mice (range: 3-5 months) were anesthetized and secured into the Bioptigen Spectral Domain Ophthalmic Imaging System. Right eye SD-OCT images were standardized by centralizing the optic nerve head (ONH) prior to image acquisition. Global and quadrant total retinal thickness (TRT) values were measured from retinal nerve fiber layer to retinal pigment epithelial layer. Posterior segment analyses also included the outer retinal layer (ORL) and inner retinal layer (IRL). Further sublayer analyses of four layers from the ORL and three layers comprising the IRL were also performed. Results: The overall mean +/- SD global TRT in a C57BL/6 mouse model was 204.41 +/- 5.19 mu m. Quadrant mean TRT values were 204.85 +/- 5.81 mu m inferiorly, 204.97 +/- 6.71 mu m nasally, 205.08 +/- 5.44 mu m temporally, and 202.74 +/- 4.85 mu m superiorly. Mean +/- SD thickness for ORL, and IRL were 126.37 +/- 10.01 mu m, and 107.03 +/- 10.98 mu m respectively. The mean +/- SD estimates for the four layers of the ORL were 18.23 +/- 2.73 mu m, 26.04 +/- 4.21 mu m, 63.8 +/- 6.23 mu m, and 19.22 +/- 4.34 mu m. Mean +/- SD values for the three IRL sublayers were 27.82 +/- 4.04 mu m, 59.62 +/- 6.66 mu m and 19.12 +/- 3.71 mu m. Conclusion: This study established normative values for the total retinal thickness and sublayer thickness for the wild-type C57BL/6 mice. Moreover, it provides a standard of retinal morphology, in a commonly used animal model, for evaluating therapeutic interventions and retinal disease pathophysiology.	[Ferguson, Lee R.; Balaiya, Sankarathi; Grover, Sandeep; Chalam, Kakarla V.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA; [Dominguez, James M., II] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chalam, KV (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA.	Kakarla.Chalam@jax.ufl.edu	Chalam, kakarla/K-7507-2019	Chalam, kakarla/0000-0001-9325-8665; Chalam, K V/0000-0002-0004-9416; Grover, Sandeep/0000-0002-3771-7510				Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Alam S, 2006, OPHTHALMOLOGY, V113, P1425, DOI 10.1016/j.ophtha.2006.03.020; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Dyer MA, 2004, MOL BRAIN RES, V132, P208, DOI 10.1016/j.molbrainres.2004.10.011; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Fukuchi T, 2001, GRAEF ARCH CLIN EXP, V239, P41, DOI 10.1007/s004170000205; Gabriele ML, 2010, INVEST OPHTH VIS SCI, V51, P6519, DOI 10.1167/iovs.10-5662; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grover S, 2009, AM J OPHTHALMOL, V148, P266, DOI 10.1016/j.ajo.2009.03.006; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Kern TS, 1996, ARCH OPHTHALMOL-CHIC, V114, P986, DOI 10.1001/archopht.1996.01100140194013; Li QH, 2001, INVEST OPHTH VIS SCI, V42, P2981; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Pang JJ, 2005, MOL VIS, V11, P152; Pignatelli V, 2004, J COMP NEUROL, V469, P351, DOI 10.1002/cne.11019; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Sabates FN, 2011, RETINA-J RET VIT DIS, V31, P1294, DOI 10.1097/IAE.0b013e3182019be2; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	31	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67265	10.1371/journal.pone.0067265	http://dx.doi.org/10.1371/journal.pone.0067265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826252	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000052
J	Fiorito, V; Crich, SG; Silengo, L; Aime, S; Altruda, F; Tolosano, E				Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela			Lack of Plasma Protein Hemopexin Results in Increased Duodenal Iron Uptake	PLOS ONE			English	Article							HEME; EXPRESSION; MICE; IDENTIFICATION; TRANSPORTER; METABOLISM; HEPCIDIN; ANEMIA; DAMAGE; DMT1	Purpose: The body concentration of iron is regulated by a fine equilibrium between absorption and losses of iron. Iron can be absorbed from diet as inorganic iron or as heme. Hemopexin is an acute phase protein that limits iron access to microorganisms. Moreover, it is the plasma protein with the highest binding affinity for heme and thus it mediates heme-iron recycling. Considering its involvement in iron homeostasis, it was postulated that hemopexin may play a role in the physiological absorption of inorganic iron. Methods and Results: Hemopexin-null mice showed elevated iron deposits in enterocytes, associated with higher duodenal H-Ferritin levels and a significant increase in duodenal expression and activity of heme oxygenase. The expression of heme-iron and inorganic iron transporters was normal. The rate of iron absorption was assessed by measuring the amount of Fe-57 retained in tissues from hemopexin-null and wild-type animals after administration of an oral dose of (FeSO4)-Fe-57 or of Fe-57-labelled heme. Higher iron retention in the duodenum of hemopexin-null mice was observed as compared with normal mice. Conversely, iron transfer from enterocytes to liver and bone marrow was unaffected in hemopexin-null mice. Conclusions: The increased iron level in hemopexin-null duodenum can be accounted for by an increased iron uptake by enterocytes and storage in ferritins. These data indicate that the lack of hemopexin under physiological conditions leads to an enhanced duodenal iron uptake thus providing new insights to our understanding of body iron homeostasis.	[Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Tolosano, E (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	emanuela.tolosano@unito.it	Tolosano, Emanuela/L-8080-2019; Aime, Silvio/J-8009-2018; Crich, Simonetta Geninatti/AAC-7506-2022; Fiorito, Veronica/AAC-3331-2022; Tolosano, Emanuela/A-4684-2015	Tolosano, Emanuela/0000-0002-1622-2340; Aime, Silvio/0000-0002-5373-4708; Crich, Simonetta Geninatti/0000-0003-2998-5424; Fiorito, Veronica/0000-0001-9063-7918; Tolosano, Emanuela/0000-0002-1622-2340	Italian Ministry of University and Research; Regione Piemonte	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte)	This work was supported by the Italian Ministry of University and Research to ET and FA, and by the Regione Piemonte to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Chiabrando D, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P261; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Chiabrando D, 2013, BLOOD CELL MOL DIS, V50, P25, DOI 10.1016/j.bcmd.2012.08.002; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Fiorito V, 2012, EUR J NUTR, V51, P783, DOI 10.1007/s00394-011-0256-6; Frazer DM, 2003, GUT, V52, P340, DOI 10.1136/gut.52.3.340; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Knutson MD, 2010, ANNU REV NUTR, V30, P149, DOI 10.1146/annurev.nutr.012809.104801; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; LANE RS, 1973, BRIT J HAEMATOL, V25, P533, DOI 10.1111/j.1365-2141.1973.tb01764.x; Marro S, 2007, GASTROENTEROLOGY, V133, P1261, DOI 10.1053/j.gastro.2007.07.004; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; Peyssonnaux C, 2008, CELL CYCLE, V7, P28, DOI 10.4161/cc.7.1.5145; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Tchernitchko D, 2002, BIOCHEM J, V363, P449, DOI 10.1042/0264-6021:3630449; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68146	10.1371/journal.pone.0068146	http://dx.doi.org/10.1371/journal.pone.0068146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826373	Green Published, gold			2022-12-25	WOS:000321150000127
J	Garcia-Arriaza, J; Arnaez, P; Gomez, CE; Sorzano, COS; Esteban, M				Garcia-Arriaza, Juan; Arnaez, Pilar; Gomez, Carmen E.; Sorzano, Carlos Oscar S.; Esteban, Mariano			Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways	PLOS ONE			English	Article							T-CELL RESPONSES; HEALTHY HIV-1-UNINFECTED VOLUNTEERS; POXVIRUS VECTORS MVA; RNA HELICASE DDX3; HIV-1 INFECTION; PHASE-1 SAFETY; ANKARA; IMMUNOGENICITY; NYVAC; DNA	Poxvirus vector Modified Vaccinia Virus Ankara (MVA) expressing HIV-1 Env, Gag, Pol and Nef antigens from clade B (termed MVA-B) is a promising HIV/AIDS vaccine candidate, as confirmed from results obtained in a prophylactic phase I clinical trial in humans. To improve the immunogenicity elicited by MVA-B, we have generated and characterized the innate immune sensing and the in vivo immunogenicity profile of a vector with a double deletion in two vaccinia virus (VACV) genes (C6L and K7R) coding for inhibitors of interferon (IFN) signaling pathways. The innate immune signals elicited by MVA-B deletion mutants (MVA-B DC6L and MVA-B DC6L/K7R) in human macrophages and monocyte-derived dendritic cells (moDCs) showed an up-regulation of the expression of IFN-beta, IFN-alpha/beta-inducible genes, TNF-alpha, and other cytokines and chemokines. A DNA prime/MVA boost immunization protocol in mice revealed that these MVA-B deletion mutants were able to improve the magnitude and quality of HIV-1-specific CD4(+) and CD8(+) T cell adaptive and memory immune responses, which were mostly mediated by CD8(+) T cells of an effector phenotype, with MVA-B DC6L/K7R being the most immunogenic virus recombinant. CD4(+) T cell responses were mainly directed against Env, while GPN-specific CD8(+) T cell responses were induced preferentially by the MVA-B deletion mutants. Furthermore, antibody levels to Env in the memory phase were slightly enhanced by the MVA-B deletion mutants compared to the parental MVA-B. These findings revealed that double deletion of VACV genes that act blocking intracellularly the IFN signaling pathway confers an immunological benefit, inducing innate immune responses and increases in the magnitude, quality and durability of the HIV-1-specific T cell immune responses. Our observations highlighted the immunomodulatory role of the VACV genes C6L and K7R, and that targeting common pathways, like IRF3/IFN-beta signaling, could be a general strategy to improve the immunogenicity of poxvirus-based vaccine candidates.	[Garcia-Arriaza, Juan; Arnaez, Pilar; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	S. Sorzano, Carlos Oscar/ABE-4884-2021; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020; Gomez, Carmen Elena/K-1940-2014; Sorzano, Carlos Oscar S S./F-2639-2016	S. Sorzano, Carlos Oscar/0000-0002-9473-283X; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; Gomez, Carmen Elena/0000-0002-5414-7935; Sorzano, Carlos Oscar S S./0000-0002-9473-283X	 [SAF2008-02036];  [FIPSE-360731/09];  [Red Sida RD12/0017/0038]	; ; 	This investigation was supported by grants from Spain, SAF2008-02036, FIPSE-360731/09 and Red Sida RD12/0017/0038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Agy MB, 1995, VIROLOGY, V214, P379, DOI 10.1006/viro.1995.0047; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 2002, J GEN VIROL, V83, P545, DOI 10.1099/0022-1317-83-3-545; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; BACAREGEN L, 1994, J VIROL, V68, P7559, DOI 10.1128/JVI.68.11.7559-7565.1994; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Gomez CE, 2012, J VIROL, V86, P5026, DOI 10.1128/JVI.06684-11; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; FERNIE BF, 1991, J VIROL, V65, P3968, DOI 10.1128/JVI.65.7.3968-3971.1991; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12; Garber DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005445; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; HANSEN MB, 1992, CLIN EXP IMMUNOL, V88, P559; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Hughes R, 2012, REV MED VIROL, V22, P257, DOI 10.1002/rmv.1708; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kutscher S, 2010, GENE THER, V17, P1372, DOI 10.1038/gt.2010.90; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Sato Y, 2000, JPN CIRC J, V64, P321, DOI 10.1253/jcj.64.321; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SHIRAZI Y, 1992, J VIROL, V66, P1321, DOI 10.1128/JVI.66.3.1321-1328.1992; Sumner RP, 2013, J GEN VIROL; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099	69	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66894	10.1371/journal.pone.0066894	http://dx.doi.org/10.1371/journal.pone.0066894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826170	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000017
J	He, MH; Zhang, LL; Wang, XC; Huo, LH; Sun, L; Feng, CY; Jing, XT; Du, DY; Liang, HB; Liu, M; Hong, ZY; Zhou, J				He, Minghao; Zhang, Linlin; Wang, Xincheng; Huo, Lihong; Sun, Lei; Feng, Chengye; Jing, Xutian; Du, Danyao; Liang, Huabin; Liu, Min; Hong, Zhangyong; Zhou, Jun			Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHROMATIN-REMODELING COMPLEX; HIV-1 TAT; PROTEIN; TRANSACTIVATION; TRANSCRIPTION; BINDING; LOOP; ACETYLTRANSFERASE; PROLIFERATION	The Tat protein of HIV-1 has several well-known properties, such as nucleocytoplasmic trafficking, transactivation of transcription, interaction with tubulin, regulation of mitotic progression, and induction of apoptosis. Previous studies have identified a couple of lysine residues in Tat that are essential for its functions. In order to analyze the functions of all the lysine residues in Tat, we mutated them individually to alanine, glutamine, and arginine. Through systematic analysis of the lysine mutants, we discovered several previously unidentified characteristics of Tat. We found that lysine acetylation could modulate the subcellular localization of Tat, in addition to the regulation of its transactivation activity. Our data also revealed that lysine mutations had distinct effects on microtubule assembly and Tat binding to bromodomain proteins. By correlation analysis, we further found that the effects of Tat on apoptosis and mitotic progression were not entirely attributed to its effect on microtubule assembly. Our findings suggest that Tat may regulate diverse cellular activities through binding to different proteins and that the acetylation of distinct lysine residues in Tat may modulate its interaction with various partners.	[He, Minghao; Zhang, Linlin; Wang, Xincheng; Huo, Lihong; Feng, Chengye; Jing, Xutian; Du, Danyao; Liang, Huabin; Hong, Zhangyong; Zhou, Jun] Nankai Univ, Coll Life Sci, Ctr AIDS Res, Tianjin 300071, Peoples R China; [Sun, Lei; Liu, Min] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Hong, ZY (corresponding author), Nankai Univ, Coll Life Sci, Ctr AIDS Res, Tianjin 300071, Peoples R China.	hongzy@nankai.edu.cn; junzhou@nankai.edu.cn	Huo, Lihong/ABI-4909-2020; Sun, Lei/N-4783-2018; Zhang, Linlin/J-6639-2019	Zhang, Linlin/0000-0003-3240-1215; Feng, Chengye/0000-0001-7330-4273; Huo, Lihong/0000-0001-7901-6758	National Science and Technology [2012ZX10001-006]; National Natural Science Foundation of China [31170820, 31171334]; National Undergraduate Training Program for Innovation [111005521]; National Basic Science Personnel Training Fund [J1103503]; 111 project [B08011]	National Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Training Program for Innovation; National Basic Science Personnel Training Fund; 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Science and Technology Major Project (2012ZX10001-006), the National Natural Science Foundation of China (31170820 and 31171334), the National Undergraduate Training Program for Innovation (111005521), the National Basic Science Personnel Training Fund (J1103503), and the 111 project (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Bukrinsky M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-49; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Gibellini D, 2005, NEW MICROBIOL, V28, P95; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Huo L, 2010, J PATHOL; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; JEANG KT, 1993, J BIOL CHEM, V268, P24940; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; RAPPAPORT J, 1989, New Biologist, V1, P101; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; TILEY LS, 1990, VIROLOGY, V178, P560, DOI 10.1016/0042-6822(90)90354-T; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Truant R, 1999, MOL CELL BIOL, V19, P1210; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055833	34	15	15	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67186	10.1371/journal.pone.0067186	http://dx.doi.org/10.1371/journal.pone.0067186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826228	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000040
J	Hu, XQ; Yuan, P; Yan, J; Feng, F; Li, XL; Liu, WH; Yang, YF				Hu, Xiaoqin; Yuan, Ping; Yan, Jin; Feng, Fei; Li, Xiaoling; Liu, Wenhui; Yang, Yanfang			Gene Polymorphisms of ADIPOQ+45T > G, UCP2-866G > A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; ADIPONECTIN GENE; PLASMA ADIPONECTIN; CELL-PROLIFERATION; PROTEIN-2 GENE; ASSOCIATION; OBESITY; ENVIRONMENT; VARIANTS	As insulin resistance (IR) is an established risk factor for colorectal cancer (CRC), we explored the association between each of the IR-related gene polymorphisms of adiponectin (ADIPOQ) rs2241766, uncoupling protein 2 (UCP2) rs659366, and fatty acid-binding protein (FABP2) rs1799883 and CRC risk. Genotyping of blood samples and collection of lifestyle and dietary habits were performed for 400 case-control pairs. Unconditional logistic regression (ULR) was applied to assess the effects of the three single nucleotide polymorphisms (SNP), environmental factors. Both ULR and generalized multifactor dimensionality reduction (GMDR) were used to test the gene-gene and gene-environment interactions on CRC risk. Subjects carrying the ADIPOQ rs2241766 TG+GG genotype had a higher CRC risk than those carrying the TT genotype (OR = 1.429, 95% CI 1.069-1.909). The additive and multiplicative interactions between ADIPOQ rs2241766 and FABP2 rs1799883 on CRC were found by ULR (RERI = 0.764, 95%CI 0.218 similar to 1.311, AP = 0.514, 95%CI 0.165 similar to 0.864, S = -1.745, 95%CI is unachievable, and P-multi = 0.017, respectively). Furthermore, the high order gene-gene interaction of the three SNPs were found by GMDR (P = 0.0107). A significant dosage effect with an increasing number of risk genotypes was observed as the risk of CRC increased (P-trend = 0.037). In GMDR, the gene-environment interaction among the three SNPs and red meat consumption on CRC risk was significant (P = 0.0107). Compared with subjects with low red meat consumption and null risk genotypes, those with high-red meat consumption and three risk genotypes had 3.439-fold CRC risk (95% CI 1.410-8.385). In conclusion, the results showed that the ADIPOQ rs2241766 TG+GG genotype increased CRC risk. Given the complexity of the carcinogen for CRC, ADIPOQ rs2241766, UCP2 rs659366, FABP2 rs1799883 and red meat consumption potentially worked together in affecting CRC risk.	[Hu, Xiaoqin; Yuan, Ping; Feng, Fei; Li, Xiaoling; Liu, Wenhui; Yang, Yanfang] Sichuan Univ, Dept Epidemiol, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China; [Yan, Jin] Sichuan Canc Hosp, Dept Intestinal Surg, Chengdu, Sichuan, Peoples R China	Sichuan University	Yang, YF (corresponding author), Sichuan Univ, Dept Epidemiol, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China.	yangyanfang2000@yahoo.com.cn			Ministry of Education of China [20090181120019]; National Natural Science Foundation of China [81102196]	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Doctoral Fund of Ministry of Education of China (Grant Number 20090181120019) and the National Natural Science Foundation of China (Grant Number 81102196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harithy RN, 2012, ONCOL LETT, V3, P176, DOI 10.3892/ol.2011.443; Albala C, 2006, REV MED CHILE, V134, P372; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chamberlain AM, 2009, METABOLISM, V58, P1222, DOI 10.1016/j.metabol.2009.04.007; Chaolu H, 2011, EXP THER MED, V2, P369, DOI 10.3892/etm.2011.199; Chen MW, 2012, MED ONCOL, V29, P3129, DOI 10.1007/s12032-012-0280-2; Chung HK, 2009, DIABETES CARE, V32, P552, DOI 10.2337/dc08-1605; Cowey SL, 2005, CANCER-AM CANCER SOC, V103, P2643, DOI 10.1002/cncr.21094; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; D'Apolito M, 2010, J CLIN INVEST, V120, P203, DOI 10.1172/JCI37672; Daimon Makoto, 2012, Nihon Rinsho, V70 Suppl 3, P256; Djiogue S, 2013, ENDOCR-RELAT CANCER, V20, pR1, DOI 10.1530/ERC-12-0324; Ferlay J, 2010, GLOBOCAN 2008 V1 2, V1.2; Georgopoulos A, 2002, J CLIN ENDOCR METAB, V87, P3735, DOI 10.1210/jc.87.8.3735; Gingras D, 2011, CANCER MICROENVIRON, V4, P133, DOI 10.1007/s12307-010-0060-5; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harano Y, 2001, Nihon Rinsho, V59 Suppl 2, P726; He BS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-94; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Kahn R, 1998, DIABETES CARE, V21, P310; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Knize M G, 1999, Adv Exp Med Biol, V459, P179; Komninou D, 2003, EXP BIOL MED, V228, P396, DOI 10.1177/153537020322800410; Kotnis A, 2005, J BIOSCIENCES, V30, P93, DOI 10.1007/BF02705154; Leng SL, 2001, CARCINOGENESIS, V22, P1625, DOI 10.1093/carcin/22.10.1625; Li YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019686; Limburg PJ, 2006, CLIN GASTROENTEROL H, V4, P1514, DOI 10.1016/j.cgh.2006.09.014; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; MCKEOWNEYSSEN G, 1994, CANCER EPIDEM BIOMAR, V3, P687; Melistas L, 2009, EUR J ENDOCRINOL, V161, P845, DOI 10.1530/EJE-09-0492; Michael M, 2007, FOOD NUTR PHYS ACT P; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Ochoa MC, 2007, MOL GENET METAB, V92, P351, DOI 10.1016/j.ymgme.2007.07.011; Ortiz AP, 2012, CANCER-AM CANCER SOC, V118, P1774, DOI 10.1002/cncr.26454; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Partida-Perez M, 2010, CANCER BIOMARK, V7, P117, DOI 10.3233/CBM-2010-0154; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Saxena A, 2012, BBA-MOL BASIS DIS, V1822, P527, DOI 10.1016/j.bbadis.2011.12.006; Schechter S, 1995, R I Med, V78, P161; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Sugiyama M, 2009, INT J ONCOL, V34, P339, DOI 10.3892/ijo_00000156; Tang FY, 2012, J NUTR BIOCHEM, V23, P1302, DOI 10.1016/j.jnutbio.2011.07.011; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Von Eynatten M, 2006, CLIN CHEM, V52, P853, DOI 10.1373/clinchem.2005.060509; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Weiss EP, 2002, PHYSIOL GENOMICS, V10, P145, DOI 10.1152/physiolgenomics.00070.2001; Wilkin TJ, 2009, INT J OBESITY, V33, P716, DOI 10.1038/ijo.2009.97; Xita N, 2005, CLIN CHEM, V51, P416, DOI 10.1373/clinchem.2004.043109; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758; Zhao P, 2011, CHINESE TUMOR REGIST; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	63	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67275	10.1371/journal.pone.0067275	http://dx.doi.org/10.1371/journal.pone.0067275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826253	gold, Green Submitted, Green Published			2022-12-25	WOS:000321150000053
J	Li, ZQ; Zhang, S; Ma, Y; Luo, JY; Wang, CY; Lv, LM; Dong, SL; Cui, JJ				Li, Zhao-Qun; Zhang, Shuai; Ma, Yan; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Dong, Shuang-Lin; Cui, Jin-Jie			First Transcriptome and Digital Gene Expression Analysis in Neuroptera with an Emphasis on Chemoreception Genes in Chrysopa pallens (Rambur)	PLOS ONE			English	Article							BINDING-PROTEINS; CHEMOSENSORY PROTEINS; LACEWINGS NEUROPTERA; PHEROMONE DETECTION; CARNEA NEUROPTERA; CIRCADIAN CLOCK; SEX-PHEROMONE; MOTH; ANTENNAE; INSECT	Background: Chrysopa pallens (Rambur) are the most important natural enemies and predators of various agricultural pests. Understanding the sophisticated olfactory system in insect antennae is crucial for studying the physiological bases of olfaction and also could lead to effective applications of C. pallens in integrated pest management. However no transcriptome information is available for Neuroptera, and sequence data for C. pallens are scarce, so obtaining more sequence data is a priority for researchers on this species. Results: To facilitate identifying sets of genes involved in olfaction, a normalized transcriptome of C. pallens was sequenced. A total of 104,603 contigs were obtained and assembled into 10,662 clusters and 39,734 singletons; 20,524 were annotated based on BLASTX analyses. A large number of candidate chemosensory genes were identified, including 14 odorant-binding proteins (OBPs), 22 chemosensory proteins (CSPs), 16 ionotropic receptors, 14 odorant receptors, and genes potentially involved in olfactory modulation. To better understand the OBPs, CSPs and cytochrome P450s, phylogenetic trees were constructed. In addition, 10 digital gene expression libraries of different tissues were constructed and gene expression profiles were compared among different tissues in males and females. Conclusions: Our results provide a basis for exploring the mechanisms of chemoreception in C. pallens, as well as other insects. The evolutionary analyses in our study provide new insights into the differentiation and evolution of insect OBPs and CSPs. Our study provided large-scale sequence information for further studies in C. pallens.	[Li, Zhao-Qun; Zhang, Shuai; Ma, Yan; Luo, Jun-Yu; Wang, Chun-Yi; Lv, Li-Min; Cui, Jin-Jie] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Li, Zhao-Qun; Dong, Shuang-Lin] Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Dong, SL (corresponding author), Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522; Ma, Yan/0000-0001-6897-5064	Ministry of Agricultural [2011ZX08011-002]; Ministry of Science and Technology [2012BAD19B05]; National Natural Science Foundation of China [31071978]	Ministry of Agricultural; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Agricultural (2011ZX08011-002), the Ministry of Science and Technology (2012BAD19B05), and the National Natural Science Foundation of China (31071978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Athhan R, 2004, J PEST SCI, V77, P17, DOI 10.1007/s10340-003-0021-6; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Doroszuk A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-167; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hoen PAC, 2008, NUCL ACIDS RES, V36; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Ferreiro MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-483; Koczor S, 2010, PEST MANAG SCI, V66, P1374, DOI 10.1002/ps.2030; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; Maibeche-Coisne M, 2002, INSECT MOL BIOL, V11, P273, DOI 10.1046/j.1365-2583.2002.00335.x; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Medina P, 2003, ENVIRON ENTOMOL, V32, P196, DOI 10.1603/0046-225X-32.1.196; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; New TR, 2002, ACTA ZOOL ACAD SCI H, V48, P209; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pottier MA, 2012, INSECT MOL BIOL, V21, P568, DOI 10.1111/j.1365-2583.2012.01160.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toth M, 2009, J CHEM ECOL, V35, P449, DOI 10.1007/s10886-009-9614-8; Vogt R.G., 2004, MOL BASIS PHEROMONE; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047954; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winterton S, 2006, AUST J ENTOMOL, V45, P235, DOI 10.1111/j.1440-6055.2006.00537.x; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang QH, 2004, J CHEM ECOL, V30, P1849, DOI 10.1023/B:JOEC.0000042406.76705.ab; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhu J, 2005, NATURWISSENSCHAFTEN, V92, P277, DOI 10.1007/s00114-005-0624-2; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	67	25	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67151	10.1371/journal.pone.0067151	http://dx.doi.org/10.1371/journal.pone.0067151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826220	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000036
J	Ljubicic, S; Bezzi, P; Brajkovic, S; Nesca, V; Guay, C; Ohbayashi, N; Fukuda, M; Abderrhamani, A; Regazzi, R				Ljubicic, Sanda; Bezzi, Paola; Brajkovic, Saska; Nesca, Valeria; Guay, Claudiane; Ohbayashi, Norihiko; Fukuda, Mitsunori; Abderrhamani, Amar; Regazzi, Romano			The GTPase Rab37 Participates in the Control of Insulin Exocytosis	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; SECRETORY GRANULES; VESICLE DOCKING; PLASMA-MEMBRANE; PC12 CELLS; GLUCOSE; EXPRESSION; RAB27A; INHIBITION; MECHANISMS	Rab37 belongs to a subclass of Rab GTPases regulating exocytosis, including also Rab3a and Rab27a. Proteomic studies indicate that Rab37 is associated with insulin-containing large dense core granules of pancreatic beta-cells. In agreement with these observations, we detected Rab37 in extracts of beta-cell lines and human pancreatic islets and confirmed by confocal microscopy the localization of the GTPase on insulin-containing secretory granules. We found that, as is the case for Rab3a and Rab27a, reduction of Rab37 levels by RNA interference leads to impairment in glucose-induced insulin secretion and to a decrease in the number of granules in close apposition to the plasma membrane. Pull-down experiments revealed that, despite similar functional effects, Rab37 does not interact with known Rab3a or Rab27a effectors and is likely to operate through a different mechanism. Exposure of insulin-secreting cells to proinflammatory cytokines, fatty acids or oxidized low-density lipoproteins, mimicking physiopathological conditions that favor the development of diabetes, resulted in a decrease in Rab37 expression. Our data identify Rab37 as an additional component of the machinery governing exocytosis of b-cells and suggest that impaired expression of this GTPase may contribute to defective insulin release in pre-diabetic and diabetic conditions.	[Ljubicic, Sanda; Bezzi, Paola; Nesca, Valeria; Guay, Claudiane; Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Brajkovic, Saska; Abderrhamani, Amar] Univ Lille 2, EGID FR 3508, INSERM U859, Lille, France; [Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Tohoku University	Regazzi, R (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	Romano.Regazzi@unil.ch	Guay, Claudiane/AAF-5381-2019; Fukuda, MItsunori/I-1511-2015; Bezzi, Paola/AAP-2440-2020	Fukuda, MItsunori/0000-0002-8620-5853; Guay, Claudiane/0000-0002-6478-8744; Regazzi, Romano/0000-0002-9773-2915	Swiss National Science Foundation [31003A-127254]; Grants-in-Aid for Scientific Research [24570206] Funding Source: KAKEN	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant number 31003A-127254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Favre D, 2011, DIABETES, V60, P3169, DOI 10.2337/db10-1743; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Izumi T, 2007, DIABETES OBES METAB, V9, P109, DOI 10.1111/j.1463-1326.2007.00789.x; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prada I, 2011, J CELL BIOL, V193, P537, DOI 10.1083/jcb.201010126; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68255	10.1371/journal.pone.0068255	http://dx.doi.org/10.1371/journal.pone.0068255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826383	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000136
J	Peltzer, N; Vanli, G; Yang, JY; Widmann, C				Peltzer, Nieves; Vanli, Gueliz; Yang, Jiang-Yan; Widmann, Christian			Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYTOPLASMIC SURVIVIN; SIGNALING PATHWAY; INDUCED APOPTOSIS; DEATH; CASPASE-3; AKT; EXPRESSION; DIFFERENTIATION; ACTIVATION	Partial cleavage of p120 RasGAP by caspase-3 in stressed cells generates an N-terminal fragment, called fragment N, which activates an anti-apoptotic Akt-dependent survival response. Akt regulates several effectors but which of these mediate fragment N-dependent cell protection has not been defined yet. Here we have investigated the role of mTORC1, Bad, and survivin in the capacity of fragment N to protect cells from apoptosis. Neither rapamycin, an inhibitor of mTORC1, nor silencing of raptor, a subunit of the mTORC1 complex, altered the ability of fragment N from inhibiting cisplatin-and Fas ligand-induced death. Cells lacking Bad, despite displaying a stronger resistance to apoptosis, were still protected by fragment N against cisplatin-induced death. Fragment N was also able to protect cells from Fas ligand-induced death in conditions where Bad plays no role in apoptosis regulation. Fragment N expression in cells did neither modulate survivin mRNA nor its protein expression. Moreover, the expression of cytoplasmic survivin, known to exert anti-apoptotic actions in cells, still occurred in UV-B-irradiated epidermis of mouse expressing a caspase-3-resistant RasGAP mutant that cannot produce fragment N. Additionally, survivin function in cell cycle progression was not affected by fragment N. These results indicate that, taken individually, mTOR, Bad, or Survivin are not required for fragment N to protect cells from cell death. We conclude that downstream targets of Akt other than mTORC1, Bad, or survivin mediate fragment N-induced protection or that several Akt effectors can compensate for each other to induce the pro-survival fragment N-dependent response.	[Peltzer, Nieves; Vanli, Gueliz; Yang, Jiang-Yan; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland	University of Lausanne	Widmann, C (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Christian.Widmann@unil.ch	Widmann, Christian/N-9851-2013; Peltzer, Nieves/AAI-2831-2020	Widmann, Christian/0000-0002-6881-0363; Peltzer, Nieves/0000-0002-4134-5852	Swiss National Science Foundation [31003A_141242/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_141242/1 (to CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Annibaldi A, 2009, EXP CELL RES, V315, P2081, DOI 10.1016/j.yexcr.2009.03.015; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Bulat N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022609; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayakawa J, 2000, CANCER RES, V60, P5988; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hu H, 2010, GUT; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Johnson NC, 2004, EXP CELL RES, V298, P9, DOI 10.1016/j.yexcr.2004.04.003; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1999, CANCER RES, V59, P3143; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Peltzer N, 2012, J DERMATOL SCI, V67, P196, DOI 10.1016/j.jdermsci.2012.05.007; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Yang JY, 2009, DIABETES, V58, P2596, DOI 10.2337/db09-0104; Yang JY, 2005, J BIOL CHEM, V280, P32835, DOI 10.1074/jbc.M504058200; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	63	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68123	10.1371/journal.pone.0068123	http://dx.doi.org/10.1371/journal.pone.0068123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826368	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000122
J	Shah, GA; Groot, JCJ; Shah, GM; Lantinga, EA				Shah, Ghulam Abbas; Groot, Jeroen C. J.; Shah, Ghulam Mustafa; Lantinga, Egbert A.			Simulation of Long-Term Carbon and Nitrogen Dynamics in Grassland-Based Dairy Farming Systems to Evaluate Mitigation Strategies for Nutrient Losses	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; AMMONIA EMISSION; CATTLE SLURRY; MODEL; MANAGEMENT; MANURE; STORAGE; GROWTH; LEVEL; DIGESTIBILITY	Many measures have been proposed to mitigate gaseous emissions and other nutrient losses from agroecosystems, which can have large detrimental effects for the quality of soils, water and air, and contribute to eutrophication and global warming. Due to complexities in farm management, biological interactions and emission measurements, most experiments focus on analysis of short-term effects of isolated mitigation practices. Here we present a model that allows simulating long-term effects at the whole-farm level of combined measures related to grassland management, animal housing and manure handling after excretion, during storage and after field application. The model describes the dynamics of pools of organic carbon and nitrogen (N), and of inorganic N, as affected by farm management in grassland-based dairy systems. We assessed the long-term effects of delayed grass mowing, housing type (cubicle and sloping floor barns, resulting in production of slurry and solid cattle manure, respectively), manure additives, contrasting manure storage methods and irrigation after application of covered manure. Simulations demonstrated that individually applied practices often result in compensatory loss pathways. For instance, methods to reduce ammonia emissions during storage like roofing or covering of manure led to larger losses through ammonia volatilization, nitrate leaching or denitrification after application, unless extra measures like irrigation were used. A strategy of combined management practices of delayed mowing and fertilization with solid cattle manure that is treated with zeolite, stored under an impermeable sheet and irrigated after application was effective to increase soil carbon stocks, increase feed self-sufficiency and reduce losses by ammonia volatilization and soil N losses. Although long-term datasets (>25 years) of farm nutrient dynamics and loss flows are not available to validate the model, the model is firmly based on knowledge of processes and measured effects of individual practices, and allows the integrated exploration of effective emission mitigation strategies.	[Shah, Ghulam Abbas; Groot, Jeroen C. J.; Shah, Ghulam Mustafa; Lantinga, Egbert A.] Wageningen Univ, Farming Syst Ecol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Groot, JCJ (corresponding author), Wageningen Univ, Farming Syst Ecol Grp, NL-6700 AP Wageningen, Netherlands.	Jeroen.Groot@wur.nl	Shah, Ghulam Abbas/AAY-4883-2020; Lantinga, Egbert/AAR-2928-2020; Shah, Dr. Ghulam Mustafa/AAZ-1981-2021	Shah, Ghulam Mustafa/0000-0003-1230-7029; Groot, Jeroen/0000-0001-6516-5170; Shah, Ghulam Abbas/0000-0002-6992-4602	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	The funding of this study provided by the Higher Education Commission of Pakistan (www.hec.gov.pk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon B, 2006, AGR ECOSYST ENVIRON, V112, P153, DOI 10.1016/j.agee.2005.08.030; Astrup R, 2008, FOREST ECOL MANAG, V256, P1659, DOI 10.1016/j.foreco.2008.07.016; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Brooks RJ, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/0895-7177(96)00103-3; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Dammgen U, 2008, ENVIRON POLLUT, V154, P488, DOI 10.1016/j.envpol.2007.03.017; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Foereid B, 2004, NUTR CYCL AGROECOSYS, V68, P13, DOI 10.1023/B:FRES.0000012231.89516.80; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; GOUDRIAAN J, 1990, ANN BOT-LONDON, V66, P695, DOI 10.1093/oxfordjournals.aob.a088084; Gouttenoire L, 2011, MODELLING TOOL REDES, P1; Grace PR, 2006, SOIL BIOL BIOCHEM, V38, P1172, DOI 10.1016/j.soilbio.2005.09.013; Groot JCJ, 2006, LIVEST SCI, V100, P99, DOI 10.1016/j.livprodsci.2005.08.008; Groot JCJ, 1997, J SCI FOOD AGR, V75, P227, DOI 10.1002/(SICI)1097-0010(199710)75:2&lt;227::AID-JSFA869&gt;3.0.CO;2-F; Groot JCJ, 2004, ECOL MODEL, V177, P297, DOI 10.1016/j.ecolmodel.2004.02.008; Groot JCJ, 2003, NJAS-WAGEN J LIFE SC, V51, P165, DOI 10.1016/S1573-5214(03)80032-5; Groot JCJ, 2012, AGR SYST, V110, P63, DOI 10.1016/j.agsy.2012.03.012; Hansen MN, 2006, ATMOS ENVIRON, V40, P4172, DOI 10.1016/j.atmosenv.2006.02.013; Hansen MN, 2003, J ENVIRON QUAL, V32, P1099, DOI 10.2134/jeq2003.1099; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Henkens PLCM, 2001, NETH J AGR SCI, V49, P117, DOI 10.1016/S1573-5214(01)80002-6; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; JACKMAN R. H., 1964, NEW ZEAL J AGR RES, V7, P445; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Kemanian AR, 2010, EUR J AGRON, V32, P22, DOI 10.1016/j.eja.2009.08.003; KIRCHMANN H, 1989, PLANT SOIL, V115, P35, DOI 10.1007/BF02220692; Kirchmann H., 1985, ACTA AGR SCAND     S, V24, P1; Kustermann B, 2010, AGR ECOSYST ENVIRON, V135, P70, DOI 10.1016/j.agee.2009.08.014; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; Misselbrook TH, 2002, BIOSYST ENG, V81, P313, DOI 10.1006/bioe.2001.0017; Mosquera J., 2006, INT C SERIES, V1293, P291, DOI DOI 10.1016/J.ICS.2006.02.041; MUMPTON FA, 1977, J ANIM SCI, V45, P1188, DOI 10.2527/jas1977.4551188x; Ndegwa PM, 2008, BIOSYST ENG, V100, P453, DOI 10.1016/j.biosystemseng.2008.05.010; Ondersteijn CJM, 2003, LIVEST PROD SCI, V84, P171, DOI 10.1016/j.livprodsci.2003.09.013; Rashid MI, 2013, ECOL APPL IN PRESS; Reijs JW, 2007, AGR ECOSYST ENVIRON, V118, P65, DOI 10.1016/j.agee.2006.04.013; Romera AJ, 2010, COMPUT ELECTRON AGR, V74, P66, DOI 10.1016/j.compag.2010.06.006; Rotz CA, 2006, APPL ENG AGRIC, V22, P773; Rotz C A, 2004, J Anim Sci, V82 E-Suppl, pE119; Rotz CA, 2005, CROP SCI, V45, P2139, DOI 10.2135/cropsci2004.0523; Rougoor CW, 1997, LIVEST PROD SCI, V47, P235, DOI 10.1016/S0301-6226(96)01408-X; Rufino MC, 2009, NUTR CYCL AGROECOSYS, V84, P229, DOI 10.1007/s10705-008-9239-2; Saffih-Hdadi K, 2008, SOIL BIOL BIOCHEM, V40, P594, DOI 10.1016/j.soilbio.2007.08.022; Schils RLM, 2005, NUTR CYCL AGROECOSYS, V71, P163, DOI 10.1007/s10705-004-2212-9; SCHOLEFIELD D, 1991, PLANT SOIL, V132, P165, DOI 10.1007/BF00010397; Shah GM, 2012, NUTR CYCL AGROECOSYS, V94, P299, DOI 10.1007/s10705-012-9543-8; Shah GM, 2012, AGR ECOSYST ENVIRON, V160, P59, DOI 10.1016/j.agee.2011.07.017; Shah GA, 2013, J AGR SCI IN PRESS; Shah GM, 2013, NUTR CYCL A IN PRESS; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Thomsen IK, 2000, J AGR SCI, V135, P151, DOI 10.1017/S0021859699008096; Thornton PK, 2001, AGR SYST, V70, P581, DOI 10.1016/S0308-521X(01)00060-9; Tipping E, 2012, ECOL MODEL, V247, P11, DOI 10.1016/j.ecolmodel.2012.08.002; van Apeldoorn DF, 2011, ECOL SOC, V16; van der Werf W, 2007, ECOL ENG, V29, P419, DOI 10.1016/j.ecoleng.2006.09.017; Van Es A.J.H., 1975, LIVEST PROD SCI, V2, P95, DOI DOI 10.1016/0301-6226(75)90029-9; Watson CA, 2005, SOIL USE MANAGE, V21, P132, DOI [10.1079/SUM2005304, 10.1079/SUM2005299]; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Whitehead DC, 1995, GRASSLAND NITROGEN C; WITTER E, 1988, BIOL WASTE, V23, P279, DOI 10.1016/0269-7483(88)90016-X	61	12	12	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67279	10.1371/journal.pone.0067279	http://dx.doi.org/10.1371/journal.pone.0067279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826255	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000055
J	Oluwafemi, S; Dewhirst, SY; Veyrat, N; Powers, S; Bruce, TJA; Caulfield, JC; Pickett, JA; Birkett, MA				Oluwafemi, Sunday; Dewhirst, Sarah Y.; Veyrat, Nathalie; Powers, Stephen; Bruce, Toby J. A.; Caulfield, John C.; Pickett, John A.; Birkett, Michael A.			Priming of Production in Maize of Volatile Organic Defence Compounds by the Natural Plant Activator cis-Jasmone	PLOS ONE			English	Article							ZEA-MAYS; APHID; PARASITOIDS; EMISSION; GENES; IDENTIFICATION; TRANSMISSION; HOMOPTERA; PHEROMONE; SIGNALS	cis-Jasmone (CJ) is a natural plant product that activates defence against herbivores in model and crop plants. In this study, we investigated whether CJ could prime defence in maize, Zea mays, against the leafhopper, Cicadulina storeyi, responsible for the transmission of maize streak virus (MSV). Priming occurs when a pre-treatment, in this case CJ, increases the potency and speed of a defence response upon subsequent attack on the plant. Here, we tested insect responses to plant volatile organic compounds (VOCs) using a Y-tube olfactometer bioassay. Our initial experiments showed that, in this system, there was no significant response of the herbivore to CJ itself and no difference in response to VOCs collected from unexposed plants compared to CJ exposed plants, both without insects. VOCs were then collected from C. storeyi-infested maize seedlings with and without CJ pre-treatment. The bioassay revealed a significant preference by this pest for VOCs from infested seedlings without the CJ pre-treatment. A timed series of VOC collections and bioassays showed that the effect was strongest in the first 22 h of insect infestation, i.e. before the insects had themselves induced a change in VOC emission. Chemical analysis showed that treatment of maize seedlings with CJ, followed by exposure to C. storeyi, led to a significant increase in emission of the defensive sesquiterpenes (E)-(1R,9S)-caryophyllene, (E)-alpha-bergamotene, (E)-beta-farnesene and (E)-4,8-dimethyl-1,3,7-nonatriene, known to act as herbivore repellents. The chemical analysis explains the behavioural effects observed in the olfactometer, as the CJ treatment caused plants to emit a blend of VOCs comprising more of the repellent components in the first 22 h of insect infestation than control plants. The speed and potency of VOC emission was increased by the CJ pre-treatment. This is the first indication that CJ can prime plants for enhanced production of defensive VOCs antagonist towards herbivores.	[Oluwafemi, Sunday] Bowen Univ, Dept Crop Prod Soil & Environm Management, Iwo, Osun State, Nigeria; [Oluwafemi, Sunday; Dewhirst, Sarah Y.; Bruce, Toby J. A.; Caulfield, John C.; Pickett, John A.; Birkett, Michael A.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England; [Veyrat, Nathalie] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Powers, Stephen] Rothamsted Res, Biomath & Bioinformat Dept, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Neuchatel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Birkett, MA (corresponding author), Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England.	mike.birkett@rothamsted.ac.uk	Bruce, Toby JA/H-3131-2011	Bruce, Toby JA/0000-0002-9912-0605; Birkett, Michael/0000-0002-3302-2025	Rothamsted International African Fellows Programme; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; BBSRC [BBS/E/C/00004945, BB/L001683/1, BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L001683/1, BBS/E/C/00005194, BBS/E/C/00004945] Funding Source: researchfish	Rothamsted International African Fellows Programme; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Rothamsted International African Fellows Programme (Fellowship to SO). Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. SO gratefully acknowledges the permission of Bowen University, Nigeria, to undertake this Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos NG, 1999, J CHEM ECOL, V25, P1411, DOI 10.1023/A:1020939112234; [Anonymous], 2005, NIST MASS SPECTR SEA; Asanzi MC, 1995, AFR ENTOMOL, V3, P173; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bruce TJA, 2003, PEST MANAG SCI, V59, P1031, DOI 10.1002/ps.730; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; Bruce TJ, 2007, CURR OPIN PLANT BIOL, V10, P387, DOI 10.1016/j.pbi.2007.05.002; Chamberlain K, 2000, MOL PLANT PATHOL, V1, P67, DOI 10.1046/j.1364-3703.2000.00009.x; D'Alessandro M, 2005, CHEM SENSES, V30, P739, DOI 10.1093/chemse/bji066; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Hegde M, 2012, PHYTOCHEMISTRY, V78, P81, DOI 10.1016/j.phytochem.2012.03.004; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; KIM SK, 1981, 3 OAU STRC WORKSH MA; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Moraes MCB, 2009, ENTOMOL EXP APPL, V131, P178, DOI 10.1111/j.1570-7458.2009.00836.x; Moraes MCB, 2008, PHYTOCHEMISTRY, V69, P9, DOI 10.1016/j.phytochem.2007.06.020; Oikawa A, 2001, PHYTOCHEMISTRY, V56, P669, DOI 10.1016/S0031-9422(00)00494-5; Oluwafemi S, 2007, ENTOMOL EXP APPL, V124, P235, DOI 10.1111/j.1570-7458.2007.00577.x; Oluwafemi S, 2011, J CHEM ECOL, V37, P40, DOI 10.1007/s10886-010-9891-2; Ozawa R, 2004, J CHEM ECOL, V30, P1797, DOI 10.1023/B:JOEC.0000042402.04012.c7; Pickett JA, 2001, TRENDS PLANT SCI, V6, P137, DOI 10.1016/S1360-1385(01)01899-4; Pickett JA, 2007, PHYTOCHEMISTRY, V68, P2937, DOI 10.1016/j.phytochem.2007.09.025; Powell W, 2003, PEST MANAG SCI, V59, P149, DOI 10.1002/ps.550; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Skelton AC, 2010, J MED ENTOMOL, V47, P798, DOI 10.1603/ME09295; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; THOTTAPPILLY G, 1993, PLANT PATHOL, V42, P494, DOI 10.1111/j.1365-3059.1993.tb01529.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010	37	27	27	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e62299	10.1371/journal.pone.0062299	http://dx.doi.org/10.1371/journal.pone.0062299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840295	Green Submitted, Green Published, gold			2022-12-25	WOS:000321424400002
J	Pradels, A; Pradon, D; Hlavackova, P; Diot, B; Vuillerme, N				Pradels, Antoine; Pradon, Didier; Hlavackova, Petra; Diot, Bruno; Vuillerme, Nicolas			Sensory Re-Weighting in Human Bipedal Postural Control: The Effects of Experimentally-Induced Plantar Pain	PLOS ONE			English	Article							MUSCLE FATIGUE; HEAD EXTENSION; SENSORIMOTOR INTEGRATION; UPRIGHT STANCE; ORIENTATION; VIBRATION; POSITION; VISION; TOUCH; SWAY	The present study was designed to assess the effects of experimentally-induced plantar pain on the displacement of centre of foot pressure during unperturbed upright stance in different sensory conditions of availability and/or reliability of visual input and somatosensory input from the vestibular system and neck. To achieve this goal, fourteen young healthy adults were asked to stand as still as possible in three sensory conditions: (1) No-vision, (2) Vision, and (3) No-vision - Head tilted backward, during two experimental conditions: (1) a No-pain condition, and (2) a condition when a painful stimulation was applied to the plantar surfaces of both feet (Plantar-pain condition). Centre of foot pressure (CoP) displacements were recorded using a force platform. Results showed that (1) experimentally-induced plantar pain increased CoP displacements in the absence of vision (No-vision condition), (2) this deleterious effect was more accentuated when somatosensory information from the vestibular and neck was altered (No-vision - Head tilted backward condition) and (3) this deleterious effect was suppressed when visual information was available (Vision condition). From a fundamental point of view, these results lend support to the sensory re-weighting hypothesis whereby the central nervous system dynamically and selectively adjusts the relative contributions of sensory inputs (i.e. the sensory weightings) in order to maintain balance when one or more sensory channels are altered by the task (novel or challenging), environmental or individual conditions. From a clinical point of view, the present findings further suggest that prevention and treatment of plantar pain may be relevant for the preservation or improvement of balance control, particularly in situations (or individuals) in which information provided by the visual, neck proprioceptive and vestibular systems is unavailable or disrupted.	[Pradels, Antoine; Hlavackova, Petra; Diot, Bruno; Vuillerme, Nicolas] Univ Grenoble Alpes, FRE AGIM Lab 3405, CNRS UJF UPMF EPHE, La Tronche, France; [Pradels, Antoine; Pradon, Didier; Vuillerme, Nicolas] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, APHP Serv Physiol & Explorat Fonct, EA 4497,CIC IT 805, Garches, France; [Pradels, Antoine] Ctr Podol Estacade, Grenoble, France; [Hlavackova, Petra] CHU Grenoble, Hop Couple Enfant, Grenoble, France; [Diot, Bruno] IDS, Montceau Les Mines, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Vuillerme, N (corresponding author), Univ Grenoble Alpes, FRE AGIM Lab 3405, CNRS UJF UPMF EPHE, La Tronche, France.	nicolas.vuillerme@agim.eu	VUILLERME, Nicolas/U-5767-2019	VUILLERME, Nicolas/0000-0003-3773-393X				Anand V, 2003, INVEST OPHTH VIS SCI, V44, P2885, DOI 10.1167/iovs.02-1031; Anand V, 2002, OPHTHAL PHYSL OPT, V22, P528, DOI 10.1046/j.1475-1313.2002.00067.x; Andersson G, 2002, ACTA OTO-LARYNGOL, V122, P284, DOI 10.1080/000164802753648169; BRANDT T, 1981, ANN NY ACAD SCI, V374, P636, DOI 10.1111/j.1749-6632.1981.tb30907.x; BRANDT T, 1986, DISORDERS POSTURE GA, P353; Buckley JG, 2005, GAIT POSTURE, V21, P59, DOI 10.1016/j.gaitpost.2003.11.005; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Hansson EE, 2010, ACTA OTO-LARYNGOL, V130, P1358, DOI 10.3109/00016489.2010.498024; Hlavackova P, 2012, GAIT POSTURE, V112, P789; Horak F, 1996, HDB PHYSIOL 12, V12, P255; JACKSON RT, 1991, ANN OTO RHINOL LARYN, V100, P63, DOI 10.1177/000348949110000110; Johnson MB, 2012, MOTOR CONTROL, V16, P81, DOI 10.1123/mcj.16.1.81; KARLBERG M, 1995, THESIS U HOSP LUND; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pinsault N, 2008, EXP BRAIN RES, V191, P99, DOI 10.1007/s00221-008-1500-z; Pinsault N, 2010, EXP BRAIN RES, V202, P253, DOI 10.1007/s00221-009-2122-9; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Pradels A, 2011, CLIN BIOMECH, V26, P424, DOI 10.1016/j.clinbiomech.2010.11.016; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; RYAN GMS, 1955, LANCET, V2, P1355; SIMONEAU GG, 1992, J GERONTOL, V47, pM151, DOI 10.1093/geronj/47.5.M151; STRAUBE A, 1992, HEAD NECK SENSORY MO, P548; Thedon T, 2011, GAIT POSTURE, V33, P686, DOI 10.1016/j.gaitpost.2011.02.027; Vuillerme N, 2008, NEUROSCIENCE, V155, P291, DOI 10.1016/j.neuroscience.2008.05.018; Vuillerme N, 2007, INT J SPORTS MED, V28, P243, DOI 10.1055/s-2006-924292; Vuillerme N, 2005, GAIT POSTURE, V21, P318, DOI 10.1016/j.gaitpost.2004.04.007; Vuillerme N, 2003, ARCH PHYS MED REHAB, V84, P1560, DOI 10.1016/S0003-9993(03)00235-1; Vuillerme N, 2002, NEUROSCI LETT, V333, P131, DOI 10.1016/S0304-3940(02)00999-0; Vuillerme N, 2001, ADAPT PHYS ACT Q, V18, P417, DOI 10.1123/apaq.18.4.417; Vuillerme N, 2008, GAIT POSTURE, V28, P521, DOI 10.1016/j.gaitpost.2008.03.005; Vuillerme N, 2007, EXP BRAIN RES, V183, P235, DOI 10.1007/s00221-007-1039-4; Vuillerme N, 2006, GAIT POSTURE, V24, P169, DOI 10.1016/j.gaitpost.2005.07.011; Zok M, 2008, MED ENG PHYS, V30, P913, DOI 10.1016/j.medengphy.2007.12.002	43	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65510	10.1371/journal.pone.0065510	http://dx.doi.org/10.1371/journal.pone.0065510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840337	gold, Green Published			2022-12-25	WOS:000321424400006
J	Speth, C; Brodde, MF; Hagleitner, M; Rambach, G; Van Aken, H; Dierich, M; Kehrel, BE				Speth, Cornelia; Brodde, Martin F.; Hagleitner, Magdalena; Rambach, Guenter; Van Aken, Hugo; Dierich, Manfred; Kehrel, Beate E.			Neutrophils Turn Plasma Proteins into Weapons against HIV-1	PLOS ONE			English	Article							HYPOCHLOROUS ACID; DISULFIDE-ISOMERASE; THIOL/DISULFIDE EXCHANGE; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR TRAPS; ALPHA-DEFENSINS; CORECEPTOR USE; MYELOPEROXIDASE; INFECTION; BINDING	As a consequence of innate immune activation granulocytes and macrophages produce hypochlorite/hypochlorous acid (HOCl) via secretion of myeloperoxidase (MPO) to the outside of the cells, where HOCl immediately reacts with proteins. Most proteins that become altered by this system do not belong to the invading microorganism but to the host. While there is no doubt that the myeloperoxidase system is capable of directly inactivating HIV-1, we hypothesized that it may have an additional indirect mode of action. We show in this article that HOCl is able to chemically alter proteins and thus turn them into Idea-Ps (Idea-P = immune defence-altered protein), potent amyloid-like and SH-groups capturing antiviral weapons against HIV-1. HOCl-altered plasma proteins (Idea-PP) have the capacity to bind efficiently and with high affinity to the HIV-1 envelope protein gp120, and to its receptor CD4 as well as to the protein disulfide isomerase (PDI). Idea-PP was able to inhibit viral infection and replication in a cell culture system as shown by reduced number of infected cells and of syncytia, resulting in reduction of viral capsid protein p24 in the culture supernatant. The unmodified plasma protein fraction had no effect. HOCl-altered isolated proteins antithrombin III and human serum albumin, taken as representative examples of the whole pool of plasma proteins, were both able to exert the same activity of binding to gp120 and inhibition of viral proliferation. These data offer an opportunity to improve the understanding of the intricacies of host-pathogen interactions and allow the generation of the following hypothetical scheme: natural immune defense mechanisms generate by posttranslational modification of plasma proteins a potent virucidal weapon that immobilizes the virus as well as inhibits viral fusion and thus entry into the host cells. Furthermore simulation of this mechanism in vitro might provide an interesting new therapeutic approach against microorganisms.	[Speth, Cornelia; Hagleitner, Magdalena; Rambach, Guenter; Dierich, Manfred] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Brodde, Martin F.; Van Aken, Hugo; Kehrel, Beate E.] Univ Munster, Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, D-48149 Munster, Germany	Medical University of Innsbruck; University of Munster	Kehrel, BE (corresponding author), Univ Munster, Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, D-48149 Munster, Germany.	kehrel@uni-muenster.de		rambach, gunter/0000-0002-7574-7868; speth, cornelia/0000-0001-5637-5993	Deutsche Forschungsgemein-schaft [SFB 293]	Deutsche Forschungsgemein-schaft(German Research Foundation (DFG))	The work was supported in parts by grants to B. E. K. from the Deutsche Forschungsgemein-schaft by SFB 293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; AKRIGG A, 1991, AIDS, V5, P153, DOI 10.1097/00002030-199102000-00004; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; CHASE MJ, 1992, P NATL ACAD SCI USA, V89, P5582, DOI 10.1073/pnas.89.12.5582; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; CHOCHOLA J, 1994, ANTIMICROB AGENTS CH, V38, P969, DOI 10.1128/AAC.38.5.969; Conant CG, 2007, CELL MICROBIOL, V9, P222, DOI 10.1111/j.1462-5822.2006.00783.x; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Crombie R, 1998, J EXP MED, V187, P25, DOI 10.1084/jem.187.1.25; Crombie R, 2000, AIDS PATIENT CARE ST, V14, P211, DOI 10.1089/108729100317821; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; ELLIS M, 1988, J INFECT DIS, V158, P1268, DOI 10.1093/infdis/158.6.1268; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Furuhata A, 2002, J BIOL CHEM, V277, P27919, DOI 10.1074/jbc.M202794200; GABRILOVICH D, 1994, SCAND J INFECT DIS, V26, P41, DOI 10.3109/00365549409008589; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Higazi AAR, 1996, J BIOL CHEM, V271, P17650, DOI 10.1074/jbc.271.30.17650; Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JINDADAMRONGWEC.S, 2010, ARCH VIROL, V149, P915; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; KEHREL BE, 2002, Patent No. 2002022150; KEHREL BE, 2004, Patent No. 20040047861; KLEBANOFF SJ, 1992, J CLIN INVEST, V89, P2014, DOI 10.1172/JCI115810; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kornbluth RS, 2004, BLOOD, V103, P1567, DOI 10.1182/blood-2003-12-4284; Lacy P, 2008, FRONT BIOSCI-LANDMRK, V13, P5559; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Pattison DI, 2007, BIOCHEMISTRY-US, V46, P9853, DOI 10.1021/bi7008294; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; PITRAK DL, 1993, J INFECT DIS, V167, P1406, DOI 10.1093/infdis/167.6.1406; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; REEVES EP, 2002, NATURE; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1983, BIOCHEM J, V210, P215, DOI 10.1042/bj2100215; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024	66	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66073	10.1371/journal.pone.0066073	http://dx.doi.org/10.1371/journal.pone.0066073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840401	gold, Green Published, Green Submitted			2022-12-25	WOS:000321424400020
J	Bhadra, T; Bhattacharyya, M; Feuerbach, L; Lengauer, T; Bandyopadhyay, S				Bhadra, Tapas; Bhattacharyya, Malay; Feuerbach, Lars; Lengauer, Thomas; Bandyopadhyay, Sanghamitra			DNA Methylation Patterns Facilitate the Identification of MicroRNA Transcription Start Sites: A Brain-Specific Study	PLOS ONE			English	Article							CPG-ISLANDS; TARGET RECOGNITION; MUTUAL INFORMATION; DATABASE; FEATURES; GENES	Predicting the transcription start sites (TSSs) of microRNAs (miRNAs) is important for understanding how these small RNA molecules, known to regulate translation and stability of protein-coding genes, are regulated themselves. Previous approaches are primarily based on genetic features, trained on TSSs of protein-coding genes, and have low prediction accuracy. Recently, a support vector machine based technique has been proposed for miRNA TSS prediction that uses known miRNA TSS for training the classifier along with a set of existing and novel CpG island based features. Current progress in epigenetics research has provided genomewide and tissue-specific reports about various phenotypic traits. We hypothesize that incorporating epigenetic characteristics into statistical models may lead to better prediction of primary transcripts of human miRNAs. In this paper, we have tested our hypothesis on brain-specific miRNAs by using epigenetic as well as genetic features to predict the primary transcripts. For this, we have used a sophisticated feature selection technique and a robust classification model. Our prediction model achieves an accuracy of more than 80% and establishes the potential of epigenetic analysis for in silico prediction of TSSs.	[Bhadra, Tapas; Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, India; [Bhattacharyya, Malay] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Feuerbach, Lars] German Canc Res Ctr, Eils Labs, Heidelberg, Germany; [Lengauer, Thomas] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, D-66123 Saarbrucken, Germany	Indian Statistical Institute; Indian Statistical Institute Kolkata; Kalyani University; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Bandyopadhyay, S (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, India.	sanghami@isical.ac.in	Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Bhadra, Tapas/ABG-5818-2021; Bhattacharyya, Malay/AAF-5036-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020	Bhadra, Tapas/0000-0001-8421-1072; Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Bhattacharyya, Malay/0000-0001-7781-1264	Department of Science and Technology, India; Swarnajayanti project of the Department of Science and Technology, Government of India [DST/SJF/ET-02/2006-07]	Department of Science and Technology, India(Department of Science & Technology (India)); Swarnajayanti project of the Department of Science and Technology, Government of India	TB gratefully acknowledges Department of Science and Technology, India, for awarding him the INSPIRE Fellowship to carry out his PhD. research work. SB gratefully acknowledges the financial support from the Swarnajayanti project grant no. DST/SJF/ET-02/2006-07 of the Department of Science and Technology, Government of India. Part of the work was conducted when SB visited the Max Planck Institute for Informatics, Saarbrucken, Germany, in 2011-12 on a Humboldt Fellowship for Experienced Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Anand A, 2010, PATTERN RECOGN LETT, V31, P2097, DOI 10.1016/j.patrec.2009.10.008; Baer C, 2012, CANCER RES, V72, P3775, DOI 10.1158/0008-5472.CAN-12-0803; Bandyopadhyay S, COMMUNICATED; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya Malay, 2012, Genomics Proteomics & Bioinformatics, V10, P310, DOI 10.1016/j.gpb.2012.08.005; Bhattacharyya M, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1743; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Duda R.O., 2000, PATTERN CLASSIFICATI; Estevez PA, 2009, IEEE T NEURAL NETWOR, V20, P189, DOI 10.1109/TNN.2008.2005601; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; La The Vinh, 2010, 2010 10th IEEE/IPSJ International Symposium on Applications and the Internet (SAINT), P395, DOI 10.1109/SAINT.2010.50; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Novik K. L., 2002, Current Issues in Molecular Biology, V4, P111; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schaefer U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013934; Schubeler D, 2012, SCIENCE, V338, P756, DOI 10.1126/science.1227243; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Vapnik V. N., 1995, NATURE STAT LAERNING; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Xin YR, 2012, NUCLEIC ACIDS RES, V40, pD1245, DOI 10.1093/nar/gkr1193; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66722	10.1371/journal.pone.0066722	http://dx.doi.org/10.1371/journal.pone.0066722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826117	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400037
J	Riau, AK; Angunawela, RI; Chaurasia, SS; Lee, WS; Tan, DT; Mehta, JS				Riau, Andri K.; Angunawela, Romesh I.; Chaurasia, Shyam S.; Lee, Wing S.; Tan, Donald T.; Mehta, Jodhbir S.			Reversible Femtosecond Laser-Assisted Myopia Correction: A Non-Human Primate Study of Lenticule Re-Implantation after Refractive Lenticule Extraction	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; COLLAGEN CROSS-LINKING; EXCIMER LASER; PHOTOREFRACTIVE KERATECTOMY; PATIENT-SATISFACTION; SURGERY; CORNEA; ECTASIA; RELEX; EPIKERATOPHAKIA	LASIK (laser-assisted in situ keratomileusis) is a common laser refractive procedure for myopia and astigmatism, involving permanent removal of anterior corneal stromal tissue by excimer ablation beneath a hinged flap. Correction of refractive error is achieved by the resulting change in the curvature of the cornea and is limited by central corneal thickness, as a thin residual stromal bed may result in biomechanical instability of the cornea. A recently developed alternative to LASIK called Refractive Lenticule Extraction (ReLEx) utilizes solely a femtosecond laser (FSL) to incise an intrastromal refractive lenticule (RL), which results in reshaping the corneal curvature and correcting the myopia and/or astigmatism. As the RL is extracted intact in the ReLEx, we hypothesized that it could be cryopreserved and re-implanted at a later date to restore corneal stromal volume, in the event of keratectasia, making ReLEx a potentially reversible procedure, unlike LASIK. In this study, we re-implanted cryopreserved RLs in a non-human primate model of ReLEx. Mild intrastromal haze, noted during the first 2 weeks after re-implantation, subsided after 8 weeks. Refractive parameters including corneal thickness, anterior curvature and refractive error indices were restored to near pre-operative values after the re-implantation. Immunohistochemistry revealed no myofibroblast formation or abnormal collagen type I expression after 8 weeks, and a significant attenuation of fibronectin and tenascin expression from week 8 to 16 after re-implantation. In addition, keratocyte re-population could be found along the implanted RL interfaces. Our findings suggest that RL cryopreservation and re-implantation after ReLEx appears feasible, suggesting the possibility of potential reversibility of the procedure, and possible future uses of RLs in treating other corneal disorders and refractive errors.	[Riau, Andri K.; Angunawela, Romesh I.; Chaurasia, Shyam S.; Lee, Wing S.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Angunawela, Romesh I.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Chaurasia, Shyam S.] Duke NUS Grad Med Sch, SRP Neurosci & Behav Disorder Program, Singapore, Singapore; [Chaurasia, Shyam S.; Tan, Donald T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Riau, AK (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	andri_riau@yahoo.com; jodmehta@gmail.com	Chaurasia, Shyam/AAB-4709-2019; Mehta, Jodhbir/O-6192-2015; Riau, Andri/P-9693-2019	Chaurasia, Shyam/0000-0001-8725-676X; Riau, Andri/0000-0002-5105-0484; Angunawela, Romesh/0000-0001-6635-5283	National Research Foundation of Singapore-Funded Translational and Clinical Research [NMRC/TCR/002-SERI/2008, NMRC/CG/SERI/2010]	National Research Foundation of Singapore-Funded Translational and Clinical Research	Funding came from a National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR/002-SERI/2008) and Centre Grant (NMRC/CG/SERI/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Ophthalmology, 2008, IS LASIK ME PAT GUID; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Angunawela RI, 2012, INVEST OPHTH VIS SCI, V53, P4975, DOI 10.1167/iovs.12-10170; Bailey MD, 2003, OPHTHALMOLOGY, V110, P1371, DOI 10.1016/S0161-6420(03)00455-X; Battat L, 2001, OPHTHALMOLOGY, V108, P1230, DOI 10.1016/S0161-6420(01)00623-6; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Bromley JG, 2010, CURR OPIN OPHTHALMOL, V21, P255, DOI 10.1097/ICU.0b013e32833a8bfe; Dexl AK, 2011, J REFRACT SURG, V27, P876, DOI 10.3928/1081597X-20110802-02; Mulet ME, 2009, OPHTHALMOLOGY, V116, P1455, DOI 10.1016/j.ophtha.2009.05.019; Evans MDM, 2011, BIOMATERIALS, V32, P3158, DOI 10.1016/j.biomaterials.2011.01.047; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Goldberg DB, 2001, J CATARACT REFR SURG, V27, P1449, DOI 10.1016/S0886-3350(01)01001-X; HENDRIX MJC, 1982, INVEST OPHTH VIS SCI, V22, P359; Ivarsen A, 2003, BRIT J OPHTHALMOL, V87, P1272, DOI 10.1136/bjo.87.10.1272; Knorz Michael C, 2002, Curr Opin Ophthalmol, V13, P242, DOI 10.1097/00055735-200208000-00010; Kymionis GD, 2012, J CATARACT REFR SURG, V38, P713, DOI 10.1016/j.jcrs.2012.01.009; Kymionis GD, 2010, J CATARACT REFR SURG, V36, P1783, DOI 10.1016/j.jcrs.2010.06.044; Lee GA, 2003, BRIT J OPHTHALMOL, V87, P432, DOI 10.1136/bjo.87.4.432; MARSHALL J, 1985, OPHTHALMOLOGY, V92, P749; MCDONALD MB, 1986, ARCH OPHTHALMOL-CHIC, V104, P1294, DOI 10.1001/archopht.1986.01050210048024; Meltendorf C, 2002, CRYOBIOLOGY, V44, P170, DOI 10.1016/S0011-2240(02)00022-6; Meltendorf C, 2007, INVEST OPHTH VIS SCI, V48, P2068, DOI 10.1167/iovs.06-1150; Mitka M, 2009, JAMA-J AM MED ASSOC, V302, P2420, DOI 10.1001/jama.2009.1763; Mohamed-Noriega K, 2011, MOL VIS, V17, P3437; Pallikaris IG, 2001, J CATARACT REFR SURG, V27, P1796, DOI 10.1016/S0886-3350(01)01090-2; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Rad AS, 2004, J REFRACT SURG, V20, pS718, DOI 10.3928/1081-597X-20040903-18; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Randleman JB, 2008, OPHTHALMOLOGY, V115, P37, DOI 10.1016/j.ophtha.2007.03.073; Riau AK, 2012, J CATARACT REFR SURG, V38, P1467, DOI 10.1016/j.jcrs.2012.03.037; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Richter E, 1998, BONE MARROW TRANSPL, V22, pS16; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Solomon KD, 2009, OPHTHALMOLOGY, V116, P691, DOI 10.1016/j.ophtha.2008.12.037; Suri K, 2012, CURR OPIN OPHTHALMOL, V23, P280, DOI 10.1097/ICU.0b013e328354865e; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; VANSETTEN GB, 1992, GRAEF ARCH CLIN EXP, V230, P178, DOI 10.1007/BF00164660; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; VOGEL A, 1994, LASER SURG MED, V15, P32, DOI 10.1002/lsm.1900150106; Vrana NE, 2007, BIOMATERIALS, V28, P4303, DOI 10.1016/j.biomaterials.2007.06.013; WERBLIN TP, 1982, CURR EYE RES, V1, P591; WILSON DR, 1990, SURV OPHTHALMOL, V34, P294, DOI 10.1016/0039-6257(90)90028-T; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 2004, NEW ENGL J MED, V351, P470, DOI 10.1056/NEJMcp033210; Wilson SE, 1998, INVEST OPHTH VIS SCI, V39, P220; Wusteman MC, 2008, CRYOBIOLOGY, V56, P62, DOI 10.1016/j.cryobiol.2007.10.177; Xiao JH, 2012, CHIN J TRAUMATOL, V15, P77, DOI 10.3760/cma.j.issn.1008-1275.2012.02.002; Zhu HY, 2010, MOL VIS, V16, P2215	51	43	50	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67058	10.1371/journal.pone.0067058	http://dx.doi.org/10.1371/journal.pone.0067058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826194	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400099
J	Turac, G; Hindley, CJ; Thomas, R; Davis, JA; Deleidi, M; Gasser, T; Karaoz, E; Pruszak, J				Turac, Gizem; Hindley, Christopher J.; Thomas, Ria; Davis, Jason A.; Deleidi, Michela; Gasser, Thomas; Karaoz, Erdal; Pruszak, Jan			Combined Flow Cytometric Analysis of Surface and Intracellular Antigens Reveals Surface Molecule Markers of Human Neuropoiesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEURONS; DIFFERENTIATION; EXPRESSION; FIXATION; PERMEABILIZATION; TRANSPLANTATION; INFLAMMATION	Surface molecule profiles undergo dynamic changes in physiology and pathology, serve as markers of cellular state and phenotype and can be exploited for cell selection strategies and diagnostics. The isolation of well-defined cell subsets is needed for in vivo and in vitro applications in stem cell biology. In this technical report, we present an approach for defining a subset of interest in a mixed cell population by flow cytometric detection of intracellular antigens. We have developed a fully validated protocol that enables the co-detection of cluster of differentiation (CD) surface antigens on fixed, permeabilized neural cell populations defined by intracellular staining. Determining the degree of co-expression of surface marker candidates with intracellular target population markers (nestin, MAP2, doublecortin, TUJ1) on neuroblastoma cell lines (SH-SY5Y, BE(2)-M17) yielded a combinatorial CD49f-/CD200(high) surface marker panel. Its application in fluorescence-activated cell sorting (FACS) generated enriched neuronal cultures from differentiated cell suspensions derived from human induced pluripotent stem cells. Our data underlines the feasibility of using the described co-labeling protocol and co-expression analysis for quantitative assays in mammalian neurobiology and for screening approaches to identify much needed surface markers in stem cell biology.	[Turac, Gizem; Hindley, Christopher J.; Thomas, Ria; Davis, Jason A.; Pruszak, Jan] Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, Emmy Noether Grp Stem Cell Biol, D-79106 Freiburg, Germany; [Turac, Gizem; Karaoz, Erdal] Kocaeli Univ, Ctr Stem Cell & Gene Therapies Res & Practice, Kocaeli, Turkey; [Thomas, Ria] Univ Freiburg, Fac Biol, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Deleidi, Michela; Gasser, Thomas] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Dept Neurodegenerat Dis, Inst Clin Brain Res, Tubingen, Germany; [Pruszak, Jan] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79106 Freiburg, Germany	University of Freiburg; Kocaeli University; University of Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Freiburg	Pruszak, J (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, Emmy Noether Grp Stem Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	jan.pruszak@anat.uni-freiburg.de	Turaç, Gizem/B-1549-2018; Pruszak, Jan/G-6972-2015; Gasser, Thomas/GNH-5293-2022; Thomas, Ria/AAX-8063-2020; Karaoz, Erdal/AAO-1470-2020	Turaç, Gizem/0000-0001-8219-2015; Pruszak, Jan/0000-0003-4297-4009; Gasser, Thomas/0000-0002-1069-1146; Thomas, Ria/0000-0003-2037-7473; Deleidi, Michela/0000-0003-0357-0124	German Research Council (DFG) [PR1132/3-1, KR2119/8-1]; Alexander von Humboldt-Foundation Postdoctoral Fellowship; Excellence Initiative of the German Research Foundation [GSC-4]; Marie Curie Career Integration [MC CIG304108]; NEUREX network (JP)	German Research Council (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Foundation Postdoctoral Fellowship; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Marie Curie Career Integration; NEUREX network (JP)	The authors' research program is funded by the German Research Council (DFG) grant PR1132/3-1 (JP). CH and MD were each supported by an Alexander von Humboldt-Foundation Postdoctoral Fellowship. Further support by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) (RT), Marie Curie Career Integration Grant MC CIG304108 (MD), DFG grant KR2119/8-1 (TG) and from the NEUREX network (JP) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Deleidi M, 2011, STEM CELLS, V29, P1052, DOI 10.1002/stem.662; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Diogo MM, 2012, BIOTECHNOL BIOENG, V109, P2699, DOI 10.1002/bit.24706; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elghetany MT, 2005, CYTOM PART B-CLIN CY, V65B, P1, DOI 10.1002/cyto.b.20051; Gerner W, 2008, VET IMMUNOL IMMUNOP, V121, P251, DOI 10.1016/j.vetimm.2007.09.019; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Humphrey RK, 2003, DIABETES, V52, P2519, DOI 10.2337/diabetes.52.10.2519; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Israel MA, 2011, GENOME MED, V3, DOI 10.1186/gm265; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kappelmayer J, 2000, J IMMUNOL METHODS, V242, P53, DOI 10.1016/S0022-1759(00)00220-9; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; POLLICE AA, 1992, CYTOMETRY, V13, P432, DOI 10.1002/cyto.990130414; Preffer F, 2009, CYTOM PART B-CLIN CY, V76B, P295, DOI 10.1002/cyto.b.20480; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; Sanchez-Pernaute R, 2005, STEM CELLS, V23, P914, DOI 10.1634/stemcells.2004-0172; Schriebl K, 2012, TISSUE ENG PT A, V18, P899, DOI [10.1089/ten.tea.2011.0311, 10.1089/ten.TEA.2011.0311]; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zelnickova P, 2007, J IMMUNOL METHODS, V327, P18, DOI 10.1016/j.jim.2007.07.006; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	43	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68519	10.1371/journal.pone.0068519	http://dx.doi.org/10.1371/journal.pone.0068519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826393	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400178
J	Beitzinger, C; Bronnhuber, A; Duscha, K; Riedl, Z; Huber-Lang, M; Benz, R; Hajos, G; Barth, H				Beitzinger, Christoph; Bronnhuber, Anika; Duscha, Kerstin; Riedl, Zsuzsanna; Huber-Lang, Markus; Benz, Roland; Hajos, Gyoergy; Barth, Holger			Designed Azolopyridinium Salts Block Protective Antigen Pores In Vitro and Protect Cells from Anthrax Toxin	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM C2-TOXIN; CURRENT NOISE-ANALYSIS; LETHAL FACTOR CLEAVES; FUSED AZOLIUM SALTS; COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; BINDING-KINETICS; EDEMA FACTOR; MALTOPORIN CHANNEL; BILAYER-MEMBRANES	Background: Several intracellular acting bacterial protein toxins of the AB-type, which are known to enter cells by endocytosis, are shown to produce channels. This holds true for protective antigen (PA), the binding component of the tripartite anthrax-toxin of Bacillus anthracis. Evidence has been presented that translocation of the enzymatic components of anthrax-toxin across the endosomal membrane of target cells and channel formation by the heptameric/octameric PA(63) binding/translocation component are related phenomena. Chloroquine and some 4-aminoquinolones, known as potent drugs against Plasmodium falciparium infection of humans, block efficiently the PA(63)-channel in a dose dependent way. Methodology/Principal Findings: Here we demonstrate that related positively charged heterocyclic azolopyridinium salts block the PA(63)-channel in the mu M range, when both, inhibitor and PA(63) are added to the same side of the membrane, the cis-side, which corresponds to the lumen of acidified endosomal vesicles of target cells. Noise-analysis allowed the study of the kinetics of the plug formation by the heterocycles. In vivo experiments using J774A.1 macrophages demonstrated that the inhibitors of PA(63)-channel function also efficiently block intoxication of the cells by the combination lethal factor and PA(63) in the same concentration range as they block the channels in vitro. Conclusions/Significance: These results strongly argue in favor of a transport of lethal factor through the PA(63)-channel and suggest that the heterocycles used in this study could represent attractive candidates for development of novel therapeutic strategies against anthrax.	[Beitzinger, Christoph; Duscha, Kerstin; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Bronnhuber, Anika; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany; [Riedl, Zsuzsanna; Hajos, Gyoergy] Hungarian Acad Sci, Inst Organ Chem, Res Ctr Nat Sci, Budapest, Hungary; [Huber-Lang, Markus] Univ Ulm, Inst Traumatol Hand & Reconstruct Surg, Med Ctr, D-89069 Ulm, Germany; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany	German Research Foundation (DFG); University of Wurzburg; Ulm University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Ulm University; Jacobs University	Benz, R (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany.	r.benz@jacobs-university.de; holger.barth@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020	Benz, Roland/0000-0002-9510-9265	Deutsche Forschungsgemeinschaft (DFG) [BA 2087/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG grant BA 2087/2-1 to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Artenstein AW, 2004, J INFECT DIS, V190, P1655, DOI 10.1086/424853; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; BAHNER CT, 1951, J AM CHEM SOC, V73, P3499, DOI 10.1021/ja01151a501; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Bezrukov SM, 2012, BIOPHYS J, V103, P1208, DOI 10.1016/j.bpj.2012.07.050; Bezrukov SM, 2000, PHYS REV LETT, V85, P202, DOI 10.1103/PhysRevLett.85.202; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONTI F, 1975, J PHYSIOL-LONDON, V248, P45, DOI 10.1113/jphysiol.1975.sp010962; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EIGEN M, 1964, PROG REACT KINET, V2, P287; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; HAJOS G, 1984, J HETEROCYCLIC CHEM, V21, P809, DOI 10.1002/jhet.5570210334; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Karginov VA, 2005, P NATL ACAD SCI USA, V102, P15075, DOI 10.1073/pnas.0507488102; Karginov VA, 2007, BIOORGAN MED CHEM, V15, P5424, DOI 10.1016/j.bmc.2007.05.058; Karginov VA, 2006, ANTIMICROB AGENTS CH, V50, P3740, DOI 10.1128/AAC.00693-06; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Kronhardt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023133; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leppla SH, 1989, ANTHRACIS ANDENYL CY, P153; Menard A, 1996, BIOCHEM J, V320, P687, DOI 10.1042/bj3200687; Menard A, 1996, FEBS LETT, V386, P161, DOI 10.1016/0014-5793(96)00422-X; MESSMER A, 1986, TETRAHEDRON, V42, P4827, DOI 10.1016/S0040-4020(01)82063-9; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; NEKOLLA S, 1994, BIOPHYS J, V66, P1388, DOI 10.1016/S0006-3495(94)80929-4; Nestorovich EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023927; Nestorovich EM, 2010, BIOPHYS J, V99, P134, DOI 10.1016/j.bpj.2010.03.070; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Palko R, 2006, J ORG CHEM, V71, P7805, DOI 10.1021/jo061361l; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; TIMARI G, 1990, J HETEROCYCLIC CHEM, V27, P2005, DOI 10.1002/jhet.5570270730; Tonello F, 2002, NATURE, V418, P386, DOI 10.1038/418386a; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Verveen A A, 1974, Prog Biophys Mol Biol, V28, P189, DOI 10.1016/0079-6107(74)90019-4; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wohnsland F, 1997, J MEMBRANE BIOL, V158, P77, DOI 10.1007/s002329900245; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zornetta I, 2010, CELL MICROBIOL, V12, P1435, DOI 10.1111/j.1462-5822.2010.01480.x	69	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66099	10.1371/journal.pone.0066099	http://dx.doi.org/10.1371/journal.pone.0066099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840407	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800030
J	Rangel-Gomez, M; Hickey, C; van Amelsvoort, T; Bet, P; Meeter, M				Rangel-Gomez, Mauricio; Hickey, Clayton; van Amelsvoort, Therese; Bet, Pierre; Meeter, Martijn			The Detection of Novelty Relies on Dopaminergic Signaling: Evidence from Apomorphine's Impact on the Novelty N2	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY; STIMULUS NOVELTY; AUDITORY-STIMULI; ERP; BRAIN; COMPONENT; MEMORY; OVEREXPRESSION; PERFORMANCE	Despite much research, it remains unclear if dopamine is directly involved in novelty detection or plays a role in orchestrating the subsequent cognitive response. This ambiguity stems in part from a reliance on experimental designs where novelty is manipulated and dopaminergic activity is subsequently observed. Here we adopt the alternative approach: we manipulate dopamine activity using apomorphine (D1/D2 agonist) and measure the change in neurological indices of novelty processing. In separate drug and placebo sessions, participants completed a von Restorff task. Apomorphine speeded and potentiated the novelty-elicited N2, an Event-Related Potential (ERP) component thought to index early aspects of novelty detection, and caused novel-font words to be better recalled. Apomorphine also decreased the amplitude of the novelty-P3a. An increase in D1/D2 receptor activation thus appears to potentiate neural sensitivity to novel stimuli, causing this content to be better encoded.	[Rangel-Gomez, Mauricio; Hickey, Clayton; Meeter, Martijn] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van Amelsvoort, Therese] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [Bet, Pierre] Vrije Univ Amsterdam Med Ctr, Dept Clin Pharmacol & Pharm, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rangel-Gomez, M (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	m.rangelgomez@vu.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717; Rangel-Gomez, Mauricio/0000-0002-9079-0346; Hickey, Clayton/0000-0002-4162-5643	VIDI grant from NWO [452-09-007]; VENI grant from NWO [016-125-283]	VIDI grant from NWO; VENI grant from NWO	MM is financially supported by the VIDI grant 452-09-007 from NWO. CH is financially supported by the VENI grant 016-125-283 from NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2010, J PSYCHOPHARMACOLOGY; ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Costa A, 2003, DEMENT GERIATR COGN, V15, P55, DOI 10.1159/000067968; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Daffner KR, 2000, PSYCHOPHYSIOLOGY, V37, P737, DOI 10.1017/S0048577200990814; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Djamshidian A, 2011, NEUROPSYCHOLOGIA, V49, P2483, DOI 10.1016/j.neuropsychologia.2011.04.026; Ferrari V, 2010, J COGNITIVE NEUROSCI, V22, P404, DOI 10.1162/jocn.2009.21244; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gabbay FH, 2010, EXP CLIN PSYCHOPHARM, V18, P470, DOI 10.1037/a0021653; Garcia-Garcia M, 2011, NEUROIMAGE, V56, P1641, DOI 10.1016/j.neuroimage.2011.02.053; Garcia-Garcia M, 2010, NEUROPSYCHOLOGIA, V48, P4136, DOI 10.1016/j.neuropsychologia.2010.10.005; Garcia-Garcia M, 2010, NEUROPSYCHOLOGIA, V48, P1483, DOI 10.1016/j.neuropsychologia.2010.01.018; Grzella I, 2001, J PSYCHIATR NEUROSCI, V26, P235; Hansenne M, 2003, HUM PSYCHOPHARM CLIN, V18, P201, DOI 10.1002/hup.468; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hazy TE, 2010, NEUROSCI BIOBEHAV R, V34, P701, DOI 10.1016/j.neubiorev.2009.11.019; Hoormann J, 1998, BEHAV RES METH INS C, V30, P103, DOI 10.3758/BF03209420; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kenemans JL, 2011, NEUROPSYCHOPHARMACOL, V36, P26, DOI 10.1038/npp.2010.157; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Kishiyama MM, 2004, J COGNITIVE NEUROSCI, V16, P15, DOI 10.1162/089892904322755511; Kopp B, 2010, COGN AFFECT BEHAV NE, V10, P316, DOI 10.3758/CABN.10.2.316; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1980, Prog Brain Res, V54, P343, DOI 10.1016/S0079-6123(08)61645-3; Nakamura K, 1998, EUR J PHARMACOL, V342, P127, DOI 10.1016/S0014-2999(97)01457-X; Pirtosek Z, 2009, PSYCHIAT DANUB, V21, P114; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Potts GF, 1996, BRAIN TOPOGR, V9, P3, DOI 10.1007/BF01191637; PRASHER D, 1991, J NEUROL NEUROSUR PS, V54, P603, DOI 10.1136/jnnp.54.7.603; Pritchard W., 1991, ADV PSYCHOPHYSIOLOGY, P43; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rangel-Gomez M, 2013, BRAIN BEHAV; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; RUZICKA E, 1994, J NEUROL NEUROSUR PS, V57, P998, DOI 10.1136/jnnp.57.8.998; SanMiguel I, 2010, BIOL PSYCHOL, V83, P143, DOI 10.1016/j.biopsycho.2009.11.012; Schellekens AFA, 2010, PSYCHOPHARMACOLOGY, V207, P559, DOI 10.1007/s00213-009-1686-1; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P409, DOI 10.1017/S0048577299981180; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Szucs D, 2007, NEUROSCI LETT, V412, P18, DOI 10.1016/j.neulet.2006.08.090; TAKESHITA S, 1994, INT J PSYCHOPHYSIOL, V16, P99, DOI 10.1016/0167-8760(94)90046-9; Tarbi EC, 2011, PSYCHOPHYSIOLOGY, V48, P624, DOI 10.1111/j.1469-8986.2010.01129.x; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038	59	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66469	10.1371/journal.pone.0066469	http://dx.doi.org/10.1371/journal.pone.0066469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840482	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800065
J	Zhang, Y; Chen, MB; Zhou, XY; Hong, XN				Zhang, Yan; Chen, Min-Bin; Zhou, Xiao-Yan; Hong, Xiao-Nan			Lymphotoxin Alpha (LTA) Polymorphism Is Associated with Prognosis of Non-Hodgkin's Lymphoma in a Chinese Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; B-CELL LYMPHOMA; RANDOMIZED CONTROLLED-TRIAL; GENETIC POLYMORPHISMS; CHOP CHEMOTHERAPY; ELDERLY-PATIENTS; DES-LYMPHOMES; RITUXIMAB; PATHWAY; RISK	Background: Non-Hodgkin's lymphoma (NHL) has been widely reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the survival and prognosis of NHL patients. To evaluate the role of such genetic variations in prognosis of NHL, we conducted this study in a Chinese population. Methods: We used the TaqMan assay to genotype six single nucleotide polymorphisms (SNPs) (TNF rs1799964T>C, LTA rs1800683G>A, IL-10 rs1800872T>G, LEP rs2167270G>A, LEPR rs1327118C>G, TNFAIP8 rs1045241C>T) for 215 NHL cases. Kaplan-Meier analysis was performed to compare progression free survival among two common genotypes. Cox proportional hazard models were used to identify independent risk factors. Results: We observed that LTA rs1800683G>A was significantly associated with risk of progression or relapse in NHL patients (HR = 1.63, 95% CI = 1.06-2.51; P = 0.028), particularly in Diffuse large B cell lymphoma (DLBCL) cases (HR = 1.50, 95% CI = 1.10-2.04, P = 0.01). Both univariate and multivariate Cox regression analysis showed that in DLBCL patients, Ann Arbor stage III/IV, elevated LDH level before treatment and LTA rs1800683 AA genotype carrier were independent risk factors for progression or relapse. While in NK/T cell lymphoma, Ann Arbor stage III/IV and elevated beta(2)-MG level before treatment indicated poorer prognosis. Conclusions: The polymorphism of LTA rs1800683G>A contributes to NHL prognosis in a Chinese population. Further large-scale and well-designed studies are needed to confirm these results.	[Zhang, Yan; Chen, Min-Bin] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Zhenjiang, Jiangsu, Peoples R China; [Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Hong, Xiao-Nan] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China	Jiangsu University; Fudan University; Fudan University	Zhang, Y (corresponding author), Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Zhenjiang, Jiangsu, Peoples R China.	zy-zl-126@126.com			National Natural Science Foundation of China [30870985]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from National Natural Science Foundation of China (30870985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid T, 2011, J EGYPT NATL CANCER, V23, P17, DOI 10.1016/j.jnci.2011.07.003; Aschebrook-Kilfoy B, 2011, J CANCER SURVIV, V6, P102; AVILES A, 1993, LEUKEMIA LYMPHOMA, V9, P377, DOI 10.3109/10428199309148537; Cabanillas Fernando, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS87, DOI 10.1016/j.clml.2011.03.029; Chae YS, 2010, CANCER CHEMOTH PHARM, V65, P571, DOI 10.1007/s00280-009-1066-x; Chen WL, 2010, ANN HEMATOL, V89, P553, DOI 10.1007/s00277-009-0870-z; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kuppers R, 2004, NEW ENGL J MED, V351, P2152, DOI 10.1056/NEJMp048257; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Lech-Maranda E, 2004, BLOOD, V103, P3529, DOI 10.1182/blood-2003-06-1850; Luminari S, 2007, HEMATOL ONCOL, V25, P189, DOI 10.1002/hon.826; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Seidemann K, 2005, J CLIN ONCOL, V23, P8414, DOI 10.1200/JCO.2005.01.2179; Seki R, 2010, INT J HEMATOL, V91, P258, DOI 10.1007/s12185-009-0475-2; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Swerdlow E., 2008, WHO CLASSIFICATION T; Warzocha K, 1998, BLOOD, V91, P3574; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846	27	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66411	10.1371/journal.pone.0066411	http://dx.doi.org/10.1371/journal.pone.0066411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840460	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800058
J	Kassam, KS; Markey, AR; Cherkassky, VL; Loewenstein, G; Just, MA				Kassam, Karim S.; Markey, Amanda R.; Cherkassky, Vladimir L.; Loewenstein, George; Just, Marcel Adam			Identifying Emotions on the Basis of Neural Activation	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN; METAANALYSIS; AMYGDALA; ANGER; REPRESENTATION; RECOGNITION; SPECIFICITY; VALENCE; CORTEX	We attempt to determine the discriminability and organization of neural activation corresponding to the experience of specific emotions. Method actors were asked to self-induce nine emotional states (anger, disgust, envy, fear, happiness, lust, pride, sadness, and shame) while in an fMRI scanner. Using a Gaussian Naive Bayes pooled variance classifier, we demonstrate the ability to identify specific emotions experienced by an individual at well over chance accuracy on the basis of: 1) neural activation of the same individual in other trials, 2) neural activation of other individuals who experienced similar trials, and 3) neural activation of the same individual to a qualitatively different type of emotion induction. Factor analysis identified valence, arousal, sociality, and lust as dimensions underlying the activation patterns. These results suggest a structure for neural representations of emotion and inform theories of emotional processing.	[Kassam, Karim S.; Markey, Amanda R.; Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Cherkassky, Vladimir L.; Just, Marcel Adam] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Kassam, KS (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	kskassam@cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Just, Marcel/0000-0003-1245-3050	National Institute of Mental Health [MH029617]; Carnegie Mellon University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH029617] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Carnegie Mellon University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded through a National Institute of Mental Health grant to M. A. J. (MH029617), and a faculty research grant from Carnegie Mellon University to G. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Cosmides L, 2004, HDB EMOTIONS; Damarla SR, 2013, HUM BRAIN M IN PRESS; Damasio A.R., 1994, DESCARTES ERROR EMOT; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Frijda N.H., 1994, EMOTION CULTURE EMPI, P51, DOI [10.1037/10152-002, DOI 10.1037/10152-002]; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Izard CE, 2007, PERSPECT PSYCHOL SCI, V2, P260, DOI [10.1111/j.1745-6916.2007.00044.x, 10.1111/j.1745-6916.2007.00053.x]; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kolodyazhniy V, 2011, PSYCHOPHYSIOLOGY, V48, P908, DOI 10.1111/j.1469-8986.2010.01170.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1995, INT AFFECTIVE PICTUR; Larsen J.T., 2008, HDB EMOTIONS, P180, DOI DOI 10.1249/00005768-200405001-00432; Leary M.R., 2000, FEELING THINKING ROL; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Levenson RW, 2003, SER AFFECTIVE SCI, P212; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Loewenstein G, 2007, SOC SCI INFORM, V46, P405, DOI 10.1177/05390184070460030106; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Mitchell JP, 2008, CURR DIR PSYCHOL SCI, V17, P142, DOI 10.1111/j.1467-8721.2008.00564.x; Mitchell T.M, 1997, MACH LEARN; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Overskeid G., 2000, REV GEN PSYCHOL, V4, P284; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2007, PERSPECT PSYCHOL SCI, V2, P281, DOI 10.1111/j.1745-6916.2007.00045.x; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; RUSSELL JA, 1995, PSYCHOL BULL, V118, P379, DOI 10.1037/0033-2909.118.3.379; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Said CP, 2010, J VISION, V10, DOI 10.1167/10.5.11; Scarantino A, 2011, EMOT REV, V3, P444, DOI 10.1177/1754073911410745; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Stemmler G, 2003, SER AFFECTIVE SCI, P131; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Winkielman P, 2004, CURR DIR PSYCHOL SCI, V13, P120, DOI 10.1111/j.0963-7214.2004.00288.x	71	134	135	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66032	10.1371/journal.pone.0066032	http://dx.doi.org/10.1371/journal.pone.0066032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840392	gold, Green Published			2022-12-25	WOS:000322361200050
J	Musa, N; Andersson, K; Burman, J; Andersson, F; Hedenstrom, E; Jansson, N; Paltto, H; Westerberg, L; Winde, I; Larsson, MC; Bergman, KO; Milberg, P				Musa, Najihah; Andersson, Klas; Burman, Joseph; Andersson, Fredrik; Hedenstrom, Erik; Jansson, Nicklas; Paltto, Heidi; Westerberg, Lars; Winde, Inis; Larsson, Mattias C.; Bergman, Karl-Olof; Milberg, Per			Using Sex Pheromone and a Multi-Scale Approach to Predict the Distribution of a Rare Saproxylic Beetle	PLOS ONE			English	Article							OSMODERMA-EREMITA SCOP.; ELATER-FERRUGINEUS; KAIROMONE SYSTEM; TREE HOLLOWS; CONSERVATION; COLEOPTERA; SIZE; SCARABAEIDAE; HABITAT; SCALES	The European red click beetle, Elater ferrugineus L., is associated with wood mould in old hollow deciduous trees. As a result of severe habitat fragmentation caused by human disturbance, it is threatened throughout its distribution range. A new pheromone-based survey method, which is very efficient in detecting the species, was used in the present study to relate the occurrence of E. ferrugineus to the density of deciduous trees. The latter data were from a recently completed regional survey in SE Sweden recording >120,000 deciduous trees. The occurrence of E. ferrugineus increased with increasing amount of large hollow and large non-hollow trees in the surrounding landscape. Quercus robur (oak) was found to be the most important substrate for E. ferrugineus, whereas two groups of tree species (Carpinus betulus, Fagus sylvatica, Ulmus glabra, vs. Acer platanoides, Aesculus hippocastanum, Fraxinus excelsior, Tilia cordata) were less important but may be a complement to oak in sustaining populations of the beetle. The occurrence of E. ferrugineus was explained by the density of oaks at two different spatial scales, within the circle radii 327 m and 4658 m. In conclusion, priority should be given to oaks in conservation management of E. ferrugineus, and then to the deciduous trees in the genera listed above. Conservation planning at large spatial and temporal scales appears to be essential for long-term persistence of E. ferrugineus. We also show that occurrence models based on strategic sampling might result in pessimistic predictions. This study demonstrates how pheromone-based monitoring make insects excellent tools for sustained feedback to models for landscape conservation management.	[Musa, Najihah; Jansson, Nicklas; Paltto, Heidi; Westerberg, Lars; Bergman, Karl-Olof; Milberg, Per] Linkoping Univ, IFM Biol, Conservat Ecol Grp, Linkoping, Sweden; [Andersson, Klas; Burman, Joseph; Winde, Inis; Larsson, Mattias C.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Andersson, Fredrik; Hedenstrom, Erik] Mid Sweden Univ, Dept Appl Sci & Design, Sundsvall, Sweden	Linkoping University; Swedish University of Agricultural Sciences; Mid-Sweden University	Bergman, KO (corresponding author), Linkoping Univ, IFM Biol, Conservat Ecol Grp, Linkoping, Sweden.	karbe@ifm.liu.se	Westerberg, Lars/AAE-5366-2019; Larsson, Mattias C/E-4791-2014; Milberg, Per/G-6153-2012	Westerberg, Lars/0000-0001-9820-3460; Milberg, Per/0000-0001-6128-1051	Marie-Claire Cronstedts Stiftelse; Wala & Folke Danielssons fond; Stiftelsen Eklandskapet i Linkopings Kommun; Skogssallskapet; European Regional Development Fund; County Administrative Board of Vasternorrland; Linnaeus initiative grant from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) [217-2006-1750]	Marie-Claire Cronstedts Stiftelse; Wala & Folke Danielssons fond; Stiftelsen Eklandskapet i Linkopings Kommun; Skogssallskapet; European Regional Development Fund(European Commission); County Administrative Board of Vasternorrland; Linnaeus initiative grant from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Sources of funding: Marie-Claire Cronstedts Stiftelse (PM), Wala & Folke Danielssons fond (NM, Stiftelsen Oscar & Lili Lamms minne (NM)(http://www.stiftelsenlamm.a.se/), Stiftelsen Eklandskapet i Linkopings Kommun (ML) (http://www.eklandskapet.nu/index2.html), Skogssallskapet (ML) (http://www.skogssallskapet.se/) the European Regional Development Fund and the County Administrative Board of Vasternorrland (EH) http://www.lansstyrelsen.se/vasternorrland/En/Pages/default.aspx. Linnaeus initiative grant (# 217-2006-1750) to IC-E3 (Insect Chemical Ecology, Ethology and Evolution) from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) (ML). http://www.formas.se/en/. The funds without URLs have no websites or specific websites for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. A., 1966, ENTOMOLOGISTS RECORD, V78, P14; Artdatabanken, 2013, SPEC FACT SHEET EL F; Bergman KO, 2012, FOREST ECOL MANAG, V265, P133, DOI 10.1016/j.foreco.2011.10.030; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; Claesson K., 2009, SKYDDSVARDA TRAD OST; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Driscoll DA, 2010, AUSTRAL ECOL, V35, P13, DOI 10.1111/j.1442-9993.2009.02007.x; Dubois GF, 2009, LANDSCAPE URBAN PLAN, V91, P152, DOI 10.1016/j.landurbplan.2008.12.009; ESRI, 2011, ARCGIS DESKT REL 10; Flate P. O., 2009, Forest & Landscape Working Papers, P65; Gardenfors U., 2010, RED LIST SWEDISH SPE; GBIF, 2012, EL FERR; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Horion A., 1953, FAUNISTIK MITTELEURO; Jackson HB, 2012, LANDSCAPE ECOL, V27, P929, DOI 10.1007/s10980-012-9757-9; Jansson N, 2009, THESIS LINKOPING U; Jansson N, 2009, BIODIVERS CONSERV, V18, P3891, DOI 10.1007/s10531-009-9687-2; Jansson N, 2009, J INSECT CONSERV, V13, P399, DOI 10.1007/s10841-008-9187-9; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Larsson MC, 2011, J INSECT CONSERV, V15, P891, DOI 10.1007/s10841-011-9388-5; Larsson MC, 2009, CONSERV BIOL, V23, P1516, DOI 10.1111/j.1523-1739.2009.01263.x; Larsson MC, 2003, J CHEM ECOL, V29, P575, DOI 10.1023/A:1022850704500; Lindenmayer DB, 2000, BIODIVERS CONSERV, V9, P15, DOI 10.1023/A:1008943713765; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Merzijevskis Aleksandras, 2010, Acta Zoologica Lituanica, V20, P242, DOI 10.2478/v10043-010-0036-1; Nilsson Sven G., 1994, Entomologisk Tidskrift, V115, P81; Oleksa A, 2007, POL J ECOL, V55, P315; Palm T, 1959, OPUSCULA ENTOMOLOG S, V16; Paltto H, 2006, BIOL CONSERV, V133, P442, DOI 10.1016/j.biocon.2006.07.006; Paltto H, 2010, CONSERV BIOL, V24, P758, DOI 10.1111/j.1523-1739.2009.01423.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Ranius T, 2002, BIODIVERS CONSERV, V11, P1759, DOI 10.1023/A:1020343030085; Ranius T, 2002, BIOL CONSERV, V103, P85, DOI 10.1016/S0006-3207(01)00124-0; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Ranius T, 1997, J INSECT CONSERV, V1, P193, DOI 10.1023/A:1018416000766; Ranius T, 2011, BIODIVERS CONSERV, V20, P2027, DOI 10.1007/s10531-011-0072-6; StatSoft Inc, 2012, STATISTICA; Svensson GP, 2008, J CHEM ECOL, V34, P189, DOI 10.1007/s10886-007-9423-x; Svensson GP, 2012, J INSECT CONSERV, V16, P549, DOI 10.1007/s10841-011-9440-5; Svensson GP, 2004, J CHEM ECOL, V30, P353, DOI 10.1023/B:JOEC.0000017982.51642.8c; Tolasch T, 2007, J CHEM ECOL, V33, P2156, DOI 10.1007/s10886-007-9365-3; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	45	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66149	10.1371/journal.pone.0066149	http://dx.doi.org/10.1371/journal.pone.0066149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840415	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200057
J	Okuyama, J; Nakajima, K; Noda, T; Kimura, S; Kamihata, H; Kobayashi, M; Arai, N; Kagawa, S; Kawabata, Y; Yamada, H				Okuyama, Junichi; Nakajima, Kana; Noda, Takuji; Kimura, Satoko; Kamihata, Hiroko; Kobayashi, Masato; Arai, Nobuaki; Kagawa, Shiro; Kawabata, Yuuki; Yamada, Hideaki			Ethogram of Immature Green Turtles: Behavioral Strategies for Somatic Growth in Large Marine Herbivores	PLOS ONE			English	Article							CHELONIA-MYDAS; HOME-RANGE; SEA-TURTLES; ACCELERATION DATA; DIVING BEHAVIOR; HABITAT USE; MOVEMENT; PATTERNS; DEPTH; INSIGHTS	Animals are assumed to obtain/conserve energy effectively to maximise their fitness, which manifests itself in a variety of behavioral strategies. For marine animals, however, these behavioral strategies are generally unknown due to the lack of high-resolution monitoring techniques in marine habitats. As large marine herbivores, immature green turtles do not need to allocate energy to reproduction but are at risk of shark predation, although it is a rare occurrence. They are therefore assumed to select/use feeding and resting sites that maximise their fitness in terms of somatic growth, while avoiding predation. We investigated fine-scale behavioral patterns (feeding, resting and other behaviors), microhabitat use and time spent on each behavior for eight immature green turtles using data loggers including: depth, global positioning system, head acceleration, speed and video sensors. Immature green turtles at Iriomote Island, Japan, spent an average of 4.8 h feeding on seagrass each day, with two peaks, between 5: 00 and 9: 00, and between 17: 00 and 20: 00. This feeding pattern appeared to be restricted by gut capacity, and thus maximised energy acquisition. Meanwhile, most of the remaining time was spent resting at locations close to feeding grounds, which allowed turtles to conserve energy spent travelling and reduced the duration of periods exposed to predation. These behavioral patterns and time allocations allow immature green turtles to effectively obtain/conserve energy for growth, thus maximising their fitness.	[Okuyama, Junichi; Nakajima, Kana; Noda, Takuji; Kimura, Satoko; Kamihata, Hiroko; Arai, Nobuaki; Kawabata, Yuuki] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Okuyama, Junichi] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Kimura, Satoko] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kobayashi, Masato; Yamada, Hideaki] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Ishigaki, Okinawa, Japan; [Arai, Nobuaki] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Kagawa, Shiro] NHK Enterprises Inc, Nat Program, Shibuya Ku, Tokyo, Japan; [Kagawa, Shiro] NHK Enterprises Inc, Sci Program, Shibuya Ku, Tokyo, Japan; [Kawabata, Yuuki] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan	Kyoto University; National Oceanic Atmospheric Admin (NOAA) - USA; Nagoya University; Japan Fisheries Research & Education Agency (FRA); Kyoto University; NHK Japan Broadcasting Corp; NHK Japan Broadcasting Corp; Nagasaki University	Okuyama, J (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	okuyamajunichi@gmail.com	Kawabata, Yuuki/H-4109-2019; Noda, Takuji/W-1420-2019	Okuyama, Junichi/0000-0002-9993-6030	Espec; Sumitomo Foundation; Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society;  [22710236]	Espec; Sumitomo Foundation; Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was partly supported by the Espec and Sumitomo Foundation, a Grant-in-Aid for JSPS Young Scientists B (JO No. 22710236) and the Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Balazs GH, 1987, NMFSSWFC71 NOAA US D; Batschelet E, 1981, CIRCULAR STAT BIOL; Biodiversity center of Japan, 2008, REP EC SURV NER WAT; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.1890/1051-0761(2000)010[0269:GTSGME]2.0.CO;2; Bjorndal KA, 2003, MAR ECOL PROG SER, V252, P273, DOI 10.3354/meps252273; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Burkholder DA, 2011, MAR ECOL PROG SER, V439, P277, DOI 10.3354/meps09313; CACERES CW, 1994, OECOLOGIA, V99, P118, DOI 10.1007/BF00317091; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Davies NB, 2012, INTRO BEHAV ECOLOGY; FORD RG, 1983, AM ZOOL, V23, P315; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Hamabata Tomoko, 2009, Bulletin of the Graduate School of Social and Cultural Studies Kyushu University, V15, P35; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Hochscheid S, 2007, COMP BIOCHEM PHYS A, V148, P360, DOI 10.1016/j.cbpa.2007.05.010; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Houghton JDR, 2008, J EXP MAR BIOL ECOL, V356, P115, DOI 10.1016/j.jembe.2007.12.008; Jones D.R, 2011, NOAANMFSSWFSC480; Lemons G, 2011, J EXP MAR BIOL ECOL, V405, P25, DOI 10.1016/j.jembe.2011.05.012; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MacDonald BD, 2013, J EXP MAR BIOL ECOL, V443, P56, DOI 10.1016/j.jembe.2013.02.033; MacDonald BD, 2012, MAR ECOL PROG SER, V461, P211, DOI 10.3354/meps09820; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MENDONCA MT, 1983, COPEIA, P1013, DOI 10.2307/1445104; Ministry of the environment government of Japan, 2006, SURV REP COR POP DYN; Ministry of the environment government of Japan, 2004, COR REEFS JAP; Mortimer Jeanne A., 1995, P103; NAGY KA, 1984, PHYSIOL ZOOL, V57, P281, DOI 10.1086/physzool.57.3.30163716; Newman Jonathan, 2007, P175; Nishizawa Hideaki, 2011, Endangered Species Research, V14, P141, DOI 10.3354/esr00355; OGDEN JC, 1983, J EXP MAR BIOL ECOL, V66, P199, DOI 10.1016/0022-0981(83)90160-0; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stearns S.C., 1992, pi; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Tanaka H, 2001, J EXP BIOL, V204, P3895; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Valentine JF, 1999, MAR ECOL PROG SER, V176, P291, DOI 10.3354/meps176291; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205; Watson KP, 1998, J EXP BIOL, V201, P2497; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; WILLIAMS SL, 1988, MAR BIOL, V98, P447, DOI 10.1007/BF00391121; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yamamoto T, 1995, ANN REP OKINAWA PREF, V57, P227	63	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65783	10.1371/journal.pone.0065783	http://dx.doi.org/10.1371/journal.pone.0065783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840367	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200034
J	Teh, LSL; Teh, LCL; Sumaila, UR				Teh, Louise S. L.; Teh, Lydia C. L.; Sumaila, U. Rashid			A Global Estimate of the Number of Coral Reef Fishers	PLOS ONE			English	Article							CLIMATE-CHANGE; CONSERVATION; MANAGEMENT; IMPACTS; BIOMASS; SABAH	Overfishing threatens coral reefs worldwide, yet there is no reliable estimate on the number of reef fishers globally. We address this data gap by quantifying the number of reef fishers on a global scale, using two approaches - the first estimates reef fishers as a proportion of the total number of marine fishers in a country, based on the ratio of reef-related to total marine fish landed values. The second estimates reef fishers as a function of coral reef area, rural coastal population, and fishing pressure. In total, we find that there are 6 million reef fishers in 99 reef countries and territories worldwide, of which at least 25% are reef gleaners. Our estimates are an improvement over most existing fisher population statistics, which tend to omit accounting for gleaners and reef fishers. Our results suggest that slightly over a quarter of the world's small-scale fishers fish on coral reefs, and half of all coral reef fishers are in Southeast Asia. Coral reefs evidently support the socioeconomic well-being of numerous coastal communities. By quantifying the number of people who are employed as reef fishers, we provide decision-makers with an important input into planning for sustainable coral reef fisheries at the appropriate scale.	[Teh, Louise S. L.; Teh, Lydia C. L.; Sumaila, U. Rashid] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Teh, LSL (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	l.teh@fisheries.ubc.ca	Sumaila, U. Rashid/ABE-6475-2020		Sea Around Us Project; Pew Charitable Trusts of Philadelphia, United States of America	Sea Around Us Project; Pew Charitable Trusts of Philadelphia, United States of America	R. Sumaila acknowledges support from the Sea Around Us Project, funded by the Pew Charitable Trusts of Philadelphia, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrivilaga Alejandro, 2004, P473; Bell JD, 2006, OCEAN COAST MANAGE, V49, P976, DOI 10.1016/j.ocecoaman.2005.12.001; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bene C, 2003, WORLD DEV, V31, P949, DOI 10.1016/S0305-750X(03)00045-7; Boblin P., 2009, MARSHALL ISLANDS COU; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2011, REEFS RISK REVISITED; Center for International Earth Science Information Network (CIESIN) Columbia University International Food Policy Research Institute (IFPRI) The World Bank (CIAT) CIdAT, 2004, GLOB RUR URB MAPP PR; Cesar H., 2003, EC WORLDWIDE CORAL R; CHAPMAN MD, 1987, HUM ECOL, V15, P267, DOI 10.1007/BF00888026; Cinner J, 2006, ENVIRON CONSERV, V22, P1; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cushion N, 2007, P 60 GULF CAR FISH I, V60, P162; Dalzell P., 1996, REEF FISHERIES, V20, P161, DOI [DOI 10.1007/978-94-015-8779-2, 10.1007/978-94-015-8779-2\_7.500]; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Gillett R, 2011, FISHERIES PACIFIC IS; Gonzalez JA, 2008, ECOL SOC, V13; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Kronen M, 2010, FISH RES, V101, P1, DOI 10.1016/j.fishres.2009.08.011; Kronen M, 2009, NEW CALEDONIA COUNTR; Kronen M., 2008, FRENCH POLYNESIA COU, P282; Kronen M, 2009, WALLIS FUTUNA RAPPOR; Kronen M, 2010, MAR POLICY, V34, P1135, DOI 10.1016/j.marpol.2010.03.013; Loper C, 2008, CONDITIONS WORLDS TR; McClanahan TR, 2009, CONSERV BIOL, V23, P662, DOI 10.1111/j.1523-1739.2008.01154.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; Muallil R, 2012, 12 INT COR REEF S 9; Munday P.L., 2000, STATUS CORAL REEFS P; National CTI Coordinating Committee of Timor-Leste, 2012, STAT COR REEF TIM LE; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; PAULY D, 1988, AMBIO, V17, P200; Pauly D, 1997, AM FISH S S, V20, P40; Pinca S., 2009, COOK ISLANDS COUNTRY; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Ruddle K., 1996, REEF FISHERIES, P137, DOI [10.1007/978-94-015-8779-2_6, DOI 10.1007/978-94-015-8779-2_6]; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Sale PF, 2008, MAR POLLUT BULL, V56, P805, DOI 10.1016/j.marpolbul.2008.04.009; Sauni S, 2008, TUVALU COUNTRY REPOR; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Starkhouse B, 2009, WHATS CATCH UNCOVERI; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Teh LSL, 2007, CORAL REEFS, V26, P251, DOI 10.1007/s00338-006-0182-x; Teh L, 2007, MAR POLICY, V31, P451, DOI 10.1016/j.marpol.2007.01.001; Teh LSL, 2011, FISH RES, V110, P450, DOI 10.1016/j.fishres.2011.06.001; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Tun K, 2004, STATUS CORAL REEFS W, V1, P235; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2012, RUR POP DEV ENV 2011; Unsworth R, 2010, CONSERV LETT, V00, P1; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Whittingham E., 2003, POVERTY REEFS; Wilkinson C, 2008, STATUS CORAL REEFS W; WWF, 2012, PROBL COR TRIANGL; Zeller D, 2006, CORAL REEFS, V25, P144, DOI 10.1007/s00338-005-0067-4	65	127	127	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65397	10.1371/journal.pone.0065397	http://dx.doi.org/10.1371/journal.pone.0065397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840327	Green Published, gold			2022-12-25	WOS:000322361200016
J	Walker, AK; Gong, Z; Park, WM; Zigman, JM; Sakata, I				Walker, Angela K.; Gong, Zhi; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro			Expression of Serum Retinol Binding Protein and Transthyretin within Mouse Gastric Ghrelin Cells	PLOS ONE			English	Article							DES-ACYL GHRELIN; STIMULATES FOOD-INTAKE; INSULIN-RESISTANCE; O-ACYLTRANSFERASE; PANCREATIC-ISLETS; PLASMA GHRELIN; ENERGY-BALANCE; MESSENGER-RNA; SECRETION; PEPTIDE	Ghrelin is an orexigenic peptide hormone produced mainly by a distinct group of dispersed endocrine cells located within the gastric oxyntic mucosa. Besides secreted gene products derived from the preproghrelin gene, which include acyl-ghrelin, desacyl-ghrelin and obestatin, ghrelin cells also synthesize the secreted protein nesfatin-1. The main goal of the current study was to identify other proteins secreted from ghrelin cells. An initial gene chip screen using mRNAs derived from highly enriched pools of mouse gastric ghrelin cells demonstrated high levels of serum retinol-binding protein (RBP4) and transthyretin (TTR), both of which are known to circulate in the bloodstream bound to each other. This high expression was confirmed by quantitative RT-PCR using as template mRNA derived from the enriched gastric ghrelin cell pools and from two ghrelin-producing cell lines (SG-1 and PG-1). RBP4 protein also was shown to be secreted into the culture medium of ghrelin cell lines. Neither acute nor chronic caloric restriction had a significant effect on RBP4 mRNA levels within stomachs of C57BL/6J mice, although both manipulations significantly decreased stomach TTR mRNA levels. In vitro studies using PG-1 cells showed no effect on RBP4 release of octanoic acid, epinephrine or norepinephrine, all of which are known to act directly on ghrelin cells to stimulate ghrelin secretion. These data provide new insights into ghrelin cell physiology, and given the known functions of RBP4 and TTR, support an emerging role for the ghrelin cell in blood glucose handling and metabolism.	[Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Gong, Zhi] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol, Saitama 3388570, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Saitama University	Zigman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	jeffrey.zigman@utsouthwestern.edu	Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295	International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen	International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen	This work was funded by an International Research Alliance with The Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; CAVALLARO T, 1990, INVEST OPHTH VIS SCI, V31, P497; Chuang JC, 2011, MOL ENDOCRINOL, V25, P1600, DOI 10.1210/me.2011-1001; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; de la Cour CD, 2001, REGUL PEPTIDES, V99, P141, DOI 10.1016/S0167-0115(01)00243-9; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Erlandsen SE, 2012, REGUL PEPT; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Gagnon J, 2013, DIABETES OBES METAB, V15, P276, DOI 10.1111/dom.12021; Gagnon J, 2013, ENDOCRINOLOGY, V154, P666, DOI 10.1210/en.2012-1994; Gagnon J, 2012, ENDOCRINOLOGY, V153, P3646, DOI 10.1210/en.2012-1040; Gourcerol G, 2007, OBESITY, V15, P2643, DOI 10.1038/oby.2007.316; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Haider DG, 2007, J CLIN ENDOCR METAB, V92, P1168, DOI 10.1210/jc.2006-1839; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Ikezaki A, 2002, DIABETES, V51, P3408, DOI 10.2337/diabetes.51.12.3408; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; JACOBSSON B, 1989, HISTOCHEMISTRY, V91, P299, DOI 10.1007/BF00493004; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kobelt P, 2008, PEPTIDES, V29, P1018, DOI 10.1016/j.peptides.2008.01.020; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Lu X, 2012, AM J PHYSL GASTROINT; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; MAKOVER A, 1989, J LIPID RES, V30, P171; MARTONE RL, 1988, BIOCHEM BIOPH RES CO, V157, P1078, DOI 10.1016/S0006-291X(88)80984-7; Mizutani M, 2009, AM J PHYSIOL-GASTR L, V297, pG974, DOI 10.1152/ajpgi.00147.2009; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Neary NM, 2006, GUT, V55, P135; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Ozawa A, 2007, ANAL BIOCHEM, V366, P182, DOI 10.1016/j.ab.2007.04.020; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Richardson SJ, 2009, FEBS J, V276, P5342, DOI 10.1111/j.1742-4658.2009.07244.x; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Robbins J., 2000, THYROID A FUNDAMENTA, V8th ed., P105; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Sanger GJ, 2008, NAT REV DRUG DISCOV, V7, P241, DOI 10.1038/nrd2444; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, pRC13, DOI 10.1007/BF03344174; SOPRANO DR, 1988, J BIOL CHEM, V263, P2934; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2012, J NEUROGASTROENTEROL, V18, P138, DOI 10.5056/jnm.2012.18.2.138; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Walker AK, 2012, PHYSIOL BEHAV, V108, P34, DOI 10.1016/j.physbeh.2012.10.003; Westermark GT, 2008, EXP DIABETES RES, DOI 10.1155/2008/429274; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yabuki A, 2004, J ANAT, V205, P239, DOI 10.1111/j.0021-8782.2004.00331.x; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64882	10.1371/journal.pone.0064882	http://dx.doi.org/10.1371/journal.pone.0064882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840311	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200008
J	Wang, GR; Surks, HK; Tang, KM; Zhu, Y; Mendelsohn, ME; Blanton, RM				Wang, Guang-rong; Surks, Howard K.; Tang, K. Mary; Zhu, Yan; Mendelsohn, Michael E.; Blanton, Robert M.			Steroid-sensitive Gene 1 Is a Novel Cyclic GMP-dependent Protein Kinase I Substrate in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NITRIC-OXIDE; MYOSIN PHOSPHATASE; PHOSPHORYLATION; EXPRESSION; BINDING; ALPHA; VIVO; DETERMINANTS; HYPERTROPHY	NO, via its second messenger cGMP, activates protein kinase GI (PKGI) to induce vascular smooth muscle cell relaxation. The mechanisms by which PKGI kinase activity regulates cardiovascular function remain incompletely understood. Therefore, to identify novel protein kinase G substrates in vascular cells, a lambda phage coronary artery smooth muscle cell library was constructed and screened for phosphorylation by PKGI. The screen identified steroid-sensitive gene 1 (SSG1), which harbors several predicted PKGI phosphorylation sites. We observed direct and cGMP-regulated interaction between PKGI and SSG1. In cultured vascular smooth muscle cells, both the NO donor S-nitrosocysteine and atrial natriuretic peptide induced SSG1 phosphorylation, and mutation of SSG1 at each of the two predicted PKGI phosphorylation sites completely abolished its basal phosphorylation by PKGI. We detected high SSG1 expression in cardiovascular tissues. Finally, we found that activation of PKGI with cGMP regulated SSG1 intracellular distribution.	[Blanton, Robert M.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center	Blanton, RM (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St,Box 80, Boston, MA 02111 USA.	rblanton@tuftsmedicalcenter.org			National Institutes of Health [HL077378, HL55309, HL074069, AG042367-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055309, P01HL077378, R01HL074069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL077378 and HL55309 (to M. E. M.), HL074069 (to H. K. S.), and AG042367-01 (to R. M. B.).	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Blanton RM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003731; Busse R, 1996, J VASC RES, V33, P181, DOI 10.1159/000159147; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hofmann F, 2000, J CELL SCI, V113, P1671; Ignarro LJ, 1996, KIDNEY INT, pS2; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Lincoln TM, 1996, METHOD ENZYMOL, V269, P149; LINCOLN TM, 1994, CYCLIC GMP BIOCH PHY; Liu Y, 2004, BIOCHEM BIOPH RES CO, V322, P497, DOI 10.1016/j.bbrc.2004.07.161; Marcantonio D, 2001, J MOL ENDOCRINOL, V26, P175, DOI 10.1677/jme.0.0260175; Marcantonio D, 2001, ENDOCRINOLOGY, V142, P2409, DOI 10.1210/endo.142.6.8154; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mirotsou M, 2006, PHYSIOL GENOMICS, V27, P86, DOI 10.1152/physiolgenomics.00028.2006; Murad F, 1996, JAMA-J AM MED ASSOC, V276, P1189, DOI 10.1001/jama.276.14.1189; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tamura N, 1996, HYPERTENSION, V27, P552, DOI 10.1161/01.HYP.27.3.552; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0	35	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24972	24983		10.1074/jbc.M113.456244	http://dx.doi.org/10.1074/jbc.M113.456244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23831687	Green Published, hybrid			2022-12-25	WOS:000330612300060
J	Au, SLK; Wong, CCL; Lee, JMF; Wong, CM; Ng, IOL				Au, Sandy Leung-Kuen; Wong, Carmen Chak-Lui; Lee, Joyce Man-Fong; Wong, Chun-Ming; Ng, Irene Oi-Lin			EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA CELLS; HISTONE METHYLTRANSFERASE EZH2; TUMOR-SUPPRESSOR GENES; GROUP PROTEIN EZH2; PROSTATE-CANCER; LYSINE-27 METHYLATION; DEVELOPMENTAL GENES; BREAST-CANCER; DLC-1 GENE	Enhancer of zeste homolog 2 (EZH2), the histone methyltransferase of the Polycomb Repressive complex 2 catalyzing histone H3 lysine 27 tri-methylation (H3K27me3), is frequently up-regulated in human cancers. In this study, we identified the tumor suppressor Deleted in liver cancer 1 (DLC1) as a target of repression by EZH2-mediated H3K27me3. DLC1 is a GTPase-activating protein for Rho family proteins. Inactivation of DLC1 results in hyper-activated Rho/ROCK signaling and is implicated in actin cytoskeleton reorganization to promote cancer metastasis. By chromatin immunoprecipitation assay, we demonstrated that H3K27me3 was significantly enriched at the DLC1 promoter region of a DLC1-nonexpressing HCC cell line, MHCC97L. Depletion of EZH2 in MHCC97L by shRNA reduced H3K27me3 level at DLC1 promoter and induced DLC1 gene re-expression. Conversely, transient overexpression of GFP-EZH2 in DLC1-expressing Huh7 cells reduced DLC1 mRNA level with a concomitant enrichment of EZH2 on DLC1 promoter. An inverse relation between EZH2 and DLC1 expression was observed in the liver, lung, breast, prostate, and ovarian cancer tissues. Treating cancer cells with the EZH2 small molecular inhibitor, 3-Deazaneplanocin A (DZNep), restored DLC1 expression in different cancer cell lines, indicating that EZH2-mediated H3K27me3 epigenetic regulation of DLC1 was a common mechanism in human cancers. Importantly, we found that DZNep treatment inhibited HCC cell migration through disrupting actin cytoskeleton network, suggesting the therapeutic potential of DZNep in targeting cancer metastasis. Taken together, our study has shed mechanistic insight into EZH2-H3K27me3 epigenetic repression of DLC1 and advocated the significant pro-metastatic role of EZH2 via repressing tumor and metastasis suppressors.	[Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Ng, IOL (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk	WONG, Chun-Ming/A-6739-2009; Wong, Carmen Chak Lui/C-4660-2009	WONG, Chun-Ming/0000-0002-2497-7858; Ng, Irene Oi-lin/0000-0001-7532-2029; Wong, Carmen Chak Lui/0000-0001-5866-4705	University of Hong Kong Seed Funding Program for Basic Research [200811159061, 201011159045]; Hong Kong Research Grants Council General Research Fund [HKU 782411M]; Hong Kong Research Grants Council Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09]	University of Hong Kong Seed Funding Program for Basic Research; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council)	The study was supported by The University of Hong Kong Seed Funding Program for Basic Research (200811159061 and 201011159045 to CMW), Hong Kong Research Grants Council General Research Fund (HKU 782411M to CMW) and Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09 to IN). IN is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shih YP, 2010, CANCER RES, V70, P8270, DOI 10.1158/0008-5472.CAN-10-1174; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Wong CC, 2008, PLOS ONE, V3, pe2779, DOI [10.1371/journal.pone.0002779, DOI 10.1371/J0URNAL.P0NE.0002779.PUBMED:18648664]; Wong CM, 2003, CANCER RES, V63, P7646; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	49	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68226	10.1371/journal.pone.0068226	http://dx.doi.org/10.1371/journal.pone.0068226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826380	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000134
J	Bednarczyk, P; Wieckowski, MR; Broszkiewicz, M; Skowronek, K; Siemen, D; Szewczyk, A				Bednarczyk, Piotr; Wieckowski, Mariusz R.; Broszkiewicz, Malgorzata; Skowronek, Krzysztof; Siemen, Detlef; Szewczyk, Adam			Putative Structural and Functional Coupling of the Mitochondrial BKCa Channel to the Respiratory Chain	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNEL; MEMBRANE; MODULATION; ACTIVATION; COMPLEX	Potassium channels have been found in the inner mitochondrial membranes of various cells. These channels regulate the mitochondrial membrane potential, the matrix volume and respiration. The activation of these channels is cytoprotective. In our study, the single-channel activity of a large-conductance Ca2+-regulated potassium channel (mitoBK(Ca) channel) was measured by patch-clamping mitoplasts isolated from the human astrocytoma (glioblastoma) U-87 MG cell line. A potassium-selective current was recorded with a mean conductance of 290 pS in symmetrical 150 mM KCl solution. The channel was activated by Ca2+ at micromolar concentrations and by the potassium channel opener NS1619. The channel was inhibited by paxilline and iberiotoxin, known inhibitors of BKCa channels. Western blot analysis, immuno-gold electron microscopy, high-resolution immunofluorescence assays and polymerase chain reaction demonstrated the presence of the BKCa channel beta 4 subunit in the inner mitochondrial membrane of the human astrocytoma cells. We showed that substrates of the respiratory chain, such as NADH, succinate, and glutamate/malate, decrease the activity of the channel at positive voltages. This effect was abolished by rotenone, antimycin and cyanide, inhibitors of the respiratory chain. The putative interaction of the beta 4 subunit of mitoBK(Ca) with cytochrome c oxidase was demonstrated using blue native electrophoresis. Our findings indicate possible structural and functional coupling of the mitoBK(Ca) channel with the mitochondrial respiratory chain in human astrocytoma U-87 MG cells.	[Bednarczyk, Piotr; Skowronek, Krzysztof; Szewczyk, Adam] Nencki Inst Expt Biol, Lab Intracellular Ion Channels, Warsaw, Poland; [Bednarczyk, Piotr] Warsaw Univ Life Sci SGGW, Dept Biophys, Warsaw, Poland; [Wieckowski, Mariusz R.] Nencki Inst Expt Biol, Lab Bioenerget & Biomembranes, Warsaw, Poland; [Skowronek, Krzysztof] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Siemen, Detlef] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Broszkiewicz, Malgorzata] Nencki Inst Expt Biol, Lab Mol & System Neuromorphol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Otto von Guericke University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Szewczyk, A (corresponding author), Nencki Inst Expt Biol, Lab Intracellular Ion Channels, Warsaw, Poland.	adam@nencki.gov.pl	Broszkiewicz, Marzenna/S-9893-2016; Bednarczyk, Piotr/B-4973-2018; Skowronek, Krzysztof/G-2855-2010	Broszkiewicz, Marzenna/0000-0002-4868-6350; Bednarczyk, Piotr/0000-0002-7125-0715; Skowronek, Krzysztof/0000-0001-9973-7085; Szewczyk, Adam/0000-0001-5519-260X; Wieckowski, Mariusz/0000-0003-0789-4521	Ministry of Science and Higher Education [793/N-DAAD/2010/0]; DAAD Short-Term Fellowship [A/08/06055]; Polish Mitochondrial Network, MitoNet.pl; DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen)	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); DAAD Short-Term Fellowship; Polish Mitochondrial Network, MitoNet.pl; DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen)	This study was supported by a grant from the Ministry of Science and Higher Education to AS (No 793/N-DAAD/2010/0) and a DAAD Short-Term Fellowship to PB (A/08/06055). The Polish Mitochondrial Network, MitoNet.pl, supported part of this study. Support to DS by the DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ASN00022011 ANSIATCC; Ardehali H, 2004, P NATL ACAD SCI USA, V101, P11880, DOI 10.1073/pnas.0401703101; Bednarczyk P, 2010, BIOCHEM BIOPH RES CO, V397, P614, DOI 10.1016/j.bbrc.2010.06.011; Cheng Y, 2008, CELL PHYSIOL BIOCHEM, V22, P127, DOI 10.1159/000149790; Cheng Y, 2011, CELL PHYSIOL BIOCHEM, V27, P191, DOI 10.1159/000327944; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Heinen A, 2007, AM J PHYSIOL-CELL PH, V292, pC148, DOI 10.1152/ajpcell.00215.2006; Kajma A, 2012, BBA-BIOENERGETICS, V1817, P1867, DOI 10.1016/j.bbabio.2012.02.029; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Koszela-Piotrowska I, 2009, BIOCHEM J, V424, P307, DOI 10.1042/BJ20090991; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Mathiisen TM, 2006, NEUROANATOMICAL TRACT-TRACING 3: MOLECULES, NEURONS, AND SYSTEMS, P72; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Piwonska M, 2008, NEUROSCIENCE, V153, P446, DOI 10.1016/j.neuroscience.2008.01.050; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Skalska J, 2008, BBA-BIOENERGETICS, V1777, P651, DOI 10.1016/j.bbabio.2008.05.007; Sokolowski B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028532; Stowe DF, 2013, BBA-BIOMEMBRANES, V1828, P427, DOI 10.1016/j.bbamem.2012.08.031; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2012, PFLUG ARCH EUR J PHY, V463, P231, DOI 10.1007/s00424-011-1058-7; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Zhang DX, 2001, CIRC RES, V89, P1177, DOI 10.1161/hh2401.101752	34	77	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68125	10.1371/journal.pone.0068125	http://dx.doi.org/10.1371/journal.pone.0068125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826369	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000123
J	Chen, JW; Feng, G; Song, Y; Wardenburg, JB; Lin, S; Inoshima, I; Otto, M; Wunderink, RG				Chen, Jiwang; Feng, Gang; Song, Yang; Wardenburg, Juliane B.; Lin, Simon; Inoshima, Ichiro; Otto, Michael; Wunderink, Richard G.			Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; ILLUMINA MICROARRAY; DISEASE-ONTOLOGY; ANTIBIOTICS; INFECTION; SEPSIS; PATHOGENESIS; MANAGEMENT; CELLS	Background: Linezolid (LZD) is beneficial to patients with MRSA pneumonia, but whether and how LZD influences global host lung immune responses at the mRNA level during MRSA-mediated pneumonia is still unknown. Methods: A lethal mouse model of MRSA pneumonia mediated by USA300 was employed to study the influence of LZD on survival, while the sublethal mouse model was used to examine the effect of LZD on bacterial clearance and lung gene expression during MRSA pneumonia. LZD (100mg/kg/day, IP) was given to C57Bl6 mice for three days. On Day 1 and Day 3 post infection, bronchoalveolar lavage fluid (BALF) protein concentration and levels of cytokines including IL6, TNF alpha, IL1 beta, Interferon-gamma and IL17 were measured. In the sublethal model, left lungs were used to determine bacterial clearance and right lungs for whole-genome transcriptional profiling of lung immune responses. Results: LZD therapy significantly improved survival and bacterial clearance. It also significantly decreased BALF protein concentration and levels of cytokines including IL6, IL1 beta, Interferon-gamma and IL17. No significant gene expression changes in the mouse lungs were associated with LZD therapy. Conclusion: LZD is beneficial to MRSA pneumonia, but it does not modulate host lung immune responses at the transcriptional level.	[Chen, Jiwang; Wunderink, Richard G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Chen, Jiwang] Univ Illinois, Sect Pulm Crit Care Med Allergy & Sleep, Chicago, IL USA; [Feng, Gang; Lin, Simon] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA; [Song, Yang] Illinois State Univ, Microbiol Grp, Sch Biol Sci, Normal, IL 61761 USA; [Wardenburg, Juliane B.; Inoshima, Ichiro] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Lin, Simon] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Otto, Michael] NIAID, Bethesda, MD 20892 USA	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Illinois State University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, JW (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	chenjw@uic.edu	song, yang/P-1033-2015	Otto, Michael/0000-0002-2222-4115; Wunderink, Richard/0000-0002-8527-4195	Pfizer [WS1826185]; National Center for Advancing Translational Sciences Grant [8UL1TR000150]; NCI Cancer Center Support Grant [NCI CA060553]; Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Center for Advancing Translational Sciences Grant; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Pfizer ASPIRE Award, Pfizer Investigator-Initiated Grant (WS1826185, to JC), the National Center for Advancing Translational Sciences Grant (8UL1TR000150) and the NCI Cancer Center Support Grant (NCI CA060553 to GF and SL) and the Intramural Research Program of the NIAID (to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Akinnusi ME, 2011, CRIT CARE MED, V39, P1944, DOI 10.1097/CCM.0b013e31821bd79e; Andes D, 2002, ANTIMICROB AGENTS CH, V46, P3484, DOI 10.1128/AAC.46.11.3484-3489.2002; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Cangara HM, 2010, MICROVASC RES, V80, P133, DOI 10.1016/j.mvr.2010.02.006; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Draganov D, 2010, ADV EXP MED BIOL, V660, P89, DOI 10.1007/978-1-60761-350-3_9; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Gill CJ, 2007, ANTIMICROB AGENTS CH, V51, P3434, DOI 10.1128/AAC.01567-06; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moitra J, 2008, TRANSL RES, V151, P141, DOI 10.1016/j.trsl.2007.12.008; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peng KT, 2010, INFECT IMMUN, V78, P2723, DOI 10.1128/IAI.00008-10; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Tacconelli E, 2009, CURR OPIN PULM MED, V15, P218, DOI 10.1097/MCP.0b013e3283292666; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96; Zhu DM, 2008, CHINESE MED J-PEKING, V121, P2258, DOI 10.1097/00029330-200811020-00010	36	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67994	10.1371/journal.pone.0067994	http://dx.doi.org/10.1371/journal.pone.0067994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826353	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000107
J	Guo, R; Abdelmohsen, K; Morin, PJ; Gorospe, M				Guo, Rong; Abdelmohsen, Kotb; Morin, Patrice J.; Gorospe, Myriam			Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; POSTTRANSCRIPTIONAL REGULATION; COLORECTAL-CANCER; INDUCE APOPTOSIS; CELL-SURVIVAL; EXPRESSION; P53; TARGET; GROWTH; GLYCOGEN-SYNTHASE-KINASE-3-BETA	Several members of the let-7 microRNA family are downregulated in ovarian and other cancers. They are thought to act as tumor suppressors by lowering growth-promoting and anti-apoptotic proteins. In order to measure cellular let-7 levels systematically, we have developed a highly sensitive let-7 reporter assay system based on the expression of a chimeric mRNA that contains the luciferase coding region and a 3'-untranslated region (UTR) bearing two let-7-binding sites. In cells expressing the reporter construct, termed pmirGLO-let7, luciferase activity was high when let-7 was absent, while luciferase activity was low when let-7 levels were elevated. The ovarian cancer cell lines BG-1 and UCI-101 were transfected with the let-7 reporter and surveyed with a library of kinase inhibitors in order to identify pathways affecting let-7 activity. Among the inhibitors causing changes in endogenous let-7 abundance, the lowering of glycogen synthase kinase 3 (GSK-3)beta function specifically increased let-7 levels and lowered luciferase activity. Similarly, silencing GSK-3 beta increased both mature and primary-let-7 levels in BG-1 cells, and decreased BG-1 cell survival. Further studies identified p53 as a downstream effector of the GSK-3 beta-mediated repression of let-7 biosynthesis. Our studies highlight GSK-3 beta as a novel therapeutic target in ovarian tumorigenesis.	[Guo, Rong; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Morin, Patrice J.] NIA, Lab Mol Biol & Immunol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Morin, Patrice J.] Amer Assoc Canc Res, Philadelphia, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Morin, PJ (corresponding author), NIA, Lab Mol Biol & Immunol, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	pat.morin@aacr.org; myriam-gorospe@nih.gov	Abdelmohsen, Kotb/AAX-4191-2020	Abdelmohsen, Kotb/0000-0001-6240-5810	National Institute on Aging-Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000511, ZIAAG000393] Funding Source: NIH RePORTER	National Institute on Aging-Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded entirely by the National Institute on Aging-Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, MOL CELL BIOL, V32, P2530, DOI 10.1128/MCB.00510-12; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; Boominathan L, 2010, NATURE PRECEDINGS, V4252, P1; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen X, 2011, ONCOGENE, V30, P2874, DOI 10.1038/onc.2011.11; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Furlong MT, 2000, GYNECOL ONCOL, V77, P97, DOI 10.1006/gyno.1999.5718; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Grammatikakis I, 2013, INT J MOL SCI, V14, P1822, DOI 10.3390/ijms14011822; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hilliard TS, 2011, ANTI-CANCER DRUG, V22, P978, DOI 10.1097/CAD.0b013e32834ac8fc; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacobs KM, 2012, INT J CELL BIOL, V35, P1052; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2010, ADV EXP MED BIOL, V700, P1, DOI 10.1007/978-1-4419-7823-3_1; Kitano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055289; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Liu SQ, 2004, J MED CHEM, V47, P999, DOI 10.1021/jm030346v; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Marasa BS, 2009, SCI SIGNAL RA, Vra69, P1126; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Stavridi ES, 2004, GENE DEV, V18, P241, DOI 10.1101/gad.1181704; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031240; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com	61	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66330	10.1371/journal.pone.0066330	http://dx.doi.org/10.1371/journal.pone.0066330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840442	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400023
J	Onteru, SK; Gorbach, DM; Young, JM; Garrick, DJ; Dekkers, JCM; Rothschild, MF				Onteru, Suneel K.; Gorbach, Danielle M.; Young, Jennifer M.; Garrick, Dorian J.; Dekkers, Jack C. M.; Rothschild, Max F.			Whole Genome Association Studies of Residual Feed Intake and Related Traits in the Pig	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR MC4R; GENETIC-PARAMETERS; LARGE WHITE; GROWTH-RATE; INSULIN; DUROC; CARCASS; EFFICIENCY; POLYMORPHISMS; SELECTION	Background: Residual feed intake (RFI), a measure of feed efficiency, is the difference between observed feed intake and the expected feed requirement predicted from growth and maintenance. Pigs with low RFI have reduced feed costs without compromising their growth. Identification of genes or genetic markers associated with RFI will be useful for marker-assisted selection at an early age of animals with improved feed efficiency. Methodology/Principal findings: Whole genome association studies (WGAS) for RFI, average daily feed intake (ADFI), average daily gain (ADG), back fat (BF) and loin muscle area (LMA) were performed on 1,400 pigs from the divergently selected ISU-RFI lines, using the Illumina PorcineSNP60 BeadChip. Various statistical methods were applied to find SNPs and genomic regions associated with the traits, including a Bayesian approach using GenSel software, and frequentist approaches such as allele frequency differences between lines, single SNP and haplotype analyses using PLINK software. Single SNP and haplotype analyses showed no significant associations (except for LMA) after genomic control and FDR. Bayesian analyses found at least 2 associations for each trait at a false positive probability of 0.5. At generation 8, the RFI selection lines mainly differed in allele frequencies for SNPs near (<0.05 Mb) genes that regulate insulin release and leptin functions. The Bayesian approach identified associations of genomic regions containing insulin release genes (e. g., GLP1R, CDKAL, SGMS1) with RFI and ADFI, of regions with energy homeostasis (e. g., MC4R, PGM1, GPR81) and muscle growth related genes (e. g., TGFB1) with ADG, and of fat metabolism genes (e. g., ACOXL, AEBP1) with BF. Specifically, a very highly significantly associated QTL for LMA on SSC7 with skeletal myogenesis genes (e. g., KLHL31) was identified for subsequent fine mapping. Conclusions/significance: Important genomic regions associated with RFI related traits were identified for future validation studies prior to their incorporation in marker-assisted selection programs.	[Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA	Iowa State University; Iowa State University	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Garrick, Dorian/Q-3239-2019; Garrick, Dorian/P-9628-2019	Garrick, Dorian/0000-0001-8640-5372	Pfizer Animal Health; National Pork Board; Iowa Pork Producers Association; ISU Center for Integrated Animal Genomics; National Needs Fellowship [2007-38420-17767]; PIC/Genus and Newsham Choice Genetics; College of Agriculture and Life Sciences	Pfizer Animal Health; National Pork Board; Iowa Pork Producers Association; ISU Center for Integrated Animal Genomics; National Needs Fellowship; PIC/Genus and Newsham Choice Genetics; College of Agriculture and Life Sciences	The authors greatly appreciate the financial support provided by Pfizer Animal Health, National Pork Board, Iowa Pork Producers Association, ISU Center for Integrated Animal Genomics, National Needs Fellowship grant no. 2007-38420-17767, PIC/Genus and Newsham Choice Genetics, and the College of Agriculture and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elhamd A, 2009, MECH DEVELOP, V126, P852, DOI 10.1016/j.mod.2009.07.006; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begriche K, 2012, GENES BRAIN BEHAV, V11, P291, DOI 10.1111/j.1601-183X.2012.00766.x; Bejamini Y, 1995, J R STAT SOC B, V57, P287; Boggess M, 2009, PIG GEN 3 C HINXT UK; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; Casey DS, 2005, J ANIM SCI, V83, P969; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Damon M, 2006, J ANIM SCI, V84, P1083, DOI 10.2527/2006.8451083x; Davoli R, 2012, MEAT SCI, V90, P887, DOI 10.1016/j.meatsci.2011.11.025; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fernando R. L., 2008, ANIMAL BREEDING GENE; Flock GB, 2012, DIABETES; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hoque MA, 2007, J ANIM SCI, V85, P1873, DOI 10.2527/jas.2006-730; Hoque MA, 2009, ASIAN AUSTRAL J ANIM, V22, P747, DOI 10.5713/ajas.2009.80467; Johnson ZB, 1999, J ANIM SCI, V77, P1679; JUNG YC, 1989, ANIM GENET, V20, P79; Kim HR, 2009, DEV DYNAM, V238, P56, DOI 10.1002/dvdy.21812; Kim KS, 2006, ANIM GENET, V37, P419, DOI 10.1111/j.1365-2052.2006.01482.x; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Kobayashi T, 2007, FEBS LETT, V581, P3157, DOI 10.1016/j.febslet.2007.05.081; Le NT, 2012, J ANIM SCI; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Li QJ, 2011, HEPATOL RES, V41, P776, DOI 10.1111/j.1872-034X.2011.00827.x; Lin CS, 2005, J ANIM SCI, V83, P2075; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Meuwissen THE, 2001, GENETICS, V157, P1819; MRODE RA, 1993, ANIM PROD, V56, P225, DOI 10.1017/S0003356100021309; Mujibi FDN, 2011, J ANIM SCI, V89, P3353, DOI 10.2527/jas.2010-3361; Nguyen NH, 2005, J ANIM BREED GENET, V122, P264, DOI 10.1111/j.1439-0388.2005.00531.x; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Okamoto K, 2012, DIABETES, V61, P1734, DOI 10.2337/db11-1201; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Onteru SK, 2011, J ANIM SCI, V89, P988, DOI 10.2527/jas.2010-3236; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Piorkowska K, 2010, MEAT SCI, V85, P297, DOI 10.1016/j.meatsci.2010.01.017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2011, R LANG ENV STAT COMP; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Saatchi M, 2012, PLANT AN GEN C 20 JA, pP0552; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strowski MZ, 2009, REGUL PEPTIDES, V157, P19, DOI 10.1016/j.regpep.2009.05.010; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Van den Maagdenberg K, 2007, ANIMAL, V1, P1089, DOI 10.1017/S1751731107000456; VonFelde A, 1996, LIVEST PROD SCI, V47, P11, DOI 10.1016/S0301-6226(96)01006-8; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Young JM, 2011, J ANIM SCI, V89, P639, DOI 10.2527/jas.2010-2892; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zeng J, 2011, THESIS IOWA STATE U	67	89	95	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e61756	10.1371/journal.pone.0061756	http://dx.doi.org/10.1371/journal.pone.0061756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840294	gold, Green Published, Green Submitted			2022-12-25	WOS:000321424400001
J	Beuzelin, C; Evnouchidou, I; Rigolet, P; Cauvet-Burgevin, A; Girard, PM; Dardalhon, D; Culina, S; Gdoura, A; van Endert, P; Francesconi, S				Beuzelin, Clementine; Evnouchidou, Irini; Rigolet, Pascal; Cauvet-Burgevin, Anne; Girard, Pierre-Marie; Dardalhon, Delphine; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter; Francesconi, Stefania			Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEGRADING ENZYME; SIGNAL INTEGRATION; TOR1 FUNCTIONS; ER STRESS; GROWTH; GENE; DEGRADATION; PEPTIDASE; APOPTOSIS	Insulin Degrading Enzyme (IDE) is a protease conserved through evolution with a role in diabetes and Alzheimer's disease. The reason underlying its ubiquitous expression including cells lacking identified IDE substrates remains unknown. Here we show that the fission yeast IDE homologue (Iph1) modulates cellular sensitivity to endoplasmic reticulum (ER) stress in a manner dependent on TORC1 (Target of Rapamycin Complex 1). Reduced sensitivity to tunicamycin was associated with a smaller number of cells undergoing apoptosis. Wild type levels of tunicamycin sensitivity were restored in iph1 null cells when the TORC1 complex was inhibited by rapamycin or by heat inactivation of the Tor2 kinase. Although Iph1 cleaved hallmark IDE substrates including insulin efficiently, its role in the ER stress response was independent of its catalytic activity since expression of inactive Iph1 restored normal sensitivity. Importantly, wild type as well as inactive human IDE complemented gene-invalidated yeast cells when expressed at the genomic locus under the control of iph1(+) promoter. These results suggest that IDE has a previously unknown function unrelated to substrate cleavage, which links sensitivity to ER stress to a pro-survival role of the TORC1 pathway.	[Beuzelin, Clementine; Rigolet, Pascal; Girard, Pierre-Marie; Dardalhon, Delphine; Francesconi, Stefania] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Beuzelin, Clementine; Girard, Pierre-Marie; Dardalhon, Delphine; Francesconi, Stefania] Ctr Univ, CNRS, Unite Mixte Rech 3348, Orsay, France; [Beuzelin, Clementine; Rigolet, Pascal] Univ Paris 11, Orsay, France; [Beuzelin, Clementine; Evnouchidou, Irini; Cauvet-Burgevin, Anne; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Beuzelin, Clementine; Evnouchidou, Irini; Cauvet-Burgevin, Anne; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter] INSERM, U1013, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Francesconi, S (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	stefania.francesconi@curie.fr	van Endert, Peter/R-4606-2017; Evnouchidou, Irini/Z-3072-2019; Rigolet, Pascal/S-8602-2018; Francesconi, Stefania/J-7910-2016	van Endert, Peter/0000-0003-3782-0750; Rigolet, Pascal/0000-0001-6868-4953; girard, pierre-marie/0000-0001-9703-4407; francesconi, stefania/0000-0002-9665-349X	Agence Nationale de la Recherche [05-BLAN-0162]; Juvenile Diabetes Research Foundation [RRG1-2008-555]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by Agence Nationale de la Recherche [05-BLAN-0162] and Juvenile Diabetes Research Foundation [RRG1-2008-555]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper BJ, 2009, YEAST, V26, P595, DOI 10.1002/yea.1709; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eswar N, 2006, CURR PROTOC BIOINFOR, V5; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; GEHM BD, 1991, ENDOCRINOLOGY, V128, P1603, DOI 10.1210/endo-128-3-1603; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kawai M, 2001, CURR GENET, V39, P166; Kim S, 2005, J BIOL CHEM, V280, P27481, DOI 10.1074/jbc.M414192200; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; PERLMAN RK, 1993, J BIOL CHEM, V268, P21538; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHII K, 1986, P NATL ACAD SCI USA, V83, P4147, DOI 10.1073/pnas.83.12.4147; Smeets MFMA, 2003, GENES CELLS, V8, P573, DOI 10.1046/j.1365-2443.2003.00657.x; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Udrisar DP, 2005, EXP BIOL MED, V230, P479; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	48	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67705	10.1371/journal.pone.0067705	http://dx.doi.org/10.1371/journal.pone.0067705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826334	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400167
J	Marques, PI; Ferreira, Z; Martins, M; Figueiredo, J; Silva, DI; Castro, P; Morales-Hojas, R; Simoes-Correia, J; Seixas, S				Marques, Patricia Isabel; Ferreira, Zelia; Martins, Manuella; Figueiredo, Joana; Silva, Diana Isabel; Castro, Patricia; Morales-Hojas, Ramiro; Simoes-Correia, Joana; Seixas, Susana			SERPINA2 Is a Novel Gene with a Divergent Function from SERPINA1	PLOS ONE			English	Article							MUTANT ALPHA(1)-ANTITRYPSIN Z; DETECTING POSITIVE SELECTION; ENDOPLASMIC-RETICULUM; INCLUSION-BODIES; MOLECULAR-BASIS; ALPHA-1-ANTITRYPSIN; DEGRADATION; GLYCOPROTEIN; ORGANIZATION; DEFICIENCY	Serine protease inhibitors (SERPINs) are a superfamily of highly conserved proteins that play a key role in controlling the activity of proteases in diverse biological processes. The SERPIN cluster located at the 14q32.1 region includes the gene coding for SERPINA1, and a highly homologous sequence, SERPINA2, which was originally thought to be a pseudogene. We have previously shown that SERPINA2 is expressed in different tissues, namely leukocytes and testes, suggesting that it is a functional SERPIN. To investigate the function of SERPINA2, we used HeLa cells stably transduced with the different variants of SERPINA2 and SERPINA1 (M1, S and Z) and leukocytes as the in vivo model. We identified SERPINA2 as a 52 kDa intracellular glycoprotein, which is localized at the endoplasmic reticulum (ER), independently of the variant analyzed. SERPINA2 is not significantly regulated by proteasome, proposing that ER localization is not due to misfolding. Specific features of SERPINA2 include the absence of insoluble aggregates and the insignificant response to cell stress, suggesting that it is a non-polymerogenic protein with divergent activity of SERPINA1. Using phylogenetic analysis, we propose an origin of SERPINA2 in the crown of primates, and we unveiled the overall conservation of SERPINA2 and A1. Nonetheless, few SERPINA2 residues seem to have evolved faster, contributing to the emergence of a new advantageous function, possibly as a chymotrypsin-like SERPIN. Herein, we present evidences that SERPINA2 is an active gene, coding for an ER-resident protein, which may act as substrate or adjuvant of ER-chaperones.	[Marques, Patricia Isabel; Ferreira, Zelia; Martins, Manuella; Figueiredo, Joana; Silva, Diana Isabel; Castro, Patricia; Simoes-Correia, Joana; Seixas, Susana] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Marques, Patricia Isabel] Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Ferreira, Zelia] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Figueiredo, Joana] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Morales-Hojas, Ramiro] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [Simoes-Correia, Joana] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Coimbra, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Coimbra	Seixas, S (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sseixas@ipatimup.pt	Seixas, Susana/I-5084-2013; Castro, Patricia/J-8537-2013; Marques, Patricia Isabel/J-9983-2019; Simões Correia, Joana/C-8755-2012; Figueiredo, Joana/J-7305-2013	Seixas, Susana/0000-0002-7035-7422; Marques, Patricia Isabel/0000-0001-6050-628X; Simões Correia, Joana/0000-0003-2623-5628; Figueiredo, Joana/0000-0002-1590-1974; Morales Hojas, Ramiro/0000-0002-4120-5964; MARTINS, Manuella/0000-0003-4490-7125; Castro, Patricia/0000-0001-9588-9065; Worman, Zelia/0000-0002-7619-7466	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-GMG/64043/2006, SFRH/BD/68940/2010, SFRH/BD/45907/2008, SFRH/BD/43763/2008, SFRH/BPD/26553/2006, SFRH/BPD/48765/2008]; POPH-QREN - Promotion of scientific employment; European Social Fund; Ministry of Education and Science	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); POPH-QREN - Promotion of scientific employment; European Social Fund(European Social Fund (ESF)); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Portuguese Foundation for Science and Technology (FCT), project grant to SS - PTDC/SAU-GMG/64043/2006. PIM (SFRH/BD/68940/2010), ZF (SFRH/BD/45907/2008), JF (SFRH/BD/43763/2008), PC (SFRH/BPD/26553/2006), and JSC (SFRH/BPD/48765/2008) are supported by FCT fellowships and funded by POPH-QREN - Promotion of scientific employment, supported by the European Social Fund and national funds of the Ministry of Education and Science. SS and RMH are supported by the programme "Ciencia 2007", financed by the POPH-QREN - Promotion of scientific employment, co-financed by the European Social Fund and national funds of the Ministry of Education and Science. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; [Anonymous], 1997, B WORLD HEALTH ORGAN, V75, P397; Askew DJ, 2007, J BIOL CHEM, V282, P24948, DOI 10.1074/jbc.M703182200; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Dahl M, 2005, EUR RESPIR J, V26, P67, DOI 10.1183/09031936.05.00135704; Davies MJ, 2008, INT J BIOCHEM CELL B, V40, P1273, DOI 10.1016/j.biocel.2007.12.017; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elliott PR, 1996, NAT STRUCT BIOL, V3, P910, DOI 10.1038/nsb1196-910; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Granell S, 2008, AUTOPHAGY, V4, P375, DOI 10.4161/auto.5605; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOFKER MH, 1988, BIOCHEM BIOPH RES CO, V155, P634, DOI 10.1016/S0006-291X(88)80542-4; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Irving JA, 2007, MOL CELLULAR ASPECTS, P1; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Janciauskiene S, 2001, ATHEROSCLEROSIS, V158, P41, DOI 10.1016/S0021-9150(00)00767-X; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; Marsden MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1768; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Seixas S, 2007, MOL BIOL EVOL, V24, P587, DOI 10.1093/molbev/msl187; Seixas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032518; Seo EJ, 2002, J BIOL CHEM, V277, P14216, DOI 10.1074/jbc.M110272200; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stepensky D, 2007, TRAFFIC, V8, P1530, DOI 10.1111/j.1600-0854.2007.00639.x; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	54	4	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66889	10.1371/journal.pone.0066889	http://dx.doi.org/10.1371/journal.pone.0066889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826168	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400079
J	Menchaca, AC; Visi, DK; Strey, OF; Teel, PD; Kalinowski, K; Allen, MS; Williamson, PC				Menchaca, Arturo C.; Visi, David K.; Strey, Otto F.; Teel, Pete D.; Kalinowski, Kevin; Allen, Michael S.; Williamson, Phillip C.			Preliminary Assessment of Microbiome Changes Following Blood-Feeding and Survivorship in the Amblyomma americanum Nymph-to-Adult Transition using Semiconductor Sequencing	PLOS ONE			English	Article							LONE STAR TICK; BACTERIAL DIVERSITY; COMMUNITY; HUMANS; ACARI; TAG	The physiology of ticks supports a diverse community of non-pathogenic and pathogenic organisms. This study aims to initially characterize the microbial community present within colony-reared Amblyomma americanum using PCR of the variable region 5 of the 16S rRNA gene followed by semiconductor sequencing and classification of sequence data using the Ribosomal Database Project and MG-RAST analysis tools. Comparison of amplicon library datasets revealed changes in the microbiomes in newly engorged nymphs, newly-molted adults, and aged adults, as well as ticks exposed to different environmental conditions. These preliminary data support the concept that microbe survivorship and diversity are partially dependent upon environmental variables and the sequence of blood feeding, molting, and aging. The maintenance and/or emergence of pathogens in ticks may be dependent in part on temporal changes in the microbial community of the tick microbiome.	[Visi, David K.; Allen, Michael S.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Visi, David K.; Allen, Michael S.] Univ N Texas, Hlth Sci Ctr, Dept Forens & Investigat Genet, Ft Worth, TX USA; [Strey, Otto F.; Teel, Pete D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kalinowski, Kevin; Allen, Michael S.] Univ N Texas, Texas Hlth Sci, Ctr Learning & Dev, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Health Science Center; Texas A&M University System; Texas A&M University College Station; University of North Texas System; University of North Texas Health Science Center	Allen, MS (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Forens & Investigat Genet, Ft Worth, TX USA.	Michael.Allen@unthsc.edu		Allen, Michael/0000-0003-2293-8078	State of Texas	State of Texas	This work was supported by the State of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Balashov Y. S., 1972, BLOODSUCKING TICKS I; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; CDC, TICK BORN DIS NIOSH; CDC, DISTR STARI; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Clay K., 2010, TICK MICROBIOME DIVE; Drummond R. O., 1987, EC IMPACT PARASITISM; Dykstra EA, 1997, J AM VET MED ASSOC, V210, P360; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; Hair JA, 1986, MORPHOLOGY PHYSL BEH; Heise SR, 2010, J MED ENTOMOL, V47, P258, DOI 10.1603/ME09197; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Jiang J, 2010, VECTOR-BORNE ZOONOT, V10, P329, DOI 10.1089/vbz.2009.0061; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; KOCH HG, 1981, J MED ENTOMOL, V18, P93, DOI 10.1093/jmedent/18.2.93; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Luo YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-386; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Romoser William S., 1996, P298; Shi WB, 2010, INSECT SCI, V17, P199, DOI 10.1111/j.1744-7917.2010.01340.x; Sonenshine DE, 1991, BIOL TICKS, V1, P159; Uchiyama T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00230; Vishnivetskaya TA, 2012, AM SOC MICR 112 GEN; Visi DK, 2013, J IND MICROBIOL BIOT, V40, P465, DOI 10.1007/s10295-013-1242-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Williamson PC, 2010, EMERG INFECT DIS; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12	37	59	59	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67129	10.1371/journal.pone.0067129	http://dx.doi.org/10.1371/journal.pone.0067129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826210	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400107
J	Nogueira-Silva, C; Piairo, P; Carvalho-Dias, E; Veiga, C; Moura, RS; Correia-Pinto, J				Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge			The Role of Glycoprotein 130 Family of Cytokines in Fetal Rat Lung Development	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-11; CILIARY NEUROTROPHIC FACTOR; PROGRAMMED CELL-DEATH; ONCOSTATIN-M; BRANCHING MORPHOGENESIS; FACTOR CNTF; EXPRESSION; GP130; CARDIOTROPHIN-1; MECHANISMS	The glycoprotein 130 (gp130) dependent family of cytokines comprises interleukin-6 (IL-6), IL-11, leukemia inhibitory factor (LIF), cardiotrophin-like cytokine (CLC), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1) and oncostatin M (OSM). These cytokines share the membrane gp130 as a common signal transducer. Recently, it was demonstrated that IL-6 promotes, whereas LIF inhibits fetal lung branching. Thus, in this study, the effects on fetal lung morphogenesis of the other classical members of the gp130-type cytokines (IL-11, CLC, CNTF, CT-1 and OSM) were investigated. We also provide the first description of these cytokines and their common gp130 receptor protein expression patterns during rat lung development. Fetal rat lung explants were cultured in vitro with increasing concentrations of IL-11, CLC, CNTF, CT-1 and OSM. Treated lung explants were morphometrically analyzed and assessed for MAPK, PI3K/AKT and STAT3 signaling modifications. IL-11, which similarly to IL-6 acts through a gp130 homodimer receptor, significantly stimulated lung growth via p38 phosphorylation. On the other hand, CLC, CNTF, CT-1 and OSM, whose receptors are gp130 heterodimers, inhibited lung growth acting in different signal-transducing pathways. Thus, the present study demonstrated that although cytokines of the gp130 family share a common signal transducer, there are specific biological activities for each cytokine on lung development. Indeed, cytokine signaling through gp130 homodimers stimulate, whereas cytokine signaling through gp130 heterodimers inhibit lung branching.	[Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge] Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal; [Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge] 3Bs PT Govt Associate Lab, Life & Hlth Sci Res Inst, Braga, Portugal; [Nogueira-Silva, Cristina] Hosp Braga, Dept Obstet & Gynecol, Braga, Portugal; [Carvalho-Dias, Emanuel] Hosp Braga, Dept Urol, Braga, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Hospital de Braga; Hospital de Braga; Hospital de Braga	Correia-Pinto, J (corresponding author), Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal.	jcp@ecsaude.uminho.pt	Moura, Rute/GYV-3259-2022; Moura, Rute S/B-4208-2011; Nogueira-Silva, Cristina/T-6998-2018; Correia-Pinto, Jorge/B-3344-2012	Moura, Rute S/0000-0003-1763-9014; Nogueira-Silva, Cristina/0000-0001-7273-2911; Correia-Pinto, Jorge/0000-0002-9265-6896; Piairo, Paulina/0000-0003-1905-671X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008, SFRH/BD/33410/2008, SFRH/BPD/15408/2005]; Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008) and by Seccao de Neonatologia da Sociedade Portuguesa de Pediatria (Grant ZERU 2008). PP was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BD/33410/2008). RSM was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BPD/15408/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Carbia-Nagashima A, 2004, IUBMB LIFE, V56, P83, DOI 10.1080/15216540410001668064; Castro CP, 2001, J ENDOCRINOL, V169, P539, DOI 10.1677/joe.0.1690539; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; de Bovis Beatrice, 2005, Cell Commun Signal, V3, P1, DOI 10.1186/1478-811X-3-1; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; Dickinson EC, 2000, J PEDIATR SURG, V35, P1079, DOI 10.1053/jpsu.2000.7826; Du XX, 1996, J CELL PHYSIOL, V168, P362; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Hata K, 2002, NEUROREPORT, V13, P735, DOI 10.1097/00001756-200204160-00039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Imamura M, 2007, EXP CELL RES, V313, P1951, DOI 10.1016/j.yexcr.2007.03.010; Jougasaki M, 2010, ADV CLIN CHEM, V52, P41, DOI 10.1016/S0065-2423(10)52002-X; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Knight DA, 2003, PHARMACOL THERAPEUT, V99, P327, DOI 10.1016/S0163-7258(03)00095-0; Kovanen PE, 1999, CURR BIOL, V9, pR899, DOI 10.1016/S0960-9822(00)80079-2; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Levesque BM, 2000, PEDIATR RES, V47, P481, DOI 10.1203/00006450-200004000-00012; Lopez N, 2006, J MOL CELL CARDIOL, V41, P902, DOI 10.1016/j.yjmcc.2006.03.433; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Minshall E, 2000, J ALLERGY CLIN IMMUN, V105, P232, DOI 10.1016/S0091-6749(00)90070-8; Morikawa Yoshihiro, 2005, Anatomical Science International, V80, P53, DOI 10.1111/j.1447-073x.2005.00100.x; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Murakami M, 2004, GROWTH FACTORS, V22, P75, DOI 10.1080/08977190410001715181; Nogueira-Silva C, 2008, PEDIATR PULM, V43, P680, DOI 10.1002/ppul.20840; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Ohta M, 1996, BIOCHEM MOL BIOL INT, V40, P671; Opal SM, 2003, J INFECT DIS, V187, P70, DOI 10.1086/345864; Ozog MA, 2002, CANCER RES, V62, P3544; Sango K, 2008, HISTOCHEM CELL BIOL, V130, P669, DOI 10.1007/s00418-008-0484-x; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Stejskal D, 2008, BIOMED PAP, V152, P9, DOI 10.5507/bp.2008.002; Stiles AD, 2001, EXP LUNG RES, V27, P569; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Taylor BK, 2000, AM J PHYSIOL-LUNG C, V278, pL1062, DOI 10.1152/ajplung.2000.278.5.L1062; Uemura A, 2002, CYTOKINE, V18, P1, DOI 10.1006/cyto.2002.1006; Vlotides G, 2004, CYTOKINE GROWTH F R, V15, P325, DOI 10.1016/j.cytogfr.2004.04.002; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Wang RJ, 2006, WORLD J GASTROENTERO, V12, P3055, DOI 10.3748/wjg.v12.i19.3055; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Waxman AB, 1998, J CLIN INVEST, V101, P1970, DOI 10.1172/JCI1337; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; White UA, 2011, CURR PHARM DESIGN, V17, P340; White UA, 2010, BIOCHEM BIOPH RES CO, V395, P48, DOI 10.1016/j.bbrc.2010.03.132; Wongtrakool C, 2008, EXP LUNG RES, V34, P481, DOI 10.1080/01902140802271842; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Zheng T, 2001, J ALLERGY CLIN IMMUN, V108, P489; Zhou DY, 2003, BRIT J PHARMACOL, V140, P1237, DOI 10.1038/sj.bjp.0705562	55	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67607	10.1371/journal.pone.0067607	http://dx.doi.org/10.1371/journal.pone.0067607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826327	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400163
J	Renicke, C; Spadaccini, R; Taxis, C				Renicke, Christian; Spadaccini, Roberta; Taxis, Christof			A Tobacco Etch Virus Protease with Increased Substrate Tolerance at the P1' position	PLOS ONE			English	Article							SITE-SPECIFIC PROTEASES; END RULE PATHWAY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; YEAST; UBIQUITIN; SPECIFICITY; SYSTEM; DEGRADATION; PROTEOLYSIS	Site-specific proteases are important tools for in vitro and in vivo cleavage of proteins. They are widely used for diverse applications, like protein purification, assessment of protein-protein interactions or regulation of protein localization, abundance or activity. Here, we report the development of a procedure to select protease variants with altered specificity based on the well-established Saccharomyces cerevisiae adenine auxotrophy-dependent red/white colony assay. We applied this method on the tobacco etch virus (TEV) protease to obtain a protease variant with altered substrate specificity at the P1' Position. In vivo experiments with tester substrates showed that the mutated TEV protease still efficiently recognizes the sequence ENLYFQ, but has almost lost all bias for the amino acid at the P1' Position. Thus, we generated a site-specific protease for synthetic approaches requiring in vivo generation of proteins or peptides with a specific N-terminal amino acid.	[Renicke, Christian; Taxis, Christof] Univ Marburg, Dept Biol Genet, Marburg, Germany; [Spadaccini, Roberta] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy	Philipps University Marburg; University of Sannio	Taxis, C (corresponding author), Univ Marburg, Dept Biol Genet, Marburg, Germany.	taxis@biologie.uni-marburg.de	Renicke, Christian/AAG-8487-2019; Taxis, Christof/P-6188-2019; Taxis, Christof/AAP-7408-2021	Renicke, Christian/0000-0003-3226-9840; Taxis, Christof/0000-0001-5952-7091; SPADACCINI, Roberta/0000-0002-2262-1065	DFG [GK1216];  [TA320/3-1]	DFG(German Research Foundation (DFG)); 	This work was supported by the DFG grants GK1216 "Intra- and Intercellular Transport and Communication" and TA320/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Barbour Leslie, 2006, Methods Mol Biol, V313, P161; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Cottier V, 2006, ANTIMICROB AGENTS CH, V50, P565, DOI 10.1128/AAC.50.2.565-571.2006; Dunkler A, 2012, METHODS MOL BIOL, V786, P115, DOI 10.1007/978-1-61779-292-2_7; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Henrichs T, 2005, P NATL ACAD SCI USA, V102, P4246, DOI 10.1073/pnas.0408520102; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jungbluth M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-176; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kim SY, 2000, ANAL BIOCHEM, V284, P42, DOI 10.1006/abio.2000.4662; MCGREW JT, 1989, YEAST, V5, P271, DOI 10.1002/yea.320050407; Moore DD, 1995, GLOB MOB SURV; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; O'Loughlin TL, 2006, MOL BIOL EVOL, V23, P764, DOI 10.1093/molbev/msj098; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Renicke C, 2013, CHEM BIOL, V20, P619, DOI 10.1016/j.chembiol.2013.03.005; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sices HJ, 1998, P NATL ACAD SCI USA, V95, P2828, DOI 10.1073/pnas.95.6.2828; SIKORSKI RS, 1989, GENETICS, V122, P19; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sun P, 2010, PROTEIN SCI, V19, P2240, DOI 10.1002/pro.506; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verhoeven KD, 2012, APPL BIOCHEM BIOTECH, V166, P1340, DOI 10.1007/s12010-011-9522-6; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200	43	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67915	10.1371/journal.pone.0067915	http://dx.doi.org/10.1371/journal.pone.0067915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826349	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400174
J	Tao, Y; Gao, L; Wu, XS; Wang, HM; Yang, G; Zhan, FH; Shi, JM				Tao, Yi; Gao, Lu; Wu, Xiaosong; Wang, Hongmei; Yang, Guang; Zhan, Fenghuang; Shi, Jumei			Down-Regulation of 11 beta-Hydroxysteroid Dehydrogenase Type 2 by Bortezomib Sensitizes Jurkat Leukemia T Cells against Glucocorticoid-Induced Apoptosis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CARCINOMA-CELLS; HUMAN PITUITARY; EXPRESSION; RECEPTOR; RESISTANCE; PROLIFERATION; MODULATION; INHIBITOR; DETERMINANT	11 beta-hydroxysteroid dehydrogenases type 2 (11 beta-HSD2), a key regulator for pre-receptor metabolism of glucocorticoids (GCs) by converting active GC, cortisol, to inactive cortisone, has been shown to be present in a variety of tumors. But its expression and roles have rarely been discussed in hematological malignancies. Proteasome inhibitor bortezomib has been shown to not only possess antitumor effects but also potentiate the activity of other chemotherapeutics. In this study, we demonstrated that 11 beta-HSD2 was highly expressed in two GC-resistant T-cell leukemic cell lines Jurkat and Molt4. In contrast, no 11 beta-HSD2 expression was found in two GC-sensitive non-hodgkin lymphoma cell lines Daudi and Raji as well as normal peripheral blood T cells. Inhibition of 11 beta-HSD2 by 11 beta-HSD inhibitor 18 beta-glycyrrhetinic acid or 11 beta-HSD2 shRNA significantly increased cortisol-induced apoptosis in Jurkat cells. Additionally, pretreatment of Jurkat cells with low-dose bortezomib resulted in increased cellular sensitivity to GC as shown by elevated induction of apoptosis, more cells arrested at G1 stage and up-regulation of GC-induced leucine zipper which is an important mediator of GC action. Furthermore, we clarified that bortezomib could dose-dependently inhibit 11 beta-HSD2 messenger RNA and protein levels as well as activity (cortisol-cortisone conversion) through p38 mitogen-activated protein kinase signaling pathway. Therefore, we suggest 11 beta-HSD2 is, at least partially if not all, responsible for impaired GC suppression in Jurkat cells and also indicate a novel mechanism by which proteasome inhibitor bortezomib may influence GC action.	[Tao, Yi; Wu, Xiaosong; Wang, Hongmei; Yang, Guang; Shi, Jumei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Hematol, Shanghai 200092, Peoples R China; [Gao, Lu] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	Tongji University; Naval Medical University; University of Iowa	Shi, JM (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Hematol, Shanghai 200092, Peoples R China.	shijumei@hotmail.com		Tao, Yi/0000-0002-7361-6063; Zhan, Fenghuang/0000-0001-6208-1676; Tao, Yi/0000-0002-0749-6614	National Natural Science Foundation of China [81071856, 30973450]; Joint Research Fund for Overseas, Hong Kong and Macao Scholars [81228016]; Shanghai Pujiang Program [11PJ1407900]; Shanghai Tenth People's Hospital Funds [12RQ112, 10RD103, 11SC103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Fund for Overseas, Hong Kong and Macao Scholars; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Tenth People's Hospital Funds	1. National Natural Science Foundation of China (No. 81071856 and 30973450 to JS), (http://www.nsfc.gov.cn/). 2. Joint Research Fund for Overseas, Hong Kong and Macao Scholars(No. 81228016 to FZ and JS), (http://www.nsfc.gov.cn/). 3. Shanghai Pujiang Program (No. 11PJ1407900 to JS), (http://www.stcsm.gov.cn). 4. Shanghai Tenth People's Hospital Funds (No. 12RQ112 to YT, No. 10RD103 and 11SC103 to JS), (http://www.shdsyy.com.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYROLDI E, 2009, FASEB J; Beesley AH, 2009, LEUKEMIA RES, V33, P321, DOI 10.1016/j.leukres.2008.08.007; Dasmahapatra G, 2006, LEUKEMIA RES, V30, P1263, DOI 10.1016/j.leukres.2006.01.005; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Eyre LJ, 2001, J CELL BIOCHEM, V81, P453, DOI 10.1002/1097-4644(20010601)81:3<453::AID-JCB1059>3.0.CO;2-Z; Fiskus W, 2011, CLIN CANCER RES, V17, P7347, DOI 10.1158/1078-0432.CCR-11-1541; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Goecke IA, 2007, MOL IMMUNOL, V44, P2115, DOI 10.1016/j.molimm.2006.07.303; Hennebold JD, 1996, AM J PHYSIOL-REG I, V270, pR1296, DOI 10.1152/ajpregu.1996.270.6.R1296; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Lauten M, 2003, HAEMATOLOGICA, V88, P1253; Leung DYM, 1997, ANN ALLERG ASTHMA IM, V79, P197, DOI 10.1016/S1081-1206(10)63003-7; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; Pacha J, 2002, STEROIDS, V67, P119, DOI 10.1016/S0039-128X(01)00143-X; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Rabbitt EH, 2002, FASEB J, V16, P36, DOI 10.1096/fj.01-0582com; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Riml S, 2004, CELL DEATH DIFFER, V11, pS65, DOI 10.1038/sj.cdd.4401413; Sai S, 2011, LEUKEMIA RES, V35, P1644, DOI 10.1016/j.leukres.2011.07.002; Schmidt S, 2006, FASEB J, V20, P2600, DOI 10.1096/fj.06-6214fje; Shang YL, 2012, AMINO ACIDS, V42, P1879, DOI 10.1007/s00726-011-0907-1; Sharma A, 2009, ENDOCRINOLOGY, V150, P4278, DOI 10.1210/en.2009-0479; Stewart PM, 1999, VITAM HORM, V57, P249; Tanaka T, 2006, EXP HEMATOL, V34, P1542, DOI 10.1016/j.exphem.2006.06.018; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Yang F, 2012, CANCER BIOL THER, V13, P349, DOI 10.4161/cbt.19239; Zhou X, 2011, MOL CARCINOG	34	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67067	10.1371/journal.pone.0067067	http://dx.doi.org/10.1371/journal.pone.0067067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826195	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400100
J	Yip, C; Ignjatovic, V; Attard, C; Monagle, P; Linden, MD				Yip, Christina; Ignjatovic, Vera; Attard, Chantal; Monagle, Paul; Linden, Matthew D.			First Report of Elevated Monocyte-Platelet Aggregates in Healthy Children	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; SURFACE P-SELECTIN; TISSUE FACTOR; TYROSINE PHOSPHORYLATION; REFERENCE VALUES; FLOW-CYTOMETRY; WHOLE-BLOOD; NEUTROPHILS; ACTIVATION; ADHESION	Platelets are subcellular fragments which circulate in blood and have well established roles in thrombosis and haemostasis in adults. Upon activation, platelets undergo granule exocytosis and express P-Selectin on the cell membrane which binds a ligand on monocytes, leading to monocyte-platelet aggregation. Elevated circulating monocyte-platelet aggregates in adults are linked to atherothrombosis, but have not been investigated in children where thrombosis is less common. This study aimed to measure monocyte-platelet aggregate formation in children using whole blood flow cytometry. Monocyte-platelet aggregates as well as activation and granule exocytosis of platelets were measured in healthy adults (n = 15, median age 28 years) and healthy children (n = 28, median age 7 years). Monocyte-platelet aggregates in healthy children were elevated compared to healthy adults (37.8 +/- 4.4% vs 15.5 +/- 1.9% respectively, p<0.01). However, this was not accompanied by any difference in platelet activation (PAC-1 binding 6.8 +/- 1.5% vs 6.3 +/- 2.0% respectively, p = ns) or granule exocytosis (P-selectin expression 4.4 +/- 0.5% vs 3.1 +/- 0.5% respectively, p = ns). Despite comparable numbers of platelets bound per monocyte (GPIb MFI 117.3 +/- 13.7 vs 130.9 +/- 28.6 respectively, p = ns), surface P-selectin expression per platelet-bound monocyte was lower in children compared to adults. We therefore provide the first data of elevated monocyte-platelet aggregates in healthy children.	[Yip, Christina] RMIT Univ, Sch Med Sci, Melbourne, Vic 3001, Australia; [Yip, Christina; Ignjatovic, Vera; Attard, Chantal; Monagle, Paul] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ignjatovic, Vera; Monagle, Paul] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Monagle, Paul] Royal Childrens Hosp, Dept Clin Haematol, Melbourne, Vic, Australia; [Linden, Matthew D.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia	Royal Melbourne Institute of Technology (RMIT); Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of Western Australia	Linden, MD (corresponding author), Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia.	matthew.linden@uwa.edu.au	Ignjatovic, Vera/F-8598-2011; Linden, Matthew D/G-9644-2012; Attard, Chantal/AAB-8406-2019	Linden, Matthew D/0000-0002-9126-2166; Attard, Chantal/0000-0002-4428-1663; Monagle, Paul/0000-0002-3970-8984; Ignjatovic, Vera/0000-0002-5548-5813	Royal Melbourne Institute of Technology University; Murdoch Childrens Research Institute	Royal Melbourne Institute of Technology University; Murdoch Childrens Research Institute	This work was supported by internal project funding provided by Royal Melbourne Institute of Technology University and the Murdoch Childrens Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard MR, 2005, J THROMB HAEMOST, V3, P2563, DOI 10.1111/j.1538-7836.2005.01603.x; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Blanks JE, 1998, EUR J IMMUNOL, V28, P433, DOI 10.1002/(SICI)1521-4141(199802)28:02<433::AID-IMMU433>3.0.CO;2-U; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Chapman LM, 2012, J IMMUNOL, V189, P916, DOI 10.4049/jimmunol.1200580; Christersson C, 2008, J THROMB HAEMOST, V6, P986, DOI 10.1111/j.1538-7836.2008.02956.x; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; FURIE B, 1995, THROMB HAEMOSTASIS, V74, P224; Gawaz M, 2006, BLOOD CELL MOL DIS, V36, P206, DOI 10.1016/j.bcmd.2005.12.022; HAMBURGER SA, 1990, BLOOD, V75, P550; Haselboeck J, 2012, ANN HEMATOL, V91, P109, DOI 10.1007/s00277-011-1249-5; Hezard N, 2003, THROMB HAEMOSTASIS, V90, P116, DOI 10.1055/s-0037-1613607; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Hoffman R.A., 2005, CURRENT PROTOCOLS CY; Ignjatovic V, 2012, PEDIATR CARDIOL, V33, P55, DOI 10.1007/s00246-011-0079-5; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Lanza GA, 2011, EUR HEART J, V32, P2042, DOI 10.1093/eurheartj/ehr109; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Linden MD, 2007, J THROMB HAEMOST, V5, P761, DOI 10.1111/j.1538-7836.2007.02462.x; Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012; Linden MD, 2006, CONTEMP CARDIOL, P487, DOI 10.1007/978-1-59745-051-5_28; Linden MD, 2004, SEMIN THROMB HEMOST, V30, P501, DOI 10.1055/s-2004-835671; Linden MD, 2005, CONT CARDIOLOGY CARD, P487; Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Newall F, 2003, J PAEDIATR CHILD H, V39, P289, DOI 10.1046/j.1440-1754.2003.00139.x; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Ponthieux A, 2003, CLIN CHEM, V49, P1544, DOI 10.1373/49.9.1544; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Smith TL, 2011, THROMB RES, V127, P391, DOI 10.1016/j.thromres.2010.10.013; Totani L, 2010, ARTERIOSCL THROM VAS, V30, P2357, DOI 10.1161/ATVBAHA.110.207480; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742	36	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67416	10.1371/journal.pone.0067416	http://dx.doi.org/10.1371/journal.pone.0067416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826296	Green Published, gold			2022-12-25	WOS:000321738400144
J	Zheng, Q; Hou, R; Zhang, JY; Ma, JW; Wu, ZS; Wang, GH; Wang, CF; Xu, JR				Zheng, Qian; Hou, Rui; Zhang, Juanyu; Ma, Jiwen; Wu, Zhongshou; Wang, Guanghui; Wang, Chenfang; Xu, Jin-Rong			The MAT Locus Genes Play Different Roles in Sexual Reproduction and Pathogenesis in Fusarium graminearum	PLOS ONE			English	Article							NEUROSPORA-CRASSA; FUNCTIONAL ANALYSES; SIGNALING PATHWAY; CELL-TYPE; GIBBERELLA; PROTEIN; ORGANIZATION; EVOLUTION; FUSION; KINASE	Sexual reproduction plays a critical role in the infection cycle of Fusarium graminearum because ascospores are the primary inoculum. As a homothallic ascomycete, F. graminearum contains both the MAT1-1 and MAT1-2-1 loci in the genome. To better understand their functions and regulations in sexual reproduction and pathogenesis, in this study we assayed the expression, interactions, and mutant phenotypes of individual MAT locus genes. Whereas the expression of MAT1-1-1 and MAT12-1 rapidly increased after perithecial induction and began to decline after 1 day post-perithecial induction (dpi), the expression of MAT1-1-2 and MAT1-1-3 peaked at 4 dpi. MAT1-1-2 and MAT1-1-3 had a similar expression profile and likely are controlled by a bidirectional promoter. Although none of the MAT locus genes were essential for perithecium formation, all of them were required for ascosporogenesis in self-crosses. In outcrosses, the mat11-1-2 and mat11-1-3 mutants were fertile but the mat1-1-1 and mat1-2-1 mutants displayed male-and female-specific defects, respectively. The mat1-2-1 mutant was reduced in FgSO expression and hyphal fusion. Mat1-1-2 interacted with all other MAT locus transcription factors, suggesting that they may form a protein complex during sexual reproduction. Mat1-1-1 also interacted with FgMcm1, which may play a role in controlling cell identity and sexual development. Interestingly, the mat1-1-1 and mat1-2-1 mutants were reduced in virulence in corn stalk rot assays although none of the MAT locus genes was important for wheat infection. The MAT1-1-1 and MAT1-2-1 genes may play a host-specific role in colonization of corn stalks.	[Zheng, Qian; Hou, Rui; Zhang, Juanyu; Ma, Jiwen; Wu, Zhongshou; Wang, Guanghui; Wang, Chenfang] Northwest Agr & Forestry Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hou, Rui; Wang, Guanghui; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xu, JR (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu		Wu, Zhongshou/0000-0001-6687-1675	National Major Project of Breeding for New Transgenic Organisms [2012ZX08009003]; National Basic Research Program of China [2012CB114002, 2013CB127703]; USDA-NIFA [2010 65110 20439]	National Major Project of Breeding for New Transgenic Organisms; National Basic Research Program of China(National Basic Research Program of China); USDA-NIFA(United States Department of Agriculture (USDA))	This work was supported the National Major Project of Breeding for New Transgenic Organisms (2012ZX08009003), the National Basic Research Program of China (2012CB114002; 2013CB127703), and a grant from the USDA-NIFA (2010 65110 20439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Badgett TC, 1999, P FUNGAL GENET C, V20, P127; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; da Silva CC, 2009, GENET MOL BIOL, V32, P354, DOI 10.1590/S1415-47572009000200023; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Ferreira AVB, 1996, MOL GEN GENET, V250, P767, DOI 10.1007/BF02172989; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Gelli A, 2002, MOL MICROBIOL, V46, P845, DOI 10.1046/j.1365-2958.2002.03213.x; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HAMER JE, 1987, MOL CELL BIOL, V7, P2352, DOI 10.1128/MCB.7.7.2352; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jacobsen S, 2002, CURR GENET, V41, P150, DOI 10.1007/s00294-002-0276-0; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Kim HK, 2008, FUNGAL GENET BIOL, V45, P1188, DOI 10.1016/j.fgb.2008.05.008; Kim HK, 2012, FEMS MICROBIOL LETT, V337, P89, DOI 10.1111/1574-6968.12012; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Lee J, 2003, MOL MICROBIOL, V50, P145, DOI 10.1046/j.1365-2958.2003.03694.x; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li YM, 2011, MOL PLANT MICROBE IN, V24, P487, DOI 10.1094/MPMI-10-10-0233; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Morohashi N, 2006, EUKARYOT CELL, V5, P1925, DOI 10.1128/EC.00105-06; Nolting N, 2006, EUKARYOT CELL, V5, P1043, DOI 10.1128/EC.00086-06; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; PHILLEY ML, 1994, GENETICS, V137, P715; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Schmelz EA, 2011, P NATL ACAD SCI USA, V108, P5455, DOI 10.1073/pnas.1014714108; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Tsong Annie E., 2007, P75; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Wang GY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051764, 10.1371/journal.pone.0039700, 10.1371/journal.pone.0047051]; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x; Zheng DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049495; Zhong HL, 1999, GENOME RES, V9, P1040, DOI 10.1101/gr.9.11.1040; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	52	60	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66980	10.1371/journal.pone.0066980	http://dx.doi.org/10.1371/journal.pone.0066980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826182	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400091
J	Liu, ZQ; Wen, XY; Wang, HB; Zhou, J; Zhao, MG; Lin, QX; Wang, Y; Li, JJ; Li, DX; Du, ZY; Yao, AN; Cao, F; Wang, CY				Liu, Zhiqiang; Wen, Xinyu; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Cao, Feng; Wang, Changyong			Molecular Imaging of Induced Pluripotent Stem Cell Immunogenicity with In Vivo Development in Ischemic Myocardium	PLOS ONE			English	Article							INFARCTED MYOCARDIUM; CARDIAC DIFFERENTIATION; IPS CELLS; CARDIOMYOCYTES; TRANSPLANTATION; ENGRAFTMENT; SURVIVAL; PROLIFERATION; OPTIMIZATION; FIBROBLASTS	Whether differentiation of induced pluripotent stem cells (iPSCs) in ischemic myocardium enhances their immunogenicity, thereby increasing their chance for rejection, is unclear. Here, we dynamically demonstrated the immunogenicity and rejection of iPSCs in ischemic myocardium using bioluminescent imaging (BLI). Murine iPSCs were transduced with a tri-fusion (TF) reporter gene consisting of firefly luciferase-red fluorescent protein-truncated thymidine kinase (fluc-mrfp-tTK). Ascorbic acid (Vc) were used to induce iPSCs to differentiate into cardiomyocytes (CM). iPSCs and iPS-CMs were intramyocardially injected into immunocompetent or immunosuppressed allogenic murine with myocardial infarction. BLI was performed to track transplanted cells. Immune cell infiltration was evaluated by immunohistochemistry. Syngeneic iPSCs were also injected and evaluated. The results demonstrated that undifferentiated iPSCs survived and proliferated in allogenic immunocompetent recipients early post-transplantation, accompanying with mild immune cell infiltration. With in vivo differentiation, a progressive immune cell infiltration could be detected. While transplantation of allogenic iPSC-CMs were observed an acute rejection from receipts. In immune-suppressed recipients, the proliferation of iPSCs could be maintained and intramyocardial teratomas were formed. Transplantation of syngeneic iPSCs and iPSC-CMs were also observed progressive immune cell infiltration. This study demonstrated that iPSC immunogenicity increases with in vivo differentiation, which will increase their chance for rejection in iPSC-based therapy.	[Liu, Zhiqiang; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Wang, Changyong] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China; [Liu, Zhiqiang; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Wang, Changyong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing, Peoples R China; [Wen, Xinyu] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China; [Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shanxi, Peoples R China; [Zhao, Mengge] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Michigan State University	Wang, CY (corresponding author), Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China.	wcy2000_te@yahoo.com	Li, Junjie/B-7068-2012	Li, Junjie/0000-0003-2152-6952	National Natural Science Foundation of China [31030032, 81101160]; National Key Basic Research and Development Program of China [2011CB606206]; National Natural Science Funds for Distinguished Young Scholar [31125013]; National High Technology Research and Development Program of China [2012AA020506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 31030032), National Key Basic Research and Development Program of China (No. 2011CB606206), National Natural Science Funds for Distinguished Young Scholar (No. 31125013), National High Technology Research and Development Program of China (No. 2012AA020506), and National Natural Science Foundation of China (No. 81101160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2003, TRANSPLANTATION, V76, P1061, DOI 10.1097/01.TP.0000090342.85649.81; Asgari S, 2010, J HEPATOL, V53, P738, DOI 10.1016/j.jhep.2010.05.009; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chan SSK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014414; Crescini E, 2013, BBA-MOL CELL RES, V1833, P140, DOI 10.1016/j.bbamcr.2012.06.024; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Huang JY, 2009, CELL RES, V19, P1127, DOI 10.1038/cr.2009.106; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Ou DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055233; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Qiao H, 2009, RADIOLOGY, V250, P821, DOI 10.1148/radiol.2503080205; Smith AJ, 2012, STEM CELL TRANSL MED, V1, P709, DOI 10.5966/sctm.2012-0066; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Vazquez-Martin A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00964; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou R, 2006, J AM COLL CARDIOL, V48, P2094, DOI 10.1016/j.jacc.2006.08.026	37	12	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66369	10.1371/journal.pone.0066369	http://dx.doi.org/10.1371/journal.pone.0066369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840453	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800053
J	Shi, H; Qi, XB; Zhong, H; Peng, Y; Zhang, XM; Ma, RZL; Su, B				Shi, Hong; Qi, Xuebin; Zhong, Hua; Peng, Yi; Zhang, Xiaoming; Ma, Runlin Z.; Su, Bing			Genetic Evidence of an East Asian Origin and Paleolithic Northward Migration of Y-chromosome Haplogroup N	PLOS ONE			English	Article							DIVERGENCE TIME; NORTHERN ROUTE; MODERN HUMANS; POPULATIONS; RESOLUTION; HERITAGE; JAPANESE; POLYMORPHISMS; PERSPECTIVE; SETTLEMENT	The Y-chromosome haplogroup N-M231 (Hg N) is distributed widely in eastern and central Asia, Siberia, as well as in eastern and northern Europe. Previous studies suggested a counterclockwise prehistoric migration of Hg N from eastern Asia to eastern and northern Europe. However, the root of this Y chromosome lineage and its detailed dispersal pattern across eastern Asia are still unclear. We analyzed haplogroup profiles and phylogeographic patterns of 1,570 Hg N individuals from 20,826 males in 359 populations across Eurasia. We first genotyped 6,371 males from 169 populations in China and Cambodia, and generated data of 360 Hg N individuals, and then combined published data on 1,210 Hg N individuals from Japanese, Southeast Asian, Siberian, European and Central Asian populations. The results showed that the sub-haplogroups of Hg N have a distinct geographical distribution. The highest Y-STR diversity of the ancestral Hg N sub-haplogroups was observed in the southern part of mainland East Asia, and further phylogeographic analyses supports an origin of Hg N in southern China. Combined with previous data, we propose that the early northward dispersal of Hg N started from southern China about 21 thousand years ago (kya), expanding into northern China 12-18 kya, and reaching further north to Siberia about 12-14 kya before a population expansion and westward migration into Central Asia and eastern/northern Europe around 8.0-10.0 kya. This northward migration of Hg N likewise coincides with retreating ice sheets after the Last Glacial Maximum (22-18 kya) in mainland East Asia.	[Shi, Hong; Qi, Xuebin; Zhong, Hua; Peng, Yi; Zhang, Xiaoming; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhong, Hua; Ma, Runlin Z.] Chinese Acad Sci, Ctr Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Zhang, Xiaoming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, H (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shihong@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Zhang, Xiaoming/AFS-9807-2022; peng, yi/J-5500-2019; Zhong, Hua/C-1262-2017; Xuebin, Qi/L-7139-2019; peng, yi/AAR-8853-2020	Zhang, Xiaoming/0000-0003-3139-2361; 	National 973 Program of China [2012CBA01303, 2012CB518202]; National Natural Science Foundation of China [91131001, 31071101, 91231203]; Natural Science Foundation of Yunnan Province [2009CD107, 2010CI044]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was supported by the National 973 Program of China (2012CBA01303 to HS; 2012CB518202 to XQ), the National Natural Science Foundation of China (91131001 and 31071101 to HS; 91231203 to BS) and the Natural Science Foundation of Yunnan Province (2009CD107 and 2010CI044 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Derenko M, 2007, J HUM GENET, V52, P763, DOI 10.1007/s10038-007-0179-5; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Nonaka I, 2007, ANN HUM GENET, V71, P480, DOI 10.1111/j.1469-1809.2006.00343.x; Peakall R., 2012, BIOINFORMATICS; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	35	29	33	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66102	10.1371/journal.pone.0066102	http://dx.doi.org/10.1371/journal.pone.0066102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840409	gold, Green Submitted, Green Published			2022-12-25	WOS:000322342800032
J	Valdez-Velazquez, LL; Quintero-Hernandez, V; Romero-Gutierrez, MT; Coronas, FIV; Possani, LD				Valdez-Velazquez, Laura L.; Quintero-Hernandez, Veronica; Teresa Romero-Gutierrez, Maria; Coronas, Fredy I. V.; Possani, Lourival D.			Mass Fingerprinting of the Venom and Transcriptome of Venom Gland of Scorpion Centruroides tecomanus	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; TITYUS-SERRULATUS SCORPIONES; RICH ANTIMICROBIAL PEPTIDES; MEXICAN SCORPION; SPECTROMETRY ANALYSIS; MOLECULAR DIVERSITY; PROTEOMIC ANALYSIS; BETA-TOXINS; CHANNELS; PURIFICATION	Centruroides tecomanus is a Mexican scorpion endemic of the State of Colima, that causes human fatalities. This communication describes a proteome analysis obtained from milked venom and a transcriptome analysis from a cDNA library constructed from two pairs of venom glands of this scorpion. High perfomance liquid chromatography separation of soluble venom produced 80 fractions, from which at least 104 individual components were identified by mass spectrometry analysis, showing to contain molecular masses from 259 to 44,392 Da. Most of these components are within the expected molecular masses for Na+- and K+-channel specific toxic peptides, supporting the clinical findings of intoxication, when humans are stung by this scorpion. From the cDNA library 162 clones were randomly chosen, from which 130 sequences of good quality were identified and were clustered in 28 contigs containing, each, two or more expressed sequence tags (EST) and 49 singlets with only one EST. Deduced amino acid sequence analysis from 53% of the total ESTs showed that 81% (24 sequences) are similar to known toxic peptides that affect Na+-channel activity, and 19% (7 unique sequences) are similar to K+-channel especific toxins. Out of the 31 sequences, at least 8 peptides were confirmed by direct Edman degradation, using components isolated directly from the venom. The remaining 19%, 4%, 4%, 15% and 5% of the ESTs correspond respectively to proteins involved in cellular processes, antimicrobial peptides, venom components, proteins without defined function and sequences without similarity in databases. Among the cloned genes are those similar to metalloproteinases.	[Valdez-Velazquez, Laura L.; Teresa Romero-Gutierrez, Maria] Univ Colima, Fac Ciencias Quim, Colima, Mexico; [Valdez-Velazquez, Laura L.; Teresa Romero-Gutierrez, Maria] Univ Colima, Fac Med, Colima, Mexico; [Quintero-Hernandez, Veronica; Coronas, Fredy I. V.; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad de Colima; Universidad de Colima; Universidad Nacional Autonoma de Mexico	Possani, LD (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	possani@ibt.unam.mx	Valdez-Velazquez, Laura L/AAM-1280-2021	Valdez-Velazquez, Laura L/0000-0001-8474-1495; Romero-Gutierrez, Teresa/0000-0002-4882-7491; Quintero-Hernandez, Veronica/0000-0002-1856-8134	Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) [IN2000113]; SEP-CONACyT [153496]	Direccion General de Asuntos del Personal Academico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially financed by grants from Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) number IN2000113 and SEP-CONACyT number 153496 to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Batista CVF, 2007, COMP BIOCHEM PHYS C, V146, P147, DOI 10.1016/j.cbpc.2006.12.004; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; BECERRIL B, 1993, GENE, V128, P165, DOI 10.1016/0378-1119(93)90559-L; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CESTELE S, 1995, J BIOL CHEM, V270, P15153, DOI 10.1074/jbc.270.25.15153; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chowell G, 2006, TOXICON, V47, P753, DOI 10.1016/j.toxicon.2006.02.004; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega R.C.R., 2013, HDB BIOL ACT PEPT, P423, DOI [10.1016/B978-0-12-385095-9.00059-2, DOI 10.1016/B978-0-12-385095-9.00059-2]; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; DehesaDavila M, 1996, COMP BIOCHEM PHYS B, V113, P331, DOI 10.1016/0305-0491(95)02031-4; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Fet V, 2000, CATALOG SCORPIONS WO; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Gao R, 2008, TOXICON, V52, P348, DOI 10.1016/j.toxicon.2008.06.003; Gennaro R, 2002, CURR PHARM DESIGN, V8, P763, DOI 10.2174/1381612023395394; Gonzalez-Santillan E, 2004, DIVERSIDAD TAXONOMIA; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hoffmann C. C., 1931, Anales del Instituto de Biologia Mexico T, V2, P291; HONG SJ, 1995, BRIT J PHARMACOL, V116, P1577, DOI 10.1111/j.1476-5381.1995.tb16375.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOVER E, 1984, BIOCHEMISTRY-US, V23, P1147, DOI 10.1021/bi00301a018; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P67, DOI 10.1085/jgp.93.1.67; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; Leipold E, 2012, J GEN PHYSIOL, V139, P305, DOI 10.1085/jgp.201110720; Lopez-Gonzalez I, 2003, BIOCHEM BIOPH RES CO, V300, P408, DOI 10.1016/S0006-291X(02)02859-0; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; MARTIN BM, 1988, TOXICON, V26, P785, DOI 10.1016/0041-0101(88)90319-4; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; Monroy Velasco J, 1960, REV MEXICANA CIENCIA, V1, P1; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Olamendi-Portugal T, 2002, BIOCHEM BIOPH RES CO, V299, P562, DOI 10.1016/S0006-291X(02)02706-7; Olamendi-Portugal T, 2008, PROTEOMICS, V8, P1919, DOI 10.1002/pmic.200700668; Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121; Pimenta AMC, 2003, RAPID COMMUN MASS SP, V17, P413, DOI 10.1002/rcm.934; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Ponce J, 2004, NUEVA ESPECIE ALACRA; Ponce-Saavedra J, 2009, REV MEX BIODIVERS, V80, P71; POSSANI LD, 1980, TOXICON, V18, P175, DOI 10.1016/0041-0101(80)90071-9; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; RAMIREZ AN, 1988, TOXICON, V26, P773, DOI 10.1016/0041-0101(88)90318-2; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; Schwartz EF, 2008, TOXICON, V51, P1499, DOI 10.1016/j.toxicon.2008.03.029; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soudani N, 2005, Arch Inst Pasteur Tunis, V82, P39; SSA, 2013, AN MORB; TAN NH, 1992, COMP BIOCHEM PHYS C, V103, P299, DOI 10.1016/0742-8413(92)90011-U; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Valdivia HH, 1998, TRENDS CARDIOVAS MED, V8, P111, DOI 10.1016/S1050-1738(97)00138-2; VAZQUEZ A, 1995, TOXICON, V33, P1161, DOI 10.1016/0041-0101(95)00058-T; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	72	48	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66486	10.1371/journal.pone.0066486	http://dx.doi.org/10.1371/journal.pone.0066486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840487	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800069
J	Takenaka, Y; Inoue, I; Nakano, T; Shinoda, Y; Ikeda, M; Awata, T; Katayama, S				Takenaka, Yasuhiro; Inoue, Ikuo; Nakano, Takanari; Shinoda, Yuichi; Ikeda, Masaaki; Awata, Takuya; Katayama, Shigehiro			A Novel Splicing Variant of Peroxisome Proliferator-Activated Receptor-gamma (Ppar gamma 1sv) Cooperatively Regulates Adipocyte Differentiation with Ppar gamma 2	PLOS ONE			English	Article							PPAR-GAMMA; MESSENGER-RNA; C/EBP-BETA; EXPRESSION; IDENTIFICATION; ADIPOGENESIS; PROMOTER; ISOFORMS; ALPHA	Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate expression of a number of genes associated with the cellular differentiation and development. Here, we show the abundant and ubiquitous expression of a newly identified splicing variant of mouse Ppar gamma (Ppar gamma 1sv) that encodes Ppar gamma 1 protein, and its importance in adipogenesis. The novel splicing variant has a unique 5'-UTR sequence, relative to those of Ppar gamma 1 and Ppar gamma 2 mRNAs, indicating the presence of a novel transcriptional initiation site and promoter for Ppar gamma expression. Ppar gamma 1sv was highly expressed in the white and brown adipose tissues at levels comparable to Ppar gamma 2. Ppar gamma 1sv was synergistically up-regulated with Ppar gamma 2 during adipocyte differentiation of 3T3-L1 cells and mouse primary cultured preadipocytes. Inhibition of Ppar gamma 1sv by specific siRNAs completely abolished the induced adipogenesis in 3T3-L1 cells. C/EBP beta and C/EBP delta activated both the Ppar gamma 1sv and Ppar gamma 2 promoters in 3T3-L1 preadipocytes. These findings suggest that Ppar gamma 1sv and Ppar gamma 2 synergistically regulate the early stage of the adipocyte differentiation.	[Takenaka, Yasuhiro; Inoue, Ikuo; Awata, Takuya; Katayama, Shigehiro] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan; [Nakano, Takanari] Saitama Med Univ, Dept Biochem, Saitama, Japan; [Shinoda, Yuichi] Misato Cent Gen Hosp, Saitama, Japan; [Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University	Takenaka, Y (corresponding author), Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan.	t_yasu@saitama-med.ac.jp; i1901018@saitama-med.ac.jp	Takenaka, Yasuhiro/HDO-7290-2022	Awata, Takuya/0000-0003-2622-8129	Grants-in-Aid for Scientific Research [25460299] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen Y, 2006, BBA-GENE STRUCT EXPR, V1759, P32, DOI 10.1016/j.bbaexp.2006.01.005; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Omi T, 2005, J ANIM BREED GENET, V122, P45, DOI 10.1111/j.1439-0388.2005.00508.x; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Strand DW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.99; Sundvold H, 2001, BIOCHEM BIOPH RES CO, V287, P383, DOI 10.1006/bbrc.2001.5602; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Zhou JM, 2002, BIOCHEM BIOPH RES CO, V293, P274, DOI 10.1016/S0006-291X(02)00138-9	21	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65583	10.1371/journal.pone.0065583	http://dx.doi.org/10.1371/journal.pone.0065583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840343	gold, Green Submitted, Green Published			2022-12-25	WOS:000322361200026
J	Justesen, BH; Hansen, RW; Martens, HJ; Theorin, L; Palmgren, MG; Martinez, KL; Pomorski, TG; Fuglsang, AT				Justesen, Bo Hojen; Hansen, Randi Westh; Martens, Helle Juel; Theorin, Lisa; Palmgren, Michael G.; Martinez, Karen L.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe			Active Plasma Membrane P-type H+-ATPase Reconstituted into Nanodiscs Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANOSCALE LIPID-BILAYERS; BLUE NATIVE ELECTROPHORESIS; PHOSPHOLIPID-BILAYER; ERYTHROCYTE CA-2+-ATPASE; ELECTRON CRYOMICROSCOPY; PROTON TRANSLOCATION; CYTOCHROME-P450 3A4; SCAFFOLD PROTEINS; BINDING; ACTIVATION	Plasma membrane H+-ATPases form a subfamily of P-type ATPases responsible for pumping protons out of cells and are essential for establishing and maintaining the crucial transmembrane proton gradient in plants and fungi. Here, we report the reconstitution of the Arabidopsis thaliana plasma membrane H+-ATPase isoform 2 into soluble nanoscale lipid bilayers, also termed nanodiscs. Based on native gel analysis and cross-linking studies, the pump inserts into nanodiscs as a functional monomer. Insertion of the H+-ATPase into nanodiscs has the potential to enable structural and functional characterization using techniques normally applicable only for soluble proteins.	[Justesen, Bo Hojen; Theorin, Lisa; Palmgren, Michael G.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg C, Denmark; [Justesen, Bo Hojen; Martens, Helle Juel; Theorin, Lisa; Palmgren, Michael G.; Pomorski, Thomas Gunther; Fuglsang, Anja Thoe] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark; [Hansen, Randi Westh; Martinez, Karen L.] Univ Copenhagen, Dept Chem, Bionanotechnol & Nanomed Lab, DK-2100 Copenhagen, Denmark; [Hansen, Randi Westh; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Pomorski, TG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	tgp@life.ku.dk; atf@life.ku.dk	Palmgren, Michael/A-9808-2013; Fuglsang, Anja Thoe/A-6733-2015; Martens, Helle/H-7710-2014; Martens, Helle/AAG-9725-2020; martinez, karen L/J-5933-2013; Pomorski, Thomas Günther/G-4804-2014; Martinez, Karen/W-3709-2019; fuglsang, anja thoe t/E-1683-2012	Palmgren, Michael/0000-0002-9982-6114; Fuglsang, Anja Thoe/0000-0003-1153-8394; Martens, Helle/0000-0002-3011-4557; Martens, Helle/0000-0002-3011-4557; martinez, karen L/0000-0003-0932-8080; Pomorski, Thomas Günther/0000-0002-4889-0829; Martinez, Karen/0000-0003-0932-8080; fuglsang, anja thoe t/0000-0003-1153-8394; Hansen, Randi Westh/0000-0001-5547-683X	UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen; Danish National Research Foundation through the PUMPKIN Center of Excellence; Carlsberg Foundation	UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen; Danish National Research Foundation through the PUMPKIN Center of Excellence; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation through the "Center for Synthetic Biology" at University of Copenhagen, by the Danish National Research Foundation through the PUMPKIN Center of Excellence, and by an equipment grant from the Carlsberg Foundation.	ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; BLANCO G, 1994, P NATL ACAD SCI USA, V91, P8542, DOI 10.1073/pnas.91.18.8542; Borch J, 2008, ANAL CHEM, V80, P6245, DOI 10.1021/ac8000644; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; Dach I, 2012, J BIOL CHEM, V287, P41963, DOI 10.1074/jbc.M112.398768; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Duan H, 2004, ARCH BIOCHEM BIOPHYS, V424, P141, DOI 10.1016/j.abb.2004.02.010; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Fuglsang AT, 2011, SIGNAL COMMUN PLANTS, P39, DOI 10.1007/978-3-642-14369-4_2; Fuglsang AT, 2003, J BIOL CHEM, V278, P42266, DOI 10.1074/jbc.M306707200; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gluck JM, 2011, ANAL BIOCHEM, V408, P46, DOI 10.1016/j.ab.2010.08.028; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Hayashi Y, 2010, PLANT CELL PHYSIOL, V51, P1186, DOI 10.1093/pcp/pcq078; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUANG LS, 1990, BIOCHIM BIOPHYS ACTA, V1039, P241, DOI 10.1016/0167-4838(90)90192-I; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jahn T, 2001, J MOL BIOL, V309, P465, DOI 10.1006/jmbi.2001.4688; Jelich-Ottmann C, 2001, J BIOL CHEM, V276, P39852, DOI 10.1074/jbc.M106746200; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P9618, DOI 10.1002/anie.200801711; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; MacColl R, 1996, J BIOL CHEM, V271, P17157, DOI 10.1074/jbc.271.29.17157; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; RADOMSKY ML, 1990, BIOMATERIALS, V11, P619, DOI 10.1016/0142-9612(90)90018-L; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skar-Gislinge N, 2010, J AM CHEM SOC, V132, P13713, DOI 10.1021/ja1030613; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILSEN B, 1987, J BIOL CHEM, V262, P10511; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	62	15	15	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26419	26429		10.1074/jbc.M112.446948	http://dx.doi.org/10.1074/jbc.M112.446948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23836891	Green Published, hybrid			2022-12-25	WOS:000330594500007
J	Kanda, T; Horikoshi, N; Murata, T; Kawashima, D; Sugimoto, A; Narita, Y; Kurumizaka, H; Tsurumi, T				Kanda, Teru; Horikoshi, Naoki; Murata, Takayuki; Kawashima, Daisuke; Sugimoto, Atsuko; Narita, Yohei; Kurumizaka, Hitoshi; Tsurumi, Tatsuya			Interaction between Basic Residues of Epstein-Barr Virus EBNA1 Protein and Cellular Chromatin Mediates Viral Plasmid Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ANTIGEN 1; MOBILITY GROUP-I; TRANSCRIPTIONAL ACTIVATION; DNA-BINDING; REPLICATION; DOMAINS; LATENT; EBV; NUCLEOSOME; CELLS	The Epstein-Barr virus (EBV) genome is episomally maintained in latently infected cells. The viral protein EBNA1 is a bridging molecule that tethers EBV episomes to host mitotic chromosomes as well as to interphase chromatin. EBNA1 localizes to cellular chromosomes (chromatin) via its chromosome binding domains (CBDs), which are rich in glycine and arginine residues. However, the molecular mechanism by which the CBDs of EBNA1 attach to cellular chromatin is still under debate. Mutation analyses revealed that stepwise substitution of arginine residues within the CBD1 (amino acids 40-54) and CBD2 (amino acids 328-377) regions with alanines progressively impaired chromosome binding activity of EBNA1. The complete arginine-to-alanine substitutions within the CBD1 and -2 regions abolished the ability of EBNA1 to stably maintain EBV-derived oriP plasmids in dividing cells. Importantly, replacing the same arginines with lysines had minimal effect, if any, on chromosome binding of EBNA1 as well as on its ability to stably maintain oriP plasmids. Furthermore, a glycine-arginine-rich peptide derived from the CBD1 region bound to reconstituted nucleosome core particles in vitro, as did a glycine-lysine rich peptide, whereas a glycine-alanine rich peptide did not. These results support the idea that the chromosome binding of EBNA1 is mediated by electrostatic interactions between the basic amino acids within the CBDs and negatively charged cellular chromatin.	[Kanda, Teru; Murata, Takayuki; Kawashima, Daisuke; Sugimoto, Atsuko; Narita, Yohei; Tsurumi, Tatsuya] Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Horikoshi, Naoki; Kurumizaka, Hitoshi] Waseda Univ, Struct Biol Lab, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Aichi Cancer Center; Waseda University	Kanda, T (corresponding author), Aichi Canc Ctr, Div Virol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	tkanda@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Narita, Yohei/0000-0002-8867-3669; Horikoshi, Naoki/0000-0003-1842-6934; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Ministry of Health Labor and Welfare; MEXT, Japan; Grants-in-Aid for Scientific Research [11J06154] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to T. K. and T. T.), by a grant-in-aid for Scientific Research from the Ministry of Health Labor and Welfare (to T. K.), and by Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan (to H. K.).	Abe A, 2004, BIOCHEM BIOPH RES CO, V320, P920, DOI 10.1016/j.bbrc.2004.06.040; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Botchan M, 2004, CELL, V117, P280, DOI 10.1016/S0092-8674(04)00410-6; Calos MP, 1998, P NATL ACAD SCI USA, V95, P4084, DOI 10.1073/pnas.95.8.4084; Coppotelli G, 2013, BIOCHEM BIOPH RES CO, V431, P706, DOI 10.1016/j.bbrc.2013.01.054; Coppotelli G, 2011, J BIOL CHEM, V286, P19565, DOI 10.1074/jbc.M111.224782; Daikoku T, 2004, J BIOL CHEM, V279, P54817, DOI 10.1074/jbc.M405911200; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; GOTOH E, 1995, BIOMED RES-TOKYO, V16, P63, DOI 10.2220/biomedres.16.63; Harrer M, 2004, J CELL SCI, V117, P3459, DOI 10.1242/jcs.01160; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Howden SE, 2006, HUM GENE THER, V17, P833, DOI 10.1089/hum.2006.17.833; Hung SC, 2001, P NATL ACAD SCI USA, V98, P1865, DOI 10.1073/pnas.031584698; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Jourdan N, 2012, J VIROL, V86, P5314, DOI 10.1128/JVI.06303-11; Kanda T, 2001, J CELL SCI, V114, P49; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kanda T, 2001, MOL CELL BIOL, V21, P3576, DOI 10.1128/MCB.21.10.3576-3588.2001; Kennedy G, 2003, MOL CELL BIOL, V23, P6901, DOI 10.1128/MCB.23.19.6901-6908.2003; Kirchmaier AL, 1997, J VIROL, V71, P1766, DOI 10.1128/JVI.71.3.1766-1775.1997; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Nayyar VK, 2009, J CELL SCI, V122, P4341, DOI 10.1242/jcs.060913; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; REEVES R, 1990, J BIOL CHEM, V265, P8573; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; SHIMIZU N, 1994, J VIROL, V68, P6069, DOI 10.1128/JVI.68.9.6069-6073.1994; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; SNUDDEN DK, 1994, EMBO J, V13, P4840, DOI 10.1002/j.1460-2075.1994.tb06810.x; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Van Scoy S, 2000, VIROLOGY, V275, P145, DOI 10.1006/viro.2000.0508; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	46	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24189	24199		10.1074/jbc.M113.491167	http://dx.doi.org/10.1074/jbc.M113.491167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836915	hybrid, Green Published			2022-12-25	WOS:000330611400057
J	Ha, DA; Goldberg, RJ; Allison, JJ; Chu, TH; Nguyen, HL				Duc Anh Ha; Goldberg, Robert J.; Allison, Jeroan J.; Thang Hong Chu; Nguyen, Hoa L.			Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam	PLOS ONE			English	Article							HYPERTENSION PREVALENCE; RISK-FACTORS; ADULTS; DISEASE; PROJECT; TRENDS; URBAN	Background: Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality in Vietnam and hypertension (HTN) is an important and prevalent risk factor for CVD in the adult Vietnamese population. Despite an increasing prevalence of HTN in this country, information about the awareness, treatment, and control of HTN is limited. The objectives of this study were to describe the prevalence, awareness, treatment, and control of HTN, and factors associated with these endpoints, in residents of a mountainous province in Vietnam. Methods: Data from 2,368 adults (age >= 25 years) participating in a population-based survey conducted in 2011 in Thai Nguyen province were analyzed. All eligible participants completed a structured questionnaire and were examined by community health workers using a standardized protocol. Results: The overall prevalence of HTN in this population was 23%. Older age, male sex, and being overweight were associated with a higher odds of having HTN, while higher educational level was associated with a lower odds of having HTN. Among those with HTN, only 34% were aware of their condition, 43% of those who were aware they had HTN received treatment and, of these, 39% had their HTN controlled. Conclusions: Nearly one in four adults in Thai Nguyen is hypertensive, but far fewer are aware of this condition and even fewer have their blood pressure adequately controlled. Public health strategies increasing awareness of HTN in the community, as well as improvements in the treatment and control of HTN, remain needed to reduce the prevalence of HTN and related morbidity and mortality.	[Duc Anh Ha] Minist Hlth, Hanoi, Vietnam; [Goldberg, Robert J.; Allison, Jeroan J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Thang Hong Chu] Thai Nguyen Dept Hlth, Thai Nguyen, Vietnam; [Nguyen, Hoa L.] Inst Populat Hlth & Dev, Hanoi, Vietnam; [Nguyen, Hoa L.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Ha, DA (corresponding author), Minist Hlth, Hanoi, Vietnam.	ddha04@gmail.com	Nguyen, Hoa/AAA-5685-2020	Nguyen, Hoa/0000-0002-4998-8510; Allison, Jeroan/0000-0003-4472-2112	FIC NIH HHS [R21 TW009740] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R21TW009740] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Aekplakorn W, 2012, J HYPERTENS, V30, P1734, DOI 10.1097/HJH.0b013e3283568158; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Altun L, 2005, J HYPERTENS, V23, P1817; [Anonymous], 2011, VIETNAM BURDEN DIS I; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Bovet P, 2003, J HYPERTENS, V21, P509, DOI 10.1097/00004872-200303000-00016; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Gee ME, 2012, CAN J CARDIOL, V28, P375, DOI 10.1016/j.cjca.2011.12.012; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Houston TK, 2011, ANN INTERN MED, V154, P77, DOI 10.7326/0003-4819-154-2-201101180-00004; IBRAHIM MM, 1995, HYPERTENSION, V26, P886, DOI 10.1161/01.HYP.26.6.886; Jaddou HY, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/828797; Kaur P, 2012, INT J PUBLIC HEALTH, V57, P87, DOI 10.1007/s00038-011-0303-3; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ministry of Health, 2011, HLTH STAT YB 2010; MOH, 2003, REP RES VIETN NAT HT; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Nissinen A, 2004, J HUM HYPERTENS, V18, P553, DOI 10.1038/sj.jhh.1001696; Nissinen A, 2001, B WORLD HEALTH ORGAN, V79, P963; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; Nguyen N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-325; Saeed AA, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/174135; Scheltens T, 2007, J HUM HYPERTENS, V21, P99, DOI 10.1038/sj.jhh.1002123; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; Tunstall-Pedoe H, 2006, BRIT MED J, V332, P629, DOI 10.1136/bmj.38753.779005.BE; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1; WILBER JA, 1973, B NEW YORK ACAD MED, V49, P510; World Health Organization, 2007, RED SALT INT POP REP; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66792	10.1371/journal.pone.0066792	http://dx.doi.org/10.1371/journal.pone.0066792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826134	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000009
J	Gopal, K; Nagarajan, P; Jedy, J; Raj, AT; Gnanaselvi, SK; Jahan, P; Sharma, Y; Shankar, EM; Kumar, JM				Gopal, Kaliappan; Nagarajan, Perumal; Jedy, Jose; Raj, Avinash T.; Gnanaselvi, S. Kalai; Jahan, Parveen; Sharma, Yogendra; Shankar, Esaki M.; Kumar, Jerald M.			beta-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe(-/-) Mice	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; VITAMIN-E; ATHEROSCLEROTIC LESIONS; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; ANTIOXIDANTS; RECEPTOR; INHIBIT	Abdominal aortic aneurysm (AAA) is a common chronic degenerative disease characterized by progressive aortic dilation and rupture. The mechanisms underlying the role of alpha-tocopherol and beta-carotene on AAA have not been comprehensively assessed. We investigated if alpha-tocopherol and beta-carotene supplementation could attenuate AAA, and studied the underlying mechanisms utilized by the antioxidants to alleviate AAA. Four-months-old Apoe(-/-) mice were used in the induction of aneurysm by infusion of angiotensin II (Ang II), and were orally administered with alpha-tocopherol and beta-carotene enriched diet for 60 days. Significant increase of LDL, cholesterol, triglycerides and circulating inflammatory cells was observed in the Ang II-treated animals, and gene expression studies showed that ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9 and MMP-12 were upregulated in the aorta of aneurysm-induced mice. Extensive plaques, aneurysm and diffusion of inflammatory cells into the tunica intima were also noticed. The size of aorta was significantly (P = 0.0002) increased (2.24 +/- 0.20 mm) in the aneurysm-induced animals as compared to control mice (1.17 +/- 0.06 mm). Interestingly, beta-carotene dramatically controlled the diffusion of macrophages into the aortic tunica intima, and circulation. It also dissolved the formation of atheromatous plaque. Further, beta-carotene significantly decreased the aortic diameter (1.33 +/- 0.12 mm) in the aneurysm-induced mice (beta-carotene, P = 0.0002). It also downregulated ICAM-1, VCAM-1, MCP-1, M-CSF, MMP-2, MMP-9, MMP-12, PPAR-alpha and PPAR-gamma following treatment. Hence, dietary supplementation of beta-carotene may have a protective function against Ang II-induced AAA by ameliorating macrophage recruitment in Apoe(-/-) mice.	[Gopal, Kaliappan; Jedy, Jose; Raj, Avinash T.; Gnanaselvi, S. Kalai; Sharma, Yogendra; Kumar, Jerald M.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Nagarajan, Perumal] Natl Inst Immunol, New Delhi 110067, India; [Jahan, Parveen] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Gopal, Kaliappan] Univ Malaya, Fac Med, Dept Orthoped, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur, Malaysia; [Shankar, Esaki M.] Univ Malaya, Fac Med, Dept Med Microbiol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Osmania University; Universiti Malaya; Universiti Malaya	Kumar, JM (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	mahesh73@ccmb.res.in	Shankar, EM/G-6444-2011; Perumal, Nagarajan/B-8736-2017; Muthu, Shankar Esaki/B-3132-2019; K, Gopal/D-6751-2012; Nagarajan, Perumal/AAJ-8599-2021; jahan, parveen/AAW-8428-2021	Perumal, Nagarajan/0000-0003-4557-4633; Muthu, Shankar Esaki/0000-0002-7866-9818; Nagarajan, Perumal/0000-0003-4557-4633; Parveen Jahan, DR/0000-0003-3203-1816	Indian Council of Medical Research, Government of India [IRIS ID. 2005-04430]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Government of India (Project IRIS ID. 2005-04430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alija AJ, 2010, ACTA BIOCHIM POL, V57, P1968; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Carrell TWG, 1999, BRIT J SURG, V86, P305, DOI 10.1046/j.1365-2168.1999.01092.x; Chinetti G, 2001, NAT MED, V7, P33; Coll T, 2008, CURR MOL PHARM, V2, P46; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Gopal K, 2010, J THROMB THROMBOLYS, V30, P154, DOI 10.1007/s11239-010-0446-8; Grimaldi PA, 2007, CELL MOL LIFE SCI, V64, P2459, DOI 10.1007/s00018-007-7278-5; Jiang F, 2007, BRIT J PHARMACOL, V152, P880, DOI 10.1038/sj.bjp.0707449; Kaipainen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000260; Kaliappan G, 2012, J THROMB THROMBOLYSI; Koul A, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-14; Leeper NJ, 2009, AM J PHYSIOL-HEART C, V296, pH1329, DOI 10.1152/ajpheart.01341.2008; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Meli DN, 2003, J INFECT DIS, V187, P1411, DOI 10.1086/374644; Munday JS, 1998, ARTERIOSCL THROM VAS, V18, P114, DOI 10.1161/01.ATV.18.1.114; Nakahashi TK, 2002, ARTERIOSCL THROM VAS, V22, P2017, DOI 10.1161/01.ATV.0000042082.38014.EA; PHONPANICHRASAMEE C, 1990, INT J VITAM NUTR RES, V60, P240; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; REAVEN PD, 1993, ARTERIOSCLER THROMB, V13, P590, DOI 10.1161/01.ATV.13.4.590; Reed A, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-32; Sadek M, 2008, SURGERY, V144, P252, DOI 10.1016/j.surg.2008.04.007; Shaish A, 1999, ARTERIOSCL THROM VAS, V19, P1470, DOI 10.1161/01.ATV.19.6.1470; SHAISH A, 1995, J CLIN INVEST, V96, P2075, DOI 10.1172/JCI118256; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sun JD, 1997, INT J VITAM NUTR RES, V67, P155; Takada T, 2010, MOL NUTR FOOD RES, V54, P616, DOI 10.1002/mnfr.200900481; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Ziegelstein RC, 2004, BIOCHEM BIOPH RES CO, V322, P68, DOI 10.1016/j.bbrc.2004.07.080; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	33	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67098	10.1371/journal.pone.0067098	http://dx.doi.org/10.1371/journal.pone.0067098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826202	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000026
J	Massicot, F; Hache, G; David, L; Chen, D; Leuxe, C; Garnier-Legrand, L; Rat, P; Laprevote, O; Coudore, F				Massicot, France; Hache, Guillaume; David, Ludivine; Chen, Dominique; Leuxe, Charlotte; Garnier-Legrand, Laure; Rat, Patrice; Laprevote, Olivier; Coudore, Francois			P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; OXIDATIVE STRESS; NEUROPATHIC PAIN; RESAZURIN METABOLISM; P2X(7) PURINOCEPTOR; CHANNEL EXPRESSION; N-ACETYLCYSTEINE; DNA-ADDUCTS; CISPLATIN; ASSAY	Limited information is available regarding the cellular mechanisms of oxaliplatin-induced painful neuropathy during exposure of patients to this drug. We therefore determined oxidative stress in cultured cells and evaluated its occurrence in C57BL/ 6 mice. Using both cultured neuroblastoma (SH-SY5Y) and macrophage (RAW 264.7) cell lines and also brain tissues of oxaliplatin-treated mice, we investigated whether oxaliplatin (OXA) induces oxidative stress and apoptosis. Cultured cells were treated with 2-200 mu M OXA for 24 h. The effects of pharmacological inhibitors of oxidative stress or inflammation (N-acetyl cysteine, ibuprofen, acetaminophen) were also tested. Inhibitors were added 30 min before OXA treatment and then in combination with OXA for 24 h. In SH-SY5Y cells, OXA caused a significant dose-dependent decrease in viability, a large increase in ROS and NO production, lipid peroxidation and mitochondrial impairment as assessed by a drop in mitochondrial membrane potential, which are deleterious for the cell. An increase in levels of negatively charged phospholipids such as cardiolipin but also phosphatidylserine and phosphatidylinositol, was also observed. Additionally, OXA caused concentration-dependent P2X7 receptor activation, increased chromatin condensation and caspase-3 activation associated with TNF-alpha and IL-6 release. The majority of these toxic effects were equally observed in Raw 264.7 which also presented high levels of PGE2. Pretreatment of SH-SY5Y cells with pharmacological inhibitors significantly reduced or blocked all the neurotoxic OXA effects. In OXA-treated mice (28 mg/kg cumulated dose) significant cold hyperalgesia and oxidative stress in the tested brain areas were shown. Our study suggests that targeting P2X7 receptor activation and mitochondrial impairment might be a potential therapeutic strategy against OXA-induced neuropathic pain.	[Massicot, France; David, Ludivine; Chen, Dominique; Leuxe, Charlotte; Garnier-Legrand, Laure; Rat, Patrice; Laprevote, Olivier] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Lab Chim Toxicol Analyt & Cellulaire,EA4463, Paris, France; [Hache, Guillaume; Coudore, Francois] Univ Paris 11, Fac Pharm, Lab NeuroPharmacol, EA3544,PRES Paris Saclay, F-92290 Chatenay Malabry, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Massicot, F (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Lab Chim Toxicol Analyt & Cellulaire,EA4463, Paris, France.	france.massicot@parisdescartes.fr		Hache, Guillaume/0000-0002-6474-8101	Adebiopharm [ER67]	Adebiopharm	This work was supported by Adebiopharm ER67. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 2010, BASIC CLIN PHARMACOL, V106, P272, DOI 10.1111/j.1742-7843.2009.00512.x; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Baron JA, 2009, RECENT RESULTS CANC, V181, P223; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Basha Riyaz, 2011, Front Biosci (Schol Ed), V3, P797, DOI 10.2741/s188; Bernabucci M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-77; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Camu F, 2003, DRUGS, V63, P1, DOI 10.2165/00003495-200363001-00002; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Debbasch C, 2001, INVEST OPHTH VIS SCI, V42, P2525; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dickey DT, 2005, J PHARMACOL EXP THER, V314, P1052, DOI 10.1124/jpet.105.087601; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Donzelli E, 2004, J NEURO-ONCOL, V67, P65, DOI 10.1023/B:NEON.0000021787.70029.ce; Du F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004593; Dunlap Beth, 2006, J Support Oncol, V4, P398; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Eltom SE, 2011, J HEALTH CARE POOR U, V22, P3, DOI 10.1353/hpu.2011.0167; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Ghazi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048351; Goodisman J, 2006, CANCER CHEMOTH PHARM, V57, P257, DOI 10.1007/s00280-005-0041-4; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Greco A, 2003, J NEUROSCI RES, V71, P844, DOI 10.1002/jnr.10543; Hache G, 2012, NEUROREPORT, V23, P525, DOI 10.1097/WNR.0b013e328353d70a; Hochberg MC, 2001, BEST PRACT RES CL RH, V15, P583, DOI 10.1053/berh.2001.0175; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Ibrahim A, 2004, ONCOLOGIST, V9, P8, DOI 10.1634/theoncologist.9-1-8; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Inoue K, 2012, EXP NEUROL, V234, P293, DOI 10.1016/j.expneurol.2011.09.016; Jamieson SMF, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-66; Jarvis MF, 2001, BRIT J PHARMACOL, V132, P259, DOI 10.1038/sj.bjp.0703793; Jerremalm E, 2009, J PHARM SCI-US, V98, P3879, DOI 10.1002/jps.21732; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Joseph EK, 2009, J PAIN, V10, P534, DOI 10.1016/j.jpain.2008.12.003; Kasseckert SA, 2012, NEUROSURGER IN PRESS; Kern W, 1999, CLIN CANCER RES, V5, P761; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; Larsson KP, 2002, J NEUROCHEM, V83, P285; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Ma W, 2003, NEUROSCIENCE, V121, P691, DOI 10.1016/S0306-4522(03)00495-0; Maciorowski Z, 1998, CYTOMETRY, V32, P44, DOI 10.1002/(SICI)1097-0320(19980501)32:1<44::AID-CYTO6>3.0.CO;2-F; Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009; MCCAFFREY TA, 1988, IN VITRO CELL DEV B, V24, P247; Mihara Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-8; Nakano A, 2011, INT J HEMATOL, V93, P727, DOI 10.1007/s12185-011-0850-7; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Neuwelt EA, 2004, J PHARMACOL EXP THER, V309, P594, DOI 10.1124/jpet.103.063347; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nishida K, 2012, J NEUROCHEM, V122, P1118, DOI 10.1111/j.1471-4159.2012.07868.x; Norcini M, 2009, PAIN, V146, P141, DOI 10.1016/j.pain.2009.07.017; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; PALMER DK, 1991, CELL IMMUNOL, V138, P473, DOI 10.1016/0008-8749(91)90170-G; Parada CA, 2003, EUR J NEUROSCI, V17, P1847, DOI 10.1046/j.1460-9568.2003.02626.x; Park SB, 2011, EXP NEUROL, V227, P120, DOI 10.1016/j.expneurol.2010.10.002; PENDYALA L, 1995, CANCER LETT, V97, P177, DOI 10.1016/0304-3835(95)03974-2; Perez-Medrano A, 2009, J MED CHEM, V52, P3366, DOI 10.1021/jm8015848; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Perrot S, 2003, TOXICOL SCI, V72, P122, DOI 10.1093/toxsci/kfg014; Perrot SB, 2003, CYTOM PART A, V55A, P7, DOI 10.1002/cyto.a.10067; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Piga R, 2007, NEUROTOXICOLOGY, V28, P67, DOI 10.1016/j.neuro.2006.07.006; Rainer Q, 2011, INT J NEUROPSYCHOPH, V8, P1; RAT P, 1994, CELL BIOL TOXICOL, V10, P329, DOI 10.1007/BF00755779; RAT P, 1995, METHOD ENZYMOL, V252, P331; Saris CP, 1996, CARCINOGENESIS, V17, P2763, DOI 10.1093/carcin/17.12.2763; Sarti P., 2002, Cell Death and Differentiation, V9, P1160, DOI 10.1038/sj.cdd.4401099; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Scheuren N, 1998, BRIT J PHARMACOL, V123, P645, DOI 10.1038/sj.bjp.0701652; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Sergeeva MG, 1997, BIOCHEMISTRY-MOSCOW+, V62, P269; Sittl R, 2012, P NATL ACAD SCI USA, V109, P6704, DOI 10.1073/pnas.1118058109; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; St-Jacques B, 2011, J NEUROCHEM, V118, P841, DOI 10.1111/j.1471-4159.2011.07230.x; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; Theile D, 2012, J PHARMACOL EXP THER, V341, P51, DOI 10.1124/jpet.111.189621; Thibault K, 2012, PAIN, V153, P1636, DOI 10.1016/j.pain.2012.04.016; Tonini G, 2002, J BIOL REG HOMEOS AG, V16, P105; Toulme E, 2010, TRANSLATIONAL PAIN R; Tripathy D, 2009, MICROVASC RES, V77, P289, DOI 10.1016/j.mvr.2009.02.002; Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009; van Leeuwen JS, 2012, TOXICOL IN VITRO, V26, P197, DOI 10.1016/j.tiv.2011.11.013; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; Zhang WJ, 2008, J CHROMATOGR B, V876, P277, DOI 10.1016/j.jchromb.2008.10.055	103	40	43	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66830	10.1371/journal.pone.0066830	http://dx.doi.org/10.1371/journal.pone.0066830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826152	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000015
J	Mizutani, Y; Sun, H; Ohno, Y; Sassa, T; Wakashima, T; Obara, M; Yuyama, K; Kihara, A; Igarashi, Y				Mizutani, Yukiko; Sun, Hui; Ohno, Yusuke; Sassa, Takayuki; Wakashima, Takeshi; Obara, Mari; Yuyama, Kohei; Kihara, Akio; Igarashi, Yasuyuki			Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation	PLOS ONE			English	Article							PERMEABILITY BARRIER HOMEOSTASIS; SPHINGOSINE 1-PHOSPHATE; SUBSTRATE-SPECIFICITY; STRATUM-CORNEUM; SKIN; ELOVL4; SYNTHASE; PPAR; EXPRESSION; BIOSYNTHESIS	The lipid lamellae in the stratum corneum is important for the epidermal permeability barrier. The lipid lamellae component ceramide (CER), comprising an ultra long-chain (ULC) fatty acid (FA) of >= 26 carbons (ULC CER), plays an essential role in barrier formation. ULC acyl-CoAs, produced by the FA elongase ELOVL4, are converted to ULC CERs by the CER synthase CERS3. In the presented study, we observed that ELOVL4 and CERS3 mRNAs increased during keratinocyte differentiation in vivo and in vitro. We also determined that peroxisome proliferator-activated receptor beta/delta is involved in the up-regulation of the mRNAs. Knockdown of CERS3 caused a reduction in the elongase activities toward ULC acyl-CoAs, suggesting that CERS3 positively regulates ULCFA. Thus, we reveal that the two key players in ULC CER production in epidermis, CERS3 and ELOVL4, are coordinately regulated at both the transcriptional and enzymatic levels.	[Mizutani, Yukiko; Sun, Hui; Obara, Mari; Yuyama, Kohei; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido, Japan; [Ohno, Yusuke; Sassa, Takayuki; Wakashima, Takeshi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita 12, Sapporo, Hokkaido 060, Japan.	kihara@pharm.hokudai.ac.jp; yigarash@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/Q-3285-2019; SASSA, Takayuki/B-2519-2012; Ohno, Yusuke/B-5621-2014	KIHARA, AKIO/0000-0001-5889-0788; Ohno, Yusuke/0000-0003-3702-1043; SASSA, Takayuki/0000-0003-3145-9829; Ohno, Yusuke/0000-0003-3702-1043; MIZUTANI, YUKIKO/0000-0002-1018-9156	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [22770095]; Sapporo Biocluster 'Bio-S'; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Biocluster 'Bio-S'; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) (22770095) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan, and in part by grants from the Sapporo Biocluster 'Bio-S', the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; Eckl KM, 2013, J INVEST DE IN PRESS; ELIAS PM, 1991, ADV LIPID RES, V24, P1; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hong I, 2010, ARCH PHARM RES, V33, P1443, DOI 10.1007/s12272-010-0919-5; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jiang YJ, 2010, J INVEST DERMATOL, V130, P511, DOI 10.1038/jid.2009.245; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li WM, 2007, INT J BIOL SCI, V3, P120; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; McMahon A, 2007, MOL VIS, V13, P258; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Stewart ME, 2001, J LIPID RES, V42, P1105; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x	35	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67317	10.1371/journal.pone.0067317	http://dx.doi.org/10.1371/journal.pone.0067317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826266	Green Published, gold			2022-12-25	WOS:000321150000061
J	Pierce, EJ; Rey, MEC				Pierce, Erica J.; Rey, M. E. Chrissie			Assessing Global Transcriptome Changes in Response to South African Cassava Mosaic Virus [ZA-99] Infection in Susceptible Arabidopsis thaliana	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; CELL-CYCLE; REPLICASE PROTEIN; DNA-REPLICATION; ABIOTIC STRESS; COMPLEX ARRAY; HOST-DEFENSE; PLANT; TOBACCO	In susceptible plant hosts, co-evolution has favoured viral strategies to evade host defenses and utilize resources to their own benefit. The degree of manipulation of host gene expression is dependent on host-virus specificity and certain abiotic factors. In order to gain insight into global transcriptome changes for a geminivirus pathosystem, South African cassava mosaic virus [ZA:99] and Arabidopsis thaliana, 4x44K Agilent microarrays were adopted. After normalization, a log2 fold change filtering of data (p<0.05) identified 1,743 differentially expressed genes in apical leaf tissue. A significant increase in differential gene expression over time correlated with an increase in SACMV accumulation, as virus copies were 5-fold higher at 24 dpi and 6-fold higher at 36 dpi than at 14 dpi. Many altered transcripts were primarily involved in stress and defense responses, phytohormone signalling pathways, cellular transport, cell-cycle regulation, transcription, oxidation-reduction, and other metabolic processes. Only forty-one genes (2.3%) were shown to be continuously expressed across the infection period, indicating that the majority of genes were transient and unique to a particular time point during infection. A significant number of pathogen-responsive genes were suppressed during the late stages of pathogenesis, while during active systemic infection (14 to 24 dpi), there was an increase in up-regulated genes in several GO functional categories. An adaptive response was initiated to divert energy from growth-related processes to defense, leading to disruption of normal biological host processes. Similarities in cell-cycle regulation correlated between SACMV and Cabbage leaf curl virus (CaLCuV), but differences were also evident. Differences in gene expression between the two geminiviruses clearly demonstrated that, while some global transcriptome responses are generally common in plant virus infections, temporal host-specific interactions are required for successful geminivirus infection. To our knowledge this is the first geminivirus microarray study identifying global differentially expressed transcripts at 3 time points.	[Pierce, Erica J.; Rey, M. E. Chrissie] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa	University of Witwatersrand	Rey, MEC (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	Chrissie.rey@wits.ac.za			National Bioinformatics Network through the Department of Science and Technology; National Research Foundation	National Bioinformatics Network through the Department of Science and Technology; National Research Foundation	Funding was from the National Bioinformatics Network through the Department of Science and Technology (www.dst.gov.za) and the National Research Foundation (www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, BMC GENOMICS, V3, pe2397; Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrietta MH, 2001, GENET MOL BIOL, V24, P61, DOI 10.1590/S1415-47572001000100010; Aranda MA, 1996, P NATL ACAD SCI USA, V93, P15289, DOI 10.1073/pnas.93.26.15289; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Berrie LC, 2001, J GEN VIROL, V82, P53, DOI 10.1099/0022-1317-82-1-53; Boevink P, 2005, PLANT PHYSIOL, V138, P1815, DOI 10.1104/pp.105.066761; Brini F, 2011, PLANT CELL PHYSIOL, V52, P676, DOI 10.1093/pcp/pcr030; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Busch W, 2007, CURR OPIN PLANT BIOL, V10, P136, DOI 10.1016/j.pbi.2007.01.002; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Carrington JC, 1998, CURR OPIN PLANT BIOL, V1, P336, DOI 10.1016/1369-5266(88)80056-6; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11; Dudits D, 2007, ANN BOT, V107, P1193; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elena SF, 2011, CURR OPIN PLANT BIOL, V14, P372, DOI 10.1016/j.pbi.2011.03.013; Epel BL, 2009, SEMIN CELL DEV BIOL, V20, P1074, DOI 10.1016/j.semcdb.2009.05.010; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Fisher R, 1970, STATISTICAL METHODS, P96; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Fregene M, 2004, PLANT MOL BIOL, V56, P563, DOI 10.1007/s11103-004-3477-8; Gafni Y, 2002, PHYSIOL MOL PLANT P, V60, P231, DOI 10.1006/pmpp.2002.0402; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Guerra-Peraza O, 2005, J GEN VIROL, V86, P1815, DOI 10.1099/vir.0.80920-0; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Gutierrez C, 2002, PHYSIOL MOL PLANT P, V60, P219, DOI 10.1006/pmpp.2002.0401; Gutierrez C, 2000, EMBO J, V19, P792, DOI 10.1093/emboj/19.5.792; Hanley-Bowdoin L, 2004, MOL PLANT PATHOL, V5, P149, DOI [10.1111/j.1364-3703.2004.00214.x, 10.1111/J.1364-3703.2004.00214.X]; Harrison BD, 2002, PHYSIOL MOL PLANT P, V60, P215, DOI 10.1006/pmpp.2002.0400; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Jeske H, 2009, CURR TOP MICROBIOL, V331, P185; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Kim DH, 2011, PLANT PHYSIOL, V157, P132, DOI 10.1104/pp.111.178681; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Love AJ, 2005, PLANT PHYSIOL, V139, P935, DOI 10.1104/pp.105.066803; Lozano-Duran R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022383; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; Maule A, 2002, CURR OPIN PLANT BIOL, V5, P279, DOI 10.1016/S1369-5266(02)00272-8; Mills-Lujan K, 2010, PROTOPLASMA, V239, P95, DOI 10.1007/s00709-009-0086-z; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; NAGAR S, 1995, PLANT CELL, V7, P705, DOI 10.1105/tpc.7.6.705; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Owens RA, 2012, MOL PLANT MICROBE IN, V25, P582, DOI 10.1094/MPMI-09-11-0258; Padmanabhan MS, 2006, MOL PLANT MICROBE IN, V19, P864, DOI 10.1094/MPMI-19-0864; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Petti C, 2009, J BIOSCI BIOENG, V107, P301, DOI 10.1016/j.jbiosc.2008.11.012; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Scarpeci TE, 2008, PLANT SIGNAL BEHAV, V3, P856, DOI 10.4161/psb.3.10.6021; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sorrell DA, 2001, PLANT PHYSIOL, V126, P1214, DOI 10.1104/pp.126.3.1214; Spaepen S, 2010, COLD SPRING HARB PER, V3; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	92	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67534	10.1371/journal.pone.0067534	http://dx.doi.org/10.1371/journal.pone.0067534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826319	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000089
J	Rebello, MR; Maliphol, AB; Medler, KF				Rebello, Michelle R.; Maliphol, Amanda B.; Medler, Kathryn F.			Ryanodine Receptors Selectively Interact with L Type Calcium Channels in Mouse Taste Cells	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; DIHYDROPYRIDINE RECEPTORS; MAMMALIAN TASTE; SPONTANEOUS EXOCYTOSIS; SYNAPTIC-TRANSMISSION; CHROMAFFIN CELLS; NERVE-TERMINALS; SKELETAL-MUSCLE; LOCAL-CONTROL; BUDS	Introduction: We reported that ryanodine receptors are expressed in two different types of mammalian peripheral taste receptor cells: Type II and Type III cells. Type II cells lack voltage-gated calcium channels (VGCCs) and chemical synapses. In these cells, ryanodine receptors contribute to the taste-evoked calcium signals that are initiated by opening inositol trisphosphate receptors located on internal calcium stores. In Type III cells that do have VGCCs and chemical synapses, ryanodine receptors contribute to the depolarization-dependent calcium influx. Methodology/Principal Findings: The goal of this study was to establish if there was selectivity in the type of VGCC that is associated with the ryanodine receptor in the Type III taste cells or if the ryanodine receptor opens irrespective of the calcium channels involved. We also wished to determine if the ryanodine receptors and VGCCs require a physical linkage to interact or are simply functionally associated with each other. Using calcium imaging and pharmacological inhibitors, we found that ryanodine receptors are selectively associated with L type VGCCs but likely not through a physical linkage. Conclusions/Significance: Taste cells are able to undergo calcium induced calcium release through ryanodine receptors to increase the initial calcium influx signal and provide a larger calcium response than would otherwise occur when L type channels are activated in Type III taste cells.	[Rebello, Michelle R.; Maliphol, Amanda B.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Medler, KF (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Medler, Kathryn/0000-0001-9664-3606	NSF [0917893]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 0917893 to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berrout J, 2009, CELL CALCIUM, V46, P30, DOI 10.1016/j.ceca.2009.03.018; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; De Crescenzo V, 2006, J NEUROSCI, V26, P7565, DOI 10.1523/JNEUROSCI.1512-06.2006; De Crescenzo V, 2012, P NATL ACAD SCI USA, V109, P610, DOI 10.1073/pnas.1115111108; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Kennedy HJ, 2002, J PHYSIOL-LONDON, V539, P15, DOI 10.1113/jphysiol.2001.013171; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lefkowitz JJ, 2009, J GEN PHYSIOL, V134, P267, DOI 10.1085/jgp.200910285; McNally JM, 2009, J NEUROSCI, V29, P14120, DOI 10.1523/JNEUROSCI.1726-09.2009; Medler KF, 2003, J NEUROSCI, V23, P2608; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Ouyang K, 2005, J BIOL CHEM, V280, P15898, DOI 10.1074/jbc.C500026200; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rebello MR, 2010, EUR J NEUROSCI, V32, P1825, DOI 10.1111/j.1460-9568.2010.07463.x; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Roberts CD, 2009, J PHYSIOL-LONDON, V587, P1657, DOI 10.1113/jphysiol.2009.170555; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; ZhuGe R, 2006, BIOPHYS J, V90, P2027, DOI 10.1529/biophysj.105.071654; Zucchi R, 1997, PHARMACOL REV, V49, P1	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68174	10.1371/journal.pone.0068174	http://dx.doi.org/10.1371/journal.pone.0068174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826376	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000130
J	Ramirez-Zamora, S; Mendez-Rodriguez, ML; Olguin-Martinez, M; Sanchez-Sevilla, L; Quintana-Quintana, M; Garcia-Garcia, N; Hernandez-Munoz, R				Ramirez-Zamora, Serafin; Mendez-Rodriguez, Miguel L.; Olguin-Martinez, Marisela; Sanchez-Sevilla, Lourdes; Quintana-Quintana, Miguel; Garcia-Garcia, Norberto; Hernandez-Munoz, Rolando			Increased Erythrocytes By-Products of Arginine Catabolism Are Associated with Hyperglycemia and Could Be Involved in the Pathogenesis of Type 2 Diabetes Mellitus	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; AMINO-ACID-TRANSPORT; OXIDATIVE STRESS; LIPID-PEROXIDATION; BLOOD-CELLS; METABOLISM; INSULIN; BIOENERGETICS; DYSFUNCTION; CITRULLINE	Diabetes mellitus (DM) is a worldwide disease characterized by metabolic disturbances, frequently associated with high risk of atherosclerosis and renal and nervous system damage. Here, we assessed whether metabolites reflecting oxidative redox state, arginine and nitric oxide metabolism, are differentially distributed between serum and red blood cells (RBC), and whether significant metabolism of arginine exists in RBC. In 90 patients with type 2 DM without regular treatment for diabetes and 90 healthy controls, paired by age and gender, we measured serum and RBC levels of malondialdehyde (MDA), nitrites, ornithine, citrulline, and urea. In isolated RBC, metabolism of L-[C-14]-arginine was also determined. In both groups, nitrites were equally distributed in serum and RBC; citrulline predominated in serum, whereas urea, arginine, and ornithine were found mainly in RBC. DM patients showed hyperglycemia and increased blood HbA(1C), and increased levels of these metabolites, except for arginine, significantly correlating with blood glucose levels. RBC were observed to be capable of catabolizing arginine to ornithine, citrulline and urea, which was increased in RBC from DM patients, and correlated with an increased affinity for arginine in the activities of putative RBC arginase (Km = 0.23 +/- 0.06 vs. 0.50 +/- 0.13 mM, in controls) and nitric oxide synthase (Km = 0.28 +/- 0.06 vs. 0.43 +/- 0.09 mM, in controls). In conclusion, our results suggest that DM alters metabolite distribution between serum and RBC, demonstrating that RBC regulate serum levels of metabolites which affect nitrogen metabolism, not only by transporting them but also by metabolizing amino acids such as arginine. Moreover, we confirmed that urea can be produced also by human RBC besides hepatocytes, being much more evident in RBC from patients with type 2 DM. These events are probably involved in the specific physiopathology of this disease, i.e., endothelial damage and dysfunction.	[Ramirez-Zamora, Serafin; Olguin-Martinez, Marisela; Sanchez-Sevilla, Lourdes; Garcia-Garcia, Norberto; Hernandez-Munoz, Rolando] Univ Nacl Autonoma Mexico, Depto Biol Celular, Inst Fisiol Celular, Mexico City, DF, Mexico; [Mendez-Rodriguez, Miguel L.] Escuela Medico Naval, Secretaria Marina Navy, Mexico City, DF, Mexico; [Quintana-Quintana, Miguel] Hosp Naval Alta Especialidad, Secretaria Marina Navy, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Hernandez-Munoz, R (corresponding author), Univ Nacl Autonoma Mexico, Depto Biol Celular, Inst Fisiol Celular, Mexico City, DF, Mexico.	rhernand@ifc.unam.mx			CONACYT [45352-Q]; PAPIIT-DGAPA, UNAM [IN 229703-3]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-DGAPA, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by Institutional (Mexico) funding grants: from CONACYT (45352-Q) and from PAPIIT-DGAPA, UNAM (IN 229703-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuja PM, 2001, CLIN CHIM ACTA, V306, P1, DOI 10.1016/S0009-8981(01)00393-X; Agli AN, 1998, EUR J APPL PHYSIOL O, V78, P502, DOI 10.1007/s004210050452; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEAUMIER L, 1995, AM J PHYSIOL-ENDOC M, V269, pE884, DOI 10.1152/ajpendo.1995.269.5.E884; CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; CRANDALL EA, 1983, DIABETES, V32, P222, DOI 10.2337/diabetes.32.3.222; FAURE P, 1993, CLIN CHEM, V39, P789; FELIG P, 1973, P NATL ACAD SCI USA, V70, P1775, DOI 10.1073/pnas.70.6.1775; FERVENZA FC, 1990, NEPHROL DIAL TRANSPL, V5, P594, DOI 10.1093/ndt/5.8.594; FITZGIBBONS JF, 1976, J CLIN INVEST, V58, P820, DOI 10.1172/JCI108534; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GERICH JE, 1974, J CLIN INVEST, V54, P833, DOI 10.1172/JCI107823; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIESMACHER A, 1995, AM J MED, V98, P469, DOI 10.1016/S0002-9343(99)80347-7; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; HERNANDEZMUNOZ R, 1984, BIOCHEM PHARMACOL, V33, P2599, DOI 10.1016/0006-2952(84)90631-2; Hoeldtke RD, 2003, J CLIN ENDOCR METAB, V88, P1624, DOI 10.1210/jc.2002-021525; HUNT JV, 1990, DIABETES, V39, P1420, DOI 10.2337/diabetes.39.11.1420; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kohli R, 2004, J NUTR, V134, P600, DOI 10.1093/jn/134.3.600; KRAFFCZYK F, 1971, CLIN CHIM ACTA, V31, P489, DOI 10.1016/0009-8981(71)90427-X; Li H, 2002, AM J PHYSIOL-REG I, V282, pR64, DOI 10.1152/ajpregu.2002.282.1.R64; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lucotti P, 2006, AM J PHYSIOL-ENDOC M, V291, pE906, DOI 10.1152/ajpendo.00002.2006; Maeda T, 2006, BIOL PHARM BULL, V29, P234, DOI 10.1248/bpb.29.234; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; MOORE WT, 1964, CLIN CHEM, V10, P1059; MORGAN DML, 1994, BIOCHEM SOC T, V22, pS387, DOI 10.1042/bst022387s; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; OHTSUKA Y, 1988, BIOCHEM BIOPH RES CO, V155, P160, DOI 10.1016/S0006-291X(88)81063-5; OLIVES B, 1995, J BIOL CHEM, V270, P15607, DOI 10.1074/jbc.270.26.15607; Omodeo-Sale F, 2010, AM J PHYSIOL-CELL PH, V299, pC148, DOI 10.1152/ajpcell.00405.2009; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paroni R, 2007, CLIN BIOCHEM, V40, P1398, DOI 10.1016/j.clinbiochem.2007.08.001; Remor AP, 2011, BBA-MOL BASIS DIS, V1812, P1460, DOI 10.1016/j.bbadis.2011.06.017; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Shab-Bidar S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-125; Srinivasan S, 2004, DIABETOLOGIA, V47, P1727, DOI 10.1007/s00125-004-1525-1; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; TUCKER EM, 1980, BIOCHEM J, V192, P33, DOI 10.1042/bj1920033; VANBROECKHOVEN CL, 1982, CLIN CHIM ACTA, V126, P209, DOI 10.1016/0009-8981(82)90294-7; VELAZQUEZ E, 1991, DIABETIC MED, V8, P752, DOI 10.1111/j.1464-5491.1991.tb01695.x; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Waugh WH, 2001, J NATL MED ASSOC, V93, P363; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Wu GY, 2000, J NUTR, V130, P2626, DOI 10.1093/jn/130.11.2626; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu B, 2005, CLIN SCI, V109, P439, DOI 10.1042/CS20050183; YOUNG JD, 1980, PROC R SOC SER B-BIO, V209, P355, DOI 10.1098/rspb.1980.0100; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	58	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66823	10.1371/journal.pone.0066823	http://dx.doi.org/10.1371/journal.pone.0066823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826148	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400062
J	Roslin, T; Wirta, H; Hopkins, T; Hardwick, B; Varkonyi, G				Roslin, Tomas; Wirta, Helena; Hopkins, Tapani; Hardwick, Bess; Varkonyi, Gergely			Indirect Interactions in the High Arctic	PLOS ONE			English	Article							QUANTITATIVE FOOD WEBS; APPARENT COMPETITION; HERBIVOROUS INSECTS; BOTTOM-UP; INTERSPECIFIC INTERACTIONS; PHYTOPHAGOUS INSECTS; COMMUNITY STRUCTURE; HOST-SPECIFICITY; PARASITOIDS; PLANTS	Indirect interactions as mediated by higher and lower trophic levels have been advanced as key forces structuring herbivorous arthropod communities around the globe. Here, we present a first quantification of the interaction structure of a herbivore-centered food web from the High Arctic. Targeting the Lepidoptera of Northeast Greenland, we introduce generalized overlap indices as a novel tool for comparing different types of indirect interactions. First, we quantify the scope for top-down-up interactions as the probability that a herbivore attacking plant species i itself fed as a larva on species j. Second, we gauge this herbivore overlap against the potential for bottom-up-down interactions, quantified as the probability that a parasitoid attacking herbivore species i itself developed as a larva on species j. Third, we assess the impact of interactions with other food web modules, by extending the core web around the key herbivore Sympistis nigrita to other predator guilds (birds and spiders). We find the host specificity of both herbivores and parasitoids to be variable, with broad generalists occurring in both trophic layers. Indirect links through shared resources and through shared natural enemies both emerge as forces with a potential for shaping the herbivore community. The structure of the host-parasitoid submodule of the food web suggests scope for classic apparent competition. Yet, based on predation experiments, we estimate that birds kill as many (8%) larvae of S. nigrita as do parasitoids (8%), and that spiders kill many more (38%). Interactions between these predator guilds may result in further complexities. Our results caution against broad generalizations from studies of limited food web modules, and show the potential for interactions within and between guilds of extended webs. They also add a data point from the northernmost insect communities on Earth, and describe the baseline structure of a food web facing imminent climate change.	[Roslin, Tomas; Wirta, Helena; Hopkins, Tapani; Hardwick, Bess] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Varkonyi, Gergely] Friendship Pk Res Ctr, Nat Environm Ctr, Finnish Environm Inst, Kuhmo, Finland	University of Helsinki; Finnish Environment Institute	Roslin, T (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	tomas.roslin@helsinki.fi	Wirta, Helena/U-1892-2019; Várkonyi, Gergely/I-2310-2012; Hopkins, Tapani/U-6088-2019; Roslin, Tomas/E-8648-2016	Wirta, Helena/0000-0002-4667-2166; Várkonyi, Gergely/0000-0002-7977-2753; Roslin, Tomas/0000-0002-2957-4791; Hopkins, Tapani/0000-0002-2256-0098; Hardwick, Bess/0000-0001-5195-6115	INTERACT under the European Community's Seventh Framework Programme; University of Helsinki [788/51/2010]; Kone foundation	INTERACT under the European Community's Seventh Framework Programme; University of Helsinki; Kone foundation	Funding by INTERACT (http://www.eu-interact.org/; project QUANTIC) under the European Community's Seventh Framework Programme, by the University of Helsinki (http://www.helsinki.fi/university/index.html; grant number 788/51/2010 to TR), and by the Kone foundation (http://www.koneensaatio.fi/en/, through a grant to HW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Ahola M., 2005, LARVAE NO EUROPEAN N; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Baiser B, 2012, GLOBAL ECOL BIOGEOGR, V21, P579, DOI 10.1111/j.1466-8238.2011.00705.x; Bay C., 1998, VEGETATION MAPPING Z; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bonsall MB, 1997, NATURE, V388, P371, DOI 10.1038/41084; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; COLINVAUX P, 1993, ECOLOGY, V2; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dobzhansky T., 1950, American Scientist, V38, P209; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Efron B., 1994, INTRO BOOTSTRAP; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Elton C. S., 1927, ANIMAL ECOLOGY; Ertl S, 2008, ZACKENBERG ECOLOGICA, P85; Fernandez-Triana J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023719; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; FRETWELL SD, 1977, PERSPECT BIOL MED, V20, P169; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Hansen BU, 2008, ADV ECOL RES, V40, P111, DOI 10.1016/S0065-2504(07)00006-2; Hansen Jannik, 2012, Bird Populations, V11, P30; Harvey JA, 2010, BIOL CONSERV, V143, P2251, DOI 10.1016/j.biocon.2010.03.004; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Hawkins BA, 1994, PATTERN PROCESS HOST; Henson KSE, 2009, ECOLOGY, V90, P1840, DOI 10.1890/07-2108.1; Hirao T, 2008, ECOL RES, V23, P159, DOI 10.1007/s11284-007-0351-6; Hodkinson ID, 2004, OIKOS, V106, P427; Hodkinson ID, 2001, OIKOS, V95, P349, DOI 10.1034/j.1600-0706.2001.950217.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Howe A, 2009, ENTOMOL EXP APPL, V131, P325, DOI 10.1111/j.1570-7458.2009.00860.x; HUNTER MD, 1992, ECOLOGY, V73, P724; JANZEN DH, 1979, HERBIVORES THEIR INT, P331; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kaartinen R, 2012, OIKOS, V121, P1771, DOI 10.1111/j.1600-0706.2012.20108.x; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; KUKAL O, 1988, J EXP BIOL, V138, P181; Larsen S, 2000, ZACKENBERG ECOLOGICA, P54; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; MacArthur R.H., 1972, pvii; MARTINEZ ND, 1993, OIKOS, V66, P403, DOI 10.2307/3544934; Martinson HM, 2012, ECOLOGY, V93, P1779, DOI 10.1890/11-1497.1; Meltofte H, 2008, ADV ECOL RES, V40, P101, DOI 10.1016/S0065-2504(07)00005-0; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Morin P., 1999, COMMUNITY ECOL; Morris RJ, 2005, ANN ZOOL FENN, V42, P449; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Novotny V, 1999, AUST J ECOL, V24, P477, DOI 10.1046/j.1440-169x.1999.00987.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; PIMENTEL D, 1984, INSECT SCI APPL, V5, P141, DOI 10.1017/S1742758400008201; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; PIMM SL, 1982, FOOD WEBS; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; R Core Team, 2012, R LANG ENV STAT COMP; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; Roslin T, 2005, ECOSCIENCE, V12, P172, DOI 10.2980/i1195-6860-12-2-172.1; Rott AS, 2000, J ANIM ECOL, V69, P274, DOI 10.1046/j.1365-2656.2000.00390.x; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Slade E, 2007, EFFECTS TROPICAL FOR; Strong D.R., 1984, INSECTS PLANTS COMMU; Tack AJM, 2011, J ANIM ECOL, V80, P108, DOI 10.1111/j.1365-2656.2010.01744.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Varkonyi G, 2013, CAN ENTOMOL, V145, P193, DOI 10.4039/tce.2013.9; WILLIAMSON MH, 1957, NATURE, V180, P422, DOI 10.1038/180422a0; WILSON E O, 1992	101	27	28	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67367	10.1371/journal.pone.0067367	http://dx.doi.org/10.1371/journal.pone.0067367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826279	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400138
J	Chen, BM; Peng, SL; D'Antonio, CM; Li, DJ; Ren, WT				Chen, Bao-Ming; Peng, Shao-Lin; D'Antonio, Carla M.; Li, Dai-Jiang; Ren, Wen-Tao			Non-Additive Effects on Decomposition from Mixing Litter of the Invasive Mikania micrantha HBK with Native Plants	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; LEAF-LITTER; ACCELERATE DECOMPOSITION; NITROGEN DYNAMICS; AQUEOUS EXTRACTS; DECAY-RATES; IMPACTS; RELEASE; LIGNIN; BIODIVERSITY	A common hypothesis to explain the effect of litter mixing is based on the difference in litter N content between mixed species. Although many studies have shown that litter of invasive non-native plants typically has higher N content than that of native plants in the communities they invade, there has been surprisingly little study of mixing effects during plant invasions. We address this question in south China where Mikania micrantha H. B. K., a non-native vine, with high litter N content, has invaded many forested ecosystems. We were specifically interested in whether this invader accelerated decomposition and how the strength of the litter mixing effect changes with the degree of invasion and over time during litter decomposition. Using litterbags, we evaluated the effect of mixing litter of M. micrantha with the litter of 7 native resident plants, at 3 ratios: M-1 (1:4, = exotic:native litter), M-2 (1:1) and M-3 (4:1, = exotic:native litter) over three incubation periods. We compared mixed litter with unmixed litter of the native species to identify if a non-additive effect of mixing litter existed. We found that there were positive significant non-additive effects of litter mixing on both mass loss and nutrient release. These effects changed with native species identity, mixture ratio and decay times. Overall the greatest accelerations of mixture decay and N release tended to be in the highest degree of invasion (mix ratio M-3) and during the middle and final measured stages of decomposition. Contrary to expectations, the initial difference in litter N did not explain species differences in the effect of mixing but overall it appears that invasion by M. micrantha is accelerating the decomposition of native species litter. This effect on a fundamental ecosystem process could contribute to higher rates of nutrient turnover in invaded ecosystems.	[Chen, Bao-Ming; Peng, Shao-Lin; Li, Dai-Jiang; Ren, Wen-Tao] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	Sun Yat Sen University; University of California System; University of California Santa Barbara	Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn	Chen, Bao-Ming/H-9024-2016	Chen, Bao-Ming/0000-0003-1891-8752; Li, Daijiang/0000-0002-0925-3421	National Natural Science Foundation of China [31070481, 31030015]; Doctoral Foundation of Ministry of Education of China [20100171120030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (31070481, 31030015) and Doctoral Foundation of Ministry of Education of China (20100171120030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; [Anonymous], [No title captured]; APLET GH, 1990, OECOLOGIA, V82, P414, DOI 10.1007/BF00317491; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Ball BA, 2009, ECOSYSTEMS, V12, P87, DOI 10.1007/s10021-008-9208-2; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B., 1980, Ecological Bulletins, V32, P373; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bragazza L, 2010, BIOL FERT SOILS, V46, P877, DOI 10.1007/s00374-010-0483-7; Chen BM, 2007, ALLELOPATHY J, V20, P307; Chen BM, 2009, ALLELOPATHY J, V23, P453; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Elgersma KJ, 2011, BIOL INVASIONS, V13, P757, DOI 10.1007/s10530-010-9866-9; Eppinga MB, 2011, J ECOL, V99, P503, DOI 10.1111/j.1365-2745.2010.01781.x; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heneghan L, 2007, PEDOBIOLOGIA, V50, P543, DOI 10.1016/j.pedobi.2006.10.002; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Huang Zhong-liang, 2000, Journal of Tropical and Subtropical Botany, V8, P131; Klotzbucher T, 2011, ECOLOGY, V92, P1052, DOI 10.1890/i0012-9658-92-5-1052; Kourtev P.S., 1999, Biological Invasions, V1, P237, DOI 10.1023/A:1010048909563; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Li DJ, 2013, PLANT SOIL, V365, P255, DOI 10.1007/s11104-012-1337-x; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Liu ZG, 2002, ECOL APPL, V12, P1406, DOI 10.1890/1051-0761(2002)012[1406:EEAPLD]2.0.CO;2; Mack MC, 2003, ECOSYSTEMS, V6, P723, DOI 10.1007/s10021-003-0119-y; Maisto G, 2011, SOIL BIOL BIOCHEM, V43, P520, DOI 10.1016/j.soilbio.2010.11.017; Makkonen M, 2013, OIKOS, V122, P987, DOI 10.1111/j.1600-0706.2012.20750.x; MCCLAUGHERTY CA, 1985, ECOLOGY, V66, P266, DOI 10.2307/1941327; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; PALM CA, 1990, BIOTROPICA, V22, P330, DOI 10.2307/2388550; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Rosemond AD, 2010, OIKOS, V119, P326, DOI 10.1111/j.1600-0706.2009.17904.x; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Scowcroft PG, 1997, J TROP ECOL, V13, P407, DOI 10.1017/S0266467400010592; Sheng ZB, 1987, BIOMASS CHEM ENG, V6, P2; Smith VC, 2003, OIKOS, V102, P235, DOI 10.1034/j.1600-0706.2003.12503.x; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; STOCK WD, 1995, OECOLOGIA, V101, P375, DOI 10.1007/BF00328825; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Ward SE, 2010, OECOLOGIA, V164, P511, DOI 10.1007/s00442-010-1636-y; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Waterhouse D.F., 1994, BIOL CONTROL WEEDS S, V125; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x; Zhang Weiyin, 2002, Yingyong Shengtai Xuebao, V13, P1684; [周先叶 Zhou Xianye], 2003, [生态科学, Ecologic Science], V22, P332	60	30	32	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66289	10.1371/journal.pone.0066289	http://dx.doi.org/10.1371/journal.pone.0066289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840435	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800045
J	Getty, A; Kovacs, AD; Lengyel-Nelson, T; Cardillo, A; Hof, C; Chan, CH; Pearce, DA				Getty, Amanda; Kovacs, Attila D.; Lengyel-Nelson, Timea; Cardillo, Andrew; Hof, Caitlin; Chan, Chun-Hung; Pearce, David A.			Osmotic Stress Changes the Expression and Subcellular Localization of the Batten Disease Protein CLN3	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; GREEN FLUORESCENT PROTEIN; HEAT-SHOCK FACTOR; MEMBRANE GLYCOPROTEIN; MAMMALIAN-CELLS; DILEUCINE MOTIF; BINDING PROTEIN; IN-VITRO; GENE; TRANSCRIPTION	Juvenile CLN3 disease (formerly known as juvenile neuronal ceroid lipofuscinosis) is a fatal childhood neurodegenerative disorder caused by mutations in the CLN3 gene. CLN3 encodes a putative lysosomal transmembrane protein with unknown function. Previous cell culture studies using CLN3-overexpressing vectors and/or anti-CLN3 antibodies with questionable specificity have also localized CLN3 in cellular structures other than lysosomes. Osmoregulation of the mouse Cln3 mRNA level in kidney cells was recently reported. To clarify the subcellular localization of the CLN3 protein and to investigate if human CLN3 expression and localization is affected by osmotic changes we generated a stably transfected BHK (baby hamster kidney) cell line that expresses a moderate level of myc-tagged human CLN3 under the control of the human ubiquitin C promoter. Hyperosmolarity (800 mOsm), achieved by either NaCl/urea or sucrose, dramatically increased the mRNA and protein levels of CLN3 as determined by quantitative real-time PCR and Western blotting. Under isotonic conditions (300 mOsm), human CLN3 was found in a punctate vesicular pattern surrounding the nucleus with prominent Golgi and lysosomal localizations. CLN3-positive early endosomes, late endosomes and cholesterol/sphingolipid-enriched plasma membrane microdomain caveolae were also observed. Increasing the osmolarity of the culture medium to 800 mOsm extended CLN3 distribution away from the perinuclear region and enhanced the lysosomal localization of CLN3. Our results reveal that CLN3 has multiple subcellular localizations within the cell, which, together with its expression, prominently change following osmotic stress. These data suggest that CLN3 is involved in the response and adaptation to cellular stress.	[Getty, Amanda; Kovacs, Attila D.; Lengyel-Nelson, Timea; Cardillo, Andrew; Hof, Caitlin; Chan, Chun-Hung; Pearce, David A.] Sanford Res USD, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Pearce, David A.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA	Sanford Health; University of South Dakota	Pearce, DA (corresponding author), Sanford Res USD, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA.	David.Pearce@sanfordhealth.org	Chan, Chun-Hung/F-5358-2015	Chan, Chun-Hung/0000-0001-9646-2944	Luke and Rachel Batten Foundation; National Institutes of Health (NIH) [R01 NS044310, R21 NS067147]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044310, R21NS067147] Funding Source: NIH RePORTER	Luke and Rachel Batten Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Luke and Rachel Batten Foundation and the National Institutes of Health (NIH) grants R01 NS044310 and R21 NS067147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-28; [Anonymous], 1995, Cell, V82, P949; Arakawa Y, 2004, BIOCHEM BIOPH RES CO, V322, P297, DOI 10.1016/j.bbrc.2004.04.208; Brenner BM, 2008, BRENNER RECTORS KIDN; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caruccio L, 1997, BIOCHEM J, V327, P341, DOI 10.1042/bj3270341; Codlin S, 2009, J CELL SCI, V122, P1163, DOI 10.1242/jcs.038323; Cooper JD, 2008, EXP NEUROL, V211, P329, DOI 10.1016/j.expneurol.2008.02.016; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ezaki J, 2003, J NEUROCHEM, V87, P1296, DOI 10.1046/j.1471-4159.2003.02132.x; Getty AL, 2010, CELL MOL LIFE SCI; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; Golabek AA, 1999, MOL GENET METAB, V66, P277, DOI 10.1006/mgme.1999.2836; Haskell RE, 2000, HUM MOL GENET, V9, P735, DOI 10.1093/hmg/9.5.735; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jarvela I, 1999, HUM MOL GENET, V8, P1091, DOI 10.1093/hmg/8.6.1091; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Kaczmarski W, 1999, MOL GENET METAB, V66, P261, DOI 10.1006/mgme.1999.2833; Kama R, 2011, J CELL BIOL, V195, P203, DOI 10.1083/jcb.201102115; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kast C, 2003, J BIOL CHEM, V278, P6787, DOI 10.1074/jbc.M210935200; Khan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046098; Kida E, 1999, MOL GENET METAB, V66, P265, DOI 10.1006/mgme.1999.2837; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Kremmidiotis G, 1999, HUM MOL GENET, V8, P523, DOI 10.1093/hmg/8.3.523; Kuper C, 2007, CURR GENOMICS, V8, P209; Kwon JM, 2011, NEUROLOGY, V77, P1801, DOI 10.1212/WNL.0b013e318237f649; Kyttala A, 2005, J BIOL CHEM, V280, P10277, DOI 10.1074/jbc.M411862200; Kyttala A, 2004, MOL BIOL CELL, V15, P1313, DOI 10.1091/mbc.E03-02-0120; Lin GGH, 2011, INSECT MOL BIOL, V20, P87, DOI 10.1111/j.1365-2583.2010.01047.x; LoCoco F, 1997, HAEMATOLOGICA, V82, P364; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Mao L, 2008, J PROTEOME RES, V7, P3968, DOI 10.1021/pr800245x; Mao QW, 2003, FEBS LETT, V555, P351, DOI 10.1016/S0014-5793(03)01274-2; Margraf LR, 1999, MOL GENET METAB, V66, P283, DOI 10.1006/mgme.1999.2830; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Michalewski MP, 1998, BIOCHEM BIOPH RES CO, V253, P458, DOI 10.1006/bbrc.1998.9210; Michalewski MP, 1999, MOL GENET METAB, V66, P272, DOI 10.1006/mgme.1999.2818; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Pedersen SF, 2002, EXP CELL RES, V277, P57, DOI 10.1006/excr.2002.5529; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Phillips SN, 2005, J NEUROSCI RES, V79, P573, DOI 10.1002/jnr.20367; Pullarkat RK, 1997, NEUROPEDIATRICS, V28, P42, DOI 10.1055/s-2007-973665; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SHIEH BH, 1993, GENOMICS, V16, P266, DOI 10.1006/geno.1993.1174; Stein CS, 2010, AM J PHYSL CELL PHYS; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Uchiumi F, 2008, GENES CELLS, V13, P1229, DOI 10.1111/j.1365-2443.2008.01240.x; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547; Wolfe DM, 2011, DIS MODEL MECH, V4, P120, DOI 10.1242/dmm.006114; Wu YL, 2012, BIOCHIMIE, V94, P384, DOI 10.1016/j.biochi.2011.08.006; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	57	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66203	10.1371/journal.pone.0066203	http://dx.doi.org/10.1371/journal.pone.0066203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840424	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800041
J	Kamata, T; Handa, M; Takakuwa, S; Sato, Y; Kawai, Y; Ikeda, Y; Aiso, S				Kamata, Tetsuji; Handa, Makoto; Takakuwa, Sonomi; Sato, Yukiko; Kawai, Yohko; Ikeda, Yasuo; Aiso, Sadakazu			Epitope Mapping for Monoclonal Antibody Reveals the Activation Mechanism for alpha V beta 3 Integrin	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; STRUCTURAL BASIS; LIGAND-BINDING; HUMAN-MELANOMA; COMPLEX; FIBRINOGEN; ADHESION; CELLS	Epitopes for a panel of anti-alpha V beta 3 monoclonal antibodies (mAbs) were investigated to explore the activation mechanism of alpha V beta 3 integrin. Experiments utilizing alpha V/alpha IIb domain-swapping chimeras revealed that among the nine mAbs tested, five recognized the ligand-binding beta-propeller domain and four recognized the thigh domain, which is the upper leg of the alpha V chain. Interestingly, the four mAbs included function-blocking as well as non-functional mAbs, although they bound at a distance from the ligand-binding site. The epitopes for these four mAbs were further determined using human-to-mouse alpha V chimeras. Among the four, P3G8 recognized an amino acid residue, Ser-528, located on the side of the thigh domain, while AMF-7, M9, and P2W7 all recognized a common epitope, Ser-462, that was located close to the a-genu, where integrin makes a sharp bend in the crystal structure. Fibrinogen binding studies for cells expressing wild-type alpha V beta 3 confirmed that AMF-7, M9, and P2W7 were inhibitory, while P3G8 was non-functional. However, these mAbs were all unable to block binding when alpha V beta 3 was constrained in its extended conformation. These results suggest that AMF-7, M9, and P2W7 block ligand binding allosterically by stabilizing the angle of the bend in the bent conformation. Thus, a switchblade-like movement of the integrin leg is indispensable for the affinity regulation of alpha V beta 3 integrin.	[Kamata, Tetsuji; Takakuwa, Sonomi; Sato, Yukiko; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Handa, Makoto] Keio Univ, Sch Med, Ctr Transfus Med & Cell Therapy, Shinjuku Ku, Tokyo, Japan; [Kawai, Yohko] Int Univ Hlth & Welf, Prevent Hlth Examinat Ctr, Minato Ku, Tokyo, Japan; [Ikeda, Yasuo] Waseda Univ, Grad Sch Adv Sci & Engn, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; International University of Health & Welfare; Waseda University	Kamata, T (corresponding author), Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan.	kamata@z7.keio.jp	Handa, Makoto/B-1121-2014		Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan	Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan	This work was supported by Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan (to TK and MH), and by a grant from Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHUNTHARAPAI A, 1993, EXP CELL RES, V205, P345, DOI 10.1006/excr.1993.1096; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; DEVRIES JE, 1986, INT J CANCER, V38, P465, DOI 10.1002/ijc.2910380403; Friedlander DR, 1996, CANCER RES, V56, P1939; HORTON MA, 1985, CANCER RES, V45, P5663; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; LEHMANN M, 1994, CANCER RES, V54, P2102; Litvinov RI, 2012, J BIOL CHEM; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; MITJANS F, 1995, J CELL SCI, V108, P2825; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; von Schlippe M, 2000, J CELL SCI, V113, P425; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66096	10.1371/journal.pone.0066096	http://dx.doi.org/10.1371/journal.pone.0066096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840404	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800029
J	Mandai, Y; Takahashi, D; Hase, K; Obata, Y; Furusawa, Y; Ebisawa, M; Nakagawa, T; Sato, T; Katsuno, T; Saito, Y; Shimaoka, T; Yokosuka, O; Yokote, K; Ohno, H				Mandai, Yasushi; Takahashi, Daisuke; Hase, Koji; Obata, Yuuki; Furusawa, Yukihiro; Ebisawa, Masashi; Nakagawa, Tomoo; Sato, Toru; Katsuno, Tatsuro; Saito, Yasushi; Shimaoka, Takeshi; Yokosuka, Osamu; Yokote, Kotaro; Ohno, Hiroshi			Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis	PLOS ONE			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; TRANSMEMBRANE CXC-CHEMOKINE; CROHNS-DISEASE; MEMORY; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; RECRUITMENT; SUBSETS; LIGAND	CD4(+) T cells play a central role in the development of inflammatory bowel disease (IBD) via high-level production of effector cytokines such as IFN-gamma and TNF-alpha. To better characterize the colitogenic CD4(+) T cells, we examined their expression of CXCR6, a chemokine receptor that is expressed by T cells upon activation and is upregulated in several inflammatory diseases. We found that 80% of colonic lamina propria CD4(+) T cells expressed CXCR6 in the CD45RB(high) T cell-transferred colitis model. CXCR6 expression was similarly upregulated in inflamed mucosa of patients with Crohn's disease. Although surface marker analysis demonstrated that both CXCR6(+) and CXCR6(-) CD4(+) T-cell subsets consist of the cells with effector and effector-memory cells, the more cells in the CXCR6(+) subset produced IFN-gamma and TNF-alpha compared to CXCR6(-) subset, and only the CXCR6(+) subset produced IL-17A. Nevertheless, adoptive retransfer of lamina propria CXCR6(+) T cells into Rag1(-/-) recipients failed to induce the disease due to limited expansion of the transferred cells. By contrast, retransfer of CXCR6(-) cells evoked colitis similar to that observed in CD4(+)CD45RB(high) T cell-transferred mice, and resulted in their conversion into CXCR6(+) cells. Collectively, these observations suggest that the CXCR6(+) CD4(+) T-cell subset consists of terminally differentiated effector cells that serve as the major source of effector cytokines in the inflamed tissue, whereas CXCR6(-)CD4(+) T-cell subset serves as a colitogenic memory compartment that retains the ability to proliferate and differentiate into CXCR6(+)CD4(+) T cells.	[Mandai, Yasushi; Nakagawa, Tomoo; Sato, Toru; Katsuno, Tatsuro; Saito, Yasushi; Yokote, Kotaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chiba, Japan; [Obata, Yuuki; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Dept Immune Regulat, Chiba, Japan; [Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Mandai, Yasushi; Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Yokohama, Kanagawa, Japan; [Hase, Koji; Obata, Yuuki; Furusawa, Yukihiro] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Bioenvironm Epigenet, Yokohama, Kanagawa, Japan; [Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Div Immunobiol, Yokohama, Kanagawa 232, Japan; [Hase, Koji; Furusawa, Yukihiro] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Mucosal Barriol,Minato Ku, Tokyo, Japan; [Shimaoka, Takeshi] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo, Japan	Chiba University; Chiba University; Chiba University; RIKEN; RIKEN; Yokohama City University; University of Tokyo; University of Tokyo	Hase, K (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Bioenvironm Epigenet, Yokohama, Kanagawa, Japan.	hase@ims.u-tokyo.ac.jp; ohno@rcai.riken.jp	Takahashi, Daisuke/C-3799-2019; Ohno, Hiroshi/L-7899-2014	Takahashi, Daisuke/0000-0001-8624-1160; Ohno, Hiroshi/0000-0001-8776-9661; Hase, Koji/0000-0001-9550-2334; Obata, Yuuki/0000-0001-5461-3521	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790383, 22689017, 24249029, 15079203, 22021046, 20113003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Young Scientists (B: #20790383) and (A: #22689017) (KH), Scientific research (A: 24249029) (HO), Scientific Research in Priority Areas (#15079203) (HO) and (#22021046) (KH), and Scientific Research on Innovative Areas (#20113003) (HO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Kanai T, 2009, INFLAMM BOWEL DIS, V15, P926, DOI 10.1002/ibd.20738; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Nemoto Y, 2007, GASTROENTEROLOGY, V132, P176, DOI 10.1053/j.gastro.2006.10.035; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; van der Voort R, 2005, ARTHRITIS RHEUM-US, V52, P1381, DOI 10.1002/art.21004; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091	28	13	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65488	10.1371/journal.pone.0065488	http://dx.doi.org/10.1371/journal.pone.0065488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840334	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200020
J	Wilson, S; Anderson, EM; Wilson, ASG; Bertram, DF; Arcese, P				Wilson, Scott; Anderson, Eric M.; Wilson, Amy S. G.; Bertram, Douglas F.; Arcese, Peter			Citizen Science Reveals an Extensive Shift in the Winter Distribution of Migratory Western Grebes	PLOS ONE			English	Article							BIRD ABUNDANCE; CLIMATE; FOOD; POPULATIONS; ECOSYSTEM; DECLINES; RECOVERY; SEABIRDS; TRENDS; STOCKS	Marine waterbirds have shown variable trends in abundance over the past four decades with some species displaying steep declines along the Pacific coast from British Columbia through California. One of the most dramatic changes has been that of western grebes (Aechmophorus occidentalis) in the Salish Sea. This region was a former core of the species wintering distribution but they have become increasingly rare prompting calls for conservation action. A more thorough understanding of this situation requires the analysis of trends at broader geographic scales as well as a consideration of mechanisms that might have led to a change in abundance. We used hierarchical modeling with a Bayesian framework applied to 36 years of Audubon Christmas Bird Count data to assess continent-wide and regional population trends in western and Clark's grebes (A. clarkii) from 1975 to 2010. Our results show that the North American wintering population of Aechmophorus grebes decreased by similar to 52% after 1975, but also that western grebes displayed strongly opposing regional patterns. Abundance decreased by about 95% over 36 years in the Salish Sea but increased by over 300% along coastal California. As a result, the mean centre of the species distribution shifted south by an estimated 895 km between 1980 and 2010. Mechanisms underlying this shift require further study but we hypothesize that it may be related to a change in the abundance and availability of their forage fish prey base. Since the mid-1980s, the Pacific sardine stock off the California coast increased from a few thousand metric tonnes to over two million. At the same time both the abundance and availability of Pacific herring declined in the Salish Sea. Studies are needed to examine this hypothesis further and additional consideration should be directed at other changes in the marine environment that may have contributed to a range shift.	[Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Anderson, Eric M.] Simon Fraser Univ, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada; [Wilson, Amy S. G.; Arcese, Peter] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Bertram, Douglas F.] Environm Canada, Sci & Technol Branch, Inst Ocean Sci, Sidney, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; Simon Fraser University; University of British Columbia; Environment & Climate Change Canada	Wilson, S (corresponding author), Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada.	ScottD.Wilson@ec.gc.ca	Wilson, Scott/AAC-7144-2021		Environment Canada	Environment Canada(CGIAR)	A portion of this work was funded by a grant and contribution by Environment Canada to PA. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript. Data collection was organized by the Audubon Society and performed by volunteers as part of the annual Audubon Christmas Bird Count.	Agler BA, 1999, WATERBIRDS, V22, P98, DOI 10.2307/1521998; Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Anderson Eric M., 2009, Marine Ornithology, V37, P19; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; Bent AC, 1919, LIFE HIST N AM DIVIN, P1; Bower John L., 2009, Marine Ornithology, V37, P9; Burger A. E., 1997, WR87 BRIT COL MIN EN; BUTCHER G S, 1990, U S Fish and Wildlife Service Biological Report, V90, P120; Carter Harry R., 2003, Marine Ornithology, V31, P1; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clowater JS, 1998, THESIS S FRASER U BU; Cogswell H. L, 1977, WATER BIRDS CALIFORN; Crawford RJM, 2007, J ORNITHOL, V148, pS253, DOI 10.1007/s10336-007-0228-z; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; DFO, 2004, 2004037 DFO CAN SCI; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Eichhorst BA, 1994, N AM BIRD BANDER, V17, P108; Erickson MA, 2010, THESIS U ALBERTA EDM; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gelman A., 2004, BAYESIAN DATA ANAL; Gjerdrum C, 2003, P NATL ACAD SCI USA, V100, P9377, DOI 10.1073/pnas.1133383100; Grosbois V, 2005, OIKOS, V109, P273, DOI 10.1111/j.0030-1299.2005.13774.x; Hayward TL, 1997, TRENDS ECOL EVOL, V12, P150, DOI 10.1016/S0169-5347(97)01002-1; HILL KT, 2009, NOAATMNMFSSWFSC452 U; Hipfner J. Mark, 2012, Marine Ornithology, V40, P39; Humple D. L., 2009, THESIS SONOMA STATE; Johnsgard PA, 1987, DIVING BIRDS N AM; Julian F, 1997, FISHERY B, V96, P271; Kery M., 2010, INTRO WINBUGS ECOLOG; Kushlan J.A., 2002, WATERBIRD CONSERVATI; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Landis WG, 2010, RISK ANAL, V30, P183, DOI 10.1111/j.1539-6924.2009.01288.x; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Morris W. F., 2002, QUANTITATIVE CONSERV; Neuchterlein GL, 1975, THESIS COLORADO STAT; Newton I., 1998, POPULATION LIMITATIO; Poole A., 1992, BIRDS N AM ONLINE; Robison KM, 2008, W CLARKS GREBE CONSE; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 2011, N AM BREEDING BIRD S; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Stick K.C., 2009, 0905 FPA; Therriault Thomas W., 2009, Marine Ornithology, V37, P3; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; Wollis S, 2010, 138 ALB SUST RES DEV; Wynn RB, 2011, BIOL LETT, V3, P529; Yanch J, 2006, 60 ALB SUST RES DEV; Zwolinski JP, 2012, FISH B-NOAA, V110, P110	53	41	42	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65408	10.1371/journal.pone.0065408	http://dx.doi.org/10.1371/journal.pone.0065408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840328	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200017
J	Butler, CF; Peet, C; Mason, AE; Voice, MW; Leys, D; Munro, AW				Butler, Christopher F.; Peet, Caroline; Mason, Amy E.; Voice, Michael W.; Leys, David; Munro, Andrew W.			Key Mutations Alter the Cytochrome P450 BM3 Conformational Landscape and Remove Inherent Substrate Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; SELF-SUFFICIENT; HEME IRON; SINGLE-MUTATION; BINDING; P450BM3; SITE; LIGAND; IDENTIFICATION; METABOLITES	Cytochrome P450 monooxygenases (P450s) have enormous potential in the production of oxychemicals, due to their unparalleled regio- and stereoselectivity. The Bacillus megaterium P450 BM3 enzyme is a key model system, with several mutants (many distant from the active site) reported to alter substrate selectivity. It has the highest reported monooxygenase activity of the P450 enzymes, and this catalytic efficiency has inspired protein engineering to enable its exploitation for biotechnologically relevant oxidations with structurally diverse substrates. However, a structural rationale is lacking to explain how these mutations have such effects in the absence of direct change to the active site architecture. Here, we provide the first crystal structures of BM3 mutants in complex with a human drug substrate, the proton pump inhibitor omeprazole. Supported by solution data, these structures reveal how mutation alters the conformational landscape and decreases the free energy barrier for transition to the substrate-bound state. Our data point to the importance of such "gatekeeper" mutations in enabling major changes in substrate recognition. We further demonstrate that these mutants catalyze the same 5-hydroxylation reaction as performed by human CYP2C19, the major human omeprazolemetabolizing P450 enzyme.	[Butler, Christopher F.; Mason, Amy E.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Peet, Caroline; Voice, Michael W.] Cypex Ltd, Dundee DD2 1NH, Scotland	University of Manchester	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F00883X1]; Industrial CASE Studentship from Cypex Ltd. [BB/G01698/1]; Biotechnology and Biological Sciences Research Council [BB/F002521/1, BB/K001884/1, BB/F00883X/1] Funding Source: researchfish; BBSRC [BB/K001884/1, BB/F002521/1, BB/F00883X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Industrial CASE Studentship from Cypex Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Research Grant BB/F00883X1 (to A. W. M. and D. L. supporting A. E. M.) and Industrial CASE Studentship BB/G01698/1 from Cypex Ltd. (to A. W. M. and M. W. V. supporting C. F. B.).	Abelo A, 2000, DRUG METAB DISPOS, V28, P966; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Carmichael AB, 2001, EUR J BIOCHEM, V268, P3117, DOI 10.1046/j.1432-1327.2001.02212.x; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dietrich M, 2009, J BIOTECHNOL, V139, P115, DOI 10.1016/j.jbiotec.2008.10.002; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; Girvan HM, 2007, J BIOL CHEM, V282, P564, DOI 10.1074/jbc.M607949200; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Ibeanu GC, 1996, J BIOL CHEM, V271, P12496, DOI 10.1074/jbc.271.21.12496; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Kuper J, 2012, ACTA CRYSTALLOGR F, V68, P1013, DOI 10.1107/S1744309112031570; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Li HY, 1999, BBA-MOL CELL BIOL L, V1441, P141, DOI 10.1016/S1388-1981(99)00161-4; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 1996, EUR J BIOCHEM, V239, P403, DOI 10.1111/j.1432-1033.1996.0403u.x; NARHI LO, 1986, J BIOL CHEM, V261, P7160; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Peters MW, 2003, J AM CHEM SOC, V125, P13442, DOI 10.1021/ja0303790; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; RENBERG L, 1989, DRUG METAB DISPOS, V17, P69; Romero PA, 2013, P NATL ACAD SCI USA, V110, pE193, DOI 10.1073/pnas.1215251110; Sawayama AM, 2009, CHEM-EUR J, V15, P11723, DOI 10.1002/chem.200900643; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Tsotsou GE, 2012, CHEM-EUR J, V18, P3582, DOI 10.1002/chem.201102470; Venkataraman H, 2012, CHEMBIOCHEM, V13, P520, DOI 10.1002/cbic.201100750; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Whitehouse CJC, 2010, CHEMBIOCHEM, V11, P2549, DOI 10.1002/cbic.201000421; Whitehouse CJC, 2009, CHEMBIOCHEM, V10, P1654, DOI 10.1002/cbic.200900279; Xu F, 2007, PROTEIN ENG DES SEL, V20, P473, DOI 10.1093/protein/gzm028; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014	58	51	54	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25387	25399		10.1074/jbc.M113.479717	http://dx.doi.org/10.1074/jbc.M113.479717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23828198	Green Published, hybrid			2022-12-25	WOS:000330619000036
J	Berry, DC; Jacobs, H; Marwarha, G; Gely-Pernot, A; O'Byrne, SM; DeSantis, D; Klopfenstein, M; Feret, B; Dennefeld, C; Blaner, WS; Croniger, CM; Mark, M; Noy, N; Ghyselinck, NB				Berry, Daniel C.; Jacobs, Hugues; Marwarha, Gurdeep; Gely-Pernot, Aurore; O'Byrne, Sheila M.; DeSantis, David; Klopfenstein, Muriel; Feret, Betty; Dennefeld, Christine; Blaner, William S.; Croniger, Colleen M.; Mark, Manuel; Noy, Noa; Ghyselinck, Norbert B.			The STRA6 Receptor Is Essential for Retinol-binding Protein-induced Insulin Resistance but Not for Maintaining Vitamin A Homeostasis in Tissues Other Than the Eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATTHEW-WOOD-SYNDROME; ADIPOSE CELL LINE; MOUSE EMBRYOGENESIS; MICE LACKING; NUCLEAR RECEPTORS; SERTOLI-CELLS; ACID; GENE; MUTATIONS; EXPRESSION	The plasma membrane protein STRA6 is thought to mediate uptake of retinol from its blood carrier retinol-binding protein (RBP) into cells and to function as a surface receptor that, upon binding of holo-RBP, activates a JAK/STAT cascade. It was suggested that STRA6 signaling underlies insulin resistance induced by elevated serum levels of RBP in obese animals. To investigate these activities in vivo, we generated and analyzed Stra6-null mice. We show that the contribution of STRA6 to retinol uptake by tissues in vivo is small and that, with the exception of the eye, ablation of Stra6 has only a modest effect on retinoid homeostasis and does not impair physiological functions that critically depend on retinoic acid in the embryo or in the adult. However, ablation of Stra6 effectively protects mice from RBP-induced suppression of insulin signaling. Thus one biological function of STRA6 in tissues other than the eye appears to be the coupling of circulating holo-RBP levels to cell signaling, in turn regulating key processes such as insulin response.	[Berry, Daniel C.; Marwarha, Gurdeep; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Berry, Daniel C.; DeSantis, David; Croniger, Colleen M.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Jacobs, Hugues; Gely-Pernot, Aurore; Klopfenstein, Muriel; Feret, Betty; Dennefeld, Christine; Mark, Manuel; Ghyselinck, Norbert B.] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, UMR7104,INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Jacobs, Hugues] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [O'Byrne, Sheila M.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Case Western Reserve University; Case Western Reserve University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	noa.noy@case.edu; norbert@igbmc.fr	GHYSELINCK, Norbert/I-6999-2015	GHYSELINCK, Norbert/0000-0003-4042-6818; MARWARHA, GURDEEP/0000-0001-5556-0003	National Institutes of Health [DK59630]; Fondation pour la Recherche Medicale [DEQ20071210544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, U24DK059630, U2CDK059630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to L. El Fertak and R. Combe who performed and analyzed the hyperinsulinemic-euglycemic clamp experiments in the Phenotyping Department of the Mouse Clinical Institute of Illkirch. The Mouse Metabolic Phenotyping Center of Case Western Reserve University is supported by National Institutes of Health Grant DK59630. The Stra6-null mouse line was established at the Mouse Clinic Institute in the Genetic Engineering and Model Validation Department of Inserm and supported by Fondation pour la Recherche Medicale Grant DEQ20071210544 (to N. B. G. and M. M.).	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Antal Cristina, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a04s80; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; BLANER WS, 1987, J BIOL CHEM, V262, P53; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dupe V, 1997, DEVELOPMENT, V124, P399; FEX G, 1988, BIOCHIM BIOPHYS ACTA, V944, P249, DOI 10.1016/0005-2736(88)90438-5; Gavrilova R, 2009, AM J MED GENET A, V149A, P2241, DOI 10.1002/ajmg.a.32998; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HELLER J, 1975, J BIOL CHEM, V250, P3613; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2007, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29b04s78; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1990, BIOCHEMISTRY-US, V29, P3883, DOI 10.1021/bi00468a013; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Ruiz A, 2007, INVEST OPHTH VIS SCI, V48, P5377, DOI 10.1167/iovs.07-0673; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SOPRANO DR, 1981, J BIOL CHEM, V256, P8256; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Vernet N, 2006, EMBO J, V25, P5816, DOI 10.1038/sj.emboj.7601447; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	54	91	93	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24528	24539		10.1074/jbc.M113.484014	http://dx.doi.org/10.1074/jbc.M113.484014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839944	Green Published, hybrid			2022-12-25	WOS:000330612300021
J	Yoshida, T; Galvez, S; Tiwari, S; Rezk, BM; Semprun-Prieto, L; Higashi, Y; Sukhanov, S; Yablonka-Reuveni, Z; Delafontaine, P				Yoshida, Tadashi; Galvez, Sarah; Tiwari, Sumit; Rezk, Bashir M.; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Yablonka-Reuveni, Zipora; Delafontaine, Patrice			Angiotensin II Inhibits Satellite Cell Proliferation and Prevents Skeletal Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CONVERTING-ENZYME-INHIBITORS; HEART-FAILURE; SELF-RENEWAL; RECEPTOR BLOCKADE; PHYSICAL FUNCTION; WEIGHT-LOSS; STEM-CELLS; ANG-II; EXPRESSION	Cachexia is a serious complication of many chronic diseases, such as congestive heart failure (CHF) and chronic kidney disease (CKD). Although patients with advanced CHF or CKD often have increased angiotensin II (Ang II) levels and cachexia and Ang II causes skeletal muscle wasting in rodents, the potential effects of Ang II on muscle regeneration are unknown. Muscle regeneration is highly dependent on the ability of a pool of muscle stem cells (satellite cells) to proliferate and to repair damaged myofibers or form new myofibers. Here we show that Ang II reduced skeletal muscle regeneration via inhibition of satellite cell (SC) proliferation. Ang II reduced the number of regenerating myofibers and decreased expression of SC proliferation/differentiation markers (MyoD, myogenin, and active-Notch) after cardiotoxin-induced muscle injury in vivo and in SCs cultured in vitro. Ang II depleted the basal pool of SCs, as detected in Myf5(nLacZ/+) mice and by FACS sorting, and this effect was inhibited by Ang II AT1 receptor (AT1R) blockade and in AT1aR-null mice. AT1R was highly expressed in SCs, and Notch activation abrogated the AT1R-mediated antiproliferative effect of Ang II in cultured SCs. In mice that developed CHF postmyocardial infarction, there was skeletal muscle wasting and reduced SC numbers that were inhibited by AT1R blockade. Ang II inhibition of skeletal muscle regeneration via AT1 receptor-dependent suppression of SC Notch and MyoD signaling and proliferation is likely to play an important role in mechanisms leading to cachexia in chronic disease states such as CHF and CKD.	[Yoshida, Tadashi; Galvez, Sarah; Tiwari, Sumit; Rezk, Bashir M.; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	Tulane University; University of Washington; University of Washington Seattle	Delafontaine, P (corresponding author), Tulane Univ, Sch Med, Inst Heart & Vasc, 1430 Tulane Ave,SL 48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Yoshida, Tadashi/0000-0002-4544-1497; Sukhanov, Sergiy/0000-0002-9223-4263; Delafontaine, Patrice/0000-0003-3744-3617	NHLBI National Institutes of Health [R01-HL070241, R01-HL080682]; National Institutes of Health National Center for Research Resources [P20-RR018766]; NIGMS National Institutes of Health [P20-GM103514, P30-GM103337, U54-GM104940]; NIA National Institutes of Health [R01AG021566, R01AG035377]; NIAMS National Institutes of Health [R21AR057794]; Muscular Dystrophy Association [135908]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080682, R21HL113705, R01HL070241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103514, P30GM103337, U54GM104940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021566, R01AG035377] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in whole or in part, by NHLBI National Institutes of Health Grants R01-HL070241 and R01-HL080682; National Institutes of Health National Center for Research Resources Grant P20-RR018766; NIGMS National Institutes of Health Grants P20-GM103514, P30-GM103337, and U54-GM104940; NIA National Institutes of Health Grants R01AG021566 and R01AG035377; and NIAMS National Institutes of Health Grant R21AR057794. This work was also supported by Muscular Dystrophy Association Grant 135908.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Ararat E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005144; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; Silva ACSE, 2006, PEDIATR RES, V60, P734, DOI 10.1203/01.pdr.0000246100.14061.bc; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Gray SL, 2009, J AM GERIATR SOC, V57, P297, DOI 10.1111/j.1532-5415.2008.02121.x; GRAZIANI G, 1993, KIDNEY INT, V44, P107, DOI 10.1038/ki.1993.219; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Johnston APW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015212; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lutken SC, 2009, AM J PHYSIOL-RENAL, V297, pF1678, DOI 10.1152/ajprenal.00010.2009; Masson S, 1998, PHARMACOL RES, V37, P213, DOI 10.1006/phrs.1998.0288; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Schulze PC, 2005, CIRC RES, V97, P418, DOI 10.1161/01.RES.0000179580.72375.c2; SEGERSVARD H, 2013, J RENIN ANG IN PRESS; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081; Skurk T, 2004, ARTERIOSCL THROM VAS, V24, P1199, DOI 10.1161/01.ATV.0000131266.38312.2e; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Sumukadas D, 2007, CAN MED ASSOC J, V177, P867, DOI 10.1503/cmaj.061339; Sun CK, 2007, INT HEART J, V48, P533, DOI 10.1536/ihj.48.533; Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Westerkamp CM, 2005, AM J PHYSIOL-REG I, V289, pR1223, DOI 10.1152/ajpregu.00730.2004; Yablonka-Reuveni Z, 2011, STEM CELLS BIOL REG, P173, DOI 10.1007/978-1-61779-021-8_11; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yoshida T, 2012, ENDOCRINOLOGY, V153, P1411, DOI 10.1210/en.2011-1764; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	54	57	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23823	23832		10.1074/jbc.M112.449074	http://dx.doi.org/10.1074/jbc.M112.449074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23831688	Green Published, hybrid			2022-12-25	WOS:000330611400022
J	Ilango, A; Shumake, J; Wetzel, W; Scheich, H; Ohl, FW				Ilango, Anton; Shumake, Jason; Wetzel, Wolfram; Scheich, Henning; Ohl, Frank W.			Electrical Stimulation of Lateral Habenula during Learning: Frequency-Dependent Effects on Acquisition but Not Retrieval of a Two-Way Active Avoidance Response	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; NEGATIVE REWARD SIGNALS; CENTRAL-NERVOUS-SYSTEM; MODULATED TONES; MOTIVATIONAL CONTROL; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; AUDITORY-CORTEX; NEURAL SYSTEMS	The lateral habenula (LHb) is an epithalamic structure involved in signaling reward omission and aversive stimuli, and it inhibits dopaminergic neurons during motivated behavior. Less is known about LHb involvement in the acquisition and retrieval of avoidance learning. Our previous studies indicated that brief electrical stimulation of the LHb, time-locked to the avoidance of aversive footshock (presumably during the positive affective "relief'' state that occurs when an aversive outcome is averted), inhibited the acquisition of avoidance learning. In the present study, we used the same paradigm to investigate different frequencies of LHb stimulation. The effect of 20 Hz vs. 50 Hz vs. 100 Hz stimulation was investigated during two phases, either during acquisition or retrieval in Mongolian gerbils. The results indicated that 50 Hz, but not 20 Hz, was sufficient to produce a long-term impairment in avoidance learning, and was somewhat more effective than 100 Hz in this regard. None of the stimulation parameters led to any effects on retrieval of avoidance learning, nor did they affect general motor activity. This suggests that, at frequencies in excess of the observed tonic firing rates of LHb neurons (>1-20 Hz), LHb stimulation may serve to interrupt the consolidation of new avoidance memories. However, these stimulation parameters are not capable of modifying avoidance memories that have already undergone extensive consolidation.	[Ilango, Anton; Shumake, Jason; Wetzel, Wolfram; Scheich, Henning; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany; [Shumake, Jason] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Scheich, Henning; Ohl, Frank W.] Otto Von Guericke Univ, Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; University of Texas System; University of Texas Austin; Otto von Guericke University	Ohl, FW (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany.	frank.ohl@lin-magdeburg.de	Shumake, Jason/AAP-3506-2020	Shumake, Jason/0000-0003-4655-436X	Deutsche Forschungsgemeinschaft DFG [SFB 779, SFB-TRR-62]; Center for Behavioral Brain Research (CBBS)	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Center for Behavioral Brain Research (CBBS)	The study was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 779, SFB-TRR-62) and from the Center for Behavioral Brain Research (CBBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Benabid AL, 2005, ACTA NEUROL BELG, V105, P149; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Chang SY, 2004, J NEUROSCI, V24, P2172, DOI 10.1523/JNEUROSCI.4891-03.2004; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Darvas M, 2011, LEARN MEMORY, V18, P136, DOI 10.1101/lm.2041211; Dinsmoor JA, 2001, J EXP ANAL BEHAV, V75, P311, DOI 10.1901/jeab.2001.75-311; Dombrowski P. A., 2012, BEHAV BRAIN IN PRESS; Domjan M., 1998, PRINCIPLES LEARNING; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; Pobbe RLH, 2010, NEUROSCI LETT, V479, P87, DOI 10.1016/j.neulet.2010.05.021; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hu WH, 2011, MED SCI MONITOR, V17, pBR153, DOI 10.12659/MSM.881802; Ide JS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00025; IIango A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00132; Ilango A, 2010, NEUROSCIENCE, V166, P752, DOI 10.1016/j.neuroscience.2010.01.010; Ilango A, 2011, BEHAV BRAIN RES, V225, P515, DOI 10.1016/j.bbr.2011.08.014; Jensen AL, 2009, EXP NEUROL, V220, P57, DOI 10.1016/j.expneurol.2009.07.023; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kowski AB, 2009, NEUROSCIENCE, V161, P1154, DOI 10.1016/j.neuroscience.2009.04.026; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; LISOPRAWSKI A, 1980, BRAIN RES, V183, P229, DOI 10.1016/0006-8993(80)90135-3; Loskota W.J., 1974, STEREOTAXIC ATLAS MO; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Matsumoto M, 2008, PROG BRAIN RES, V171, P399, DOI 10.1016/S0079-6123(08)00658-4; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; MCCULLOUGH LD, 1993, NEUROSCIENCE, V52, P919, DOI 10.1016/0306-4522(93)90538-Q; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ohl FW, 1999, LEARN MEMORY, V6, P347; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Pobbe RLH, 2008, LIFE SCI, V82, P1256, DOI 10.1016/j.lfs.2008.04.012; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schlund MW, 2011, BEHAV BRAIN RES, V225, P437, DOI 10.1016/j.bbr.2011.07.054; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Sharp PE, 2006, BEHAV BRAIN RES, V166, P55, DOI 10.1016/j.bbr.2005.07.004; Shelton L, 2012, PROG NEUROBIOL, V96, P208, DOI 10.1016/j.pneurobio.2012.01.004; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Shumake J, 2003, BEHAV COGN NEUROSCI, V2, P3198; Shumake J, 2010, BRAIN RES, V1343, P218, DOI 10.1016/j.brainres.2010.05.015; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Stark H, 2000, EUR J PHARMACOL, V405, P263, DOI 10.1016/S0014-2999(00)00558-6; Stark H, 1999, NEUROSCI LETT, V264, P77, DOI 10.1016/S0304-3940(99)00174-3; THORNTON EW, 1984, BEHAV BRAIN RES, V12, P327, DOI 10.1016/0166-4328(84)90158-X; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; ValeMartinez A, 1997, NEUROBIOL LEARN MEM, V68, P68, DOI 10.1006/nlme.1997.3777; VALENSTEIN ES, 1964, SCIENCE, V145, P1456, DOI 10.1126/science.145.3639.1456; VANHOESEN GW, 1969, J COMP PHYSIOL PSYCH, V68, P80, DOI 10.1037/h0027643; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; Wickens J, 2008, NEURON, V60, P530, DOI 10.1016/j.neuron.2008.11.002; WILCOX KS, 1986, PHYSIOL BEHAV, V36, P413, DOI 10.1016/0031-9384(86)90307-0; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yeomans J. S., 1990, PRINCIPLES BRAIN STI	74	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65684	10.1371/journal.pone.0065684	http://dx.doi.org/10.1371/journal.pone.0065684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840355	gold, Green Published, Green Submitted			2022-12-25	WOS:000321148400007
J	Ling, ZQ; Lv, P; Lu, XX; Yu, JL; Han, J; Ying, LS; Zhu, X; Zhu, WY; Fang, XH; Wang, S; Wu, YC				Ling, Zhi-Qiang; Lv, Ping; Lu, Xiao-Xiao; Yu, Jiang-Liu; Han, Jing; Ying, Li-Sha; Zhu, Xin; Zhu, Wang-Yu; Fang, Xian-Hua; Wang, Shi; Wu, Yi-Chen			Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; MODULATED DOWN-REGULATION; TUMOR DNA; ESOPHAGEAL CANCER; EXPRESSION; HYPERMETHYLATION; PLASMA; GENE; PROGRESSION; CARCINOMA	Background: Methylated DNA in fluids may be a suitable biomarker for cancer patients. XAF1 has been shown to be frequently down-regulated in human gastric cancer (GC). Here, we investigated if XAF1 methylation in GC could be a useful biomarker. Methods: Real-time RT-PCR was used to detect XAF1 mRNA expression; immunohistochemistry and western blot were used to examine XAF1 protein expression in GC tissues (n = 202) and their corresponding para-cancerous histological normal tissues (PCHNTs). Real-time methylation specific-PCR was used to investigate XAF1 promoter methylation in the same panel of GC tissues, their PCHNTs and sera. Results: We confirmed frequent XAF1 down-regulation in both mRNA and protein levels in GC tissues as compared to normal controls and PCHNTs. XAF1 hypermethylation was evidenced in 83.2% (168/202) of GC tissues and 27.2% (55/202) of PCHNTs, while no methylation was detected in the 88 normal controls. The methylation level in GC tissues was significantly higher than that in PCHNTs (p < 0.05). The hypermethylation of XAF1 significantly correlated with the down-regulation of XAF1 in GC tissues in both mRNA and protein levels (p < 0.001 each). Moreover, we detected high frequency of XAF1 methylation (69.8%, 141 out of 202) in the sera DNAs from the same patients, while the sera DNAs from 88 non-tumor controls were negative for XAF1 methylation. The XAF1 methylation in both GC tissues and in the sera could be a good biomarker for diagnosis of GC (AUC = 0.85 for tissue and AUC = 0.91 for sera) and significantly correlated with poorer prognosis (p < 0.001). In addition, after-surgery negative-to-positive transition of XAF1 methylation in sera strongly associated with tumor recurrence. Conclusions: 1) Dysfunction of XAF1 is frequent and is regulated through XAF1 promoter hypermethylation; 2) Detection of circulating methylated XAF1 DNAs in the serum may be a useful biomarker in diagnosis, evaluating patient's outcome (prognosis and recurrence) for GC patients.	[Ling, Zhi-Qiang; Lv, Ping; Lu, Xiao-Xiao; Yu, Jiang-Liu; Han, Jing; Ying, Li-Sha; Zhu, Xin; Zhu, Wang-Yu; Wu, Yi-Chen] Zhejiang Prov Canc Hosp, Zhejiang Canc Ctr, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Fang, Xian-Hua] Zhejiang Prov Canc Hosp, Dept Pathol, Zhejiang Canc Ctr, Hangzhou, Zhejiang, Peoples R China; [Wang, Shi] Zhejiang Prov Canc Hosp, Dept Endoscopy, Zhejiang Canc Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Ling, ZQ (corresponding author), Zhejiang Prov Canc Hosp, Zhejiang Canc Ctr, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China.	lingzq@hotmail.com			Science and Technology General Project of Zhejiang Province [2009C33143]; Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs [2011RCA009]	Science and Technology General Project of Zhejiang Province; Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs	This research was supported by a grant from the Science and Technology General Project of Zhejiang Province (no. 2009C33143), and partly by a grant from the Backbone Talent of Zhejiang Provincial Medicine and Hygiene Platform Programs (no. 2011RCA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byun DS, 2003, CANCER RES, V63, P7068; Charlet J, 2012, BIOCHEM PHARMACOL, V83, P858, DOI 10.1016/j.bcp.2012.01.009; David S, 2011, CANCER BIOMARK, V9, P493, DOI 10.3233/CBM-2011-0169; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Ge MH, 2011, HUM PATHOL, V42, P1862, DOI 10.1016/j.humpath.2011.02.003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hashemi MR, 2008, CYTOPATHOLOGY, V19, P179, DOI 10.1111/j.1365-2303.2007.00417.x; He J, 2011, ONCOTARGET, V2, P178; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kempkensteffen C, 2007, CANCER LETT, V254, P227, DOI 10.1016/j.canlet.2007.03.006; Lee MG, 2006, ONCOGENE, V25, P5807, DOI 10.1038/sj.onc.1209867; Ling ZQ, 2012, EJSO-EUR J SURG ONC, V38, P326, DOI 10.1016/j.ejso.2012.01.008; Ling ZQ, 2011, DIGEST DIS SCI, V56, P2992, DOI 10.1007/s10620-011-1774-z; Ling ZQ, 2011, INT J MOL MED, V27, P625, DOI 10.3892/ijmm.2011.640; Ling ZQ, 2010, CANCER LETT, V297, P244, DOI 10.1016/j.canlet.2010.05.017; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Lu XX, 2012, CANCER-AM CANCER SOC, V118, P5507, DOI 10.1002/cncr.27604; Luebke T, 2005, WORLD J SURG, V29, P1422, DOI 10.1007/s00268-005-7795-z; Mao WM, 2011, ARCH MED RES, V42, P182, DOI 10.1016/j.arcmed.2011.04.002; Muller I, 2006, ANN NY ACAD SCI, V1075, P222, DOI 10.1196/annals.1368.030; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469; Sincic N, 2011, CURR OPIN ONCOL, V23, P69, DOI 10.1097/CCO.0b013e3283412eb4; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Tian XY, 2012, J CLIN GASTROENTEROL, V46, P285, DOI 10.1097/MCG.0b013e318249c4cd; Tu SP, 2009, INT J CANCER, V125, P688, DOI 10.1002/ijc.24282; Vinayanuwattikun C, 2011, J THORAC ONCOL, V6, P1818, DOI 10.1097/JTO.0b013e318226b46f; Yu M, 2012, MITOCHONDR DNA, V23, P329, DOI 10.3109/19401736.2012.696625; Yu QM, 2012, J SURG ONCOL, V106, P765, DOI 10.1002/jso.23116; Zhang H, 2011, WORLD J GASTROENTERO, V17, P3257, DOI 10.3748/wjg.v17.i27.3257; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	34	48	54	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67195	10.1371/journal.pone.0067195	http://dx.doi.org/10.1371/journal.pone.0067195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826230	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000041
J	MacLean, EL; Sandel, AA; Bray, J; Oldenkamp, RE; Reddy, RB; Hare, BA				MacLean, Evan L.; Sandel, Aaron A.; Bray, Joel; Oldenkamp, Ricki E.; Reddy, Rachna B.; Hare, Brian A.			Group Size Predicts Social but Not Nonsocial Cognition in Lemurs	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; RELATIVE BRAIN SIZE; EULEMUR-FULVUS; NEOCORTEX SIZE; NETWORK SIZE; EVOLUTION; INTELLIGENCE; BEHAVIOR; SOCIOECOLOGY; COMPLEXITY	The social intelligence hypothesis suggests that living in large social networks was the primary selective pressure for the evolution of complex cognition in primates. This hypothesis is supported by comparative studies demonstrating a positive relationship between social group size and relative brain size across primates. However, the relationship between brain size and cognition remains equivocal. Moreover, there have been no experimental studies directly testing the association between group size and cognition across primates. We tested the social intelligence hypothesis by comparing 6 primate species (total N = 96) characterized by different group sizes on two cognitive tasks. Here, we show that a species' typical social group size predicts performance on cognitive measures of social cognition, but not a nonsocial measure of inhibitory control. We also show that a species' mean brain size (in absolute or relative terms) does not predict performance on either task in these species. These data provide evidence for a relationship between group size and social cognition in primates, and reveal the potential for cognitive evolution without concomitant changes in brain size. Furthermore our results underscore the need for more empirical studies of animal cognition, which have the power to reveal species differences in cognition not detectable by proxy variables, such as brain size.	[MacLean, Evan L.; Bray, Joel; Reddy, Rachna B.; Hare, Brian A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Sandel, Aaron A.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Oldenkamp, Ricki E.] No Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Hare, Brian A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; University of Michigan System; University of Michigan; Northern Michigan University; Duke University	MacLean, EL (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	maclean@duke.edu		MacLean, Evan/0000-0001-7595-662X; Sandel, Aaron/0000-0003-3060-5310	NSF [BCS-0923791]; National Evolutionary Synthesis Center (NSF) [EF-0905606]; National Science Foundation [NSF-BCS-08-27552, NSF-BCS-10-25172]; Duke University URS grants; Duke University Mechanisms of Behavior award	NSF(National Science Foundation (NSF)); National Evolutionary Synthesis Center (NSF); National Science Foundation(National Science Foundation (NSF)); Duke University URS grants; Duke University Mechanisms of Behavior award	We thank Isabel Bernstein, Camila Caceres, and Jesse St. Clair for help with data collection. We thank Sarah Zehr, David Brewer and the Duke Lemur Center staff for making this research possible. We thank the editor and two anonymous reviewers for their helpful comments on an earlier draft of this manuscript. We thank Christine Wall and Kari Allen for statistical advice, and the Anthrotree workshop which is supported by the NSF (BCS-0923791) and the National Evolutionary Synthesis Center (NSF grant EF-0905606) for training in phylogenetic comparative methods.; This work was supported in part by the National Science Foundation grants NSF-BCS-08-27552 and NSF-BCS-10-25172 to BH, Duke University URS grants to JB, RR, and AS, and a Duke University Mechanisms of Behavior award to RO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1999, PRACTICAL STAT MED R; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Balda Russell P., 1996, Current Ornithology, V13, P33; Banerjee K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005883; Barton R. A., 1999, COMP PRIMATE SOCIOEC, P167, DOI DOI 10.1017/CBO9780511542466.010; Barton RA, 1996, P ROY SOC B-BIOL SCI, V263, P173, DOI 10.1098/rspb.1996.0028; Barton RA, 2006, EVOL ANTHROPOL, V15, P224, DOI 10.1002/evan.20105; Bayart F, 2005, AM J PRIMATOL, V67, P299, DOI 10.1002/ajp.20186; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Boogert NJ, 2011, ANIM BEHAV, V81, P1209, DOI 10.1016/j.anbehav.2011.03.004; Botting JL, 2011, FOLIA PRIMATOL, V82, P165, DOI 10.1159/000333142; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Byrne RW, 1988, MACHIAVELLIAN INTELL, Vxiv; Cheney DL, 1990, MONKEYS SEE WORLD IN, Vx; Cheney DL, 2007, BABOON METAPHYSICS E, Vx; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Curtis DJ, 1999, FOLIA PRIMATOL, V70, P79, DOI 10.1159/000021679; de Waal FBM, 2003, ANIMAL SOCIAL COMPLE, Vxiv; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Emery NJ, 2007, PHILOS T R SOC B, V362, P485, DOI 10.1098/rstb.2006.2022; Erhart EM, 2008, AM J PHYS ANTHROPOL, V136, P183, DOI 10.1002/ajpa.20793; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Genty E, 2006, J EXP PSYCHOL-ANIM B, V32, P196, DOI 10.1037/0097-7403.32.2.196; Gigerenzer G., 1997, MACHIAVELLIAN INTELL, V2, P264; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; HOLLOWAY RL, 1966, AM J PHYS ANTHROPOL, V25, P305, DOI 10.1002/ajpa.1330250310; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Humphrey N. K., 1976, GROWING POINTS ETHOL, P303; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jerison HJ, 1973, EVOLUTION BRAIN INTE, Vxiv; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; KAPPELER PM, 1993, ETHOLOGY, V93, P125; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; KREBS J. R., 1984, BEHAV ECOLOGY, V2nd, P380; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Lakshminarayanan V. R., 2009, J NEUROSCI PSYCHOL E, V2, P12, DOI [DOI 10.1037/A0015457, 10.1037/a0015457]; Liedtke J, 2011, ANIM COGN, V14, P143, DOI 10.1007/s10071-010-0347-4; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; MacLean EL, 2009, J HUM EVOL, V56, P471, DOI 10.1016/j.jhevol.2008.12.005; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nunn CL, 2001, ADV PRIMATO, P159; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Preuss TM, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P138; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; RICHARD AF, 1991, ANNU REV ECOL SYST, V22, P145, DOI 10.1146/annurev.es.22.110191.001045; Richard AF, 1978, BEHAV VARIATION CASE; Ruiz A, 2009, ANIM COGN, V12, P427, DOI 10.1007/s10071-008-0202-z; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Sandel AA, 2011, ANIM BEHAV, V81, P925, DOI 10.1016/j.anbehav.2011.01.020; Santos LR, 1999, J COMP PSYCHOL, V113, P186; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Shepherd SV, 2008, ANIM COGN, V11, P13, DOI 10.1007/s10071-007-0083-6; SHERRY DF, 1987, PSYCHOL REV, V94, P439, DOI 10.1037/0033-295X.94.4.439; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Smaers JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009123; Tomasello M, 2004, ANIM COGN, V7, P213, DOI 10.1007/s10071-004-0227-x; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Vasey N, 2007, PRIMATES, V48, P41, DOI 10.1007/s10329-006-0010-5; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Wobber V, 2009, BEHAV PROCESS, V81, P423, DOI 10.1016/j.beproc.2009.04.003	79	50	51	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66359	10.1371/journal.pone.0066359	http://dx.doi.org/10.1371/journal.pone.0066359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840450	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400027
J	Auclair, Y; Konig, B; Lindholm, AK				Auclair, Yannick; Koenig, Barbara; Lindholm, Anna K.			A Selfish Genetic Element Influencing Longevity Correlates with Reactive Behavioural Traits in Female House Mice (Mus domesticus)	PLOS ONE			English	Article							AMERICAN RED SQUIRRELS; FALSE DISCOVERY RATE; LIFE-HISTORY; INDIVIDUAL-DIFFERENCES; GASTEROSTEUS-ACULEATUS; REPRODUCTIVE SUCCESS; AVIAN PERSONALITIES; ANIMAL PERSONALITY; MOUSE-POPULATION; RISK-ASSESSMENT	According to theory in life-history and animal personality, individuals with high fitness expectations should be risk-averse, while individuals with low fitness expectations should be more bold. In female house mice, a selfish genetic element, the t haplotype, is associated with increased longevity under natural conditions, representing an appropriate case study to investigate this recent theory empirically. Following theory, females heterozygous for the t haplotype (+/t) are hypothesised to express more reactive personality traits and be more shy, less explorative and less active compared to the shorter-lived homozygous wildtype females (+/+). As males of different haplotype do not differ in survival, no similar pattern is expected. We tested these predictions by quantifying boldness, exploration, activity, and energetic intake in both +/t and +/+ mice. +/t females, unlike +/+ ones, expressed some reactive-like personality traits: +/t females were less active, less prone to form an exploratory routine and tended to ingest less food. Taken together these results suggest that differences in animal personality may contribute to the survival advantage observed in +/t females but fail to provide full empirical support for recent theory.	[Auclair, Yannick; Koenig, Barbara; Lindholm, Anna K.] Univ Zurich, Inst Evolutionary Biol & Environm Studios Anim Be, Zurich, Switzerland	University of Zurich	Auclair, Y (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studios Anim Be, Zurich, Switzerland.	yannick.auclair@ieu.uzh.ch	Lindholm, Anna K/E-5207-2012; Koenig, Barbara/M-9214-2013	Lindholm, Anna K/0000-0001-8460-9769; Konig, Barbara/0000-0001-7696-4736	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This project was funded by the Swiss National Science Foundation and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BENUS RF, 1987, BEHAVIOUR, V100, P105, DOI 10.1163/156853987X00099; BERRY R J, 1970, Field Studies, V3, P219; BERRY RJ, 1971, EXP GERONTOL, V6, P187, DOI 10.1016/S0531-5565(71)80018-9; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Cote J, 2008, P ROY SOC B-BIOL SCI, V275, P2851, DOI 10.1098/rspb.2008.0783; Crawley MJ, 2007, J ANIM ECOL; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; David M, 2011, ANIM BEHAV, V81, P219, DOI 10.1016/j.anbehav.2010.10.008; DICKMAN CR, 1984, J ZOOL, V204, P521, DOI 10.1111/j.1469-7998.1984.tb02384.x; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Exnerova A, 2010, P ROY SOC B-BIOL SCI, V277, P723, DOI 10.1098/rspb.2009.1673; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; Gray SJ, 2000, ANIM BEHAV, V60, P765, DOI 10.1006/anbe.2000.1527; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; HAMMERBERG C, 1975, NATURE, V258, P296, DOI 10.1038/258296a0; HURST JL, 1989, ANIM BEHAV, V37, P705, DOI 10.1016/0003-3472(89)90057-2; JEDRZEJEWSKI W, 1993, OIKOS, V68, P251, DOI 10.2307/3544837; KONIG B, 1988, J ZOOL, V216, P195; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kraus C, 2005, J ANIM ECOL, V74, P171, DOI 10.1111/j.1365-2656.2004.00910.x; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; LENINGTON S, 1988, BEHAV GENET, V18, P549, DOI 10.1007/BF01065521; LENINGTON S, 1991, ADV STUD BEHAV, V20, P51; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindholm AK, 2013, ECOL EVOL, V3, P1231, DOI 10.1002/ece3.534; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; Manser A, 2009, INFLUENCE SELFISH GE; Manser A, 2011, EVOLUTION, V65, P2435, DOI 10.1111/j.1558-5646.2011.01336.x; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Marques JM, 2008, PHYSIOL BEHAV, V93, P139, DOI 10.1016/j.physbeh.2007.08.006; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; MORITA T, 1992, P NATL ACAD SCI USA, V89, P6851, DOI 10.1073/pnas.89.15.6851; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nunes AC, 2009, BEHAV ECOL, V20, P1252, DOI 10.1093/beheco/arp122; PENNYCUIK PR, 1986, J ANIM ECOL, V55, P371, DOI 10.2307/4715; PERRIGO G, 1990, BEHAVIOUR, V114, P191, DOI 10.1163/156853990X00112; Pillay N, 2003, BEHAVIOUR, V140, P125, DOI 10.1163/156853903763999944; Quinn JL, 2005, BEHAVIOUR, V142, P1377, DOI 10.1163/156853905774539391; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Wilson ADM, 2010, BEHAV ECOL SOCIOBIOL, V64, P703, DOI 10.1007/s00265-009-0888-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	72	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67130	10.1371/journal.pone.0067130	http://dx.doi.org/10.1371/journal.pone.0067130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826211	gold, Green Published, Green Accepted			2022-12-25	WOS:000321738400108
J	Markina-Inarrairaegui, A; Pantazopoulou, A; Espeso, EA; Penalva, MA				Markina-Inarrairaegui, Ane; Pantazopoulou, Areti; Espeso, Eduardo A.; Penalva, Miguel A.			The Aspergillus nidulans Peripheral ER: Disorganization by ER Stress and Persistence during Mitosis	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM MEMBRANE; FILAMENTOUS FUNGI; SEC PROTEINS; TIP GROWTH; IN-VIVO; TRANSLOCATION; COMPLEX; YEAST; LOCALIZATION	The genetically amenable fungus Aspergillus nidulans is well suited for cell biology studies involving the secretory pathway and its relationship with hyphal tip growth by apical extension. We exploited live-cell epifluorescence microscopy of the ER labeled with the translocon component Sec63, endogenously tagged with GFP, to study the organization of 'secretory' ER domains. The Sec63 A. nidulans ER network includes brightly fluorescent peripheral strands and more faintly labeled nuclear envelopes. In hyphae, the most abundant peripheral ER structures correspond to plasma membrane-associated strands that are polarized, but do not invade the hyphal tip dome, at least in part because the subapical collar of endocytic actin patches constrict the cortical strands in this region. Thus the subapical endocytic ring might provide an attachment for ER strands, thereby ensuring that the growing tip remains 'loaded' with secretory ER. Acute disruption of secretory ER function by reductive stress-mediated induction of the unfolded protein response results in the reversible aggregation of ER strands, cessation of exocytosis and swelling of the hyphal tips. The secretory ER is insensitive to brefeldin A treatment and does not undergo changes during mitosis, in agreement with the reports that apical extension continues at normal rates during this period.	[Markina-Inarrairaegui, Ane; Pantazopoulou, Areti; Espeso, Eduardo A.; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Dept Biol Celular & Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Penalva, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Biol Celular & Mol, Madrid, Spain.	penalva@cib.csic.es	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Pantazopoulou, Areti/G-7381-2015; Penalva, Miguel A/G-2295-2015	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Penalva, Miguel A/0000-0002-3102-2806; Pantazopoulou, Areti/0000-0002-1985-6525	Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain; Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain	Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain; Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain	Funding provided by Subdireccion General de Proyectos de Investigacion, Ministerio de Economia y Competitividad, Spain (http://www.idi.mineco.gob.es) Direccion General de Universidades e Investigacion de la Comunidad de Madrid, Spain (http://www.madrimasd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Breakspear A, 2007, FEMS MICROBIOL LETT, V277, P90, DOI 10.1111/j.1574-6968.2007.00945.x; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Gladfelter AS, 2010, CURR OPIN MICROBIOL, V13, P720, DOI 10.1016/j.mib.2010.09.012; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Hohmann-Marriott MF, 2006, NEW PHYTOL, V172, P208, DOI 10.1111/j.1469-8137.2006.01868.x; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Lee SC, 2008, FEMS MICROBIOL LETT, V283, P216, DOI 10.1111/j.1574-6968.2008.01174.x; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Pantazopoulou A, 2011, TRAFFIC, V12, P386, DOI 10.1111/j.1600-0854.2011.01164.x; Pantazopoulou A, 2009, MOL BIOL CELL, V20, P4335, DOI 10.1091/mbc.E09-03-0254; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Penalva Miguel A, 2012, Cell Logist, V2, P2; Prescott AR, 2001, TRAFFIC, V2, P321, DOI 10.1034/j.1600-0854.2001.002005321.x; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riquelme M, 2003, PROTOPLASMA, V222, P211, DOI 10.1007/s00709-003-0020-8; Saloheimo M, 2003, MOL MICROBIOL, V47, P1149, DOI 10.1046/j.1365-2958.2003.03363.x; Sims AH, 2005, APPL ENVIRON MICROB, V71, P2737, DOI 10.1128/AEM.71.5.2737-2747.2005; Straube A, 2005, EMBO J, V24, P1674, DOI 10.1038/sj.emboj.7600644; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ukil L, 2009, MOL BIOL CELL, V20, P2132, DOI 10.1091/mbc.E08-10-1046; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	49	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67154	10.1371/journal.pone.0067154	http://dx.doi.org/10.1371/journal.pone.0067154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826221	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400112
J	Watanabe, Y; Singamsetty, S; Zou, BB; Guo, LP; Stefanovski, D; Alonso, LC; Garcia-Ocana, A; O'Donnell, CP; McVerry, BJ				Watanabe, Yoshio; Singamsetty, Srikanth; Zou, Baobo; Guo, Lanping; Stefanovski, Darko; Alonso, Laura C.; Garcia-Ocana, Adolfo; O'Donnell, Christopher P.; McVerry, Bryan J.			Exogenous Glucose Administration Impairs Glucose Tolerance and Pancreatic Insulin Secretion during Acute Sepsis in Non-Diabetic Mice	PLOS ONE			English	Article							HYPERGLYCEMIA; THERAPY; MODEL; HYPERINSULINEMIA; INTERLEUKIN-1; HYPOGLYCEMIA; CONTRIBUTES; SENSITIVITY; RESISTANCE	Objectives: The development of hyperglycemia and the use of early parenteral feeding are associated with poor outcomes in critically ill patients. We therefore examined the impact of exogenous glucose administration on the integrated metabolic function of endotoxemic mice using our recently developed frequently sampled intravenous glucose tolerance test (FSIVGTT). We next extended our findings using a cecal ligation and puncture (CLP) sepsis model administered early parenteral glucose support. Methods: Male C57BL/6J mice, 8-12 weeks, were instrumented with chronic indwelling arterial and venous catheters. Endotoxemia was initiated with intra-arterial lipopolysaccharide (LPS; 1 mg/kg) in the presence of saline or glucose infusion (100 mu L/hr), and an FSIVGTT was performed after five hours. In a second experiment, catheterized mice underwent CLP and the impact of early parenteral glucose administration on glucose homeostasis and mortality was assessed over 24 hrs. Measurements: And MAIN RESULTS: Administration of LPS alone did not impair metabolic function, whereas glucose administration alone induced an insulin sensitive state. In contrast, LPS and glucose combined caused marked glucose intolerance and insulin resistance and significantly impaired pancreatic insulin secretion. Similarly, CLP mice receiving parenteral glucose developed fulminant hyperglycemia within 18 hrs (all > 600 mg/dl) associated with increased systemic cytokine release and 40% mortality, whereas CLP alone (85 +/- 2 mg/dL) or sham mice receiving parenteral glucose (113 +/- 3 mg/dL) all survived and were not hyperglycemic. Despite profound hyperglycemia, plasma insulin in the CLP glucose- infused mice (3.7 +/- 1.2 ng/ml) was not higher than sham glucose infused mice (2.1 +/- 0.3 ng/ml). Conclusions: The combination of parenteral glucose support and the systemic inflammatory response in the acute phase of sepsis induces profound insulin resistance and impairs compensatory pancreatic insulin secretion, leading to the development of fulminant hyperglycemia.	[Watanabe, Yoshio; Singamsetty, Srikanth; Zou, Baobo; Guo, Lanping; O'Donnell, Christopher P.; McVerry, Bryan J.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Stefanovski, Darko] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Alonso, Laura C.; Garcia-Ocana, Adolfo] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McVerry, BJ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	mcverrybj@upmc.edu	McVerry, Bryan/AAS-7790-2021	McVerry, Bryan/0000-0002-1175-4874; O'Donnell, Christopher/0000-0002-9120-6850	University of Pittsburgh Medical Center Competitive Medical Research Fund; University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine; University of Pittsburgh Metabolic Center	University of Pittsburgh Medical Center Competitive Medical Research Fund; University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine; University of Pittsburgh Metabolic Center	Funding for this work was provided by the University of Pittsburgh Medical Center Competitive Medical Research Fund (BJM), the University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine (CPO), and the University of Pittsburgh Metabolic Center (BJM, CPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; BERK JL, 1970, ANN SURG, V171, P400, DOI 10.1097/00000658-197003000-00013; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; FRANKENFIELD DC, 1994, JPEN-PARENTER ENTER, V18, P398, DOI 10.1177/0148607194018005398; Hagiwara S, 2009, CRIT CARE MED, V37, P2223, DOI 10.1097/CCM.0b013e3181a007c6; Heuer JG, 2006, J TRAUMA, V60, P865, DOI 10.1097/01.ta.0000215565.29846.ab; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE766, DOI 10.1152/ajpendo.00468.2003; Losser MR, 2010, CRIT CARE, V14, DOI 10.1186/cc9100; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; MEHTA VK, 1994, EUR J ENDOCRINOL, V130, P208, DOI 10.1530/eje.0.1300208; NAYLOR JM, 1985, AM J PHYSIOL, V248, pE309, DOI 10.1152/ajpendo.1985.248.3.E309; Patino JF, 1999, WORLD J SURG, V23, P553, DOI 10.1007/PL00012346; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vila G, 2007, J CLIN ENDOCR METAB, V92, P3930, DOI 10.1210/jc.2007-1194; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Woodske ME, 2009, CRIT CARE MED, V37, P2596, DOI 10.1097/CCM.0b013e3181a9338a	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67716	10.1371/journal.pone.0067716	http://dx.doi.org/10.1371/journal.pone.0067716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826335	gold, Green Accepted, Green Published			2022-12-25	WOS:000321738400168
J	Gouveia, K; Hurst, JL				Gouveia, Kelly; Hurst, Jane L.			Reducing Mouse Anxiety during Handling: Effect of Experience with Handling Tunnels	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ENVIRONMENTAL ENRICHMENT; BEHAVIOR; MICE; REACTIVITY; RESPONSES; STRESS; RATS	Handling stress is a well-recognised source of variation in animal studies that can also compromise the welfare of research animals. To reduce background variation and maximise welfare, methods that minimise handling stress should be developed and used wherever possible. Recent evidence has shown that handling mice by a familiar tunnel that is present in their home cage can minimise anxiety compared with standard tail handling. As yet, it is unclear whether a tunnel is required in each home cage to improve response to handling. We investigated the influence of prior experience with home tunnels among two common strains of laboratory mice: ICR(CD-1) and C57BL/6. We compared willingness to approach the handler and anxiety in an elevated plus maze test among mice picked up by the tail, by a home cage tunnel or by an external tunnel shared between cages. Willingness to interact with the handler was much greater for mice handled by a tunnel, even when this was unfamiliar, compared to mice picked up by the tail. Once habituated to handling, C57BL/6 mice were most interactive towards a familiar home tunnel, whereas the ICR strain showed strong interaction with all tunnel handling regardless of any experience of a home cage tunnel. Mice handled by a home cage or external tunnel showed less anxiety in an elevated plus maze than those picked up by the tail. This study shows that using a tunnel for routine handling reduces anxiety among mice compared to tail handling regardless of prior familiarity with tunnels. However, as home cage tunnels can further improve response to handling in some mice, we recommend that mice are handled with a tunnel provided in their home cage where possible as a simple practical method to minimise handling stress.	[Gouveia, Kelly; Hurst, Jane L.] Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England	University of Liverpool	Hurst, JL (corresponding author), Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England.	jhurst@liverpool.ac.uk	Hurst, Jane L/G-8793-2015	Hurst, Jane L/0000-0002-3728-9624	National Centre for the Replacement, Refinement and Reduction of Animals in Research [Hurst.J.14-07-2009]; National Centre for the Replacement [NC/K500446/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This study was supported by a studentship from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (Hurst.J.14-07-2009) awarded to JLH and held by KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Festing MFW, 1998, ATLA-ALTERN LAB ANIM, V26, P283; Howard B R, 2002, ILAR J, V43, P194; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kim S, 2002, BEHAV PROCESS, V60, P181, DOI 10.1016/S0376-6357(02)00085-2; Koyama S, 2004, HORM BEHAV, V46, P303, DOI 10.1016/j.yhbeh.2004.03.002; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maurer BM, 2008, APPL ANIM BEHAV SCI, V114, P554, DOI 10.1016/j.applanim.2008.04.013; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; Michalikova S, 2010, BEHAV BRAIN RES, V207, P402, DOI 10.1016/j.bbr.2009.10.028; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Nicol CJ, 2008, APPL ANIM BEHAV SCI, V110, P341, DOI 10.1016/j.applanim.2007.05.006; Nunez JF, 1996, PHYSIOL BEHAV, V60, P1355, DOI 10.1016/S0031-9384(96)00225-9; Pankevich DE, 2006, BEHAV NEUROSCI, V120, P925, DOI 10.1037/0735-7044.120.4.925; Parmigiani S, 1999, NEUROSCI BIOBEHAV R, V23, P957, DOI 10.1016/S0149-7634(99)00029-9; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195	23	102	103	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66401	10.1371/journal.pone.0066401	http://dx.doi.org/10.1371/journal.pone.0066401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840458	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800057
J	Seni, J; Bwanga, F; Najjuka, CF; Makobore, P; Okee, M; Mshana, SE; Kidenya, BR; Joloba, ML; Kateete, DP				Seni, Jeremiah; Bwanga, Freddie; Najjuka, Christine F.; Makobore, Patson; Okee, Moses; Mshana, Stephen E.; Kidenya, Benson R.; Joloba, Moses L.; Kateete, David P.			Molecular Characterization of Staphylococcus aureus from Patients with Surgical Site Infections at Mulago Hospital in Kampala, Uganda	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL SUSCEPTIBILITY; NASAL CARRIAGE; MULTIPLEX PCR; EPIDEMIOLOGY; IDENTIFICATION; SURVEILLANCE; EVOLUTION; MARKER; MRSA	Background: The prevalence of Methicillin resistant Staphylococcus aureus (MRSA) is progressively increasing globally with significant regional variation. Understanding the Staphylococcus aureus lineages is crucial in controlling nosocomial infections. Recent studies on S. aureus in Uganda have revealed an escalating burden of MRSA. However, the S. aureus genotypes circulating among patients are not known. Here, we report S. aureus lineages circulating in patients with surgical site infections (SSI) at Mulago National hospital, Kampala, Uganda. Methods: A cross-sectional study involving 314 patients with SSI at Mulago National Hospital was conducted from September 2011 to April 2012. Pus swabs from the patients' SSI were processed using standard microbiological procedures. Methicillin sensitive Staphylococcus aureus (MSSA) and MRSA were identified using phenotypic tests and confirmed by PCR-detection of the nuc and mecA genes, respectively. SCCmec genotypes were determined among MRSA isolates using multiplex PCR. Furthermore, to determine lineages, spa sequence based-genotyping was performed on all S. aureus isolates. Results: Of the 314 patients with SSI, S. aureus accounted for 20.4% (64/314), of which 37.5% (24/64) were MRSA. The predominant SCCmec types were type V (33.3%, 8/24) and type I (16.7%, 4/24). The predominant spa lineages were t645 (17.2%, 11/64) and t4353 (15.6%, 10/64), and these were found to be clonally circulating in all the surgical wards. On the other hand, lineages t064, t355, and t4609 were confined to the obstetrics and gynecology wards. A new spa type (t10277) was identified from MSSA isolate. On multivariate logistic regression analysis, cancer and inducible clindamycin resistance remained as independent predictors of MRSA-SSI. Conclusion: SCCmec types I and V are the most prevalent MRSA mecA types from the patients' SSI. The predominant spa lineages (t645 and t4353) are clonally circulating in all the surgical wards, calling for strengthening of infection control practices at Mulago National Hospital.	[Seni, Jeremiah; Bwanga, Freddie; Najjuka, Christine F.; Okee, Moses; Joloba, Moses L.; Kateete, David P.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Makobore, Patson] Makerere Univ, Coll Hlth Sci, Dept Surg, Kampala, Uganda; [Seni, Jeremiah; Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci Bugando, Dept Microbiol & Immunol, Mwanza, Tanzania; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci Bugando, Dept Biochem & Mol Biol, Mwanza, Tanzania	Makerere University; Makerere University	Seni, J (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	senijj80@gmail.com	Mshana, Stephen/AAE-1900-2022; Kateete, David Patrick/HCH-5603-2022	Joloba, Moses/0000-0002-0334-9983; Seni, Jeremiah/0000-0003-2420-5329; Kateete, David Patrick/0000-0001-8075-3069	Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania	Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania	This work was funded by Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania to JS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi IK, 2010, INT J INFECT CONTROL, V6; Anguzu J R, 2007, Afr Health Sci, V7, P148; [Anonymous], 2011, 21 INFORMATIONAL SUP, V31; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Kateete DP, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-23; Kesah C, 2003, CLIN MICROBIOL INFEC, V9, P153, DOI 10.1046/j.1469-0691.2003.00531.x; Khandavilli S, 2009, J HOSP INFECT, V71, P29, DOI 10.1016/j.jhin.2008.09.011; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koneman EW, 1997, COLOR ATLAS TXB DIAG, V5th; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mawalla B, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-21; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Moremi N, 2012, J INFECT DEV COUNTR, V6, P620, DOI 10.3855/jidc.2093; Mshana S. S., 2009, Tanzania Journal of Health Research, V11, P59; Ojulong J, 2009, Tanzan J Health Res, V11, P149; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Onyango MD, 2009, J INFECT DEV COUNTR, V3, P685; Peng Q, 2010, AFRICAN J MICROBIOLO, V4; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Shittu AO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-125; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Shopsin B, 2001, EMERG INFECT DIS, V7, P323, DOI 10.3201/eid0702.010236; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; Truong H, 2011, SAMJ S AFR MED J, V101, P413; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9	38	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66153	10.1371/journal.pone.0066153	http://dx.doi.org/10.1371/journal.pone.0066153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840416	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800037
J	Kostova, D; Reed, C; Finelli, L; Cheng, PY; Gargiullo, PM; Shay, DK; Singleton, JA; Meltzer, MI; Lu, PJ; Bresee, JS				Kostova, Deliana; Reed, Carrie; Finelli, Lyn; Cheng, Po-Yung; Gargiullo, Paul M.; Shay, David K.; Singleton, James A.; Meltzer, Martin I.; Lu, Peng-Jun; Bresee, Joseph S.			Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011	PLOS ONE			English	Article							COST-EFFECTIVENESS; SEASONAL INFLUENZA; EFFICACY; VACCINES; PNEUMONIA; FAILURE; NETWORK; ADULTS; IMPACT	Context: The goal of influenza vaccination programs is to reduce influenza-associated disease outcomes. Therefore, estimating the reduced burden of influenza as a result of vaccination over time and by age group would allow for a clear understanding of the value of influenza vaccines in the US, and of areas where improvements could lead to greatest benefits. Objective: To estimate the direct effect of influenza vaccination in the US in terms of averted number of cases, medically-attended cases, and hospitalizations over six recent influenza seasons. Design: Using existing surveillance data, we present a method for assessing the impact of influenza vaccination where impact is defined as either the number of averted outcomes or as the prevented disease fraction (the number of cases estimated to have been averted relative to the number of cases that would have occurred in the absence of vaccination). Results: We estimated that during our 6-year study period, the number of influenza illnesses averted by vaccination ranged from a low of approximately 1.1 million (95% confidence interval (CI) 0.6-1.7 million) during the 2006-2007 season to a high of 5 million (CI 2.9-8.6 million) during the 2010-2011 season while the number of averted hospitalizations ranged from a low of 7,700 (CI 3,700-14,100) in 2009-2010 to a high of 40,400 (CI 20,800-73,000) in 2010-2011. Prevented fractions varied across age groups and over time. The highest prevented fraction in the study period was observed in 2010-2011, reflecting the post-pandemic expansion of vaccination coverage. Conclusions: Influenza vaccination programs in the US produce a substantial health benefit in terms of averted cases, clinic visits and hospitalizations. Our results underscore the potential for additional disease prevention through increased vaccination coverage, particularly among nonelderly adults, and increased vaccine effectiveness, particularly among the elderly.	[Kostova, Deliana; Reed, Carrie; Finelli, Lyn; Cheng, Po-Yung; Gargiullo, Paul M.; Shay, David K.; Bresee, Joseph S.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Singleton, James A.; Lu, Peng-Jun] Ctr Dis Control & Prevent, Immunizat Serv Div, Atlanta, GA USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Enter & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kostova, D (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	kiv0@cdc.gov	Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472; Shay, David/0000-0001-9619-4820				BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, JAMA-J AM MED ASSOC, V244, P2547, DOI 10.1001/jama.244.22.2547; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Biggerstaff M, 2012, AM J PUBLIC HEALTH, V102, pE21, DOI 10.2105/AJPH.2012.300651; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; DALESSIO DJ, 1969, J AMER MED ASSOC, V210, P485, DOI 10.1001/jama.210.3.485; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Kamimoto L, 2010, 27 ANN BEH RISK FACT; KEREN G, 1988, J MED VIROL, V25, P85, DOI 10.1002/jmv.1890250112; Maciosek MV, 2006, AM J PREV MED, V31, P72, DOI 10.1016/j.amepre.2006.03.008; Meltzer MI, 2005, VACCINE, V23, P1004, DOI 10.1016/j.vaccine.2004.07.040; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Reed C, 2011, P 49 ANN M IDSA OCT; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Roberts S, 2006, OBSTET GYNECOL, V107, P1323, DOI 10.1097/01.AOG.0000210225.45986.99; Salo H, 2006, VACCINE, V24, P4934, DOI 10.1016/j.vaccine.2006.03.057; Shay D, 2011, WORKING PAPER UNPUB; Singleton JA, 2011, M ADV COMM IMM PRACT; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1; STRASSBURG MA, 1986, VACCINE, V4, P38, DOI 10.1016/S0264-410X(86)80002-0; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574	32	147	151	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66312	10.1371/journal.pone.0066312	http://dx.doi.org/10.1371/journal.pone.0066312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840439	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200067
J	Moreau, C; Liu, Q; Graeff, R; Wagner, GK; Thomas, MP; Swarbrick, JM; Shuto, S; Lee, HC; Hao, Q; Potter, BVL				Moreau, Christelle; Liu, Qun; Graeff, Richard; Wagner, Gerd K.; Thomas, Mark P.; Swarbrick, Joanna M.; Shuto, Satoshi; Lee, Hon Cheung; Hao, Quan; Potter, Barry V. L.			CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5 '-Diphosphate Ribose Template	PLOS ONE			English	Article							CYCLIC-ADP-RIBOSE; MEDICINAL CHEMISTRY; GENETIC ALGORITHM; CALCIUM-RELEASE; DIPHOSPHORIBOSE; HYDROLYSIS; PHARMACOLOGY; DEGRADATION; DERIVATIVES; CYCLIZATION	Few inhibitors exist for CD38, a multifunctional enzyme catalyzing the formation and metabolism of the Ca2+-mobilizing second messenger cyclic adenosine 5'-diphosphoribose (cADPR). Synthetic, non-hydrolyzable ligands can facilitate structure-based inhibitor design. Molecular docking was used to reproduce the crystallographic binding mode of cyclic inosine 5'-diphosphoribose (N1-cIDPR) with CD38, revealing an exploitable pocket and predicting the potential to introduce an extra hydrogen bond interaction with Asp-155. The purine C-8 position of N1-cIDPR (IC50 276 mu M) was extended with an amino or diaminobutane group and the 8-modified compounds were evaluated against CD38-catalyzed cADPR hydrolysis. Crystallography of an 8-amino N1-cIDPR: CD38 complex confirmed the predicted interaction with Asp-155, together with a second H-bond from a realigned Glu-146, rationalizing the improved inhibition (IC50 56 mu M). Crystallography of a complex of cyclic ADP-carbocyclic ribose (cADPcR, IC50 129 mu M) with CD38 illustrated that Glu-146 hydrogen bonds with the ligand N6-amino group. Both 8-amino N1-cIDPR and cADPcR bind deep in the active site reaching the catalytic residue Glu-226, and mimicking the likely location of cADPR during catalysis. Substantial overlap of the N1-cIDPR "northern'' ribose monophosphate and the cADPcR carbocyclic ribose monophosphate regions suggests that this area is crucial for inhibitor design, leading to a new compound series of N1-inosine 5'-monophosphates (N1-IMPs). These small fragments inhibit hydrolysis of cADPR more efficiently than the parent cyclic compounds, with the best in the series demonstrating potent inhibition (IC50 = 7.6 mu M). The lower molecular weight and relative simplicity of these compounds compared to cADPR make them attractive as a starting point for further inhibitor design.	[Moreau, Christelle; Wagner, Gerd K.; Thomas, Mark P.; Swarbrick, Joanna M.; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Liu, Qun; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, Macromolar Diffract Facil, Ithaca, NY 14853 USA; [Graeff, Richard] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Bath; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; Hokkaido University; University of Hong Kong	Potter, BVL (corresponding author), Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	V.L.Potter@bath.ac.uk	Watt, Joanna M/F-2603-2010; Shuto, Satoshi/AAH-4998-2020; Liu, Qun/A-8757-2011; Lee, Hon Cheung/C-4329-2009; Hao, Quan/C-4304-2009; Potter, Barry/AAX-4781-2020; Wagner, Gerd/D-4759-2013	Watt, Joanna M/0000-0003-2854-6622; Shuto, Satoshi/0000-0001-7850-8064; Liu, Qun/0000-0002-1179-290X; Wagner, Gerd/0000-0003-1086-2301; Hao, Quan/0000-0002-9642-0514	Wellcome Trust [084068, 082837]; Hong Kong General Research Fund [769107, 768408, 769309, 770610]; National Institutes of Health [RR01646]	Wellcome Trust(Wellcome TrustEuropean Commission); Hong Kong General Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Wellcome Trust through Project Grant No 084068 and Programme Grant 082837 (to BVLP) and by Hong Kong General Research Fund Grants 769107, 768408, 769309, and 770610 (to HCL) and by National Institutes of Health Grant RR01646 (to QH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashamu GA, 1997, BIOCHEMISTRY-US, V36, P9509, DOI 10.1021/bi9705671; Bailey VC, 1996, FEBS LETT, V379, P227, DOI 10.1016/0014-5793(95)01515-9; Briggs AP, 1922, J BIOL CHEM, V53, P13; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dong M, 2011, ORG BIOMOL CHEM, V9, P3246, DOI 10.1039/c0ob00768d; Elliott TS, 2012, MEDCHEMCOMM, V3, P735, DOI 10.1039/c2md20079a; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 2004, CURR MOL MED, V4, P239, DOI 10.2174/1566524043360771; Guse AH, 2002, BIOCHEMISTRY-US, V41, P6744, DOI 10.1021/bi020171b; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kellenberger E, 2011, BIOORG MED CHEM LETT, V21, P3939, DOI 10.1016/j.bmcl.2011.05.022; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kirchberger T, 2006, BRIT J PHARMACOL, V149, P337, DOI 10.1038/sj.bjp.0706869; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2007, J BIOL CHEM, V282, P24825, DOI 10.1074/jbc.M701653200; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Moreau C, 2006, CHEM COMMUN, P1127, DOI 10.1039/b517916e; Moreau C, 2006, J MED CHEM, V49, P5162, DOI 10.1021/jm060275a; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potter BVL, 2004, CURR MOL MED, V4, P303, DOI 10.2174/1566524043360744; Sauve AA, 2002, BIOCHEMISTRY-US, V41, P8455, DOI 10.1021/bi0258795; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Shuto S, 2001, J AM CHEM SOC, V123, P8750, DOI 10.1021/ja010756d; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wagner GK, 2005, J ORG CHEM, V70, P4810, DOI 10.1021/jo050085s; Wagner GK, 2003, CHEM COMMUN, P1944, DOI 10.1039/b305660k; Wall KA, 1998, BIOCHEM J, V335, P631, DOI 10.1042/bj3350631; Zhang FJ, 1999, BIOORGAN MED CHEM, V7, P653, DOI 10.1016/S0968-0896(98)00256-9; Zhou Y, 2012, CHEMMEDCHEM, V7, P223, DOI 10.1002/cmdc.201100487	45	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66247	10.1371/journal.pone.0066247	http://dx.doi.org/10.1371/journal.pone.0066247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840430	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200064
J	Burd, NA; Hamer, HM; Pennings, B; Pellikaan, WF; Senden, JMG; Gijsen, AP; van Loon, LJC				Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Pellikaan, Wilbert F.; Senden, Joan M. G.; Gijsen, Annemie P.; van Loon, Luc J. C.			Substantial Differences between Organ and Muscle Specific Tracer Incorporation Rates in a Lactating Dairy Cow	PLOS ONE			English	Article							TISSUE PROTEIN-SYNTHESIS; INTRINSICALLY LABELED MILK; HUMAN-NUTRITION RESEARCH; AMINO-ACIDS; RESISTANCE EXERCISE; SKELETAL-MUSCLE; NEONATAL PIGS; WHEY-PROTEIN; ELDERLY-MEN; WHOLE-BODY	We aimed to produce intrinsically L-[1-C-13]phenylalanine labeled milk and beef for subsequent use in human nutrition research. The collection of the various organ tissues after slaughter allowed for us to gain insight into the dynamics of tissue protein turnover in vivo in a lactating dairy cow. One lactating dairy cow received a constant infusion of L-[1-C-13]phenylalanine (450 mu mol/min) for 96 h. Plasma and milk were collected prior to, during, and after the stable isotope infusion. Twenty-four hours after cessation of the infusion the cow was slaughtered. The meat and samples of the various organ tissues (liver, heart, lung, udder, kidney, rumen, small intestine, and colon) were collected and stored. Approximately 210 kg of intrinsically labeled beef (bone and fat free) with an average L-[1-C-13]phenylalanine enrichment of 1.8 +/- 0.1 mole percent excess (MPE) was obtained. The various organ tissues differed substantially in L-[1-C-13]phenylalanine enrichments in the tissue protein bound pool, the highest enrichment levels were achieved in the kidney (11.7 MPE) and the lowest enrichment levels in the skeletal muscle tissue protein of the cow (between 1.5-2.4 MPE). The estimated protein synthesis rates of the various organ tissues should be regarded as underestimates, particularly for the organs with the higher turnover rates and high secretory activity, due to the lengthened (96 h) measurement period necessary for the production of the intrinsically labeled beef. Our data demonstrates that there are relatively small differences in L-[1-C-13]phenylalanine enrichments between the various meat cuts, but substantial higher enrichment values are observed in the various organ tissues. We conclude that protein turnover rates of various organs are much higher when compared to skeletal muscle protein turnover rates in large lactating ruminants.	[Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Senden, Joan M. G.; van Loon, Luc J. C.] TIFN, Wageningen, Netherlands; [Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Senden, Joan M. G.; Gijsen, Annemie P.; van Loon, Luc J. C.] MUMC, Dept Human Movement Sci, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Pellikaan, Wilbert F.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); Wageningen University & Research	van Loon, LJC (corresponding author), TIFN, Wageningen, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Burd, Nicholas/0000-0001-5581-3154	Top Institute Food and Nutrition (TIFN)	Top Institute Food and Nutrition (TIFN)	Top Institute Food and Nutrition (TIFN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARACOS VE, 1991, BRIT J NUTR, V66, P451, DOI 10.1079/BJN19910047; BAUMANN PQ, 1994, AM J PHYSIOL, V267, pE203, DOI 10.1152/ajpendo.1994.267.2.E203; Bequette BJ, 1997, P NUTR SOC, V56, P593, DOI 10.1079/PNS19970060; BOIRIE Y, 1995, J NUTR, V125, P92; BUCHANAN DL, 1961, ARCH BIOCHEM BIOPHYS, V94, P500, DOI 10.1016/0003-9861(61)90078-9; Burd NA, 2012, BRIT J NUTR, V108, P958, DOI 10.1017/S0007114511006271; Burd NA, 2009, J APPL PHYSIOL, V106, P1692, DOI 10.1152/japplphysiol.91351.2008; CARRARO F, 1991, METABOLISM, V40, P553, DOI 10.1016/0026-0495(91)90043-V; CHAMPREDON C, 1990, J NUTR, V120, P1006, DOI 10.1093/jn/120.9.1006; Dangin M, 2002, J NUTR, V132, p3228S, DOI 10.1093/jn/131.10.3228S; Davis TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE880, DOI 10.1152/ajpendo.00517.2001; Davis TA, 1999, AM J PHYSIOL-ENDOC M, V277, pE103, DOI 10.1152/ajpendo.1999.277.1.E103; EISEMANN JH, 1989, BRIT J NUTR, V62, P657, DOI 10.1079/BJN19890066; GARLICK PJ, 1991, P NUTR SOC, V50, P217, DOI 10.1079/PNS19910031; GARLICK PJ, 1975, BIOCHIM BIOPHYS ACTA, V414, P71, DOI 10.1016/0005-2787(75)90126-4; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507; Hanigan MD, 2009, J NUTR, V139, P1118, DOI 10.3945/jn.108.103002; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; Lescoat P, 1997, REPROD NUTR DEV, V37, P493, DOI 10.1051/rnd:19970502; LOBLEY GE, 1992, BRIT J NUTR, V68, P373, DOI 10.1079/BJN19920096; LOBLEY GE, 1980, BRIT J NUTR, V43, P491, DOI 10.1079/BJN19800116; LOBLEY GE, 1993, J NUTR, V123, P337, DOI 10.1093/jn/123.suppl_2.337; LOBLEY GE, 1994, BRIT J NUTR, V71, P3, DOI 10.1079/BJN19940106; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; Pennings B, 2011, J DAIRY SCI, V94, P4366, DOI 10.3168/jds.2011-4451; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; PREEDY VR, 1988, BIOCHEM J, V250, P179, DOI 10.1042/bj2500179; Reeds PJ, 2003, J NUTR, V133, p2953S, DOI 10.1093/jn/133.9.2953S; RENNIE MJ, 1994, AM J PHYSIOL, V266, pE298, DOI 10.1152/ajpendo.1994.266.3.E298; SCHAEFER AL, 1986, BRIT J NUTR, V56, P281, DOI 10.1079/BJN19860107; Schei I, 2007, ANIMAL, V1, P501, DOI 10.1017/S175173110768505X; SCHWENK WF, 1985, AM J PHYSIOL, V248, pE482, DOI 10.1152/ajpendo.1985.248.4.E482; Spears RA, 2003, J DAIRY SCI, V86, P4178, DOI 10.3168/jds.S0022-0302(03)74033-8; Suryawan A, 2009, AMINO ACIDS, V37, P97, DOI 10.1007/s00726-008-0149-z; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Ternman E, 2012, APPL ANIM BEHAV SCI, V140, P25, DOI 10.1016/j.applanim.2012.05.005; Tessari P, 1996, J CLIN INVEST, V98, P1481, DOI 10.1172/JCI118937; van Loon LJC, 2009, J DAIRY SCI, V92, P4812, DOI 10.3168/jds.2009-2317; vanEijk HMH, 1997, J CHROMATOGR B, V691, P287, DOI 10.1016/S0378-4347(96)00475-6; VANES AJH, 1978, LIVEST PROD SCI, V5, P331, DOI 10.1016/0301-6226(78)90029-5; Vanhatalo A, 2003, J DAIRY SCI, V86, P3260, DOI 10.3168/jds.S0022-0302(03)73929-0; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007	47	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68109	10.1371/journal.pone.0068109	http://dx.doi.org/10.1371/journal.pone.0068109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826365	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000119
J	Chen, HF; Liu, MD; Chen, P; Chen, LH; Chang, YH; Wen, PC; Li, CY				Chen, Hua-Fen; Liu, Ming-Der; Chen, Peter; Chen, Li-Huan; Chang, Ya-Hui; Wen, Pei-Chun; Li, Chung-Yi			Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							SEX STRATIFICATIONS; MELLITUS; TAIWAN; HEALTH; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; INSURANCE; ONSET; JAPAN	Objective: We investigated the overall and age-specific risks of developing breast and endometrial cancer among women with diabetes in a population-based cohort study. Methods: Women with diabetes (n = 319310) and age-matched controls (n = 319308), selected from ambulatory care claims and beneficiary registry in 2000, respectively were linked to the in-patient claims (2000-2008) to identify admissions due to breast (ICD-9-CM: 174) and endometrial (ICD-9-CM: 182) cancer. The person-year approach with Poisson assumption was used to estimate the incidence density rate. The age-specific hazard ratios (HRs) of above malignancies in relation to diabetes with multivariate Cox proportional hazard regression. Results: The overall incidence density rate of breast and endometrial cancer was estimated at 1.21 and 0.21 per 10,000 patient-years, respectively, for diabetes. The corresponding figures for controls were lower at 1.00 and 0.14 per 10,000 patient-years. Compared with the controls, the covariate adjusted HR for breast and endometrial cancer was 1.42 (95% confidence interval (CI) 1.34-1.50) and 1.71 (95% CI 1.48-1.97), respectively in women with diabetes. Elderly (>=65 years) diabetes had the highest HR (1.61) of breast cancer, while the highest HR (1.85) of endometrial cancer was observed in diabetes aged <=50 years. Conclusions: Diabetes may significantly increase the risks of breast and endometrial cancer in all age stratifications. Health education for strict adherence of cancer screening program in women with diabetes is essential.	[Chen, Hua-Fen] Far Eastern Mem Hosp, Dept Endocrinol, New Taipei City, Taiwan; [Chen, Hua-Fen] Fujen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Liu, Ming-Der] Hungkuang Univ, Coll Gen Educ, Taichung, Taiwan; [Liu, Ming-Der] Natl United Univ, Ctr Gen Educ, Miaoli, Taiwan; [Chen, Peter] Cent Med Hosp Grp, Dept Gastroenterol, New Taipei City, Taiwan; [Chen, Li-Huan] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan; [Chen, Li-Huan] Chang Gung Univ, Grad Inst Nursing, Tao Yuan, Taiwan; [Chang, Ya-Hui; Wen, Pei-Chun; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan; [Wen, Pei-Chun] Buddhist Tzu Chi Gen Hosp, Dept Dent, Dalin Branch, Chiayi, Taiwan; [Li, Chung-Yi] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; Hungkuang University; National United University; Chang Gung University; National Cheng Kung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; China Medical University Taiwan	Wen, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan.	t86004047@mail.ncku.edu.tw	LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908	National Scientific Council [NSC-100-2314-B-006-052]	National Scientific Council	This study was supported by a grant from the National Scientific Council (grant number: NSC-100-2314-B-006-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Anderson KE, 2001, CANCER EPIDEM BIOMAR, V10, P611; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bowker SL, 2011, DIABETES CARE, V34, P2542, DOI 10.2337/dc11-1199; Bureau of health promotion, 2009, CANC STAT; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chen HF, 2011, DIABETES CARE, V34, P1177, DOI 10.2337/dc10-2006; Chen HF, 2010, HEPATOLOGY, V52, P155, DOI 10.1002/hep.23641; Chuang LM, 2001, DIABETES RES CLIN PR, V54, pS55; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Friberg E, 2007, CANCER EPIDEM BIOMAR, V16, P276, DOI 10.1158/1055-9965.EPI-06-0751; Gordis L, 2000, EPIDEMIOLOGY, V8; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050; Lambe M, 2011, CANCER CAUSE CONTROL, V22, P1163, DOI 10.1007/s10552-011-9794-8; Largent JA, 2010, CANCER CAUSE CONTROL, V21, P1615, DOI 10.1007/s10552-010-9590-x; LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lindemann K, 2008, BRIT J CANCER, V98, P1582, DOI 10.1038/sj.bjc.6604313; Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P349, DOI 10.1007/s10549-006-9172-5; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mataltiotakis IM, 2008, SURG ONCOL, V17, P289, DOI 10.1016/j.suronc.2008.01.002; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Parazzini F, 1999, INT J CANCER, V81, P539, DOI 10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q; Pinho Valéria Fernandes de Souza, 2005, Cad. Saúde Pública, V21, P351, DOI 10.1590/S0102-311X2005000200002; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Saltzman BS, 2008, AM J EPIDEMIOL, V167, P607, DOI 10.1093/aje/kwm333; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Weiderpass E, 1997, INT J CANCER, V71, P360, DOI 10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360	38	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67420	10.1371/journal.pone.0067420	http://dx.doi.org/10.1371/journal.pone.0067420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826297	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000080
J	Mestrovic, N; Pavlek, M; Car, A; Castagnone-Sereno, P; Abad, P; Plohl, M				Mestrovic, Nevenka; Pavlek, Martina; Car, Ana; Castagnone-Sereno, Philippe; Abad, Pierre; Plohl, Miroslav			Conserved DNA Motifs, Including the CENP-B Box-like, Are Possible Promoters of Satellite DNA Array Rearrangements in Nematodes	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; ALPHA-SATELLITE; MELOIDOGYNE-CHITWOODI; EVOLUTIONARY DYNAMICS; CENTROMERE SATELLITES; SEQUENCE ALIGNMENT; M-FALLAX; M-HAPLA; GENOME; RECOMBINATION	Tandemly arrayed non-coding sequences or satellite DNAs (satDNAs) are rapidly evolving segments of eukaryotic genomes, including the centromere, and may raise a genetic barrier that leads to speciation. However, determinants and mechanisms of satDNA sequence dynamics are only partially understood. Sequence analyses of a library of five satDNAs common to the root-knot nematodes Meloidogyne chitwoodi and M. fallax together with a satDNA, which is specific for M. chitwoodi only revealed low sequence identity (32-64%) among them. However, despite sequence differences, two conserved motifs were recovered. One of them turned out to be highly similar to the CENP-B box of human alpha satDNA, identical in 10-12 out of 17 nucleotides. In addition, organization of nematode satDNAs was comparable to that found in alpha satDNA of human and primates, characterized by monomers concurrently arranged in simple and higher-order repeat (HOR) arrays. In contrast to alpha satDNA, phylogenetic clustering of nematode satDNA monomers extracted either from simple or from HOR array indicated frequent shuffling between these two organizational forms. Comparison of homogeneous simple arrays and complex HORs composed of different satDNAs, enabled, for the first time, the identification of conserved motifs as obligatory components of monomer junctions. This observation highlights the role of short motifs in rearrangements, even among highly divergent sequences. Two mechanisms are proposed to be involved in this process, i.e., putative transposition-related cut-and-paste insertions and/or illegitimate recombination. Possibility for involvement of the nematode CENP-B box-like sequence in the transposition-related mechanism and together with previously established similarity of the human CENP-B protein and pogo-like transposases implicate a novel role of the CENP-B box and related sequence motifs in addition to the known function in centromere protein binding.	[Mestrovic, Nevenka; Pavlek, Martina; Car, Ana; Plohl, Miroslav] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Castagnone-Sereno, Philippe; Abad, Pierre] Inst Sophia Agrobiotech, French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Castagnone-Sereno, Philippe; Abad, Pierre] UNSA, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Castagnone-Sereno, Philippe; Abad, Pierre] Inst Sophia Agrobiotech, CNRS, Sophia Antipolis, France	Rudjer Boskovic Institute; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Mestrovic, N (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	nevenka@irb.hr	Pavlek, Martina/AAD-9359-2019; Plohl, Miroslav/AAQ-6428-2021; Car, Ana/AAT-5455-2020	Pavlek, Martina/0000-0001-6710-0581	Ministry of Science, Education and Sports of the Republic Croatia [098-0982913-2756]; INRA (Institut National de la Recherche Agronomique)	Ministry of Science, Education and Sports of the Republic Croatia(Ministry of Science, Education and Sports, Republic of Croatia); INRA (Institut National de la Recherche Agronomique)	This research was financially supported by grants from the Ministry of Science, Education and Sports of the Republic Croatia (http://public.mzos.hr) (no. 098-0982913-2756) and INRA (Institut National de la Recherche Agronomique) (http://www.international.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alkan C, 2007, PLOS COMPUT BIOL, V3, P1807, DOI 10.1371/journal.pcbi.0030181; Alkan C, 2011, GENOME RES, V21, P137, DOI 10.1101/gr.111278.110; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Castagnone-Sereno P, 1998, J MOL EVOL, V46, P225, DOI 10.1007/PL00006297; Castagnone-Sereno P, 1998, MOL BIOL EVOL, V15, P1115, DOI 10.1093/oxfordjournals.molbev.a026019; Castagnone-Sereno P, 2000, GENOME, V43, P346, DOI 10.1139/gen-43-2-346; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; EARNSHAW WC, 1991, COLD SH Q B, V56, P675; Fantaccione S, 2005, FEBS LETT, V579, P2519, DOI 10.1016/j.febslet.2005.03.064; Fowler KJ, 2000, GENOME RES, V10, P30; Hall SE, 2005, GENETICS, V170, P1913, DOI 10.1534/genetics.104.038208; Hall SE, 2003, GENOME RES, V13, P195, DOI 10.1101/gr.593403; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Kuhn GCS, 2009, HEREDITY, V102, P453, DOI 10.1038/hdy.2009.9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; Lopez CC, 1998, NUCLEIC ACIDS RES, V26, P4168, DOI 10.1093/nar/26.18.4168; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; Masumoto H, 1993, CHROMOSOME SEGREGATI, P31, DOI DOI 10.1007/9783-64284938-1_3; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Mestrovic N, 2009, MOL PHYLOGENET EVOL, V50, P204, DOI 10.1016/j.ympev.2008.10.013; Mestrovic N, 2006, MOL BIOL EVOL, V23, P2316, DOI 10.1093/molbev/msl119; Mravinac B, 2010, MOL BIOL EVOL, V27, P1857, DOI 10.1093/molbev/msq068; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Rosandic M, 2003, J THEOR BIOL, V221, P29, DOI 10.1006/jtbi.2003.3165; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Sambrook J, 2001, MOL CLONING LAB MANU; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; Swofford D. L., 2002, MESQUITE MODULAR SYS, V4, P1; Talbert PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000326; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; vanderBeek JG, 1997, PHYTOPATHOLOGY, V87, P1061, DOI 10.1094/PHYTO.1997.87.10.1061; WARBURTON PE, 1993, MOL CELL BIOL, V13, P6520, DOI 10.1128/MCB.13.10.6520; Zijlstra C, 2000, EUR J PLANT PATHOL, V106, P283, DOI 10.1023/A:1008765303364	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67328	10.1371/journal.pone.0067328	http://dx.doi.org/10.1371/journal.pone.0067328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826269	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000063
J	Aghcheh, RK; Druzhinina, IS; Kubicek, CP				Aghcheh, Razieh Karimi; Druzhinina, Irina S.; Kubicek, Christian P.			The Putative Protein Methyltransferase LAE1 of Trichoderma atroviride Is a Key Regulator of Asexual Development and Mycoparasitism	PLOS ONE			English	Article							VELVET-LIKE COMPLEX; SECONDARY METABOLISM; CONIDIATION; EXPRESSION; REESEI; PHOTOSTIMULATION; MORPHOGENESIS; COMPONENTS; VIRULENCE; GROWTH	In Ascomycota the protein methyltransferase LaeA is a global regulator that affects the expression of secondary metabolite gene clusters, and controls sexual and asexual development. The common mycoparasitic fungus Trichoderma atroviride is one of the most widely studied agents of biological control of plant-pathogenic fungi that also serves as a model for the research on regulation of asexual sporulation (conidiation) by environmental stimuli such as light and/or mechanical injury. In order to learn the possible involvement of LAE1 in these two traits, we assessed the effect of deletion and overexpression of lae1 gene on conidiation and mycoparasitic interaction. In the presence of light, conidiation was 50% decreased in a Delta lae1 and 30-50% increased in lae1-overexpressing (OElae1) strains. In darkness, Delta lae1 strains did not sporulate, and the OElae1 strains produced as much spores as the parent strain. Loss-of-function of lae1 also abolished sporulation triggered by mechanical injury of the mycelia. Deletion of lae1 also increased the sensitivity of T. atroviride to oxidative stress, abolished its ability to defend against other fungi and led to a loss of mycoparasitic behaviour, whereas the OElae1 strains displayed enhanced mycoparasitic vigor. The loss of mycoparasitic activity in the Dlae1 strain correlated with a significant underexpressionn of several genes normally upregulated during mycoparasitic interaction (proteases, GH16 beta-glucanases, polyketide synthases and small cystein-rich secreted proteins), which in turn was reflected in the partial reduction of formation of fungicidal water soluble metabolites and volatile compounds. Our study shows T. atroviride LAE1 is essential for asexual reproduction in the dark and for defense and parasitism on other fungi.	[Aghcheh, Razieh Karimi; Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1040 Vienna, Austria; [Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Austrian Ctr Ind Biotechnol, A-1040 Vienna, Austria	Technische Universitat Wien; Austrian Centre of Industrial Biotechnology; Technische Universitat Wien	Kubicek, CP (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1040 Vienna, Austria.	ckubicek@mail.zserv.tuwien.ac.at	Druzhinina, Irina S./AAK-7054-2021	Druzhinina, Irina S./0000-0003-2821-5268; Karimi Aghcheh, Razieh/0000-0003-0027-1030	Austrian Science Fund [P 21266]; Austrian Science Fund (FWF) [P 21266] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by a grant of the Austrian Science Fund to CPK:P 21266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Atanasova L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-121; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Carreras-Villasenor N, 2012, MICROBIOL-SGM, V158, P3, DOI 10.1099/mic.0.052688-0; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Chang PK, 2012, FUNGAL BIOL-UK, V116, P298, DOI 10.1016/j.funbio.2011.12.003; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Druzhinina IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009191; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; Friedl MA, 2008, APPL ENVIRON MICROB, V74, P245, DOI 10.1128/AEM.02068-07; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hernandez-Onate MA, 2012, P NATL ACAD SCI USA, V109, P14918, DOI 10.1073/pnas.1209396109; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kullnig CM, 2001, MYCOL RES, V105, P770, DOI 10.1017/S0953756201229967; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Omann M, 2010, J SIGNAL TRANSDUCT, P123; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Roze LV, 2010, BMC BIOCH, V24, p[11, 33]; Schrey AW, 2012, MOL ECOL, V21, P2559, DOI 10.1111/j.1365-294X.2012.05487.x; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Steyaert JM, 2010, MICROBIOL-SGM, V156, P2887, DOI 10.1099/mic.0.041715-0; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542	40	29	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67144	10.1371/journal.pone.0067144	http://dx.doi.org/10.1371/journal.pone.0067144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826217	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400111
J	Hsiao, SC; Liu, H; Holstlaw, TA; Liu, C; Francis, CY; Francis, MB				Hsiao, Sonny C.; Liu, Hong; Holstlaw, Taylor A.; Liu, Cheng; Francis, Catherine Y.; Francis, Matthew B.			Real Time Assays for Quantifying Cytotoxicity with Single Cell Resolution	PLOS ONE			English	Article							ANTI-CD20 ANTIBODY IDEC-C2B8; NATURAL-KILLER-CELL; IN-VITRO; RITUXIMAB; COMPLEMENT; LYMPHOMA; THERAPY; DNA; RESISTANCE; ADHESION	A new live cell-based assay platform has been developed for the determination of complement dependent cytotoxicity (CDC), antibody dependent cellular cytotoxicity (ADCC), and overall cytotoxicity in human whole blood. In these assays, the targeted tumor cell populations are first labeled with fluorescent Cell Tracker dyes and immobilized using a DNA-based adhesion technique. This allows the facile generation of live cell arrays that are arranged arbitrarily or in ordered rectilinear patterns. Following the addition of antibodies in combination with serum, PBMCs, or whole blood, cell death within the targeted population can be assessed by the addition of propidium iodide (PI) as a viability probe. The array is then analyzed with an automated microscopic imager. The extent of cytotoxicity can be quantified accurately by comparing the number of surviving target cells to the number of dead cells labeled with both Cell Tracker and PI. Excellent batch-to-batch reproducibility has been achieved using this method. In addition to allowing cytotoxicity analysis to be conducted in real time on a single cell basis, this new assay overcomes the need for hazardous radiochemicals. Fluorescently-labeled antibodies can be used to identify individual cells that bear the targeted receptors, but yet resist the CDC and ADCC mechanisms. This new approach also allows the use of whole blood in cytotoxicity assays, providing an assessment of antibody efficacy in a highly relevant biological mixture. Given the rapid development of new antibody-based therapeutic agents, this convenient assay platform is well-poised to streamline the drug discovery process significantly.	[Hsiao, Sonny C.; Holstlaw, Taylor A.; Francis, Catherine Y.] Adheren Inc, Berkeley, CA USA; [Liu, Hong; Liu, Cheng] Eureka Therapeut, Emeryville, CA USA; [Francis, Matthew B.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Francis, Matthew B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hsiao, SC (corresponding author), Adheren Inc, Berkeley, CA USA.	sonny@adheren.com						Amoroso A, 2011, FRONT BIOSCI-LANDMRK, V16, P770, DOI 10.2741/3719; Anderson DR, 1997, BIOCHEM SOC T, V25, P705, DOI 10.1042/bst0250705; Bannerji R, 2003, J CLIN ONCOL, V21, P1466, DOI 10.1200/JCO.2003.06.012; Bornstein GG, 2010, INVEST NEW DRUG, V28, P561, DOI 10.1007/s10637-009-9291-z; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; BRUNNER KT, 1968, IMMUNOLOGY, V14, P181; Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421; Chow KU, 2002, HAEMATOLOGICA, V87, P33; Dalle S, 2008, ANTI-CANCER AGENT ME, V8, P523, DOI 10.2174/187152008784533071; Douglas ES, 2009, LAB CHIP, V9, P2010, DOI 10.1039/b821690h; Gancz D, 2009, MOL IMMUNOL, V46, P2794, DOI 10.1016/j.molimm.2009.05.009; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Gupta P, 2012, BLOOD, V119, P3767, DOI 10.1182/blood-2011-09-381988; Harjunpaa A, 2000, SCAND J IMMUNOL, V51, P634; Hsiao SC, 2008, ANGEW CHEM INT EDIT, V47, P8473, DOI 10.1002/anie.200802525; Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n; JOHANN S, 1995, J IMMUNOL METHODS, V185, P209, DOI 10.1016/0022-1759(95)00116-R; Khattak SF, 2006, BIOTECHNOL LETT, V28, P1361, DOI 10.1007/s10529-006-9104-9; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kosits C, 2000, Oncol Nurs Forum, V27, P51; Liadi I, 2013, JOVE-J VIS EXP, DOI 10.3791/50058; Lv M, 2010, CANCER LETT, V294, P66, DOI 10.1016/j.canlet.2010.01.023; Onoe H, 2012, LANGMUIR, V28, P8120, DOI 10.1021/la204863s; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Vugmeyster Y, 2003, CYTOM PART A, V52A, P101, DOI 10.1002/cyto.a.10030; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wu L, 2010, CANCER LETT, V292, P208, DOI 10.1016/j.canlet.2009.12.004; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405	29	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66739	10.1371/journal.pone.0066739	http://dx.doi.org/10.1371/journal.pone.0066739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826123	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400043
J	Mann, JFS; Mckay, PF; Arokiasamy, S; Patel, RK; Tregoning, JS; Shattock, RJ				Mann, Jamie F. S.; Mckay, Paul F.; Arokiasamy, Samantha; Patel, Reeyeshkumar K.; Tregoning, John S.; Shattock, Robin J.			Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; VACCINE ANTIGEN; INFLUENZA-VIRUS; HIV VACCINES; IMMUNIZATION; PROTEIN; PRIME; EXPRESSION	Increasing evidence suggests that mucosally targeted vaccines will enhance local humoral and cellular responses whilst still eliciting systemic immunity. We therefore investigated the capacity of nasal, sublingual or vaginal delivery of DNA-PEI polyplexes to prime immune responses prior to mucosal protein boost vaccination. Using a plasmid expressing the model antigen HIV CN54gp140 we show that each of these mucosal surfaces were permissive for DNA priming and production of antigen-specific antibody responses. The elicitation of systemic immune responses using nasally delivered polyplexed DNA followed by recombinant protein boost vaccination was equivalent to a systemic prime-boost regimen, but the mucosally applied modality had the advantage in that significant levels of antigen-specific IgA were detected in vaginal mucosal secretions. Moreover, mucosal vaccination elicited both local and systemic antigen-specific IgG(+) and IgA(+) antibody secreting cells. Finally, using an Influenza challenge model we found that a nasal or sublingual, but not vaginal, DNA prime/protein boost regimen protected against infectious challenge. These data demonstrate that mucosally applied plasmid DNA complexed to PEI followed by a mucosal protein boost generates sufficient antigen-specific humoral antibody production to protect from mucosal viral challenge.	[Mann, Jamie F. S.; Mckay, Paul F.; Arokiasamy, Samantha; Tregoning, John S.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Dept Med, London, England; [Patel, Reeyeshkumar K.] St Georges Univ London, Ctr Infect, Div Clin Sci, London, England	Imperial College London; St Georges University London	Mann, JFS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Dept Med, London, England.	j.mann@imperial.ac.uk		Mann, Jamie/0000-0001-7037-1286; Tregoning, John/0000-0001-8093-8741; McKay, Paul/0000-0001-5195-6254	Bill & Melinda Gates Foundation; Wellcome Trust, under the Grand Challenges in Global Health Initiative [37872]; CUT'HIVAC under a European Commission FP7 award [241904]; Wellcome Trust; Fondation Dormeur; Imperial College Central Biological Research Facility [70/7457]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust, under the Grand Challenges in Global Health Initiative(Wellcome Trust); CUT'HIVAC under a European Commission FP7 award; Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Dormeur; Imperial College Central Biological Research Facility	This work was funded in part by a grant to SGUL by the Bill & Melinda Gates Foundation and the Wellcome Trust, under the Grand Challenges in Global Health Initiative (grant number 37872) and by CUT'HIVAC under a European Commission FP7 award (grant number 241904). The CN54 env plasmid was developed as part of the UK HIV Vaccine Consortium (www.ukhvc.org). The UK HVC is funded by an award from the Wellcome Trust for the provision of GMP vaccines, clinical trial support, and laboratory assays. The authors are also are grateful to the Fondation Dormeur for the provision of an equipment grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Simon Jeffs (Imperial College London, UK), Roger Tatoud (UK HVC, Imperial College London) and Dietmar Katinger (Polymun Scientific, AUT) for the provision of plasmids and antigen. GENEART AG (Regensburg, Germany) owns a European Patent EP1240333B1 covering the complete clade C/B' HIV-1 97CN54 coding sequence and codon optimized genes. The VRC 8400 CMV/R backbone vector used to construct the plasmid DNA has been developed by the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (Bethesda, USA). Support for the animal work in these studies was provided by the Imperial College Central Biological Research Facility (project license no. 70/7457). The authors wish to thank Mr Ivan Vallado for his contribution to the work. The authors declared no conflicts of interest.	Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Azizi A, 2010, VACCINE, V28, P4015, DOI 10.1016/j.vaccine.2010.04.018; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Bivas-Benita M, 2013, MUCOSAL IMMUNOL; Bivas-Benita M, 2010, J VIROL, V84, P5764, DOI 10.1128/JVI.02202-09; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; De Calisto J, 2011, METHODS MOL BIOL, V757, P411, DOI 10.1007/978-1-61779-166-6_24; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jiang HX, 2011, IMMUNOL RES, V49, P147, DOI 10.1007/s12026-010-8178-6; Kantele A, 1999, J IMMUNOL, V162, P5173; Klavinskis LS, 1997, VACCINE, V15, P818, DOI 10.1016/S0264-410X(96)00278-2; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Lindholm C, 2004, INFECT IMMUN, V72, P1004, DOI 10.1128/IAI.72.2.1004-1009.2004; Lu S, 2006, SPRINGER SEMIN IMMUN, V28, P255, DOI 10.1007/s00281-006-0028-1; Mann JFS, 2012, J CONTROL RELEASE, V158, P240, DOI 10.1016/j.jconrel.2011.11.009; Marks E, 2011, EUR J IMMUNOL, V41, P2642, DOI 10.1002/eji.201041297; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Richmond JFL, 1998, J VIROL, V72, P9092, DOI 10.1128/JVI.72.11.9092-9100.1998; Rush CM, 2010, VACCINE, V28, P1620, DOI 10.1016/j.vaccine.2009.11.014; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wang Z, 2009, CHINESE MED J-PEKING, V122, P2339, DOI 10.3760/cma.j.issn.0366-6999.2009.19.028; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yao XD, 2007, J REPROD IMMUNOL, V75, P106, DOI 10.1016/j.jri.2007.04.008	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67412	10.1371/journal.pone.0067412	http://dx.doi.org/10.1371/journal.pone.0067412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826293	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400142
J	Nagai, K; Miyoshi, M; Kake, T; Fukushima, N; Matsuura, M; Shibata, E; Yamada, S; Yoshikawa, K; Kanayama, H; Fukawa, T; Yamaguchi, K; Izaki, H; Mima, A; Abe, N; Araoka, T; Murakami, T; Kishi, F; Kishi, S; Tominaga, T; Moriya, T; Abe, H; Doi, T				Nagai, Kojiro; Miyoshi, Masashi; Kake, Takei; Fukushima, Naoshi; Matsuura, Motokazu; Shibata, Eriko; Yamada, Satoshi; Yoshikawa, Kazuhiro; Kanayama, Hiro-omi; Fukawa, Tomoya; Yamaguchi, Kunihisa; Izaki, Hirofumi; Mima, Akira; Abe, Naoko; Araoka, Toshikazu; Murakami, Taichi; Kishi, Fumi; Kishi, Seiji; Tominaga, Tatsuya; Moriya, Tatsumi; Abe, Hideharu; Doi, Toshio			Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MESANGIAL CELL-PROLIFERATION; KIDNEY INJURY MOLECULE-1; OXFORD CLASSIFICATION; DIABETIC-NEPHROPATHY; GAS6; EXPRESSION; DISEASE; LIGAND; GLOMERULONEPHRITIS	Background: Gas6 is a growth factor that causes proliferation of mesangial cells in the development of glomerulonephritis. Gas6 can bind to three kinds of receptors; Axl, Dtk, and Mer. However, their expression and functions are not entirely clear in the different glomerular cell types. Meanwhile, representative cell cycle regulatory protein p27 has been reported to be expressed in podocytes in normal glomeruli with decreased expression in proliferating glomeruli, which inversely correlated with mesangial proliferation in human IgA nephropathy (IgAN). Methods: The aim of this study is to clarify Gas6 involvement in the progression of IgAN. Expression of Gas6/Axl/Dtk was examined in 31 biopsy proven IgAN cases. We compared the expression levels with histological severity or clinical data. Moreover, we investigated the expression of Gas6 and its receptors in cultured podocytes. Results: In 28 of 31 cases, Gas6 was upregulated mainly in podocytes. In the other 3 cases, Gas6 expression was induced in endothelial and mesangial cells, which was similar to animal nephritis models. Among 28 podocyte type cases, the expression level of Gas6 correlated with the mesangial hypercellularity score of IgAN Oxford classification and urine protein excretion. It also inversely correlated with p27 expression in glomeruli. As for the receptors, Axl was mainly expressed in endothelial and mesangial cells, while Dtk was expressed in podocytes. In vitro, Dtk was expressed in cultured murine podocytes, and the expression of p27 was decreased by Gas6 stimulation. Conclusions: Gas6 was uniquely upregulated in either endothelial/mesangial cells or podocytes in IgAN. The expression pattern can be used as a marker to classify IgAN. Gas6 has a possibility to be involved in not only mesangial proliferation via Axl, but also podocyte injury via Dtk in IgAN.	[Nagai, Kojiro; Miyoshi, Masashi; Matsuura, Motokazu; Shibata, Eriko; Yamada, Satoshi; Yoshikawa, Kazuhiro; Mima, Akira; Abe, Naoko; Araoka, Toshikazu; Murakami, Taichi; Kishi, Fumi; Kishi, Seiji; Tominaga, Tatsuya; Abe, Hideharu; Doi, Toshio] Univ Tokushima, Grad Sch Med, Dept Nephrol, Tokushima 770, Japan; [Kake, Takei; Fukushima, Naoshi] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [Kanayama, Hiro-omi; Fukawa, Tomoya; Yamaguchi, Kunihisa; Izaki, Hirofumi] Univ Tokushima, Grad Sch Med, Dept Urol, Tokushima 770, Japan; [Tominaga, Tatsuya] Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan	Tokushima University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Tokushima University; Kitasato University	Nagai, K (corresponding author), Univ Tokushima, Grad Sch Med, Dept Nephrol, Tokushima 770, Japan.	knagai@clin.med.tokushima-u.ac.jp	Fukawa, Tomoya/AFV-7106-2022		Ministry of Health, Labour and Welfare of Japan [24591202]; Japan Science and Technology Agency	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-aid for Scientific Research 24591202, Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research, from the Ministry of Health, Labour and Welfare of Japan and Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; CROSIER KE, 1994, GROWTH FACTORS, V11, P137, DOI 10.3109/08977199409001055; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Ding HL, 2007, CLIN IMMUNOL, V123, P227, DOI 10.1016/j.clim.2007.01.010; Ebefors K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018575; Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; Liu LL, 2012, CLIN EXP IMMUNOL, V169, P148, DOI 10.1111/j.1365-2249.2012.04604.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Murakami T, 2010, AM J NEPHROL, V32, P505, DOI 10.1159/000321366; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nystrom J, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-13; O'Donnell K, 1999, AM J PATHOL, V154, P1171, DOI 10.1016/S0002-9440(10)65369-2; Onda K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-64; Peters HPE, 2011, NEPHROL DIAL TRANSPL, V26, P3581, DOI 10.1093/ndt/gfr135; Qiu LQ, 2004, LAB INVEST, V84, P1112, DOI 10.1038/labinvest.3700144; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shankland SJ, 1996, KIDNEY INT, V50, P1230, DOI 10.1038/ki.1996.432; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Xu PC, 2011, NEPHROL DIAL TRANSPL, V26, P3229, DOI 10.1093/ndt/gfr023; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66759	10.1371/journal.pone.0066759	http://dx.doi.org/10.1371/journal.pone.0066759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826128	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400046
J	Tiklova, K; Tsarouhas, V; Samakovlis, C				Tiklova, Katarina; Tsarouhas, Vasilios; Samakovlis, Christos			Control of Airway Tube Diameter and Integrity by Secreted Chitin-Binding Proteins in Drosophila	PLOS ONE			English	Article							SEPTATE JUNCTIONS; EPITHELIAL TUBES; MORPHOGENESIS; REQUIREMENT; ELONGATION; MATRIX; ENDOCYTOSIS; EXPANSION; ENCODES; CUTICLE	The transporting function of many branched tubular networks like our lungs and circulatory system depend on the sizes and shapes of their branches. Understanding the mechanisms of tube size control during organ development may offer new insights into a variety of human pathologies associated with stenoses or cystic dilations in tubular organs. Here, we present the first secreted luminal proteins involved in tube diametric expansion in the Drosophila airways. obst-A and gasp are conserved among insect species and encode secreted proteins with chitin binding domains. We show that the widely used tracheal marker 2A12, recognizes the Gasp protein. Analysis of obst-A and gasp single mutants and obst-A; gasp double mutant shows that both genes are primarily required for airway tube dilation. Similarly, Obst-A and Gasp control epidermal cuticle integrity and larval growth. The assembly of the apical chitinous matrix of the airway tubes is defective in gasp and obst-A mutants. The defects become exaggerated in double mutants indicating that the genes have partially redundant functions in chitin structure modification. The phenotypes in luminal chitin assembly in the airway tubes are accompanied by a corresponding reduction in tube diameter in the mutants. Conversely, overexpression of Obst-A and Gasp causes irregular tube expansion and interferes with tube maturation. Our results suggest that the luminal levels of matrix binding proteins determine the extent of diametric growth. We propose that Obst-A and Gasp organize luminal matrix assembly, which in turn controls the apical shapes of adjacent cells during tube diameter expansion.	[Tiklova, Katarina; Tsarouhas, Vasilios; Samakovlis, Christos] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Tsarouhas, Vasilios/AAG-8226-2020	Tsarouhas, Vasilios/0000-0002-2933-1351	Cancerfonden; Vetenskapsradet	Cancerfonden(Swedish Cancer Society); Vetenskapsradet(Swedish Research Council)	The work was supported by grants from Cancerfonden and Vetenskapsradet to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Norum M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010802; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; Syed ZA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002850; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	35	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67415	10.1371/journal.pone.0067415	http://dx.doi.org/10.1371/journal.pone.0067415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826295	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400143
J	Van Der Velden, J; Sum, G; Barker, D; Koumoundouros, E; Barcham, G; Wulff, H; Castle, N; Bradding, P; Snibson, K				Van Der Velden, Joanne; Sum, Grace; Barker, Donna; Koumoundouros, Emmanuel; Barcham, Garry; Wulff, Heike; Castle, Neil; Bradding, Peter; Snibson, Kenneth			K(Ca)3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma	PLOS ONE			English	Article							K+ CHANNELS; CELLS; EXACERBATIONS; PROLIFERATION; ANGIOGENESIS; INFLAMMATION; ACTIVATION; CHALLENGE; LUNGS	Background: The Ca2+-activated K+ channel K(Ca)3.1 is expressed in several structural and inflammatory airway cell types and is proposed to play an important role in the pathophysiology of asthma. The aim of the current study was to determine whether inhibition of K(Ca)3.1 modifies experimental asthma in sheep. Methodology and Principal Findings: Atopic sheep were administered either 30 mg/kg Senicapoc (ICA-17073), a selective inhibitor of the K(Ca)3.1-channel, or vehicle alone (0.5% methylcellulose) twice daily (orally). Both groups received fortnightly aerosol challenges with house dust mite allergen for fourteen weeks. A separate sheep group received no allergen challenges or drug treatment. In the vehicle-control group, twelve weeks of allergen challenges resulted in a 60 +/- 19% increase in resting airway resistance, and this was completely attenuated by treatment with Senicapoc (0.25 +/- 12%; n = 10, P = 0.0147). The vehicle-control group had a peak-early phase increase in lung resistance of 82 +/- 21%, and this was reduced by 58% with Senicapoc treatment (24 +/- 14%; n = 10, P = 0.0288). Senicapoc-treated sheep also demonstrated reduced airway hyperresponsiveness, requiring a significantly higher dose of carbachol to increase resistance by 100% compared to allergen-challenged vehicle-control sheep (20 +/- 5 vs. 52 +/- 18 breath-units of carbachol; n = 10, P = 0.0340). Senicapoc also significantly reduced eosinophil numbers in bronchoalveolar lavage taken 48 hours post-allergen challenge, and reduced vascular remodelling. Conclusions: These findings suggest that K(Ca)3.1-activity contributes to allergen-induced airway responses, inflammation and vascular remodelling in a sheep model of asthma, and that inhibition of K(Ca)3.1 may be an effective strategy for blocking allergen-induced airway inflammation and hyperresponsiveness in humans.	[Van Der Velden, Joanne; Sum, Grace; Barker, Donna; Koumoundouros, Emmanuel; Barcham, Garry; Snibson, Kenneth] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia; [Van Der Velden, Joanne] Univ Melbourne, Dept Pharmacol, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Dept Elect & Elect Engn, Parkville, Vic 3052, Australia; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Castle, Neil] Icagen Inc, Durham, NC USA; [Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Melbourne; University of Melbourne; University of Melbourne; University of California System; University of California Davis; University of Leicester	Snibson, K (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.	ksnibson@unimelb.edu.au	wulff, Heike/Z-2056-2019; Sum, Grace/C-7349-2015; KOUMOUNDOUROS, EMMANUEL/H-5766-2016	Sum, Grace/0000-0001-8503-8523; Barker, Donna/0000-0003-2005-5239; Bradding, Peter/0000-0001-8403-0319; Snibson, Kenneth/0000-0003-4772-9408; KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X	National Health and Medical Research Council (NHMRC) of Australia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by the National Health and Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Koumoundouros E, 2006, EXP LUNG RES, V32, P321, DOI 10.1080/01902140600916960; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Molinari JF, 1995, J APPL PHYSIOL, V79, P1966, DOI 10.1152/jappl.1995.79.6.1966; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Siddiqui S, 2007, J ALLERGY CLIN IMMUN, V120, P813, DOI 10.1016/j.jaci.2007.05.028; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; Van der Velden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037161; Van der Velden J, 2012, EXP LUNG RES, V38, P307, DOI 10.3109/01902148.2012.697975; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	24	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66886	10.1371/journal.pone.0066886	http://dx.doi.org/10.1371/journal.pone.0066886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826167	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400078
J	Jrad-Lamine, A; Henry-Berger, J; Damon-Soubeyrand, C; Saez, F; Kocer, A; Janny, L; Pons-Rejraji, H; Munn, DH; Mellor, AL; Gharbi, N; Cadet, R; Guiton, R; Aitken, RJ; Drevet, JR				Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Saez, Fabrice; Kocer, Ayhan; Janny, Laurent; Pons-Rejraji, Hanae; Munn, David H.; Mellor, Andrew L.; Gharbi, Najoua; Cadet, Remi; Guiton, Rachel; Aitken, Robert J.; Drevet, Joel R.			Indoleamine 2,3-Dioxygenase 1 (Ido1) Is Involved in the Control of Mouse Caput Epididymis Immune Environment	PLOS ONE			English	Article							REGULATORY T-CELLS; POLYUNSATURATED FATTY-ACIDS; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; TGF-BETA; EXPRESSION; TOLERANCE; INFLAMMATION; CYCLOOXYGENASE-1; LEPTIN	The epididymis maintains a state of immune tolerance towards spermatozoa while also protecting them and itself against infection and acute inflammation. The immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (Ido1) participates in this delicate local equilibrium. Using the mouse Ido1(-/-) model, we show here that the absence of IDO1 expression leads in the epididymis but not in serum to (1) an increase in the inflammatory state as evidenced by changes in the content of cytokines and chemokines, (2) the engagement of a Th1-driven inflammatory response as evidenced by changes in the Th17/Treg as well as Th1/Th2 equilibria, as well as (3) differences in the content of lipid intermediates classically involved in inflammation. Despite this more pronounced inflammatory state, Ido1(-/-) animals succeed in preserving the local epididymal immune situation due to the activation of compensatory mechanisms that are discussed.	[Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Saez, Fabrice; Kocer, Ayhan; Janny, Laurent; Pons-Rejraji, Hanae; Cadet, Remi; Guiton, Rachel; Drevet, Joel R.] Clermont Univ, INSERM, CNRS, GReD Lab,U1103,UMR 6293, Aubiere, France; [Janny, Laurent; Pons-Rejraji, Hanae] CECOS, CHU Estaing, Clermont Ferrand, France; [Munn, David H.; Mellor, Andrew L.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Mellor, Andrew L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Jrad-Lamine, Aicha; Gharbi, Najoua] Fac Sci Tunis, Dept Biol, Tunis 1060, Tunisia; [Aitken, Robert J.] Univ Newcastle, Prior Res Ctr Reprod Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); University of Newcastle	Drevet, JR (corresponding author), Clermont Univ, INSERM, CNRS, GReD Lab,U1103,UMR 6293, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; PONS, HANAE/X-8673-2019; Aitken, Robert John/AAY-8238-2020; Drevet, Joël/W-2692-2019	PONS, HANAE/0000-0002-9779-9693; Aitken, Robert John/0000-0002-9152-156X; Drevet, Joël/0000-0003-3077-6558; Guiton, Rachel/0000-0002-7155-8736; Munn, David/0000-0002-7711-2858	French Ministry of Higher Education; CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale)	French Ministry of Higher Education; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Institutional fundings from the French Ministry of Higher Education, the CNRS (Centre National de la Recherche Scientifique) and the INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, INT ARCH ALLERGY IMM, V118, P391, DOI 10.1159/000024145; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Balaji Thotakura, 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P357; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Belladonna ML, 2007, TRANSPLANTATION, V84, pS17, DOI 10.1097/01.tp.0000269199.16209.22; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Caspar-Bauguil S, 2009, J PHYSIOL BIOCHEM, V65, P423, DOI 10.1007/BF03185938; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Chen WH, 2004, CELL MOL IMMUNOL, V1, P328; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen YG, 2009, INT J COMPUT INT SYS, V2, P1, DOI 10.2991/jnmp.2009.2.1.1; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; FOLCH J, 1957, J BIOL CHEM, V226, P497; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jrad-Lamine A, 2011, J BIOL CHEM, V286, P8030, DOI 10.1074/jbc.M110.172114; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; La Cava A, 2004, J MOL MED, V82, P4, DOI 10.1007/s00109-003-0492-1; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Munn DH, 2010, EUR J IMMUNOL, V40, P315, DOI 10.1002/eji.200940238; NASHAN D, 1989, INT J ANDROL, V12, P85, DOI 10.1111/j.1365-2605.1989.tb01289.x; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Petitjean G, 2012, AIDS, V26, P139, DOI 10.1097/QAD.0b013e32834e1484; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Tardy AL, 2008, J LIPID RES, V49, P1445, DOI 10.1194/jlr.M700561-JLR200; Tone S, 2007, INT C SER, V1304, P233; Vieu C, 2002, J LIPID RES, V43, P510; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; Widner B, 1997, CLIN CHEM, V43, P2424; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; Zhao GQ, 1998, DEVELOPMENT, V125, P1103; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	57	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66494	10.1371/journal.pone.0066494	http://dx.doi.org/10.1371/journal.pone.0066494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840489	gold, Green Published			2022-12-25	WOS:000322342800070
J	Kumarathasan, P; Vincent, R; Blais, E; Saravanamuthu, A; Gupta, P; Wyatt, H; Mitchel, R; Hannan, M; Trivedi, A; Whitman, S				Kumarathasan, Prem; Vincent, Renaud; Blais, Erica; Saravanamuthu, Anu; Gupta, Pallavi; Wyatt, Heather; Mitchel, Ronald; Hannan, Mohammed; Trivedi, Akilesh; Whitman, Stewart			Cardiovascular Changes in Atherosclerotic ApoE-Deficient Mice Exposed to Co60 (gamma) Radiation	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; ISLAND ACCIDENT AREA; OXIDATIVE STRESS; IONIZING-RADIATION; TYROSINE NITRATION; NITRIC-OXIDE; IN-VIVO; DISEASE; MORTALITY; CANCER	Background: There is evidence for a role of ionizing radiation in cardiovascular diseases. The goal of this work was to identify changes in oxidative and nitrative stress pathways and the status of the endothelinergic system during progression of atherosclerosis in ApoE-deficient mice after single and repeated exposure to ionizing radiation. Methods and Results: B6.129P2-ApoE tmlUnc mice on a low-fat diet were acutely exposed (whole body) to Co60 (gamma) (single dose 0, 0.5, and 2 Gy) at a dose rate of 36.32 cGy/min, or repeatedly (cumulative dose 0 and 2 Gy) at a dose-rate of 0.1 cGy/min for 5 d/wk, over a period of 4 weeks. Biological endpoints were investigated after 3-6 months of recovery post-radiation. The nitrative stress marker 3-nitrotyrosine and the vasoregulator peptides endothelin-1 and endothelin-3 in plasma were increased (p<0.05) in a dose-dependent manner 3-6 months after acute or chronic exposure to radiation. The oxidative stress marker 8-isoprostane was not affected by radiation, while plasma 8-hydroxydeoxyguanosine and L-3,4-dihydroxyphenylalanine decreased (p<0.05) after treatment. At 2Gy radiation dose, serum cholesterol was increased (p = 0.008) relative to controls. Percent lesion area increased (p = 0.005) with age of animal, but not with radiation treatment. Conclusions: Our observations are consistent with persistent nitrative stress and activation of the endothelinergic system in ApoE-/- mice after low-level ionizing radiation exposures. These mechanisms are known factors in the progression of atherosclerosis and other cardiovascular diseases.	[Kumarathasan, Prem; Blais, Erica; Saravanamuthu, Anu; Gupta, Pallavi] Hlth Canada, Analyt Biochem & Prote Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Vincent, Renaud; Hannan, Mohammed] Hlth Canada, Inhalat Toxicol Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Wyatt, Heather; Mitchel, Ronald] Atom Energy Canada Ltd, Chalk River Labs, Radiol Protect Res & Instrumentat Branch, Chalk River, ON K0J 1J0, Canada; [Trivedi, Akilesh] Hlth Canada, Radiat Protect Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Whitman, Stewart] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada	Health Canada; Health Canada; Atomic Energy of Canada Limited; Health Canada; University of Ottawa	Kumarathasan, P (corresponding author), Hlth Canada, Analyt Biochem & Prote Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada.	premkumari.kumarathasan@hc-sc.gc.ca			Health Canada; AECL (Atomic Energy of Canada Limited)	Health Canada; AECL (Atomic Energy of Canada Limited)	The work was supported by operational funds at Health Canada and AECL (Atomic Energy of Canada Limited). Outside of the investigators directly involved in the study, the institutional funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Ashmore JP, 1998, AM J EPIDEMIOL, V148, P564, DOI 10.1093/oxfordjournals.aje.a009682; Azzam EI, 2004, HUM EXP TOXICOL, V23, P61, DOI 10.1191/0960327104ht418oa; Azzam EI, 2002, CANCER RES, V62, P5436; Basavaraju SR, 2002, MED PHYS, V29, P2391, DOI 10.1118/1.1509442; Bielecki A, 2012, J ANAL TOXICOL, V36, P595, DOI 10.1093/jat/bks070; Boerma M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/858262; Bohm F, 2002, ATHEROSCLEROSIS, V160, P215, DOI 10.1016/S0021-9150(01)00564-0; Broome EJ, 2002, RADIAT RES, V158, P181, DOI 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2; CRAWLEY DE, 1992, J APPL PHYSIOL, V72, P1425, DOI 10.1152/jappl.1992.72.4.1425; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441; Friedlander AH, 2003, J AM DENT ASSOC, V134, P1615, DOI 10.14219/jada.archive.2003.0108; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Ilnytskyy Y, 2009, ENVIRON MOL MUTAGEN, V50, P105, DOI 10.1002/em.20440; Ivanov VK, 2006, HEALTH PHYS, V90, P199, DOI 10.1097/01.HP.0000175835.31663.ea; Kooy NW, 1997, CRIT CARE MED, V25, P812, DOI 10.1097/00003246-199705000-00017; Koturbash I, 2008, INT J RADIAT ONCOL, V70, P554, DOI 10.1016/j.ijrobp.2007.09.039; Koturbash I, 2007, CARCINOGENESIS, V28, P1831, DOI 10.1093/carcin/bgm053; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Kumarathasan P, 2001, ANAL BIOCHEM, V299, P37, DOI 10.1006/abio.2001.5362; LERMAN A, 1995, CIRCULATION, V92, P2426, DOI 10.1161/01.CIR.92.9.2426; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martinez F, 1996, NEPHROL DIAL TRANSPL, V11, P270, DOI 10.1093/oxfordjournals.ndt.a027252; Michaud DS, 2005, INT J RADIAT BIOL, V81, P299, DOI 10.1080/09553000500084795; Minamino T, 1997, CIRCULATION, V95, P221, DOI 10.1161/01.CIR.95.1.221; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Mitchel REJ, 1999, RADIAT RES, V152, P273, DOI 10.2307/3580327; Mitchel REJ, 2002, RADIAT RES, V158, P458, DOI 10.1667/0033-7587(2002)158[0458:IOPETL]2.0.CO;2; Monseau V, 2013, PLOS ONE, V8, P1; Montani D, 2007, CHEST, V131, P101, DOI 10.1378/chest.06-0682; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; O'Sullivan B, 2003, SEMIN RADIAT ONCOL, V13, P274, DOI 10.1016/S1053-4296(03)00037-7; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pawlak K, 2004, AM J NEPHROL, V24, P154, DOI 10.1159/000076244; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Sauvageau S, 2008, PEPTIDES, V29, P2039, DOI 10.1016/j.peptides.2008.08.003; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Sowa M, 2006, EXP SUPPL, V96, P293; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Talbott EO, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.2307/3454617; Trivedi A, 2004, J ENVIRON PATHOL TOX, V23, P99, DOI 10.1615/JEnvPathToxOncol.v23.i2.20; Wakeford R, 2004, ONCOGENE, V23, P6404, DOI 10.1038/sj.onc.1207896; Wong FL, 1999, RADIAT RES, V151, P736, DOI 10.2307/3580213; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yi A, 2009, KOREAN J RADIOL, V10, P496, DOI 10.3348/kjr.2009.10.5.496	55	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65486	10.1371/journal.pone.0065486	http://dx.doi.org/10.1371/journal.pone.0065486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840332	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800011
J	Li, LP; Wang, ZH; Zerbe, S; Abdusalih, N; Tang, ZY; Ma, M; Yin, LK; Mohammat, A; Han, WX; Fang, JY				Li, Liping; Wang, Zhiheng; Zerbe, Stefan; Abdusalih, Nurbay; Tang, Zhiyao; Ma, Ming; Yin, Linke; Mohammat, Anwar; Han, Wenxuan; Fang, Jingyun			Species Richness Patterns and Water-Energy Dynamics in the Drylands of Northwest China	PLOS ONE			English	Article							CROSS-TAXON CONGRUENCE; WOODY PLANT; BROAD-SCALE; VASCULAR PLANTS; SPATIAL SCALE; DIVERSITY; CLIMATE; BIODIVERSITY; CONCORDANCE; DETERMINANTS	Dryland ecosystems are highly vulnerable to climatic and land-use changes, while the mechanisms underlying patterns of dryland species richness are still elusive. With distributions of 3637 native vascular plants, 154 mammals, and 425 birds in Xinjiang, China, we tested the water-energy dynamics hypothesis for species richness patterns in Central Asian drylands. Our results supported the water-energy dynamics hypothesis. We found that species richness of all three groups was a humpshaped function of energy availability, but a linear function of water availability. We further found that water availability had stronger effects on plant richness, but weaker effects on vertebrate richness than energy availability. We conducted piecewise linear regressions to detect the breakpoints in the relationship between species richness and potential evapotranspiration which divided Xinjiang into low and high energy regions. The concordance between mammal and plant richness was stronger in high than in low energy regions, which was opposite to that between birds and plants. Plant richness had stronger effects than climate on mammal richness regardless of energy levels, but on bird richness only in high energy regions. The changes in the concordance between vertebrate and plant richness along the climatic gradient suggest that cautions are needed when using concordance between taxa in conservation planning.	[Li, Liping; Tang, Zhiyao; Fang, Jingyun] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol,Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Wang, Zhiheng] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Li, Liping; Zerbe, Stefan] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Abdusalih, Nurbay] Xinjiang Univ, Minist Educ, Coll Resources & Environm Sci, Key Lab Oasis Ecol, Urumqi, Peoples R China; [Ma, Ming; Yin, Linke; Mohammat, Anwar] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China	Peking University; University of Copenhagen; Free University of Bozen-Bolzano; Xinjiang University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; China Agricultural University	Li, LP (corresponding author), Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol,Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.	liliping@pku.edu.cn	Han, Wenxuan/B-8791-2016; Li, Liping/C-2574-2011; MaMing, Roller/AAJ-1085-2020; Tang, Zhiyao/B-8795-2008; Wang, Zhiheng/G-1750-2010	Han, Wenxuan/0000-0001-8678-7147; Li, Liping/0000-0002-5550-1932; Wang, Zhiheng/0000-0003-0808-7780; Tang, Zhiyao/0000-0003-0154-6403	Funds for Creative Research Groups of China [31021001]; Sino-Japan Project [2010DFA31290]	Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Sino-Japan Project	This study was supported by the Funds for Creative Research Groups of China (Grant No. 31021001) and Sino-Japan Project (Grant No. 2010DFA31290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2000, J ZOOL, V251, P205, DOI 10.1111/j.1469-7998.2000.tb00605.x; Apdukader A, 2002, CHECKLIST MAMMALS XI; Brown JH, 1998, BIOGEOGRAPHY SUNDERL; Chen C. D, 1998, BIODIVERSITY CHINA C; Commissione Redactorum Florae Xinjiangensis, 1992, FLOR XINJ; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Dang RL, 2001, B BOT RES, V21, P519; Editorial Committee of Chinese Physical Geography of the Chinese Academy of Sciences, 1984, CHIN PHYS GEOGR CLIM; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Grace J.B., 2006, STRUCT EQ MOD NAT; Groombridge B., 2002, World atlas of biodiversity: earth's living resources in the 21st century; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2004, DIVERS DISTRIB, V10, P247, DOI 10.1111/j.1366-9516.2004.00085.x; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lei FM, 2006, INTEGR ZOOL, V1, P162, DOI 10.1111/j.1749-4877.2006.00037.x; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P25; Li LiPing, 2011, Ganhanqu Yanjiu (Arid Zone Research), V28, P1, DOI 10.3724/SP.J.1148.2011.00001; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P60; Lin Xin, 2009, Shengwu Duoyangxing, V17, P652, DOI 10.3724/SP.J.1003.2009.09065; Ma M, 2001, CHECKLIST BIRDS XINJ; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Moreno-Rueda G, 2010, REV ECOL-TERRE VIE, V65, P265; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; Qian H, 2009, J BIOGEOGR, V36, P1685, DOI 10.1111/j.1365-2699.2009.02128.x; R Core Team, 2021, R LANG ENV STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Santi E, 2010, J NAT CONSERV, V18, P2, DOI 10.1016/j.jnc.2009.02.003; Schuldt A, 2009, ECOGRAPHY, V32, P1019, DOI 10.1111/j.1600-0587.2009.05973.x; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; THORNTHWAITE C. W., 1955, Unasylva, V9, P51; Virtanen R, 2009, FRESHWATER BIOL, V54, P1651, DOI 10.1111/j.1365-2427.2009.02212.x; Wang SP, 2010, CHINESE SCI BULL, V55, P1968, DOI 10.1007/s11434-010-3236-y; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wei WS, 2008, CHINESE SCI BULL, V53, P22, DOI 10.1007/s11434-008-6002-7; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; Xinjiang Integrated Survey Team & Institute of Botany Chinese Academy of Sciences, 1978, VEG ITS UT XINJ; [徐卫华 XU WeiHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P271; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063; Zhao SQ, 2006, DIVERS DISTRIB, V12, P189, DOI 10.1111/j.1366-9516.2005.00215.x	58	43	58	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66450	10.1371/journal.pone.0066450	http://dx.doi.org/10.1371/journal.pone.0066450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840472	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800060
J	Ghezzo, A; Visconti, P; Abruzzo, PM; Bolotta, A; Ferreri, C; Gobbi, G; Malisardi, G; Manfredini, S; Marini, M; Nanetti, L; Pipitone, E; Raffaelli, F; Resca, F; Vignini, A; Mazzanti, L				Ghezzo, Alessandro; Visconti, Paola; Abruzzo, Provvidenza M.; Bolotta, Alessandra; Ferreri, Carla; Gobbi, Giuseppe; Malisardi, Gemma; Manfredini, Stefano; Marini, Marina; Nanetti, Laura; Pipitone, Emanuela; Raffaelli, Francesca; Resca, Federica; Vignini, Arianna; Mazzanti, Laura			Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features	PLOS ONE			English	Article							FATTY-ACID COMPOSITIONS; FALSE DISCOVERY RATE; DOCOSAHEXAENOIC ACID; LIPID-PEROXIDATION; SPECTRUM DISORDERS; BRAIN; INFLAMMATION; BIOMARKERS; ASSAY; OMEGA-3-FATTY-ACIDS	It has been suggested that oxidative stress may play a role in the pathogenesis of Autism Spectrum Disorders (ASD), but the literature reports somewhat contradictory results. To further investigate the issue, we evaluated a high number of peripheral oxidative stress parameters, and some related issues such as erythrocyte membrane functional features and lipid composition. Twenty-one autistic children (Au) aged 5 to 12 years, were gender and age-matched with 20 typically developing children (TD). Erythrocyte thiobarbituric acid reactive substances, urinary isoprostane and hexanoyl-lysine adduct levels were elevated in Au, thus confirming the occurrence of an imbalance of the redox status of Au, whilst other oxidative stress markers or associated parameters (urinary 8-oxo-dG, plasma radical absorbance capacity and carbonyl groups, erythrocyte superoxide dismutase and catalase activities) were unchanged. A very significant reduction of Na+/K+-ATPase activity (-66%, p<0.0001), a reduction of erythrocyte membrane fluidity and alteration in erythrocyte fatty acid membrane profile (increase in monounsaturated fatty acids, decrease in EPA and DHA-omega 3 with a consequent increase in omega 6/omega 3 ratio) were found in Au compared to TD, without change in membrane sialic acid content. Some Au clinical features appear to be correlated with these findings; in particular, hyperactivity score appears to be related with some parameters of the lipidomic profile and membrane fluidity. Oxidative stress and erythrocyte membrane alterations may play a role in the pathogenesis of ASD and prompt the development of palliative therapeutic protocols. Moreover, the marked decrease in NKA could be potentially utilized as a peripheral biomarker of ASD.	[Ghezzo, Alessandro; Abruzzo, Provvidenza M.; Bolotta, Alessandra; Marini, Marina] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Visconti, Paola; Gobbi, Giuseppe; Resca, Federica] Osped Maggiore Bologna, Neuropsichiat Unit, Bologna, Italy; [Abruzzo, Provvidenza M.; Bolotta, Alessandra; Marini, Marina] Don Carlo Gnocchi Fdn ONLUS, Milan, Italy; [Ferreri, Carla] CNR, ISOF, I-40126 Bologna, Italy; [Malisardi, Gemma; Manfredini, Stefano] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy; [Malisardi, Gemma; Manfredini, Stefano] Univ Ferrara, AmbrosiaLab, I-44100 Ferrara, Italy; [Nanetti, Laura; Raffaelli, Francesca; Vignini, Arianna; Mazzanti, Laura] Polytech Univ Marche, Dept Clin Sci Biochem, Ancona, Italy; [Pipitone, Emanuela] Azienda USL, Bologna, Italy	University of Bologna; AUSL di Bologna; IRCCS Fondazione Don Carlo Gnocchi Onlus; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); University of Ferrara; University of Ferrara; Marche Polytechnic University; AUSL di Bologna	Marini, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	marina.marini@unibo.it	FERRERI, CARLA/G-6821-2013; Marini, Marina/B-1490-2012; Marini, Marina/Y-6191-2019; Abruzzo, Provvidenza Maria/G-7009-2015; Manfredini, Stefano/B-7052-2015	FERRERI, CARLA/0000-0002-1359-0869; Marini, Marina/0000-0003-1932-7380; Marini, Marina/0000-0003-1932-7380; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; Manfredini, Stefano/0000-0003-1348-4422; VIGNINI, ARIANNA/0000-0002-2496-7932	ANGSA (Associazione Nazionale Genitori Soggetti Autistici)	ANGSA (Associazione Nazionale Genitori Soggetti Autistici)	The present work was exclusively supported by a legacy of late Ms. Maria Luisa Cimadori, a member of ANGSA (Associazione Nazionale Genitori Soggetti Autistici). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzo PM, 2010, FREE RADICAL RES, V44, P563, DOI 10.3109/10715761003692487; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amminger GP, 2007, BIOL PSYCHIAT, V61, P551, DOI 10.1016/j.biopsych.2006.05.007; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Anselmi CV, 2010, J INTERV CARD ELECTR, V27, P95, DOI 10.1007/s10840-009-9466-8; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bell JG, 2010, BRIT J NUTR, V103, P1160, DOI 10.1017/S0007114509992881; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent S, 2011, J AUTISM DEV DISORD, V41, P545, DOI 10.1007/s10803-010-1078-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradstreet JJ, 2010, ALTERN MED REV, V15, P15; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Bu B, 2006, PROSTAG LEUKOTR ESS, V74, P215, DOI 10.1016/j.plefa.2006.02.001; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; CORASH LM, 1974, J LAB CLIN MED, V84, P147; DENNY PC, 1983, CLIN CHIM ACTA, V131, P333, DOI 10.1016/0009-8981(83)90103-1; Farook MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043030; Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026; Ferreri C, 2012, EXPERT REV MOL DIAGN, V12, P767, DOI [10.1586/erm.12.73, 10.1586/ERM.12.73]; Fiorini R, 1991, APPL FLUORESC TECH, V3, P33; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Geier DA, 2008, EXPERT REV MOL DIAGN, V8, P671, DOI 10.1586/14737159.8.6.671; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; James S, 2011, COCHRANE DB SYST REV; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Ji LN, 2009, LIFE SCI, V85, P788, DOI 10.1016/j.lfs.2009.10.008; Kamboj SS, 2009, NEUROSCIENCE, V162, P349, DOI 10.1016/j.neuroscience.2009.05.002; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim M, 2010, NUTR RES, V30, P756, DOI 10.1016/j.nutres.2010.10.005; KITAO T, 1983, EXPERIENTIA, V39, P1362, DOI 10.1007/BF01990105; Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Kurup RK, 2003, INT J NEUROSCI, V113, P1537, DOI 10.1080/00207450390231482; Lord C., 1999, AUTISM DIAGNOSTIC OB; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Meguid NA, 2011, BIOL TRACE ELEM RES, V143, P58, DOI 10.1007/s12011-010-8840-9; Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19; Mosig MO, 2001, GENETICS, V157, P1683; MURPHY MG, 1990, J NUTR BIOCHEM, V1, P68, DOI 10.1016/0955-2863(90)90052-M; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Orr SK, 2008, CURR OPIN INVEST DR, V9, P735; Ou PM, 1996, J BIOCHEM BIOPH METH, V31, P59, DOI 10.1016/0165-022X(95)00039-T; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Pecorelli A, 2012, BRAIN DEV APR, P23; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Pessina F, 2004, N-S ARCH PHARMACOL, V370, P521, DOI 10.1007/s00210-004-0998-2; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; RENNIE CM, 1979, CLIN CHIM ACTA, V98, P119, DOI 10.1016/0009-8981(79)90172-4; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; Roid G.H., 1997, LEITER INT PERFORMAN; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schengrund CL, 2012, NEUROCHEM RES, V37, P1201, DOI 10.1007/s11064-011-0697-6; Schopler E., 1988, CHILDHOOD AUTISM RAT; Schopler E., 2005, PSYCHOEDUCATIONAL PR, V3rd edition, DOI [10.1037/t52601-000, DOI 10.1037/T52601-000]; SHERIDAN NP, 1988, J CELL PHYSIOL, V134, P117, DOI 10.1002/jcp.1041340114; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Skoumalova A, 2012, CELL BIOCHEM FUNCT, V30, P205, DOI 10.1002/cbf.1836; Sobenin IA, 1998, J LIPID RES, V39, P2293; Sultana R, 2006, ANTIOXID REDOX SIGN, V8, P2021, DOI 10.1089/ars.2006.8.2021; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Tsaluchidu S, 2008, BMC PSYCHIAT S1, V8, pS1; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; VANDERVEGT SGL, 1985, BRIT J HAEMATOL, V61, P393, DOI 10.1111/j.1365-2141.1985.tb02843.x; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vignini A, 2009, REPROD BIOMED ONLINE, V18, P132, DOI 10.1016/S1472-6483(10)60435-X; WARREN L, 1959, J BIOL CHEM, V234, P1971	80	101	106	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66418	10.1371/journal.pone.0066418	http://dx.doi.org/10.1371/journal.pone.0066418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840462	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200073
J	Miller, DAW; Nichols, JD; Gude, JA; Rich, LN; Podruzny, KM; Hines, JE; Mitchell, MS				Miller, David A. W.; Nichols, James D.; Gude, Justin A.; Rich, Lindsey N.; Podruzny, Kevin M.; Hines, James E.; Mitchell, Michael S.			Determining Occurrence Dynamics when False Positives Occur: Estimating the Range Dynamics of Wolves from Public Survey Data	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPECIES OCCURRENCE; CAPTURE-RECAPTURE; CITIZEN SCIENCE; OBSERVER BIAS; MODELS; ERRORS; CALL; STATES; MISIDENTIFICATION	Large-scale presence-absence monitoring programs have great promise for many conservation applications. Their value can be limited by potential incorrect inferences owing to observational errors, especially when data are collected by the public. To combat this, previous analytical methods have focused on addressing non-detection from public survey data. Misclassification errors have received less attention but are also likely to be a common component of public surveys, as well as many other data types. We derive estimators for dynamic occupancy parameters (extinction and colonization), focusing on the case where certainty can be assumed for a subset of detections. We demonstrate how to simultaneously account for non-detection (false negatives) and misclassification (false positives) when estimating occurrence parameters for gray wolves in northern Montana from 2007-2010. Our primary data source for the analysis was observations by deer and elk hunters, reported as part of the state's annual hunter survey. This data was supplemented with data from known locations of radio-collared wolves. We found that occupancy was relatively stable during the years of the study and wolves were largely restricted to the highest quality habitats in the study area. Transitions in the occupancy status of sites were rare, as occupied sites almost always remained occupied and unoccupied sites remained unoccupied. Failing to account for false positives led to over estimation of both the area inhabited by wolves and the frequency of turnover. The ability to properly account for both false negatives and false positives is an important step to improve inferences for conservation from large-scale public surveys. The approach we propose will improve our understanding of the status of wolf populations and is relevant to many other data types where false positives are a component of observations.	[Miller, David A. W.; Nichols, James D.; Hines, James E.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Miller, David A. W.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Gude, Justin A.; Podruzny, Kevin M.] Montana Fish Wildlife & Pk, Helena, MT USA; [Rich, Lindsey N.; Mitchell, Michael S.] Univ Montana, Montana Cooperat Wildlife Res Unit, US Geol Survey, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Miller, DAW (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA.	dxm84@psu.edu	Nichols, James/AAF-7336-2020; Miller, David AW/E-4492-2012	Miller, David AW/0000-0002-3011-3677	sale of hunting and fishing licenses in Montana; Pittman-Robertson program	sale of hunting and fishing licenses in Montana; Pittman-Robertson program	Funding for data collection was provided by the sale of hunting and fishing licenses in Montana, the Pittman-Robertson program administered by the United States Fish and Wildlife Service, and the United States Fish and Wildlife Service wolf recovery program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; BART J, 1985, WILSON BULL, V97, P161; Campbell M, 2011, AUK, V128, P303, DOI 10.1525/auk.2011.10005; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Farmer RG, 2012, AUK, V129, P76, DOI 10.1525/auk.2012.11129; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanauska-Brown L., 2012, MONTANA GRAY WOLF CO; Hanks EM, 2011, ECOL APPL, V21, P1173, DOI 10.1890/09-1549.1; Hines, 2017, OCCUPANCY ESTIMATION; Hines J. E., 2010, PRESENCE3 SOFTWARE E; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Lotz A, 2007, J WILDLIFE MANAGE, V71, P675, DOI 10.2193/2005-759; Lukacs PM, 2011, WILDLIFE SOC B, V35, P430, DOI 10.1002/wsb.61; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; McClintock BT, 2010, ECOLOGY, V91, P2446, DOI 10.1890/09-1287.1; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Miller DAW, 2012, J ANIM ECOL, V81, P1288, DOI 10.1111/j.1365-2656.2012.02001.x; Miller DAW, 2012, ECOL APPL, V22, P1665; Molinari-Jobin A, 2012, ANIM CONSERV, V15, P266, DOI 10.1111/j.1469-1795.2011.00511.x; Oakleaf JK, 2006, J WILDLIFE MANAGE, V70, P554, DOI 10.2193/0022-541X(2006)70[554:HSBRWI]2.0.CO;2; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Rich LN, 2012, J MAMMAL, V93, P722, DOI 10.1644/11-MAMM-A-079.2; Rich LN, 2013, J WILDLIFE IN PRESS; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sewell D, 2010, BIOL CONSERV, V143, P2102, DOI 10.1016/j.biocon.2010.05.019; Shea CP, 2011, J N AM BENTHOL SOC, V30, P446, DOI 10.1899/10-073.1; Waddle JH, 2009, HERPETOL CONSERV BIO, V4, P384; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wright JA, 2009, BIOMETRICS, V65, P833, DOI 10.1111/j.1541-0420.2008.01165.x; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	42	67	67	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65808	10.1371/journal.pone.0065808	http://dx.doi.org/10.1371/journal.pone.0065808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840372	gold, Green Published			2022-12-25	WOS:000322361200038
J	Rudrapatna, VA; Bangi, E; Cagan, RL				Rudrapatna, V. A.; Bangi, E.; Cagan, R. L.			A Jnk-Rho-Actin remodeling positive feedback network directs Src-driven invasion	ONCOGENE			English	Article						Drosophila; Cofilin; Actin; Jnk; invasion; enabled	NUCLEAR ACTIN; CELL BIOLOGY; DROSOPHILA; CANCER; MICROENVIRONMENT; TRANSCRIPTION; LOCALIZATION; EXPRESSION; APOPTOSIS; MIGRATION	Current models of tumor cell invasion propose that oncogenic signaling converges upon key orchestrators of cytoskeletal dynamics, including c-Jun N-terminal kinase (Jnk) and RhoGTPase family members; these signals dynamically direct Actin remodeling proteins (ARPs) to catalyze the cytoskeletal changes required for migration. Src is a key driver of tumor aggression, metastasis and patient mortality. To clarify how Src regulates Actin dynamics to promote invasive migration, we performed a genetic modifier screen in a Drosophila model of invasion. Nine genes linked to Actin dynamics were identified that mediate invasion in situ. We found that ARPs were required for many oncogenic effects of Src including Mmp1 expression and initiation of apoptosis. Surprisingly, they were also regulators of Jnk pathway activity: both Src and the small GTPase Rho1 activated Jnk in a manner dependent on ARPs during invasion. Our results suggest that ARPs are not simply downstream executors of signal transduction pathways. Rather, they participate in a positive feedback network involving canonical oncogenic signaling pathways that promote tumor invasion.	[Rudrapatna, V. A.; Bangi, E.; Cagan, R. L.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Cagan, RL (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, One Gustave L Levy Pl,Annenberg 25-40, New York, NY 10029 USA.	ross.cagan@mssm.edu	Cagan, Ross Leigh/AAV-9528-2021; Tsai, Yu-Chen/B-5852-2008	Rudrapatna, Vivek/0000-0003-1789-3004; Cagan, Ross/0000-0001-5297-450X	National Institutes of Health [NCI R01 CA109730, 5R01EY011495];  [5T32CA078207];  [5T32GM007280]; NATIONAL CANCER INSTITUTE [R01CA109730, T32CA078207] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Cagan laboratory for important discussions and especially Jay Pendse for statistical assistance and Ruth Johnson for discussions and support regarding actin remodeling. Stocks were obtained from the Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center and the National Institute of Genetics Fly Stock Center. VAR was supported by 5T32CA078207 and 5T32GM007280. This work was also supported by the National Institutes of Health grants NCI R01 CA109730 and 5R01EY011495.	Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Cagan RL, 2012, DEV CELL, V22, P472, DOI 10.1016/j.devcel.2012.02.014; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1310, DOI 10.1016/j.bcp.2008.05.028; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Rudrapatna VA, 2013, EMBO REP, V14, P172, DOI 10.1038/embor.2012.217; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vidal M, 2010, AM J PATHOL, V176, P3007, DOI 10.2353/ajpath.2010.090253; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	25	25	25	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2801	2806		10.1038/onc.2013.232	http://dx.doi.org/10.1038/onc.2013.232			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23831567				2022-12-25	WOS:000337231700013
J	Mary, S; Fehrentz, JA; Damian, M; Gaibelet, G; Orcel, H; Verdie, P; Mouillac, B; Martinez, J; Marie, J; Baneres, JL				Mary, Sophie; Fehrentz, Jean-Alain; Damian, Marjorie; Gaibelet, Gerald; Orcel, Helene; Verdie, Pascal; Mouillac, Bernard; Martinez, Jean; Marie, Jacky; Baneres, Jean-Louis			Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation A STUDY WITH A PURIFIED HETERODIMER ASSEMBLED INTO LIPID DISCS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; RHODOPSIN; ACTIVATION; EXPRESSION; ARRESTIN; AGONIST; BINDING; DIMER; SUFFICIENT; DOMAIN	Heterodimerization of G protein-coupled receptors has an impact on their signaling properties, but the molecular mechanisms underlying heteromer-directed selectivity remain elusive. Using purified monomers and dimers reconstituted into lipid discs, we explored how dimerization impacts the functional and structural behavior of the ghrelin receptor. In particular, we investigated how a naturally occurring truncated splice variant of the ghrelin receptor exerts a dominant negative effect on ghrelin signaling upon dimerization with the full-length receptor. We provide direct evidence that this dominant negative effect is due to the ability of the non-signaling truncated receptor to restrict the conformational landscape of the full-length protein. Indeed, associating both proteins within the same disc blocks all agonist-and signaling protein-induced changes in ghrelin receptor conformation, thus preventing it from activating its cognate G protein and triggering arrestin 2 recruitment. This is an unambiguous demonstration that allosteric conformational events within dimeric assemblies can be directly responsible for modulation of signaling mediated by G protein-coupled receptors.	[Mary, Sophie; Fehrentz, Jean-Alain; Damian, Marjorie; Gaibelet, Gerald; Verdie, Pascal; Martinez, Jean; Marie, Jacky; Baneres, Jean-Louis] Univ Montpellier 1 & 2, IBMM, CNRS, UMR 5247,Fac Pharm, F-34093 Montpellier 5, France; [Gaibelet, Gerald; Orcel, Helene; Mouillac, Bernard] Univ Montpellier 1 & 2, IGF, INSERM, U661,UMR 5203,CNRS, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Baneres, JL (corresponding author), Fac Pharm Montpellier, IBMM, 15 Ave Charles Flahault,BP 14491, F-34093 Montpellier 5, France.	baneres@univ-montp1.fr	verdie, pascal/AAM-4228-2020; MOUILLAC, Bernard/M-3896-2014; Martinez, Jean/R-9421-2019	MOUILLAC, Bernard/0000-0002-3906-8673; Martinez, Jean/0000-0002-9267-4621; VERDIe, Pascal/0000-0002-5807-0293; Baneres, jean-louis/0000-0001-7078-1285	Centre National de la Recherche Scientifique (CNRS); Montpellier I University; Agence Nationale pour la Recherche [PCV08_323163, ANR-10-BLAN-1208]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Montpellier I University; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), by Montpellier I University, and by Agence Nationale pour la Recherche Contracts PCV08_323163 and ANR-10-BLAN-1208.	Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Cordoba-Chacon J, 2011, ANN NY ACAD SCI, V1220, P6, DOI 10.1111/j.1749-6632.2011.05985.x; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kojima M, 2010, ANN NY ACAD SCI, V1200, P140, DOI 10.1111/j.1749-6632.2010.05516.x; Kozasa Tohru, 2003, V237, P21; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Nag K, 2007, BIOCHEM BIOPH RES CO, V362, P1037, DOI 10.1016/j.bbrc.2007.08.107; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wise Helen, 2012, J Mol Signal, V7, P13, DOI 10.1186/1750-2187-7-13; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328	45	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24656	24665		10.1074/jbc.M113.453423	http://dx.doi.org/10.1074/jbc.M113.453423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839942	hybrid, Green Published			2022-12-25	WOS:000330612300033
J	Singh, PK; Sarwar, M; Maklashina, E; Kotlyar, V; Rajagukguk, S; Tomasiak, TM; Cecchini, G; Iverson, TM				Singh, Prashant K.; Sarwar, Maruf; Maklashina, Elena; Kotlyar, Violetta; Rajagukguk, Sany; Tomasiak, Thomas M.; Cecchini, Gary; Iverson, Tina M.			Plasticity of the Quinone-binding Site of the Complex II Homolog Quinol:Fumarate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI FUMARATE REDUCTASE; SUCCINATE-UBIQUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; CATALYTIC-ACTIVITY; ELECTRON-TRANSFER; MENAQUINONE; DEHYDROGENASE; PROTEINS; ORIENTATIONS; INHIBITORS	Respiratory processes often use quinone oxidoreduction to generate a transmembrane proton gradient, making the 2H(+)/2e(-) quinone chemistry important for ATP synthesis. There are a variety of quinones used as electron carriers between bioenergetic proteins, and some respiratory proteins can functionally interact with more than one quinone type. In the case of complex II homologs, which couple quinone chemistry to the inter-conversion of succinate and fumarate, the redox potentials of the biologically available ubiquinone and menaquinone aid in driving the chemical reaction in one direction. In the complex II homolog quinol: fumarate reductase, it has been demonstrated that menaquinol oxidation requires at least one proton shuttle, but many of the remaining mechanistic details of menaquinol oxidation are not fully understood, and little is known about ubiquinone reduction. In the current study, structural and computational studies suggest that the sequential removal of the two menaquinol protons may be accompanied by a rotation of the naphthoquinone ring to optimize the interaction with a second proton shuttling pathway. However, kinetic measurements of site-specific mutations of quinol: fumarate reductase variants show that ubiquinone reduction does not use the same pathway. Computational docking of ubiquinone followed by mutagenesis instead suggested redundant proton shuttles lining the ubiquinone-binding site or from direct transfer from solvent. These data show that the quinone-binding site provides an environment that allows multiple amino acid residues to participate in quinone oxidoreduction. This suggests that the quinone-binding site in complex II is inherently plastic and can robustly interact with different types of quinones.	[Singh, Prashant K.; Sarwar, Maruf; Tomasiak, Thomas M.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Maklashina, Elena; Kotlyar, Violetta; Rajagukguk, Sany; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Adm Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu; tina.iverson@vanderbilt.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086, R01GM079419, R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817.	Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2003, FEBS LETT, V545, P31, DOI 10.1016/S0014-5793(03)00390-9; Cheng VWT, 2008, BIOCHEMISTRY-US, V47, P9107, DOI 10.1021/bi801008e; Crofts A. R., 2013, BIOCH BIOPH IN PRESS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; HOLLANDER R, 1976, FEBS LETT, V72, P98, DOI 10.1016/0014-5793(76)80821-6; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008; Iverson TM, 2002, J BIOL CHEM, V277, P16124, DOI 10.1074/jbc.M200815200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Leger C, 2001, BIOCHEMISTRY-US, V40, P11234, DOI 10.1021/bi010889b; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Luna-Chavez C, 2000, PROTEIN EXPRES PURIF, V19, P188, DOI 10.1006/prep.2000.1238; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P1877, DOI 10.1016/j.bbabio.2010.02.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustafa G, 2008, J BIOL CHEM, V283, P28169, DOI 10.1074/jbc.M804938200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddock ML, 2007, BIOCHEMISTRY-US, V46, P8234, DOI 10.1021/bi7005256; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pokkuluri PR, 2002, BIOCHEMISTRY-US, V41, P5998, DOI 10.1021/bi0118963; Rothery RA, 2005, FEBS J, V272, P313, DOI 10.1111/j.1742-4658.2004.04469.x; Rothery RA, 1998, EUR J BIOCHEM, V254, P588, DOI 10.1046/j.1432-1327.1998.2540588.x; Sharma P, 2012, FEBS J, V279, P3364, DOI 10.1111/j.1742-4658.2012.08608.x; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; SMITH MW, 1983, J BACTERIOL, V154, P344, DOI 10.1128/JB.154.1.344-350.1983; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Tomasiak TM, 2011, J BIOL CHEM, V286, P3047, DOI 10.1074/jbc.M110.192849; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Yang XD, 1998, J BIOL CHEM, V273, P31916, DOI 10.1074/jbc.273.48.31916; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	45	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24293	24301		10.1074/jbc.M113.487082	http://dx.doi.org/10.1074/jbc.M113.487082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836905	Green Published, hybrid			2022-12-25	WOS:000330612300002
J	Cardoso, EC; Pereira, NZ; Mitsunari, GE; Oliveira, LMD; Ruocco, RMSA; Francisco, RPV; Zugaib, M; Duarte, AJD; Sato, MN				Cardoso, Elaine Cristina; Pereira, Natalli Zanete; Mitsunari, Gabrielle Eimi; da Silva Oliveira, Luanda Mara; Ruocco, Rosa Maria S. A.; Vieira Francisco, Rossana Pulcineli; Zugaib, Marcelo; da Silva Duarte, Alberto Jose; Sato, Maria Notomi			TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CELLULAR IMMUNE-RESPONSES; INNATE IMMUNITY; MICROBIAL TRANSLOCATION; UNINFECTED INFANTS; TYPE-1 INFECTION; EARLY-LIFE; IN-UTERO; BLOOD; EXPRESSION	Mother-to-child transmission (MTCT) of HIV-1 has been significantly reduced with the use of antiretroviral therapies, resulting in an increased number of HIV-exposed uninfected infants. The consequences of HIV infection on the innate immune system of both mother-newborn are not well understood. In this study, we analyzed peripheral blood and umbilical cord blood (CB) collected from HIV-1-infected and uninfected pregnant women. We measured TNF-alpha, IL-10 and IFN-alpha secretion after the stimulation of the cells with agonists of both extracellular Toll-like receptors (TLRs) (TLR2, TLR4 and TLR5) and intracellular TLRs (TLR7, TLR7/8 and TLR9). Moreover, as an indicator of the innate immune response, we evaluated the responsiveness of myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs) to TLRs that are associated with the antiviral response. Our results showed that peripheral blood mononuclear cells (PBMCs) from HIV-1-infected mothers and CB were defective in TNF-alpha production after activation by TLR2, TLR5, TLR3 and TLR7. However, the TNF-alpha response was preserved after TLR7/8 (CL097) stimulation, mainly in the neonatal cells. Furthermore, only CL097 activation was able to induce IL-10 and IFN-alpha secretion in both maternal and CB cells in the infected group. An increase in IFN-alpha secretion was observed in CL097-treated CB from HIV-infected mothers compared with control mothers. The effectiveness of CL097 stimulation was confirmed by observation of similar mRNA levels of interferon regulatory factor-7 (IRF-7), IFN-alpha and TNF-alpha in PBMCs of both groups. The function of both mDCs and pDCs was markedly compromised in the HIV-infected group, and although TLR7/TLR8 activation overcame the impairment in TNF-alpha secretion by mDCs, such stimulation was unable to reverse the dysfunctional type I IFN response by pDCs in the HIV-infected samples. Our findings highlight the dysfunction of innate immunity in HIV-infected mother-newborn pairs. The activation of the TLR7/8 pathway could function as an adjuvant to improve maternal-neonatal innate immunity.	[Cardoso, Elaine Cristina; Pereira, Natalli Zanete; Mitsunari, Gabrielle Eimi; da Silva Oliveira, Luanda Mara; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil; [Ruocco, Rosa Maria S. A.; Vieira Francisco, Rossana Pulcineli; Zugaib, Marcelo] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Sato, MN (corresponding author), Univ Sao Paulo, Sch Med, Dept Dermatol, Lab Dermatol & Immunodeficiencies, Sao Paulo, Brazil.	marisato@usp.br	Duarte, Alberto J S/D-4382-2012; Sato, Maria N/C-1196-2012; Francisco, Rossana Pulcineli Vieira/AAG-7461-2020; Sato, Maria N/C-2853-2012; Francisco, Rossana PV/C-5648-2012; Pereira, Nátalli Zanete/U-7291-2019; Zugaib, Marcelo/A-5724-2013; da Silva Oliveira, Luanda Mara/E-7273-2013	Sato, Maria N/0000-0002-7911-1824; Francisco, Rossana Pulcineli Vieira/0000-0002-9981-8069; Francisco, Rossana PV/0000-0002-9981-8069; Pereira, Nátalli Zanete/0000-0002-8875-9470; Zugaib, Marcelo/0000-0003-1155-2671; da Silva Oliveira, Luanda Mara/0000-0003-0903-8219	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/55962-3]; Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/55962-3) and the Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; [Anonymous], 2012, BJOG, P1; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burlingham WJ, 2009, NEW ENGL J MED, V360, P1355, DOI 10.1056/NEJMcibr0810752; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; Charrier E, 2012, CELL IMMUNOL, V276, P114, DOI 10.1016/j.cellimm.2012.04.010; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; de Brito CA, 2009, IMMUNOTHERAPY-UK, V1, P883, DOI 10.2217/IMT.09.38; Desai S, 2007, JAIDS-J ACQ IMM DEF, V45, P501, DOI 10.1097/QAI.0b013e3180654811; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dolcini G, 2003, AIDS RES HUM RETROV, V19, P857, DOI 10.1089/088922203322493021; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Futata EA, 2012, EXPERT REV ANTI-INFE, V10, P289, DOI [10.1586/eri.12.9, 10.1586/ERI.12.9]; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Meier A, 2007, EXPERT REV ANTI-INFE, V5, P323, DOI 10.1586/14787210.5.3.323; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Morgado JM, 2008, TRANSPL IMMUNOL, V19, P55, DOI 10.1016/j.trim.2007.11.002; Mussi-Pinhata MM, 2007, PEDIATR INFECT DIS J, V26, P1032, DOI 10.1097/INF.0b013e31812f56ed; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Velilla PA, 2008, CLIN IMMUNOL, V126, P243, DOI 10.1016/j.clim.2007.11.004; Villacres MC, 2012, J INFECT DIS, V206, P780, DOI 10.1093/infdis/jis380; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391	53	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67036	10.1371/journal.pone.0067036	http://dx.doi.org/10.1371/journal.pone.0067036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826189	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000021
J	Dituri, F; Mazzocca, A; Peidro, FJ; Papappicco, P; Fabregat, I; De Santis, F; Paradiso, A; Sabba, C; Giannelli, G				Dituri, Francesco; Mazzocca, Antonio; Juan Peidro, Fernando; Papappicco, Patrizia; Fabregat, Isabel; De Santis, Flavia; Paradiso, Angelo; Sabba, Carlo; Giannelli, Gianluigi			Differential Inhibition of the TGF-beta Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-beta Receptor Type II	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA GROWTH; TRANSFORMING GROWTH-FACTOR-BETA-1; VASCULAR INVASION; CANCER; BLOCKS; METASTASIS; STROMA	We investigated blocking the TGF-beta signaling pathway in HCC using two small molecule inhibitors (LY2157299, LY2109761) and a neutralizing humanized antibody (D10) against TGF-beta RII. LY2157299 and LY2109761 inhibited HCC cell migration on Laminin-5, Fibronectin, Vitronectin, Fibrinogen and Collagen-I and de novo phosphorylation of pSMAD2. LY2157299 inhibited HCC migration and cell growth independently of the expression levels of TGF-beta RII. In contrast to LY2157299, D10 showed a reduction in pSMAD2 only after a short exposure. This study supports the use of LY2157299 in clinical trials, and presents new insights into TGF-beta receptor cycling in cancer cells.	[Dituri, Francesco; Mazzocca, Antonio; Papappicco, Patrizia; De Santis, Flavia; Giannelli, Gianluigi] Univ Bari, Sch Med, Dept Emergency & Organ Transplantat, Sect Internal Med Allergol & Immunol, Bari, Italy; [Juan Peidro, Fernando; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Paradiso, Angelo] Natl Canc Inst, Clin Expt Oncol Lab, Bari, Italy; [Sabba, Carlo] Univ Bari, Sch Med, Dept Interdisciplinary Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro	Giannelli, G (corresponding author), Univ Bari, Sch Med, Dept Emergency & Organ Transplantat, Sect Internal Med Allergol & Immunol, Bari, Italy.	g.giannelli@intmed.uniba.it	paradiso, angelo V/J-9457-2018; Dituri, Francesco/K-5819-2016; Fabregat, Isabel/H-7038-2015; Giannelli, Gianluigi/K-5123-2016	MAZZOCCA, Antonio/0000-0003-0940-7352; Sabba', Carlo/0000-0002-9874-8740; Fabregat, Isabel/0000-0003-0136-8440; Giannelli, Gianluigi/0000-0002-5140-8060	Italian Association of Cancer Research (AIRC) [IG11389]	Italian Association of Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association of Cancer Research (AIRC) (grant number IG11389 to G.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Colombo M, 1999, J HEPATOL, V31, P25, DOI 10.1016/S0168-8278(99)80370-5; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Giannelli G, 2002, AM J PATHOL, V161, P183, DOI 10.1016/S0002-9440(10)64170-3; Giannelli G, 2011, BBA-REV CANCER, V1815, P214, DOI 10.1016/j.bbcan.2010.11.004; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; ITO N, 1991, CANCER RES, V51, P4080; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634	24	80	88	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67109	10.1371/journal.pone.0067109	http://dx.doi.org/10.1371/journal.pone.0067109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826206	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000029
J	Fang, DD; Zhang, CC; Gu, Y; Jani, JP; Cao, J; Tsaparikos, K; Yuan, J; Thiel, M; Jackson-Fisher, A; Zong, Q; Lappin, PB; Hayashi, T; Schwab, RB; Wong, A; John-Baptiste, A; Bagrodia, S; Los, G; Bender, S; Christensen, J; VanArsdale, T				Fang, Douglas D.; Zhang, Cathy C.; Gu, Yin; Jani, Jitesh P.; Cao, Joan; Tsaparikos, Konstantinos; Yuan, Jing; Thiel, Melissa; Jackson-Fisher, Amy; Zong, Qing; Lappin, Patrick B.; Hayashi, Tomoko; Schwab, Richard B.; Wong, Anthony; John-Baptiste, Annette; Bagrodia, Shubha; Los, Geritt; Bender, Steve; Christensen, James; VanArsdale, Todd			Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation	PLOS ONE			English	Article							PI3K; PATHWAY; GROWTH; BREAST; GENE; SUBPOPULATION; PROMOTES; SURVIVAL; OVARIAN; TARGET	PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide) mutations can help predict the antitumor activity of phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway inhibitors in both preclinical and clinical settings. In light of the recent discovery of tumor-initiating cancer stem cells (CSCs) in various tumor types, we developed an in vitro CSC model from xenograft tumors established in mice from a colorectal cancer patient tumor in which the CD133+/EpCAM+ population represented tumor-initiating cells. CD133+/EpCAM+ CSCs were enriched under stem cell culture conditions and formed 3-dimensional tumor spheroids. Tumor spheroid cells exhibited CSC properties, including the capability for differentiation and self-renewal, higher tumorigenic potential and chemo-resistance. Genetic analysis using an OncoCarta (TM) panel revealed a PIK3CA (H1047R) mutation in these cells. Using a dual PI3K/mTOR inhibitor, PF-04691502, we then showed that blockage of the PI3K/mTOR pathway inhibited the in vitro proliferation of CSCs and in vivo xenograft tumor growth with manageable toxicity. Tumor growth inhibition in mice was accompanied by a significant reduction of phosphorylated Akt (pAKT) (S473), a well-established surrogate biomarker of PI3K/mTOR signaling pathway inhibition. Collectively, our data suggest that PF-04691502 exhibits potent anticancer activity in colorectal cancer by targeting both PIK3CA (H1047R) mutant CSCs and their derivatives. These results may assist in the clinical development of PF-04691502 for the treatment of a subpopulation of colorectal cancer patients with poor outcomes.	[Fang, Douglas D.; Zhang, Cathy C.; Gu, Yin; Jani, Jitesh P.; Cao, Joan; Tsaparikos, Konstantinos; Yuan, Jing; Thiel, Melissa; Jackson-Fisher, Amy; Bagrodia, Shubha; Los, Geritt; Bender, Steve; Christensen, James; VanArsdale, Todd] Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA; [Zong, Qing; Lappin, Patrick B.; Wong, Anthony; John-Baptiste, Annette] Pfizer Global Res & Dev, Drug Safety Res & Dev, San Diego, CA USA; [Hayashi, Tomoko; Schwab, Richard B.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA	Pfizer; Pfizer; University of California System; University of California San Diego	Zhang, CC (corresponding author), Pfizer Global Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA.	cathy.zhang@pfizer.com	Schwab, Richard/AAX-9262-2020		Pfizer	Pfizer(Pfizer)	The authors have the following interests. All authors are either current or former employees of Pfizer, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bander AG, 2006, P NATL ACAD SCI USA, V103, P1475; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Don ASA, 2011, REV RECENT CLIN TRIA, V6, P24, DOI 10.2174/157488711793980147; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Hong ZY, 2011, CARCINOGENESIS, V32, P1550, DOI 10.1093/carcin/bgr176; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Martelli AM, 2011, CURR MED CHEM, V18, P2715; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ong CW, 2010, MODERN PATHOL, V23, P450, DOI 10.1038/modpathol.2009.181; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, FASEB J, V24, P4291, DOI 10.1096/fj.10-159970; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185	47	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67258	10.1371/journal.pone.0067258	http://dx.doi.org/10.1371/journal.pone.0067258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826249	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000050
J	Johansson, A; Enroth, S; Gyllensten, U				Johansson, Asa; Enroth, Stefan; Gyllensten, Ulf			Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan	PLOS ONE			English	Article							MONOZYGOTIC TWINS; METHYLATION; GENE; IDENTIFICATION; DISCORDANCE; DISORDERS; DISEASE; AGE	DNA methylation plays an important role in development of disease and the process of aging. In this study we examine DNA methylation at 476,366 sites throughout the genome of white blood cells from a population cohort (N = 421) ranging in age from 14 to 94 years old. Age affects DNA methylation at almost one third (29%) of the sites (Bonferroni adjusted P-value <0.05), of which 60.5% becomes hypomethylated and 39.5% hypermethylated with increasing age. DNA methylation sites that are located within CpG islands (CGIs) more often become hypermethylated compared to sites outside an island. CpG sites in promoters are more unaffected by age, whereas sites in enhancers more often becomes hypo-or hypermethylated. Hypermethylated sites are overrepresented among genes that are involved in DNA binding, transcription regulation, processes of anatomical structure and developmental process and cortex neuron differentiation (P-value down to P = 9.14* 10(-67)). By contrast, hypomethylated sites are not strongly overrepresented among any biological function or process. Our results indicate that the 23% of the variation in DNA methylation is attributed chronological age, and that hypermethylation is more site-specific than hypomethylation. It appears that the change in DNA methylation partly overlap with regions that change histone modifications with age, indicating an interaction between the two major epigenetic mechanisms. Epigenetic modifications and change in gene expression over time most likely reflects the natural process of aging and variation between individuals might contribute to the development of age-related phenotypes and diseases such as type II diabetes, autoimmune and cardiovascular disease.	[Johansson, Asa; Enroth, Stefan; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab Uppsala, Uppsala, Sweden; [Johansson, Asa] Uppsala Univ, Univ Uppsala Hosp, Uppsala Clin Res Ctr, Uppsala, Sweden	SciLifeLab; Uppsala University; Uppsala University; Uppsala University Hospital	Johansson, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab Uppsala, Uppsala, Sweden.	asa.johansson@igp.uu.se	Johansson, Åsa/G-5270-2011; Enroth, Stefan/C-7396-2009; Johansson, Åsa/AAG-6799-2021	Johansson, Åsa/0000-0002-2915-4498; Enroth, Stefan/0000-0002-5056-9137; Johansson, Åsa/0000-0002-2915-4498	Swedish Medical Research Council [K2007-66X-20270-01-3, 2011-2354]; Foundation for Strategic Research (SSF); Swedish Society for Medical Research (SSMF)	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Society for Medical Research (SSMF)	This work was supported by the Swedish Medical Research Council (K2007-66X-20270-01-3 to UG, 2011-2354 to AJ); the Foundation for Strategic Research (SSF); and the Swedish Society for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elashoff MR, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-26; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li J, 2007, J MACH LEARN RES, V8, P1687; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Mascalzoni D, 2010, EUR J HUM GENET, V18, P296, DOI 10.1038/ejhg.2009.155; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; R Core Team, 2012, R LANG ENV STAT COMP; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Skinner MK, 2010, NATURE, V467, P922, DOI 10.1038/467922a; Tang B, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.61; Winnefeld M, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-165, 10.1186/gb4033]	31	213	216	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67378	10.1371/journal.pone.0067378	http://dx.doi.org/10.1371/journal.pone.0067378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826282	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000071
J	Liu, H; Ma, YN; Fang, F; Zhang, Y; Zou, LP; Yang, YL; Zhu, SN; Wang, ST; Zheng, XF; Pei, P; Li, L; Wu, HR; Xiao, Y; Xu, YF; Wang, LW; Cao, YY; Pan, H; Qi, Y				Liu, Hui; Ma, Yinan; Fang, Fang; Zhang, Ying; Zou, Liping; Yang, Yanling; Zhu, Sainan; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Wang, Liwen; Cao, Yanyan; Pan, Hong; Qi, Yu			Wild-Type Mitochondrial DNA Copy Number in Urinary Cells as a Useful Marker for Diagnosing Severity of the Mitochondrial Diseases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; A3243G MUTATION; MTDNA; MELAS; PHENOTYPE; POPULATION; DEAFNESS; GENE; LOAD	The genotype-phenotype relationship in diseases with mtDNA point mutations is still elusive. The maintenance of wild-type mtDNA copy number is essential to the normal mitochondrial oxidative function. This study examined the relationship between mtDNA copy number in blood and urine and disease severity of the patients harboring A3243G mutation. We recruited 115 A3243G patients, in which 28 were asymptomatic, 42 were oligo-symptomatic, and 45 were poly-symptomatic. Increase of total mtDNA copy number without correlation to the proportion of mutant mtDNA was found in the A3243G patients. Correlation analyses revealed that wild-type mtDNA copy number in urine was the most important factor correlated to disease severity, followed by proportion of mutant mtDNA in urine and proportion of mutant mtDNA in blood. Wild-type copy number in urine negatively correlated to the frequencies of several major symptoms including seizures, myopathy, learning disability, headache and stroke, but positively correlated to the frequencies of hearing loss and diabetes. Besides proportion of mutant mtDNA in urine, wild-type copy number in urine is also an important marker for disease severity of A3243G patients.	[Liu, Hui; Ma, Yinan; Zhang, Ying; Wang, Songtao; Zheng, Xuefei; Pei, Pei; Li, Lin; Wu, Hairong; Xiao, Yang; Xu, Yufeng; Pan, Hong; Qi, Yu] Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China; [Fang, Fang] Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Zou, Liping] Beijing 301 Hosp, Dept Pediat, Beijing, Peoples R China; [Yang, Yanling] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100871, Peoples R China; [Wang, Liwen; Cao, Yanyan] Capital Inst Pediat, Dept Neurol, Beijing, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Capital Institute of Pediatrics (CIP)	Ma, YN (corresponding author), Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China.	mayinan1014@163.com; qiyu0724@163.com			National Natural Science Foundation of China [81271256]; Capital Medical Development Foundation of China [2009-2022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Medical Development Foundation of China	This work was supported by the National Natural Science Foundation of China (grant number 81271256); the Capital Medical Development Foundation of China (grant number 2009-2022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Francisci S, 1998, CURR GENET, V33, P110, DOI 10.1007/s002940050315; Guillausseau PJ, 2004, DIABETES METAB, V30, P181, DOI 10.1016/S1262-3636(07)70105-2; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701; Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005; Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x; Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oka T, 1996, DIABETIC MED, V13, pS98; Rinaldi T, 2003, GENE, V303, P63, DOI 10.1016/S0378-1119(02)01154-X; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209	21	11	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67146	10.1371/journal.pone.0067146	http://dx.doi.org/10.1371/journal.pone.0067146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826218	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000034
J	Sterratt, DC				Sterratt, David C.			On the Importance of Countergradients for the Development of Retinotopy: Insights from a Generalised Gierer Model	PLOS ONE			English	Article							HALF RETINAL PROJECTION; RETINOTECTAL PROJECTION; EPHRIN-AS; OPPOSING GRADIENTS; TOPOGRAPHIC MAPS; DRIVING-FORCE; OPTIC TECTUM; COMPETITION; MECHANISMS; RECEPTORS	During the development of the topographic map from vertebrate retina to superior colliculus (SC), EphA receptors are expressed in a gradient along the nasotemporal retinal axis. Their ligands, ephrin-As, are expressed in a gradient along the rostrocaudal axis of the SC. Countergradients of ephrin-As in the retina and EphAs in the SC are also expressed. Disruption of any of these gradients leads to mapping errors. Gierer's (1981) model, which uses well-matched pairs of gradients and countergradients to establish the mapping, can account for the formation of wild type maps, but not the double maps found in EphA knock-in experiments. I show that these maps can be explained by models, such as Gierer's (1983), which have gradients and no countergradients, together with a powerful compensatory mechanism that helps to distribute connections evenly over the target region. However, this type of model cannot explain mapping errors found when the countergradients are knocked out partially. I examine the relative importance of countergradients as against compensatory mechanisms by generalising Gierer's (1983) model so that the strength of compensation is adjustable. Either matching gradients and countergradients alone or poorly matching gradients and countergradients together with a strong compensatory mechanism are sufficient to establish an ordered mapping. With a weaker compensatory mechanism, gradients without countergradients lead to a poorer map, but the addition of countergradients improves the mapping. This model produces the double maps in simulated EphA knock-in experiments and a map consistent with the Math5 knock-out phenotype. Simulations of a set of phenotypes from the literature substantiate the finding that countergradients and compensation can be traded off against each other to give similar maps. I conclude that a successful model of retinotopy should contain countergradients and some form of compensation mechanism, but not in the strong form put forward by Gierer.	Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland	University of Edinburgh	Sterratt, DC (corresponding author), Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	david.c.sterratt@ed.ac.uk		Sterratt, David C/0000-0001-9092-9099	Wellcome Trust [083205/B/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	DCS was supported by The Wellcome Trust (grant number 083205/B/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2010, 2010, COLD SPRING HARB PER, V2.; ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; Bevins N, 2011, J NEUROSCI, V31, P10302, DOI 10.1523/JNEUROSCI.1652-11.2011; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GAZE R M, 1970, Experimental Brain Research, V10, P171; Gebhardt C, 2012, DEVELOPMENT, V139, P335, DOI 10.1242/dev.070474; GIERER A, 1983, PROC R SOC SER B-BIO, V218, P77, DOI 10.1098/rspb.1983.0027; GIERER A, 1981, BIOL CYBERN, V42, P69, DOI 10.1007/BF00335161; GIERER A, 1987, DEVELOPMENT, V101, P479; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; Grimbert F, 2012, J NEUROSCI, V32, P9755, DOI 10.1523/JNEUROSCI.6180-11.2012; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Hayfield T, 2008, J STAT SOFTW, V27, P1; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Nissenbaum D, 2010, THESIS U CAMBRIDGE; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; R Core Team, 2012, R LANG ENV STAT COMP; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; SCHMIDT JT, 1978, J COMP NEUROL, V177, P257, DOI 10.1002/cne.901770206; SCHMIDT JT, 1978, J COMP NEUROL, V177, P279, DOI 10.1002/cne.901770207; Simpson HD, 2011, BIOL CYBERN, V104, P9, DOI 10.1007/s00422-011-0417-y; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sterratt D, 2011, PRINCIPLES COMPUTATI; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Suetterlin P, 2012, SEMIN CELL DEV BIOL, V23, P1, DOI 10.1016/j.semcdb.2011.10.015; Triplett JW, 2011, P NATL ACAD SCI USA, V108, P19060, DOI 10.1073/pnas.1102834108; Tsigankov D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-155; Tsigankov DN, 2006, J COMPUT NEUROSCI, V21, P101, DOI 10.1007/s10827-006-9575-7; VONDERMALSBURG C, 1977, P NATL ACAD SCI USA, V74, P5176, DOI 10.1073/pnas.74.11.5176; WHITELAW VA, 1981, J NEUROSCI, V1, P1369; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; YOON M, 1971, EXP NEUROL, V33, P395, DOI 10.1016/0014-4886(71)90031-8; YOON M, 1972, AM ZOOL, V12, pR22	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67096	10.1371/journal.pone.0067096	http://dx.doi.org/10.1371/journal.pone.0067096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826201	Green Published, gold			2022-12-25	WOS:000321150000025
J	Champion, K; Chiu, L; Ferbas, J; Pepe, M				Champion, Keith; Chiu, Laura; Ferbas, John; Pepe, Michael			Endotoxin Neutralization as a Biomonitor for Inflammatory Bowel Disease	PLOS ONE			English	Article							SEVERE SEPSIS; LIPID-A; ANTIENDOTOXIN ANTIBODIES; INTESTINAL PERMEABILITY; SYSTEMIC ENDOTOXEMIA; HUMORAL COMPONENT; CROHNS-DISEASE; PROTEIN; INACTIVATION; GENDER	Gram-negative bacterial endotoxin is a potent immunostimulant implicated in the development and/or progression of a variety of diseases. The mammalian immune system has both innate and adaptive immune responses to neutralize endotoxin. In this study, a system was developed to monitor bacterial exposure by measuring the extent and nature of endotoxin neutralization in plasma. In control patients, females had higher levels of endotoxin neutralization than males, mirroring clinical outcomes from bacterial infection and sepsis. In addition to the total amount of neutralization, we used inactivation techniques to elucidate the nature of this activity and develop a system to compare early and late immune responses. Using this method to monitor patients with inflammatory bowel disease, we found a more robust total response that relies more on long-term, adaptive components of the immune system and less on early, innate components. Our results indicate that endotoxin neutralization is a valuable method to discern inflammatory bowel disease patients from a control population. Additionally, the nature of neutralization may be valuable in monitoring disease severity and/or the role of medication.	[Champion, Keith; Pepe, Michael] BioDtech Inc, Birmingham, AL USA; [Chiu, Laura; Ferbas, John] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA	Amgen	Champion, K (corresponding author), BioDtech Inc, Birmingham, AL USA.	kchampion@biodtechinc.com			BioDtech, Inc.; Amgen, Inc.	BioDtech, Inc.; Amgen, Inc.(Amgen)	KC and MP are both employed and own stock options in BioDtech, Inc., whose company partly funded this study. LC and JF are employees of Amgen, Inc., whose company partly funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adrie C, 2007, CHEST, V132, P1786, DOI 10.1378/chest.07-0420; Al-Muzairai IA, 2008, TRANSPL P, V40, P2198, DOI 10.1016/j.transproceed.2008.07.045; Barclay G R, 1995, Prog Clin Biol Res, V392, P263; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BERGER D, 1990, FEBS LETT, V277, P33, DOI 10.1016/0014-5793(90)80803-Q; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; BJORNSON BH, 1988, INFECT IMMUN, V56, P1602, DOI 10.1128/IAI.56.6.1602-1607.1988; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; Foxman B, 2002, AM J MED, V113, p5S; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hardy Karolyn W., 2001, Journal of Neurochemistry, V78, P1183, DOI 10.1046/j.1471-4159.2001.00486.x; JACKSON SK, 1993, EUR J CLIN INVEST, V23, P540, DOI 10.1111/j.1365-2362.1993.tb00963.x; Jirillo E, 1991, Acta Neurol (Napoli), V13, P188; JOHNS MA, 1988, INFECT IMMUN, V56, P1593, DOI 10.1128/IAI.56.6.1593-1601.1988; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KATSCHINSKI B, 1993, DIGEST DIS SCI, V38, P1596, DOI 10.1007/BF01303165; KEENE WR, 1961, J CLIN INVEST, V40, P302, DOI 10.1172/JCI104257; KRUIS W, 1984, DIGEST DIS SCI, V29, P502, DOI 10.1007/BF01296269; LANDY M, 1960, ANN NY ACAD SCI, V88, P1273, DOI 10.1111/j.1749-6632.1960.tb20118.x; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; Macfarlane S, 2009, CRIT REV CL LAB SCI, V46, P25, DOI [10.1080/10408360802485792, 10.1080/10408360802485792 ]; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; MARGET W, 1987, INFECTION, V15, P142, DOI 10.1007/BF01650220; MARTSEV SP, 1995, FEBS LETT, V361, P173, DOI 10.1016/0014-5793(95)00145-Y; MATTSBYBALTZER I, 1984, REV INFECT DIS, V6, P553; Maury E, 2003, J CRIT CARE, V18, P115, DOI 10.1053/jcrc.2003.50004; MCGUE M, 1990, HUM HERED, V40, P231, DOI 10.1159/000153935; Mehrzad J, 2007, VET RES, V38, P655, DOI 10.1051/vetres:2007024; MODICA MA, 1989, EXP CLIN IMMUNOGENET, V6, P251; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; ODEH M, 1994, J CLIN GASTROENTEROL, V19, P146, DOI 10.1097/00004836-199409000-00016; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORIISHI T, 1995, GUT, V36, P891, DOI 10.1136/gut.36.6.891; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Petsch D, 1998, ANAL BIOCHEM, V259, P42, DOI 10.1006/abio.1998.2655; Poelstra K, 1997, LAB INVEST, V76, P319; PORAT R, 1992, INFECT IMMUN, V60, P1756, DOI 10.1128/IAI.60.5.1756-1760.1992; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rampton DS, 2011, J RHEUMATOL, V38, P43, DOI 10.3899/jrheum.110904; RAYNAUD M, 1973, J INFECT DIS, V128, pS35, DOI 10.1093/infdis/128.Supplement_1.S35; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; SCHETTERS T, 1988, J IMMUNOL METHODS, V109, P193, DOI 10.1016/0022-1759(88)90242-6; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; SKARNES RC, 1958, J EXP MED, V108, P685, DOI 10.1084/jem.108.5.685; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872; Welcker K, 2004, EUR J MED RES, V9, P456; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; WILMOTT RW, 1994, PEDIATR PULM, V18, P21, DOI 10.1002/ppul.1950180107; YAMAGUCHI Y, 1986, P SOC EXP BIOL MED, V181, P163	60	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67736	10.1371/journal.pone.0067736	http://dx.doi.org/10.1371/journal.pone.0067736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826338	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400170
J	Gutierrez, A; Beltran, G; Warringer, J; Guillamon, JM				Gutierrez, Alicia; Beltran, Gemma; Warringer, Jonas; Guillamon, Jose M.			Genetic Basis of Variations in Nitrogen Source Utilization in Four Wine Commercial Yeast Strains	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; METHIONINE SALVAGE PATHWAY; ALCOHOLIC FERMENTATION; CATABOLITE REPRESSION; ENOLOGICAL CONDITIONS; ASSIMILABLE NITROGEN; SYNTHETIC GRAPE; BUDDING YEAST; TRAIT; METABOLISM	The capacity of wine yeast to utilize the nitrogen available in grape must directly correlates with the fermentation and growth rates of all wine yeast fermentation stages and is, thus, of critical importance for wine production. Here we precisely quantified the ability of low complexity nitrogen compounds to support fast, efficient and rapidly initiated growth of four commercially important wine strains. Nitrogen substrate abundance in grape must failed to correlate with the rate or the efficiency of nitrogen source utilization, but well predicted lag phase length. Thus, human domestication of yeast for grape must growth has had, at the most, a marginal impact on wine yeast growth rates and efficiencies, but may have left a surprising imprint on the time required to adjust metabolism from non growth to growth. Wine yeast nitrogen source utilization deviated from that of the lab strain experimentation, but also varied between wine strains. Each wine yeast lineage harbored nitrogen source utilization defects that were private to that strain. By a massive hemizygote analysis, we traced the genetic basis of the most glaring of these defects, near inability of the PDM wine strain to utilize methionine, as consequence of mutations in its ARO8, ADE5,7 and VBA3 alleles. We also identified candidate causative mutations in these genes. The methionine defect of PDM is potentially very interesting as the strain can, in some circumstances, overproduce foul tasting H2S, a trait which likely stems from insufficient methionine catabolization. The poor adaptation of wine yeast to the grape must nitrogen environment, and the presence of defects in each lineage, open up wine strain optimization through biotechnological endeavors.	[Gutierrez, Alicia; Guillamon, Jose M.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Paterna, Valencia, Spain; [Beltran, Gemma; Guillamon, Jose M.] Univ Rovira & Virgili, Fac Enol, Dept Bioquim & Biotecnol, E-43007 Tarragona, Spain; [Warringer, Jonas] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Rovira i Virgili; University of Gothenburg	Guillamon, JM (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Paterna, Valencia, Spain.	guillamon@iata.csic.es	Guillamon, Jose/AAB-4251-2019; Beltran, Gemma/C-6416-2015; Guillamon, Jose/I-2040-2015	Guillamon, Jose/0000-0001-5414-0787; Beltran, Gemma/0000-0002-7071-205X; Guillamon, Jose/0000-0001-5414-0787	AGROVIN Company; "Centro para el Desarrollo Tecnologico Industrial (CDTI) in the context of the Project CENIT DEMETER; Spanish government [AGL2010-22001-C02-01, AGL2009-07331]; CSIC	AGROVIN Company; "Centro para el Desarrollo Tecnologico Industrial (CDTI) in the context of the Project CENIT DEMETER; Spanish government(Spanish GovernmentEuropean Commission); CSIC	This work has been financially supported by AGROVIN Company (http://www.agrovin.com/) and "Centro para el Desarrollo Tecnologico Industrial (CDTI; http://www.cdti.es/) in the context of the Project CENIT DEMETER and by the grants AGL2010-22001-C02-01 and AGL2009-07331, from the Spanish government, awarded to JMG and GB respectively. AG also wants to thank to CSIC for her "JAE-PRE" grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As required by the journal, the authors can state that, in spite of the partial funding from a commercial source (AGROVIN Company), this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Beltran G, 2005, J AGR FOOD CHEM, V53, P996, DOI 10.1021/jf0487001; Beltran G, 2004, FEMS YEAST RES, V4, P625, DOI 10.1016/j.femsyr.2003.12.004; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; Bisson L F., 1999, AM J ENOL VITICULT, V150, P1; Cooper T., 1982, MOL BIOL YEAST SACCH, P399; Cordente AG, 2009, FEMS YEAST RES, V9, P446, DOI 10.1111/j.1567-1364.2009.00489.x; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Guillamon JM, 1998, ARCH MICROBIOL, V169, P387, DOI 10.1007/s002030050587; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gutierrez A, 2012, FOOD MICROBIOL, V31, P25, DOI 10.1016/j.fm.2012.02.012; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; JIRANEK V, 1995, APPL ENVIRON MICROB, V61, P461, DOI 10.1128/AEM.61.2.461-467.1995; Katou T, 2008, YEAST, V25, P799, DOI 10.1002/yea.1634; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, MOL BIOL YEAST SACCH, P238; Martinez-Moreno R, 2012, FEMS YEAST RES, V12, P477, DOI 10.1111/j.1567-1364.2012.00802.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Novo MT, 2003, INT J FOOD MICROBIOL, V86, P153, DOI 10.1016/S0168-1605(03)00253-8; Ottosson LG, 2010, EUKARYOT CELL, V9, P1635, DOI 10.1128/EC.00078-10; OUGH CS, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON NITROGEN IN GRAPES AND WINE, P165; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Riou C, 1997, YEAST, V13, P903, DOI 10.1002/(SICI)1097-0061(199708)13:10<903::AID-YEA145>3.3.CO;2-T; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Salmon JM, 1998, APPL ENVIRON MICROB, V64, P3831; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Varela C, 2004, APPL ENVIRON MICROB, V70, P3392, DOI 10.1128/AEM.70.6.3392-3400.2004; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019	51	45	45	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67166	10.1371/journal.pone.0067166	http://dx.doi.org/10.1371/journal.pone.0067166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826223	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400113
J	Isik, G; Chung, NPY; van Montfort, T; Menis, S; Matthews, K; Schief, WR; Moore, JP; Sanders, RW				Isik, Gozde; Chung, Nancy P. Y.; van Montfort, Thijs; Menis, Sergey; Matthews, Katie; Schief, William R.; Moore, John P.; Sanders, Rogier W.			An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COLONY-STIMULATING FACTOR; 2ND HYPERVARIABLE REGION; NEUTRALIZING ANTIBODY; RECOMBINANT GLYCOPROTEIN-120; METASTATIC MELANOMA; VACCINE EFFICACY; PARTIAL DELETION; MACAQUE MONKEYS; IMMUNE-RESPONSE	Broadly neutralizing antibodies (bNAbs) that target the HIV-1 envelope glycoproteins (Env) can prevent virus acquisition, but several Env properties limit its ability to induce an antibody response that is of sufficient quantity and quality. The immunogenicity of Env can be increased by fusion to co-stimulatory molecules and here we describe novel soluble Env trimers with embedded interleukin-4 (IL-4) or interleukin-21 (IL-21) domains, designed to activate B cells that recognize Env. In particular, the chimeric Env(IL-21) molecule activated B cells efficiently and induced the differentiation of antibody secreting plasmablast-like cells. We studied whether we could increase the activity of the embedded IL-21 by designing a chimeric IL-21/IL-4 (ChimIL-21/4) molecule and by introducing amino acid substitutions in the receptor binding domain of IL-21 that were predicted to enhance its binding. In addition, we incorporated IL-21 into a cleavable Env trimer and found that insertion of IL-21 did not impair Env cleavage, while Env cleavage did not impair IL-21 activity. These studies should guide the further design of chimeric proteins and Env(IL-21) may prove useful in improving antibody responses against HIV-1.	[Isik, Gozde; van Montfort, Thijs; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Chung, Nancy P. Y.; Matthews, Katie; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Menis, Sergey] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, San Diego, CA USA; [Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, San Diego, CA USA; [Schief, William R.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, San Diego, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Schief, William/ABF-3645-2020	Schief, William/0000-0002-1120-0150; Isik, Gozde/0000-0002-1329-6782	Aids Fonds (the Netherlands) [2008013, 2009012]; National Institutes of Health [POI AI82362, R37 AI36082]; Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, P01AI082362] Funding Source: NIH RePORTER	Aids Fonds (the Netherlands)(Netherlands Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Aids Fonds (the Netherlands) grants #2008013 and #2009012 and by National Institutes of Health Grants POI AI82362 and R37 AI36082. RWS is a recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research, and a Starting Investigator grant from the European Research Council (ERC-StG-2011-280829-SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung NPY, 2012, J IMMUNOL, V189, P5257, DOI 10.4049/jimmunol.1201905; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denecker G, 1997, CYTOKINE, V9, P631, DOI 10.1006/cyto.1997.0218; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Isik G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060126; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; JUST U, 1993, GROWTH FACTORS, V9, P291, DOI 10.3109/08977199308991589; Kang LS, 2010, J BIOL CHEM, V285, P12223, DOI 10.1074/jbc.M110.101444; KLEIN B, 1982, EXP HEMATOL, V10, P373; Kuhlman B, 2001, P NATL ACAD SCI USA, V98, P10687, DOI 10.1073/pnas.181354398; Kutzler MA, 2004, J CLIN INVEST, V114, P1241, DOI 10.1172/JCI200423467; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Parren PWHI, 1997, CHEM IMMUNOL, V65, P18; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu HF, 2011, J LEUKOCYTE BIOL, V90, P205, DOI 10.1189/jlb.1010579; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	88	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67309	10.1371/journal.pone.0067309	http://dx.doi.org/10.1371/journal.pone.0067309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826263	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400132
J	Lin, CC; Lee, CH; Fuh, CS; Juan, HF; Huang, HC				Lin, Chen-Ching; Lee, Chia-Hsien; Fuh, Chiou-Shann; Juan, Hsueh-Fen; Huang, Hsuan-Cheng			Link Clustering Reveals Structural Characteristics and Biological Contexts in Signed Molecular Networks	PLOS ONE			English	Article							GENETIC INTERACTIONS; YEAST; PROTEINS; BALANCE; ORGANIZATION; COMMUNITIES; PATHWAY; COMPLEX; CELLS	Many biological networks are signed molecular networks which consist of positive and negative links. To reveal the distinct features between links with different signs, we proposed signed link-clustering coefficients that assess the similarity of interaction profiles between linked molecules. We found that positive links tended to cluster together, while negative links usually behaved like bridges between positive clusters. Positive links with higher adhesiveness tended to share protein domains, be associated with protein-protein interactions and make intra-connections within protein complexes. Negative links that were more bridge-like tended to make interconnections between protein complexes. Utilizing the proposed measures to group positive links, we observed hierarchical modules that could be well characterized by functional annotations or known protein complexes. Our results imply that the proposed sign-specific measures can help reveal the network structural characteristics and the embedded biological contexts of signed links, as well as the functional organization of signed molecular networks.	[Lin, Chen-Ching; Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan; [Lin, Chen-Ching; Lee, Chia-Hsien; Fuh, Chiou-Shann; Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Ctr Syst Biol, Dept Life Sci, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; hsuancheng@ym.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Fuh, Chiou-Shann/0000-0002-6174-2556; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [99-2621-B-010-001-MY3, 99-2621-B-002-005-MY3]; National Taiwan University Frontier an Innovative Research Projects [99R70437]; National Health Research Institutes [NHRI-EX101-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Frontier an Innovative Research Projects; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by grants from the National Science Council of Taiwan (99-2621-B-010-001-MY3 and 99-2621-B-002-005-MY3), National Taiwan University Frontier an Innovative Research Projects (99R70437), and National Health Research Institutes (NHRI-EX101-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateson William, 1905, REPORTS EVOLUTION CO, V2, P1; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; DOBZHANSKY T, 1946, GENETICS, V31, P269; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Hummon NP, 2003, SOC NETWORKS, V25, P17, DOI 10.1016/S0378-8733(02)00019-9; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lin CC, 2009, J PROTEOME RES, V8, P1925, DOI 10.1021/pr8008786; Madi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017445; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Roth D, 2011, BIOCOMMUNICATION SOI; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67089	10.1371/journal.pone.0067089	http://dx.doi.org/10.1371/journal.pone.0067089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826198	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400102
J	Nunez, MA; Hayward, J; Horton, TR; Amico, GC; Dimarco, RD; Barrios-Garcia, MN; Simberloff, D				Nunez, Martin A.; Hayward, Jeremy; Horton, Thomas R.; Amico, Guillermo C.; Dimarco, Romina D.; Barrios-Garcia, M. Noelia; Simberloff, Daniel			Exotic Mammals Disperse Exotic Fungi That Promote Invasion by Exotic Trees	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BOAR SUS-SCROFA; MOUNT-ST-HELENS; WILD BOAR; ECTOMYCORRHIZAL FUNGI; SOUTHERN-HEMISPHERE; SEQUENCE ALIGNMENT; SPORE DISPERSAL; PINE INVASIONS; IDENTIFICATION	Biological invasions are often complex phenomena because many factors influence their outcome. One key aspect is how non-natives interact with the local biota. Interaction with local species may be especially important for exotic species that require an obligatory mutualist, such as Pinaceae species that need ectomycorrhizal (EM) fungi. EM fungi and seeds of Pinaceae disperse independently, so they may use different vectors. We studied the role of exotic mammals as dispersal agents of EM fungi on Isla Victoria, Argentina, where many Pinaceae species have been introduced. Only a few of these tree species have become invasive, and they are found in high densities only near plantations, partly because these Pinaceae trees lack proper EM fungi when their seeds land far from plantations. Native mammals (a dwarf deer and rodents) are rare around plantations and do not appear to play a role in these invasions. With greenhouse experiments using animal feces as inoculum, plus observational and molecular studies, we found that wild boar and deer, both non-native, are dispersing EM fungi. Approximately 30% of the Pinaceae seedlings growing with feces of wild boar and 15% of the seedlings growing with deer feces were colonized by non-native EM fungi. Seedlings growing in control pots were not colonized by EM fungi. We found a low diversity of fungi colonizing the seedlings, with the hypogeous Rhizopogon as the most abundant genus. Wild boar, a recent introduction to the island, appear to be the main animal dispersing the fungi and may be playing a key role in facilitating the invasion of pine trees and even triggering their spread. These results show that interactions among non-natives help explain pine invasions in our study area.	[Nunez, Martin A.; Dimarco, Romina D.; Barrios-Garcia, M. Noelia; Simberloff, Daniel] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Nunez, Martin A.; Amico, Guillermo C.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Hayward, Jeremy; Horton, Thomas R.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	University of Tennessee System; University of Tennessee Knoxville; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nunez, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mnunez@utk.edu	Nuñez, Martin A./B-2735-2010; Amico, Guillermo C c/HGD-9402-2022	Nuñez, Martin A./0000-0003-0324-5479; Dimarco, Romina D./0000-0002-1751-0643; Amico, Guillermo/0000-0002-3709-3111; Horton, Tom/0000-0002-2112-9618	National Science Foundation [DEB 949175, DEB 948930]; Division Of Environmental Biology [0949175, 0948930] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the National Science Foundation, awards #DEB 949175 and #DEB 948930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1987, T BRIT MYCOL SOC, V88, P413, DOI 10.1016/S0007-1536(87)80019-0; ALLEN MF, 1992, MYCOL RES, V96, P447, DOI 10.1016/S0953-7562(09)81089-7; Relva MA, 2010, BIOL INVASIONS, V12, P303, DOI 10.1007/s10530-009-9623-0; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Aylor DE, 2003, ECOLOGY, V84, P1989, DOI 10.1890/01-0619; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Barroetavena C, 2005, NOVA HEDWIGIA, V80, P453, DOI 10.1127/0029-5035/2005/0080-0453; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Buller A. H. R., 1922, RES FUNGI; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Chapela IH, 2001, SOIL BIOL BIOCHEM, V33, P1733, DOI 10.1016/S0038-0717(01)00098-0; CHUCHOU M, 1990, SOIL BIOL BIOCHEM, V22, P959; CHUCHOU M, 1981, SOIL BIOL BIOCHEM, V13, P247, DOI 10.1016/0038-0717(81)90029-8; Collier FA, 2009, J ECOL, V97, P950, DOI 10.1111/j.1365-2745.2009.01544.x; DARDAILLON M, 1986, BEHAV PROCESS, V13, P251, DOI 10.1016/0376-6357(86)90088-4; Davis M. R., 1996, New Zealand Journal of Forestry Science, V26, P380; Dickie IA, 2008, NEW PHYTOL, V180, P263, DOI 10.1111/j.1469-8137.2008.02635.x; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galante TE, 2011, MYCOLOGIA, V103, P1175, DOI 10.3852/10-388; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gardes M, 1996, Methods Mol Biol, V50, P177; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gehring CA, 2002, ECOL LETT, V5, P540, DOI 10.1046/j.1461-0248.2002.00353.x; GENARD M, 1988, CAN J ZOOL, V66, P2324, DOI 10.1139/z88-347; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; James TY, 2001, MOL ECOL, V10, P471, DOI 10.1046/j.1365-294x.2001.01224.x; JANOS DP, 1995, ECOLOGY, V76, P1852, DOI 10.2307/1940717; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Kretzer A, 1996, MYCOLOGIA, V88, P776, DOI 10.2307/3760972; LAMB RJ, 1979, AUST FOREST RES, V9, P25; Li A, 2010, 5 IUFRO PHYTOPHTHORA; Li DW, 2005, MYCOL RES, V109, P1235, DOI 10.1017/S0953756205003953; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Malloch D., 1992, FUNGAL COMMUNITY ITS, V2nd ed, P147; Mangan SA, 2002, OECOLOGIA, V131, P587, DOI 10.1007/s00442-002-0907-7; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Martin VL, 2012, 25 REUN ARG EC LUJ; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MIKOLA P., 1970, Mycorrhizal inoculation in afforestation, P123; Mikola P, 1953, KARSTENIA, V2, P33; Molina R, 1992, SPECIFICITY PHENOMEN, P357; Nguyen NH, 2012, FUNGAL ECOL, V5, P741, DOI 10.1016/j.funeco.2012.05.006; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; Nunez MA, 2008, AUSTRAL ECOL, V33, P317, DOI 10.1111/j.1442-9993.2007.01819.x; Nunez MA, 2011, OIKOS, V120, P1311, DOI 10.1111/j.1600-0706.2011.19504.x; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Richardson DM, 2006, PRESLIA, V78, P375; Richardson David M., 1998, P450; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Richardson DM, 2004, DIVERS DISTRIB, V10, P321, DOI 10.1111/j.1366-9516.2004.00096.x; RICHARDSON DM, 1994, J BIOGEOGR, V21, P511, DOI 10.2307/2845655; Richardson DM, 1998, CONSERV BIOL, V12, P18, DOI 10.1046/j.1523-1739.1998.96392.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simberloff D, 2003, ENVIRON MANAGE, V31, P263, DOI 10.1007/s00267-002-2794-4; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff Daniel, 2002, Biological Invasions, V4, P35, DOI 10.1023/A:1020576408884; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; Smith AH, 1966, PRELIMINARY ACCOUNT; Sodeikat G, 2002, Z JAGDWISS, V48, P161, DOI 10.1007/BF02192404; TRAPPE JM, 1976, MYCOLOGIA, V68, P433, DOI 10.2307/3759016; Vazquez Diego P., 2002, Biological Invasions, V4, P175, DOI 10.1023/A:1020522923905; Vellinga EC, 2009, NEW PHYTOL, V181, P960, DOI 10.1111/j.1469-8137.2008.02728.x; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zenni RD, 2013, OIKOS, V122, P801, DOI 10.1111/j.1600-0706.2012.00254.x	72	71	75	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66832	10.1371/journal.pone.0066832	http://dx.doi.org/10.1371/journal.pone.0066832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826154	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400065
J	Shmueli, MD; Schnaider, L; Rosenblum, D; Herzog, G; Gazit, E; Segal, D				Shmueli, Merav D.; Schnaider, Lee; Rosenblum, Daniel; Herzog, Gal; Gazit, Ehud; Segal, Daniel			Structural Insights into the Folding Defects of Oncogenic pVHL Lead to Correction of Its Function In Vitro	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU GENE; BIOLOGICALLY-ACTIVE PRODUCT; RENAL-CELL CARCINOMA; TUMORIGENIC MUTATIONS; PROLYL HYDROXYLATION; ORGANIC OSMOLYTES; ELONGIN-C; HIF-ALPHA; VHL GENE	Loss of function mutations in the von Hippel-Lindau (pVHL) tumor suppressor protein are tumorigenic. In silico analysis of the structure and folding of WT pVHL identified in its core an aromatic tetrahedron, essential for stabilizing the protein. The mutations disrupt the aromatic tetrahedron, leading to misfolding of pVHL. Using biophysical methods we confirmed the in silico predictions, demonstrating that mutant pVHL proteins have lower stability than the WT, distort the core domain and as a result reduce the ability of the protein to bind its target HIF-1 alpha. Using bacterial pVHL-EGFP based assay we screened for osmolytes capable of restoring folding of mutant pVHL. Among them, Arginine was the most effective and was verified by in vitro assays as a potent re-folder of pVHL. This resulted in functional restoration of the mutant proteins to the level of the WT.	[Shmueli, Merav D.; Schnaider, Lee; Rosenblum, Daniel; Herzog, Gal; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Segal, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019; Shmueli, Merav/HDM-9859-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Shmueli, Merav/0000-0002-9196-7633; Rosenblum, Daniel/0000-0001-9602-6026; Segal, Daniel/0000-0002-6777-505X	Israel Cancer Association; Cancer Biology Research Center, Tel Aviv University	Israel Cancer Association; Cancer Biology Research Center, Tel Aviv University	This work was supported in part by grants from the Israel Cancer Association (http://en.cancer.org.il/) and the Cancer Biology Research Center, Tel Aviv University,(http://www.tau.ac.il/institutes/cbrc/) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arjumand W, 2012, TUMOR BIOL, V33, P9, DOI 10.1007/s13277-011-0257-3; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Blankenship C, 1999, ONCOGENE, V18, P1529, DOI 10.1038/sj.onc.1202473; Bourne PE, 2004, BRIEF BIOINFORM, V5, P23, DOI 10.1093/bib/5.1.23; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chang YC, 2010, BIOCHEMISTRY-US, V49, P5086, DOI 10.1021/bi100222h; Chen CH, 2009, LANGMUIR, V25, P6717, DOI 10.1021/la9002065; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gryczynski I, 2004, PHOTOCHEM PHOTOBIOL, V80, P482, DOI 10.1562/2004-08-13-RA-273.1; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; LAKOWICZ JR, 1983, BIOCHEMISTRY-US, V22, P1741, DOI 10.1021/bi00277a001; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; MARTENSON RE, 1978, J BIOL CHEM, V253, P8887; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Nagaraj NS, 2010, EXPERT REV PROTEOMIC, V7, P613, DOI 10.1586/EPR.10.70; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Roe JS, 2006, CELL CYCLE, V5, P2054, DOI 10.4161/cc.5.18.3247; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; SHUIN T, 1994, CANCER RES, V54, P2852; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsvetkov P, 2009, NAT CHEM BIOL, V5, P778, DOI 10.1038/nchembio.233; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WHALEY JM, 1994, AM J HUM GENET, V55, P1092; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	63	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66333	10.1371/journal.pone.0066333	http://dx.doi.org/10.1371/journal.pone.0066333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840444	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800048
J	Zhang, ZQ; Li, D; Xu, HR; Xin, Y; Zhang, TT; Ma, LX; Wang, X; Chen, ZL; Zhang, ZY				Zhang, Zhiqiang; Li, Duo; Xu, Huarong; Xin, Ying; Zhang, Tingting; Ma, Lixia; Wang, Xin; Chen, Zhilong; Zhang, Zhiying			A Simple and Efficient Method for Assembling TALE Protein Based on Plasmid Library	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; DNA; NUCLEASES; EFFECTORS; TRANSCRIPTION; CONSTRUCTION; RECOGNITION; ACTIVATION; KNOCKOUT; CLONING	DNA binding domain of the transcription activator-like effectors (TALEs) from Xanthomonas sp. consists of tandem repeats that can be rearranged according to a simple cipher to target new DNA sequences with high DNA-binding specificity. This technology has been successfully applied in varieties of species for genome engineering. However, assembling long TALE tandem repeats remains a big challenge precluding wide use of this technology. Although several new methodologies for efficiently assembling TALE repeats have been recently reported, all of them require either sophisticated facilities or skilled technicians to carry them out. Here, we described a simple and efficient method for generating customized TALE nucleases (TALENs) and TALE transcription factors (TALE-TFs) based on TALE repeat tetramer library. A tetramer library consisting of 256 tetramers covers all possible combinations of 4 base pairs. A set of unique primers was designed for amplification of these tetramers. PCR products were assembled by one step of digestion/ligation reaction. 12 TALE constructs including 4 TALEN pairs targeted to mouse Gt(ROSA)26Sor gene and mouse Mstn gene sequences as well as 4 TALE-TF constructs targeted to mouse Oct4, c-Myc, Klf4 and Sox2 gene promoter sequences were generated by using our method. The construction routines took 3 days and parallel constructions were available. The rate of positive clones during colony PCR verification was 64% on average. Sequencing results suggested that all TALE constructs were performed with high successful rate. This is a rapid and cost-efficient method using the most common enzymes and facilities with a high success rate.	[Zhang, Zhiqiang; Li, Duo; Xu, Huarong; Xin, Ying; Zhang, Tingting; Ma, Lixia; Wang, Xin; Chen, Zhilong; Zhang, Zhiying] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, ZY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn		Zhang, Zhiqiang/0000-0002-3855-8101; Zhang, Zhiying/0000-0001-6012-0889	National Natural Science Foundation of China (NSFC) [31172186]; 973 program [2011CBA01002]; Genetically Modified Organisms Breeding Major Projects of China [2013XZ08008-003]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China	This study was supported by the National Natural Science Foundation of China (NSFC) (31172186) (http://www.nsfc.gov.cn) and 973 program (2011CBA01002) (http://www.973.gov.cn/AreaAppl.aspx) and grant 'Genetically Modified Organisms Breeding Major Projects of China (2013XZ08008-003) (http://www.nmp.gov.cn/).' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pennisi E, 2012, SCIENCE, V338, P1408, DOI 10.1126/science.338.6113.1408; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	27	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66459	10.1371/journal.pone.0066459	http://dx.doi.org/10.1371/journal.pone.0066459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840477	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800063
J	Klohs, J; Politano, IW; Deistung, A; Grandjean, J; Drewek, A; Dominietto, M; Keist, R; Schweser, F; Reichenbach, JR; Nitsch, RM; Knuesel, I; Rudin, M				Klohs, Jan; Politano, Igna Wojtyna; Deistung, Andreas; Grandjean, Joanes; Drewek, Anna; Dominietto, Marco; Keist, Ruth; Schweser, Ferdinand; Reichenbach, Juergen R.; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus			Longitudinal Assessment of Amyloid Pathology in Transgenic ArcA beta Mice Using Multi-Parametric Magnetic Resonance Imaging	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBRAL AMYLOIDOSIS; IN-VIVO; QUANTITATIVE MRI; CONTRAST AGENT; DIFFUSION; ANGIOPATHY; MICROVASCULATURE	Magnetic resonance imaging (MRI) can be used to monitor pathological changes in Alzheimer's disease (AD). The objective of this longitudinal study was to assess the effects of progressive amyloid-related pathology on multiple MRI parameters in transgenic arcA beta mice, a mouse model of cerebral amyloidosis. Diffusion-weighted imaging (DWI), T-1-mapping and quantitative susceptibility mapping (QSM), a novel MRI based technique, were applied to monitor structural alterations and changes in tissue composition imposed by the pathology over time. Vascular function and integrity was studied by assessing blood-brain barrier integrity with dynamic contrast-enhanced MRI and cerebral microbleed (CMB) load with susceptibility weighted imaging and QSM. A linear mixed effects model was built for each MRI parameter to incorporate effects within and between groups (i.e. genotype) and to account for changes unrelated to the disease pathology. Linear mixed effects modelling revealed a strong association of all investigated MRI parameters with age. DWI and QSM in addition revealed differences between arcA beta and wt mice over time. CMBs became apparent in arcA beta mice with 9 month of age; and the CMB load reflected disease stage. This study demonstrates the benefits of linear mixed effects modelling of longitudinal imaging data. Moreover, the diagnostic utility of QSM and assessment of CMB load should be exploited further in studies of AD.	[Klohs, Jan; Politano, Igna Wojtyna; Grandjean, Joanes; Dominietto, Marco; Keist, Ruth; Rudin, Markus] ETH, Inst Biomed Engn, Zurich, Switzerland; [Klohs, Jan; Politano, Igna Wojtyna; Grandjean, Joanes; Dominietto, Marco; Keist, Ruth; Rudin, Markus] Univ Zurich, Zurich, Switzerland; [Klohs, Jan; Grandjean, Joanes; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Klohs, Jan; Grandjean, Joanes; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus] ETH, Zurich, Switzerland; [Deistung, Andreas; Schweser, Ferdinand; Reichenbach, Juergen R.] Univ Jena, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena Univ Hosp, Jena, Germany; [Drewek, Anna] ETH, Seminar Stat, Zurich, Switzerland; [Nitsch, Roger M.] Univ Zurich, Div Psychiat Res, Zurich, Switzerland; [Knuesel, Irene; Rudin, Markus] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Klohs, J (corresponding author), ETH, Inst Biomed Engn, Zurich, Switzerland.	klohs@biomed.ee.ethz.ch	Schweser, Ferdinand/Q-6932-2019; Grandjean, Joanes/T-7614-2019; Grandjean, Joanes/AAV-2468-2020; Klohs, Jan/K-2142-2016; Reichenbach, Jürgen R./B-4333-2011; Deistung, Andreas/AAN-9412-2021	Schweser, Ferdinand/0000-0003-0399-9211; Grandjean, Joanes/0000-0001-8413-0491; Klohs, Jan/0000-0003-4065-2807; Reichenbach, Jürgen R./0000-0002-2640-0630; Knuesel, Irene/0000-0003-0396-9952; Deistung, Andreas/0000-0002-2427-1302	Swiss National Science Foundation [3100A0-112835, 310030-126029, 310030-132629]; German Research Foundation [RE 1123/9-2]; Carl Zeiss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Carl Zeiss Foundation	The work was supported by the Swiss National Science Foundation (grants 3100A0-112835 and 310030-126029 to MR; 310030-132629 to IK), by the German Research Foundation Grant RE 1123/9-2) and by the Carl Zeiss Foundation (dissertation fellowship to FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badea A, 2010, NEUROIMAGE, V50, P416, DOI 10.1016/j.neuroimage.2009.12.070; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; BRUNBERG JA, 1995, AM J NEURORADIOL, V16, P361; Chamberlain R, 2009, MAGN RESON MED, V61, P1158, DOI 10.1002/mrm.21951; Cheng YCN, 2009, PHYS MED BIOL, V54, P1169, DOI 10.1088/0031-9155/54/5/005; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Delatour B, 2006, NEUROBIOL AGING, V27, P835, DOI 10.1016/j.neurobiolaging.2005.04.011; El Tayara NE, 2006, NEUROBIOL DIS, V22, P199, DOI 10.1016/j.nbd.2005.10.013; Falangola MF, 2007, NMR BIOMED, V20, P343, DOI 10.1002/nbm.1163; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Giesel FL, 2010, EUR RADIOL, V20, P2461, DOI 10.1007/s00330-010-1805-8; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kahle P J, 2001, Expert Opin Ther Targets, V5, P125, DOI 10.1517/14728222.5.1.125; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Klohs J, 2011, J CEREBR BLOOD F MET, V31, P2282, DOI 10.1038/jcbfm.2011.118; Klohs J, 2011, NEUROSCIENTIST, V17, P539, DOI 10.1177/1073858410383433; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Lo RY, 2012, NEUROLOGY, V78, P1376, DOI 10.1212/WNL.0b013e318253d5b3; MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Mueggler T, 2004, EUR J NEUROSCI, V20, P811, DOI 10.1111/j.1460-9568.2004.03534.x; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; Princz-Kranz FL, 2010, NEUROBIOL DIS, V40, P284, DOI 10.1016/j.nbd.2010.06.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; RUDICK RA, 1983, NEUROBIOL AGING, V4, P283, DOI 10.1016/0197-4580(83)90004-0; Rudin M, 2005, NMR BIOMED, V18, P308, DOI 10.1002/nbm.961; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Teipel SJ, 2011, WORLD J BIOL PSYCHIA, V12, P109, DOI 10.3109/15622975.2011.603222; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Thiessen JD, 2010, BRAIN STRUCT FUNCT, V215, P29, DOI 10.1007/s00429-010-0271-z; Van Dijck A, 2011, NEUROMETHODS, V48, P53, DOI 10.1007/978-1-60761-898-0_4; Vanhoutte G, 2011, NEUROMETHODS, V48, P187, DOI 10.1007/978-1-60761-898-0_11; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; VORBRODT AW, 1994, FOLIA HISTOCHEM CYTO, V32, P63; Weidensteiner C, 2009, MAGN RESON MED, V62, P35, DOI 10.1002/mrm.21985; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	52	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66097	10.1371/journal.pone.0066097	http://dx.doi.org/10.1371/journal.pone.0066097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840405	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000322361200054
J	Liu, R; Guo, XG; Park, Y; Wang, J; Huang, XM; Hollenbeck, A; Blair, A; Chen, HL				Liu, Rui; Guo, Xuguang; Park, Yikyung; Wang, Jian; Huang, Xuemei; Hollenbeck, Albert; Blair, Aaron; Chen, Honglei			Alcohol Consumption, Types of Alcohol, and Parkinson's Disease	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; NATIONAL-INSTITUTES; PLASMA URATE; RISK; RESVERATROL; PREDICTOR; DEMENTIA; DECLINE	Background: The epidemiologic evidence on alcohol consumption and Parkinson's disease (PD) is equivocal. We prospectively examined total alcohol consumption and consumption of specific types of alcoholic beverage in relation to future risk of PD. Methods: The study comprised 306,895 participants (180,235 male and 126,660 female) ages 50-71 years in 1995-1996 from the NIH-AARP Diet and Health Study. Consumption of alcoholic beverages in the past 12 months was assessed in 1995-1996. Multivariate odds ratios (OR) and 95% confidence intervals (CI) were obtained from logistic regression models. Results: A total of 1,113 PD cases diagnosed between 2000 and 2006 were included in the analysis. Total alcohol consumption was not associated with PD. However, the association differed by types of alcoholic beverages. Compared with non-beer drinkers, the multivariate ORs for beer drinkers were 0.79 (95% CI: 0.68, 0.92) for <1 drink/day, 0.73 (95% CI: 0.50, 1.07) for 1-1.99 drinks/day, and 0.86 (95% CI: 0.60, 1.21) for >= 2 drinks/day. For liquor consumption, a monotonic increase in PD risk was suggested: ORs (95% CI) were 1.06 (0.91, 1.23), 1.22 (0.94, 1.58), and 1.35 (1.02, 1.80) for<1, 1-1.99, and >= 2 drinks/day, respectively (P for trend <0.03). Additional analyses among exclusive drinkers of one specific type of alcoholic beverage supported the robustness of these findings. The results for wine consumption were less clear, although a borderline lower PD risk was observed when comparing wine drinkers of 1-1.99 drinks/day with none drinkers (OR = 0.74, 95% CI: 0.53, 1.02). Conclusions: Our results suggest that beer and liquor consumption may have opposite associations with PD: low to moderate beer consumption with lower PD risk and greater liquor consumption with higher risk. These findings and potential underlying mechanisms warrant further investigations.	[Liu, Rui; Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Guo, Xuguang] Westat Corp, Res Triangle Pk, NC USA; [Park, Yikyung; Blair, Aaron] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Wang, Jian] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Hollenbeck, Albert] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Westat; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; American Association of Retired Persons (AARP)	Liu, R (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	liur2@niehs.nih.gov	Hollenbeck, Albert/AAG-9461-2020	Park, Yikyung/0000-0002-6281-489X; Chen, Honglei/0000-0003-3446-7779	National Institute of Health; National Institute of Environmental Health Sciences [Z01-ES-101986]; National Cancer Institute [Z01 CP010196-02]; NATIONAL CANCER INSTITUTE [Z01CP010196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the intramural research program of the National Institute of Health, the National Institute of Environmental Health Sciences (Z01-ES-101986) and the National Cancer Institute (Z01 CP010196-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P207, DOI 10.1016/0376-8716(85)90001-8; Cao G, 2000, NUTR CLIN CARE, V3, P76, DOI DOI 10.1046/J.1523-5408.2000.00024.X; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Friday JE, 2006, MYPYRAMID EQUIVALENT; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Hellenbrand W, 1996, NEUROLOGY, V47, P644, DOI 10.1212/WNL.47.3.644; Hernan MA, 2003, ANN NEUROL, V54, P170, DOI 10.1002/ana.10611; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Mann Laura B, 2004, Pathophysiology, V10, P105, DOI 10.1016/j.pathophys.2003.10.011; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; Palacios N, 2012, MOVEMENT DISORD, V27, P980, DOI 10.1002/mds.25050; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307	24	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66452	10.1371/journal.pone.0066452	http://dx.doi.org/10.1371/journal.pone.0066452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840473	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200081
J	Nery, MF; Gonzalez, DJ; Opazo, JC				Nery, Mariana F.; Gonzalez, Dimar J.; Opazo, Juan C.			How to Make a Dolphin: Molecular Signature of Positive Selection in Cetacean Genome	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; GENES; ACCURACY; RESOLUTION; KIDNEYS; WHALES; CHANCE; ORIGIN; MOUSE; POWER	Cetaceans are unique in being the only mammals completely adapted to an aquatic environment. This adaptation has required complex changes and sometimes a complete restructuring of physiology, behavior and morphology. Identifying genes that have been subjected to selection pressure during cetacean evolution would greatly enhance our knowledge of the ways in which genetic variation in this mammalian order has been shaped by natural selection. Here, we performed a genome-wide scan for positive selection in the dolphin lineage. We employed models of codon substitution that account for variation of selective pressure over branches on the tree and across sites in a sequence. We analyzed 7,859 nuclear-coding ortholog genes and using a series of likelihood ratio tests (LRTs), we identified 376 genes (4.8%) with molecular signatures of positive selection in the dolphin lineage. We used the cow as the sister group and compared estimates of selection in the cetacean genome to this using the same methods. This allowed us to define which genes have been exclusively under positive selection in the dolphin lineage. The enrichment analysis found that the identified positively selected genes are significantly over-represented for three exclusive functional categories only in the dolphin lineage: segment specification, mesoderm development and system development. Of particular interest for cetacean adaptation to an aquatic life are the following GeneOntology targets under positive selection: genes related to kidney, heart, lung, eye, ear and nervous system development.	[Nery, Mariana F.; Gonzalez, Dimar J.; Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Nery, Mariana F.] Univ Austral Chile, Fac Ciencias, Programa Doctorado Ciencias Menc Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Nery, MF (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	mariananery@gmail.com; jopazo@gmail.com		Nery, Mariana/0000-0001-6501-0486; Opazo, Juan C./0000-0001-7938-4083	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 11080181]; CONICYT Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant to JCO from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 11080181). MFN was supported by a doctoral fellowship from CONICYT Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2008, ENCY MARINE MAMMALS, P562; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fordyce Ewan, 2001, P169; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; HILL DA, 1989, ACTA ANAT, V135, P53; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Kishida T, 2012, GENE, V492, P349, DOI 10.1016/j.gene.2011.11.013; Kooyman G, 2008, ENCY MARINE MAMMALS, P327; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Maluf NSR, 1998, ANAT RECORD, V250, P34; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nery MF, 2012, MOL PHYLOGENET EVOL, V64, P685, DOI 10.1016/j.ympev.2012.04.012; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Oelschlager HHA, 2008, BRAIN RES BULL, V75, P450, DOI 10.1016/j.brainresbull.2007.10.051; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shapiro JA, 2005, GENE, V345, P91, DOI 10.1016/j.gene.2004.11.020; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Suyama M, 2011, NUCLEIC ACIDS RES, V34, pW609; Tarpley RJ, 1997, ANAT RECORD, V247, P556; Thewissen J.G.M., 2009, Evolution Education and Outreach, V2, P272; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Thewissen JGM, 2001, BIOSCIENCE, V51, P1037, DOI 10.1641/0006-3568(2001)051[1037:WOAAPC]2.0.CO;2; Thewissen JGM, 1996, SENCKENBERG, V191, P1; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VARDY PH, 1981, J MORPHOL, V167, P13, DOI 10.1002/jmor.1051670103; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326	59	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65491	10.1371/journal.pone.0065491	http://dx.doi.org/10.1371/journal.pone.0065491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840335	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200021
J	Vijayaraghavan, S; Karami, A; Aeinehband, S; Behbahani, H; Grandien, A; Nilsson, B; Ekdahl, KN; Lindblom, RPF; Piehl, F; Darreh-Shori, T				Vijayaraghavan, Swetha; Karami, Azadeh; Aeinehband, Shahin; Behbahani, Homira; Grandien, Alf; Nilsson, Bo; Ekdahl, Kristina N.; Lindblom, Rickard P. F.; Piehl, Fredrik; Darreh-Shori, Taher			Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway	PLOS ONE			English	Article							BUTYRYLCHOLINESTERASE K-VARIANT; HUMAN CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E EPSILON-4; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MESSENGER-RNA; DIURNAL OSCILLATION; NONNEURONAL ACETYLCHOLINE; MONONUCLEAR LEUKOCYTES; MULTIPLE-SCLEROSIS	Acetylcholine (ACh), the classical neurotransmitter, also affects a variety of nonexcitable cells, such as endothelia, microglia, astrocytes and lymphocytes in both the nervous system and secondary lymphoid organs. Most of these cells are very distant from cholinergic synapses. The action of ACh on these distant cells is unlikely to occur through diffusion, given that ACh is very short-lived in the presence of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), two extremely efficient ACh-degrading enzymes abundantly present in extracellular fluids. In this study, we show compelling evidence for presence of a high concentration and activity of the ACh-synthesizing enzyme, choline-acetyltransferase (ChAT) in human cerebrospinal fluid (CSF) and plasma. We show that ChAT levels are physiologically balanced to the levels of its counteracting enzymes, AChE and BuChE in the human plasma and CSF. Equilibrium analyses show that soluble ChAT maintains a steady-state ACh level in the presence of physiological levels of fully active ACh-degrading enzymes. We show that ChAT is secreted by cultured human-brain astrocytes, and that activated spleen lymphocytes release ChAT itself rather than ACh. We further report differential CSF levels of ChAT in relation to Alzheimer's disease risk genotypes, as well as in patients with multiple sclerosis, a chronic neuroinflammatory disease, compared to controls. Interestingly, soluble CSF ChAT levels show strong correlation with soluble complement factor levels, supporting a role in inflammatory regulation. This study provides a plausible explanation for the long-distance action of ACh through continuous renewal of ACh in extracellular fluids by the soluble ChAT and thereby maintenance of steady-state equilibrium between hydrolysis and synthesis of this ubiquitous cholinergic signal substance in the brain and peripheral compartments. These findings may have important implications for the role of cholinergic signaling in states of inflammation in general and in neurodegenerative disease, such as Alzheimer's disease and multiple sclerosis in particular.	[Vijayaraghavan, Swetha; Karami, Azadeh; Darreh-Shori, Taher] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Behbahani, Homira] Karolinska Inst, Div Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Grandien, Alf] Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden; [Aeinehband, Shahin; Lindblom, Rickard P. F.; Piehl, Fredrik] Dept Clin Neurosci, Unit Neuroimmunol, Stockholm, Sweden; [Nilsson, Bo; Ekdahl, Kristina N.] Uppsala Univ, Dept Immunol Genet & Pathol, Div Clin Immunol, Uppsala, Sweden; [Ekdahl, Kristina N.] Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Linnaeus University	Darreh-Shori, T (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden.	Taher.Darreh-Shori@ki.se	DARREH-SHORI, TAHER/G-3931-2013; Ekdahl, Kristina Nilsson/B-5301-2012; Nilsson, Bo/B-3102-2012	Nilsson, Bo/0000-0003-0057-2730; Darreh-Shori, Taher/0000-0003-1176-6258; Lindblom, Rickard/0000-0001-7913-4981	Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations; Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; Alzheimer Foundation in Sweden; Ake Wiberg Foundation	Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations(Karolinska Institutet); Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; Alzheimer Foundation in Sweden; Ake Wiberg Foundation	This research was supported by the Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations; Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); the foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; the Alzheimer Foundation in Sweden and Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIAMAMPANDRY C, 1993, NEUROBIOL AGING, V14, P367, DOI 10.1016/0197-4580(93)90123-S; Anglade P, 2010, BIOMED RES-TOKYO, V31, P1, DOI 10.2220/biomedres.31.1; AQUILONIUS SM, 1976, J NEUROCHEM, V27, P317, DOI 10.1111/j.1471-4159.1976.tb01588.x; Behbahani H, 2010, NEUROCHEM INT, V57, P668, DOI 10.1016/j.neuint.2010.08.004; CHAO LP, 1974, J NEUROCHEM, V23, P697, DOI 10.1111/j.1471-4159.1974.tb04393.x; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Darreh-Shori T, 2006, NEUROBIOL DIS, V24, P326, DOI 10.1016/j.nbd.2006.07.013; Darreh-Shori T, 2004, J NEUROCHEM, V88, P1102, DOI 10.1046/j.1471-4159.2003.02230.x; Darreh-Shori T, 2013, NEUROBIOL A IN PRESS; Darreh-Shori T, 2009, ALZHEIMERS DEMENTIA, V5, pP225; Darreh-Shori T, 2012, J ALZHEIMERS DIS, V28, P443, DOI 10.3233/JAD-2011-111088; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, P1236, DOI 10.1016/j.neurobiolaging.2009.07.015; DEKOSKY ST, 1989, NEUROCHEM RES, V14, P191, DOI 10.1007/BF00969638; Dobransky T, 2005, J NEUROCHEM, V95, P305, DOI 10.1111/j.1471-4159.2005.03367.x; Dobransky T, 2003, J BIOL CHEM, V278, P5883, DOI 10.1074/jbc.M212080200; ECKERNAS SA, 1979, MED BIOL, V57, P36; Ferris S, 2009, PHARMACOGENET GENOM, V19, P635, DOI 10.1097/FPC.0b013e32832f8c17; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; FROISSART C, 1979, CELL MOL BIOL, V24, P199; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; Fujii T, 1995, NEUROSCI LETT, V201, P207, DOI 10.1016/0304-3940(95)12180-3; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Fujimoto K, 2001, LIFE SCI, V69, P1629, DOI 10.1016/S0024-3205(01)01237-1; GOODMAN DR, 1984, CHEM-BIOL INTERACT, V49, P39, DOI 10.1016/0009-2797(84)90051-6; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8; GROSMAN DD, 1995, J NEUROCHEM, V65, P484; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; JOHNSON S, 1971, CLIN CHIM ACTA, V35, P421, DOI 10.1016/0009-8981(71)90216-6; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Lane R, 2008, PHARMACOGENET GENOM, V18, P289, DOI 10.1097/FPC.0b013e3282f63f29; Lehman DJ, 2000, HUM GENET, V106, P447, DOI 10.1007/s004390000277; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; MADER M, 1988, J CLIN CHEM CLIN BIO, V26, P857; MASSARELLI R, 1977, NEUROSCI LETT, V5, P95, DOI 10.1016/0304-3940(77)90171-9; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MENZEL EJ, 1988, ANAL CHIM ACTA, V205, P183, DOI 10.1016/S0003-2670(00)82327-2; MESULAM MM, 1994, ANN NEUROL, V36, P722, DOI 10.1002/ana.410360506; NACHMANSOHN D, 1955, METHOD ENZYMOL, V1, P619, DOI 10.1016/0076-6879(55)01109-9; Ni L, 2007, PEDIATR RES, V61, P15, DOI 10.1203/01.pdr.0000249981.70618.18; Nunes-Tavares N, 2012, J BIOL CHEM, V287, P19377, DOI 10.1074/jbc.M111.321448; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PENG JH, 1980, NEUROCHEM RES, V5, P943, DOI 10.1007/BF00966135; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SASTRY BVR, 1981, J PHARMACOL EXP THER, V216, P378; Serobyan N, 2007, LIFE SCI, V80, P2352, DOI 10.1016/j.lfs.2007.04.017; SINGH I, 1994, NEUROBIOL AGING, V15, P643, DOI 10.1016/0197-4580(94)00059-X; SINGH VK, 1975, BRAIN RES, V96, P187, DOI 10.1016/0006-8993(75)90595-8; Tooyama I, 2000, J CHEM NEUROANAT, V17, P217, DOI 10.1016/S0891-0618(99)00043-5; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Veerhuis R, 2011, CURR ALZHEIMER RES, V8, P34, DOI 10.2174/156720511794604589; Wang Y, 2011, AM J PATHOL, V178, P1509, DOI 10.1016/j.ajpath.2011.01.006; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wiebusch H, 1999, HUM GENET, V104, P158, DOI 10.1007/s004390050929; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015	63	66	69	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65936	10.1371/journal.pone.0065936	http://dx.doi.org/10.1371/journal.pone.0065936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840379	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200042
J	Drosten, M; Lechuga, CG; Barbacid, M				Drosten, M.; Lechuga, C. G.; Barbacid, M.			Ras signaling is essential for skin development	ONCOGENE			English	Article						Ras signaling; keratinocytes; senescence; epidermis; hair follicles	HAIR FOLLICLE DEVELOPMENT; K-RAS; EGF RECEPTOR; CELL-CYCLE; EPIDERMAL HOMEOSTASIS; TYROSINE KINASE; STEM-CELLS; ADULT MICE; H-RAS; N-RAS	Proliferation in the epidermis is a tightly controlled process. During skin development, epidermis formation and hair follicle morphogenesis crucially depend on the regulated balance between proliferation and differentiation. Here we deleted all three Ras loci (H-Ras, N-Ras and K-Ras) from keratinocytes in vitro as well as specifically from the epidermis in mice using a K5Cre strain. Upon Ras elimination, keratinocytes ceased proliferation and entered into senescence without any signs of apoptosis induction. Constitutive activation of the mitogen-activated protein kinase pathway was able to partially rescue the proliferative defects. In mice, Ras signaling was essential for proper development of the epidermis and hair follicles. Deletion of the three Ras loci during epidermis formation in mouse embryos caused a dramatic decrease in proliferation, resulting in a substantially thinner epidermis and delayed appearance of differentiation markers. We could not detect apoptotic or senescent cells in these embryos suggesting that loss of Ras protein expression only leads to severe hypoproliferation. These observations provide genetic evidence for an essential role of Ras proteins in the control of keratinocyte and epidermal proliferation.	[Drosten, M.; Lechuga, C. G.; Barbacid, M.] Spanish Natl Canc Res Ctr, CNIO, Mol Oncol Programme, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Drosten, M (corresponding author), Spanish Natl Canc Res Ctr, Mol Oncol Programme, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	mdrosten@cnio.es; mbarbacid@cnio.es		Drosten, Matthias/0000-0002-3205-456X	European Research Council [ERC-AG/250297-RAS AHEAD]; Spanish Ministry of Economy and Competitiveness [SAF2011-30173]; Autonomous Community of Madrid [S2011/BDM-2470/ONCOCYCLE]; EU-Framework Programme [LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET, HEALTH-2010-260791/EUROCANPLATFORM]	European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Autonomous Community of Madrid; EU-Framework Programme	We thank the Histopatholoy and Confocal Microscopy Units at the CNIO for their help. This work was supported by grants from the European Research Council (ERC-AG/250297-RAS AHEAD), EU-Framework Programme (LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET and HEALTH-2010-260791/EUROCANPLATFORM), Spanish Ministry of Economy and Competitiveness (SAF2011-30173) and Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE) to MB.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kern F, 2011, BRIT J CANCER, V104, P229, DOI 10.1038/sj.bjc.6606009; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee J, 2012, SEMIN CELL DEV BIOL, V23, P906, DOI 10.1016/j.semcdb.2012.08.003; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Stewart S, 2000, J BIOL CHEM, V275, P8854, DOI 10.1074/jbc.275.12.8854; Tarutani M, 2003, CANCER RES, V63, P319; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; TRIGG MJ, 1972, J ZOOL, V68, P165, DOI 10.1111/j.1469-7998.1972.tb01346.x; Truong AB, 2006, GENE DEV, V20, p[63, 8723]; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	52	26	28	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2857	2865		10.1038/onc.2013.254	http://dx.doi.org/10.1038/onc.2013.254			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23831572				2022-12-25	WOS:000337231800005
J	Arning, L; Ocklenburg, S; Schulz, S; Ness, V; Gerding, WM; Hengstler, JG; Falkenstein, M; Epplen, JT; Gunturkun, O; Beste, C				Arning, Larissa; Ocklenburg, Sebastian; Schulz, Stefanie; Ness, Vanessa; Gerding, Wanda M.; Hengstler, Jan G.; Falkenstein, Michael; Epplen, Joerg T.; Guentuerkuen, Onur; Beste, Christian			PCSK6 VNTR Polymorphism Is Associated with Degree of Handedness but Not Direction of Handedness	PLOS ONE			English	Article							RELATIVE HAND SKILL; INCONSISTENT HANDEDNESS; LINKAGE ANALYSIS; LRRTM1; GENE; SCHIZOPHRENIA; HERITABILITY; EVOLUTION; MEMORY; TWINS	Although the left and right human cerebral hemispheres differ both functionally and anatomically, the mechanisms that underlie the establishment of these hemispheric specializations, as well as their physiological and behavioral implications, remain largely unknown. Since cerebral asymmetry is strongly correlated with handedness, and handedness is assumed to be influenced by a number of genetic and environmental factors, we performed an association study of LRRTM1 rs6733871 and a number of polymorphisms in PCSK6 and different aspects of handedness assessed with the Edinburgh handedness inventory in a sample of unrelated healthy adults (n = 1113). An intronic 33bp variable-number tandem repeat (VNTR) polymorphism in PCSK6 (rs10523972) shows a significant association (significance threshold: p < 0.0025, adjusted for multiple comparisons) with a handedness category comparison (P = 0.0005) and degree of handedness (P = 0.001). These results provide further evidence for the role of PCSK6 as candidate for involvement in the biological mechanisms that underlie the establishment of normal brain lateralization and thus handedness and support the assumption that the degree of handedness, instead the direction, may be the more appropriate indicator of cerebral organization.	[Arning, Larissa; Gerding, Wanda M.; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Ocklenburg, Sebastian; Schulz, Stefanie; Ness, Vanessa; Guentuerkuen, Onur; Beste, Christian] Ruhr Univ Bochum, Dept Psychol, Inst Cognit Neurosci, Bochum, Germany; [Hengstler, Jan G.; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Arning, L (corresponding author), Ruhr Univ Bochum, Dept Human Genet, Univ Str 150, Bochum, Germany.	larissa.arning@rub.de	Ocklenburg, Sebastian/O-5867-2017; Hengstler, Jan G./O-1415-2013; Falkenstein, Michael/ABA-7497-2020	Ocklenburg, Sebastian/0000-0001-5882-3200; Hengstler, Jan/0000-0002-1427-5246; Epplen, Joerg T./0000-0002-6087-3327; Gunturkun, Onur/0000-0003-4173-5233	DFG [BE4045/10-1]; Ruhr-University of Bochum	DFG(German Research Foundation (DFG)); Ruhr-University of Bochum	This work was supported by a DFG Emmy-Noether grant [BE4045/10-1 to C.B.] and a Cutting-Edge Grant from the Ruhr-University of Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Constam DB, 2000, GENE DEV, V14, P1146; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crow TJ, 2009, LATERALITY, V14, P3, DOI 10.1080/13576500802574984; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Francks C, 2003, AM J HUM GENET, V72, P499, DOI 10.1086/367548; Francks C, 2002, AM J HUM GENET, V70, P800, DOI 10.1086/339249; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Geschwind DH, 2002, P NATL ACAD SCI USA, V99, P3176, DOI 10.1073/pnas.052494999; Kempe V, 2009, PSYCHON B REV, V16, P480, DOI 10.3758/PBR.16.3.480; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Lyle KB, 2012, J EXP PSYCHOL LEARN, V38, P187, DOI 10.1037/a0024831; Lyle KB, 2011, MEMORY, V19, P613, DOI 10.1080/09658211.2011.595418; Mcmanus C, 2009, LATERALITY, V14, P1, DOI 10.1080/13576500802542577; McManus IC, 2013, ANN NEW YOR IN PRESS; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Medland SE, 2006, TWIN RES HUM GENET, V9, P46, DOI 10.1375/183242706776402885; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Scerri TS, 2011, HUM MOL GENET, V20, P608, DOI 10.1093/hmg/ddq475; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Van Agtmael T, 2002, EUR J HUM GENET, V10, P623, DOI 10.1038/sj.ejhg.5200851; Warren DM, 2006, LATERALITY, V11, P508, DOI 10.1080/13576500600761056; Zhong M, 1996, FEBS LETT, V396, P31, DOI 10.1016/0014-5793(96)01059-9	27	67	67	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67251	10.1371/journal.pone.0067251	http://dx.doi.org/10.1371/journal.pone.0067251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826248	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000049
J	Kim, H; Kim, K; Kim, DW; Jung, HD; Cheong, HM; Kim, KH; Kim, DS; Kim, YJ				Kim, Hak; Kim, Kisoon; Kim, Dae-Won; Jung, Hee-Dong; Cheong, Hyang Min; Kim, Ki Hwan; Kim, Dong Soo; Kim, You-Jin			Identification of Recombinant Human Rhinovirus A and C in Circulating Strains from Upper and Lower Respiratory Infections	PLOS ONE			English	Article							CLINICAL-FEATURES; GENETIC DIVERSITY; SPECIES C; HRV-C; CHILDREN; ILLNESS; EPIDEMIOLOGY; GENOTYPE; SEQUENCE	Human rhinoviruses (HRVs), in the Enterovirus genus within the family Picornaviridae, are a highly prevalent cause of acute respiratory infection (ARI). Enteroviruses are genetically highly variable, and recombination between serotypes is known to be a major contribution to their diversity. Recently it was reported that recombination events in HRVs cause the diversity of HRV-C. This study analyzed parts of the viral genes spanning the 5' non-coding region (NCR) through to the viral protein (VP) encoding sequences of 105 HRV field isolates from 51 outpatient cases of Acute Respiratory Infectious Network (ARINET) and 54 inpatient cases of severe lower respiratory infection (SLRI) surveillance, in order to identify recombination in field samples. When analyzing parts of the 5' NCR and VP4/VP2 encoding sequences, we found intra-and interspecies recombinants in field strains of HRV-A and -C. Nineteen cases of recombination events (18.1%) were found among 105 field strains. For HRV-A, there were five cases (4.8%) of intraspecies recombination events and three cases (2.8%) of interspecies recombination events. For HRV-C, there were four cases (3.8%) of intraspecies recombination events and seven cases (6.7%) of interspecies recombination events. Recombination events were significantly more frequently observed in the ARINET samples (18 cases) than in the SLRI samples (1 case; P< 0.0001). The recombination breakpoints were located in nucleotides (nt) 472-554, which comprise stem-loop 5 in the internal ribosomal entry site (IRES), based on the HRV-B 35 sequence (accession no. FJ445187). Our findings regarding genomic recombination in circulating HRV-A and -C strains suggest that recombination might play a role in HRV fitness and could be a possible determinant of disease severity caused by various HRV infections in patients with ARI.	[Kim, Hak; Kim, Kisoon; Jung, Hee-Dong; Cheong, Hyang Min; Kim, You-Jin] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Infect Dis, Div Resp Viruses, Chungbuk, South Korea; [Kim, Dae-Won] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Immun & Pathol, Syst Biol Team, Chungbuk, South Korea; [Kim, Ki Hwan; Kim, Dong Soo] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Yonsei University; Yonsei University Health System	Kim, YJ (corresponding author), Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Infect Dis, Div Resp Viruses, Chungbuk, South Korea.	youjin3693@gmail.com		Kim, Hak/0000-0003-2439-9354	Korea NIH [2011-N47001-00]	Korea NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported with funds from the intramural research fund of Korea NIH (2011-N47001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bochkov YA, 2012, MICROBES INFECT, V14, P485, DOI 10.1016/j.micinf.2011.12.011; BORMAN A, 1992, VIROLOGY, V188, P685, DOI 10.1016/0042-6822(92)90523-R; Chun JK, 2009, EUR J CLIN MICROBIOL, V28, P841, DOI 10.1007/s10096-009-0701-0; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; HUGHES PJ, 1988, J GEN VIROL, V69, P49, DOI 10.1099/0022-1317-69-1-49; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kafasla P, 2010, EMBO J, V29, P3710, DOI 10.1038/emboj.2010.231; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Landa-Cardena A, 2012, VIRUSES-BASEL, V4, P200, DOI 10.3390/v4020200; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Liu GHF, 2012, PHARM STAT, V11, P163, DOI 10.1002/pst.540; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MCINTYRE CL, 2013, ARCH VIROL, P43931; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mulders MN, 2000, J GEN VIROL, V81, P803, DOI 10.1099/0022-1317-81-3-803; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 1999, J MED VIROL, V58, P100, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;100::AID-JMV16&gt;3.0.CO;2-D; PELON W, 1957, P SOC EXP BIOL MED, V94, P262; Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smuts HE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-65; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	42	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68081	10.1371/journal.pone.0068081	http://dx.doi.org/10.1371/journal.pone.0068081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826363	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000117
J	Soininen, EM; Ravolainen, VT; Brathen, KA; Yoccoz, NG; Gielly, L; Ims, RA				Soininen, Eeva M.; Ravolainen, Virve T.; Brathen, Kari Anne; Yoccoz, Nigel G.; Gielly, Ludovic; Ims, Rolf A.			Arctic Small Rodents Have Diverse Diets and Flexible Food Selection	PLOS ONE			English	Article							DIFFERING GROWTH FORM; MAMMALIAN HERBIVORES; FUNCTIONAL-RESPONSE; HABITAT USE; VACCINIUM-MYRTILLUS; MICROTINE RODENTS; TUNDRA PLANTS; VOLE; COMPETITION; VEGETATION	The ecology of small rodent food selection is poorly understood, as mammalian herbivore food selection theory has mainly been developed by studying ungulates. Especially, the effect of food availability on food selection in natural habitats where a range of food items are available is unknown. We studied diets and selectivity of grey-sided voles (Myodes rufocanus) and tundra voles (Microtus oeconomus), key herbivores in European tundra ecosystems, using DNA metabarcoding, a novel method enabling taxonomically detailed diet studies. In order to cover the range of food availabilities present in the wild, we employed a large-scale study design for sampling data on food availability and vole diets. Both vole species had ingested a range of plant species and selected particularly forbs and grasses. Grey-sided voles also selected ericoid shrubs and tundra voles willows. Availability of a food item rarely affected its utilization directly, although seasonal changes of diets and selection suggest that these are positively correlated with availability. Moreover, diets and selectivity were affected by availability of alternative food items. These results show that the focal sub-arctic voles have diverse diets and flexible food preferences and rarely compensate low availability of a food item with increased searching effort. Diet diversity itself is likely to be an important trait and has previously been underrated owing to methodological constraints. We suggest that the roles of alternative food item availability and search time limitations for small rodent feeding ecology should be investigated.	[Soininen, Eeva M.; Ravolainen, Virve T.; Brathen, Kari Anne; Yoccoz, Nigel G.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Gielly, Ludovic] Univ Grenoble 1, Lab ECol Alpine, Grenoble, France	UiT The Arctic University of Tromso; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Soininen, EM (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	eeva.soininen@uit.no	Soininen, Eeva/AAJ-5909-2021; Gielly, Ludovic/ADQ-6036-2022; Bråthen, Kari Anne/AAN-4666-2020; Yoccoz, Nigel/C-8561-2014	Soininen, Eeva/0000-0003-4280-8350; Bråthen, Kari Anne/0000-0003-0942-1074; Yoccoz, Nigel/0000-0003-2192-1039	Norwegian Research Council; Oskar Huttunen Foundation; Norwegian Directorate for Nature Management	Norwegian Research Council(Research Council of NorwayEuropean Commission); Oskar Huttunen Foundation; Norwegian Directorate for Nature Management	This study was funded by Norwegian Research Council (http://www.forskningsradet.no/, project Ecosystem Finnmark), Oskar Huttunen Foundation http://www.oskhuttusensaatio.net/, PhD-scholarship for EMS) and Norwegian Directorate for Nature Management (http://http://www.dirnat.no/, support for EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; ANDERSSON M, 1986, OIKOS, V46, P93, DOI 10.2307/3565385; Bates D., 2008, LME4 LINEAR MIXED EF; BATZLI GO, 1980, ARCTIC ALPINE RES, V12, P483, DOI 10.2307/1550496; BATZLI GO, 1990, ARCTIC ALPINE RES, V22, P51, DOI 10.2307/1551720; Berg T.B., 2003, THESIS U COPENHAGEN; Bergvall UA, 2005, ECOLOGY, V86, P2450, DOI 10.1890/04-0978; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Brathen KA, 2004, J VEG SCI, V15, P653, DOI 10.1111/j.1654-1103.2004.tb02307.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Bren M, 2011, COMPOSITIONS COMPOSI; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CHAPIN FS, 1986, J ECOL, V74, P707; CHAPIN FS, 1989, FUNCT ECOL, V3, P73, DOI 10.2307/2389677; CHAPIN FS, 1980, J ECOL, V68, P189; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Dahlgren J, 2007, OECOLOGIA, V152, P525, DOI 10.1007/s00442-007-0664-8; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Ggbczynska Z., 1970, Acta theriol., V15, P33; Gilbert S, 2013, BASIC APPL ECOL, V14, P12, DOI 10.1016/j.baae.2012.11.005; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; GROSS JE, 1993, ECOLOGY, V74, P778, DOI 10.2307/1940805; Hamback PA, 2004, OIKOS, V106, P85, DOI 10.1111/j.0030-1299.2004.13029.x; Hamback PA, 1997, OIKOS, V80, P276, DOI 10.2307/3546596; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hansson L., 1978, Holarctic Ecology, V1, P16; Harju A, 1996, THESIS U JOENSUU; Henden JA, 2011, BASIC APPL ECOL, V12, P413, DOI 10.1016/j.baae.2011.05.006; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Hjalten J, 1996, OIKOS, V76, P181, DOI 10.2307/3545760; Hobbs NT, 2003, ECOLOGY, V84, P666; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; IMS RA, 1987, OIKOS, V50, P103, DOI 10.2307/3565406; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Iversen M, 2009, J VEG SCI, V20, P903, DOI 10.1111/j.1654-1103.2009.01088.x; Jensen PM, 1993, BIOL LEMMINGS, P547; Jensen SP, 1999, J THEOR BIOL, V199, P63, DOI 10.1006/jtbi.1999.0941; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; JUNG HJG, 1981, J MAMMAL, V62, P286, DOI 10.2307/1380705; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; LEE WB, 1993, J COMP PHYSIOL B, V163, P337, DOI 10.1007/BF00347785; LEE WB, 1993, FUNCT ECOL, V7, P427, DOI 10.2307/2390030; LUNDBERG P, 1988, J ANIM ECOL, V57, P999, DOI 10.2307/5107; Marell A, 2006, BASIC APPL ECOL, V7, P13, DOI 10.1016/j.baae.2005.04.005; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; MYLLYMAKI A, 1971, Annales Zoologici Fennici, V8, P177; Mysterud A, 2011, BASIC APPL ECOL, V12, P195, DOI 10.1016/j.baae.2011.03.002; Nersesian CL, 2012, BEHAV ECOL, V23, P879, DOI 10.1093/beheco/ars049; Oksanen T, 2008, EVOL ECOL RES, V10, P415; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Owl MY, 1998, FUNCT ECOL, V12, P4, DOI 10.1046/j.1365-2435.1998.00151.x; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Predavec M, 2000, CAN J ZOOL, V78, P1885, DOI 10.1139/cjz-78-11-1885; Provenza FD, 2007, CROP SCI, V47, P382, DOI 10.2135/cropsci2006.02.0083; Pusenius J, 2003, ECOSCIENCE, V10, P155, DOI 10.1080/11956860.2003.11682762; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; R Development Core Team, 2011, R LANG ENV STAT COMP; Ravolainen VT, 2010, ECOSYSTEMS, V13, P157, DOI 10.1007/s10021-009-9308-7; Ravolainen VT, 2011, BASIC APPL ECOL, V12, P643, DOI 10.1016/j.baae.2011.09.009; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Saetnan ER, 2009, J MAMMAL, V90, P183, DOI 10.1644/07-MAMM-A-259.1; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Soininen EM, 2013, OIKOS, V122, P30, DOI 10.1111/j.1600-0706.2012.20689.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; Speed JDM, 2010, J ECOL, V98, P1002, DOI 10.1111/j.1365-2745.2010.01685.x; Swihart Robert K., 2009, BMC Ecology, V9, P5, DOI 10.1186/1472-6785-9-5; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TAST J, 1974, Aquilo Ser Zoologica, V15, P25; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Langevelde F, 2008, ECOL MODEL, V213, P273, DOI 10.1016/j.ecolmodel.2007.12.009; Vare H, 2005, SUURI POHJOLAN KASVI; Vehvilainen H, 2006, ECOGRAPHY, V29, P497, DOI 10.1111/j.0906-7590.2006.04457.x; WILLIAMS LR, 1990, ECOLOGY, V71, P797, DOI 10.2307/1940331; Ylonen H, 2008, RODENT SOC ECOLOGICA, P345; Yoccoz N. G., 2004, Animal Biodiversity and Conservation, V27, P427; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zuur Alain F., 2009, P1; [No title captured]	92	39	43	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68128	10.1371/journal.pone.0068128	http://dx.doi.org/10.1371/journal.pone.0068128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826371	gold, Green Published			2022-12-25	WOS:000321150000125
J	Liu, RY; Rao, HY; Wang, JH; Xie, XW; Jiang, D; Pan, XB; Zhao, P; Zhang, HH; Wei, L				Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhao, Ping; Zhang, Henghui; Wei, Lai			Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313-327 and 432-443 of Hepatitis C Virus E1E2 Glycoproteins	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; VIRAL CLEARANCE; SINGLE-SOURCE; CELL ENTRY; INFECTION; PARTICLES; HCV; E2; ASSOCIATION; INDUCTION	It has been reported that monoclonal antibodies (MAbs) to the E1E2 glycoproteins may have the potential to prevent hepatitis C virus (HCV) infection. The protective epitopes targeted by these MAbs have been mapped to the region sencompassing amino acids 313-327 and 432-443. In this study, we synthesized these two peptides and tested the reactivity of serum samples from 336 patients, 210 of which were from Chronic Hepatitis C (CHC) patients infected with diverse HCV genotypes. The remaining 126 samples were isolated from patients who had spontaneously cleared HCV infection. In the chronic HCV-infected group (CHC group), the prevalence of human serum antibodies reactive to epitopes 313-327 and 432-443 was 24.29% (51 of 210) and 4.76% (10 of 210), respectively. In the spontaneous clearance group (SC group), the prevalence was 0.79% (1 of 126) and 12.70% (16 of 126), respectively. The positive serum samples that contained antibodies reactive to epitope 313-327 neutralized HCV pseudo particles (HCVpp) bearing the envelope glycoproteins of genotypes 1a or 1b and/or 4, but genotypes 2a, 3a, 5 and 6 were not neutralized. The neutralizing activity of these serum samples could not be inhibited by peptide 313-327. Six samples (SC17, SC38, SC86, SC92, CHC75 and CHC198) containing antibodies reactive to epitope 432-443 had cross-genotype neutralizing activities. The neutralizing activity of SC38, SC86, SC92 and CHC75 was partially inhibited by peptide 432-443. However, the neutralizing activity of sample SC17 for genotype 4HCVpp and sample CHC198 for genotype 1b HCVppwere notinhibited by the peptide. This study identifies the neutralizing ability of endogenous anti-HCV antibodies and warrants the exploration of antibodies reactive to epitope 432-443 as sources for future antibody therapies.	[Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhang, Henghui; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China; [Liu, Ruyu; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Jiang, Dong; Pan, Xiaoben; Zhang, Henghui; Wei, Lai] Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing, Peoples R China; [Zhao, Ping] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China	Peking University; Naval Medical University	Wei, L (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China.	weelai@163.com			National Science and Technology Major Project [2012ZX10002003]	National Science and Technology Major Project	The work was sponsored by National Science and Technology Major Project (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Diamond MS, 2012, PLOS PATHOG, V8; DIETZSCHOLD B, 1990, J VIROL, V64, P3804, DOI 10.1128/JVI.64.8.3804-3809.1990; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Knapp S, 2003, IMMUNOGENETICS, V55, P362, DOI 10.1007/s00251-003-0594-5; Kopp M, 2009, VIROLOGY, V84, P1666; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li Y, 2012, P NATL ACAD SCI US; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895; Ndongo N, 2010, HEPATOLOGY, V52, P1531, DOI 10.1002/hep.23862; Ndongo N, 2009, J MED VIROL, V81, P1726, DOI 10.1002/jmv.21562; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rosnoblet C, 2012, J BIOL CHEM; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMMONDS P, 1993, J CLIN MICROBIOL, V31, P1493, DOI 10.1128/JCM.31.6.1493-1503.1993; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Tarr AW, 2012, J VIROL, V86, P2739, DOI 10.1128/JVI.06492-11; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Watanabe T, 2012, GUT; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66872	10.1371/journal.pone.0066872	http://dx.doi.org/10.1371/journal.pone.0066872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826163	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400074
J	Seraphim, TV; Alves, MM; Silva, IM; Gomes, FER; Silva, KP; Murta, SMF; Barbosa, LRS; Borges, JC				Seraphim, Thiago V.; Alves, Marina M.; Silva, Indjara M.; Gomes, Francisco E. R.; Silva, Kelly P.; Murta, Silvane M. F.; Barbosa, Leandro R. S.; Borges, Julio C.			Low Resolution Structural Studies Indicate that the Activator of Hsp90 ATPase 1 (Aha1) of Leishmania braziliensis Has an Elongated Shape Which Allows Its Interaction with Both N- and M-Domains of Hsp90	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; PROTEIN SECONDARY STRUCTURE; MOLECULAR CHAPERONE HSP90; HEAT-SHOCK PROTEINS; X-RAY-SCATTERING; COCHAPERONE AHA1; CLIENT PROTEIN; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL DYNAMICS; PROTOZOAN PARASITES	The Hsp90 molecular chaperone is essential for protein homeostasis and in the maturation of proteins involved with cell-cycle control. The low ATPase activity of Hsp90 is critical to drive its functional cycle, which is dependent on the Hsp90 cochaperones. The Activator of Hsp90 ATPase-1 (Aha1) is a protein formed by two domains, N- and C-terminal, that stimulates the Hsp90 ATPase activity by several folds. Although the relevance of Aha1 for Hsp90 functions has been proved, as well as its involvement in the desensitization to inhibitors of the Hsp90, the knowledge on its overall structure and behavior in solution is limited. In this work we present the functional and structural characterization of Leishmania braziliensis Aha1 (LbAha1). This protozoan is the causative agent of cutaneous and mucocutaneous leishmaniasis, a neglected disease. The recombinant LbAha1 behaves as an elongated monomer and is organized into two folded domains interconnected by a flexible linker. Functional experiments showed that LbAha1 interacts with L. braziliensis Hsp90 (LbHsp90) with micromolar dissociation constant in a stoichiometry of 2 LbAha1 to 1 LbHsp90 dimer and stimulates 10-fold the LbHsp90 ATPase activity showing positive cooperativity. Furthermore, the LbHsp90:: LbAha1 complex is directed by enthalphy and opposed by entropy, probably due to the spatial freedom restrictions imposed by the proteins' interactions. Small-angle X-ray scattering data allowed the reconstruction of low resolution models and rigid body simulations of LbAha1, indicating its mode of action on LbHsp90. Western blot experiments allowed Aha1 identification (as well as Hsp90) in three Leishmania species at two temperatures, suggesting that Aha1 is a cognate protein. All these data shed light on the LbAha1 mechanism of action, showing that it has structural dimensions and flexibility that allow interacting with both N-terminal and middle domains of the LbHsp90.	[Seraphim, Thiago V.; Alves, Marina M.; Silva, Indjara M.; Gomes, Francisco E. R.; Silva, Kelly P.; Borges, Julio C.] Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil; [Seraphim, Thiago V.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, BR-13560 Sao Carlos, SP, Brazil; [Murta, Silvane M. F.] Ctr Pesquisa Rene Rachou, Belo Horizonte, MG, Brazil; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, Dept Fis Geral, Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Borges, JC (corresponding author), Univ Sao Paulo, Inst Quim Sao Carlos, Sao Carlos, SP, Brazil.	borgesjc@iqsc.usp.br	Borges, Julio C/C-6160-2008; Barbosa, L. R. S./AAN-7787-2020; gomes, edvan/ABF-1792-2021; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Seraphim, Thiago V/J-9949-2013; Murta, Silvane Fonseca Murta/ABE-9410-2021; Barbosa, Leandro Ramos Souza/E-6577-2012	Borges, Julio C/0000-0003-4856-748X; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Murta, Silvane Fonseca Murta/0000-0002-8523-2155; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Vargas Seraphim, Thiago/0000-0002-8682-8962	Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2007/05001-4, 2008/09025-8, 2010/19242-6, 2011/23110-0, 2012/50161-8, 2012/01953-9]; Conselho Nacional de Pesquisa e Desenvolvimento [303792/2009-4, 479229/2011-2]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/): grants #2007/05001-4; #2008/09025-8; #2010/19242-6; #2011/23110-0; #2012/50161-8; #2012/01953-9; and Conselho Nacional de Pesquisa e Desenvolvimento (http://www.cnpq.br): grants #303792/2009-4 and #479229/2011-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Borges JC, 2011, CURR MED CHEM, V18, P1276; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Petersen ALDA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049496; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Laskowski R. A., 1994, PROCHECK V 3 0 PROGR; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pullen L, 2011, J BIOL CHEM, V286, P11091, DOI 10.1074/jbc.M111.223131; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Roy N, 2012, BBA-MOL CELL RES, V1823, P707, DOI 10.1016/j.bbamcr.2011.12.003; Shonhai A, 2011, PROTEIN PEPTIDE LETT, V18, P143, DOI 10.2174/092986611794475002; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Silva KP, 2013, BBA-PROTEINS PROTEOM, V1834, P351, DOI 10.1016/j.bbapap.2012.08.004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker, 1955, SMALL ANGLE SCATTERI, P7; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2007, WORLD HEALD ORG CONT; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Zhou YL, 2005, THERMOCHIM ACTA, V426, P173, DOI 10.1016/j.tca.2004.07.018; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	48	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66822	10.1371/journal.pone.0066822	http://dx.doi.org/10.1371/journal.pone.0066822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826147	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400061
J	Leuenberger, N; Schumacher, YO; Pradervand, S; Sander, T; Saugy, M; Pottgiesser, T				Leuenberger, Nicolas; Schumacher, Yorck Olaf; Pradervand, Sylvain; Sander, Thomas; Saugy, Martial; Pottgiesser, Torben			Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion	PLOS ONE			English	Article							IRON STATUS; MARKERS; CELLS; ERYTHROPOIESIS	MicroRNAs (miRNAs) are small non-coding RNAs that regulate various biological processes. Cell-free miRNAs measured in blood plasma have emerged as specific and sensitive markers of physiological processes and disease. In this study, we investigated whether circulating miRNAs can serve as biomarkers for the detection of autologous blood transfusion, a major doping technique that is still undetectable. Plasma miRNA levels were analyzed using high-throughput quantitative real-time PCR. Plasma samples were obtained before and at several time points after autologous blood transfusion (blood bag storage time 42 days) in 10 healthy subjects and 10 controls without transfusion. Other serum markers of erythropoiesis were determined in the same samples. Our results revealed a distinct change in the pattern of circulating miRNAs. Ten miRNAs were upregulated in transfusion samples compared with control samples. Among these, miR-30b, miR-30c, and miR-26b increased significantly and showed a 3.9-, 4.0-, and 3.0-fold change, respectively. The origin of these miRNAs was related to pulmonary and liver tissues. Erythropoietin (EPO) concentration decreased after blood reinfusion. A combination of miRNAs and EPO measurement in a mathematical model enhanced the efficiency of autologous transfusion detection through miRNA analysis. Therefore, our results lay the foundation for the development of miRNAs as novel blood-based biomarkers to detect autologous transfusion.	[Leuenberger, Nicolas; Saugy, Martial] Univ Ctr Legal Med, Swiss Lab Doping Anal, Geneva, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] Univ Ctr Legal Med, Swiss Lab Doping Anal, Lausanne, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] Univ Lausanne, Lausanne, Switzerland; [Schumacher, Yorck Olaf; Sander, Thomas; Pottgiesser, Torben] Univ Hosp Freiburg, Dept Sports Med, Freiburg, Germany; [Schumacher, Yorck Olaf] Aspetar Orthoped & Sports Med Hosp, Doha, Qatar; [Pradervand, Sylvain] Univ Lausanne, Genom Technol Facil, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Freiburg; Aspetar Orthopaedic & Sports Medicine Hospital; University of Lausanne	Leuenberger, N (corresponding author), Univ Ctr Legal Med, Swiss Lab Doping Anal, Geneva, Switzerland.	Nicolas.leuenberger@chuv.ch		Pottgiesser, Torben/0000-0003-4925-8478	Exiqon grant program; "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag" [IIA1-070303/10-11]	Exiqon grant program; "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag"	The authors are grateful to the Partnership for Clean Competition and Exiqon grant program for providing funds. In addition, the hematology and clinical chemistry analyses were in part funded by a grant of the "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag" (IIA1-070303/10-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Ashenden M, 2011, VOX SANG, V101, P320, DOI 10.1111/j.1423-0410.2011.01493.x; Audran M, 1999, MED SCI SPORT EXER, V31, P639, DOI 10.1097/00005768-199905000-00003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; DellaValle DM, 2012, MED SCI SPORT EXER, V44, P1552, DOI 10.1249/MSS.0b013e3182517ceb; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Hod EA, 2011, BLOOD, V118, P6675, DOI 10.1182/blood-2011-08-371849; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwiatkowski JL, 2011, J BLOOD MED, V2, P135, DOI 10.2147/JBM.S13065; Leuenberger N, 2011, DRUG TEST ANAL, V3, P771, DOI 10.1002/dta.370; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; McClung JP, 2012, J TRACE ELEM MED BIO, V26, P124, DOI 10.1016/j.jtemb.2012.03.006; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monfort N, 2012, TRANSFUSION, V52, P647, DOI 10.1111/j.1537-2995.2011.03331.x; Mossuz P, 2005, CLIN CHEM, V51, P1018, DOI 10.1373/clinchem.2004.047365; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Pottgiesser T, 2011, TRANSFUSION, V51, P1707, DOI 10.1111/j.1537-2995.2011.03076.x; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Schumacher YO, 2012, DRUG TEST ANAL, V4, P846, DOI 10.1002/dta.406; Sottas PE, 2012, BIOANALYSIS, V4, P1645, DOI [10.4155/BIO.12.130, 10.4155/bio.12.130]; Thevis M, 2012, DRUG TEST ANAL, V4, P2, DOI 10.1002/dta.415; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vlaar APJ, 2012, TRANSFUS CLIN BIOL, V19, P117, DOI 10.1016/j.tracli.2012.03.001; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	35	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66309	10.1371/journal.pone.0066309	http://dx.doi.org/10.1371/journal.pone.0066309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840438	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800047
J	Li, QT; Lu, QJ; Lu, HY; Tian, SF; Lu, QX				Li, Qiutang; Lu, Qingjun; Lu, Huayi; Tian, Shifu; Lu, Qingxian			Systemic Autoimmunity in TAM Triple Knockout Mice Causes Inflammatory Brain Damage and Cell Death	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERCELLULAR-ADHESION MOLECULE-1; RECEPTOR TYROSINE KINASES; TYRO-3 FAMILY RECEPTORS; HUMAN ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; LUPUS-PRONE MICE; MRL-LPR MICE; BLOOD-BRAIN; MULTIPLE-SCLEROSIS	The Tyro3, Axl and Mertk (TAM) triply knockout (TKO) mice exhibit systemic autoimmune diseases, with characteristics of increased proinflammatory cytokine production, autoantibody deposition and autoreactive lymphocyte infiltration into a variety of tissues. Here we show that TKO mice produce high level of serum TNF-alpha and specific autoantibodies deposited onto brain blood vessels. The brain-blood barrier (BBB) in mutant brains exhibited increased permeability for Evans blue and fluorescent-dextran, suggesting a breakdown of the BBB in the mutant brains. Impaired BBB integrity facilitated autoreactive T cells infiltrating into all regions of the mutant brains. Brain autoimmune disorder caused accumulation of the ubiquitin-reactive aggregates in the mutant hippocampus, and early formation of autofluorescent lipofuscins in the neurons throughout the entire brains. Chronic neuroinflammation caused damage of the hippocampal mossy fibers and neuronal apoptotic death. This study shows that chronic systemic inflammation and autoimmune disorders in the TKO mice cause neuronal damage and death.	[Li, Qiutang; Lu, Huayi; Tian, Shifu; Lu, Qingxian] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA; [Lu, Qingxian] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Li, Qiutang; Lu, Qingxian] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Lu, Qingjun] Capital Med Univ, Sch Basic Med, Beijing, Peoples R China; [Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	University of Louisville; University of Louisville; University of Louisville; Capital Medical University; Capital Medical University	Lu, QX (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA.	q.lu@louisville.edu			National Institutes of Health (NIH) [R01-EY018830];  [NIH R01-EY01989]; NATIONAL EYE INSTITUTE [R01EY018830] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) grant R01-EY018830 and general support by The Research-to-Prevent-Blindness Foundation and core facility at the Department of Ophthalmology, University of Louisville. QLI was supported by grant NIH R01-EY01989. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott NJ, 2003, LUPUS, V12, P908, DOI 10.1191/0961203303lu501oa; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickstein JB, 2000, AM J PHYSIOL-REG I, V279, pR148, DOI 10.1152/ajpregu.2000.279.1.R148; Dobbie MS, 1999, BRAIN RES, V830, P330, DOI 10.1016/S0006-8993(99)01436-5; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gray Douglas A, 2003, Sci Aging Knowledge Environ, V2003, pRE6, DOI 10.1126/sageke.2003.34.re6; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; James WG, 2006, CLIN EXP IMMUNOL, V144, P299, DOI 10.1111/j.1365-2249.2006.03056.x; Jiao YQ, 2007, EXP NEUROL, V205, P569, DOI 10.1016/j.expneurol.2007.03.025; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li ZM, 2003, INT J BIOCHEM CELL B, V35, P547, DOI 10.1016/S1357-2725(02)00384-9; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Ma XX, 2006, J NEUROIMMUNOL, V179, P26, DOI 10.1016/j.jneuroim.2006.06.023; MacKenzie-Graham A, 2009, NEUROIMAGE, V48, P637, DOI 10.1016/j.neuroimage.2009.06.073; McHale JF, 1999, J IMMUNOL, V163, P3993; Melaragno MG, 2004, J MOL CELL CARDIOL, V37, P881, DOI 10.1016/j.yjmcc.2004.06.018; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Ozaki H, 1999, J IMMUNOL, V163, P553; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Radic MZ, 2006, J IMMUNOL, V176, P68, DOI 10.4049/jimmunol.176.1.68; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sakic B, 2000, J NEUROIMMUNOL, V104, P147, DOI 10.1016/S0165-5728(99)00277-5; Sakic B, 1998, J NEUROIMMUNOL, V87, P162, DOI 10.1016/S0165-5728(98)00085-X; SAKIC B, 1993, BEHAV BRAIN RES, V54, P57, DOI 10.1016/0166-4328(93)90048-U; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; SCHNIDER A, 1995, J NEUROL NEUROSUR PS, V59, P644, DOI 10.1136/jnnp.59.6.644-a; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Smith SS, 2008, NEUROSCI LETT, V442, P158, DOI 10.1016/j.neulet.2008.07.005; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Tomietto P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1461, DOI 10.1002/art.23098; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; Vaknin-Dembinsky A, 2007, J NEUROL SCI, V259, P90, DOI 10.1016/j.jns.2006.11.022; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Yang GY, 1999, MOL BRAIN RES, V69, P135, DOI 10.1016/S0169-328X(99)00007-8; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	58	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64812	10.1371/journal.pone.0064812	http://dx.doi.org/10.1371/journal.pone.0064812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840307	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800005
J	Srivastava, S; Ratha, BK				Srivastava, Shilpee; Ratha, B. K.			Unique Hepatic Cytosolic Arginase Evolved Independently in Ureogenic Freshwater Air-Breathing Teleost, Heteropneustes fossilis	PLOS ONE			English	Article							ORNITHINE-UREA CYCLE; RAT-LIVER ARGINASE; NITRIC-OXIDE; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL ARGINASE; NITROGEN-METABOLISM; MOLECULAR-FORMS; METAL-IONS; L-ARGININE; ENZYMES	Hepatic cytosolic arginase (ARG I), an enzyme of the urea cycle operating in the liver of ureotelic animals, is reported to be present in an ammoniotelic freshwater air-breathing teleost, Heteropneustes fossilis which has ureogenic potential. Antibodies available against mammalian ARG I showed no cross reactivity with the H. fossilis ARG I. We purified unique ARG I from H. fossilis liver. Purified ARG I is a homotrimer with molecular mass 75 kDa and subunit molecular mass of 24 kDa. The pI value of the enzyme was 8.5. It showed maximum activity at pH 10.5 and 55 degrees C. The Km of purified enzyme for L-arginine was 2.65+/-0.39 mM. L-ornithine and N-omega-hydroxy-L-arginine showed inhibition of the ARG I activity, with Ki values 0.52+/-0.02 mM and 0.08+/-0.006 mM, respectively. Antibody raised against the purified fish liver ARG I showed exclusive specificity, and has no cross reactivity against fish liver ARG II and mammalian liver ARG I and ARG II. We found another isoform of arginase bound to the outer membrane of the mitochondria which was released by 150-200 mM KCl in the extraction medium. This isoform was immunologically different from the soluble cytosolic and mitochondrial arginase. The results of present study support that hepatic cytosolic arginase evolved in this ureogenic freshwater teleost, H. fossilis. Phylogenetic analysis confirms an independent evolution event that occurred much after the evolution of the cytosolic arginase of ureotelic vertebrates.	[Srivastava, Shilpee; Ratha, B. K.] Banaras Hindu Univ, Dept Zool, Biochem Adaptat Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Srivastava, S (corresponding author), Assam Univ Silchar, Dept Biotechnol, Silchar, Assam, India.	shilp.vastava@gmail.com		Srivastava, Shilpee/0000-0003-0995-2916	University Grants Commission, Department of Science and Technology; Banaras Hindu University; UGC research fellowship in science for meritorious students	University Grants Commission, Department of Science and Technology; Banaras Hindu University; UGC research fellowship in science for meritorious students	The study was financially supported by the University Grants Commission, Department of Science and Technology and Banaras Hindu University. S.S. was supported by UGC research fellowship in science for meritorious students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PM, 1995, J EXP BIOL, V198, P755; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; BASCUR L, 1966, BIOCHIM BIOPHYS ACTA, V128, P149, DOI 10.1016/0926-6593(66)90151-2; BORKOVICH KA, 1987, J BIOL CHEM, V262, P7081; BROWN GW, 1959, J BIOL CHEM, V234, P1769; Cama E, 2003, BIOCHEMISTRY-US, V42, P8445, DOI 10.1021/bi034340j; CARVAJAL N, 1987, COMP BIOCHEM PHYS B, V88, P229, DOI 10.1016/0305-0491(87)90105-2; CARVAJAL N, 1995, COMP BIOCHEM PHYS B, V112, P153, DOI 10.1016/0305-0491(95)00027-6; CASEY CA, 1985, COMP BIOCHEM PHYS B, V82, P307, DOI 10.1016/0305-0491(85)90246-9; CASEY CA, 1982, J BIOL CHEM, V257, P8449; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; CHEUNG CW, 1981, ARCH BIOCHEM BIOPHYS, V209, P643, DOI 10.1016/0003-9861(81)90324-6; Colleluori DM, 2001, BIOCHEMISTRY-US, V40, P9356, DOI 10.1021/bi010783g; Custot J, 1997, J AM CHEM SOC, V119, P4086, DOI 10.1021/ja970285o; Dabir S, 2005, INT J BIOL SCI, V1, P114; DAGHIGH F, 1994, BIOCHEM BIOPH RES CO, V202, P174, DOI 10.1006/bbrc.1994.1909; Di Costanzo L, 2010, ARCH BIOCHEM BIOPHYS, V496, P101, DOI 10.1016/j.abb.2010.02.004; DKHAR J, 1991, BIOCHEM INT, V25, P1061; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitzpatrick JM, 2009, INT J PARASITOL, V39, P267, DOI 10.1016/j.ijpara.2008.06.015; FREEDLAND RA, 1984, BIOCHIM BIOPHYS ACTA, V802, P407, DOI 10.1016/0304-4165(84)90357-X; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P255, DOI 10.3109/13813459409003940; GARGANTA CL, 1986, ANAL BIOCHEM, V154, P388, DOI 10.1016/0003-2697(86)90003-5; GASIOROWSKA I, 1970, ACTA BIOCHIM POL, V17, P19; Gotoh T, 1996, FEBS LETT, V395, P119, DOI 10.1016/0014-5793(96)01015-0; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Jansen G, 2006, MOL PHYLOGENET EVOL, V38, P65, DOI 10.1016/j.ympev.2005.09.011; JANSSENS PA, 1966, SCIENCE, V152, P358, DOI 10.1126/science.152.3720.358; JENKINSON CP, 1994, BIOCHEM MED METAB B, V51, P156, DOI 10.1006/bmmb.1994.1020; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Joerink M, 2006, MOL IMMUNOL, V43, P1116, DOI 10.1016/j.molimm.2005.07.022; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kossel A, 1904, HOPPE SEYLERZ Z PHYS, P321; KUHN NJ, 1995, ARCH BIOCHEM BIOPHYS, V320, P24, DOI 10.1006/abbi.1995.1338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maarsingh H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-23; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; MORA J, 1965, BIOCHEM J, V96, P588, DOI 10.1042/bj0960588; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nissim I, 2005, J BIOL CHEM, V280, P17715, DOI 10.1074/jbc.M500607200; PACE CN, 1980, ANAL BIOCHEM, V109, P261, DOI 10.1016/0003-2697(80)90646-6; Patil NB, 1990, BIOTECHNOL TECH, V4, P133; PATTERTON D, 1994, J BIOL CHEM, V269, P25328; Perozich J, 1998, BBA-PROTEIN STRUCT M, V1382, P23, DOI 10.1016/S0167-4838(97)00131-3; POREMBSKA Z, 1984, ACTA BIOCHIM POL, V31, P223; Porembska Zofia, 1993, Acta Biochimica Polonica, V40, P465; RECZKOWSKI RS, 1994, ARCH BIOCHEM BIOPHYS, V312, P31, DOI 10.1006/abbi.1994.1276; Saha N, 2007, FISH PHYSIOL BIOCHEM, V33, P283, DOI 10.1007/s10695-007-9172-3; SAHA N, 1987, J EXP ZOOL, V241, P137, DOI 10.1002/jez.1402410117; SAHA N, 1994, COMP BIOCHEM PHYS B, V108, P315, DOI 10.1016/0305-0491(94)90083-3; Saha N, 1998, COMP BIOCHEM PHYS A, V120, P195, DOI 10.1016/S1095-6433(98)00026-9; SINGH RA, 1990, ARCH INT PHYSIOL BIO, V98, P411, DOI 10.3109/13813459009114003; SPECTOR EB, 1994, INT J DEV NEUROSCI, V12, P337, DOI 10.1016/0736-5748(94)90083-3; Srivastava S, 2013, COMP BIOCHEM PHYS B, V164, P133, DOI 10.1016/j.cbpb.2012.11.007; Steele SL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P216, DOI 10.1086/427052; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARRAB R, 1974, EUR J BIOCHEM, V49, P457, DOI 10.1111/j.1432-1033.1974.tb03850.x; Tormanen CD, 2006, J ENZYM INHIB MED CH, V21, P119, DOI 10.1080/14756360500483420; Tormanen CD, 1997, J INORG BIOCHEM, V66, P111, DOI 10.1016/S0162-0134(96)00191-2; TOURIAN A, 1975, BIOCHEMISTRY-US, V14, P4055, DOI 10.1021/bi00689a020; TURKOGLU S, 1991, INT J BIOCHEM, V23, P147, DOI 10.1016/0020-711X(91)90182-M; Turner GE, 2006, BBA-GEN SUBJECTS, V1760, P848, DOI 10.1016/j.bbagen.2006.02.012; Viator Ryan J., 2008, BMC Biochemistry, V9, P15, DOI 10.1186/1471-2091-9-15; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Withers PC, 1998, CLIN EXP PHARMACOL P, V25, P722, DOI 10.1111/j.1440-1681.1998.tb02284.x; Wright PA, 2004, J EXP BIOL, V207, P2033, DOI 10.1242/jeb.00958; ZAMECKA E, 1988, BIOCHEM MED METAB B, V39, P258, DOI 10.1016/0885-4505(88)90083-7	71	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66057	10.1371/journal.pone.0066057	http://dx.doi.org/10.1371/journal.pone.0066057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840400	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800027
J	Dalmais, M; Antelme, S; Ho-Yue-Kuang, S; Wang, Y; Darracq, O; d'Yvoire, MB; Cezard, L; Legee, F; Blondet, E; Oria, N; Troadec, C; Brunaud, V; Jouanin, L; Hofte, H; Bendahmane, A; Lapierre, C; Sibout, R				Dalmais, Marion; Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Blondet, Eddy; Oria, Nicolas; Troadec, Christelle; Brunaud, Veronique; Jouanin, Lise; Hoefte, Herman; Bendahmane, Abdelafid; Lapierre, Catherine; Sibout, Richard			A TILLING Platform for Functional Genomics in Brachypodium distachyon	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; AGROBACTERIUM-MEDIATED TRANSFORMATION; INDUCED POINT MUTATIONS; DOWN-REGULATION; ARABIDOPSIS-THALIANA; MAIZE; GENE; DISCOVERY; LIGNINS; MUTANT	The new model plant for temperate grasses, Brachypodium distachyon offers great potential as a tool for functional genomics. We have established a sodium azide-induced mutant collection and a TILLING platform, called "BRACHYTIL", for the inbred line Bd21-3. The TILLING collection consists of DNA isolated from 5530 different families. Phenotypes were reported and organized in a phenotypic tree that is freely available online. The tilling platform was validated by the isolation of mutants for seven genes belonging to multigene families of the lignin biosynthesis pathway. In particular, a large allelic series for BdCOMT6, a caffeic acid O-methyl transferase was identified. Some mutants show lower lignin content when compared to wild-type plants as well as a typical decrease of syringyl units, a hallmark of COMT-deficient plants. The mutation rate was estimated at one mutation per 396 kb, or an average of 680 mutations per line. The collection was also used to assess the Genetically Effective Cell Number that was shown to be at least equal to 4 cells in Brachypodium distachyon. The mutant population and the TILLING platform should greatly facilitate functional genomics approaches in this model organism.	[Dalmais, Marion; Blondet, Eddy; Troadec, Christelle; Brunaud, Veronique; Bendahmane, Abdelafid] Univ Evry Val dEssonne, INRA, URGV, Evry, France; [Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Oria, Nicolas; Jouanin, Lise; Hoefte, Herman; Lapierre, Catherine; Sibout, Richard] INRA, Inst Jean Pierre Bourgin, Saclay Plant Sci, F-78026 Versailles, France; [Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Oria, Nicolas; Jouanin, Lise; Hoefte, Herman; Lapierre, Catherine; Sibout, Richard] AgroParisTech, Inst Jean Pierre Bourgin, Saclay Plant Sci, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sibout, R (corresponding author), INRA, Inst Jean Pierre Bourgin, Saclay Plant Sci, F-78026 Versailles, France.	richard.sibout@versailles.inra.fr	Lapierre, Catherine/AAD-9209-2020	TROADEC, Christelle/0000-0003-1927-7352; ORCID, Stef/0000-0002-3661-2784; Dalmais, Marion/0000-0002-1673-3095; Bendahmane, Abdelhafid/0000-0003-3246-868X	European FP7 project [211982]; Agence Nationale de la Recherche (ANR) [ANR-08-KBBE-004, ANR-10-BLAN-1528]	European FP7 project; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was funded by the European FP7 project no 211982 "RENEWALL" and the Agence Nationale de la Recherche (ANR) projects ANR-08-KBBE-004 "CELLWALL" and ANR-10-BLAN-1528 "PHENOWALL". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2012, PLANT PHYSL; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bragg JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041916; BretagneSagnard B, 1996, J EXP BOT, V47, P189, DOI 10.1093/jxb/47.2.189; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen L, 2004, FUNCT PLANT BIOL, V31, P235, DOI 10.1071/FP03254; Courtial A, MAYDICA IN PRESS; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; GRAND C, 1985, PHYSIOL VEG, V23, P905; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Harrington MJ, 2012, ADV BOT RES, V61, P77, DOI 10.1016/B978-0-12-416023-1.00003-3; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Jung JH, 2011, IN VITRO CELL DEV-AN, V47, pS36; Kim Bong Gyu, 2005, Agricultural Chemistry and Biotechnology, V48, P113; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; LAPIERRE C, 1988, CR ACAD SCI III-VIE, V307, P723; LAPIERRE C, 1995, RES CHEM INTERMEDIAT, V21, P397, DOI 10.1007/BF03052266; LAPIERRE C, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P133; Lapierre C., 2010, LIGNIN LIGNANS ADV C, P11, DOI [10.1201/ebk1574444865-c2, DOI 10.1201/EBK1574444865-C2]; Lee SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-5; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Louie GV, 2010, PLANT CELL, V22, P4114, DOI 10.1105/tpc.110.077578; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Oliver AL, 2005, CROP SCI, V45, P2234, DOI 10.2135/cropsci2004.0644; Pacurar DI, 2008, TRANSGENIC RES, V17, P965, DOI 10.1007/s11248-007-9159-y; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Ralph J, 2001, 5 HYDROXYCONIFERYL A, V2001, P27; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Robert D, 2000, ABSTR PAP AM CHEM S, V219, pU270; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Slade AJ, 2005, TRANSGENIC RES, V14, P109, DOI 10.1007/s11248-005-2770-x; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Thole V, 2009, NAT PROTOC, V4, P650, DOI 10.1038/nprot.2009.32; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; VIGNOLS F, 1995, PLANT CELL, V7, P407, DOI 10.1105/tpc.7.4.407; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Weil CF, 2009, PLANT PHYSIOL, V149, P158, DOI 10.1104/pp.108.128785; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	56	48	48	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65503	10.1371/journal.pone.0065503	http://dx.doi.org/10.1371/journal.pone.0065503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840336	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200022
J	Grindon, AJ; Davison, A				Grindon, Adele J.; Davison, Angus			Irish Cepaea nemoralis Land Snails Have a Cryptic Franco-Iberian Origin That Is Most Easily Explained by the Movements of Mesolithic Humans	PLOS ONE			English	Article							GENETIC-VARIATION; SOFTWARE PACKAGE; SELECTION; MODEL; DNA; COLONIZATION; POPULATIONS; DISPERSAL; ACCURATE; IRELAND	The origins of flora and fauna that are only found in Ireland and Iberia, but which are absent from intervening countries, is one of the enduring questions of biogeography. As Southern French, Iberian and Irish populations of the land snail Cepaea nemoralis sometimes have a similar shell character, we used mitochondrial phylogenies to begin to understand if there is a shared "Lusitanian" history. Although much of Europe contains snails with A and D lineages, by far the majority of Irish individuals have a lineage, C, that in mainland Europe was only found in a restricted region of the Eastern Pyrenees. A past extinction of lineage C in the rest of Europe cannot be ruled out, but as there is a more than 8000 year continuous record of Cepaea fossils in Ireland, the species has long been a food source in the Pyrenees, and the Garonne river that flanks the Pyrenees is an ancient human route to the Atlantic, then we suggest that the unusual distribution of the C lineage is most easily explained by the movements of Mesolithic humans. If other Irish species have a similarly cryptic Lusitanian element, then this raises the possibility of a more widespread and significant pattern.	[Grindon, Adele J.; Davison, Angus] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham	Davison, A (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	angus.davison@nottingham.ac.uk	Davison, Angus/C-3156-2009	Davison, Angus/0000-0003-2554-8585	University of Nottingham, Genetics Society; Malacological Society of London; Conchological Society of Great Britain and Ireland	University of Nottingham, Genetics Society; Malacological Society of London; Conchological Society of Great Britain and Ireland	The work was supported by the University of Nottingham, Genetics Society, the Carr Scholarship the Malacological Society of London, and the Conchological Society of Great Britain and Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arias P., 2005, PYRENEAN PREHISTORY, V2, P123; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2013, J BIOGEOGR, V40, P335, DOI 10.1111/j.1365-2699.2012.02789.x; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Cook L. M., 1960, Proceedings of the Malacological Society of London, V34, P1; Cunliffe B., 2001, FACING OCEAN ATLANTI; Davison A, 2000, BIOL J LINN SOC, V70, P697, DOI 10.1006/bijl.1999.0426; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Edwards CJ, 2012, QUATERNARY SCI REV, V57, P95, DOI 10.1016/j.quascirev.2012.10.010; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Herman JS, 2011, P ROY SOC B-BIOL SCI, V278, P3601, DOI 10.1098/rspb.2011.0321; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jesse R, 2011, PLOS ONE, V6, P7; Jordan NR, 2012, CONSERV GENET, V13, P1195, DOI 10.1007/s10592-012-0365-7; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Lubell D., 2004, DOCUMENTA PRAEHISTOR, V31, P1; Mascheretti S, 2003, P ROY SOC B-BIOL SCI, V270, P1593, DOI 10.1098/rspb.2003.2406; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; McDevitt AD, 2011, HEREDITY; MOORE PD, 1987, NATURE, V328, P381, DOI 10.1038/328381a0; O'Meara DB, 2012, BIOL J LINN SOC, V106, P893, DOI 10.1111/j.1095-8312.2012.01927.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; PREECE RC, 1986, J BIOGEOGR, V13, P487, DOI 10.2307/2844814; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P4287, DOI 10.1098/rspb.2009.1422; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Speller GR, 2006, MOLLUSCAN BIOSTRAIGR; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Welter-Schultes FW, 2008, J MOLLUS STUD, V74, P79, DOI 10.1093/mollus/eym047; Wernham C., 2002, MIGRATION ATLAS MOVE; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	47	27	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65792	10.1371/journal.pone.0065792	http://dx.doi.org/10.1371/journal.pone.0065792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840368	gold, Green Submitted, Green Published			2022-12-25	WOS:000322361200035
J	Hess, BM; Xue, JF; Markillie, LM; Taylor, RC; Wiley, HS; Ahring, BK; Linggi, B				Hess, Becky M.; Xue, Junfeng; Markillie, Lye Meng; Taylor, Ronald C.; Wiley, H. Steven; Ahring, Birgitte K.; Linggi, Bryan			Coregulation of Terpenoid Pathway Genes and Prediction of Isoprene Production in Bacillus subtilis Using Transcriptomics	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOSYNTHETIC-PATHWAY; EXPRESSION; BACTERIA; LEAVES; MICROORGANISMS; IDENTIFICATION; METABOLISM; EVOLUTION; EMISSION	The isoprenoid pathway converts pyruvate to isoprene and related isoprenoid compounds in plants and some bacteria. Currently, this pathway is of great interest because of the critical role that isoprenoids play in basic cellular processes, as well as the industrial value of metabolites such as isoprene. Although the regulation of several pathway genes has been described, there is a paucity of information regarding system level regulation and control of the pathway. To address these limitations, we examined Bacillus subtilis grown under multiple conditions and determined the relationship between altered isoprene production and gene expression patterns. We found that with respect to the amount of isoprene produced, terpenoid genes fall into two distinct subsets with opposing correlations. The group whose expression levels positively correlated with isoprene production included dxs, which is responsible for the commitment step in the pathway, ispD, and two genes that participate in the mevalonate pathway, yhfS and pksG. The subset of terpenoid genes that inversely correlated with isoprene production included ispH, ispF, hepS, uppS, ispE, and dxr. A genome-wide partial least squares regression model was created to identify other genes or pathways that contribute to isoprene production. These analyses showed that a subset of 213 regulated genes was sufficient to create a predictive model of isoprene production under different conditions and showed correlations at the transcriptional level. We conclude that gene expression levels alone are sufficiently informative about the metabolic state of a cell that produces increased isoprene and can be used to build a model that accurately predicts production of this secondary metabolite across many simulated environmental conditions.	[Hess, Becky M.; Xue, Junfeng; Ahring, Birgitte K.] Washington State Univ Tricities, Bioprod Sci & Engn Lab, Richland, WA USA; [Hess, Becky M.] Pacific NW Natl Lab, Chem & Biol Signature Sci Grp, Richland, WA 99352 USA; [Markillie, Lye Meng] Pacific NW Natl Lab, Richland, WA 99352 USA; [Taylor, Ronald C.] Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA; [Wiley, H. Steven; Linggi, Bryan] Pacific NW Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA	Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Linggi, B (corresponding author), Pacific NW Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA.	Bryan.Linggi@pnnl.gov		Taylor, Ronald/0000-0001-9777-9767; Wiley, Steven/0000-0003-0232-6867	Washington State University; Washington State STAR researcher program; United States Department of Energy (DOE); United States Department of Energy [DE-AC05-76RL01830]	Washington State University; Washington State STAR researcher program; United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	Funding is provided by Washington State University and financial support from the Washington State STAR researcher program to B. A. K. Portions of this work were conducted as part of a multi-capability research campaign in the W. R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the United States Department of Energy (DOE) and is a contribution of the PNNL Foundational Scientific Focus Area. Pacific Northwest National Laboratory is a multi-program national laboratory operated by Battelle for the United States Department of Energy under contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Broun P, 2001, P NATL ACAD SCI USA, V98, P8925, DOI 10.1073/pnas.171310598; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Connolly J.D., 1991, DICT TERPENOIDS, P2156; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; HARTFORD OM, 1992, J GEN MICROBIOL, V138, P2061, DOI 10.1099/00221287-138-10-2061; Julsing MK, 2007, APPL MICROBIOL BIOT, V75, P1377, DOI 10.1007/s00253-007-0953-5; Kajiwara S, 1997, BIOCHEM J, V324, P421, DOI 10.1042/bj3240421; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karin JJ, 2012, PHYS BIOL, V9; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Krogh S, 1996, MICROBIOL-UK, V142, P2031, DOI 10.1099/13500872-142-8-2031; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUZMA J, 1995, CURR MICROBIOL, V30, P97, DOI 10.1007/BF00294190; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Loreto F, 2001, PLANT PHYSIOL, V126, P993, DOI 10.1104/pp.126.3.993; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mathews J, 2009, INT J HYDROGEN ENERG, V34, P7404, DOI 10.1016/j.ijhydene.2009.05.078; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Nguyen HD, 2007, CURR MICROBIOL, V55, P89, DOI 10.1007/s00284-006-0419-5; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nuccio ML, 1999, CURR OPIN PLANT BIOL, V2, P128, DOI 10.1016/S1369-5266(99)80026-0; Park SJ, 2005, APPL MICROBIOL BIOT, V68, P567, DOI 10.1007/s00253-005-0081-z; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shirk MC, 2002, BIOTECHNOL PROGR, V18, P1109, DOI 10.1021/bp0255412; Sivy TL, 2011, BIOSCI BIOTECH BIOCH, V75, P2376, DOI 10.1271/bbb.110572; Sivy TL, 2002, BIOCHEM BIOPH RES CO, V294, P71, DOI 10.1016/S0006-291X(02)00435-7; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Wagner WP, 2000, J NAT PROD, V63, P37, DOI 10.1021/np990286p; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033509; Yang ZRW, 2004, PROTEIN SCI, V13, P830, DOI 10.1110/ps.03330104; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513	60	24	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66104	10.1371/journal.pone.0066104	http://dx.doi.org/10.1371/journal.pone.0066104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840410	Green Submitted, gold, Green Published			2022-12-25	WOS:000322361200056
J	Mao, HY; Lu, XL; Karush, JM; Huang, XY; Yang, X; Ba, YN; Wang, Y; Liu, NS; Zhou, JQ; Lian, JF				Mao, Haiyan; Lu, Xiaoli; Karush, Justin Michael; Huang, Xiaoyan; Yang, Xi; Ba, Yanna; Wang, Ying; Liu, Ningsheng; Zhou, Jianqing; Lian, Jiangfang			Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin	PLOS ONE			English	Article							LONG-QT SYNDROME; HERG POTASSIUM CHANNEL; K+ CHANNEL; CARDIAC-ARRHYTHMIA; I-KR; MECHANISM; MUTATION; BINDING; G601S; AFTERDEPOLARIZATIONS	Background: Treatment of LQT2 is inadequate. Many drugs which can pharmacologically rescue defective protein trafficking in LQT2 also result in potent blockade of HERG current, negating their therapeutic benefit. It is reported that PD-118057 and thapsigargin can rescue LQT2 without hERG channel blockade, but the precise mechanism of action is unknown. Furthermore, the effect of PD-118057 and thapsigargin on the dominant negative E637K-hERG mutant has not been previously investigated. Objective: In this study, we investigated: (a) the effect of PD-118057 and thapsigargin on the current amplitudes of WT-hERG and WT/E637K-hERG channels; (b) the effect of PD-118057 and thapsigargin on the biophysical properties of WT-hERG and WT/E637K-hERG channels; (c) whether drug treatment can rescue channel processing and trafficking defects of the WT/E637K-hERG mutant. Methods: The whole-cell Patch-clamp technique was used to assess the effect of PD-118057 and thapsigargin on the electrophysiological characteristics of the rapidly activating delayed rectifier K+ current (I-kr) of the hERG protein channel. Western blot was done to investigate pharmacological rescue on hERG protein channel function. Results: In our study, PD-118057 was shown to significantly enhance both the maximum current amplitude and tail current amplitude, but did not alter the gating and kinetic properties of the WT-hERG channel, with the exception of accelerating steady-state inactivation. Additionally, thapsigargin shows a similar result as PD-118057 for the WT-hERG channel, but with the exception of attenuating steady-state inactivation. However, for the WT/E637K-hERG channel, PD-118057 had no effect on either the current or on the gating and kinetic properties. Furthermore, thapsigargin treatment did not alter the current or the gating and kinetic properties of the WT/E637K-hERG channel, with the exception of opening at more positive voltages. Conclusion: Our findings illustrate that neither PD-118057 nor thapsigargin play a role in correcting the dominant-negative effect of the E637K-hERG mutant.	[Mao, Haiyan; Huang, Xiaoyan; Yang, Xi; Ba, Yanna; Wang, Ying; Zhou, Jianqing; Lian, Jiangfang] Ningbo Univ, Sch Med, LiHuiLi Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Lu, Xiaoli] Peoples Hosp Anji Cty, Huzhou, Peoples R China; [Karush, Justin Michael] Mem Sloan Kettering Canc Ctr, Dept Thorac Surg, New York, NY 10021 USA; [Liu, Ningsheng] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Ningbo University; Memorial Sloan Kettering Cancer Center; Nanjing Medical University	Lian, JF (corresponding author), Ningbo Univ, Sch Med, LiHuiLi Hosp, Ningbo 315211, Zhejiang, Peoples R China.	hjmpin@163.com	lu, xl/HDO-8340-2022		Advanced Key Scientific and Technological Programs of NingBo [2011C51001]; Fund of NingBo Science and Technology Innovation team [2011B82015]; National Natural Science Foundation of China [30772155]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science [2009A02]	Advanced Key Scientific and Technological Programs of NingBo; Fund of NingBo Science and Technology Innovation team; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science	The research was supported by the grants from: Advanced Key Scientific and Technological Programs of NingBo (2011C51001), Fund of NingBo Science and Technology Innovation team (2011B82015), National Natural Science Foundation of China (30772155), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science(2009A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akimoto K, 1998, HUM MUTAT, pS184; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; ANTZELEVITCH C, 1994, J AM COLL CARDIOL, V23, P259, DOI 10.1016/0735-1097(94)90529-0; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Casis O, 2006, MOL PHARMACOL, V69, P658, DOI 10.1124/mol.105.019943; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Hayashi K, 2002, CARDIOVASC RES, V54, P67, DOI 10.1016/S0008-6363(02)00240-7; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; Huang N, 2011, CELL BIOL INT, V35, P193, DOI 10.1042/CBI20100022; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Lian JF, 2010, CAN J CARDIOL, V26, P417, DOI 10.1016/S0828-282X(10)70439-6; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Perry M, 2009, P NATL ACAD SCI USA, V106, P20075, DOI 10.1073/pnas.0906597106; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Schwartz PJ, 2001, CIRCULATION, V103, P89; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; SURAWICZ B, 1989, J AM COLL CARDIOL, V14, P172, DOI 10.1016/0735-1097(89)90069-7; Thomas D, 2003, CARDIOVASC RES, V59, P14, DOI 10.1016/S0008-6363(03)00386-9; Zhou J, 2005, MOL PHARMACOL, V68, P876, DOI 10.1124/mol.105.014035; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	41	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65481	10.1371/journal.pone.0065481	http://dx.doi.org/10.1371/journal.pone.0065481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840331	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200019
J	Vanlandingham, PA; Fore, TR; Chastain, LR; Royer, SM; Bao, H; Reist, NE; Zhang, B				Vanlandingham, Phillip A.; Fore, Taylor R.; Chastain, Lerin R.; Royer, Suzanne M.; Bao, Hong; Reist, Noreen E.; Zhang, Bing			Epsin 1 Promotes Synaptic Growth by Enhancing BMP Signal Levels in Motoneuron Nuclei	PLOS ONE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; CLATHRIN-MEDIATED ENDOCYTOSIS; FACTOR-BETA 2; TGF-BETA; C-ELEGANS; DEUBIQUITINATING ENZYME; RETROGRADE SIGNAL; AXONAL-TRANSPORT; DENDRITIC GROWTH; NERVOUS-SYSTEM	Bone morphogenetic protein (BMP) retrograde signaling is crucial for neuronal development and synaptic plasticity. However, how the BMP effector phospho-Mother against decapentaplegic (pMad) is processed following receptor activation remains poorly understood. Here we show that Drosophila Epsin1/Liquid facets (Lqf) positively regulates synaptic growth through post-endocytotic processing of pMad signaling complex. Lqf and the BMP receptor Wishful thinking (Wit) interact genetically and biochemically. lqf loss of function (LOF) reduces bouton number whereas overexpression of lqf stimulates bouton growth. Lqf-stimulated synaptic overgrowth is suppressed by genetic reduction of wit. Further, synaptic pMad fails to accumulate inside the motoneuron nuclei in lqf mutants and lqf suppresses synaptic overgrowth in spinster (spin) mutants with enhanced BMP signaling by reducing accumulation of nuclear pMad. Interestingly, lqf mutations reduce nuclear pMad levels without causing an apparent blockage of axonal transport itself. Finally, overexpression of Lqf significantly increases the number of multivesicular bodies (MVBs) in the synapse whereas lqf LOF reduces MVB formation, indicating that Lqf may function in signaling endosome recycling or maturation. Based on these observations, we propose that Lqf plays a novel endosomal role to ensure efficient retrograde transport of BMP signaling endosomes into motoneuron nuclei.	[Vanlandingham, Phillip A.; Fore, Taylor R.; Chastain, Lerin R.; Bao, Hong; Zhang, Bing] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Royer, Suzanne M.; Reist, Noreen E.] Colorado State Univ, Dept Biomed Sci, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA	University of Oklahoma System; University of Oklahoma - Norman; Colorado State University	Zhang, B (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	zhangbing@Missouri.edu		Fore, Taylor/0000-0002-8144-613X; Reist, Noreen/0000-0002-1647-3166	NIH/NINDS [RO1 NS060878]; NSF [IOS-0822236, IOS-1025556]; Direct For Biological Sciences [1126578] Funding Source: National Science Foundation	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by an NIH/NINDS grant (RO1 NS060878 to B.Z.) and in part by NSF grants (IOS-0822236 and IOS-1025556 to B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bao H, 2008, TRAFFIC, V9, P2190, DOI 10.1111/j.1600-0854.2008.00832.x; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Chin J, 2006, J NEUROPHYSIOL, V95, P3286, DOI 10.1152/jn.00770.2005; Chin J, 2002, J NEUROSCI, V22; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Csikos G, 2009, AUTOPHAGY, V5, P636, DOI 10.4161/auto.5.5.8168; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; Dent EW, 2011, ADV NEUROBIOL, V5, P97, DOI 10.1007/978-1-4419-7368-9_6; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hurd DD, 1996, GENETICS, V144, P1075; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; O'Connor-Giles KM, 2008, FLY, V2, DOI 10.4161/fly.7133; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Reist NE, 1998, J NEUROSCI, V18, P7662; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tian XL, 2004, DEVELOPMENT, V131, P5807, DOI 10.1242/dev.01459; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Von Bartheld CS, 2011, PROG NEUROBIOL, V93, P313, DOI 10.1016/j.pneurobio.2011.01.003; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; White JQ, 2012, NEURON, V75, P593, DOI 10.1016/j.neuron.2012.03.044; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wu CB, 2009, J PROTEOMICS, V72, P46, DOI 10.1016/j.jprot.2008.10.007; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65997	10.1371/journal.pone.0065997	http://dx.doi.org/10.1371/journal.pone.0065997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840387	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200046
J	Yan, R; Konarev, PV; Iannuzzi, C; Adinolfi, S; Roche, B; Kelly, G; Simon, L; Martin, SR; Py, B; Barras, F; Svergun, DI; Pastore, A				Yan, Robert; Konarev, Petr V.; Iannuzzi, Clara; Adinolfi, Salvatore; Roche, Beatrice; Kelly, Geoff; Simon, Lea; Martin, Stephen R.; Py, Beatrice; Barras, Frederic; Svergun, Dmitri I.; Pastore, Annalisa			Ferredoxin Competes with Bacterial Frataxin in Binding to the Desulfurase IscS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DESULFURASE; ELECTRON-TRANSFER; BIOLOGICAL MACROMOLECULES; ADRENODOXIN REDUCTASE; SOLUTION SCATTERING; BOVINE ADRENODOXIN; CLUSTER FORMATION; CRYSTAL-STRUCTURE; 4FE-4S CLUSTERS; 2FE-2S CLUSTER	The bacterial iron-sulfur cluster (isc) operon is an essential machine that is highly conserved from bacteria to primates and responsible for iron-sulfur cluster biogenesis. Among its components are the genes for the desulfurase IscS that provides sulfur for cluster formation, and a specialized ferredoxin (Fdx) whose role is still unknown. Preliminary evidence suggests that IscS and Fdx interact but nothing is known about the binding site and the role of the interaction. Here, we have characterized the interaction using a combination of biophysical tools and mutagenesis. By modeling the Fdx.IscS complex based on experimental restraints we show that Fdx competes for the binding site of CyaY, the bacterial ortholog of frataxin and sits in a cavity close to the enzyme active site. By in vivo mutagenesis in bacteria we prove the importance of the surface of interaction for cluster formation. Our data provide the first structural insights into the role of Fdx in cluster assembly.	[Yan, Robert; Iannuzzi, Clara; Adinolfi, Salvatore; Kelly, Geoff; Simon, Lea; Martin, Stephen R.; Pastore, Annalisa] MRC Natl Inst Med Res, London NW7 1AA, England; [Konarev, Petr V.; Svergun, Dmitri I.] DESY, EMBL, D-22603 Hamburg, Germany; [Roche, Beatrice; Py, Beatrice; Barras, Frederic] Aix Marseille Univ, F-13009 Marseille, France; [Py, Beatrice; Barras, Frederic] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, UMR 7283, F-13009 Marseille, France	MRC National Institute for Medical Research; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Pastore, A (corresponding author), MRC Natl Inst Med Res, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	Yan, Robert/GYU-0395-2022; Konarev, Petr V/W-1380-2017	Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696; ADINOLFI, Salvatore/0000-0003-1319-5516; Barras, Frederic/0000-0003-3458-2574; IANNUZZI, Clara/0000-0003-0092-5997	Medical Research Council; European Union EFACTS consortium; Medical Research Council [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887, MC_PC_13054] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union EFACTS consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Medical Research Council and the European Union EFACTS consortium.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Heinz A, 2005, BIOCHEM BIOPH RES CO, V338, P491, DOI 10.1016/j.bbrc.2005.08.077; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Muller EC, 2001, EUR J BIOCHEM, V268, P1837, DOI 10.1046/j.1432-1327.2001.02058.x; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Yang WY, 2002, J BIOL CHEM, V277, P12868, DOI 10.1074/jbc.M109485200; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	48	59	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24777	24787		10.1074/jbc.M113.480327	http://dx.doi.org/10.1074/jbc.M113.480327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23839945	Green Published, hybrid			2022-12-25	WOS:000330612300043
J	Munoz, AR; Marquez, AL; Real, R				Munoz, Antonio-Roman; Luz Marquez, Ana; Real, Raimundo			Updating Known Distribution Models for Forecasting Climate Change Impact on Endangered Species	PLOS ONE			English	Article							EAGLE HIERAAETUS-FASCIATUS; IMPORTANT BIRD AREAS; BONELLIS EAGLE; LAND-USE; POTENTIAL IMPACTS; SPRING ARRIVAL; HABITAT; CONSERVATION; POPULATION; RANGE	To plan endangered species conservation and to design adequate management programmes, it is necessary to predict their distributional response to climate change, especially under the current situation of rapid change. However, these predictions are customarily done by relating de novo the distribution of the species with climatic conditions with no regard of previously available knowledge about the factors affecting the species distribution. We propose to take advantage of known species distribution models, but proceeding to update them with the variables yielded by climatic models before projecting them to the future. To exemplify our proposal, the availability of suitable habitat across Spain for the endangered Bonelli's Eagle (Aquila fasciata) was modelled by updating a pre-existing model based on current climate and topography to a combination of different general circulation models and Special Report on Emissions Scenarios. Our results suggested that the main threat for this endangered species would not be climate change, since all forecasting models show that its distribution will be maintained and increased in mainland Spain for all the XXI century. We remark on the importance of linking conservation biology with distribution modelling by updating existing models, frequently available for endangered species, considering all the known factors conditioning the species' distribution, instead of building new models that are based on climate change variables only.	[Munoz, Antonio-Roman; Luz Marquez, Ana; Real, Raimundo] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Munoz, Antonio-Roman] Fdn Migres, Pelayo, Algeciras, Spain; [Munoz, Antonio-Roman] Univ Malaga, Fac Educ Sci, Depto Didact Matemat Ciencias Sociales & Ciencias, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga	Munoz, AR (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	roman@uma.es	Márquez, Ana Luz/K-8345-2014; MUÑOZ, Antonio Román/K-8259-2014; Real, Raimundo/E-6559-2010	Márquez, Ana Luz/0000-0001-5586-9334; MUÑOZ, Antonio Román/0000-0002-0253-7632; Real, Raimundo/0000-0002-6642-1284	Ministerio de Ciencia e Innovacion of Spain; FEDER [CGL2009-11316/BOS]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	This work was partially financed by the Ministerio de Ciencia e Innovacion of Spain and FEDER (project CGL2009-11316/BOS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; Alagador D, 2011, BIOL CONSERV, V144, P811, DOI 10.1016/j.biocon.2010.11.011; Ali S, 2001, HDB BIRDS INDIA PAKI, VI; Aragon P, 2010, GLOBAL ECOL BIOGEOGR, V19, P40, DOI 10.1111/j.1466-8238.2009.00488.x; Balbontin J, 2005, BIOL CONSERV, V126, P74, DOI 10.1016/j.biocon.2005.04.023; Balbontin J, 2003, BIOL CONSERV, V109, P417, DOI 10.1016/S0006-3207(02)00168-4; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; BirdLife International, 2004, BIRDS EUR POP EST TR; BirdLife International/EBCC, 2000, BIRDLIFE CONS SER, V10; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Brunet M, 2007, GENERACION ESCENARIO; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Calef MP, 2005, J BIOGEOGR, V32, P863, DOI 10.1111/j.1365-2699.2004.01185.x; Capel TT, 1981, CLIMAS ESPANA; Carrascal LM, 2009, ECOL RES, V24, P565, DOI 10.1007/s11284-008-0527-8; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Castro A, 2008, ARDEOLA, V55, P71; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Del Moral J.C., 2018, AGUILA PERDICERA ESP, DOI [10.31170/0066, DOI 10.31170/0066]; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elorriaga J, 2013, OSTRICH, V84, P41, DOI 10.2989/00306525.2013.772922; Elorriaga Javier, 2010, British Birds, V103, P396; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Estes LD, 2011, ANIM CONSERV, V14, P521, DOI 10.1111/j.1469-1795.2011.00457.x; European Raptors, BIOL CONS WEBS; Farfan MA, 2008, ITAL J ZOOL, V75, P161, DOI 10.1080/11250000701868717; FERNANDEZ C, 1990, Journal of Raptor Research, V24, P124; Font I., 2000, CLIMATOLOGIA ESPANA; Freeman SN, 2003, IBIS, V145, P400, DOI 10.1046/j.1474-919X.2003.00177.x; Gaston A, 2010, ECOL MODEL, V221, P2576, DOI 10.1016/j.ecolmodel.2010.07.016; Gil Sanchez Jose Ma., 1996, Ardeola, V43, P189; Gil-Sanchez JM, 2004, BIOL CONSERV, V118, P685, DOI 10.1016/j.biocon.2003.10.017; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; Hannah L, 2005, CLIMATE CHANGE BIODI, P363; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; HUSTLER K, 1988, CONDOR, V90, P583, DOI 10.2307/1368346; IPCC, 2008, CLIMATE CHANGE 2007; IPCC, 2001, ADV CLIM CHANG RES; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kuncheva LI, 2001, FUZZY SET SYST, V122, P401, DOI 10.1016/S0165-0114(99)00161-X; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leggett J, 1992, CLIMATE CHANGE 1992, P69; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lopez-Lopez P, 2007, ANIM CONSERV, V10, P208, DOI 10.1111/j.1469-1795.2006.00089.x; Lopez-Lopez P, 2006, J ORNITHOL, V147, P97, DOI 10.1007/s10336-005-0019-3; Lopez-Lopez P, 2004, ARDEOLA, V51, P275; Lopez-Lopez P, 2007, BIODIVERS CONSERV, V16, P3755, DOI 10.1007/s10531-007-9179-1; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Marquez AL, 2011, CLIMATIC CHANGE, V108, P135, DOI 10.1007/s10584-010-0010-8; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Moleon M, 2006, AGUILA PERDICERA ESP, P24; Moleon M, 2011, J RAPTOR RES, V45, P353, DOI 10.3356/JRR-11-30.1; Morillo C, 2000, BIOL CONSERV, V95, P165, DOI 10.1016/S0006-3207(00)00031-8; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Munoz AR, 2013, ACTA ORNITH IN PRESS, V48; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Niamir A, 2011, DIVERS DISTRIB, V17, P1173, DOI 10.1111/j.1472-4642.2011.00793.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry ML, 2000, ASSESSMENT POTENTIAL; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portner H.O., 2022, CLIM CHANG 2001 IMP; Ptaszyk J, 2003, J ORNITHOL, V144, P323, DOI 10.1046/j.1439-0361.2003.03011.x; Randin CF, 2009, J VEG SCI, V20, P996, DOI 10.1111/j.1654-1103.2009.01098.x; Real J, 1997, BIOL CONSERV, V79, P59, DOI 10.1016/S0006-3207(96)00100-0; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Real J., 2004, LIBRO ROJO AVES ESPA, P154; Real J., 2003, ATLAS AVES REPROD ES, P192; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Rivalan P, 2010, IBIS, V152, P6, DOI 10.1111/j.1474-919X.2009.00977.x; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; Rocamora G., 1994, BIRDLIFE CONSERV SER, P184; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Sanz JJ, 2003, GLOBAL CHANGE BIOL, V9, P461, DOI 10.1046/j.1365-2486.2003.00575.x; Serreze MC, 2010, CONSERV BIOL, V24, P10, DOI 10.1111/j.1523-1739.2009.01408.x; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomson DL, 1997, J ANIM ECOL, V66, P414, DOI 10.2307/5986; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tryjanowski P, 2005, J ORNITHOL, V146, P200, DOI 10.1007/s10336-005-0079-4; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walther GR., 2001, FINGERPRINTS CLIMATE; White C.M., 1994, NEW WORLD VULTURES G; Zalakevicius M, 2006, J ORNITHOL, V147, P326, DOI 10.1007/s10336-005-0016-6	104	15	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65462	10.1371/journal.pone.0065462	http://dx.doi.org/10.1371/journal.pone.0065462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840330	gold, Green Published, Green Submitted			2022-12-25	WOS:000321148400005
J	Wang, P; Huang, SS; Wang, F; Ren, Y; Hehir, M; Wang, X; Cai, J				Wang, Ping; Huang, Shuaishuai; Wang, Feng; Ren, Yu; Hehir, Michael; Wang, Xue; Cai, Jie			Cyclic AMP-Response Element Regulated Cell Cycle Arrests in Cancer Cells	PLOS ONE			English	Article							A GENE-EXPRESSION; BINDING-PROTEIN; BCL-2 EXPRESSION; D1 EXPRESSION; TRANSCRIPTION FACTOR; MEDIATED ACTIVATION; DOWN-REGULATION; BETA-CATENIN; CREB; TRICHOSANTHIN	Recently, we have demonstrated that trichosanthin (TCS), a promising agent for the treatment of cervical adenocarcinoma, inhibited HeLa cell proliferation through the PKC/MAPK/CREB signal pathway. Furthermore, TCS down-regulated Bcl-2 expression was abrogated by a decoy oligonucleotide (OGN) to the cyclic AMP-responsive element (CRE). The decoy OGN blocked the binding of CRE-binding protein (CREB) to Bcl-2. These results suggested that CRE-mediated gene expression may play a pivotal role in HeLa cell proliferation. However, little is known about the effect of TCS on cell cycle arrests, particularly, whether the genes involved in cell cycle were regulated by CRE. Our present study shows that the arrests of S, G1 and G2/M phases were accompanied by the significant down-regulation of cyclin A, D1 and CDK 2, 4 in HeLa cells, cyclin D1, E and CDK 2, 4 in Caski and C33a cells, and cyclin A, B1, E and CDK 2 in SW1990 cells. However, the cell cycle arrests were reversed via the significant up-regulation of cyclin A and D1, by the combined treatment of TCS and CRE. In conclusion, these data demonstrate for the first time that specific cell cycle arrests in cancer cells can be induced by TCS by inhibiting the binding of CREB to CRE on genes related to cell proliferation.	[Wang, Ping; Huang, Shuaishuai; Hehir, Michael; Wang, Xue] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Feng] Ningbo Univ, Ningbo Med Ctr, LiHuiLi Hosp, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Ren, Yu] Ningbo Univ, Ningbo Urol & Nephrol Hosp, Dept Urol Surg, Ningbo 315211, Zhejiang, Peoples R China; [Cai, Jie] Ningbo Univ, Sch Med, Ningbo Women & Childrens Hosp, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Ningbo University; Ningbo University	Wang, P (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China.	pinoav@hotmail.com; doctor_caijie@hotmail.com			National Natural Science Foundation of China [81071653]; Natural Science Foundation of Zhejiang Province [Y2111136]; Advanced Key Scientific and Technological Programs of Ningbo [2011C51005]; Natural Science Foundation of Ningbo City [2011A610050]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Advanced Key Scientific and Technological Programs of Ningbo; Natural Science Foundation of Ningbo City; K. C. Wong Magna Fund in Ningbo University	This work was supported by the grants from the National Natural Science Foundation of China (81071653), Natural Science Foundation of Zhejiang Province (Y2111136), Advanced Key Scientific and Technological Programs of Ningbo (2011C51005), Natural Science Foundation of Ningbo City (2011A610050) and K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Catalano S, 2009, J CELL PHYSIOL, V218, P490, DOI 10.1002/jcp.21622; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Freeland K, 2001, MOL BRAIN RES, V92, P98, DOI 10.1016/S0169-328X(01)00158-9; Giampuzzi M, 2005, BBA-MOL CELL RES, V1745, P370, DOI 10.1016/j.bbamcr.2005.04.012; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiang QS, 2011, MOL BIOL REP, V38, P2863, DOI 10.1007/s11033-010-0432-4; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kim MJ, 2006, J ENDOCRINOL, V188, P623, DOI 10.1677/joe.1.06480; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; MARAGANORE JM, 1987, J BIOL CHEM, V262, P11628; Moriuchi A, 2003, BIOCHEM BIOPH RES CO, V300, P415, DOI 10.1016/S0006-291X(02)02867-X; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; Park YG, 2001, BIOCHEM BIOPH RES CO, V281, P1213, DOI 10.1006/bbrc.2001.4521; Peng B, 2008, GYNECOL ONCOL, V108, P173, DOI 10.1016/j.ygyno.2007.09.016; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Saeki K, 1999, BIOCHEM J, V338, P49, DOI 10.1042/0264-6021:3380049; Schneider G, 2002, J BIOL CHEM, V277, P43599, DOI 10.1074/jbc.M204787200; Sherr CJ, 2000, CANCER RES, V60, P3689; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang P, 2007, LIFE SCI, V81, P1130, DOI 10.1016/j.lfs.2007.08.016; Wang P, 2007, BIOCHEM BIOPH RES CO, V363, P101, DOI 10.1016/j.bbrc.2007.08.141; Wang P, 2010, BIOMATERIALS, V31, P6201, DOI 10.1016/j.biomaterials.2010.04.034; Wang P, 2010, MOL BIOL REP, V37, P1891, DOI 10.1007/s11033-009-9629-9; Wang P, 2009, CELL BIOL INT, V33, P1149, DOI 10.1016/j.cellbi.2009.08.002; Wang P, 2009, CELL BIOL TOXICOL, V25, P479, DOI 10.1007/s10565-008-9102-x; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Won YJ, 2009, BIOCHEM BIOPH RES CO, V380, P655, DOI 10.1016/j.bbrc.2009.01.159; Yamazoe S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-53; Yu Z, 2007, GYNECOL ONCOL, V106, P541, DOI 10.1016/j.ygyno.2007.05.024; Zhao K, 2012, MOL BIOL REP, V39, P2607, DOI 10.1007/s11033-011-1013-x	40	17	24	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65661	10.1371/journal.pone.0065661	http://dx.doi.org/10.1371/journal.pone.0065661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840351	gold, Green Submitted, Green Published			2022-12-25	WOS:000321148400006
J	Yuan, Y; Yokoyama, M; Maeda, Y; Terasawa, H; Harada, S; Sato, H; Yusa, K				Yuan, Yuzhe; Yokoyama, Masaru; Maeda, Yosuke; Terasawa, Hiromi; Harada, Shinji; Sato, Hironori; Yusa, Keisuke			Structure and Dynamics of the gp120 V3 Loop That Confers Noncompetitive Resistance in R5 HIV-1(JR-FL) to Maraviroc	PLOS ONE			English	Article							MOLECULE CCR5 INHIBITOR; VIRUS TYPE-1 ENVELOPE; HIV-1 GP120; DETERMINANTS; VICRIVIROC; ESCAPE; ENTRY; SENSITIVITY; CORECEPTOR; INFECTION	Maraviroc, an (HIV-1) entry inhibitor, binds to CCR5 and efficiently prevents R5 human immunodeficiency virus type 1 (HIV-1) from using CCR5 as a coreceptor for entry into CD4(+) cells. However, HIV-1 can elude maraviroc by using the drug-bound form of CCR5 as a coreceptor. This property is known as noncompetitive resistance. HIV-1(V3-M5) derived from HIV-1(JR-FLan) is a noncompetitive-resistant virus that contains five mutations (I304V/F312W/T314A/E317D/I318V) in the gp120 V3 loop alone. To obtain genetic and structural insights into maraviroc resistance in HIV-1, we performed here mutagenesis and computer-assisted structural study. A series of site-directed mutagenesis experiments demonstrated that combinations of V3 mutations are required for HIV-1(JR-FLan) to replicate in the presence of 1 mu M maraviroc, and that a T199K mutation in the C2 region increases viral fitness in combination with V3 mutations. Molecular dynamic (MD) simulations of the gp120 outer domain V3 loop with or without the five mutations showed that the V3 mutations induced (i) changes in V3 configuration on the gp120 outer domain, (ii) reduction of an anti-parallel beta-sheet in the V3 stem region, (iii) reduction in fluctuations of the V3 tip and stem regions, and (iv) a shift of the fluctuation site at the V3 base region. These results suggest that the HIV-1 gp120 V3 mutations that confer maraviroc resistance alter structure and dynamics of the V3 loop on the gp120 outer domain, and enable interactions between gp120 and the drug-bound form of CCR5.	[Yuan, Yuzhe] Chinese Acad Med Sci, Transfus Transmitted Dis Ctr, Inst Blood Transfus, Chengdu, Sichuan Provinc, Peoples R China; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Maeda, Yosuke; Terasawa, Hiromi; Harada, Shinji] Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Kumamoto, Japan; [Yusa, Keisuke] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; National Institute of Infectious Diseases (NIID); Kumamoto University; National Institute of Health Sciences - Japan	Yusa, K (corresponding author), Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan.	yusak@nihs.go.jp			Ministry of Health, Labour and Welfare; Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan; National Natural Science Foundation of China [81201329]; Chinese Academy of Medical Sciences; Peking Union Medical College; Grants-in-Aid for Scientific Research [23590548] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences; Peking Union Medical College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare and by the Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan. Y.Y. was supported by National Natural Science Foundation of China (81201329), scholarship for youth from Chinese Academy of Medical Sciences and Peking Union Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2007, ANTIMICROB AGENTS CH, V51, P707, DOI 10.1128/AAC.01079-06; Berro R, 2012, VIROLOGY, V427, P158, DOI 10.1016/j.virol.2012.02.006; Case D, 2006, AMBER 9; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Fadel H, 2007, DRUG TODAY, V43, P749, DOI 10.1358/dot.2007.43.11.1131763; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Maeda Y, 2011, AIDS CLIN RES; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Marozsan AJ, 2005, VIROLOGY, V338, P182, DOI 10.1016/j.virol.2005.04.035; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Ode H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00258; Ogert RA, 2008, VIROLOGY, V373, P387, DOI 10.1016/j.virol.2007.12.009; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Westby Mike, 2010, Antiviral Chemistry & Chemotherapy, V20, P179, DOI 10.3851/IMP1507; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530; Yuan YZ, 2011, VIROLOGY, V413, P293, DOI 10.1016/j.virol.2011.02.019; Yusa K, 2005, J BIOL CHEM, V280, P30083, DOI 10.1074/jbc.M414360200	38	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65115	10.1371/journal.pone.0065115	http://dx.doi.org/10.1371/journal.pone.0065115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840315	gold, Green Submitted, Green Published			2022-12-25	WOS:000321148400003
J	Gandolfi, B; Alhaddad, H; Affolter, VK; Brockman, J; Haggstrom, J; Joslin, SEK; Koehne, AL; Mullikin, JC; Outerbridge, CA; Warren, WC; Lyons, LA				Gandolfi, Barbara; Alhaddad, Hasan; Affolter, Verena K.; Brockman, Jeffrey; Haggstrom, Jens; Joslin, Shannon E. K.; Koehne, Amanda L.; Mullikin, James C.; Outerbridge, Catherine A.; Warren, Wesley C.; Lyons, Leslie A.			To the Root of the Curl: A Signature of a Recent Selective Sweep Identifies a Mutation That Defines the Cornish Rex Cat Breed	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE HYPOTRICHOSIS; PROTEIN-COUPLED RECEPTOR; HYPOHIDROTIC ECTODERMAL DYSPLASIA; HAIR FOLLICLE DEVELOPMENT; WOOLLY HAIR; DOMESTIC CAT; COAT MUTANT; P2RY5 GENE; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID	The cat (Felis silvestris catus) shows significant variation in pelage, morphological, and behavioral phenotypes amongst its over 40 domesticated breeds. The majority of the breed specific phenotypic presentations originated through artificial selection, especially on desired novel phenotypic characteristics that arose only a few hundred years ago. Variations in coat texture and color of hair often delineate breeds amongst domestic animals. Although the genetic basis of several feline coat colors and hair lengths are characterized, less is known about the genes influencing variation in coat growth and texture, especially rexoid - curly coated types. Cornish Rex is a cat breed defined by a fixed recessive curly coat trait. Genome-wide analyses for selection (d(i), Tajima's D and nucleotide diversity) were performed in the Cornish Rex breed and in 11 phenotypically diverse breeds and two random bred populations. Approximately 63K SNPs were used in the analysis that aimed to localize the locus controlling the rexoid hair texture. A region with a strong signature of recent selective sweep was identified in the Cornish Rex breed on chromosome A1, as well as a consensus block of homozygosity that spans approximately 3 Mb. Inspection of the region for candidate genes led to the identification of the lysophosphatidic acid receptor 6 (LPAR6). A 4 bp deletion in exon 5, c.250_253_delTTTG, which induces a premature stop codon in the receptor, was identified via Sanger sequencing. The mutation is fixed in Cornish Rex, absent in all straight haired cats analyzed, and is also segregating in the German Rex breed. LPAR6 encodes a G protein-coupled receptor essential for maintaining the structural integrity of the hair shaft; and has mutations resulting in a wooly hair phenotype in humans.	[Gandolfi, Barbara; Alhaddad, Hasan; Joslin, Shannon E. K.; Lyons, Leslie A.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Affolter, Verena K.; Koehne, Amanda L.] Univ Calif Davis, Sch Vet Med, Dept Pathol, Davis, CA 95616 USA; [Brockman, Jeffrey] Hills Pet Nutr Ctr, Topeka, KS USA; [Haggstrom, Jens] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Mullikin, James C.] NHGRI, Comparat Genom Unit, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Outerbridge, Catherine A.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Warren, Wesley C.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of California System; University of California Davis; University of California System; University of California Davis; Swedish University of Agricultural Sciences; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Davis; Washington University (WUSTL)	Gandolfi, B (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	bgandolfi@ucdavis.edu		Alhaddad, Hasan/0000-0001-7904-2913; Lyons, Leslie/0000-0002-1628-7726; /0000-0001-5470-1193; Haggstrom, Jens/0000-0003-3402-023X	National Center for Research Resources; Office of Research Infrastructure Programs of the National Institute of Health [R24 RR016094]; Winn Feline Foundation [W10-14, W11-041]; Center for Companion Animal Health at University of California Davis [2010-09-F]; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation [2008-36-F]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institute of Health; Winn Feline Foundation; Center for Companion Animal Health at University of California Davis; George and Phyllis Miller Feline Health Fund of the San Francisco Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the National Center for Research Resources and the Office of Research Infrastructure Programs of the National Institute of Health through Grant Number R24 RR016094, the Winn Feline Foundation (W10-14, W11-041), the Center for Companion Animal Health at University of California Davis (2010-09-F) (http://www.vetmed.ucdavis.edu/ccah/index.cfm), and the George and Phyllis Miller Feline Health Fund of the San Francisco Foundation (2008-36-F). Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (http://www.morrisanimalfoundation.org)via a donation from Hill's Pet Food, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Bach LH, 2012, CYTOGENET GENOME RES, V137, P7, DOI 10.1159/000339416; Bal E, 2007, HUM MUTAT, V28, P703, DOI 10.1002/humu.20500; Baumer A, 2000, EUR J HUM GENET, V8, P443, DOI 10.1038/sj.ejhg.5200506; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chien AJ, 2006, J AM ACAD DERMATOL, V54, pS35, DOI 10.1016/j.jaad.2005.01.092; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Diribarne M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019281; Farooq M, 2013, HUM MUTAT; Filler S, 2012, J HERED, V103, P727, DOI 10.1093/jhered/ess039; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Harada K, 2013, INT J DERMATOL, V52, P572, DOI 10.1111/j.1365-4632.2012.05775.x; HARDEN TK, 1995, ANNU REV PHARMACOL, V35, P541, DOI 10.1146/annurev.pharmtox.35.1.541; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; Horev L, 2010, J EUR ACAD DERMATOL, V24, P858, DOI 10.1111/j.1468-3083.2009.03514.x; Ishida Y, 2006, GENOMICS, V88, P698, DOI 10.1016/j.ygeno.2006.06.006; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; JUDE AC, 1953, NATURE, V172, P81, DOI 10.1038/172081b0; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kikkawa Y, 2003, GENETICS, V165, P721; Kuramoto T, 2010, J VET MED SCI; Kurban M, 2012, J EUR ACAD DERMATOL; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2009, ARCH DERMATOL RES, V301, P621, DOI 10.1007/s00403-009-0971-5; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Petukhova L, 2008, GENOMICS, V92, P273, DOI 10.1016/j.ygeno.2008.06.009; Petukhova L, 2009, HUM HERED, V68, P117, DOI 10.1159/000212504; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; ROBINSON R, 1969, GENETICA, V40, P597, DOI 10.1007/BF01787384; ROBINSON R, 1973, J HERED, V64, P47, DOI 10.1093/oxfordjournals.jhered.a108339; ROBINSON R, 1971, GENETICA, V42, P466, DOI 10.1007/BF00122078; ROBINSON R, 1972, GENETICA, V43, P236, DOI 10.1007/BF00123630; ROBINSON R, 1968, GENETICA, V39, P351, DOI 10.1007/BF02324474; Searle A. G., 1956, Journal of Genetics, V54, P506, DOI 10.1007/BF02982964; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Shimomura Y, 2012, J DERMATOL, V39, P3, DOI 10.1111/j.1346-8138.2011.01395.x; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Shimomura Y, 2010, AM J HUM GENET, V86, P632, DOI 10.1016/j.ajhg.2010.02.025; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; Tanahashi K, 2012, J EUR ACAD DERMATOL; Tariq M, 2009, BRIT J DERMATOL, V160, P1006, DOI 10.1111/j.1365-2133.2009.09046.x; Tariq M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00730; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; van Steensel MAM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.021030; Wasif N, 2011, HUM GENET, V129, P419, DOI 10.1007/s00439-010-0938-9; Whiting PW, 1919, AM NAT, V53, P473, DOI 10.1086/279726; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Zhigachev A. I., 2000, Genetika, V36, P538	75	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67105	10.1371/journal.pone.0067105	http://dx.doi.org/10.1371/journal.pone.0067105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826204	gold, Green Submitted, Green Published			2022-12-25	WOS:000321150000027
J	Gaitan-Espitia, JD; Nespolo, RF; Opazo, JC				Diego Gaitan-Espitia, Juan; Nespolo, Roberto F.; Opazo, Juan C.			The Complete Mitochondrial Genome of the Land Snail Cornu aspersum (Helicidae: Mollusca): Intra-Specific Divergence of Protein-Coding Genes and Phylogenetic Considerations within Euthyneura	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; COMPLETE SEQUENCE; HELIX-ASPERSA; EVOLUTIONARY RELATIONSHIPS; SUBSTITUTION; GASTROPODA; DNA; ORGANIZATION; SYSTEMATICS; SELECTION	The complete sequences of three mitochondrial genomes from the land snail Cornu aspersum were determined. The mitogenome has a length of 14050 bp, and it encodes 13 protein-coding genes, 22 transfer RNA genes and two ribosomal RNA genes. It also includes nine small intergene spacers, and a large AT-rich intergenic spacer. The intra-specific divergence analysis revealed that COX1 has the lower genetic differentiation, while the most divergent genes were NADH1, NADH3 and NADH4. With the exception of Euhadra herklotsi, the structural comparisons showed the same gene order within the family Helicidae, and nearly identical gene organization to that found in order Pulmonata. Phylogenetic reconstruction recovered Basommatophora as polyphyletic group, whereas Eupulmonata and Pulmonata as paraphyletic groups. Bayesian and Maximum Likelihood analyses showed that C. aspersum is a close relative of Cepaea nemoralis, and with the other Helicidae species form a sister group of Albinaria caerulea, supporting the monophyly of the Stylommatophora clade.	[Diego Gaitan-Espitia, Juan; Nespolo, Roberto F.; Opazo, Juan C.] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Diego Gaitan-Espitia, Juan] Univ Austral Chile, Fac Ciencias, Programa Doctorado Ciencias Menc Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Opazo, JC (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	jopazo@gmail.com	Gaitan-Espitia, Juan Diego/A-9945-2012; Nespolo, Roberto/D-5601-2015; Nespolo, Roberto/D-5601-2015	Gaitan-Espitia, Juan Diego/0000-0001-8781-5736; Nespolo, Roberto/0000-0001-9337-0606; Opazo, Juan C./0000-0001-7938-4083; Nespolo, Roberto/0000-0003-0825-9618	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090423]; CONICYT Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant to RFN from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1090423). JDGE was supported by a doctoral fellowship from CONICYT Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Arnaud JF, 2003, HEREDITY, V90, P451, DOI 10.1038/sj.hdy.6800256; Artacho P, 2006, INTEGR COMP BIOL, V46, pE167; Barker G.M., 2001, P1, DOI 10.1079/9780851993188.0001; Blier PU, 2006, J EXP ZOOL PART B, V306B, P425, DOI 10.1002/jez.b.21089; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brown WM, 1985, MOL EVOLUTIONARY GEN, DOI DOI 10.1007/978-1-4684-4988-4_2; Carlini DB, 1999, B MAR SCI, V64, P57; Dayrat B, 2002, ZOOL J LINN SOC-LOND, V135, P403, DOI 10.1046/j.1096-3642.2002.00018.x; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; Gaitan-Espitia JD, 2013, EVOL ECOL RES, V15, P61; Gaitan-Espitia JD, 2013, COMP BIOCHEM PHYS A, V165, P169, DOI 10.1016/j.cbpa.2013.03.002; Dreyer H, 2004, MOL PHYLOGENET EVOL, V31, P605, DOI 10.1016/j.ympev.2003.08.007; Drummond AJ, 2010, GENEIOUS; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Grande C, 2002, MOL BIOL EVOL, V19, P1672, DOI 10.1093/oxfordjournals.molbev.a003990; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; HATZOGLOU E, 1995, GENETICS, V140, P1353; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; Klussmann-Kolb A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-57; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Madison W., 2005, MACCLADE 4 ANAL PHYL; McArthur AG, 2003, SM S COMP E, P140; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Naya DE, 2011, EVOL ECOL RES, V13, P647; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Peltanova A, 2012, BIOL INVASIONS, V14, P759, DOI 10.1007/s10530-011-0121-9; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Ray DA, 2002, J EXP ZOOL, V294, P334, DOI 10.1002/jez.10198; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roth B., 2006, CHECKLIST LAND SNAIL, V3; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Simison W. Brian, 2008, P447; Simison WB, 2006, MOL PHYLOGENET EVOL, V39, P562, DOI 10.1016/j.ympev.2005.11.006; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wade CM, 2000, J MOLLUS STUD, V66, P565, DOI 10.1093/mollus/66.4.565; Wade CM, 2006, BIOL J LINN SOC, V87, P593, DOI 10.1111/j.1095-8312.2006.00596.x; Wade CM, 2001, P ROY SOC B-BIOL SCI, V268, P413, DOI 10.1098/rspb.2000.1372; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Wirth T, 1999, MOL BIOL EVOL, V16, P1645, DOI 10.1093/oxfordjournals.molbev.a026078; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamazaki N, 1997, GENETICS, V145, P749	58	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67299	10.1371/journal.pone.0067299	http://dx.doi.org/10.1371/journal.pone.0067299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826260	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400129
J	Huys, A; Thibault, PA; Wilson, JA				Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.			Modulation of Hepatitis C Virus RNA Accumulation and Translation by DDX6 and miR-122 Are Mediated by Separate Mechanisms	PLOS ONE			English	Article							MESSENGER-RNA; P-BODY; PROCESSING BODIES; INFECTIOUS VIRUS; STRESS GRANULES; CELL-LINES; REPLICATION; MICRORNA; HELICASE; COMPONENTS	DDX6 and other P-body proteins are required for efficient replication of Hepatitis C Virus (HCV) by unknown mechanisms. DDX6 has been implicated in miRNA induced gene silencing, and since efficient HCV replication and translation relies on the cellular microRNA, miR-122, we hypothesized that DDX6 had a role in the mechanism of action of miR-122. However, by using multiple HCV translation and replication assays we have found this is not the case. DDX6 silencing decreased HCV replication and translation, but did not affect the ability of miR-122 to stimulate HCV translation or promote HCV RNA accumulation. In addition, the negative effect of DDX6 silencing on HCV replication and translation was not dependent on miR-122 association with the HCV genome. Thus, DDX6 does not have a role in the activity of miR-122, and it appears that DDX6 and miR-122 modulate HCV through distinct pathways. This effect was seen in both Huh7.5 cells and in Hep3B cells, indicating that the effects are not cell type specific. Since infections by other viruses in the Flaviviridae family, including Dengue and West Nile Virus, also disrupt P-bodies and are regulated by DDX6, we speculate that DDX6 may have a common function that support the replication of several Flaviviruses.	[Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Wilson, JA (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	joyce.wilson@usask.ca	Thibault, Patricia A./K-1570-2015	Thibault, Patricia A./0000-0002-7313-0848; Wilson, Joyce/0000-0002-5051-3088	University of Saskatchewan College of Graduate Studies; Department of Microbiology and Immunology; NSERC; National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC); University of Saskatchewan; National Science and Engineering Research Foundation [RGPIN-342475]; Saskatchewan Health Research Foundation, (RAPID)	University of Saskatchewan College of Graduate Studies; Department of Microbiology and Immunology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC)(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; National Science and Engineering Research Foundation; Saskatchewan Health Research Foundation, (RAPID)	A.H. acknowledges the University of Saskatchewan College of Graduate Studies, and the Department of Microbiology and Immunology for funding. P.A.T. would also like to acknowledge the NSERC and the National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC) for masters and doctoral scholarships. J.A.W. acknowledges funding provided by the University of Saskatchewan, National Science and Engineering Research Foundation (RGPIN-342475) and Saskatchewan Health Research Foundation, (RAPID 1927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Beckham CJ, 2007, J VIROL, V81, P9759, DOI 10.1128/JVI.00844-07; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Braun JE, 2013, ADV EXP MED BIOL, V768, P147, DOI 10.1007/978-1-4614-5107-5_9; Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, HYBRIDOMA HYBRIDOM, V22, P79, DOI 10.1089/153685903321947996; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Larsen LSZ, 2008, J VIROL, V82, P2501, DOI 10.1128/JVI.01814-07; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Mas A, 2006, J VIROL, V80, P246, DOI 10.1128/JVI.80.1.246-251.2006; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Miyaji K, 2003, J VIRAL HEPATITIS, V10, P241, DOI 10.1046/j.1365-2893.2003.00447.x; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perez-Vilaro G, 2012, J VIROL, V86, P8740, DOI 10.1128/JVI.07167-11; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Yao B, 2011, METHODS MOL BIOL, V725, P45, DOI 10.1007/978-1-61779-046-1_4; Yu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002303; Zhang C, 2012, VIROLOGY, V433, P479, DOI 10.1016/j.virol.2012.08.039	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67437	10.1371/journal.pone.0067437	http://dx.doi.org/10.1371/journal.pone.0067437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826300	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400147
J	Mikaelsson, E; Osterborg, A; Jeddi-Tehrani, M; Kokhaei, P; Ostadkarampour, M; Hadavi, R; Gholamin, M; Akhondi, M; Shokri, F; Rabbani, H; Mellstedt, H				Mikaelsson, Eva; Osterborg, Anders; Jeddi-Tehrani, Mahmood; Kokhaei, Parviz; Ostadkarampour, Mahyar; Hadavi, Reza; Gholamin, Mehran; Akhondi, Mehdi; Shokri, Fazel; Rabbani, Hodjattallah; Mellstedt, Hakan			A Proline/Arginine-Rich End Leucine-Rich Repeat Protein (PRELP) Variant Is Uniquely Expressed in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MATRIX PROTEIN; FIBROMODULIN; BINDS	Proline/arginine-rich end leucine-rich repeat protein (PRELP) belongs to the small leucine-rich proteoglycan (SLRP) family, normally expressed in extracellular matrix of collagen-rich tissues. We have previously reported on another SLRP, fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). PRELP is structurally similar to FMOD with adjacent localization on chromosome 1 (1q32.1). As cluster-upregulation of genes may occur in malignancies, the aim of our study was to analyze PRELP expression in CLL. PRELP was expressed (RT-PCR) in all CLL patients (30/30), as well as in some patients with mantle cell lymphoma (3/5), but not in healthy donor leukocytes (0/20) or tumor samples from other hematological malignancies (0/35). PRELP was also detected in CLL cell-lines (4/4) but not in cell-lines from other hematological tumors (0/9). PRELP protein was detected in all CLL samples but not in normal leukocytes. Deglycosylation experiments revealed a CLL-unique 38 kDa core protein, with an intact signal peptide. This 38 kDa protein was, in contrast to the normal 55 kDa size, not detected in serum which, in combination with the uncleaved signal peptide, suggests cellular retention. The unique expression of a 38 kDa PRELP in CLL cells may suggest involvement in the pathobiology of CLL and merits further studies.	[Mikaelsson, Eva; Osterborg, Anders; Jeddi-Tehrani, Mahmood; Kokhaei, Parviz; Mellstedt, Hakan] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Immune & Gene Therapy Lab, Stockholm, Sweden; [Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden; [Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden; [Jeddi-Tehrani, Mahmood; Ostadkarampour, Mahyar; Hadavi, Reza; Shokri, Fazel; Rabbani, Hodjattallah] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran; [Kokhaei, Parviz] Semnan Univ Med Sci, Dept Immunol, Semnan, Iran; [Gholamin, Mehran] Mashhad Univ Med Sci, Sch Med, Human Genet Lab, Immunol Res Ctr, Mashhad, Iran; [Akhondi, Mehdi] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Shokri, Fazel] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Academic Center for Education, Culture & Research (ACECR); Semnan University of Medical Sciences; Mashhad University Medical Science; Academic Center for Education, Culture & Research (ACECR); Tehran University of Medical Sciences	Mikaelsson, E (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Immune & Gene Therapy Lab, Stockholm, Sweden.	eva.mikaelsson@ki.se	Jeddi-Tehrani, Mahmood/HDM-1013-2022; kokhaei, parviz/I-5326-2017; gholamin, mehran/O-2519-2018	gholamin, mehran/0000-0002-0123-5755; Asgari, Mohammad Reza/0000-0003-0263-7614; Kokhaei, Parviz/0000-0001-6544-4209; Akhondi, Mohammad mehdi/0000-0003-1707-3874; Jeddi-Tehrani, Mahmood/0000-0002-8831-4711	Swedish Cancer Society; Stockholm County Council; Torsten and Ragnar Soderberg Foundation; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Cancer and Allergy Foundation; Swedish Research Council/SIDA/SAREC; Felix Mindus Research Foundation; EU-grant [EUCAAD-200755]; Iranian Ministry of Health and Medical Education; Karolinska Institute Foundations	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Torsten and Ragnar Soderberg Foundation; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Cancer and Allergy Foundation; Swedish Research Council/SIDA/SAREC; Felix Mindus Research Foundation; EU-grant; Iranian Ministry of Health and Medical Education; Karolinska Institute Foundations(Karolinska Institutet)	The study was supported by grants from the Swedish Cancer Society, the Stockholm County Council, the Torsten and Ragnar Soderberg Foundation, the Cancer Society in Stockholm, the King Gustaf V Jubilee Fund, the Cancer and Allergy Foundation, the Swedish Research Council/SIDA/SAREC, Felix Mindus Research Foundation, EU-grant (EUCAAD-200755) the Iranian Ministry of Health and Medical Education, the Cancer and Allergy Foundation, and the Karolinska Institute Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Harris N. L., 2000, Histopathology (Oxford), V36, P69; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lu YP, 2002, PATHOL INT, V52, P519, DOI 10.1046/j.1440-1827.2002.01384.x; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Rufo A, 2008, BONE, V42, pS39, DOI 10.1016/j.bone.2007.12.062; SZTROLOVICS R, 1994, GENOMICS, V23, P715, DOI 10.1006/geno.1994.1567; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476	18	9	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67601	10.1371/journal.pone.0067601	http://dx.doi.org/10.1371/journal.pone.0067601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826326	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400162
J	Steigen, A; Nylund, A; Karlsbakk, E; Akoll, P; Fiksdal, IU; Nylund, S; Odong, R; Plarre, H; Semyalo, R; Skar, C; Watanabe, K				Steigen, Andreas; Nylund, Are; Karlsbakk, Egil; Akoll, Peter; Fiksdal, Ingrid U.; Nylund, Stian; Odong, Robinson; Plarre, Heidrun; Semyalo, Ronald; Skar, Cecilie; Watanabe, Kuninori			'Cand. Actinochlamydia clariae' gen. nov., sp. nov., a Unique Intracellular Bacterium Causing Epitheliocystis in Catfish (Clarias gariepinus) in Uganda	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CANDIDATUS-CLAVOCHLAMYDIA-SALMONICOLA; CHLAMYDIA-PSITTACI; ATLANTIC SALMON; PROTOCHLAMYDIA-AMOEBOPHILA; PISCICHLAMYDIA SALMONIS; ACANTHAMOEBA-POLYPHAGA; SURFACE PROJECTIONS; ORDER CHLAMYDIALES; CELL	Background and Objectives: Epitheliocystis, caused by bacteria infecting gill epithelial cells in fish, is common among a large range of fish species in both fresh-and seawater. The aquaculture industry considers epitheliocystis an important problem. It affects the welfare of the fish and the resulting gill disease may lead to mortalities. In a culture facility in Kampala, Uganda, juveniles of the African sharptooth catfish (Clarias gariepinus) was observed swimming in the surface, sometimes belly up, showing signs of respiratory problems. Histological examination of gill tissues from this fish revealed large amounts of epitheliocysts, and also presence of a few Ichthyobodo sp. and Trichodina sp. Methods and Results: Sequencing of the epitheliocystis bacterium 16S rRNA gene shows 86.3% similarity with Candidatus Piscichlamydia salmonis causing epitheliocystis in Atlantic salmon (Salmo salar). Transmission electron microscopy showed that the morphology of the developmental stages of the bacterium is similar to that of members of the family Chlamydiaceae. The similarity of the bacterium rRNA gene sequences compared with other chlamydia-like bacteria ranged between 80.5% and 86.3%. Inclusions containing this new bacterium have tubules/channels (termed actinae) that are radiating from the inclusion membrane and opening on the cell surface or in neighbouring cells. Conclusions: Radiation of tubules/channels (actinae) from the inclusion membrane has never been described in any of the other members of Chlamydiales. It seems to be a completely new character and an apomorphy. We propose the name Candidatus Actinochlamydia clariae gen. nov., sp. nov. (Actinochlamydiaceae fam. nov., order Chlamydiales, phylum Chlamydiae) for this new agent causing epitheliocystis in African sharptooth catfish.	[Steigen, Andreas; Nylund, Are; Nylund, Stian; Plarre, Heidrun; Watanabe, Kuninori] Univ Bergen, Dept Biol, Bergen, Norway; [Karlsbakk, Egil; Fiksdal, Ingrid U.; Skar, Cecilie] Inst Marine Res, N-5024 Bergen, Norway; [Akoll, Peter; Odong, Robinson] Makerere Univ, Dept Zool, Kampala, Uganda; [Semyalo, Ronald] Kampala Univ, Dept Biol, Kampala, Uganda	University of Bergen; Institute of Marine Research - Norway; Makerere University	Steigen, A (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	andreas.steigen@bio.uib.no	Akoll, Peter/AAW-9968-2021; Odong, Robinson/AAX-4173-2020		University of Bergen, Bergen, Norway	University of Bergen, Bergen, Norway	The study has been funded by the University of Bergen, Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADLEY TM, 1988, DIS AQUAT ORGAN, V4, P9, DOI 10.3354/dao004009; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; Corsaro D, 2010, EUR J PROTISTOL, V46, P86, DOI 10.1016/j.ejop.2009.11.002; Crespo S, 1999, DIS AQUAT ORGAN, V37, P61, DOI 10.3354/dao037061; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Draghi A, 2007, DIS AQUAT ORGAN, V76, P27, DOI 10.3354/dao076027; Draghi A, 2010, DIS AQUAT ORGAN, V89, P39, DOI 10.3354/dao02171; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Garritya G. M., 2001, BERGEYS MANUAL SYSTE, P119, DOI DOI 10.1002/9781118960608.BM00031; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Groff JM, 1996, J VET DIAGN INVEST, V8, P172, DOI 10.1177/104063879600800206; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; HODINKA RL, 1986, INFECT IMMUN, V54, P855, DOI 10.1128/IAI.54.3.855-863.1986; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Horn M, 2000, MICROBIOL-SGM, V146, P1231, DOI 10.1099/00221287-146-5-1231; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Isaksen TE, 2012, PARASITOL INT, V61, P675, DOI 10.1016/j.parint.2012.07.006; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Kahane S, 2001, APPL ENVIRON MICROB, V67, P4789, DOI 10.1128/AEM.67.10.4789-4795.2001; Karlsen M, 2008, ENVIRON MICROBIOL, V10, P208, DOI 10.1111/j.1462-2920.2007.01445.x; Kostanjsek R, 2004, INT J SYST EVOL MICR, V54, P543, DOI 10.1099/ijs.0.02802-0; KUO CC, 1988, INFECT IMMUN, V56, P1668, DOI 10.1128/IAI.56.6.1668-1672.1988; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; MATSUMOTO A, 1973, J BACTERIOL, V116, P1355, DOI 10.1128/JB.116.3.1355-1363.1973; MATSUMOTO A, 1982, J BACTERIOL, V151, P1040, DOI 10.1128/JB.151.2.1040-1042.1982; MATSUMOTO A, 1976, J ELECTRON MICROSC, V25, P169; Meijer A, 2006, APPL ENVIRON MICROB, V72, P284, DOI 10.1128/AEM.72.1.284-290.2006; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; MOULDER JW, 1964, PSITTACOSIS GROUP BA; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Nylund A, 1998, J AQUAT ANIM HEALTH, V10, P43, DOI 10.1577/1548-8667(1998)010&lt;0043:AMSOTE&gt;2.0.CO;2; Nylund A, 2008, ARCH VIROL, V153, P1299, DOI 10.1007/s00705-008-0117-7; Nylund S, CHARACTERIZATI UNPUB; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; PLEHN M, 1920, ZBL BAKT PARASITE 1, V85, P275; Polkinghorne A, 2010, DIS AQUAT ORGAN, V91, P75, DOI 10.3354/dao02255; Repstad O, 2011, THESIS U BERGEN, P86; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Schmidt-Posthaus H, 2012, ENVIRON MICROBIOL, V14, P2048, DOI 10.1111/j.1462-2920.2011.02670.x; STORZ J, 1971, International Journal of Systematic Bacteriology, V21, P332; Stride MC, 2013, APPL ENVIRON MICROB, V79, P1590, DOI 10.1128/AEM.02899-12; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; Suchland RJ, 2005, INFECT IMMUN, V73, P3954, DOI 10.1128/IAI.73.7.3954-3962.2005; SWANSON AF, 1994, INFECT IMMUN, V62, P24, DOI 10.1128/IAI.62.1.24-28.1994; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Vilinn Tolas I, 2012, DIS AQUAT ORGAN, P72	52	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66840	10.1371/journal.pone.0066840	http://dx.doi.org/10.1371/journal.pone.0066840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826156	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400067
J	Wang, XJ; Misawa, R; Zielinski, MC; Cowen, P; Jo, JH; Periwal, V; Ricordi, C; Khan, A; Szust, J; Shen, JH; Millis, M; Witkowski, P; Hara, M				Wang, Xiaojun; Misawa, Ryosuke; Zielinski, Mark C.; Cowen, Peter; Jo, Junghyo; Periwal, Vipul; Ricordi, Camillo; Khan, Aisha; Szust, Joel; Shen, Junhui; Millis, Michael; Witkowski, Piotr; Hara, Manami			Regional Differences in Islet Distribution in the Human Pancreas - Preferential Beta-Cell Loss in the Head Region in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RAT; MASS; QUANTIFICATION; ARCHITECTURE; POLYPEPTIDE; INSULIN; CANCER; SECRETION; GLUCAGON; SURVIVAL	While regional heterogeneity in islet distribution has been well studied in rodents, less is known about human pancreatic histology. To fill gaps in our understanding, regional differences in the adult human pancreas were quantitatively analyzed including the pathogenesis of type 2 diabetes (T2D). Cadaveric pancreas specimens were collected from the head, body and tail regions of each donor, including subjects with no history of diabetes or pancreatic diseases (n = 23) as well as patients with T2D (n = 12). The study further included individuals from whom islets were isolated (n = 7) to study islet yield and function in a clinical setting of islet transplantation. The whole pancreatic sections were examined using an innovative large-scale image capture and unbiased detailed quantitative analyses of the characteristics of islets from each individual (architecture, size, shape and distribution). Islet distribution/density is similar between the head and body regions, but is >2-fold higher in the tail region. In contrast to rodents, islet cellular composition and architecture were similar throughout the pancreas and there was no difference in glucose-stimulated insulin secretion in islets isolated from different regions of the pancreas. Further studies revealed preferential loss of large islets in the head region in patients with T2D. The present study has demonstrated distinct characteristics of the human pancreas, which should provide a baseline for the future studies integrating existing research in the field and helping to advance bi-directional research between humans and preclinical models.	[Wang, Xiaojun; Misawa, Ryosuke; Millis, Michael; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Wang, Xiaojun] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China; [Zielinski, Mark C.; Cowen, Peter; Shen, Junhui; Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Jo, Junghyo; Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Ricordi, Camillo; Khan, Aisha; Szust, Joel] Univ Miami, Cell Transplant Ctr, Miami, FL USA	University of Chicago; Army Medical University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Miami	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu	Hara, Masayuki/AAH-4361-2019; RICORDI, CAMILLO/AAA-4740-2019; Jo, Junghyo/D-4889-2011	Ricordi, Camillo/0000-0001-8092-7153; Zielinski, Mark/0000-0002-6950-6689	US Public Health Service Grant [DK-020595, DK-072473, AG-042151]; intramural research program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, ZIADK075038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); intramural research program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study is supported by US Public Health Service Grant DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (to MH); and the intramural research program of the NIH, NIDDK (to JJ and VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Bouvier AM, 2010, PANCREAS, V39, P1243, DOI 10.1097/MPA.0b013e3181e1d5b3; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chandra J, 2012, CLIN RADIOL     0703, V3; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; ELAYAT AA, 1995, J ANAT, V186, P629; GERSELL DJ, 1979, DIABETES, V28, P11, DOI 10.2337/diabetes.28.1.11; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hornblad A, 2011, ISLETS, V3, P204, DOI 10.4161/isl.3.4.16417; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Kilimnik G, 2012, ISLETS, V4, P167, DOI 10.4161/isl.19256; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2011, JOVE-J VIS EXP, DOI 10.3791/2471; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; LECLERCQMEYER V, 1985, HORM RES, V21, P19, DOI 10.1159/000180021; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; ORCI L, 1978, LANCET, V2, P1200; R Development Core Team, 2011, R LANG ENV STAT COMP; RAHIER J, 1983, J CLIN ENDOCR METAB, V56, P441, DOI 10.1210/jcem-56-3-441; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Sata N, 2009, J HEPATO-BILIARY-PAN, V16, P485, DOI 10.1007/s00534-009-0077-7; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; TASAKA Y, 1989, TOHOKU J EXP MED, V159, P123, DOI 10.1620/tjem.159.123; TRIMBLE ER, 1981, AM J PHYSIOL, V240, pE422, DOI 10.1152/ajpendo.1981.240.4.E422; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055501; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Yukawa M, 1999, ANAT HISTOL EMBRYOL, V28, P13, DOI 10.1046/j.1439-0264.1999.00148.x	41	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67454	10.1371/journal.pone.0067454	http://dx.doi.org/10.1371/journal.pone.0067454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826303	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400149
J	Li, H; Li, N; Xu, Q; Xiao, CL; Wang, HC; Guo, Z; Zhang, J; Sun, XS; He, QY				Li, Hui; Li, Nan; Xu, Qian; Xiao, Chuanle; Wang, Hongcui; Guo, Zhong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu			Lipoprotein FtsB in Streptococcus pyogenes Binds Ferrichrome in Two Steps with Residues Tyr137 and Trp204 as Critical Ligands	PLOS ONE			English	Article							IRON TRANSPORT; PROTEIN FHUD; SIDEROPHORE; MANGANESE; MTSABC	Lipoprotein FtsB is a component of the FtsABCD transporter that is responsible for ferrichrome binding and uptake in the Gram-positive pathogen Streptococcus pyogenes. In the present study, FtsB was cloned and purified from the bacteria and its Fch binding characteristics were investigated in detail by using various biophysical and biochemical methods. Based on the crystal structures of homogeneous proteins, FtsB was simulated to have bi-lobal structure forming a deep cleft with four residues in the cleft as potential ligands for Fch binding. With the assistance of site-directed mutagenesis, residue Trp204 was confirmed as a key ligand and Tyr137 was identified to be another essential residue for Fch binding. Kinetics experiments demonstrated that Fch binding in FtsB occurred in two steps, corresponding to the bindings to Tyr137 at N-lobe and Trp204 from C-lobe, respectively, and so that closing the protein conformation. Without either residue Tyr137 or Trp204, Fch binding in the protein as mutants Fch-Y137A and Fch-W204A may have a loose conformation, resembling the apo-proteins in proteolysis resistance and migration behaviors in native gel. This study revealed the inconsistence in the key amino acids among Fch-binding proteins from Gram-positive and -negative bacteria, providing interesting findings for understanding the differences between Gram-positive and -negative bacteria in the mechanism of iron uptake via siderophore (Fch) binding and transport.	[Li, Hui; Li, Nan; Xu, Qian; Xiao, Chuanle; Wang, Hongcui; Guo, Zhong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Jinan University	Sun, XS (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	tsunxs@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014	He, Qing-Yu/0000-0003-0503-9492	National Natural Science Foundation of China [21271086, 31000373]; Guangdong Natural Science Research Grant [32209003, 10451063201005247]; Fundamental Research Funds for the Central Universities [11610101, 21611201]; Pearl River Rising Star of Science and Technology of Guangzhou City [2011J2200003]; National Program on Key Basic Research Project (973 Program) [2011CB910701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Research Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Pearl River Rising Star of Science and Technology of Guangzhou City; National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (21271086, to QYH; 31000373, to XS) Guangdong Natural Science Research Grant (32209003, to QYH; 10451063201005247 to QYH), the Fundamental Research Funds for the Central Universities (11610101 to QYH; 21611201, to XS), the Pearl River Rising Star of Science and Technology of Guangzhou City (2011J2200003, to XS) and National Program on Key Basic Research Project (973 Program, 2011CB910701, to XS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, BIOMETALS, V15, P121, DOI 10.1023/A:1015249530156; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Hanks TS, 2006, INFECT IMMUN, V74, P5132, DOI 10.1128/IAI.00176-06; Hanks TS, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-62; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Nies D., 2007, MOL MICROBIOLOGY HEA, P189, DOI DOI 10.1007/7171; Raymond KN, 2004, BIOCH PHYS PROPERTIE, P3; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun XS, 2009, J INORG BIOCHEM, V103, P1074, DOI 10.1016/j.jinorgbio.2009.05.004; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	22	7	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65682	10.1371/journal.pone.0065682	http://dx.doi.org/10.1371/journal.pone.0065682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840354	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800016
J	Kernbauer, E; Maier, V; Rauch, I; Muller, M; Decker, T				Kernbauer, Elisabeth; Maier, Verena; Rauch, Isabella; Mueller, Mathias; Decker, Thomas			Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes	PLOS ONE			English	Article							SUPPRESS MACROPHAGE ACTIVATION; IFN; MICE; INDUCTION; RESISTANT; APOPTOSIS; SUSCEPTIBILITY; LYMPHOCYTES; INTERNALIN; INVASION	Listeria monocytogenes is a food-borne pathogen which causes mild to life threatening disease in humans. Ingestion of contaminated food delivers the pathogen to the gastrointestinal tract, where it crosses the epithelial barrier and spreads to internal organs. Type I interferons (IFN-I) are produced during infection and decrease host resistance after systemic delivery of L. monocytogenes. Here we show that mice benefit from IFN-I production following infection with L. monocytogenes via the gastrointestinal route. Intragastric infection lead to increased lethality of IFN-I receptor chain 1-deficient (Ifnar1-/-) animals and to higher bacterial numbers in liver and spleen. Compared to infection from the peritoneum, bacteria infecting via the intestinal tract localized more often to periportal and pericentral regions of the liver and less frequently to the margins of liver lobes. Vigorous replication of intestine-borne L. monocytogenes in the livers of Ifnar1-/- mice 48 h post infection was accompanied by the formation of large inflammatory infiltrates in this organ and massive death of surrounding hepatocytes. This was not observed in Ifnar1-/- mice after intraperitoneal infection. The inflammatory response to infection is shaped by alterations in splenic cytokine production, particularly IFN gamma, which differs after intragastric versus intraperitoneal infection. Taken together, our data suggest that the adverse or beneficial role of a cytokine may vary with the route of infection and that IFN-I are not harmful when infection with L. monocytogenes occurs via the natural route.	[Kernbauer, Elisabeth; Maier, Verena; Rauch, Isabella; Decker, Thomas] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Mueller, Mathias] Univ Vet Med Vienna, Biomodels Austria, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Decker, T (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	thomas.decker@univie.ac.at	Rauch, Isabella/AAN-6495-2020	Rauch, Isabella/0000-0003-1897-5693; Muller, Mathias/0000-0002-7879-3552	Austrian Science Foundation [SFB-28]; Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Foundation through SFB-28 to TD and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; BUKHOLM G, 1984, INFECT IMMUN, V45, P62, DOI 10.1128/IAI.45.1.62-66.1984; Cabanes D, 2008, CURR PROTOC MICROBIO, V9; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2007, IMMUNOL RES, V38, P333, DOI 10.1007/s12026-007-0017-z; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chiba S, 2011, MICROBIOL IMMUNOL, V55, P123, DOI 10.1111/j.1348-0421.2010.00292.x; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Czuprynski CJ, 2003, INFECT IMMUN, V71, P682, DOI 10.1128/IAI.71.2.682-689.2003; Dai WJ, 1997, J IMMUNOL, V158, P2259; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kernbauer E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002763; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Monk IR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-318; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pietras EM, 2011, CELL RES, V21, P1068, DOI 10.1038/cr.2011.59; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rauch I, 2013, JAK STAT, P96; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Rogers HW, 1996, J IMMUNOL, V156, P679; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	43	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65007	10.1371/journal.pone.0065007	http://dx.doi.org/10.1371/journal.pone.0065007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840314	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200009
J	Grelard, A; Guichard, P; Bonnafous, P; Marco, S; Lambert, O; Manin, C; Ronzon, F; Dufourc, EJ				Grelard, Axelle; Guichard, Paul; Bonnafous, Pierre; Marco, Sergio; Lambert, Olivier; Manin, Catherine; Ronzon, Frederic; Dufourc, Erick J.			Hepatitis B subvirus particles display both a fluid bilayer membrane and a strong resistance to freeze drying: a study by solid-state NMR, light scattering, and cryo-electron microscopy/tomography	FASEB JOURNAL			English	Article						deuterium labeling; lipid incorporation; order parameter; lipid thickness; trapped water	BOND ORDER PARAMETERS; MAGNETIC-RESONANCE; LIPID-BILAYERS; C-C; 3-DIMENSIONAL RECONSTRUCTION; DYNAMICS; PROTEIN; CHOLESTEROL; TEMPERATURE; PHASE	Hepatitis B surface antigen (HBsAg) subvirus particles produced from yeast share immunological determinants with mature viruses, which enable the use of HBsAg as a potent antigen for human vaccination. Because the intimate structure of such pseudoviral particles is still a matter of debate, we investigated the robustness of the external barrier and its structure and dynamics using the noninvasive solid-state NMR technique. This barrier is made of 60% proteins and 40% lipids. Phospholipids represent 83% of all lipids, and chain unsaturation is of 72%. Dynamics was reported by embedding small amounts of deuterium chain-labeled unsaturated phospholipid into the external barrier of entire subviral particles, while controlling particle integrity by cryoelectron microscopy, tomography, and light scattering. Variable preparation modes were used, from mild incubation of small unilamellar vesicles to very stringent incorporation with freeze-drying. A lipid bilayer structure of 4- to 5-nm thickness was evidenced with a higher rigidity than that of synthetic phospholipid vesicles, but nonetheless reflecting a fluid membrane (50-52% of maximum rigidity) in agreement with the elevated unsaturation content. The HBsAg particles of 20- to 24-nm diameter were surprisingly found resistant to lyophilization, in such a way that trapped water inside particles could not be removed. These dual properties bring more insight into the mode of action of native subviral particles and their recombinant counterparts used in vaccines.Grelard, A., Guichard, P., Bonnafous, P., Marco, S., Lambert, O., Manin, C., Ronzon, F., and Dufourc, E. J. Hepatitis B subvirus particles display both a fluid bilayer membrane and a strong resistance to freeze drying: a study by solid-state NMR, light scattering, and cryo-electron microscopy/tomography.	[Grelard, Axelle; Bonnafous, Pierre; Lambert, Olivier; Dufourc, Erick J.] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CBMN, UMR 5248, Pessac, France; [Grelard, Axelle; Bonnafous, Pierre; Lambert, Olivier] CNRS, Inst Chem & Biol Membranes & Nanoobjects, CBMN, UMR5248, Pessac, France; [Guichard, Paul; Marco, Sergio; Dufourc, Erick J.] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Guichard, Paul; Marco, Sergio] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [Manin, Catherine; Ronzon, Frederic] Sanofi Pasteur, Marcy Letoile, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay	Dufourc, EJ (corresponding author), CBMN, UMR5248, Allee Geoffroy St Hilaire, F-33600 Pessac, France.	e.dufourc@cbmn.u-bordeaux.fr	marco, SERGIO/E-4875-2017; Bonnafous, Pierre/M-7845-2014; Guichard, Paul/AAL-8603-2020; DUFOURC, Erick Joel/AAA-4992-2020	Guichard, Paul/0000-0002-0363-1049; DUFOURC, Erick Joel/0000-0002-8221-9326; GRELARD, Axelle/0000-0002-6708-2253; Lambert, Olivier/0000-0002-5651-8082	Tres Grands Equipements de Resonance Magnetique Nucleaire a Tres Haut Champ, Federation de Recherche (TGE RMN THC FR) [3050]; Sanofi Pasteur (Lyon, France)	Tres Grands Equipements de Resonance Magnetique Nucleaire a Tres Haut Champ, Federation de Recherche (TGE RMN THC FR); Sanofi Pasteur (Lyon, France)	The Aquitaine Government is thanked for supporting equipment setup in the Institute of Chemistry and Biology of Membranes and Nanoobjects/Institut Europeen de Chimie et Biologie. Financial support from the Tres Grands Equipements de Resonance Magnetique Nucleaire a Tres Haut Champ, Federation de Recherche (TGE RMN THC FR) 3050 for conducting the research is gratefully acknowledged. Tino Kreil is thanked for reading the manuscript and improving the English. This study was also funded by Sanofi Pasteur (Lyon, France).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aussenac F, 2003, LANGMUIR, V19, P10468, DOI 10.1021/la034268q; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; BLOOM M, 1981, CHEM PHYS LETT, V80, P198, DOI 10.1016/0009-2614(81)80089-9; BOTHOREL P, 1974, CHEM PHYS LIPIDS, V12, P96, DOI 10.1016/0009-3084(74)90048-6; BOTHOREL P, 1968, CR ACAD SCI D NAT, V266, P2492; Buchoux S, 2008, BIOPHYS J, V95, P3840, DOI 10.1529/biophysj.107.128322; BULDT G, 1979, J MOL BIOL, V134, P673, DOI 10.1016/0022-2836(79)90479-0; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Cevc G., 1993, PHOSPHOLIPIDS HDB, V2ZxaucDNWHcC; CULLIS PR, 1978, NATURE, V271, P672, DOI 10.1038/271672a0; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; Dichtelmuller H, 2002, BIOLOGICALS, V30, P135, DOI 10.1006/biol.2002.0332; Diminsky D, 1997, VACCINE, V15, P637, DOI 10.1016/S0264-410X(96)00239-3; Douliez JP, 1998, J CHEM PHYS, V109, P2513, DOI 10.1063/1.476823; Douliez JP, 1996, J PHYS CHEM-US, V100, P17083, DOI 10.1021/jp961457r; Douliez JP, 1996, J PHYS CHEM-US, V100, P18450, DOI 10.1021/jp961220v; DOULIEZ JP, 1995, BIOPHYS J, V68, P1727, DOI 10.1016/S0006-3495(95)80350-4; Dufourc E. J., 2009, WILEY ENCY CHEM BIOL; DUFOURC EJ, 1984, BIOCHEMISTRY-US, V23, P6062, DOI 10.1021/bi00320a025; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; FERNANDEZPUENTE L, 1994, EUROPHYS LETT, V28, P181, DOI 10.1209/0295-5075/28/3/005; Gamier-Lhomme M, 2007, BBA-BIOMEMBRANES, V1768, P2516, DOI 10.1016/j.bbamem.2007.06.004; GARNIER M, 2006, SIGNAL TRANSDUCTION, V6, P133; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Garnier-Lhomme Marie, 2009, V462, P89, DOI 10.1007/978-1-60327-115-8_6; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102; Greiner VJ, 2010, BIOCHIMIE, V92, P994, DOI 10.1016/j.biochi.2010.04.014; Grelard Axelle, 2009, V462, P111, DOI 10.1007/978-1-60327-115-8_7; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Larijani B, 2006, LIPIDS, V41, P925, DOI 10.1007/s11745-006-5045-2; LEONARD A, 1991, BIOCHIMIE, V73, P1295, DOI 10.1016/0300-9084(91)90092-F; Leonard A., 1993, B MAGN RESON, V15, P124; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Maringer K, 2012, J VIROL, V86, P12971, DOI 10.1128/JVI.01913-12; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; MEIER P, 1987, P NATL ACAD SCI USA, V84, P3704, DOI 10.1073/pnas.84.11.3704; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Milhiet PE, 2011, BIOCHIMIE, V93, P254, DOI 10.1016/j.biochi.2010.09.018; Park SH, 2008, J MAGN RESON, V193, P133, DOI 10.1016/j.jmr.2008.04.033; PETERSEN NO, 1977, BIOCHEMISTRY-US, V16, P2657, DOI 10.1021/bi00631a012; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; Raffard G, 2000, LANGMUIR, V16, P7655, DOI 10.1021/la000564g; Roberts KL, 2009, J GEN VIROL, V90, P1582, DOI 10.1099/vir.0.009092-0; Satoh O, 2000, J BIOCHEM-TOKYO, V127, P543, DOI 10.1093/oxfordjournals.jbchem.a022639; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; SCHINDLER H, 1975, BIOCHEMISTRY-US, V14, P2283, DOI 10.1021/bi00682a001; SCHMITZ G, 1991, J LIPID RES, V32, P1539; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STERNIN E, 1983, J MAGN RESON, V55, P274, DOI 10.1016/0022-2364(83)90239-1; THURMOND RL, 1993, BIOCHEMISTRY-US, V32, P5394, DOI 10.1021/bi00071a015; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; Tu K, 1996, BIOPHYS J, V70, P595, DOI 10.1016/S0006-3495(96)79623-6; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1	65	20	20	1	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4316	4326		10.1096/fj.13-232843	http://dx.doi.org/10.1096/fj.13-232843			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23839934				2022-12-25	WOS:000329747100040
J	Qi, YF; Chen, JB; Lay, A; Don, A; Vadas, M; Xia, P				Qi, Yanfei; Chen, Jinbiao; Lay, Angelina; Don, Anthony; Vadas, Mathew; Xia, Pu			Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic beta-cell death in diet-induced obese mice	FASEB JOURNAL			English	Article						apoptosis; lipotoxicity; sphingolipids; type 2 diabetes	ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; FATTY-ACIDS; APOPTOSIS; PALMITATE; 1-PHOSPHATE; GLUCOSE; GROWTH; SPHINGOSINE-1-PHOSPHATE; CONTRIBUTES	Lipotoxic stress-induced -cell death (lipotoxicity) is recognized as a key contributor to the development of type 2 diabetes mellitus (T2DM). The current study reports a critical role of sphingosine kinase 1 (SphK1) in -cell survival under lipotoxic conditions. In an attempt to investigate the role of SphK1 in lipotoxicity in vivo, we fed Sphk1(-/-) and wild-type (WT) mice with a high-fat diet (HFD) or normal chow diet. Remarkably, while HFD-fed WT mice developed glucose intolerance and compensatory hyperinsulinemia, all HFD-fed Sphk1(-/-) mice manifested evident diabetes, accompanied by a nearly 3-fold reduction in insulin levels compared with the WT mice. Pancreatic -cell mass was increased by 140% in HFD-fed WT mice but decreased to 50% in HFD-fed Sphk1(-/-) mice, in comparison with the chow diet control groups, respectively. Accordingly, by blocking the enzyme activity, expression of a dominant negative form of SphK1 markedly promoted palmitate-induced cell death in MIN6 and INS-1 -cell lines. Moreover, primary islets isolated from Sphk1(-/-) mice exhibited higher susceptibility to lipotoxicity than WT controls. Of note, sphingosine 1-phosphate (S1P) profoundly abrogated lipotoxicity in cells or the cells lacking SphK1 activity and Sphk1(-/-) islets, highlighting a pivotal role of S1P in -cell survival under lipotoxic conditions. These findings could suggest a new therapeutic strategy for preventing -cell death and thus the onset of T2DM.Qi, Y., Chen, J., Lay, A., Don, A., Vadas, M., Xia, P. Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic -cell death in diet-induced obese mice.	[Qi, Yanfei; Chen, Jinbiao; Xia, Pu] Univ Sydney, Signal Transduct Program, Sydney, NSW 2006, Australia; [Lay, Angelina; Vadas, Mathew] Univ Sydney, Vasc Biol Program, Centenary Inst, Sydney Med Sch, Sydney, NSW 2006, Australia; [Don, Anthony] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Don, Anthony] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Xia, Pu] Fudan Univ, Dept Endocrinol, Zhongshan Hosp, Shanghai 200433, Peoples R China	University of Sydney; University of Sydney; Centenary Institute; University of New South Wales Sydney; University of New South Wales Sydney; Fudan University	Xia, P (corresponding author), Fudan Univ, Dept Endocrinol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	xiapu_fudan@163.com	Don, Anthony Simon/AAE-9687-2021; Qi, Yanfei/ABC-1242-2021; Chen, Jinbiao/J-5868-2013; Chen, Jinbiao/N-9905-2019; Xia, Pu/G-3090-2010; Vadas, Mathew/R-1378-2019	Don, Anthony Simon/0000-0003-1655-1184; Qi, Yanfei/0000-0003-1391-4111; Chen, Jinbiao/0000-0003-0339-5880; Chen, Jinbiao/0000-0003-0339-5880; Xia, Pu/0000-0003-4705-8878; 	Australian National Health and Medical Research Council (NHMRC) [349348, 571408]; Cancer Institute NSW Fellowship; Fudan University Distinguished Professorship; NHMRC scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Fellowship; Fudan University Distinguished Professorship; NHMRC scholarship(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Dr. Richard Proia (U.S. National Institutes of Health, Bethesda, MD, USA) for providing sphk1<SUP>-/-</SUP> mouse colonies; Dr. Carol Wadham (Centenary Institute) for reviewing and editing the manuscript; Dr. Ross D. Laybutt (Garvan Institute, Darlinghurst, NSW, Australia) for technical guidance of islet isolation; and Dr. Timothy Couttas (University of New South Wales) for technical assistance. This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC; project 349348 and program 571408). P.X. is funded by a Cancer Institute NSW Fellowship and a Fudan University Distinguished Professorship, and Y.Q. by an NHMRC scholarship. The authors report no conflicts of interest.	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cerasi E., 2011, MEDICOGRAPHIA, V33, P7; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hasan NM, 2012, ARCH BIOCHEM BIOPHYS, V518, P23, DOI 10.1016/j.abb.2011.11.016; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma MM, 2007, DIABETOLOGIA, V50, P891, DOI 10.1007/s00125-006-0589-5; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Newsholme P, 2007, CLIN SCI, V112, P27, DOI 10.1042/CS20060115; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Wong JWH, 2012, ANAL CHEM, V84, P470, DOI 10.1021/ac2026578; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004	49	64	64	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4294	4304		10.1096/fj.13-230052	http://dx.doi.org/10.1096/fj.13-230052			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23839933				2022-12-25	WOS:000329747100038
J	Roberts, DJ; Tan-Sah, VP; Smith, JM; Miyamoto, S				Roberts, David J.; Tan-Sah, Valerie P.; Smith, Jeffery M.; Miyamoto, Shigeki			Akt Phosphorylates HK-II at Thr-473 and Increases Mitochondrial HK-II Association to Protect Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; DEPENDENT ANION CHANNEL; C-TERMINAL HALVES; HEXOKINASE-II; CYCLOPHILIN-D; PERMEABILITY TRANSITION; MAMMALIAN HEXOKINASE; ENERGY-METABOLISM; BOUND HEXOKINASE; CELL METABOLISM	Hexokinase II (HK-II) is an enzyme that catalyzes the first step in glycolysis and localizes not only in the cytosol but also at mitochondria. Akt, activated by insulin-like growth factor 1 (IGF-1) treatment in neonatal rat ventricular myocytes, translocates to mitochondria and increases mitochondrial HK-II binding. Expression of an HK-II-dissociating peptide diminished IGF-1-induced increases in mitochondrial HK-II as well as protection against hydrogen peroxide treatment, suggesting an important role of mitochondrial HK-II in IGF-1/Akt-mediated protection. We hypothesized, on the basis of an Akt phosphorylation consensus sequence present in HK-II, that Thr-473 is the target of Akt kinase activity. Indeed, recombinant kinase-active Akt robustly phosphorylates WT HK-II, but not Thr-473 mutants. Phosphomimetic (T473D) HK-II, but not non-phosphorylatable (T473A) HK-II, constitutively increased mitochondrial binding compared with WTHK-II and concomitantly confers greater protection against hydrogen peroxide. Glucose 6-phosphate (G-6P), a product of the catalytic activity of HK-II, is well known to dissociate HK-II from mitochondria. Addition of G-6P to isolated mitochondria dose-dependently dissociates WT HK-II, and this response is inhibited significantly in mitochondria isolated from cardiomyocytes expressing T473D HK-II. Pretreatment with IGF-1 also inhibits G-6P-induced overexpressed or endogenous HK-II dissociation, and this response was blocked by Akt inhibition. These results show that Akt phosphorylation of HK-II at Thr-473 is responsible for the Akt-mediated increase in HK-II binding to mitochondria. This increase is, at least in part, due to the decreased sensitivity to G-6P-induced dissociation. Thus, phosphorylation-mediated regulation of mitochondrial HK-II would be a critical component of the protective effect of Akt.	[Roberts, David J.; Tan-Sah, Valerie P.; Smith, Jeffery M.; Miyamoto, Shigeki] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Miyamoto, S (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smiyamoto@ucsd.edu	Miyamoto, Shigeki/L-4004-2019		National Institutes of Health [HL097037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097037, R56HL097037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL097037 (to S. M.).	Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Ahn KJ, 2009, BMB REP, V42, P350, DOI 10.5483/BMBRep.2009.42.6.350; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; ARORA KK, 1988, J BIOL CHEM, V263, P17422; AUBERTFOUCHER E, 1984, ARCH BIOCHEM BIOPHYS, V232, P391, DOI 10.1016/0003-9861(84)90554-X; Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Culbert AA, 2002, BBA-GENE STRUCT EXPR, V1578, P43, DOI 10.1016/S0167-4781(02)00481-5; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Jennings RB, 2001, J MOL CELL CARDIOL, V33, P1571, DOI 10.1006/jmcc.2001.1425; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1449, DOI 10.1016/0022-2828(91)90190-W; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591; Li C, 2013, FREE RADICAL BIO MED, V60, P29, DOI 10.1016/j.freeradbiomed.2013.01.013; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Matsui T, 2001, CIRCULATION, V104, P330; MAYER SE, 1966, MOL PHARMACOL, V2, P393; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Osawa H, 1996, J BIOL CHEM, V271, P16690, DOI 10.1074/jbc.271.28.16690; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; ROSE IA, 1967, J BIOL CHEM, V242, P1635; RUSSELL RR, 1992, J CLIN INVEST, V90, P1972, DOI 10.1172/JCI116076; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Smeele KMA, 2011, CIRC RES, V108, P1165, DOI 10.1161/CIRCRESAHA.111.244962; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; XIE GC, 1988, ARCH BIOCHEM BIOPHYS, V267, P803, DOI 10.1016/0003-9861(88)90090-2; Yang JY, 2013, J MOL CELL CARDIOL, V59, P167, DOI 10.1016/j.yjmcc.2013.02.016; Zuurbier CJ, 2005, AM J PHYSIOL-HEART C, V289, pH496, DOI 10.1152/ajpheart.01182.2004	64	147	151	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23798	23806		10.1074/jbc.M113.482026	http://dx.doi.org/10.1074/jbc.M113.482026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836898	hybrid, Green Published			2022-12-25	WOS:000330611400019
J	Vezzi, V; Onaran, HO; Molinari, P; Guerrini, R; Balboni, G; Calo, G; Costa, T				Vezzi, Vanessa; Onaran, H. Ongun; Molinari, Paola; Guerrini, Remo; Balboni, Gianfranco; Calo, Girolamo; Costa, Tommaso			Ligands Raise the Constraint That Limits Constitutive Activation in G Protein-coupled Opioid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX MODEL; BETA(2) ADRENERGIC-RECEPTOR; DMT-TIC PHARMACOPHORE; INVERSE AGONISTS; ALPHA-1B-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; BINDING PROTEINS; WILD-TYPE; ANTAGONISM; MUTATION	Using a cell-free bioluminescence resonance energy transfer strategy we compared the levels of spontaneous and ligand-induced receptor-G protein coupling in delta (DOP) and mu (MOP) opioid receptors. In this assay GDP can suppress spontaneous coupling, thus allowing its quantification. The level of constitutive activity was 4-5 times greater at the DOP than at the MOP receptor. A series of opioid analogues with a common peptidomimetic scaffold displayed remarkable inversions of efficacy in the two receptors. Agonists that enhanced coupling above the low intrinsic level of the MOP receptor were inverse agonists in reducing the greater level of constitutive coupling of the DOP receptor. Yet the intrinsic activities of such ligands are identical when scaled over the GDP base line of both receptors. This pattern is in conflict with the predictions of the ternary complex model and the "two state" extensions. According to this theory, the order of spontaneous and ligand-induced coupling cannot be reversed if a shift of the equilibrium between active and inactive forms raises constitutive activation in one receptor type. We propose that constitutive activation results from a lessened intrinsic barrier that restrains spontaneous coupling. Any ligand, regardless of its efficacy, must enhance this constraint to stabilize the ligand-bound complexed form.	[Vezzi, Vanessa; Molinari, Paola; Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy; [Onaran, H. Ongun] Ankara Univ, Fac Med, Dept Pharmacol, Mol Biol & Technol Res & Dev Unit, TR-06100 Ankara, Turkey; [Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Balboni, Gianfranco] Univ Cagliari, Dept Life & Environm Sci, I-09124 Cagliari, Italy; [Calo, Girolamo] Univ Ferrara, Dept Med Sci, I-09124 Ferrara, Italy	Istituto Superiore di Sanita (ISS); Ankara University; University of Ferrara; University of Cagliari; University of Ferrara	Costa, T (corresponding author), Ist Super Sanita, Dip Farmaco, Viale Regina Elena 299, I-00161 Rome, Italy.	tomcosta@iss.it	Vezzi, Vanessa/H-7084-2018; Onaran, Ongun/AAI-5348-2020; Gianfranco, Balboni/K-1503-2019; costa, tommaso/AAD-3714-2019	Vezzi, Vanessa/0000-0002-7649-345X; Onaran, Ongun/0000-0001-6766-4774; costa, tommaso/0000-0002-8729-3357; molinari, paola/0000-0002-8454-0121; Guerrini, Remo/0000-0002-7619-0918	TUBITAK, the Scientific and Technological Research Council of Turkey [SBAG 110S 159]	TUBITAK, the Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported in part by Grant SBAG 110S 159 (to H. O. O.) from TUBITAK, the Scientific and Technological Research Council of Turkey.	ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; Balboni G, 2005, J MED CHEM, V48, P8112, DOI 10.1021/jm058259l; Balboni G, 2004, J MED CHEM, V47, P4066, DOI 10.1021/jm040033f; Balboni G, 2003, BIOORGAN MED CHEM, V11, P5435, DOI 10.1016/j.bmc.2003.09.039; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Casella I, 2011, BIOCHEM J, V438, P191, DOI 10.1042/BJ20110374; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; COSTA T, 1992, MOL PHARMACOL, V41, P549; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Kaya AI, 2009, J PHARMACOL EXP THER, V329, P350, DOI 10.1124/jpet.108.149989; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Neilan CL, 1999, BRIT J PHARMACOL, V128, P556, DOI 10.1038/sj.bjp.0702816; ONARAN HO, 1993, MOL PHARMACOL, V43, P245; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pradines JR, 2001, J MATH BIOL, V43, P313, DOI 10.1007/s002850100086; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salvadori S, 1997, J MED CHEM, V40, P3100, DOI 10.1021/jm9607663; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Soudijn W, 2005, MED RES REV, V25, P398, DOI 10.1002/med.20031; Tryoen-Toth P, 2005, J PHARMACOL EXP THER, V313, P410, DOI 10.1124/jpet.104.077321; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; Zocher M, 2012, STRUCTURE, V20, P1391, DOI 10.1016/j.str.2012.05.010	37	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23964	23978		10.1074/jbc.M113.474452	http://dx.doi.org/10.1074/jbc.M113.474452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836900	Green Published, hybrid			2022-12-25	WOS:000330611400035
J	Basu, S; Ray, A; Dittel, BN				Basu, Sreemanti; Ray, Avijit; Dittel, Bonnie N.			Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens	PLOS ONE			English	Article							MARGINAL ZONE; IMMUNE-RESPONSE; 2-ARACHIDONOYLGLYCEROL; LYMPHOCYTES; ACTIVATION; MICE	The cannabinoid receptor 2 (CB2) has been reported to modulate B cell functions including migration, proliferation and isotype class switching. Since these processes are required for the generation of the germinal center (GC) and antigen-specific plasma and memory cells following immunization with a T-dependent antigen, CB2 has the capacity to alter the quality and magnitude of T-dependent immune responses. To address this question, we immunized WT and CB2(-/-) mice with the T-dependent antigen 4-hydroxy-3-nitrophenylacetyl (NP)-chicken-gamma-globulin (CGG) and measured GC B cell formation and the generation of antigen-specific B cells and serum immunoglobulin (Ig). While there was a significant reduction in the number of splenic GC B cells in CB2(-/-) mice early in the response there was no detectable difference in the number of NP-specific IgM and IgG1 plasma cells. There was also no difference in NP-specific IgM and class switched IgG1 in the serum. In addition, we found no defect in the homing of plasma cells to the bone marrow (BM) and affinity maturation, although memory B cell cells in the spleen were reduced in CB2(-/-) mice. CB2-deficient mice also generated similar levels of antigen-specific IgM and IgG in the serum as WT following immunization with sheep red blood cells (sRBC). This study demonstrates that although CB2 plays a role in promoting GC and memory B cell formation/maintenance in the spleen, it is dispensable on all immune cell types required for the generation of antigen-specific IgM and IgG in T-dependent immune responses.	[Basu, Sreemanti; Ray, Avijit; Dittel, Bonnie N.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Basu, Sreemanti; Dittel, Bonnie N.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Dittel, BN (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	bonnie.dittel@bcw.edu	Ray, Avijit/K-5611-2015	Ray, Avijit/0000-0002-1732-9836	National Institutes of Health [R01 AI069358]; National Multiple Sclerosis Research Grant [4432-A-5]; Blood Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Research Grant; Blood Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI069358, the National Multiple Sclerosis Research Grant 4432-A-5 and the Blood Center Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2008, J NEUROIMMUNE PHARM, V3, P35, DOI 10.1007/s11481-007-9088-9; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Koganei A, 2007, J IMMUNOTOXICOL, V4, P77, DOI 10.1080/15476910601161691; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Newton CA, 2012, J NEUROIMMUNE PHARM, V7, P591, DOI 10.1007/s11481-012-9361-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Springs AEB, 2008, J LEUKOCYTE BIOL, V84, P1574, DOI 10.1189/jlb.0508282; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Tanikawa T, 2007, MICROBIOL IMMUNOL, V51, P1013, DOI 10.1111/j.1348-0421.2007.tb03985.x; Ziring D, 2006, IMMUNOGENETICS, V58, P714, DOI 10.1007/s00251-006-0138-x	27	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67587	10.1371/journal.pone.0067587	http://dx.doi.org/10.1371/journal.pone.0067587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826323	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000091
J	Koehoorn, M; Trask, CM; Teschke, K				Koehoorn, Mieke; Trask, Catherine M.; Teschke, Kay			Recruitment for Occupational Research: Using Injured Workers as the Point of Entry into Workplaces	PLOS ONE			English	Article							WOOD DUST; HEALTH; SAFETY; EXPOSURE; RISK; INDUSTRIES; CHALLENGES; STRATEGIES; HAZARDS; COST	Objective: To investigate the feasibility, costs and sample representativeness of a recruitment method that used workers with back injuries as the point of entry into diverse working environments. Methods: Workers' compensation claims were used to randomly sample workers from five heavy industries and to recruit their employers for ergonomic assessments of the injured worker and up to 2 co-workers. Results: The final study sample included 54 workers from the workers' compensation registry and 72 co-workers. This sample of 126 workers was based on an initial random sample of 822 workers with a compensation claim, or a ratio of 1 recruited worker to approximately 7 sampled workers. The average recruitment cost was CND$262/injured worker and CND$240/participating worksite including co-workers. The sample was representative of the heavy industry workforce, and was successful in recruiting the self-employed (8.2%), workers from small employers (, 20 workers, 38.7%), and workers from diverse working environments (49 worksites, 29 worksite types, and 51 occupations). Conclusions: The recruitment rate was low but the cost per participant reasonable and the sample representative of workers in small worksites. Small worksites represent a significant portion of the workforce but are typically underrepresented in occupational research despite having distinct working conditions, exposures and health risks worthy of investigation.	[Koehoorn, Mieke; Teschke, Kay] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Trask, Catherine M.] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada	University of British Columbia; University of Saskatchewan	Koehoorn, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	mieke.koehoorn@ubc.ca		Trask, Catherine/0000-0003-0799-1735	WorkSafeBC Research Secretariat [RS202/03-013]; University of British Columbia Centre for Health and Environment Research; Michael Smith Foundation for Health Research; WorkSafeBC Training Award; Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program)	WorkSafeBC Research Secretariat; University of British Columbia Centre for Health and Environment Research; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); WorkSafeBC Training Award; Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program)(Canadian Institutes of Health Research (CIHR))	The work was supported in part by the WorkSafeBC Research Secretariat (grant #RS202/03-013) and the University of British Columbia Centre for Health and Environment Research. The authors were supported in part by a Michael Smith Foundation for Health Research Senior Scholar Award (http://www.msfhr.org), a Michael Smith Foundation for Health Research PhD Trainee Award, a WorkSafeBC Training Award (http://www.worksafebc.com) and by the Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program; http://www.bridge.ubc.ca). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Association of Workers Compensation Boards of Canada (AWCBC), 2008, KEY STAT MEAS; BARBEAU E, 2004, PREV CHRONIC DIS, V1, P1; Barbeau EM, 2007, INT J HEALTH SERV, V37, P127, DOI 10.2190/B0N2-5850-6467-0230; Bolen S, 2006, CANCER-AM CANCER SOC, V106, P1197, DOI 10.1002/cncr.21745; Brunette MJ, 2004, INJURY PREV, V10, P244, DOI 10.1136/ip.2004.005389; Bull N, 2002, OCCUP MED-OXFORD, V52, P70, DOI 10.1093/occmed/52.2.70; Butterfield PG, 2003, APPL NURS RES, V16, P46, DOI 10.1053/apnr.2003.50004; Eakin JM, 1998, SOCIOL HEALTH ILL, V20, P896, DOI 10.1111/1467-9566.00134; Eakin JM, 2010, CAN J PUBLIC HEALTH, V101, pS29, DOI 10.1007/BF03403843; EDERER F, 1975, AM J EPIDEMIOL, V102, P111, DOI 10.1093/oxfordjournals.aje.a112138; Kidd P, 2004, AM J IND MED, V45, P297, DOI 10.1002/ajim.10335; Koehoorn M, 2010, J OCCUP ENVIRON MED, V52, P908, DOI 10.1097/JOM.0b013e3181f02806; Lavoue J, 2013, ANN OCCUP HYG, V57, P77, DOI 10.1093/annhyg/mes055; Lee T, 2011, ANN OCCUP HYG, V55, P180, DOI 10.1093/annhyg/meq075; Lentz TJ, 2006, J OCCUP ENVIRON HYG, V3, pD8, DOI 10.1080/15459620500496715; Mathiassen SE, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-76; Mayhew C., 1997, IND RELAT J, V28, P192, DOI [10.1111/1468-2338.00054, DOI 10.1111/1468-2338.00054]; Messing K, 1997, WOMEN HEALTH, V25, P39, DOI 10.1300/J013v25n04_03; Mills PK, 2007, ENVIRON RES, V104, P282, DOI 10.1016/j.envres.2006.11.008; Moser M, 2004, 200417 NR NAT I WORK, P17; Office of the Information and Privacy Commissioner, 2006, FREED INF PROT PRIV; Parker DL, 2012, AM J IND MED, V55, P474, DOI 10.1002/ajim.22027; Quinlan M, 1999, ECON IND DEMOCRACY, V20, P427, DOI 10.1177/0143831X99203005; Rezagholi M, 2010, ANN OCCUP HYG, V54, P858, DOI 10.1093/annhyg/meq072; Rongo LMB, 2004, J EXPO ANAL ENV EPID, V14, P544, DOI 10.1038/sj.jea.7500375; Rytkonen E, 2006, INT ARCH OCC ENV HEA, V79, P521, DOI 10.1007/s00420-005-0079-y; Schmiemann M., 2008, ENTERPRISES SIZE CLA; Sobeih TM, 2006, J OCCUP ENVIRON MED, V48, P68, DOI 10.1097/01.jom.0000181756.38010.d2; Stoddard AM, 2005, PREV CHRONIC DIS, V2, P1; Teschke K, 2010, CAN J PUBLIC HEALTH, V101, P159, DOI 10.1007/BF03404364; Trask C, 2010, PREMUS 2010 AUG 29 S; Trask C, 2007, AM J IND MED, V50, P687, DOI 10.1002/ajim.20497; Village J, 2009, APPL ERGON, V40, P538, DOI 10.1016/j.apergo.2008.09.001; Western Economic Diversification Canada and BC Stats, 2007, SMALL BUS PROF 2007; WorkSafeBC, 2005, STAT 2005 AW ACT; WorkSafeBC, 2007, SMALL BUS STAT 2003; Yin-Poole W., 2012, MANY WEAPONS ARE BOR	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68354	10.1371/journal.pone.0068354	http://dx.doi.org/10.1371/journal.pone.0068354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826387	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000140
J	Lindauer, E; Dupuis, L; Muller, HP; Neumann, H; Ludolph, AC; Kassubek, J				Lindauer, Eva; Dupuis, Luc; Mueller, Hans-Peter; Neumann, Heiko; Ludolph, Albert C.; Kassubek, Jan			Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SPINAL-CORD-INJURY; HUNTINGTONS-DISEASE PATIENTS; RESTING ENERGY-EXPENDITURE; BODY-MASS INDEX; ALZHEIMERS-DISEASE; NUTRITIONAL-STATUS; ALS PATIENTS; DYSFUNCTION; FAT; METABOLISM	Background: amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that leads to death within a few years after diagnosis. Malnutrition and weight loss are frequent and are indexes of poor prognosis. Total body fat and fat distribution have not been studied in ALS patients. Objectives: Our aim was to describe adipose tissue content and distribution in ALS patients. Design: We performed a cross-sectional study in a group of ALS patients (n = 62, mean disease duration 22 months) along with age and gender matched healthy controls (n = 62) using a MRI-based method to study quantitatively the fat distribution. Results: Total body fat of ALS patients was not changed as compared with controls. However, ALS patients displayed increased visceral fat and an increased ratio of visceral to subcutaneous fat. Visceral fat was not correlated with clinical severity as judged using the ALS functional rating scale (ALS-FRS-R), while subcutaneous fat in ALS patients correlated positively with ALS-FRS-R and disease progression. Multiple regression analysis showed that gender and ALS-FRS-R, but not site of onset, were significant predictors of total and subcutaneous fat. Increased subcutaneous fat predicted survival in male patients but not in female patients (p<0.05). Conclusions: Fat distribution is altered in ALS patients, with increased visceral fat as compared with healthy controls. Subcutaneous fat content is a predictor of survival of ALS patients.	[Lindauer, Eva; Mueller, Hans-Peter; Ludolph, Albert C.; Kassubek, Jan] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Dupuis, Luc] INSERM, U1118, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Fac Med, Strasbourg, France; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ulm University	Ludolph, AC (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	albert.ludolph@rku.de	Dupuis, Luc/A-6981-2012; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Kassubek, Jan/GPX-0910-2022	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270				Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Baltadzhieva R, 2005, CURR OPIN NEUROL, V18, P487, DOI 10.1097/01.wco.0000183114.76056.0e; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Buchholz AC, 2004, CURR OPIN CLIN NUTR, V7, P635, DOI 10.1097/00075197-200411000-00008; Desport JC, 2000, AMYOTROPH LATERAL SC, V1, P91; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2003, AM J CLIN NUTR, V77, P1179, DOI 10.1093/ajcn/77.5.1179; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gibbons ZC, 2008, AMYOTROPH LATERAL SC, V9, P67, DOI 10.1080/17482960701642437; Gorgey AS, 2011, J SPINAL CORD MED, V34, P99, DOI 10.1179/107902610X12911165975106; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Jawaid A, 2010, EUR J NEUROL; Jawaid A.MurthySB, 2010, AMYOTROPH LATERAL SC; Karlsborg M, 2003, EUR J NEUROL, V10, P229, DOI 10.1046/j.1468-1331.2003.00578.x; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Liusuwan A, 2004, J SPINAL CORD MED, V27, pS24, DOI 10.1080/10790268.2004.11753781; Liusuwan RA, 2007, J SPINAL CORD MED, V30, pS105; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; Nelson MD, 2007, J SPINAL CORD MED, V30, pS127; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Sabour H, 2012, NUTRITION, V28, P143, DOI 10.1016/j.nut.2011.04.007; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Tanko LB, 2003, CIRCULATION, V107, P1626, DOI 10.1161/01.CIR.0000057974.74060.68; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wang YF, 2005, AM J CLIN NUTR, V81, P555	46	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67783	10.1371/journal.pone.0067783	http://dx.doi.org/10.1371/journal.pone.0067783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826340	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000098
J	Luo, D; Qian, YQ; Han, L; Liu, JX; Sun, ZY				Luo, Dong; Qian, Yong-Qiang; Han, Lei; Liu, Jun-Xiang; Sun, Zhen-Yuan			Phenotypic Responses of a Stoloniferous Clonal Plant Buchloe dactyloides to Scale-Dependent Nutrient Heterogeneity	PLOS ONE			English	Article							DIVISION-OF-LABOR; ENVIRONMENTAL HETEROGENEITY; PHYSIOLOGICAL INTEGRATION; MORPHOLOGICAL PLASTICITY; FRAGARIA-CHILOENSIS; PHOTOSYNTHETIC EFFICIENCY; GROWTH; RAMETS; BENEFITS; NITROGEN	Clonal plants could modify phenotypic responses to nutrients heterogeneously distributed both in space and time by physiological integration. It will take times to do phenotypic responses to modifications which are various in different growth periods. An optimal phenotype is reached when there is a match between nutrient conditions and foraging ability. A single plantlet of Buchloe dactyloides with two stolons was transplanted into heterogeneous nutrient conditions. One stolon grew in homogeneous nutrient patch, while the other cultured in different scales of heterogeneous nutrient patches. As compared to the other nutrient treatment, heterogeneous nutrient treatments with small scale of 25x25 cm resulted in a higher biomass, and larger number of ramets, clumps and stolons in B. dactyloides at both genet and clonal fragment levels. Significant differences of number of ramets, clumps and stolons were detected at the rapid growth stage, but not in the early stage of the experiment. Foraging ability was more efficient in heterogeneous than in homogeneous nutrient conditions as assessed by higher root mass and root to shoot ratio. Different nutrient treatments did not prompt significant differences in internode and root length. Physiological integration significantly increased biomass, but did not influence other growth or morphological characters. These results suggest that physiological integration modifies phenotypic plasticity of B. dactyloides for efficient foraging of nutrients in heterogeneous nutrient conditions. These effects are more pronounced at genet and clonal fragment levels when the patch scale is 25x25 cm. Time is a key factor when phenotypic plasticity of B. dactyloides in heterogeneous nutrient conditions is examined.	[Luo, Dong] China Agr Univ, Coll Agr & Biotechnol, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Luo, Dong; Qian, Yong-Qiang; Han, Lei; Liu, Jun-Xiang; Sun, Zhen-Yuan] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Sun, ZY (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	sunzy@caf.ac.cn			National Natural Science Foundation of China [31070625, 31100505]; grant for National Non-profit Research Institutions [CAFYBB2012043, RIF2010-11]; Beijing Natural Science Foundation [6122031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant for National Non-profit Research Institutions; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research is supported by the National Natural Science Foundation of China (31070625, 31100505), grant for National Non-profit Research Institutions (CAFYBB2012043, RIF2010-11), and Beijing Natural Science Foundation (6122031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; BULLOCK JM, 1994, NEW PHYTOL, V128, P737, DOI 10.1111/j.1469-8137.1994.tb04037.x; Cain ML, 1999, OECOLOGIA, V118, P397, DOI 10.1007/s004420050741; CAIN ML, 1994, ECOLOGY, V75, P933, DOI 10.2307/1939417; Caldwell M.M., 1994, EXPLOITATION ENV HET; Day KJ, 2001, THESIS U SUSSEX UK; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; de Kroon H., 1990, CLONAL GROWTH PLANTS, P113; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; EVANS JP, 1992, AM J BOT, V79, P1344, DOI 10.2307/2445132; Farley RA, 1999, J ECOL, V87, P849, DOI 10.1046/j.1365-2745.1999.00396.x; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; GERSANI M, 1992, PLANT CELL ENVIRON, V15, P463, DOI 10.1111/j.1365-3040.1992.tb00997.x; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 1999, J EXP BOT, V50, P1243, DOI 10.1093/jexbot/50.336.1243; Huber H, 1998, OIKOS, V81, P576, DOI 10.2307/3546778; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; Hutchings M.J., 2000, ECOLOGICAL CONSEQUEN, P91; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Jackson RB, 1996, J ECOL, V84, P891, DOI 10.2307/2960560; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Liu HD, 2009, FLORA, V204, P298, DOI 10.1016/j.flora.2008.03.003; Macek P, 2003, PLANT ECOL, V168, P31, DOI 10.1023/A:1024460525317; Marshall C, 1999, PLANT ECOL, V141, P1; Oborny B, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P155; OBORNY B, 1994, FOLIA GEOBOT PHYTOTX, V29, P139, DOI 10.1007/BF02803791; Oborny B., 1995, ABSTR BOT, V11, P115; Pigliucci M, 2003, AM NAT, V161, P68, DOI 10.1086/345460; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; Price EAC, 1999, PLANT ECOL, V141, P3, DOI 10.1023/A:1009838300691; Qian YQ, 2010, J AM SOC HORTIC SCI, V135, P310, DOI 10.21273/JASHS.135.4.310; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2005, INT J PLANT SCI, V166, P795, DOI 10.1086/431804; Ryel RJ, 1998, ECOLOGY, V79, P2735, DOI 10.1890/0012-9658(1998)079[2735:NAFSWP]2.0.CO;2; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; SCHMID B, 1990, EVOL TREND PLANT, V4, P25; SKALOVA H, 1992, FUNCT ECOL, V6, P282, DOI 10.2307/2389518; SLADE AJ, 1987, OECOLOGIA, V73, P425, DOI 10.1007/BF00385260; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Weinig C, 2001, EVOLUTION, V55, P930, DOI 10.1554/0014-3820(2001)055[0930:PPEILC]2.0.CO;2; Welham CVJ, 2002, OECOLOGIA, V130, P231, DOI 10.1007/s004420100791; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; WIJESINGHE DK, 1994, J ECOL, V82, P495, DOI 10.2307/2261258; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1111/j.1365-2745.2001.00618.x; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426	65	9	12	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67396	10.1371/journal.pone.0067396	http://dx.doi.org/10.1371/journal.pone.0067396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826285	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000073
J	Xu, J; Audenaert, K; Hofte, M; De Vleesschauwer, D				Xu, Jing; Audenaert, Kris; Hofte, Monica; De Vleesschauwer, David			Abscisic Acid Promotes Susceptibility to the Rice Leaf Blight Pathogen Xanthomonas oryzae pv oryzae by Suppressing Salicylic Acid-Mediated Defenses	PLOS ONE			English	Article							REAL-TIME PCR; DISEASE RESISTANCE; PSEUDOMONAS-SYRINGAE; BOTRYTIS-CINEREA; ABIOTIC STRESS; ANTAGONISTIC INTERACTION; FUNCTIONAL-ANALYSIS; MAGNAPORTHE-GRISEA; HORMONE CROSSTALK; SIGNALING PATHWAY	The plant hormone abscisic acid (ABA) is involved in a wide variety of plant processes, including the initiation of stress-adaptive responses to various environmental cues. Recently, ABA also emerged as a central factor in the regulation and integration of plant immune responses, although little is known about the underlying mechanisms. Aiming to advance our understanding of ABA-modulated disease resistance, we have analyzed the impact, dynamics and interrelationship of ABA and the classic defense hormone salicylic acid (SA) during progression of rice infection by the leaf blight pathogen Xanthomonas oryzae pv. oryzae (Xoo). Consistent with ABA negatively regulating resistance to Xoo, we found that exogenously administered ABA renders rice hypersusceptible to infection, whereas chemical and genetic disruption of ABA biosynthesis and signaling, respectively, led to enhanced Xoo resistance. In addition, we found successful Xoo infection to be associated with extensive reprogramming of ABA biosynthesis and response genes, suggesting that ABA functions as a virulence factor for Xoo. Interestingly, several lines of evidence indicate that this immune-suppressive effect of ABA is due at least in part to suppression of SA-mediated defenses that normally serve to limit pathogen growth. Resistance induced by the ABA biosynthesis inhibitor fluridone, however, appears to operate in a SA-independent manner and is likely due to induction of non-specific physiological stress. Collectively, our findings favor a scenario whereby virulent Xoo hijacks the rice ABA machinery to cause disease and highlight the importance of ABA and its crosstalk with SA in shaping the outcome of rice-Xoo interactions.	[Xu, Jing; Audenaert, Kris; Hofte, Monica; De Vleesschauwer, David] Univ Ghent, Phytopathol Lab, B-9000 Ghent, Belgium; [Audenaert, Kris] Ghent Univ Coll, Fac Appl Biosci Engn, Ghent, Belgium	Ghent University; Ghent University; HOGENT University College of Applied Sciences & Arts	De Vleesschauwer, D (corresponding author), Univ Ghent, Phytopathol Lab, B-9000 Ghent, Belgium.	david.devleesschauwer@ugent.be	Hofte, Monica MR/A-6154-2008; De Vleesschauwer, David/L-9126-2014	De Vleesschauwer, David/0000-0002-1992-0734; Hofte, Monica/0000-0002-0850-3249	Ghent University BOF/GOA; China Scholarship Council; Research Foundation Flanders (FWO-Vlaanderen)	Ghent University BOF/GOA(Ghent University); China Scholarship Council(China Scholarship Council); Research Foundation Flanders (FWO-Vlaanderen)(FWO)	Financial support was provided by grants from the Special Research Fund of Ghent University BOF/GOA (http://www.ugent.be/en/research/funding) and by grants from the China Scholarship Council to J.X. and the Research Foundation Flanders (FWO-Vlaanderen, www.fwo.be) to D.D.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuo E. A., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P49; Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/J.1364-3703.2007.00437.X, 10.1111/j.1364-3703.2007.00437.x]; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Bailey TA, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P185, DOI 10.1007/978-1-4020-9500-9_19; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; De Vleesschauwer D, 2012, PLANT PHYSIOL, V158, P1833, DOI 10.1104/pp.112.193672; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goel AK, 2008, MOL PLANT MICROBE IN, V21, P361, DOI 10.1094/MPMI-21-3-0361; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Ho YP, 2013, MOL PLANT MICROBE IN, DOI [10.1094/mpmi-1006-1012-0164-r, DOI 10.1094/MPMI-1006-1012-0164-R]; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Koga H, 2004, PHYSIOL MOL PLANT P, V65, P3, DOI 10.1016/j.pmpp.2004.11.002; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Mang HG, 2012, PLANT CELL, V24, P1271, DOI 10.1105/tpc.112.096198; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mohr PG, 2007, FUNCT INTEGR GENOMIC, V7, P181, DOI 10.1007/s10142-006-0041-4; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Oritani T, 2003, NAT PROD REP, V20, P414, DOI 10.1039/b109859b; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Taylor IB, 2000, J EXP BOT, V51, P1563, DOI 10.1093/jexbot/51.350.1563; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Watanabe H, 2001, PLANT GROWTH REGUL, V34, P273, DOI 10.1023/A:1013333718573; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang DL, 2008, MOL PLANT, V1, P528, DOI 10.1093/mp/ssn021; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yazawa K, 2012, PHYSIOL MOL PLANT P, V78, P1, DOI 10.1016/j.pmpp.2011.12.003; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang ZL, 2009, PLANT MOL BIOL, V70, P139, DOI 10.1007/s11103-009-9463-4	72	106	107	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67413	10.1371/journal.pone.0067413	http://dx.doi.org/10.1371/journal.pone.0067413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826294	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000079
J	Mouritsen, H; Atema, J; Kingsford, MJ; Gerlach, G				Mouritsen, Henrik; Atema, Jelle; Kingsford, Michael J.; Gerlach, Gabriele			Sun Compass Orientation Helps Coral Reef Fish Larvae Return to Their Natal Reef	PLOS ONE			English	Article							REGIONAL MAGNETIC-FIELDS; GREAT-BARRIER-REEF; PELAGIC LARVAE; PRESETTLEMENT FISHES; MONARCH BUTTERFLIES; SWIMMING ABILITIES; MIGRATING BIRDS; MARINE FISHES; SEA-TURTLES; POPULATIONS	Reef fish sustain populations on isolated reefs and show genetic diversity between nearby reefs even though larvae of many species are swept away from the natal site during pelagic dispersal. Retention or recruitment to natal reefs requires orientation capabilities that enable larvae to find their way. Although olfactory and acoustically based orientation has been implicated in homing when larvae are in the reef's vicinity, it is still unclear how they cope with greater distances. Here we show evidence for a sun compass mechanism that can bring the larvae to the vicinity of their natal reef. In a circular arena, pre-settlement larvae and early settlers (<24 hours) of the cardinal fish, Ostorhinchus doederleini, showed a strong SSE directional swimming response, which most likely has evolved to compensate for the locally prevailing large scale NNW current drift. When fish were clock-shifted 6 hours, they changed their orientation by ca. 180 degrees as predicted by the tropical sun curve at One Tree Island, i.e. they used a time-compensated sun compass. Furthermore, the fish oriented most consistently at times of the day when the sun azimuth is easy to determine. Microsatellite markers showed that the larvae that had just arrived at One Tree Island genetically belonged to either the local reef population or to Fitzroy Reef located 12 kilometers to the SSE. The use of a sun compass adds a missing long-distance link to the hierarchy of other sensory abilities that can direct larvae to the region of origin, including their natal reef. Predominant local recruitment, in turn, can contribute to genetic isolation and potential speciation.	[Mouritsen, Henrik; Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensor, D-26111 Oldenburg, Germany; [Atema, Jelle] Boston Univ, Marine Program, Boston, MA 02215 USA; [Kingsford, Michael J.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Kingsford, Michael J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Boston University; James Cook University; James Cook University	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de; atema@bu.edu; Gabriele.gerlach@uni-oldenburg.de	Gerlach, Gabriele/K-5919-2012; Mouritsen, Henrik/A-5401-2010; Kingsford, Michael J/C-2015-2008	Mouritsen, Henrik/0000-0001-7082-4839; Kingsford, Michael J/0000-0003-1704-6198	Volkswagen Stiftung; DFG [Ge842/6-1]; ARC; ARC Centre of Excellence for Coral Reef Studies;  [7236-02]	Volkswagen Stiftung(Volkswagen); DFG(German Research Foundation (DFG)); ARC(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); 	This work was funded by a Lichtenberg professorship from the Volkswagen Stiftung to HM; DFG Ge842/6-1 to GG; Grant no. 7236-02, ARC grants, and funding from the ARC Centre of Excellence for Coral Reef Studies to MJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1996, J EXP BIOL, V199, P9; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Barber PH, 2002, P ROY SOC B-BIOL SCI, V269, P1591, DOI 10.1098/rspb.2002.2026; Batschelet E, 1981, CIRCULAR STAT BIOL; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Burgess SC, 2007, MAR ECOL PROG SER, V341, P233, DOI 10.3354/meps341233; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Finn MD, 1996, MAR FRESHWATER RES, V47, P423, DOI 10.1071/MF9960423; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Fuxjager MJ, 2011, J EXP BIOL, V214, P2504, DOI 10.1242/jeb.055921; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GOODYEAR CP, 1969, ANIM BEHAV, V17, P636, DOI 10.1016/S0003-3472(69)80005-9; HASLER AD, 1958, LIMNOL OCEANOGR, V3, P353, DOI 10.4319/lo.1958.3.4.0353; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; HELBIG AJ, 1989, ETHOLOGY, V82, P307; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kingsford M, 1997, J FISH BIOL, V51, P176, DOI 10.1111/j.1095-8649.1997.tb06099.x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Kingsford MJ, 2001, MAR BIOL, V138, P853, DOI 10.1007/s002270000455; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Miller-Sims V, 2004, MOL ECOL NOTES, V4, P336, DOI 10.1111/j.1471-8286.2004.00689.x; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Mouritsen H, 2013, P NATL ACAD SCI USA, V110, P7348, DOI 10.1073/pnas.1221701110; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Planes S, 1998, MAR BIOL, V130, P361, DOI 10.1007/s002270050256; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; WILTSCHKO R, 1978, OIKOS, V30, P195, DOI 10.2307/3543479; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	52	56	59	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66039	10.1371/journal.pone.0066039	http://dx.doi.org/10.1371/journal.pone.0066039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840396	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000321424400018
J	Du, WG; Tu, MC; Radder, RS; Shine, R				Du, Wei-Guo; Tu, Ming-Chung; Radder, Rajkumar S.; Shine, Richard			Can Reptile Embryos Influence Their Own Rates of Heating and Cooling?	PLOS ONE			English	Article							WATER; EGG; THERMOREGULATION; EVOLUTION; EXCHANGE; PYTHONS	Previous investigations have assumed that embryos lack the capacity of physiological thermoregulation until they are large enough for their own metabolic heat production to influence nest temperatures. Contrary to intuition, reptile embryos may be capable of physiological thermoregulation. In our experiments, egg-sized objects (dead or infertile eggs, water-filled balloons, glass jars) cooled down more rapidly than they heated up, whereas live snake eggs heated more rapidly than they cooled. In a nest with diel thermal fluctuations, that hysteresis could increase the embryo's effective incubation temperature. The mechanisms for controlling rates of thermal exchange are unclear, but may involve facultative adjustment of blood flow. Heart rates of snake embryos were higher during cooling than during heating, the opposite pattern to that seen in adult reptiles. Our data challenge the view of reptile eggs as thermally passive, and suggest that embryos of reptile species with large eggs can influence their own rates of heating and cooling.	[Du, Wei-Guo; Tu, Ming-Chung; Radder, Rajkumar S.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Tu, Ming-Chung] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	University of Sydney; Chinese Academy of Sciences; Institute of Zoology, CAS; National Taiwan Normal University	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Du, Wei-Guo/K-1071-2014		Australian Research Council; Taiwan National Science Council; Chinese Academy of Sciences	Australian Research Council(Australian Research Council); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Chinese Academy of Sciences(Chinese Academy of Sciences)	The Australian Research Council, the Taiwan National Science Council and "One Hundred Talent Programme'' of the Chinese Academy of Sciences supported this work financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1985, COPEIA, P703, DOI 10.2307/1444764; Bartholomew G.A., 1982, Biology of Reptilia, V12, P167; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; Denny MW, 1993, AIR WATER BIOL PHYS, P145; Du WG, 2011, P NATL ACAD SCI USA, V108, P9513, DOI 10.1073/pnas.1102965108; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Dzialowski EM, 2001, J THERM BIOL, V26, P231, DOI 10.1016/S0306-4565(00)00050-4; Ewert MA, 2003, J THERM BIOL, V28, P159, DOI 10.1016/S0306-4565(02)00053-0; Gans C, 1982, BIOL REPTILIA, P1; GRIGG GC, 1979, J THERM BIOL, V4, P95, DOI 10.1016/0306-4565(79)90052-4; Huey R.B., 1982, Biology of Reptilia, V12, P25; McCue Marshall D., 2004, P71; PACKARD GC, 1980, AM ZOOL, V20, P351; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R., 2004, P187; Shine R., 1988, BIOL REPTILIA, P275; SLIP DJ, 1988, J ZOOL, V216, P367; Somma L. A., 2003, PARENTAL BEHAV LEPID; Stahlschmidt ZR, 2008, ETHOLOGY, V114, P1113, DOI 10.1111/j.1439-0310.2008.01553.x; Tattersall GJ, 2006, RESP PHYSIOL NEUROBI, V154, P302, DOI 10.1016/j.resp.2006.02.011; TURNER JS, 1990, J THERM BIOL, V15, P211, DOI 10.1016/0306-4565(90)90004-2; Valenzuela N., 2004, P211; Zaar M, 2004, COMP BIOCHEM PHYS A, V137, P675, DOI 10.1016/j.cbpb.2004.01.028; Zbinden JA, 2006, J EXP MAR BIOL ECOL, V334, P151, DOI 10.1016/j.jembe.2006.01.021	24	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67095	10.1371/journal.pone.0067095	http://dx.doi.org/10.1371/journal.pone.0067095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826200	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400103
J	Sceneay, J; Liu, MCP; Chen, A; Wong, CSF; Bowtell, DDL; Moller, A				Sceneay, Jaclyn; Liu, Mira C. P.; Chen, Anna; Wong, Christina S. F.; Bowtell, David D. L.; Moeller, Andreas			The Antioxidant N-Acetylcysteine Prevents HIF-1 Stabilization under Hypoxia In Vitro but Does Not Affect Tumorigenesis in Multiple Breast Cancer Models In Vivo	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; INDUCIBLE FACTOR 1-ALPHA; PAS DOMAIN PROTEIN-1; LUNG-CANCER; PROLYL HYDROXYLATION; RANDOMIZED-TRIAL; ORTHOTOPIC MODEL; PROSTATE-CANCER; TUMOR-GROWTH; O-2 TENSION	Intratumoral hypoxia is a poor prognostic factor associated with reduced disease-free survival in many cancer types, including breast cancer. Hypoxia encourages tumor cell proliferation, stimulates angiogenesis and lymphangiogenesis, and promotes epithelial-mesenchymal transition and metastasis. Tumor cells respond to a hypoxic state by stabilizing the Hif-1 alpha subunit of the Hypoxia-Inducible Factor (HIF) transcription factor to promote expression of various tumor-and metastasis-promoting hypoxic response genes. The antioxidant N-acetylcysteine (NAC) was recently shown to prevent Hif-1 alpha stabilization under hypoxia, and has been identified as a potential alternative method to target the hypoxic response in tumors. We utilized three orthotopic syngeneic murine models of breast cancer, the PyMT, EO771 and 4T1.2 models, to investigate the ability of NAC to modulate the hypoxic response in vitro and in vivo. While NAC prevented Hif-1 alpha stabilization under hypoxia in vitro and increased levels of glutathione in the blood of mice in vivo, this did not translate to a difference in tumor growth or the hypoxic state of the tumor compared to untreated control mice. In addition, NAC treatment actually increased metastatic burden in an experimental metastasis model. This work raises questions regarding the validity of NAC as an anti-tumorigenic agent in breast cancer, and highlights the need to further investigate its properties in vivo in different cancer models.	[Sceneay, Jaclyn; Liu, Mira C. P.; Chen, Anna; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom & Genet Lab, East Melbourne, Vic, Australia; [Sceneay, Jaclyn; Chen, Anna; Bowtell, David D. L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Sceneay, Jaclyn; Wong, Christina S. F.; Moeller, Andreas] Queensland Inst Med Res, Tumour Microenvironm Lab, Herston, Qld 4006, Australia; [Bowtell, David D. L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Melbourne	Moller, A (corresponding author), Queensland Inst Med Res, Tumour Microenvironm Lab, Bramston Terrace, Herston, Qld 4006, Australia.	andreas.moller@qimr.edu.au	Bowtell, David/H-1007-2016; Möller, Andreas/O-1063-2015; Wong, Christina SF/G-9972-2017	Bowtell, David/0000-0001-9089-7525; Möller, Andreas/0000-0002-8618-6998; Chen, Anna/0000-0002-2534-7014	Association of International Cancer Research [09/0676]; State Trustees Australia Foundation; National Breast Cancer Foundation Australia [ECF-11-09]	Association of International Cancer Research; State Trustees Australia Foundation; National Breast Cancer Foundation Australia	Association of International Cancer Research (www.aicr.org.uk) project grant (09/0676) to AM, State Trustees Australia Foundation (http://www.statetrustees.com.au/community/state-trustees-australia-foundation) scholarship to JS, National Breast Cancer Foundation Australia (www.nbcf.org.au) Fellowship (ECF-11-09) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J PATHOL, V164, P1683, DOI 10.1016/S0002-9440(10)63727-3; Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ALBINI A, 1995, INT J CANCER, V61, P121, DOI 10.1002/ijc.2910610121; Albini A, 2001, CANCER RES, V61, P8171; Allegra L, 2002, ARZNEIMITTEL-FORSCH, V52, P669; Bidwell B. N., 2012, NAT MED; Brok J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003328.pub2; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; CASEY AE, 1951, P SOC EXP BIOL MED, V77, P358; D'Agostini F, 1998, INT J ONCOL, V13, P217; Davreux CJ, 1997, SHOCK, V8, P432, DOI 10.1097/00024382-199712000-00007; DeFlora S, 1996, INT J CANCER, V67, P842, DOI 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heller AR, 2001, CRIT CARE MED, V29, P272, DOI 10.1097/00003246-200102000-00009; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kelloff G J, 1994, J Cell Biochem Suppl, V20, P63; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kummar S, 2011, CLIN CANCER RES, V17, P5123, DOI 10.1158/1078-0432.CCR-11-0682; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; LOEHRER PJ, 1986, CANCER TREAT REP, V70, P919; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; MAASILTA P, 1992, RADIOTHER ONCOL, V25, P192, DOI 10.1016/0167-8140(92)90267-X; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mantovani G, 2003, J MOL MED-JMM, V81, P664, DOI 10.1007/s00109-003-0476-1; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; MORGAN LR, 1982, EUR J CANCER CLIN ON, V18, P113, DOI 10.1016/0277-5379(82)90035-9; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; PASTORINO U, 1991, ONCOLOGY-BASEL, V48, P131; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sceneay J, 2012, CANC RES; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimojo Y, 2012, CLIN EXP METASTASIS; Sjoo F, 2003, BONE MARROW TRANSPL, V32, P349, DOI 10.1038/sj.bmt.1704143; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; van Zandwijk N, 2000, JNCI-J NATL CANCER I, V92, P977, DOI 10.1093/jnci/92.12.977; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Young RJ, 2010, METHODS MOL BIOL, V611, P151, DOI 10.1007/978-1-60327-345-9_12; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	66	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66388	10.1371/journal.pone.0066388	http://dx.doi.org/10.1371/journal.pone.0066388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840457	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800056
J	Yasui, K; Reimer, JD; Liu, YH; Yao, XY; Kubo, D; Shu, DG; Li, Y				Yasui, Kinya; Reimer, James D.; Liu, Yunhuan; Yao, Xiaoyong; Kubo, Daisuke; Shu, Degan; Li, Yong			A Diploblastic Radiate Animal at the Dawn of Cambrian Diversification with a Simple Body Plan: Distinct from Cnidaria?	PLOS ONE			English	Article							NEMATOSTELLA-VECTENSIS; SOUTHERN SHAANXI; ESTABLISHMENT; GASTRULATION; PUNCTATUS; METAZOAN; POSITION; POLARITY; CHINA; AXIS	Background: Microfossils of the genus Punctatus include developmental stages such as blastula, gastrula, and hatchlings, and represent the most complete developmental sequence of animals available from the earliest Cambrian. Despite the extremely well-preserved specimens, the evolutionary position of Punctatus has relied only on their conical remains and they have been tentatively assigned to cnidarians. We present a new interpretation of the Punctatus body plan based on the developmental reconstruction aided by recent advances in developmental biology. Results: Punctatus developed from a rather large egg, gastrulated in a mode of invagination from a coeloblastura, and then formed a mouth directly from the blastopore. Spiny benthic hatchlings were distinguishable from swimming or crawling ciliate larvae found in cnidarians and sponges. A mouth appeared at the perihatching embryonic stage and was renewed periodically during growth, and old mouths transformed into the body wall, thus elongating the body. Growing animals retained a small blind gut in a large body cavity without partitioning by septa and did not form tentacles, pedal discs or holdfasts externally. A growth center at the oral pole was sufficient for body patterning throughout life, and the body patterning did not show any bias from radial symmetry. Conclusions: Contrary to proposed cnidarian affinity, the Punctatus body plan has basic differences from that of cnidarians, especially concerning a spacious body cavity separating ectoderm from endoderm. The lack of many basic cnidarian characters in the body patterning of Punctatus leads us to consider its own taxonomic group, potentially outside of Cnidaria.	[Yasui, Kinya] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 724, Japan; [Reimer, James D.] Univ Ryukyus, Trans Disciplinary Org Subtrop Isl Studies, Rising Star Program, Nishihara, Okinawa 90301, Japan; [Liu, Yunhuan; Yao, Xiaoyong] Changan Univ, Univ Museum Geol, Xian, Peoples R China; [Liu, Yunhuan; Shu, Degan] Northwest Univ, Early Life Inst, Dept Geol, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China; [Kubo, Daisuke] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Li, Yong] Changan Univ, Sch Earth Sci & Land Resources, Key Lab Western Chinas Mineral Resources & Geol, Xian, Peoples R China	Hiroshima University; University of the Ryukyus; Chang'an University; Northwest University Xi'an; University of Tokyo; Chang'an University	Yasui, K (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 724, Japan.	furaha@sci.hiroshima-u.ac.jp	Reimer, James Davis/AAP-1331-2020	yao, xiaoyong/0000-0002-9329-8955				Amiel A, 2009, DEV BIOL, V327, P191, DOI 10.1016/j.ydbio.2008.12.007; Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; BLADESECKELBARGER PI, 1992, BIOL BULL-US, V182, P41, DOI 10.2307/1542179; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Byrum C.A., 2004, P33; Chen F, 2008, CHINESE SCI BULL, V53, P3860, DOI 10.1007/s11434-008-0452-9; Chiori R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004231; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; Dong XP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0071; Dornbos S. Q., 2000, GSATODAY GEOL SOC AM, V10, P2; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Freeman G., 1980, P97; FREEMAN G, 1977, J EMBRYOL EXP MORPH, V42, P237; Greeff R, 1869, Z WISS ZOOL, V20, P37; Han JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013276; Heip C, 1975, 10 EUR S MAR BIOL OS, V2, P285; Ishii H, 2003, J PLANKTON RES, V25, P1447, DOI 10.1093/plankt/fbg094; Kraus Y, 2006, DEV GENES EVOL, V216, P119, DOI 10.1007/s00427-005-0038-3; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Leme JDM, 2008, PALAEONTOLOGY, V51, P649, DOI 10.1111/j.1475-4983.2008.00775.x; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li P, 2007, CHINESE SCI BULL, V52, P2820, DOI 10.1007/s11434-007-0447-y; Li Z.P., 1984, SHAANXI GEOLOGY, V2, P73; Liu Yun-huan, 2009, Acta Palaeontologica Sinica, V48, P688; Martin VJ, 1977, BIOL BULL, V192, P345; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; MORRIS SC, 1992, J PALEONTOL, V66, P384, DOI 10.1017/S0022336000033953; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Schuchert P, 2006, REV SUISSE ZOOL, V113, P325, DOI 10.5962/bhl.part.80356; Sendino C, 2011, ACTA PALAEONTOL POL, V56, P659, DOI 10.4202/app.2010.0028; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steiner M, 2004, GEOBIOS-LYON, V37, P259, DOI 10.1016/j.geobios.2003.08.001; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; van Iten H., 1991, P145; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; Van Iten H, 2010, PALAEONTOLOGY, V53, P191, DOI 10.1111/j.1475-4983.2009.00925.x; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8; Zhao Y, 1999, LETHAIA, V32, P181, DOI 10.1111/j.1502-3931.1999.tb00538.x	43	13	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65890	10.1371/journal.pone.0065890	http://dx.doi.org/10.1371/journal.pone.0065890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840375	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800022
J	Cho, Y; Hazen, BC; Russell, AP; Kralli, A				Cho, Yoshitake; Hazen, Bethany C.; Russell, Aaron P.; Kralli, Anastasia			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 (PGC-1)- and Estrogen-related Receptor (ERR)-induced Regulator in Muscle 1 (PERM1) Is a Tissue-specific Regulator of Oxidative Capacity in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA ERR-ALPHA; MITOCHONDRIAL BIOGENESIS; NUCLEAR RECEPTOR; GENE-EXPRESSION; FIBER-TYPE; TRANSCRIPTIONAL CONTROL; ENERGY-METABOLISM; PGC-1 COACTIVATORS; CREATINE-KINASE	Mitochondrial oxidative metabolism and energy transduction pathways are critical for skeletal and cardiac muscle function. The expression of genes important for mitochondrial biogenesis and oxidative metabolism are under the control of members of the peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) family of transcriptional coactivators and the estrogen-related receptor (ERR) subfamily of nuclear receptors. Perturbations in PGC-1 and/or ERR activities have been associated with alterations in capacity for endurance exercise, rates of muscle atrophy, and cardiac function. The mechanism( s) by which PGC-1 and ERR proteins regulate muscle-specific transcriptional programs is not fully understood. We show here that PGC-1 alpha and ERRs induce the expression of a so far uncharacterized muscle-specific protein, PGC-1- and ERR-induced regulator in muscle 1 (Perm1), which regulates the expression of selective PGC-1/ERR target genes. Perm1 is required for the basal as well as PGC-1 alpha-enhanced expression of genes with roles in glucose and lipid metabolism, energy transfer, and contractile function. Silencing of Perm1 in cultured myotubes compromises respiratory capacity and diminishes PGC-1 alpha-induced mitochondrial biogenesis. Our findings support a role for Perm1 acting downstream of PGC-1 alpha and ERRs to regulate muscle-specific pathways important for energy metabolism and contractile function. Elucidating the function of Perm1 may enable novel approaches for the treatment of disorders with compromised skeletal muscle bioenergetics, such as mitochondrial myopathies and age-related/disease-associated muscle atrophies.	[Cho, Yoshitake; Hazen, Bethany C.; Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood 3125, Australia	Scripps Research Institute; Deakin University	Kralli, A (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kralli@scripps.edu		Russell, Aaron/0000-0002-7323-9501	National Institutes of Health from the NIDDK [R01DK095686]; American Heart Association Postdoctoral Fellowship [12POST8610009]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095686] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK095686 from the NIDDK (to A. K.). This work was also supported by American Heart Association Postdoctoral Fellowship 12POST8610009 (to Y. C.).	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DiMauro S, 2006, CURR OPIN RHEUMATOL, V18, P636, DOI 10.1097/01.bor.0000245729.17759.f2; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gorselink M, 2001, AM J PHYSIOL-ENDOC M, V281, pE619, DOI 10.1152/ajpendo.2001.281.3.E619; Greenhaff PL, 2001, J PHYSIOL-LONDON, V537, P657; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ingwall JS, 2009, CIRC-HEART FAIL, V2, P275, DOI 10.1161/CIRCHEARTFAILURE.109.885301; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MacIntosh B., 2005, SKELETAL MUSCLE FORM, P208; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2011, CANCER RES, V71, P2518, DOI 10.1158/0008-5472.CAN-10-1315; van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wallace DC, 2000, AM HEART J, V139, pS70, DOI 10.1067/mhj.2000.103934; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	70	62	73	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25207	25218		10.1074/jbc.M113.489674	http://dx.doi.org/10.1074/jbc.M113.489674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836911	hybrid, Green Published			2022-12-25	WOS:000330619000020
J	Epstein, JH; Baker, ML; Zambrana-Torrelio, C; Middleton, D; Barr, JA; DuBovi, E; Boyd, V; Pope, B; Todd, S; Crameri, G; Walsh, A; Pelican, K; Fielder, MD; Davies, AJ; Wang, LF; Daszak, P				Epstein, Jonathan H.; Baker, Michelle L.; Zambrana-Torrelio, Carlos; Middleton, Deborah; Barr, Jennifer A.; DuBovi, Edward; Boyd, Victoria; Pope, Brian; Todd, Shawn; Crameri, Gary; Walsh, Allyson; Pelican, Katey; Fielder, Mark D.; Davies, Angela J.; Wang, Lin-Fa; Daszak, Peter			Duration of Maternal Antibodies against Canine Distemper Virus and Hendra Virus in Pteropid Bats	PLOS ONE			English	Article							NIPAH VIRUS; EMERGING VIRUSES; RESERVOIR HOSTS; INFECTION; HENIPAVIRUS; VACCINATION; GIGANTEUS; PLACENTA; MEASLES	Old World frugivorous bats have been identified as natural hosts for emerging zoonotic viruses of significant public health concern, including henipaviruses (Nipah and Hendra virus), Ebola virus, and Marburg virus. Epidemiological studies of these viruses in bats often utilize serology to describe viral dynamics, with particular attention paid to juveniles, whose birth increases the overall susceptibility of the population to a viral outbreak once maternal immunity wanes. However, little is understood about bat immunology, including the duration of maternal antibodies in neonates. Understanding duration of maternally derived immunity is critical for characterizing viral dynamics in bat populations, which may help assess the risk of spillover to humans. We conducted two separate studies of pregnant Pteropus bat species and their offspring to measure the half-life and duration of antibodies to 1) canine distemper virus antigen in vaccinated captive Pteropus hypomelanus; and 2) Hendra virus in wild-caught, naturally infected Pteropus alecto. Both of these pteropid bat species are known reservoirs for henipaviruses. We found that in both species, antibodies were transferred from dam to pup. In P. hypomelanus pups, titers against CDV waned over a mean period of 228.6 days (95% CI: 185.4-271.8) and had a mean terminal phase half-life of 96.0 days (CI 95%: 30.7-299.7). In P. alecto pups, antibodies waned over 255.13 days (95% CI: 221.0-289.3) and had a mean terminal phase half-life of 52.24 days (CI 95%: 33.76-80.83). Each species showed a duration of transferred maternal immunity of between 7.5 and 8.5 months, which was longer than has been previously estimated. These data will allow for more accurate interpretation of age-related Henipavirus serological data collected from wild pteropid bats.	[Epstein, Jonathan H.; Zambrana-Torrelio, Carlos; Daszak, Peter] EcoHlth Alliance, New York, NY 10001 USA; [Baker, Michelle L.; Middleton, Deborah; Barr, Jennifer A.; Boyd, Victoria; Todd, Shawn; Crameri, Gary; Wang, Lin-Fa] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [DuBovi, Edward] Cornell Univ, Anim Hlth Diagnost Ctr, Ithaca, NY USA; [Pope, Brian] Lubee Bat Conservancy, Gainesville, FL USA; [Walsh, Allyson] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Pelican, Katey] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Epstein, Jonathan H.; Fielder, Mark D.; Davies, Angela J.] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore	EcoHealth Alliance; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Cornell University; Zoological Society of San Diego; University of Minnesota System; University of Minnesota Twin Cities; Kingston University; National University of Singapore	Epstein, JH (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.	epstein@ecohealthalliance.org	Baker, Michelle/AAX-9171-2020; Crameri, Gary/H-8441-2013; daszak, peter/U-4588-2017; Zambrana-Torrelio, Carlos/AAH-3911-2020; wang, lin/GSE-3040-2022; Baker, Michelle L/C-9694-2013; amsalu, ribka/G-8780-2019	Baker, Michelle/0000-0002-7993-9971; daszak, peter/0000-0002-2046-5695; Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Baker, Michelle L/0000-0002-7993-9971; Barr, Jennifer/0000-0001-5266-9142; Wang, Lin-Fa/0000-0003-2752-0535	National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease [K08AI067549]; NIH Fogarty International Center [R01TW005869]; Australian Research Council [FT110100234]; Commonwealth Science and Industrial Research Organization OCE Science Leaders award; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI067549] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Australian Research Council(Australian Research Council); Commonwealth Science and Industrial Research Organization OCE Science Leaders award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease award K08AI067549; NIH Fogarty International Center award R01TW005869; Australian Research Council Future Fellowship FT110100234; Commonwealth Science and Industrial Research Organization OCE Science Leaders award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Enders AC, 2012, PLACENTA, V33, P319, DOI 10.1016/j.placenta.2012.02.008; Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hasebe F, 2012, EMERG INFECT DIS, V18, P536, DOI 10.3201/eid1803.111121; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Henipavirus Ecology Research Group (HERG), 2006, P186; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jones DP, 2000, MAMMALIAN SPECIES, V639, P1, DOI [10.1644/1545-1410(2000)639<0001:PH>2.0.CO;2, DOI 10.1644/1545-1410(2000)639<0001:PH>2.0.CO;2]; Karim KB, 1996, ANN ANAT, V178, P523, DOI 10.1016/S0940-9602(96)80110-5; Kunz T., 2000, MAMMAL SPECIES, V642, P1, DOI 10.1644/1545-1410(2000)6422.0.co;2; Larson LJ, 2006, VET THER, V7, P113; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Mouzin DE, 2004, JAVMA-J AM VET MED A, V224, P55, DOI 10.2460/javma.2004.224.55; Muller T, 2005, J VET MED B, V52, P432, DOI 10.1111/j.1439-0450.2005.00896.x; Olson JG, 2002, EMERG INFECT DIS, V8, P987, DOI 10.3201/eid0809.010515; Pastoret PP, 2007, J COMP PATHOL, V137, pS2, DOI 10.1016/j.jcpa.2007.04.003; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Philbey AW, 2008, AUST VET J, V86, P449, DOI 10.1111/j.1751-0813.2008.00361.x; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; Sohayati AL, 2007, PTEROPUS HYPOMELANUS; TALIAFERRO WH, 1957, J CELL COMPAR PHYSL, V50, P1, DOI 10.1002/jcp.1030500403; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wynne JW, PLOS ONE; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	52	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67584	10.1371/journal.pone.0067584	http://dx.doi.org/10.1371/journal.pone.0067584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826322	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000321150000090
J	Garg, R; Caino, MC; Kazanietz, MG				Garg, Rachana; Caino, M. Cecilia; Kazanietz, Marcelo G.			Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes	PLOS ONE			English	Article							PROTEIN-KINASE-C; PROSTATE-CANCER CELLS; NF-KAPPA-B; ESTER-INDUCED APOPTOSIS; DELTA; ACTIVATION; EPSILON; RECEPTOR; PHOSPHORYLATION; EXPRESSION	Background: Activation of protein kinase C (PKC), a family of serine-threonine kinases widely implicated in cancer progression, has major impact on gene expression. In a recent genome-wide analysis of prostate cancer cells we identified distinctive gene expression profiles controlled by individual PKC isozymes and highlighted a prominent role for PKC delta in transcriptional activation. Principal Findings: Here we carried out a thorough bioinformatics analysis to dissect transcriptional networks controlled by PKC alpha, PKC delta, and PKC epsilon, the main diacylglycerol/phorbol ester PKCs expressed in prostate cancer cells. Despite the remarkable differences in the patterns of transcriptional responsive elements (REs) regulated by each PKC, we found that c-Rel represents the most frequent RE in promoters regulated by all three PKCs. In addition, promoters of PKC delta-regulated genes were particularly enriched with REs for CREB, NF-E2, RREB, SRF, Oct-1, Evi-1, and NF-kappa B. Most notably, by using transcription factor-specific RNAi we were able to identify subsets of PKC delta-regulated genes modulated by c-Rel and CREB. Furthermore, PKC delta-regulated genes condensed under the c-Rel transcriptional regulation display significant functional interconnections with biological processes such as angiogenesis, inflammatory response, and cell motility. Conclusion/Significance: Our study identified candidate transcription factors in the promoters of PKC regulated genes, in particular c-Rel was found as a key transcription factor in the control of PKC delta-regulated genes. The deconvolution of PKC-regulated transcriptional networks and their nodes may greatly help in the identification of PKC effectors and have significant therapeutics implications.	[Garg, Rachana; Caino, M. Cecilia; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kazanietz, MG (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Garg, Rachana/AAQ-9518-2020	Garg, Rachana/0000-0002-7808-1053; Caino, M. Cecilia/0000-0001-8294-8070	NIH [R01-CA89202]; Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01-CA89202 from NIH to M.G.K. R.G. is supported by a post-doctoral fellowship from the Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kandil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029934; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Chen XF, 2003, CANCER RES, V63, P1059; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garg R, 2008, CARCINOGENESIS, V29, P1249, DOI 10.1093/carcin/bgn114; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gugasyan R, 2004, MOL CELL BIOL, V24, P5733, DOI 10.1128/MCB.24.13.5733-5745.2004; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mukhopadhyay NK, 2006, EXP CELL RES, V312, P3782, DOI 10.1016/j.yexcr.2006.07.017; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Parthasarathy S, 2011, J GASTROEN HEPATOL, V26, P382, DOI 10.1111/j.1440-1746.2010.06526.x; Persaud SD, 2005, INT J ONCOL, V27, P149; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Satomi Y, 2012, ANTICANCER RES, V32, P807; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; TAN TH, 1992, MOL CELL BIOL, V12, P4067, DOI 10.1128/MCB.12.9.4067; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wermuth PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027110; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zhu Tongbo, 2010, Genes Cancer, V1, P142, DOI 10.1177/1947601909360989	55	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67319	10.1371/journal.pone.0067319	http://dx.doi.org/10.1371/journal.pone.0067319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826267	gold, Green Submitted, Green Published			2022-12-25	WOS:000321150000062
J	Williams, RL; Goodenough, AE; Hart, AG; Stafford, R				Williams, Rachel L.; Goodenough, Anne E.; Hart, Adam G.; Stafford, Richard			Using Long-Term Volunteer Records to Examine Dormouse (Muscardinus avellanarius) Nestbox Selection	PLOS ONE			English	Article							COMMON DORMOUSE; SITE SELECTION; NESTING-BEHAVIOR; CONSERVATION; SCIENCE; PROGRAMS; SUCCESS; EDGE; L.	Within ecology, there are unanswered questions about species-habitat interactions, which could potentially be resolved by a pragmatic analysis of a long-term volunteer-collected dataset. Here, we analysed 18 years of volunteer-collected data from a UK dormouse nestbox monitoring programme to determine the influence of habitat variables on nestbox choice by common dormice (Muscardinus avellanarius). We measured a range of habitat variables in a coppiced woodland in Gloucestershire, UK, and analysed these in relation to dormouse nestbox occupancy records (by dormice, other small mammals, and birds) collected by volunteers. While some characteristics of the woodland had changed over 18 years, simple transformation of the data and interpretation of the results indicated that the dataset was informative. Using stepwise regressions, multiple environmental and ecological factors were found to determine nestbox selection. Distance from the edge of the wood was the most influential (this did not change over 18 years), with boxes in the woodland interior being selected preferentially. There was a significant negative relationship with the presence of ferns (indicative of damp shady conditions). The presence of oak (a long-lived species), and the clumped structural complexity of the canopy were also important factors in the final model. There was no evidence of competition between dormice and birds or other mammals. The results provide greater understanding of artificial dormouse nest-site requirements and indicate that, in terms of habitat selection, long-term volunteer-collected datasets contribute usefully to understanding the requirements of species with an important conservation status.	[Williams, Rachel L.; Goodenough, Anne E.; Hart, Adam G.] Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England; [Stafford, Richard] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England	University of Gloucestershire; Bournemouth University	Williams, RL (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England.	rachel.williams_31@hotmail.com	Stafford, Rick/B-1059-2013	Stafford, Rick/0000-0002-1964-5787; Goodenough, Anne/0000-0002-7662-6670				ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bracewell M, 2009, NEST MAT PREFERENCES; Brewer C, 2002, CONSERV BIOL, V16, P4, DOI 10.1046/j.1523-1739.2002.01613.x; BRIGHT PW, 1994, J APPL ECOL, V31, P329, DOI 10.2307/2404547; BRIGHT PW, 1992, J ZOOL, V226, P589, DOI 10.1111/j.1469-7998.1992.tb07502.x; BRIGHT PW, 1991, J ZOOL, V224, P177, DOI 10.1111/j.1469-7998.1991.tb04797.x; BRIGHT PW, 1990, BIOL CONSERV, V54, P307, DOI 10.1016/0006-3207(90)90143-D; Carey AB, 1997, J WILDLIFE MANAGE, V61, P684, DOI 10.2307/3802176; Chanin P, 2003, 524 ENGL NAT; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; Crick HQP, 2003, BIRD STUDY, V50, P254, DOI 10.1080/00063650309461318; Cudworth NL, 2011, J WILDLIFE MANAGE, V75, P1668, DOI 10.1002/jwmg.194; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Eden S, 2009, LIVING DORMICE; England Natural, 2008, LIC APPL FORMS; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Fowler J., 1998, PRACTICAL STAT FIELD, P130; Goodenough A. E., 2012, ISRN Ecology, V2012, P619842; Goodenough AE, 2009, ACTA OECOL, V35, P598, DOI 10.1016/j.actao.2009.05.003; Goodenough AE, 2008, ETHOL ECOL EVOL, V20, P375, DOI 10.1080/08927014.2008.9522518; Goswami A, 2007, RESOUR ENERG DEV, V4, P89; Harris S, 2004, MAMMAL REV, V34, P157, DOI 10.1046/j.0305-1838.2003.00030.x; Higby Louisa K., 2012, International Journal of Zoology, V2012, P1; Irwin A., 1995, CITIZEN SCI STUDY PE, DOI DOI 10.4324/9780203202395; Jukaitis R, 2000, EST J ECOL, V5, P42; Juskaitis R, 2003, FOLIA ZOOL, V52, P239; Juskaitis Rimvydas, 2007, Acta Zoologica Lituanica, V17, P151; Juskaitis R, 2007, POL J ECOL, V55, P795; Juskaitis Rimvydas, 1997, Natura Croatica, V6, P177; Kaneko Y., 2010, INT J ECOL, V2010; Kilgas P, 2012, J ORNITHOL, V153, P833, DOI 10.1007/s10336-011-0801-3; Koops K, 2012, AM J PHYS ANTHROPOL, V148, P351, DOI 10.1002/ajpa.22056; Kuroe M, 2007, ACTA THERIOL, V52, P355, DOI 10.1007/BF03194233; Lutermann H, 2010, ANIM BEHAV, V79, P1211, DOI 10.1016/j.anbehav.2010.02.017; Magana M, 2010, IBIS, V152, P77, DOI 10.1111/j.1474-919X.2009.00976.x; Marsh ACW, 2000, ACTA THERIOL, V45, P443, DOI 10.4098/AT.arch.00-45; McCaffrey Rachel E., 2005, Urban Habitats, V3, P70; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; MINOT EO, 1986, J ANIM ECOL, V55, P331, DOI 10.2307/4712; MORRIS DW, 1991, AM NAT, V138, P702, DOI 10.1086/285244; MORRIS PA, 1990, BIOL CONSERV, V51, P1, DOI 10.1016/0006-3207(90)90027-M; Newman C, 2003, BIOL CONSERV, V113, P189, DOI 10.1016/S0006-3207(02)00374-9; dos Santos AJN, 2012, SCI AGR, V69, P281, DOI 10.1590/S0103-90162012000400008; Page CN, 1997, FERNS BRITAIN IRELAN; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; PTES, 2012, DORM MON; PTES and Natural England, 2012, NAT DORM MON PROGR S; RICHARDS CGJ, 1984, MAMMAL REV, V14, P19, DOI 10.1111/j.1365-2907.1984.tb00335.x; Sara M, 2003, ACTA ZOOL HUNG S1, V49; Smith GC, 2007, WILDLIFE RES, V34, P427; Solomon NG, 2005, J MAMMAL, V86, P555, DOI 10.1644/1545-1542(2005)86[555:FANLOP]2.0.CO;2; Thode H.C., 2002, TESTING NORMALITY; Wolton R, 2009, MAMMALIA, V73, P7, DOI 10.1515/MAMM.2009.001	54	12	13	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67986	10.1371/journal.pone.0067986	http://dx.doi.org/10.1371/journal.pone.0067986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826351	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000105
J	Raybaud, V; Beaugrand, G; Goberville, E; Delebecq, G; Destombe, C; Valero, M; Davoult, D; Morin, P; Gevaert, F				Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal; Gevaert, Francois			Decline in Kelp in West Europe and Climate	PLOS ONE			English	Article							LAMINARIA-DIGITATA; PATTERNS; SEAWEEDS; MACROALGAE; TEMPERATE; IMPACT; ERRORS	Kelp ecosystems form widespread underwater forests playing a major role in structuring the biodiversity at a regional scale. Some seaweeds such as Laminaria digitata are also economically important, being exploited for their alginate and iodine content. Although some studies have shown that kelp ecosystems are regressing and that multiple causes are likely to be at the origin of the disappearance of certain populations, the extent to which global climate change may play a role remains speculative. Here we show that many populations of L. digitata along European coasts are on the verge of local extinction due to a climate-caused increase in sea temperature. By modeling the spatial distribution of the seaweed, we evaluate the possible implications of global climate change for the geographical patterns of the species using temperature data from the Coupled Model Intercomparison Project phase 5 (CMIP5). Projections of the future range of L. digitata throughout the 21st century show large shifts in the suitable habitat of the kelp and a northward retreat of the southern limit of its current geographic distribution from France to Danish coasts and the southern regions of the United Kingdom. However, these projections depend on the intensity of warming. A medium to high warming is expected to lead to the extirpation of the species as early as the first half of the 21st century and there is high confidence that regional extinction will spread northwards by the end of this century. These changes are likely to cause the decline of species whose life cycle is closely dependent upon L. digitata and lead to the establishment of new ecosystems with lower ecological and economic values.	[Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Gevaert, Francois] Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Gevaert, Francois] CNRS, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Goberville, Eric] Univ Lille 1, UMR GEPV 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal] Univ Paris 06, UMR AD2M 7144, Lab Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France; [Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal] CNRS, UMR AD2M 7144, Lab Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Raybaud, V (corresponding author), Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France.	virginie.raybaud@univ-lille1.fr	Morin, Pascal/A-1112-2016; Valero, Myriam/C-7550-2011; Goberville, Eric/A-2621-2017; Davoult, dominique/D-5932-2012; Valero, Myriam/M-6052-2019; Gevaert, Francois/B-9629-2018	Morin, Pascal/0000-0003-2766-1821; Valero, Myriam/0000-0002-9000-1423; Goberville, Eric/0000-0002-1843-7855; Davoult, dominique/0000-0001-8678-3998; Valero, Myriam/0000-0002-9000-1423; Gevaert, Francois/0000-0002-5078-1154; Destombe, Christophe/0000-0001-5656-9659; BEAUGRAND, GREGORY/0000-0002-0712-5223; Raybaud, Virginie/0000-0001-6426-3326	"region Nord-Pas de Calais", through the program BIODIMAR; Centre National de la Recherche Scientifique (CNRS)	"region Nord-Pas de Calais", through the program BIODIMAR(Region Hauts-de-France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the "region Nord-Pas de Calais", through the program BIODIMAR and the "Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J.G., 2007, EOS T AM GEOPHYS UN, V88, P14, DOI [10.1029/2007EO020003, DOI 10.1029/2007EO020003]; [Anonymous], 1998, LAMINAIRES COTES BRE; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Bekkby T, 2011, DEV SPATIAL MODELS S; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; Billot C, 2003, MARINE ECOLOGY PROGR, V253, P21; Birkett D, 1998, OVERVIEW DYNAMIC SEN, VVII, P174; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BREEMAN AM, 1994, BOT MAR, V37, P171, DOI 10.1515/botm.1994.37.3.171; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Clayton MN, 1997, POLAR BIOL, V17, P141, DOI 10.1007/s003000050116; Cosson J, 1999, CRYPTOGAMIE ALGOL, V20, P35, DOI 10.1016/S0181-1568(99)80005-1; Cosson J, 1973, SOC PHYCOL FRANCE B, P104; Davoult D, 2011, CAH BIOL MAR, V52, P429; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elton C. S., 1927, ANIMAL ECOLOGY; Engelen AH, 2011, CAH BIOL MAR, V52, P441; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gayral P, 1973, EXPOSE SYNOPTIQUE DO; Gevaert F, 2008, J SEA RES, V60, P215, DOI 10.1016/j.seares.2008.06.006; Grinnell J., 1917, Auk Cambridge Mass, V34; Hardy F, 2006, CHECK LIST ATLAS SEA; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; HAWKINS SJ, 1985, MAR ECOL PROG SER, V20, P265, DOI 10.3354/meps020265; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IBANEZ F, 1981, LIMNOL OCEANOGR, V26, P336, DOI 10.4319/lo.1981.26.2.0336; Karsten U, 2007, PHYCOL RES, V55, P257, DOI 10.1111/j.1440-1835.2007.00468.x; Laepple T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033576; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Levitus S., 1982, CLIMATOLOGICAL ATLAS; Lippert H, 2001, POLAR BIOL, V24, P512; Luning K, 1990, SEAWEEDS THEIR ENV B; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Meleder V, 2010, MAR BIOL, V157, P1525, DOI 10.1007/s00227-010-1426-4; MIELKE PW, 1981, MON WEATHER REV, V109, P120, DOI 10.1175/1520-0493(1981)109<0120:AOMRPP>2.0.CO;2; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Pedersen M, 2001, HYDROBIOLOGIA, V459, P83, DOI 10.1023/A:1012506507322; Perez R., 1971, Revue des Travaux, Institut des Peches Maritimes, V35, P287; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Podesta GP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017178; Raybaud V, 2011, J MARINE SYST, V84, P1, DOI 10.1016/j.jmarsys.2010.08.001; Rombouts I, 2012, ESTUAR COAST SHELF S, V99, P153, DOI 10.1016/j.ecss.2011.12.026; Sainsbury K.J., 1982, THEORY MANAGEMENT TR, V360, P167; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STOCKWELL DRB, 2007, NICHE MODELING PREDI; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Valero M, 2011, CAH BIOL MAR, V52, P467; Van den Hoek C, 1990, DEV HYDROBIOL, P57; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]	59	111	112	12	221	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66044	10.1371/journal.pone.0066044	http://dx.doi.org/10.1371/journal.pone.0066044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840397	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400019
J	Zhang, MM; Zhang, S; Wu, J; Sun, Y; Li, LL; Du, WJ; Liu, JJ; Hou, JB; Yu, B				Zhang, Maomao; Zhang, Shuo; Wu, Jian; Sun, Yong; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo			The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats	PLOS ONE			English	Article							REGULATORY T-CELLS; DONOR LYMPHOCYTE INFUSION; IN-VIVO; TRANSPLANTATION TOLERANCE; GRAFT-REJECTION; INDUCTION; CD4(+)CD25(+); ACTIVATION; MATURATION; IMMUNITY	Protosappanin A (PrA), an immunosuppressive ingredient of the medicinal herb Caesalpinia sappan L, prolongs heart allograft survival in rats, possibly by impairing the function of antigen-presenting cells (APCs). We examined the effects of PrA on the maturation and function of dendritic cells (DCs), a potent class of APCs, and the downstream cell-cell and intracellular signaling pathways mediating the immunosuppressive activity of PrA. PrA inhibited LPS-stimulated maturation of Wistar rat DCs in vitro as reflected by reduced expression of costimulatory molecules (CD80 and CD86) and reduced expression of TLR4 and NF-kappa B, two critical signaling components for antigen recognition. PrA also enhanced the release of IL-10 and decreased the release of IL-12 from DCs, but had no effect on the production of TGF-beta. In mixed cultures, Wistar DCs pretreated with PrA impaired the proliferation of Sprague Dawley (SD) rat T cells while promoting the expansion of SD rat CD4(+)CD25(+) regulatory T cells (Tregs). Both oral PrA treatment and infusion of PrA-pretreated Wistar DCs prolonged cardiac allograft survival (Wistar donor, SD recipient) and expanded recipient CD4(+)CD25(+)Foxp3(+) Tregs. Donor spleen cells, but not spleen cells from a third rat strain (DA), supported the expansion of recipient CD4(+)CD25(+)Foxp3(+) Tregs and suppressed recipient T cell proliferation. We conclude that PrA triggers a tolerogenic state in DCs that allows for the induction of alloantigen-specific Tregs and the suppression of allograft rejection in vivo.	[Zhang, Maomao; Zhang, Shuo; Wu, Jian; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo] Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Maomao; Zhang, Shuo; Wu, Jian; Sun, Yong; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Hou, JB (corresponding author), Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China.	jingbohou@163.com		Hou, Jingbo/0000-0002-9671-5099	National Natural Science Foundation of China [81200180]; New Teachers' Fund for Doctor Stations, Ministry of Education [20122307120021]; Postdoctoral Foundation of China [2011M501065]; Foundation of Heilongjiang Educational Committee [12531286]; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education) [KF201001, KF201211]; Second Affliated Hospital of Harbin Medical University [BS2011-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education; Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Foundation of Heilongjiang Educational Committee; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education); Second Affliated Hospital of Harbin Medical University	This work was supported by the National Natural Science Foundation of China (81200180), New Teachers' Fund for Doctor Stations, Ministry of Education (20122307120021), the Postdoctoral Foundation of China (2011M501065), Foundation of Heilongjiang Educational Committee (12531286), Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education, KF201001, KF201211), and the doctoral research fund of Second Affliated Hospital of Harbin Medical University (BS2011-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Beriou G, 2005, TRANSPLANTATION, V79, P969, DOI 10.1097/01.TP.0000158277.50073.35; Bonham CA, 2002, J IMMUNOL, V169, P3382, DOI 10.4049/jimmunol.169.6.3382; Borges FT, 2012, J AM SOC NEPHROL; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Cobbold SP, 2008, J NEPHROL, V21, P485; Coquerelle C, 2008, IMMUNOL LETT, V119, P12, DOI 10.1016/j.imlet.2008.05.005; Critchley WR, 2012, IMMUNOLOGY, V136, P123, DOI 10.1111/j.1365-2567.2012.03560.x; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Hattori T, 2012, J LEUKOCYTE BIOL, V91, P621, DOI 10.1189/jlb.1011500; Huurman VAL, 2009, AM J TRANSPLANT, V9, P382, DOI 10.1111/j.1600-6143.2008.02479.x; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Lange C, 2007, IMMUNOL CELL BIOL, V85, P575, DOI 10.1038/sj.icb.7100088; Lundsgaard D, 2005, DIABETES, V54, P1040, DOI 10.2337/diabetes.54.4.1040; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; McCurry KR, 2006, TRANSPL INT, V19, P525, DOI 10.1111/j.1432-2277.2006.00306.x; Moreau A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00218; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shen EX, 2011, CELL BIOL INT, V35, P705, DOI 10.1042/CBI20100528; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Thomson AW, 2009, TRANSPLANTATION, V87, pS86, DOI 10.1097/TP.0b013e3181a2dcec; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Wu J, 2008, TRANSPL P, V40, P3719, DOI 10.1016/j.transproceed.2008.06.097; Wu J, 2010, N-S ARCH PHARMACOL, V381, P83, DOI 10.1007/s00210-009-0461-5; Xia GL, 2006, BIOL BLOOD MARROW TR, V12, P397, DOI 10.1016/j.bbmt.2005.11.519; Xia GL, 2004, BIOL BLOOD MARROW TR, V10, P748, DOI 10.1016/j.bbmt.2004.07.004; Yang H, 2012, TRANSPLANTATION, V93, P580, DOI 10.1097/TP.0b013e318244dd67; Zhang M, 2004, J MOL MED, V82, P240, DOI 10.1007/s00109-003-0521-0; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013	39	4	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66336	10.1371/journal.pone.0066336	http://dx.doi.org/10.1371/journal.pone.0066336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840445	gold, Green Submitted, Green Published			2022-12-25	WOS:000321424400025
J	Denaro, G; Valenti, D; Spagnolo, B; Basilone, G; Mazzola, S; Zgozi, SW; Aronica, S; Bonanno, A				Denaro, Giovanni; Valenti, Davide; Spagnolo, Bernardo; Basilone, Gualtiero; Mazzola, Salvatore; Zgozi, Salem W.; Aronica, Salvatore; Bonanno, Angelo			Dynamics of Two Picophytoplankton Groups in Mediterranean Sea: Analysis of the Deep Chlorophyll Maximum by a Stochastic Advection-Reaction-Diffusion Model	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; NOISE; PHYTOPLANKTON; PROCHLOROCOCCUS; LIGHT; GROWTH; COMPETITION; ECOSYSTEM; STRAIT; FLUCTUATIONS	A stochastic advection-reaction-diffusion model with terms of multiplicative white Gaussian noise, valid for weakly mixed waters, is studied to obtain the vertical stationary spatial distributions of two groups of picophytoplankton, i.e., picoeukaryotes and Prochlorococcus, which account about for 60% of total chlorophyll on average in Mediterranean Sea. By numerically solving the equations of the model, we analyze the one-dimensional spatio-temporal dynamics of the total picophytoplankton biomass and nutrient concentration along the water column at different depths. In particular, we integrate the equations over a time interval long enough, obtaining the steady spatial distributions for the cell concentrations of the two picophytoplankton groups. The results are converted into chlorophyll a and divinil chlorophyll a concentrations and compared with experimental data collected in two different sites of the Sicily Channel (southern Mediterranean Sea). The comparison shows that real distributions are well reproduced by theoretical profiles. Specifically, position, shape and magnitude of the theoretical deep chlorophyll maximum exhibit a good agreement with the experimental values.	[Denaro, Giovanni; Valenti, Davide; Spagnolo, Bernardo] Univ Palermo, Dipartimento Fis & Chim, Grp Interdisciplinary Phys & Consorzio Nazl Inter, Unita Palermo, Palermo, Italy; [Basilone, Gualtiero; Mazzola, Salvatore; Aronica, Salvatore; Bonanno, Angelo] CNR, Ist Ambiente Marino Costiero, Unita Operat Supporto Capo Granitola, Trapani, Italy; [Zgozi, Salem W.] Marine Biol Res Ctr, Tajura, Libya	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Valenti, D (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Grp Interdisciplinary Phys & Consorzio Nazl Inter, Unita Palermo, Palermo, Italy.	davide.valenti@unipa.it; bernardo.spagnolo@unipa.it; angelo.bonanno@iamc.cnr.it	Valenti, Davide/K-9228-2015; Basilone, Gualtiero/D-2896-2017; Bonanno, Angelo/H-9025-2013; Spagnolo, Bernardo/F-6973-2014	Valenti, Davide/0000-0001-5496-1518; Basilone, Gualtiero/0000-0002-5732-5055; Bonanno, Angelo/0000-0002-3868-751X; Spagnolo, Bernardo/0000-0002-6625-3989; Mazzola, Salvatore/0000-0002-4622-8129; aronica, salvatore/0000-0003-3489-1473	Short visit grant, within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC [4933]; Italian Ministry of University and Research	Short visit grant, within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The work was supported by the following: 1) Short visit grant, ref. n. 4933 within ESF Scientific Programme "Exploring the Physics of Small Devices (EPSD)", Unit PESC, coordinated by Prof. Christian Van den Broeck (http://www.esf.org/activities/research-networking-programmes/physical-and-engineering-sciences-pesc/current-research-networking-programmes/exploring-the-physics-of-small-devices-epsd.html); 2) Italian Ministry of University and Research (no specific grant) (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; BARRERA P, 1993, J PHYS A-MATH GEN, V26, pL559, DOI 10.1088/0305-4470/26/13/001; Basilone G, 2004, FISH RES, V68, P9, DOI 10.1016/j.fishres.2004.02.012; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2006, AQUAT MICROB ECOL, V44, P127, DOI 10.3354/ame044127; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Caruso A, 2005, FLUCT NOISE LETT, V5, pL349, DOI 10.1142/S0219477505002768; Casotti R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001541; Casotti R, 2000, MAR ECOL PROG SER, V195, P15, DOI 10.3354/meps195015; Chichigina O, 2005, FLUCT NOISE LETT, V5, pL243, DOI 10.1142/S0219477505002616; Chichigina OA, 2008, EUR PHYS J B, V65, P347, DOI 10.1140/epjb/e2008-00226-6; Chichigina OA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021134; CIUCHI S, 1993, PHYS REV E, V47, P3915, DOI 10.1103/PhysRevE.47.3915; Ciuchi S, 1996, PHYS REV E, V54, P706, DOI 10.1103/PhysRevE.54.706; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; Denaro G, 2013, ACTA PHYS POL B, V44, P977, DOI 10.5506/APhysPolB.44.977; Denaro G, 2013, ECOL COMPLEX, V13, P21, DOI 10.1016/j.ecocom.2012.10.002; Dimier C, 2007, J PHYCOL, V43; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Ebeling W, 2005, FLUCT NOISE LETT, V5, pL159, DOI 10.1142/S0219477505002495; Estrada M, 1996, SCI MAR, V60, P55; Fennel K, 2003, LIMNOL OCEANOGR, V48, P1521, DOI 10.4319/lo.2003.48.4.1521; Fiasconaro A, 2006, EUR PHYS J B, V50, P189, DOI 10.1140/epjb/e2006-00058-4; FOGG GE, 1991, NEW PHYTOL, V118, P191, DOI 10.1111/j.1469-8137.1991.tb00974.x; Garc?a-Ojalvo J., 1999, NOISE SPATIALLY EXTE; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; Giuffrida A, 2009, EUR FOOD RES TECHNOL, V228, P767, DOI 10.1007/s00217-008-0988-6; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; GRAHAM R, 1982, PHYS REV A, V25, P1731, DOI 10.1103/PhysRevA.25.1731; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hickman AE, 2010, MAR ECOL PROG SER, V406, P1, DOI 10.3354/meps08588; Horsthemke W., 1984, NOISE INDUCED TRANSI; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huppert A, 2005, J THEOR BIOL, V236, P276, DOI 10.1016/j.jtbi.2005.03.012; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; La Barbera A, 2002, PHYSICA A, V314, P120, DOI 10.1016/S0378-4371(02)01173-1; La Cognata A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011121; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Liu QX, 2008, J STAT MECH THEORY E, V2008; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; Manor A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.030601; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; Melbourne-Thomas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055093; Mendonca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029526; Mikhailov AS, 1996, SPRINGER SERIES SYNE; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Munoz MA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056102; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PREZELIN BB, 1991, AQUAT SCI, V53, P136, DOI 10.1007/BF00877058; Provata A, 2008, EUR PHYS J B, V65, P307, DOI 10.1140/epjb/e2008-00380-9; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; REDNER S, 1990, AM J PHYS, V58, P267, DOI 10.1119/1.16497; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Ryabov AB, 2012, THEOR ECOL-NETH, V5, P373, DOI 10.1007/s12080-012-0158-0; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Ryabov AB, 2010, J THEOR BIOL, V263, P120, DOI 10.1016/j.jtbi.2009.10.034; SCHENZLE A, 1979, PHYS REV A, V20, P1628, DOI 10.1103/PhysRevA.20.1628; SHIGESADA N, 1981, J MATH BIOL, V12, P311, DOI 10.1007/BF00276919; Somette D, 2000, SPRINGER SERIES SYNE, P178; Spagnolo B, 2005, PROG THEOR PHYS SUPP, P312, DOI 10.1143/PTPS.157.312; Spagnolo B, 2004, MATH BIOSCI ENG, V1, P185; Spagnolo B, 2003, FLUCT NOISE LETT, V3, pL177, DOI 10.1142/S0219477503001245; Spagnolo B, 2002, J PHYS-CONDENS MAT, V14, P2247, DOI 10.1088/0953-8984/14/9/313; Spagnolo B, 2002, PHYSICA A, V315, P114, DOI 10.1016/S0378-4371(02)01245-1; Spagnolo B, 2009, EUR PHYS J B, V69, P133, DOI 10.1140/epjb/e2009-00162-y; Spagnolo B, 2008, INT J BIFURCAT CHAOS, V18, P2643; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; Turpin D.H., 1988, P316; Valenti D, 2008, ECOL MODEL, V213, P449, DOI 10.1016/j.ecolmodel.2008.01.023; Valenti D, 2006, EUR PHYS J B, V50, P199, DOI 10.1140/epjb/e2006-00102-5; Valenti D, 2004, ACTA PHYS POL B, V35, P1481; Valenti D, 2012, ACTA PHYS POL B, V43, P1227, DOI 10.5506/APhysPolB.43.1227; Valenti D, 2004, PHYSICA A, V331, P477, DOI 10.1016/j.physa.2003.09.036; Valenti D, 2007, PHYSICA A, V382, P311, DOI 10.1016/j.physa.2007.03.044; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Weston K, 2005, J PLANKTON RES, V27, P909, DOI 10.1093/plankt/fbi064; Worden AZ, 2008, MICROBIAL ECOLOGY OC; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoshiyama K, 2009, AM NAT, V174, P190, DOI 10.1086/600113; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	99	101	101	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66765	10.1371/journal.pone.0066765	http://dx.doi.org/10.1371/journal.pone.0066765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826130	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400048
J	Han, M; Huang, XF; Chen, DC; Xiu, M; Kosten, TR; Zhang, XY				Han, Mei; Huang, Xu-Feng; Chen, Da Chun; Xiu, Meihong; Kosten, Thomas R.; Zhang, Xiang Yang			Diabetes and Cognitive Deficits in Chronic Schizophrenia: A Case-Control Study	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA; NEUROPSYCHOLOGICAL STATUS; REPEATABLE BATTERY; GENDER-DIFFERENCES; SOCIAL COGNITION; DETERMINANTS; PERFORMANCE; IMPAIRMENT; MEMORY; BRAIN	Cognitive impairment occurs in both schizophrenia and diabetes. There is currently limited understanding whether schizophrenia with diabetes has more serious cognitive deficits than schizophrenia without diabetes or diabetes only. This study assessed cognitive performance in 190 healthy controls, 106 diabetes only, 127 schizophrenia without diabetes and 55 schizophrenia with diabetes. This study was conducted from January 2008 to December 2010. Compared to healthy controls, all patient groups had significantly decreased total and five index RBANS scores (all p<0.01-p<0.001), except for the visuospatial/constructional index. Schizophrenia with diabetes performed worse than schizophrenia without diabetes in immediate memory (p<0.01) and total RBANS scores (<0.05), and showed a trend for decreased attention (p = 0.052) and visuospatial/constructional capacity (p = 0.063). Schizophrenia with diabetes performed worse than diabetes only in immediate memory (p<0.001) and attention (p<0.05), and showed a trend for decreased total RBANS scores (p = 0.069). Regression analysis showed that the RBANS had modest correlations with schizophrenia' PANSS scores, their duration of current antipsychotic treatment, and diagnosis of diabetes. Schizophrenia with co-morbid diabetes showed more cognitive impairment than schizophrenia without diabetes and diabetes only, especially in immediate memory and attention.	[Han, Mei; Huang, Xu-Feng] Univ Wollongong, Ctr Translat Neurosci, Sch Hlth Sci, IHMRI, Wollongong, NSW, Australia; [Han, Mei; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Chen, Da Chun; Xiu, Meihong; Kosten, Thomas R.; Zhang, Xiang Yang] Peking Univ, Beijing HuiLongGuan Hosp, Beijing 100871, Peoples R China; [Kosten, Thomas R.; Zhang, Xiang Yang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Kosten, Thomas R.; Zhang, Xiang Yang] Michael E DeBakey VA Med Ctr, Houston, TX USA	University of Wollongong; Peking University; Baylor College of Medicine; Baylor College of Medicine	Huang, XF (corresponding author), Univ Wollongong, Ctr Translat Neurosci, Sch Hlth Sci, IHMRI, Wollongong, NSW, Australia.	xhuang@uow.edu.au; xyzhang@bcm.edu	Huang, Xu-Feng/H-7408-2015; Huang, Xu-Feng/D-6053-2013; Kosten, Thomas/AAI-5998-2021	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; 	United States National Institutes of Health [U01-MH79639, K05-DA0454, P50-DA18827]; Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC); Stanley Medical Research Institute [03T-459, 05T-726]; National Health and Medical Research Committee of Australia (NHMRC) [635245]; Schizophrenia Research Institute (SRI) Australia; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000454] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC)(US Department of Veterans Affairs); Stanley Medical Research Institute; National Health and Medical Research Committee of Australia (NHMRC); Schizophrenia Research Institute (SRI) Australia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the United States National Institutes of Health U01-MH79639, K05-DA0454, P50-DA18827 and the Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC), and the Stanley Medical Research Institute (03T-459 and 05T-726), the National Health and Medical Research Committee of Australia (NHMRC) (635245) and the Schizophrenia Research Institute (SRI) Australia (2010). These funders had no further role in study design; in the collection, analysis and interpretation of data; in writing of the report; and in the decision to submit the paper for publication.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albus M, 2006, EUR ARCH PSY CLIN N, V256, P442, DOI 10.1007/s00406-006-0667-1; Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Cheng Y, 2011, ARCH MED SCI, V7, P850, DOI 10.5114/aoms.2011.25561; Condray Ruth, 2011, Front Biosci (Schol Ed), V3, P298, DOI 10.2741/s153; Convit A, 2005, NEUROBIOL AGING, V26, pS31, DOI 10.1016/j.neurobiolaging.2005.09.018; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Crosby-Nwaobi R, 2012, DIABETES RES CLIN PR, V96, P101, DOI 10.1016/j.diabres.2011.11.010; Daban C, 2005, J PSYCHIATR RES, V39, P391, DOI 10.1016/j.jpsychires.2004.09.001; De Silva PN, 2011, MED HYPOTHESES, V77, P529, DOI 10.1016/j.mehy.2011.06.022; Dickinson D, 2008, PSYCHOSOMATICS, V49, P123, DOI 10.1176/appi.psy.49.2.123; Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504; du Bois TM, 2009, EUR NEUROPSYCHOPHARM, V19, P256, DOI 10.1016/j.euroneuro.2008.12.002; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Guo Xiaofeng, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P724, DOI 10.3969/j.issn.1672-7347.2011.08.004; Hall J, 2010, PSYCHOL MED, V40, P761, DOI 10.1017/S0033291709991000; Han M, 2012, PROG NEURO-PSYCHOPH, V39, P358, DOI 10.1016/j.pnpbp.2012.07.010; Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100; Heckers S, 2010, CURR TOP BEHAV NEURO, V4, P529, DOI 10.1007/7854_2010_43; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; JAKOBSEN J, 1987, DIABETES, V36, P597, DOI 10.2337/diabetes.36.5.597; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2007, J CLIN PSYCHIAT, V68, P8; Konradi C, 2011, SCHIZOPHR RES, V131, P165, DOI 10.1016/j.schres.2011.06.007; Kumar Rajeev, 2009, Indian J Psychiatry, V51 Suppl 1, pS35; Leifker FR, 2009, SCHIZOPHR RES, V115, P82, DOI 10.1016/j.schres.2009.09.004; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Newcomer JW, 1999, SCHIZOPHRENIA BULL, V25, P321, DOI 10.1093/oxfordjournals.schbul.a033381; Papanikolaou Y, 2006, DIABETOLOGIA, V49, P855, DOI 10.1007/s00125-006-0183-x; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Ruis C, 2009, DIABETES CARE, V32, P1261, DOI 10.2337/dc08-2143; Shean Glenn D, 2007, Expert Rev Neurother, V7, P817, DOI 10.1586/14737175.7.7.817; Smith M, 2008, BRIT J PSYCHIAT, V192, P406, DOI 10.1192/bjp.bp.107.037184; Sota TL, 2003, SCHIZOPHR RES, V62, P175, DOI 10.1016/S0920-9964(02)00373-0; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens A, 2002, PSYCHOPHARMACOLOGY, V160, P299, DOI 10.1007/s00213-001-0974-1; Stone WS, 2011, NEUROBIOL LEARN MEM, V96, P544, DOI 10.1016/j.nlm.2011.04.006; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Umegaki H, 2012, GERIATR GERONTOL INT, V12, P103, DOI 10.1111/j.1447-0594.2011.00817.x; van den Berg E, 2006, DRUG TODAY, V42, P741, DOI 10.1358/dot.2006.42.11.1003542; Vaz-Serra A, 2010, ACTA MEDICA PORT, V23, P1043; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; [World Health Organization Organization WH], 1998, REP WHO CONS OB, P3; Zhang BH, 2009, RELIABILITY VALIDITY, V28, P865; Zhang XY, 2012, J CLIN PSYCHIAT, V73, P1025, DOI 10.4088/JCP.11m07422	57	16	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66299	10.1371/journal.pone.0066299	http://dx.doi.org/10.1371/journal.pone.0066299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840437	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800046
J	Liu, GH; Gasser, RB; Nejsum, P; Wang, Y; Chen, Q; Song, HQ; Zhu, XQ				Liu, Guo-Hua; Gasser, Robin B.; Nejsum, Peter; Wang, Yan; Chen, Qiang; Song, Hui-Qun; Zhu, Xing-Quan			Mitochondrial and Nuclear Ribosomal DNA Evidence Supports the Existence of a New Trichuris Species in the Endangered Francois' Leaf-Monkey	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NONHUMAN-PRIMATES; ITS1-5.8S-ITS2 SEGMENT; NEMATODA TRICHURIDAE; HELMINTH-PARASITES; TRICHIURA; SEQUENCE; SUIS; PIG; GENOMES	The whipworm of humans, Trichuris trichiura, is responsible for a neglected tropical disease (NTD) of major importance in tropical and subtropical countries of the world. Whipworms also infect animal hosts, including pigs, dogs and non-human primates, cause clinical disease (trichuriasis) similar to that of humans. Although Trichuris species are usually considered to be host specific, it is not clear whether non-human primates are infected with T. trichiura or other species. In the present study, we sequenced the complete mitochondrial (mt) genome as well as the first and second internal transcribed spacers (ITS-1 and ITS-2) of Trichuris from the Francois' leaf-monkey (langur), and compared them with homologous sequences from human-and pig-derived Trichuris. In addition, sequence comparison of a conserved mt ribosomal gene among multiple individual whipworms revealed substantial nucleotide differences among these three host species but limited sequence variation within each of them. The molecular data indicate that the monkey-derived whipworm is a separate species from that of humans. Future work should focus on detailed population genetic and morphological studies (by electron microscopy) of whipworms from various non-humans primates and humans.	[Liu, Guo-Hua; Wang, Yan; Song, Hui-Qun; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia; [Nejsum, Peter] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Nejsum, Peter] Univ Copenhagen, Dept Basic Anim & Vet Sci, Copenhagen, Denmark; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Chen, Qiang] Guangzhou ZhongDa Med Equipment Co Ltd, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Melbourne; University of Copenhagen; University of Copenhagen; Hunan Agricultural University	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia.	robinbg@unimelb.edu.au; xingquanzhu1@hotmail.com	Gasser, Robin/ABH-6185-2020	Gasser, Robin/0000-0002-4423-1690; Nejsum, Peter/0000-0002-6673-8505	International Science & Technology Cooperation Program of China [2013DFA31840]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Melbourne Water Corporation (MWC); Alexander von Humboldt Foundation	International Science & Technology Cooperation Program of China; Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Water Corporation (MWC); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the International Science & Technology Cooperation Program of China (Grant No. 2013DFA31840) to XQZ and RBG. This work was also supported by the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006) to XQZ. RBG's research is supported by the Australian Research Council (ARC), National Health and Medical Research Council (NHMRC) and Melbourne Water Corporation (MWC); the Alexander von Humboldt Foundation is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Callejon R, 2009, PARASITOL RES, V104, P715, DOI 10.1007/s00436-008-1280-1; Callejon R, 2012, VET PARASITOL, V186, P350, DOI 10.1016/j.vetpar.2011.11.033; Callejon R, 2010, PARASITOL RES, V107, P631, DOI 10.1007/s00436-010-1908-9; CHANDLER ASA C., 1930, JOUR PARASITOL, V16, P198, DOI 10.2307/3271514; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cutillas C, 2004, J PARASITOL, V90, P648, DOI 10.1645/GE-3295RN; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2009, ACTA TROP, V111, P299, DOI 10.1016/j.actatropica.2009.05.011; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; Robles MD, 2011, J PARASITOL, V97, P319, DOI 10.1645/GE-2434.1; DUBIN S, 1975, AM J PUBLIC HEALTH, V65, P1242, DOI 10.2105/AJPH.65.11.1242; Duckworth JW, 2010, PRIMATE CONSERV, P1; Gasser RB, 1999, INT J PARASITOL, V29, P1965, DOI 10.1016/S0020-7519(99)00153-8; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hu G, 2002, 19 C INT PRIM SOC 4, P74; Hu HG, 1993, J SICHUAN TEACH COLL, V14, P62; Hu M, 2002, INT J PARASITOL, V32, P145, DOI 10.1016/S0020-7519(01)00316-2; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Jex AR, 2010, BIOTECHNOL ADV, V28, P151, DOI 10.1016/j.biotechadv.2009.11.002; Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79; Khalafalla RE, 2011, PARASITOL RES, V108, P337, DOI 10.1007/s00436-010-2066-9; KNIGHT RA, 1971, J PARASITOL, V57, P302, DOI 10.2307/3278032; Lavrov DV, 2001, GENETICS, V157, P621; Legesse M, 2004, ACTA TROP, V90, P231, DOI 10.1016/j.actatropica.2003.12.003; Li HQ, 2007, J YANAN U NATURAL SC, V26, P60; Li YB, 2007, ORYX, V41, P38, DOI 10.1017/S0030605307001500; Lin K, 2011, FUJIAN ANIM HUSBANDR, V6, P1; Liu GH, 2013, J HELMINTHO IN PRESS; Liu GH, 2012, INFECT GENET EVOL, V12, P1635, DOI 10.1016/j.meegid.2012.08.005; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Liu GH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001539; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma Q, 2004, CHINESE J ZOOL, V39, P53; Michaud C, 2003, J MED PRIMATOL, V32, P341, DOI 10.1046/j.1600-0684.2003.00037.x; Munene E, 1998, VET PARASITOL, V78, P195, DOI 10.1016/S0304-4017(98)00143-5; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nissen S, 2012, VET PARASITOL, V188, P68, DOI 10.1016/j.vetpar.2012.03.004; Oliveros R, 2000, PARASITOL RES, V86, P1008, DOI 10.1007/PL00008519; OOI HK, 1993, J VET MED SCI, V55, P363, DOI 10.1292/jvms.55.363; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qi M, 2011, CHINA ANIM HUSBANDRY, V38, P188; Ravasi DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044187; Ravasi DF, 2012, S AFR J WILDL RES, V42, P35; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Salaba O, 2013, PARASITOL R IN PRESS; Spakulova, 1994, SYST PARASITOL, V29, P113; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traversa D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-32; Wei L.-y., 1990, Chinese Journal of Zoology, V25, P3; Yang MingHa, 1998, Chinese Journal of Veterinary Medicine, V24, P19; Zhu XQ, 1999, INT J PARASITOL, V29, P469, DOI 10.1016/S0020-7519(98)00226-4	60	35	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66249	10.1371/journal.pone.0066249	http://dx.doi.org/10.1371/journal.pone.0066249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840431	gold, Green Published			2022-12-25	WOS:000322342800043
J	Vaumourin, E; Gasqui, P; Buffet, JP; Chapuis, JL; Pisanu, B; Ferquel, E; Vayssier-Taussat, M; Vourc'h, G				Vaumourin, Elise; Gasqui, Patrick; Buffet, Jean-Philippe; Chapuis, Jean-Louis; Pisanu, Benoit; Ferquel, Elisabeth; Vayssier-Taussat, Muriel; Vourc'h, Gwenael			A Probabilistic Model in Cross-Sectional Studies for Identifying Interactions between Two Persistent Vector-Borne Pathogens in Reservoir Populations	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; BANK VOLES; DIFFERENTIAL TRANSMISSION; SPECIES COOCCURRENCE; COMMUNITY STRUCTURE; BARTONELLA SPP.; INFECTION; RODENTS	Background: In natural populations, individuals are infected more often by several pathogens than by just one. In such a context, pathogens can interact. This interaction could modify the probability of infection by subsequent pathogens. Identifying when pathogen associations correspond to biological interactions is a challenge in cross-sectional studies where the sequence of infection cannot be demonstrated. Methodology/Principal Findings: Here we modelled the probability of an individual being infected by one and then another pathogen, using a probabilistic model and maximum likelihood statistics. Our model was developed to apply to cross-sectional data, vector-borne and persistent pathogens, and to take into account confounding factors. Our modelling approach was more powerful than the commonly used Chi-square test of independence. Our model was applied to detect potential interaction between Borrelia afzelii and Bartonella spp. that infected a bank vole population at 11% and 57% respectively. No interaction was identified. Conclusions/Significance: The modelling approach we proposed is powerful and can identify the direction of potential interaction. Such an approach can be adapted to other types of pathogens, such as non-persistents. The model can be used to identify when co-occurrence patterns correspond to pathogen interactions, which will contribute to understanding how organism communities are assembled and structured. In the long term, the model's capacity to better identify pathogen interactions will improve understanding of infectious risk.	[Vaumourin, Elise; Gasqui, Patrick; Vourc'h, Gwenael] INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France; [Vaumourin, Elise; Buffet, Jean-Philippe; Vayssier-Taussat, Muriel] INRA, USC Bartonella & Tiques, Maisons Alfort, France; [Chapuis, Jean-Louis; Pisanu, Benoit] Museum Natl Hist Nat, UMR CNRS CERSP P6 7204, F-75231 Paris, France; [Ferquel, Elisabeth] Inst Pasteur, Equipe Borrelia, Paris, France	INRAE; INRAE; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vaumourin, E (corresponding author), INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France.	elise.vaumourin@clermont.inra.fr			Animal Health department of National Institute of Agronomic Research; Auvergne region; Metaprogramme MEM (projet Patho-ID) of INRA; EU [FP7-261504 EDENext]	Animal Health department of National Institute of Agronomic Research; Auvergne region(Region Auvergne-Rhone-Alpes); Metaprogramme MEM (projet Patho-ID) of INRA; EU(European Commission)	This modelling work was supported by the Animal Health department of National Institute of Agronomic Research (http://www.inra.fr), Auvergne region (http://www.auvergnesciences.com), the Metaprogramme MEM (projet Patho-ID) of INRA and the EU grant FP7-261504 EDENext. It is catalogued by the EDENext Steering Committee as EDENext090 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anguita J, 2003, FEMS MICROBIOL REV, V27, P493, DOI 10.1016/S0168-6445(03)00036-6; Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10; Bajer A, 2001, PARASITOLOGY, V122, P43, DOI 10.1017/S0031182000007058; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Bergemann Tracy L, 2012, J Biom Biostat, VSuppl 7; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Bown KJ, 2004, EMERG INFECT DIS, V10, P684, DOI 10.3201/eid1004.030455; Buffet JP, 2012, COMP IMMUNOL MICROB, V35, P583, DOI 10.1016/j.cimid.2012.07.002; Chomel BB, 2009, VET RES, V40, p1 22; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Fabre F, 2010, J THEOR BIOL, V265, P377, DOI 10.1016/j.jtbi.2010.04.027; Fenner AL, 2011, J ANIM ECOL, V80, P835, DOI 10.1111/j.1365-2656.2011.01825.x; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Greene CE, 1996, J CLIN MICROBIOL, V34, P1682, DOI 10.1128/JCM.34.7.1682-1685.1996; Halos L, 2005, VET RES, V36, P79, DOI 10.1051/vetres:2004052; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hellard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029618; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Kosoy M, 2004, VECTOR-BORNE ZOONOT, V4, P296, DOI 10.1089/vbz.2004.4.296; Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; LUFT BJ, 1993, RES MICROBIOL, V144, P251, DOI 10.1016/0923-2508(93)90009-Q; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Maurer JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/annurev.food.080708.100730; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Paziewska A, 2012, PARASITOLOGY, V139, P881, DOI 10.1017/S0031182012000170; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Saisongkorh Watcharee, 2009, Journal of the Medical Association of Thailand, V92, P707; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinski E, 2006, ANN AGR ENV MED, V13, P295; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Slots J, 2003, J PERIODONTAL RES, V38, P318, DOI 10.1034/j.1600-0765.2003.00659.x; Sonenshine D.E., 1993, BIOL TICKS; Soubeyrand S, 2007, J R SOC INTERFACE, V4, P985, DOI 10.1098/rsif.2007.1154; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Tadin A, 2012, VECTOR-BORNE ZOONOT, V12, P388, DOI 10.1089/vbz.2011.0632; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tello JS, 2008, OIKOS, V117, P693, DOI [10.1111/j.2008.0030-1299.16212.x, 10.1111/j.0030-1299.2008.16212.x]; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Tsai YL, 2010, AM J TROP MED HYG, V83, P917, DOI 10.4269/ajtmh.2010.10-0083; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	60	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66167	10.1371/journal.pone.0066167	http://dx.doi.org/10.1371/journal.pone.0066167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840418	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800039
J	Lefevre, J; Savarin, P; Gans, P; Hamon, L; Clement, MJ; David, MO; Bosc, C; Andrieux, A; Curmi, PA				Lefevre, Julien; Savarin, Philippe; Gans, Pierre; Hamon, Loic; Clement, Marie-Jeanne; David, Marie-Odile; Bosc, Christophe; Andrieux, Annie; Curmi, Patrick A.			Structural Basis for the Association of MAP6 Protein with Microtubules and Its Regulation by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-STABLE MICROTUBULES; STOP GENE MTAP6; BINDING DOMAIN; IN-VITRO; TUBULIN; BRAIN; PHOSPHORYLATION; SCHIZOPHRENIA; EXPRESSION; STABILITY	Microtubules are highly dynamic alpha beta-tubulin polymers. In vitro and in living cells, microtubules are most often cold-and nocodazole-sensitive. When present, the MAP6/STOP family of proteins protects microtubules from cold-and nocodazole-induced depolymerization but the molecular and structure determinants by which these proteins stabilize microtubules remain under debate. We show here that a short protein fragment from MAP6-N, which encompasses its Mn1 and Mn2 modules (MAP6(90-177)), recapitulates the function of the full-length MAP6-N protein toward microtubules, i.e. its ability to stabilize microtubules in vitro and in cultured cells in ice-cold conditions or in the presence of nocodazole. We further show for the first time, using biochemical assays and NMR spectroscopy, that these effects result from the binding of MAP6(90-177) to microtubules with a 1:1 MAP6(90-177): tubulin heterodimer stoichiometry. NMR data demonstrate that the binding of MAP6(90-177) to microtubules involve its two Mn modules but that a single one is also able to interact with microtubules in a closely similar manner. This suggests that the Mn modules represent each a full microtubule binding domain and that MAP6 proteins may stabilize microtubules by bridging tubulin heterodimers from adjacent protofilaments or within a protofilament. Finally, we demonstrate that Ca2+-calmodulin competes with microtubules for MAP6(90-177) binding and that the binding mode of MAP6(90-177) to microtubules and Ca2+-calmodulin involves a common stretch of amino acid residues on the MAP6(90-177) side. This result accounts for the regulation of microtubule stability in cold condition by Ca2+-calmodulin.	[Lefevre, Julien; Savarin, Philippe; Hamon, Loic; Clement, Marie-Jeanne; David, Marie-Odile; Curmi, Patrick A.] Univ Evry Val dEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France; [Gans, Pierre] Inst Biol Struct Jean Pierre Ebel, Lab Resonance Magnet Nucl, F-38027 Grenoble, France; [Bosc, Christophe; Andrieux, Annie] Univ Grenoble 1, Team Physiopathol Cytosquelette, INSERM, U836,Inst Neurosci,CEA,iRTSV,GPC, F-38042 Grenoble 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lefevre, J (corresponding author), Univ Evry Val dEssonne, INSERM, UMR829, Lab Struct Activite Biomol Normales & Pathol, F-91025 Evry, France.	julien.lefevre@univ-evry.fr; pcurmi@univ-evry.fr	Bosc, Christophe/Q-8877-2019; DAVID, Marie-Odile/AAE-2972-2021; David, Marie-Odile MO/B-2917-2014; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; CURMI, Patrick/G-4036-2013	Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; hamon, loic/0000-0003-2032-7994; CURMI, Patrick A./0000-0001-5045-8501	PRES UniversSud	PRES UniversSud	Recipient of a postdoctoral fellowship from the PRES UniversSud. To whom correspondence may be addressed. Tel.: 33-1-69-47-01-83; E-mail: julien.lefevre@univ-evry.fr.	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BAN C, 1994, ACTA CRYSTALLOGR D, V50, P50, DOI 10.1107/S0907444993007991; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Benardais K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012753; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Bonnet C, 2002, BIOCHEM BIOPH RES CO, V297, P787, DOI 10.1016/S0006-291X(02)02294-5; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Bouvier D, 2003, BIOCHEMISTRY-US, V42, P11484, DOI 10.1021/bi034746w; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delotterie D, 2010, PSYCHOPHARMACOLOGY, V208, P131, DOI 10.1007/s00213-009-1712-3; Delphin C, 2012, J BIOL CHEM, V287, P35127, DOI 10.1074/jbc.M112.398339; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Denarier E, 1998, BIOCHEM BIOPH RES CO, V243, P791, DOI 10.1006/bbrc.1998.8179; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOB D, 1982, BIOCHEMISTRY-US, V21, P509, DOI 10.1021/bi00532a015; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAKIUCHI S, 1981, FEBS LETT, V132, P141, DOI 10.1016/0014-5793(81)80448-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE YC, 1984, J BIOL CHEM, V259, P8041; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Makarov AA, 2007, BIOCHEMISTRY-US, V46, P14899, DOI 10.1021/bi701803s; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MARGOLIS RL, 1990, EMBO J, V9, P4095, DOI 10.1002/j.1460-2075.1990.tb07631.x; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P110, DOI 10.3109/15622970903490626; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MINAMI Y, 1993, J BIOL CHEM, V268, P9604; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; PADILLA R, 1990, MOL CELL BIOCHEM, V97, P35; Shimizu H, 2006, SCHIZOPHR RES, V84, P244, DOI 10.1016/j.schres.2006.03.017; WEBB BC, 1980, BIOCHEMISTRY-US, V19, P1993, DOI 10.1021/bi00550a041; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	51	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24910	24922		10.1074/jbc.M113.457267	http://dx.doi.org/10.1074/jbc.M113.457267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23831686	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000330612300055
J	Dudkiewicz, M; Lenart, A; Pawlowski, K				Dudkiewicz, Malgorzata; Lenart, Anna; Pawlowski, Krzysztof			A Novel Predicted Calcium-Regulated Kinase Family Implicated in Neurological Disorders	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; CYSTEINE-RICH DOMAIN; CRYSTAL-STRUCTURE; GOLGI PROTEIN; SEQUENCE; AUTISM; PHOSPHORYLATES; CANCER; SERVER; GENES	The catalogues of protein kinases, the essential effectors of cellular signaling, have been charted in Metazoan genomes for a decade now. Yet, surprisingly, using bioinformatics tools, we predicted protein kinase structure for proteins coded by five related human genes and their Metazoan homologues, the FAM69 family. Analysis of three-dimensional structure models and conservation of the classic catalytic motifs of protein kinases present in four out of five human FAM69 proteins suggests they might have retained catalytic phosphotransferase activity. An EF-hand Ca2+-binding domain in FAM69A and FAM69B proteins, inserted within the structure of the kinase domain, suggests they may function as Ca2+-dependent kinases. The FAM69 genes, FAM69A, FAM69B, FAM69C, C3ORF58 (DIA1) and CXORF36 (DIA1R), are by large uncharacterised molecularly, yet linked to several neurological disorders in genetics studies. The C3ORF58 gene is found deleted in autism, and resides in the Golgi. Unusually high cysteine content and presence of signal peptides in some of the family members suggest that FAM69 proteins may be involved in phosphorylation of proteins in the secretory pathway and/or of extracellular proteins.	[Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland; [Lenart, Anna; Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Warsaw, Poland.	krzysztof_pawlowski@sggw.pl	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Dudkiewicz, Malgorzata/0000-0003-4432-2530				Alcina A, 2010, EUR J HUM GENET, V18, P827, DOI 10.1038/ejhg.2009.240; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014534; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014547; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Beltrami A, 2011, CRYSTAL STRUCTURE HU; Bonardi V, 2012, CURR OPIN IMMUNOL, V24, P41, DOI 10.1016/j.coi.2011.12.006; Boudsocq M, 2012, BIOCHEM J, V447, P291, DOI 10.1042/BJ20112072; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Hall T, 2012, BIOEDIT; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Imuta Y, 2009, DEV DYNAM, V238, P210, DOI 10.1002/dvdy.21822; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jensen LR, 2007, EUR J HUM GENET, V15, P68, DOI 10.1038/sj.ejhg.5201714; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Kinoshita M, 2009, DEVELOPMENT, V136, P2069, DOI 10.1242/dev.026435; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molendijk AJ, 2008, PLANT J, V53, P909, DOI 10.1111/j.1365-313X.2007.03384.x; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakagawa H, 2011, INT J BIOCHEM CELL B, V43, P423, DOI 10.1016/j.biocel.2010.11.015; Papoian GA, 2004, P NATL ACAD SCI USA, V101, P3352, DOI 10.1073/pnas.0307851100; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prichard MN, 2009, REV MED VIROL, V19, P215, DOI 10.1002/rmv.615; Ruiz-Trillo I, 2004, CURR BIOL, V14, pR946, DOI 10.1016/j.cub.2004.10.037; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samir Amina Azizi, 2000, Molecular Cell Biology Research Communications, V4, P188, DOI 10.1006/mcbr.2000.0277; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Suga H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002733; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Takatalo MS, 2009, J DENT RES, V88, P534, DOI 10.1177/0022034509338452; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tennant-Eyles AJ, 2011, BIOCHEM BIOPH RES CO, V406, P471, DOI 10.1016/j.bbrc.2011.02.076; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	88	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66427	10.1371/journal.pone.0066427	http://dx.doi.org/10.1371/journal.pone.0066427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840464	gold, Green Published, Green Submitted			2022-12-25	WOS:000321148400013
J	Boyle, PA; Yu, L; Gamble, KJ; Bennett, DA				Boyle, Patricia A.; Yu, Lei; Gamble, Keith J.; Bennett, David A.			Temporal Discounting Is Associated with an Increased Risk of Mortality among Community-Based Older Persons without Dementia	PLOS ONE			English	Article							DELAYED REWARDS; AGE-DIFFERENCES; LIFE; RATES; PREFERENCES	Background: Temporal discounting is an important determinant of many health and financial outcomes, but we are not aware of studies that have examined the association of temporal discounting with mortality. Methods: Participants were 406 older persons without dementia from the Rush Memory and Aging Project, a longitudinal cohort study of aging. Temporal discounting was measured using standard preference elicitation questions. Individual discount rates were estimated using a well-established hyperbolic function and used to predict the risk of mortality during up to 5 years of follow-up. Results: The mean estimate of discounting was 0.45 (SD = 0.33, range: 0.08-0.90), with higher scores indicating a greater propensity to prefer smaller immediate rewards over larger but delayed ones. During up to 5 years of follow-up (mean = 3.6 years), 62 (15% of 406) persons died. In a proportional hazards model adjusted for age, sex, and education, temporal discounting was associated with an increased risk of mortality (HR = 1.103, 95% CI 1.024, 1.190, p = 0.010). Thus, a person with the highest discount rate (score = 0.90) was about twice more likely to die over the study period compared to a person with the lowest discount rate (score = 0.08). Further, the association of discounting with mortality persisted after adjustment for the level of global cognitive function, the burden of vascular risk factors and diseases, and an indicator of psychological well being (i.e., purpose in life). Conclusion: Temporal discounting is associated with an increased risk of mortality in old age after accounting for global cognitive function and indicators of physical and mental health.	[Boyle, Patricia A.; Yu, Lei; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Boyle, Patricia A.] Rush Univ, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA; [Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gamble, Keith J.] Depaul Univ, Dept Finance, Chicago, IL 60604 USA	Rush University; Rush University; Rush University; DePaul University	Boyle, PA (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.	Patricia_Boyle@rush.edu	Yu, Lei/AAT-3685-2020		National Institute on Aging [R21AG30765, R01AG17917, R01AG34374, R01AG33678]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [R01AG034374, R01AG017917, R01AG033678] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants R21AG30765 (Bennett), R01AG17917 (Bennett), R01AG34374 (Boyle), R01AG33678 (Boyle), and the Illinois Department of Public Health. The funding agencies had no role in the design, conduct, or interpretation of the data or preparation of the manuscript.	Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2012, ANN NEUROL, V72, P599, DOI 10.1002/ana.23654; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Hesketh B, 1988, J VOCAT BEHAV, V52, P89; Hsu M, 2008, ADV HEALTH ECON HEAL, V20, P203, DOI 10.1016/S0731-2199(08)20009-9; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Laibson D, 1998, EUR ECON REV, V42, P861, DOI 10.1016/S0014-2921(97)00132-3; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; Meier S, 2010, AM ECON J-APPL ECON, V2, P193, DOI 10.1257/app.2.1.193; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; SAS Institute, SAS STAT US GUID VER; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Taylor M., 2009, FINANCIAL CAPABILITY; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661	29	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67376	10.1371/journal.pone.0067376	http://dx.doi.org/10.1371/journal.pone.0067376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826281	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000070
J	Parets, SE; Conneely, KN; Kilaru, V; Fortunato, SJ; Syed, TA; Saade, G; Smith, AK; Menon, R				Parets, Sasha E.; Conneely, Karen N.; Kilaru, Varun; Fortunato, Stephen J.; Syed, Tariq Ali; Saade, George; Smith, Alicia K.; Menon, Ramkumar			Fetal DNA Methylation Associates with Early Spontaneous Preterm Birth and Gestational Age	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; CORTICOTROPIN-RELEASING HORMONE; HUMAN-PREGNANCY; MEMBRANE RUPTURE; GROWTH; DISEASE; ARRAY; RISK; TRANSCRIPTION; EPIGENETICS	Spontaneous preterm birth (PTB, <37 weeks gestation) is a major public health concern, and children born preterm have a higher risk of morbidity and mortality throughout their lives. Recent studies suggest that fetal DNA methylation of several genes varies across a range of gestational ages (GA), but it is not yet clear if fetal epigenetic changes associate with PTB. The objective of this study is to interrogate methylation patterns across the genome in fetal leukocyte DNA from African Americans with early PTB (24(1/7)-34(0/7) weeks; N = 22) or term births (39(0/7)-40(6/7) weeks; N = 28) and to evaluate the association of each CpG site with PTB and GA. DNA methylation was assessed across the genome with the HumanMethylation450 BeadChip. For each individual sample and CpG site, the proportion of DNA methylation was estimated. The associations between methylation and PTB or GA were evaluated by fitting a separate linear model for each CpG site, adjusting for relevant covariates. Overall, 29 CpG sites associated with PTB (FDR<.05; 5.7x10(-10)<p<2.9x10(-6)) independent of GA. Also, 9637 sites associated with GA (FDR<.05; 9.5x10(-16)<p<1.0x10(-3)), with 61.8% decreasing in methylation with shorter GA. GA-associated CpG sites were depleted in the CpG islands of their respective genes (p<2.2x10(-16)). Gene set enrichment analysis (GSEA) supported enrichment of GA-associated CpG sites in genes that play a role in embryonic development as well as the extracellular matrix. Additionally, this study replicated the association of several CpG sites associated with gestational age in other studies (CRHBP, PIK3CD and AVP). Dramatic differences in fetal DNA methylation are evident in fetuses born preterm versus at term, and the patterns established at birth may provide insight into the long-term consequences associated with PTB.	[Parets, Sasha E.; Smith, Alicia K.] Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA; [Conneely, Karen N.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA USA; [Kilaru, Varun; Smith, Alicia K.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA; [Syed, Tariq Ali; Saade, George; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA	Emory University; Emory University; Emory University; University of Texas System; University of Texas Medical Branch Galveston	Smith, AK (corresponding author), Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA.	alicia.smith@emory.edu; Ram.menon@utmb.edu	Fortunato, Stephen J/L-7545-2013; Smith, Alicia/W-6809-2019	Smith, Alicia/0000-0002-8537-5156	March of Dimes, USA [21-FY08-557]; NIMH [MH085806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	March of Dimes, USA(March of Dimes); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by Grants from March of Dimes, USA (#21-FY08-557) to R Menon and NIMH (MH085806) to Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Aparicio IM, 2010, REPRODUCTION, V140, P83, DOI 10.1530/REP-10-0040; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Barker DJP, 2010, EUR J HEART FAIL, V12, P819, DOI 10.1093/eurjhf/hfq069; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, PRETERM BIRTH CAUSES; Beyan H, 2012, GENOME RES, V22, P2138, DOI 10.1101/gr.134304.111; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botsis D, 2006, EUR J OBSTET GYN R B, V128, P108, DOI 10.1016/j.ejogrb.2005.10.022; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fortunato SJ, 1999, J PERINAT MED, V27, P362, DOI 10.1515/JPM.1999.049; Ginder GD, 2008, CURR TOP DEV BIOL, V82, P85, DOI 10.1016/S0070-2153(07)00004-X; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harris SJ, 2009, CURR OPIN INVEST DR, V10, P1151; Hillhouse EW, 2002, REPRODUCTION, V124, P323, DOI 10.1530/reprod/124.3.323; Hobel CJ, 1999, ANN NY ACAD SCI, V897, P54, DOI 10.1111/j.1749-6632.1999.tb07878.x; Hogg K, 2012, CLIN PHARMACOL THER, V92, P716, DOI 10.1038/clpt.2012.141; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jeffcoat M K, 2001, Ann Periodontol, V6, P183, DOI 10.1902/annals.2001.6.1.183; Kilaru V, 2012, EPIGENETICS-US, V7, P225, DOI 10.4161/epi.7.3.19284; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; LOCKWOOD CJ, 1994, AM J OBSTET GYNECOL, V171, P146, DOI 10.1016/0002-9378(94)90461-8; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Martina NA, 1997, J CLIN ENDOCR METAB, V82, P1894, DOI 10.1210/jc.82.6.1894; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P887, DOI 10.1067/mob.2000.108878; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Menon R, 2012, REPROD SCI, V19, P6, DOI 10.1177/1933719111424446; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; PERKINS AV, 1993, J ENDOCRINOL, V138, P149, DOI 10.1677/joe.0.1380149; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Romero R, 2002, AM J OBSTET GYNECOL, V187, P1125, DOI 10.1067/mob.2002.127312; Rutanen EM, 1996, CLIN CHIM ACTA, V253, P91, DOI 10.1016/0009-8981(96)80001-E; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Stunkel W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039744; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tency I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049042; Vogel I, 2004, IN VIVO, V18, P37; Wang DL, 2012, EPIGENETICS-US, V7, P594, DOI 10.4161/epi.20117; Watanabe T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003132; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Yuan W, 2001, EUR J EPIDEMIOL, V17, P829, DOI 10.1023/A:1015626329533	58	69	69	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67489	10.1371/journal.pone.0067489	http://dx.doi.org/10.1371/journal.pone.0067489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826308	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000084
J	Haeno, H; Maruvka, YE; Iwasa, Y; Michor, F				Haeno, Hiroshi; Maruvka, Yosef E.; Iwasa, Yoh; Michor, Franziska			Stochastic Tunneling of Two Mutations in a Population of Cancer Cells	PLOS ONE			English	Article							COLORECTAL-CANCER; DYNAMICS; INSTABILITY; INITIATION; EVOLUTION; LEUKEMIA; THERAPY; CRYPT; MODEL; TIME	Cancer initiation, progression, and the emergence of drug resistance are driven by specific genetic and/or epigenetic alterations such as point mutations, structural alterations, DNA methylation and histone modification changes. These alterations may confer advantageous, deleterious or neutral effects to mutated cells. Previous studies showed that cells harboring two particular alterations may arise in a fixed-size population even in the absence of an intermediate state in which cells harboring only the first alteration take over the population; this phenomenon is called stochastic tunneling. Here, we investigated a stochastic Moran model in which two alterations emerge in a cell population of fixed size. We developed a novel approach to comprehensively describe the evolutionary dynamics of stochastic tunneling of two mutations. We considered the scenarios of large mutation rates and various fitness values and validated the accuracy of the mathematical predictions with exact stochastic computer simulations. Our theory is applicable to situations in which two alterations are accumulated in a fixed-size population of binary dividing cells.	[Haeno, Hiroshi; Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Maruvka, Yosef E.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Maruvka, Yosef E.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Iwasa, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	yohiwasa@kyudai.jp; michor@jimmy.harvard.edu	Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852; Maruvka, Yosef/0000-0002-8918-9887	NCI; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altland A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.088101; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Iwasa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017866; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lehmann L, 2009, THEOR POPUL BIOL, V76, P35, DOI 10.1016/j.tpb.2009.03.006; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 2001, CANCER RES, V61, P3230; Lynch M, 2010, P NATL ACAD SCI USA, V107, P16577, DOI 10.1073/pnas.1010836107; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2004, CELL CYCLE, V3, P358; Moran P., 1962, STAT PROCESSES EVOLU; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; Perucho M, 1996, BIOL CHEM, V377, P675; Proulx SR, 2011, THEOR POPUL BIOL, V80, P197, DOI 10.1016/j.tpb.2011.07.003; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schweinsberg J, 2008, ELECTRON J PROBAB, V13, P1442, DOI 10.1214/EJP.v13-540; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Weinreich DM, 2005, EVOLUTION, V59, P1175; Weissman DB, 2010, GENETICS, V186, P1389, DOI 10.1534/genetics.110.123240; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65724	10.1371/journal.pone.0065724	http://dx.doi.org/10.1371/journal.pone.0065724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840359	Green Published, gold, Green Submitted			2022-12-25	WOS:000321424400011
J	Tsekouras, K; Goncharenko, I; Colvin, ME; Huang, KC; Gopinathan, A				Tsekouras, Konstantinos; Goncharenko, Igor; Colvin, Michael E.; Huang, Kerwyn Casey; Gopinathan, Ajay			Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell Targeting	PLOS ONE			English	Article							LOW-AFFINITY; MULTIVALENCY; SURFACE	Although targeting of cancer cells using drug-delivering nanocarriers holds promise for improving therapeutic agent specificity, the strategy of maximizing ligand affinity for receptors overexpressed on cancer cells is suboptimal. To determine design principles that maximize nanocarrier specificity for cancer cells, we studied a generalized kinetics-based theoretical model of nanocarriers with one or more ligands that specifically bind these overexpressed receptors. We show that kinetics inherent to the system play an important role in determining specificity and can in fact be exploited to attain orders of magnitude improvement in specificity. In contrast to the current trend of therapeutic design, we show that these specificity increases can generally be achieved by a combination of low rates of endocytosis and nanocarriers with multiple low-affinity ligands. These results are broadly robust across endocytosis mechanisms and drug-delivery protocols, suggesting the need for a paradigm shift in receptor-targeted drug-delivery design.	[Tsekouras, Konstantinos; Goncharenko, Igor; Gopinathan, Ajay] Univ Calif Merced, Dept Phys, Merced, CA USA; [Colvin, Michael E.] Univ Calif Merced, Dept Chem & Biochem, Merced, CA USA; [Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Merced; University of California System; University of California Merced; Stanford University	Huang, KC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	kchuang@stanford.edu; agopinathan@ucmerced.edu		Tsekouras, Konstantinos/0000-0002-4936-5620; Gopinathan, Ajay/0000-0002-9369-8780	National Science Foundation [EF-1038697]; James S. McDonnell Foundation; University of California Institute for Mexico; United States (UC MEXUS); George E. Brown, Jr. Award	National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation; University of California Institute for Mexico; United States (UC MEXUS); George E. Brown, Jr. Award	The authors acknowledge support from National Science Foundation grant EF-1038697. AG also acknowledges support from a James S. McDonnell Foundation Award, a University of California Institute for Mexico and the United States (UC MEXUS) grant, and a George E. Brown, Jr. Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2011, CURR MED CHEM, V18, P1367; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Badjic JD, 2005, ACCOUNTS CHEM RES, V38, P723, DOI 10.1021/ar040223k; Baker M, 2010, NATURE, V464, P1225, DOI 10.1038/4641225a; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Hlavacek WS, 2002, MATH BIOSCI, V176, P185, DOI 10.1016/S0025-5564(02)00091-3; Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Joshi A, 2008, CHEM-EUR J, V14, P7738, DOI 10.1002/chem.200800278; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kolomeisky AB, 2011, J PHYS CHEM LETT, V2, P1502, DOI 10.1021/jz2004914; Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273; Licata NA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158102; Martinez-Veracoechea FJ, 2011, P NATL ACAD SCI USA, V108, P10963, DOI 10.1073/pnas.1105351108; Mulder A, 2004, ORG BIOMOL CHEM, V2, P3409, DOI 10.1039/b413971b; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Poirier C, 2008, BBA-BIOMEMBRANES, V1778, P2450, DOI 10.1016/j.bbamem.2008.07.005; Rolland O, 2009, NEW J CHEM, V33, P1809, DOI 10.1039/b901054h; Ross JF, 1994, CANCER, V73, P9; Wang SH, 2011, SOFT MATTER, V7, P4435, DOI 10.1039/c0sm01417f; Wu AM, 2005, NAT 245 BIOTECHNOL, V23, P9	25	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65623	10.1371/journal.pone.0065623	http://dx.doi.org/10.1371/journal.pone.0065623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840346	gold, Green Submitted, Green Published			2022-12-25	WOS:000321424400009
J	Ge, J; Tian, AX; Wang, QS; Kong, PZ; Yu, Y; Li, XQ; Cao, XC; Feng, YM				Ge, Jie; Tian, Ai-Xian; Wang, Qing-Shan; Kong, Peng-Zhou; Yu, Yue; Li, Xiao-Qing; Cao, Xu-Chen; Feng, Yu-Mei			The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GENETIC POLYMORPHISMS; ADJUVANT CHEMOTHERAPY; P1 POLYMORPHISMS; GSTM1; GSTT1; M1; T1; SUSCEPTIBILITY; METABOLISM	The glutathione-S-transferase (GST) family contributes to the inactivation of various toxic compounds formed as secondary metabolites during oxidative stress. GSTP1 accounts for the majority of the GST family enzymatic activity, and the activity of GSTP1 enzyme can be altered by the presence of the Ile105Val polymorphism. In this study, we examined the polymorphic frequency of GSTP1 Ile105Val genotype in 920 breast cancer patients and 783 healthy controls in women of North China. Results showed that GSTP1 105Val allele (Ile/Val and Val/Val) was associated with a higher breast cancer risk (OR = 1.38, 95% CI: 1.14-1.69; P = 0.001) and more aggressive tumors with histological grade III (OR = 1.15, 95% CI: 1.05-1.26; P = 0.001), lymph node metastases (OR = 2.35, 95% CI: 1.72-3.21; P < 0.001), as well as ER negative (OR = 1.77, 95% CI: 1.31-2.39; P < 0.001) than those carrying the Ile/Ile allele. However, the patients with the GSTP1 105Val genotype had a better disease free survival after cyclophosphamide (CTX)-based chemotherapy than those with Ile/Ile (HR = 0.77, 95% CI: 0.45-0.91; P < 0.001). Furthermore, in vitro cellular experiments demonstrated that breast cancer cells with the GSTP1 105Val allele were significantly more sensitive to CTX-induced proliferation inhibition. Thus, we conclude that the GSTP1 105Val allele increases breast cancer risk and aggressiveness and enhance response to CTX-based chemotherapy in women of North China. Detection of the GSTP1 Ile105Val genotype may help screen for high-risk populations and direct individualized therapy.	[Ge, Jie; Tian, Ai-Xian; Wang, Qing-Shan; Kong, Peng-Zhou; Yu, Yue; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Ge, Jie; Cao, Xu-Chen] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Surg, Tianjin, Peoples R China; [Ge, Jie; Wang, Qing-Shan; Li, Xiao-Qing; Cao, Xu-Chen; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Treatment, Minist Educ, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	ymfeng@tijmu.edu.cn	Yu, Yue/AAG-8381-2020	Yu, Yue/0000-0003-2053-9866	National Natural Science Foundation of China [30872518, 81272357]; Major Program of Applied Basic Research Projects of Tianjin [06YFJMJC12900, 09JCZDJC19800]; Technology Program of Tianjin Health Bureau [2011kZ83]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin; Technology Program of Tianjin Health Bureau	This study was supported by the National Natural Science Foundation of China (No. 30872518 and No. 81272357), the Major Program of Applied Basic Research Projects of Tianjin (No. 06YFJMJC12900 and No. 09JCZDJC19800) and the Technology Program of Tianjin Health Bureau (No. 2011kZ83). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Chen XH, 2011, BREAST CANCER RES TR, V125, P575, DOI 10.1007/s10549-010-1032-7; Chia S, 2008, J CLIN ONCOL, V26, P786, DOI 10.1200/JCO.2008.15.0243; Curran JE, 2000, CANCER LETT, V153, P113, DOI 10.1016/S0304-3835(00)00361-X; DIRVEN HAAM, 1994, CANCER RES, V54, P6215; Egan KM, 2004, CANCER EPIDEM BIOMAR, V13, P197, DOI 10.1158/1055-9965.EPI-03-0294; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Hohaus S, 2005, CLIN CANCER RES, V11, P2175, DOI 10.1158/1078-0432.CCR-04-1250; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansson AS, 1998, J MOL BIOL, V278, P687, DOI 10.1006/jmbi.1998.1708; Kadouri L, 2008, BRIT J CANCER, V98, P2006, DOI 10.1038/sj.bjc.6604394; Kim SU, 2004, J BIOCHEM MOL BIOL, V37, P582; Lee SA, 2008, AM J CLIN NUTR, V87, P753, DOI 10.1093/ajcn/87.3.753; Levine MN, 2006, NEW ENGL J MED, V355, P1920, DOI 10.1056/NEJMe068204; Millikan R, 2000, CANCER EPIDEM BIOMAR, V9, P567; Mitrunen K, 2001, CANCER EPIDEM BIOMAR, V10, P229; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Samson M, 2007, ASIAN PAC J CANCER P, V8, P253; Saxena A, 2012, EXP THER MED, V4, P1097, DOI 10.3892/etm.2012.710; Saxena A, 2009, BREAST CANCER RES TR, V115, P537, DOI 10.1007/s10549-008-0098-y; SCHRODER KR, 1995, ARCH TOXICOL, V69, P505, DOI 10.1007/s002040050205; Sergentanis TN, 2010, BREAST CANCER RES TR, V121, P195, DOI 10.1007/s10549-009-0520-0; Sivonova M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-32; Smith G, 1995, CANCER SURV, V25, P27; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vogl FD, 2004, CANCER EPIDEM BIOMAR, V13, P1473; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; White DL, 2008, AM J EPIDEMIOL, V167, P377, DOI 10.1093/aje/kwm315; Yang G, 2005, CANCER-AM CANCER SOC, V103, P52, DOI 10.1002/cncr.20729; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023	35	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67589	10.1371/journal.pone.0067589	http://dx.doi.org/10.1371/journal.pone.0067589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826324	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400160
J	Liu, YC; Ferguson, JF; Xue, CY; Silverman, IM; Gregory, B; Reilly, MP; Li, MY				Liu, Yichuan; Ferguson, Jane F.; Xue, Chenyi; Silverman, Ian M.; Gregory, Brian; Reilly, Muredach P.; Li, Mingyao			Evaluating the Impact of Sequencing Depth on Transcriptome Profiling in Human Adipose	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; INFLAMMATION; ENDOTOXIN; DISEASE; BIOMARKERS	Recent advances in RNA sequencing (RNA-Seq) have enabled the discovery of novel transcriptomic variations that are not possible with traditional microarray-based methods. Tissue and cell specific transcriptome changes during pathophysiological stress in disease cases versus controls and in response to therapies are of particular interest to investigators studying cardiometabolic diseases. Thus, knowledge on the relationships between sequencing depth and detection of transcriptomic variation is needed for designing RNA-Seq experiments and for interpreting results of analyses. Using deeply sequenced Illumina HiSeq 2000 101 bp paired-end RNA-Seq data derived from adipose of a healthy individual before and after systemic administration of endotoxin (LPS), we investigated the sequencing depths needed for studies of gene expression and alternative splicing (AS). In order to detect expressed genes and AS events, we found that similar to 100 to 150 million (M) filtered reads were needed. However, the requirement on sequencing depth for the detection of LPS modulated differential expression (DE) and differential alternative splicing (DAS) was much higher. To detect 80% of events, similar to 300 M filtered reads were needed for DE analysis whereas at least 400 M filtered reads were necessary for detecting DAS. Although the majority of expressed genes and AS events can be detected with modest sequencing depths (similar to 100 M filtered reads), the estimated gene expression levels and exon/intron inclusion levels were less accurate. We report the first study that evaluates the relationship between RNA-Seq depth and the ability to detect DE and DAS in human adipose. Our results suggest that a much higher sequencing depth is needed to reliably identify DAS events than for DE genes.	[Liu, Yichuan; Li, Mingyao] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ferguson, Jane F.; Xue, Chenyi; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Silverman, Ian M.; Gregory, Brian] Univ Penn, Perelman Sch Med, Dept Biol, Philadelphia, PA 19104 USA; [Silverman, Ian M.; Gregory, Brian] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Reilly, MP (corresponding author), Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	muredach@mail.med.upenn.edu; mingyao@mail.med.upenn.edu	Ferguson, Jane/C-7154-2011; Gregory, Brian D/G-2890-2010; Liu, Yichuan/AAF-3893-2021	Ferguson, Jane/0000-0001-6896-1025; Reilly, Muredach/0000-0002-3035-9386; LIU, YICHUAN/0000-0003-2023-072X; Silverman, Ian/0000-0003-3819-6726	pilot grant from Penn Genomes Frontiers Institute [R01-HL-113147]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000003]; NIH-NHLBI SCCOR Project grant [P50-HL-083799];  [R01-HG-004517];  [R01-HG-005854];  [R01-HL-111694];  [R01-DK-090505];  [U01-HL-108636];  [K24-HL-107643]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113147, K24HL107643, R01HL111694, P50HL083799, U01HL108636] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005854, R01HG004517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	pilot grant from Penn Genomes Frontiers Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH-NHLBI SCCOR Project grant; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a pilot grant from Penn Genomes Frontiers Institute and R01-HL-113147 (ML and MPR) as well as by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003 and a NIH-NHLBI SCCOR Project grant (P50-HL-083799) to MPR. ML is also supported by R01-HG-004517 and R01-HG-005854. MPR is also supported by R01-HL-111694, R01-DK-090505, U01-HL-108636, and K24-HL-107643. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Hudgins LC, 2003, J LIPID RES, V44, P1489, DOI 10.1194/jlr.M200440-JLR200; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Pedrotty DM, 2012, PROG CARDIOVASC DIS, V55, P64, DOI 10.1016/j.pcad.2012.06.003; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shah R, 2009, DIABETES, V58, P2211, DOI 10.2337/db09-0256; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	30	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66883	10.1371/journal.pone.0066883	http://dx.doi.org/10.1371/journal.pone.0066883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826166	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400077
J	Ragunathan, P; Sridaran, D; Weigel, A; Shabayek, S; Spellerberg, B; Ponnuraj, K				Ragunathan, Preethi; Sridaran, Divya; Weigel, Anja; Shabayek, Sarah; Spellerberg, Barbara; Ponnuraj, Karthe			Metal Binding Is Critical for the Folding and Function of Laminin Binding Protein, Lmb of Streptococcus agalactiae	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; ZINC TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; ZNUA; REVEALS; FAMILY	Lmb is a 34 kDa laminin binding surface adhesin of Streptococcus agalactiae. The structure of Lmb reported by us recently has shown that it consists of a metal binding crevice, in which a zinc ion is coordinated to three highly conserved histidines. To elucidate the structural and functional significance of the metal ion in Lmb, these histidines have been mutated to alanine and single, double and triple mutants were generated. These mutations resulted in insolubility of the protein and revealed altered secondary and tertiary structures, as evidenced by circular dichroism and fluorescence spectroscopy studies. The mutations also significantly decreased the binding affinity of Lmb to laminin, implicating the role played by the metal binding residues in maintaining the correct conformation of the protein for its binding to laminin. A highly disordered loop, proposed to be crucial for metal acquisition in homologous structures, was deleted in Lmb by mutation (Delta Lmb) and its crystal structure was solved at 2.6 angstrom. The Delta Lmb structure was identical to the native Lmb structure with a bound zinc ion and exhibited laminin binding activity similar to wild type protein, suggesting that the loop might not have an important role in metal acquisition or adhesion in Lmb. Targeted mutations of histidine residues confirmed the importance of the zinc binding crevice for the structure and function of the Lmb adhesin.	[Ragunathan, Preethi; Sridaran, Divya; Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Chennai, Tamil Nadu, India; [Weigel, Anja; Shabayek, Sarah; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany	University of Madras; Ulm University	Spellerberg, B (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de; pkarthe@hotmail.com	Spellerberg, Barbara/D-3443-2011; Shabayek, Sarah/AAG-1960-2019	Spellerberg, Barbara/0000-0001-7552-8764; Shabayek, Sarah/0000-0001-8218-674X	Department of Biotechnology (DBT), Government of India; Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany; Department of Science and Technology, Government of India; Ministry of Foreign Affairs/Sincrotrone Trieste, Italy	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Foreign Affairs/Sincrotrone Trieste, Italy	Department of Biotechnology (DBT), Government of India and Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany for financial support and Department of Science and Technology, Government of India, and Ministry of Foreign Affairs/Sincrotrone Trieste, Italy, for the financial support to visit Elettra synchrotron facility for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Bartels K.S., 2003, AUTOMAR MANUAL V 1 4; BROWN JC, 1990, BIOCHEM J, V270, P463, DOI 10.1042/bj2700463; Gorelik JV, 2001, CELL BIOL INT, V25, P395, DOI 10.1006/cbir.2000.0642; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Maruvada R, 2009, FASEB J, V23, P3967, DOI 10.1096/fj.09-138149; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Ragunathan P, 2009, ACTA CRYSTALLOGR D, V65, P1262, DOI 10.1107/S0907444909038359; Ragunathan P, 2009, ACTA CRYSTALLOGR F, V65, P492, DOI 10.1107/S1744309109012743; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w	20	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67517	10.1371/journal.pone.0067517	http://dx.doi.org/10.1371/journal.pone.0067517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826314	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400154
J	Rohban, R; Reinisch, A; Etchart, N; Schallmoser, K; Hofmann, NA; Szoke, K; Brinchmann, JE; Rad, EB; Rohde, E; Strunk, D				Rohban, Rokhsareh; Reinisch, Andreas; Etchart, Nathalie; Schallmoser, Katharina; Hofmann, Nicole A.; Szoke, Krisztina; Brinchmann, Jan E.; Rad, Ehsan Bonyadi; Rohde, Eva; Strunk, Dirk			Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HUMAN-ENDOTHELIAL-CELLS; Q-VD-OPH; INFLAMMATORY CASPASES; CORD BLOOD; GENE-EXPRESSION; STEM-CELLS; APOPTOSIS; VITRO; ANGIOGENESIS	Therapeutic neo-vasculogenesis in vivo can be achieved by the co-transplantation of human endothelial colony-forming progenitor cells (ECFCs) with mesenchymal stem/progenitor cells (MSPCs). The underlying mechanism is not completely understood thus hampering the development of novel stem cell therapies. We hypothesized that proteomic profiling could be used to retrieve the in vivo signaling signature during the initial phase of human neo-vasculogenesis. ECFCs and MSPCs were therefore either transplanted alone or co-transplanted subcutaneously into immune deficient mice. Early cell signaling, occurring within the first 24 hours in vivo, was analyzed using antibody microarray proteomic profiling. Vessel formation and persistence were verified in parallel transplants for up to 24 weeks. Proteomic analysis revealed significant alteration of regulatory components including caspases, calcium/calmodulin-dependent protein kinase, DNA protein kinase, human ErbB2 receptor-tyrosine kinase as well as mitogen-activated protein kinases. Caspase-4 was selected from array results as one therapeutic candidate for targeting vascular network formation in vitro as well as modulating therapeutic vasculogenesis in vivo. As a proof-of-principle, caspase-4 and general caspase-blocking led to diminished endothelial network formation in vitro and significantly decreased vasculogenesis in vivo. Proteomic profiling ex vivo thus unraveled a signaling signature which can be used for target selection to modulate neo-vasculogenesis in vivo.	[Rohban, Rokhsareh; Reinisch, Andreas; Etchart, Nathalie; Schallmoser, Katharina; Hofmann, Nicole A.; Strunk, Dirk] Med Univ Graz, Stem Cell Res Unit, Graz, Austria; [Reinisch, Andreas; Etchart, Nathalie; Strunk, Dirk] Med Univ Graz, Div Hematol & Stem Cell Transplantat, Graz, Austria; [Etchart, Nathalie; Schallmoser, Katharina] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Schallmoser, Katharina; Rohde, Eva] Paracelsus Med Univ, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Szoke, Krisztina; Brinchmann, Jan E.] Univ Oslo, Inst Basic Med Sci, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Dermatol, Canc Biol Unit, Graz, Austria; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Pediat & Adolescence Surg, Graz, Austria; [Strunk, Dirk] Paracelsus Med Univ, Inst Expt & Clin Cell Therapy, Salzburg, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University; University of Oslo; Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University	Strunk, D (corresponding author), Med Univ Graz, Stem Cell Res Unit, Graz, Austria.	dirk.strunk@pmu.ac.at	Schallmoser, Katharina/V-4734-2017; Strunk, Dirk/V-4598-2017; Rohde, Eva/V-5766-2017	Schallmoser, Katharina/0000-0002-7204-0058; Strunk, Dirk/0000-0003-1810-867X; Rohde, Eva/0000-0001-8692-886X; Reinisch, Andreas/0000-0001-9333-7689	Austrian Research Foundation (FFG) [N211-NAN]; Adult Stem Cell Research Foundation; Medical University of Graz	Austrian Research Foundation (FFG)(Austrian Science Fund (FWF)); Adult Stem Cell Research Foundation; Medical University of Graz	This work was supported by the Austrian Research Foundation (FFG, grant N211-NAN; DS), the Adult Stem Cell Research Foundation and a young investigator starting grant of the Medical University of Graz (AR). RR and NAH are fellows of the PhD program Molecular Medicine at the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Das SB, 2005, ONCOL REP, V14, P1059; Dasari VR, 2010, AGING-US, V2, P791, DOI 10.18632/aging.100217; DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015; DUMONT DJ, 1992, ONCOGENE, V7, P1471; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hofmann NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044468; Hofmann Nicole A, 2012, Methods Mol Biol, V879, P381, DOI 10.1007/978-1-61779-815-3_23; Kersse K, 2007, BIOCHEM SOC T, V35, P1508, DOI 10.1042/BST0351508; Kim KW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002275; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mead LE, 2008, CURR PROTOC STEM CEL; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Moretti L, 2009, MOL CANCER THER, V8, P1270, DOI 10.1158/1535-7163.MCT-08-0893; Mukhopadhyay D, 1996, BIOCHEM BIOPH RES CO, V229, P733, DOI 10.1006/bbrc.1996.1873; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Reinisch A, 2009, J VIS EXP; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Rohde E, 2007, STEM CELLS, V25, P1746, DOI 10.1634/stemcells.2006-0833; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Segura I, 2002, FASEB J, V16, DOI 10.1096/fj.01-0819com; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Szoke K, 2012, CELL TRANSPLANT, V21, P235, DOI 10.3727/096368911X580518; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66909	10.1371/journal.pone.0066909	http://dx.doi.org/10.1371/journal.pone.0066909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826172	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400082
J	Jairam, PM; de Jong, PA; Mali, WPTM; Isgum, I; de Koning, HJ; van der Aalst, C; Oudkerk, M; Vliegenthart, R; van der Graaf, Y				Jairam, Pushpa M.; de Jong, Pim A.; Mali, Willem P. Th. M.; Isgum, Ivana; de Koning, Harry J.; van der Aalst, Carlijn; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; van der Graaf, Yolanda			Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; COMPUTED-TOMOGRAPHY; PRIMARY PREVENTION; NATURAL-HISTORY; CESSATION; CALCIUM; REDUCTION; LESIONS; EVENTS; STROKE	Background: Current smokers have an increased cardiovascular disease (CVD) risk compared to ex-smokers due to reversible as well as irreversible effects of smoking. We investigated if current smokers remain to have an increased CVD risk compared to ex-smokers in subjects with a long and intense smoking history. We in addition studied if the effect of smoking continuation on CVD risk is independent of or modified by the presence of cardiovascular calcifications. Methods: The cohort used comprised a sample of 3559 male lung cancer screening trial participants. We conducted a case-cohort study using all CVD cases and a random sample of 10% (n = 341) from the baseline cohort (subcohort). A weighted Cox proportional hazards model was used to estimate the hazard ratios for current smoking status in relation to CVD events. Results: During a median follow-up of 2.6 years (max. 3.7 years), 263 fatal and non-fatal cardiovascular events (cases) were identified. Age, packyears and cardiovascular calcification adjusted hazard ratio of current smokers compared to former smokers was 1.33 (95% confidence interval 1.00-1.77). In additional analyses that incorporated multiplicative interaction terms, neither coronary nor aortic calcifications modified the association between smoking status and cardiovascular risk (P = 0.08). Conclusions: Current smokers have an increased CVD risk compared to former smokers even in subjects with a long and intense smoking history. Smoking exerts its hazardous effects on CVD risk by pathways partly independent of cardiovascular calcifications.	[Jairam, Pushpa M.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Jairam, Pushpa M.; de Jong, Pim A.; Mali, Willem P. Th. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Koning, Harry J.; van der Aalst, Carlijn] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Oudkerk, Matthijs; Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Jairam, PM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	pjairam@umcutrecht.nl	Isgum, Ivana/H-8659-2014; Mali, Willem PThM/I-1123-2014; de+Koning, Harry/AAF-9062-2019; de Jong, Pim A/G-7220-2014; van der Aalst, Carlijn/AAG-7522-2019	Isgum, Ivana/0000-0003-1869-5034; Mali, Willem PThM/0000-0003-4391-0904; de+Koning, Harry/0000-0003-4682-3646; de Jong, Pim A/0000-0003-4840-6854; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organization for Health Research and Development (ZonMw); Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee (ROTS); Erasmus Trust Fund; Stichting tegen Kanker; Vlaamse Liga tegen Kanker	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany(Siemens AG); G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee (ROTS); Erasmus Trust Fund; Stichting tegen Kanker; Vlaamse Liga tegen Kanker	The current study is a part of the NELSON study and is supported by the Netherlands Organization for Health Research and Development (ZonMw), Koningin Wilhelmina Fonds (KWF), Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ), Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee (ROTS), Erasmus Trust Fund, Stichting tegen Kanker and Vlaamse Liga tegen Kanker. No relationship with industry exists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BENJAMIN EJ, 1992, NEW ENGL J MED, V327, P374, DOI 10.1056/NEJM199208063270602; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5; Eisen A, 2008, CIRCULATION, V118, P1328, DOI 10.1161/CIRCULATIONAHA.107.712141; Elmariah S, 2012, J AM COLL CARDIOL; Goldenberg I, 2003, ARCH INTERN MED, V163, P2301, DOI 10.1001/archinte.163.19.2301; Gondrie MJ, EUR RADIOL, V21, P963; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; HALON DA, 1983, AM J CARDIOL, V52, P921, DOI 10.1016/0002-9149(83)90506-4; Jacobs PC, J COMPUT ASSIST TOMO, V34, P279; Jockel KH, 2009, ATHEROSCLEROSIS, V203, P221, DOI 10.1016/j.atherosclerosis.2008.05.041; Johnson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035332; Khan R, 2009, CAN J CARDIOL, V25, P533, DOI 10.1016/S0828-282X(09)70144-8; MacLean D R, 1999, Can J Cardiol, V15 Suppl G, p17G; McElduff P, 1998, AUST NZ J PUBL HEAL, V22, P787, DOI 10.1111/j.1467-842X.1998.tb01494.x; McEvoy JW, 2012, JACC-CARDIOVASC IMAG, V5, P1037, DOI 10.1016/j.jcmg.2012.02.017; Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Paas G, 2002, RES VALIDITY LMR; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Rivera JJ, 2009, ATHEROSCLEROSIS, V206, P451, DOI 10.1016/j.atherosclerosis.2009.05.027; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schmermund A, 2000, AM J CARDIOL, V86, P127, DOI 10.1016/S0002-9149(00)00847-X; Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; STRONG JP, 1992, ARCH PATHOL LAB MED, V116, P1268; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; WHO, 2013, CARD DIS CVD PREV CO; WHO, 2010, INT STAT CLASS DIS R; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Wong ND, 2003, AM J CARDIOL, V92, P951, DOI 10.1016/S0002-9149(03)00976-7	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66484	10.1371/journal.pone.0066484	http://dx.doi.org/10.1371/journal.pone.0066484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840486	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800068
J	Midtvedt, T; Zabarovsky, E; Norin, E; Bark, J; Gizatullin, R; Kashuba, V; Ljungqvist, O; Zabarovska, V; Mollby, R; Ernberg, I				Midtvedt, Tore; Zabarovsky, Eugene; Norin, Elisabeth; Bark, Johan; Gizatullin, Rinat; Kashuba, Vladimir; Ljungqvist, Olle; Zabarovska, Veronika; Mollby, Roland; Ernberg, Ingemar			Increase of Faecal Tryptic Activity Relates to Changes in the Intestinal Microbiome: Analysis of Crohn's Disease with a Multidisciplinary Platform	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SECRETORY TRYPSIN-INHIBITOR; GERM-FREE; PHYSIOLOGICAL-ACTIVITY; SPECIES COMPOSITION; MICROFLORA; FLORA; MICROARRAYS; SYSTEMS; STRAIN	Objective: To investigate-by molecular, classical and functional methods-the microbiota in biopsies and faeces from patients with active Crohn's disease (CD) and controls. Design: The microbiota in biopsies was investigated utilizing a novel molecular method and classical cultivation technology. Faecal samples were investigated by classical technology and four functional methods, reflecting alterations in short chain fatty acids pattern, conversion of cholesterol and bilirubin and inactivation of trypsin. Results: By molecular methods we found more than 92% similarity in the microbiota on the biopsies from the two groups. However, 4.6% of microbes found in controls were lacking in CD patients. Furthermore, NotI representation libraries demonstrate two different clusters representing CD patients and controls, respectively. Utilizing conventional technology, Bacteroides (alt. Parabacteroides) was less frequently detected in the biopsies from CD patients than from controls. A similar reduction in the number of Bacteroides was found in faecal samples. Bacteroides is the only group of bacteria known to be able to inactivate pancreatic trypsin. Faecal tryptic activity was high in CD patients, and inversely correlated to the levels of Bacteroides. Conclusions: CD patients have compositional and functional alterations in their intestinal microbiota, in line with the global description hypothesis rather than the candidate microorganism theory. The most striking functional difference was high amount of faecal tryptic activity in CD patients, inversely correlated to the levels of Bacteroides in faeces.	[Midtvedt, Tore; Zabarovsky, Eugene; Norin, Elisabeth; Gizatullin, Rinat; Kashuba, Vladimir; Zabarovska, Veronika; Mollby, Roland; Ernberg, Ingemar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Ljungqvist, Olle] Orebro Univ Hosp, Dept Surg, Orebro, Sweden; [Bark, Johan] Sophiahemmet Hosp, Stockholm Gastro Ctr, IBD Unit, Stockholm, Sweden	Karolinska Institutet; Orebro University	Ernberg, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	ingemar.ernberg@ki.se	Kashuba, Vladimir/AAO-7742-2020; Kashuba, Vladimir I/N-3732-2017	Kashuba, Vladimir I/0000-0001-9416-8282; Norin, Elisabeth/0000-0001-5589-6850	Stitching af Jochnick Foundation; Vetenskapsradet (VR); Cancerfonden; Soderbergska stiftelsen; Karolinska Institutet Funds; Bengt E Gustafsson Funds	Stitching af Jochnick Foundation; Vetenskapsradet (VR)(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Soderbergska stiftelsen; Karolinska Institutet Funds; Bengt E Gustafsson Funds	This study was supported primarily by a generous donation from the Stitching af Jochnick Foundation (c/o Citco Nederland B.V., Naritaweg 165, 1043 BW Amsterdam, the Netherlands) and also, to some extent by grants from Vetenskapsradet (VR), Cancerfonden, Soderbergska stiftelsen, Karolinska Institutet Funds and Bengt E Gustafsson Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JS, 2002, PEDIAT ALLERG IMM-UK, V13, P402, DOI 10.1034/j.1399-3038.2002.01062.x; Benno P., 2003, Microbial Ecology in Health and Disease, V15, P169, DOI 10.1080/08910600310020622; BENNO P, 1993, SCAND J GASTROENTERO, V28, P839, DOI 10.3109/00365529309104019; BERGSTRAND LO, 1981, ACTA CHIR SCAND, V147, P711; BERGSTRAND LO, 1981, ACTA CHIR SCAND, V147, P707; Bergstrand LO, 1981, THESIS KAROLINSKA I; Cardona ME, 2001, SCAND J LAB ANIM SCI, V28, P75; Collinder E, 2000, EQUINE VET J, V32, P222, DOI 10.2746/042516400776563653; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DUMONCEAU JM, 1994, ACTA GASTRO-ENT BELG, V57, P301; HOVERSTAD T, 1984, SCAND J GASTROENTERO, V19, P375, DOI 10.1080/00365521.1984.12005738; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Marchbank T, 1996, AM J PATHOL, V148, P715; Marteau P, 2004, ALIMENT PHARM THER, V20, P18, DOI 10.1111/j.1365-2036.2004.02062.x; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT AC, 1988, J PEDIATR GASTR NUTR, V7, P559, DOI 10.1097/00005176-198807000-00014; Norin E, 1988, MICROB ECOL HEALTH D, V1, P65; Norin E., 2006, GASTROINTESTINAL MIC, P273; NORIN KE, 1986, LAB ANIM, V20, P234, DOI 10.1258/002367786780865656; NORIN KE, 1986, LAB ANIM, V20, P67, DOI 10.1258/002367786781062188; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; PLAYFORD RJ, 1995, AM J PATHOL, V146, P310; Ramare F, 1996, APPL ENVIRON MICROB, V62, P1434, DOI 10.1128/AEM.62.4.1434-1436.1996; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SAXERHOLT H, 1984, SCAND J CLIN LAB INV, V44, P573, DOI 10.3109/00365518409083613; Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818; Suzuki T, 2008, J PHARMACOL SCI, V106, P469, DOI 10.1254/jphs.FP0071422; VANDEMERWE JP, 1982, DIGESTION, V24, P1, DOI 10.1159/000198767; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; World Health Organization, 1997, INT J OCCUP MED ENV, V10, P113; Zabarovska V, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng005; Zabarovsky ER, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng096; ZIJLSTRA JB, 1977, CLIN CHIM ACTA, V78, P243, DOI 10.1016/0009-8981(77)90312-6	37	36	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66074	10.1371/journal.pone.0066074	http://dx.doi.org/10.1371/journal.pone.0066074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840402	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800028
J	Arnett, EB; Hein, CD; Schirmacher, MR; Huso, MMP; Szewczak, JM				Arnett, Edward B.; Hein, Cris D.; Schirmacher, Michael R.; Huso, Manuela M. P.; Szewczak, Joseph M.			Evaluating the Effectiveness of an Ultrasonic Acoustic Deterrent for Reducing Bat Fatalities at Wind Turbines	PLOS ONE			English	Article							ENERGY FACILITIES; ECHOLOCATING BATS; SOCIAL CALLS; VARIABILITY; HYPOTHESES; IMPACTS; NOISE	Large numbers of bats are killed by wind turbines worldwide and minimizing fatalities is critically important to bat conservation and acceptance of wind energy development. We implemented a 2-year study testing the effectiveness of an ultrasonic acoustic deterrent for reducing bat fatalities at a wind energy facility in Pennsylvania. We randomly selected control and treatment turbines that were searched daily in summer and fall 2009 and 2010. Estimates of fatality, corrected for field biases, were compared between treatment and control turbines. In 2009, we estimated 21-51% fewer bats were killed per treatment turbine than per control turbine. In 2010, we determined an approximate 9% inherent difference between treatment and control turbines and when factored into our analysis, variation increased and between 2% more and 64% fewer bats were killed per treatment turbine relative to control turbines. We estimated twice as many hoary bats were killed per control turbine than treatment turbine, and nearly twice as many silver-haired bats in 2009. In 2010, although we estimated nearly twice as many hoary bats and nearly 4 times as many silver-haired bats killed per control turbine than at treatment turbines during the treatment period, these only represented an approximate 20% increase in fatality relative to the pre-treatment period for these species when accounting for inherent differences between turbine sets. Our findings suggest broadband ultrasound broadcasts may reduce bat fatalities by discouraging bats from approaching sound sources. However, effectiveness of ultrasonic deterrents is limited by distance and area ultrasound can be broadcast, in part due to rapid attenuation in humid conditions. We caution that an operational deterrent device is not yet available and further modifications and experimentation are needed. Future efforts must also evaluate cost-effectiveness of deterrents in relation to curtailment strategies to allow a cost-benefit analysis for mitigating bat fatalities.	[Arnett, Edward B.; Hein, Cris D.; Schirmacher, Michael R.] Bat Conservat Int, Austin, TX USA; [Huso, Manuela M. P.] US Geol Survey, Forest & Range Expt Stn, Corvallis, OR USA; [Szewczak, Joseph M.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	United States Department of the Interior; United States Geological Survey; California State University System; California State Polytechnic University, Humboldt	Arnett, EB (corresponding author), Theodore Roosevelt Conservat Partnership, Loveland, CO USA.	earnett@trcp.org	Huso, Manuela M/F-9771-2013	Hein, Cris/0000-0003-3040-7998	Iberdrola Renewables; U.S. Department of Energy (DOE); National Renewable Energy Lab; Pennsylvania Game Commission; Bat Conservation International; American Wind and Wildlife Institute; American Wind Energy Association	Iberdrola Renewables; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Renewable Energy Lab; Pennsylvania Game Commission; Bat Conservation International; American Wind and Wildlife Institute; American Wind Energy Association	This study was funded by Iberdrola Renewables, U.S. Department of Energy (DOE), National Renewable Energy Lab, Pennsylvania Game Commission, Bat Conservation International, American Wind and Wildlife Institute, and member companies of the American Wind Energy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett EB, 2013, BAT EVOLUTI IN PRESS; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2009, J MAMMAL, V90, P1341, DOI 10.1644/09-MAMM-S-104R.1; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; BELTON P., 1962, ENTOMOL EXPTL ET APPL, V5, P281, DOI 10.1111/j.1570-7458.1962.tb00592.x; Brown R.G., 1972, WOODY PLANTS MARYLAN; Cochran WG., 1963, SAMPLING TECHNIQUES; Cryan PM, 2008, J WILDLIFE MANAGE, V72, P845, DOI 10.2193/2007-371; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Energy Information Administration, 2010, ANN EN OUTL 2010 PRO; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gillam EH, 2007, ANIM BEHAV, V74, P277, DOI 10.1016/j.anbehav.2006.12.006; GRIFFIN DR, 1963, J EXP ZOOL, V152, P229, DOI 10.1002/jez.1401520303; Griffin DR, 1958, LISTENING DARK; Hewitt JE, 2001, ECOL APPL, V11, P1502, DOI 10.2307/3060935; Horn JW, 2008, J WILDLIFE MANAGE, V72, P123, DOI 10.2193/2006-465; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Huang F, 2011, J STORED PRODUCTS RE, V39, P413; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLEY S, 1980, B ENVIRON CONTAM TOX, V25, P503, DOI 10.1007/BF01985562; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kunz Thomas H., 2009, P1; Larsen RJ, 2007, ACTA CHIROPTEROL, V9, P423, DOI 10.3161/1733-5329(2007)9[423:MNBSAC]2.0.CO;2; MACKEY RL, 1989, CAN J ZOOL, V67, P1167, DOI 10.1139/z89-168; Manly B.F.J., 1997, RANDOMIZATION MONTE; MOHL B, 1989, J COMP PHYSIOL A, V165, P119, DOI 10.1007/BF00613805; Nicholls B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006246; Parson S, 2009, ECOLOGICAL BEHAV MET; Pennsylvania Game Commission, 2007, PENNS GAM COMM WIND; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Racey PA, 2003, BAT ECOLOGY, P680; Robbins LW, 2008, NORTHEAST NAT, V15, P275, DOI 10.1656/1092-6194(2008)15[275:ETEOTS]2.0.CO;2; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Steele R.G.D., 1997, PRINCIPLES PROCEDURE, P666; Strausbaugh P.D., 1978, FLORA W VIRGINIA; Strickland M.D., 2011, COMPREHENSIVE GUIDE; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Winhold L, 2008, NORTHEAST NAT, V15, P263, DOI 10.1656/1092-6194(2008)15[263:NSFBIT]2.0.CO;2; Winhold L, 2008, ACTA CHIROPTEROL, V10, P359, DOI 10.3161/150811008X414935	45	48	52	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65794	10.1371/journal.pone.0065794	http://dx.doi.org/10.1371/journal.pone.0065794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840369	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200036
J	Bae, YJ; Hwang, YW; Yoon, SY; Kim, S; Lee, T; Lee, YS; Kwon, HS; Cho, YS; Shin, MJ; Moon, HB; Kim, TB				Bae, Yun-Jeong; Hwang, Ye Won; Yoon, Sun-young; Kim, Sujeong; Lee, Taehoon; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Shin, Myung Jin; Moon, Hee-Bom; Kim, Tae-Bum			The Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity Reactions	PLOS ONE			English	Article							IODINATED CONTRAST-MEDIA; SURVEILLANCE; PREVENTION; MANAGEMENT; ALLERGY; KOREA	Background: Non-ionic radiocontrast media (RCM) is rarely associated with hypersensitivity reactions. Premedication of patients who reacted previously to RCM with systemic corticosteroids and/or antihistamines can help reduce recurrent hypersensitivity reactions. However, premedication is still not prescribed in many cases for various reasons. This study aimed to determine the effectiveness of our novel RCM hypersensitivity surveillance and automatic recommending system for premedication. Methods and Results: Hospitalized patients with a history of RCM hypersensitivity were identified in an electronic medical record system that included a mandatory reporting system for past adverse drug reactions. In 2009, a novel automatic prescription system was added that classified index RCM reactions by severity and dispensed appropriate corticosteroid and/or antihistamine pretreatment prior to new RCM exposures. The data from 12 months under the previous system and 12 months under the current system were compared. The two systems had similar overall premedication rates (91% and 95%) but the current system was associated with a significantly higher corticosteroid premedication rate (65% vs. 14%), which significantly reduced the breakthrough reaction rate (6.7% vs. 15.2%). The current system was also associated with increased corticosteroid and antihistamine premedication of patients with a mild index reaction (61% vs. 7%) and a reduction in their breakthrough reaction rate (6% vs. 15%). Conclusions: Premedication with corticosteroid and/or antihistamine, which was increased by our novel automatic prescription system, significantly reduced breakthrough reactions in patients with a history of RCM hypersensitivity.	[Bae, Yun-Jeong; Yoon, Sun-young; Kim, Sujeong; Lee, Taehoon; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Div Allergy & Clin Immunol, Dept Internal Med,Asan Med Ctr, Seoul, South Korea; [Bae, Yun-Jeong] Asan Med Ctr, Dept Hlth Med, Hlth Screening & Promot Ctr, Seoul, South Korea; [Hwang, Ye Won; Kwon, Hyouk-Soo; Cho, You Sook; Kim, Tae-Bum] Asan Med Ctr, Pharmacovigilance Ctr, Seoul, South Korea; [Shin, Myung Jin] Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, TB (corresponding author), Univ Ulsan, Coll Med, Div Allergy & Clin Immunol, Dept Internal Med,Asan Med Ctr, Seoul, South Korea.	allergy@medimail.co.kr	Lee, Taehoon/AHA-1437-2022	Lee, Taehoon/0000-0002-9224-0866; Cho, You Sook/0000-0001-8767-2667	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-PG01]	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant from the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-PG01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockow K, 2005, ALLERGY, V60, P150, DOI 10.1111/j.1398-9995.2005.00745.x; Caimmi S, 2010, CLIN EXP ALLERGY, V40, P805, DOI 10.1111/j.1365-2222.2010.03493.x; Christiansen C, 2005, TOXICOLOGY, V209, P185, DOI 10.1016/j.tox.2004.12.020; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; Dormann H, 2000, DRUG SAFETY, V22, P161, DOI 10.2165/00002018-200022020-00007; Freed KS, 2001, AM J ROENTGENOL, V176, P1389, DOI 10.2214/ajr.176.6.1761389; GREENBERGER PA, 1991, J ALLERGY CLIN IMMUN, V87, P867, DOI 10.1016/0091-6749(91)90135-B; Idee JM, 2005, FUND CLIN PHARMACOL, V19, P263, DOI 10.1111/j.1472-8206.2005.00326.x; Kim SH, 2011, EUR J RADIOL, V80, P363, DOI 10.1016/j.ejrad.2010.06.014; Kopp AF, 2008, ACTA RADIOL, V49, P902, DOI 10.1080/02841850802282811; LASSER EC, 1987, NEW ENGL J MED, V317, P845, DOI 10.1056/NEJM198710013171401; Liccardi G, 2008, J INVEST ALLERG CLIN, V18, P1; Park CS, 2008, PHARMACOEPIDEM DR S, V17, P919, DOI 10.1002/pds.1612; Segal AJ, 2011, INVEST RADIOL, V46, P147, DOI 10.1097/RLI.0b013e3181f5409e; Thomsen HS, 2011, EUR J RADIOL, V80, P77, DOI 10.1016/j.ejrad.2010.12.104; Thong BYH, 2003, ANN ALLERG ASTHMA IM, V90, P342, DOI 10.1016/S1081-1206(10)61804-2; Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66014	10.1371/journal.pone.0066014	http://dx.doi.org/10.1371/journal.pone.0066014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840391	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200049
J	Stanley, DA; Knight, ME; Stout, JC				Stanley, Dara A.; Knight, Mairi E.; Stout, Jane C.			Ecological Variation in Response to Mass-Flowering Oilseed Rape and Surrounding Landscape Composition by Members of a Cryptic Bumblebee Complex	PLOS ONE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; NEST DENSITY; COLONY GROWTH; SIBSHIP RECONSTRUCTION; FORAGING DISTANCE; CONSERVATION; DECLINE; SCALE; BEES; DNA	The Bombus sensu stricto species complex is a widespread group of cryptic bumblebee species which are important pollinators of many crops and wild plants. These cryptic species have, until now, largely been grouped together in ecological studies, and so little is known about their individual colony densities, foraging ranges or habitat requirements, which can be influenced by land use at a landscape scale. We used mass-flowering oilseed rape fields as locations to sample bees of this complex, as well as the second most common visitor to oilseed rape B. lapidarius, and molecular RFLP methods to distinguish between the cryptic species. We then used microsatellite genotyping to identify sisters and estimate colony densities, and related both proportions of cryptic species and their colony densities to the composition of the landscape surrounding the fields. We found B. lucorum was the most common member of the complex present in oilseed rape followed by B. terrestris. B. cryptarum was also present in all but one site, with higher proportions found in the east of the study area. High numbers of bumblebee colonies were estimated to be using oilseed rape fields as a forage resource, with B. terrestris colony numbers higher than previous estimates from non-mass-flowering fields. We also found that the cryptic species responded differently to surrounding landscape composition: both relative proportions of B. cryptarum in samples and colony densities of B. lucorum were negatively associated with the amount of arable land in the landscape, while proportions and colony densities of other species did not respond to landscape variables at the scale measured. This suggests that the cryptic species have different ecological requirements (which may be scale-dependent) and that oilseed rape can be an important forage resource for many colonies of bumblebees. Given this, we recommend sustainable management of this crop to benefit bumblebees.	[Stanley, Dara A.; Stout, Jane C.] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Stanley, Dara A.; Stout, Jane C.] Univ Dublin Trinity Coll, Trinity Ctr Biodivers Res, Dublin 2, Ireland; [Knight, Mairi E.] Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England	Trinity College Dublin; Trinity College Dublin; University of Plymouth	Stanley, DA (corresponding author), Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland.	stanleyd@tcd.ie	Stanley, Dara/K-2295-2012; Stout, Jane/AAS-8867-2020; Stanley, Dara/AAR-2947-2020; Stout, Jane C/B-1631-2010	Stanley, Dara/0000-0001-8948-8409; Stout, Jane/0000-0002-2027-0863; Stanley, Dara/0000-0001-8948-8409; Stout, Jane C/0000-0002-2027-0863	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme [2007-B-CD-1-S1]; Irish Government under the National Development Plan	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme; Irish Government under the National Development Plan	This research was funded by the project SIMBIOSYS (www.simbiosys.ie, 2007-B-CD-1-S1) as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme, financed by the Irish Government under the National Development Plan 2007-2013, administered on behalf of the Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency (EPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bommarco R, 2012, OECOLOGIA, V169, P1025, DOI 10.1007/s00442-012-2271-6; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Byrne E, 2011, THESIS TRINITY COLL; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Carvell C, 2012, OIKOS, V121, P734, DOI 10.1111/j.1600-0706.2011.19832.x; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; EPA, 2006, COR LAND COV IR LAND; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Fitzpatrick U, 2006, REGIONAL RED LIST IR; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Frondel M, 2005, ENERG POLICY, V35, P1675; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hanley ME, 2011, OIKOS, V120, P1618, DOI 10.1111/j.1600-0706.2011.19233.x; Heard MS, 2007, BIOL LETTERS, V3, P638, DOI 10.1098/rsbl.2007.0425; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Morandin LA, 2007, BASIC APPL ECOL, V8, P117, DOI 10.1016/j.baae.2006.06.003; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; R Core Team, 2022, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Tanaka H, 2001, INSECT SOC, V48, P44, DOI 10.1007/PL00001744; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waters J, 2011, INSECT CONSERV DIVER, V4, P46, DOI 10.1111/j.1752-4598.2010.00101.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wolf S, 2010, APIDOLOGIE, V41, P45, DOI 10.1051/apido/2009048; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zuur Alain F., 2009, P1	61	11	11	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65516	10.1371/journal.pone.0065516	http://dx.doi.org/10.1371/journal.pone.0065516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840338	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200023
J	Jorgensen, R; Pesnot, T; Lee, HJ; Palcic, MM; Wagner, GK				Jorgensen, Rene; Pesnot, Thomas; Lee, Ho Jun; Palcic, Monica M.; Wagner, Gerd K.			Base-modified Donor Analogues Reveal Novel Dynamic Features of a Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP-A; GROUP-B TRISACCHARIDE; CONFORMATIONAL-CHANGES; INHIBITION; SUBSTRATE; MECHANISMS; COMPLEX; GENE	Glycosyltransferases (GTs) are enzymes that are involved, as Nature's "glycosylation reagents," in many fundamental biological processes including cell adhesion and blood group biosynthesis. Although of similar importance to that of other large enzyme families such as protein kinases and proteases, the undisputed potential of GTs for chemical biology and drug discovery has remained largely unrealized to date. This is due, at least in part, to a relative lack of GT inhibitors and tool compounds for structural, mechanistic, and cellular studies. In this study, we have used a novel class of GT donor analogues to obtain new structural and enzymological information for a representative blood group GT. These analogues interfere with the folding of an internal loop and the C terminus, which are essential for catalysis. Our experiments have led to the discovery of an entirely new active site folding mode for this enzyme family, which can be targeted in inhibitor development, similar to the DFG motif in protein kinases. Taken together, our results provide new insights into substrate binding, dynamics, and utilization in this important enzyme family, which can very likely be harnessed for the rational development of new GT inhibitors and probes.	[Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark; [Jorgensen, Rene; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Pesnot, Thomas] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Lee, Ho Jun] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Wagner, Gerd K.] Kings Coll London, Sch Biomed Sci, Inst Pharmaceut Sci, London SE1 9NH, England; [Wagner, Gerd K.] Kings Coll London, Dept Chem, London SE1 9NH, England	Statens Serum Institut; University of East Anglia; University of Alberta; University of London; King's College London; University of London; King's College London	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk; gerd.wagner@kcl.ac.uk	Wagner, Gerd/D-4759-2013; Jørgensen, René/P-5619-2014	Wagner, Gerd/0000-0003-1086-2301; Jørgensen, René/0000-0003-0672-466X	Engineering and Physical Sciences Research Council [EP/D059186/1]; Medical Research Council [G0901746]; Danish Council for Independent Research/Natural Sciences; Medical Sciences; EPSRC [EP/D059186/1] Funding Source: UKRI; MRC [G0901746] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Medical Sciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Engineering and Physical Sciences Research Council Grant EP/D059186/1 (to G. K. W.), the Medical Research Council Grant G0901746 (to G. K. W.), and the Danish Council for Independent Research/Natural Sciences (to M. M. P.) and Medical Sciences (to R. J.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Descroix K, 2012, J MED CHEM, V55, P2015, DOI 10.1021/jm201154p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Jorgensen R, 2012, ANGEW CHEM INT EDIT, V51, P4171, DOI 10.1002/anie.201108345; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martin MP, 2012, ACS CHEM BIOL, V7, P698, DOI 10.1021/cb200508b; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; SETO NOL, 1995, EUR J BIOCHEM, V234, P323, DOI 10.1111/j.1432-1033.1995.323_c.x; Weadge J. T., 2008, WILEY ENCY CHEM BIOL, V2, P198; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200; Yazer MH, 2005, VOX SANG, V89, P161, DOI 10.1111/j.1423-0410.2005.00688.x	27	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 6	2013	288	36					26201	26208		10.1074/jbc.M113.465963	http://dx.doi.org/10.1074/jbc.M113.465963			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302RT	23836908	Green Published, hybrid			2022-12-25	WOS:000330623300050
J	Li, Y; He, LN; Zeng, N; Sahu, D; Cadenas, E; Shearn, C; Li, W; Stiles, BL				Li, Yang; He, Lina; Zeng, Ni; Sahu, Divya; Cadenas, Enrique; Shearn, Colin; Li, Wei; Stiles, Bangyan L.			Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Signaling Regulates Mitochondrial Biogenesis and Respiration via Estrogen-related Receptor alpha (ERR alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; CANCER-CELLS; COACTIVATOR PGC-1; BREAST-CANCER; COPY NUMBER; METABOLISM; STRESS	Mitochondrial abnormalities are associated with cancer development, yet how oncogenic signals affect mitochondrial functions has not been fully understood. In this study, we investigate the relationship between mitochondrial alterations and PI3K/protein kinase B (AKT) signaling activation using hepatocytes and liver tissues as our experimental models. We show here that liver-specific deletion of Pten, which leads to activation of PI3K/AKT, is associated with elevated oxidative stress, increased mitochondrial mass, and augmented respiration accompanied by enhanced glycolysis. Consistent with these observations, estrogen-related receptor alpha (ERR alpha), an orphan nuclear receptor known for its role in mitochondrial biogenesis, is up-regulated in the absence of phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Our pharmacological and genetic studies show that PI3K/AKT activity regulates the expression of ERR alpha and mitochondrial biogenesis/respiration. Furthermore, cAMP-response element-binding protein, as a downstream target of AKT, plays a role in the regulation of ERR alpha, independent of PKA signaling. ERR alpha regulates reactive oxygen species production, and ERR alpha knockdown attenuates proliferation and colony-forming potential in Pten-null hepatocytes. Finally, analysis of clinical datasets from liver tissues showed a negative correlation between expressions of ERR alpha and PTEN in patients with liver cancer. Therefore, this study has established a previously unrecognized link between a growth signal and mitochondrial metabolism.	[Li, Yang; He, Lina; Zeng, Ni; Cadenas, Enrique; Stiles, Bangyan L.] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Stiles, Bangyan L.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Cadenas, Enrique] Univ So Calif, Keck Sch Med, Dept Biochem, Los Angeles, CA 90033 USA; [Sahu, Divya; Li, Wei] Univ So Calif, Dept Dermatol, Norris Comprehens Canc Ctr, Keck Med Ctr, Los Angeles, CA 90033 USA; [Shearn, Colin] Univ Colorado, Sch Pharm, Aurora, CO 80045 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Colorado System; University of Colorado Anschutz Medical Campus	Stiles, BL (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	bstiles@usc.edu			National Institutes of Health from University of Southern California Liver Center [P30DK48522]; NCI [5U 54 CA114868, R01CA154986-01A1]; National Institutes of Health from NIDDK [R01 DK084241-01A1]; NATIONAL CANCER INSTITUTE [R01CA154986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075928, R01DK084241, P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health from University of Southern California Liver Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Pilot Grant P30DK48522 from University of Southern California Liver Center and Grants 5U 54 CA114868 and R01CA154986-01A1 from NCI.; Supported by National Institutes of Health Grant R01 DK084241-01A1 from NIDDK.	Abid MDN, 2013, INT J MOL MED, V32, P389, DOI 10.3892/ijmm.2013.1394; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Bellavia M, 2012, MED HYPOTHESES, V79, P731, DOI 10.1016/j.mehy.2012.08.012; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cui XJ, 2012, ANTIOXID REDOX SIGN, V16, P1212, DOI 10.1089/ars.2012.4532; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galicia VA, 2010, GASTROENTEROLOGY, V139, P2170, DOI 10.1053/j.gastro.2010.09.002; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Han A, 2012, BIOL OPEN, V1, P1169, DOI 10.1242/bio.20122246; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martel-Gallegos G, 2013, BBA-GEN SUBJECTS, V1830, P4650, DOI 10.1016/j.bbagen.2013.05.023; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shaik ZP, 2008, AM J PHYSIOL-RENAL, V294, pF423, DOI 10.1152/ajprenal.00463.2007; Shaywitz AJ, 2008, CELL METAB, V8, P179, DOI 10.1016/j.cmet.2008.08.011; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vivekanandan P, 2010, MODERN PATHOL, V23, P790, DOI 10.1038/modpathol.2010.51; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Xi G, 2013, J BIOL CHEM, V288, P15641, DOI 10.1074/jbc.M113.456046; Yao J, 2012, NEUROBIOL AGING, V33, P1507, DOI 10.1016/j.neurobiolaging.2011.03.001; Yin PH, 2004, BRIT J CANCER, V90, P2390, DOI 10.1038/sj.bjc.6601838; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zamkova M, 2013, CELL CYCLE, V12, P826, DOI 10.4161/cc.23723; Zeng N, 2011, MOL CANCER RES, V9, P1708, DOI 10.1158/1541-7786.MCR-11-0299	65	46	46	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25007	25024		10.1074/jbc.M113.450353	http://dx.doi.org/10.1074/jbc.M113.450353			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836899	hybrid, Green Published			2022-12-25	WOS:000330619000003
J	Bocedi, A; Fabrini, R; Farrotti, A; Stella, L; Ketterman, AJ; Pedersen, JZ; Allocati, N; Lau, PCK; Grosse, S; Eltis, LD; Ruzzini, A; Edwards, TE; Morici, L; Del Grosso, E; Guidoni, L; Bovi, D; Lo Bello, M; Federici, G; Parker, MW; Board, PG; Ricci, G				Bocedi, Alessio; Fabrini, Raffaele; Farrotti, Andrea; Stella, Lorenzo; Ketterman, Albert J.; Pedersen, Jens Z.; Allocati, Nerino; Lau, Peter C. K.; Grosse, Stephan; Eltis, Lindsay D.; Ruzzini, Antonio; Edwards, Thomas E.; Morici, Laura; Del Grosso, Erica; Guidoni, Leonardo; Bovi, Daniele; Lo Bello, Mario; Federici, Giorgio; Parker, Michael W.; Board, Philip G.; Ricci, Giorgio			The Impact of Nitric Oxide Toxicity on the Evolution of the Glutathione Transferase Superfamily A PROPOSAL FOR AN EVOLUTIONARY DRIVING FORCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGLUTATHIONYL-IRON COMPLEX; S-TRANSFERASE; ACTIVE-SITE; IN-VIVO; FUNCTIONAL POLYMORPHISM; OCHROBACTRUM-ANTHROPI; CRYSTAL-STRUCTURE; PROTON RELEASE; NO-CARRIERS; BINDING	Glutathione transferases (GSTs) are protection enzymes capable of conjugating glutathione (GSH) to toxic compounds. During evolution an important catalytic cysteine residue involved in GSH activation was replaced by serine or, more recently, by tyrosine. The utility of these replacements represents an enigma because they yield no improvements in the affinity toward GSH or in its reactivity. Here we show that these changes better protect the cell from nitric oxide (NO) insults. In fact the dinitrosyl.diglutathionyl.iron complex (DNDGIC), which is formed spontaneously when NO enters the cell, is highly toxic when free in solution but completely harmless when bound to GSTs. By examining 42 different GSTs we discovered that only the more recently evolved Tyr-based GSTs display enough affinity for DNDGIC (K-D < 10(-9) M) to sequester the complex efficiently. Ser-based GSTs and Cys-based GSTs show affinities 10(2)-10(4) times lower, not sufficient for this purpose. The NO sensitivity of bacteria that express only Cys-based GSTs could be related to the low or null affinity of their GSTs for DNDGIC. GSTs with the highest affinity (Tyr-based GSTs) are also over-represented in the perinuclear region of mammalian cells, possibly for nucleus protection. On the basis of these results we propose that GST evolution in higher organisms could be linked to the defense against NO.	[Bocedi, Alessio; Fabrini, Raffaele; Farrotti, Andrea; Stella, Lorenzo; Morici, Laura; Del Grosso, Erica; Ricci, Giorgio] Univ Rome, Dept Chem Sci & Technol, I-00133 Rome, Italy; [Pedersen, Jens Z.; Lo Bello, Mario] Univ Rome, Dept Biol, I-00133 Rome, Italy; [Ketterman, Albert J.] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom 73170, Thailand; [Allocati, Nerino] Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Natl Res Council Canada, Montreal, PQ 3775, Canada; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Dept Chem, Montreal, PQ 3775, Canada; [Lau, Peter C. K.; Grosse, Stephan] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ 3775, Canada; [Eltis, Lindsay D.; Ruzzini, Antonio] Univ British Columbia, Dept Microbiol & Biochem, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Edwards, Thomas E.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA USA; [Edwards, Thomas E.] Emerald BioStruct Inc, Bainbridge Isl, WA 98110 USA; [Guidoni, Leonardo; Bovi, Daniele] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Guidoni, Leonardo] Univ Aquila, Dept Phys & Chem Sci, I-67100 Laquila, Italy; [Federici, Giorgio] Childrens Hosp IRCCS Bambin Gesu, I-00165 Rome, Italy; [Parker, Michael W.] St Vincents Inst Med Res, ACRF Rational Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Board, Philip G.] Australian Natl Univ, Mol Genet Grp, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Sapienza University Rome; Sapienza University Rome; Mahidol University; G d'Annunzio University of Chieti-Pescara; McGill University; National Research Council Canada; McGill University; McGill University; University of British Columbia; Sapienza University Rome; University of L'Aquila; IRCCS Bambino Gesu; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; Australian National University; John Curtin School of Medical Research	Ricci, G (corresponding author), Univ Rome, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Parker, Michael W/F-9069-2013; Bovi, Daniele/E-2166-2015; Guidoni, Leonardo/G-3759-2011; Ruzzini, Antonio/M-2776-2017; Del Grosso, Erica/GPT-3066-2022; Stella, Lorenzo/A-7996-2010; Eltis, Lindsay D/J-8272-2015	Parker, Michael W/0000-0002-3101-1138; Guidoni, Leonardo/0000-0002-2497-9482; Ruzzini, Antonio/0000-0002-5697-5371; Stella, Lorenzo/0000-0002-5489-7381; Eltis, Lindsay D/0000-0002-6774-8158; Del Grosso, Erica/0000-0002-0022-7796; Edwards, Thomas/0000-0002-0474-8003; Ricci, Giorgio/0000-0002-7108-2846; ALLOCATI, Nerino/0000-0003-2670-8085	Italian Institution FONDAZIONE ROMA-Terzo Settore grant; Mahidol University; European Research Council [240624]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council	Italian Institution FONDAZIONE ROMA-Terzo Settore grant; Mahidol University; European Research Council(European Research Council (ERC)European Commission); Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Italian Institution FONDAZIONE ROMA-Terzo Settore grant (to G. R.), grants from the Mahidol University (to A. J. K.), and European Research Council Project 240624 "MultiscaleChemBio" within the VII Framework Program of the European Union (to L. G.).; Supported by the Victorian Government's Operational Infrastructure Support Program and is a National Health and Medical Research Council Senior Principal Research Fellow.	Allocati N, 2008, PROTEINS, V71, P16, DOI 10.1002/prot.21835; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Caccuri AM, 2002, BIOCHEMISTRY-US, V41, P4686, DOI 10.1021/bi0158425; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Caccuri AM, 2001, J BIOL CHEM, V276, P5427, DOI 10.1074/jbc.M002819200; Caccuri AM, 1998, BIOCHEMISTRY-US, V37, P3028, DOI 10.1021/bi971903g; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Edwards TE, 2011, ACTA CRYSTALLOGR F, V67, P1038, DOI 10.1107/S1744309111009493; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Favaloro B, 1998, BIOCHEM J, V335, P573, DOI 10.1042/bj3350573; FLATGAARD JE, 1993, CANCER CHEMOTH PHARM, V33, P63, DOI 10.1007/BF00686025; Fortin PD, 2006, J BACTERIOL, V188, P4424, DOI 10.1128/JB.01849-05; Gal A, 1996, P NATL ACAD SCI USA, V93, P15102, DOI 10.1073/pnas.93.26.15102; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hoppner J, 2004, ACTA CRYSTALLOGR D, V60, P1496, DOI 10.1107/S090744490401460X; Johnson KA, 2003, BIOCHEMISTRY-US, V42, P10084, DOI 10.1021/bi034449r; Keese MA, 1997, BIOCHEM PHARMACOL, V54, P1307, DOI 10.1016/S0006-2952(97)00348-1; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Lobysheva II, 1999, FEBS LETT, V454, P177, DOI 10.1016/S0014-5793(99)00777-2; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOZER TJ, 1983, BIOCHEMISTRY-US, V22, P1068, DOI 10.1021/bi00274a011; Nebert Daniel W., 2004, Human Genomics, V1, P460; Neese F, 2000, CHEM PHYS LETT, V325, P93, DOI 10.1016/S0009-2614(00)00662-X; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; NOODLEMAN L, 1988, J AM CHEM SOC, V110, P1001, DOI 10.1021/ja00212a003; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Pearson WR, 2005, METHOD ENZYMOL, V401, P186, DOI 10.1016/S0076-6879(05)01012-8; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tan KL, 1996, BIOCHEM J, V319, P315, DOI 10.1042/bj3190315; Tetlow N, 2004, PHARMACOGENETICS, V14, P657, DOI 10.1097/00008571-200410000-00003; Tetlow N, 2004, PHARMACOGENETICS, V14, P111, DOI 10.1097/00008571-200402000-00005; TOMAREV SI, 1993, J BIOL CHEM, V268, P4534; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Wongsantichon J, 2010, BIOCHEM J, V428, P25, DOI 10.1042/BJ20091939; Ye SF, 2010, J AM CHEM SOC, V132, P3646, DOI 10.1021/ja9091616	64	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24936	24947		10.1074/jbc.M113.476135	http://dx.doi.org/10.1074/jbc.M113.476135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828197	hybrid, Green Published			2022-12-25	WOS:000330612300057
J	Kawauchi, J; Inoue, M; Fukuda, M; Uchida, Y; Yasukawa, T; Conaway, RC; Conaway, JW; Aso, T; Kitajima, S				Kawauchi, Junya; Inoue, Makoto; Fukuda, Mizue; Uchida, Yohei; Yasukawa, Takashi; Conaway, Ronald C.; Conaway, Joan W.; Aso, Teijiro; Kitajima, Shigetaka			Transcriptional Properties of Mammalian Elongin A and Its Role in Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR ELONGIN; GENE-EXPRESSION; IN-VIVO; FACTOR-SIII; FACTORS TFIIS; INITIATION; PROMOTER; COMPLEX; ATF3	Elongin A was shown previously to be capable of potently activating the rate of RNA polymerase II (RNAPII) transcription elongation in vitro by suppressing transient pausing by the enzyme at many sites along DNA templates. The role of Elongin A in RNAPII transcription in mammalian cells, however, has not been clearly established. In this report, we investigate the function of Elongin A in RNAPII transcription. We present evidence that Elongin A associates with the IIO form of RNAPII at sites of newly transcribed RNA and is relocated to dotlike domains distinct from those containing RNAPII when cells are treated with the kinase inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Significantly, Elongin A is required for maximal induction of transcription of the stress response genes ATF3 and p21 in response to several stimuli. Evidence from structure-function studies argues that Elongin A transcription elongation activity, but not its ubiquitination activity, is most important for its function in induction of transcription of ATF3 and p21. Taken together, our data provide new insights into the function of Elongin A in RNAPII transcription and bring to light a previously unrecognized role for Elongin A in the regulation of stress response genes.	[Kawauchi, Junya; Inoue, Makoto; Fukuda, Mizue; Uchida, Yohei; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Dept Biochem Genet, Med Res Inst, Tokyo 1138510, Japan; [Yasukawa, Takashi; Aso, Teijiro] Kochi Med Sch, Dept Funct Genom, Nankoku, Kochi 7838505, Japan; [Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Tokyo Medical & Dental University (TMDU); Kochi University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp		Conaway, Joan/0000-0002-2786-0663	Japan Society for the Promotion of Science KAKENHI [18012015, 18055008, 21590302, 21590311, 24118002]; Medical Research Institute, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [24590279] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Institute, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 18012015, 18055008, and 21590302 (to S. K.), 21590311 (to T. A.), and 24118002 (to J. K.) and by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University.	Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 2000, J BIOL CHEM, V275, P6546, DOI 10.1074/jbc.275.9.6546; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; Grande MA, 1997, J CELL SCI, V110, P1781; Guglielmi B, 2007, P NATL ACAD SCI USA, V104, P16062, DOI 10.1073/pnas.0704534104; Hai T, 1999, GENE EXPRESSION, V7, P321; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lis JT, 2000, GENE DEV, V14, P792; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miyata K, 2007, CELL DEATH DIFFER, V14, P716, DOI 10.1038/sj.cdd.4402067; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; TAN SY, 1994, J BIOL CHEM, V269, P25684; vanSteensel B, 1996, J CELL SCI, V109, P787; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; Yamazaki K, 2003, J BIOL CHEM, V278, P13585, DOI 10.1074/jbc.C300047200; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yasukawa T, 2007, BIOCHEM BIOPH RES CO, V352, P237, DOI 10.1016/j.bbrc.2006.11.012; Yasukawa T, 2012, CELL REP, V2, P1129, DOI 10.1016/j.celrep.2012.09.031; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	68	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24302	24315		10.1074/jbc.M113.496703	http://dx.doi.org/10.1074/jbc.M113.496703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23828199	Green Published, hybrid			2022-12-25	WOS:000330612300003
J	He, Y; Lian, GL; Lin, SY; Ye, ZY; Li, QX				He, Ying; Lian, Guili; Lin, Shuyong; Ye, Zhiyun; Li, Qinxi			MDM2 Inhibits Axin-Induced p53 Activation Independently of Its E3 Ligase Activity	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNA-DAMAGE; DEGRADATION; COMPLEX; DAXX; PROTEIN; PATHWAY; KINASE	MDM2 plays a crucial role in negatively regulating the functions of tumor suppressor p53. Here we show that MDM2 can inhibit Axin-stimulated p53-dependent apoptosis by suppressing p53 phosphorylation at Ser 46 and apoptosis-related p53 transactivational activity. Interestingly, the ubiquitin E3 ligase activity of MDM2 is not required for this inhibitory effect. Mechanically, either wildtype MDM2 or its E3-dead mutant, disrupts the Axin-based HIPK2/p53 complex formation by blocking the binding of p53 and HIPK2 to Axin. MDM2Dp53, a deletion mutant that lacks p53 binding domain fails to exert the inhibitory effect, demonstrating that the interaction of MDM2 and p53, but not its E3 ligase activity toward p53 plays key role in suppressing Axin-stimulated p53 activation. Our results thus have revealed a novel aspect of the mechanism by which MDM2 regulates p53 activities.	[He, Ying; Lian, Guili; Lin, Shuyong; Ye, Zhiyun; Li, Qinxi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University	Li, QX (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	liqinxi@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012	Lin, Shu-Yong/0000-0002-4419-1713	"973" program [2009CB522200]; Natural Science Foundation of China [31101014, 30871280]; Fundamental Research Funds for the Central Universities [2011]; project 111 [B06016];  [NCET-09-0675]	"973" program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); project 111(Ministry of Education, China - 111 Project); 	This work was supported by the "973" program (2009CB522200), the grants from Natural Science Foundation of China (#31101014 and #30871280), the program for NCET-09-0675, the Fundamental Research Funds for the Central Universities (#2011) and the "project 111" (#B06016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Lin SC, 2007, CELL RES, V17, P301, DOI 10.1038/cr.2007.16; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	21	5	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67529	10.1371/journal.pone.0067529	http://dx.doi.org/10.1371/journal.pone.0067529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826318	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000088
J	Ouyang, ZT; Gao, Y; Xie, X; Guo, HQ; Zhang, TT; Zhao, B				Ouyang, Zu-Tao; Gao, Yu; Xie, Xiao; Guo, Hai-Qiang; Zhang, Ting-Ting; Zhao, Bin			Spectral Discrimination of the Invasive Plant Spartina alterniflora at Multiple Phenological Stages in a Saltmarsh Wetland	PLOS ONE			English	Article							CHONGMING ISLAND; VEGETATION; DONGTAN	Spartina alterniflora has widely invaded the saltmarshes of the Yangtze River Estuary and brought negative effects to the ecosystem. Remote sensing technique has recently been used to monitor its distribution, but the similar morphology and canopy structure among S. alterniflora and its neighbor species make it difficult even with high-resolution images. Nevertheless, these species have divergence on phenological stages throughout the year, which cause distinguishing spectral characteristics among them and provide opportunities for discrimination. The field spectra of the S. alterniflora community as well as its major victims, native Phragmites australis and Scirpus mariqueter, were measured in 2009 and 2010 at multi-phenological stages in the Yangtze River Estuary, aiming to find the most appropriate periods for mapping S. alterniflora. Collected spectral data were analyzed separately for every stage firstly by re-sampling reflectance curves into continued 5-nm-wide hyper-spectral bands and then by re-sampling into broad multi-spectral bands - the same as the band ranges of the TM sensor, as well as calculating commonly used vegetation indices. The results showed that differences among saltmarsh communities' spectral characteristics were affected by their phenological stages. The germination and early vegetative growth stage and the flowering stage were probably the best timings to identify S. alterniflora. Vegetation indices like NDVI, ANVI, VNVI, and RVI are likely to enhance spectral separability and also make it possible to discriminate S. alterniflora at its withering stage.	[Ouyang, Zu-Tao; Gao, Yu; Xie, Xiao; Guo, Hai-Qiang; Zhang, Ting-Ting; Zhao, Bin] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Ouyang, Zu-Tao] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	Fudan University; University System of Ohio; University of Toledo	Zhao, B (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China.	zhaobin@fudan.edu.cn	Zhao, Bin/I-3651-2013; Zhao, Bin/E-5349-2010	Zhao, Bin/0000-0002-3530-2469; 	National Natural Science Foundation of China [31170450, 30870409, 40471087]; Science and Technology Commission of Shanghai [10dz1200603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by a grant from the National Natural Science Foundation of China (Grant Nos. 31170450, 30870409, and 40471087) and the Science and Technology Commission of Shanghai (No. 10dz1200603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2010, WETL ECOL MANAG, V18, P281, DOI 10.1007/s11273-009-9169-z; Artigas FJ, 2005, INT J REMOTE SENS, V26, P5209, DOI 10.1080/01431160500218952; BEST E P H, 1981, Hydrobiological Bulletin, V15, P165, DOI 10.1007/BF02255175; Chen ZY, 2004, HYDROBIOLOGIA, V528, P99, DOI 10.1007/s10750-004-1888-9; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Daughtry CST, 1998, REMOTE SENS ENVIRON, V64, P192, DOI 10.1016/S0034-4257(98)00002-9; EVERITT JH, 1987, WEED SCI, V35, P427; Gao Zhan-Guo, 2006, Zhiwu Shengtai Xuebao, V30, P252; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; He MM, 2010, INT J REMOTE SENS, V31, P4319, DOI 10.1080/01431160903252343; Hochberg EJ, 2003, IEEE T GEOSCI REMOTE, V41, P1724, DOI 10.1109/TGRS.2003.815408; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Koger CH, 2003, WEED TECHNOL, V17, P696, DOI 10.1614/WT02-122; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Ma ZJ, 2004, BIODIVERS CONSERV, V13, P333, DOI 10.1023/B:BIOC.0000006502.96131.59; Ouyang ZT, 2011, ECOL INFORM, V6, P136, DOI 10.1016/j.ecoinf.2011.01.002; Pena-Barragan JM, 2006, WEED RES, V46, P10, DOI 10.1111/j.1365-3180.2006.00488.x; Pu R. L., 2000, HYPERSPECTRAL REMOTE; Richards J, 1993, REMOTE SENSING DIGIT, V2nd; Rosso PH, 2005, INT J REMOTE SENS, V26, P5169, DOI 10.1080/01431160500218770; Rouse J.W., 1973, NASA GODDARD SPACE F, P303, DOI DOI 10.1021/JF60203A024; Schmidt KS, 2003, REMOTE SENS ENVIRON, V85, P92, DOI 10.1016/S0034-4257(02)00196-7; Swain P.H., 1978, REMOTE SENSING QUANT; Thomson AG, 2004, INT J REMOTE SENS, V25, P4151, DOI 10.1080/01431160310001647688; Yan YE, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012838; Zhao B, 2005, CHINESE GEOGR SCI, V15, P151, DOI 10.1007/s11769-005-0008-8	27	44	45	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67315	10.1371/journal.pone.0067315	http://dx.doi.org/10.1371/journal.pone.0067315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826265	gold, Green Submitted, Green Published			2022-12-25	WOS:000321150000060
J	Wong, TT; Collodi, P				Wong, Ten-Tsao; Collodi, Paul			Inducible Sterilization of Zebrafish by Disruption of Primordial Germ Cell Migration	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CHEMOKINE; EXPRESSION; GENE; ANTISENSE; GUIDANCE; RECEPTOR; CXCR4; RNA	During zebrafish development, a gradient of stromal-derived factor 1a (Sdf1a) provides the directional cue that guides the migration of the primordial germ cells (PGCs) to the gonadal tissue. Here we describe a method to produce large numbers of infertile fish by inducing ubiquitous expression of Sdf1a in zebrafish embryos resulting in disruption of the normal PGC migration pattern. A transgenic line of zebrafish, Tg(hsp70:sdf1a-nanos3, EGFP), was generated that expresses Sdf1a under the control of the heat-shock protein 70 (hsp70) promoter and nanos3 3'UTR. To better visualize the PGCs, the Tg(hsp70: sdf1a-nanos3, EGFP) fish were crossed with another transgenic line, Tg(kop:DsRed-nanos3), that expresses DsRed driven by the PGC-specific kop promoter. Heat treatment of the transgenic embryos caused an induction of Sdf1a expression throughout the embryo resulting in the disruption of their normal migration. Optimal embryo survival and disruption of PGC migration was achieved when transgenic embryos at the 4- to 8-cell stage were incubated at 34.5 degrees C for 18 hours. Under these conditions, disruption of PGC migration was observed in 100% of the embryos. Sixty-four adult fish were developed from three separate batches of heat-treated embryos and all were found to be infertile males. When each male was paired with a wild-type female, only unfertilized eggs were produced and histological examination revealed that each of the adult male fish possessed severely under-developed gonads that lacked gametes. The results demonstrate that inducible Sdf1a expression is an efficient and reliable strategy to produce infertile fish. This approach makes it convenient to generate large numbers of infertile adult fish while also providing the capability to maintain a fertile brood stock.	[Wong, Ten-Tsao; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wong, TT (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	Wong20@purdue.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	Purdue Office of Technology Commercialization	Purdue Office of Technology Commercialization	This work was supported by a Trask Innovation Fund grant from the Purdue Office of Technology Commercialization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI PKMM, 1989, AQUACULTURE, V76, P157, DOI 10.1016/0044-8486(89)90260-3; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; BARTLEY DM, 1997, FAO AQUACULTURE NEWS, V17, P7; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Donaldson EM, 1987, CURRENT STATUS INDEU, P108; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Hu W, 2007, AQUACULTURE, V271, P498, DOI 10.1016/j.aquaculture.2007.04.075; Johnstone R, 1993, RECENT ADV AQUACULTU, P69; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koprunner M, 2001, GENE DEV, V15, P2877; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Seligny JFPD, 2010, STATE WORLD FISHERY; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Uzbekova S, 2000, J MOL ENDOCRINOL, V25, P337, DOI 10.1677/jme.0.0250337; Van Eenennaam AL, 2011, NAT BIOTECHNOL, V29, P706, DOI 10.1038/nbt.1938; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong TT, 2013, BIOCHEM BIOPH RES CO, V430, P347, DOI 10.1016/j.bbrc.2012.11.014; Wong TT, 2004, BIOL REPROD, V71, P1026, DOI 10.1095/biolreprod.104.028019; Zohar Y, 2004, PATENT FULL TEXT IMA	32	24	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68455	10.1371/journal.pone.0068455	http://dx.doi.org/10.1371/journal.pone.0068455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826390	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000143
J	Lindstrom, BR; Mattsson-Marn, IB; Golkar, A; Olsson, A				Lindstrom, Bjorn R.; Mattsson-Marn, Isak Berglund; Golkar, Armita; Olsson, Andreas			In Your Face: Risk of Punishment Enhances Cognitive Control and Error-Related Activity in the Corrugator Supercilii Muscle	PLOS ONE			English	Article							PREFRONTAL CORTEX; MOTIVATIONAL INFLUENCES; RESPONSE-INHIBITION; FACIAL EXPRESSIONS; INTEGRATIVE THEORY; NEGATIVE AFFECT; CINGULATE; DOPAMINE; INSIGHTS; MODEL	Cognitive control is needed when mistakes have consequences, especially when such consequences are potentially harmful. However, little is known about how the aversive consequences of deficient control affect behavior. To address this issue, participants performed a two-choice response time task where error commissions were expected to be punished by electric shocks during certain blocks. By manipulating (1) the perceived punishment risk (no, low, high) associated with error commissions, and (2) response conflict (low, high), we showed that motivation to avoid punishment enhanced performance during high response conflict. As a novel index of the processes enabling successful cognitive control under threat, we explored electromyographic activity in the corrugator supercilii (cEMG) muscle of the upper face. The corrugator supercilii is partially controlled by the anterior midcingulate cortex (aMCC) which is sensitive to negative affect, pain and cognitive control. As hypothesized, the cEMG exhibited several key similarities with the core temporal and functional characteristics of the Error-Related Negativity (ERN) ERP component, the hallmark index of cognitive control elicited by performance errors, and which has been linked to the aMCC. The cEMG was amplified within 100 ms of error commissions (the same time-window as the ERN), particularly during the high punishment risk condition where errors would be most aversive. Furthermore, similar to the ERN, the magnitude of error cEMG predicted post-error response time slowing. Our results suggest that cEMG activity can serve as an index of avoidance motivated control, which is instrumental to adaptive cognitive control when consequences are potentially harmful.	[Lindstrom, Bjorn R.; Mattsson-Marn, Isak Berglund; Golkar, Armita; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lindstrom, Bjorn R.; Golkar, Armita; Olsson, Andreas] Stockholm Brain Inst, Stockholm, Sweden	Karolinska Institutet	Lindstrom, BR (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	bjorn.lindstrom@ki.se		Golkar, Armita/0000-0003-3077-0391	Swedish Science Council (Vetenskapsradet) [421-2010-2084]	Swedish Science Council (Vetenskapsradet)(Swedish Research Council)	This research was supported by a grant from Swedish Science Council (Vetenskapsradet; 421-2010-2084) to A.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2012, COGNITION, V124, P117, DOI 10.1016/j.cognition.2012.05.009; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D. M., 2007, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Bradley MM, 2005, PSYCHOL SCI, V16, P468; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Chiew KS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00279; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dayan P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P175, DOI 10.1016/B978-0-12-374176-9.00012-9; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; DeCaro MS, 2011, J EXP PSYCHOL GEN, V140, P390, DOI 10.1037/a0023466; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Gomez P, 2007, J EXP PSYCHOL GEN, V136, P389, DOI 10.1037/0096-3445.136.3.389; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; MacDonald KB, 2008, PSYCHOL REV, V115, P1012, DOI 10.1037/a0013327; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; Morecraft RJ, 2004, NEUROLOGIST, V10, P235, DOI 10.1097/01.nrl.0000138734.45742.8d; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Mushtaq F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00249; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riesel A, 2012, PSYCHOPHYSIOLOGY, V49, P239, DOI 10.1111/j.1469-8986.2011.01298.x; Robinson OJ, 2011, COGN AFFECT BEHAV NE, V11, P217, DOI 10.3758/s13415-011-0030-5; Schacht A, 2010, COGN AFFECT BEHAV NE, V10, P349, DOI 10.3758/CABN.10.3.349; Schacht A, 2009, PSYCHOL RES-PSYCH FO, V73, P843, DOI 10.1007/s00426-008-0192-0; Schouppe N, 2012, Q J EXP PSYCHOL, V65, P1052, DOI 10.1080/17470218.2012.685080; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	68	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65692	10.1371/journal.pone.0065692	http://dx.doi.org/10.1371/journal.pone.0065692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840356	Green Submitted, Green Published, gold			2022-12-25	WOS:000321424400010
J	Vincent, EE; Elder, DJE; Curwen, J; Kilgour, E; Hers, I; Tavare, JM				Vincent, Emma E.; Elder, Douglas J. E.; Curwen, Jon; Kilgour, Elaine; Hers, Ingeborg; Tavare, Jeremy M.			Targeting Non-Small Cell Lung Cancer Cells by Dual Inhibition of the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; IGF-I; MONOCLONAL-ANTIBODIES; CLINICAL DEVELOPMENT; BINDING PROTEIN-3; HYBRID RECEPTORS; PROSTATE-CANCER; PLASMA-LEVELS; EXPRESSION; LINES	Phase III trials of the anti-insulin-like growth factor-1 receptor (IGF1R) antibody figitumumab in non-small cell lung cancer (NSCLC) patients have been discontinued owing to lack of survival benefit. We investigated whether inhibition of the highly homologous insulin receptor (IR) in addition to the IGF1R would be more effective than inhibition of the IGF1R alone at preventing the proliferation of NSCLC cells. Signalling through IGF1R and IR in the NSCLC cell lines A549 and Hcc193 was stimulated by a combination of IGF1, IGF2 and insulin. It was inhibited by antibodies that block ligand binding, alpha IR3 (IGF1R) and IR47-9 (IR), and by the ATP-competitive small molecule tyrosine kinase inhibitors AZ12253801 and NVPAWD742 which inhibit both IGF1R and IR tyrosine kinases. The effect of inhibitors was determined by an anchorage-independent proliferation assay and by analysis of Akt phosphorylation. In Hcc193 cells the reduction in cell proliferation and Akt phosphorylation due to anti-IGF1R antibody was enhanced by antibody-mediated inhibition of the IR whereas in A549 cells, with a relatively low IR: IGF1R expression ratio, it was not. In each cell line proliferation and Akt phosphorylation were more effectively inhibited by AZ12253801 and NVPAWD742 than by combined alpha IR3 and IR47-9. When the IGF1R alone is inhibited, unencumbered signalling through the IR can contribute to continued NSCLC cell proliferation. We conclude that small molecule inhibitors targeting both the IR and IGF1R more effectively reduce NSCLC cell proliferation in a manner independent of the IR: IGF1R expression ratio, providing a therapeutic rationale for the treatment of this disease.	[Vincent, Emma E.; Elder, Douglas J. E.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Curwen, Jon; Kilgour, Elaine] AstraZeneca, CIRA Discovery, Macclesfield, Cheshire, England; [Hers, Ingeborg] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; AstraZeneca; University of Bristol	Tavare, JM (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	j.tavare@bristol.ac.uk	Hers, Ingeborg/ABG-3357-2020	Vincent, Emma/0000-0002-8917-7384; Hers, Ingeborg/0000-0002-6467-5715	Medical Research Council; AstraZeneca; British Heart Foundation [PG/10/100/28658, FS/12/3/29232] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); British Heart Foundation(British Heart Foundation)	The work described was funded by grants from the Medical Research Council and AstraZeneca to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Basu B, 2011, BRIT J CANCER, V104, P1, DOI 10.1038/sj.bjc.6606023; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Dalby AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050253; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Dent P, 2005, BIOCHEM PHARMACOL, V70, P1685, DOI 10.1016/j.bcp.2005.08.020; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; FAVONI RE, 1994, INT J CANCER, V56, P858, DOI 10.1002/ijc.2910560618; Feng Y, 2006, MOL CANCER THER, V5, P114, DOI 10.1158/1535-7163.MCT-05-0252; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Goya M, 2004, CANCER RES, V64, P6252, DOI 10.1158/0008-5472.CAN-04-0919; Gridelli C, 2010, EXPERT OPIN INV DRUG, V19, P631, DOI 10.1517/13543781003767434; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Gualberto A, 2010, CLIN CANCER RES, V16, P4654, DOI 10.1158/1078-0432.CCR-10-0089; Gualberto A, 2009, CURR DRUG TARGETS, V10, P923, DOI 10.2174/138945009789577945; Hakam A, 1999, HUM PATHOL, V30, P1128, DOI 10.1016/S0046-8177(99)90027-8; Hellawell GO, 2002, CANCER RES, V62, P2942; Jassem J, 2010, J CLIN ONCOL S, V28; KAISER U, 1993, J CANCER RES CLIN, V119, P665, DOI 10.1007/BF01215985; KAREY KP, 1988, CANCER RES, V48, P4083; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kornprat P, 2006, J CLIN PATHOL, V59, P202, DOI 10.1136/jcp.2005.028480; KULL FC, 1983, J BIOL CHEM, V258, P6561; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Massoner P, 2010, BRIT J CANCER, V103, P1479, DOI 10.1038/sj.bjc.6605932; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014124; MILAZZO G, 1992, CANCER RES, V52, P3924; NAKANISHI Y, 1988, J CLIN INVEST, V82, P354, DOI 10.1172/JCI113594; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; OSBORNE CK, 1976, P NATL ACAD SCI USA, V73, P4536, DOI 10.1073/pnas.73.12.4536; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; PAPA V, 1993, CANCER RES, V53, P3736; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petridou E, 2003, ONCOLOGY-BASEL, V64, P341, DOI 10.1159/000070291; PILLEMER G, 1992, INT J CANCER, V50, P80, DOI 10.1002/ijc.2910500117; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prince SN, 2007, MOL CANCER THER, V6, P607, DOI 10.1158/1535-7163.MCT-06-0509; Quinn KA, 1996, J BIOL CHEM, V271, P11477, DOI 10.1074/jbc.271.19.11477; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sachdev D, 2003, CANCER RES, V63, P627; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; Ulanet DB, 2010, P NATL ACAD SCI US; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Vincent EE, 2011, BR J CANC; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Warshamana-Greene GS, 2004, MOL CANCER THER, V3, P527; Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yeh J, 2008, LUNG CANCER, V60, P166, DOI 10.1016/j.lungcan.2007.09.023; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhang H, 2010, ONCOGENE, V29, P2517, DOI 10.1038/onc.2010.17; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	64	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66963	10.1371/journal.pone.0066963	http://dx.doi.org/10.1371/journal.pone.0066963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826179	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400088
J	Hawse, WF; Gloor, BE; Ayres, CM; Kho, K; Nuter, E; Baker, BM				Hawse, William F.; Gloor, Brian E.; Ayres, Cory M.; Kho, Kevin; Nuter, Elizabeth; Baker, Brian M.			Peptide Modulation of Class I Major Histocompatibility Complex Protein Molecular Flexibility and the Implications for Immune Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; MHC CLASS-I; IMMUNOGLOBULIN-LIKE RECEPTOR; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; ANTIGENIC PEPTIDES; BINDING MECHANISM; HLA-B27 SUBTYPES; VACCINE-DESIGN; LIGAND	T cells use the alpha beta Tcell receptor (TCR) to recognize antigenic peptides presented by class I major histocompatibility complex proteins (pMHCs) on the surfaces of antigen-presenting cells. Flexibility in both TCRs and peptides plays an important role in antigen recognition and discrimination. Less clear is the role of flexibility in the MHC protein; although recent observations have indicated that mobility in the MHC can impact TCR recognition in a peptide-dependent fashion, the extent of this behavior is unknown. Here, using hydrogen/deuterium exchange, fluorescence anisotropy, and structural analyses, we show that the flexibility of the peptide binding groove of the class I MHC protein HLA-A*0201 varies significantly with different peptides. The variations extend throughout the binding groove, impacting regions contacted by TCRs as well as other activating and inhibitory receptors of the immune system. Our results are consistent with statistical mechanical models of protein structure and dynamics, in which the binding of different peptides alters the populations and exchange kinetics of sub-states in the MHC conformational ensemble. Altered MHC flexibility will influence receptor engagement, impacting conformational adaptations, entropic penalties associated with receptor recognition, and the populations of binding-competent states. Our results highlight a previously unrecognized aspect of the "altered self" mechanism of immune recognition and have implications for specificity, cross-reactivity, and antigenicity in cellular immunity.	[Hawse, William F.; Gloor, Brian E.; Ayres, Cory M.; Kho, Kevin; Nuter, Elizabeth; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Baker, Brian M.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Baker, BM (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	brian-baker@nd.edu	Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964	National Institutes of Health Grant from the NIGMS [GM067079]; National Science Foundation [MCB-0448298]; American Cancer Society [PF-11-143-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIGMS; National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067079 from the NIGMS (to B. M. B.). This work was also supported by Grant MCB-0448298 from the National Science Foundation.; Supported by Fellowship PF-11-143-01 from the American Cancer Society.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Cerutti DS, 2008, BIOCHEMISTRY-US, V47, P12065, DOI 10.1021/bi800894u; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Miller DW, 1997, PROTEIN SCI, V6, P2166; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Painter CA, 2012, IMMUNOL REV, V250, P144, DOI 10.1111/imr.12003; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Reichert D, 2012, J BIOMOL STRUCT DYN, V30, P617, DOI 10.1080/07391102.2012.689695; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	50	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24372	24381		10.1074/jbc.M113.490664	http://dx.doi.org/10.1074/jbc.M113.490664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836912	hybrid, Green Published			2022-12-25	WOS:000330612300009
J	Mastrocola, AS; Kim, SH; Trinh, AT; Rodenkirch, LA; Tibbetts, RS				Mastrocola, Adam S.; Kim, Sang Hwa; Trinh, Anthony T.; Rodenkirch, Lance A.; Tibbetts, Randal S.			The RNA-binding Protein Fused in Sarcoma (FUS) Functions Downstream of Poly(ADP-ribose) Polymerase (PARP) in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; AMYOTROPHIC-LATERAL-SCLEROSIS; CELL-FREE FORMATION; HISTONE H2AX; IN-VIVO; REPAIR; GENE; ACTIVATION; PHOSPHORYLATION; TDP-43	The list of factors that participate in the DNA damage response to maintain genomic stability has expanded significantly to include a role for proteins involved in RNA processing. Here, we provide evidence that the RNA-binding protein fused in sarcoma/translocated in liposarcoma (FUS) is a novel component of the DNA damage response. We demonstrate that FUS is rapidly recruited to sites of laser-induced DNA double-strand breaks (DSBs) in a manner that requires poly(ADP-ribose) (PAR) polymerase activity, but is independent of ataxia-telangiectasia mutated kinase function. FUS recruitment is mediated by the arginine/glycine-rich domains, which interact directly with PAR. In addition, we identify a role for the prion-like domain in promoting accumulation of FUS at sites of DNA damage. Finally, depletion of FUS diminished DSB repair through both homologous recombination and nonhomologous end-joining, implicating FUS as an upstream participant in both pathways. These results identify FUS as a new factor in the immediate response to DSBs that functions downstream of PAR polymerase to preserve genomic integrity.	[Mastrocola, Adam S.; Kim, Sang Hwa; Trinh, Anthony T.; Tibbetts, Randal S.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Mastrocola, Adam S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Rodenkirch, Lance A.] Univ Wisconsin, WM Keck Lab Biol Imaging, Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Human Oncol, 1111 Highland Ave, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health Grants [CA115783, T32 ES007015]; NATIONAL CANCER INSTITUTE [R01CA115783, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA115783 (to R. S. T) and T32 ES007015 (to A. S. M.).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Ahn JY, 2000, CANCER RES, V60, P5934; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hong ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060208; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krietsch J., 2012, MOL ASPECTS MED S, VS0098-2997, P00139; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Oh SM, 2010, ONCOGENE, V29, P1017, DOI 10.1038/onc.2009.411; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Perrotti D, 1998, EMBO J, V17, P4442, DOI 10.1093/emboj/17.15.4442; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pitson G, 2004, INT J RADIAT ONCOL, V60, P522, DOI 10.1016/j.ijrobp.2004.03.009; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sakasai R, 2008, J BIOL CHEM, V283, P13549, DOI 10.1074/jbc.M710197200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STOLOW DT, 1995, NUCLEIC ACIDS RES, V23, P835, DOI 10.1093/nar/23.5.835; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zinszner H, 1997, J CELL SCI, V110, P1741	82	156	157	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24731	24741		10.1074/jbc.M113.497974	http://dx.doi.org/10.1074/jbc.M113.497974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23833192	Green Published, hybrid			2022-12-25	WOS:000330612300039
J	Gonzalez, LM; Williamson, I; Piedrahita, JA; Blikslager, AT; Magness, ST				Gonzalez, Liara M.; Williamson, Ian; Piedrahita, Jorge A.; Blikslager, Anthony T.; Magness, Scott T.			Cell Lineage Identification and Stem Cell Culture in a Porcine Model for the Study of Intestinal Epithelial Regeneration	PLOS ONE			English	Article							MOUSE SMALL INTESTINE; SMALL-BOWEL RESECTION; GLUCAGON-LIKE PEPTIDE-2; BARRIER FUNCTION; IN-VITRO; PANETH CELLS; SECRETORY-CELL; GROWTH-FACTOR; BRUSH-BORDER; GASTROINTESTINAL-TRACT	Significant advances in intestinal stem cell biology have been made in murine models; however, anatomical and physiological differences between mice and humans limit mice as a translational model for stem cell based research. The pig has been an effective translational model, and represents a candidate species to study intestinal epithelial stem cell (IESC) driven regeneration. The lack of validated reagents and epithelial culture methods is an obstacle to investigating IESC driven regeneration in a pig model. In this study, antibodies against Epithelial Adhesion Molecule 1 (EpCAM) and Villin marked cells of epithelial origin. Antibodies against Proliferative Cell Nuclear Antigen (PCNA), Minichromosome Maintenance Complex 2 (MCM2), Bromodeoxyuridine (BrdU) and phosphorylated Histone H3 (pH3) distinguished proliferating cells at various stages of the cell cycle. SOX9, localized to the stem/progenitor cells zone, while HOPX was restricted to the +4/'reserve' stem cell zone. Immunostaining also identified major differentiated lineages. Goblet cells were identified by Mucin 2 (MUC2); enteroendocrine cells by Chromogranin A (CGA), Gastrin and Somatostatin; and absorptive enterocytes by carbonic anhydrase II (CAII) and sucrase isomaltase (SIM). Transmission electron microscopy demonstrated morphologic and subcellular characteristics of stem cell and differentiated intestinal epithelial cell types. Quantitative PCR gene expression analysis enabled identification of stem/progenitor cells, post mitotic cell lineages, and important growth and differentiation pathways. Additionally, a method for long-term culture of porcine crypts was developed. Biomarker characterization and development of IESC culture in the porcine model represents a foundation for translational studies of IESC-driven regeneration of the intestinal epithelium in physiology and disease.	[Gonzalez, Liara M.; Piedrahita, Jorge A.; Blikslager, Anthony T.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Gonzalez, Liara M.; Blikslager, Anthony T.] N Carolina State Univ, Dept Clin Sci, Raleigh, NC 27695 USA; [Piedrahita, Jorge A.] N Carolina State Univ, Raleigh, NC 27695 USA; [Williamson, Ian; Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Chapel Hill, NC USA; [Williamson, Ian; Magness, Scott T.] Univ N Carolina, UNC NCSU Biomed Engn, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magness, ST (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	magness@med.unc.edu		Williamson, Ian/0000-0003-2795-6099; Blikslager, Anthony/0000-0002-0867-7310; Magness, Scott/0000-0002-2746-1224	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000083]; NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP) [R01DK091427, R03DK089126, T32RR024394]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR024394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089126, P30DK034987, R01DK091427] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011130] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR000083 (STM/JP). Additional support provided by R01DK091427 (STM), R03DK089126 (STM), NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP) T32RR024394. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd KM, 2012, ANN SURG, V256, P494, DOI 10.1097/SLA.0b013e318265f310; Ahlman H, 2001, ANN ONCOL, V12, pS63, DOI 10.1093/annonc/12.suppl_2.S63; Amasaki T, 2001, J VET MED SCI, V63, P967, DOI 10.1292/jvms.63.967; Argenzio RA, 1997, J PHARMACOL EXP THER, V283, P692; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Bines JE, 2002, J GASTROEN HEPATOL, V17, P1170, DOI 10.1046/j.1440-1746.2002.02872.x; Bjerknes M, 2006, DEV BIOL, V300, P722, DOI 10.1016/j.ydbio.2006.07.040; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Blikslager AT, 1997, SURGERY, V121, P526, DOI 10.1016/S0039-6060(97)90107-0; Blikslager AT, 1999, SURGERY, V125, P186, DOI 10.1016/S0039-6060(99)70264-3; Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28; Block T, 2011, EUR J VASC ENDOVASC, V41, P281, DOI 10.1016/j.ejvs.2010.09.012; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; Cilieborg MS, 2011, J NUTR, V141, P223, DOI 10.3945/jn.110.128561; Davidson LA, 2012, BBA-MOL BASIS DIS, V1822, P1600, DOI 10.1016/j.bbadis.2012.06.011; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Dellmann H, 1987, TXB VET HISTOLOGY, P187; DOBBINS WO, 1991, ULTRASTRUCT PATHOL, V15, P15, DOI 10.3109/01913129109021301; Du Plessis J, 2013, J HEPATOL, V58, P1125, DOI 10.1016/j.jhep.2013.01.038; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Foster DM, 2012, GASTROENTEROLOGY, V143, P133, DOI 10.1053/j.gastro.2012.03.030; Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garrison AP, 2009, AM J PHYSIOL-GASTR L, V296, pG643, DOI 10.1152/ajpgi.90588.2008; Gayle J, 2002, SURGERY, V132, P461, DOI 10.1067/msy.2002.125320; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Gookin JL, 2006, AM J PHYSIOL-GASTR L, V290, pG164, DOI 10.1152/ajpgi.00460.2004; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Johansson ME, 2013, NAT REV GASTRO HEPAT, DOI DOI 10.1038/NRGASTR0.2013.35.ACCESSED; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; Li QM, 2011, INT J MOL SCI, V12, P1727, DOI 10.3390/ijms12031727; Lichtenstein GR, 2010, INFLAMM BOWEL DIS, V16, P338, DOI 10.1002/ibd.20997; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; MYER MS, 1982, ONDERSTEPOORT J VET, V49, P131; Nagy ES, 2004, J PEDIATR GASTR NUTR, V39, P487, DOI 10.1097/00005176-200411000-00008; National Institute of Health, 2012, NIH S IMPR AN MOD RE; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Paris MC, 2004, DIGEST DIS SCI, V49, P1688, DOI 10.1023/B:DDAS.0000043388.52260.2f; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pereira-Fantini PM, 2008, JPEN-PARENTER ENTER, V32, P266, DOI 10.1177/0148607108316197; Pereira-Fantini PM, 2008, J PEDIATR GASTR NUTR, V46, P20, DOI 10.1097/01.mpg.0000304449.46434.06; Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; PortelaGomes GM, 1997, J HISTOCHEM CYTOCHEM, V45, P815, DOI 10.1177/002215549704500606; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Potten CS, 2001, CELL GROWTH DIFFER, V12, P265; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Pruitt SC, 2010, STEM CELLS, V28, P1250, DOI 10.1002/stem.450; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; RHOADS JM, 1989, J PEDIATR GASTR NUTR, V9, P225, DOI 10.1097/00005176-198908000-00016; RHOADS JM, 1990, AM J PHYSIOL, V259, pG99, DOI 10.1152/ajpgi.1990.259.1.G99; RHOADS JM, 1991, GASTROENTEROLOGY, V100, P683, DOI 10.1016/0016-5085(91)80012-X; Rizk P, 2012, WIRES SYST BIOL MED, V4, P475, DOI 10.1002/wsbm.1176; RODRIGUEZ IR, 1984, EUR J BIOCHEM, V143, P575, DOI 10.1111/j.1432-1033.1984.tb08408.x; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Rowland KJ, 2011, AM J PHYSIOL-GASTR L, V301, pG1, DOI 10.1152/ajpgi.00039.2011; Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; Schwartz CA, 2012, ROFO-FORTSCHR RONTG, V184, P520, DOI 10.1055/s-0031-1299414; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tang ZH, 2010, ACAD RADIOL, V17, P1146, DOI 10.1016/j.acra.2010.04.014; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Trautmann A, 1952, FUNDAMENTALS HISTOLO; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Voortman T, 2012, J AGR FOOD CHEM, V60, P9035, DOI 10.1021/jf2045697; WAGNER JE, 1973, CAN J COMP MED, V37, P177; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhou C, 2013, ALCOHOL, V47, P231, DOI 10.1016/j.alcohol.2013.01.003; ZWEIBAUM A, 1984, INT J CANCER, V34, P591, DOI 10.1002/ijc.2910340502	113	89	91	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66465	10.1371/journal.pone.0066465	http://dx.doi.org/10.1371/journal.pone.0066465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840480	Green Published, Green Submitted, gold			2022-12-25	WOS:000321148400014
J	Qu, J; Jakobs, TC				Qu, Juan; Jakobs, Tatjana C.			The Time Course of Gene Expression during Reactive Gliosis in the Optic Nerve	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; AXONAL-TRANSPORT; RAT GLAUCOMA; MOUSE RETINA; ASTROCYTES; HEAD; INJURY; MODEL; BRAIN; NEURONS	Reactive gliosis is a complex process that involves changes in gene expression and morphological remodeling. The mouse optic nerve, where astrocytes, microglia and oligodendrocytes interact with retinal ganglion cell axons and each other, is a particularly suitable model for studying the molecular mechanisms of reactive gliosis. We triggered gliosis at the mouse optic nerve head by retro orbital nerve crush. We followed the expression profiles of 14,000 genes from 1 day to 3 months, as the optic nerve formed a glial scar. The transcriptome showed profound changes. These were greatest shortly after injury; the numbers of differentially regulated genes then dropped, returning nearly to resting levels by 3 months. Different genes were modulated with very different time courses, and functionally distinct groups of genes responded in partially overlapping waves. These correspond roughly to two quick waves of inflammation and cell proliferation, a slow wave of tissue remodeling and debris removal, and a final stationary phase that primarily reflects permanent structural changes in the axons. Responses from astrocytes, microglia and oligodendrocytes were distinctively different, both molecularly and morphologically. Comparisons to other models of brain injury and to glaucoma indicated that the glial responses depended on both the tissue and the injury. Attempts to modulate glial function after axonal injuries should consider different mechanistic targets at different times following the insult.	[Qu, Juan; Jakobs, Tatjana C.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Jakobs, TC (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02138 USA.	tatjana_jakobs@meei.harvard.edu		Jakobs, Tatjana/0000-0002-8104-9206	National Institutes of Health (NIH) [EY019703, EY14104]; Research to Prevent Blindness; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY019703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by National Institutes of Health (NIH) grant EY019703, core grant EY14104, and grants from Research to Prevent Blindness and the Massachusetts Lions Eye Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito U, 2007, STROKE, V38, P2577, DOI 10.1161/STROKEAHA.107.484394; Jakobs TC, 2007, MOL VIS, V13, P933; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jakobs TC, 2003, J COMP NEUROL, V465, P361, DOI 10.1002/cne.10845; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Kalmar B, 2001, NEUROCHEM INT, V38, P453, DOI 10.1016/S0197-0186(00)00090-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Morcos Y, 2000, J NEUROCYTOL, V29, P665, DOI 10.1023/A:1010835404754; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nolte C, 2001, GLIA, V33, P72; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Pena JDO, 1999, EXP EYE RES, V68, P29, DOI 10.1006/exer.1998.0577; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yanagi M, 2008, SCHIZOPHR RES, V100, P291, DOI 10.1016/j.schres.2007.11.042; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	47	78	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67094	10.1371/journal.pone.0067094	http://dx.doi.org/10.1371/journal.pone.0067094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826199	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000024
J	Kling, RC; Lanig, H; Clark, T; Gmeiner, P				Kling, Ralf C.; Lanig, Harald; Clark, Timothy; Gmeiner, Peter			Active-State Models of Ternary GPCR Complexes: Determinants of Selective Receptor-G-Protein Coupling	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DOPAMINE-D-2 RECEPTOR; SYNTHETIC PEPTIDES; STRUCTURAL BASIS; AMINO-TERMINUS; BINDING; ACTIVATION; AGONIST; SPECIFICITY; G-ALPHA(I1)	Based on the recently described crystal structure of the beta(2) adrenergic receptor - G(s)-protein complex, we report the first molecular-dynamics simulations of ternary GPCR complexes designed to identify the selectivity determinants for receptor-G-protein binding. Long-term molecular dynamics simulations of agonist-bound beta 2AR-G alpha s and D2R-G alpha, complexes embedded in a hydrated bilayer environment and computational alanine-scanning mutagenesis identified distinct residues of the N-terminal region of intracellular loop 3 to be crucial for coupling selectivity. Within the G-protein, specific amino acids of the alpha 5-helix, the C-terminus of the G alpha-subunit and the regions around alpha N-beta 1 and alpha 4-beta 6 were found to determine receptor recognition. Knowledge of these determinants of receptor-G-protein binding selectivity is essential for designing drugs that target specific receptor/G-protein combinations.	[Kling, Ralf C.; Gmeiner, Peter] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Kling, Ralf C.; Lanig, Harald; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Clark, Timothy] Univ Portsmouth, Ctr Mol Design, Portsmouth, Hants, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Portsmouth	Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany.	peter.gmeiner@fau.de	Gmeiner, Peter/N-5275-2015	Gmeiner, Peter/0000-0002-4127-197X; Clark, Timothy/0000-0001-7931-4659; Lanig, Harald/0000-0003-1593-5557				Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Babin V., 2008, AMBER; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bradshaw RT, 2011, PROTEIN ENG DES SEL, V24, P197, DOI 10.1093/protein/gzq047; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coley C, 2000, J NEUROCHEM, V74, P358, DOI 10.1046/j.1471-4159.2000.0740358.x; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Fowler JC, 2012, MOL PHARM; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gazi L, 2003, BRIT J PHARMACOL, V138, P775, DOI 10.1038/sj.bjp.0705116; Goetz A, 2011, J MOL BIOL; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Katritch V, 2012, ANN REV PHARM TOXICO; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Miller III B. R., 2012, J CHEM THEORY COMPUT; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Nickolls SA, 2003, BIOCHEM PHARMACOL, V65, P1139, DOI 10.1016/S0006-2952(03)00040-6; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Romanelli RJ, 2010, RECEPT SER, P137, DOI 10.1007/978-1-60327-333-6_6; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Tschammer N, 2011, J MED CHEM, V54, P2477, DOI 10.1021/jm101639t; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VOSS T, 1993, J BIOL CHEM, V268, P4637; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108	65	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67244	10.1371/journal.pone.0067244	http://dx.doi.org/10.1371/journal.pone.0067244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826246	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400126
J	Kocarek, P; John, V; Hulva, P				Kocarek, Petr; John, Vaclav; Hulva, Pavel			When the Body Hides the Ancestry: Phylogeny of Morphologically Modified Epizoic Earwigs Based on Molecular Evidence	PLOS ONE			English	Article							DERMAPTERA; EVOLUTION; INSECTA; SUBSTITUTION; CHROMOSOMES; FORFICULINA; INFERENCE; OVARIES; MODEL	Here, we present a study regarding the phylogenetic positions of two enigmatic earwig lineages whose unique phenotypic traits evolved in connection with ectoparasitic relationships with mammals. Extant earwigs (Dermaptera) have traditionally been divided into three suborders: the Hemimerina, Arixeniina, and Forficulina. While the Forficulina are typical, well-known, free-living earwigs, the Hemimerina and Arixeniina are unusual epizoic groups living on molossid bats (Arixeniina) or murid rodents (Hemimerina). The monophyly of both epizoic lineages is well established, but their relationship to the remainder of the Dermaptera is controversial because of their extremely modified morphology with paedomorphic features. We present phylogenetic analyses that include molecular data (18S and 28S ribosomal DNA and histone-3) for both Arixeniina and Hemimerina for the first time. This data set enabled us to apply a rigorous cladistics approach and to test competing hypotheses that were previously scattered in the literature. Our results demonstrate that Arixeniidae and Hemimeridae belong in the dermapteran suborder Neodermaptera, infraorder Epidermaptera, and superfamily Forficuloidea. The results support the sister group relationships of Arixeniidae+Chelisochidae and Hemimeridae+Forficulidae. This study demonstrates the potential for rapid and substantial macroevolutionary changes at the morphological level as related to adaptive evolution, in this case linked to the utilization of a novel trophic niche based on an epizoic life strategy. Our results also indicate that the evolutionary consequences of the transition to an ectoparazitic mode of living, which is extremely rare in earwigs, have biased previous morphology-based hypotheses regarding the phylogeny of this insect group.	[Kocarek, Petr] Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [John, Vaclav; Hulva, Pavel] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Fac Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	University of Ostrava; Charles University Prague; University of Ostrava	Kocarek, P (corresponding author), Univ Ostrava, Fac Sci, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic.	petr.kocarek@osu.cz	Kocarek, Petr/C-2989-2011	Kocarek, Petr/0000-0002-1739-0143	Charles University in Prague [SVV-2012-265 206]; University of Ostrava [SGS21/PrF/2013]	Charles University in Prague; University of Ostrava	The funding was provided by an Institutional Research Support grant from the Charles University in Prague (reg. no. SVV-2012-265 206) and an Institutional Research Support grant from the University of Ostrava (reg. no. SGS21/PrF/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J.C., 2004, MOL MARKERS NATURAL; Burr M, 1911, GENERA INSECTORUM FA, V122; Colgan DJ, 2003, INSECT SYST EVOL, V34, P65, DOI 10.1163/187631203788964935; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deem LS, 2012, DERMAPTERA SPECIES F; DERIJK P, 1994, NUCLEIC ACIDS RES, V22, P3495; DERIJK P, 1992, NUCLEIC ACIDS RES, V20, P2075, DOI 10.1093/nar/20.suppl.2075; Engel Michael S., 2003, Transactions of the Kansas Academy of Science, V106, P115, DOI 10.1660/0022-8443(2003)106[0115:TEOKWA]2.0.CO;2; Engel MS, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)539[1:FNFED]2.0.CO;2; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Giles E. T., 1963, Transactions of the Royal Entomological Society of London, V115, P95; Grimaldi David, 2005, pi; Guillet S, 2001, EVOL ECOL RES, V3, P441; HAAS F, 1995, SYST ENTOMOL, V20, P85, DOI 10.1111/j.1365-3113.1995.tb00085.x; Haas F, 2001, EUR J ENTOMOL, V98, P445, DOI 10.14411/eje.2001.065; Haas F, 2000, ARTHROPOD STRUCT DEV, V29, P137, DOI 10.1016/S1467-8039(00)00025-6; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hanson H. J., 1933, Entomologiske Meddelelser, V18, P349; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Hendlirsch A, 1925, HDB ENTOMOLOGIE, V3, P472; Heymons Richard, 1911, Deutsche Entomologische Zeitschrift, V1911; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jarvis KJ, 2005, SYST ENTOMOL, V30, P442, DOI 10.1111/j.1365-3113.2004.00276.x; Jordan K., 1909, Novitates Zoologicae Tring, V16; Kamimura Y, 2004, ANN ENTOMOL SOC AM, V97, P903, DOI 10.1603/0013-8746(2004)097[0903:ISOTOO]2.0.CO;2; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klass KD, 2001, ZOOL J LINN SOC-LOND, V131, P251, DOI 10.1111/j.1096-3642.2001.tb02239.x; Kocarek P, 2009, TROP ZOOL, V22, P237; Lecointre G, 2005, ZOOL SCR, V34, P101, DOI 10.1111/j.1463-6409.2005.00168.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; NAKATA S, 1974, PAC INSECTS, V16, P307; Page RDM, 2000, MOL EVOLUTION PHYLOG; Patterson C., 1987, MOL MORPHOLOGY EVOLU; Popham E. J., 1962, Proceedings of the Zoological Society of London, V139, P429; Popham E. J., 1961, Proceedings of the Royal Entomological Society of London (B), V30, P19; POPHAM EDWARD J., 1965, PROC ZOOL SOC LONDON, V146, P1; POPHAM EJ, 1985, Z ZOOL SYST EVOL, V23, P199; Popham EJ, 2000, J NAT HIST, V34, P2007, DOI 10.1080/00222930050144837; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rehn J. A. G., 1935, Proceedings of the Academy of Natural Sciences of Philadelphia, V87, P457; REHN JAMES A. G., 1937, PROC ACAD NAT SCI PHILADELPHIA, V89, P331; Rentz D.C.F., 1991, P360; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sakai S., 1982, Dermapterorum Catalogus, V14, P1; Sakai S., 1987, P496; Sakai S, 1988, INT C ENT 18, P62; Saussure H, 1879, MEM SOC HIST NAT GEN, V26, P399; Sharp D, 1892, ENTOMOL MON MAG, V28, P212; Sharp D, 1895, CAMBRIDGE NATURAL HI, V5, P217; STEINMANN H, 1973, Folia Entomologica Hungarica, V26, P145; Steinmann H, 1989, DERMAPTERA CATADERMA, V108; Steinmann H, 1993, DERMAPTERA EUDERMAPT, V108; Steinmann H, 1990, DERMAPTERA EUDERMAPT, V106; Steinmann H, 1986, DERMAPTERA CATADERMA, V102; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tworzydlo W, 2013, ZOOL ANZ, V252, P410, DOI 10.1016/j.jcz.2012.11.002; Tworzydlo W, 2010, ACTA BIOL CRACOV BOT, V52, P95; Tworzydlo W, 2010, ARTHROPOD STRUCT DEV, V39, P360, DOI 10.1016/j.asd.2010.05.004; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Walker F, 1871, CATALOGUE SPECIMEN 5; Warnow T, 2012, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1308; WHITE MJD, 1972, CHROMOSOMA, V36, P338, DOI 10.1007/BF00336792; WHITE MJD, 1971, CHROMOSOMA, V34, P183; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wirth T, 1999, MOL BIOL EVOL, V16, P1645, DOI 10.1093/oxfordjournals.molbev.a026078	68	34	36	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66900	10.1371/journal.pone.0066900	http://dx.doi.org/10.1371/journal.pone.0066900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826171	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400081
J	Kuo, LT; Tsai, SY; Chang, CC; Kuo, KT; Huang, APH; Tsai, JC; Tseng, HM; Kuo, MF; Tu, YK				Kuo, Lu-Ting; Tsai, Shao-Yu; Chang, Cheng-Chi; Kuo, Kuang-Ting; Huang, Abel Po-Hao; Tsai, Jui-Chang; Tseng, Ham-Min; Kuo, Meng-Fai; Tu, Yong-Kwang			Genetic and Epigenetic Alterations in Primary-Progressive Paired Oligodendroglial Tumors	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; IDH2 MUTATIONS; PROMOTER METHYLATION; SURVIVAL; 19Q; GLIOMAS; 10Q; HYBRIDIZATION; ASTROCYTOMAS; TEMOZOLOMIDE	The aim of the present study was to identify genetic and epigenetic alterations involved in the progression of oligodendroglial tumors. We characterized 21 paired, World Health Organization (WHO) grade II and III oligodendroglial tumors from patients who received craniotomies for the partial or complete resection of primary and secondary oligodendroglial tumors. Tumor DNA was analyzed for alterations in selected genetic loci (1p36, 9p22, 10q23-24, 17p13, 19q13, 22q12), isocitrate dehydrogenase 1 (IDH1), isocitrate dehydrogenase 2 (IDH2) and the CpG island methylation status of critical tumor-related genes (MGMT, P16, DAPK, PTEN, RASSF1A, Rb1). Alterations of these markers were common early in the tumorigenesis. In the primary tumors we identified 12 patients (57.1%) with 1p36 deletions, 17 (81.0%) with 19q13 deletions, 9 (42.9%) with 1p36/19q13 codeletions, 11 (52.3%) with 9p22 deletions, and 12 (57.1%) with IDH1 mutation. Epigenetic analysis detected promoter methylation of the MGMT, P16, DAPK, PTEN, RASSF1A, and Rb1 genes in 38.1%, 19.0%, 38.1%, 33.3%, 66.7%, and 14.3% of primary tumors, respectively. After progression, additional losses of 1p, 9p, 10q, 17p, 19q and 22q were observed in 3 (14.3%), 1 (4.8%), 3 (14.3%), 2 (9.5%), 1 (4.8%) and 3 (14.3%) cases, respectively. Additional methylations of the MGMT, P16, DAPK, PTEN, RASSF1A, and RB1 promoters was observed in 4 (19.0%), 2 (9.5%), 0 (0%), 6 (28.6%), 2(9.5%) and 3 (14.3%) cases, respectively. The status of IDH1 mutation remained unchanged in all tumors after progression. The primary tumors of three patients with subsequent progression to high-grade astrocytomas, all had 9p deletion, intact 1p, intact 10q and unmethylated MGMT. Whether this may represent a molecular signature of patients at-risk for the development of aggressive astrocytomas needs further investigation.	[Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Yun Lin branch, Dept Surg, Div Neurosurg, Yun Lin Cty, Taiwan; [Tsai, Shao-Yu] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Chang, Cheng-Chi] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 10764, Taiwan; [Kuo, Kuang-Ting] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Huang, Abel Po-Hao; Tsai, Jui-Chang; Tseng, Ham-Min; Kuo, Meng-Fai; Tu, Yong-Kwang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, MF (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan.	Y01951@ms1.ylh.gov.tw	Kuo, Lu-Ting/AAU-3205-2021	TSAI, JUI-CHANG/0000-0003-2723-6841; Tu, Yong-kwang/0000-0003-2113-1176; TSAI, SHAO-YU/0000-0002-2874-5202; KUO, MENG-FAI/0000-0002-1803-2719; Kuo, Lu-Ting/0000-0002-1405-8700; HUANG, ABEL PO-HAO/0000-0002-5689-6761; KUO, KUAN-TING/0000-0002-3657-1652	National Taiwan University Hospital [NTUH95A18, NTUH96N018]; National Science Council [98-2314-B-002-045-MY2]	National Taiwan University Hospital(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from National Taiwan University Hospital (NTUH95A18, NTUH96N018)(L. Kuo) and the National Science Council (98-2314-B-002-045-MY2)(L. Kuo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ME, 2003, CANCER GENET CYTOGEN, V144, P134, DOI 10.1016/S0165-4608(02)00928-7; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; Burton EC, 2002, CANCER RES, V62, P6205; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Campbell BA, 2008, J NEURO-ONCOL, V89, P37, DOI 10.1007/s11060-008-9597-2; Dehais C, 2006, CANCER-AM CANCER SOC, V107, P1891, DOI 10.1002/cncr.22211; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Ferrer-Luna R, 2011, J NEURO-ONCOL, V103, P71, DOI 10.1007/s11060-010-0369-4; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 1996, ONCOGENE, V13, P1065; Ino Y, 2001, CLIN CANCER RES, V7, P839; Jeuken JWM, 2011, BRAIN PATHOL, V21, P308, DOI 10.1111/j.1750-3639.2010.00447.x; Jha P, 2010, NEUROSURGERY, V67, P1681, DOI 10.1227/NEU.0b013e3181f743f5; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; Kuo LT, 2009, INT J CANCER, V124, P2872, DOI 10.1002/ijc.24303; Lass U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041298; Lavon I, 2007, CLIN CANCER RES, V13, P1429, DOI 10.1158/1078-0432.CCR-06-2050; NARAHARA K, 1985, HUM GENET, V71, P37, DOI 10.1007/BF00295665; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PEGG AE, 1990, CANCER RES, V50, P6119; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Sasaki H, 2001, AM J PATHOL, V159, P359, DOI 10.1016/S0002-9440(10)61702-6; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Schmidt MC, 2002, J NEUROPATH EXP NEUR, V61, P321, DOI 10.1093/jnen/61.4.321; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Walker C, 2006, NEUROLOGY, V66, P1661, DOI 10.1212/01.wnl.0000218270.12495.9a; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67139	10.1371/journal.pone.0067139	http://dx.doi.org/10.1371/journal.pone.0067139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826216	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400110
J	Song, YP; Ma, W; Yi, XR; Wang, SM; Sun, XJ; Tian, JM; Wang, SK; Zheng, CM; Zhang, BY; Xu, ZJ; Marley, G				Song, Yapei; Ma, Wei; Yi, Xiangren; Wang, Shumei; Sun, Xiaojie; Tian, Jiming; Wang, Shukang; Zheng, Chunmei; Zhang, Bingyin; Xu, Zhijian; Marley, Gifty			Chronic Diseases Knowledge and Related Factors among the Elderly in Jinan, China	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; MEDICATION; PREVENTION; PREVALENCE; ATTITUDES; ADHERENCE; CANCER	Background: It has been reported that the prevalence of chronic diseases is high among old people and they have poor chronic diseases knowledge. This study was therefore designed to evaluate the awareness rate of chronic diseases knowledge among people aged over 60 years, to explore its related factors and to provide evidence for future health education. Methods: A cross-sectional study was conducted from April to August in 2011. People aged 60 years and above from 3 communities in Jinan were selected by cluster sampling. Nine hundred and twenty five participants were interviewed face-to-face using a structured questionnaire. Results: The awareness rates of chronic diseases knowledge varied from 29.5% to 90.2%. Four healthy lifestyles including quitting smoking and less drinking, keeping broad-minded, maintaining balanced diet and moderate physical activity were best known (from 86.3% to 90.2%). The least known knowledge were 2 complications of hypertension: nephropathy (29.5%) and retinopathy (37.2%). Participants with the following characteristics or behaviors were more likely to have higher chronic diseases knowledge: younger age, female, Han Chinese, higher level of education, having health insurance, participating in societies, having family history of chronic diseases, frequently gathering with friends/relatives, usually going to provincial hospitals/hospitals affiliated with medical universities, usually going to municipal hospitals and usually going to community health center/station. Conclusions: Old people in Jinan had incomplete chronic diseases knowledge and the overall awareness rate was not high. The older people's chronic diseases knowledge should be improved and health education programs should target males, older people with lower educational level, having no health insurance, having no family history of chronic diseases, participating in no societies, and less frequently gathering with friends/relatives. Also, lower level medical facilities should improve their skills of health education.	[Song, Yapei; Ma, Wei; Wang, Shumei; Wang, Shukang; Zhang, Bingyin; Xu, Zhijian; Marley, Gifty] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yi, Xiangren; Tian, Jiming; Zheng, Chunmei] Shandong Univ, Coll Phys Educ, Jinan 250100, Peoples R China; [Sun, Xiaojie] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ma, W (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China.	weima@sdu.edu.cn	Ma, Wei/C-4748-2019; Ma, Wei/L-2374-2019	Ma, Wei/0000-0002-8092-3280; Ma, Wei/0000-0002-8092-3280; Marley, Gifty/0000-0002-0025-3062	Independent Innovation Foundation of Shandong University (IIFSDU) [2010JC008]	Independent Innovation Foundation of Shandong University (IIFSDU)	This study was supported by the Independent Innovation Foundation of Shandong University (IIFSDU) 2010JC008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; Bruce DG, 2003, J DIABETES COMPLICAT, V17, P82, DOI 10.1016/S1056-8727(02)00191-5; Chekuri A, 2012, J OBSTET GYNAECOL, V32, P691, DOI 10.3109/01443615.2012.689889; Chen JH, 2011, CHIN PRIM HLTH CARE, V25, P47; [陈洁 Chen Jie], 2010, [中国全科医学, Chinese General Practice], V13, P2794; Chen W Q, 2013, CHINA CANC, V22, P2; China National Committee on Ageing, 2006, FOR REP CHIN POP AG; Chinese Health Ministry Information Office, 2009, NTR; Fan YL, 2007, MODERN PREVENTIVE ME, V34, P1535; Franklin SS, 2004, AM J HYPERTENS, V17, p49S, DOI 10.1016/j.amjhyper.2004.08.020; Gao L.P., 2011, CHINESE HLTH EC, V30, P91; Guan J, 2005, CHIN GEN PRACT, V8, P1741; He C, 2010, PRACTICAL PREVENTIVE, V17, P1547; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Karaeren H, 2009, ANATOL J CARDIOL, V9, P183; Koo JH, 2012, GASTROINTEST ENDOSC, V76, P126, DOI 10.1016/j.gie.2012.03.168; Leng Yan, 2011, Chinese Journal of Prevention and Control of Chronic Diseases, V19, P38; [利基林 Li Jilin], 2011, [中国公共卫生, China Public Health], V27, P472; Li L, 2006, CHINESE HLTH EC, V25, P36; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li LM, 2007, EPIDEMIOLOGY, P231; Liu L-Y, 2009, CHIN J PUBLIC HLTH, V25, P1275; [刘向东 LIU Xiangdong], 2006, [中国糖尿病杂志, Chinese Journal of Diabetes], V14, P275; Luo HB, 2004, CHINA J MODERN MED, V14, P80; Ma JS, 2004, CHIN J PUBLIC HLTH, V20, P751; Mamudu HM, 2011, GLOB PUBLIC HEALTH, V6, P347, DOI 10.1080/17441692.2011.574230; Ministry of Health of the People's Republic of China, 2011, NAT BAS PUBL HLTH SE; Ministry of Health of the People's Republic of China, 2008, MAIN COND 3 NAT DEAT; Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1; Niu TH, 2010, CHIN PRIM HLTH CARE, V24, P37; Ong CS, 2010, PREV MED, V50, P304, DOI 10.1016/j.ypmed.2010.02.013; STAMLER J, 1984, AM J MED, V76, P13, DOI 10.1016/0002-9343(84)90953-7; Sun JD, 2008, ESTIMATION BURDEN MA; UN, 2010, WORLD POPULATION AGI; Vierck E, 2003, AGING DEMOGRAPHICS H, V127; Wang RL, 2011, J NINGXIA MED U, V33, P953; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2009, GLOB HLTH RISKS MORT; Wright-Nunes JA, 2012, PATIENT EDUC COUNS, V88, P184, DOI 10.1016/j.pec.2012.02.015; Wu XM, 2011, CHINA MOD DOCT, V49, P27; Yang J, 2005, CHIN J PUBLIC HLTH, V21, P131; Zhang JJ, 2010, CHIN J HLTH ED, V26, P905; Zhou G, 2011, CHIN J HLTH ED, V27, P490; Zhou Qin, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P587; Zhou W, 2007, CHIN J HLTH ED, V23, P868	47	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68599	10.1371/journal.pone.0068599	http://dx.doi.org/10.1371/journal.pone.0068599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826394	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400179
J	Spotorno, N; Cheylus, A; Van Der Henst, JB; Noveck, IA				Spotorno, Nicola; Cheylus, Anne; Van Der Henst, Jean-Baptiste; Noveck, Ira A.			What's behind a P600? Integration Operations during Irony Processing	PLOS ONE			English	Article							ERP EVIDENCE; LANGUAGE COMPREHENSION; BRAIN OSCILLATIONS; EEG ALPHA; MEMORY; DISCOURSE; SENTENCE; SYNCHRONIZATION; POTENTIALS; RETRIEVAL	The combined knowledge of word meanings and grammatical rules does not allow a listener to grasp the intended meaning of a speaker's utterance. Pragmatic inferences on the part of the listener are also required. The present work focuses on the processing of ironic utterances (imagine a slow day being described as "really productive'') because these clearly require the listener to go beyond the linguistic code. Such utterances are advantageous experimentally because they can serve as their own controls in the form of literal sentences (now imagine an active day being described as "really productive'') as we employ techniques from electrophysiology (EEG). Importantly, the results confirm previous ERP findings showing that irony processing elicits an enhancement of the P600 component (Regel et al., 2011). More original are the findings drawn from Time Frequency Analysis (TFA) and especially the increase of power in the gamma band in the 280-400 time-window, which points to an integration among different streams of information relatively early in the comprehension of an irony. This represents a departure from traditional accounts of language processing which generally view pragmatic inferences as late-arriving. We propose that these results indicate that unification operations between the linguistic code and contextual information play a critical role throughout the course of irony processing and earlier than previously thought.	[Spotorno, Nicola; Cheylus, Anne; Van Der Henst, Jean-Baptiste; Noveck, Ira A.] Univ Lyon, Lab Langage Cerveau & Cognit L2C2, Ctr Natl Rech Sci, Bron, France; [Noveck, Ira A.] CRFJ, Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS)	Spotorno, N (corresponding author), Univ Lyon, Lab Langage Cerveau & Cognit L2C2, Ctr Natl Rech Sci, Bron, France.	nicola.spotorno@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022	Cheylus, Anne/0000-0002-4243-3686	CNRS, Universite de Lyon; Centre de recherche francais a Jerusalem (CRFJ)	CNRS, Universite de Lyon(Centre National de la Recherche Scientifique (CNRS)); Centre de recherche francais a Jerusalem (CRFJ)	Work was supported by CNRS, Universite de Lyon and Centre de recherche francais a Jerusalem (CRFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Amenta S, 2008, NEUROPSYCHOL TRENDS, P7, DOI 10.7358/neur-2008-003-amen; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bastiaansen M., 2012, OXFORD HDB EVENT REL, P31, DOI [10.1093/oxfordhb/9780195374148.013.0024, DOI 10.1093/OXFORDHB/9780195374148.013.0024, DOI 10.1371/journal.pone.0018993]; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Bianchi C., 2004, SEMANTICS PRAGMATICS; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; CLARK HH, 1984, J EXP PSYCHOL GEN, V113, P121, DOI 10.1037/0096-3445.113.1.121; Cornejo C, 2007, J PSYCHOLINGUIST RES, V36, P411, DOI 10.1007/s10936-007-9052-0; Coulson S, 2010, ITAL J LINGUIST, V22, P107; De Grauwe S, 2010, NEUROPSYCHOLOGIA, V48, P1965, DOI 10.1016/j.neuropsychologia.2010.03.017; Filik R, 2010, COGNITION, V116, P421, DOI 10.1016/j.cognition.2010.06.005; Fischler I, 2006, PROGR BRAIN RES UNDE, V156; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 2004, BRAIN RES, V1000, P72, DOI 10.1016/j.brainres.2003.10.057; Friederici AD, 2007, BRAIN RES, V1146, P50, DOI 10.1016/j.brainres.2006.08.038; Geangu E, 2012, SOCIAL COGNITIVE AFF; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Giora R., 1999, METAPHOR SYMBOL, V14, P241, DOI [10.1207/S15327868MS1404_1, DOI 10.1207/S15327868MS1404_, DOI 10.1207/S15327868MS1404_1]; Giora R, 2009, APPL COGN LINGUIST, V10, P383; Grice H. P., 1975, SYNTAX SEMANTICS, V3, P41, DOI DOI 10.1163/9789004368811_003; Grice P., 1989, STUDIES WAY WORDS; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Katz AN, 2004, CURR DIR PSYCHOL SCI, V13, P186, DOI 10.1111/j.0963-7214.2004.00304.x; Katz AN, 2003, DISCOURSE PROCESS, V36, P19, DOI 10.1207/S15326950DP3601_2; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch Wolfgang, 1994, STRUCTURE LONG TERM; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lattner S, 2003, NEUROSCI LETT, V339, P191, DOI 10.1016/S0304-3940(03)00027-2; Meinhardt J, 2012, NEUROIMAGE, V63, P623, DOI 10.1016/j.neuroimage.2012.07.019; Meinhardt J, 2011, DEV COGN NEUROS-NETH, V1, P67, DOI 10.1016/j.dcn.2010.08.001; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Nieuwland MS, 2010, J MEM LANG, V63, P324, DOI 10.1016/j.jml.2010.06.005; Noveck IA, 2003, BRAIN LANG, V85, P203, DOI 10.1016/S0093-934X(03)00053-1; Pexman PM, 2008, CURR DIR PSYCHOL SCI, V17, P286, DOI 10.1111/j.1467-8721.2008.00591.x; Pexman PM, 2000, DISCOURSE PROCESS, V29, P201, DOI 10.1207/S15326950dp2903_2; Pfurtscheller G., 1999, HDB ELECTROENCEPHALO, V6; Recanati F, 2004, LITERAL MEANING; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Sabbagh MA, 2000, PSYCHOL SCI, V11, P46, DOI 10.1111/1467-9280.00213; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Sterman MB, 1996, BRAIN TOPOGR, V9, P21, DOI 10.1007/BF01191639; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tarski Alfred, 1944, PHILOS PHENOMEN RES, V4, P341, DOI [10.2307/2102968, DOI 10.2307/2102968]; Turner K, 2005, SEMANTICS MEETS PRAG; van Berkum J. J., 2004, ANN M COGN NEUR SOC; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Varela F., 2001, NATURE REV NEUROSCIE, V2; Weiss S, 2003, NEUROKOGNITION SPRAC; Wilson D., 2012, MEANING RELEVANCE	74	72	74	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66839	10.1371/journal.pone.0066839	http://dx.doi.org/10.1371/journal.pone.0066839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826155	Green Published, gold			2022-12-25	WOS:000321738400066
J	Vasluian, E; de Jong, IGM; Janssen, WGM; Poelma, MJ; van Wijk, I; Reinders-Messelink, HA; van der Sluis, CK				Vasluian, Ecaterina; de Jong, Ingrid G. M.; Janssen, Wim G. M.; Poelma, Margriet J.; van Wijk, Iris; Reinders-Messelink, Heleen A.; van der Sluis, Corry K.			Opinions of Youngsters with Congenital Below-Elbow Deficiency, and Those of Their Parents and Professionals Concerning Prosthetic Use and Rehabilitation Treatment	PLOS ONE			English	Article							UPPER-LIMB DEFICIENCY; ONLINE FOCUS GROUPS; QUALITY-OF-LIFE; HEALTH-CARE; CHILDREN; MANAGEMENT; AMPUTEES; ADULTS; EPIDEMIOLOGY; PRESCRIPTION	Background: Youngsters with unilateral congenital below-elbow deficiency (UCBED) seem to function well with or without a prosthesis. Reasons for rejecting prostheses have been reported earlier, but unfortunately not those of the children themselves. Furthermore, reasons for acceptance are underexplored in the literature. Objectives: To investigate opinions of children and early and late adolescents with UCBED, and those of their parents and healthcare professionals, concerning (1) reasons to wear or not to wear prostheses and (2) about rehabilitation care. Methods: During one week of online focus group interviews, 42 children of 8-12 y/o, early and late adolescents of 13-16 and 17-20 y/o, 17 parents, and 19 healthcare professionals provided their opinions on various topics. This study addresses prosthetic use or non-use of prosthetics and rehabilitation care. Data were analyzed using the framework approach. Results: Cosmesis was considered to be the prime factor for choosing and wearing a prosthesis, since this was deemed especially useful in avoiding stares from others. Although participants functioned well without prostheses, they agreed that it was an adjuvant in daily-life activities and sports. Weight and limited functionality constituted rejection reasons for a prosthesis. Children and adolescents who had accepted that they were different no longer needed the prosthesis to avoid being stared at. The majority of participants highly valued the peer-to-peer contact provided by the healthcare professionals. Conclusions: For children and adolescents with UCBED, prostheses appeared particularly important for social integration, but much less so for functionality. Peer-to-peer contact seemed to provide support during the process of achieving social integration and should be embedded in the healthcare process.	[Vasluian, Ecaterina; de Jong, Ingrid G. M.; Reinders-Messelink, Heleen A.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Janssen, Wim G. M.] Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands; [Poelma, Margriet J.] Rehabil Ctr De Sint Maartensklin, Nijmegen, Netherlands; [van Wijk, Iris] Rehabil Ctr De Hoogstraat, Utrecht, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Sint Maartens Clinic	Vasluian, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	e.golea.vasluian@umcg.nl			OIM Foundation; Beatrixoord Foundation; Orthopedietechniek De Hoogstraat Foundation; Gratama Foundation	OIM Foundation; Beatrixoord Foundation; Orthopedietechniek De Hoogstraat Foundation; Gratama Foundation	This study was financed by grants from national foundations: the OIM Foundation, Beatrixoord Foundation, Orthopedietechniek De Hoogstraat Foundation and the Gratama Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no further financial relationships relevant to this article to disclose.	Atkins DJ., 1996, J PROSTHET ORTHOT, V8, P2, DOI DOI 10.1097/00008526-199600810-00003; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P71, DOI 10.1080/17483100601138959; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Biddiss EA, 2008, DISABIL REHABIL-ASSI, V3, P181, DOI 10.1080/17483100701869826; Buffart LM, 2007, J REHABIL MED, V39, P379, DOI 10.2340/16501977-0068; BURGER H, 1994, PROSTHET ORTHOT INT, V18, P25; CURRAN B, 1991, PROSTHET ORTHOT INT, V15, P82; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Davids JR, 2006, J BONE JOINT SURG AM, V88A, P1294, DOI 10.2106/JBJS.E.00982; Davidson Judith, 2002, J Hand Ther, V15, P62, DOI 10.1016/S0894-1130(02)50011-9; de Jong IGM, 2012, J REHABIL MED, V44, P885, DOI 10.2340/16501977-1027; de Jong IGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037099; DIMDI, 2005, INT CLASS FUNCT DIS; Donkervoort M, 2009, DEV MED CHILD NEUROL, V51, P53, DOI 10.1111/j.1469-8749.2008.03115.x; Ekblom AG, 2010, J HAND SURG-AM, V35A, P1742, DOI 10.1016/j.jhsa.2010.07.007; Endacott Ruth, 2007, Accid Emerg Nurs, V15, P234; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Fraser CM, 1998, PROSTHET ORTHOT INT, V22, P216; Gaiser TJ, 1997, SOC SCI COMPUT REV, V15, P135, DOI 10.1177/089443939701500202; Giele H, 2001, J HAND SURG-AM, V26A, P628, DOI 10.1053/jhsu.2001.26121; Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192; Hadders-Algra M, 2013, EARLY HUM DEV, V89, P49, DOI 10.1016/j.earlhumdev.2012.07.011; Huizing K, 2010, PROSTHET ORTHOT INT, V34, P166, DOI 10.3109/03093640903584993; Jain S, 1996, ARCH PHYS MED REHAB, V77, pS9, DOI 10.1016/S0003-9993(96)90237-3; James MA, 2006, J BONE JOINT SURG AM, V88A, P2356, DOI 10.2106/JBJS.E.01146; Jang CH, 2011, ANN REHABIL MED-ARM, V35, P907, DOI 10.5535/arm.2011.35.6.907; Kanas JL, 2009, J PEDIATR REHAB MED, V2, P181, DOI 10.3233/PRM-2009-0082; KEJLAA GH, 1993, PROSTHET ORTHOT INT, V17, P157; Koskimies E, 2011, J HAND SURG-AM, V36A, P1058, DOI 10.1016/j.jhsa.2011.03.015; KREBS DE, 1991, PHYS THER, V71, P920, DOI 10.1093/ptj/71.12.920; Kreitner C, 1994, Rehab Manag, V7, P25; Kuyper MA, 2001, PROSTHET ORTHOT INT, V25, P228, DOI 10.1080/03093640108726606; Mathiesen AM, 2012, J GENET COUNS, V21, P862, DOI 10.1007/s10897-012-9518-6; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Meurs M, 2006, PROSTHET ORTHOT INT, V30, P165, DOI 10.1080/03093640600731710; Montoya-Weiss M.M., 1998, EUR J MARKETING, V32, P713, DOI DOI 10.1108/03090569810224100; Mundhenke L, 2010, SCAND J OCCUP THER, V17, P130, DOI [10.3109/11038120903114386, 10.1080/11038120903114386]; Murray CD, 2009, DISABIL REHABIL, V31, P573, DOI 10.1080/09638280802240290; Nelson VS, 2006, ARCH PHYS MED REHAB, V87, pS3, DOI 10.1016/j.apmr.2005.11.022; Ping L.C., 2001, J EDUC ENQ, V2, P50, DOI [10.1016/j.msard.2021.103473, DOI 10.1016/J.MSARD.2021.103473]; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pope C, 2006, QUALITATIVE RES HLTH, P153; Postema K, 1999, CLIN REHABIL, V13, P243, DOI 10.1191/026921599668801945; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Ritchie S, 2011, PROSTHET ORTHOT INT, V35, P332, DOI 10.1177/0309364611420326; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Saradjan A, 2008, DISABIL REHABIL, V30, P871, DOI 10.1080/09638280701427386; SCHOR EL, 1986, PEDIATRICS, V77, P834; Sheffler LC, 2009, J BONE JOINT SURG AM, V91A, P2852, DOI 10.2106/JBJS.H.01108; SILCOX DH, 1993, J BONE JOINT SURG AM, V75A, P1781, DOI 10.2106/00004623-199312000-00007; Tates K, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-15; Wagner L.V., 2007, JPO J PROSTHETICS OR, V19, P51, DOI [10.1097/JPO.0b013e3180421539, DOI 10.1097/JPO.0B013E3180421539]; Zinchiak M, 2001, ONLINE FOCUS GROUP F; Zwaanswijk Marieke, 2007, BMC Pediatr, V7, P35, DOI 10.1186/1471-2431-7-35	55	26	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67101	10.1371/journal.pone.0067101	http://dx.doi.org/10.1371/journal.pone.0067101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826203	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400104
J	Paubelle, E; Zylbersztejn, F; Alkhaeir, S; Suarez, F; Callens, C; Dussiot, M; Isnard, F; Rubio, MT; Damaj, G; Gorin, NC; Marolleau, JP; Monteiro, RC; Moura, IC; Hermine, O				Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Suarez, Felipe; Callens, Celine; Dussiot, Michael; Isnard, Francoise; Rubio, Marie-Therese; Damaj, Gandhi; Gorin, Norbert-Claude; Marolleau, Jean-Pierre; Monteiro, Renato C.; Moura, Ivan C.; Hermine, Olivier			Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure	PLOS ONE			English	Article							DIFFERENTIATING AGENTS; OLDER PATIENTS; AML; CYTOGENETICS; TRIAL; CELLS; CARE	The prognosis of acute myeloid leukemia (AML) in elderly (>= 65 years) patients is poor and treatment remains non-consensual especially for those who are not eligible for intensive therapies. Our group has shown that in vitro the iron chelator deferasirox (DFX) synergizes with vitamin D (VD) to promote monocyte differentiation in primary AML cells. Herein, we present results from a retrospective case-control study in which the association of DFX (1-2 g/d) and 25-hydroxycholecalciferol (100,000 IU/week) (DFX/VD) was proposed to patients following demethylating agents failure. Median survival of patients treated with DFX/VD combination (n = 17) was significantly increased in comparison with matched patients receiving best supportive care (BSC) alone (n = 13) (10.4 versus 4 months respectively). In addition, the only factor associated to an increased overall survival in DFX/VD-treated patients was serum VD levels. We conclude that DFX/VD treatment correlated with increased overall survival of AML patients in this retrospective cohort of elderly patients.	[Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Callens, Celine; Dussiot, Michael; Hermine, Olivier] Univ Paris 05, Fac Med, Hop Necker, CNRS UMR 8147, Paris, France; [Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Dussiot, Michael; Monteiro, Renato C.; Moura, Ivan C.] INSERM U699, Paris, France; [Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Suarez, Felipe; Dussiot, Michael; Moura, Ivan C.; Hermine, Olivier] Univ Sorbonne Paris Cite, Hop Necker, IHU Imagine, AP HP, Paris, France; [Paubelle, Etienne; Suarez, Felipe; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Clin, Paris, France; [Dussiot, Michael; Hermine, Olivier] Lab Excellence Globules Rouges GR Ex, Paris, France; [Isnard, Francoise; Rubio, Marie-Therese] Univ Paris 06, Dept Hematol, AP HP Hop St Antoine, Paris, France; [Damaj, Gandhi; Marolleau, Jean-Pierre] CHU Sud, Amiens, France; [Monteiro, Renato C.] Hop Bichat Claude Bernard, AP HP, Serv Immunol, F-75877 Paris, France; [Monteiro, Renato C.; Moura, Ivan C.] Fac Med, Paris, France; [Monteiro, Renato C.; Moura, Ivan C.] Univ Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hermine, O (corresponding author), Univ Paris 05, Fac Med, Hop Necker, CNRS UMR 8147, Paris, France.	olivier.hermine@nck.aphp.fr	Moura, Ivan C/A-9510-2013; Hermine, Olivier/Q-7072-2018; Monteiro, Renato C/U-8633-2017; Cruz Moura, Ivan/A-9510-2013	Moura, Ivan C/0000-0002-2977-0354; Monteiro, Renato C/0000-0001-5202-5646; Cruz Moura, Ivan/0000-0002-8418-2803; Hermine, Olivier/0000-0003-2574-3874	Fondation pour la Recherche Medicale (FRM); fondation de France; Ligue contre le cancer, le canceropole; Institut National du Cancer (INCA); association Laurette Fugain; Association pour la Recherche contre le Cancer (ARC)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); fondation de France(Fondation de France); Ligue contre le cancer, le canceropole; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); association Laurette Fugain; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	The Fondation pour la Recherche Medicale (FRM), the fondation de France, Ligue contre le cancer, le canceropole, Institut National du Cancer (INCA), association Laurette Fugain and the Association pour la Recherche contre le Cancer (ARC) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; Estey E, 2009, BEST PRACT RES CL HA, V22, P529, DOI 10.1016/j.beha.2009.08.007; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Ferrero D, 2004, HAEMATOLOGICA, V89, P619; Frohling S, 2006, BLOOD, V108, P3280, DOI 10.1182/blood-2006-04-014324; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hughes PJ, 2010, LEUKEMIA RES, V34, P553, DOI 10.1016/j.leukres.2009.09.010; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Lichtman SM, 1999, AM J HEMATOL, V61, P262, DOI 10.1002/(SICI)1096-8652(199908)61:4<262::AID-AJH7>3.0.CO;2-B; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Messa E, 2010, HAEMATOL-HEMATOL J, V95, P1308, DOI 10.3324/haematol.2009.016824; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Quintas-Cardama A, 2012, BLOOD; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004	16	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65998	10.1371/journal.pone.0065998	http://dx.doi.org/10.1371/journal.pone.0065998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840388	Green Submitted, gold, Green Published			2022-12-25	WOS:000322342800026
J	Schmidlin, T; Hurlimann, E; Silue, KD; Yapi, RB; Houngbedji, C; Kouadio, BA; Acka-Douabele, CA; Kouassi, D; Ouattara, M; Zouzou, F; Bonfoh, B; N'Goran, EK; Utzinger, J; Raso, G				Schmidlin, Thomas; Huerlimann, Eveline; Silue, Kigbafori D.; Yapi, Richard B.; Houngbedji, Clarisse; Kouadio, Bernadette A.; Acka-Douabele, Cinthia A.; Kouassi, Dongo; Ouattara, Mamadou; Zouzou, Fabien; Bonfoh, Bassirou; N'Goran, Eliezer K.; Utzinger, Juerg; Raso, Giovanna			Effects of Hygiene and Defecation Behavior on Helminths and Intestinal Protozoa Infections in Taabo, Cote d'Ivoire	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SCHISTOSOMA-HAEMATOBIUM; PARASITIC INFECTIONS; ETHER-CONCENTRATION; HOOKWORM INFECTION; DIFFERENT SETTINGS; STOOL SAMPLES; KATO-KATZ; DIAGNOSIS; HEALTH	Background: More than 1 billion people are currently infected with soil-transmitted helminths and schistosomes. The global strategy to control helminthiases is the regular administration of anthelmintic drugs to at-risk populations. However, rapid re-infection occurs in areas where hygiene, access to clean water, and sanitation are inadequate. Methodology: In July 2011, inhabitants from two villages and seven hamlets of the Taabo health demographic surveillance system in south-central Cote d'Ivoire provided stool and urine samples. Kato-Katz and ether-concentration methods were used for the diagnosis of Schistosoma mansoni, soil-transmitted helminths (Ascaris lumbricoides, Trichuris trichiura, and hookworm), and intestinal protozoa. Urine samples were subjected to a filtration method for the diagnosis of Schistosoma haematobium. A questionnaire was administered to households to obtain information on knowledge, attitude, practice, and beliefs in relation to hygiene, sanitation, and defecation behavior. Logistic regression models were employed to assess for associations between questionnaire data and parasitic infections. Principal Findings: A total of 1,894 participants had complete data records. Parasitological examinations revealed prevalences of hookworm, S. haematobium, T. trichiura, S. mansoni, and A. lumbricoides of 33.5%, 7.0%, 1.6%, 1.3% and 0.8%, respectively. Giardia intestinalis and Entamoeba histolytica/E. dispar were detected in 15.0% and 14.4% of the participants, respectively. Only one out of five households reported the presence of a latrine, and hence, open defecation was common. Logistic regression analysis revealed that age, sex, socioeconomic status, hygiene, and defecation behavior are determinants for helminths and intestinal protozoa infections. Conclusions/Significance: We found that inadequate sanitation and hygiene behavior are associated with soil-transmitted helminths and intestinal protozoa infections in the Taabo area of south-central Cote d'Ivoire. Our data will serve as a benchmark to monitor the effect of community-led total sanitation and hygiene education to reduce the transmission of helminthiases and intestinal protozoa infections.	[Schmidlin, Thomas; Huerlimann, Eveline; Utzinger, Juerg; Raso, Giovanna] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Schmidlin, Thomas; Huerlimann, Eveline; Utzinger, Juerg; Raso, Giovanna] Univ Basel, Basel, Switzerland; [Schmidlin, Thomas; Huerlimann, Eveline; Silue, Kigbafori D.; Yapi, Richard B.; Houngbedji, Clarisse; Kouadio, Bernadette A.; Acka-Douabele, Cinthia A.; Kouassi, Dongo; Zouzou, Fabien; Bonfoh, Bassirou; N'Goran, Eliezer K.; Raso, Giovanna] Ctr Suisse Rech Sci Cote dIvoire, Dept Environm & Sante, Abidjan, Cote Ivoire; [Silue, Kigbafori D.; Yapi, Richard B.; Ouattara, Mamadou; N'Goran, Eliezer K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Houngbedji, Clarisse] Univ Nangui Abrogoua, Unite Format & Rech Sci Nat, Abidjan, Cote Ivoire; [Kouadio, Bernadette A.] Univ Alassane Ouattara, Unite Format & Rech Commun Milieu & Soc, Bouake, Cote Ivoire; [Kouassi, Dongo] Univ Felix Houphouet Boigny, Unite Format & Rech Sci Terre & Ressources Minier, Abidjan, Cote Ivoire	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Raso, G (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	giovanna.raso@unibas.ch	Huerlimann, Eveline/J-2687-2019	Huerlimann, Eveline/0000-0001-6212-8198; Yapi, Richard Brou/0000-0002-5167-2961; Dongo, Kouassi/0000-0002-2032-290X; Kigbafori Dieudonne, Silue/0000-0003-1003-9294; Ouattara, Mamadou/0000-0002-4650-9676	UBS Optimus Foundation; Swiss National Science Foundation [IZ70Z0_123900, 32003B_132949/1]; Swiss Tropical and Public Health Institute	UBS Optimus Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Tropical and Public Health Institute	This study received financial support from the UBS Optimus Foundation. Jurg Utzinger and Giovanna Raso acknowledge financial support from the Swiss National Science Foundation (project no. IZ70Z0_123900 and project no. 32003B_132949/1). Thomas Schmidlin acknowledges financial support from the Swiss Tropical and Public Health Institute (Teaching & Training). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acka CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000910; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; [Anonymous], 2008, HDB COMMUNITY LED TO; [Anonymous], 2006, PREV CHEM HUM HELM C; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Becker SL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001292; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Cort WW, 1929, AM J HYG, V10, P0614, DOI 10.1093/oxfordjournals.aje.a112772; Coulibaly JT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-135; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Ejemot RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub2; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Furst T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064380; Furst T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001855; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Jenkins MW, 2007, SOC SCI MED, V64, P2427, DOI 10.1016/j.socscimed.2007.03.010; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; Kouadio M'Bra Kd, 2013, BMC Hematol, V13, P5, DOI 10.1186/2052-1839-13-5; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; MARTI H, 1990, SCHWEIZ MED WSCHR, V120, P1473; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Montresor A., 1998, WORLD HLTH ORG; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; N'Goran EK, 2001, TROP MED INT HEALTH, V6, P817, DOI 10.1046/j.1365-3156.2001.00785.x; QUINNELL RJ, 1993, PARASITOLOGY, V106, P379, DOI 10.1017/S0031182000067123; Raso G, 2005, TROP MED INT HEALTH, V10, P42, DOI 10.1111/j.1365-3156.2004.01352.x; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Righetti AA, 2012, AM J TROP MED HYG, V87, P425, DOI 10.4269/ajtmh.2012.11-0788; SAVIOLI L, 1990, AM J TROP MED HYG, V43, P289, DOI 10.4269/ajtmh.1990.43.289; Savioli L, 2009, PARASITOLOGY, V136, P1677, DOI 10.1017/S0031182009991181; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scherrer AU, 2009, ACTA TROP, V109, P226, DOI 10.1016/j.actatropica.2008.11.015; Singer BH, 2007, P NATL ACAD SCI USA, V104, P16038, DOI 10.1073/pnas.0700900104; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STILES CHARLES WARDELL, 1939, JOUR PARASITOL, V25, P283, DOI 10.2307/3272014; Toure S, 2008, B WORLD HEALTH ORGAN, V86, P780, DOI 10.2471/BLT.07.048694; Utzinger J, 2003, LANCET, V362, P1932, DOI 10.1016/S0140-6736(03)14968-9; Utzinger J, 2010, CLIN MICROBIOL INFEC, V16, P267, DOI 10.1111/j.1469-0691.2009.02782.x; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; Utzinger J, 2011, ACTA TROP, V120, pS121, DOI 10.1016/j.actatropica.2010.08.020; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WALSH JA, 1986, REV INFECT DIS, V8, P228; *WHO, 2002, WHO TRAD MED STRAT 2; WHO UNICEF, 2010, PROGR SAN DRINK WAT; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	60	61	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65722	10.1371/journal.pone.0065722	http://dx.doi.org/10.1371/journal.pone.0065722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840358	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000322342800017
J	Zhang, FR; Zeng, XF; Yang, FJ; Huang, ZM; Liu, H; Ma, X; Qiao, SY				Zhang, Fengrui; Zeng, Xiangfang; Yang, Fengjuan; Huang, Zhimin; Liu, Hong; Ma, Xi; Qiao, Shiyan			Dietary N-Carbamylglutamate Supplementation Boosts Intestinal Mucosal Immunity in Escherichia coli Challenged Piglets	PLOS ONE			English	Article							L-ARGININE; SERUM IGA; GROWTH; PERFORMANCE; DIARRHEA; ANTIGEN	N-carbamylglutamate (NCG) has been shown to enhance performance in neonatal piglets. However, few studies have demonstrated the effect of NCG on the intestinal mucosal barrier. This study was conducted to determine the effects of dietary NCG supplementation on intestinal mucosal immunity in neonatal piglets after an Escherichia coli (E. coli) challenge. New-born piglets (4 d old) were assigned randomly to one of four treatments (n = 7), including (I) sham challenge, (II) sham challenge +50 mg/kg NCG, (III) E. coli challenge, and (IV) E. coli challenge +50 mg/kg NCG. On d 8, pigs in the E. coli challenge groups (III and IV) were orally challenged with 5 mL of E. coli K88 (10(8) CFU/mL), whereas pigs in the sham challenge groups (I and II) were orally dosed with an equal volume of water. On d 13, all piglets were sacrificed, and samples were collected and examined. The results show that average daily gain in the E. coli challenged piglets (III and IV) was decreased (P-E.coli<0.05). However, it tended to be higher in the NCG treated piglets (II and IV). Ileum secretory IgA, as well as IFN-gamma, IL-2, IL-4 and IL-10 in ileal homogenates, were increased in E. coli challenged piglets (III and IV). Similarly, ileum SIgA and IL-10 levels, and CD4+ percentage in NCG treated piglets (II and IV) were higher than no-NCG treated piglets (P-NCG<0.05). However, the IL-2 level was only decreased in the piglets of E. coli challenge + NCG group (IV) compared with E. coli challenge group (III) (P<0.05). No change in the IL-2 level of the sham challenged piglets (III) was observed. In conclusion, dietary NCG supplementation has some beneficial effects on intestinal mucosal immunity in E. coli challenged piglets, which might be associated with stimulated lymphocyte proliferation and cytokine synthesis. Our findings have an important implication that NCG may be used to reduce diarrhea in neonatal piglets.	[Zhang, Fengrui; Zeng, Xiangfang; Yang, Fengjuan; Huang, Zhimin; Liu, Hong; Ma, Xi; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Qiao, SY (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, Beijing 100094, Peoples R China.	qiaoshy@mafic.ac.cn	Ma, Xi/J-4625-2019	Ma, Xi/0000-0003-4562-9331	National Key Basic Research Program of China [2012CB124702, 2013CB117303]	National Key Basic Research Program of China(National Basic Research Program of China)	This project was financially supported by National Key Basic Research Program of China (No: 2012CB124702 and 2013CB117303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC. Arilington V, 2003, OFF METH AN ASS OFF; BARBUL A, 1990, NUTRITION, V6, P53; Borghetti P, 2006, VET IMMUNOL IMMUNOP, V110, P17, DOI 10.1016/j.vetimm.2005.09.001; Camerlink I, 2010, HOMEOPATHY, V99, P57, DOI 10.1016/j.homp.2009.10.003; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Frank JW, 2007, J NUTR, V137, P315, DOI 10.1093/jn/137.2.315; GUFFON N, 1995, J INHERIT METAB DIS, V18, P61, DOI 10.1007/BF00711374; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; JONES GW, 1972, INFECT IMMUN, V6, P918, DOI 10.1128/IAI.6.6.918-927.1972; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim SW, 2007, J NUTR, V137, P2168; Kobayashi T, 1998, BIOSCI BIOTECH BIOCH, V62, P2334, DOI 10.1271/bbb.62.2334; KRAMER DR, 1995, IMMUNOL CELL BIOL, V73, P389, DOI 10.1038/icb.1995.61; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; MarkowskaDaniel I, 1996, COMP IMMUNOL MICROB, V19, P219, DOI 10.1016/0147-9571(96)00008-2; O'Connor MF, 2001, ANESTH ANALG, V93, P809, DOI 10.1097/00000539-200110000-00001; Ochoa JB, 2001, JPEN-PARENTER ENTER, V25, P23, DOI 10.1177/014860710102500123; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; Puiman PJ, 2011, J NUTR, V141, P63, DOI 10.3945/jn.110.131888; Qiao SF, 2005, WORLD J GASTROENTERO, V11, P6216, DOI 10.3748/wjg.v11.i39.6216; Ren WK, 2013, BRIT J NUTR, V109, P867, DOI 10.1017/S0007114512002681; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Vaerman JP, 1997, VET IMMUNOL IMMUNOP, V58, P301, DOI 10.1016/S0165-2427(97)00041-X; WILSON MR, 1974, J ANIM SCI, V38, P1018, DOI 10.2527/jas1974.3851018x; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 2004, J NUTR, V134, p2783S, DOI 10.1093/jn/134.10.2783S; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Yi GF, 2005, J ANIM SCI, V83, P634; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041192; Zhu H, 2012, INNATE IMMUNITY	34	27	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66280	10.1371/journal.pone.0066280	http://dx.doi.org/10.1371/journal.pone.0066280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840434	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200065
J	Yadav, H; Lee, JH; Lloyd, J; Walter, P; Rane, SG				Yadav, Hariom; Lee, Ji-Hyeon; Lloyd, John; Walter, Peter; Rane, Sushil G.			Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT-MICROBIOTA INTERACTIONS; INSULIN-RESISTANCE; PLASMA-CONCENTRATIONS; OBESITY; INFLAMMATION; HEALTH; ENERGY; PREBIOTICS; LINK	Obesity and diabetes are associated with excess caloric intake and reduced energy expenditure resulting in a negative energy balance. The incidence of diabetes has reached epidemic proportions, and childhood diabetes and obesity are increasing alarmingly. Therefore, it is important to develop safe, easily deliverable, and economically viable treatment alternatives for these diseases. Here, we provide data supporting the candidacy of probiotics as such a therapeutic modality against obesity and diabetes. Probiotics are live bacteria that colonize the gastrointestinal tract and impart beneficial effects for health. However, their widespread prescription as medical therapies is limited primarily because of the paucity of our understanding of their mechanism of action. Here, we demonstrate that the administration of a probiotic, VSL#3, prevented and treated obesity and diabetes in several mouse models. VSL#3 suppressed body weight gain and insulin resistance via modulation of the gut flora composition. VSL#3 promoted the release of the hormone GLP-1, resulting in reduced food intake and improved glucose tolerance. The VSL#3-induced changes were associated with an increase in the levels of a short chain fatty acid (SCFA), butyrate. Using a cell culture system, we demonstrate that butyrate stimulated the release of GLP-1 from intestinal L-cells, thereby providing a plausible mechanism for VSL#3 action. These findings suggest that probiotics such as VSL#3 can modulate the gut microbiota-SCFA-hormone axis. Moreover, our results indicate that probiotics are of potential therapeutic utility to counter obesity and diabetes.	[Yadav, Hariom; Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Lloyd, John] NIDDK, Biol Chem Lab, NIH, Bethesda, MD 20892 USA; [Walter, Peter] NIDDK, Clin Mass Spectrometry Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rane, SG (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health from the Intramural Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107, ZICDK075039] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health from the Intramural Program of NIDDK.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Belkina AC, 2010, CURR OPIN ENDOCRINOL, V17, P472, DOI 10.1097/MED.0b013e32833c5c48; BROWN JP, 1977, CRC CR REV FOOD SCI, V8, P229, DOI 10.1080/10408397709527224; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Delzenne N, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c2; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ehrlich SD, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2209-c1; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Fehervari Z., 2012, NAT IMMUNOL, V13, P946; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hussain SS, 2013, INT J OBESITY, V37, P625, DOI 10.1038/ijo.2012.93; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kazaks A, 2003, PRIMARY CARE, V30, P301, DOI 10.1016/S0095-4543(03)00011-3; Kim MS, 2011, ANN NY ACAD SCI, V1229, P140, DOI 10.1111/j.1749-6632.2011.06098.x; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin CY, 2010, NUTR METAB CARDIOVAS, V20, P713, DOI 10.1016/j.numecd.2009.06.005; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mengheri E, 2008, J CLIN GASTROENTEROL, V42, pS177, DOI 10.1097/MCG.0b013e31817eedc4; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Parise RA, 2008, J CHROMATOGR B, V872, P141, DOI 10.1016/j.jchromb.2008.07.032; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Rijkers GT, 2011, BRIT J NUTR, V106, P1291, DOI 10.1017/S000711451100287X; Rosas-Vargas H, 2011, ARCH MED RES, V42, P482, DOI 10.1016/j.arcmed.2011.09.005; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Spiller R, 2005, GASTROENTEROLOGY, V128, P783, DOI 10.1053/j.gastro.2005.01.018; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002; Zhu X., 2007, U. S. Patent, Patent No. [7,276,358 B1, 7276358]	50	403	431	14	109	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25088	25097		10.1074/jbc.M113.452516	http://dx.doi.org/10.1074/jbc.M113.452516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836895	Green Published, hybrid			2022-12-25	WOS:000330619000009
J	Muller, MS; Scheu, S; Jousset, A				Mueller, Maren Stella; Scheu, Stefan; Jousset, Alexandre			Protozoa Drive the Dynamics of Culturable Biocontrol Bacterial Communities	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS CHA0; SOIL-BORNE PATHOGENS; BIOSYNTHETIC LOCUS; BIOLOGICAL-CONTROL; PLANT-PATHOGENS; RHIZOSPHERE; 2,4-DIACETYLPHLOROGLUCINOL; SPP.; POPULATIONS; SUPPRESSION	Some soil bacteria protect plants against soil-borne diseases by producing toxic secondary metabolites. Such beneficial biocontrol bacteria can be used in agricultural systems as alternative to agrochemicals. The broad spectrum toxins responsible for plant protection also inhibit predation by protozoa and nematodes, the main consumers of bacteria in soil. Therefore, predation pressure may favour biocontrol bacteria and contribute to plant health. We analyzed the effect of Acanthamoeba castellanii on semi-natural soil bacterial communities in a microcosm experiment. We determined the frequency of culturable bacteria carrying genes responsible for the production of the antifungal compounds 2,4-diacetylphloroglucinol (DAPG), pyrrolnitrin (PRN) and hydrogen cyanide (HCN) in presence and absence of A. castellanii. We then measured if amoebae affected soil suppressiveness in a bioassay with sugar beet seedlings confronted to the fungal pathogen Rhizoctonia solani. Amoebae increased the frequency of both DAPG and HCN positive bacteria in later plant growth phases (2 and 3 weeks), as well as the average number of biocontrol genes per bacterium. The abundance of DAPG positive bacteria correlated with disease suppression, suggesting that their promotion by amoebae may enhance soil health. However, the net effect of amoebae on soil suppressiveness was neutral to slightly negative, possibly because amoebae slow down the establishment of biocontrol bacteria on the recently emerged seedlings used in the assay. The results indicate that microfaunal predators foster biocontrol bacterial communities. Understanding interactions between biocontrol bacteria and their predators may thus help developing environmentally friendly management practices of agricultural systems.	[Mueller, Maren Stella; Scheu, Stefan; Jousset, Alexandre] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany	University of Gottingen	Jousset, A (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	ajousse@gwdg.de	Scheu, Stefan/H-7049-2015; Jousset, Alexandre/C-7607-2011		German Science Foundation (DFG); Georg August University Gottingen	German Science Foundation (DFG)(German Research Foundation (DFG)); Georg August University Gottingen	The authors acknowledge support by the Open Access Program of the German Science Foundation (DFG) and the Publication Funds of the Georg August University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KS, 2004, BIOL FERT SOILS, V40, P230, DOI 10.1007/s00374-004-0774-y; [Anonymous], 1988, NEW KEY FRESHWATER S; Baehler E, 2006, MOL PLANT MICROBE IN, V19, P313, DOI 10.1094/MPMI-19-0313; Bennett AJ, 2008, BIOL CONTROL, V44, P349, DOI 10.1016/j.biocontrol.2007.11.005; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; FENTON AM, 1992, APPL ENVIRON MICROB, V58, P3873, DOI 10.1128/AEM.58.12.3873-3878.1992; Garbeva P, 2004, SOIL BIOL BIOCHEM, V36, P1453, DOI 10.1016/j.soilbio.2004.03.009; GOULD WD, 1985, APPL ENVIRON MICROB, V49, P28, DOI 10.1128/AEM.49.1.28-32.1985; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Henkes GJ, 2011, J EXP BOT, V62, P4337, DOI 10.1093/jxb/err149; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; KEEL C, 1990, SYMBIOSIS, V9, P327; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Mazzola M, 2009, APPL ENVIRON MICROB, V75, P6804, DOI 10.1128/AEM.01272-09; Neidig N, 2011, MICROB ECOL, V61, P853, DOI 10.1007/s00248-011-9821-z; Pedersen AL, 2011, FEMS MICROBIOL LETT, V316, P16, DOI 10.1111/j.1574-6968.2010.02182.x; Pedersen AL, 2009, MICROB ECOL, V57, P501, DOI 10.1007/s00248-008-9455-y; Prieme A, 1996, FEMS MICROBIOL ECOL, V21, P59; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenberg K, 2009, ISME J, V3, P675, DOI 10.1038/ismej.2009.11; Svercel M, 2007, J MICROBIOL METH, V70, P209, DOI 10.1016/j.mimet.2007.03.018; VOSS JG, 1964, J GEN MICROBIOL, V35, P313, DOI 10.1099/00221287-35-2-313; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	32	18	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66200	10.1371/journal.pone.0066200	http://dx.doi.org/10.1371/journal.pone.0066200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840423	Green Published, gold			2022-12-25	WOS:000321424400021
J	Bryan, C; Rice, C; Harkisheimer, M; Schultz, DC; Skordalakes, E				Bryan, Christopher; Rice, Cory; Harkisheimer, Michael; Schultz, David C.; Skordalakes, Emmanuel			Structure of the Human Telomeric Stn1-Ten1 Capping Complex	PLOS ONE			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; BINDING-PROTEIN; END-PROTECTION; POLYMERASE-ALPHA; CHROMOSOME ENDS; CDC13; STN1; RPA; PROMOTES	The identification of the human homologue of the yeast CST in 2009 posed a new challenge in our understanding of the mechanism of telomere capping in higher eukaryotes. The high-resolution structure of the human Stn1-Ten1 (hStn1-Ten1) complex presented here reveals that hStn1 consists of an OB domain and tandem C-terminal wHTH motifs, while hTen1 consists of a single OB fold. Contacts between the OB domains facilitate formation of a complex that is strikingly similar to the replication protein A (RPA) and yeast Stn1-Ten1 (Ten1) complexes. The hStn1-Ten1 complex exhibits non-specific single-stranded DNA activity that is primarily dependent on hStn1. Cells expressing hStn1 mutants defective for dimerization with hTen1 display elongated telomeres and telomere defects associated with telomere uncapping, suggesting that the telomeric function of hCST is hTen1 dependent. Taken together the data presented here show that the structure of the hStn1-Ten1 subcomplex is conserved across species. Cell based assays indicate that hTen1 is critical for the telomeric function of hCST, both in telomere protection and downregulation of telomerase function.	[Bryan, Christopher; Rice, Cory; Harkisheimer, Michael; Schultz, David C.; Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA USA; [Bryan, Christopher; Skordalakes, Emmanuel] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Rice, Cory; Skordalakes, Emmanuel] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Skordalakes, E (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA USA.	skorda@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833; Rice, Cory/0000-0003-2270-030X	National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [5 R01 GM088332-03]; Wistar Cancer Center Support Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815, T32CA009171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wistar Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (5 R01 GM088332-03) and The Wistar Cancer Center Support Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gelinas AD, 2009, P NATL ACAD SCI USA, V106, P19298, DOI 10.1073/pnas.0909203106; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CH, 2012, CELL RES, V22, P1681, DOI 10.1038/cr.2012.132; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Otwinowski Z, 1991, ISOMORPHOUS SCATTERI; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Qian W, 2010, PROTEIN EXPRES PURIF, V73, P107, DOI 10.1016/j.pep.2010.05.006; Qian W, 2009, CELL RES, V19, P849, DOI 10.1038/cr.2009.67; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Wellinger RJ, 2009, MOL CELL, V36, P168, DOI 10.1016/j.molcel.2009.10.001; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Xu L, 2009, GENETICS, V183, P793, DOI 10.1534/genetics.109.108894	57	54	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66756	10.1371/journal.pone.0066756	http://dx.doi.org/10.1371/journal.pone.0066756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826127	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400045
J	Wilson, TW; Fox, HS; Robertson, KR; Sandkovsky, U; O'Neill, J; Heinrichs-Graham, E; Knott, NL; Swindells, S				Wilson, Tony W.; Fox, Howard S.; Robertson, Kevin R.; Sandkovsky, Uriel; O'Neill, Jennifer; Heinrichs-Graham, Elizabeth; Knott, Nichole L.; Swindells, Susan			Abnormal MEG Oscillatory Activity during Visual Processing in the Prefrontal Cortices and Frontal Eye-Fields of the Aging HIV Brain	PLOS ONE			English	Article							DEFAULT MODE NETWORK; WORKING-MEMORY; RESTING-STATE; NEUROCOGNITIVE DISORDERS; ANTIRETROVIRAL TREATMENT; MAGNETOENCEPHALOGRAPHY; ACTIVATION; LOCALIZATION; IMPAIRMENT; INFECTION	Objective: Shortly after infection, HIV enters the brain and causes widespread inflammation and neuronal damage, which ultimately leads to neuropsychological impairments. Despite a large body of neuroscience and imaging studies, the pathophysiology of these HIV-associated neurocognitive disorders (HAND) remains unresolved. Previous neuroimaging studies have shown greater activation in HIV-infected patients during strenuous tasks in frontal and parietal cortices, and less activation in the primary sensory cortices during rest and sensory stimulation. Methods: High-density magnetoencephalography (MEG) was utilized to evaluate the basic neurophysiology underlying attentive, visual processing in older HIV-infected adults and a matched non-infected control group. Unlike other neuroimaging methods, MEG is a direct measure of neural activity that is not tied to brain metabolism or hemodynamic responses. During MEG, participants fixated on a centrally-presented crosshair while intermittent visual stimulation appeared in their top-right visual-field quadrant. All MEG data was imaged in the time-frequency domain using beamforming. Results: Uninfected controls had increased neuronal synchronization in the 6-12 Hz range within the right dorsolateral prefrontal cortex, right frontal eye-fields, and the posterior cingulate. Conversely, HIV-infected patients exhibited decreased synchrony in these same neural regions, and the magnitude of these decreases was correlated with neuropsychological performance in several cortical association regions. Conclusions: MEG-based imaging holds potential as a noninvasive biomarker for HIV-related neuronal dysfunction, and may help identify patients who have or may develop HAND. Reduced synchronization of neural populations in the association cortices was strongly linked to cognitive dysfunction, and likely reflects the impact of HIV on neuronal and neuropsychological health.	[Wilson, Tony W.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Wilson, Tony W.] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE USA; [Sandkovsky, Uriel; O'Neill, Jennifer; Swindells, Susan] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Wilson, Tony W.; Heinrichs-Graham, Elizabeth; Knott, Nichole L.] Univ Nebraska Med Ctr, Ctr Magnetoencephalog, Omaha, NE USA; [Robertson, Kevin R.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; [Heinrichs-Graham, Elizabeth] Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Nebraska System	Wilson, TW (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	Tony.W.Wilson@gmail.com		Heinrichs-Graham, Elizabeth/0000-0002-7914-5258; Wilson, Tony W/0000-0002-5053-8306; Fox, Howard/0000-0003-2032-374X	NIH [P30 MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant P30 MH062261 (HSF). The Center for Magnetoencephalography at the University of Nebraska Medical Center was founded through an endowment from an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Ances B, 2011, NEUROIMAGE, V54, P2156, DOI 10.1016/j.neuroimage.2010.09.081; Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Becker JT, 2012, J NEUROSCI METH, V206, P176, DOI 10.1016/j.jneumeth.2012.02.022; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Chang L, 2008, J NEUROIMMUNE PHARM, V3, P95, DOI 10.1007/s11481-007-9092-0; Chang L, 2004, NEUROIMAGE, V23, P1336, DOI 10.1016/j.neuroimage.2004.07.067; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lentz MR, 2009, NEUROLOGY, V72, P1465, DOI 10.1212/WNL.0b013e3181a2e90a; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Talairach G, 1988, COPLANAR STEREOTAXIC; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Woods SP, 2005, ARCH CLIN NEUROPSYCH, V20, P1061, DOI 10.1016/j.acn.2005.06.007; Yiannoutsos CT, 2004, NEUROIMAGE, V23, P928, DOI 10.1016/j.neuroimage.2004.07.033	48	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66241	10.1371/journal.pone.0066241	http://dx.doi.org/10.1371/journal.pone.0066241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840428	Green Published, gold			2022-12-25	WOS:000322342800042
J	Bennett, AE; Macrae, AM; Moore, BD; Caul, S; Johnson, SN				Bennett, Alison E.; Macrae, Anna M.; Moore, Ben D.; Caul, Sandra; Johnson, Scott N.			Early Root Herbivory Impairs Arbuscular Mycorrhizal Fungal Colonization and Shifts Defence Allocation in Establishing Plantago lanceolata	PLOS ONE			English	Article							DETERRENT IRIDOID GLYCOSIDES; FOLIAR-FEEDING INSECTS; CHEMICAL DEFENSE; GROWTH-RESPONSES; VINE WEEVILS; HOST-PLANT; INDUCTION; MUTUALISM; PERFORMANCE; GENERALIST	Research into plant-mediated indirect interactions between arbuscular mycorrhizal (AM) fungi and insect herbivores has focussed on those between plant shoots and above-ground herbivores, despite the fact that only below-ground herbivores share the same part of the host plant as AM fungi. Using Plantago lanceolata L., we aimed to characterise how early root herbivory by the vine weevil (Otiorhynchus sulcatus F.) affected subsequent colonization by AM fungi (Glomus spp.) and determine how the two affected plant growth and defensive chemistry. We exposed four week old P. lanceolata to root herbivory and AM fungi using a 2x2 factorial design (and quantified subsequent effects on plant biomass and iridoid glycosides (IGs) concentrations. Otiorhynchus sulcatus reduced root growth by c. 64%, whereas plant growth was unaffected by AM fungi. Root herbivory reduced extent of AM fungal colonization (by c. 61%). O. sulcatus did not influence overall IG concentrations, but caused qualitative shifts in root and shoot IGs, specifically increasing the proportion of the more toxic catalpol. These changes may reflect defensive allocation in the plant against further attack. This study demonstrates that very early root herbivory during plant development can shape future patterns of AM fungal colonization and influence defensive allocation in the plant.	[Bennett, Alison E.; Caul, Sandra; Johnson, Scott N.] James Hutton Inst, Dundee, Scotland; [Macrae, Anna M.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Moore, Ben D.] James Hutton Inst, Aberdeen, Scotland	James Hutton Institute; University of Dundee; James Hutton Institute	Bennett, AE (corresponding author), James Hutton Inst, Dundee, Scotland.	alibenne@bio.indiana.edu	Johnson, Scott/HDN-6310-2022; Moore, Ben D/C-3447-2008; Johnson, Scott N/B-2268-2012; Moore, Ben/AAE-7885-2020	Moore, Ben D/0000-0002-6995-4721; Moore, Ben/0000-0002-6995-4721; Johnson, Scott/0000-0002-8388-8345	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	This research was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) Workpackage Themes one and three. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bennett AE, 2009, OECOLOGIA, V160, P771, DOI 10.1007/s00442-009-1338-5; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BIRCH ANE, 1992, J SCI FOOD AGR, V60, P1, DOI 10.1002/jsfa.2740600102; Bobbitt JM, 1969, CYCLOPENTANOID TERPE, P1; Bowers M.D., 1991, P297; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Clark KE, 2012, CROP PROT, V32, P76, DOI 10.1016/j.cropro.2011.10.008; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Currie AF, 2006, SOIL BIOL BIOCHEM, V38, P1994, DOI 10.1016/j.soilbio.2005.11.015; Currie AF, 2011, APPL SOIL ECOL, V47, P77, DOI 10.1016/j.apsoil.2010.12.002; Darrow K, 1999, J CHEM ECOL, V25, P1427, DOI 10.1023/A:1020991229072; De Deyn GB, 2009, OECOLOGIA, V160, P433, DOI 10.1007/s00442-009-1312-2; Delph LF, 2004, EVOLUTION, V58, P1936, DOI 10.1111/j.0014-3820.2004.tb00481.x; DUFF RB, 1965, BIOCHEM J, V96, P1; Erb M, 2008, PLANT PHYSIOL, V146, P867, DOI 10.1104/pp.107.112169; Erb M, 2009, TRENDS PLANT SCI, V14, P653, DOI 10.1016/j.tplants.2009.08.006; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Fuchs A, 2004, J CHEM ECOL, V30, P1723, DOI 10.1023/B:JOEC.0000042398.13765.83; GANGE AC, 1994, NEW PHYTOL, V128, P79, DOI 10.1111/j.1469-8137.1994.tb03989.x; Gange AC, 2001, NEW PHYTOL, V150, P611, DOI 10.1046/j.1469-8137.2001.00137.x; GANGE AC, 1994, ENTOMOL EXP APPL, V70, P115, DOI 10.1007/BF02380519; Gange Alan C., 2007, P124, DOI 10.1017/CBO9780511542701.007; GARDNER DR, 1988, J CHEM ECOL, V14, P2147, DOI 10.1007/BF01014022; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; JOHNS T, 1990, EUPHYTICA, V50, P203, DOI 10.1007/BF00023646; Johnson SN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P153, DOI 10.1079/9781845934613.0153; Johnson S, 2008, EAST EUR JEW AFF, V38, P1, DOI 10.1080/13501670801912053; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, AGR FOREST ENTOMOL, V12, P277, DOI 10.1111/j.1461-9563.2010.00473.x; Johnson SN, 2003, OECOLOGIA, V134, P388, DOI 10.1007/s00442-002-1139-6; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, CHEMOECOLOGY, V12, P185, DOI 10.1007/PL00012667; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Oghushi T, 2007, ECOLOGICAL COMMUNITI; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Smith FF, 1932, BIOL CONTROL BLACK V; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamp NE, 1996, ECOLOGY, V77, P535, DOI 10.2307/2265628; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; van Dam NM, 2006, CHEMOECOLOGY, V16, P17, DOI 10.1007/s00049-005-0323-7; Wamberg C, 2003, PEDOBIOLOGIA, V47, P281, DOI 10.1078/0031-4056-00191; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9	59	20	20	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66053	10.1371/journal.pone.0066053	http://dx.doi.org/10.1371/journal.pone.0066053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840398	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200052
J	Gusmao, R; Quintao, S; McDaid, D; Arensman, E; Van Audenhove, C; Coffey, C; Varnik, A; Varnik, P; Coyne, J; Hegerl, U				Gusmao, Ricardo; Quintao, Sonia; McDaid, David; Arensman, Ella; Van Audenhove, Chantal; Coffey, Claire; Vaernik, Airi; Vaernik, Peeter; Coyne, James; Hegerl, Ulrich			Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study	PLOS ONE			English	Article							MENTAL-DISORDERS; RATES; PREVENTION; ALCOHOL; HEALTH; DEPRESSION; COUNTRIES; PATTERNS; BEHAVIOR; HUNGARY	Background: Research concerning the association between use of antidepressants and incidence of suicide has yielded inconsistent results and is the subject of considerable controversy. The first aim is to describe trends in the use of antidepressants and rates of suicide in Europe, adjusted for gross domestic product, alcohol consumption, unemployment, and divorce. The second aim is to explore if any observed reduction in the rate of suicide in different European countries preceded the trend for increased use of antidepressants. Methods: Data were obtained for 29 European countries between 1980 and 2009. Pearson correlations were used to explore the direction and magnitude of associations. Generalized linear mixed models and Poisson regression distribution were used to clarify the effects of antidepressants on suicide rates, while an autoregressive adjusted model was used to test the interaction between antidepressant utilization and suicide over two time periods: 1980-1994 and 1995-2009. Findings: An inverse correlation was observed in all countries between recorded Standardised Death Rate (SDR) for suicide and antidepressant Defined Daily Dosage (DDD), with the exception of Portugal. Variability was marked in the association between suicide and alcohol, unemployment and divorce, with countries depicting either a positive or a negative correlation with the SDR for suicide. Every unit increase in DDD of an antidepressant per 1000 people per day, adjusted for these confounding factors, reduces the SDR by 0.088. The correlation between DDD and suicide related SDR was negative in both time periods considered, albeit more pronounced between 1980 and 1994. Conclusions: Suicide rates have tended to decrease more in European countries where there has been a greater increase in the use of antidepressants. These findings underline the importance of the appropriate use of antidepressants as part of routine care for people diagnosed with depression, therefore reducing the risk of suicide.	[Gusmao, Ricardo; Quintao, Sonia] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, Dept Saude Mental, P-1200 Lisbon, Portugal; [Gusmao, Ricardo] Ctr Hosp Lisboa Ocidental, Dept Psiquiatria & Saude Mental, Lisbon, Portugal; [McDaid, David] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, Personal Social Serv Res Unit, London WC2A 2AE, England; [Arensman, Ella; Coffey, Claire] Natl Suicide Res Fdn, Cork, Ireland; [Van Audenhove, Chantal] Katholieke Univ Leuven, LUCAS, Louvain, Belgium; [Vaernik, Airi; Vaernik, Peeter] Estonian Swedish Mental Hlth & Suicidol Inst ERSI, Tallinn, Estonia; [Coyne, James] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Coyne, James] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands; [Hegerl, Ulrich] Univ Leipzig, Dept Psychiat, D-04109 Leipzig, Germany	Universidade Nova de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; University of London; London School Economics & Political Science; KU Leuven; University of Pennsylvania; Pennsylvania Medicine; University of Groningen; Leipzig University	Gusmao, R (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, CEDOC, Dept Saude Mental, P-1200 Lisbon, Portugal.	rgusmao@mac.com	Gusmao, Ricardo/AAT-5016-2020; McDaid, David/E-5959-2014	Gusmao, Ricardo/0000-0002-6334-4607; McDaid, David/0000-0003-0744-2664; Van Audenhove, Chantal/0000-0002-5504-5439; Arensman, Ella/0000-0003-0376-1203; Quintao, Sonia/0000-0003-0199-7618; Hegerl, Ulrich/0000-0002-3039-7470	European Community [223138]	European Community(European Commission)	The OSPI project has received funding from the European Community's Seventh Framework Programme, FP7/2007-2013 (http://ec.europa.eu/research/fp7/index_en.cfm) under grant agreement no223138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus D, 2003, MMW Fortschr Med, V145, P42; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Barth A, 2011, J OCCUP ENVIRON MED, V53, P313, DOI 10.1097/JOM.0b013e31820d161c; Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Bradvik L, 2010, ARCH SUICIDE RES, V14, P266, DOI 10.1080/13811118.2010.494146; Bridge JA, 2008, INT REV PSYCHIATR, V20, P209, DOI 10.1080/09540260801889245; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Carta MG, 2004, SOC PSYCH PSYCH EPID, V39, P883, DOI 10.1007/s00127-004-0871-0; Ciuna A, 2004, EUR J CLIN PHARMACOL, V60, P629, DOI 10.1007/s00228-004-0810-8; Desai RA, 2005, AM J PSYCHIAT, V162, P311, DOI 10.1176/appi.ajp.162.2.311; Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D; Fernandez A, 2007, BRIT J PSYCHIAT, V190, P172, DOI 10.1192/bjp.bp.106.023507; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hegerl U, 2007, WORLD J BIOL PSYCHIA; Hegerl U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-428; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Hirschfeld RMA, 2000, ARCH GEN PSYCHIAT, V57, P325, DOI 10.1001/archpsyc.57.4.325; Isacsson G, 2000, ACTA PSYCHIAT SCAND, V102, P113, DOI 10.1034/j.1600-0447.2000.102002113.x; ISACSSON G, 1994, BRIT MED J, V308, P506, DOI 10.1136/bmj.308.6927.506; Isacsson G, 1996, J AFFECT DISORDERS, V41, P1, DOI 10.1016/0165-0327(96)00050-X; Johannessen HA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-68; Kadusevicius Edmundas, 2006, Medicina (Kaunas), V42, P1020; Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Knapp M., 2007, MENTAL HLTH POLICY P; Knapp M., 2007, J MENT HEALTH, V16, p167, DOI [DOI 10.1080/09638230701279857, 10.1080/09638230701279857]; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; LEWIS G, 1994, LANCET, V344, P822, DOI 10.1016/S0140-6736(94)92379-5; Ludwig J, 2005, J POLICY ANAL MANAG, V24, P249, DOI 10.1002/pam.20089; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Milane MS, 2006, PLOS MED, V3, P816, DOI 10.1371/journal.pmed.0030190; Milea D, 2010, CURR MED RES OPIN, V26, P1343, DOI 10.1185/03007991003772096; Moller HJ, 2008, EUR ARCH PSY CLIN N, V258, P3, DOI 10.1007/s00406-008-3002-1; Moller HJ, 2006, EUR ARCH PSY CLIN N, V256, P476, DOI 10.1007/s00406-006-0689-8; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Moller-Leimkuhler AM, 2000, FORTSCHR NEUROL PSYC, V68, P489, DOI 10.1055/s-2000-10030; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; OECD, OECD HLTH DAT PHARM; Organization for Economic Co-Operation and Development, 2012, HLTH GLANC EUR 2012; Organization for Economic Co-operation and Development, 2009, SOC GLANC 2009 OECD; Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767; Pirkola S, 2009, LANCET, V373, P147, DOI 10.1016/S0140-6736(08)61848-6; Pirkola S, 2007, PSYCHIAT SERV, V58, P221, DOI 10.1176/appi.ps.58.2.221; Po W, 1993, PHARMACOEPIDEM DR S, V2, P79; Pomerantz JM, 2004, J CLIN PSYCHIAT, V65, P395; Pompili M, 2010, INT J ENV RES PUB HE, V7, P1392, DOI 10.3390/ijerph7041392; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rihmer Z, 2000, BRIT J PSYCHIAT, V177, P84, DOI 10.1192/bjp.177.1.84; Rihmer Z, 1995, J AFFECT DISORDERS, V35, P147, DOI 10.1016/0165-0327(95)00055-0; Rihmer Z, 2001, ACTA PSYCHIAT SCAND, V103, P238; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; Shah A, 2010, INT J SOC PSYCHIATR, V56, P448, DOI 10.1177/0020764009342384; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; SKOG OJ, 1995, ADDICTION, V90, P1053, DOI 10.1046/j.1360-0443.1995.90810534.x; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P163; Stone KJ, 2003, AM FAM PHYSICIAN, V68, P498; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; TEICHER MH, 1993, DRUG SAFETY, V8, P186, DOI 10.2165/00002018-199308030-00002; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Varnik P, 2010, FORENSIC SCI INT, V202, P86, DOI 10.1016/j.forsciint.2010.04.032; van der PoeL C.L., 2011, CRISIS, P2011; van Praag H M, 2002, Crisis, V23, P77; Van Praag HM, 2003, WORLD J BIOL PSYCHIA, V4, P184, DOI 10.1080/15622970310029917; Viola R, 2008, PHARMACOEPIDEM DR S, V17, P401, DOI 10.1002/pds.1574; Wasserman D, 1998, ACTA PSYCHIAT SCAND, V98, P1, DOI 10.1111/j.1600-0447.1998.tb10758.x; Wheeler BW, 2009, PHARMACOEPIDEM DR S, V18, P579, DOI 10.1002/pds.1753; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A; WHO Regional Office for Europe, 2011, EUR HLTH ALL DAT HFA; WHO Regional Office for Europe, 2011, EUR MORT DAT MDB; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; World Health Organization, 2007, WHO GLOB INF SYST AL; Zahl PH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-62; Zhang J, 2009, EUR PSYCHIAT	84	84	84	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66455	10.1371/journal.pone.0066455	http://dx.doi.org/10.1371/journal.pone.0066455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840475	Green Published, gold, Green Accepted			2022-12-25	WOS:000322361200082
J	Stevens, A; Nocita, M; Toth, G; Montanarella, L; van Wesemael, B				Stevens, Antoine; Nocita, Marco; Toth, Gergely; Montanarella, Luca; van Wesemael, Bas			Prediction of Soil Organic Carbon at the European Scale by Visible and Near InfraRed Reflectance Spectroscopy	PLOS ONE			English	Article							NIR; MANAGEMENT; MODELS; MATTER; CLAY	Soil organic carbon is a key soil property related to soil fertility, aggregate stability and the exchange of CO2 with the atmosphere. Existing soil maps and inventories can rarely be used to monitor the state and evolution in soil organic carbon content due to their poor spatial resolution, lack of consistency and high updating costs. Visible and Near Infrared diffuse reflectance spectroscopy is an alternative method to provide cheap and high-density soil data. However, there are still some uncertainties on its capacity to produce reliable predictions for areas characterized by large soil diversity. Using a large-scale EU soil survey of about 20,000 samples and covering 23 countries, we assessed the performance of reflectance spectroscopy for the prediction of soil organic carbon content. The best calibrations achieved a root mean square error ranging from 4 to 15 g C kg(-1) for mineral soils and a root mean square error of 50 g C kg(-1) for organic soil materials. Model errors are shown to be related to the levels of soil organic carbon and variations in other soil properties such as sand and clay content. Although errors are similar to 5 times larger than the reproducibility error of the laboratory method, reflectance spectroscopy provides unbiased predictions of the soil organic carbon content. Such estimates could be used for assessing the mean soil organic carbon content of large geographical entities or countries. This study is a first step towards providing uniform continental-scale spectroscopic estimations of soil organic carbon, meeting an increasing demand for information on the state of the soil that can be used in biogeochemical models and the monitoring of soil degradation.	[Stevens, Antoine; Nocita, Marco; van Wesemael, Bas] UCLouvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain, Belgium; [Nocita, Marco; Toth, Gergely; Montanarella, Luca] Commiss European Communities, Joint Res Ctr, SOIL Act Land Resource Management Unit, I-21020 Ispra, Italy	Universite Catholique Louvain; European Commission Joint Research Centre; EC JRC ISPRA Site	Stevens, A (corresponding author), UCLouvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain, Belgium.	antoine.stevens@uclouvain.be	Montanarella, Luca/AAE-7112-2019; Van+Wesemael, Bas/Y-2444-2019	Stevens, Antoine/0000-0002-1588-7519; van Wesemael, Bas/0000-0003-4007-0241; Toth, Gergely/0000-0002-4201-1678	European Commission (FP7-ENV-2007-1) under the DIGISOIL project [211523]	European Commission (FP7-ENV-2007-1) under the DIGISOIL project	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The research in this paper is funded by the European Commission (FP7-ENV-2007-1) under the DIGISOIL project (no211523). A. S. is postdoctoral researcher of the Fonds de la Recherche scientifique-FNRS (F.R.S.-FNRS, Belgium).	African Union Commission, 2012, AFR UN HUM RIGHTS ME, P5; [Anonymous], 2004, NEARINFRARED SPECTRO; Baritz R, 2011, SOIL CARBON IN SENSITIVE EUROPEAN ECOSYSTEMS: FROM SCIENCE TO LAND MANAGEMENT, P49; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E, 2009, REMOTE SENS ENVIRON, V113, pS38, DOI 10.1016/j.rse.2008.09.019; Ben-Dor E., 1999, MANUAL REMOTE SENSIN, V3, P111; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; BENDOR E, 1995, SOIL SCI SOC AM J, V59, P364, DOI 10.2136/sssaj1995.03615995005900020014x; BREIMAN L., 1984, CRC PRESS; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown DJ, 2005, GEODERMA, V129, P251, DOI 10.1016/j.geoderma.2005.01.001; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; CLARK RN, 1984, J GEOPHYS RES, V89, P6329, DOI 10.1029/JB089iB07p06329; ELVIDGE CD, 1990, INT J REMOTE SENS, V11, P1775, DOI 10.1080/01431169008955129; European Commission and the Europan Soil Bureau Network, 2004, EUR SOIL DAT DISTR; Eurostat, 2009, C3 EUR; Eurostat, 2009, LUCAS 2009 SURV; FAO IUSS Working Group, 1998, WORLD REF BAS SOIL R; Fearn T., 2010, CHEMOMETRIC SPACE, V21, P13; Fearn T, 2008, NIR NEWS, V16, P7; Ge YF, 2011, GEODERMA, V161, P202, DOI 10.1016/j.geoderma.2010.12.020; Genot V, 2011, J NEAR INFRARED SPEC, V19, P117, DOI 10.1255/jnirs.923; Hastie T., 2009, UNSUPERVISED LEARNIN; ICRAF-ISRIC, 2010, GLOB DISTR SOIL SPEC; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Kuang B, 2012, EUR J SOIL SCI, V63, P421, DOI 10.1111/j.1365-2389.2012.01456.x; Kuhn M, 2012, CARET CLASSIFICATION; Kuhn M., 2012, VARIABLE SELECTION U; Ladoni M, 2010, PRECIS AGRIC, V11, P82, DOI 10.1007/s11119-009-9123-3; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; N?meth T., 2011, LAND QUALITY LAND US, P209; Nduwamungu C, 2009, CAN J SOIL SCI, V89, P531, DOI 10.4141/CJSS08076; O'Rourke SM, 2011, SOIL USE MANAGE, V27, P143, DOI 10.1111/j.1475-2743.2011.00337.x; Quinlan J.R., 1993, MACHINE LEARNING P 1, P236, DOI [10.1016/B978-1-55860-307-3.50037-X, DOI 10.1016/B978-1-55860-307-3.50037-X]; R Development Core Team, 2012, R LANG ENV STAT COMP; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Rossel RAV, 2012, EUR J SOIL SCI, V63, P848, DOI 10.1111/j.1365-2389.2012.01495.x; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; Sorensen LK, 2005, SOIL SCI SOC AM J, V69, P159, DOI 10.2136/sssaj2005.0159; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stenberg B, 2010, GEODERMA, V158, P15, DOI 10.1016/j.geoderma.2010.04.008; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; van Wesemael B, 2010, P NATL ACAD SCI USA, V107, P14926, DOI 10.1073/pnas.1002592107; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Viscarra Rossel R. A., 2009, NIR NEWS, V20, P14, DOI [10.1255/nirn.1131, DOI 10.1255/NIRN.1131]; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; West LT, 2010, SOIL CARBON STOCKS U, P14	55	238	246	17	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66409	10.1371/journal.pone.0066409	http://dx.doi.org/10.1371/journal.pone.0066409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840459	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200071
J	Wen, YW; Tsai, YW; Wu, DBC; Chen, PF				Wen, Yu-Wen; Tsai, Yi-Wen; Wu, David Bin-Chia; Chen, Pei-Fen			The Impact of Outliers on Net-Benefit Regression Model in Cost-Effectiveness Analysis	PLOS ONE			English	Article							EFFECTIVENESS ACCEPTABILITY CURVES; ECONOMIC-EVALUATION; ROBUST ESTIMATION; CLINICAL-TRIAL; ALONGSIDE; FRAMEWORK; THERAPY; RATIOS	Ordinary least square (OLS) in regression has been widely used to analyze patient-level data in cost-effectiveness analysis (CEA). However, the estimates, inference and decision making in the economic evaluation based on OLS estimation may be biased by the presence of outliers. Instead, robust estimation can remain unaffected and provide result which is resistant to outliers. The objective of this study is to explore the impact of outliers on net-benefit regression (NBR) in CEA using OLS and to propose a potential solution by using robust estimations, i.e. Huber M-estimation, Hampel M-estimation, Tukey's bisquare M-estimation, MM-estimation and least trimming square estimation. Simulations under different outlier-generating scenarios and an empirical example were used to obtain the regression estimates of NBR by OLS and five robust estimations. Empirical size and empirical power of both OLS and robust estimations were then compared in the context of hypothesis testing. Simulations showed that the five robust approaches compared with OLS estimation led to lower empirical sizes and achieved higher empirical powers in testing cost-effectiveness. Using real example of antiplatelet therapy, the estimated incremental net-benefit by OLS estimation was lower than those by robust approaches because of outliers in cost data. Robust estimations demonstrated higher probability of cost-effectiveness compared to OLS estimation. The presence of outliers can bias the results of NBR and its interpretations. It is recommended that the use of robust estimation in NBR can be an appropriate method to avoid such biased decision making.	[Wen, Yu-Wen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Coll Med, Tao Yuan, Taiwan; [Tsai, Yi-Wen] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei 112, Taiwan; [Wu, David Bin-Chia] Monash Univ Sunway Campus, Discipline Pharm, Kuala Lumpur, Malaysia; [Chen, Pei-Fen] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Miaoli, Taiwan	Chang Gung University; National Yang Ming Chiao Tung University; Monash University; Monash University Sunway; National Health Research Institutes - Taiwan	Wu, DBC (corresponding author), Monash Univ Sunway Campus, Discipline Pharm, Kuala Lumpur, Malaysia.	david.wu@monash.edu	wen, yu/AAJ-7482-2021; Wu, David Bin-Chia/H-3267-2019; Chen, Pei-Fen/K-8584-2013	Chen, Pei-Fen/0000-0001-5470-321X	Chang Gung Medical Research Program [CMRPD1A0272]	Chang Gung Medical Research Program	This research was supported by the grant: the Chang Gung Medical Research Program grant (Grant Number: CMRPD1A0272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alma OG, 2011, J CONT MATH SCI, V6, P409; Anderson C., 2003, UNDERSTANDING STAT, V2, P79, DOI DOI 10.1207/S15328031US0202_01; [Anonymous], 2004, PRACTICAL ASSESSMENT; Anscombe Frank J., 1960, TECHNOMETRICS J STAT, V2, P123; Bhuridej P, 2007, J PUBLIC HEALTH DENT, V67, P191, DOI 10.1111/j.1752-7325.2007.00025.x; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Donoho D., 1983, FESTSCHRIFT EL LEHMA, P157; Edgeworth F.Y., 1887, HERMATHENA, V13, P279; HAMPEL FR, 1974, J AM STAT ASSOC, V69, P383, DOI 10.2307/2285666; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoch JS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-68; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hund E, 2002, ANAL CHIM ACTA, V463, P53, DOI 10.1016/S0003-2670(02)00337-9; Indurkhya A, 2001, STAT MED, V20, P1469, DOI 10.1002/sim.683; Irvine L, 2010, AGE AGEING, V39, P710, DOI 10.1093/ageing/afq108; KRASKER WS, 1982, J AM STAT ASSOC, V77, P595, DOI 10.2307/2287719; Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016; LAWRANCE AJ, 1995, J R STAT SOC B, V57, P181; Liang YZ, 1996, CHEMOMETR INTELL LAB, V32, P1, DOI 10.1016/0169-7439(95)00006-2; Lin S-W, 2006, 11 ANN C AS PAC DEC, P569; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; Lynch FL, 2011, ARCH GEN PSYCHIAT, V68, P253, DOI 10.1001/archgenpsychiatry.2011.9; Maronna R.A., 2006, ROBUST STAT; Momeni M, 2010, WORLD ACAD SCI ENG T, V47, P521; Roberts TE, 2011, BMJ, V342; Rousseeuw P. J., 2003, ROBUST REGRESSION OU; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Rousseeuw PJ, 1984, ROBUST NONLINEAR TIM, P256; Safiih LM, 2010, 6 IMT GT C MATH STAT, P449; Schumacker R.E., 2002, MULTIPLE LINEAR REGR, V28, P10; Seber G.A., 1977, LINEAR REGRESSION AN; SIMPSON DG, 1992, J AM STAT ASSOC, V87, P439, DOI 10.2307/2290275; Tukey JW, 1977, EXPLORATORY DATA ANA; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Vazquez-Polo FJ, 2005, HEALTH ECON, V14, P545, DOI 10.1002/hec.947; Welsch RE, 1980, REGRESSION SENSITIVI; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; Wu David Bin-Chia, 2012, J Med Econ, V15, P434, DOI 10.3111/13696998.2011.653510; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Yohai VJ, 1991, DIRECTIONS ROBUST 2	41	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65930	10.1371/journal.pone.0065930	http://dx.doi.org/10.1371/journal.pone.0065930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840378	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200041
J	Jeon, S; Jha, MK; Ock, J; Seo, J; Jin, M; Cho, H; Lee, WH; Suk, K				Jeon, Sangmin; Jha, Mithilesh Kumar; Ock, Jiyeon; Seo, Jungwan; Jin, Myungwon; Cho, Heejung; Lee, Won-Ha; Suk, Kyoungho			Role of Lipocalin-2-Chemokine Axis in the Development of Neuropathic Pain following Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; GELATINASE-ASSOCIATED LIPOCALIN; DORSAL-ROOT GANGLIA; GENE-EXPRESSION; NEUTROPHIL INFILTRATION; MECHANICAL ALLODYNIA; GLIAL ACTIVATION; SPINAL GLIA; MOUSE-BRAIN; RAT MODELS	Lipocalin 2 (LCN2), which is also known as 24p3 and neutrophil gelatinase-associated lipocalin (NGAL), binds small, hydrophobic ligands and interacts with cell surface receptor 24p3R to regulate diverse cellular processes. In the present study, we examined the role of LCN2 in the pathogenesis of neuropathic pain using a mouse model of spared nerve injury (SNI). Lcn2 mRNA levels were significantly increased in the dorsal horn of the spinal cord after SNI, and LCN2 protein was mainly localized in neurons of the dorsal and ventral horns. LCN2 receptor 24p3R was expressed in spinal neurons and microglia after SNI. Lcn2-deficient mice exhibited significantly less mechanical pain hypersensitivity during the early phase after SNI, and an intrathecal injection of recombinant LCN2 protein elicited mechanical pain hypersensitivity in naive animals. Lcn2 deficiency, however, did not affect acute nociceptive pain. Lcn2-deficient mice showed significantly less microglial activation and proalgesic chemokine (CCL2 and CXCL1) production in the spinal cord after SNI than wild-type mice, and recombinant LCN2 protein induced the expression of these chemokines in cultured neurons. Furthermore, the expression of LCN2 and its receptor was detected in neutrophils and macrophages in the sciatic nerve following SNI, suggesting the potential role of peripheral LCN2 in neuropathic pain. Taken together, our results indicate that LCN2 plays a critical role in the development of pain hypersensitivity following peripheral nerve injury and suggest that LCN2 mediates neuropathic pain by inducing chemokine expression and subsequent microglial activation.	[Jeon, Sangmin; Jha, Mithilesh Kumar; Ock, Jiyeon; Seo, Jungwan; Jin, Myungwon; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 700422, South Korea; [Cho, Heejung] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr		Jha, Mithilesh Kumar/0000-0002-9526-0053	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea by National Research Foundation (NRF) [A111345]; Ministry of Education, Science and Technology (MEST) of the Korean government [2012-0009328]; Kyungpook National University	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea by National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST) of the Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kyungpook National University	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111345), by National Research Foundation (NRF) grants funded by the Ministry of Education, Science and Technology (MEST) of the Korean government (Grant 2012-0009328), and by the Kyungpook National University Research Fund, 2012.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Biber K, 2011, EMBO J, V30, P1864, DOI 10.1038/emboj.2011.89; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Brack A, 2004, PAIN, V111, P1, DOI 10.1016/j.pain.2004.06.020; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Flower DR, 1996, BIOCHEM J, V318, P1; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Jeon SM, 2009, BRAIN RES, V1251, P103, DOI 10.1016/j.brainres.2008.11.046; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jin SX, 2003, J NEUROSCI, V23, P4017; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; KJELDSEN L, 1994, BLOOD, V83, P799; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacManus JP, 2004, J CEREBR BLOOD F MET, V24, P657, DOI 10.1097/01.WCB.0000123141.67811.91; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Nilsen-Hamilton M, 2003, ANN NY ACAD SCI, V995, P94, DOI 10.1111/j.1749-6632.2003.tb03213.x; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Poh KW, 2012, J NEUROSCI, V32, P35, DOI 10.1523/JNEUROSCI.2389-11.2012; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaw SK, 2008, EXP NEUROL, V210, P286, DOI 10.1016/j.expneurol.2007.11.024; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Watkins LR, 2007, BRAIN BEHAV IMMUN, V21, P131, DOI 10.1016/j.bbi.2006.10.011; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	66	27	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24116	24127		10.1074/jbc.M113.454140	http://dx.doi.org/10.1074/jbc.M113.454140			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836894	Green Published, hybrid			2022-12-25	WOS:000330611400047
J	Lu, HR; Hallstrom, TC				Lu, Huarui; Hallstrom, Timothy C.			The Nuclear Protein UHRF2 Is a Direct Target of the Transcription Factor E2F1 in the Induction of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; HEMI-METHYLATED DNA; RING FINGER PROTEIN; SRA DOMAIN; RETINOBLASTOMA GENE; TUMOR SUPPRESSORS; UBIQUITIN LIGASE; S PHASE; P53; NIRF	The E2F1 transcription factor is active in many types of solid tumors and can function as either an oncogene or tumor suppressor in vivo. E2F1 activity is connected with a variety of cell fates including proliferation, apoptosis, senescence, differentiation, and autophagy, and these effects are mediated through differential target gene expression. E2F1-induced cell death is an innate anti-cancer mechanism to kill cells with a spontaneous oncogenic mutation that might otherwise form a cancer. Relatively little is known about the molecular circuitry that tips E2F1 balance toward proliferation during normal growth versus apoptosis during oncogenic stress, and which pathways mediate this decision. To further explore these mechanisms, we utilized an unbiased shRNA screen to identify candidate genes that mediate E2F1-induced cell death. We identified the ubiquitin-like with PHD and ring finger domains 2 (UHRF2) gene as an important mediator of E2F1-induced cell death. UHRF2 encodes a nuclear protein involved in cell-cycle regulation. Several of these domains have been shown to be essential for the regulation of cell proliferation, and UHRF2 has been implicated as an oncogene in some settings. Other reports have suggested that UHRF2 causes growth arrest, functions as a tumor suppressor, and is deleted in a variety of tumors. We show that UHRF2 is a transcriptional target of E2F, that it directly interacts with E2F1, and is required for E2F1 induction of apoptosis and transcription of a number of important apoptotic regulators.	[Lu, Huarui; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hallstrom, TC (corresponding author), 420 Delaware St SE, Minneapolis, MN 55455 USA.	halls026@umn.edu			Children's Cancer Research Fund, Minneapolis, MN	Children's Cancer Research Fund, Minneapolis, MN	This work was supported in part by Children's Cancer Research Fund, Minneapolis, MN.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BANDARA LR, 1991, NATURE, V352, P249, DOI 10.1038/352249a0; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Clement PMJ, 2003, EUR J BIOCHEM, V270, P4254, DOI 10.1046/j.1432-1033.2003.03806.x; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hellerbrand C, 2008, GUT, V57, P243, DOI 10.1136/gut.2007.129544; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Hu JJ, 2010, BMB REP, V43, P17, DOI 10.5483/BMBRep.2010.43.1.017; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Koguchi K, 1997, BBA-GENE STRUCT EXPR, V1353, P209, DOI 10.1016/S0167-4781(97)00106-1; Li YY, 2004, BIOCHEM BIOPH RES CO, V319, P464, DOI 10.1016/j.bbrc.2004.04.190; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2011, CELL CYCLE, V10, P3284, DOI 10.4161/cc.10.19.17176; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rodriguez JM, 2006, J BIOL CHEM, V281, P22729, DOI 10.1074/jbc.M604705200; Rogoff HA, 2002, MOL CELL BIOL, V22, P5308, DOI 10.1128/MCB.22.15.5308-5318.2002; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	46	25	28	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23833	23843		10.1074/jbc.M112.447276	http://dx.doi.org/10.1074/jbc.M112.447276			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23833190	Green Published, hybrid			2022-12-25	WOS:000330611400023
J	Tee, MK; Miller, WL				Tee, Meng Kian; Miller, Walter L.			Phosphorylation of Human Cytochrome P450c17 by p38 alpha Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; SIDE-CHAIN-CLEAVAGE; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; ACTIVATED PROTEIN-KINASE; NEONATAL PIG TESTIS; SERINE PHOSPHORYLATION; INSULIN-RECEPTOR; PREMATURE ADRENARCHE; MICROSOMAL CYTOCHROME-P-450; 17,20-LYASE ACTIVITY	Cytochrome P450c17, a steroidogenic enzyme encoded by the CYP17A1 gene, catalyzes the steroid 17 alpha-hydroxylation needed for glucocorticoid synthesis, which may or may not be followed by 17,20 lyase activity needed for sex steroid synthesis. Whether or not P450c17 catalyzes 17,20 lyase activity is determined by three post-translational mechanisms influencing availability of reducing equivalents donated by P450 oxidoreductase (POR). These are increased amounts of POR, the allosteric action of cytochrome b(5) to promote POR-P450c17 interaction, and Ser/Thr phosphorylation of P450c17, which also appears to promote POR-P450c17 interaction. The kinase(s) that phosphorylates P450c17 is unknown. In a series of kinase inhibition experiments, the pyridinyl imidazole drugs SB202190 and SB203580 inhibited 17,20 lyase but not 17 alpha-hydroxylase activity in human adrenocortical HCI-H295A cells, suggesting an action on p38 alpha or p38 beta. Co-transfection of non-steroidogenic COS-1 cells with P450c17 and p38 expression vectors showed that p38 alpha, but not p38 beta, conferred 17,20 lyase activity on P450c17. Antiserum to P450c17 co-immunoprecipitated P450c17 and both p38 isoforms; however, knockdown of p38 alpha, but not knockdown of p38 beta, inhibited 17,20 lyase activity in NCI-H295A cells. Bacterially expressed human P450c17 was phosphorylated by p38 alpha in vitro at a non-canonical site, conferring increased 17,20 lyase activity. This phosphorylation increased the maximum velocity, but not the Michaelis constant, of the 17,20 lyase reaction. p38 alpha phosphorylates P450c17 in a fashion that confers increased 17,20 lyase activity, implying that the production of adrenal androgens (adrenarche) is a regulated event.	[Tee, Meng Kian; Miller, Walter L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Rm 1427 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.	wlmlab@ucsf.edu			National Institutes of Health [R01DK37922, R01GM73020]; University of California San Francisco Academic Senate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Academic Senate(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01DK37922 and R01GM73020. This work was also supported by a grant from the University of California San Francisco Academic Senate and a private donation.	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; APTER D, 1979, ACTA PAEDIATR SCAND, V68, P599, DOI 10.1111/j.1651-2227.1979.tb05062.x; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Biason-Lauber A, 2000, ENDOCRINOLOGY, V141, P1446, DOI 10.1210/en.141.4.1446; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; Bremer AA, 2008, FERTIL STERIL, V89, P1039, DOI 10.1016/j.fertnstert.2008.02.091; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; CHIN JE, 1993, J BIOL CHEM, V268, P6338; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; CUTLER GB, 1978, ENDOCRINOLOGY, V103, P2112, DOI 10.1210/endo-103-6-2112; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Diamanti-Kandarakis E, 2005, HUM REPROD UPDATE, V11, P631, DOI 10.1093/humupd/dmi025; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; FEVOLD HR, 1989, MOL ENDOCRINOL, V3, P968, DOI 10.1210/mend-3-6-968; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Gao LL, 2013, MOL CELL ENDOCRINOL, V374, P108, DOI 10.1016/j.mce.2013.04.012; GAZDAR AF, 1990, CANCER RES, V50, P5488; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Govind A, 1999, J CLIN ENDOCR METAB, V84, P38, DOI 10.1210/jc.84.1.38; Guasti L, 2013, MOL CELL ENDOCRINOL, V371, P182, DOI 10.1016/j.mce.2013.01.014; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Idkowiak J, 2011, EUR J ENDOCRINOL, V165, P189, DOI 10.1530/EJE-11-0223; IMAI T, 1993, J BIOL CHEM, V268, P19681; Inagaki K, 2009, ENDOCRINOLOGY, V150, P1921, DOI 10.1210/en.2008-0851; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kempna P, 2010, ENDOCRINOLOGY, V151, P3686, DOI 10.1210/en.2010-0093; KOMINAMI S, 1992, J STEROID BIOCHEM, V42, P57, DOI 10.1016/0960-0760(92)90011-7; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LeeRobichaud P, 1997, BIOCHEM J, V321, P857, DOI 10.1042/bj3210857; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Manna P. R., 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/821615, DOI 10.1155/2011/821615]; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mathieu AP, 2002, J STEROID BIOCHEM, V80, P99, DOI 10.1016/S0960-0760(01)00172-8; Mesiano S, 1997, J CLIN ENDOCR METAB, V82, P1390, DOI 10.1210/jc.82.5.1390; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 2009, REV ENDOCR METAB DIS, V10, P3, DOI 10.1007/s11154-008-9102-4; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Miller WL, 1997, STEROIDS, V62, P133, DOI 10.1016/S0039-128X(96)00172-9; Miller WL, 1999, ACTA PAEDIATR, V88, P60, DOI 10.1111/j.1651-2227.1999.tb14405.x; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; OMURA T, 1962, J BIOL CHEM, V237, P1375; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; OPPENHEIMER E, 1995, J CLIN ENDOCR METAB, V80, P614, DOI 10.1210/jc.80.2.614; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Pandey AV, 2003, J BIOL CHEM, V278, P2837, DOI 10.1074/jbc.M209527200; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remer T, 1999, J CLIN ENDOCR METAB, V84, P3936, DOI 10.1210/jc.84.11.3936; Rodriguez H, 1997, J CLIN ENDOCR METAB, V82, P365, DOI 10.1210/jc.82.2.365; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; SAKAI N, 1992, FEBS LETT, V301, P60, DOI 10.1016/0014-5793(92)80210-8; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; SKLAR CA, 1980, J CLIN ENDOCR METAB, V51, P548, DOI 10.1210/jcem-51-3-548; SMAIL PJ, 1982, ENDOCRINOLOGY, V111, P844, DOI 10.1210/endo-111-3-844; STADTMAUER L, 1986, J BIOL CHEM, V261, P3402; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; TREMBLAY Y, 1994, DNA CELL BIOL, V13, P1199, DOI 10.1089/dna.1994.13.1199; VOUTILAINEN R, 1987, P NATL ACAD SCI USA, V84, P1590, DOI 10.1073/pnas.84.6.1590; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P202, DOI 10.1210/jcem-63-1-202; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	94	35	37	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23903	23913		10.1074/jbc.M113.460048	http://dx.doi.org/10.1074/jbc.M113.460048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836902	Green Published, hybrid			2022-12-25	WOS:000330611400030
J	Zhou, XJ; Ding, Q; Chen, ZY; Yun, HF; Wang, HB				Zhou, Xianju; Ding, Qi; Chen, Zhuoyou; Yun, Huifang; Wang, Hongbing			Involvement of the GluN2A and GluN2B Subunits in Synaptic and Extrasynaptic N-methyl-D-aspartate Receptor Function and Neuronal Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; IN-VITRO; CELL-DEATH; DEVELOPMENTAL-CHANGES; DEPENDENT REGULATION; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ROLES; CORTICAL-NEURONS; NR2B SUBUNITS	GluN2A and GluN2B are the major subunits of functional NMDA receptors (NMDAR). Previous studies have suggested that GluN2A and GluN2B may differentially mediate NMDAR function at synaptic and extrasynaptic locations and play opposing roles in excitotoxicity, such as neurodegeneration triggered by ischemic stroke and brain injury. By using pharmacological and molecular approaches to suppress or enhance the function of GluN2A and GluN2B in cultured cortical neurons, we examined NMDAR-mediated, bidirectional regulation of prosurvival signaling (i.e. the cAMP response element-binding protein (CREB)-Bdnf cascade) and cell death. Inhibition of GluN2A or GluN2B attenuated the up-regulation of prosurvival signaling triggered by the activation of either synaptic or extrasynaptic NMDAR. Inhibition of GluN2A or GluN2B also attenuated the down-regulation of prosurvival signaling triggered by the coactivation of synaptic and extrasynaptic receptors. The effects of GluN2B on CREB-Bdnf signaling were larger than those of GluN2A. Consistently, compared with suppression of GluN2A, suppression of GluN2B resulted in more reduction of NMDA- and oxygen glucose deprivation-induced excitotoxicity as well as NMDAR-mediated elevation of intracellular calcium. Moreover, excitotoxicity and down-regulation of CREB were exaggerated in neurons overexpressing GluN2A or GluN2B. Together, we found that GluN2A and GluN2B are involved in the function of both synaptic and extrasynaptic NMDAR, demonstrating that they play similar rather than opposing roles in NMDAR-mediated bidirectional regulation of prosurvival signaling and neuronal death.	[Zhou, Xianju; Ding, Qi; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Zhou, Xianju; Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Zhou, Xianju; Chen, Zhuoyou] Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Neurol, Changzhou 213003, Peoples R China; [Yun, Huifang] Nanjing Med Univ, Affiliated Hosp, Changzhou Peoples Hosp 2, Dept Anesthesiol, Changzhou 213003, Peoples R China	Michigan State University; Michigan State University; Nanjing Medical University; Nanjing Medical University	Zhou, XJ (corresponding author), Changzhou 2 Peoples Hosp, Dept Neurol, 29 Xinglong Alley, Changzhou 213003, Peoples R China.	hippocampus2007@gmail.com; wangho@msu.edu			National Institutes of Health [MH093445, NS072668]; American Heart Association [10POST4450000]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS072668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH093445 and NS072668. This work was also supported by American Heart Association Postdoctoral Fellowship 10POST4450000.	Barneda-Zahonero B, 2012, J BIOL CHEM, V287, P11351, DOI 10.1074/jbc.M111.272427; Benarroch EE, 2011, NEUROLOGY, V76, P1750, DOI 10.1212/WNL.0b013e31821b7cc9; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; BRORSON JR, 1994, J NEUROSCI, V14, P187; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Friedman LK, 2010, INT J DEV NEUROSCI, V28, P195, DOI 10.1016/j.ijdevneu.2009.11.002; Gao C, 2010, HIPPOCAMPUS, V20, P1072, DOI 10.1002/hipo.20705; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Miwa H, 2008, J PHYSIOL-LONDON, V586, P2539, DOI 10.1113/jphysiol.2007.147652; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morikawa E, 1998, J NEUROSCI, V18, P9727; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Navon H, 2012, J MOL NEUROSCI, V46, P100, DOI 10.1007/s12031-011-9532-4; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; PIZZI M, 1991, EUR J PHARMACOL, V209, P169, DOI 10.1016/0014-2999(91)90166-N; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Stanika RI, 2012, J NEUROSCI, V32, P6642, DOI 10.1523/JNEUROSCI.6008-11.2012; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Ullian EM, 2004, MOL CELL NEUROSCI, V26, P544, DOI 10.1016/j.mcn.2004.05.002; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhou XJ, 2012, J NEUROCHEM, V122, P295, DOI 10.1111/j.1471-4159.2012.07787.x; Zhou XJ, 2011, J NEUROCHEM, V119, P1205, DOI 10.1111/j.1471-4159.2011.07528.x; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	58	79	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24151	24159		10.1074/jbc.M113.482000	http://dx.doi.org/10.1074/jbc.M113.482000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839940	Green Published, hybrid			2022-12-25	WOS:000330611400050
J	Troggio, M; Surbanovski, N; Bianco, L; Moretto, M; Giongo, L; Banchi, E; Viola, R; Fernandez, FF; Costa, F; Velasco, R; Cestaro, A; Sargent, DJ				Troggio, Michela; Surbanovski, Nada; Bianco, Luca; Moretto, Marco; Giongo, Lara; Banchi, Elisa; Viola, Roberto; Fernandez, Felicdad Fernandez; Costa, Fabrizio; Velasco, Riccardo; Cestaro, Alessandro; Sargent, Daniel James			Evaluation of SNP Data from the Malus Infinium Array Identifies Challenges for Genetic Analysis of Complex Genomes of Polyploid Origin	PLOS ONE			English	Article							GENOTYPING ASSAY; BRASSICA-NAPUS; LINKAGE MAP; MAIZE; DISCOVERY; SEQUENCES; ROSACEAE; HISTORY; QUALITY; MARKERS	High throughput arrays for the simultaneous genotyping of thousands of single-nucleotide polymorphisms (SNPs) have made the rapid genetic characterisation of plant genomes and the development of saturated linkage maps a realistic prospect for many plant species of agronomic importance. However, the correct calling of SNP genotypes in divergent polyploid genomes using array technology can be problematic due to paralogy, and to divergence in probe sequences causing changes in probe binding efficiencies. An Illumina Infinium II whole-genome genotyping array was recently developed for the cultivated apple and used to develop a molecular linkage map for an apple rootstock progeny (M432), but a large proportion of segregating SNPs were not mapped in the progeny, due to unexpected genotype clustering patterns. To investigate the causes of this unexpected clustering we performed BLAST analysis of all probe sequences against the 'Golden Delicious' genome sequence and discovered evidence for paralogous annealing sites and probe sequence divergence for a high proportion of probes contained on the array. Following visual re-evaluation of the genotyping data generated for 8,788 SNPs for the M432 progeny using the array, we manually re-scored genotypes at 818 loci and mapped a further 797 markers to the M432 linkage map. The newly mapped markers included the majority of those that could not be mapped previously, as well as loci that were previously scored as monomorphic, but which segregated due to divergence leading to heterozygosity in probe annealing sites. An evaluation of the 8,788 probes in a diverse collection of Malus germplasm showed that more than half the probes returned genotype clustering patterns that were difficult or impossible to interpret reliably, highlighting implications for the use of the array in genome-wide association studies.	[Troggio, Michela; Surbanovski, Nada; Bianco, Luca; Moretto, Marco; Giongo, Lara; Banchi, Elisa; Viola, Roberto; Costa, Fabrizio; Velasco, Riccardo; Cestaro, Alessandro; Sargent, Daniel James] Fdn Edmund Mach, Ctr Res & Innovat, San Michele All Adige, Italy; [Fernandez, Felicdad Fernandez] East Malling Res, East Malling, Kent, England	Fondazione Edmund Mach	Sargent, DJ (corresponding author), Fdn Edmund Mach, Ctr Res & Innovat, San Michele All Adige, Italy.	dan.sargent@fmach.it	Sargent, Daniel James/A-2933-2014; Viola, Roberto/D-2277-2010; Viola, Roberto/F-3657-2014	Sargent, Daniel James/0000-0002-6686-7147; Cestaro, Alessandro/0000-0003-1439-5165; Bianco, Luca/0000-0002-0196-8422; Moretto, Marco/0000-0003-4555-7243; Viola, Roberto/0000-0002-8202-8503; Costa, Fabrizio/0000-0003-1416-1078; Banchi, Elisa/0000-0002-6598-0447; Velasco, Riccardo/0000-0002-8760-5031	research office of the Provincia Autonoma di Trento	research office of the Provincia Autonoma di Trento	This work was funded by the research office of the Provincia Autonoma di Trento. The funding was awarded to the Fondazione Edmund Mach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Force A, 1999, AM ZOOL, V39, p78A; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Martinez-Garcia PJ, 2013, PLANT MOL BIOL, V81, P161, DOI 10.1007/s11103-012-9989-8; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neidle S., 2002, NUCL ACID STRUCTURE; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Sargent DJ, 2009, TREE GENET GENOMES, V5, P133, DOI 10.1007/s11295-008-0178-5; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123	34	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67407	10.1371/journal.pone.0067407	http://dx.doi.org/10.1371/journal.pone.0067407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826289	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000077
J	Anderson, LN; Cotterchio, M; Knight, JA; Borgida, A; Gallinger, S; Cleary, SP				Anderson, Laura N.; Cotterchio, Michelle; Knight, Julia A.; Borgida, Ayelet; Gallinger, Steven; Cleary, Sean P.			Genetic Variants in Vitamin D Pathway Genes and Risk of Pancreas Cancer; Results from a Population-Based Case-Control Study in Ontario, Canada	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; 25-HYDROXYVITAMIN D; PROLIFERATION; DIETARY; BREAST	Recent studies of 25-hydroxyvitamin D (25(OH)D) levels and pancreas cancer have suggested a potential role of the vitamin D pathway in the etiology of this fatal disease. Variants in vitamin-D related genes are known to affect 25(OH)D levels and function and it is unknown if these variants may influence pancreatic cancer risk. The association between 87 single nucleotide polymorphisms (SNPs) in 11 genes was evaluated within the Ontario Pancreas Cancer Study, a population-based case-control study. Pancreatic cancer cases with pathology confirmed adenocarcinoma were identified from the Ontario Cancer Registry (n = 628) and controls were identified through random digit dialing (n = 1193). Age and sex adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated by multivariate logistic regression. SNPs in the CYP24A1, CYP2R1, calcium sensing receptor (CASR), vitamin D binding protein (GC), retinoid X receptor-alpha (RXRA) and megalin (LRP2) genes were significantly associated with pancreas cancer risk. For example, pancreas cancer risk was inversely associated with CYP2R1 rs10741657 (AA versus GG, OR = 0.70; 95%CI: 0.51-0.95) and positively with CYP24A1 rs6127119 (TT versus CC. OR = 1.94; 95%CI: 1.28-2.94). None of the associations were statistically significant after adjustment for multiple comparisons. Vitamin D pathway gene variants may be associated with pancreas cancer risk and future studies are needed to understand the possible role of vitamin D in tumorigenesis and may have implications for cancer-prevention strategies.	[Anderson, Laura N.; Knight, Julia A.; Gallinger, Steven; Cleary, Sean P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cotterchio, Michelle; Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle] Canc Care Ontario, Canc Prevent & Control, Toronto, ON, Canada; [Borgida, Ayelet] Mt Sinai Hosp, Zane Cohen Digest Dis Clin Res Ctr, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven; Cleary, Sean P.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Cleary, SP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sean.cleary@uhn.on.ca	Knight, Julia/A-6843-2012; Anderson, Laura/K-4707-2019; Knight, Julia/R-5617-2019; Gallinger, Steven/E-4575-2013	Anderson, Laura/0000-0002-6106-5073; Knight, Julia/0000-0002-7610-7635; Cleary, Sean/0000-0002-5274-9983	Robert Elliott and Paul Wilson Fund; Canadian Institute for Health Research [MOP119412]; National Institutes of Health (as part of the PACGENE consortium) [R01 CA97075]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; Colon Cancer Family Registry (CFRs) and Principle Investigators; National Cancer Institute of Canada [13304]; NATIONAL CANCER INSTITUTE [R01CA097075, U01CA074783, UM1CA167551, U24CA074783, K22CA095011] Funding Source: NIH RePORTER	Robert Elliott and Paul Wilson Fund; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (as part of the PACGENE consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ontario Registry for Studies of Familial Colorectal Cancer; Colon Cancer Family Registry (CFRs) and Principle Investigators; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by funding from the Robert Elliott and Paul Wilson Fund, the Canadian Institute for Health Research (MOP119412), the National Institutes of Health (R01 CA97075, as part of the PACGENE consortium), and the National Cancer Institute, National Institutes of Health under RFA number CA-95-011, the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and through cooperative agreements with members of the Colon Cancer Family Registry (CFRs) and Principle Investigators, and the National Cancer Institute of Canada (grant number 13304). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government or the CFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Andreassen TK, 2006, HORM METAB RES, V38, P279, DOI 10.1055/s-2006-925348; Bao Y, 2010, BRIT J CANCER, V102, P1422, DOI 10.1038/sj.bjc.6605658; Chlebowski RT, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2846; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Dong LM, 2008, CANCER EPIDEM BIOMAR, V17, P2755, DOI 10.1158/1055-9965.EPI-08-0388; Fleet JC, 2012, BIOCHEM J, V441, P61, DOI 10.1042/BJ20110744; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Holt SK, 2008, CLIN CANCER RES, V14, P3823, DOI 10.1158/1078-0432.CCR-07-4566; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jacobs ET, 2010, CARCINOGENESIS, V31, P1412, DOI 10.1093/carcin/bgq127; Jang JH, 2012, CARCINOGENESIS, V33, P818, DOI 10.1093/carcin/bgs028; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Persons KS, 2010, ANTICANCER RES, V30, P1875; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Sanchez GV, 2012, MOL CARCINOGEN, V51, P119, DOI 10.1002/mc.20833; Schwartz GG, 2008, CANCER BIOL THER, V7, P430, DOI 10.4161/cbt.7.3.5418; Schwartz GG, 2004, CARCINOGENESIS, V25, P1015, DOI 10.1093/carcin/bgh086; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Warnes G., 2008, GENETICS POPULATION; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Zablotska LB, 2011, CANCER CAUSE CONTROL, V22, P91, DOI 10.1007/s10552-010-9678-3; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897; Zhang XH, 2011, BEST PRACT RES CL GA, V25, P485, DOI 10.1016/j.bpg.2011.10.001	33	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66768	10.1371/journal.pone.0066768	http://dx.doi.org/10.1371/journal.pone.0066768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826131	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400049
J	Bjorndal, B; Brattelid, T; Strand, E; Vigerust, NF; Frodahl, G; Svingen, T; Svardal, A; Nygard, O; Berge, RK				Bjorndal, Bodil; Brattelid, Trond; Strand, Elin; Vigerust, Natalya Filipchuk; Frodahl, Gard; Svingen, Tveitevag; Svardal, Asbjorn; Nygard, Ottar; Berge, Rolf Kristian			Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; SKELETAL-MUSCLE; FATTY-ACIDS; ALPHA-ACTIVATION; BETA-OXIDATION; PEROXISOME; ACYLCARNITINES; GENE; FENOFIBRATE; INDUCTION	Peroxisome proliferator-activated receptors (PPARs) are important in the regulation of lipid and glucose metabolism. Recent studies have shown that PPAR alpha-activation by WY 14,643 regulates the metabolism of amino acids. We investigated the effect of PPAR activation on plasma amino acid levels using two PPAR alpha activators with different ligand binding properties, tetradecylthioacetic acid (TTA) and fish oil, where the pan-PPAR agonist TTA is a more potent ligand than omega-3 polyunsaturated fatty acids. In addition, plasma L-carnitine esters were investigated to reflect cellular fatty acid catabolism. Male Wistar rats (Rattus norvegicus) were fed a high-fat (25% w/w) diet including TTA (0.375%, w/w), fish oil (10%, w/w) or a combination of both. The rats were fed for 50 weeks, and although TTA and fish oil had hypotriglyceridemic effects in these animals, only TTA lowered the body weight gain compared to high fat control animals. Distinct dietary effects of fish oil and TTA were observed on plasma amino acid composition. Administration of TTA led to increased plasma levels of the majority of amino acids, except arginine and lysine, which were reduced. Fish oil however, increased plasma levels of only a few amino acids, and the combination showed an intermediate or TTA-dominated effect. On the other hand, TTA and fish oil additively reduced plasma levels of the L-carnitine precursor gamma-butyrobetaine, as well as the carnitine esters acetylcarnitine, propionylcarnitine, valeryl/isovalerylcarnitine, and octanoylcarnitine. These data suggest that while both fish oil and TTA affect lipid metabolism, strong PPAR alpha activation is required to obtain effects on amino acid plasma levels. TTA and fish oil may influence amino acid metabolism through different metabolic mechanisms.	[Bjorndal, Bodil; Strand, Elin; Vigerust, Natalya Filipchuk; Frodahl, Gard; Svingen, Tveitevag; Svardal, Asbjorn; Nygard, Ottar; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Brattelid, Trond] Natl Inst Nutr & Seafood Res, NIFES, Bergen, Norway; [Nygard, Ottar; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Bjorndal, B (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Bodil.Bjorndal@k2.uib.no	Bjørndal, Bodil/HDN-4287-2022; Bjørndal, Bodil/H-6143-2017	Bjørndal, Bodil/0000-0001-9718-5117	NordForsk [070010]; Research Council of Norway [190287/110]; European Community's Seventh Framework Program (FP7) [201668]; Western Norway Regional Health Authority	NordForsk; Research Council of Norway(Research Council of Norway); European Community's Seventh Framework Program (FP7); Western Norway Regional Health Authority	This study was financially supported by grants from NordForsk, grant 070010, MitoHealth; the Research Council of Norway, grant 190287/110; and the European Community's Seventh Framework Program (FP7/2007-2013), grant 201668, AtheroRemo. The Western Norway Regional Health Authority also supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerschlaeger M, 2004, TOXICOL SCI, V78, P229, DOI 10.1093/toxsci/kfh071; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benetti Elisa, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P273; Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011; Bjorndal B, 2011, EUR J NUTR, V46, P679; Blaak EE, 2005, BEST PRACT RES CL EN, V19, P391, DOI 10.1016/j.beem.2005.04.001; Burri L, 2011, FRONT NUTRIGENOMICS, V2, P1, DOI DOI 10.3389/FGENE.2011.0004522303341; Burri L, 2011, LIPIDS, V46, P679, DOI 10.1007/s11745-011-3536-2; Chaput E, 2000, BIOCHEM BIOPH RES CO, V271, P445, DOI 10.1006/bbrc.2000.2647; ENGLARD S, 1985, BIOCHEMISTRY-US, V24, P1110, DOI 10.1021/bi00326a007; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hagland HR, 2013, BIOCHEM BIOPH RES CO, V430, P573, DOI 10.1016/j.bbrc.2012.11.111; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; HOPPEL CL, 1986, BIOCHEM SOC T, V14, P673, DOI 10.1042/bst0140673; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Lopez-Huertas E, 2012, BRIT J NUTR, V107, pS185, DOI 10.1017/S0007114512001572; Lovas K, 2009, DIABETES OBES METAB, V11, P304, DOI 10.1111/j.1463-1326.2008.00958.x; Lu Y, 2011, PHYSIOL GENOMICS, V43, P1307, DOI 10.1152/physiolgenomics.00100.2011; Madsen L, 2002, J LIPID RES, V43, P742; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; PAIK WK, 1975, ADV ENZYMOL RAMB, V42, P227; Pyper S.R., 2010, NUCL RECEPT SIGNAL, V8; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Schoonjans K, 1996, J LIPID RES, V37, P907; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SPYDEVOLD O, 1989, BIOCHIM BIOPHYS ACTA, V1003, P72, DOI 10.1016/0005-2760(89)90101-X; STEIN R, 1982, ARCH BIOCHEM BIOPHYS, V217, P324, DOI 10.1016/0003-9861(82)90508-2; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ueland T, 2013, INT J CARDIOL, V167, P1892, DOI 10.1016/j.ijcard.2012.04.150; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Vernez L, 2004, RAPID COMMUN MASS SP, V18, P1233, DOI 10.1002/rcm.1470; Vigerust NF, 2012, FERTIL STERIL, V98, P1620, DOI 10.1016/j.fertnstert.2012.08.024; Vigerust NF, 2012, J NUTR BIOCHEM, V23, P1384, DOI 10.1016/j.jnutbio.2011.08.006; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; Wrzesinski K, 2013, J PROTEOMICS, V84, P61, DOI 10.1016/j.jprot.2013.03.027; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	47	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66926	10.1371/journal.pone.0066926	http://dx.doi.org/10.1371/journal.pone.0066926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826175	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400085
J	Borries, C; Gordon, AD; Koenig, A				Borries, Carola; Gordon, Adam D.; Koenig, Andreas			Beware of Primate Life History Data: A Plea for Data Standards and a Repository	PLOS ONE			English	Article							LANGURS PRESBYTIS-ENTELLUS; FEMALE JAPANESE MACAQUES; RING-TAILED LEMURS; REPRODUCTIVE PARAMETERS; HANUMAN LANGURS; GESTATION LENGTH; METABOLIC-RATE; MATERNAL INVESTMENT; NATIONAL-PARK; BODY-WEIGHT	Life history variables such as the age at first reproduction and the interval between consecutive births are measures of investment in growth and reproduction in a particular population or species. As such they allow for meaningful comparisons of the speed of growth and reproduction between species and between larger taxa. Especially in primates such life history research has far reaching implications and has led for instance to the "grandmother hypothesis". Other links have been proposed with respect to dietary adaptations: Because protein is essential for growth and one of the primary sources of protein, leaves, occurs much less seasonally than fruits, it has been predicted that folivorous primates should grow faster compared to frugivorous ones. However, when comparing folivorous Asian colobines with frugivorous Asian macaques we recently documented a longer, instead of a shorter gestation length in folivores while age at first reproduction and interbirth interval did not differ. This supports earlier findings for Malagasy lemurs in which all life history variables tested were significantly longer in folivores compared to frugivores. Wondering why these trends were not apparent sooner, we tried to reconstruct our results for Asian primates with data from four popular life history compilations. However, this attempt failed; even the basic, allometric relationship with adult female body mass that is typical for life history variables could not be recovered. This negative result hints at severe problems with data quality. Here we show that data quality can be improved significantly by standardizing the variables and by controlling for factors such as nutritional conditions or infant mortality. Ideally, in the future, revised primate life history data should be collated in a central database accessible to everybody. In the long run such an initiative should be expanded to include all mammalian species.	[Borries, Carola; Koenig, Andreas] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Gordon, Adam D.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Borries, C (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	carola.borries@stonybrook.edu	Koenig, Andreas/G-6705-2013; Borries, Carola/L-8517-2013; Gordon, Adam/AAB-9006-2019; Koenig, Andreas/AAE-6492-2020	Koenig, Andreas/0000-0003-1494-9156; Borries, Carola/0000-0001-5262-1405; Gordon, Adam/0000-0002-1807-4644; Koenig, Andreas/0000-0003-1494-9156	Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation	Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation	AD Gordon was partially supported in the writing of this manuscript by a Hunt Postdoctoral Fellowship from The Wenner-Gren Foundation (www.wennergren.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Altmann J, 2003, AM J HUM BIOL, V15, P401, DOI 10.1002/ajhb.10157; Alvarez HP, 2000, AM J PHYS ANTHROPOL, V113, P435, DOI 10.1002/1096-8644(200011)113:3<435::AID-AJPA11>3.0.CO;2-O; [Anonymous], 2012, LANG ENV STAT COMP; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; ASQUITH PJ, 1989, YEARB PHYS ANTHROPOL, V32, P129; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; Barrickman NL, 2008, J HUM EVOL, V54, P568, DOI 10.1016/j.jhevol.2007.08.012; Barton RA, 2011, P NATL ACAD SCI USA, V108, P6169, DOI 10.1073/pnas.1019140108; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Borries C, 1997, BEHAV ECOL SOCIOBIOL, V41, P139, DOI 10.1007/s002650050373; Borries C, 2001, BEHAV ECOL SOCIOBIOL, V50, P391, DOI 10.1007/s002650100391; Borries C, 2011, AM J PHYS ANTHROPOL, V144, P286, DOI 10.1002/ajpa.21403; BRAMBLETT CA, 1975, J MAMMAL, V56, P940, DOI 10.2307/1379672; Bronson FH, 1989, MAMMALIAN REPROD BIO; Capellini I, 2011, AM NAT, V177, P86, DOI 10.1086/657435; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Catlett KK, 2010, AM J PHYS ANTHROPOL, V142, P391, DOI 10.1002/ajpa.21236; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Cords M, 2010, INT J PRIMATOL, V31, P409, DOI [10.1007/s10764-010-9400-z, 10.1007/s10764-010-9405-7]; CosmanJD LoweKA, 2018, CURR BIOL, V28, P3, DOI 10.1016/j.cub.2018.11.007; Covert HH, 2012, EVOL ANTHROPOL, V21, P84, DOI 10.1002/evan.21301; CROCKETT CM, 1987, AM J PRIMATOL, V13, P369, DOI 10.1002/ajp.1350130403; Cross J.F., 1981, Dodo, P30; CZEKALA NM, 1983, BIOL REPROD, V28, P289, DOI 10.1095/biolreprod28.2.289; Delson E., 1980, P10; Delson Eric, 1994, P11; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dubman E, 2012, BIOL LETTERS, V8, P998, DOI 10.1098/rsbl.2012.0642; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; EISENBER.JF, 1973, J MAMMAL, V54, P954, DOI 10.2307/1379089; ELIAS MF, 1977, AM J CLIN NUTR, V30, P355, DOI 10.1093/ajcn/30.3.355; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; EVANS CS, 1968, J ZOOL, V156, P181; Fedigan Linda M., 2012, P165; Fedigan LM, 2008, AM J PHYS ANTHROPOL, V137, P82, DOI 10.1002/ajpa.20848; FEDIGAN LM, 1995, AM J PRIMATOL, V37, P9, DOI 10.1002/ajp.1350370103; Fujita S, 2004, AM J PRIMATOL, V64, P367, DOI 10.1002/ajp.20086; GLANDER KE, 1980, AM J PHYS ANTHROPOL, V53, P25, DOI 10.1002/ajpa.1330530106; Godfrey LR, 2004, AM J PHYS ANTHROPOL, V123, P250, DOI 10.1002/ajpa.10315; Godfrey LR, 2001, AM J PHYS ANTHROPOL, V114, P192, DOI 10.1002/1096-8644(200103)114:3<192::AID-AJPA1020>3.0.CO;2-Q; Gordon AD, 2006, INT J PRIMATOL, V27, P27, DOI 10.1007/s10764-005-9003-2; Groves CP, 2001, PRIMATE TAXONOMY; Guthrie EH, 2011, AM J PHYS ANTHROPOL, V145, P446, DOI 10.1002/ajpa.21525; Harvey P.H., 1989, Special Publication of the British Ecological Society, P305; Harvey P.H., 1987, P181; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hawkes K., 2006, EVOLUTION HUMAN LIFE; Hawkes K, 2006, SCH AM RES, P45; Hearn J.P., 1982, International Zoo Yearbook, V22, P138, DOI 10.1111/j.1748-1090.1982.tb02022.x; Hendrickx A. G., 1995, NONHUMAN PRIMATES BI, P147; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hrdy S.B., 1987, P370; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; IZARD MK, 1988, AM J PRIMATOL, V16, P331, DOI 10.1002/ajp.1350160405; Janson Charles H., 1993, P57; Jin T, 2009, AM J PRIMATOL, V71, P558, DOI 10.1002/ajp.20688; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kappeler Peter M., 2012, P101; KIHLSTROM JE, 1972, COMP BIOCHEM PHYSIOL, V43, P673, DOI 10.1016/0300-9629(72)90254-X; Koenig A, 1997, J ZOOL, V243, P215, DOI 10.1111/j.1469-7998.1997.tb02778.x; Koenig A, 2001, EVOL ANTHROPOL, V10, P122, DOI 10.1002/evan.1026; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Koyama N, 2001, PRIMATES, V42, P1, DOI 10.1007/BF02640684; KRIEWALDT FH, 1968, LAB ANIM CARE, V18, P361; Lee PC, 2012, INT J PRIMATOL, V33, P1309, DOI 10.1007/s10764-011-9536-5; Leigh S. R., 2011, PRIMATES PERSPECTIVE, P418; LEIGH SR, 1994, AM J PHYS ANTHROPOL, V94, P499, DOI 10.1002/ajpa.1330940406; LEIGH SR, 1994, ZOO BIOL, V13, P21, DOI 10.1002/zoo.1430130105; LITTLE BB, 1989, AM J PHYS ANTHROPOL, V80, P213, DOI 10.1002/ajpa.1330800209; Lu A, 2010, AM J PRIMATOL, V72, P1073, DOI 10.1002/ajp.20866; Lyons SK, 2010, PHILOS T R SOC B, V365, P3681, DOI 10.1098/rstb.2010.0263; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Matin R.D., 1992, P238; McNeilly AS, 2006, ANN NY ACAD SCI, V709, P145; Meyer D, 2011, MOL PHYLOGENET EVOL, V59, P311, DOI 10.1016/j.ympev.2011.02.015; MICHOD RE, 1979, AM NAT, V113, P531, DOI 10.1086/283411; Mumby H, 2008, EVOL BIOL, V35, P287, DOI 10.1007/s11692-008-9040-9; Mustoe AC, 2012, GEN COMP ENDOCR, V175, P519, DOI 10.1016/j.ygcen.2011.12.020; Nakamichi M, 2009, PRIMATES, V50, P153, DOI 10.1007/s10329-009-0134-5; National Research Council US, 1981, TECHN STUD PRIM POP; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Nguyen N, 2006, THESIS PRINCETON U P; NIGI H, 1976, Primates, V17, P81, DOI 10.1007/BF02381568; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Pochron ST, 2004, AM J PHYS ANTHROPOL, V125, P61, DOI 10.1002/ajpa.10266; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAJPUROHIT LS, 1991, PRIMATES, V32, P213, DOI 10.1007/BF02381178; Ramirez-Llorens P, 2008, AM J PRIMATOL, V70, P473, DOI 10.1002/ajp.20522; RASMUSSEN DT, 1988, AM J PHYS ANTHROPOL, V75, P357, DOI 10.1002/ajpa.1330750307; Reichard Ulrich H., 2012, P237; Robbins AM, 2009, BEHAVIOUR, V146, P525, DOI 10.1163/156853909X426354; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Roff Derek A., 1992; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; ROSS C, 1992, PRIMATES, V33, P207, DOI 10.1007/BF02382750; Rowe N, 2011, ALL WORLDS PRIMATES; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Schwartz GT, 2005, J HUM EVOL, V49, P702, DOI 10.1016/j.jhevol.2005.08.006; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; SILK JB, 1986, INT J PRIMATOL, V7, P583, DOI 10.1007/BF02736663; Skinner MM, 2006, SCH AM RES, P331; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; SMUTS B, 1989, AM J PRIMATOL, V19, P229, DOI 10.1002/ajp.1350190405; SOMMER V, 1992, AM J PRIMATOL, V28, P1, DOI 10.1002/ajp.1350280102; Stearns S.C., 1992, pi; Stewart K.J., 1988, P22; Strier KB, 2005, AM J PRIMATOL, V67, P1, DOI 10.1002/ajp.20165; STRUHSAKER TT, 1991, BEHAVIOUR, V117, P182, DOI 10.1163/156853991X00526; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Terasawa E, 2012, ENDOCRINOLOGY, V153, P1696, DOI 10.1210/en.2011-1970; Turbill C, 2011, P ROY SOC B-BIOL SCI, V278, P3355, DOI 10.1098/rspb.2011.0190; Van Belle S, 2009, AM J PRIMATOL, V71, P153, DOI 10.1002/ajp.20635; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; WATANABE K, 1992, PRIMATES, V33, P1, DOI 10.1007/BF02382760; WATTS DP, 1989, ETHOLOGY, V81, P1; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wich SA, 2007, AM J PRIMATOL, V69, P641, DOI 10.1002/ajp.20386; Ziegler T, 2000, AM J PRIMATOL, V51, P119, DOI 10.1002/(SICI)1098-2345(200006)51:2<119::AID-AJP2>3.0.CO;2-O	135	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67200	10.1371/journal.pone.0067200	http://dx.doi.org/10.1371/journal.pone.0067200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826232	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400117
J	Copeland, HE; Pocewicz, A; Naugle, DE; Griffiths, T; Keinath, D; Evans, J; Platt, J				Copeland, Holly E.; Pocewicz, Amy; Naugle, David E.; Griffiths, Tim; Keinath, Doug; Evans, Jeffrey; Platt, James			Measuring the Effectiveness of Conservation: A Novel Framework to Quantify the Benefits of Sage-Grouse Conservation Policy and Easements in Wyoming	PLOS ONE			English	Article							ENERGY DEVELOPMENT; POPULATIONS; SELECTION	Increasing energy and housing demands are impacting wildlife populations throughout western North America. Greater sage-grouse (Centrocercus urophasianus), a species known for its sensitivity to landscape-scale disturbance, inhabits the same low elevation sage-steppe in which much of this development is occurring. Wyoming has committed to maintain sage-grouse populations through conservation easements and policy changes that conserves high bird abundance "core'' habitat and encourages development in less sensitive landscapes. In this study, we built new predictive models of oil and gas, wind, and residential development and applied build-out scenarios to simulate future development and measure the efficacy of conservation actions for maintaining sage-grouse populations. Our approach predicts sage-grouse population losses averted through conservation action and quantifies return on investment for different conservation strategies. We estimate that without conservation, sage-grouse populations in Wyoming will decrease under our long-term scenario by 14-29% (95% CI: 4-46%). However, a conservation strategy that includes the "core area'' policy and $250 million in targeted easements could reduce these losses to 9-15% (95% CI: 3-32%), cutting anticipated losses by roughly half statewide and nearly two-thirds within sage-grouse core breeding areas. Core area policy is the single most important component, and targeted easements are complementary to the overall strategy. There is considerable uncertainty around the magnitude of our estimates; however, the relative benefit of different conservation scenarios remains comparable because potential biases and assumptions are consistently applied regardless of the strategy. There is early evidence based on a 40% reduction in leased hectares inside core areas that Wyoming policy is reducing potential for future fragmentation inside core areas. Our framework using build-out scenarios to anticipate species declines provides estimates that could be used by decision makers to determine if expected population losses warrant ESA listing.	[Copeland, Holly E.; Pocewicz, Amy] Nature Conservancy, Lander, WY USA; [Naugle, David E.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Griffiths, Tim] Nat Resources Conservat Serv, Bozeman, MT USA; [Keinath, Doug] Univ Wyoming, Laramie, WY 82071 USA; [Evans, Jeffrey] Nature Conservancy, Laramie, WY USA; [Platt, James] Nature Conservancy, Minneapolis, MN USA	Nature Conservancy; University of Montana System; University of Montana; University of Wyoming; Nature Conservancy	Copeland, HE (corresponding author), Nature Conservancy, Lander, WY USA.	hcopeland@tnc.org		Evans, Jeffrey/0000-0002-5533-7044	Natural Resources Conservation Service, Sage Grouse Initiaive Program	Natural Resources Conservation Service, Sage Grouse Initiaive Program	This study was funded by a grant from the Natural Resources Conservation Service, Sage Grouse Initiaive Program (http://www.sagegrouseinitiative.com/). One of the study authors, Tim Griffiths, had a coordinating role in the grant process. Tim played an advisory role in preparation of this manuscript and helped conceive the project, but otherwise had no role in study design, data collection and analysis, or decision to publish.	Bastian C, 2010, ESTIMATING MARKET VA; Beier P., 2007, CONCEPTUAL STEPS DES; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Bureau of Land Management, 2012, WY2012019 BUR LAND M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Copeland Holly E., 2011, P7; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty K, 2010, MAPPING BREEDING DEN, P1; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; ESRI, 2011, ARCGIS DESKT REL 10; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Fishburn IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004996; Garton EO, 2011, STUD AVIAN BIOL, P293; Gude PH, 2006, LANDSCAPE URBAN PLAN, V77, P131, DOI 10.1016/j.landurbplan.2005.02.004; Hagen CA, 2011, STUD AVIAN BIOL, P95; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; IHS Incorporated, 2007, OIL GAS WELL DAT; Johnson D. H., 2011, INFLUENCES ENV ANTHR; Kiesecker JM, 2007, FRONT ECOL ENVIRON, V5, P125, DOI 10.1890/1540-9295(2007)5[125:CEICAQ]2.0.CO;2; Knick ST, 2011, STUD AVIAN BIOL, P1; Love D, 2010, UPDATED GEOLOGIC MAP; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; Mitchell M.W., 2011, OJS, V01, P205, DOI [10.4236/ojs.2011.13024, DOI 10.4236/OJS.2011.13024]; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; National Renewable Energy Laboratory, 2008, ANN AV WIND RES POT; Naugle DE, 2011, STUD AVIAN BIOL, P489; O'Donnell MS, 2010, SPATIAL MAPPING ATTR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pocewicz A, 2011, BIOL CONSERV, V144, P567, DOI 10.1016/j.biocon.2010.10.012; R Core Team, 2021, R LANG ENV STAT COMP; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Schrag A, 2011, GEOJOURNAL, V76, P561, DOI 10.1007/s10708-010-9369-3; State of Wyoming Executive Department, 2011, 20115 STAT WYOM EX D; Taylor RL, 2012, VIABILITY ANAL CONSE; *US DOE, 2008, 20 EN 2030 INCR WIND; US Energy Information Administration, 2013, WYOM STAT PROF EN ES; US Government Accountability Office, 2006, GAO06730; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilson RR, 2013, CONSERV LETT, V00, P1; Wisdom MJ, 2011, STUD AVIAN BIOL, P451; Wyoming Department of Revenue, 2012, CAMA DAT DOWNL; Wyoming Governor's Sage-Grouse Implementation Team, 2010, WYOM SAG GROUS COR A; Wyoming Housing Database Partnership, 2010, 2010 WYOM HOUS NEEDS; Wyoming Wildlife Consultants, 2007, IRR LANDS WYOM	58	41	42	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67261	10.1371/journal.pone.0067261	http://dx.doi.org/10.1371/journal.pone.0067261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826250	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400127
J	Figueroa, CM; Kuhn, ML; Falaschetti, CA; Solamen, L; Olsen, KW; Ballicora, MA; Iglesias, AA				Figueroa, Carlos M.; Kuhn, Misty L.; Falaschetti, Christine A.; Solamen, Ligin; Olsen, Kenneth W.; Ballicora, Miguel A.; Iglesias, Alberto A.			Unraveling the Activation Mechanism of the Potato Tuber ADP-Glucose Pyrophosphorylase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS; MOLECULAR-DYNAMICS; REGULATORY ENZYME; ADPGLUCOSE PYROPHOSPHORYLASES; ALLOSTERIC REGULATION; SCANNING MUTAGENESIS; BINDING-SITES; N-TERMINUS	ADP-glucose pyrophosphorylase regulates the synthesis of glycogen in bacteria and of starch in plants. The enzyme from plants is mainly activated by 3-phosphoglycerate and is a heterotetramer comprising two small and two large subunits. Here, we found that two highly conserved residues are critical for triggering the activation of the potato tuber ADP-glucose pyrophosphorylase, as shown by site-directed mutagenesis. Mutations in the small subunit, which bears the catalytic function in this potato tuber form, had a more dramatic effect on disrupting the allosteric activation than those introduced in the large subunit, which is mainly modulatory. Our results strongly agree with a model where the modified residues are located in loops responsible for triggering the allosteric activation signal for this enzyme, and the sensitivity to this activation correlates with the dynamics of these loops. In addition, previous biochemical data indicates that the triggering mechanism is widespread in the enzyme family, even though the activator and the quaternary structure are not conserved.	[Figueroa, Carlos M.; Iglesias, Alberto A.] Univ Nacl Litoral, Inst Agrobiotecnol Litoral, Santa Fe, Argentina; [Figueroa, Carlos M.; Iglesias, Alberto A.] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina; [Figueroa, Carlos M.; Kuhn, Misty L.; Falaschetti, Christine A.; Solamen, Ligin; Olsen, Kenneth W.; Ballicora, Miguel A.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA	National University of the Littoral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Loyola University Chicago	Iglesias, AA (corresponding author), Univ Nacl Litoral, Inst Agrobiotecnol Litoral, Santa Fe, Argentina.	iglesias@fbcb.unl.edu.ar		Figueroa, Carlos Maria/0000-0003-4047-0480; Iglesias, Alberto/0000-0001-9729-7338; Ballicora, Miguel/0000-0002-5324-0724	National Science Foundation [MCB 1024945]; ANPCyT [PICT'08 1754]; CONICET [NSF] [PIP 2519]; UNL [CAI+D Orientado]; Fulbright Fellowship; American Society of Plant Biologists; Carbon Scholar Fellowship (Loyola University Chicago); Mulcahy Scholarship (Loyola University Chicago); John Simon Guggenheim Memorial Foundation; Div Of Molecular and Cellular Bioscience [1024945] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ANPCyT(ANPCyT); CONICET [NSF](Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL [CAI+D Orientado]; Fulbright Fellowship; American Society of Plant Biologists; Carbon Scholar Fellowship (Loyola University Chicago); Mulcahy Scholarship (Loyola University Chicago); John Simon Guggenheim Memorial Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants to MAB from the National Science Foundation [MCB 1024945] and to AAI from ANPCyT [PICT'08 1754], CONICET [PIP 2519 and for collaboration with NSF], and UNL [CAI+D Orientado]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CMF was a recipient of a Fulbright Fellowship. CAF was recipient of the Summer Undergraduate Research Fellowship from the American Society of Plant Biologists and the Carbon Scholar Fellowship (Loyola University Chicago). LS is the recipient of a Mulcahy Scholarship (Loyola University Chicago). AAI received a Fellowship from The John Simon Guggenheim Memorial Foundation. CMF and AAI are members of the Researcher Career from CONICET.	BALL K, 1994, J BIOL CHEM, V269, P24706; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2006, BIOCHEM BIOPH RES CO, V343, P216, DOI 10.1016/j.bbrc.2006.02.123; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Boehlein SK, 2010, PLANT PHYSIOL, V152, P85, DOI 10.1104/pp.109.146928; Boehlein SK, 2009, PLANT PHYSIOL, V149, P318, DOI 10.1104/pp.108.126862; CHARNG YY, 1994, J BIOL CHEM, V269, P24107; CHARNG YY, 1992, PLANT MOL BIOL, V20, P37, DOI 10.1007/BF00029147; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; GHOSH HP, 1965, BIOCHEMISTRY-US, V4, P1354, DOI 10.1021/bi00883a020; GHOSH HP, 1965, J BIOL CHEM, V240, pP960; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iglesias AA, 2006, PLANT CELL PHYSIOL, V47, P523, DOI 10.1093/pcp/pcj021; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kuhn ML, 2009, J BIOL CHEM, V284, P34092, DOI 10.1074/jbc.M109.037614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MORELL M, 1988, J BIOL CHEM, V263, P633; Pessarakli A. A, 2005, HDB PHOTOSYNTHESIS, P525; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Vinson VJ, 2009, SCIENCE, V324, P197, DOI 10.1126/science.324.5924.197; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	42	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66824	10.1371/journal.pone.0066824	http://dx.doi.org/10.1371/journal.pone.0066824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826149	Green Published, gold			2022-12-25	WOS:000321738400063
J	Fischer, C; Koblmuller, S; Gully, C; Schlotterer, C; Sturmbauer, C; Thallinger, GG				Fischer, Christoph; Koblmueller, Stephan; Guelly, Christian; Schloetterer, Christian; Sturmbauer, Christian; Thallinger, Gerhard G.			Complete Mitochondrial DNA Sequences of the Threadfin Cichlid (Petrochromis trewavasae) and the Blunthead Cichlid (Tropheus moorii) and Patterns of Mitochondrial Genome Evolution in Cichlid Fishes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; LAKE TANGANYIKA; SELECTION; ALIGNMENT; MODEL; SITES; ACCURACY; GENES; RATES; PHYLOGENETICS	The cichlid fishes of the East African Great Lakes represent a model especially suited to study adaptive radiation and speciation. With several African cichlid genome projects being in progress, a promising set of closely related genomes is emerging, which is expected to serve as a valuable data base to solve questions on genotype-phenotype relations. The mitochondrial (mt) genomes presented here are the first results of the assembly and annotation process for two closely related but eco-morphologically highly distinct Lake Tanganyika cichlids, Petrochromis trewavasae and Tropheus moorii. The genomic sequences comprise 16,588 bp (P. trewavasae) and 16,590 bp (T. moorii), and exhibit the typical mitochondrial structure, with 13 protein-coding genes, 2 rRNA genes, 22 tRNA genes, and a non-coding control region. Analyses confirmed that the two species are very closely related with an overall sequence similarity of 96%. We analyzed the newly generated sequences in the phylogenetic context of 21 published labroid fish mitochondrial genomes. Consistent with other vertebrates, the D-loop region was found to evolve faster than protein-coding genes, which in turn are followed by the rRNAs; the tRNAs vary greatly in the rate of sequence evolution, but on average evolve the slowest. Within the group of coding genes, ND6 evolves most rapidly. Codon usage is similar among examined cichlid tribes and labroid families; although a slight shift in usage patterns down the gene tree could be observed. Despite having a clearly different nucleotide composition, ND6 showed a similar codon usage. C-terminal ends of Cox1 exhibit variations, where the varying number of amino acids is related to the structure of the obtained phylogenetic tree. This variation may be of functional relevance for Cox1 synthesis.	[Fischer, Christoph; Thallinger, Gerhard G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Koblmueller, Stephan; Sturmbauer, Christian] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Schloetterer, Christian] Univ Vet Med Vienna, Inst Populat Genet, Vienna, Austria	Graz University of Technology; University of Graz; Medical University of Graz; University of Veterinary Medicine Vienna	Sturmbauer, C (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Austria.	Christian.Sturmbauer@uni-graz.at; Gerhard.Thallinger@tugraz.at	Schlötterer, Christian/G-6326-2010; Schlötterer, Christian/Q-5264-2019	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Koblmuller, Stephan/0000-0002-1024-3220; Thallinger, Gerhard G./0000-0002-2864-5404	Austria Science Fund project Cichlid [FWF] [P22737]; EU [BM1006]; Austrian Ministry of Science and Research GEN-AU project BIN [FFG] [820962]; Austrian Science Fund (FWF) [P 22737] Funding Source: researchfish	Austria Science Fund project Cichlid [FWF]; EU(European Commission); Austrian Ministry of Science and Research GEN-AU project BIN [FFG]; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austria Science Fund project Cichlid [FWF Grant P22737], by the EU-FP7 COST Action SeqAhead [EC Grant BM1006] and by the Austrian Ministry of Science and Research GEN-AU project BIN [FFG Grant 820962]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Barlow G., 2002, CICHLID FISHES NATUR; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANN RL, 1984, GENETICS, V106, P479; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Csardi N., 2006, INT J COMP SYST, V1695, P1; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FROESE R., 2012, FISHBASE; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Guderley H, 2002, J EXP BIOL, V205, P2237; Hardewig I, 1999, AM J PHYSIOL-REG I, V277, pR508, DOI 10.1152/ajpregu.1999.277.2.R508; He AY, 2011, MOL BIOL REP, V38, P2015, DOI 10.1007/s11033-010-0324-7; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kartavtsev YP, 2007, GENE, V396, P13, DOI 10.1016/j.gene.2007.01.027; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kimura M, 1985, NEUTRAL THEORY MOL E; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koonin EV, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100029; Kunstner A, 2011, GENOME BIOL EVOL, V3, P1381, DOI 10.1093/gbe/evr112; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Maddison W. P., 2012, MESQUITE MODULAR SYS; MADSEN CS, 1993, MOL CELL BIOL, V13, P2162, DOI 10.1128/MCB.13.4.2162; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Moola S, 2011, ANN M SOC MOL BIOL E, P1; MORGAN BJT, 1995, APPL STAT-J ROY ST C, V44, P117, DOI 10.2307/2986199; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Pages H, 2012, BIOSTRINGS STRING OB; Pamplona Reinald, 2011, J Aging Res, V2011, P807108, DOI 10.4061/2011/807108; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2012, R LANG ENV STAT COMP; Rambaut A., 2011, TRACER 1 5; Rican O, 2008, MOL PHYLOGENET EVOL, V49, P941, DOI 10.1016/j.ympev.2008.07.022; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J, 2001, MOL CLONING LAB MANU; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sturmbauer C, 2003, HYDROBIOLOGIA, V500, P51, DOI 10.1023/A:1024680201436; Subramanian S, 2011, GENOME BIOL EVOL, V3, P1324, DOI 10.1093/gbe/evr108; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe A. S., 2011, MRBAYES5D; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Warnow T., 2012, PLOS CURR, V4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Widmann J, 2010, RNA, V16, P1469, DOI 10.1261/rna.726010; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Zwickl DJ, 2004, SYST BIOL, V53, P877, DOI 10.1080/10635150490522584	85	28	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67048	10.1371/journal.pone.0067048	http://dx.doi.org/10.1371/journal.pone.0067048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826193	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400098
J	Kmet, M; Guo, C; Edmondson, C; Chen, B				Kmet, Muriel; Guo, Chao; Edmondson, Carina; Chen, Bin			Directed Differentiation of Human Embryonic Stem Cells into Corticofugal Neurons Uncovers Heterogeneous Fezf2-Expressing Subpopulations	PLOS ONE			English	Article							SUBCORTICAL PROJECTION NEURONS; EFFICIENT NEURAL CONVERSION; CEREBRAL-CORTEX; MOTOR-NEURONS; HEAD INDUCTION; DEVELOPING NEOCORTEX; EXPRESSION CLONING; SONIC HEDGEHOG; RADIAL GLIA; WNT	Understanding how neuronal diversity is achieved within the cerebral cortex remains a major challenge in neuroscience. The advent of human embryonic stem cells (hESCs) as a model system provides a unique opportunity to study human corticogenesis in vitro and to identify the mechanisms that promote neuronal differentiation to achieve neuronal diversity in human brain. The transcription factor Fezf2 is necessary and sufficient for the specification of subcerebral projection neurons in mouse. However, its function during human corticogenesis is poorly understood. This study reports the differentiation of a hFezf2-YFP hESC reporter line into corticofugal projection neurons capable of extending axons toward the spinal cord upon transplantation into neonatal mouse brains. Additionally, we show that triple inhibition of the TGF beta/BMP/Wnt-Shh pathway promotes the generation of hFezf2-expressing cells in vitro. Finally, this study unveils the isolation of two novel and distinct populations of hFezf2-YFP expressing cells reminiscent of the distinct Fezf2-expressing neuronal subtypes in the developing mouse brain. Overall our data suggest that the directed differentiation of hESCs into corticofugal neurons provides a useful model to identify the molecular mechanisms regulating human corticofugal differentiation and survival.	[Kmet, Muriel; Guo, Chao; Edmondson, Carina; Chen, Bin] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Chen, B (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	bchen@ucsc.edu	guo, chao/E-2849-2014		SEED grant from the California Institute of Regenerative Medicine (CIRM) [RS1-00170]; CIRM [TG2-01157]	SEED grant from the California Institute of Regenerative Medicine (CIRM); CIRM(California Institute for Regenerative Medicine)	This work was supported by a SEED grant from the California Institute of Regenerative Medicine (CIRM) RS1-00170 to BC and MK was a CIRM training grant TG2-01157 scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bedogni F, P NATL ACAD SCI US, V107, P13129; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cecchi C, 2002, GENE, V291, P1, DOI 10.1016/S0378-1119(02)00623-6; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiao E, 2008, METHOD CELL BIOL, V86, P1, DOI 10.1016/S0091-679X(08)00001-0; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jeong JY, 2007, DEVELOPMENT, V134, P127, DOI 10.1242/dev.02705; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Shu TZ, 2003, J NEUROSCI, V23, P203; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Zhu H, 2010, NEUROSCI RES, V68, P73, DOI 10.1016/j.neures.2010.05.007	67	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67292	10.1371/journal.pone.0067292	http://dx.doi.org/10.1371/journal.pone.0067292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826257	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400128
J	Wallerstedt, SM; Fastbom, J; Johnell, K; Sjoberg, C; Landahl, S; Sundstrom, A				Wallerstedt, Susanna M.; Fastbom, Johan; Johnell, Kristina; Sjoberg, Christina; Landahl, Sten; Sundstrom, Anders			Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System-A Longitudinal Analysis	PLOS ONE			English	Article							MEDICATION ERRORS; ELDERLY-PATIENTS; NURSING-HOMES; HEALTH-CARE; QUALITY; PRESCRIPTION; DEMENTIA	Background: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature of this association, by performing a longitudinal analysis of the drug treatment before and after the transition to MDD. Methods: Inclusion critera in this register-based study were inhabitants in Region Vastra Gotaland, Sweden, who, at >= 65 years of age and between 1st July 2006 and 30th June 2010, filled their first MDD prescription. For each individual, prescribed drugs were estimated at three month intervals before and after (maximum 3 years, respectively) the first date of filling an MDD prescription (index date). Results: A total of 30,922 individuals matched the inclusion criteria (mean age: 83.2 years; 59.9% female). There was a temporal association between the transition to MDD and an increased number of drugs: 5.4 +/- 3.9 and 7.5 +/- 3.8 unique drugs three months before and after the index date, respectively, as well as worse outcomes on several indicators of prescribing quality. When either data before or after the index date were used, a multi-level regression analysis predicted the number of drugs at the index date at 5.76 (95% confidence limits: 5.71; 5.80) and 7.15 (7.10; 7.19), respectively, for an average female individual (83.2 years, 10.8 unique diagnoses, 2.4 healthcare contacts/three months). The predicted change in the number of drugs, from three months before the index date to the index date, was greater when data before this date was used as compared with data after this date: 0.12 (0.09; 0.14) versus 0.02 (-0.01; 0.05). Conclusions: After the patients entered the MDD system, they had an increased number of drugs, more often potentially harmful drug treatment, and fewer changes in drug treatment. These findings support a causal relationship between such a system and safety concerns as regards prescribing practices.	[Wallerstedt, Susanna M.] Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden; [Fastbom, Johan; Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fastbom, Johan; Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden; [Sjoberg, Christina] Sahlgrenska Univ Hosp Molndal, Dept Geriatr, Molndal, Sweden; [Landahl, Sten] Sahlgrens Acad, Dept Geriatr, Molndal, Sweden; [Sundstrom, Anders] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden	Sahlgrenska University Hospital; Karolinska Institutet; Stockholm University; Sahlgrenska University Hospital; Karolinska Institutet	Wallerstedt, SM (corresponding author), Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden.	susanna.wallerstedt@pharm.gu.se	Wallerstedt, Susanna/AAE-5607-2020	Wallerstedt, Susanna/0000-0001-7238-1680; Landahl, Sten/0000-0001-7251-9192	Swedish Medical Products Agency	Swedish Medical Products Agency	The study was funded by the Swedish Medical Products Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassaad A, 2013, J EVAL CLIN PRACT, V19, P185, DOI 10.1111/j.1365-2753.2011.01798.x; Bakken Toril, 2003, Tidsskr Nor Laegeforen, V123, P3595; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; Bergkvist A, 2009, EUR J CLIN PHARMACOL, V65, P1037, DOI 10.1007/s00228-009-0680-1; Bergman A, 2007, SCAND J PRIM HEALTH, V25, P9, DOI 10.1080/02813430600991980; Hoven JL, 2005, EUR J CLIN PHARMACOL, V60, P831, DOI 10.1007/s00228-004-0845-x; Johnell K, 2008, SCAND J PRIM HEALTH, V26, P86, DOI 10.1080/02813430802022196; Johnell K, 2007, ANN PHARMACOTHER, V41, P1243, DOI 10.1345/aph.1K154; Larsen Anna Bira, 2007, Res Social Adm Pharm, V3, P265, DOI 10.1016/j.sapharm.2006.10.002; McGraw C, 2000, Br J Community Nurs, V5, P326; MEANS BJ, 1975, AM J HOSP PHARM, V32, P186, DOI 10.1093/ajhp/32.2.186; Medical Products Agency, 2013, UTV DOSTJ, P10; Midlov P, 2005, PHARM WORLD SCI, V27, P116, DOI 10.1007/s11096-004-3705-y; Midlov P, 2012, INT J CLIN PHARM-NET, V34, P113, DOI 10.1007/s11096-011-9599-6; MURRAY MD, 1993, ANN PHARMACOTHER, V27, P616; Nordling S, 2009, VILKEN NYTTA HAR APO, P24, DOI The Swedish Institute for Health Economics; Olsson J, 2010, CLIN DRUG INVEST, V30, P289, DOI 10.2165/11534320-000000000-00000; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Sjoberg C, 2012, EUR J CLIN PHARMACOL, V68, P1095, DOI 10.1007/s00228-012-1230-9; Sjoberg C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026574; Sjoqvist F, 2012, INTERAKTION MELLAN L; Swedish Council on Technology Assessment in Health Care, 2009, CAN DRUG CONS ELD BE, p[12, 19]; Wekre LJ, 2012, SCAND J PUBLIC HEALT, V40, P523, DOI 10.1177/1403494812455468; Wekre LJ, 2011, SCAND J PRIM HEALTH, V29, P45, DOI 10.3109/02813432.2011.554002; Wekre LJ, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038745	25	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67088	10.1371/journal.pone.0067088	http://dx.doi.org/10.1371/journal.pone.0067088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826197	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400101
J	Kaplinsky, NJ; Gilbert, SF; Cebra-Thomas, J; Lillevali, K; Saare, M; Chang, EY; Edelman, HE; Frick, MA; Guan, Y; Hammond, RM; Hampilos, NH; Opoku, DSB; Sariahmed, K; Sherman, EA; Watson, R				Kaplinsky, Nicholas J.; Gilbert, Scott F.; Cebra-Thomas, Judith; Lillevaeli, Kersti; Saare, Merly; Chang, Eric Y.; Edelman, Hannah E.; Frick, Melissa A.; Guan, Yin; Hammond, Rebecca M.; Hampilos, Nicholas H.; Opoku, David S. B.; Sariahmed, Karim; Sherman, Eric A.; Watson, Ray			The Embryonic Transcriptome of the Red-Eared Slider Turtle (Trachemys scripta)	PLOS ONE			English	Article							CARAPACIAL RIDGE; EVOLUTION; ALIGNMENT; ORIGIN; SERIES; GENES; FORMS; SHELL	The bony shell of the turtle is an evolutionary novelty not found in any other group of animals, however, research into its formation has suggested that it has evolved through modification of conserved developmental mechanisms. Although these mechanisms have been extensively characterized in model organisms, the tools for characterizing them in non-model organisms such as turtles have been limited by a lack of genomic resources. We have used a next generation sequencing approach to generate and assemble a transcriptome from stage 14 and 17 Trachemys scripta embryos, stages during which important events in shell development are known to take place. The transcriptome consists of 231,876 sequences with an N-50 of 1,166 bp. GO terms and EC codes were assigned to the 61,643 unique predicted proteins identified in the transcriptome sequences. All major GO categories and metabolic pathways are represented in the transcriptome. Transcriptome sequences were used to amplify several cDNA fragments designed for use as RNA in situ probes. One of these, BMP5, was hybridized to a T. scripta embryo and exhibits both conserved and novel expression patterns. The transcriptome sequences should be of broad use for understanding the evolution and development of the turtle shell and for annotating any future T. scripta genome sequences.	[Kaplinsky, Nicholas J.; Gilbert, Scott F.; Chang, Eric Y.; Edelman, Hannah E.; Frick, Melissa A.; Guan, Yin; Hammond, Rebecca M.; Hampilos, Nicholas H.; Opoku, David S. B.; Sariahmed, Karim; Sherman, Eric A.; Watson, Ray] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Cebra-Thomas, Judith] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Lillevaeli, Kersti; Saare, Merly] Univ Tartu, Dept Dev Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Lillevaeli, Kersti] Univ Tartu, Dept Physiol, Fac Med, EE-50090 Tartu, Estonia	Swarthmore College; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; University of Tartu; University of Tartu	Kaplinsky, NJ (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	nkaplin1@swarthmore.edu	Lilleväli, Kersti/AGD-6838-2022	Lilleväli, Kersti/0000-0001-5470-3818; Frick, Melissa/0000-0002-2402-2728; Kaplinsky, Nick/0000-0002-1759-1826; Watson, Ray/0000-0003-0697-6912; Sherman, Erin/0000-0002-1835-8604	Swarthmore College; Estonian Ministry of Education and Research [SF0180019s11]	Swarthmore College; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was funded by Swarthmore College (Swarthmore.edu). KL and MS were supported by grant SF0180019s11 from Estonian Ministry of Education and Research (http://www.hm.ee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; Cebra-Thomas J, 2005, J EXP ZOOL PART B, V304B, P558, DOI 10.1002/jez.b.21059; Cebra-Thomas JA, 2007, EVOL DEV, V9, P267, DOI 10.1111/j.1525-142X.2007.00159.x; Clark K, 2001, GENESIS, V31, P111, DOI 10.1002/gene.10012; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford NG, 2012, BIOL LETT; Darnell DK, 2007, CYTOGENET GENOME RES, V117, P30, DOI 10.1159/000103162; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAFFNEY E S, 1990, Bulletin of the American Museum of Natural History, P1; GAFFNEY ES, 1987, SCIENCE, V237, P289, DOI 10.1126/science.237.4812.289; Geetha-Loganathan P, 2006, ANAT EMBRYOL, V211, pS87, DOI 10.1007/s00429-006-0129-6; Gilbert Scott F., 2008, P1; Gilbert Scott F., 2009, V266, P57, DOI 10.1007/978-1-4020-9636-5_5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GREEN EL, 1946, AM NAT, V80, P619, DOI 10.1086/281482; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; Guenther C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000308; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawashima-Ohya Y, 2011, EVOL DEV, V13, P260, DOI 10.1111/j.1525-142X.2011.00474.x; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; Milinkovitch MC, 2007, J EXP ZOOL PART B, V308B, P337, DOI 10.1002/jez.b.21180; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Moustakas JE, 2008, EVOL DEV, V10, P29, DOI 10.1111/j.1525-142X.2007.00210.x; Rowan BA, 2011, DEV CELL, V21, P65, DOI 10.1016/j.devcel.2011.05.021; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Storm EE, 1996, DEVELOPMENT, V122, P3969; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Wang Z, 2013, NAT GENET; Wilkinson DG, 1993, SITU HYBRIDIZATION P, P75; YNTEMA CL, 1970, J MORPHOL, V132, P235, DOI 10.1002/jmor.1051320209; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	41	17	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66357	10.1371/journal.pone.0066357	http://dx.doi.org/10.1371/journal.pone.0066357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840449	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200069
J	Kucharova, V; Strand, TA; Almaas, E; Naas, AE; Brautaset, T; Valla, S				Kucharova, Veronika; Strand, Trine Aakvik; Almaas, Eivind; Naas, Adrian E.; Brautaset, Trygve; Valla, Svein			Non-Invasive Analysis of Recombinant mRNA Stability in Escherichia coli by a Combination of Transcriptional Inducer Wash-Out and qRT-PCR	PLOS ONE			English	Article							GENE-EXPRESSION; PM PROMOTER; SIGMA(70) SUBUNIT; SIGNAL SEQUENCES; LEVEL PRODUCTION; DNA-REGION; STEM-LOOP; TRANSLATION; POLYMERASE; PROTEINS	mRNA stability is one among many parameters that can potentially affect the level of recombinant gene expression in bacteria. Blocking of the entire prokaryotic transcription machinery by addition of rifampicin is commonly used in protocols for analysis of mRNA stability. Here we show that such treatment can be effectively replaced by a simple, non-invasive method based on removal of the relevant transcriptional inducers and that the mRNA decay can then be followed by qRT-PCR. To establish the methodology we first used the m-toluate-inducible XylS/Pm expression cassette as a model system and analyzed several examples of DNA modifications causing gene expression stimulation in Escherichia coli. The new method allowed us to clearly discriminate whether an improvement in mRNA stability contributes to observed increases in transcript amounts for each individual case. To support the experimental data a simple mathematical fitting model was developed to calculate relative decay rates. We extended the relevance of the method by demonstrating its application also for an IPTG-inducible expression cassette (LacI/P-tac) and by analyzing features of the bacteriophage T7-based expression system. The results suggest that the methodology is useful in elucidating factors controlling mRNA stability as well as other specific features of inducible expression systems. Moreover, as expression systems based on diffusible inducers are almost universally available, the concept can be most likely used to measure mRNA decay for any gene in any cell type that is heavily used in molecular biology research.	[Kucharova, Veronika; Almaas, Eivind; Naas, Adrian E.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Strand, Trine Aakvik; Brautaset, Trygve] SINTEF Mat & Chem, Dept Mol Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); SINTEF	Valla, S (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	svein.valla@biotech.ntnu.no	Pettersen, Veronika Kuchařová/X-2818-2019	Pettersen, Veronika Kuchařová/0000-0002-7108-9562; Almaas, Eivind/0000-0002-9125-326X	Research Council of Norway [182672/i40]	Research Council of Norway(Research Council of Norway)	The project was funded by the Research Council of Norway, grant no. 182672/i40. Web-site: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Arnold TE, 1998, RNA, V4, P319; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Aune TEV, 2010, MICROB BIOTECHNOL, V3, P38, DOI 10.1111/j.1751-7915.2009.00126.x; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Berg L, 2009, MICROB BIOTECHNOL, V2, P379, DOI 10.1111/j.1751-7915.2009.00107.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carrier TA, 1997, BIOTECHNOL PROGR, V13, P699, DOI 10.1021/bp970095h; Carrier TA, 1997, BIOTECHNOL BIOENG, V55, P577, DOI 10.1002/(SICI)1097-0290(19970805)55:3<577::AID-BIT16>3.3.CO;2-6; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Gong F, 2003, J BACTERIOL, V185, P6472, DOI 10.1128/JB.185.21.6472-6476.2003; Graumann Klaus, 2006, Biotechnology Journal, V1, P164, DOI 10.1002/biot.200500051; Heggeset TMB, 2013, APPL ENVIRON MICROB, V79, P559, DOI 10.1128/AEM.02407-12; Huang Jr C, 2012, J IND MICROBIOL BIOT, P1; Iost I, 1995, EMBO J, P14; Jakobsen OM, 2006, J BACTERIOL, P188; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Makarova OV, 1995, P NATL ACAD SCI USA, V92, P12250, DOI 10.1073/pnas.92.26.12250; Marques S, 1999, MOL MICROBIOL, V31, P1105, DOI 10.1046/j.1365-2958.1999.01249.x; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Seber G. A. F., 2003, NONLINEAR REGRESSION; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Sletta H, 2004, APPL ENVIRON MICROB, V70, P7033, DOI 10.1128/AEM.70.12.7033-7039.2004; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Srivastava P, 2005, PROTEIN EXPRES PURIF, V40, P221, DOI 10.1016/j.pep.2004.06.017; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Vytvytska O, 2000, GENE DEV, V14, P1109; Wegrzyn A, 1998, FEBS LETT, V440, P172, DOI 10.1016/S0014-5793(98)01449-5; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Winther-Larsen HC, 2000, METAB ENG, V2, P92, DOI 10.1006/mben.1999.0143; Winther-Larsen HC, 2000, METAB ENG, V2, P79, DOI 10.1006/mben.1999.0142	59	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66429	10.1371/journal.pone.0066429	http://dx.doi.org/10.1371/journal.pone.0066429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840466	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200076
J	Kuhnast, S; Louwe, MC; Heemskerk, MM; Pieterman, EJ; van Klinken, JB; van den Berg, SAA; Smit, JWA; Havekes, LM; Rensen, PCN; van der Hoorn, JWA; Princen, HMG; Jukema, JW				Kuhnast, Susan; Louwe, Mieke C.; Heemskerk, Mattijs M.; Pieterman, Elsbet J.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.; van der Hoorn, Jose W. A.; Princen, Hans M. G.; Jukema, J. Wouter			Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; NICOTINIC-ACID; COMBINATION THERAPY; PREVENTION; STATIN; HDL; TRIGLYCERIDES; INFLAMMATION	Objective: Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-cholesterol. Despite evidence for an atheroprotective effect of niacin from previous small clinical studies, the large outcome trials, AIM-HIGH and HPS2-THRIVE did not reveal additional beneficial effects of niacin (alone or in combination with laropiprant) on top of statin treatment. We aimed to address this apparent discrepancy by investigating the effects of niacin without and with simvastatin on atherosclerosis development and determine the underlying mechanisms, in APOE*3Leiden.CETP mice, a model for familial dysbetalipoproteinemia (FD). Approach and Results: Mice were fed a western-type diet containing cholesterol without or with niacin (120 mg/kg/day), simvastatin (36 mg/kg/day) or their combination for 18 weeks. Similarly as in FD patients, niacin reduced total cholesterol by -39% and triglycerides by -50%, (both P<0.001). Simvastatin and the combination reduced total cholesterol (-30%; -55%, P<0.001) where the combination revealed a greater reduction compared to simvastatin (-36%, P<0.001). Niacin decreased total cholesterol and triglycerides primarily by increasing VLDL clearance. Niacin increased HDL-cholesterol (+28%, P<0.01) and mildly increased reverse cholesterol transport. All treatments reduced monocyte adhesion to the endothelium (-46%; -47%, P<0.01; -53%, P<0.001), atherosclerotic lesion area (-78%; -49%, P<0.01; -87%, P<0.001) and severity. Compared to simvastatin, the combination increased plaque stability index [(SMC+collagen)/macrophages] (3-fold, P<0.01). Niacin and the combination reduced T cells in the aortic root (-71%, P<0.01; -81%, P<0.001). Lesion area was strongly predicted by nonHDL-cholesterol (R-2 = 0.69, P<0.001) and to a much lesser extent by HDL-cholesterol (R-2 = 0.20, P<0.001). Conclusion: Niacin decreases atherosclerosis development mainly by reducing nonHDL-cholesterol with modest HDL-cholesterol-raising and additional anti-inflammatory effects. The additive effect of niacin on top of simvastatin is mostly dependent on its nonHDL-cholesterol-lowering capacities. These data suggest that clinical beneficial effects of niacin are largely dependent on its ability to lower LDL-cholesterol on top of concomitant lipid-lowering therapy.	[Kuhnast, Susan; Pieterman, Elsbet J.; Havekes, Louis M.; van der Hoorn, Jose W. A.; Princen, Hans M. G.] TNO Metab Hlth Res, Leiden, Netherlands; [Kuhnast, Susan; van der Hoorn, Jose W. A.; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Louwe, Mieke C.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Heemskerk, Mattijs M.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Kuhnast, Susan; Louwe, Mieke C.; Heemskerk, Mattijs M.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.; van der Hoorn, Jose W. A.; Jukema, J. Wouter] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kuhnast, S (corresponding author), TNO Metab Hlth Res, Leiden, Netherlands.	susan.jordaan@tno.nl	Jukema, J. Wouter/ABD-6503-2021; Louwe, Mieke/ABH-3414-2020; Rensen, Patrick C.N./D-7176-2018; van den Berg, Sjoerd A/R-9541-2018; Smit, J.W.A./H-8091-2014; Louwe, Mieke C./ABC-2290-2020; Princen, Hans MG/AID-9392-2022	Jukema, J. Wouter/0000-0002-3246-8359; Rensen, Patrick C.N./0000-0002-8455-4988; Smit, J.W.A./0000-0003-1052-9314; Princen, Hans MG/0000-0002-7206-1596; /0000-0003-2790-5144; Louwe, Mieke C./0000-0002-4797-4991; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505	project PREDICCt [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Dutch Heart Foundation [2009T038]	project PREDICCt; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and was supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. PCNR is an Established Investigator of the Dutch Heart Foundation (grant 2009T038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijland S, 2010, J BIOL CHEM, V285, P25168, DOI 10.1074/jbc.M110.123992; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Blumenthal RS, 2009, NEW ENGL J MED, V361, P2178, DOI 10.1056/NEJMe0908838; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CARLSON LA, 1973, ATHEROSCLEROSIS, V18, P1, DOI 10.1016/0021-9150(73)90113-5; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; DEKNIJFF P, 1991, J CLIN INVEST, V88, P643, DOI 10.1172/JCI115349; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Foks AC, 2011, ATHEROSCLEROSIS, V218, P53, DOI 10.1016/j.atherosclerosis.2011.04.029; Giugliano RP, 2011, NEW ENGL J MED, V365, P2318, DOI 10.1056/NEJMe1112346; GRUNDY SM, 1981, J LIPID RES, V22, P24; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; HOOGWERF BJ, 1984, ATHEROSCLEROSIS, V51, P251, DOI 10.1016/0021-9150(84)90172-2; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Lee JMS, 2009, J AM COLL CARDIOL, V54, P1787, DOI 10.1016/j.jacc.2009.06.036; Li ZS, 2012, BIOCHEM PHARMACOL, V84, P821, DOI 10.1016/j.bcp.2012.06.020; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; McBride R, 2011, AM HEART J, V161, P538, DOI 10.1016/j.ahj.2010.12.007; McKenney J, 2010, J CLIN LIPIDOL, V4, P105, DOI 10.1016/j.jacl.2010.02.002; Meyers CD, 2004, CURR OPIN LIPIDOL, V15, P659, DOI 10.1097/00041433-200412000-00006; Michos ED, 2012, J AM COLL CARDIOL, V59, P2058, DOI 10.1016/j.jacc.2012.01.045; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Niesor EJ, 2010, J LIPID RES, V51, P3443, DOI 10.1194/jlr.M008706; Rensen PCN, 1997, J LIPID RES, V38, P1070; Sanford M, 2008, DRUGS, V68, P2373, DOI 10.2165/0003495-200868160-00008; Sharma M, 2011, CURR OPIN CARDIOL, V26, P420, DOI 10.1097/HCO.0b013e3283499ef1; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van der Hoorn JWA, 2009, BRIT J PHARMACOL, V156, P1067, DOI 10.1111/j.1476-5381.2008.00109.x; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Wang W, 2001, AM J PHYSIOL-ENDOC M, V280, pE540, DOI 10.1152/ajpendo.2001.280.3.E540; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129	46	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66467	10.1371/journal.pone.0066467	http://dx.doi.org/10.1371/journal.pone.0066467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840481	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200084
J	Manfrin, C; Tom, M; De Moro, G; Gerdol, M; Guarnaccia, C; Mosco, A; Pallavicini, A; Giulianini, PG				Manfrin, Chiara; Tom, Moshe; De Moro, Gianluca; Gerdol, Marco; Guarnaccia, Corrado; Mosco, Alessandro; Pallavicini, Alberto; Giulianini, Piero Giulio			Application of D-Crustacean Hyperglycemic Hormone Induces Peptidases Transcription and Suppresses Glycolysis-Related Transcripts in the Hepatopancreas of the Crayfish Pontastacus leptodactylus - Results of a Transcriptomic Study	PLOS ONE			English	Article							EYESTALK ABLATION; ASTACUS-LEPTODACTYLUS; KURUMA PRAWN; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ASPECTS; CANCER-PRODUCTUS; FAMILY PEPTIDES; CHH; ISOFORMS; GLAND	The crustacean Hyperglycemic Hormone (cHH) is a neuropeptide present in many decapods. Two different chiral isomers are simultaneously present in Astacid crayfish and their specific biological functions are still poorly understood. The present study is aimed at better understanding the potentially different effect of each of the isomers on the hepatopancreatic gene expression profile in the crayfish Pontastacus leptodactylus, in the context of short term hyperglycemia. Hence, two different chemically synthesized cHH enantiomers, containing either L- or D-Phe(3), were injected to the circulation of intermolt females following removal of their X organ-Sinus gland complex. The effects triggered by the injection of the two alternate isomers were detected after one hour through measurement of circulating glucose levels. Triggered changes of the transcriptome expression profile in the hepatopancreas were analyzed by RNA-seq. A whole transcriptome shotgun sequence assembly provided the assumedly complete transcriptome of P. leptodactylus hepatopancreas, followed by RNA-seq analysis of changes in the expression level of many genes caused by the application of each of the hormone isomers. Circulating glucose levels were much higher in response to the D-isoform than to the L-isoform injection, one hour from injection. Similarly, the RNA-seq analysis confirmed a stronger effect on gene expression following the administration of D-cHH, while just limited alterations were caused by the L-isomer. These findings demonstrated a more prominent short term effect of the D-cHH on the transcription profile and shed light on the effect of the D-isomer on specific functional gene groups. Another contribution of the study is the construction of a de novo assembly of the hepatopancreas transcriptome, consisting of 39,935 contigs, that dramatically increases the molecular information available for this species and for crustaceans in general, providing an efficient tool for studying gene expression patterns in this organ.	[Manfrin, Chiara; De Moro, Gianluca; Gerdol, Marco; Mosco, Alessandro; Pallavicini, Alberto; Giulianini, Piero Giulio] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Tom, Moshe] Israel Oceanog & Limnol Res, Haifa, Israel; [Guarnaccia, Corrado] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	University of Trieste; Israel Oceanographic & Limnological Research Institute; International Center for Genetic Engineering & Biotechnology (ICGEB)	Giulianini, PG (corresponding author), Univ Trieste, Dipartimento Sci Vita, Trieste, Italy.	giuliani@units.it	Gerdol, Marco/D-2115-2013; Pallavicini, Alberto/H-9281-2019; Pallavicini, Alberto/J-4158-2012	Gerdol, Marco/0000-0001-6411-0813; Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Giulianini, Piero Giulio/0000-0001-5356-7754; Mosco, Alessandro/0000-0002-4885-3665; De Moro, Gianluca/0000-0002-5542-0278	PRIN (Progetti di Ricerca di Interesse Nazionale), Ministero dell'Istruzione, dell'Universita e della Ricerca [20109XZEPR_002]	PRIN (Progetti di Ricerca di Interesse Nazionale), Ministero dell'Istruzione, dell'Universita e della Ricerca	This work was supported by PRIN (Progetti di Ricerca di Interesse Nazionale) 2010-11 Prot. 20109XZEPR_002, Ministero dell'Istruzione, dell'Universita e della Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2002, NOVART FDN SYMP, V247, P66; Avarre JC, 2001, GEN COMP ENDOCR, V124, P257, DOI 10.1006/gcen.2001.7710; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Balik Ismet, 2005, Turkish Journal of Zoology, V29, P295; Barim O, 2010, ECOTOX ENVIRON SAFE, V73, P138, DOI 10.1016/j.ecoenv.2009.08.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castro PF, 2012, J CRUSTACEAN BIOL, V32, P607, DOI 10.1163/193724012X634206; Ceccaldi H.J., 1989, AQUACULTURE, V9, P243, DOI DOI 10.1007/S00248-011-9936-2; CHANG ES, 1985, AM ZOOL, V25, P179; Chaves AR, 2000, COMP BIOCHEM PHYS A, V126, P407, DOI 10.1016/S1095-6433(00)00225-7; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Kleijn DPV, 1998, J ENDOCRINOL, V156, P291, DOI 10.1677/joe.0.1560291; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Fernandez-Pozo N, COMMUNICATION; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Giulianini Piero Giulio, 2006, P225; Giulianini PG, 2007, MICRON, V38, P49, DOI 10.1016/j.micron.2006.03.019; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harlioglu AG, 2012, FOOD SCI TECHNOL INT, V18, P93, DOI 10.1177/1082013211414261; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Hsu YWA, 2008, GEN COMP ENDOCR, V155, P517, DOI 10.1016/j.ygcen.2007.09.001; Hubenova Tania A., 2009, AACL Bioflux, V2, P261; JAMES MO, 1989, XENOBIOTICA, V19, P1063, DOI 10.3109/00498258909043162; Jia CX, 2012, MOL CELL PROTEOMICS, V11, P1951, DOI 10.1074/mcp.M112.020537; Jung Hyang-Jin, 2011, PLOS ONE, P6; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kawahara-Miki R, 2011, PLOS ONE, P6; Keller R, 1988, METABOLIC HORMONE CR, P315; Khayat M, 1998, GEN COMP ENDOCR, V110, P307, DOI 10.1006/gcen.1998.7078; Lebaupain F, 2012, PEPTIDES, V34, P65, DOI 10.1016/j.peptides.2012.01.019; Lee KJ, 2007, GEN COMP ENDOCR, V154, P174, DOI 10.1016/j.ygcen.2007.05.019; Malev O, 2010, COMP BIOCHEM PHYS C, V152, P433, DOI 10.1016/j.cbpc.2010.07.006; Mosco A, 2012, PLOS ONE, P7; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Nagai C, 2011, GEN COMP ENDOCR, V172, P293, DOI 10.1016/j.ygcen.2011.03.019; Okumura T, 2006, COMP BIOCHEM PHYS A, V143, P246, DOI 10.1016/j.cbpa.2005.12.002; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; Ollivaux C, 2009, FEBS J, V276, P4790, DOI 10.1111/j.1742-4658.2009.07180.x; Palacios E., 1999, Journal of Applied Aquaculture, V9, P1, DOI 10.1300/J028v09n03_01; Rivera-Perez C, 2010, AQUACULTURE, V300, P163, DOI 10.1016/j.aquaculture.2009.12.030; ROSAS C, 1993, COMP BIOCHEM PHYS A, V104, P183, DOI 10.1016/0300-9629(93)90027-2; Santos EA, 1997, PHYSIOL ZOOL, V70, P415, DOI 10.1086/515846; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; SEDLMEIER D, 1988, REGUL PEPTIDES, V20, P91, DOI 10.1016/0167-0115(88)90042-0; Serrano L, 2004, J HISTOCHEM CYTOCHEM, V52, P1129, DOI 10.1369/jhc.4A6292.2004; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; Soyez D, 2003, RECENT DATA CRUSTACE; Stemmler EA, 2007, GEN COMP ENDOCR, V154, P184, DOI 10.1016/j.ygcen.2007.06.025; Sudha K, 2007, J CRUSTACEAN BIOL, V27, P304, DOI 10.1651/S-2750.1; Susanto GN, 2001, J EXP ZOOL, V289, P433, DOI 10.1002/jez.1024; Team R. D. C, 2011, R LANG ENV STAT COMP; TESHIMA S, 1989, COMP BIOCHEM PHYS B, V92, P45, DOI 10.1016/0305-0491(89)90311-8; Tsutsui N, 2005, GEN COMP ENDOCR, V144, P232, DOI 10.1016/j.ygcen.2005.06.001; Tunca E, 2013, ARCH ENV CONTAM TOXI; Uawisetwathana U, 2011, PLOS ONE, P6; VANHERP F, 1978, AQUACULTURE, V14, P289, DOI 10.1016/0044-8486(78)90013-3; Venkitraman PR, 2008, ITAL J ZOOL, V75, P345, DOI 10.1080/11250000802255905; Vilella S, 2003, J COMP PHYSIOL B, V173, P679, DOI 10.1007/s00360-003-0379-z; VOGT G, 1989, HISTOCHEMISTRY, V91, P373, DOI 10.1007/BF00493824; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zmora N, 2009, SALINE SYSTEMS, P5	69	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65176	10.1371/journal.pone.0065176	http://dx.doi.org/10.1371/journal.pone.0065176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840318	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200011
J	Singh, SP; Agnihotri, P; Pratap, JV				Singh, Saurabh Pratap; Agnihotri, Pragati; Pratap, J. Venkatesh			Characterization of a Novel Putative S-Adenosylmethionine Decarboxylase-Like Protein from Leishmania donovani	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; ORNITHINE-DECARBOXYLASE; PUTRESCINE ACTIVATION; VISCERAL LEISHMANIASIS; ALLOSTERIC REGULATION; STRUCTURAL BASIS; BINDING; BRAZILIENSIS; INHIBITION; PREDICTION	In addition to the S-adenosylmethionine decarboxylase (AD) present in all organisms, trypanosomatids including Leishmania spp. possess an additional copy, annotated as the putative S-adenosylmethionine decarboxylase-like proenzyme (ADL). Phylogenetic analysis confirms that ADL is unique to trypanosomatids and has several unique features such as lack of autocatalytic cleavage and a distinct evolutionary lineage, even from trypanosomatid ADs. In Trypanosoma ADL was found to be enzymaticaly dead but plays an essential regulatory role by forming a heterodimer complex with AD. However, no structural or functional information is available about ADL from Leishmania spp. Here, in this study, we report the cloning, expression, purification, structural and functional characterization of Leishmania donovani (L. donovani) ADL using biophysical, biochemical and computational techniques. Biophysical studies show that, L. donovani ADL binds S-adenosylmethionine (SAM) and putrescine which are natural substrates of AD. Computational modeling and docking studies showed that in comparison to the ADs of other organisms including human, residues involved in putrescine binding are partially conserved while the SAM binding residues are significantly different. In silico protein-protein interaction study reveals that L. donovani ADL can interact with AD. These results indicate that L. donovani ADL posses a novel substrate binding property and may play an essential role in polyamine biosynthesis with a different mode of function from known proteins of the S-adenosylmethionine decarboxylase super family.	[Singh, Saurabh Pratap; Agnihotri, Pragati; Pratap, J. Venkatesh] Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Pratap, JV (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	jvpratap@cdri.res.in	Singh, Saurabh Pratap/AAI-2988-2020; Agnihotri, Pragati/AAA-3087-2019	Singh, Saurabh Pratap/0000-0001-7604-645X; Agnihotri, Pragati/0000-0003-3392-0594	CSIR network	CSIR network(Council of Scientific & Industrial Research (CSIR) - India)	Funding from CSIR network projects - "Genomics and Informatics Solutions for Integrating Biology (GENESIS)" and "Understanding the role of the Host molecule in Parasite Infection (HOPE)" is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Basselin M, 2000, MOL BIOCHEM PARASIT, V109, P37, DOI 10.1016/S0166-6851(00)00234-6; Bennett EM, 2002, BIOCHEMISTRY-US, V41, P14509, DOI 10.1021/bi026710u; Beswick TC, 2006, BIOCHEMISTRY-US, V45, P7797, DOI 10.1021/bi0603975; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clyne T, 2002, BIOCHEMISTRY-US, V41, P13207, DOI 10.1021/bi026541d; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Coutinho SG, 1996, EXP PARASITOL, V84, P144, DOI 10.1006/expr.1996.0100; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; Ekstrom JL, 2001, BIOCHEMISTRY-US, V40, P9495, DOI 10.1021/bi010736o; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; GILLIS D, 1995, PEDIATR INFECT DIS J, V14, P247, DOI 10.1097/00006454-199503000-00019; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Kandpal M, 1997, LIFE SCI, V60, P1793, DOI 10.1016/S0024-3205(97)00139-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinch LN, 1999, MOL BIOCHEM PARASIT, V101, P1, DOI 10.1016/S0166-6851(98)00181-9; Kinch LN, 2000, BIOCHEMISTRY-US, V39, P3336, DOI 10.1021/bi991493r; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krauth-Siegel Luise R., 2007, V44, P231; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; MACHADO ES, 1992, MEM I OSWALDO CRUZ, V87, P487, DOI 10.1590/S0074-02761992000400005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; METCALF BW, 1979, MOL PHARMACOL, V16, P539; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; PAINTER GR, 1991, J BIOL CHEM, V266, P19362; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PEGG AE, 1988, J BIOL CHEM, V263, P11008; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; Persson K, 1998, BIOCHEM J, V333, P527, DOI 10.1042/bj3330527; Picard-Jean F, 2007, BIOCHEM J, V407, P331, DOI 10.1042/BJ20070853; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Roberts SC, 2002, J BIOL CHEM, V277, P5902, DOI 10.1074/jbc.M110118200; Roberts SC, 2001, MOL BIOCHEM PARASIT, V115, P217, DOI 10.1016/S0166-6851(01)00293-6; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STANLEY BA, 1994, J BIOL CHEM, V269, P7901; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Tolbert WD, 2001, BIOCHEMISTRY-US, V40, P9484, DOI 10.1021/bi010735w; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Xiong HS, 1997, J BIOL CHEM, V272, P28342, DOI 10.1074/jbc.272.45.28342	55	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65912	10.1371/journal.pone.0065912	http://dx.doi.org/10.1371/journal.pone.0065912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840377	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200040
J	Tharadra, SK; Medina, A; Ray, A				Tharadra, Sana Khalid; Medina, Adriana; Ray, Anandasankar			Advantage of the Highly Restricted Odorant Receptor Expression Pattern in Chemosensory Neurons of Drosophila	PLOS ONE			English	Article							FEEDBACK-REGULATION ENSURES; GENE CHOICE; ANTENNAL LOBE; AVOIDANCE-BEHAVIOR; OLFACTORY NEURONS; SYSTEM; MOUSE; LARVA; CIRCUIT; TASTE	A fundamental molecular feature of olfactory systems is that individual neurons express only one receptor from a large odorant receptor gene family. While numerous theories have been proposed, the functional significance and evolutionary advantage of generating a sophisticated one-receptor-per neuron expression pattern is not well understood. Using the genetically tractable Drosophila melanogaster as a model, we demonstrate that the breakdown of this highly restricted expression pattern of an odorant receptor in neurons leads to a deficit in the ability to exploit new food sources. We show that animals with ectopic co-expression of odorant receptors also have a competitive disadvantage in a complex environment with limiting food sources. At the level of the olfactory system, we find changes in both the behavioral and electrophysiological responses to odorants that are detected by endogenous receptors when an olfactory receptor is broadly misexpressed in chemosensory neurons. Taken together these results indicate that restrictive expression patterns and segregation of odorant receptors to individual neuron classes are important for sensitive odor-detection and appropriate olfactory behaviors.	[Tharadra, Sana Khalid; Medina, Adriana; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	Whitehall Foundation	Whitehall Foundation	This work was partly funded by a grant given to Anandasankar Ray by the Whitehall Foundation (http://www.whitehall.org/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Jafari S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001280; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Serizawa S, 2005, CHEM SENSES, V30, pI99, DOI 10.1093/chemse/bjh133; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sim CK, 2012, GENE DEV, V26, P2483, DOI 10.1101/gad.201665.112; Stortkuhl KF, 2005, CHEM SENSES, V30, P81, DOI 10.1093/chemse/bji003; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Tom W, 2011, MOL CELL NEUROSCI, V46, P252, DOI 10.1016/j.mcn.2010.09.008; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	32	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66173	10.1371/journal.pone.0066173	http://dx.doi.org/10.1371/journal.pone.0066173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840419	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200058
J	Toseland, CP; Webb, MR				Toseland, Christopher P.; Webb, Martin R.			ATPase Mechanism of the 5'-3' DNA Helicase, RecD2 EVIDENCE FOR A PRE-HYDROLYSIS CONFORMATION CHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT NUCLEOTIDE ANALOGS; PHOSPHATE-BINDING PROTEIN; PCRA HELICASE; INORGANIC-PHOSPHATE; ESCHERICHIA-COLI; INITIATOR PROTEIN; RNA HELICASE; STRANDED-DNA; TRANSLOCATION; CYCLE	The superfamily 1 helicase, RecD2, is a monomeric, bacterial enzyme with a role in DNA repair, but with 5'-3' activity unlike most enzymes from this superfamily. Rate constants were determined for steps within the ATPase cycle of RecD2 in the presence of ssDNA. The fluorescent ATP analog, mantATP (2'(3')-O( N-methylanthraniloyl) ATP), was used throughout to provide a complete set of rate constants and determine the mechanism of the cycle for a single nucleotide species. Fluorescence stopped-flow measurements were used to determine rate constants for adenosine nucleotide binding and release, quenched-flow measurements were used for the hydrolytic cleavage step, and the fluorescent phosphate biosensor was used for phosphate release kinetics. Some rate constants could also be measured using the natural substrate, ATP, and these suggested a similar mechanism to that obtained with mantATP. The data show that a rearrangement linked to Mg2+ coordination, which occurs before the hydrolysis step, is rate-limiting in the cycle and that this step is greatly accelerated by bound DNA. This is also shown here for the PcrA 3'-5' helicase and so may be a general mechanism governing superfamily 1 helicases. The mechanism accounts for the tight coupling between translocation and ATPase activity.	[Toseland, Christopher P.; Webb, Martin R.] MRC Natl Inst Med Res, London NW7 1AA, England; [Toseland, Christopher P.] Univ Munich, Inst Zellulare Physiol, D-80336 Munich, Germany; [Toseland, Christopher P.] Univ Munich, Inst Physiol, Ctr NanoSci, D-80336 Munich, Germany	MRC National Institute for Medical Research; University of Munich; University of Munich	Webb, MR (corresponding author), MRC Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	mwebb@nimr.mrc.ac.uk	Toseland, Chris/AAC-8517-2019	Toseland, Chris/0000-0002-1641-7535; Webb, Martin/0000-0002-0134-9621	Medical Research Council, UK [U117512742]; MRC [MC_U117512742] Funding Source: UKRI; Medical Research Council [MC_U117512742] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council, UK Grant U117512742	Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cao WX, 2011, J MOL BIOL, V409, P399, DOI 10.1016/j.jmb.2011.04.004; Chisty LT, 2013, NUCLEIC ACIDS RES, V41, P5010, DOI 10.1093/nar/gkt194; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P3309, DOI 10.1021/bi00465a023; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Leatherbarrow R J, 2007, GRAFIT VERSION 6; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14550, DOI 10.1021/bi00252a023; Nixon AE, 1998, ANAL BIOCHEM, V265, P299, DOI 10.1006/abio.1998.2916; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Toseland CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038270; Toseland CP, 2011, METHODS MOL BIOL, V778, P161, DOI 10.1007/978-1-61779-261-8_11; Toseland CP, 2010, METHODS, V51, P259, DOI 10.1016/j.ymeth.2010.02.012; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Webb Martin R., 2003, P131; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334	33	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25183	25193		10.1074/jbc.M113.484667	http://dx.doi.org/10.1074/jbc.M113.484667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839989	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000330619000018
J	Dias, J; Renault, L; Perez, J; Mirande, M				Dias, Jose; Renault, Louis; Perez, Javier; Mirande, Marc			Small-angle X-ray Solution Scattering Study of the Multi-aminoacyl-tRNA Synthetase Complex Reveals an Elongated and Multi-armed particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; EUKARYOTIC MULTISYNTHETASE COMPLEX; LEUCYL-TRANSFER RNA; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; MULTIENZYME COMPLEX; ELECTRON-MICROSCOPY; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; BINDING DOMAIN	In animal cells, nine aminoacyl-tRNA synthetases are associated with the three auxiliary proteins p18, p38, and p43 to form a stable and conserved large multi-aminoacyl-tRNA synthetase complex (MARS), whose molecular mass has been proposed to be between 1.0 and 1.5 MDa. The complex acts as a molecular hub for coordinating protein synthesis and diverse regulatory signal pathways. Electron microscopy studies defined its low resolution molecular envelope as an overall rather compact, asymmetric triangular shape. Here, we have analyzed the composition and homogeneity of the native mammalian MARS isolated from rabbit liver and characterized its overall internal structure, size, and shape at low resolution by hydrodynamic methods and small-angle x-ray scattering in solution. Our data reveal that the MARS exhibits a much more elongated and multi-armed shape than expected from previous reports. The hydrodynamic and structural features of the MARS are large compared with other supramolecular assemblies involved in translation, including ribosome. The large dimensions and non-compact structural organization of MARS favor a large protein surface accessibility for all its components. This may be essential to allow structural rearrangements between the catalytic and cis-acting tRNA binding domains of the synthetases required for binding the bulky tRNA substrates. This non-compact architecture may also contribute to the spatiotemporal controlled release of some of its components, which participate in non-canonical functions after dissociation from the complex.	[Dias, Jose; Renault, Louis; Mirande, Marc] CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Perez, Javier] Orme Merisiers St Aubin, SOLEIL Synchrotron, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Renault, L (corresponding author), CNRS, Ctr Rech Gif, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Louis.Renault@lebs.cnrs-gif.fr; Marc.Mirande@lebs.cnrs-gif.fr		Dias, Jose/0000-0002-7625-0618; RENAULT, Louis/0000-0003-1722-074X	Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer; Agence Nationale de Recherche sur le SIDA	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique, the Association pour la Recherche sur le Cancer, and the Agence Nationale de Recherche sur le SIDA.	Agou F, 1996, J BIOL CHEM, V271, P29295, DOI 10.1074/jbc.271.46.29295; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GULIK A, 1984, MOL BIOL REP, V10, P23, DOI 10.1007/BF00775150; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; JOHNSON DL, 1981, P NATL ACAD SCI-BIOL, V78, P4059, DOI 10.1073/pnas.78.7.4059; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; Kim K. R., 2013, PROTEINS, DOI [10.1002/prot.24306, DOI 10.1002/PR0T.24306]; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim Y, 2000, J BIOL CHEM, V275, P27062; Koehler C, 2013, NUCLEIC ACIDS RES, V41, P667, DOI 10.1093/nar/gks1072; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; Norcum MT, 1999, J BIOL CHEM, V274, P12205, DOI 10.1074/jbc.274.18.12205; Norcum MT, 2002, FEBS LETT, V512, P298, DOI 10.1016/S0014-5793(02)02262-7; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Norcum MT, 1999, FEBS LETT, V447, P217; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019	64	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23979	23989		10.1074/jbc.M113.489922	http://dx.doi.org/10.1074/jbc.M113.489922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836901	hybrid, Green Published			2022-12-25	WOS:000330611400036
J	Ozkan-Dagliyan, I; Chiou, YY; Ye, R; Hassan, BH; Ozturk, N; Sancar, A				Ozkan-Dagliyan, Irem; Chiou, Yi-Ying; Ye, Rui; Hassan, Bachar H.; Ozturk, Nuri; Sancar, Aziz			Formation of Arabidopsis Cryptochrome 2 Photobodies in Mammalian Nuclei APPLICATION AS AN OPTOGENETIC DNA DAMAGE CHECKPOINT SWITCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT INTERACTION; BLUE-LIGHT; COP1 ACTIVITY; PROTEIN; PHYTOCHROME; MECHANISMS; CRY2; SPA1; PHOSPHORYLATION; DEGRADATION	Nuclear bodies are discrete suborganelle structures that perform specialized functions in eukaryotic cells. In plant cells, light can induce de novo formation of nuclear bodies called photobodies (PBs) composed of the photosensory pigments, phytochrome (PHY) or cryptochrome (CRY). The mechanisms of formation, the exact compositions, and the functions of plant PBs are not known. Here, we have expressed Arabidopsis CRY2 (AtCRY2) in mammalian cells and analyzed its fate after blue light exposure to understand the requirements for PB formation, the functions of PBs, and their potential use in cell biology. We found that light efficiently induces AtCRY2-PB formation in mammalian cells, indicating that, other than AtCRY2, no plant-specific proteins or nucleic acids are required for AtCRY2-PB formation. Irradiation of AtCRY2 led to its degradation; however, degradation was not dependent upon photobody formation. Furthermore, we found that AtCRY2 photobody formation is associated with light-stimulated interaction with mammalian COP1 E3 ligase. Finally, we demonstrate that by fusing AtCRY2 to the TopBP1 DNA damage checkpoint protein, light-induced AtCRY2 PBs can be used to activate DNA damage signaling pathway in the absence of DNA damage.	[Ozkan-Dagliyan, Irem; Chiou, Yi-Ying; Ye, Rui; Hassan, Bachar H.; Ozturk, Nuri; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011; 邱, 奕穎/E-8593-2018	Ozturk, Nuri/0000-0001-5206-4127; 邱, 奕穎/0000-0002-8742-8848	National Institutes of Health [GM31082, GM032833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031082, R37GM031082, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31082 and GM032833 (to A. S.).	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Gu NN, 2012, MOL PLANT, V5, P85, DOI 10.1093/mp/ssr052; Hassan BH, 2013, J BIOL CHEM, V288, P18903, DOI 10.1074/jbc.M113.475517; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Liu B, 2011, GENE DEV, V25, P1029, DOI 10.1101/gad.2025011; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Van Buskirk EK, 2012, PLANT PHYSIOL, V158, P52, DOI 10.1104/pp.111.186411; Wang HY, 1999, CURR BIOL, V9, P711, DOI 10.1016/S0960-9822(99)80314-5; Weidler G, 2012, PLANT CELL, V24, P2610, DOI 10.1105/tpc.112.098210; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yu XH, 2009, PLANT CELL, V21, P118, DOI 10.1105/tpc.108.061663; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384; Zuo ZC, 2012, MOL PLANT, V5, P726, DOI 10.1093/mp/sss007; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	32	29	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23244	23251		10.1074/jbc.M113.493361	http://dx.doi.org/10.1074/jbc.M113.493361			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23833191	Green Published, hybrid			2022-12-25	WOS:000330598200031
J	Carcagno, S; Semal, C; Demany, L				Carcagno, Samuele; Semal, Catherine; Demany, Laurent			No Need for Templates in the Auditory Enhancement Effect	PLOS ONE			English	Article							INFERIOR COLLICULUS; SPECTRAL AMPLITUDE; FREQUENCY; MASKING; ADAPTATION; HEARING; NOISE	The audibility of a target tone in a multitone background masker is enhanced by the presentation of a precursor sound consisting of the masker alone. There is evidence that precursor-induced neural adaptation plays a role in this perceptual enhancement. However, the precursor may also be strategically used by listeners as a spectral template of the following masker to better segregate it from the target. In the present study, we tested this hypothesis by measuring the audibility of a target tone in a multitone masker after the presentation of precursors which, in some conditions, were made dissimilar to the masker by gating their components asynchronously. The precursor and the following sound were presented either to the same ear or to opposite ears. In either case, we found no significant difference in the amount of enhancement produced by synchronous and asynchronous precursors. In a second experiment, listeners had to judge whether a synchronous multitone complex contained exactly the same tones as a preceding precursor complex or had one tone less. In this experiment, listeners performed significantly better with synchronous than with asynchronous precursors, showing that asynchronous precursors were poorer perceptual templates of the synchronous multitone complexes. Overall, our findings indicate that precursor-induced auditory enhancement cannot be fully explained by the strategic use of the precursor as a template of the following masker. Our results are consistent with an explanation of enhancement based on selective neural adaptation taking place at a central locus of the auditory system.	[Carcagno, Samuele] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France; Univ Bordeaux 2, Neurophysiol Lab, CNRS, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Carcagno, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France.	samuele.carcagno@u-bordeaux2.fr	Carcagno, Samuele/H-4015-2019; Semal, Catherine/D-8592-2014; Demany, Laurent/D-7984-2014	Carcagno, Samuele/0000-0002-1868-5795; Semal, Catherine/0000-0002-2075-6265; Demany, Laurent/0000-0001-5549-9628	Agence Nationale de la Recherche (LEAP, Programme Blanc)	Agence Nationale de la Recherche (LEAP, Programme Blanc)(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr; LEAP, Programme Blanc 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne AJ, 2011, J ACOUST SOC AM, V129, P2088, DOI 10.1121/1.3552880; Carcagno S., BASIC ASPEC IN PRESS; Carcagno S, 2012, JARO-J ASSOC RES OTO, V13, P693, DOI 10.1007/s10162-012-0339-y; CARLYON RP, 1989, HEARING RES, V41, P223, DOI 10.1016/0378-5955(89)90014-2; Erviti M, 2011, J ACOUST SOC AM, V129, P3837, DOI 10.1121/1.3589257; Guinan JJ, 2011, SPRINGER HANDB AUDIT, V38, P39, DOI 10.1007/978-1-4419-7070-1_3; Hicks ML, 1999, J ACOUST SOC AM, V105, P326, DOI 10.1121/1.424526; HOLM S, 1979, SCAND J STAT, V6, P65; Kidd G, 2011, J ACOUST SOC AM, V130, P3926, DOI 10.1121/1.3658442; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lilaonitkul W, 2012, J NEUROPHYSIOL, V107, P1598, DOI 10.1152/jn.00549.2011; Lilaonitkul W, 2009, JARO-J ASSOC RES OTO, V10, P459, DOI 10.1007/s10162-009-0163-1; Lilaonitkul W, 2009, J NEUROPHYSIOL, V101, P1394, DOI 10.1152/jn.90925.2008; Moore B. C. J., 1995, HDB PERCEPTION COGNI, V6, P387, DOI DOI 10.1016/B978-012505626-7/50013-3; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Nelson PC, 2010, J NEUROSCI, V30, P6577, DOI 10.1523/JNEUROSCI.0277-10.2010; PALMER AR, 1995, J ACOUST SOC AM, V97, P1786, DOI 10.1121/1.412055; POPELAR J, 1982, ACTA NEUROBIOL EXP, V42, P299; Richards VM, 2004, J ACOUST SOC AM, V116, P2278, DOI 10.1121/1.1784433; Schouten JF, 1940, P K NED AKAD WETENSC, V43, P356; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; Strickland EA, 2004, J ACOUST SOC AM, V115, P2234, DOI 10.1121/1.1691036; SUMMERFIELD Q, 1984, PERCEPT PSYCHOPHYS, V35, P203, DOI 10.3758/BF03205933; SUMMERFIELD Q, 1987, J ACOUST SOC AM, V81, P700, DOI 10.1121/1.394838; THIBODEAU LM, 1991, J ACOUST SOC AM, V89, P2843, DOI 10.1121/1.400722; Viemeister N.F., BASIC ASPEC IN PRESS; Viemeister N.F., 1980, PSYCHOPHYSICAL PHYSL, P190, DOI DOI 10.1007/978-94-009-9144-6_28; VIEMEISTER NF, 1982, J ACOUST SOC AM, V71, P1502, DOI 10.1121/1.387849; Walsh KP, 2010, J ACOUST SOC AM, V127, P955, DOI 10.1121/1.3279832; WRIGHT BA, 1992, PHILOS T ROY SOC B, V336, P325, DOI 10.1098/rstb.1992.0065	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67874	10.1371/journal.pone.0067874	http://dx.doi.org/10.1371/journal.pone.0067874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826348	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000321150000103
J	Chen, GQ; Liu, XH; Zhang, LL; Cao, HJ; Lu, JP; Lin, FC				Chen, Guoqing; Liu, Xiaohong; Zhang, Lilin; Cao, Huijuan; Lu, Jianping; Lin, Fucheng			Involvement of MoVMA11, a Putative Vacuolar ATPase c ' Subunit, in Vacuolar Acidification and Infection-Related Morphogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; GENES-ENCODING SUBUNITS; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; APPRESSORIUM TURGOR; CATALYTIC SUBUNIT; CYTOSOLIC PH; PROTON PUMPS	Many functions of vacuole depend on the activity of vacuolar ATPase which is essential to maintain an acidic lumen and create the driving forces for massive fluxes of ions and metabolites through vacuolar membrane. In filamentous fungus Magnaporthe oryzae, subcellular colocalization and quinacrine staining suggested that the V1V0 domains of V-ATPase were fully assembled and the vacuoles were kept acidic during infection-related developments. Targeted gene disruption of MoVMA11 gene, encoding the putative c' subunit of V-ATPase, impaired vacuolar acidification and mimicked the phenotypes of yeast V-ATPase mutants in the poor colony morphology, abolished asexual and sexual reproductions, selective carbon source utilization, and increased calcium and heavy metals sensitivities, however, not in the typical pH conditional lethality. Strikingly, aerial hyphae of the MoVMA11 null mutant intertwined with each other to form extremely thick filamentous structures. The results also implicated that MoVMA11 was involved in cell wall integrity and appressorium formation. Abundant non-melanized swollen structures and rare, small appressoria without penetration ability were produced at the hyphal tips of the Delta Movma11 mutant on onion epidermal cells. Finally, the MoVMA11 null mutant lost pathogenicity on both intact and wounded host leaves. Overall, our data indicated that MoVMA11, like other fungal VMA genes, is associated with numerous cellular functions and highlighted that V-ATPase is essential for infection-related morphogenesis and pathogenesis in M. oryzae.	[Chen, Guoqing; Liu, Xiaohong; Cao, Huijuan; Lin, Fucheng] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Lilin; Lu, Jianping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Fucheng] Zhengzhou Tobacco Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou Tobacco Research Institute of CNTC	Lin, FC (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fuchenglin@zju.edu.cn	Lin, Fucheng/ABE-7591-2021; Lu, Jianping/AFL-6811-2022; Chen, Guoqing/W-5308-2019	Lin, Fucheng/0000-0002-4127-8143; Lu, Jianping/0000-0001-9601-0040; Chen, Guoqing/0000-0002-8448-6938	National Natural Science Foundation of China [30925029, 31000077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grants (No. 30925029 and 31000077) funded by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Chavez C, 2006, J BIOL CHEM, V281, P27052, DOI 10.1074/jbc.M603883200; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Dou XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016439; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forster C, 1999, J BIOL CHEM, V274, P9442, DOI 10.1074/jbc.274.14.9442; Gao HM, 2013, RES MICROBIOL, V164, P300, DOI 10.1016/j.resmic.2013.01.001; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Graham LA, 2000, J EXP BIOL, V203, P61; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2000, J EXP BIOL, V203, P81; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kuroki Y, 2002, FEMS MICROBIOL LETT, V209, P277, DOI 10.1016/S0378-1097(02)00551-7; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lichter A, 1998, FUNGAL GENET BIOL, V25, P63, DOI 10.1006/fgbi.1998.1087; Liu TB, 2008, J ZHEJIANG UNIV-SC B, V9, P811, DOI 10.1631/jzus.B0860011; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Melin P, 2004, MICROBIOL-SGM, V150, P743, DOI 10.1099/mic.0.26807-0; Mitchell TK, 2003, NEW PHYTOL, V159, P53, DOI 10.1046/j.1469-8137.2003.00787.x; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohneda M, 2002, FUNGAL GENET BIOL, V37, P29, DOI 10.1016/S1087-1845(02)00033-6; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Powell AJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-147; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rho HS, 2001, MOL CELLS, V12, P407; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schachtschabel D, 2012, FUNGAL GENET BIOL, V49, P284, DOI 10.1016/j.fgb.2011.12.008; Strasser B, 2011, EMBO J, V30, P4126, DOI 10.1038/emboj.2011.335; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; VALENT B, 1991, GENETICS, V127, P87; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Veses V, 2008, CURR OPIN MICROBIOL, V11, P503, DOI 10.1016/j.mib.2008.09.017; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	70	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67804	10.1371/journal.pone.0067804	http://dx.doi.org/10.1371/journal.pone.0067804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826342	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000099
J	Hu, JR; Li, Y; Li, P				Hu, Jianran; Li, Yu; Li, Ping			MARVELD1 Inhibits Nonsense-Mediated RNA Decay by Repressing Serine Phosphorylation of UPF1	PLOS ONE			English	Article							EXON-JUNCTION COMPLEX; SURVEILLANCE COMPLEX; PROTEIN; TRANSLATION; EXPRESSION; BINDING; IDENTIFICATION; NMD	We have observed low expression levels of MARVELD1, a novel tumor repressor, in multiple tumors; however, its function in normal cells has not been explored. We recently reported that MARVELD1 interacts with importin beta 1, which plays an important role in nonsense-mediated RNA decay(NMD). Here, we demonstrate that MARVELD1 substantially inhibits nonsense-mediated RNA decay by decreasing the pioneer round of translation but not steady-state translation, and we identify MARVELD1 as an important component of the molecular machinery containing UPF1 and Y14. Furthermore, we determined the specific regions of MARVELD1 and UPF1 responsible for their interaction. We also showed that MARVELD1 promotes the dissociation of SMG1 from UPF1, resulting in the repression of serine phosphorylation of UPF1, and subsequently blocks the recruitment of SMG5, which is required for ensuing SMG5-mediated exonucleolytic decay. Our observations provide molecular insight into the potential function of MARVELD1 in nonsense-mediated RNA decay.	[Hu, Jianran; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Li, Ping] Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@126.com		, Ping/0000-0002-7741-1321				Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cho H, 2013, NUCLEIC ACIDS RES, V41, P1319, DOI 10.1093/nar/gks1222; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Fiorini F, 2013, NUCLEIC ACIDS RES, V41, P1; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shigeoka T, 2012, NUCLEIC ACIDS RES, V40, P6887, DOI 10.1093/nar/gks344; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Wang D, 2011, J BIOL CHEM, V286, P40038, DOI 10.1074/jbc.M111.266361; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Wang Shan, 2009, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V25, P735; Wang S, 2009, CANCER LETT, V282, P77, DOI 10.1016/j.canlet.2009.03.008; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yu YT, 2012, CANCER SCI, V103, P716, DOI 10.1111/j.1349-7006.2012.02220.x; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3	30	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68291	10.1371/journal.pone.0068291	http://dx.doi.org/10.1371/journal.pone.0068291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826386	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000139
J	Roche, LM; Kromschroeder, L; Atwill, ER; Dahlgren, RA; Tate, KW				Roche, Leslie M.; Kromschroeder, Lea; Atwill, Edward R.; Dahlgren, Randy A.; Tate, Kenneth W.			Water Quality Conditions Associated with Cattle Grazing and Recreation on National Forest Lands	PLOS ONE			English	Article							WESTERN SIERRA-NEVADA; ESCHERICHIA-COLI; ORGANIC NITROGEN; MANAGEMENT STRATEGIES; INDICATOR BACTERIA; FECAL-COLIFORM; SURFACE RUNOFF; STREAM; PERSISTENCE; TRANSPORT	There is substantial concern that microbial and nutrient pollution by cattle on public lands degrades water quality, threatening human and ecological health. Given the importance of clean water on multiple-use landscapes, additional research is required to document and examine potential water quality issues across common resource use activities. During the 2011 grazing-recreation season, we conducted a cross sectional survey of water quality conditions associated with cattle grazing and/or recreation on 12 public lands grazing allotments in California. Our specific study objectives were to 1) quantify fecal indicator bacteria (FIB; fecal coliform and E. coli), total nitrogen, nitrate, ammonium, total phosphorus, and soluble-reactive phosphorus concentrations in surface waters; 2) compare results to a) water quality regulatory benchmarks, b) recommended maximum nutrient concentrations, and c) estimates of nutrient background concentrations; and 3) examine relationships between water quality, environmental conditions, cattle grazing, and recreation. Nutrient concentrations observed throughout the grazing-recreation season were at least one order of magnitude below levels of ecological concern, and were similar to U. S. Environmental Protection Agency (USEPA) estimates for background water quality conditions in the region. The relative percentage of FIB regulatory benchmark exceedances widely varied under individual regional and national water quality standards. Relative to USEPA's national E. coli FIB benchmarks-the most contemporary and relevant standards for this study-over 90% of the 743 samples collected were below recommended criteria values. FIB concentrations were significantly greater when stream flow was low or stagnant, water was turbid, and when cattle were actively observed at sampling. Recreation sites had the lowest mean FIB, total nitrogen, and soluble-reactive phosphorus concentrations, and there were no significant differences in FIB and nutrient concentrations between key grazing areas and non-concentrated use areas. Our results suggest cattle grazing, recreation, and provisioning of clean water can be compatible goals across these national forest lands.	[Roche, Leslie M.; Kromschroeder, Lea; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Dahlgren, Randy A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056; Dahlgren, Randy/0000-0002-8961-875X	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by USDA Forest Service, Pacific Southwest Region. The funders did provide field data collection assistance. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Ahearn DS, 2004, J HYDROL, V295, P47, DOI 10.1016/j.jhydrol.2004.02.016; Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Allan J.D., 2021, STREAM ECOLOGY STRUC, DOI DOI 10.1007/978-3-030-61286-3; Alm EW, 2006, J GREAT LAKES RES, V32, P401, DOI 10.3394/0380-1330(2006)32[401:PAPGOT]2.0.CO;2; [Anonymous], 2000, AMBIENT WATER QUALIT; [Anonymous], 2008, SOIL SURVEY GEOGRAPH; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Bernal S, 2005, BIOGEOCHEMISTRY, V75, P351, DOI 10.1007/s10533-005-1246-7; BLM, 1999, UT STUD RES MEAS; Brunson MW, 1996, J RANGE MANAGE, V49, P69, DOI 10.2307/4002728; Byappanahalli Muruleedhara N., 2006, Journal of Water and Health, V4, P313, DOI 10.2166/wh.2006.018; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Campbell JL, 2000, BIOGEOCHEMISTRY, V49, P123, DOI 10.1023/A:1006383731753; Clark ML, 2000, 004198 US GEOL SURV; Clary WP, 2000, J RANGE MANAGE, V53, P562, DOI 10.2307/4003148; Cline C, 1973, EFFECTS FOREST FERTI; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; CVRWQCB, 2011, WAT QUAL CONTR PLAN; Dahlgren R. A., 2004, Environmental instrumentation and analysis handbook, P547, DOI 10.1002/0471473332.ch25; Delcurto T, 2005, RANGELAND ECOL MANAG, V58, P119, DOI 10.2111/1551-5028(2005)58&lt;119:MSFSBC&gt;2.0.CO;2; Derlet RW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/760108; Derlet RW, 2006, WILD ENVIRON MED, V17, P15, DOI 10.1580/PR05-05.1; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; DORAN JW, 1981, J SOIL WATER CONSERV, V36, P166; Eaton A. D., 2005, STANDARD METHODS EXA; Edwards DR, 1997, T ASAE, V40, P103, DOI 10.13031/2013.21254; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; GARY HL, 1983, J SOIL WATER CONSERV, V38, P124; Gentner BJ, 2002, J RANGE MANAGE, V55, P2, DOI 10.2307/4003256; George MR, 2011, CONSERVATION BENEFIT, P213; Green MB, 2006, J AM WATER RESOUR AS, V42, P659, DOI 10.1111/j.1752-1688.2006.tb04483.x; Hill BH, 2010, FRESHWATER BIOL, V55, P1005, DOI 10.1111/j.1365-2427.2009.02337.x; Huntsinger L., 2010, PASTORALISM, V1, P9; Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040; Jamieson RC, 2003, WATER QUAL RES J CAN, V38, P33, DOI 10.2166/wqrj.2003.004; Kaushal SS, 2005, BIOGEOCHEMISTRY, V74, P303, DOI 10.1007/s10533-004-4723-5; Knox AK, 2007, CALIF AGR, V61, P159, DOI 10.3733/ca.v061n04p159; Krupa M, 2011, AGR ECOSYST ENVIRON, V144, P290, DOI 10.1016/j.agee.2011.09.004; LAU YL, 1993, WATER RES, V27, P355, DOI 10.1016/0043-1354(93)90034-F; LEONARD RL, 1979, ECOL MONOGR, V49, P281, DOI 10.2307/1942486; Lewis DJ, 2009, WATER SCI TECHNOL, V60, P1731, DOI 10.2166/wst.2009.561; Long JS, 1997, REGRESSION MODELS CA; LRWQCB, 2005, WAT QUAL CONTR PLAN; MACDONALD LH, 1991, 910991001 US EPA; Mackenthun K. M., 1973, CLEANER AQUATIC ENV; Miller WW, 2005, WATER AIR SOIL POLL, V163, P3, DOI 10.1007/s11270-005-7473-7; Myers L., 2012, Journal of Environmental Protection, V3, P823; North Coast Regional Water Quality Control Board (NCRWQCB), 2011, WAT QUAL CONTR PLAN; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porath ML, 2002, J ANIM SCI, V80, P346; Puckett M, 2002, QUALITY ASSURANCE MA; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Roche LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035734; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SCHEPERS JS, 1982, J ENVIRON QUAL, V11, P351, DOI 10.2134/jeq1982.00472425001100030005x; Schnabel WE, 2010, J COLD REG ENG, V24, P54, DOI 10.1061/(ASCE)CR.1943-5495.0000013; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; StataCorp, 2019, STATA STAT SOFTWARE; STEPHENSON GR, 1982, J RANGE MANAGE, V35, P119, DOI 10.2307/3898537; Sulak A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P43; Tate KW, 2007, ENVIRON MONIT ASSESS, V124, P289, DOI 10.1007/s10661-006-9226-5; TAYLOR FR, 1989, GREAT BASIN NAT, V49, P491; TIEDEMANN AR, 1987, J RANGE MANAGE, V40, P322, DOI 10.2307/3898729; USEPA, 1986, QUAL CRIT WAT; USEPA, 1987, SURF WAT MON FRAM CH; USEPA, 2012, RECREATIONAL WATER Q; USFS, 1995, SHAST TRIN NAT FOR L; USFS, 2004, 2004 SIERR NEV FOR P; USFS, 2011, GRAZ STAT SUMM FISC; USFS, 2009, CALVEG 2000 USDA FOR; USFS, 1990, TAH NAT FOR LAND RES; USFS, 2012, NAT VIS US MON RES U, VUSDA Forest Service; USFS, 1988, PLUM NAT FOR LAND RE; USFS, 2010, KLAM NAT FOR LAND RE; USFS, 2010, STAN NAT FOR LAND RE; van Verseveld WJ, 2008, J HYDROL, V358, P268, DOI 10.1016/j.jhydrol.2008.06.009; VANDONSEL DJ, 1971, WATER RES, V5, P1079, DOI 10.1016/0043-1354(71)90040-6; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; YU ZS, 1994, COMMUN SOIL SCI PLAN, V25, P3161, DOI 10.1080/00103629409369255	84	29	30	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68127	10.1371/journal.pone.0068127	http://dx.doi.org/10.1371/journal.pone.0068127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826370	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000124
J	Sharma, M; Kumar, L; Jain, A; Verma, V; Sharma, V; Kushwaha, B; Lal, N; Kumar, L; Rawat, T; Dwivedi, AK; Maikhuri, JP; Sharma, VL; Gupta, G				Sharma, Monika; Kumar, Lokesh; Jain, Ashish; Verma, Vikas; Sharma, Vikas; Kushwaha, Bhavana; Lal, Nand; Kumar, Lalit; Rawat, Tara; Dwivedi, Anil K.; Maikhuri, Jagdamba P.; Sharma, Vishnu L.; Gupta, Gopal			Designed Chemical Intervention with Thiols for Prophylactic Contraception	PLOS ONE			English	Article							NON-DETERGENT SPERMICIDES; TRICHOMONAS-VAGINALIS; SPERM MOTILITY; IN-VITRO; ANAEROBIC PROTOZOA; DISULFIDE ESTERS; POTENT; AGENTS; METRONIDAZOLE; NITAZOXANIDE	Unlike somatic cells, sperm have several-fold more available-thiols that are susceptible to redox-active agents. The present study explains the mechanism behind the instant sperm-immobilizing and trichomonacidal activities of pyrrolidinium pyrrolidine-1-carbodithioate (PPC), a novel thiol agent rationally created for prophylactic contraception by minor chemical modifications of some known thiol drugs. PPC, and its three derivatives (with potential active-site blocked by alkylation), were synthesized and evaluated against live human sperm and metronidazole-susceptible and resistant Trichomonas vaginalis, in vitro. Sperm hexokinase activity was evaluated by coupled enzyme assay. PPC irreversibly immobilized 100% human sperm in similar to 30 seconds and totally eliminated Trichomonas vaginalis more efficiently than nonoxynol-9 and metronidazole. It significantly inhibited (P<0.001) thiol-sensitive sperm hexokinase. However, the molecule completely lost all its biological activities once its thiol group was blocked by alkylation. PPC was subsequently formulated into a mucoadhesive vaginal film using GRaS excipients and evaluated for spermicidal and microbicidal activities (in vitro), and contraceptive efficacy in rabbits. PPC remained fully active in quick-dissolving, mucoadhesive vaginal-film formulation, and these PPC-films significantly reduced pregnancy and fertility rates in rabbits. The films released similar to 90% of PPC in simulated vaginal fluid (pH 4.2) at 37 degrees C in 5 minutes, in vitro. We have thus discovered a common target (reactive thiols) on chiefly-anaerobic, redox-sensitive cells like sperm and Trichomonas, which is susceptible to designed chemical interference for prophylactic contraception. The active thiol in PPC inactivates sperm and Trichomonas via interference with crucial sulfhydryl-disulfide based reactions, e. g. hexokinase activation in human sperm. In comparison to non-specific surfactant action of OTC spermicide nonoxynol-9, the action of thiol-active PPC is apparently much more specific, potent and safe. PPC presents a proof-of-concept for prophylactic contraception via manipulation of thiols in vagina for selective targeting of sperm and Trichomonas, and qualifies as a promising lead for the development of dually protective vaginal-contraceptive.	[Sharma, Monika; Kumar, Lokesh; Jain, Ashish; Verma, Vikas; Sharma, Vikas; Kushwaha, Bhavana; Maikhuri, Jagdamba P.; Gupta, Gopal] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Lal, Nand; Kumar, Lalit; Rawat, Tara; Sharma, Vishnu L.] CSIR Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India; [Dwivedi, Anil K.] CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Gupta, G (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	gupta.gopal@rediffmail.com	Jain, Ashish/GOJ-9782-2022; Kumar, Lokesh/AAB-6852-2019; Kushwaha, Bhavana/T-8371-2019	Jain, Ashish/0000-0003-4053-9265; Kumar, Lokesh/0000-0001-7073-9618; dwivedi, monika/0000-0001-6158-8096	University Grants Commission, New Delhi; Indian Council of Medical Research, New Delhi; Council of Scientific and Industrial Research, New Delhi, India; CSIR Network Project (PROGRAM); Ministry of Health and Family Welfare, Government of India	University Grants Commission, New Delhi(University Grants Commission, India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Network Project (PROGRAM); Ministry of Health and Family Welfare, Government of India	Authors acknowledge the grant of research fellowships by the University Grants Commission, New Delhi (LK, VS, NL), the Indian Council of Medical Research, New Delhi (VV, AJ) and the Council of Scientific and Industrial Research, New Delhi (LK), India. VV is enrolled with the Integral University, Lucknow, India, for PhD. This study was supported by grants from the CSIR Network Project (PROGRAM) and Ministry of Health and Family Welfare, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adagu IS, 2002, J ANTIMICROB CHEMOTH, V49, P103, DOI 10.1093/jac/49.1.103; Bach SP, 2000, GASTROENTEROLOGY, V118, P81, DOI 10.1016/S0016-5085(00)70416-1; Castle PE, 1998, CONTRACEPTION, V58, P51, DOI 10.1016/S0010-7824(98)00059-6; Damme VL, 2002, LANCET, V360, P971; duBouchet L, 1998, SEX TRANSM DIS, V25, P176, DOI 10.1097/00007435-199803000-00012; Dwivedi AK, 2007, BIOORGAN MED CHEM, V15, P6642, DOI 10.1016/j.bmc.2007.08.024; Gupta G, 2005, HUM REPROD, V20, P2301, DOI 10.1093/humrep/dei041; HOMM RE, 1976, CONTRACEPTION, V13, P479, DOI 10.1016/S0010-7824(76)80033-9; Jain A, 2011, ANTIMICROB AGENTS CH, V55, P4343, DOI 10.1128/AAC.00199-11; Jain RK, 2007, HUM REPROD, V22, P708, DOI 10.1093/humrep/del448; Jain RK, 2010, HUM REPROD, V25, P1165, DOI 10.1093/humrep/deq036; Jain RK, 2009, HUM REPROD, V24, P590, DOI 10.1093/humrep/den415; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kumar L, 2011, BIOORG MED CHEM LETT, V21, P176, DOI 10.1016/j.bmcl.2010.11.042; Kumar STVSK, 2006, BIOORGAN MED CHEM, V14, P6593, DOI 10.1016/j.bmc.2006.06.003; MACLEOD J, 1951, J GEN PHYSIOL, V34, P705, DOI 10.1085/jgp.34.5.705; MERCADO E, 1976, BIOL REPROD, V14, P632, DOI 10.1095/biolreprod14.5.632; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nakamura N, 2008, BIOL REPROD, V79, P537, DOI 10.1095/biolreprod.108.067561; NESBAKKEN R, 1963, BIOCHEM J, V87, P526, DOI 10.1042/bj0870526; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; Sobel J. D., 2001, Clinical Infectious Diseases, V33, P1341, DOI 10.1086/323034; Somers PK, 2000, FREE RADICAL BIO MED, V28, P1532, DOI 10.1016/S0891-5849(00)00257-4; Stephenson J., 2000, JAMA-J AM MED ASSOC, V8, P284; TARRANT ME, 1973, BIOCHEM PHARMACOL, V22, P639, DOI 10.1016/0006-2952(73)90378-X; Tayal SC, 2010, INT J STD AIDS, V21, P217, DOI 10.1258/ijsa.2009.009085; Thorn G.D., 1962, DITHIOCARBAMATES REL; Turner RM, 2003, J ANDROL, V24, P790; Upcroft JA, 2001, ANTIMICROB AGENTS CH, V45, P1810, DOI 10.1128/AAC.45.6.1810-1814.2001; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wright JM, 2010, PARASITOL RES, V107, P847, DOI 10.1007/s00436-010-1938-3; Zodpey S P, 2007, Indian J Public Health, V51, P70	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67365	10.1371/journal.pone.0067365	http://dx.doi.org/10.1371/journal.pone.0067365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826278	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000068
J	Shokhirev, MN; Hoffmann, A				Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander			FlowMax: A Computational Tool for Maximum Likelihood Deconvolution of CFSE Time Courses	PLOS ONE			English	Article							LYMPHOCYTE DIVISION; CELL; MODEL; PROLIFERATION; FLUORESCENCE; NF-KAPPA-B1; ACTIVATION; SURVIVAL; GROWTH; TPL2	The immune response is a concerted dynamic multi-cellular process. Upon infection, the dynamics of lymphocyte populations are an aggregate of molecular processes that determine the activation, division, and longevity of individual cells. The timing of these single-cell processes is remarkably widely distributed with some cells undergoing their third division while others undergo their first. High cell-to-cell variability and technical noise pose challenges for interpreting popular dye-dilution experiments objectively. It remains an unresolved challenge to avoid under-or over-interpretation of such data when phenotyping gene-targeted mouse models or patient samples. Here we develop and characterize a computational methodology to parameterize a cell population model in the context of noisy dye-dilution data. To enable objective interpretation of model fits, our method estimates fit sensitivity and redundancy by stochastically sampling the solution landscape, calculating parameter sensitivities, and clustering to determine the maximum-likelihood solution ranges. Our methodology accounts for both technical and biological variability by using a cell fluorescence model as an adaptor during population model fitting, resulting in improved fit accuracy without the need for ad hoc objective functions. We have incorporated our methodology into an integrated phenotyping tool, FlowMax, and used it to analyze B cells from two NFkB knockout mice with distinct phenotypes; we not only confirm previously published findings at a fraction of the expended effort and cost, but reveal a novel phenotype of nfkb1/p105/50 in limiting the proliferative capacity of B cells following B-cell receptor stimulation. In addition to complementing experimental work, FlowMax is suitable for high throughput analysis of dye dilution studies within clinical and pharmacological screens with objective and quantitative conclusions.	[Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander] San Diego Ctr Syst Biol, La Jolla, CA USA; [Shokhirev, Maxim Nikolaievich] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu			NSF [DGE-1144086]; NIH/NIAID [AI083453]; San Diego Center for Systems Biology (SDCSB); NIGMS [P50 GM085763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); San Diego Center for Systems Biology (SDCSB); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.N. Shokhirev is funded by an NSF Graduate Research Fellowship (DGE-1144086). The study was supported by NIH/NIAID grant AI083453 and the San Diego Center for Systems Biology (SDCSB) funded by NIGMS grant P50 GM085763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GR, 2006, BBA-MOL CELL RES, V1763, P174, DOI 10.1016/j.bbamcr.2005.12.010; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2008, BLOOD, V112, P5063, DOI 10.1182/blood-2007-10-120832; Banks HT, 2011, J IMMUNOL METHODS, V373, P143, DOI 10.1016/j.jim.2011.08.014; Callard R, 2007, IMMUNOL REV, V216, P119; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Hasenauer J, 2012, B MATH BIOL, V74, P2692, DOI 10.1007/s11538-012-9774-5; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Hyrien O, 2008, J AM STAT ASSOC, V103, P222, DOI 10.1198/016214507000000194; Hyrien O, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-41; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Luzyanina T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-26; Metzger P, 2012, P 9 INT WORKSH COMP, P60; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67620	10.1371/journal.pone.0067620	http://dx.doi.org/10.1371/journal.pone.0067620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826329	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000093
J	Fletcher, JM; Tefft, N				Fletcher, Jason M.; Tefft, Nathan			The Long-Term Effects of Stress on Partner Weight Characteristics	PLOS ONE			English	Article							PREFERENCES; CYCLE	Background: Recent experimental evidence suggests that stressed males find heavier women more attractive than non-stressed males. The aim of this study is to examine whether these results also appear in actual mating patterns of adults from a national sample. Methods: Regression analysis linking partner weight measures to own measures of childhood stress, as measured by mistreatment. Cross-sectional data from the National Longitudinal Study of Adolescent Health, Romantic Partners Sample is used to measure partner weight, childhood stressful events, and socio-demographic characteristics. Childhood experiences of adult mistreatment are retrospectively collected. Results: Men who experienced childhood mistreatment are more likely to have obese female partners during young adulthood. The results are strongest for interactions with social services, adult neglect and physical abuse. We also present novel evidence of the opposite association in similarly stressed women whose male partners are more likely to be thin. Conclusions: These results suggest that preferences for partner characteristics are sensitive to histories of stress and that previously hypothesized patterns occur outside the experimental setting.	[Fletcher, Jason M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA; [Tefft, Nathan] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA	Yale University; University of Washington; University of Washington Seattle	Fletcher, JM (corresponding author), Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA.	jason.fletcher@yale.edu						Becker GS, 1974, UMI, P299; Braun MF, 2006, J SOC PERS RELAT, V23, P805, DOI 10.1177/0265407506068264; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Buckingham ET, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0342-3; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Courtiol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013010; Fletcher JM, 2009, SOC SCI MED, V68, P799, DOI 10.1016/j.socscimed.2008.12.005; Gobin RL, 2012, J TRAUMA DISSOCIATIO, V13, P152, DOI 10.1080/15299732.2012.642752; Gowin JL, 2013, PSYCHOPHARMACOLOGY, V227, P661, DOI 10.1007/s00213-013-2992-1; Larson CM, 2013, HORM BEHAV, V63, P128, DOI 10.1016/j.yhbeh.2012.10.005; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Neigh GN, 2009, TRAUMA VIOLENCE ABUS, V10, P389, DOI 10.1177/1524838009339758; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pettijohn T. F., 2009, J SOC EVOL CULT PSYC, V3, P216, DOI [DOI 10.1037/H0099321, 10.1037/h0099321]; Swami V, 2008, J SOCIO-ECON, V37, P1363, DOI DOI 10.1016/j.socec.2007.03.006; Swami V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042593; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702	18	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66353	10.1371/journal.pone.0066353	http://dx.doi.org/10.1371/journal.pone.0066353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840447	gold, Green Submitted, Green Published			2022-12-25	WOS:000321424400026
J	Baum, E; Randall, AZ; Zeller, M; Barbour, AG				Baum, Elisabeth; Randall, Arlo Z.; Zeller, Michael; Barbour, Alan G.			Inferring Epitopes of a Polymorphic Antigen Amidst Broadly Cross-Reactive Antibodies Using Protein Microarrays: A Study of OspC Proteins of Borrelia burgdorferi	PLOS ONE			English	Article							OUTER SURFACE PROTEIN; LINKED-IMMUNOSORBENT-ASSAY; LYME-DISEASE SPIROCHETE; SENSU-STRICTO; HEMATOGENOUS DISSEMINATION; ACTIVE IMMUNIZATION; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; C OSPC; INFECTION	Epitope mapping studies aim to identify the binding sites of antibody-antigen interactions to enhance the development of vaccines, diagnostics and immunotherapeutic compounds. However, mapping is a laborious process employing time-and resource-consuming 'wet bench' techniques or epitope prediction software that are still in their infancy. For polymorphic antigens, another challenge is characterizing cross-reactivity between epitopes, teasing out distinctions between broadly cross-reactive responses, limited cross-reactions among variants and the truly type-specific responses. A refined understanding of cross-reactive antibody binding could guide the selection of the most informative subsets of variants for diagnostics and multivalent subunit vaccines. We explored the antibody binding reactivity of sera from human patients and Peromyscus leucopus rodents infected with Borrelia burgdorferi to the polymorphic outer surface protein C (OspC), an attractive candidate antigen for vaccine and improved diagnostics for Lyme disease. We constructed a protein microarray displaying 23 natural variants of OspC and quantified the degree of cross-reactive antibody binding between all pairs of variants, using Pearson correlation calculated on the reactivity values using three independent transforms of the raw data: (1) logarithmic, (2) rank, and (3) binary indicators. We observed that the global amino acid sequence identity between OspC pairs was a poor predictor of cross-reactive antibody binding. Then we asked if specific regions of the protein would better explain the observed cross-reactive binding and performed in silico screening of the linear sequence and 3-dimensional structure of OspC. This analysis pointed to residues 179 through 188 the fifth C-terminal helix of the structure as a major determinant of type-specific cross-reactive antibody binding. We developed bioinformatics methods to systematically analyze the relationship between local sequence/structure variation and cross-reactive antibody binding patterns among variants of a polymorphic antigen, and this method can be applied to other polymorphic antigens for which immune response data is available for multiple variants.	[Baum, Elisabeth; Barbour, Alan G.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Baum, Elisabeth; Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Randall, Arlo Z.; Zeller, Michael] Univ Calif Irvine, Sch Informat & Comp Sci, Inst Genom & Bioinformat, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Baum, E (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.	ebaum@uci.edu		Baum-Jones, Elisabeth/0000-0001-6348-3378	National Institutes of Health [AI078734, K99 LM010821, AI100236, AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI078734, R21AI100236, U54AI065359] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM010821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding provided by National Institutes of Health grants AI078734 (EB), K99 LM010821 (AR), and AI100236 and AI065359 (AGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Brown EL, 2005, VACCINE, V23, P3687, DOI 10.1016/j.vaccine.2005.02.006; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chen Ping, 2011, Virologica Sinica, V26, P1, DOI 10.1007/s12250-011-3159-4; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Du WD, 2007, DIAGN MICR INFEC DIS, V59, P355, DOI 10.1016/j.diagmicrobio.2007.06.006; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gilmore RD, 1996, INFECT IMMUN, V64, P2234, DOI 10.1128/IAI.64.6.2234-2239.1996; Girard YA, 2009, APPL ENVIRON MICROB, V75, P7243, DOI 10.1128/AEM.01704-09; Ivanova L, 2009, CLIN IMMUNOL, V132, P393, DOI 10.1016/j.clim.2009.05.017; Jobe DA, 2003, CLIN DIAGN LAB IMMUN, V10, P573, DOI 10.1128/CDLI.10.4.573-578.2003; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kraiczy P, 2000, J MED MICROBIOL, V49, P917, DOI 10.1099/0022-1317-49-10-917; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lovrich SD, 2005, CLIN DIAGN LAB IMMUN, V12, P746, DOI 10.1128/CDLI.12.6.746-751.2005; Mathiesen MJ, 1998, J CLIN MICROBIOL, V36, P3474, DOI 10.1128/JCM.36.12.3474-3479.1998; Mathiesen MJ, 1998, INFECT IMMUN, V66, P4073; Mbow ML, 1999, INFECT IMMUN, V67, P5470, DOI 10.1128/IAI.67.10.5470-5472.1999; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; PREACMURSIC V, 1992, INFECTION, V20, P342, DOI 10.1007/BF01710681; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Rousselle JC, 1998, J INFECT DIS, V178, P733, DOI 10.1086/515382; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhong WM, 1997, P NATL ACAD SCI USA, V94, P12533, DOI 10.1073/pnas.94.23.12533	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67445	10.1371/journal.pone.0067445	http://dx.doi.org/10.1371/journal.pone.0067445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826301	Green Published, gold			2022-12-25	WOS:000321738400148
J	Erho, N; Crisan, A; Vergara, IA; Mitra, AP; Ghadessi, M; Buerki, C; Bergstralh, EJ; Kollmeyer, T; Fink, S; Haddad, Z; Zimmermann, B; Sierocinski, T; Ballman, KV; Triche, TJ; Black, PC; Karnes, RJ; Klee, G; Davicioni, E; Jenkins, RB				Erho, Nicholas; Crisan, Anamaria; Vergara, Ismael A.; Mitra, Anirban P.; Ghadessi, Mercedeh; Buerki, Christine; Bergstralh, Eric J.; Kollmeyer, Thomas; Fink, Stephanie; Haddad, Zaid; Zimmermann, Benedikt; Sierocinski, Thomas; Ballman, Karla V.; Triche, Timothy J.; Black, Peter C.; Karnes, R. Jeffrey; Klee, George; Davicioni, Elai; Jenkins, Robert B.			Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy	PLOS ONE			English	Article							GENE-EXPRESSION; ADJUVANT RADIOTHERAPY; TISSUE BIOMARKER; POSTOPERATIVE RADIOTHERAPY; SYSTEMIC PROGRESSION; RADIATION-THERAPY; HIGH-RISK; SIGNATURE; ANTIGEN; PROTEIN	Purpose: Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression signature detected in the primary tumor represents true biological potential of aggressive disease and provides improved prediction of early prostate cancer metastasis. Methods: A nested case-control design was used to select 639 patients from the Mayo Clinic tumor registry who underwent radical prostatectomy between 1987 and 2001. A genomic classifier (GC) was developed by modeling differential RNA expression using 1.4 million feature high-density expression arrays of men enriched for rising PSA after prostatectomy, including 213 who experienced early clinical metastasis after biochemical recurrence. A training set was used to develop a random forest classifier of 22 markers to predict for cases - men with early clinical metastasis after rising PSA. Performance of GC was compared to prognostic factors such as Gleason score and previous gene expression signatures in a withheld validation set. Results: Expression profiles were generated from 545 unique patient samples, with median follow-up of 16.9 years. GC achieved an area under the receiver operating characteristic curve of 0.75 (0.67-0.83) in validation, outperforming clinical variables and gene signatures. GC was the only significant prognostic factor in multivariable analyses. Within Gleason score groups, cases with high GC scores experienced earlier death from prostate cancer and reduced overall survival. The markers in the classifier were found to be associated with a number of key biological processes in prostate cancer metastatic disease progression. Conclusion: A genomic classifier was developed and validated in a large patient cohort enriched with prostate cancer metastasis patients and a rising PSA that went on to experience metastatic disease. This early metastasis prediction model based on genomic expression in the primary tumor may be useful for identification of aggressive prostate cancer.	[Erho, Nicholas; Crisan, Anamaria; Vergara, Ismael A.; Ghadessi, Mercedeh; Buerki, Christine; Haddad, Zaid; Zimmermann, Benedikt; Sierocinski, Thomas; Triche, Timothy J.; Davicioni, Elai] GenomeDx Biosci, Res & Dev, Vancouver, BC, Canada; [Mitra, Anirban P.; Triche, Timothy J.] Univ So Calif, Dept Pathol & Lab Med, Los Angeles, CA USA; [Bergstralh, Eric J.; Ballman, Karla V.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Kollmeyer, Thomas; Fink, Stephanie; Klee, George; Jenkins, Robert B.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA; [Black, Peter C.] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada; [Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN USA	GenomeDx Biosciences; University of Southern California; Mayo Clinic; Mayo Clinic; University of British Columbia; Mayo Clinic	Jenkins, RB (corresponding author), Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA.	rjenkins@mayo.edu	Mitra, Anirban P/A-9101-2008; Black, Peter/AAE-8424-2020	Mitra, Anirban P/0000-0002-6549-5943; Black, Peter/0000-0002-2919-7068; Erho, Nicholas/0000-0002-5857-2701; Ballman, Karla/0000-0002-4492-0357; haddad, zaid/0000-0001-8483-4800; Davicioni, Elai/0000-0001-9136-099X; Vergara, Ismael/0000-0002-2960-2967	National Research Council of Canada, Industrial Research Assistance Program; Mayo Clinic Prostate Cancer [SPORE P50 CA91956]; GenomeDx Biosciences Inc.; National Research Council - Industrial Research Assistance Program; Beckman Coulter; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	National Research Council of Canada, Industrial Research Assistance Program; Mayo Clinic Prostate Cancer; GenomeDx Biosciences Inc.; National Research Council - Industrial Research Assistance Program; Beckman Coulter; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Research Council of Canada, Industrial Research Assistance Program (http://www.nrc-cnrc.gc.ca/eng/irap/index.html), and the Mayo Clinic Prostate Cancer SPORE P50 CA91956 (PI: Donald Tindall Ph.D.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: NE, AC, IV, MG, CB, ZH, BZ, TS, TT, and ED are employees of GenomeDx Biosciences Inc. ED and TT own stock in GenomeDx Biosciences Inc. ED has received research funding from GenomeDx Biosciences Inc. and the National Research Council - Industrial Research Assistance Program. PB has received research funding from GenomeDx Biosciences Inc. GK has received research funding from Beckman Coulter. KB, EB, RC, SF, RK, RJ, and TK have declared that no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Agell L, 2012, AM J PATHOL, V181, P1585, DOI 10.1016/j.ajpath.2012.08.005; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; Berney DM, 2009, BRIT J CANCER, V100, P888, DOI 10.1038/sj.bjc.6604951; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bismar TA, 2006, NEOPLASIA, V8, P59, DOI 10.1593/neo.05664; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brimo F, 2013, EUR UROL, V63, P892, DOI 10.1016/j.eururo.2012.10.015; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen Q, 2006, CANCER LETT, V244, P274, DOI 10.1016/j.canlet.2005.12.027; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Crisan A, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.30_suppl.90; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Deftos LJ, 1998, PROSTATE, P23; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; KORN EL, 1986, STAT MED, V5, P255, DOI 10.1002/sim.4780050306; Kristiansen G, 2008, BRIT J CANCER, V99, P939, DOI 10.1038/sj.bjc.6604614; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Larkin SET, 2012, BRIT J CANCER, V106, P157, DOI 10.1038/bjc.2011.490; LaTulippe E, 2002, CANCER RES, V62, P4499; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer D., 2012, E1071 MISC FUNCTIONS; Mishra MV, 2011, FUTURE ONCOL, V7, P1429, DOI [10.2217/FON.11.120, 10.2217/fon.11.120]; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Patel AR, 2011, NAT REV UROL, V8, P385, DOI 10.1038/nrurol.2011.80; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Swanson GP, 2011, J CANCER, V2, P1, DOI 10.7150/jca.2.1; Talantov D, 2010, J UROLOGY, V184, P1521, DOI 10.1016/j.juro.2010.05.084; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VANDENBERG C, 1995, CLIN CANCER RES, V1, P11; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; Vergara Ismael A., 2012, Frontiers in Genetics, V3, P23, DOI 10.3389/fgene.2012.00023; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	72	416	435	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66855	10.1371/journal.pone.0066855	http://dx.doi.org/10.1371/journal.pone.0066855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826159	Green Published, gold			2022-12-25	WOS:000321738400069
J	Koba, C; Haruta, M; Matsunaga, Y; Matsumura, K; Haga, E; Sasaki, Y; Ikeda, T; Takamatsu, K; Nishimura, Y; Senju, S				Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Nishimura, Yasuharu; Senju, Satoru			Therapeutic Effect of Human iPS-Cell-Derived Myeloid Cells Expressing IFN-beta against Peritoneally Disseminated Cancer in Xenograft Models	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MACROPHAGE ACTIVATION; GAMMA-INTERFERON; DENDRITIC CELLS; GASTRIC-CANCER; IN-VITRO; DIRECTED DIFFERENTIATION; INDUCTION; GENERATION; MONOCYTES	We recently developed a method to generate myeloid cells with proliferation capacity from human iPS cells. iPS-ML (iPS-cell-derived myeloid/macrophage line), generated by introducing proliferation and anti-senescence factors into iPS-cell-derived myeloid cells, grew continuously in an M-CSF-dependent manner. A large number of cells exhibiting macrophage-like properties can be readily obtained by using this technology. In the current study, we evaluated the possible application of iPS-ML in anti-cancer therapy. We established a model of peritoneally disseminated gastric cancer by intraperitoneally injecting NUGC-4 human gastric cancer cells into SCID mice. When iPS-ML were injected intraperitoneally into the mice with pre-established peritoneal NUGC-4 tumors, iPS-ML massively accumulated and infiltrated into the tumor tissues. iPS-ML expressing IFN-beta (iPS-ML/IFN-beta) significantly inhibited the intra-peritoneal growth of NUGC-4 cancer. Furthermore, iPS-ML/IFN-beta also inhibited the growth of human pancreatic cancer MIAPaCa-2 in a similar model. iPS-ML are therefore a promising treatment agent for peritoneally disseminated cancers, for which no standard treatment is currently available.	[Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Biomed Sci, Dept Immunogenet, Kumamoto, Japan; [Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Senju, Satoru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kumamoto University; Japan Science & Technology Agency (JST)	Senju, S (corresponding author), Kumamoto Univ, Grad Sch Biomed Sci, Dept Immunogenet, Kumamoto, Japan.	senjusat@gpo.kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019		MEXT, Japan [23650609, 24300334, 23659158]; Princess Takamatsu Cancer Research Fund; Ministry of Health and Welfare, Japan; Japan Science and Technology Agency (JST)	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-Aid Nos. 23650609 and 24300334 to Y.N. and 23659158 to S.S. from the MEXT, Japan; a grant to Y.N. from Princess Takamatsu Cancer Research Fund; Research Grant to S.S. for Intractable Diseases from Ministry of Health and Welfare, Japan; and a grant to S.S. from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 1994, Vnitr Lek, V40, P329; ANDREESEN R, 1990, CANCER RES, V50, P7450; Andreesen R, 1998, J LEUKOCYTE BIOL, V64, P419, DOI 10.1002/jlb.64.4.419; BACIK I, 1994, J IMMUNOL, V152, P381; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Bonnotte B, 2001, J IMMUNOL, V167, P5077, DOI 10.4049/jimmunol.167.9.5077; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Haruta M, 2012, GENE THER; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kim DY, 2006, ACTA CHIR BELG, V106, P665; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Kuniyasu H, 1997, CELL GROWTH DIFFER, V8, P47; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Lindmark H, 2004, EXP CELL RES, V300, P335, DOI 10.1016/j.yexcr.2004.06.025; Loyer V, 1999, J IMMUNOL, V163, P6462; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Matsunaga Y, 2008, J IMMUNOL, V181, P6635, DOI 10.4049/jimmunol.181.9.6635; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Monnet I, 2002, CHEST, V121, P1921, DOI 10.1378/chest.121.6.1921; Moore KJ, 1998, ARTERIOSCL THROM VAS, V18, P1647, DOI 10.1161/01.ATV.18.10.1647; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Odegaard JI, 2007, J LEUKOCYTE BIOL, V81, P711, DOI 10.1189/jlb.0906590; PACE JL, 1985, J IMMUNOL, V134, P977; PACE JL, 1983, J IMMUNOL, V130, P2011; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Sharkis SJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003920; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Shyu RY, 2000, J SURG ONCOL, V75, P122, DOI 10.1002/1096-9098(200010)75:2<122::AID-JSO9>3.0.CO;2-4; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yonemura Y, 2007, CANCER SCI, V98, P11, DOI 10.1111/j.1349-7006.2006.00350.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	43	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67567	10.1371/journal.pone.0067567	http://dx.doi.org/10.1371/journal.pone.0067567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826321	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400159
J	Martinez-Vazquez, A; Gonzalez-Hernandez, A; Dominguez, A; Rachubinski, R; Riquelme, M; Cuellar-Mata, P; Guzman, JCT				Martinez-Vazquez, Azul; Gonzalez-Hernandez, Angelica; Dominguez, Angel; Rachubinski, Richard; Riquelme, Meritxell; Cuellar-Mata, Patricia; Torres Guzman, Juan Carlos			Identification of the Transcription Factor Znc1p, which Regulates the Yeast-to-Hypha Transition in the Dimorphic Yeast Yarrowia lipolytica	PLOS ONE			English	Article							CANDIDA-ALBICANS; FILAMENT FORMATION; INVASIVE GROWTH; GENE-EXPRESSION; PROTEIN-KINASE; REPRESSOR; PATHWAY; MORPHOGENESIS; COMPONENTS; REVEALS	The dimorphic yeast Yarrowia lipolytica is used as a model to study fungal differentiation because it grows as yeast-like cells or forms hyphal cells in response to changes in environmental conditions. Here, we report the isolation and characterization of a gene, ZNC1, involved in the dimorphic transition in Y. lipolytica. The ZNC1 gene encodes a 782 amino acid protein that contains a Zn(II)(2)C-6 fungal-type zinc finger DNA-binding domain and a leucine zipper domain. ZNC1 transcription is elevated during yeast growth and decreases during the formation of mycelium. Cells in which ZNC1 has been deleted show increased hyphal cell formation. Znc1p-GFP localizes to the nucleus, but mutations within the leucine zipper domain of Znc1p, and to a lesser extent within the Zn(II)(2)C-6 domain, result in a mislocalization of Znc1p to the cytoplasm. Microarrays comparing gene expression between znc1::URA3 and wild-type cells during both exponential growth and the induction of the yeast-to-hypha transition revealed 1,214 genes whose expression was changed by 2-fold or more under at least one of the conditions analyzed. Our results suggest that Znc1p acts as a transcription factor repressing hyphal cell formation and functions as part of a complex network regulating mycelial growth in Y. lipolytica.	[Martinez-Vazquez, Azul; Gonzalez-Hernandez, Angelica; Cuellar-Mata, Patricia; Torres Guzman, Juan Carlos] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico; [Dominguez, Angel] Univ Salamanca, Dept Microbiol & Genet, CIETUS IBSAL, E-37008 Salamanca, Spain; [Rachubinski, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Riquelme, Meritxell] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico	Universidad de Guanajuato; University of Salamanca; University of Alberta; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Guzman, JCT (corresponding author), Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Campus Guanajuato, Guanajuato, Mexico.	torguz@ugto.mx	Riquelme, Meritxell/K-8345-2015; Guzman, Juan Carlos Torres/K-7107-2012	Riquelme, Meritxell/0000-0002-2580-326X; Guzman, Juan Carlos Torres/0000-0002-1386-9499; Martinez-Vazquez, Ma Azul del Rocio/0000-0003-2658-350X	Consejo Nacional de Ciencia y Tecnologia (CONACyT); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG); Secretaria de Educacion Publica (SEP); University of Guanajuato; CONACyT, Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG); Secretaria de Educacion Publica (SEP); University of Guanajuato; CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (www.conacyt.gob.mx); Consejo Estatal de Ciencia y Tecnologia del Estado de Guanajuato (CONCyTEG (www.concyteg.gob.mx); Secretaria de Educacion Publica (SEP) (www.sep.gob.mx); University of Guanajuato (www.ugto.mx). Azul Martinez-Vazquez received a fellowship from CONACyT, Mexico. Richard Rachubinski is an International Research Scholar of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akache B, 2001, NUCLEIC ACIDS RES, V29, P2181, DOI 10.1093/nar/29.10.2181; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Beckerich J M, 1998, Int Microbiol, V1, P123; Berman J, 2004, PATHOGENIC FUNGI: STRUCTURAL BIOLOGY AND TAXONOMY, P101; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blanchin-Roland S, 2005, MICROBIOL-SGM, V151, P3627, DOI 10.1099/mic.0.28196-0; Bolker M, 2001, MICROBIOL-SGM, V147, P1395, DOI 10.1099/00221287-147-6-1395; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Cervantes-Chavez JA, 2007, FEMS YEAST RES, V7, P929, DOI 10.1111/j.1567-1364.2007.00265.x; Cervantes-Chavez JA, 2006, FEMS YEAST RES, V6, P801, DOI 10.1111/j.1567-1364.2006.00084.x; Cervantes-Chavez JA, 2009, FUNGAL GENET BIOL, V46, P390, DOI 10.1016/j.fgb.2009.02.005; Chang JL, 2007, EUKARYOT CELL, V6, P1528, DOI 10.1128/EC.00185-07; Chavel CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000883; Chen DC, 1997, APPL MICROBIOL BIOT, V48, P232, DOI 10.1007/s002530051043; Costa M, 2007, MICROBIOL-SGM, V153, P4194, DOI 10.1099/mic.0.2007/009332-0; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Dominguez A, 1998, Int Microbiol, V1, P131; Dominguez A, 2000, Contrib Microbiol, V5, P151; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fernandez-Abalos JM, 1998, MOL MICROBIOL, V27, P121, DOI 10.1046/j.1365-2958.1998.00664.x; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Hauser M, 2007, FEMS YEAST RES, V7, P84, DOI 10.1111/j.1567-1364.2006.00151.x; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hogan DA, 2011, CURR OPIN MICROBIOL, V14, P682, DOI 10.1016/j.mib.2011.09.014; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hurtado CAR, 2000, J BACTERIOL, V182, P2376, DOI 10.1128/JB.182.9.2376-2386.2000; Hurtado CAR, 1999, J BACTERIOL, V181, P3051, DOI 10.1128/JB.181.10.3051-3057.1999; Hurtado CAR, 2002, MICROBIOL-SGM, V148, P3725, DOI 10.1099/00221287-148-11-3725; Hurtado CAR, 2002, EUKARYOT CELL, V1, P526, DOI 10.1128/EC.1.4.526-537.2002; Jimenez-Bremont JF, 2008, MICROBIOL RES, V163, P717, DOI 10.1016/j.micres.2008.05.001; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Maicas S, 2005, COMP FUNCT GENOM, V6, P345, DOI 10.1002/cfg.492; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Mofunanya A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-41; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Morin M, 2007, J MASS SPECTROM, V42, P1453, DOI 10.1002/jms.1284; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; NUTTLEY WM, 1993, YEAST, V9, P507, DOI 10.1002/yea.320090506; OGRYDZIAK D, 1982, MOL GEN GENET, V188, P179, DOI 10.1007/BF00332672; Olmedo M, 2010, GENETICS, V184, P651, DOI 10.1534/genetics.109.109975; Perez-Campo FM, 2001, CURR MICROBIOL, V43, P429, DOI 10.1007/s002840010333; Ramon AM, 1999, RES MICROBIOL, V150, P95, DOI 10.1016/S0923-2508(99)80027-8; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Ruiz-Herrera J, 2002, ARCH MICROBIOL, V178, P477, DOI 10.1007/s00203-002-0478-3; Sambrook J, 2001, MOL CLONING LAB MANU; Szabo R, 2002, FEMS MICROBIOL LETT, V206, P45, DOI 10.1111/j.1574-6968.2002.tb10984.x; Szabo R, 2001, MOL GENET GENOMICS, V265, P172, DOI 10.1007/s004380000405; Morales-Vargas AT, 2012, RES MICROBIOL, V163, P378, DOI 10.1016/j.resmic.2012.03.002; TorresGuzman JC, 1997, MOL CELL BIOL, V17, P6283, DOI 10.1128/MCB.17.11.6283; van Dyk D, 2003, GENETICS, V165, P1045; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x	66	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66790	10.1371/journal.pone.0066790	http://dx.doi.org/10.1371/journal.pone.0066790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826133	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400051
J	Gerber, PA; Hevezi, P; Buhren, BA; Martinez, C; Schrumpf, H; Gasis, M; Grether-Beck, S; Krutmann, J; Homey, B; Zlotnik, A				Gerber, Peter Arne; Hevezi, Peter; Buhren, Bettina Alexandra; Martinez, Cynthia; Schrumpf, Holger; Gasis, Marcia; Grether-Beck, Susanne; Krutmann, Jean; Homey, Bernhard; Zlotnik, Albert			Systematic Identification and Characterization of Novel Human Skin-Associated Genes Encoding Membrane and Secreted Proteins	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; WHEY ACIDIC PROTEIN; BREAST-CANCER; BARRIER FUNCTION; KERATINOCYTE DIFFERENTIATION; ANTIMICROBIAL ACTIVITY; EXPRESSION ANALYSIS; CELL-PROLIFERATION; COUPLED RECEPTORS; ATOPIC-DERMATITIS	Through bioinformatics analyses of a human gene expression database representing 105 different tissues and cell types, we identified 687 skin-associated genes that are selectively and highly expressed in human skin. Over 50 of these represent uncharacterized genes not previously associated with skin and include a subset that encode novel secreted and plasma membrane proteins. The high levels of skin-associated expression for eight of these novel therapeutic target genes were confirmed by semi-quantitative real time PCR, western blot and immunohistochemical analyses of normal skin and skin-derived cell lines. Four of these are expressed specifically by epidermal keratinocytes; two that encode G-protein-coupled receptors (GPR87 and GPR115), and two that encode secreted proteins (WFDC5 and SERPINB7). Further analyses using cytokine-activated and terminally differentiated human primary keratinocytes or a panel of common inflammatory, autoimmune or malignant skin diseases revealed distinct patterns of regulation as well as disease associations that point to important roles in cutaneous homeostasis and disease. Some of these novel uncharacterized skin genes may represent potential biomarkers or drug targets for the development of future diagnostics or therapeutics.	[Hevezi, Peter; Zlotnik, Albert] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Gerber, Peter Arne; Buhren, Bettina Alexandra; Martinez, Cynthia; Schrumpf, Holger; Gasis, Marcia; Homey, Bernhard] Univ Dusseldorf, Dept Dermatol, Dusseldorf, Germany; [Grether-Beck, Susanne; Krutmann, Jean] Leibniz Res Inst Environm Med, Inst Umweltmed Forsch, Dusseldorf, Germany	University of California System; University of California Irvine; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Zlotnik, A (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	azlotnik@uci.edu	Gerber, Peter Arne/M-2746-2013	Gerber, Peter Arne/0000-0003-1657-1863	National Institutes of Health-National Institute of Allergy and Infectious Diseases [R21AI906278, R01-AI093548]; MAARS from European Union [EU-HEALTH.2010.2.4.5-2]; German Research Foundation [Ho 2092/5-2]; University of Duesseldorf; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093548] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MAARS from European Union; German Research Foundation(German Research Foundation (DFG)); University of Duesseldorf; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The University of California Irvine group was supported by R21AI906278 and R01-AI093548 (to A.Z.) grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases. The Duesseldorf group was supported by a MAARS EU-HEALTH.2010.2.4.5-2 from the European Union, and Ho 2092/5-2 from the German Research Foundation (to BH) and a Strategic Research Grant of the University of Duesseldorf (Strategischer Forschungsfond - SFF, "Novel skin genes - roles in homeostasis and disease") to PAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle DD, 2003, J CELL BIOCHEM, V88, P290, DOI 10.1002/jcb.10339; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Blumenberg M, 2006, OMICS, V10, P243, DOI 10.1089/omi.2006.10.243; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Carter D, 2002, BIOCHEMISTRY-US, V41, P6714, DOI 10.1021/bi0159884; Chassain C, 2001, J NEUROSCI METH, V111, P9, DOI 10.1016/S0165-0270(01)00425-3; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Colpitts TL, 2002, TUMOR BIOL, V23, P263, DOI 10.1159/000068566; Culleton J, 2007, INT J CANCER, V120, P1087, DOI 10.1002/ijc.22471; Curto EV, 2002, BIOCHEM BIOPH RES CO, V291, P1052, DOI 10.1006/bbrc.2002.6542; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Fredriksson R, 2002, FEBS LETT, V531, P407, DOI 10.1016/S0014-5793(02)03574-3; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gregori C, 1998, J BIOL CHEM, V273, P25237, DOI 10.1074/jbc.273.39.25237; Grether-Beck S, 2008, EXP DERMATOL, V17, P771, DOI 10.1111/j.1600-0625.2007.00693.x; Grether-Beck S, 2012, J INVEST DERMATOL, V132, P1561, DOI 10.1038/jid.2012.42; Gugger M, 2008, DIS MARKERS, V24, P41, DOI 10.1155/2008/857474; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Henderson RH, 2010, MOL VIS, V16, P46; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Li GL, 2011, BIOMARK MED, V5, P249, DOI [10.2217/BMM.11.20, 10.2217/bmm.11.20]; Liu ZZ, 2010, CLIN EXP METASTAS, V27, P251, DOI 10.1007/s10585-010-9323-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Miksicek RJ, 2002, CANCER RES, V62, P2736; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Miyata T, 2002, J CLIN INVEST, V109, P585, DOI 10.1172/JCI200214336; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; RAUBENHEIMER EJ, 1987, CRC CR REV CL LAB SC, V25, P161, DOI 10.3109/10408368709105881; Ray R, 2005, J BIOL CHEM, V280, P9761, DOI 10.1074/jbc.C400581200; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Remington SG, 2008, INVEST OPHTH VIS SCI, V49, P2856, DOI 10.1167/iovs.07-1496; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Samudre SS, 2010, INVEST OPHTH VIS SCI, V52, P6265; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sjodin A, 2003, J INVEST DERMATOL, V121, P428, DOI 10.1046/j.1523-1747.2003.12374.x; Sjodin A, 2008, ANTICANCER RES, V28, P1493; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Spiekstra SW, 2005, EXP DERMATOL, V14, P109, DOI 10.1111/j.0906-6705.2005.00226.x; Stewart GD, 2008, CURR OPIN CLIN NUTR, V11, P208, DOI 10.1097/MCO.0b013e3282fb7b8d; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Watson MA, 1996, CANCER RES, V56, P860; Weigelt B, 2003, J CANCER RES CLIN, V129, P735, DOI 10.1007/s00432-003-0514-y; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Wong DJ, 2005, J INVEST DERMATOL, V125, P175, DOI 10.1111/j.0022-202X.2005.23827.x; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yoon JM, 2010, INT J MOL MED, V26, P415, DOI 10.3892/ijmm_00000481; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhang X, 2009, MOL REPROD DEV, V76, P160, DOI 10.1002/mrd.20938; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621	82	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e63949	10.1371/journal.pone.0063949	http://dx.doi.org/10.1371/journal.pone.0063949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840300	Green Published, gold			2022-12-25	WOS:000322342800003
J	Liu, SY; Liu, TC; Teng, YL; Lee, LA; Lai, TJ; Wu, CM				Liu, Shu-Yu; Liu, Tien-Chen; Teng, Ya-Ling; Lee, Li-Ang; Lai, Te-Jen; Wu, Che-Ming			Environmental Sounds Recognition in Children with Cochlear Implants	PLOS ONE			English	Article							PRELINGUALLY DEAF-CHILDREN; SPEECH-INTELLIGIBILITY; AUDITORY PERFORMANCE; PERCEPTION	The aims of this study were (1) to document the recognition performance of environmental sounds (ESs) in Mandarin-speaking children with cochlear implants (CIs) and to analyze the possible associated factors with the ESs recognition; (2) to examine the relationship between perception of ESs and receptive vocabulary level; and (3) to explore the acoustic factors relevant to perceptual outcomes of daily ESs in pediatric CI users. Forty-seven prelingually deafened children between ages 4 to 10 years participated in this study. They were divided into pre-school (group A: age 4-6) and school-age (group B: age 7 to 10) groups. Sound Effects Recognition Test (SERT) and the Chinese version of the revised Peabody Picture Vocabulary Test (PPVT-R) were used to assess the auditory perception ability. The average correct percentage of SERT was 61.2% in the preschool group and 72.3% in the older group. There was no significant difference between the two groups. The ESs recognition performance of children with CIs was poorer than that of their hearing peers (90% in average). No correlation existed between ESs recognition and receptive vocabulary comprehension. Two predictive factors: pre-implantation residual hearing and duration of CI usage were found to be associated with recognition performance of daily-encountered ESs. Acoustically, sounds with distinct temporal patterning were easier to identify for children with CIs. In conclusion, we have demonstrated that ESs recognition is not easy for children with CIs and a low correlation existed between linguistic sounds and ESs recognition in these subjects. Recognition ability of ESs in children with CIs can only be achieved by natural exposure to daily-encountered auditory stimuli if sounds other than speech stimuli were less emphasized in routine verbal/oral habilitation program. Therefore, task-specific measures other than speech materials can be helpful to capture the full profile of auditory perceptual progress after implantation.	[Liu, Shu-Yu; Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Liu, Shu-Yu] Chung Shan Med Univ, Sch Speech Language Pathol & Audiol, Taichung, Taiwan; [Liu, Tien-Chen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Teng, Ya-Ling] Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan; [Lee, Li-Ang; Wu, Che-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, TJ (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	tejenlai@hotmail.com; bobwu506@hotmail.com	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; CHE-MING, WU/0000-0001-5245-0482				Allen MC, 1998, AM J OTOL, V19, P742; Finitzo-Hieber T, 1977, SOUND EFFECTS RECOGN; FINITZOHIEBER T, 1980, EAR HEARING, V1, P271, DOI 10.1097/00003446-198009000-00007; Forli F, 2011, ACTA OTORHINOLARYNGO, V31, P281; Gygi B, 2007, FRONT BIOSCI-LANDMRK, V12, P3152, DOI 10.2741/2303; Inverso Y, 2009, PERSPECTIVES HEARING, V19, P43; Inverso Y, 2010, EAR HEARING, V31, P505, DOI 10.1097/AUD.0b013e3181d99a52; Kelsay DMR, 1996, AM J OTOL, V17, P866; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Limb Charles J, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P337, DOI 10.1097/01.moo.0000244192.59184.bd; Liu SY, 2011, INT J PEDIATR OTORHI, V75, P12; Liu SY, 2010, J SPEECH LANG HEAR A, V26, P1; Lu L., 1994, PEABODY PICTURE VOCA; Proops DW, 1999, J LARYNGOL OTOL, V113, P5, DOI 10.1017/S0022215100146018; Ramsdell D.A.., 1978, HEARING AND DEAFNESS, P499; Reed CM, 2005, EAR HEARING, V26, P48, DOI 10.1097/00003446-200502000-00005; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; Shafiro V, 2008, EAR HEARING, V29, P775, DOI 10.1097/AUD.0b013e31817e08ea; Shafiro V, 2012, TRENDS AMPLIF, V16, P83, DOI 10.1177/1084713812454225; Shafiro V, 2011, EAR HEARING, V32, P511, DOI 10.1097/AUD.0b013e3182064a87; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Wang NM, 2011, OTOL NEUROTOL, V32, P937, DOI 10.1097/MAO.0b013e31821789d1; Wu CM, 2008, CLIN OTOLARYNGOL, V33, P35, DOI 10.1111/j.1749-4486.2007.01585.x; Wu CM, 2011, AUDIOL NEURO-OTOL, V16, P359, DOI 10.1159/000322310; Zheng Y, 2011, INT J PEDIATR OTORHI, V75, P1418, DOI 10.1016/j.ijporl.2011.08.005	26	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66100	10.1371/journal.pone.0066100	http://dx.doi.org/10.1371/journal.pone.0066100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840408	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800031
J	Szulkin, A; Nilsonne, G; Mundt, F; Wasik, AM; Souri, P; Hjerpe, A; Dobra, K				Szulkin, Adam; Nilsonne, Gustav; Mundt, Filip; Wasik, Agata M.; Souri, Pega; Hjerpe, Anders; Dobra, Katalin			Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy	PLOS ONE			English	Article							PROTEASOME INHIBITOR PS-341; ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER CELLS; PLEURAL MESOTHELIOMA; LUNG-CANCER; INDUCED APOPTOSIS; PHASE-II; THIOREDOXIN REDUCTASE; PROTEIN EXPRESSION; MULTIPLE-MYELOMA	Background: Malignant mesothelioma cells have an epithelioid or sarcomatoid morphology, both of which may be present in the same tumor. The sarcomatoid phenotype is associated with worse prognosis and heterogeneity of mesothelioma cells may contribute to therapy resistance, which is often seen in mesothelioma. This study aimed to investigate differences in sensitivity between mesothelioma cell lines to anti-cancer drugs. We studied two novel drugs, selenite and bortezomib and compared their effect to four conventional drugs. We also investigated the immunoreactivity of potential predictive markers for drug sensitivity; Pgp, MRP-1, ERCC1, RRM1, TS, xCT and proteasome 20S subunit. Materials and methods: We treated six mesothelioma cell lines with selenite, bortezomib, carboplatin, pemetrexed, doxorubicin or gemcitabine as single agents and in combinations. Viability was measured after 24 and 48 hours. Immunocytochemistry was used to detect predictive markers. Results: As a single agent, selenite was effective on four out of six cell lines, and in combination with bortezomib yielded the greatest response in the studied mesothelioma cell lines. Cells with an epithelioid phenotype were generally more sensitive to the different drugs than the sarcomatoid cells. Extensive S-phase arrest was seen in pemetrexed-sensitive cell lines. MRP-1 predicted sensitivity of cell lines to treatment with carboplatin and xCT predicted pemetrexed effect. Conclusions: The observed heterogeneity in sensitivity of mesothelioma cell lines with different morphology highlights the need for more individualized therapy, requiring development of methods to predict drug sensitivity of individual tumors. Selenite and bortezomib showed a superior effect compared to conventional drugs, motivating clinical testing of these agents as future treatment regime components for patients with malignant mesothelioma.	[Szulkin, Adam; Nilsonne, Gustav; Mundt, Filip; Wasik, Agata M.; Souri, Pega; Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Nilsonne, Gustav] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Nilsonne, Gustav] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University	Szulkin, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	adam.szulkin@ki.se		Nilsonne, Gustav/0000-0001-5273-0150	Swedish Heart and Lung Foundation; AFA Insurance; Cancer Research Foundations of Radiumhemmet; Cancer and Allergy foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AFA Insurance; Cancer Research Foundations of Radiumhemmet; Cancer and Allergy foundation	This study has been supported by the Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/), AFA Insurance (http://www.afaforsakring.se/), The Cancer Research Foundations of Radiumhemmet (www.rahfo.se) and the Cancer and Allergy foundation (www.cancerochallergifonden.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; BALDEW GS, 1991, BIOCHEM PHARMACOL, V41, P1429, DOI 10.1016/0006-2952(91)90558-M; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bjorkhem-Bergman L, 2002, BIOCHEM PHARMACOL, V63, P1875, DOI 10.1016/S0006-2952(02)00981-4; Blayney JK, 2012, EUR J CANCER, V48, P2983, DOI 10.1016/j.ejca.2012.05.018; Borczuk AC, 2007, ONCOGENE, V26, P610, DOI 10.1038/sj.onc.1209809; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; CAVALIERI RR, 1966, J NUCL MED, V7, P197; Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; ELFERINK F, 1987, CANCER TREAT REP, V71, P1231; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Endo K, 1996, CANCER, V77, P1681; Fan TWM, 2006, DRUG METAB REV, V38, P707, DOI 10.1080/03602530600959599; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Gandin V, 2009, FEBS J, V276, P532, DOI 10.1111/j.1742-4658.2008.06800.x; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Hazarika M, 2005, CLIN CANCER RES, V11, P982; Hillerdal G, 2008, J THORAC ONCOL, V3, P1325, DOI 10.1097/JTO.0b013e31818b174d; Hu HB, 2006, MOL CANCER THER, V5, P1873, DOI 10.1158/1535-7163.MCT-06-0063; Kim TS, 2003, BIOCHEM PHARMACOL, V66, P2301, DOI 10.1016/j.bcp.2003.08.021; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; KLOMINEK J, 1989, CANCER RES, V49, P6118; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; LeBlanc R, 2002, CANCER RES, V62, P4996; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Ma WL, 2009, CLIN CANCER RES, V15, P3820, DOI 10.1158/1078-0432.CCR-08-3034; Madeja Z, 2005, BIOCHEM PHARMACOL, V69, P1765, DOI 10.1016/j.bcp.2005.02.023; Matondo M, 2010, LEUKEMIA RES, V34, P498, DOI 10.1016/j.leukres.2009.09.020; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; Nilsonne G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-92; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Pakdaman A, 1998, BIOL TRACE ELEM RES, V62, P1, DOI 10.1007/BF02820015; PELINENLUND K, 1990, CARCINOGENESIS, V11, P673, DOI 10.1093/carcin/11.4.673; Philippeaux MM, 2004, HISTOCHEM CELL BIOL, V122, P249, DOI 10.1007/s00418-004-0701-1; Ren SX, 2010, CANCER INVEST, V28, P1078, DOI 10.3109/07357901003735659; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Righi L, 2010, J CLIN ONCOL, V28, P1534, DOI 10.1200/JCO.2009.25.9275; Rudolf E, 2008, CELL BIOL TOXICOL, V24, P123, DOI 10.1007/s10565-007-9022-1; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shih C, 1997, CANCER RES, V57, P1116; Sieja K, 2004, GYNECOL ONCOL, V93, P320, DOI 10.1016/j.ygyno.2003.12.013; Soini Y, 2001, ANN ONCOL, V12, P1239, DOI 10.1023/A:1012292230480; Su CX, 2011, MED ONCOL, V28, P1411, DOI 10.1007/s12032-010-9553-9; Sun XJ, 2006, CANCER LETT, V232, P161, DOI 10.1016/j.canlet.2005.02.022; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Sun XJ, 2000, DIFFERENTIATION, V66, P181, DOI 10.1111/j.1432-0436.2000.660404.x; Suzuki Y, 2001, IND HEALTH, V39, P183, DOI 10.2486/indhealth.39.183; Team RC, 2012, R LANG ENV STAT COMP; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Tonkinson JL, 1999, CANCER RES, V59, P3671; US food and drug administration, 2004, AL PROD LAB ROCKV; US food and drug administration, 2003, DOX HYDR PROD LAB RO; US food and drug administration, 1996, GEMZ PROD LAB ROCKV; US food and drug administration, 2008, VELC PROD LAB ROCKV; US food and drug administration, 2004, PAR PROD LAB ROCKV; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260; Wang Y, 2009, CANC CHEMOTHER PHARM; Weir L, 2011, ANAL BIOCHEM, V414, P31, DOI 10.1016/j.ab.2011.02.030; Yang TY, 2011, EUR J PHARMACOL, V663, P17, DOI 10.1016/j.ejphar.2011.04.057; Zhao R, 2006, CANCER RES, V66, P2296, DOI 10.1158/0008-5472.CAN-05-2216; Zimling ZG, 2012, CANCER CHEMOTH PHARM, V70, P743, DOI 10.1007/s00280-012-1965-0; Zimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193; Zucali PA, 2011, CLIN CANCER RES, V17, P2581, DOI 10.1158/1078-0432.CCR-10-2873	81	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65903	10.1371/journal.pone.0065903	http://dx.doi.org/10.1371/journal.pone.0065903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840376	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800023
J	Ahooghalandari, P; Hanke, N; Thorpe, M; Witte, A; Messinger, J; Hellman, L				Ahooghalandari, Parvin; Hanke, Nina; Thorpe, Michael; Witte, Andreas; Messinger, Josef; Hellman, Lars			Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors	PLOS ONE			English	Article							EXTENDED SUBSTRATE-SPECIFICITY; ANGIOTENSIN-II; RECOGNITION PROFILE; GRANULE PROTEASES; SERINE PROTEASES; ALPHA-CHYMASE; SIMILARITIES; CLONING; CARBOXYPEPTIDASE; REGULATORS	Chymotrypsin-like serine proteases are found in high abundance in mast cell granules. By site-directed mutatgenesis, we have previously shown that basic amino acids in positions 143 and 192 (Arg and Lys respectively) of the human mast cell chymase are responsible for an acidic amino acid residue preference in the P2' position of substrates. In order to study the influence of these two residues in determining the specificity of chymase inhibitors, we have synthesized five different potent inhibitors of the human chymase. The inhibitory effects of these compounds were tested against the wild-type enzyme, against two single mutants Arg143Gln and Lys192Met and against a double mutant, Arg143Gln+Lys192Met. We observed a markedly reduced activity of all five inhibitors with the double mutant, indicating that these two basic residues are involved in conferring the specificity of these inhibitors. The single mutants showed an intermediate phenotype, with the strongest effect on the inhibitor by the mutation in Lys192. The Lys192 and the double mutations also affected the rate of cleavage of angiotensin I but did not seem to affect the specificity in the cleavage of the Tyr(4)-Ile(5) bond. A more detailed knowledge about which amino acids that confer the specificity of an enzyme can prove to be of major importance for development of highly specific inhibitors for the human chymase and other medically important enzymes.	[Ahooghalandari, Parvin; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden; [Hanke, Nina; Witte, Andreas; Messinger, Josef] Abbott Prod, Hannover, Germany	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080	Swedish National Research Council (VRNT); Abbott AG Germany	Swedish National Research Council (VRNT); Abbott AG Germany	This study was supported by grants from the Swedish National Research Council (VRNT) and from Abbott AG Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Guo CY, 2001, J CLIN INVEST, V107, P703, DOI 10.1172/JCI9997; HUANG RY, 1994, IMMUNOGENETICS, V40, P397, DOI 10.1007/BF00177823; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Muilenburg DJ, 2002, BBA-PROTEIN STRUCT M, V1596, P346, DOI 10.1016/S0167-4838(02)00224-8; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Saito K, 2003, BIOCHEM BIOPH RES CO, V302, P773, DOI 10.1016/S0006-291X(03)00263-8; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; Serafin W E, 1990, Monogr Allergy, V27, P31; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65988	10.1371/journal.pone.0065988	http://dx.doi.org/10.1371/journal.pone.0065988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840386	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200045
J	Li, F; Yu, X; Szynkarski, CK; Meng, C; Zhou, BY; Barhoumi, R; White, RE; Heaps, CL; Stallone, JN; Han, GC				Li, Fen; Yu, Xuan; Szynkarski, Claudia K.; Meng, Cong; Zhou, Beiyan; Barhoumi, Rola; White, Richard E.; Heaps, Cristine L.; Stallone, John N.; Han, Guichun			Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; VASCULAR INJURY RESPONSE; GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; INTIMAL HYPERPLASIA; BLOOD-PRESSURE; CANCER CELLS; EXPRESSION; GPR30; INDUCTION	Background: Vascular pathology and dysfunction are direct life-threatening outcomes resulting from atherosclerosis or vascular injury, which are primarily attributed to contractile smooth muscle cells (SMCs) dedifferentiation and proliferation by re-entering cell cycle. Increasing evidence suggests potent protective effects of G-protein coupled estrogen receptor 1 (GPER) activation against cardiovascular diseases. However, the mechanism underlying GPER function remains poorly understood, especially if it plays a potential role in modulating coronary artery smooth muscle cells (CASMCs). Methodology/Principal Findings: The objective of our study was to understand the functional role of GPER in CASMC proliferation and differentiation in coronary arteries using from humans and swine models. We found that the GPER agonist, G-1, inhibited both human and porcine CASMC proliferation in a concentration- (10(-8) to 10(-5) M) and time-dependent manner. Flow cytometry revealed that treatment with G-1 significantly decreased the proportion of S-phase and G2/M cells in the growing cell population, suggesting that G-1 inhibits cell proliferation by slowing progression of the cell cycle. Further, G-1-induced cell cycle retardation was associated with decreased expression of cyclin B, up-regulation of cyclin D1, and concomitant induction of p21, and partially mediated by suppressed ERK1/2 and Akt pathways. In addition, G-1 induces SMC differentiation evidenced by increased alpha-smooth muscle actin (alpha-actin) and smooth muscle protein 22 alpha (SM22 alpha) protein expressions and inhibits CASMC migration induced by growth medium. Conclusion: GPER activation inhibits CASMC proliferation by suppressing cell cycle progression via inhibition of ERK1/2 and Akt phosphorylation. GPER may constitute a novel mechanism to suppress intimal migration and/or synthetic phenotype of VSMC.	[Li, Fen; Yu, Xuan; Szynkarski, Claudia K.; Heaps, Cristine L.; Stallone, John N.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA; [Meng, Cong; Zhou, Beiyan] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX USA; [Barhoumi, Rola] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Li, Fen] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan Province, Peoples R China; [White, Richard E.] Philadelphia Coll Osteopath Med, Dept Basic Sci, Suwanee, GA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Henan Normal University	Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Yu, Xuan/0000-0003-3343-7105; Zhou, Beiyan/0000-0003-0638-2428	American Heart Association [11BGIA7370061]; NIH-NCRR [1S10RR22532-01]; NIH [P30-ES09106, P42-ES04917, T32 ES07273, R01 ES002710]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Beginning Grant-In-Aid from American Heart Association [11BGIA7370061 to G.H.]. Confocal microscopy was performed in the Texas A&M University College of Veterinary Medicine & Biomedical Sciences Image Analysis Laboratory, supported by NIH-NCRR (1S10RR22532-01), and NIH grants P30-ES09106, P42-ES04917, T32 ES07273 and R01 ES002710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chaterji S, 2010, TISSUE ENG PT A, V16, P1901, DOI [10.1089/ten.tea.2009.0271, 10.1089/ten.TEA.2009.0271]; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dubey RK, 2000, ARTERIOSCL THROM VAS, V20, P964, DOI 10.1161/01.ATV.20.4.964; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; FOEGH ML, 1994, J VASC SURG, V19, P722, DOI 10.1016/S0741-5214(94)70047-8; Granada JF, 2005, ARTERIOSCL THROM VAS, V25, P2343, DOI 10.1161/01.ATV.0000184779.01822.9d; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Karas RH, 1999, P NATL ACAD SCI USA, V96, P15133, DOI 10.1073/pnas.96.26.15133; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kawagoe J, 2007, ENDOCRINOLOGY, V148, P6092, DOI 10.1210/en.2007-0188; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Liu HM, 2007, LIFE SCI, V80, P800, DOI 10.1016/j.lfs.2006.11.014; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mathew OP, 2010, BIOMED PHARMACOTHER, V64, P733, DOI 10.1016/j.biopha.2010.09.017; Odenlund M, 2009, AMINO ACIDS, V36, P273, DOI 10.1007/s00726-008-0060-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riendeau V, 2009, FREE RADICAL RES, V43, P1019, DOI 10.1080/10715760903040610; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Selzman CH, 1998, J SURG RES, V80, P380, DOI 10.1006/jsre.1998.5487; Sivritas D, 2011, BASIC RES CARDIOL, V106, P563, DOI 10.1007/s00395-011-0174-z; Takahashi K, 2003, J ENDOCRINOL, V178, P319, DOI 10.1677/joe.0.1780319; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tian JQ, 1999, AM J PHYSIOL-CELL PH, V276, pC1245, DOI 10.1152/ajpcell.1999.276.6.C1245; YAN GZ, 1995, J NEUROSCI, V15, P6200; Yena S, 2006, ANN CHIR, V131, P22, DOI 10.1016/j.anchir.2005.08.005; Yu JJ, 2005, J CLIN MICROBIOL, V43, P5462, DOI 10.1128/JCM.43.11.5462-5469.2005; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011; Yun ES, 2011, TOXICOL IN VITRO, V25, P1335, DOI 10.1016/j.tiv.2011.05.001; Zhao Y, 2013, BIOCH BIOPHYS RES CO	42	50	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64771	10.1371/journal.pone.0064771	http://dx.doi.org/10.1371/journal.pone.0064771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840305	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200004
J	Yoon, I; Hamaguchi, K; Borzenets, IV; Finkelstein, G; Mooney, R; Donald, BR				Yoon, Inho; Hamaguchi, Kosuke; Borzenets, Ivan V.; Finkelstein, Gleb; Mooney, Richard; Donald, Bruce R.			Intracellular Neural Recording with Pure Carbon Nanotube Probes	PLOS ONE			English	Article							MICROELECTRODE ARRAY; ACTION-POTENTIALS; ELECTRODE ARRAYS; CHANNELRHODOPSIN-2	The computational complexity of the brain depends in part on a neuron's capacity to integrate electrochemical information from vast numbers of synaptic inputs. The measurements of synaptic activity that are crucial for mechanistic understanding of brain function are also challenging, because they require intracellular recording methods to detect and resolve millivolt-scale synaptic potentials. Although glass electrodes are widely used for intracellular recordings, novel electrodes with superior mechanical and electrical properties are desirable, because they could extend intracellular recording methods to challenging environments, including long term recordings in freely behaving animals. Carbon nanotubes (CNTs) can theoretically deliver this advance, but the difficulty of assembling CNTs has limited their application to a coating layer or assembly on a planar substrate, resulting in electrodes that are more suitable for in vivo extracellular recording or extracellular recording from isolated cells. Here we show that a novel, yet remarkably simple, millimeter-long electrode with a sub-micron tip, fabricated from self-entangled pure CNTs can be used to obtain intracellular and extracellular recordings from vertebrate neurons in vitro and in vivo. This fabrication technology provides a new method for assembling intracellular electrodes from CNTs, affording a promising opportunity to harness nanotechnology for neuroscience applications.	[Yoon, Inho; Donald, Bruce R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Hamaguchi, Kosuke; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Borzenets, Ivan V.; Finkelstein, Gleb] Duke Univ, Dept Phys, Durham, NC 27706 USA; [Donald, Bruce R.] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Donald, Bruce R.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu; brd+plos13@cs.duke.edu	Borzenets, Ivan/M-9912-2015	Borzenets, Ivan/0000-0002-1577-8312; Hamaguchi, Kosuke/0000-0002-0540-320X; Mooney, Richard/0000-0002-3308-1367	Duke Institute for Brain Sciences; National Institutes of Health [NS-79929, GM-65982, GM-78031]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	Duke Institute for Brain Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by a grant to R.M., G.F., and B.R.D. from the Duke Institute for Brain Sciences, and by National Institutes of Health grants (NS-79929 (to R. M. and B. R. D), GM-65982 (to B. R. D), and GM-78031 (to B. R. D)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043194; Borzenets IV, 2012, J APPL PHYS, V111, DOI 10.1063/1.3702802; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; de Asis ED, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125101; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Ensell G, 1996, J MICROELECTROMECH S, V5, P117, DOI 10.1109/84.506199; Jensen W, 2006, IEEE T BIO-MED ENG, V53, P934, DOI 10.1109/TBME.2006.872824; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Ma J, 2009, ACS NANO, V3, P3679, DOI 10.1021/nn900787h; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; Musallam S, 2007, J NEUROSCI METH, V160, P122, DOI 10.1016/j.jneumeth.2006.09.005; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; Pellinen DS, 2005, P ANN INT IEEE EMBS, P5272, DOI 10.1109/IEMBS.2005.1615669; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Shoval A, 2009, FRONTIERS NEUROENGIN, P2; Tang J, 2003, ADV MATER, V15, P1352, DOI 10.1002/adma.200305086; Voge CM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/011001; Wise KD, 2004, P IEEE, V92, P76, DOI 10.1109/JPROC.2003.820544; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Yeh SR, 2009, LANGMUIR, V25, P7718, DOI 10.1021/la900264x; Zheng JP, 2010, TALANTA, V81, P1045, DOI 10.1016/j.talanta.2010.01.059	25	42	43	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65715	10.1371/journal.pone.0065715	http://dx.doi.org/10.1371/journal.pone.0065715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840357	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200032
J	Yu, Y; Liu, ZQ; Liu, XY; Yang, L; Geng, XR; Yang, G; Liu, ZG; Zheng, PY; Yang, PC				Yu, Yong; Liu, Zhi-Qiang; Liu, Xiao-Yu; Yang, Li; Geng, Xiao-Rui; Yang, Gui; Liu, Zhi-Gang; Zheng, Peng-Yuan; Yang, Ping-Chang			Stress-Derived Corticotropin Releasing Factor Breaches Epithelial Endotoxin Tolerance	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLAUDIN-2 EXPRESSION; PSYCHOLOGICAL STRESS; BARRIER DYSFUNCTION; CROHNS-DISEASE; MUCOSAL INFLAMMATION; PSYCHOSOCIAL STRESS; MAST-CELLS; RAT MODEL; PERMEABILITY	Background and aims: Loss of the endotoxin tolerance of intestinal epithelium contributes to a number of intestinal diseases. The etiology is not clear. Psychological stress is proposed to compromise the intestinal barrier function. The present study aims to elucidate the role of the stress-derived corticotropin releasing factor (CRF) in breaching the established intestinal epithelial endotoxin tolerance. Methods: Epithelial cells of HT-29, T84 and MDCK were exposed to lipopolysaccharide to induce the endotoxin tolerance; the cells were then stimulated with CRF. The epithelial barrier function was determined using as indicators of the endotoxin tolerant status. A water-avoid stress mouse model was employed to test the role of CRF in breaching the established endotoxin tolerance in the intestine. Results: The established endotoxin tolerance in the epithelial cell monolayers was broken down by a sequent exposure to CRF and LPS manifesting a marked drop of the transepithelial resistance (TER) and an increase in the permeability to a macromolecular tracer, horseradish peroxidase (HRP). The exposure to CRF also increased the expression of Cldn2 in the epithelial cells, which could be mimicked by over expression of TLR4 in epithelial cells. Over expression of Cldn2 resulted in low TER in epithelial monolayers and high permeability to HRP. After treating mice with the 10-day chronic stress, the intestinal epithelial barrier function was markedly compromised, which could be prevented by blocking either CRF, or TLR4, or Cldn2. Conclusions: Psychological stress-derived CRF can breach the established endotoxin tolerance in the intestinal mucosa.	[Yu, Yong; Liu, Zhi-Qiang; Yang, Li; Zheng, Peng-Yuan] Zhengzhou Univ, Dept Gastroenterol, Hosp 2, Zhengzhou 450052, Peoples R China; [Liu, Xiao-Yu; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Allergy & Immunol Inst, Sch Med, Shenzhen, Peoples R China; [Geng, Xiao-Rui; Yang, Gui] ENT Hosp, Longgang Cent Hosp, Shenzhen, Peoples R China; [Geng, Xiao-Rui; Yang, Gui] Shenzhen ENT Inst, Shenzhen, Peoples R China	Zhengzhou University; Shenzhen University	Zheng, PY (corresponding author), Zhengzhou Univ, Dept Gastroenterol, Hosp 2, Zhengzhou 450052, Peoples R China.	pengyuanzheng@163.com; pcy2356@163.com	Yang, Ping-Chang/K-4669-2019		973 Program of China [2011CB512006]; Natural Science Foundation of SZU [000004]; National Natural Science Foundation of China [81271950, 31101280, 31070799]; Shenzhen Municipal Research Key Laboratory Programme [SW201110010]	973 Program of China(National Basic Research Program of China); Natural Science Foundation of SZU; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Research Key Laboratory Programme	This study was supported by grants from 973 Program (#2011CB512006) of China, the Natural Science Foundation of SZU (#000004), the National Natural Science Foundation of China (No. 81271950, 31101280, 31070799) and Shenzhen Municipal Research Key Laboratory Programme (SW201110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; CIOCCA DR, 1990, BREAST CANCER RES TR, V15, P175, DOI 10.1007/BF01806354; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Demaude J, 2009, LIFE SCI, V84, P847, DOI 10.1016/j.lfs.2009.03.016; Denizot J, 2012, INFLAMM BOWEL DIS, V18, P294, DOI 10.1002/ibd.21787; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Hashimoto M, 2001, PHYSIOL BEHAV, V73, P125, DOI 10.1016/S0031-9384(01)00473-5; Henriksen M, 2006, SCAND J GASTROENTERO, V41, P1037, DOI 10.1080/00365520600554527; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; HONGKUAN F, 2004, J ENDOTOXIN RES, V10, P71; Kim DH, 2010, J KOREAN MED SCI, V25, P1330, DOI 10.3346/jkms.2010.25.9.1330; Kosztolanyi A, 2012, HORM BEHAV, V61, P734, DOI 10.1016/j.yhbeh.2012.03.011; Kuge T, 2006, LIFE SCI, V79, P913, DOI 10.1016/j.lfs.2006.03.002; Lenoir C, 2008, LIFE SCI, V82, P519, DOI 10.1016/j.lfs.2007.12.007; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Naliboff BD, 2012, AM J GASTROENTEROL, V107, P451, DOI 10.1038/ajg.2011.377; Pasternak BA, 2010, INFLAMM BOWEL DIS, V16, P856, DOI 10.1002/ibd.21132; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Roth MK, 2012, NEUROPHARMACOLOGY, V63, P1118, DOI 10.1016/j.neuropharm.2012.07.034; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Seksik P, 2010, INNATE IMMUN-LONDON, V16, P381, DOI 10.1177/1753425909357076; Smith AJ, 2010, JAIDS-J ACQ IMM DEF, V55, P306, DOI 10.1097/QAI.0b013e3181ecfeca; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Sun LL, 2011, CURR OPIN GASTROEN, V27, P321, DOI 10.1097/MOG.0b013e32834661b4; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tang LY, 2008, CAN J GASTROENTEROL, V22, P475, DOI 10.1155/2008/109218; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Vicario M, 2010, BRAIN BEHAV IMMUN, V24, P1166, DOI 10.1016/j.bbi.2010.06.002; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Wallon C, 2011, GASTROENTEROLOGY, V140, P1597, DOI 10.1053/j.gastro.2011.01.042; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wu L, 2007, IMMUNOL CELL BIOL, V85, P538, DOI 10.1038/sj.icb.7100079; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yu LC, 2012, J ALLERGY CAIRO; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zheng PY, 2009, GUT, V58, P1473, DOI 10.1136/gut.2009.181701	42	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65760	10.1371/journal.pone.0065760	http://dx.doi.org/10.1371/journal.pone.0065760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840363	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200033
J	Steelman, AJ; Smith, R; Welsh, CJ; Li, JR				Steelman, Andrew J.; Smith, Roger; Welsh, C. Jane; Li, Jianrong			Galectin-9 Protein Is Up-regulated in Astrocytes by Tumor Necrosis Factor and Promotes Encephalitogenic T-cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; IFN-GAMMA; AUTOIMMUNE ENCEPHALOMYELITIS; REACTIVE ASTROCYTES; ENDOTHELIAL-CELLS; TIM-3 EXPRESSION; CONTROLLED TRIAL; NATALIZUMAB; ACTIVATION; INDUCTION	Demyelination and axonal damage in multiple sclerosis (MS) are thought to be a consequence of inflammatory processes that are perpetuated by activated glia and infiltrating leukocytes. Galectin-9 is a beta-galactoside binding lectin capable of modulating immune responses and appears to be up-regulated in MS. However, its role in the pathogenesis of MS has yet to be determined. Here, we report that proinflammatory cytokines induce galectin-9 (Gal-9) expression in primary astrocytes and the mechanism by which TNF up-regulates Gal-9. Astrocytes did not express Gal-9 under basal conditions nor did IL-6, IL-10, or IL-13 trigger Gal-9 expression. In contrast, IL-1 beta, IFN-gamma, and particularly TNF up-regulated Gal-9 in astrocytes. TNF-induced Gal-9 expression was dependent on TNF receptor 1 (TNFR1) as TNF failed to induce Gal-9 in TNFR1(-/-) astrocytes. Blockade of the JNK MAP kinase pathway with the JNK inhibitor SP600125 abrogated TNF-induced Gal-9, whereas p38 and MEK inhibitors had minimal effects. Furthermore, specific knockdown of c-Jun via siRNA in astrocytes before TNF treatment greatly suppressed Gal-9 transcription, suggesting that TNF induces astroglial Gal-9 through the TNF/TNFR1/JNK/c-Jun signaling pathway. Finally, utilizing astrocytes from Lgals9 mutant (Gal-9(-/-)) mice as well as a myelin basic protein-specific Tim-3(+) encephalitogenic T-cell clone (LCN-8), we found that conditioned medium from TNF-stimulated Gal-9(-/-) but not Gal-9(-/-) astrocytes increased the percentage of apoptotic encephalitogenic T-cells. Together, our results suggest that Gal-9 is induced in astrocytes by TNF via the JNK/c-Jun pathway and that astrocyte-derived Gal-9 may function as an immunoregulatory protein in response to ongoing neuroinflammation.	[Steelman, Andrew J.; Welsh, C. Jane; Li, Jianrong] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Smith, Roger; Welsh, C. Jane] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Li, JR (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, Mail Stop 4458, College Stn, TX 77843 USA.	jrli@cvm.tamu.edu	Li, Jianrong/C-4126-2011	Li, Jianrong/0000-0002-8232-9322; Smith, Roger/0000-0001-5645-8422	National Institutes of Health [R01NS060017]; National Multiple Sclerosis Society [RG3975, RG4586, FG1937]; College of Veterinary Medicine Texas AM University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060017, R56NS060017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); College of Veterinary Medicine Texas AM University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS060017 (to J. L.). This work was also supported by National Multiple Sclerosis Society Research Grants RG3975 and RG4586 (to J. L.) and Postdoctoral Fellowship FG1937 (to A. J. S.) and a College of Veterinary Medicine Texas A&M University postdoctoral research training grant (to A. J. S.).	Abdelbary NH, 2011, J INFECT DIS, V203, P948, DOI 10.1093/infdis/jiq153; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Allen SJ, 2010, J VIROL, V84, P12315, DOI 10.1128/JVI.01600-10; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Bachmann R, 1999, AM J PATHOL, V154, P1417, DOI 10.1016/S0002-9440(10)65395-3; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; Bechmann I, 2002, J NEUROIMMUNOL, V132, P60, DOI 10.1016/S0165-5728(02)00311-9; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Ferber IA, 1996, J IMMUNOL, V156, P5; Gimsa U, 2004, J MOL MED-JMM, V82, P364, DOI 10.1007/s00109-004-0531-6; Hara H, 2011, J NEUROIMMUNOL, V233, P135, DOI 10.1016/j.jneuroim.2010.12.011; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Imaizumi T, 2007, GLYCOBIOLOGY, V17, p12C, DOI 10.1093/glycob/cwm045; Ishikawa A, 2004, IMMUNOL CELL BIOL, V82, P410, DOI 10.1111/j.0818-9641.2004.01248.x; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kim S, 2012, BRAIN PATHOL, V22, P41, DOI 10.1111/j.1750-3639.2011.00501.x; Kim S, 2011, J NEUROCHEM, V116, P53, DOI 10.1111/j.1471-4159.2010.07084.x; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Koito Hisami, 2009, J Vis Exp, DOI 10.3791/1304; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lensch M, 2006, INT J BIOCHEM CELL B, V38, P1741, DOI 10.1016/j.biocel.2006.04.004; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Park WS, 2011, BIOCHEM BIOPH RES CO, V411, P259, DOI 10.1016/j.bbrc.2011.06.110; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stancic M, 2011, NEUROPATH APPL NEURO, V37, P654, DOI 10.1111/j.1365-2990.2011.01184.x; Steelman AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-89; Steelman AJ, 2009, BRAIN BEHAV IMMUN, V23, P830, DOI 10.1016/j.bbi.2009.03.010; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Xiao BG, 1998, J NEUROIMMUNOL, V89, P113, DOI 10.1016/S0165-5728(98)00123-4; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	58	48	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23776	23787		10.1074/jbc.M113.451658	http://dx.doi.org/10.1074/jbc.M113.451658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836896	Green Published, hybrid			2022-12-25	WOS:000330611400017
J	Daniil, G; Zannis, VI; Chroni, A				Daniil, Georgios; Zannis, Vassilis I.; Chroni, Angeliki			Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; BINDING CASSETTE TRANSPORTER; ATHEROSCLEROTIC LESION DEVELOPMENT; ABCG1(-/-) BONE-MARROW; B TYPE-I; ALVEOLAR MACROPHAGES; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; DEFICIENT MICE	ATP binding cassette transporter G1 (ABCG1) mediates the cholesterol transport from cells to high-density lipoprotein (HDL), but the role of apolipoprotein A-I (apoA-I), the main protein constituent of HDL, in this process is not clear. To address this, we measured cholesterol efflux from HEK293 cells or J774 mouse macrophages overexpressing ABCG1 using as acceptors reconstituted HDL (rHDL) containing wild-type or various mutant apoA-I forms. It was found that ABCG1-mediated cholesterol efflux was severely reduced (by 89%) when using rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)]. ABCG1-mediated cholesterol efflux was not affected or moderately decreased by rHDL containing amino-terminal deletion mutants and several mid-region deletion or point apoA-I mutants, and was restored to 69-99% of control by double deletion mutants apoA-I[Delta(1-41)Delta(185-243)] and apoA-I[Delta(1-59)Delta(185-243)]. These findings suggest that the central helices alone of apoA-I associated to rHDL can promote ABCG1-mediated cholesterol efflux. Further analysis showed that rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)] only slightly reduced (by 22%) the ABCG1-mediated efflux of 7-ketocholesterol, indicating that depending on the sterol type, structural changes in rHDL-associated apoA-I affect differently the ABCG1-mediated efflux of cholesterol and 7-ketocholesterol. Overall, our findings demonstrate that rHDL-associated apoA-I structural changes affect the capacity of rHDL to accept cellular cholesterol by an ABCG1-mediated process. The structure-function relationship seen here between rHDL-associated apoA-I mutants and ABCG1-mediated cholesterol efflux closely resembles that seen before in lipid-free apoA-I mutants and ABCA1-dependent cholesterol efflux, suggesting that both processes depend on the same structural determinants of apoA-I.	[Daniil, Georgios; Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	National Centre of Scientific Research "Demokritos"; Boston University; Boston University	Chroni, A (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	achroni@bio.demokritos.gr		Chroni, Angeliki/0000-0003-3107-1189	General Secretariat of Research and Technology of Greece [Synergasia 09SYN-12-897]; Ministry of Education, Lifelong Learning and Religious Affairs of Greece [Thalis 3569]; Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; National Institutes of Health [HL48739]; National Center for Scientific Research "Demokritos"	General Secretariat of Research and Technology of Greece(Greek Ministry of Development-GSRT); Ministry of Education, Lifelong Learning and Religious Affairs of Greece; Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Scientific Research "Demokritos"	Funding for this work was provided by the General Secretariat of Research and Technology of Greece (Synergasia 09SYN-12-897), the Ministry of Education, Lifelong Learning and Religious Affairs of Greece (Thalis 3569), the Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease and the National Institutes of Health (grant HL48739). GD received financial support from the graduate student fellowship program of National Center for Scientific Research "Demokritos". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bach D, 2008, BIOCHEMISTRY-US, V47, P3004, DOI 10.1021/bi702070b; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chroni A, 2004, BIOCHEMISTRY-US, V43, P10442, DOI 10.1021/bi049782p; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Cuchel M, 2010, ARTERIOSCL THROM VAS, V30, P526, DOI 10.1161/ATVBAHA.109.196105; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GALLA HJ, 1980, BIOCHIM BIOPHYS ACTA, V596, P108, DOI 10.1016/0005-2736(80)90174-1; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Hashimoto M, 1999, EXP GERONTOL, V34, P687, DOI 10.1016/S0531-5565(99)00025-X; KAN CC, 1992, BIOCHEMISTRY-US, V31, P1866, DOI 10.1021/bi00121a040; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Khalil N, 1996, AM J RESP CELL MOL, V15, P252, DOI 10.1165/ajrcmb.15.2.8703482; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P2086, DOI 10.1161/01.ATV.0000041405.07367.B5; Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Lindstedt L, 1996, J CLIN INVEST, V97, P2174, DOI 10.1172/JCI118658; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Lindstedt L, 2000, BIOCHEM BIOPH RES CO, V277, P552, DOI 10.1006/bbrc.2000.3704; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Lorenzi I, 2008, BBA-MOL CELL BIOL L, V1781, P306, DOI 10.1016/j.bbalip.2008.04.006; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Out R, 2007, ARTERIOSCL THROM VAS, V27, P594, DOI 10.1161/01.ATV.0000257136.24308.0c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Sankaranarayanan S, 2009, J LIPID RES, V50, P275, DOI 10.1194/jlr.M800362-JLR200; Schou J, 2012, ARTERIOSCL THROM VAS, V32, P506, DOI 10.1161/ATVBAHA.111.234872; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Wang M, 2007, J LIPID RES, V48, P633, DOI 10.1194/jlr.M600470-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	61	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67993	10.1371/journal.pone.0067993	http://dx.doi.org/10.1371/journal.pone.0067993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826352	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000106
J	Lattanzi, A; Gentner, B; Corno, D; Di Tomaso, T; Mestdagh, P; Speleman, F; Naldini, L; Gritti, A				Lattanzi, Annalisa; Gentner, Bernhard; Corno, Daniela; Di Tomaso, Tiziano; Mestdagh, Pieter; Speleman, Frank; Naldini, Luigi; Gritti, Angela			Dynamic Activity of miR-125b and miR-93 during Murine Neural Stem Cell Differentiation In Vitro and in the Subventricular Zone Neurogenic Niche	PLOS ONE			English	Article							ADULT NEUROGENESIS; MICRORNA EXPRESSION; SITU HYBRIDIZATION; LENTIVIRAL VECTOR; MIRNA EXPRESSION; PROLIFERATION; ROLES; BRAIN; CLUSTER; PATHWAY	Several microRNAs (miRNAs) that are either specifically enriched or highly expressed in neurons and glia have been described, but the identification of miRNAs modulating neural stem cell (NSC) biology remains elusive. In this study, we exploited high throughput miRNA expression profiling to identify candidate miRNAs enriched in NSC/early progenitors derived from the murine subventricular zone (SVZ). Then, we used lentiviral miRNA sensor vectors (LV. miRT) to monitor the activity of shortlisted miRNAs with cellular and temporal resolution during NSC differentiation, taking advantage of in vitro and in vivo models that recapitulate physiological neurogenesis and gliogenesis and using known neuronal-and glial-specific miRNAs as reference. The LV. miRT platform allowed us monitoring endogenous miRNA activity in low represented cell populations within a bulk culture or within the complexity of CNS tissue, with high sensitivity and specificity. In this way we validated and extended previous results on the neuronal-specific miR-124 and the astroglial-specific miR-23a. Importantly, we describe for the first time a cell type-and differentiation stage-specific modulation of miR-93 and miR-125b in SVZ-derived NSC cultures and in the SVZ neurogenic niche in vivo, suggesting key roles of these miRNAs in regulating NSC function.	[Lattanzi, Annalisa; Gentner, Bernhard; Corno, Daniela; Di Tomaso, Tiziano; Naldini, Luigi; Gritti, Angela] Ist Sci San Raffaele, Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy; [Lattanzi, Annalisa] Univ Perugia, Sect Biochem & Mol Biol, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Mestdagh, Pieter; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Naldini, Luigi] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Perugia; Ghent University; Ghent University Hospital; Vita-Salute San Raffaele University	Gritti, A (corresponding author), Ist Sci San Raffaele, Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy.	gritti.angela@hsr.it	Gritti, Angela/K-2729-2016; speleman, frank/AAR-5184-2020	Gritti, Angela/0000-0002-9845-0370; speleman, frank/0000-0002-6628-8559; Mestdagh, Pieter/0000-0001-7821-9684; Gentner, Bernhard/0000-0001-6024-4718; Lattanzi, Annalisa/0000-0002-3953-9172; NALDINI, Luigi/0000-0002-7835-527X	Comitato Telethon Fondazione Onlus [TGT06B02, TGT11B02, TGT11D02]; ERC	Comitato Telethon Fondazione Onlus(Fondazione Telethon); ERC(European Research Council (ERC)European Commission)	Partial funding for this work has been provided by Comitato Telethon Fondazione Onlus (Grants TGT06B02 and TGT11B02 to A. G; TGT11D02 to L.N.) and ERC grant to L.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian S, 2013, CELL REP; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cavazzin C, 2006, GLIA; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Stefano B, 2011, STEM CELLS, V29, P1684, DOI 10.1002/stem.726; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Farrell BC, 2011, INT J DEV NEUROSCI, V29, P31, DOI 10.1016/j.ijdevneu.2010.10.001; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gao ZL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00067; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gritti A, 2009, J COMP NEUROL, V517, P333, DOI 10.1002/cne.22153; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071; Lattanzi A, 2010, HUM MOL GENET, V19, P2208, DOI 10.1093/hmg/ddq099; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maiorano NA, 2010, RNA BIOL, V7, P528, DOI 10.4161/rna.7.5.12262; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Neri M, 2011, STEM CELLS, V29, P1559, DOI 10.1002/stem.701; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sachdeva R, 2010, P NATL ACAD SCI USA, V107, P11602, DOI 10.1073/pnas.1006568107; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silver DJ, 2009, TRENDS NEUROSCI, V32, P303, DOI 10.1016/j.tins.2009.01.008; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stappert L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059011, 10.1371/annotation/b03fbc42-8f70-4873-9cce-854e48249a13]; Thompson RC, 2007, METHODS, V43, P153, DOI 10.1016/j.ymeth.2007.04.008; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	68	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67411	10.1371/journal.pone.0067411	http://dx.doi.org/10.1371/journal.pone.0067411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826292	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000078
J	Leong, S; Simo, G; Camara, M; Jamonneau, V; Kabore, J; Ilboudo, H; Bucheton, B; Hoheisel, JD; Clayton, C				Leong, Smiths; Simo, Gustave; Camara, Mamadou; Jamonneau, Vincent; Kabore, Jacques; Ilboudo, Hamidou; Bucheton, Bruno; Hoheisel, Joerg D.; Clayton, Christine			The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS DIAGNOSIS; MICRORNA EXPRESSION; CANCER CELLS; PROLIFERATION; BIOMARKERS; DISEASE; SERUM; SURVEILLANCE; PATHOGENESIS	Simple, reliable tools for diagnosis of human African Trypanosomiases could ease field surveillance and enhance patient care. In particular, current methods to distinguish patients with (stage II) and without (stage I) brain involvement require samples of cerebrospinal fluid. We describe here an exploratory study to find out whether miRNAs from peripheral blood leukocytes might be useful in diagnosis of human trypanosomiasis, or for determining the stage of the disease. Using microarrays, we measured miRNAs in samples from Trypanosoma brucei gambiense-infected patients (9 stage I, 10 stage II), 8 seronegative parasite-negative controls and 12 seropositive, but parasite-negative subjects. 8 miRNAs (out of 1205 tested) showed significantly lower expression in patients than in seronegative, parasite-negative controls, and 1 showed increased expression. There were no clear differences in miRNAs between patients in different disease stages. The miRNA profiles could not distinguish seropositive, but parasitologically negative samples from controls and results within this group did not correlate with those from the trypanolysis test. Some of the regulated miRNAs, or their predicted mRNA targets, were previously reported changed during other infectious diseases or cancer. We conclude that the changes in miRNA profiles of peripheral blood lymphocytes in human African trypanosomiasis are related to immune activation or inflammation, are probably disease-non-specific, and cannot be used to determine the disease stage. The approach has little promise for diagnostics but might yield information about disease pathology.	[Leong, Smiths; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum DKFZ, Div Funct Genome Anal, Heidelberg, Germany; [Simo, Gustave] Univ Dschang, Dept Biochem, Dschang, West Cameroon, Cameroon; [Camara, Mamadou] Programme Natl Lutte Trypanosomiase Humaine Afric, Conakry, Guinea; [Camara, Mamadou; Jamonneau, Vincent; Kabore, Jacques; Ilboudo, Hamidou; Bucheton, Bruno] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Jamonneau, Vincent; Bucheton, Bruno] Inst Rech Dev, UMR 177, Montpellier, France; [Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institut de Recherche pour le Developpement (IRD); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Jamonneau, Vincent/K-1124-2016; Clayton, Christine/K-7700-2019	Jamonneau, Vincent/0000-0001-8427-0769; Clayton, Christine/0000-0002-6384-0731; Bauer, Andrea/0000-0002-7919-0497; ILBOUDO, Hamidou/0000-0003-3936-7718; Camara, Mamadou/0000-0001-7785-6649	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD); Alexander von Humboldt Foundation	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	SL was supported by a grant from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD). GS was supported by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2012, ADV GENET, V80, P1, DOI 10.1016/B978-0-12-404742-6.00001-6; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Biyashev D, 2012, BLOOD, V119, P2679, DOI 10.1182/blood-2011-07-370635; Boda C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006184; Boeri M, 2012, CANCER J, V18, P268, DOI 10.1097/PPO.0b013e318258b743; Bucheton B, 2011, PARASITE IMMUNOL, V33, P438, DOI 10.1111/j.1365-3024.2011.01287.x; Burchmore R, 2012, EXPERT REV ANTI-INFE, V10, P1283, DOI [10.1586/ERI.12.124, 10.1586/eri.12.124]; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Courtin D, 2006, TROP MED INT HEALTH, V11, P647, DOI 10.1111/j.1365-3156.2006.01612.x; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Delic D, 2011, PARASITOL RES, V108, P1111, DOI 10.1007/s00436-010-2152-z; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dumas Michel, 1996, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V190, P395; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; El-Assaad F, 2011, INFECT IMMUN, V79, P2379, DOI 10.1128/IAI.01136-10; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Hu GK, 2010, J INFECT DIS, V202, P125, DOI 10.1086/653212; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Huang Y, 2012, NUCLEIC ACIDS RES, V40, P10478, DOI 10.1093/nar/gks789; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ilboudo H, 2011, MICROBES INFECT, V13, P943, DOI 10.1016/j.micinf.2011.05.007; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Jamonneau V, 2004, ANN TROP MED PARASIT, V98, P329, DOI 10.1179/000349804225003406; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; KAZYUMBA G, 1986, CLIN EXP IMMUNOL, V65, P10; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; Lejon V, 2002, T ROY SOC TROP MED H, V96, P329, DOI 10.1016/S0035-9203(02)90115-X; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Liston A, 2012, CELL MOL LIFE SCI, V69, P3533, DOI 10.1007/s00018-012-1124-0; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; Maina N, 2004, INFECT IMMUN, V72, P3063, DOI 10.1128/IAI.72.5.3063-3065.2004; Morrison LJ, 2010, INFECT IMMUN, V78, P1096, DOI 10.1128/IAI.00943-09; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; OKOMOASSOUMOU MC, 1995, AM J TROP MED HYG, V53, P539, DOI 10.4269/ajtmh.1995.53.539; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Rhind SG, 1997, CLIN IMMUNOL IMMUNOP, V83, P185, DOI 10.1006/clin.1997.4350; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Stelzer Gil, 2011, Human Genomics, V5, P709; Sternberg J, 2010, PARASITOLOG IN PRESS; Tiberti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040909; Vickers K.C., 2012, HEPATOLOGY; Wang JX, 2012, STEM CELLS, V30, P1405, DOI 10.1002/stem.1121; Wastling SL, 2011, PARASITOLOGY, V138, P1480, DOI 10.1017/S0031182011000230; Zeiner GM, 2010, RNA, V16, P1268, DOI 10.1261/rna.2069310; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhang Z, 2012, OSTEOARTHR CARTILAGE, V20, P1638, DOI 10.1016/j.joca.2012.08.024; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702	62	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67312	10.1371/journal.pone.0067312	http://dx.doi.org/10.1371/journal.pone.0067312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826264	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000059
J	Zhang, H; Yang, Y; Takeda, A; Yoshimura, T; Oshima, Y; Sonoda, KH; Ishibashi, T				Zhang, Han; Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Sonoda, Koh-Hei; Ishibashi, Tatsuro			A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO ANGIOGENESIS; MACULAR DEGENERATION; CYTOKINE PRODUCTION; VEGF EXPRESSION; GENE-EXPRESSION; BINDING-SITES; FACTOR PAF; CELLS; RAT	Choroidal neovascularization (CNV) is a critical pathogenesis in age-related macular degeneration (AMD), the most common cause of blindness in developed countries. To date, the precise molecular and cellular mechanisms underlying CNV have not been elucidated. Platelet-activating factor (PAF) has been previously implicated in angiogenesis; however, the roles of PAF and its receptor (PAF-R) in CNV have not been addressed. The present study reveals several important findings concerning the relationship of the PAF-R signaling with CNV. PAF-R was detected in a mouse model of laser-induced CNV and was upregulated during CNV development. Experimental CNV was suppressed by administering WEB2086, a novel PAF-R antagonist. WEB2086-dependent suppression of CNV occurred via the inhibition of macrophage infiltration and the expression of proangiogenic (vascular endothelial growth factor) and proinflammatory molecules (monocyte chemotactic protein-1 and IL-6) in the retinal pigment epithelium-choroid complex. Additionally, WEB2086-induced PAF-R blockage suppresses experimentally induced subretinal fibrosis, which resembles the fibrotic subretinal scarring observed in neovascular AMD. As optimal treatment modalities for neovascular AMD would target the multiple mechanisms of AMD-associated vision loss, including neovascularization, inflammation and fibrosis, our results suggest PAF-R as an attractive molecular target in the treatment of AMD.	[Zhang, Han; Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Japan; [Zhang, Han] China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China; [Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan	Kyushu University; China Medical University; Yamaguchi University	Zhang, H (corresponding author), Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Japan.	zhanghan0614@139.com		Zhang, Han/0000-0002-9338-0051; Yoshimura, Takeru/0000-0002-5983-7193	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [23689071] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants C (K-H. S.) and grant-in-aid for Young Scientists (A) (A. T.) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; BRAQUET P, 1989, J LIPID MEDIATOR, V1, P75; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BUSSOLINO F, 1995, J CLIN INVEST, V96, P940, DOI 10.1172/JCI118142; CAMUSSI G, 1995, J IMMUNOL, V154, P6492; Camussi G, 1997, J IMMUNOL, V158, P1302; CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974; Chen J, 1997, J PHARMACOL EXP THER, V280, P1219; COHEN RA, 1994, CURR EYE RES, V13, P139, DOI 10.3109/02713689409042408; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; DOMINGO MT, 1989, BIOCHEM BIOPH RES CO, V160, P250, DOI 10.1016/0006-291X(89)91648-3; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Fukuda AI, 1996, HUM REPROD, V11, P2746; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GIRI SN, 1995, EXP LUNG RES, V21, P287, DOI 10.3109/01902149509068833; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Grossniklaus HE, 2002, MOL VIS, V8, P119; He YG, 2009, CURR EYE RES, V34, P957, DOI 10.3109/02713680903231135; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Hwang JC, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20100924-01; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Kasperska-Zajac A, 2008, INFLAMMATION, V31, P112, DOI 10.1007/s10753-007-9056-9; Kent D, 2003, MOL VIS, V9, P747; Kim HA, 2011, CELL PHYSIOL BIOCHEM, V27, P55, DOI 10.1159/000325205; Ko HM, 2002, CANCER RES, V62, P1809; Ma X, 2004, INVEST OPHTH VIS SCI, V45, P2915, DOI 10.1167/iovs.04-0128; Ma X, 2000, INVEST OPHTH VIS SCI, V41, P1696; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; MONTRUCCHIO G, 1994, J EXP MED, V180, P377, DOI 10.1084/jem.180.1.377; Montrucchio G, 2000, ARTERIOSCL THROM VAS, V20, P80, DOI 10.1161/01.ATV.20.1.80; Montrucchio G, 1998, AM J PATHOL, V153, P1589, DOI 10.1016/S0002-9440(10)65747-1; Mori M, 1997, INVEST OPHTH VIS SCI, V38, P2672; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Nilsson G, 2000, IMMUNOLOGY, V99, P314, DOI 10.1046/j.1365-2567.2000.00972.x; Ogata M, 2004, ANESTH ANALG, V98, P1767, DOI 10.1213/01.ANE.0000112310.93297.AF; Proudfoot JM, 2003, J PHARMACOL EXP THER, V305, P846, DOI 10.1124/jpet.102.047795; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Ruiz-Ortega M, 1998, NEPHROL DIAL TRANSPL, V13, P886, DOI 10.1093/ndt/13.4.886; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Semkova I, 2003, INVEST OPHTH VIS SCI, V44, P5349, DOI 10.1167/iovs.02-0732; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; THIERRY A, 1989, EUR J PHARMACOL, V163, P97, DOI 10.1016/0014-2999(89)90400-7; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang HH, 1997, J IMMUNOL, V158, P2771; Yang Y, 2004, GUT, V53, P877, DOI 10.1136/gut.2003.024893; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhang H, 2009, BIOCHEM BIOPH RES CO, V381, P471, DOI 10.1016/j.bbrc.2009.01.178	61	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68173	10.1371/journal.pone.0068173	http://dx.doi.org/10.1371/journal.pone.0068173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826375	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000129
J	Becker, AM; Dao, KH; Han, BK; Kornu, R; Lakhanpal, S; Mobley, AB; Li, QZ; Lian, Y; Wu, TF; Reimold, AM; Olsen, NJ; Karp, DR; Chowdhury, FZ; Farrar, JD; Satterthwaite, AB; Mohan, C; Lipsky, PE; Wakeland, EK; Davis, LS				Becker, Amy M.; Dao, Kathryn H.; Han, Bobby Kwanghoon; Kornu, Roger; Lakhanpal, Shuchi; Mobley, Angela B.; Li, Quan-Zhen; Lian, Yun; Wu, Tianfu; Reimold, Andreas M.; Olsen, Nancy J.; Karp, David R.; Chowdhury, Fatema Z.; Farrar, J. David; Satterthwaite, Anne B.; Mohan, Chandra; Lipsky, Peter E.; Wakeland, Edward K.; Davis, Laurie S.			SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; GENE-EXPRESSION; PROTEIN-INTERACTION; IFN-ALPHA; MEMORY; ACTIVATION; INTERLEUKIN-10; INFLAMMATION; LYMPHOPENIA	Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is characterized by defective immune tolerance combined with immune cell hyperactivity resulting in the production of pathogenic autoantibodies. Previous gene expression studies employing whole blood or peripheral blood mononuclear cells (PBMC) have demonstrated that a majority of patients with active disease have increased expression of type I interferon (IFN) inducible transcripts known as the IFN signature. The goal of the current study was to assess the gene expression profiles of isolated leukocyte subsets obtained from SLE patients. Subsets including CD19(+) B lymphocytes, CD3(+) CD4(+) T lymphocytes and CD33(+) myeloid cells were simultaneously sorted from PBMC. The SLE transcriptomes were assessed for differentially expressed genes as compared to healthy controls. SLE CD33(+) myeloid cells exhibited the greatest number of differentially expressed genes at 208 transcripts, SLE B cells expressed 174 transcripts and SLE CD3(+) CD4(+) T cells expressed 92 transcripts. Only 4.4% (21) of the 474 total transcripts, many associated with the IFN signature, were shared by all three subsets. Transcriptional profiles translated into increased protein expression for CD38, CD63, CD107a and CD169. Moreover, these studies demonstrated that both SLE lymphoid and myeloid subsets expressed elevated transcripts for cytosolic RNA and DNA sensors and downstream effectors mediating IFN and cytokine production. Prolonged upregulation of nucleic acid sensing pathways could modulate immune effector functions and initiate or contribute to the systemic inflammation observed in SLE.	[Becker, Amy M.; Mobley, Angela B.; Li, Quan-Zhen; Lian, Yun; Chowdhury, Fatema Z.; Farrar, J. David; Satterthwaite, Anne B.; Mohan, Chandra; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Becker, Amy M.; Dao, Kathryn H.; Han, Bobby Kwanghoon; Kornu, Roger; Lakhanpal, Shuchi; Wu, Tianfu; Reimold, Andreas M.; Olsen, Nancy J.; Karp, David R.; Satterthwaite, Anne B.; Mohan, Chandra; Davis, Laurie S.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Lipsky, Peter E.] NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Davis, LS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Laurie.Davis@UTSouthwestern.edu	Mohan, Chandra/GPX-8233-2022; Wu, Tianfu/G-6672-2019	Wu, Tianfu/0000-0003-4406-1449; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [P50AR055503, R01AR45293]; UT Southwestern Arthritis Center Flow Cytometry Core; MedImmune; Novo Nordisk; Novo Nordisk, Genentech/Roche; Human Genome Sciences; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045293, P50AR055503] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UT Southwestern Arthritis Center Flow Cytometry Core; MedImmune(AstraZenecaMedimmune); Novo Nordisk(Novo Nordisk); Novo Nordisk, Genentech/Roche; Human Genome Sciences(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P50AR055503 (Mohan), the UT Southwestern Arthritis Center Flow Cytometry Core (Davis) and the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR45293 (Davis). Dr. Nancy Olsen has equity interest in a company, ArthroChip LLC, which develops assays for autoimmune diseases and she has also obtained funding from MedImmune, Novo Nordisk, Genentech/Roche and Human Genome Sciences. Dr. David Karp has received research funding from Human Genome Sciences. None of these funds were used for the current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Carella C, 2006, BLOOD, V107, P1124, DOI 10.1182/blood-2005-03-1196; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Choubey D, 2011, J INTERF CYTOK RES, V31, P893, DOI 10.1089/jir.2011.0073; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096; de Herve MGD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019366; Dorner T, 2004, LUPUS, V13, P283, DOI 10.1191/0961203304lu1014oa; Efremov DG, 2007, AUTOIMMUN REV, V7, P102, DOI 10.1016/j.autrev.2007.02.021; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Furukawa H, 2013, HUM IMMUNOL, V74, P170, DOI 10.1016/j.humimm.2012.11.007; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Han BK, 2005, LUPUS, V14, P598, DOI 10.1191/0961203305lu2171oa; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Harada T, 2007, AUTOIMMUNITY, V40, P1, DOI 10.1080/08916930601095148; Heinlen LD, 2010, J MOL MED, V88, P719, DOI 10.1007/s00109-010-0618-1; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; ISENBERG DA, 1982, ACTA HAEMATOL-BASEL, V67, P242, DOI 10.1159/000207070; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; Jones BM, 1999, AUTOIMMUNITY, V31, P117, DOI 10.3109/08916939908994055; Katsiari CG, 2006, AUTOIMMUN REV, V5, P118, DOI 10.1016/j.autrev.2005.08.009; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kim K, 2009, GENES IMMUN, V10, P482, DOI 10.1038/gene.2009.5; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kleinewietfeld M, 2013, NATURE; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2007, J IMMUNOL, V178, P1960, DOI 10.4049/jimmunol.178.3.1960; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lee J, 2009, J IMMUNOL, V182, P4116, DOI 10.4049/jimmunol.0803391; Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Liu Z, 2011, J IMMUNOL, V187, P1506, DOI 10.4049/jimmunol.1004142; Lugar PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044362; Mathian A, 2011, EUR J IMMUNOL, V41, P863, DOI 10.1002/eji.201040649; Mellor-Pita S, 2009, CYTOM PART B-CLIN CY, V76B, P261, DOI 10.1002/cyto.b.20468; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Petri Michelle, 1995, Current Opinion in Rheumatology, V7, P395, DOI 10.1097/00002281-199509000-00006; RIVERO SJ, 1978, ARTHRITIS RHEUM, V21, P295, DOI 10.1002/art.1780210302; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Silva FPG, 2008, LEUKEMIA, V22, P1639, DOI 10.1038/leu.2008.34; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Vinuesa Carola G., 2001, Current Molecular Medicine (Hilversum), V1, P689, DOI 10.2174/1566524013363276; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; WINFIELD JB, 1975, ARTHRITIS RHEUM, V18, P587, DOI 10.1002/art.1780180609; Wu C, 2013, NATURE; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Ye S, 2003, RHEUMATOLOGY, V42, P1155, DOI 10.1093/rheumatology/keg315; Yin XY, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-21; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407	77	136	137	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67003	10.1371/journal.pone.0067003	http://dx.doi.org/10.1371/journal.pone.0067003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826184	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400092
J	Burzaco, J; Conde, M; Parada, LA; Zugaza, JL; Dehaye, JP; Marino, A				Burzaco, Jaione; Conde, Manuel; Parada, Luis A.; Zugaza, Jose L.; Dehaye, Jean-Paul; Marino, Aida			ATP Antagonizes Thrombin-Induced Signal Transduction through 12(S)-HETE and cAMP	PLOS ONE			English	Article							INDUCED PLATELET-AGGREGATION; EXTRACELLULAR ATP; CYCLIC-GMP; P2X(1) RECEPTORS; BLOOD-PLATELETS; PROTEIN-KINASE; P2 RECEPTORS; ACTIVATION; ADP; INHIBITION	In this study we have investigated the role of extracellular ATP on thrombin induced-platelet aggregation (TIPA) in washed human platelets. ATP inhibited TIPA in a dose-dependent manner and this inhibition was abolished by apyrase but not by adenosine deaminase (ADA) and it was reversed by extracellular magnesium. Antagonists of P2Y(1) and P2Y(12) receptors had no effect on this inhibition suggesting that a P2X receptor controlled ATP-mediated TIPA inhibition. ATP also blocked inositol phosphates (IP1, IP2, IP3) generation and [Ca2+]i mobilization induced by thrombin. Thrombin reduced cAMP levels which were restored in the presence of ATP. SQ-22536, an adenylate cyclase (AC) inhibitor, partially reduced the inhibition exerted by ATP on TIPA. 12-lipoxygenase (12-LO) inhibitors, nordihidroguaretic acid (NDGA) and 15(S)-hydroxy-5,8,11,13-eicosatetraenoic acid (15(S)-HETE), strongly prevented ATP-mediated TIPA inhibition. Additionally, ATP inhibited the increase of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) induced by thrombin. Pretreatment with both SQ-22536 and NDGA almost completely abolished ATP-mediated TIPA inhibition. Our results describe for the first time that ATP implicates both AC and 12-LO pathways in the inhibition of human platelets aggregation in response to agonists.	[Burzaco, Jaione; Conde, Manuel; Marino, Aida] Univ Basque Country, Fac Sci & Technol, Dept Biochem & Mol Biol, Bilbao, Spain; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, Salta, Argentina; [Zugaza, Jose L.] Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain; [Zugaza, Jose L.] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Zugaza, Jose L.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Dehaye, Jean-Paul] Univ Libre Bruxelles, Inst Pharm, Biochem & Cellular Biol Lab, Brussels, Belgium	University of Basque Country; University of Basque Country; Basque Foundation for Science; Universite Libre de Bruxelles	Zugaza, JL (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain.	joseluis.zugaza@ehu.es; aida.marino@ehu.es	Bustelo, Xose R./A-9526-2010	Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; MARINO SANCHEZ, AIDA LUISA/0000-0003-3208-0677	Ministerio de Educacion y Ciencia of Spain [AP2000-2943]; Department of Education of the Basque Government [BFI01.108]; Department of Industry of the Basque Government [S-PE11UN018]; University of the Basque Country [EHU11/08, UFI 11/20, 42.310-15941/04]; Fonds de la Recherche Scientifique Medicale of Belgium [3.4.528.07]; Ministerio de Educacion y Ciencia [BFU2004-02124/BMC, BFU/2007-62728/BMC]	Ministerio de Educacion y Ciencia of Spain(Spanish Government); Department of Education of the Basque Government; Department of Industry of the Basque Government; University of the Basque Country; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Ministerio de Educacion y Ciencia(Spanish Government)	J.B. was supported by grant AP2000-2943 from the Ministerio de Educacion y Ciencia of Spain. M.G.M. was supported by grant no BFI01.108 from the Department of Education of the Basque Government. J.L.Z. was supported by grants from Department of Industry of the Basque Government (S-PE11UN018) and University of the Basque Country (EHU11/08 and UFI 11/20), J.P.D. was supported by grant 3.4.528.07 from the Fonds de la Recherche Scientifique Medicale of Belgium and A. M. was supported in part by grants BFU2004-02124/BMC and BFU/2007-62728/BMC from the Ministerio de Educacion y Ciencia and 42.310-15941/04 from University of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2003, J THROMB HAEMOST, V1, P798, DOI 10.1046/j.1538-7836.2003.00138.x; Alexander S, 1995, MEASUREMENTS CYCLE A, P63; Alzola E, 1998, J BIOL CHEM, V273, P30208, DOI 10.1074/jbc.273.46.30208; AZULA FJ, 1993, AM J PHYSIOL, V265, pC1681, DOI 10.1152/ajpcell.1993.265.6.C1681; Azula FJ, 1996, MOL PHARMACOL, V50, P367; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bursnstock G, 2012, BIOESSAYS, V34, P218; Calzada C, 1997, BIOCHEM J, V325, P495, DOI 10.1042/bj3250495; Cauwenberghs S, 2006, TRANSFUSION, V46, P1018, DOI 10.1111/j.1537-2995.2006.00837.x; CHAMBERS DA, 1967, ARCH BIOCHEM BIOPHYS, V119, P173, DOI 10.1016/0003-9861(67)90444-4; Corriden R, 2007, AM J PHYSIOL-CELL PH, V293, pC1420, DOI 10.1152/ajpcell.00271.2007; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DRAGAN YP, 1990, BIOCHEM PHARMACOL, V39, P27, DOI 10.1016/0006-2952(90)90644-Z; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Erhardt JA, 2006, J THROMB HAEMOST, V4, P882, DOI 10.1111/j.1538-7836.2006.01849.x; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Gachet C, 2005, PHARMACOL THERAPEUT, V108, P180, DOI 10.1016/j.pharmthera.2005.03.009; Garcia AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026035; Gonzalez-Nunez D, 2001, HYPERTENSION, V37, P334, DOI 10.1161/01.HYP.37.2.334; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GRANDT R, 1986, BIOCHEM J, V237, P669, DOI 10.1042/bj2370669; Gratacap MP, 2011, ADV ENZYME REGUL, V51, P106, DOI 10.1016/j.advenzreg.2010.09.011; Grenegard M, 2008, J BIOL CHEM, V283, P18493, DOI 10.1074/jbc.M800358200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hechler B, 2011, PURINERG SIGNAL, V7, P293, DOI 10.1007/s11302-011-9247-6; HOURANI SMO, 1991, PHARMACOL REV, V43, P243; Ishii-Watabe A, 2000, BIOCHEM PHARMACOL, V59, P1345, DOI 10.1016/S0006-2952(00)00279-3; Jackson SP, 2004, BIOCHEM SOC T, V32, P387, DOI 10.1042/BST0320387; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Kaur G, 2010, BLOOD, V115, P3128, DOI 10.1182/blood-2009-04-214601; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; KRISHNAMURTHI S, 1988, BIOCHEM J, V250, P209, DOI 10.1042/bj2500209; Lan Z, 2005, AM J CLIN PATHOL, V123, P172, DOI 10.1309/Y9EC63RW3XG1V313; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Mahaut-Smith MP, 2004, PLATELETS, V15, P131, DOI 10.1080/09537100410001682788; Marcondes S, 2006, P NATL ACAD SCI USA, V103, P3434, DOI 10.1073/pnas.0509397103; MAURICE DH, 1990, MOL PHARMACOL, V37, P671; MCMILLIAN MK, 1993, BRIT J PHARMACOL, V108, P453, DOI 10.1111/j.1476-5381.1993.tb12825.x; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Metioui M, 1996, J CELL PHYSIOL, V168, P462, DOI 10.1002/(SICI)1097-4652(199608)168:2<462::AID-JCP25>3.0.CO;2-3; Morita I, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P219; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Nigam S, 2005, BIOCHEM BIOPH RES CO, V338, P161, DOI 10.1016/j.bbrc.2005.09.065; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Nylander S, 2003, BLOOD COAGUL FIBRIN, V14, P159, DOI 10.1097/00001721-200302000-00007; Oury C, 2001, THROMB HAEMOSTASIS, V86, P1264; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Schoenwaelder SM, 2007, J BIOL CHEM, V282, P28648, DOI 10.1074/jbc.M704358200; SEILER S, 1991, THROMB RES, V62, P31, DOI 10.1016/0049-3848(91)90666-K; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; SOSLAU G, 1995, BBA-MOL CELL RES, V1268, P73, DOI 10.1016/0167-4889(95)00051-S; Soslau G, 1997, BBA-MOL CELL RES, V1355, P131, DOI 10.1016/S0167-4889(96)00123-1; SOSLAU G, 1993, BIOCHIM BIOPHYS ACTA, V1177, P199, DOI 10.1016/0167-4889(93)90041-M; Stafford NP, 2003, ARTERIOSCL THROM VAS, V23, P1928, DOI 10.1161/01.ATV.0000089330.88461.D6; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Vaidyula VR, 2003, BRIT J HAEMATOL, V121, P491, DOI 10.1046/j.1365-2141.2003.04296.x; van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883; ZOCCARATO F, 1991, BIOCHIM BIOPHYS ACTA, V1092, P72, DOI 10.1016/0167-4889(91)90178-Z	67	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67117	10.1371/journal.pone.0067117	http://dx.doi.org/10.1371/journal.pone.0067117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826207	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400105
J	Diezko, R; Suske, G				Diezko, Rolf; Suske, Guntram			Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Activation Function 1 (AF1) Domain	PLOS ONE			English	Article							15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SUMO MODIFICATION; GENE-EXPRESSION; RXR-ALPHA; PHOSPHORYLATION; TRANSREPRESSION; TRANSCRIPTION; REGULATOR; THIAZOLIDINEDIONES; ADIPOGENESIS	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor regulating adipogenesis, glucose homeostasis and inflammatory responses. The activity of PPAR gamma is controlled by post-translational modifications including SUMOylation and phosphorylation that affects its biological and molecular functions. Several important aspects of PPAR gamma SUMOylation including SUMO isoform-specificity and the impact of ligand binding on SUMOylation remain unresolved or contradictory. Here, we present a comprehensive study of PPAR gamma 1 SUMOylation. We show that PPAR gamma 1 can be modified by SUMO1 and SUMO2. Mutational analyses revealed that SUMOylation occurs exclusively within the N-terminal activation function 1 (AF1) domain predominantly at lysines 33 and 77. Ligand binding to the C-terminal ligand-binding domain (LBD) of PPAR gamma 1 reduces SUMOylation of lysine 33 but not of lysine 77. SUMOylation of lysine 33 and lysine 77 represses basal and ligand-induced activation by PPAR gamma 1. We further show that lysine 365 within the LBD is not a target for SUMOylation as suggested in a previous report, but it is essential for full LBD activity. Our results suggest that PPAR gamma ligands negatively affect SUMOylation by interdomain communication between the C-terminal LBD and the N-terminal AF1 domain. The ability of the LBD to regulate the AF1 domain may have important implications for the evaluation and mechanism of action of therapeutic ligands that bind PPAR gamma.	[Diezko, Rolf; Suske, Guntram] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany	Philipps University Marburg	Suske, G (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany.	Suske@imt.uni-marburg.de		Suske, Guntram/0000-0002-4807-0513	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation''	Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation''	This work was supported by a grant of the priority research program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) "Tumor and Inflammation'' to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014; Floyd ZE, 2004, OBES RES, V12, P921, DOI 10.1038/oby.2004.112; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jain MK, 2008, NAT MED, V14, P603, DOI 10.1038/nm0608-603; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Liu B, 2009, MOL CELL, V35, P731, DOI 10.1016/j.molcel.2009.09.002; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Treuter E, 2007, MOL CELL, V25, P178, DOI 10.1016/j.molcel.2007.01.009; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Wadosky KM, 2012, AM J PHYSIOL-HEART C, V302, pH515, DOI 10.1152/ajpheart.00703.2011; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x	41	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66947	10.1371/journal.pone.0066947	http://dx.doi.org/10.1371/journal.pone.0066947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826177	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400086
J	Jin, Z; Zhang, WH; Chai, WR; Zheng, YQ; Zhi, JM				Jin, Zhu; Zhang, Wenhui; Chai, Weiran; Zheng, Yanqian; Zhi, Jianming			Antibodies against AT1 Receptors Are Associated with Vascular Endothelial and Smooth Muscle Function Impairment: Protective Effects of Hydroxysafflor Yellow A	PLOS ONE			English	Article							ANGIOTENSIN-II; AGONISTIC AUTOANTIBODIES; CELLS; PREECLAMPSIA; EXPRESSION	Ample evidence has shown that autoantibodies against AT1 receptors (AT1-AA) are closely associated with human cardiovascular disease. The aim of this study was to investigate mechanisms underlying AT1-AA-induced vascular structural and functional impairments in the formation of hypertension, and explore ways for preventive treatment. We used synthetic peptide corresponding to the sequence of the second extracellular loop of the AT1 receptor (165-191) to immunize rats and establish an active immunization model. Part of the model received preventive therapy by losartan (20 mg/kg/day) and hyroxysafflor yellow A (HSYA) (10 mg/kg/day). The result show that systolic blood pressure (SBP) and heart rate (HR) of immunized rats was significantly higher, and closely correlated with the plasma AT1-Ab titer. The systolic response of thoracic aortic was increased, but diastolic effects were attenuated markedly. Histological observation showed that the thoracic aortic endothelium of the immunized rats became thinner or ruptured, inflammatory cell infiltration, medial smooth muscle cell proliferation and migration, the vascular wall became thicker. There was no significant difference in serum antibody titer between losartan and HSYA groups and the immunized group. The vascular structure and function were reversed, and plasma biochemical parameters were also improved significantly in the two treatment groups. These results suggest that AT1-Ab could induce injury to vascular endothelial cells, and proliferation of smooth muscle cells. These changes were involved in the formation of hypertension. Treatment with AT1 receptor antagonists and anti oxidative therapy could block the pathogenic effect of AT1-Ab on vascular endothelial and smooth muscle cells.	[Jin, Zhu; Zhang, Wenhui; Zheng, Yanqian; Zhi, Jianming] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China; [Chai, Weiran] Shanghai Jiao Tong Univ, Sch Med, Dept Assisted Reprod Technol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhi, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China.	zhjm169lihl@gmail.com			National Natural Science Foundation of China [31101070]; Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine [05xj21006, 12XJ10041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine	This work was supported by grants from the National Natural Science Foundation of China (No. 31101070). This work was also supported by the grant from Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine (05xj21006 and 12XJ10041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlstrom M, 2010, HYPERTENSION, V56, P907, DOI 10.1161/HYPERTENSIONAHA.110.159301; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Dragun D, 2009, THROMB HAEMOSTASIS, V101, P643, DOI 10.1160/TH08-10-0710; He HB, 2008, PHYTOTHER RES, V22, P1107, DOI 10.1002/ptr.2468; Hu CP, 2007, HYPERTENSION, V50, P952, DOI 10.1161/HYPERTENSIONAHA.107.096446; Jin Z, 2011, ACTA BIOCH BIOPH SIN, V43, P970, DOI 10.1093/abbs/gmr096; LaMarca B, 2012, GENDER MED, V9, P139, DOI 10.1016/j.genm.2012.03.001; LaMarca B, 2011, CURR OPIN PHARMACOL, V11, P175, DOI 10.1016/j.coph.2011.01.003; LaMarca B, 2009, HYPERTENSION, V54, P905, DOI 10.1161/HYPERTENSIONAHA.109.137935; Liu X, 2009, BIOORG MED CHEM LETT, V19, P2896, DOI 10.1016/j.bmcl.2009.03.070; Lobysheva I, 2011, ARTERIOSCL THROM VAS, V31, P2098, DOI 10.1161/ATVBAHA.111.230623; Sun R.Y, 1987, PHARM STAT, P410; Tan X, 2011, J PHYSIOL PHARMACOL, V62, P21; Tian JW, 2008, PHARMACOLOGY, V82, P121, DOI 10.1159/000141653; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Walther T, 2007, CURR HYPERTENS REP, V9, P128, DOI 10.1007/s11906-007-0023-5; Wang XW, 2011, CARDIOVASC DRUG THER, V25, P401, DOI 10.1007/s10557-011-6331-7; Wenzel K, 2011, HYPERTENSION, V58, P77, DOI 10.1161/HYPERTENSIONAHA.111.171348; Xia Y, 2007, J IMMUNOL, V179, P3391, DOI 10.4049/jimmunol.179.6.3391; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	21	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67020	10.1371/journal.pone.0067020	http://dx.doi.org/10.1371/journal.pone.0067020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826187	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400094
J	Mahoney, CE; Brewer, JM; Bittman, EL				Mahoney, Carrie E.; Brewer, Judy McKinley; Bittman, Eric L.			Central Control of Circadian Phase in Arousal-Promoting Neurons	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; CLOCK GENE-EXPRESSION; SUPRACHIASMATIC-NUCLEUS; LOCUS-COERULEUS; OREXIN NEURONS; IN-VIVO; PERIPHERAL-TISSUES; LOCOMOTOR-ACTIVITY; PHOTIC REGULATION; PACEMAKER OUTPUT	Cells of the dorsomedial/lateral hypothalamus (DMH/LH) that produce hypocretin (HCRT) promote arousal in part by activation of cells of the locus coeruleus (LC) which express tyrosine hydroxylase (TH). The suprachiasmatic nucleus (SCN) drives endogenous daily rhythms, including those of sleep and wakefulness. These circadian oscillations are generated by a transcriptional-translational feedback loop in which the Period (Per) genes constitute critical components. This cell-autonomous molecular clock operates not only within the SCN but also in neurons of other brain regions. However, the phenotype of such neurons and the nature of the phase controlling signal from the pacemaker are largely unknown. We used dual fluorescent in situ hybridization to assess clock function in vasopressin, HCRT and TH cells of the SCN, DMH/LH and LC, respectively, of male Syrian hamsters. In the first experiment, we found that Per1 expression in HCRT and TH oscillated in animals held in constant darkness with a peak phase that lagged that in AVP cells of the SCN by several hours. In the second experiment, hamsters induced to split their locomotor rhythms by exposure to constant light had asymmetric Per1 expression within cells of the middle SCN at 6 h before activity onset (AO) and in HCRT cells 9 h before and at AO. We did not observe evidence of lateralization of Per1 expression in the LC. We conclude that the SCN communicates circadian phase to HCRT cells via lateralized neural projections, and suggests that Per1 expression in the LC may be regulated by signals of a global or bilateral nature.	[Mahoney, Carrie E.; Brewer, Judy McKinley; Bittman, Eric L.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Brewer, Judy McKinley; Bittman, Eric L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Bittman, EL (corresponding author), Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA.	elb@bio.umass.edu			National Institute of Mental Health [RO1-MH-070019];  [5 T32 MH020051]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070019, T32MH020051] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institute of Mental Health Grant RO1-MH-070019, and CEM was supported by the institutional training grant 5 T32 MH020051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Akiyama M, 1999, J NEUROSCI, V19, P1115; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Amir S, 2004, J NEUROSCI, V24, P781, DOI 10.1523/JNEUROSCI.4488-03.2004; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Beuckmann CT, 2002, J MOL MED, V80, P329, DOI 10.1007/s00109-002-0322-x; BROWN MH, 1986, BRAIN RES BULL, V16, P705, DOI 10.1016/0361-9230(86)90142-5; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Butler MP, 2012, EUR J NEUROSCI, V36, P2556, DOI 10.1111/j.1460-9568.2012.08166.x; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Cvetkovic V, 2004, J NEUROCHEM, V91, P911, DOI 10.1111/j.1471-4159.2004.02776.x; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; de la Iglesia HO, 2004, MOL BRAIN RES, V127, P121, DOI 10.1016/j.molbrainres.2004.05.018; de la Iglesia HO, 2003, J NEUROSCI, V23, P7412; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; Devilbiss DM, 2012, NEUROPSYCHOPHARMACOL, V37, P2020, DOI 10.1038/npp.2012.50; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Espana RA, 2005, J COMP NEUROL, V481, P160, DOI 10.1002/cne.20369; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; EVANS J, 2011, TLS TIMES LIT S 0909, P6, DOI DOI 10.1371/J0URNAL.P0NE.0015869); Fadel J, 2002, J NEUROSCI, V22, P6742; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gompf HS, 2008, BRAIN RES, V1224, P43, DOI 10.1016/j.brainres.2008.05.060; Gonzalez JA, 2012, EUR J NEUROSCI, V35, P1426, DOI 10.1111/j.1460-9568.2012.08057.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hickok JR, 2010, NEUROENDOCRINOLOGY, V91, P110, DOI 10.1159/000243163; Horvath TL, 1999, J COMP NEUROL, V415, P145; Hughes ATL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018926; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; INOUYE SIT, 1983, BRAIN RES, V279, P53, DOI 10.1016/0006-8993(83)90162-2; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Jordan SD, 2012, MOL CELL ENDOCRINOL; Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI [10.1042/bse0490137, 10.1042/BSE0480137]; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; Kilduff TS, 2001, J COMP NEUROL, V435, P1, DOI 10.1002/cne.1189; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kriegsfeld LJ, 2003, EUR J NEUROSCI, V17, P212, DOI 10.1046/j.1460-9568.2003.02431.x; Lee S, 2012, J COMP NEUROL, V520, P3617, DOI 10.1002/cne.23116; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Li M, 2011, NEUROL SCI, V32, P625, DOI 10.1007/s10072-011-0597-1; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Mahoney CE, 2010, AM J PHYSIOL-REG I, V299, pR751, DOI 10.1152/ajpregu.00746.2009; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MEAD S, 1992, J NEUROSCI, V12, P2516; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Peyron C, 1998, J NEUROSCI, V18, P9996; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramanathan C, 2008, NEUROSCI LETT, V441, P86, DOI 10.1016/j.neulet.2008.06.019; REA MA, 1993, J BIOL RHYTHM, V8, pS59; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Sellix MT, 2006, AM J PHYSIOL-REG I, V290, pR1309, DOI 10.1152/ajpregu.00555.2005; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Tong YH, 2004, J BIOL RHYTHM, V19, P113, DOI 10.1177/0748730403262871; Torterolo Pablo, 2011, Front Neurol, V2, P14, DOI 10.3389/fneur.2011.00014; Torterolo P, 2009, BRAIN RES, V1268, P76, DOI 10.1016/j.brainres.2009.02.055; Tournier BB, 2003, NEUROSCIENCE, V118, P317, DOI 10.1016/S0306-4522(03)00008-3; Tsunematsu T, 2008, J NEUROSCI, V28, P228, DOI 10.1523/JNEUROSCI.3490-07.2008; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wendt MK, 2011, JOVE-J VIS EXP, DOI 10.3791/3245; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamamoto S, 2001, J COMP NEUROL, V430, P518; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yan L, 2005, J NEUROSCI, V25, P9017, DOI 10.1523/JNEUROSCI.2538-05.2005; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x; Yan LL, 2002, EUR J NEUROSCI, V15, P1153, DOI 10.1046/j.1460-9568.2002.01955.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zhang CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007151; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619	110	13	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67173	10.1371/journal.pone.0067173	http://dx.doi.org/10.1371/journal.pone.0067173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826226	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400115
J	Shi, CZ; Liang, Y; Yang, J; Xia, Y; Chen, HQ; Han, HZ; Yang, YZ; Wu, W; Gao, RY; Qin, HL				Shi, Chenzhang; Liang, Yong; Yang, Jun; Xia, Yang; Chen, Hongqi; Han, Huazhong; Yang, Yongzhi; Wu, Wen; Gao, Renyuan; Qin, Huanlong			MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury	PLOS ONE			English	Article							ULCERATIVE-COLITIS; BOWEL-DISEASE; INCREASED EXPRESSION; LIVER-REGENERATION; BARRIER FUNCTION; GENE-EXPRESSION; CDC42; MICE; DIFFERENTIATION; EFFECTOR	Background: MicroRNA-21 (miR-21) is overexpressed in most inflammatory diseases, but its physiological role in gut inflammation and tissue injury is poorly understood. The goal of this work is to understand the role of miR-21 in colitis and damage progression of intestine in a genetically modified murine model. Methods: Experimental colitis was induced in miR-21 KO and wild-type (WT) mice by 3.5% dextran sulphate sodium (DSS) administration for 7 days. Disease activity index(DAI), blood parameters, intestinal permeability, histopathologic injury, cytokine and chemokine production, and epithelial cells apoptosis were examined in colons of miR-21 KO and WT mice. Results: miR-21 was overexpressed in intestine of inflammatory bowel diseases (IBD) and acute intestinal obstruction (AIO) patients when compared with normal intestinal tissues. Likewise, miR-21 was up-regulated in colon of IL-10 KO mice when compared with control mice. WT mice rapidly lost weight and were moribund 5 days after treatment with 3.5% DSS, while miR-21 KO mice survived for at least 6 days. Elevated leukocytes and more severe histopathology were observed in WT mice when compared with miR-21 KO mice. Elevated levels of TNF-alpha and macrophage inflammatory protein-2(MIP-2) in colon culture supernatants from WT mice exhibited significant higher than miR-21 KO mice. Furthermore, CD3 and CD68 positive cells, intestinal permeability and apoptosis of epithelial cells were significantly increased in WT mice when compared with miR-21 KO mice. Finally, we found that miR-21 regulated the intestinal barrier function through modulating the expression of RhoB and CDC42. Conclusion: Our results suggest that miR-21 is overexpressed in intestinal inflammation and tissue injury, while knockout of miR-21 in mice improve the survival rate in DSS-induced fatal colitis through protecting against inflammation and tissue injury. Therefore, attenuated expression of miR-21 in gut may prevent the onset or progression of inflammatory bowel disease in patients.	[Shi, Chenzhang; Liang, Yong; Yang, Jun; Xia, Yang; Chen, Hongqi; Han, Huazhong; Yang, Yongzhi; Wu, Wen; Gao, Renyuan; Qin, Huanlong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qin, HL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Sch Med, Dept Gen Surg, Shanghai 200030, Peoples R China.	hlqin10@163.com	huanlong, Qin/B-3844-2015		National Natural Science Foundation Key projects of China [81230057]; National Natural Science Foundation of China [81172325]; Major Basic Research Program of Shanghai [12DZ1930502]	National Natural Science Foundation Key projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Program of Shanghai	This work was supported by grants from National Natural Science Foundation Key projects of China (No. 81230057), National Natural Science Foundation of China (No. 81172325), and the Major Basic Research Program of Shanghai (No 12DZ1930502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Danese S, 2007, GUT, V56, P855, DOI 10.1136/gut.2006.114314; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Flamant M, 2011, GUT, V60, P473, DOI 10.1136/gut.2010.229237; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Liu H, 2013, J BIOL CHEM, V288, P9261, DOI 10.1074/jbc.M112.433730; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Spencer DM, 2002, GASTROENTEROLOGY, V122, P94, DOI 10.1053/gast.2002.30308; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vetrano S, 2008, GASTROENTEROLOGY, V135, P173, DOI 10.1053/j.gastro.2008.04.002; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Yang YZ, 2013, BIOCHEM BIOPH RES CO, V434, P746, DOI 10.1016/j.bbrc.2013.03.122; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	43	111	115	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66814	10.1371/journal.pone.0066814	http://dx.doi.org/10.1371/journal.pone.0066814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826144	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400058
J	Sonnweber, RS; Stobbe, N; Romero, OZ; Slice, DE; Fieder, M; Wallner, B				Sonnweber, Ruth S.; Stobbe, Nina; Romero, Olmo Zavala; Slice, Dennis E.; Fieder, Martin; Wallner, Bernard			A New Method for the Analysis of Soft Tissues with Data Acquired under Field Conditions	PLOS ONE			English	Article							MACAQUES MACACA-SYLVANUS; GEOMETRIC MORPHOMETRICS; SHAPE; REVOLUTION; SWELLINGS; BIOLOGY; SIZE	Analyzing soft-tissue structures is particularly challenging due to the lack of homologous landmarks that can be reliably identified across time and specimens. This is particularly true when data are to be collected under field conditions. Here, we present a method that combines photogrammetric techniques and geometric morphometrics methods (GMM) to quantify soft tissues for their subsequent volumetric analysis. We combine previously developed methods for landmark data acquisition and processing with a custom program for volumetric computations. Photogrammetric methods are a particularly powerful tool for field studies as they allow for image acquisition with minimal equipment requirements and for the acquisition of the spatial coordinates of points (anatomical landmarks or others) from these images. For our method, a limited number of homologous landmarks, i.e., points that can be found on any specimen independent of space and time, and further distinctive points, which may vary over time, space and subject, are identified on two-dimensional photographs and their three-dimensional coordinates estimated using photogrammetric methods. The three-dimensional configurations are oriented by the spatial principal components (PCs) of the homologous points. Crucially, this last step orients the configuration such that x and y-information (PC1 and PC2 coordinates) constitute an anatomically-defined plane with the z-values (PC3 coordinate) in the direction of interest for volume computation. The z-coordinates are then used to estimate the volume of the tissue. We validate our method using a physical, geometric model of known dimensions and physical (wax) models designed to approximate perineal swellings in female macaques. To demonstrate the usefulness and potential of our method, we use it to estimate the volumes of Barbary macaque sexual swellings recorded in the field with video images. By analyzing both the artificial data and real monkey swellings, we validate our method's accuracy and illustrate its potential for application in important areas of biological research.	[Sonnweber, Ruth S.; Stobbe, Nina] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Romero, Olmo Zavala; Slice, Dennis E.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Slice, Dennis E.; Fieder, Martin; Wallner, Bernard] Univ Vienna, Dept Anthropol, Vienna, Austria; [Sonnweber, Ruth S.] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; State University System of Florida; Florida State University; University of Vienna; University of Vienna	Sonnweber, RS (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	ruth-sophie.sonnweber@univie.ac.at	Sonnweber, Ruth/AAV-3181-2020; Wallner, Bernard/B-1089-2009	Sonnweber, Ruth/0000-0001-9850-1492; Zavala-Romero, Olmo/0000-0001-7088-3820	ERC (European Research Council) [230604]	ERC (European Research Council)(European Research Council (ERC))	While writing the manuscript, Ruth Sonnweber and Nina Stobbe were supported by ERC (European Research Council) Advanced Grant SOMACCA (The Syntax of Mind: A Computational Comparative Apporach) (230604) awarded to W. Tecumseh Fitch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; BOOKSTEIN FL, 1982, ANNU REV ECOL SYST, V13, P451, DOI 10.1146/annurev.es.13.110182.002315; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Chiari Y, 2008, BIOL J LINN SOC, V95, P425, DOI 10.1111/j.1095-8312.2008.01055.x; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; Dixon AF, 1983, PRIMATE SEXUALITY CO; Hennessy RJ, 2002, BIOL PSYCHIAT, V51, P507, DOI 10.1016/S0006-3223(01)01327-0; Hennessy RJ, 2001, EUR J ORTHODONT, V23, P275, DOI 10.1093/ejo/23.3.275; KUSTER J, 1984, FOLIA PRIMATOL, V43, P69, DOI 10.1159/000156173; Mohle U, 2005, AM J PRIMATOL, V66, P351, DOI 10.1002/ajp.20161; Postma M, 2013, POLAR BIOL, V36, P719, DOI 10.1007/s00300-013-1298-4; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Sheets HD, PRACTICAL COMPANION; SLICE DE, 1998, SOFTWARE MORPHOMETRI; Waite JN, 2009, POLAR BIOL, V32, P1221, DOI 10.1007/s00300-009-0649-7; Wallner B, 2006, NEUROENDOCRINOL LETT, V27, P253; Zinner D, 2002, NATURE, V420, P142, DOI 10.1038/420142a	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67521	10.1371/journal.pone.0067521	http://dx.doi.org/10.1371/journal.pone.0067521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826315	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400155
J	MacKay, KB; Tu, YP; Young, SG; Clarke, SG				MacKay, Kennen B.; Tu, Yiping; Young, Stephen G.; Clarke, Steven G.			Circumventing Embryonic Lethality with Lcmt1 Deficiency: Generation of Hypomorphic Lcmt1 Mice with Reduced Protein Phosphatase 2A Methyltransferase Expression and Defects in Insulin Signaling	PLOS ONE			English	Article							LEUCINE CARBOXYL METHYLTRANSFERASE; PP2A CATALYTIC SUBUNIT; MIDDLE TUMOR-ANTIGEN; TAU-HYPERPHOSPHORYLATION; REGULATORY SUBUNITS; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; ALPHA SUBUNIT; OKADAIC ACID; BOVINE BRAIN	Protein phosphatase 2A (PP2A), the major serine/threonine phosphatase in eukaryotic cells, is a heterotrimeric protein composed of structural, catalytic, and targeting subunits. PP2A assembly is governed by a variety of mechanisms, one of which is carboxyl-terminal methylation of the catalytic subunit by the leucine carboxyl methyltransferase LCMT1. PP2A is nearly stoichiometrically methylated in the cytosol, and although some PP2A targeting subunits bind independently of methylation, this modification is required for the binding of others. To examine the role of this methylation reaction in mammalian tissues, we generated a mouse harboring a gene-trap cassette within intron 1 of Lcmt1. Due to splicing around the insertion, Lcmt1 transcript and LCMT1 protein levels were reduced but not eliminated. LCMT1 activity and methylation of PP2A were reduced in a coordinate fashion, suggesting that LCMT1 is the only PP2A methyltransferase. These mice exhibited an insulin-resistance phenotype, indicating a role for this methyltransferase in signaling in insulin-sensitive tissues. Tissues from these animals will be vital for the in vivo identification of methylation-sensitive substrates of PP2A and how they respond to differing physiological conditions.	[MacKay, Kennen B.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [MacKay, Kennen B.; Young, Stephen G.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Tu, Yiping; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	clarke@mbi.ucla.edu		Young, Stephen/0000-0001-7270-3176	National Institutes of Health [GM026020, AG035626]; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020, T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health grants GM026020 and AG035626 (www.nih.gov) and by the Ellison Medical Foundation (www.ellisonfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; Dissmeyer N, 2011, METHODS MOL BIOL, V779, P7, DOI 10.1007/978-1-61779-264-9_2; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Godet AN, 2011, M S-MED SCI, V27, P1106, DOI 10.1051/medsci/20112712017; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gu PY, 2012, GENESIS, V50, P429, DOI 10.1002/dvg.20815; Guenin S, 2008, INT J ONCOL, V32, P49; GUO H, 1993, J BIOL CHEM, V268, P11193; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Himsworth HP, 2011, DIABETIC MED, V28, P1440, DOI 10.1111/j.1464-5491.2011.3508.x; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Jangati GR, 2007, ENDOCRINE, V31, P248, DOI 10.1007/s12020-007-0046-3; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jin J, 2012, PHILOS T R SOC B, V367, P2540, DOI 10.1098/rstb.2012.0106; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2007, NEUROREPORT, V18, P2005, DOI 10.1097/WNR.0b013e3282f29100; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mayer BJ, 2012, FEBS LETT, V586, P2575, DOI 10.1016/j.febslet.2012.05.002; Mayfield J, 1998, AM FAM PHYSICIAN, V58, P1355; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Mumby M, 2001, SCI STKE SIGNAL TRAN; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nolan CJ, 2010, J GASTROEN HEPATOL, V25, P1594, DOI 10.1111/j.1440-1746.2010.06473.x; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Palanivel R, 2004, AM J PHYSIOL-ENDOC M, V286, pE1032, DOI 10.1152/ajpendo.00587.2003; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sents W, 2012, FEBS J; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tremblay ML, 2008, CELL METAB, V7, P101, DOI 10.1016/j.cmet.2008.01.004; Tsai ML, 2011, ACTA CRYSTALLOGR D, V67, P14, DOI 10.1107/S0907444910042204; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Vazquez-Higuera Jose L, 2011, BMC Res Notes, V4, P327, DOI 10.1186/1756-0500-4-327; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, J BIOL CHEM, V269, P1981; Xiong Y, 2013, NEUROBIOL AGING, V34, P745, DOI 10.1016/j.neurobiolaging.2012.07.003; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zhou XW, 2008, NEUROBIOL DIS, V31, P386, DOI 10.1016/j.nbd.2008.05.013; Zwaenepoel K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-393	84	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65967	10.1371/journal.pone.0065967	http://dx.doi.org/10.1371/journal.pone.0065967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840384	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800024
J	Reddy, V; Markova, G; Wallot, S				Reddy, Vasudevi; Markova, Gabriela; Wallot, Sebastian			Anticipatory Adjustments to Being Picked Up in Infancy	PLOS ONE			English	Article							POSTURAL ADJUSTMENTS; EYE; ATTENTION; ABILITY; OBJECT; AUTISM; HAND; FACE	Anticipation of the actions of others is often used as a measure of action understanding in infancy. In contrast to studies of action understanding which set infants up as observers of actions directed elsewhere, in the present study we explored anticipatory postural adjustments made by infants to one of the most common adult actions directed to them - picking them up. We observed infant behavioural changes and recorded their postural shifts on a pressure mat in three phases: (i) a prior Chat phase, (ii) from the onset of Approach of the mother's arms, and (iii) from the onset of Contact. In Study 1, eighteen 3-month-old infants showed systematic global postural changes during Approach and Contact, but not during Chat. There was an increase in specific adjustments of the arms (widening or raising) and legs (stiffening and extending or tucking up) during Approach and a decrease in thrashing/general movements during Contact. Shifts in postural stability were evident immediately after onset of Approach and more slowly after Contact, with no regular shifts during Chat. In Study 2 we followed ten infants at 2, 3 and 4 months of age. Anticipatory behavioural adjustments during Approach were present at all ages, but with greater differentiation from a prior Chat phase only at 3 and 4 months. Global postural shifts were also more phase differentiated in older infants. Moreover, there was significantly greater gaze to the mother's hands during Approach at 4 months. Early anticipatory adjustments to being picked up suggest that infants' awareness of actions directed to the self may occur earlier than of those directed elsewhere, and thus enable infants' active participation in joint actions from early in life.	[Reddy, Vasudevi] Univ Portsmouth, Portsmouth, Hants, England; [Markova, Gabriela] Acad Sci Czech Republ, Prague, Czech Republic; [Wallot, Sebastian] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark	University of Portsmouth; Czech Academy of Sciences; Aarhus University	Reddy, V (corresponding author), Univ Portsmouth, Portsmouth, Hants, England.	vasu.reddy@port.ac.uk		Wallot, Sebastian/0000-0002-3626-3940; Markova, Gabriela/0000-0003-1092-0137	University of Portsmouth, United Kingdom; Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" [264828]; Czech Science Foundation [P407/10/P610]; Institute of Psychology ASCR [AV0Z70250504]	University of Portsmouth, United Kingdom; Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity"; Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Psychology ASCR	The research was supported by the University of Portsmouth, United Kingdom. VR and SW were supported by the Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-2010-ITN, 264828). GM was supported by a grant of the Czech Science Foundation (P407/10/P610) and the Institute of Psychology ASCR (AV0Z70250504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2004, INFANT BEHAV DEV, V27, P64, DOI 10.1016/j.infbeh.2003.06.005; [Anonymous], 2006, SUBJECTIVITY SELFHOO; ATKINSON J, 1984, HUM NEUROBIOL, V3, P61; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Bernstein N.A., 1967, COORDINATION REGULAT; Bertenthal B, 1998, NEUROSCI BIOBEHAV R, V22, P515, DOI 10.1016/S0149-7634(97)00038-9; BRADDICK OJ, 1983, BEHAV BRAIN RES, V10, P141, DOI 10.1016/0166-4328(83)90160-2; Brisson J, 2012, AUTISM, V16, P420, DOI 10.1177/1362361311423385; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Dusing SC, 2010, PHYS THER, V90, P1838, DOI 10.2522/ptj.2010033; Einspieler C, 2008, J PSYCHOL, V216, P148; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hadders-Algra M, 1998, NEUROSCI BIOBEHAV R, V22, P501, DOI 10.1016/S0149-7634(97)00036-5; Hadders-Algra Mijna, 2005, Neural Plasticity, V12, P99, DOI 10.1155/NP.2005.99; Hedberg A, 2004, EXP BRAIN RES, V157, P10, DOI 10.1007/s00221-003-1811-z; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kanner L, 1943, NERV CHILD, V2, P217; LAMB ME, 1986, INT J BEHAV DEV, V9, P235, DOI 10.1177/016502548600900207; Leudar I, 2004, THEOR PSYCHOL, V14, P601, DOI 10.1177/0959354304046175; Lock A, 1984, LANGUAGE DEV, P39; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Prechtl H., 1984, CONTINUITY NEURAL FU, P1; PRECHTL HFR, 1989, WENNER-GR C, V55, P59; Reddy V, 2003, TRENDS COGN SCI, V7, P397, DOI 10.1016/S1364-6613(03)00191-8; REDDY V., 2008, INFANTS KNOW MINDS; Reddy V, 2000, DEVELOPMENTAL SCI, V3, P186, DOI 10.1111/1467-7687.00112; Robertson SS, 2009, DEVELOPMENTAL SCI, V12, P297, DOI 10.1111/j.1467-7687.2008.00766.x; ROCHAT P, 1995, INFANT BEHAV DEV, V18, P53, DOI 10.1016/0163-6383(95)90007-1; Rosander K, 2011, NEUROPSYCHOLOGIA, V49, P2911, DOI 10.1016/j.neuropsychologia.2011.06.018; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; Schilbach L., BEHAV BRAIN IN PRESS; Service V., 1984, LANGUAGE DEV, P132; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trevarthen C, 1986, NATO ASI SER, P209; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; VONHOFSTEN C, 1982, DEV PSYCHOL, V18, P450, DOI 10.1037/0012-1649.18.3.450; VONHOFSTEN C, 1984, DEV PSYCHOL, V20, P378, DOI 10.1037/0012-1649.20.3.378; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WHITE BL, 1964, CHILD DEV, V35, P349, DOI 10.1111/j.1467-8624.1964.tb05944.x; Witherington DC, 2002, INFANCY, V3, P495, DOI 10.1207/S15327078IN0304_05; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7	51	85	85	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65289	10.1371/journal.pone.0065289	http://dx.doi.org/10.1371/journal.pone.0065289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840324	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800010
J	Zhao, WJ; Li, D; Liu, ZJ; Zheng, XL; Wang, J; Wang, EK				Zhao, Wenjing; Li, Dan; Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang			Spiclomazine Induces Apoptosis Associated with the Suppression of Cell Viability, Migration and Invasion in Pancreatic Carcinoma Cells	PLOS ONE			English	Article							CANCER; INDUCTION; PROLIFERATION; MITOCHONDRIA; METASTASIS; ACTIVATION; RESISTANCE	The effective treatment for pancreatic carcinoma remains critically needed. Herein, this current study showed that spiclomazine treatment caused a reduction in viability in pancreatic carcinoma cell lines CFPAC-1 and MIA PaCa-2 in vitro. It was notable in this regard that, compared with pancreatic carcinoma cells, normal human embryonic kidney (HEK-293) and liver (HL-7702) cells were more resistant to the antigrowth effect of spiclomazine. Biochemically, spiclomazine treatment regulated the expression of protein levels in the apoptosis related pathways. Consistent with this effect, spiclomazine reduced the mitochondria membrane potential, elevated reactive oxygen species, and activated caspase-3/9. In addition, a key finding from this study was that spiclomazine suppressed migration and invasion of cancer cells through down-regulation of MMP-2/9. Collectively, the proposed studies did shed light on the antiproliferation effect of spiclomazine on pancreatic carcinoma cell lines, and further clarified the mechanisms that spiclomazine induced apoptosis associated with the suppression of migration and invasion.	[Zhao, Wenjing; Li, Dan; Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, New York, NY USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	zjliu@ciac.jl.cn; jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	李, 丹/O-1545-2017; , 汪尔康/P-1748-2019	李, 丹/0000-0001-5904-871X; 	National Natural Science Foundation of China [11174105, 21190040]; 973 Project [2009CB930100, 2010CB933600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China)	The work was funded by the following: National Natural Science Foundation of China (11174105, 21190040); 973 Project (2009CB930100, 2010CB933600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beauparlant P, 2003, CURR OPIN DRUG DISC, V6, P179; Bouchier-Hayes L, 2008, METHODS, V44, P222, DOI 10.1016/j.ymeth.2007.11.007; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen HM, 2009, CANCER LETT, V286, P161, DOI 10.1016/j.canlet.2009.05.040; Chodon D, 2007, MOL CELL BIOCHEM, V297, P73, DOI 10.1007/s11010-006-9324-2; Chu CS, 2007, CANCER LETT, V250, P268, DOI 10.1016/j.canlet.2006.10.020; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Ducreux M, 2007, BEST PRACT RES CL GA, V21, P997, DOI 10.1016/j.bpg.2007.10.025; Evans Douglas B., 1997, P1054; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Li D, 2013, EUR J PHARM SCI, V48, P658, DOI 10.1016/j.ejps.2012.12.023; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043; Ma D, 2011, AM J BIOMED SCI, V3, P278, DOI DOI 10.5099/AJ110400278; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Murtaza I, 2009, CANCER RES, V69, P1156, DOI 10.1158/0008-5472.CAN-08-2917; Mutou Y, 2008, TOXICOL IN VITRO, V22, P864, DOI 10.1016/j.tiv.2008.01.001; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Oberstein PE, 2011, J PANCREAS, V12, P96; Pan MH, 2007, FOOD CHEM, V102, P788, DOI 10.1016/j.foodchem.2006.06.019; Rastogi RP, 2009, EXCLI J, V8, P155; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Ren DD, 2006, TOXICOL IN VITRO, V20, P1411, DOI 10.1016/j.tiv.2006.06.011; Ruiz Y, 2008, PHYTOCHEMISTRY, V69, P432, DOI 10.1016/j.phytochem.2007.07.025; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang J, 2009, CANCER LETT, V283, P193, DOI 10.1016/j.canlet.2009.03.039; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; You BR, 2010, TOXICOL IN VITRO, V24, P1356, DOI 10.1016/j.tiv.2010.04.009; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	46	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66362	10.1371/journal.pone.0066362	http://dx.doi.org/10.1371/journal.pone.0066362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840452	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800052
J	Bokulich, NA; Ohta, M; Richardson, PM; Mills, DA				Bokulich, Nicholas A.; Ohta, Moe; Richardson, Paul M.; Mills, David A.			Monitoring Seasonal Changes in Winery-Resident Microbiota	PLOS ONE			English	Article							DIVERSITY; YEASTS; GRAPE; IDENTIFICATION; BACTERIA; STRAINS; FUNGI; ENVIRONMENT; SEQUENCES; ECOSYSTEM	During the transformation of grapes to wine, wine fermentations are exposed to a large area of specialized equipment surfaces within wineries, which may serve as important reservoirs for two-way transfer of microbes between fermentations. However, the role of winery environments in shaping the microbiota of wine fermentations and vectoring wine spoilage organisms is poorly understood at the systems level. Microbial communities inhabiting all major equipment and surfaces in a pilot-scale winery were surveyed over the course of a single harvest to track the appearance of equipment microbiota before, during, and after grape harvest. Results demonstrate that under normal cleaning conditions winery surfaces harbor seasonally fluctuating populations of bacteria and fungi. Surface microbial communities were dependent on the production context at each site, shaped by technological practices, processing stage, and season. During harvest, grape-and fermentation-associated organisms populated most winery surfaces, acting as potential reservoirs for microbial transfer between fermentations. These surfaces harbored large populations of Saccharomyces cerevisiae and other yeasts prior to harvest, potentially serving as an important vector of these yeasts in wine fermentations. However, the majority of the surface communities before and after harvest comprised organisms with no known link to wine fermentations and a near-absence of spoilage-related organisms, suggesting that winery surfaces do not overtly vector wine spoilage microbes under normal operating conditions.	[Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Richardson, Paul M.] MicroTrek Inc, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mills, DA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David/GXF-1821-2022; Mills, David Andrew/G-2282-2011	Mills, David Andrew/0000-0003-1913-9865; Bokulich, Nicholas/0000-0002-1784-8935	Wine Spectator Scholarship; Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation); American Wine Society Educational Foundation Scholarship; Dannon Probiotics Fellow Program (The Dannon Company, Inc.)	Wine Spectator Scholarship; Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation); American Wine Society Educational Foundation Scholarship; Dannon Probiotics Fellow Program (The Dannon Company, Inc.)	NAB was supported by a Wine Spectator Scholarship, the Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation), a 2012-2013 American Wine Society Educational Foundation Scholarship, and the 2012-2013 Dannon Probiotics Fellow Program (The Dannon Company, Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Bokulich NA, 2013, APPL ENV MI IN PRESS; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Bokulich NA, 2012, J AM SOC BREW CHEM, V70, P150, DOI 10.1094/ASBCJ-2012-0709-01; Bokulich NA, 2012, BMB REP, V45, P377, DOI 10.5483/BMBRep.2012.45.7.148; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Ciccarone C, 2012, INT J FOOD SCI TECH, V47, P1138, DOI 10.1111/j.1365-2621.2012.02952.x; Dolci P, 2009, J APPL MICROBIOL, V106, P278, DOI 10.1111/j.1365-2672.2008.04001.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Garijo P, 2009, INT J FOOD MICROBIOL, V136, P142, DOI 10.1016/j.ijfoodmicro.2009.08.018; Garijo P, 2008, INT J FOOD MICROBIOL, V125, P141, DOI 10.1016/j.ijfoodmicro.2008.03.014; Gonzalez A, 2012, BIOINFORMATICS, V28, P436, DOI 10.1093/bioinformatics/btr685; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martins G, 2012, INT J FOOD MICROBIOL, V158, P93, DOI 10.1016/j.ijfoodmicro.2012.06.013; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mercado L, 2007, FOOD MICROBIOL, V24, P403, DOI 10.1016/j.fm.2006.06.005; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Ocon E, 2011, J FOOD SCI, V76, pM169, DOI 10.1111/j.1750-3841.2011.02097.x; Ocon E, 2010, FOOD MICROBIOL, V27, P1023, DOI 10.1016/j.fm.2010.06.012; PEYNAUD EMILE, 1959, AMER JOUR ENOL AND VITICULTURE, V10, P69; Picco AM, 2004, AM J ENOL VITICULT, V55, P355; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; Sabate J, 2002, MICROBIOL RES, V157, P267, DOI 10.1078/0944-5013-00163; Santamaria P, 2008, EUR FOOD RES TECHNOL, V227, P1563, DOI 10.1007/s00217-008-0855-5; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Tofalo R, 2012, FOOD MICROBIOL, V29, P18, DOI 10.1016/j.fm.2011.08.014; Van Hoorde K, 2010, FOOD MICROBIOL, V27, P425, DOI 10.1016/j.fm.2009.12.001	51	132	133	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66437	10.1371/journal.pone.0066437	http://dx.doi.org/10.1371/journal.pone.0066437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840468	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200078
J	Georgy, GS; Nassar, NN; Mansour, HA; Abdallah, DM				Georgy, Gehan S.; Nassar, Noha N.; Mansour, Hanaa A.; Abdallah, Dalaal M.			Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TNF-ALPHA; NEUROTROPHIC FACTOR; TRANSGENIC MODEL; GENE-EXPRESSION; NERVOUS-SYSTEM; DENTATE GYRUS; BRAIN; NEUROGENESIS; APOPTOSIS	Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly associated with diabetes and previous studies addressed the protective effect of BDNF in metabolic syndrome and type 2 diabetes; hence this work aimed to evaluate the potential neuroprotective effect of CBL in modulating the complications of hyperglycaemia experimentally induced by streptozotocin (STZ) on the rat brain hippocampus. To this end, male adult Sprague Dawley rats were divided into (i) vehicle- (ii) CBL- and (iii) STZ diabetic-control as well as (iv) STZ+CBL groups. Diabetes was confirmed by hyperglycemia and elevated glycated haemoglobin (HbA1c%), which were associated by weight loss, elevated tumor necrosis factor (TNF)-alpha and decreased insulin growth factor (IGF)-1 beta in the serum. Uncontrolled hyperglycemia caused learning and memory impairments that corroborated degenerative changes, neuronal loss and expression of caspase (Casp)-3 in the hippocampal area of STZ-diabetic rats. Behavioral deficits were associated by decreased hippocampal glutamate (GLU), glycine, serotonin (5-HT) and dopamine. Moreover, diabetic rats showed an increase in hippocampal nitric oxide and thiobarbituric acid reactive substances versus decreased non-protein sulfhydryls. Though CBL did not affect STZ-induced hyperglycemia, it partly improved body weight as well as HbA1c%. Such effects were associated by enhancement in both learning and memory as well as apparent normal cellularity in CA1 and CA3 areas and reduced Casp-3 expression. CBL improved serum TNF-alpha and IGF-1 beta, GLU and 5-HT as well as hampering oxidative biomarkers. In conclusion, CBL possesses neuroprotection against diabetes-associated cerebral neurodegeneration and cognitive decline via anti-inflammatory, antioxidant and antiapototic effects.	[Georgy, Gehan S.; Mansour, Hanaa A.] Natl Org Drug Control & Res NODCAR, Dept Pharmacol, Giza, Egypt; [Nassar, Noha N.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	National Organization for Drug Control & Research (NODCAR); Egyptian Knowledge Bank (EKB); Cairo University	Nassar, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	nnagah@yahoo.com	mansour, ossama/F-4592-2010; Abdallah, Dalaal/GVT-0783-2022	mansour, ossama/0000-0001-8814-6431; 	Cairo University; National Organization of Drug Control and Research (NODCAR)	Cairo University(Cairo University); National Organization of Drug Control and Research (NODCAR)	Financial support was provided by Cairo University and the National Organization of Drug Control and Research (NODCAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, CAN J NEUROL SCI, V39, P311, DOI 10.1017/S0317167100013433; Al-Shorbagy MY, 2012, CAN J PHYSIOL PHARM, V90, P13, DOI [10.1139/Y11-096, 10.1139/y11-096]; Allegri RF, 2012, DRUG TODAY, V48, P25, DOI 10.1358/dot.2012.48(Suppl.A).1739721; Alvarez XA, 2009, INT J NEUROPSYCHOPH, V12, P867, DOI 10.1017/S1461145709990101; Arab L, 2011, CURR NEUROPHARMACOL, V9, P693, DOI 10.2174/157015911798376334; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Baquer NZ, 2009, BIOGERONTOLOGY, V10, P377, DOI 10.1007/s10522-009-9226-2; Baydas G, 2003, FREE RADICAL BIO MED, V35, P797, DOI 10.1016/S0891-5849(03)00408-8; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BISSE E, 1985, J CHROMATOGR, V344, P81, DOI 10.1016/S0378-4347(00)82009-5; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Comim CM, 2012, NEUROSCI LETT, V523, P104, DOI 10.1016/j.neulet.2012.06.051; Convit A, 2003, P NATL ACAD SCI USA, V100, P2019, DOI 10.1073/pnas.0336073100; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Denis I, 2013, AGEING RES REV, V12, P579, DOI 10.1016/j.arr.2013.01.007; Deniz S, 1997, CLIN CHIM ACTA, V265, P77; Eder P, 2001, HISTOCHEM J, V33, P605, DOI 10.1023/A:1016394031947; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Francis PT, 2010, NEUROPHARMACOLOGY, V59, P221, DOI 10.1016/j.neuropharm.2010.02.010; Garmanchuk L. V., 2009, Eksperimental'naya i Klinicheskaya Farmakologiya, V72, P28; Gillery Philippe, 2001, Journal de la Societe de Biologie, V195, P387; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Hu NW, 2012, PHARMACOL BIOCHEM BE, V100, P855, DOI 10.1016/j.pbb.2011.04.013; Ingaramo PI, 2011, MOL IMMUNOL, V48, P1397, DOI 10.1016/j.molimm.2011.03.015; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kar Manoj, 1999, Indian Journal of Experimental Biology, V37, P190; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kirana H, 2011, PHARMACOGN RES, V3, P30, DOI 10.4103/0974-8490.79112; KONTUR P, 1984, J NEUROSCI METH, V11, P5, DOI 10.1016/0165-0270(84)90003-7; Kuhad A, 2008, LIFE SCI, V83, P128, DOI 10.1016/j.lfs.2008.05.013; Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Miura Y, 2003, P NATL ACAD SCI USA, V100, P2777, DOI 10.1073/pnas.2628048100; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murali YK, 2007, EXP CLIN ENDOCR DIAB, V115, P641, DOI 10.1055/s-2007-982500; Narayanan SN, 2010, UPSALA J MED SCI, V115, P91, DOI 10.3109/03009730903552661; Ono M, 2000, METABOLISM, V49, P129, DOI 10.1016/S0026-0495(00)90988-0; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Plosker GL, 2010, CNS DRUGS, V24, P263, DOI 10.2165/11204820-000000000-00000; PRINS HK, 1969, BIOCH METHODS RED CE, P126; Ramachandran S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/571721; Ren J, 2007, RESTOR NEUROL NEUROS, V25, P25; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rong LL, 2005, RESTOR NEUROL NEUROS, V23, P355; Saravia F, 2004, J NEUROENDOCRINOL, V16, P704, DOI 10.1111/j.1365-2826.2004.01223.x; Sen S, 2005, BIOPHYS CHEM, V113, P289, DOI 10.1016/j.bpc.2004.05.005; Serkina EV, 2008, ZH NEVROL PSIKHIATR, V108, P62; Sharma B, 2011, PSYCHOPHARMACOLOGY, V215, P677, DOI 10.1007/s00213-011-2164-0; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Trinder P., 1969, ANN CLIN BIOCHEM, V6, P24, DOI DOI 10.1177/000456326900600108; Ullah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027093; Windisch M, 1998, J NEURAL TRANSM-SUPP, P289; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200; Zai GCM, 2012, PROG NEURO-PSYCHOPH, V39, P96, DOI 10.1016/j.pnpbp.2012.05.014	68	24	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64847	10.1371/journal.pone.0064847	http://dx.doi.org/10.1371/journal.pone.0064847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840309	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200007
J	Huang, L; Kuwahara, I; Matsumoto, K				Huang, L.; Kuwahara, I.; Matsumoto, K.			EWS represses cofilin 1 expression by inducing nuclear retention of cofilin 1 mRNA	ONCOGENE			English	Article						EWS; CFL1; RNA-binding protein	ACTIN-DEPOLYMERIZING FACTOR; CELL-CYCLE; PROTEIN; CANCER; BINDING; SARCOMA; PHOSPHORYLATION; IDENTIFICATION; INVOLVEMENT; ADF/COFILIN	In Ewing's sarcoma family tumors (ESFTs), the proto-oncogene EWS that encodes an RNA-binding protein is fused by chromosomal translocation to the gene encoding one of the E-twenty six (ETS) family of transcription factors, most commonly friend leukemia virus integration 1 (FLI-1). Although EWS/FLI-1 chimeric proteins are necessary for carcinogenesis, additional events seem to be required for transformation to occur. We have previously reported that a protein product of an EWS mRNA target, whose expression is negatively regulated by EWS but not by EWS/FLI-1, contributes to ESFT development. However, the mechanism by which EWS represses protein expression remains to be elucidated. Here, we report that overexpression of full-length EWS repressed protein expression and induced nuclear retention of reporter mRNAs in a tethering assay. In contrast, when a mutant lacking the EWS C-terminal nuclear localization signal (classified as a PY-NLS) was expressed, reporter protein expression was upregulated, and the number of cells exporting reporter mRNA to the cytoplasm increased. EWS binds to the 3'-untranslated region in another mRNA target, cofilin 1 (CFL1), and negatively regulates the expression of CFL1. Overexpression of EWS induced nuclear retention of CFL1 mRNA. Furthermore, ESFT cell proliferation and metastatic potential were suppressed by small interfering RNA-mediated CFL1 knockdown. Together, our findings suggest that EWS induces nuclear retention of CFL1 mRNA, thereby suppressing expression of CFL1, and that CFL1 promotes development of ESFT. Targeting CFL1 might therefore provide another novel approach for treatment of this aggressive disease.	[Huang, L.; Kuwahara, I.; Matsumoto, K.] RIKEN, Mol Entomol Lab, Wako, Saitama 3510198, Japan; [Huang, L.] Dalian Med Univ, Dept Pathophysiol, Dalian, Peoples R China; [Matsumoto, K.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	RIKEN; Dalian Medical University; Japan Science & Technology Agency (JST)	Matsumoto, K (corresponding author), RIKEN, Chem Genet Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumok@riken.jp	Huang, Lin/AAI-5740-2020; Matsumoto, Ken/F-9083-2013	Matsumoto, Ken/0000-0002-7864-3394	Ministry of Education, Culture, Sports, Science and Technology of Japan; PRESTO program from Japan Science and Technology Agency; RIKEN Foreign Postdoctoral Researchers Program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO program from Japan Science and Technology Agency; RIKEN Foreign Postdoctoral Researchers Program	We thank Dr Yasufumi Minami for providing plasmids and Dr Shinichi Nakagawa for kindly teaching us the detailed methods for in situ hybridization. This study was supported, in part, by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; PRESTO program from Japan Science and Technology Agency; and RIKEN Foreign Postdoctoral Researchers Program. L Huang was a foreign postdoctoral researcher of RIKEN.	Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Castro MAA, 2010, CANCER-AM CANCER SOC, V116, P3645, DOI 10.1002/cncr.25125; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Estornes Y, 2007, INT J CANCER, V121, P2162, DOI 10.1002/ijc.22911; Felsch JS, 1999, CURR BIOL, V9, P485, DOI 10.1016/S0960-9822(99)80214-0; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Huang L, 2012, CANCER RES, V72, P1260, DOI 10.1158/0008-5472.CAN-11-2254; Kovar H, 2001, CANCER RES, V61, P5992; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Lee YJ, 2005, MOL BIOTECHNOL, V31, P1, DOI 10.1385/MB:31:1:001; Leemann-Zakaryan Ruzanna P., 2011, Sarcoma, V2011, P218483, DOI 10.1155/2011/218483; Martoglio AM, 2000, MOL MED, V6, P750, DOI 10.1007/BF03402191; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Neilsen Paul M., 2011, Sarcoma, V2011, P746939, DOI 10.1155/2011/746939; Nowak D, 2010, EUR J HISTOCHEM, V54, P59, DOI 10.4081/ejh.2010.e14; Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rehklau K, 2012, CELL DEATH DIFFER, V19, P958, DOI 10.1038/cdd.2011.180; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Subbiah Vivek, 2011, Sarcoma, V2011, P686985, DOI 10.1155/2011/686985; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terrier P, 1996, SEMIN DIAGN PATHOL, V13, P250; Toretsky JA, 2010, LANCET ONCOL, V11, P105, DOI 10.1016/S1470-2045(09)70391-2; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yap CT, 2005, CELL MOTIL CYTOSKEL, V60, P153, DOI 10.1002/cm.20053; Zakaryan RP, 2006, J MOL BIOL, V363, P27, DOI 10.1016/j.jmb.2006.08.018	46	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 5	2014	33	23					2995	3003		10.1038/onc.2013.255	http://dx.doi.org/10.1038/onc.2013.255			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EL	23831569				2022-12-25	WOS:000337232200006
J	Famooto, A; Almujtaba, M; Dareng, E; Akarolo-Anthony, S; Ogbonna, C; Offiong, R; Olaniyan, O; Wheeler, CM; Doumatey, A; Rotimi, CN; Adeyemo, A; Adebamowo, CA				Famooto, Ayo; Almujtaba, Maryam; Dareng, Eileen; Akarolo-Anthony, Sally; Ogbonna, Celestine; Offiong, Richard; Olaniyan, Olayinka; Wheeler, Cosette M.; Doumatey, Ayo; Rotimi, Charles N.; Adeyemo, Adebowale; Adebamowo, Clement A.			RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women	PLOS ONE			English	Article							DIAMOND-BLACKFAN-ANEMIA; CERVICAL-CANCER; ASSOCIATION; REGISTRY; TOOL	High risk HPV (hrHPV) infection is a necessary cause of cervical cancer but the host genetic determinants of infection are poorly understood. We enrolled 267 women who presented to our cervical cancer screening program in Abuja, Nigeria between April 2012 and August 2012. We collected information on demographic characteristics, risk factors of cervical cancer and obtained samples of blood and cervical exfoliated cells from all participants. We used Roche Linear Array HPV Genotyping Test(R) to characterize the prevalent HPV according to manufacturer's instruction; Sequenom Mass Array to test 21 SNPs in genes/regions previously associated with hrHPV and regression models to examine independent factors associated with HPV infection. We considered a p<0.05 as significant because this is a replication study. There were 65 women with and 202 women without hrHPV infection. Under the allelic model, we found significant association between two SNPs, rs2305809 on RPS19 and rs2342700 on TYMS, and prevalent hrHPV infection. Multivariate analysis of hrHPV risk adjusted for age, body mass index, smoking, age of menarche, age at sexual debut, lifetime total number of sexual partners and the total number of pregnancies as covariates, yielded a p-value of 0.071 and 0.010 for rs2305809 and rs2342700, respectively. Our findings in this unique population suggest that a number of genetic risk variants for hrHPV are shared with other population groups. Definitive studies with larger sample sizes and using genome wide approaches are needed to understand the genetic architecture of hrHPV risk in multiple populations.	[Famooto, Ayo; Almujtaba, Maryam; Dareng, Eileen; Akarolo-Anthony, Sally; Ogbonna, Celestine; Adebamowo, Clement A.] Inst Human Virol, Dept Res & Training, Abuja, FCT, Nigeria; [Akarolo-Anthony, Sally; Adebamowo, Clement A.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Offiong, Richard] Univ Abuja, Teaching Hosp, Gwagwalada, FCT, Nigeria; [Olaniyan, Olayinka] Natl Hosp, Abuja, FCT, Nigeria; [Wheeler, Cosette M.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Doumatey, Ayo; Rotimi, Charles N.; Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Inst Human Virol, Baltimore, MD 21201 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Adebamowo, CA (corresponding author), Inst Human Virol, Dept Res & Training, Abuja, FCT, Nigeria.	cadebamowo@som.umaryland.edu	Adebamowo, Clement/C-8778-2011	Adebamowo, Clement/0000-0002-6571-2880; Dareng, Eileen/0000-0003-0802-419X; Adebamowo, Sally/0000-0003-4713-2433; Adeyemo, Adebowale/0000-0002-3105-3231	National Cancer Institute [D43CA153792]; NATIONAL CANCER INSTITUTE [D43CA153792] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described was supported by Award Number D43CA153792 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franklin Joshua D, 2011, J Biomed Inform, V44 Suppl 1, pS103, DOI 10.1016/j.jbi.2011.05.008; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hemminki K, 1999, INT J CANCER, V82, P775, DOI 10.1002/(SICI)1097-0215(19990909)82:6<775::AID-IJC1>3.0.CO;2-V; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lipton JM, 2001, J PEDIAT HEMATOL ONC, V23, P39, DOI 10.1097/00043426-200101000-00009; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399; Moore EE, 2012, TWIN RES HUM GENET, V15, P79, DOI 10.1375/twin.15.1.79; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Safaeian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033619; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x; Zelmanowicz A, 2004, PAP REPORT, V15, P113; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	23	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66930	10.1371/journal.pone.0066930	http://dx.doi.org/10.1371/journal.pone.0066930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826176	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000018
J	Masaoka, A; Gassman, NR; Horton, JK; Kedar, PS; Witt, KL; Hobbs, CA; Kissling, GE; Tano, K; Asagoshi, K; Wilson, SH				Masaoka, Aya; Gassman, Natalie R.; Horton, Julie K.; Kedar, Padmini S.; Witt, Kristine L.; Hobbs, Cheryl A.; Kissling, Grace E.; Tano, Keizo; Asagoshi, Kenjiro; Wilson, Samuel H.			Interaction between DNA Polymerase beta and BRCA1	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MOUSE FIBROBLASTS; OXIDATIVE STRESS; COMET ASSAY; DAMAGE; CANCER; RADIATION	The breast cancer 1 (BRCA1) protein is a tumor suppressor playing roles in DNA repair and cell cycle regulation. Studies of DNA repair functions of BRCA1 have focused on double-strand break (DSB) repair pathways and have recently included base excision repair (BER). However, the function of BRCA1 in BER is not well defined. Here, we examined a BRCA1 role in BER, first in relation to alkylating agent (MMS) treatment of cells and the BER enzyme DNA polymerase beta (pol beta). MMS treatment of BRCA1 negative human ovarian and chicken DT40 cells revealed hypersensitivity, and the combined gene deletion of BRCA1 and pol beta in DT40 cells was consistent with these factors acting in the same repair pathway, possibly BER. Using cell extracts and purified proteins, BRCA1 and pol beta were found to interact in immunoprecipitation assays, yet in vivo and in vitro assays for a BER role of BRCA1 were negative. An alternate approach with the human cells of immunofluorescence imaging and laser-induced DNA damage revealed negligible BRCA1 recruitment during the first 60 s after irradiation, the period typical of recruitment of pol beta and other BER factors. Instead, 15 min after irradiation, BRCA1 recruitment was strong and there was gamma-H2AX co-localization, consistent with DSBs and repair. The rapid recruitment of pol beta was similar in BRCA1 positive and negative cells. However, a fraction of pol beta initially recruited remained associated with damage sites much longer in BRCA1 positive than negative cells. Interestingly, pol beta expression was required for BRCA1 recruitment, suggesting a partnership between these repair factors in DSB repair.	[Masaoka, Aya; Gassman, Natalie R.; Horton, Julie K.; Kedar, Padmini S.; Asagoshi, Kenjiro; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Witt, Kristine L.] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC USA; [Kissling, Grace E.] NIEHS, Biostatist Branch, NIH, Res Triangle Pk, NC USA; [Hobbs, Cheryl A.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA; [Tano, Keizo] Kyoto Univ, Inst Res Reactor, Dept Radiat Life Sci & Radiat Med Sci, Kumatori, Osaka 59004, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyoto University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Gassman, Natalie/0000-0002-8488-2332	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050159]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20510051, 24510072]; NATIONAL CANCER INSTITUTE [U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, ZIAES050159, Z01ES050159, ZIAES103106] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Project Numbers Z01-ES050158 and Z01-ES050159 from the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(to SHW), and by Grants-in-Aid (20510051, 24510072) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Masaoka A, 2012, J BIOL CHEM, V287, P27648, DOI 10.1074/jbc.M112.370759; Masaoka A, 2009, DNA REPAIR, V8, P1290, DOI 10.1016/j.dnarep.2009.08.004; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; MIZUMOTO K, 1993, BIOCHEM PHARMACOL, V46, P1811, DOI 10.1016/0006-2952(93)90587-M; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sehl ME, 2009, CLIN CANCER RES, V15, P2192, DOI 10.1158/1078-0432.CCR-08-1417; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Tano K, 2007, DNA REPAIR, V6, P869, DOI 10.1016/j.dnarep.2007.01.011; Tarapore P, 2012, CELL CYCLE, V11, P2931, DOI 10.4161/cc.21396; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66801	10.1371/journal.pone.0066801	http://dx.doi.org/10.1371/journal.pone.0066801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826138	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000010
J	Takem, EN; Affara, M; Amambua-Ngwa, A; Okebe, J; Ceesay, SJ; Jawara, M; Oriero, E; Nwakanma, D; Pinder, M; Clifford, C; Taal, M; Sowe, M; Suso, P; Mendy, A; Mbaye, A; Drakeley, C; D'Alessandro, U				Takem, Ebako N.; Affara, Muna; Amambua-Ngwa, Alfred; Okebe, Joseph; Ceesay, Serign J.; Jawara, Musa; Oriero, Eniyou; Nwakanma, Davis; Pinder, Margaret; Clifford, Caitlin; Taal, Makie; Sowe, Momodou; Suso, Penda; Mendy, Alphonse; Mbaye, Amicoleh; Drakeley, Chris; D'Alessandro, Umberto			Detecting Foci of Malaria Transmission with School Surveys: A Pilot Study in the Gambia	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; PLASMODIUM-FALCIPARUM; PRESCHOOL-CHILDREN; NUTRITIONAL-STATUS; CLINICAL MALARIA; WESTERN KENYA; AFRICA; AREA; SCHOOLCHILDREN; SURVEILLANCE	Background: In areas of declining malaria transmission such as in The Gambia, the identification of malaria infected individuals becomes increasingly harder. School surveys may be used to identify foci of malaria transmission in the community. Methods: The survey was carried out in May-June 2011, before the beginning of the malaria transmission season. Thirty two schools in the Upper River Region of The Gambia were selected with probability proportional to size; in each school approximately 100 children were randomly chosen for inclusion in the study. Each child had a finger prick blood sample collected for the determination of antimalarial antibodies by ELISA, malaria infection by microscopy and PCR, and for haemoglobin measurement. In addition, a simple questionnaire on socio-demographic variables and the use of insecticide-treated bed nets was completed. The cut-off for positivity for antimalarial antibodies was obtained using finite mixture models. The clustered nature of the data was taken into account in the analyses. Results: A total of 3,277 children were included in the survey. The mean age was 10 years (SD = 2.7) [range 4-21], with males and females evenly distributed. The prevalence of malaria infection as determined by PCR was 13.6% (426/3124) [95% CI = 12.2-16.3] with marked variation between schools (range 3-25%, p < 0.001), while the seroprevalence was 7.8% (234/2994) [95% CI = 6.4-9.8] for MSP1(19), 11.6% (364/2997) [95% CI = 9.4-14.5] for MSP2, and 20.0% (593/2973) [95% CI = 16.5-23.2) for AMA1. The prevalence of all the three antimalarial antibodies positive was 2.7% (79/2920). Conclusions: This survey shows that malaria prevalence and seroprevalence before the transmission season were highly heterogeneous.	[Takem, Ebako N.; Affara, Muna; Amambua-Ngwa, Alfred; Okebe, Joseph; Ceesay, Serign J.; Jawara, Musa; Oriero, Eniyou; Nwakanma, Davis; Pinder, Margaret; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Clifford, Caitlin] Univ Manchester, Manchester, Lancs, England; [Taal, Makie; Sowe, Momodou; Suso, Penda; Mendy, Alphonse] Natl Publ Hlth Lab, Kotu, Gambia; [Mbaye, Amicoleh] Minist Basic & Secondary Educ, Banjul, Gambia; [Drakeley, Chris] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM)	Takem, EN (corresponding author), MRC Unit, Fajara, Gambia.	etakem@mrc.gm	Okebe, Joseph/Y-1664-2019; Amambua-Ngwa, Alfred/ABA-7305-2020; Amambua-Ngwa, Alfred/AHD-7882-2022; Amambua-Ngwa, Alfred/HGU-8062-2022; Pinder, Margaret/AAQ-7129-2020	Okebe, Joseph/0000-0001-5466-1611; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Oriero, Eniyou/0000-0002-7911-6457; Nwakanma, Davis/0000-0002-6706-6069	Medical Research Council Unit, The Gambia; Medical Research Council [MC_EX_MR/K02440X/1, MC_UP_A900_1119] Funding Source: researchfish; MRC [MC_EX_MR/K02440X/1, MC_UP_A900_1119] Funding Source: UKRI	Medical Research Council Unit, The Gambia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by Medical Research Council Unit, The Gambia (core funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; CAMPBELL H, 1987, LANCET, V1, P859; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Custodio E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-225; DALESSANDRO U, 1995, LANCET, V346, P462, DOI 10.1016/S0140-6736(95)91321-1; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deribew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010775; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Magnussen P, 2001, TROP MED INT HEALTH, V6, P273, DOI 10.1046/j.1365-3156.2001.00720.x; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Midzi N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-169; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Ndyomugyenyi R, 2007, TROP MED INT HEALTH, V12, P230, DOI 10.1111/j.1365-3165.2006.01767.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Oduro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026305; Okello G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-185; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; RILEY EM, 1993, PARASITE IMMUNOL, V15, P513, DOI 10.1111/j.1365-3024.1993.tb00639.x; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Wang SJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-40; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 1995, PHYS STAT US INT ANT	56	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67108	10.1371/journal.pone.0067108	http://dx.doi.org/10.1371/journal.pone.0067108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826205	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000321150000028
J	Hatier, JHB; Clearwater, MJ; Gould, KS				Hatier, Jean-Hugues B.; Clearwater, Michael J.; Gould, Kevin S.			The Functional Significance of Black-Pigmented Leaves: Photosynthesis, Photoprotection and Productivity in Ophiopogon planiscapus 'Nigrescens'	PLOS ONE			English	Article							GREEN LEAVES; ANTHOCYANIN ACCUMULATION; QUERCUS-COCCIFERA; LOW-TEMPERATURE; YOUNG LEAVES; LIGHT; RED; PROTECTION; AUTUMN; PHOTOINHIBITION	Black pigmented leaves are common among horticultural cultivars, yet are extremely rare across natural plant populations. We hypothesised that black pigmentation would disadvantage a plant by reducing photosynthesis and therefore shoot productivity, but that this trait might also confer protective benefits by shielding chloroplasts against photo-oxidative stress. CO2 assimilation, chlorophyll a fluorescence, shoot biomass, and pigment concentrations were compared for near isogenic green- and black-leafed Ophiopogon planiscapus 'Nigrescens'. The black leaves had lower maximum CO2 assimilation rates, higher light saturation points and higher quantum efficiencies of photosystem II (PSII) than green leaves. Under saturating light, PSII photochemistry was inactivated less and recovered more completely in the black leaves. In full sunlight, green plants branched more abundantly and accumulated shoot biomass quicker than the black plants; in the shade, productivities of the two morphs were comparable. The data indicate a light-screening, photoprotective role of foliar anthocyanins. However, limitations to photosynthetic carbon assimilation are relatively small, insufficient to explain the natural scarcity of black-leafed plants.	[Hatier, Jean-Hugues B.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Clearwater, Michael J.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Gould, Kevin S.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Auckland; University of Waikato; Victoria University Wellington	Gould, KS (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	kevin.gould@vuw.ac.nz	Clearwater, Mike/AAU-9562-2020	Clearwater, Michael/0000-0002-8563-0671				Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Arscott DB, 2000, J N AM BENTHOL SOC, V19, P263, DOI 10.2307/1468069; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; Cai ZQ, 2005, PHOTOSYNTHETICA, V43, P91, DOI 10.1007/s11099-005-1098-3; Close DC, 2005, J PLANT PHYSIOL, V162, P37, DOI 10.1016/j.jplph.2003.10.001; Close DC, 2003, BOT REV, V69, P149, DOI 10.1663/0006-8101(2003)069[0149:TEOFA]2.0.CO;2; Davies KM, 2004, ANNU PLANT REV, V14, P214; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; Gould K.S., 2005, FLAVONOIDS CHEM BIOC; GOULD KS, 1995, NATURE, V378, P241, DOI 10.1038/378241b0; Gould KS, 2002, PLANT CELL ENVIRON, V25, P1261, DOI 10.1046/j.1365-3040.2002.00905.x; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Hada H, 2003, PLANT CELL ENVIRON, V26, P1691, DOI 10.1046/j.1365-3040.2003.01087.x; Hatier JHB, 2007, FUNCT PLANT BIOL, V34, P130, DOI 10.1071/FP06220; Hoch WA, 2003, PLANT PHYSIOL, V133, P1296, DOI 10.1104/pp.103.027631; HODGSON EA, 1965, T ROY SOC NZ BOT, V3, P67; Huber H, 1997, OECOLOGIA, V110, P478, DOI 10.1007/s004420050183; Hughes NM, 2007, NEW PHYTOL, V175, P675, DOI 10.1111/j.1469-8137.2007.02133.x; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; IRELAND RR, 1982, BRYOLOGIST, V85, P112, DOI 10.2307/3243151; Karageorgou P, 2006, TREE PHYSIOL, V26, P613, DOI 10.1093/treephys/26.5.613; KROL M, 1995, CAN J BOT, V73, P1119, DOI 10.1139/b95-122; LEE DW, 1987, BIOTROPICA, V19, P161, DOI 10.2307/2388739; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Manetas Y, 2003, FUNCT PLANT BIOL, V30, P265, DOI 10.1071/FP02226; Manetas Y, 2002, PHOTOSYNTHETICA, V40, P349, DOI 10.1023/A:1022614722629; Markham KR, 2004, Z NATURFORSCH C, V59, P625; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MURRAY BM, 1987, BRYOLOGIST, V90, P15, DOI 10.2307/3243268; MURRAY JR, 1991, PLANT PHYSIOL, V97, P343, DOI 10.1104/pp.97.1.343; Neill SO, 2002, PLANT CELL ENVIRON, V25, P539, DOI 10.1046/j.1365-3040.2002.00837.x; Newsham KK, 2003, OECOLOGIA, V135, P327, DOI 10.1007/s00442-003-1191-x; Nishio JN, 2000, PLANT CELL ENVIRON, V23, P539, DOI 10.1046/j.1365-3040.2000.00563.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; OSMOND CB, 1987, NEW PHYTOL, V106, P161; OSMOND CB, 1995, J EXP BOT, V46, P1351, DOI 10.1093/jxb/46.special_issue.1351; PERSSON H., 1950, BRYOLOGIST, V53, P172; Pietrini F, 2002, PLANT CELL ENVIRON, V25, P1251, DOI 10.1046/j.1365-3040.2002.00917.x; Platt K, 2004, BLACK MAGIC PURPLE P; SAYRE GENEVA, 1955, BRYOLOGIST, V58, P323; Shao L, 2008, FUNCT PLANT BIOL, V35, P714, DOI 10.1071/FP08069; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Sun JD, 1998, PLANT CELL PHYSIOL, V39, P1020, DOI 10.1093/oxfordjournals.pcp.a029298; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; VITT DH, 1980, NEW ZEAL J BOT, V18, P367, DOI 10.1080/0028825X.1980.10427254; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WEATHERALL IL, 1991, NEW ZEAL J BOT, V29, P197, DOI 10.1080/0028825X.1991.10416721	53	28	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67850	10.1371/journal.pone.0067850	http://dx.doi.org/10.1371/journal.pone.0067850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826347	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400173
J	Silvar, C; Perovic, D; Nussbaumer, T; Spannagl, M; Usadel, B; Casas, A; Igartua, E; Ordon, F				Silvar, Cristina; Perovic, Dragan; Nussbaumer, Thomas; Spannagl, Manuel; Usadel, Bjoern; Casas, Ana; Igartua, Ernesto; Ordon, Frank			Towards Positional Isolation of Three Quantitative Trait Loci Conferring Resistance to Powdery Mildew in Two Spanish Barley Landraces	PLOS ONE			English	Article							MAP-BASED CLONING; DISEASE-RESISTANCE; GENETIC DIVERSITY; HIGH-RESOLUTION; LINKAGE MAP; GENOME; REGION; WHEAT; RICE; EVOLUTION	Three quantitative trait loci (QTL) conferring broad spectrum resistance to powdery mildew, caused by the fungus Blumeria graminis f. sp. hordei, were previously identified on chromosomes 7HS, 7HL and 6HL in the Spanish barley landrace-derived lines SBCC097 and SBCC145. In the present work, a genome-wide putative linear gene index of barley ( Genome Zipper) and the first draft of the physical, genetic and functional sequence of the barley genome were used to go one step further in the shortening and explicit demarcation on the barley genome of these regions conferring resistance to powdery mildew as well as in the identification of candidate genes. First, a comparative analysis of the target regions to the barley Genome Zippers of chromosomes 7H and 6H allowed the development of 25 new gene-based molecular markers, which slightly better delimit the QTL intervals. These new markers provided the framework for anchoring of genetic and physical maps, figuring out the outline of the barley genome at the target regions in SBCC097 and SBCC145. The outermost flanking markers of QTLs on 7HS, 7HL and 6HL defined a physical area of 4 Mb, 3.7 Mb and 3.2 Mb, respectively. In total, 21, 10 and 16 genes on 7HS, 7HL and 6HL, respectively, could be interpreted as potential candidates to explain the resistance to powdery mildew, as they encode proteins of related functions with respect to the known pathogen defense-related processes. The majority of these were annotated as belonging to the NBS-LRR class or protein kinase family.	[Silvar, Cristina] Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain; [Silvar, Cristina; Perovic, Dragan; Ordon, Frank] Julius Kuhn Inst, Inst Resistance Res & Stress Tolerance, Quedlinburg, Germany; [Nussbaumer, Thomas; Spannagl, Manuel] Helmholtz Zentrum Munchen, MIPS IBIS, Neuherberg, Germany; [Usadel, Bjoern] Rhein Westfal TH Aachen, Inst Biol 1, Aachen, Germany; [Casas, Ana; Igartua, Ernesto] CSIC, Aula Expt Stn, Dept Genet & Plant Prod, Zaragoza, Spain	Universidade da Coruna; Julius Kuhn-Institut; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; RWTH Aachen University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Silvar, C (corresponding author), Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain.	c.silvar@udc.es	Igartua, Ernesto/E-7691-2012; Usadel, Björn/E-1932-2011; Casas, Ana Maria/G-3898-2011; Silvar, Cristina/G-5141-2010; Perovic, Dragan G/C-1149-2008	Igartua, Ernesto/0000-0003-2938-1719; Usadel, Björn/0000-0003-0921-8041; Casas, Ana Maria/0000-0003-3484-2655; Silvar, Cristina/0000-0002-1782-8045; Perovic, Dragan G/0000-0002-0292-1693; Spannagl, Manuel/0000-0003-0701-7035	German Federal Ministry of Education and Research within the KBBE-II call [0315702B]; Spanish Ministry of Science and Innovation [EUI2009-04075]; University of Coruna; Deutscher Akademischer Austausch Dienst; Direct For Biological Sciences [1337525] Funding Source: National Science Foundation; Division Of Undergraduate Education [0941984] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1343533] Funding Source: National Science Foundation	German Federal Ministry of Education and Research within the KBBE-II call; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Coruna; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Project ExpResBar, funded by the German Federal Ministry of Education and Research under grant number 0315702B within the KBBE-II call, and by the Spanish Ministry of Science and Innovation, grant number EUI2009-04075. The University of Coruna and the Deutscher Akademischer Austausch Dienst funded mobility fellowships for CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Bulgarelli D, 2004, THEOR APPL GENET, V108, P1401, DOI 10.1007/s00122-003-1557-9; Bulgarelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012599; Caldwell KS, 2004, PLANT PHYSIOL, V136, P3177, DOI 10.1104/pp.104.044081; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Condon F, 2008, CROP SCI, V48, P1027, DOI 10.2135/cropsci2007.07.0415; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Drader T, 2009, THEOR APPL GENET, V118, P811, DOI 10.1007/s00122-008-0941-x; Dreiseitl A, 2003, GENET RESOUR CROP EV, V50, P345, DOI 10.1023/A:1023953819787; Feuillet C, 2012, FUNCT INTEGR GENOMIC, V12, P573, DOI 10.1007/s10142-012-0300-5; FISCHBECK G, 1991, INTEGRATED CONTROL OF CEREAL MILDEWS : VIRULENCE PATTERNS AND THEIR CHANGE, P247; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042578; Igartua E, 1998, GENET RESOUR CROP EV, V45, P475, DOI 10.1023/A:1008662515059; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; JANSEN RC, 1994, GENETICS, V136, P1447; Jones DA, 1996, ADV BOT RES ADV PLAN, V24, P90; Jorgensen JH, 1997, EUPHYTICA, V97, P227, DOI 10.1023/A:1003032424968; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Konig J, 2012, MOL BREEDING, V30, P1253, DOI 10.1007/s11032-012-9712-0; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kunzel G, 2000, GENETICS, V154, P397; Lasa JM, 2008, MONOGRAFIAS INIA; Lee J, 2002, TRENDS PLANT SCI, V7, P97, DOI 10.1016/S1360-1385(02)02229-X; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li WL, 2002, GENETICS, V160, P1153; Liu ZH, 2010, PLANT GENOME-US, V3, P41, DOI 10.3835/plantgenome2010.02.0002; Lopez P. B., 1994, Ceres (Rome), V26, P41; Malysheva-Otto L, 2007, MOL BREEDING, V20, P309, DOI 10.1007/s11032-007-9093-y; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pourkheirandish M, 2007, THEOR APPL GENET, V114, P1357, DOI 10.1007/s00122-007-0522-4; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Sato K, 2009, HEREDITY, V103, P110, DOI 10.1038/hdy.2009.57; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Schulte D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-247; Shahinnia F, 2012, THEOR APPL GENET, V124, P373, DOI 10.1007/s00122-011-1712-7; Silvar C, 2011, THEOR APPL GENET, V123, P1019, DOI 10.1007/s00122-011-1644-2; Silvar C, 2011, PLANT BREEDING, V130, P195, DOI 10.1111/j.1439-0523.2010.01843.x; Silvar C, 2010, PLANT BREEDING, V129, P45, DOI 10.1111/j.1439-0523.2009.01700.x; Silvar C, 2013, EUR J PLANT PATHOL, V136, P459, DOI 10.1007/s10658-013-0178-7; Silvar C, 2012, THEOR APPL GENET, V124, P49, DOI 10.1007/s00122-011-1686-5; Silvar C, 2010, MOL BREEDING, V25, P581, DOI 10.1007/s11032-009-9354-z; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Thiel T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-209; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Varshney RK, 2007, ADV GENET, V58, P121, DOI 10.1016/S0065-2660(06)58005-8; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	69	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67336	10.1371/journal.pone.0067336	http://dx.doi.org/10.1371/journal.pone.0067336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826271	Green Published, gold			2022-12-25	WOS:000321738400135
J	Tseng, WEJ; Chen, CM; Chen, YC; Yi, Z; Tan, EK; Wu, YR				Tseng, Wei-En Johnny; Chen, Chiung-Mei; Chen, Yi-Chun; Yi, Zhao; Tan, Eng-King; Wu, Yih-Ru			Genetic Variations of GAK in Two Chinese Parkinson's Disease Populations: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; G-ASSOCIATED KINASE; ALPHA-SYNUCLEIN; CATHEPSIN-D; METAANALYSIS; TOXICITY; LOCUS; IDENTIFICATION; AGGREGATION; REPLICATION	Cyclin G-associated kinase (GAK) modifies alpha-synuclein expression levels and affects the susceptibility of Parkinson's disease (PD). The single-nucleotide polymorphism (SNP) rs1564282 of GAK gene has a significant association to the risk of PD among Caucasian populations. To date there is only one data with regards to ethnic Chinese from Mainland China. Here, we conducted a case-control study in two independent cohorts of Han Chinese populations from Taiwan and Singapore to validate this association. A total of 1,755 subjects (871 PD patients and 884 controls) were recruited. The results showed that neither the CT, TT genotypes nor the minor allele T of SNP rs1564282 were associated with PD among the subjects from Taiwan and Singapore as well as in the pooled analysis. Differences in our study population with regards to published literature may be due to epigenetic factors and gene-gene or gene-environmental interactions. Further studies in other Chinese populations will be of interest to validate these findings.	[Tseng, Wei-En Johnny; Chen, Chiung-Mei; Chen, Yi-Chun; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Yi, Zhao; Tan, Eng-King] Singapore Gen Hosp, Natl Neurosci Inst, Singapore, Singapore	Chang Gung Memorial Hospital; Chang Gung University; National Neuroscience Institute (NNI); Singapore General Hospital	Wu, YR (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan.	yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG391182, CMRPG 3A0132]; National Science Council, Executive Yuan, Taiwan [NSC 101-2314-B-182A-065-]; National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School(National University of SingaporeNational Medical Research Council, Singapore)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG391182; CMRPG 3A0132); National Science Council, Executive Yuan, Taiwan (NSC 101-2314-B-182A-065-) and "National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dean A., OPENEPI OPEN SOURCE; Dumitriu A, 2011, HUM MOL GENET, V20, P1478, DOI 10.1093/hmg/ddr026; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Li NN, 2012, HUM GENET, V131, P1089, DOI 10.1007/s00439-011-1133-3; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Susa M, 2010, MOL CANCER THER, V9, P3342, DOI 10.1158/1535-7163.MCT-10-0637	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67506	10.1371/journal.pone.0067506	http://dx.doi.org/10.1371/journal.pone.0067506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826309	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400152
J	Yoshikawa, M; Kojima, H; Yaguchi, Y; Okada, N; Saito, H; Moriyama, H				Yoshikawa, Mamoru; Kojima, Hiromi; Yaguchi, Yuichiro; Okada, Naoko; Saito, Hirohisa; Moriyama, Hiroshi			Cholesteatoma Fibroblasts Promote Epithelial Cell Proliferation through Overexpression of Epiregulin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MIDDLE-EAR CHOLESTEATOMA; MESSENGER-RNA EXPRESSION; FACTOR RECEPTOR; CANCER-CELLS; AMPHIREGULIN; STROMA; INTERLEUKIN-1-ALPHA; BETACELLULIN; ANGIOGENESIS	To investigate whether keratinocytes proliferate in response to epiregulin produced by subepithelial fibroblasts derived from middle ear cholesteatoma. Tissue samples were obtained from patients undergoing tympanoplasty. The quantitative polymerase chain reaction and immunohistochemistry were performed to examine epiregulin expression and localization in cholesteatoma tissues and retroauricular skin tissues. Fibroblasts were cultured from cholesteatoma tissues and from normal retroauricular skin. These fibroblasts were used as feeder cells for culture with a human keratinocyte cell line (PHK16-0b). To investigate the role of epiregulin in colony formation by PHK16-0b cells, epiregulin mRNA expression was knocked down in fibroblasts by using short interfering RNA and epiregulin protein was blocked with a neutralizing antibody. Epiregulin mRNA expression was significantly elevated in cholesteatoma tissues compared with that in normal retroauricular skin. Staining for epiregulin was more intense in the epithelial cells and subepithelial fibroblasts of cholesteatoma tissues than in retroauricular skin. When PHK16-0b cells were cultured with cholesteatoma fibroblasts, their colony-forming efficiency was 50% higher than when these cells were cultured with normal skin fibroblasts. Also, knockdown of epiregulin mRNA in cholesteatoma fibroblasts led to greater suppression of colony formation than knockdown in skin fibroblasts. Furthermore, the colony-forming efficiency of PHK16-0b cells was significantly reduced after treatment with an epiregulin neutralizing antibody in co-culture with cholesteatoma fibroblasts, but not in co-culture with skin fibroblasts. These results suggest that keratinocyte hyperproliferation in cholesteatoma is promoted through overexpression of epiregulin by subepithelial fibroblasts via epithelial-mesenchymal interactions, which may play a crucial role in the pathogenesis of middle ear cholesteatoma.	[Yoshikawa, Mamoru] Toho Univ, Sch Med, Dept Otorhinolaryngol, Meguro Ku, Tokyo, Japan; [Kojima, Hiromi; Yaguchi, Yuichiro; Moriyama, Hiroshi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Minato Ku, Tokyo, Japan; [Okada, Naoko; Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo, Japan	Toho University; Jikei University; National Center for Child Health & Development - Japan	Yoshikawa, M (corresponding author), Toho Univ, Sch Med, Dept Otorhinolaryngol, Meguro Ku, Tokyo, Japan.	mamoru.yoshikawa@med.toho-u.ac.jp	岡田, 直子/GRI-9555-2022	岡田, 直子/0000-0002-3378-5778; Saito, Hirohisa/0000-0002-6630-8337	KAKEN; Grants-in-Aid for Scientific Research [24592582] Funding Source: KAKEN	KAKEN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKEN (http://kaken.nii.ac.jp/d/p/22591891.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Chung JW, 1998, ACTA OTO-LARYNGOL, V118, P386; El Ghalbzouri A, 2002, CELL TISSUE RES, V310, P189, DOI 10.1007/s00441-002-0621-0; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Inatomi O, 2006, INT J MOL MED, V18, P497; Ishibashi T, 1997, ACTA OTO-LARYNGOL, V117, P714, DOI 10.3109/00016489709113465; Kaminski A, 2006, INT J MOL MED, V18, P941; KOJIMA H, 1994, ACTA OTO-LARYNGOL, V114, P423, DOI 10.3109/00016489409126081; Kojima H, 1996, ARCH OTOLARYNGOL, V122, P157; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Kuramochi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-88; Li SW, 2008, P NATL ACAD SCI USA, V105, P3539, DOI 10.1073/pnas.0712397105; Li XD, 2010, ONKOLOGIE, V33, P353, DOI 10.1159/000315380; Lindvall C, 2003, CANCER RES, V63, P1743; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Riese DJ, 1996, ONCOGENE, V12, P345; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; SCHILLING V, 1992, AM J OTOL, V13, P350; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Shirakata Y, 2007, J DERMATOL SCI, V45, P69, DOI 10.1016/j.jdermsci.2006.08.010; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sudhoff H, 2000, AM J OTOL, V21, P793; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yamamoto T, 2004, ANTICANCER RES, V24, P2007; Yamamoto-Fukuda T, 2003, LAB INVEST, V83, P123, DOI 10.1097/01.LAB.0000050763.64145.CB; Yetiser S, 2002, OTOL NEUROTOL, V23, P647, DOI 10.1097/00129492-200209000-00007; Yoshikawa M, 2006, ARCH OTOLARYNGOL, V132, P734, DOI 10.1001/archotol.132.7.734	36	16	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66725	10.1371/journal.pone.0066725	http://dx.doi.org/10.1371/journal.pone.0066725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826119	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400039
J	Chung, TH; Mulligan, G; Fonseca, R; Chng, WJ				Chung, Tae-Hoon; Mulligan, George; Fonseca, Rafael; Chng, Wee Joo			A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MOLECULAR CLASSIFICATION; GENOMIC INSTABILITY; CANCER; AMPLIFICATION; PATHOGENESIS; ABERRATIONS; PROGRESSION; PREDICTION; SURVIVAL	Multiple myeloma (MM) is characterized by complex genetic abnormalities whose complexity signifies varying degree of chromosomal instability (CIN). In this study, we introduced a novel CIN measure, chromosome instability genome event count (CINGEC), which considered both copy number aberrations and interstitial breakpoints from high-resolution genome-wide assays. When assessed in two aCGH MM datasets, higher CINGEC was associated with poor survival. We then derived a CINGEC-associated gene expression profile (GEP) signature, CINGECS, using a dataset that has both aCGH and GEP. Genes in CINGECS were mainly involved in DNA damage responses besides in aneuploidy and other generic oncogenic processes contrary to other CIN associated GEP signatures. Finally, we confirmed its survival association in three GEP datasets that encompassed newly diagnosed patients treated with transplant-based protocol with or without novel agents for induction as well as relapsed patients treated with bortezomib. Furthermore, CINGECS was independent of many GEP-based prognostic signatures. In conclusion, our novel CIN measure has definite biological and clinical significance in myeloma.	[Chung, Tae-Hoon; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mulligan, George] Millenium Takeda Oncol, Cambridge, MA USA; [Fonseca, Rafael] Mayo Clin, Ctr Comprehens Canc, Scottsdale, AZ USA; [Chng, Wee Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chng, Wee Joo] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore	National University of Singapore; Takeda Pharmaceutical Company Ltd; Takeda Oncology; Mayo Clinic; Mayo Clinic Phoenix; National University of Singapore; National University of Singapore	Chng, WJ (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	mdccwj@nus.edu.sg		Chung, Tae Hoon/0000-0003-1737-6322; Fonseca, Rafael/0000-0002-5938-3769	NMRC Clinician Scientist Investigator award; Singapore Cancer Syndicate Grant; Singapore National Research Foundation; Ministry of Education under the Research Center of Excellence Programme; Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation;  [SPORE CA90297052];  [P01 CA62242];  [R01 CA83724];  [ECOG CA 21115T]; NATIONAL CANCER INSTITUTE [R01CA083724, P01CA062242, U10CA021115] Funding Source: NIH RePORTER	NMRC Clinician Scientist Investigator award(National Medical Research Council, Singapore); Singapore Cancer Syndicate Grant; Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education under the Research Center of Excellence Programme; Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	WJC is supported by NMRC Clinician Scientist Investigator award. This work is partly supported by Singapore Cancer Syndicate Grant. This material is based on research/work supported by the Singapore National Research Foundation and the Ministry of Education under the Research Center of Excellence Programme. RF is a Clinical Investigator of the Damon Runyon Cancer Research Fund. This work is supported by grants SPORE CA90297052, P01 CA62242, R01 CA83724, ECOG CA 21115T, Predolin Foundation, Mayo Clinic Cancer Center and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Boyd KD, 2011, GENE CHROMOSOME CANC, V50, P765, DOI 10.1002/gcc.20899; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chng WJ, 2010, LEUKEMIA, V24, P833, DOI 10.1038/leu.2010.21; Chng WJ, 2008, BLOOD, V111, P1603, DOI 10.1182/blood-2007-06-097774; Chng WJ, 2006, BLOOD, V107, P3669, DOI 10.1182/blood-2005-09-3810; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Dickens NJ, 2010, CLIN CANCER RES, V16, P1856, DOI 10.1158/1078-0432.CCR-09-2831; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Khatri P, 2005, NUCLEIC ACIDS RES, V33, pW762, DOI 10.1093/nar/gki472; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kuiper R, 2012, LEUKEMIA, V26, P2406, DOI 10.1038/leu.2012.127; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ouillette P, 2010, CLIN CANCER RES, V16, P835, DOI 10.1158/1078-0432.CCR-09-2534; Ozery-Flato M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r61; Schwender H, 2009, SIGGENES MULTIPLE TE; Seshan V.E., DNACOPY DNA COPY NUM; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shaughnessy J, 2005, HEMATOLOGY, V10, P117, DOI 10.1080/10245330512331390140; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Snijders AM, 2008, GENE CHROMOSOME CANC, V47, P71, DOI 10.1002/gcc.20509; Stewart AK, 2007, EXPERT REV MOL DIAGN, V7, P453, DOI 10.1586/14737159.7.4.453; Stewart AK, 2005, J CLIN ONCOL, V23, P6339, DOI 10.1200/JCO.2005.05.023; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	44	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66361	10.1371/journal.pone.0066361	http://dx.doi.org/10.1371/journal.pone.0066361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840451	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800051
J	Hsueh, YS; Lin, CL; Chiang, NJ; Yen, CC; Li, CF; Shan, YS; Ko, CH; Shih, NY; Wang, LM; Chen, TS; Chen, LT				Hsueh, Yuan-Shuo; Lin, Chih-Lung; Chiang, Nai-Jung; Yen, Chueh-Chuan; Li, Chien-Feng; Shan, Yan-Shen; Ko, Ching-Huai; Shih, Neng-Yao; Wang, Ling-Mei; Chen, Ting-Shou; Chen, Li-Tzong			Selecting Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor with Secondary KIT Activation-Loop Domain Mutations	PLOS ONE			English	Article							C-KIT; IMATINIB RESISTANCE; ANTITUMOR-ACTIVITY; FREE SURVIVAL; NILOTINIB; SORAFENIB; SAFETY; PHARMACOKINETICS; DASATINIB; PROGNOSIS	Advanced gastrointestinal stromal tumors (GIST), a KIT oncogene-driven tumor, on imatinib mesylate (IM) treatment may develop secondary KIT mutations to confer IM-resistant phenotype. Second-line sunitinib malate (SU) therapy is largely ineffective for IM-resistant GISTs with secondary exon 17 (activation-loop domain) mutations. We established an in vitro cell-based platform consisting of a series of COS-1 cells expressing KIT cDNA constructs encoding common primary +/- secondary mutations observed in GISTs, to compare the activity of several commercially available tyrosine kinase inhibitors on inhibiting the phosphorylation of mutant KIT proteins at their clinically achievable plasma steady-state concentration (Css). The inhibitory efficacies on KIT exon 11/17 mutants were further validated by growth inhibition assay on GIST48 cells, and underlying molecular-structure mechanisms were investigated by molecular modeling. Our results showed that SU more effectively inhibited mutant KIT with secondary exon 13 or 14 mutations than those with secondary exon 17 mutations, as clinically indicated. On contrary, at individual Css, nilotinib and sorafenib more profoundly inhibited the phosphorylation of KIT with secondary exon 17 mutations and the growth of GIST48 cells than IM, SU, and dasatinib. Molecular modeling analysis showed fragment deletion of exon 11 and point mutation on exon 17 would lead to a shift of KIT conformational equilibrium toward active form, for which nilotinib and sorafenib bound more stably than IM and SU. In current preclinical study, nilotinib and sorafenib are more active in IM-resistant GISTs with secondary exon 17 mutation than SU that deserve further clinical investigation.	[Hsueh, Yuan-Shuo; Chiang, Nai-Jung; Li, Chien-Feng; Shih, Neng-Yao; Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsueh, Yuan-Shuo; Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Lin, Chih-Lung; Wang, Ling-Mei; Chen, Ting-Shou] Ind Technol Res Inst, Biomed Technol Lab, Hsinchu, Taiwan; [Lin, Chih-Lung; Wang, Ling-Mei; Chen, Ting-Shou] Ind Technol Res Inst, Device Res Lab, Hsinchu, Taiwan; [Chiang, Nai-Jung; Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Yen, Chueh-Chuan] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Yen, Chueh-Chuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Li, Chien-Feng] Chi Mei Fdn, Med Ctr, Dept Pathol, Tainan, Taiwan; [Shan, Yan-Shen] Natl Cheng Kung Univ Hosp, Dept Surg, Div Gen Surg, Tainan 70428, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; Industrial Technology Research Institute - Taiwan; Industrial Technology Research Institute - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, TS (corresponding author), Ind Technol Res Inst, Biomed Technol Lab, Hsinchu, Taiwan.	CTS@itri.org.tw; leochen@nhri.org.tw	Chen, Li-Tzong/D-2071-2010; Shih, Neng-Yao/D-2086-2010	Li, Chien-Feng/0000-0002-9527-7576; Hsueh, Yuan-Shuo/0000-0002-2584-9380	Department of Health [DOH95-97-TD-I-111-TM004, DOH-101-TD111-004]; National Health Research Institute [98A1CASP02-014]	Department of Health; National Health Research Institute(National Health Research Institutes - Taiwan)	Research funds were supported to National Institute of Cancer Research from Department of Health (DOH95-97-TD-I-111-TM004 and DOH-101-TD111-004) and National Health Research Institute (98A1CASP02-014). Research compounds from Novartis and Bayer, and honorarium from Novartis, TTY, and Pharmaengine were provided to Li-Tzong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Cauchi C, 2012, CANCER CHEMOTH PHARM, V69, P977, DOI 10.1007/s00280-011-1785-7; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; Demetri GD, 2009, CLIN CANCER RES, V15, P5910, DOI 10.1158/1078-0432.CCR-09-0542; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; George S, 2009, EUR J CANCER, V45, P1959, DOI 10.1016/j.ejca.2009.02.011; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Italiano A, 2012, ANN SURG ONCOL, V19, P1551, DOI 10.1245/s10434-011-2120-6; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kim KP, 2011, CANCER CHEMOTH PHARM, V68, P285, DOI 10.1007/s00280-010-1479-6; Kindler HL, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.10009; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Martin J, 2005, J CLIN ONCOL, V23, P6190, DOI 10.1200/JCO.2005.19.554; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Park SH, 2012, INVEST NEW DRUG, V30, P2377, DOI 10.1007/s10637-012-9795-9; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; Sawaki A, 2011, CANCER-AM CANCER SOC, V117, P4633, DOI 10.1002/cncr.26120; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Trent JC, 2011, J CLIN ONCOL, V29; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9	35	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65762	10.1371/journal.pone.0065762	http://dx.doi.org/10.1371/journal.pone.0065762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840364	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800020
J	Cooper, CB; Voss, MA				Cooper, Caren B.; Voss, Margaret A.			Avian Incubation Patterns Reflect Temporal Changes in Developing Clutches	PLOS ONE			English	Article							EGG TEMPERATURE; INTERMITTENT INCUBATION; BEHAVIOR; EMBRYOS; HEAT; TIME; ATTENTIVENESS; ENERGETICS; COSTS	Incubation conditions for eggs influence offspring quality and reproductive success. One way in which parents regulate brooding conditions is by balancing the thermal requirements of embryos with time spent away from the nest for self-maintenance. Age related changes in embryo thermal tolerance would thus be expected to shape parental incubation behavior. We use data from unmanipulated Black-capped Chickadee (Poecile atricapillus) nests to examine the temporal dynamics of incubation, testing the prediction that increased heat flux from eggs as embryos age influences female incubation behavior and/or physiology to minimize temperature fluctuations. We found that the rate of heat loss from eggs increased with embryo age. Females responded to increased egg cooling rates by altering incubation rhythms (more frequent, shorter on-and off-bouts), but not brood patch temperature. Consequently, as embryos aged, females were able to increase mean egg temperature and decrease variation in temperature. Our findings highlight the need to view full incubation as more than a static rhythm; rather, it is a temporally dynamic and finely adjustable parental behavior. Furthermore, from a methodological perspective, intra- and inter-specific comparisons of incubation rhythms and average egg temperatures should control for the stage of incubation.	[Cooper, Caren B.] Cornell Lab Ornithol, Ithaca, NY USA; [Voss, Margaret A.] Penn State Univ, Sch Sci, Erie, PA 16563 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Cooper, CB (corresponding author), Cornell Lab Ornithol, Ithaca, NY USA.	caren.cooper@cornell.edu	Voss, Margaret/C-9359-2011	Voss, Margaret/0000-0002-7969-4871; Cooper, Caren/0000-0001-6263-8892				AFTON AD, 1979, CAN J ZOOL, V57, P1052, DOI 10.1139/z79-133; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Arnold TW, 2011, CONDOR, V113, P107, DOI 10.1525/cond.2011.100001; BAKKEN GS, 1976, J THERM BIOL, V1, P169, DOI 10.1016/0306-4565(76)90009-7; Bryan SM, 1999, P ROY SOC B-BIOL SCI, V266, P157, DOI 10.1098/rspb.1999.0616; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CLARK MM, 1995, TRENDS ECOL EVOL, V10, P151, DOI 10.1016/S0169-5347(00)89025-4; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Cooper CB, 2011, FUNCT ECOL, V25, P769, DOI 10.1111/j.1365-2435.2011.01847.x; Cooper CB, 2005, J FIELD ORNITHOL, V76, P352, DOI 10.1648/0273-8570-76.4.352; DAVIS SD, 1984, AUK, V101, P556, DOI 10.1093/auk/101.3.556; Deeming DC, 2002, OX ORN SER, V13, P63; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; HAFTORN S, 1988, ORNIS SCAND, V19, P97, DOI 10.2307/3676458; Hainsworth FR, 2002, OX ORN SER, V13, P223; Hainsworth FR, 1998, J AVIAN BIOL, V29, P113, DOI 10.2307/3677188; Larsen VA, 2003, J ANIM ECOL, V72, P784, DOI 10.1046/j.1365-2656.2003.00751.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; Mortola JP, 2009, COMP BIOCHEM PHYS A, V153, P359, DOI 10.1016/j.cbpa.2009.02.041; MORTON ML, 1985, AUK, V102, P25, DOI 10.2307/4086819; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Poussart C, 2000, CONDOR, V102, P292, DOI 10.1650/0010-5422(2000)102[0292:TTROED]2.0.CO;2; Reid JM, 2002, OX ORN SER, V13, P314; Reid JM, 1999, ANIM BEHAV, V58, P1161, DOI 10.1006/anbe.1999.1241; RICKLEFS RE, 1968, CONDOR, V70, P121, DOI 10.2307/1365955; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Skutch A. F., 1957, Ibis, V99, P69, DOI 10.1111/j.1474-919X.1957.tb01934.x; Smith S.M., 1997, BLACK CAPPED CHICKAD; SMITH SM, 1967, CONDOR, V69, P344, DOI 10.2307/1366198; TAZAWA H, 1989, COMP BIOCHEM PHYS A, V92, P613, DOI 10.1016/0300-9629(89)90376-9; Tazawa H, 2001, J THERM BIOL, V26, P281, DOI 10.1016/S0306-4565(01)00031-6; Tinbergen JM, 2002, OX ORN SER, V13, P299; Turner J.S., 1991, P117; Turner JS, 2002, OX ORN SER, V13, P119; TURNER JS, 1987, J EXP ZOOL, P99; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Voss MA, 2001, J THERM BIOL, V26, P121, DOI 10.1016/S0306-4565(00)00032-2; Wang JM, 2011, AUK, V128, P454, DOI 10.1525/auk.2011.10208; Wang JM, 2009, ANIM BEHAV, V78, P601, DOI 10.1016/j.anbehav.2009.05.022; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WHITE FN, 1974, SCIENCE, V186, P107, DOI 10.1126/science.186.4159.107; Wiebe KL, 2000, BEHAV ECOL SOCIOBIOL, V48, P463; WILLIAMS JB, 1993, CONDOR, V95, P115, DOI 10.2307/1369392; Williams Joseph B., 1996, P375	45	16	17	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65521	10.1371/journal.pone.0065521	http://dx.doi.org/10.1371/journal.pone.0065521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840339	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200024
J	Ji, J; Wang, SQ; Liu, YJ; He, QQ				Ji, Jie; Wang, Su-qing; Liu, Yu-jian; He, Qi-qiang			Physical Activity and Lung Function Growth in a Cohort of Chinese School Children: A Prospective Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PULMONARY-FUNCTION; HEALTH; EXERCISE; LEVEL	Backgrounds/objectives: Evidence on the association between physical activity and lung function in children is sparse. The aim of this study was to evaluate children's lung function growth in relation to their physical activity level in Chinese children. Methods: A total of 1713 school children aged 9.89 +/- 0.86 years who were asthma-free at baseline were followed-up for 18 months from 2006 to 2008 in Guangzhou, China. Information on physical activity and other socio-economic status were obtained from self-administered questionnaires. Lung function tests were performed with a standard procedure. Results: At the baseline survey, physically active girls had significantly higher forced vital capacity (FVC) than inactive girls (1.79 l vs. 1.75 l, p<0.05). The growth rates for lung function indices were significantly higher for girls who were physically active at either or both follow-up surveys than those inactive at both surveys during the follow-up period forced expiratory flows at 25% (FEF25) difference per year (dpy) (0.20 l/s vs. 0.15 l/s), forced expiratory flows at 75% (FEF75) dpy (0.57 l/s vs. 0.45 l/s) and forced expiratory flows between 25% and 75% (FEF25-75) dpy (0.36 l/s vs. 0.28 l/s) (all p<0.05). Conclusions: Physical activity is positively associated with lung function growth among Chinese school-aged girls. Promotion of physical activity among children is of great importance.	[Ji, Jie; Wang, Su-qing; Liu, Yu-jian; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Wuhan 430072, Hubei Province, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012					Berntsen S, 2008, PEDIATR EXERC SCI, V20, P402, DOI 10.1123/pes.20.4.402; Cheng YJ, 2003, BRIT J SPORT MED, V37, P521, DOI 10.1136/bjsm.37.6.521; Donaldson AV, 2012, INT J CHRONIC OBSTR, V7, P523, DOI 10.2147/COPD.S28247; Drenowatz C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-214; Eisenmann JC, 1999, PEDIATR EXERC SCI, V11, P208, DOI 10.1123/pes.11.3.208; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallerod B, 2011, SOC SCI MED, V72, P116, DOI 10.1016/j.socscimed.2010.09.036; He QQ, 2008, PUBLIC HEALTH, V122, P1425, DOI 10.1016/j.puhe.2008.06.010; Jakes RW, 2002, AM J EPIDEMIOL, V156, P139, DOI 10.1093/aje/kwf021; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; JONES PRM, 1977, ANN HUM BIOL, V4, P155, DOI 10.1080/03014467700002041; Meszaros D, 2010, RESP MED, V104, P808, DOI 10.1016/j.rmed.2009.12.001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Oja P, 2011, EPMA J, V2, P253, DOI 10.1007/s13167-011-0090-1; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Rosenkranz SK, 2012, J APPL PHYSIOL, V112, P1174, DOI 10.1152/japplphysiol.00663.2011; Seed L, 2012, RESP CARE, V57, P61, DOI 10.4187/respcare.01430; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Wetter TJ, 2001, J APPL PHYSIOL, V91, P847, DOI 10.1152/jappl.2001.91.2.847; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781	22	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66098	10.1371/journal.pone.0066098	http://dx.doi.org/10.1371/journal.pone.0066098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840406	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200055
J	Schmidt, S; Gericke, B; Fracasso, G; Ramarli, D; Colombatti, M; Naim, HY				Schmidt, Sonja; Gericke, Birthe; Fracasso, Giulio; Ramarli, Dunia; Colombatti, Marco; Naim, Hassan Y.			Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ANTIBODY CROSS-LINKING; ANCHORED PROTEINS; LIPID RAFTS; INTERNALIZATION; EXPRESSION; ASSOCIATION; CANCER; CELLS	Prostate-specific membrane antigen (PSMA) is a type-II membrane glycoprotein that was initially identified in LNCaP cells. It is expressed at elevated levels in prostate cancer. In view of the correlation between the expression levels of PSMA and disease grade and stage, PSMA is considered to be one of the most promising biomarkers in the diagnosis and treatment of prostate cancer. In LNCaP cells PSMA undergoes internalization via clathrin-coated pits followed by accumulation in the endosomes. PSMA associates with different types of detergent-resistant membranes (DRMs) along the secretory pathway. Its mature form is mainly insoluble in Lubrol WX, but does not associate with Triton X-100-DRMs. To understand the mechanism of PSMA internalization we investigated its association during internalization with DRMs. For this purpose, internalization was induced by antibody cross-linking. We demonstrate at the biochemical and cell biological levels that: [i] exclusively homodimers of PSMA are associated with Lubrol WX-DRMs, [ii] antibody-induced cross-linking of PSMA molecules results in a time-dependent partitioning into another DRMs type, namely Triton X-100-DRMs, and [iii] concomitant with its association with Triton-X-100-DRMs internalization of PSMA occurs along tubulin filaments. In a previous work (Colombatti et al. (2009) PLoS One 4: e4608) we demonstrated that the small GTPases RAS and RAC1 and the MAPKs p38 and ERK1/2 are activated during antibody cross-linking. As downstream effects of this activation we observed a strong induction of NF-kB associated with an increased expression of IL-6 and CCL5 genes and that IL-6 and CCL5 enhanced the proliferative potential of LNCaP cells synergistically. These observations together with findings reported here hypothesize a fundamental role of DRMs during activation of PSMA as platforms for trafficking, endocytosis and signalling. Understanding these mechanisms constitutes an essential prerequisite for utilization of PSMA as a therapeutically suitable target in prostate cancer.	[Schmidt, Sonja; Gericke, Birthe; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [Fracasso, Giulio; Ramarli, Dunia; Colombatti, Marco] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy	University of Veterinary Medicine Hannover, Foundation; University of Verona	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany.	Hassan.naim@tiho-hannover.de	Fracasso, Giulio/O-3955-2019; Fracasso, Giulio/E-1271-2013	Fracasso, Giulio/0000-0003-3024-0307; Fracasso, Giulio/0000-0003-3024-0307; Gericke, Birthe/0000-0002-9181-4493	University of Veterinary Medicine Hannover; AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools (; University of Verona; Fondazione Cariverona project Verona Nanomedicine Initiative; Fondazione Cariverona/AIRC Progetto Regionale	University of Veterinary Medicine Hannover; AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools ((Fondazione AIRC per la ricerca sul cancro); University of Verona; Fondazione Cariverona project Verona Nanomedicine Initiative(Fondazione Cariverona); Fondazione Cariverona/AIRC Progetto Regionale(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by institutional funds provided by the University of Veterinary Medicine Hannover (to HYN), AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools (funding attributed to MC), by the University of Verona, by Fondazione Cariverona project Verona Nanomedicine Initiative (to MC) and by Fondazione Cariverona/AIRC Progetto Regionale (to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MO, 2007, BIOORGAN MED CHEM, V15, P6678, DOI 10.1016/j.bmc.2007.08.006; Anilkumar G, 2003, CANCER RES, V63, P2645; Anilkumar G, 2006, MICROVASC RES, V72, P54, DOI 10.1016/j.mvr.2006.03.004; Ballangrud AM, 2001, CANCER RES, V61, P2008; Bander NH, 2003, J UROLOGY, V170, P1717, DOI 10.1097/01.ju.0000091655.77601.0c; Barinka C, 2008, J MOL BIOL, V376, P1438, DOI 10.1016/j.jmb.2007.12.066; Castelletti D, 2008, BIOCHEM J, V409, P149, DOI 10.1042/BJ20070396; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chang SS, 1999, CANCER RES, V59, P3192; Christiansen JJ, 2005, MOL CANCER THER, V4, P704, DOI 10.1158/1535-7163.MCT-04-0171; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; Fracasso G, 2002, PROSTATE, V53, P9, DOI 10.1002/pros.10117; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Goodman OB, 2007, INT J ONCOL, V31, P1199; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; ISRAELI RS, 1993, CANCER RES, V53, P227; ISRAELI RS, 1994, CANCER RES, V54, P1807; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Liu H, 1998, CANCER RES, V58, P4055; Marta CB, 2005, J BIOL CHEM, V280, P8985, DOI 10.1074/jbc.M413174200; Marta CB, 2003, J NEUROSCI, V23, P5461; McDevitt MR, 2000, CANCER RES, V60, P6095; Nanus DM, 2003, J UROLOGY, V170, pS84, DOI 10.1097/01.ju.0000095151.97404.7c; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rajasekaran SA, 2003, MOL BIOL CELL, V14, P4835, DOI 10.1091/mbc.E02-11-0731; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schulke N, 2003, P NATL ACAD SCI USA, V100, P12590, DOI 10.1073/pnas.1735443100; Silver DA, 1997, CLIN CANCER RES, V3, P81; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66193	10.1371/journal.pone.0066193	http://dx.doi.org/10.1371/journal.pone.0066193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840421	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200059
J	Teng, CY; Dang, YK; Danne, JC; Waller, RF; Green, BR				Teng, Chang Ying; Dang, Yunkun; Danne, Jillian C.; Waller, Ross F.; Green, Beverley R.			Mitochondrial Genes of Dinoflagellates Are Transcribed by a Nuclear-Encoded Single-Subunit RNA Polymerase	PLOS ONE			English	Article							SPLICED LEADER; GENOME; FRAGMENTS; EVOLUTION; IDENTIFICATION; ORGANIZATION; REPLICATION; CDNAS	Dinoflagellates are a large group of algae that contribute significantly to marine productivity and are essential photosynthetic symbionts of corals. Although these algae have fully-functioning mitochondria and chloroplasts, both their organelle genomes have been highly reduced and the genes fragmented and rearranged, with many aberrant transcripts. However, nothing is known about their RNA polymerases. We cloned and sequenced the gene for the nuclear-encoded mitochondrial polymerase (RpoTm) of the dinoflagellate Heterocapsa triquetra and showed that the protein presequence targeted a GFP construct into yeast mitochondria. The gene belongs to a small gene family, which includes a variety of 3'-truncated copies that may have originated by retroposition. The catalytic C-terminal domain of the protein shares nine conserved sequence blocks with other single-subunit polymerases and is predicted to have the same fold as the human enzyme. However, the N-terminal (promoter binding/transcription initiation) domain is not well-conserved. In conjunction with the degenerate nature of the mitochondrial genome, this suggests a requirement for novel accessory factors to ensure the accurate production of functional mRNAs.	[Teng, Chang Ying; Dang, Yunkun; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Teng, Chang Ying] Ludong Univ, Dept Life Sci, Yantai, Shandong, Peoples R China; [Danne, Jillian C.; Waller, Ross F.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia	University of British Columbia; Ludong University; University of Melbourne	Green, BR (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	brgreen@mail.ubc.ca	Waller, Ross F/D-5761-2016; Green, Beverley R./AAJ-5199-2021	Waller, Ross F/0000-0001-6961-9344; Green, Beverley R./0000-0002-4021-9387	Natural Sciences and Engineering Research Council of Canada [4688-12]; Australian Research Council [DP0663590]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	Funding provided by Natural Sciences and Engineering Research Council of Canada grant 4688-12 to BRG (http://www.nserc-crsng.gc.ca); Australian Research Council grant DP0663590 to RFW (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Chang CC, 1999, PLANT CELL, V11, P911, DOI 10.1105/tpc.11.5.911; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Dang Y, 2009, GENE, V442, P73, DOI 10.1016/j.gene.2009.04.006; Danne JC, 2011, J MOL BIOL, V408, P643, DOI 10.1016/j.jmb.2011.02.057; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Huang G, 2000, LETT APPL MICROBIOL, V31, P149, DOI 10.1046/j.1365-2672.2000.00781.x; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Jackson CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056777; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Kabeya Y, 2005, PLANT PHYSIOL, V138, P369, DOI 10.1104/pp.105.059501; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 1999, NATURE PROTOCOLS, V4, P363; Krause K, 2011, PLANTA, V234, P647, DOI 10.1007/s00425-011-1494-9; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Li JN, 2001, MOL BIOCHEM PARASIT, V113, P261, DOI 10.1016/S0166-6851(01)00223-7; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Miller ML, 2006, CURR GENET, V49, P259, DOI 10.1007/s00294-005-0053-y; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Norman JE, 2001, J MOL EVOL, V53, P351, DOI 10.1007/s002390010225; Patron NJ, 2007, BIOESSAYS, V29, P1048, DOI 10.1002/bies.20638; Richter U, 2002, GENE, V290, P95, DOI 10.1016/S0378-1119(02)00583-8; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Swayne Theresa C, 2007, Methods Mol Biol, V372, P433, DOI 10.1007/978-1-59745-365-3_31; Toyoshima Y, 2005, CRIT REV PLANT SCI, V24, P59, DOI 10.1080/07352680590910438; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-379; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zhang ZD, 2001, MOL BIOL EVOL, V18, P1558, DOI 10.1093/oxfordjournals.molbev.a003942	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65387	10.1371/journal.pone.0065387	http://dx.doi.org/10.1371/journal.pone.0065387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840326	Green Published, gold			2022-12-25	WOS:000322361200015
J	Ye, YXH; Woolfit, M; Huttley, GA; Rances, E; Caragata, EP; Popovici, J; O'Neill, SL; McGraw, EA				Ye, Yixin H.; Woolfit, Megan; Huttley, Gavin A.; Rances, Edwige; Caragata, Eric P.; Popovici, Jean; O'Neill, Scott L.; McGraw, Elizabeth A.			Infection with a Virulent Strain of Wolbachia Disrupts Genome Wide-Patterns of Cytosine Methylation in the Mosquito Aedes aegypti	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; DNA METHYLATION; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; SEQUENCE; VECTOR; DENGUE; CELLS; CONSERVATION; TRNA(ASP)	Background: Cytosine methylation is one of several reversible epigenetic modifications of DNA that allow a greater flexibility in the relationship between genotype and phenotype. Methylation in the simplest models dampens gene expression by modifying regions of DNA critical for transcription factor binding. The capacity to methylate DNA is variable in the insects due to diverse histories of gene loss and duplication of DNA methylases. Mosquitoes like Drosophila melanogaster possess only a single methylase, DNMT2. Description: Here we characterise the methylome of the mosquito Aedes aegypti and examine its relationship to transcription and test the effects of infection with a virulent strain of the endosymbiont Wolbachia on the stability of methylation patterns. Conclusion: We see that methylation in the A. aegypti genome is associated with reduced transcription and is most common in the promoters of genes relating to regulation of transcription and metabolism. Similar gene classes are also methylated in aphids and honeybees, suggesting either conservation or convergence of methylation patterns. In addition to this evidence of evolutionary stability, we also show that infection with the virulent wMelPop Wolbachia strain induces additional methylation and demethylation events in the genome. While most of these changes seem random with respect to gene function and have no detected effect on transcription, there does appear to be enrichment of genes associated with membrane function. Given that Wolbachia lives within a membrane-bound vacuole of host origin and retains a large number of genes for transporting host amino acids, inorganic ions and ATP despite a severely reduced genome, these changes might represent an evolved strategy for manipulating the host environments for its own gain. Testing for a direct link between these methylation changes and expression, however, will require study across a broader range of developmental stages and tissues with methods that detect splice variants.	[Ye, Yixin H.; Woolfit, Megan; Rances, Edwige; Caragata, Eric P.; Popovici, Jean; O'Neill, Scott L.; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Huttley, Gavin A.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Monash University; Australian National University; John Curtin School of Medical Research	McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	beth.mcgraw@monash.edu	Popovici, Jean/K-7192-2014; O'Neill, Scott L/B-3568-2009; Huttley, Gavin A/G-5169-2015; McGraw, Elizabeth/GRF-0434-2022; O'Neill, Scott/R-9560-2019; McGraw, Elizabeth/A-6658-2012	Popovici, Jean/0000-0002-3135-1175; O'Neill, Scott L/0000-0002-4131-3615; Huttley, Gavin A/0000-0001-7224-2074; O'Neill, Scott/0000-0002-4131-3615; McGraw, Elizabeth/0000-0001-7973-088X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by The National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Caragata EP, 2011, INSECT MOL BIOL, V20, P215, DOI 10.1111/j.1365-2583.2010.01059.x; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Guo XB, 2011, J GASTROEN HEPATOL, V26, P1685, DOI 10.1111/j.1440-1746.2011.06808.x; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt BG, 2010, GENOME BIOL EVOL, V2, P719, DOI 10.1093/gbe/evq057; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; ONeill SL, 1997, INFLUENTIAL PASSENGE; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Saridaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019708; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zeh JA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00375; Zheng YS, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3671970; Zhou YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-123; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	64	48	48	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66482	10.1371/journal.pone.0066482	http://dx.doi.org/10.1371/journal.pone.0066482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840485	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200085
J	Vascotto, C; Lirussi, L; Poletto, M; Tiribelli, M; Damiani, D; Fabbro, D; Damante, G; Demple, B; Colombo, E; Tell, G				Vascotto, C.; Lirussi, L.; Poletto, M.; Tiribelli, M.; Damiani, D.; Fabbro, D.; Damante, G.; Demple, B.; Colombo, E.; Tell, G.			Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology	ONCOGENE			English	Article						APE1/Ref-1; NPM1; acute myeloid leukemia; base excision repair	REDOX FACTOR-I; ACUTE MYELOID-LEUKEMIA; BASE EXCISION-REPAIR; N-TERMINAL DOMAIN; OXIDATIVE STRESS; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVITY; LYSINE RESIDUES; NPM1 MUTATIONS; GENE MUTATION	Nucleophosmin 1 (NPM1) is a nucleolar protein involved in ribosome biogenesis, stress responses and maintaining genome stability. One-third of acute myeloid leukemias (AMLs) are associated with aberrant localization of NPM1 to the cytoplasm (NPM1c +). This mutation is critical during leukemogenesis and constitutes a good prognostic factor for chemotherapy. At present, there is no clear molecular basis for the role of NPM1 in DNA repair and the tumorigenic process. We found that the nuclear apurinic/apyrimidinic endonuclease 1 (APE1), a core enzyme in base excision DNA repair (BER) of DNA lesions, specifically interacts with NPM1 within nucleoli and the nucleoplasm. Cytoplasmic accumulation of APE1 is associated with cancers including, as we show, NPM1c + AML. Here we show that NPM1 stimulates APE1 BER activity in cells. We provide evidence that expression of the NPM1c + variant causes cytoplasmic accumulation of APE1 in: (i) a heterologous cell system (HeLa cells); (ii) the myeloid cell line OCI/AML3 stably expressing NPM1c + ; and (iii) primary lymphoblasts of NPM1c + AML patients. Consistent with impaired APE1 localization, OCI/AML3 cells and blasts of AML patients have impaired BER activity. Cytoplasmic APE1 in NPM1c + myeloid cells is truncated due to proteolysis. Thus, the good prognostic response of NPM1c + AML to chemotherapy may result from the cytoplasmic relocalization of APE1 and the consequent BER deficiency. NPM1 thus has an indirect but significant role in BER in vivo that may also be important for NPM1c + tumorigenesis.	[Vascotto, C.; Lirussi, L.; Poletto, M.; Fabbro, D.; Damante, G.; Tell, G.] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Tiribelli, M.; Damiani, D.] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy; [Demple, B.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Colombo, E.] Univ Milan, Dept Med Surg & Dent, Milan, Italy	University of Udine; University of Udine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Milan	Tell, G (corresponding author), Univ Udine, Dept Med & Biol Sci, Piazzale Kolbe 4, I-33100 Udine, Italy.	gianluca.tell@uniud.it	Tiribelli, Mario/G-7989-2018; Colombo, Emanuela/AAO-7810-2020; Damante, Giuseppe/AAC-5200-2022; Colombo, Emanuela/AAO-8113-2020; damiani, daniela/AAD-4629-2022	Tiribelli, Mario/0000-0001-9449-2621; Colombo, Emanuela/0000-0003-2079-7398; damiani, daniela/0000-0002-1663-4468; Damante, Giuseppe/0000-0003-2312-4009; Tell, Gianluca/0000-0001-8845-6448; vascotto, carlo/0000-0003-4431-029X	AIRC [IG10269]; MIUR [FIRB_RBRN07BMCT, PRIN2008_CCPKRP_003]; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant	AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant	We greatly thank the National Center for Advancing Translational Sciences (NCATS) and Dr David M Wilson III for providing the APE1 specific inhibitor (compound 3). We also thank Dr Malgorzata M Kamocka from the Indiana University School of Medicine, Department of Medicine, Division of Nephrology, Indiana Center for Biological Microscopy, Indianapolis, IN, USA. for her helpful suggestions during IF analyses, Dr Laura Cesaratto for cell-viability assays and Sofia Tell for kind support. This work was supported by grants from: AIRC (IG10269) and MIUR (FIRB_RBRN07BMCT and PRIN2008_CCPKRP_003) to GT. This work has been also supported by a UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant to GT.	Angkeow P, 2002, CELL DEATH DIFFER, V9, P717, DOI 10.1038/sj.cdd.4401025; Ballmaier D, 2006, TOXICOLOGY, V221, P166, DOI 10.1016/j.tox.2006.01.009; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Cilloni D, 2008, LEUKEMIA, V22, P1234, DOI 10.1038/leu.2008.68; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; den Besten W, 2005, CELL CYCLE, V4, P1593; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2005, NEW ENGL J MED, V352, P740; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Falini B, 2011, BLOOD, V117, P1109, DOI 10.1182/blood-2010-08-299990; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fantini D, 2010, NUCLEIC ACIDS RES, V38, P8239, DOI 10.1093/nar/gkq691; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; He TR, 2003, AM J PHYSIOL-HEART C, V285, pH804, DOI 10.1152/ajpheart.01080.2002; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Lirussi L, 2012, MOL BIOL CELL, V23, P4079, DOI 10.1091/mbc.E12-04-0299; Londero AP, EXPRESSION PRO UNPUB; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Ozaki M, 2002, FASEB J, V16, P889, DOI 10.1096/fj.01-0664fje; Pianta A, 2010, HEMATOL ONCOL, V28, P151, DOI 10.1002/hon.906; Pitiot AS, 2007, LEUKEMIA, V21, P1564, DOI 10.1038/sj.leu.2404679; Poletto M, 2013, BIOCHEM J, V452, P545, DOI 10.1042/BJ20121277; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Wang HF, 2011, CANCER RES, V71, P68, DOI 10.1158/0008-5472.CAN-10-0030; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wei SJ, 2000, CANCER RES, V60, P6688; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wilson DM, 2010, CELL MOL LIFE SCI, V67, P3621, DOI 10.1007/s00018-010-0488-2; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200; Yu ET, 2011, MUTAT RES-GEN TOX EN, V722, P140, DOI 10.1016/j.mrgentox.2010.06.015; Ziel KA, 2004, FASEB J, V18, P986, DOI 10.1096/fj.03-1160fje	64	44	44	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2876	2887		10.1038/onc.2013.251	http://dx.doi.org/10.1038/onc.2013.251			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23831574				2022-12-25	WOS:000337231800007
J	Carroll, J; Ding, S; Fearnley, IM; Walker, JE				Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			Post-translational Modifications near the Quinone Binding Site of Mammalian Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; PROTEIN ARGININE METHYLTRANSFERASES; NUCLEAR-ENCODED SUBUNITS; AMINO-ACID-SEQUENCE; MASS-SPECTROMETRY; PROTEOMIC ANALYSIS; MOLECULAR MASSES; ATP SYNTHASE; IDENTIFICATION	Complex I (NADH: ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 44 protein subunits with one arm buried in the inner membrane of the mitochondrion and the orthogonal arm protruding about 100 angstrom into the matrix. The protruding arm contains the binding sites for NADH, the primary acceptor of electrons flavin mononucleotide (FMN), and a chain of seven iron-sulfur clusters that carries the electrons one at a time from FMN to a coenzyme Q molecule bound in the vicinity of the junction between the two arms. In the structure of the closely related bacterial enzyme from Thermus thermophilus, the quinone is thought to bind in a tunnel that spans the interface between the two arms, with the quinone head group close to the terminal iron-sulfur cluster, N2. The tail of the bound quinone is thought to extend from the tunnel into the lipid bilayer. In the mammalian enzyme, it is likely that this tunnel involves three of the subunits of the complex, ND1, PSST, and the 49-kDa subunit. An arginine residue in the 49-kDa subunit is symmetrically dimethylated on the omega-NG and omega-N-G' nitrogen atoms of the guanidino group and is likely to be close to cluster N2 and to influence its properties. Another arginine residue in the PSST subunit is hydroxylated and probably lies near to the quinone. Both modifications are conserved in mammalian enzymes, and the former is additionally conserved in Pichia pastoris and Paracoccus denitrificans, suggesting that they are functionally significant.	[Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council; MRC [MC_U105663148] Funding Source: UKRI; Medical Research Council [MC_U105663148] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; ARIZMENDI JM, 1992, FEBS LETT, V313, P80, DOI 10.1016/0014-5793(92)81189-S; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Brame CJ, 2004, RAPID COMMUN MASS SP, V18, P877, DOI 10.1002/rcm.1421; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bridges HR, 2010, MOL CELL PROTEOMICS, V9, P2318, DOI 10.1074/mcp.M110.001255; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200; Carroll J, 2007, P NATL ACAD SCI USA, V104, P14330, DOI 10.1073/pnas.0706817104; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; FEARNLEY IM, 1994, BIOCHEM SOC T, V22, P551, DOI 10.1042/bst0220551; FEARNLEY IM, 1989, EMBO J, V8, P665, DOI 10.1002/j.1460-2075.1989.tb03424.x; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmisano G, 2007, PROTEOMICS, V7, P1575, DOI 10.1002/pmic.200600801; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Raman B, 2001, NUCLEIC ACIDS RES, V29, P3377, DOI 10.1093/nar/29.16.3377; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Schilling B, 2005, FEBS LETT, V579, P2485, DOI 10.1016/j.febslet.2005.03.061; Skehel JM, 1998, FEBS LETT, V438, P301, DOI 10.1016/S0014-5793(98)01317-9; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Walker JE, 2009, METHOD ENZYMOL, V456, P111, DOI 10.1016/S0076-6879(08)04406-6; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993	55	28	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24799	24808		10.1074/jbc.M113.488106	http://dx.doi.org/10.1074/jbc.M113.488106			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836892	hybrid, Green Published			2022-12-25	WOS:000330612300045
J	Bzhalava, D; Johansson, H; Ekstrom, J; Faust, H; Moller, B; Eklund, C; Nordin, P; Stenquist, B; Paoli, J; Persson, B; Forslund, O; Dillner, J				Bzhalava, Davit; Johansson, Hanna; Ekstrom, Johanna; Faust, Helena; Moller, Birgitta; Eklund, Carina; Nordin, Peter; Stenquist, Bo; Paoli, John; Persson, Bengt; Forslund, Ola; Dillner, Joakim			Unbiased Approach for Virus Detection in Skin Lesions	PLOS ONE			English	Article							CUTANEOUS HUMAN PAPILLOMAVIRUSES; SQUAMOUS-CELL CARCINOMA; TRANSPLANT RECIPIENTS; PYROSEQUENCING READS; DNA; CANCER; CLASSIFICATION; IDENTIFICATION; GENERATION; DIVERSITY	To assess presence of virus DNA in skin lesions, swab samples from 82 squamous cell carcinomas of the skin (SCCs), 60 actinic keratoses (AKs), paraffin-embedded biopsies from 28 SCCs and 72 kerathoacanthomas (KAs) and fresh-frozen biopsies from 92 KAs, 85 SCCs and 92 AKs were analyzed by high throughput sequencing (HTS) using 454 or Ion Torrent technology. We found total of 4,284 viral reads, out of which 4,168 were Human Papillomavirus (HPV)-related, belonging to 15 known (HPV8, HPV12, HPV20, HPV36, HPV38, HPV45, HPV57, HPV59, HPV104, HPV105, HPV107, HPV109, HPV124, HPV138, HPV147), four previously described putative (HPV 915 F 06 007 FD1, FA73, FA101, SE42) and two putatively new HPV types (SE46, SE47). SE42 was cloned, sequenced, designated as HPV155 and found to have 76% similarity to the most closely related known HPV type. In conclusion, an unbiased approach for viral DNA detection in skin tumors has found that, although some new putative HPVs were found, known HPV types constituted most of the viral DNA.	[Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Hosp, Dept Clin Microbiol, S-10401 Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Hosp, Dept Pathol, S-10401 Stockholm, Sweden; [Johansson, Hanna; Ekstrom, Johanna; Faust, Helena; Forslund, Ola; Dillner, Joakim] Lund Univ, Dept Med Microbiol, Skane Univ Hosp, Malmo, Sweden; [Nordin, Peter] Lakarhuset, Dermatol Clin, Gothenburg, Sweden; [Stenquist, Bo; Paoli, John] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol,Sahlgrenska Univ Hosp, S-41124 Gothenburg, Sweden; [Persson, Bengt] Linkoping Univ, IFM Bioinformat, Linkoping, Sweden; [Persson, Bengt] Swedish E Sci Res Ctr, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Linkoping University	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	joakim.dillner@ki.se	Paoli, John/P-7629-2018	Paoli, John/0000-0003-1326-8535; Faust, Helena/0000-0002-4532-2025; Persson, Bengt/0000-0003-3165-5344; Bzhalava, Davit/0000-0002-7646-7892	Swedish Cancer Society [110569]; Swedish Research Council [3468]; Swedish government strategic program on Biomarkers in Cancer Research (BioCARE)	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government strategic program on Biomarkers in Cancer Research (BioCARE)	The work was supported by the Swedish Cancer Society (110569), the Swedish Research Council (3468) and the Swedish government strategic program on Biomarkers in Cancer Research (BioCARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2008, IARC PUBL, VIX, P1; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Bzhalava D, 2012, VIROLOGY, V432, P427, DOI 10.1016/j.virol.2012.06.022; Chen Z, 2007, J GEN VIROL, V88, P2952, DOI 10.1099/vir.0.83178-0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chouhy D, 2010, VIROLOGY, V397, P205, DOI 10.1016/j.virol.2009.11.020; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, J CUTAN PATHOL, V30, P423, DOI 10.1034/j.1600-0560.2003.00092.x; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Johansson H., 2013, VIROLOGY; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Oberyszyn TM, 2008, CANCER LETT, V261, P127, DOI 10.1016/j.canlet.2008.01.009; Pfister H, 1997, CLIN DERMATOL, V15, P335, DOI 10.1016/S0738-081X(96)00162-9; Reichrath J, 2006, PROG BIOPHYS MOL BIO, V92, P9, DOI 10.1016/j.pbiomolbio.2006.02.010; Schatz MC, 2011, BRIEF BIOINFORM; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Vasiljevic N, 2009, INT J CANCER, V124, P2361, DOI 10.1002/ijc.24197; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC	52	44	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65953	10.1371/journal.pone.0065953	http://dx.doi.org/10.1371/journal.pone.0065953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840382	Green Published, gold, Green Submitted			2022-12-25	WOS:000321148400009
J	Alam, T; Wai, P; Held, D; Vakili, STT; Forsberg, E; Sollinger, H				Alam, Tausif; Wai, Philip; Held, Dustie; Vakili, Sahar Taba Taba; Forsberg, Erik; Sollinger, Hans			Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production	PLOS ONE			English	Article							ENGINEERED K-CELLS; IN-VIVO; GENE-TRANSFER; SKELETAL-MUSCLE; TRANSGENE EXPRESSION; PLASMID DNA; STEM-CELLS; LIVER; THERAPY; HEPATOCYTES	Type 1 diabetes mellitus (T1DM) is caused by immune destruction of insulin-producing pancreatic beta-cells. Commonly used insulin injection therapy does not provide a dynamic blood glucose control to prevent long-term systemic T1DM-associated damages. Donor shortage and the limited long-term success of islet transplants have stimulated the development of novel therapies for T1DM. Gene therapy-based glucose-regulated hepatic insulin production is a promising strategy to treat T1DM. We have developed gene constructs which cause glucose-concentration-dependent human insulin production in liver cells. A novel set of human insulin expression constructs containing a combination of elements to improve gene transcription, mRNA processing, and translation efficiency were generated as minicircle DNA preparations that lack bacterial and viral DNA. Hepatocytes transduced with the new constructs, ex vivo, produced large amounts of glucose-inducible human insulin. In vivo, insulin minicircle DNA (TA1m) treated streptozotocin (STZ)-diabetic rats demonstrated euglycemia when fasted or fed, ad libitum. Weight loss due to uncontrolled hyperglycemia was reversed in insulin gene treated diabetic rats to normal rate of weight gain, lasting similar to 1 month. Intraperitoneal glucose tolerance test (IPGT) demonstrated in vivo glucose-responsive changes in insulin levels to correct hyperglycemia within 45 minutes. A single TA1m treatment raised serum albumin levels in diabetic rats to normal and significantly reduced hypertriglyceridemia and hypercholesterolemia. Elevated serum levels of aspartate transaminase, alanine aminotransferase, and alkaline phosphatase were restored to normal or greatly reduced in treated rats, indicating normalization of liver function. Non-viral insulin minicircle DNA-based TA1m mediated glucose-dependent insulin production in liver may represent a safe and promising approach to treat T1DM.	[Alam, Tausif; Wai, Philip; Held, Dustie; Vakili, Sahar Taba Taba; Forsberg, Erik; Sollinger, Hans] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Alam, T (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.	alam@surgery.wisc.edu			Juvenile Diabetes Research Foundation; Roche Organ Transplant Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Roche Organ Transplant Research Foundation	This study was supported in the early phase, in part, by a grant from Juvenile Diabetes Research Foundation to TA and by Roche Organ Transplant Research Foundation to TA. Both grants have since expired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam T, 2002, TRANSPLANTATION, V74, P1781, DOI 10.1097/01.TP.0000039333.11465.D9; Auricchio A, 2002, GENE THER, V9, P963, DOI 10.1038/sj.gt.3301746; Baiu D, 2011, CURR DIABETES REP, V11, P392, DOI 10.1007/s11892-011-0218-7; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Burkhardt BR, 2005, FEBS LETT, V579, P5759, DOI 10.1016/j.febslet.2005.09.060; Chen GX, 2000, DIABETES, V49, P562, DOI 10.2337/diabetes.49.4.562; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Dong HJ, 2002, DIABETES, V51, P130, DOI 10.2337/diabetes.51.1.130; Falqui L, 1999, HUM GENE THER, V10, P1753, DOI 10.1089/10430349950017437; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Imai J, 2005, BIOCHEM BIOPH RES CO, V326, P402, DOI 10.1016/j.bbrc.2004.11.047; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kim SC, 2010, CURR STEM CELL RES T, V5, P190; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Liu F, 2005, ADV GENET, V54, P43, DOI 10.1016/S0065-2660(05)54003-3; Lu YC, 2005, ENDOCRINOLOGY, V146, P2610, DOI 10.1210/en.2004-1109; Martinenghi S, 2002, GENE THER, V9, P1429, DOI 10.1038/sj.gt.3301804; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Nostro MC, 2012, SEMINARS CELL DEV BI; OGAWA A, 1992, J CLIN INVEST, V90, P497, DOI 10.1172/JCI115886; Okura H, 2009, J ARTIF ORGANS, V12, P123, DOI 10.1007/s10047-009-0455-6; Ren B, 2007, DIABETOLOGIA, V50, P1910, DOI 10.1007/s00125-007-0722-0; Riu E, 2002, DIABETES, V51, P704, DOI 10.2337/diabetes.51.3.704; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shaw JAM, 2002, J ENDOCRINOL, V172, P653, DOI 10.1677/joe.0.1720653; Shen X, 2007, MOL THER, V15, P1955, DOI 10.1038/sj.mt.6300293; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Tabiin Muhammad T, 2004, J Autoimmune Dis, V1, P3, DOI 10.1186/1740-2557-1-3; Tang SC, 2004, J GENE MED, V6, P1003, DOI 10.1002/jgm.587; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Thule PM, 2000, GENE THER, V7, P1744, DOI 10.1038/sj.gt.3301297; Thule PM, 2000, GENE THER, V7, P205, DOI 10.1038/sj.gt.3301076; Tian J, 2008, MOL THER, V16, P1146, DOI 10.1038/mt.2008.79; Tuch BE, 2003, GENE THER, V10, P490, DOI 10.1038/sj.gt.3301911; Unniappan S, 2009, J MOL MED, V87, P703, DOI 10.1007/s00109-009-0465-0; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P149, DOI 10.1111/j.1745-7270.2008.00387.x; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	47	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67515	10.1371/journal.pone.0067515	http://dx.doi.org/10.1371/journal.pone.0067515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826312	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000086
J	Lin, CM; Fang, CL; Hseu, YC; Chen, CL; Wang, JW; Hsu, SL; Tu, MD; Hung, ST; Tai, C; Uen, YH; Lin, KY				Lin, Chun-Mao; Fang, Chia-Lang; Hseu, You-Cheng; Chen, Chun-Liang; Wang, Jin-Wun; Hsu, Sheng-Lung; Tu, Ming-Dao; Hung, Shih-Ting; Tai, Chein; Uen, Yih-Huei; Lin, Kai-Yuan			Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; EXPRESSION; GENES; MICRORNAS; CARCINOMA; APOPTOSIS; PROTEIN; MOUSE; MICE	Colon cancer is one of the most common malignant cancers worldwide but the current therapeutic approaches for advanced colon cancer are less efficient. This study investigated associations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised colon tissues from 263 patients with colon cancer. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed X-2 tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P = 0.0041), distant metastasis (P < 0.0001), and stage (P = 0.0001). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P < 0.001). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for colon cancer (P = 0.001). Overexpression of nuclear SOX4 may be used as a marker to predict the outcome of patients with colon cancer.	[Lin, Chun-Mao] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem, Taipei, Taiwan; [Lin, Chun-Mao] Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Hseu, You-Cheng] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Chun-Liang; Wang, Jin-Wun; Hsu, Sheng-Lung] Chi Mei Hosp Chiali, Dept Surg, Tainan, Taiwan; [Tu, Ming-Dao] Chi Mei Hosp Chiali, Dept Family Med, Tainan, Taiwan; [Hung, Shih-Ting; Uen, Yih-Huei; Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Tai, Chein] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Uen, Yih-Huei] Chi Mei Hosp Chiali, Superintendents Off, Tainan, Taiwan; [Uen, Yih-Huei] Southern Taiwan Univ Sci & Technol, Inst Biomed Engn, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Lin, KY (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	d84306@yahoo.com.tw		Lin, Chun-Mao/0000-0002-8366-4026	Chi Mei Medical Center [101CM-TMU-03]	Chi Mei Medical Center	This work was supported by a grant from Chi Mei Medical Center (Grant No. 101CM-TMU-03) (http://www.chimei.org. tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Voulgari A, 2009, BIOCHIM BIOPHYS ACTA, V1796, P5; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang CG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-41; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67128	10.1371/journal.pone.0067128	http://dx.doi.org/10.1371/journal.pone.0067128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826209	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000030
J	Lopez-Sanchez, M; Munoz-Esquerre, M; Huertas, D; Gonzalez-Costello, J; Ribas, J; Manresa, F; Dorca, J; Santos, S				Lopez-Sanchez, Marta; Munoz-Esquerre, Mariana; Huertas, Daniel; Gonzalez-Costello, Jose; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud			High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VOLUME REDUCTION SURGERY; AIR-FLOW OBSTRUCTION; HEART-FAILURE; ELDERLY-PATIENTS; EMPHYSEMA; HYPERTENSION; PERFORMANCE; POPULATION; DIMENSIONS	Background: A subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). Objectives: To evaluate the prevalence of LVDD in stable severe COPD patients, to analyze its relationship with exercise capacity and to look for its possible causes (lung hyperinflation, ventricular interdependence or inflammatory mechanisms). Methods: We evaluated 106 consecutive outpatients with severe COPD (FEV1 between 30-50%). Thirty-three (31%) were excluded because of previous heart disease. A pulmonary function test, a 6-minute walking test (6MWT), a Doppler echocardiography test, including diastolic dysfunction parameters, and an analysis of arterial blood gases, NT-proBNP and serum inflammatory markers (CRP, leucocytes), were performed in all patients. Results: The prevalence of LVDD in severe stable COPD patients was 90% (80% type I, n=57, and 10% type II, n=7). A significant association between a lower E/A ratio (higher LVDD type I) and a lower exercise tolerance (6-minute walked distance (6MWD)) was found (r=0.29, p<0.05). The fully adjusted multivariable linear regression model demonstrated that a lower E/A ratio, a DLCO in the quartile 4th and a higher tobacco consumption were associated with a lower 6MWD (76, 57 and 0.7 metres, respectively, p<0.05). A significant correlation between E/A ratio and PaO2 was observed (r=0.26, p<0.05), but not with static lung hyperinflation, inflammation or right ventricle overload parameters. Conclusion: In stable severe COPD patients, the prevalence of LVDD is high and this condition might contribute in their lower exercise tolerance. Hypoxemia could have a concomitant role in their pathogenesis.	[Lopez-Sanchez, Marta; Munoz-Esquerre, Mariana; Huertas, Daniel; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud] Hosp Univ Bellvitge, Dept Pulm Med, Barcelona, Spain; [Lopez-Sanchez, Marta] Hosp Univ Bellvitge, Dept Cardiol, Barcelona, Spain; [Munoz-Esquerre, Mariana; Gonzalez-Costello, Jose; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud] Univ Barcelona, Pneumol Res Grp, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Santos, S (corresponding author), Hosp Univ Bellvitge, Dept Pulm Med, Barcelona, Spain.	saludsantos@bellvitgehospital.cat	Munoz-Esquerre, Mariana/F-7386-2012; Dorca, Jordi/Q-3617-2016; González-Costello, José/AAX-8465-2021	Dorca, Jordi/0000-0002-8137-878X; González-Costello, José/0000-0002-7437-3630; Santos, Salud/0000-0002-5835-1028; Ribas Sola, Jesus/0000-0001-7356-4307	Societat Catalana de Pneumologia (SOCAP); Fundacio Catalana de Pneumologia (FUCAP); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)	Societat Catalana de Pneumologia (SOCAP); Fundacio Catalana de Pneumologia (FUCAP); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)	Supported by grants from the Societat Catalana de Pneumologia (SOCAP) 2010, Fundacio Catalana de Pneumologia (FUCAP 2011-12) and Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Abroug F, 2006, AM J RESP CRIT CARE, V174, P990, DOI 10.1164/rccm.200603-380OC; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Criner GJ, 2007, AM J RESP CRIT CARE, V176, P253, DOI 10.1164/rccm.200608-1114OC; Cuttica MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029069; DINHXUAN AT, 1991, NEW ENGL J MED, V324, P1539, DOI 10.1056/NEJM199105303242203; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Funk GC, 2008, CHEST, V133, P1354, DOI 10.1378/chest.07-2685; Jorgensen K, 2003, CHEST, V124, P1863, DOI 10.1378/chest.124.5.1863; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kasner M, 2012, AM J RESP CRIT CARE, V186, P181, DOI 10.1164/rccm.201110-1860OC; Larsen KO, 2006, AM J PHYSIOL-HEART C, V291, pH507, DOI 10.1152/ajpheart.00862.2005; Malerba M, 2011, J BIOL REG HOMEOS AG, V25, P443; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Noordegraaf AV, 1997, CHEST, V112, P640, DOI 10.1378/chest.112.3.640; Peinado VI, 1999, AM J RESP CRIT CARE, V159, P1605, DOI 10.1164/ajrccm.159.5.9807059; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabinovich RA, 2004, ARCH BRONCONEUMOL, V40, P80; Rakowski H, 1996, J Am Soc Echocardiogr, V9, P736, DOI 10.1016/S0894-7317(96)90076-0; Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Vassaux C, 2008, EUR RESPIR J, V32, P1275, DOI 10.1183/09031936.00151707; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Yilmaz R, 2005, J AM SOC ECHOCARDIOG, V18, P873, DOI 10.1016/j.echo.2005.01.016	40	39	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68034	10.1371/journal.pone.0068034	http://dx.doi.org/10.1371/journal.pone.0068034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826360	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000114
J	Schlacher, TA; Strydom, S; Connolly, RM; Schoeman, D				Schlacher, Thomas A.; Strydom, Simone; Connolly, Rod M.; Schoeman, David			Donor-Control of Scavenging Food Webs at the Land-Ocean Interface	PLOS ONE			English	Article							OFF-ROAD VEHICLES; GHOST CRABS; SANDY-BEACH; VERTEBRATE SCAVENGERS; BURROW ARCHITECTURE; COASTAL DUNES; IMPACTS; OCYPODE; HABITAT; SUBSIDIES	Food webs near the interface of adjacent ecosystems are potentially subsidised by the flux of organic matter across system boundaries. Such subsidies, including carrion of marine provenance, are predicted to be instrumental on open-coast sandy shores where in situ productivity is low and boundaries are long and highly permeable to imports from the sea. We tested the effect of carrion supply on the structure of consumer dynamics in a beach-dune system using broad-scale, repeated additions of carcasses at the strandline of an exposed beach in eastern Australia. Carrion inputs increased the abundance of large invertebrate scavengers (ghost crabs, Ocypode spp.), a numerical response most strongly expressed by the largest size-class in the population, and likely due to aggregative behaviour in the short term. Consumption of carrion at the beach-dune interface was rapid and efficient, driven overwhelmingly by facultative avian scavengers. This guild of vertebrate scavengers comprises several species of birds of prey (sea eagles, kites), crows and gulls, which reacted strongly to concentrations of fish carrion, creating hotspots of intense scavenging activity along the shoreline. Detection of carrion effects at several trophic levels suggests that feeding links arising from carcasses shape the architecture and dynamics of food webs at the land-ocean interface.	[Schlacher, Thomas A.; Strydom, Simone; Schoeman, David] Univ Sunshine Coast, Fac Sci, Maroochydore, Qld, Australia; [Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Southport, Qld 4215, Australia	University of the Sunshine Coast; Griffith University	Schlacher, TA (corresponding author), Univ Sunshine Coast, Fac Sci, Maroochydore, Qld, Australia.	tschlach@usc.edu.au	Connolly, Rod M/C-4094-2008; Schlacher, Thomas/J-4614-2016	Connolly, Rod M/0000-0001-6223-1291; Schlacher, Thomas/0000-0003-2184-9217; Schoeman, David/0000-0003-1258-0885	University of the Sunshine Coast	University of the Sunshine Coast	Financial support for this study was provided by the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock AW, 1902, NATURALIST INDIAN SE; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Baayen RH, 2011, LANGUAGER DATA SETS; Barreiro F, 2011, MAR ECOL PROG SER, V433, P65, DOI 10.3354/meps09130; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; Bascom W., 1980, WAVES BEACHES DYNAMI; Bates D, 2012, LME4 LINEAR MIXED EF; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Boekel C, 1976, AUST BIRD WATCHER, V6, P245; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROWN AC, 1981, J EXP MAR BIOL ECOL, V49, P51, DOI 10.1016/0022-0981(81)90146-5; Brown AC, 1996, REV CHIL HIST NAT, V69, P469; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Cott H, 1929, P ZOOL SOC LOND, P755; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192458; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2010, ESTUAR COAST, V33, P67, DOI 10.1007/s12237-009-9239-8; ECKERT J, 1971, Emu, V71, P61; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Everding S, 2000, EMU, V100, P192, DOI 10.1071/MU9808; Fisher NI, 1995, STAT ANAL CIRCULAR D; Gosper D.G., 1983, Corella, V7, P7; Guarino F, 2001, WILDLIFE RES, V28, P627, DOI 10.1071/WR01001; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; IWAMOTO T, 1986, Ecological Research, V1, P249, DOI 10.1007/BF02348682; Keough MJ, 2000, ECOL APPL, V10, P871, DOI 10.1890/1051-0761(2000)010[0871:LVPPOA]2.0.CO;2; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; King D., 1999, MONITORS BIOL VARANI; Kostecke RM, 2001, J FIELD ORNITHOL, V72, P439, DOI 10.1648/0273-8570-72.3.439; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Lillywhite Harvey B., 2008, South American Journal of Herpetology, V3, P175, DOI 10.2994/1808-9798(2008)3[175:TEOICS]2.0.CO;2; Lillywhite HB, 2008, BIOSCIENCE, V58, P947, DOI 10.1641/B581008; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2010, ENVIRON MANAGE, V45, P1352, DOI 10.1007/s00267-010-9491-5; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; MacGillivray WDK, 1929, EMU, V29, P115; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; McLachlan A, 2006, ECOLOGY SANDY SHORES; Meager JJ, 2012, DIVERS DISTRIB, V18, P294, DOI 10.1111/j.1472-4642.2011.00873.x; Moss D, 2006, COAST MANAGE, V34, P133, DOI 10.1080/08920750500379383; PHILLIPS M, 1991, WILDLIFE RES, V18, P677, DOI 10.1071/WR9910677; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rassweiler A, 2011, MAR FRESHWATER RES, V62, P510, DOI 10.1071/MF10194; ROSE A B, 1973, Emu, V73, P177; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Rowley I., 1973, CSIRO Wildl Res, V18, P131, DOI 10.1071/CWR9730131; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; Schlacher TA, 2010, VIE MILIEU, V60, P313; Schlacher TA, 2008, HYDROBIOLOGIA, V610, P345, DOI 10.1007/s10750-008-9426-9; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Schlacher TA, 2008, J COASTAL RES, V24, P234, DOI 10.2112/06-0691.1; Schlacher TA, 2007, COAST MANAGE, V35, P567, DOI 10.1080/08920750701593402; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2013, ACTA OECOL, V48, P7, DOI 10.1016/j.actao.2013.01.007; Schlacher TA, 2013, ESTUAR COAST SHELF S, V118, P31, DOI 10.1016/j.ecss.2012.12.016; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; SIMONETTI JA, 1984, MAMMALIA, V48, P608; SMITH GC, 1985, EMU, V85, P198, DOI 10.1071/MU9850198; Smith J. I. D, 1992, THESIS U QUEENSLAND; SPILLER DA, 1992, J ARACHNOL, V20, P179; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Thompson Luke M. C., 2008, Journal of Coastal Conservation, V12, P67, DOI 10.1007/s11852-008-0032-9; TROTT TJ, 1984, J EXP MAR BIOL ECOL, V78, P237; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; WELLINS CA, 1989, J CHEM ECOL, V15, P1161, DOI 10.1007/BF01014819; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Witman JD, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P335; Wolcott T.G., 1988, P55, DOI 10.1017/CBO9780511753428.004; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x; Zar J. H., 2009, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	85	33	33	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68221	10.1371/journal.pone.0068221	http://dx.doi.org/10.1371/journal.pone.0068221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826379	gold, Green Published			2022-12-25	WOS:000321150000133
J	Uguru, GC; Mondhe, M; Goh, S; Hesketh, A; Bibb, MJ; Good, L; Stach, JEM				Uguru, Gabriel C.; Mondhe, Madhav; Goh, Shan; Hesketh, Andrew; Bibb, Mervyn J.; Good, Liam; Stach, James E. M.			Synthetic RNA Silencing of Actinorhodin Biosynthesis in Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTIBIOTIC PRODUCTION; GENE-EXPRESSION; ANTISENSE RNAS; IDENTIFICATION; INHIBITION; ACTIVATION; PATHWAY; GROWTH; PREDICTION	We demonstrate the first application of synthetic RNA gene silencers in Streptomyces coelicolor A3(2). Peptide nucleic acid and expressed antisense RNA silencers successfully inhibited actinorhodin production. Synthetic RNA silencing was target-specific and is a new tool for gene regulation and metabolic engineering studies in Streptomyces.	[Uguru, Gabriel C.; Mondhe, Madhav; Stach, James E. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goh, Shan; Good, Liam] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, London, England; [Hesketh, Andrew; Bibb, Mervyn J.] John Innes Ctr, Norwich, Norfolk, England	Newcastle University - UK; University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Stach, JEM (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jem.stach@ncl.ac.uk	Goh, Shan/A-7261-2010	Goh, Shan/0000-0002-9028-0303; Hesketh, Andrew/0000-0001-5220-8733; Stach, James/0000-0001-8787-2407; Good, Liam/0000-0002-2798-8640	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E017053/1]; BBSRC [BB/E017053/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000607, BB/E017053/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/E017053/1 (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Ausable FM, 1996, CURRENT PROTOCOLS MO; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good Liam, 2002, Methods Mol Biol, V208, P237; Hebert CG, 2008, CURR OPIN BIOTECH, V19, P500, DOI 10.1016/j.copbio.2008.08.006; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hindra, 2010, J BACTERIOL, V192, P4973, DOI 10.1128/JB.00681-10; HJALT TAH, 1995, NUCLEIC ACIDS RES, V23, P571, DOI 10.1093/nar/23.4.571; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kang SG, 1998, FEMS MICROBIOL LETT, V168, P221, DOI 10.1111/j.1574-6968.1998.tb13277.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; McArthur M, 2008, P NATL ACAD SCI USA, V105, P1020, DOI 10.1073/pnas.0710724105; McArthur M, 2006, NUCLEIC ACIDS RES, V34, P5395, DOI 10.1093/nar/gkl649; Minas W, 2000, ANTON LEEUW INT J G, V78, P297, DOI 10.1023/A:1010254013352; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROMERO NM, 1995, FEMS MICROBIOL LETT, V127, P79; ROMERO NM, 1992, NUCLEIC ACIDS RES, V20, P2767, DOI 10.1093/nar/20.11.2767; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Tezuka T, 2009, J BACTERIOL, V191, P4896, DOI 10.1128/JB.00087-09; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	38	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67509	10.1371/journal.pone.0067509	http://dx.doi.org/10.1371/journal.pone.0067509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826310	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000085
J	Bohm, J; Vasli, N; Malfatti, E; Le Gras, S; Feger, C; Jost, B; Monnier, N; Brocard, J; Karasoy, H; Gerard, M; Walter, MC; Reilich, P; Biancalana, V; Kretz, C; Messaddeq, N; Marty, I; Lunardi, J; Romero, NB; Laporte, J				Boehm, Johann; Vasli, Nasim; Malfatti, Edoardo; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Monnier, Nicole; Brocard, Julie; Karasoy, Hatice; Gerard, Marion; Walter, Maggie C.; Reilich, Peter; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Marty, Isabelle; Lunardi, Joel; Romero, Norma B.; Laporte, Jocelyn			An Integrated Diagnosis Strategy for Congenital Myopathies	PLOS ONE			English	Article							CENTRAL CORE DISEASE; RECESSIVE RYR1 MUTATIONS; RYANODINE RECEPTOR GENE; MALIGNANT HYPERTHERMIA; NEMALINE MYOPATHY; SKELETAL-MUSCLE; NEBULIN GENE; COMMON-CAUSE; OPHTHALMOPLEGIA	Congenital myopathies are severe muscle disorders affecting adults as well as children in all populations. The diagnosis of congenital myopathies is constrained by strong clinical and genetic heterogeneity. Moreover, the majority of patients present with unspecific histological features, precluding purposive molecular diagnosis and demonstrating the need for an alternative and more efficient diagnostic approach. We used exome sequencing complemented by histological and ultrastructural analysis of muscle biopsies to identify the causative mutations in eight patients with clinically different skeletal muscle pathologies, ranging from a fatal neonatal myopathy to a mild and slowly progressive myopathy with adult onset. We identified RYR1 (ryanodine receptor) mutations in six patients and NEB (nebulin) mutations in two patients. We found novel missense and nonsense mutations, unraveled small insertions/deletions and confirmed their impact on splicing and mRNA/protein stability. Histological and ultrastructural findings of the muscle biopsies of the patients validated the exome sequencing results. We provide the evidence that an integrated strategy combining exome sequencing with clinical and histopathological investigations overcomes the limitations of the individual approaches to allow a fast and efficient diagnosis, accelerating the patient's access to a better healthcare and disease management. This is of particular interest for the diagnosis of congenital myopathies, which involve very large genes like RYR1 and NEB as well as genetic and phenotypic heterogeneity.	[Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] Inst Genet & Biol Mol & Cellulaire, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Feger, Claire; Kretz, Christine; Laporte, Jocelyn] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Malfatti, Edoardo; Romero, Norma B.] GHU La Pitie Salpetrere, Unite Morphol Neuromusculaire, Inst Myol, Paris, France; [Malfatti, Edoardo] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Malfatti, Edoardo; Romero, Norma B.] Univ Paris 06, INSERM, CNRS, Inst Myol,GHU La Pitie Salpetriere,UR76,UMR 974,U, Paris, France; [Malfatti, Edoardo; Romero, Norma B.] GHU La Pitie Salpetriere, AP HP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France; [Le Gras, Stephanie; Jost, Bernard] Inst Genet & Biol Mol & Cellulaire, DNA Microarrays & Sequencing Platform, Illkirch Graffenstaden, France; [Monnier, Nicole; Lunardi, Joel] CHU Grenoble, Lab Biochim Genet & Mol, F-38043 Grenoble, France; [Brocard, Julie; Marty, Isabelle] INSERM, U836, Inst Neurosci, La Tronche, France; [Karasoy, Hatice] Ege Univ, Sch Med, Dept Neurol, Izmir, Turkey; [Gerard, Marion] CHU Caen, Serv Genet, Caen, France; [Walter, Maggie C.; Reilich, Peter] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Biancalana, Valerie] Nouvel Hop Civil, Fac Med, Lab Diagnost Genet, Strasbourg, France; [Messaddeq, Nadia] Inst Genet & Biol Mol & Cellulaire, Imaging Ctr, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Siena; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Ege University; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Munich; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laporte, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.	jocelyn@igbmc.fr	Böhm, Johann/O-1652-2016; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/O-4888-2019; Marty, Isabelle/ABF-5362-2020; Marty, Isabelle/N-7114-2017; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/J-7008-2012	Böhm, Johann/0000-0001-8019-9504; Marty, Isabelle/0000-0003-3625-913X; Bohm, Johann/0000-0001-7370-3469; Le Gras, Stephanie/0000-0001-6293-6507; Brocard, Julie/0000-0001-9345-5191	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre national de la recherche scientifique (CNRS); University of Strasbourg; College de France; GIS Institute; Association Francaise contre les myopathies; Muscular Dystrophy Association (United States of America); Myotubular Trust; Agence Nationale de la Recherche (ANR); Muscular Dystrophy Association (MDA) [2010-52655]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; College de France; GIS Institute; Association Francaise contre les myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association (United States of America)(Muscular Dystrophy Association); Myotubular Trust; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre national de la recherche scientifique (CNRS), University of Strasbourg, College de France and grants from ANR, GIS Institute for rare diseases and IBiSA, Association Francaise contre les myopathies, Muscular Dystrophy Association (United States of America) and the Myotubular Trust. This work was supported by the INSERM, the CNRS, University of Strasbourg, College de France and grants from the Agence Nationale de la Recherche (ANR, grant CM-WES), Muscular Dystrophy Association (MDA, grant 2010-52655) and Myotubular Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Bevilacqua JA, 2011, NEUROPATH APPL NEURO, V37, P271, DOI 10.1111/j.1365-2990.2010.01149.x; Bohm J, 2012, ACTA NEUROPATHOL; Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Romero NB, 2003, BRAIN, V126, P2341, DOI 10.1093/brain/awg244; Sewry CA, 2008, J MUSCLE RES CELL M, V29, P231, DOI 10.1007/s10974-008-9155-8; Vasli N, 2013, ACTA NEUROPATHOL, V125, P173, DOI 10.1007/s00401-012-1072-7; Wallgren-Pettersson C, 2002, NEUROMUSCULAR DISORD, V12, P674, DOI 10.1016/S0960-8966(02)00065-2; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221	30	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67527	10.1371/journal.pone.0067527	http://dx.doi.org/10.1371/journal.pone.0067527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826317	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400157
J	Suzuki, T; Iyoda, M; Shibata, T; Ohtaki, H; Matsumoto, K; Shindo-Hirai, Y; Kuno, Y; Wada, Y; Yamamoto, Y; Kawaguchi, M; Shioda, S; Akizawa, T				Suzuki, Taihei; Iyoda, Masayuki; Shibata, Takanori; Ohtaki, Hirokazu; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Wada, Yukihiro; Yamamoto, Yasutaka; Kawaguchi, Mio; Shioda, Seiji; Akizawa, Tadao			Therapeutic Effects of Human Mesenchymal Stem Cells in Wistar-Kyoto Rats with Anti-Glomerular Basement Membrane Glomerulonephritis	PLOS ONE			English	Article							NEPHROTOXIC SERUM NEPHRITIS; MARROW STROMAL CELLS; REGULATORY T-CELLS; IMMUNE-RESPONSE; RENAL INJURY; CRESCENTIC GLOMERULONEPHRITIS; GLOMERULAR INJURY; TRANSPLANTATION; KIDNEY; MICE	Introduction: Multipotent mesenchymal stem cells (MSCs) have become a promising therapeutic approach in many clinical conditions. The hypothesis that MSCs can provide a potential therapy for human anti-glomerular basement membrane (GBM) glomerulonephritis (GN) was tested. Methods: Nephrotoxic serum nephritis was induced in Wistar-Kyoto rats on day 0. Groups of animals were given either human MSCs (hMSCs, 3 x 10(6)) or vehicle by intravenous injection on day 4; all rats were sacrificed at either day 7 or day 13. Results: Fluorescently labeled hMSCs were localized in glomeruli and tubulointerstitium 5 h after hMSC administration and persisted until 48 h, but hMSCs were barely detectable after 7 days. hMSC-treated rats had decreased kidney weight, proteinuria, and glomerular tuft area at each time point. The serum creatinine level and degree of glomerular crescent formation were decreased by hMSC treatment on day 13. ED1-positive macrophages, CD8-positive cells, and TUNEL-positive apoptotic cells in glomeruli were reduced by hMSC treatment on day 7, and this trend in apoptotic cells persisted to day 13. Renal cortical mRNA for TNF-alpha, IL-1 beta, and IL-17, and the serum IL-17A level were decreased, whereas renal cortical mRNA for IL-4 and Foxp3 and the serum IL-10 level were increased in the MSC-treated group on day 7. Collagen types I and III and TGF-beta mRNA were decreased by hMSC treatment on day 13. Conclusion: The present results demonstrated that anti-inflammatory and immunomodulatory effects were involved in the mechanism of attenuating established experimental anti-GBM GN by hMSCs. These results suggest that hMSCs are a promising therapeutic candidate for the treatment of anti-GBM GN.	[Suzuki, Taihei; Iyoda, Masayuki; Shibata, Takanori; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Wada, Yukihiro; Yamamoto, Yasutaka; Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Ohtaki, Hirokazu; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Kawaguchi, Mio] Univ Tsukuba, Inst Clin Med, Dept Resp Med, Tsukuba, Ibaraki 305, Japan	Showa University; Showa University; University of Tsukuba	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	iyoda@med.showa-u.ac.jp			Ministry of Health, Labor and Welfare, Japan; Kyowa Hakko Kirin Co., Ltd.; Chugai Pharmaceutical Co., Ltd.	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Chugai Pharmaceutical Co., Ltd.	This work is supported in part by a Grant-in-Aid for the Research Group on Progressive Renal Diseases from the Ministry of Health, Labor and Welfare, Japan. T.A. is supported by a research grant from Kyowa Hakko Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; T.A received funding from Kyowa Hakko Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coelho SN, 1997, KIDNEY INT, V51, P646, DOI 10.1038/ki.1997.94; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Fujinaka H, 1997, J IMMUNOL, V158, P4978; Fujinaka H, 1997, J AM SOC NEPHROL, V8, P1174; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Herrera MB, 2004, INT J MOL MED, V14, P1035; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Hou M, 2007, INT J CARDIOL, V115, P220, DOI 10.1016/j.ijcard.2006.03.028; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Iyoda M, 2010, AM J PHYSIOL-RENAL, V298, pF779, DOI 10.1152/ajprenal.00198.2009; Iyoda M, 2009, KIDNEY INT, V75, P1060, DOI 10.1038/ki.2009.43; KAWASAKI K, 1993, J IMMUNOL, V150, P1074; KAWASAKI K, 1992, KIDNEY INT, V41, P1517, DOI 10.1038/ki.1992.221; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kitching AR, 1997, KIDNEY INT, V52, P52, DOI 10.1038/ki.1997.303; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; KOBAYASHI K, 1995, KIDNEY INT, V47, P454, DOI 10.1038/ki.1995.58; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Paust HJ, 2011, KIDNEY INT, V80, P155, DOI 10.1038/ki.2011.108; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Reynolds J, 2002, J AM SOC NEPHROL, V13, P359, DOI 10.1681/ASN.V132359; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Song CH, 2009, J VIROL, V83, P5918, DOI 10.1128/JVI.00165-09; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Tang WW, 1996, KIDNEY INT, V50, P665, DOI 10.1038/ki.1996.363; Tipping PG, 1997, EUR J IMMUNOL, V27, P530, DOI 10.1002/eji.1830270226; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Zhuo WL, 2011, UROL INT, V86, P191, DOI 10.1159/000319366	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67475	10.1371/journal.pone.0067475	http://dx.doi.org/10.1371/journal.pone.0067475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826305	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400150
J	Watanabe, K; Watson, E; Cremona, ML; Millings, EJ; Lefkowitch, JH; Fischer, SG; LeDuc, CA; Leibel, RL				Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Lefkowitch, Jay H.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.			ILDR2: An Endoplasmic Reticulum Resident Molecule Mediating Hepatic Lipid Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; LIPOPROTEIN RECEPTOR; METABOLIC DISEASE; DROPLET FORMATION; BINDING PROTEIN; VLDL SECRETION; FATTY LIVER	Ildr2, a modifier of diabetes susceptibility in obese mice, is expressed in most organs, including islets and hypothalamus, with reduced levels in livers of diabetes-susceptible B6. DBA mice congenic for a 1.8 Mb interval of Chromosome 1. In hepatoma and neuronal cells, ILDR2 is primarily located in the endoplasmic reticulum membrane. We used adenovirus vectors that express shRNA or are driven by the CMV promoter, respectively, to knockdown or overexpress Ildr2 in livers of wild type and ob/ob mice. Livers in knockdown mice were steatotic, with increased hepatic and circulating triglycerides and total cholesterol. Increased circulating VLDL, without reduction in triglyceride clearance suggests an effect of reduced hepatic ILDR2 on hepatic cholesterol clearance. In animals that overexpress Ildr2, hepatic triglyceride and total cholesterol levels were reduced, and strikingly so in ob/ob mice. There were no significant changes in body weight, energy expenditure or glucose/insulin homeostasis in knockdown or overexpressing mice. Knockdown mice showed reduced expression of genes mediating synthesis and oxidation of hepatic lipids, suggesting secondary suppression in response to increased hepatic lipid content. In Ildr2-overexpressing ob/ob mice, in association with reduced liver fat content, levels of transcripts related to neutral lipid synthesis and cholesterol were increased, suggesting "relief'' of the secondary suppression imposed by lipid accumulation. Considering the fixed location of ILDR2 in the endoplasmic reticulum, we investigated the possible participation of ILDR2 in ER stress responses. In general, Ildr2 overexpression was associated with increases, and knockdown with decreases in levels of expression of molecular components of canonical ER stress pathways. We conclude that manipulation of Ildr2 expression in liver affects both lipid homeostasis and ER stress pathways. Given these reciprocal interactions, and the relatively extended time-course over which these studies were conducted, we cannot assign causal primacy to either the effects on hepatic lipid homeostasis or ER stress responses.	[Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA; [Watanabe, Kazuhisa; Watson, Elizabeth; Cremona, Maria Laura; Millings, Elizabeth J.; Fischer, Stuart G.; LeDuc, Charles A.; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Lefkowitch, Jay H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University	Leibel, RL (corresponding author), Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10027 USA.	rl232@columbia.edu	Watanabe, Kazuhisa/ABY-2241-2022	LeDuc, Charles/0000-0002-2073-5050; Watanabe, Kazuhisa/0000-0002-5640-0818	United States National Institutes of Health [RO1-DK 066518, P30 DK63608-09, P30 DK26687-31]; Manpei Suzuki Diabetes Foundation; Russell Berrie Foundation; National Science Foundation Graduate Research Fellowship Program [DGE 11-44155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK066518, T32DK007647, P30DK063608] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; Russell Berrie Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the United States National Institutes of Health (http://www.nih.gov/): RO1-DK 066518, P30 DK63608-09 (http://derc.cumc.columbia.edu/), P30 DK26687-31 (http://www.nyorc.org/), by a grant from the Manpei Suzuki Diabetes Foundation (http://www.suzuki-manpe-df.or.jp/english/index.html), by the Russell Berrie Foundation (http://www.russellberriefoundation.org/home.php), and by the National Science Foundation Graduate Research Fellowship Program (http://www.nsfgrfp.org/): DGE 11-44155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; de Meijer VE, 2010, METABOLISM, V59, P1092, DOI 10.1016/j.metabol.2009.11.006; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Eto K, 2002, DIABETES, V51, pS414, DOI 10.2337/diabetes.51.2007.S414; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hauge H, 2004, BIOCHEM BIOPH RES CO, V323, P970, DOI 10.1016/j.bbrc.2004.08.188; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Higashi T, 2012, J CELL SCI; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kamper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035972; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lattuada G, 2011, CURR DIABETES REP, V11, P167, DOI 10.1007/s11892-011-0190-2; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Linnik KM, 1998, J BIOL CHEM, V273, P21368, DOI 10.1074/jbc.273.33.21368; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Mesli S, 2004, EUR J BIOCHEM, V271, P3103, DOI 10.1111/j.1432-1033.2004.04223.x; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; NAGATA Y, 1987, J LIPID RES, V28, P684; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Stenger C, 2010, FASEB J, V24, P4218, DOI 10.1096/fj.10-160440; Strnad P, 2008, HISTOCHEM CELL BIOL, V129, P735, DOI 10.1007/s00418-008-0431-x; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785; Zagaria A, 2012, LEUKEMIA RES, V36, P852, DOI 10.1016/j.leukres.2012.01.026; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	66	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67234	10.1371/journal.pone.0067234	http://dx.doi.org/10.1371/journal.pone.0067234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826244	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400124
J	Wolf, M; Chen, SL; Song, JY; Ankenbrand, M; Muller, T				Wolf, Matthias; Chen, Shilin; Song, Jingyuan; Ankenbrand, Markus; Mueller, Tobias			Compensatory Base Changes in ITS2 Secondary Structures Correlate with the Biological Species Concept Despite Intragenomic Variability in ITS2 Sequences - A Proof of Concept	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL-RNA; COMMON CORE; DNA BARCODE; DATABASE; REGION; TOOL	Compensatory base changes (CBCs) in internal transcribed spacer 2 (ITS2) rDNA secondary structures correlate with Ernst Mayr's biological species concept. This hypothesis also referred to as the CBC species concept recently was subjected to large-scale testing, indicating two distinct probabilities. (1) If there is a CBC then there are two different species with a probability of similar to 0.93. (2) If there is no CBC then there is the same species with a probability of similar to 0.76. In ITS2 research, however, the main problem is the multicopy nature of ITS2 sequences. Most recently, 454 pyrosequencing data have been used to characterize more than 5000 intragenomic variations of ITS2 regions from 178 plant species, demonstrating that mutation of ITS2 is frequent, with a mean of 35 variants per species, respectively per individual organism. In this study, using those 454 data, the CBC criterion is reconsidered in the light of intragenomic variability, a proof of concept, a necessary criterion, expecting no intragenomic CBCs in variant ITS2 copies. In accordance with the CBC species concept, we could demonstrate that the probability that there is no intragenomic CBC is similar to 0.99.	[Wolf, Matthias; Ankenbrand, Markus; Mueller, Tobias] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Chen, Shilin; Song, Jingyuan] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	University of Wurzburg; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Wolf, M (corresponding author), Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany.	matthias.wolf@biozentrum.uni-wuerzburg.de	Wolf, Matthias/A-5580-2008; Ankenbrand, Markus/C-2564-2014; Ankenbrand, Markus J./V-6660-2019	Wolf, Matthias/0000-0003-2004-1806; Ankenbrand, Markus/0000-0002-6620-807X; Ankenbrand, Markus J./0000-0002-6620-807X	land Bavaria, Germany; Fundamental Research Funds for the Central Universities of China [2012C02]	land Bavaria, Germany; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	Matthias Wolf (corresponding author) as well as Tobias Muller (last author) are government employees of the land Bavaria, Germany. So the work has been supported by the land Bavaria, Germany. Additionally, we would like to add the following statement: Shilin Chen and Jingyuan Song have been supported by the Fundamental Research Funds for the Central Universities of China (No. 2012C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bernoulli J, 1713, ARS CONJECTANDI OPUS; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2002, J MOL EVOL, V54, P246, DOI 10.1007/s00239-001-0006-0; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI [10.3410/f.1163590.625341, DOI 10.3410/F.1163590.625341]; Engelmann JC, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2008.02199.x; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merget B., 2012, JOVE-J VIS EXP   MAR, V61, P3806, DOI [10.3791/3806, DOI 10.3791/3806]; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; R Development Core Team, 2011, R LANG ENV STAT COMP; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102	32	97	100	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66726	10.1371/journal.pone.0066726	http://dx.doi.org/10.1371/journal.pone.0066726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826120	Green Published, gold			2022-12-25	WOS:000321738400040
J	Ly, BTK; Chi, HT; Yamagishi, M; Kano, Y; Hara, Y; Nakano, K; Sato, Y; Watanabe, T				Bui Thi Kim Ly; Hoang Thanh Chi; Yamagishi, Makoto; Kano, Yasuhiko; Hara, Yukihiko; Nakano, Kazumi; Sato, Yuko; Watanabe, Toshiki			Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; TYROSINE KINASE DOMAIN; LEUKEMIA-CELLS; MUTATIONS; RECEPTOR; GALLATE; CANCER; IDENTIFICATION; BINDING; GENE	Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a block in differentiation and uncontrolled proliferation. FLT3 is a commonly mutated gene found in AML patients. In clinical trials, the presence of a FLT3-ITD mutation significantly correlates with an increased risk of relapse and dismal overall survival. Therefore, activated FLT3 is a promising molecular target for AML therapies. In this study, we have shown that green tea polyphenols including (-)-epigallocatechin-3-gallate (EGCG), (-)-epigallocatechin (EGC), and (-)-epicatechin-3-gallate (ECG) suppress the proliferation of AML cells. Interestingly, EGCG, EGC and ECG showed the inhibition of FLT3 expression in cell lines harboring FLT3 mutations. In the THP-1 cells harboring FLT3 wild-type, EGCG showed the suppression of cell proliferation but did not suppress the expression of FLT3 even at the concentration that suppress 100% cell proliferation. Moreover, EGCG-, EGC-and ECG-treated cells showed the suppression of MAPK, AKT and STAT5 phosphorylation. Altogether, we suggest that green tea polyphenols could serve as reagents for treatment or prevention of leukemia harboring FLT3 mutations.	[Bui Thi Kim Ly; Hoang Thanh Chi; Yamagishi, Makoto; Nakano, Kazumi; Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kano, Yasuhiko] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi, Japan; [Hara, Yukihiko] Hara Off Inc, Tea Solut, Sumida Ku, Tokyo, Japan; [Sato, Yuko] Japanese Red Cross Coll Nursing, Shibuya Ku, Tokyo, Japan	University of Tokyo; Tochigi Prefectural Cancer Center	Chi, HT (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan.	hoangchidc1985@yahoo.com	Ly, Bui/AAX-8740-2020; Hoang, Chi/AAX-8732-2020; Ly, Bui Thi Kim/AAZ-1145-2021	Hoang, Chi/0000-0002-6638-1235; Ly, Bui Thi Kim/0000-0002-8433-7035	Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC); Honjo International Scholarship Foundation	Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This work was supported by the Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC). BTKL is a recipient of the scholarship from the Honjo International Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P983, DOI 10.1046/j.1365-2141.2001.02850.x; Ahn HY, 1999, MOL BIOL CELL, V10, P1093, DOI 10.1091/mbc.10.4.1093; Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Breitenbuecher F, 2009, BLOOD, V113, P4074, DOI 10.1182/blood-2007-11-125476; Chen ZP, 1998, CANCER LETT, V129, P173, DOI 10.1016/S0304-3835(98)00108-6; Chi HT, 2009, CANCER BIOL THER, V8, P1934; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; DORMER P, 1980, LEUKEMIA RES, V4, P231, DOI 10.1016/0145-2126(80)90082-X; Drexler HG, 1996, LEUKEMIA, V10, P588; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Guo SQ, 2006, CANCER RES, V66, P5322, DOI 10.1158/0008-5472.CAN-05-4287; IIDA S, 1992, LEUKEMIA RES, V16, P1155, DOI 10.1016/0145-2126(92)90113-L; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; KANO Y, 1988, CANCER RES, V48, P351; Kano Y, 1998, CANCER CHEMOTH PHARM, V42, P91, DOI 10.1007/s002800050790; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 1999, BLOOD, V93, P3074; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; LANGE B, 1987, BLOOD, V70, P192; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Li M, 2007, CANCER EPIDEM BIOMAR, V16, P598, DOI 10.1158/1055-9965.EPI-06-0892; Li YY, 2009, MOL PHARMACEUT, V6, P1152, DOI 10.1021/mp900037p; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; MAROC N, 1993, ONCOGENE, V8, P909; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Nakao M, 1996, LEUKEMIA, V10, P1911; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Pianetti S, 2002, CANCER RES, V62, P652; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Ravandi F, LEUK RES, V34, P752; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Shimizu M, 2008, CANCER LETT, V262, P10, DOI 10.1016/j.canlet.2007.11.026; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Ustun C, 2009, EXPERT OPIN INV DRUG, V18, P1445, DOI 10.1517/13543780903179278; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yin ZY, 2009, BIOCHEMISTRY-US, V48, P336, DOI 10.1021/bi801637q	53	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66378	10.1371/journal.pone.0066378	http://dx.doi.org/10.1371/journal.pone.0066378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840454	Green Submitted, gold, Green Published			2022-12-25	WOS:000322342800054
J	Que, XC; Widhopf, GF; Amir, S; Hartvigsen, K; Hansen, LF; Woelkers, D; Tsimikas, S; Binder, CJ; Kipps, TJ; Witztum, JL				Que, Xuchu; Widhopf, George F., II; Amir, Shahzada; Hartvigsen, Karsten; Hansen, Lotte F.; Woelkers, Douglas; Tsimikas, Sotirios; Binder, Christoph J.; Kipps, Thomas J.; Witztum, Joseph L.			IGHV1-69-Encoded Antibodies Expressed in Chronic Lymphocytic Leukemia React with Malondialdehyde-Acetaldehyde Adduct, an Immunodominant Oxidation-Specific Epitope	PLOS ONE			English	Article							B-CELL REPERTOIRE; MONOCLONAL-ANTIBODIES; APOPTOTIC CELLS; OXIDIZED LDL; HEAVY-CHAIN; IMMUNOGLOBULIN HEAVY; POSITIVE SELECTION; GENES; RECEPTORS; NEUTRALIZATION	The immunoglobulins expressed by chronic lymphocytic leukemia (CLL) B cells are highly restricted, suggesting they are selected for binding either self or foreign antigen. Of the immunoglobulin heavy-chain variable (IGHV) genes expressed in CLL, IGHV1-69 is the most common, and often is expressed with little or no somatic mutation, and restricted IGHD and IGHJ gene usage. We found that antibodies encoded by one particular IGHV1-69 subset, designated CLL69C, with the HCDR3 encoded by the IGHD3-3 gene in reading frame 2 and IGHJ6, specifically bound to oxidation-specific epitopes (OSE), which are products of enhanced lipid peroxidation and a major target of innate natural antibodies. Specifically, CLL69C bound immunodominant OSE adducts termed MAA (malondialdehyde-acetaldehyde-adducts), which are found on apoptotic cells, inflammatory tissues, and atherosclerotic lesions. It also reacted specifically with MAA-specific peptide mimotopes. Light chain shuffling indicated that non-stochastically paired L chain of IGLV3-9 contributes to the antigen binding of CLL69C. A nearly identical CLL69C Ig heavy chain was identified from an MAA-enriched umbilical cord phage displayed Fab library, and a derived Fab with the same HCDR3 rearrangement displayed identical MAA-binding properties. These data support the concept that OSE (MAA-epitopes), which are ubiquitous products of inflammation, may play a role in clonal selection and expansion of CLL B cells.	[Que, Xuchu; Widhopf, George F., II; Hartvigsen, Karsten; Hansen, Lotte F.; Tsimikas, Sotirios; Binder, Christoph J.; Kipps, Thomas J.; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Widhopf, George F., II; Kipps, Thomas J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Amir, Shahzada; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Hartvigsen, Karsten] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Woelkers, Douglas] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, A-1010 Vienna, Austria	University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of Vienna; University of Copenhagen; University of California System; University of California San Diego; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Que, XC (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	xque@ucsd.edu; jwitztum@ucsd.edu	Que, Xuchu/H-2741-2019	Binder, Christoph J./0000-0001-8313-7050; Que, Xuchu/0000-0002-6751-5493	National Institutes of Health [RO1 HL086559, HL088093, P01-CA081534, R37-CA049870]; Leducq Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R37CA049870, P01CA081534] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086559, P01HL088093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants RO1 HL086559 (XQ, CJB, JLW), HL088093 (XQ, CJB, JLW), P01-CA081534 for the CLL Research Consortium and R37-CA049870 (TJK) and the Leducq Foundation (CJB and JLW). XQ was supported in part by Grant-in-Aid from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2012, J LIPID RES; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chiorazzi N, 2012, CELL RES; Chiorazzi N, 2013, CELL RES, V23, P182, DOI 10.1038/cr.2012.152; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Duryee MJ, 2010, FREE RADICBIOLMED; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Forconi F, 2010, BLOOD, V115, P71, DOI 10.1182/blood-2009-06-225813; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Johnson TA, 1997, J IMMUNOL, V158, P235; KIPPS TJ, 1991, J CLIN INVEST, V87, P2087, DOI 10.1172/JCI115239; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kipps TJ, 2010, WILLIAMS HEMATOLOGY, P1431; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; MAGEED RA, 1986, RHEUMATOL INT, V6, P179, DOI 10.1007/BF00541285; MARTIN T, 1992, J EXP MED, V175, P983, DOI 10.1084/jem.175.4.983; Mauerer K, 2005, BRIT J HAEMATOL, V129, P499, DOI 10.1111/j.1365-2141.2005.05480.x; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Potter KN, 2003, BLOOD, V101, P3082, DOI 10.1182/blood-2002-08-2432; Quinn ER, 2001, BLOOD, V98, P3745, DOI 10.1182/blood.V98.13.3745; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; SCHROEDER HW, 1994, IMMUNOL TODAY, V15, P288, DOI 10.1016/0167-5699(94)90009-4; Shaw PX, 2001, ARTERIOSCL THROM VAS, V21, P1333, DOI 10.1161/hq0801.093587; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tobin G, 2006, HEMATOL ONCOL, V24, P7, DOI 10.1002/hon.760; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Widhopf GF, 2008, BLOOD, V111, P3137, DOI 10.1182/blood-2007-02-073130; Widhopf GF, 2001, J IMMUNOL, V166, P95, DOI 10.4049/jimmunol.166.1.95	43	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65203	10.1371/journal.pone.0065203	http://dx.doi.org/10.1371/journal.pone.0065203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840319	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800008
J	Shang, XW; Li, JY; Tao, QS; Li, J; Li, X; Zhang, LH; Liu, XC; Wang, Q; Shi, XZ; Zhao, YH; Hu, S; Jiang, LX; Yang, Y				Shang, Xianwen; Li, Jiongyi; Tao, Qiushan; Li, Jing; Li, Xi; Zhang, Lihua; Liu, Xiancheng; Wang, Qing; Shi, Xiuzhong; Zhao, Yuhong; Hu, Shuang; Jiang, Lixin; Yang, Ying			Educational Level, Obesity and Incidence of Diabetes among Chinese Adult Men and Women Aged 18-59 Years Old: An 11-Year Follow-Up Study	PLOS ONE			English	Article							RISK-FACTORS; LIFE-STYLE; SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; TYPE-2; PREVALENCE; PREVENTION; AMERICAN; DISEASE	Objective: To determine whether educational level and overweight/obesity was associated with the development of diabetes among Chinese adult men and women. Methods: A cohort (2000-2011) of 10 704 participants aged 18-59 years (8 238 men, 2 466 women) in Qingdao Port Health Study (QPHS) were recruited in this study. The personal lifestyle, height, weight, waist circumference, resting heart rate, blood pressure, fasting blood glucose, total cholesterol, triglycerides and plasma uric acid were collected annually in a comprehensive health checkup program. Cox proportional hazards regression models were used to estimate the association of factors and incidence of diabetes. Results: During 110 825 person-years of follow-up, 1 056 new onset cases (9.5 per 1 000 person-years) of diabetes were identified. With normal weight as reference, the multiple-adjusted hazard ratio (HR) (95% CI) of diabetes was 1.69(1.38-2.09) for overweight and 2.24(1.66-3.02) for obesity among men, which was 1.81(1.12-2.92) and 2.58(1.37-4.86) among women, respectively. Compared with the participants with high educational level, those with low educational level had a higher risk of diabetes (multiple-adjusted HR (95% CI): 1.43(1.11-1.86)) among men. The association was not found among women and the adjusted HR (95% CI) of diabetes was 1.56(0.89-2.76). The increased risks of low educational level were independent of mediators among men, through normal weight (P for trend = 0.0313) and overweight (P for trend = 0.0212) group but not obesity group (P for trend = 0.0957). Conclusion: Baseline overweight/obesity was an independent risk factor for diabetes for both men and women. Low educational level was adversely associated with incidence of diabetes through normal weight, overweight and obesity groups, with the association being substantially attenuated by mediating factors only in the obesity group among men. The association was not found among women.	[Shang, Xianwen; Li, Jing; Li, Xi; Zhang, Lihua; Wang, Qing; Hu, Shuang; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, China Oxford Ctr Int Hlth Res,State Key Lab Cardi, Beijing 100730, Peoples R China; [Shang, Xianwen; Li, Jing; Li, Xi; Zhang, Lihua; Wang, Qing; Hu, Shuang; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Jiongyi; Liu, Xiancheng; Shi, Xiuzhong; Zhao, Yuhong; Yang, Ying] Qingdao Fuwai Hosp, Qingdao, Shandong, Peoples R China; [Tao, Qiushan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, China Oxford Ctr Int Hlth Res,State Key Lab Cardi, Beijing 100730, Peoples R China.	lixin.jiang@fwoxford.org; qdfw@163.com		Shang, Xianwen/0000-0001-6143-9349; Shang, Xianwen/0000-0002-2362-3222; Li, Xi/0000-0003-2249-688X				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Agardh EE, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-60; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Bourdel-Marchasson I, 2000, DIABETIC MED, V17, P675, DOI 10.1046/j.1464-5491.2000.00362.x; Cabrera C, 2005, EUR J EPIDEMIOL, V20, P229, DOI 10.1007/s10654-004-5961-5; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; KINSEY JD, 1994, J NUTR, V124, pS1878, DOI 10.1093/jn/124.suppl_9.1878S; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Leyva F, 1998, ARTERIOSCL THROM VAS, V18, P208, DOI 10.1161/01.ATV.18.2.208; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Liu Jing-chao, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P311; Organization WH, 1999, DEF DIAGN CLASS DI 1; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Sheet NDF, 2005, GEN INF NAT EST DIAB; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; Wang CS, 2007, AM J EPIDEMIOL, V166, P196, DOI 10.1093/aje/kwm061; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	34	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66479	10.1371/journal.pone.0066479	http://dx.doi.org/10.1371/journal.pone.0066479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840484	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800067
J	Teixeira, LCRS; Yeargeau, E; Balieiro, FC; Piccolo, MC; Peixoto, RS; Greer, CW; Rosado, AS				Teixeira, Lia C. R. S.; Yeargeau, Etienne; Balieiro, Fabiano C.; Piccolo, Marisa C.; Peixoto, Raquel S.; Greer, Charles W.; Rosado, Alexandre S.			Plant and Bird Presence Strongly Influences the Microbial Communities in Soils of Admiralty Bay, Maritime Antarctica	PLOS ONE			English	Article							ROSS SEA REGION; BACTERIAL DIVERSITY; RHIZOSPHERE SOIL; VASCULAR PLANTS; GRASSLAND SOILS; PENGUIN; ISLAND; MICROARRAY; POPULATION; RESPONSES	Understanding the environmental factors that shape microbial communities is crucial, especially in extreme environments, like Antarctica. Two main forces were reported to influence Antarctic soil microbes: birds and plants. Both birds and plants are currently undergoing relatively large changes in their distribution and abundance due to global warming. However, we need to clearly understand the relationship between plants, birds and soil microorganisms. We therefore collected rhizosphere and bulk soils from six different sampling sites subjected to different levels of bird influence and colonized by Colobanthus quitensis and Deschampsia antarctica in Admiralty Bay, King George Island, Maritime Antarctic. Microarray and qPCR assays targeting 16S rRNA genes of specific taxa were used to assess microbial community structure, composition and abundance and analyzed with a range of soil physico-chemical parameters. The results indicated significant rhizosphere effects in four out of the six sites, including areas with different levels of bird influence. Acidobacteria were significantly more abundant in soils with little bird influence (low nitrogen) and in bulk soil. In contrast, Actinobacteria were significantly more abundant in the rhizosphere of both plant species. At two of the sampling sites under strong bird influence (penguin colonies), Firmicutes were significantly more abundant in D. antarctica rhizosphere but not in C. quitensis rhizosphere. The Firmicutes were also positively and significantly correlated to the nitrogen concentrations in the soil. We conclude that the microbial communities in Antarctic soils are driven both by bird and plants, and that the effect is taxa-specific.	[Teixeira, Lia C. R. S.; Peixoto, Raquel S.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Lab Ecol Microbiana Mol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil; [Yeargeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Balieiro, Fabiano C.] Empresa Brasileira Pesquisa Agropecuaria EMBRAPA, Rio De Janeiro, RJ, Brazil; [Piccolo, Marisa C.] Univ Sao Paulo, Lab Ciclagem Nutr, Ctr Energia Nucl Agr, BR-05508 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; National Research Council Canada; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Rosado, AS (corresponding author), Univ Fed Rio de Janeiro, Lab Ecol Microbiana Mol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil.	asrosado@micro.ufrj.br	piccolo, marisa de Cássia/D-6149-2012; Balieiro, Fabiano/AAQ-5915-2020; Yergeau, Etienne/AAZ-6145-2020; Yergeau, Etienne/B-5344-2008; Balieiro, Fabiano C/J-4390-2017; Teixeira, Lia/AFV-0851-2022; Peixoto, Raquel/V-2554-2019; Rosado, Alexandre Soares/G-1955-2012	piccolo, marisa de Cássia/0000-0003-2163-5630; Yergeau, Etienne/0000-0002-7112-3425; Balieiro, Fabiano C/0000-0002-0229-6672; Teixeira, Lia/0000-0002-2874-1973; Rosado, Alexandre Soares/0000-0001-5135-1394; Peixoto, Raquel/0000-0002-9536-3132	Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity [403, 520194/2006-3]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de \Nivel Superior) [5445-09-4]; Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CAPES	Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity; CAPES (Coordenacao de Aperfeicoamento de Pessoal de \Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial and logistic support from the Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity # 403 "MIDIAPI Microbial Diversity of Terrestrial and Maritime ecosystems in the Antarctic Peninsula" (520194/2006-3). L.C.R.S. Teixeira was supported by a doctoral fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal de vertical bar Nivel Superior) (5445-09-4). Professors A.S.R. and R.S.P. are also supported by Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1989, COLON WATERBIRD, V12, P30, DOI 10.2307/1521309; Aislabie J, 2009, CAN J MICROBIOL, V55, P21, DOI 10.1139/W08-126; Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1997, MANUAL METODOS ANALI; Avery LM, 2003, POLAR BIOL, V26, P525, DOI 10.1007/s00300-003-0515-y; Beller HR, 2002, ENVIRON SCI TECHNOL, V36, P3977, DOI 10.1021/es025556w; Convey P, 2006, PLANT ECOL, V182, P1, DOI 10.1007/s11258-005-9022-2; de Ridder-Duine AS, 2005, SOIL BIOL BIOCHEM, V37, P349, DOI 10.1016/j.soilbio.2004.08.005; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Ganzert L, 2011, FEMS MICROBIOLOGY EC; Ganzert L, 2011, FEMS MICROBIOL ECOL, V76, P476, DOI 10.1111/j.1574-6941.2011.01068.x; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kielak A, 2008, FEMS MICROBIOL ECOL, V63, P372, DOI 10.1111/j.1574-6941.2007.00428.x; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Michel RFM, 2006, SOIL SCI SOC AM J, V70, P1370, DOI 10.2136/sssaj2005.0178; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Simas FNB, 2008, GEODERMA, V144, P116, DOI 10.1016/j.geoderma.2007.10.019; Simas FNB, 2007, GEODERMA, V138, P191, DOI 10.1016/j.geoderma.2006.11.011; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Sokal RR., 1995, INTRO BIOSTATISTICS; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; WHITE MG, 1975, IBIS, V117, P371, DOI 10.1111/j.1474-919X.1975.tb04224.x; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yergeau E, 2008, ENVIRON MICROBIOL, V10, P2223, DOI 10.1111/j.1462-2920.2008.01644.x; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Yergeau E, 2007, FEMS MICROBIOL ECOL, V59, P436, DOI 10.1111/j.1574-6941.2006.00200.x; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09; Zdanowski MK, 2004, FEMS MICROBIOL ECOL, V50, P163, DOI 10.1016/j.femsec.2004.06.012; Zhu RB, 2009, ANTARCT SCI, V21, P427, DOI 10.1017/S0954102009990204	49	20	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66109	10.1371/journal.pone.0066109	http://dx.doi.org/10.1371/journal.pone.0066109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840411	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800033
J	Zennaro, C; Rastaldi, MP; Pascolo, L; Stebel, M; Trevisan, E; Artero, M; Tiribelli, C; Di Maso, V; Carraro, M				Zennaro, Cristina; Rastaldi, Maria Pia; Pascolo, Lorella; Stebel, Marco; Trevisan, Elisa; Artero, Mary; Tiribelli, Claudio; Di Maso, Vittorio; Carraro, Michele			Podocyte Expression of Membrane Transporters Involved in Puromycin Aminonucleoside-Mediated Injury	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; P-GLYCOPROTEIN; PERMEABILITY FACTORS; IN-VITRO; RAT; IDENTIFICATION; POLYPEPTIDE; NEPHROTOXICITY; FAMILY; KIDNEY	Several complex mechanisms contribute to the maintenance of the intricate ramified morphology of glomerular podocytes and to interactions with neighboring cells and the underlying basement membrane. Recently, components of small molecule transporter families have been found in the podocyte membrane, but expression and function of membrane transporters in podocytes is largely unexplored. To investigate this complex field of investigation, we used two molecules which are known substrates of membrane transporters, namely Penicillin G and Puromycin Aminonucleoside (PA). We observed that Penicillin G pre-administration prevented both in vitro and in vivo podocyte damage caused by PA, suggesting the engagement of the same membrane transporters by the two molecules. Indeed, we found that podocytes express a series of transporters which are known to be used by Penicillin G, such as members of the Organic Anion Transporter Polypeptides (OATP/Oatp) family of influx transporters, and P-glycoprotein, a member of the MultiDrug Resistance (MDR) efflux transporter family. Expression of OATP/Oatp transporters was modified by PA treatment. Similarly, in vitro PA treatment increased mRNA and protein expression of P-glycoprotein, as well as its activity, confirming the engagement of the molecule upon PA administration. In summary, we have characterized some of the small molecule transporters present at the podocyte membrane, focusing on those used by PA to enter and exit the cell. Further investigation will be needed to understand precisely the role of these transporter families in maintaining podocyte homeostasis and in the pathogenesis of podocyte injury.	[Zennaro, Cristina; Tiribelli, Claudio; Di Maso, Vittorio; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Stebel, Marco; Trevisan, Elisa] Univ Trieste, Dept Life Sci, Trieste, Italy; [Artero, Mary] Azienda Osped Univ Osped Riuniti Trieste, Trieste, Italy; [Tiribelli, Claudio] AREA Sci Pk, Liver Res Ctr, Trieste, Italy; [Pascolo, Lorella] IRCCS Burlo Garofolo Ist Cura Carattere Sci Mater, Trieste, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Trieste; IRCCS Burlo Garofolo	Carraro, M (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	m.carraro@fmc.units.it	Pascolo, Lorella/AAB-5207-2020; Tiribelli, Claudio/A-4716-2014	Pascolo, Lorella/0000-0003-1044-7263; CARRARO, MICHELE/0000-0002-8940-3361; Tiribelli, Claudio/0000-0001-6596-7595; ZENNARO, Cristina/0000-0003-4755-1064	Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy; Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy; Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy	Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy; Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy; Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy	This work was supported by grants from "Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy", "Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy" and by "Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLOREUSS E, 1994, AM J PHYSIOL-CELL PH, V267, pC1351, DOI 10.1152/ajpcell.1994.267.5.C1351; Candido R, 2005, AM J HYPERTENS, V18, P844, DOI 10.1016/j.amjhyper.2004.12.021; Carraro M, 2004, NEPHROL DIAL TRANSPL, V19, P1969, DOI 10.1093/ndt/gfh343; Carraro M, 2001, DIABETOLOGIA, V12, P143; Chen L, 2009, NEUROCHEM RES, V34, P411, DOI 10.1007/s11064-008-9797-3; del Moral RG, 1998, EXP NEPHROL, V6, P89; DIAMOND JR, 1986, AM J PATHOL, V122, P481; Doublier S, 2005, INT J MOL MED, V16, P49; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Gloy J, 2000, AM J PHYSIOL-RENAL, V278, pF999, DOI 10.1152/ajprenal.2000.278.6.F999; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Ito A, 2003, INVEST OPHTH VIS SCI, V44, P4877, DOI 10.1167/iovs.02-1108; Jung SM, 2006, EXP MOL MED, V38, P485, DOI 10.1038/emm.2006.57; Kim RB, 2003, EUR J CLIN INVEST, V33, P1, DOI 10.1046/j.1365-2362.33.s2.5.x; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lee WK, 2007, EXP MOL MED, V39, P787, DOI 10.1038/emm.2007.85; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Roch R, 2003, RENAL HANDLING DRUGS, P21; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; Xia L, 2009, AM J PHYSIOL-RENAL, V296, pF1307, DOI 10.1152/ajprenal.00046.2009; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203	25	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66159	10.1371/journal.pone.0066159	http://dx.doi.org/10.1371/journal.pone.0066159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840417	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800038
J	Hasegawa, Y; Tachibana, Y; Sakagami, J; Zhang, M; Urade, M; Ono, T				Hasegawa, Yoko; Tachibana, Yoshihisa; Sakagami, Joe; Zhang, Min; Urade, Masahiro; Ono, Takahiro			Flavor-Enhanced Modulation of Cerebral Blood Flow during Gum Chewing	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; ORBITOFRONTAL CORTEX; BRAIN ACTIVATION; TASTE; STIMULATION; HUMANS; MONKEY; AREAS; PET	Background: Flavor perception, the integration of taste and odor, is a critical factor in eating behavior. It remains unclear how such sensory signals influence the human brain systems that execute the eating behavior. Methods: We tested cerebral blood flow (CBF) in the frontal lobes bilaterally while subjects chewed three types of gum with different combinations of taste and odor: no taste/no odor gum (C-gum), sweet taste/no odor gum (T-gum), and sweet taste/lemon odor gum (TO-gum). Simultaneous recordings of transcranial Doppler ultrasound (TCD) and near infrared spectrometer (NIRS) were used to measure CBF during gum chewing in 25 healthy volunteers. Bilateral masseter muscle activity was also monitored. Results: We found that subjects could discriminate the type of gum without prior information. Subjects rated the TO-gum as the most flavorful gum and the C-gum as the least flavorful. Analysis of masseter muscle activity indicated that masticatory motor output during gum chewing was not affected by taste and odor. The TCD/NIRS measurements revealed significantly higher hemodynamic signals when subjects chewed the TO-gum compared to when they chewed the C-gum and T-gum. Conclusions: These data suggest that taste and odor can influence brain activation during chewing in sensory, cognitive, and motivational processes rather than in motor control.	[Hasegawa, Yoko; Urade, Masahiro] Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo 6638501, Japan; [Hasegawa, Yoko; Sakagami, Joe; Ono, Takahiro] Osaka Univ, Div Oromaxillofacial Regenerat, Course Integrated Oral Sci, Grad Sch Dent, Suita, Osaka, Japan; [Tachibana, Yoshihisa] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 444, Japan; [Zhang, Min] Fourth Mil Med Univ, Dept Gen Dent & Emergency, Sch Stomatol, Xian 710032, Peoples R China	Hyogo College of Medicine; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Air Force Military Medical University	Hasegawa, Y (corresponding author), Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo 6638501, Japan.	cem17150@hyo-med.ac.jp; ono@dent.osaka-u.ac.jp	Morosolli, Aline/P-1984-2014	Hasegawa, Yoko/0000-0001-9112-5981	KAKENHI from the Ministry of Education, Science and Culture of Japan [21791887, 23792263]; Global COE Program in "In Silico Medicine'' of Osaka University	KAKENHI from the Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program in "In Silico Medicine'' of Osaka University	This study was supported by KAKENHI from the Ministry of Education, Science and Culture of Japan (grant numbers 21791887 and 23792263) and the Global COE Program in "In Silico Medicine'' of Osaka University. The authors declare no conflict of interest with any financial organization regarding the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1992, TRANSCRANIAL DOPPLER; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cerf-Ducastel B, 2003, BRAIN RES, V986, P39, DOI 10.1016/S0006-8993(03)03168-8; Cruz A, 2000, NATURE, V403, P889, DOI 10.1038/35002581; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Hasegawa Y, 2007, J DENT RES, V86, P64, DOI 10.1177/154405910708600110; Hasegawa Y, 2009, CLIN ORAL INVEST; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kobayashi M, 2002, EUR J NEUROSCI, V16, P975, DOI 10.1046/j.1460-9568.2002.02151.x; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Momose T, 1997, ARCH ORAL BIOL, V42, P57, DOI 10.1016/S0003-9969(96)00081-7; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ono T, 2007, J NEUROL, V254, P1427, DOI 10.1007/s00415-007-0570-3; Onozuka M, 2002, J DENT RES, V81, P743, DOI 10.1177/154405910208101104; Onozuka M, 2003, J DENT RES, V82, P657, DOI 10.1177/154405910308200817; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Salmon G, 1973, ATLAS ARTERIES HUMAN; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Takada T, 2004, NEUROSCI LETT, V360, P137, DOI 10.1016/j.neulet.2004.02.052; Villringer K, 1997, ADV EXP MED BIOL, V413, P149; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243	29	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66313	10.1371/journal.pone.0066313	http://dx.doi.org/10.1371/journal.pone.0066313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840440	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200068
J	Dustrude, ET; Wilson, SM; Ju, WN; Xiao, YC; Khanna, R				Dustrude, Erik T.; Wilson, Sarah M.; Ju, Weina; Xiao, Yucheng; Khanna, Rajesh			CRMP2 Protein SUMOylation Modulates NaV1.7 Channel Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; RESPONSE MEDIATOR PROTEIN-2; TRAUMATIC BRAIN-INJURY; SPINAL SENSORY NEURONS; ROOT GANGLION NEURONS; GROWTH CONE COLLAPSE; SUMO MODIFICATION; SLOW INACTIVATION; NEUROPATHIC PAIN; ANTICONVULSANT LACOSAMIDE	Voltage-gated sodium channel (NaV) trafficking is incompletely understood. Post-translational modifications of NaVs and/or auxiliary subunits and protein-protein interactions have been posited as NaV-trafficking mechanisms. Here, we tested if modification of the axonal collapsin response mediator protein 2 (CRMP2) by a small ubiquitin-like modifier (SUMO) could affect NaV trafficking; CRMP2 alters the extent of NaV slow inactivation conferred by the anti-epileptic (R)-lacosamide, implying NaV-CRMP2 functional coupling. Expression of a CRMP2 SUMOylation-incompetent mutant (CRMP2-K374A) in neuronal model catecholamine A differentiated (CAD) cells did not alter lacosamide-induced NaV slow inactivation compared with CAD cells expressing wild type CRMP2. Like wild type CRMP2, CRMP2-K374A expressed robustly in CAD cells. Neurite outgrowth, a canonical CRMP2 function, was moderately reduced by the mutation but was still significantly higher than enhanced GFP-transfected cortical neurons. Notably, huwentoxin-IV-sensitive NaV1.7 currents, which predominate in CAD cells, were significantly reduced in CAD cells expressing CRMP2-K374A. Increasing deSUMOylation with sentrin/SUMO-specific protease SENP1 or SENP2 in wild type CRMP2-expressing CAD cells decreased NaV1.7 currents. Consistent with a reduction in current density, biotinylation revealed a significant reduction in surface NaV1.7 levels in CAD cells expressing CRMP2-K374A; surface NaV1.7 expression was also decreased by SENP1 + SENP2 overexpression. Currents in HEK293 cells stably expressing NaV1.7 were reduced by CRMP2-K374A in a manner dependent on the E2-conjugating enzyme Ubc9. No decrement in current density was observed in HEK293 cells co-expressing CRMP2-K374A and NaV1.1 or NaV1.3. Diminution of sodium currents, largely NaV1.7, was recapitulated in sensory neurons expressing CRMP2-K374A. Our study elucidates a novel regulatory mechanism that utilizes CRMP2 SUMOylation to choreograph NaV1.7 trafficking.	[Dustrude, Erik T.; Wilson, Sarah M.; Khanna, Rajesh] Indiana Univ Sch Med, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ju, Weina; Xiao, Yucheng; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 West Walnut St,R2 Bldg,Rm 478, Indianapolis, IN 46202 USA.	khanna5@iu.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health Clinical and Translational Sciences Grant from the Indiana Clinical and Translational Sciences Institute [RR025761]; NCRR Project Development Team; Indiana State Department of Health-Spinal Cord and Brain Injury Fund [A70-9-079138]; National Scientist Development Grant from the American Heart Association [SDG5280023]; Neurofibromatosis New Investigator Award from the Department of Defense/Congressionally Directed Medical Research Program [NF1000099]; Stark fellowships; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER	National Institutes of Health Clinical and Translational Sciences Grant from the Indiana Clinical and Translational Sciences Institute; NCRR Project Development Team; Indiana State Department of Health-Spinal Cord and Brain Injury Fund; National Scientist Development Grant from the American Heart Association; Neurofibromatosis New Investigator Award from the Department of Defense/Congressionally Directed Medical Research Program; Stark fellowships; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Clinical and Translational Sciences Grant RR025761 from the Indiana Clinical and Translational Sciences Institute funded by NCRR Project Development Team. This work was also supported by the Indiana State Department of Health-Spinal Cord and Brain Injury Fund A70-9-079138 (to R. K.), National Scientist Development Grant SDG5280023 from the American Heart Association (to R. K.), and Neurofibromatosis New Investigator Award NF1000099 from the Department of Defense/Congressionally Directed Medical Research Program (to R. K.).; Supported in part by Stark fellowships.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Benson M, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P117, DOI 10.1007/978-90-481-2649-1_7; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Casini S, 2010, CARDIOVASC RES, V85, P691, DOI 10.1093/cvr/cvp352; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; Chi XX, 2007, J NEUROPHYSIOL, V98, P2683, DOI 10.1152/jn.00437.2007; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Duprez E, 1999, J CELL SCI, V112, P381; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Errington AC, 2006, NEUROPHARMACOLOGY, V50, P1016, DOI 10.1016/j.neuropharm.2006.02.002; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Hodgdon KE, 2012, NEUROSCIENCE, V206, P237, DOI 10.1016/j.neuroscience.2011.12.045; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Ju WN, 2013, CHANNELS, V7, P153, DOI 10.4161/chan.24224; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kim CH, 2001, MOL BRAIN RES, V95, P153, DOI 10.1016/S0169-328X(01)00226-1; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; King AM, 2012, ACS CHEM NEUROSCI, V3, P1037, DOI 10.1021/cn300129d; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Leclere PG, 2005, J NEUROSCI METH, V142, P137, DOI 10.1016/j.jneumeth.2004.08.012; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Park KD, 2010, ORG BIOMOL CHEM, V8, P2803, DOI 10.1039/c000987c; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Theile JW, 2011, MOL PHARMACOL, V80, P724, DOI 10.1124/mol.111.072751; Vacher H, 2012, EPILEPSIA, V53, P21, DOI 10.1111/epi.12032; Wang LH, 1997, J NEUROCHEM, V69, P2261; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P90, DOI 10.1021/cn100089b; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wilson SM, 2012, J BIOL CHEM, V287, P35065, DOI 10.1074/jbc.M112.378695; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; Wolff C, 2012, CNS NEUROSCI THER, V18, P493, DOI 10.1111/j.1755-5949.2012.00313.x; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	80	59	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24316	24331		10.1074/jbc.M113.474924	http://dx.doi.org/10.1074/jbc.M113.474924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836888	Green Published, hybrid			2022-12-25	WOS:000330612300004
J	Caballero-Franco, C; Choo, MK; Sano, Y; Ritprajak, P; Sakurai, H; Otsu, K; Mizoguchi, A; Park, JM				Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Sakurai, Hiroaki; Otsu, Kinya; Mizoguchi, Atsushi; Park, Jin Mo			Tuning of Protein Kinase Circuitry by p38 alpha Is Vital for Epithelial Tissue Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; MAP KINASE; CELL PROLIFERATION; JNK ACTIVATION; DOUBLE-BLIND; P38; STEM; INHIBITION; ALPHA	The epithelium of mucosal and skin surfaces serves as a permeability barrier and affords mechanisms for local immune defense. Crucial to the development and maintenance of a properly functioning epithelium is the balance of cell proliferation, differentiation, and death. Here we show that this balance depends on cross-regulatory interactions among multiple protein kinase-mediated signals and their coordinated transmission. From an investigation of conditional gene knock-out mice, we find that epithelial-specific loss of the protein kinase p38 alpha leads to aberrant activation of TAK1, JNK, EGF receptor, and ERK in distinct microanatomical areas of the intestines and skin. Consequently, the epithelial tissues display excessive proliferation, inadequate differentiation, and sensitivity to apoptosis. These anomalies leave the tissue prone to damage and collapse at the trigger of an environmental insult. The vulnerability of p38 alpha-deficient epithelium predicts adverse effects of long term pharmacological p38 alpha inhibition; yet such limitations could be overcome by concomitant blockade of one or more of the dysregulated protein kinase signaling pathways.	[Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Caballero-Franco, Celia; Choo, Min-Kyung; Sano, Yasuyo; Ritprajak, Patcharee; Mizoguchi, Atsushi; Park, Jin Mo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ritprajak, Patcharee] Chulalongkorn Univ, Fac Dent, Dept Microbiol & Immunol, Bangkok 10330, Thailand; [Ritprajak, Patcharee] Chulalongkorn Univ, Fac Dent, Dent Res Unit Oral Microbiol, Bangkok 10330, Thailand; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Mizoguchi, Atsushi] Massachusetts Gen Hosp, Dept Pathol, Mol Pathol Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Chulalongkorn University; Chulalongkorn University; University of Toyama; Osaka University; University of London; King's College London; Harvard University; Massachusetts General Hospital	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 Thirteenth St, Charlestown, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu	Sakurai, Hiroaki/AAE-4294-2019	Sakurai, Hiroaki/0000-0003-0657-9570	National Institutes of Health [AI074957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant AI074957 (to J. M. P.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guma M, 2012, ARTHRITIS RHEUM-US, V64, P2887, DOI 10.1002/art.34489; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mbalaviele G, 2006, J PHARMACOL EXP THER, V317, P1044, DOI 10.1124/jpet.105.100362; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Ritprajak P, 2012, P NATL ACAD SCI USA, V109, P9089, DOI 10.1073/pnas.1202984109; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vereecke L, 2011, TRENDS MOL MED, V17, P584, DOI 10.1016/j.molmed.2011.05.011; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	49	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23788	23797		10.1074/jbc.M113.452029	http://dx.doi.org/10.1074/jbc.M113.452029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23836897	hybrid, Green Published			2022-12-25	WOS:000330611400018
J	Piekna-Przybylska, D; Sharma, G; Bambara, RA				Piekna-Przybylska, Dorota; Sharma, Gaurav; Bambara, Robert A.			Mechanism of HIV-1 RNA Dimerization in the Central Region of the Genome and Significance for Viral Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; G-QUADRUPLEX STRUCTURES; MESSENGER-RNA; REVERSE-TRANSCRIPTASE; G-QUARTET; MOLECULAR-WEIGHT; PROMOTER REGION; SARCOMA-VIRUS; RECOMBINATION; DNA	The genome of HIV-1 consists of two identical or nearly identical RNA molecules. The RNA genomes are held in the same, parallel orientation by interactions at the dimer initiation site (DIS). Previous studies showed that in addition to interactions at DIS, sequences located 100 nucleotides downstream from the 5' splice site can dimerize in vitro through an intermolecular G-quartet structure. Here we report that the highly conserved G-rich sequence in the middle portion of the HIV-1 genome near the central polypurine tract (cPPT) dimerizes spontaneously under high ionic strength in the absence of protein. The antisense RNA does not dimerize, strongly indicating that RNA dimerization does not exclusively involve A: U and G: C base pairing. The cation-dependent reverse transcriptase pausing profile, CD spectra profile, and cation-dependent association and thermal dissociation characteristics indicate G-quartet structures. Different forms of G-quartets are formed including monomers and, significantly, intermolecular dimers. Our results indicate that RNA genome dimerization and parallel alignment initiated through interactions at DIS may be greatly expanded and stabilized by formation of an intermolecular G-quartet at a distant site near the cPPT. It is likely that formation of G-quartet structure near the cPPT in vivo keeps the RNA genomes in proximity over a long range, promoting genetic recombination in numerous hot spots.	[Piekna-Przybylska, Dorota; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Sharma, Gaurav] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Sharma, Gaurav/A-1154-2007	Sharma, Gaurav/0000-0001-9735-9519	National Institutes of Health [GM049573, GM097334]; University of Rochester Developmental Center for AIDS Research Grant [P30 AI078498]; University of Rochester School of Medicine and Dentistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573, R01GM097334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Developmental Center for AIDS Research Grant; University of Rochester School of Medicine and Dentistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049573 (to R. A. B.) and GM097334 (to G. S.) and University of Rochester Developmental Center for AIDS Research Grant P30 AI078498 (NIAID). This work was also supported by the University of Rochester School of Medicine and Dentistry.	AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; BENDER W, 1978, J VIROL, V25, P888, DOI 10.1128/JVI.25.3.888-896.1978; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; Fan J, 2007, INFECT GENET EVOL, V7, P717, DOI 10.1016/j.meegid.2007.07.012; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; KUNG HJ, 1976, CELL, V7, P609, DOI 10.1016/0092-8674(76)90211-7; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Ly H, 1999, J VIROL, V73, P7255, DOI 10.1128/JVI.73.9.7255-7261.1999; Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644; MANGEL WF, 1974, P NATL ACAD SCI USA, V71, P4541, DOI 10.1073/pnas.71.11.4541; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; Moore MD, 2007, J VIROL, V81, P4002, DOI 10.1128/JVI.02589-06; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; MURTI KG, 1981, J VIROL, V37, P411, DOI 10.1128/JVI.37.1.411-419.1981; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Ortiz-Conde BA, 1999, J VIROL, V73, P7165, DOI 10.1128/JVI.73.9.7165-7174.1999; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Shen N, 2000, J VIROL, V74, P5729, DOI 10.1128/JVI.74.12.5729-5735.2000; Shen W, 2011, J BIOL CHEM, V286, P29838, DOI 10.1074/jbc.M111.262352; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Smargiasso N, 2008, J AM CHEM SOC, V130, P10208, DOI 10.1021/ja801535e; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	47	25	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24140	24150		10.1074/jbc.M113.477265	http://dx.doi.org/10.1074/jbc.M113.477265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839990	Green Published, hybrid			2022-12-25	WOS:000330611400049
J	Wright, S; Boyd, MA; Yunihastuti, E; Law, M; Sirisanthana, T; Hoy, J; Pujari, S; Lee, MP; Petoumenos, K				Wright, Stephen; Boyd, Mark A.; Yunihastuti, Evy; Law, Matthew; Sirisanthana, Thira; Hoy, Jennifer; Pujari, Sanjay; Lee, Man Po; Petoumenos, Kathy		Int Epidemiologic Databases	Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region	PLOS ONE			English	Article							HIV OBSERVATIONAL DATABASE; RESOURCE-LIMITED SETTINGS; VIROLOGICAL FAILURE; GENERAL-POPULATION; VIRAL LOAD; BASE-LINE; MORTALITY; AIDS; PREDICTORS; INFECTION	Background: In the Asia-Pacific region many countries have adopted the WHO's public health approach to HIV care and treatment. We performed exploratory analyses of the factors associated with first major modification to first-line combination antiretroviral therapy (ART) in resource-rich and resource-limited countries in the region. Methods: We selected treatment naive HIV-positive adults from the Australian HIV Observational Database (AHOD) and the TREAT Asia HIV Observational Database (TAHOD). We dichotomised each country's per capita income into high/uppermiddle (T-H) and lower-middle/low (T-L). Survival methods stratified by income were used to explore time to first major modification of first-line ART and associated factors. We defined a treatment modification as either initiation of a new class of antiretroviral (ARV) or a substitution of two or more ARV agents from within the same ARV class. Results: A total of 4250 patients had 961 major modifications to first-line ART in the first five years of therapy. The cumulative incidence (95% CI) of treatment modification was 0.48 (0.44-0.52), 0.33 (0.30-0.36) and 0.21 (0.18-0.23) for AHOD, T-H and T-L respectively. We found no strong associations between typical patient characteristic factors and rates of treatment modification. In AHOD, relative to sites that monitor twice-yearly (both CD4 and HIV RNA-VL), quarterly monitoring corresponded with a doubling of the rate of treatment modifications. In T-H, relative to sites that monitor once-yearly (both CD4 and HIV RNA-VL), monitoring twice-yearly corresponded to a 1.8 factor increase in treatment modifications. In T-L, no sites on average monitored both CD4 & HIV RNA-VL concurrently once-yearly. We found no differences in rates of modifications for once-or twice-yearly CD4 count monitoring. Conclusions: Low-income countries tended to have lower rates of major modifications made to first-line ART compared to higher-income countries. In higher-income countries, an increased rate of RNA-VL monitoring was associated with increased modifications to first-line ART.	[Wright, Stephen; Boyd, Mark A.; Law, Matthew; Petoumenos, Kathy] Kirby Inst, Sydney, NSW, Australia; [Boyd, Mark A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Yunihastuti, Evy] Cipto Mangunkusumo Gen Hosp, Jakarta, Indonesia; [Sirisanthana, Thira] Chiang Mai Univ, Chiang Mai 50000, Thailand; [Hoy, Jennifer] Alfred Hosp, Melbourne, Vic, Australia; [Hoy, Jennifer] Monash Univ, Melbourne, Vic 3004, Australia; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Lee, Man Po] Queen Elizabeth Hosp, Kowloon, Hong Kong, Peoples R China	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University of Indonesia; Chiang Mai University; Florey Institute of Neuroscience & Mental Health; Monash University	Wright, S (corresponding author), Kirby Inst, Sydney, NSW, Australia.	swright@kirby.unsw.edu.au	Yunihastuti, Evy/AGD-5382-2022; Hoy, Jennifer/AAK-7968-2020; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Wright, Stephen/G-9643-2014	Yunihastuti, Evy/0000-0001-6650-0559; Wright, Stephen/0000-0002-8593-6056; Boyd, Mark/0000-0002-6848-3307; Templeton, David/0000-0003-2157-9587; Hoy, Jennifer/0000-0002-6948-7086; Law, Matthew/0000-0002-3540-8837	United States National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute [U01AI069907]; Australian Government Department of Health and Ageing; Faculty of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	United States National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Faculty of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The TREAT Asia HIV Observational Database and the Australian HIV Observational Database are initiatives of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the United States National Institutes of Health's National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907), and the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds. The Kirby Institute is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achhra Amit C, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P160, DOI 10.1177/1545109711402213; Australian HIV Observational Database, 2002, HIV MED, V3, P28; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boyd MA, 2012, LANCET, V380, P1860, DOI 10.1016/S0140-6736(12)61154-4; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Joint United Nations Programme on HIV/AIDS, 2011, HIV AS PAC GETT ZER, P1; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Oyomopito R, 2010, HIV MED, V11, P519, DOI 10.1111/j.1468-1293.2010.00822.x; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Reekie J, 2008, AIDS, V22, P2381, DOI 10.1097/QAD.0b013e328317a6eb; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; World Bank, WORLD BANK GNI PER C; World Health Organization, 2011, ANT THER HIV INF AD, P1; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e64902	10.1371/journal.pone.0064902	http://dx.doi.org/10.1371/journal.pone.0064902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840312	Green Published, gold			2022-12-25	WOS:000321148400002
J	Griffeth, VEM; Blockley, NP; Simon, AB; Buxton, RB				Griffeth, Valerie E. M.; Blockley, Nicholas P.; Simon, Aaron B.; Buxton, Richard B.			A New Functional MRI Approach for Investigating Modulations of Brain Oxygen Metabolism	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CALIBRATED-BOLD FMRI; OXIDATIVE-METABOLISM; SOMATOSENSORY STIMULATION; VISUAL-STIMULATION; SIGNAL CHANGES; EVOKED BOLD; BASE-LINE; 1.5 TESLA; ACTIVATION	Functional MRI (fMRI) using the blood oxygenation level dependent (BOLD) signal is a common technique in the study of brain function. The BOLD signal is sensitive to the complex interaction of physiological changes including cerebral blood flow (CBF), cerebral blood volume (CBV), and cerebral oxygen metabolism (CMRO2). A primary goal of quantitative fMRI methods is to combine BOLD imaging with other measurements (such as CBF measured with arterial spin labeling) to derive information about CMRO2. This requires an accurate mathematical model to relate the BOLD signal to the physiological and hemodynamic changes; the most commonly used of these is the Davis model. Here, we propose a new nonlinear model that is straightforward and shows heuristic value in clearly relating the BOLD signal to blood flow, blood volume and the blood flow-oxygen metabolism coupling ratio. The model was tested for accuracy against a more detailed model adapted for magnetic fields of 1.5, 3 and 7T. The mathematical form of the heuristic model suggests a new ratio method for comparing combined BOLD and CBF data from two different stimulus responses to determine whether CBF and CMRO2 coupling differs. The method does not require a calibration experiment or knowledge of parameter values as long as the exponential parameter describing the CBF-CBV relationship remains constant between stimuli. The method was found to work well for 1.5 and 3T but is prone to systematic error at 7T. If more specific information regarding changes in CMRO2 is required, then with accuracy similar to that of the Davis model, the heuristic model can be applied to calibrated BOLD data at 1.5T, 3T and 7T. Both models work well over a reasonable range of blood flow and oxygen metabolism changes but are less accurate when applied to a simulated caffeine experiment in which CBF decreases and CMRO2 increases.	[Griffeth, Valerie E. M.; Simon, Aaron B.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Griffeth, Valerie E. M.; Simon, Aaron B.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Blockley, Nicholas P.; Buxton, Richard B.] Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Buxton, Richard B.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Buxton, RB (corresponding author), Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA.	rbuxton@ucsd.edu		Blockley, Nicholas/0000-0003-2595-8285	National Institutes of Health (NIH) [NS-36722, MH-095298, EB-00790, EB-009830]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding from National Institutes of Health (NIH) grants NS-36722, MH-095298, EB-00790 and EB-009830 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Blockley NP, 2008, MAGN RESON MED, V60, P1313, DOI 10.1002/mrm.21792; Blockley NP, NMR BIOMEDI IN PRESS; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Chiarelli PA, 2007, MAGN RESON MED, V57, P538, DOI 10.1002/mrm.21171; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P1856, DOI 10.1038/jcbfm.2009.107; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gauthier CJ, 2011, NEUROIMAGE, V54, P1001, DOI 10.1016/j.neuroimage.2010.09.059; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Griffeth VEM, 2011, NEUROIMAGE, V57, P809, DOI 10.1016/j.neuroimage.2011.04.064; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Jones M, 2005, NEUROIMAGE, V27, P609, DOI 10.1016/j.neuroimage.2005.04.036; Kastrup A, 2002, NEUROIMAGE, V15, P74, DOI 10.1006/nimg.2001.0916; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; Kim T, 2007, J CEREBR BLOOD F MET, V27, P1235, DOI 10.1038/sj.jcbfm.9600429; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; Lin AL, 2008, MAGN RESON MED, V60, P380, DOI 10.1002/mrm.21655; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; Moradi F, 2012, NEUROIMAGE; Moradi F, 2012, NEUROIMAGE, V59, P601, DOI 10.1016/j.neuroimage.2011.07.078; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Pike GB, 2012, NEUROIMAGE, V62, P1234, DOI 10.1016/j.neuroimage.2011.10.046; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P47, DOI 10.1002/mrm.10355; Simon AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054816; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; St Lawrence KS, 2003, MAGNET RESON MED, V50, P99, DOI 10.1002/mrm.10502; Stefanovic B, 2005, NEUROIMAGE, V28, P205, DOI 10.1016/j.neuroimage.2005.05.038; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Stephan KE, 2007, NEUROIMAGE, V38, P387, DOI 10.1016/j.neuroimage.2007.07.040; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506	46	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68122	10.1371/journal.pone.0068122	http://dx.doi.org/10.1371/journal.pone.0068122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826367	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000121
J	Krishnamoorthy, S; Liu, ZH; Hong, AL; Zhu, RJ; Chen, HS; Li, TB; Zhou, XC; Gao, XL				Krishnamoorthy, Srinivasan; Liu, Zhonghua; Hong, Ailing; Zhu, Ruijuan; Chen, Haosi; Li, Tongbin; Zhou, Xiaochuan; Gao, Xiaolian			A Novel Phosphopeptide Microarray Based Interactome Map in Breast Cancer Cells Reveals Phosphoprotein-GRB2 Cell Signaling Networks	PLOS ONE			English	Article							GRB2 BINDING-SITE; T-BOC CHEMISTRY; TYROSINE KINASE; PHOSPHORYLATION SITES; PEPTIDE-SYNTHESIS; ACTIVATION MOTIF; MAST-CELLS; IN-VIVO; RECEPTOR; PROTEIN	The architecture of cellular proteins connected to form signaling pathways in response to internal and external cues is much more complex than a group of simple protein-protein interactions. Post translational modifications on proteins (e.g., phosphorylation of serine, threonine and tyrosine residues on proteins) initiate many downstream signaling events leading to protein-protein interactions and subsequent activation of signaling cascades leading to cell proliferation, cell differentiation and cell death. As evidenced by a rapidly expanding mass spectrometry database demonstrating protein phosphorylation at specific motifs, there is currently a large gap in understanding the functional significance of phosphoproteins with respect to their specific protein connections in the signaling cascades. A comprehensive map that interconnects phospho-motifs in pathways will enable identification of nodal protein interactions that are sensitive signatures indicating a disease phenotype from the physiological hemostasis and provide clues into control of disease. Using a novel phosphopeptide microarray technology, we have mapped endogenous tyrosine-phosphoproteome interaction networks in breast cancer cells mediated by signaling adaptor protein GRB2, which transduces cellular responses downstream of several RTKs through the Ras-ERK signaling cascade. We have identified several previously reported motif specific interactions and novel interactions. The peptide microarray data indicate that various phospho-motifs on a single protein are differentially regulated in various cell types and shows global downregulation of phosphoprotein interactions specifically in cells with metastatic potential. The study has revealed novel phosphoprotein mediated signaling networks, which warrants further detailed analysis of the nodes of protein-protein interaction to uncover their biomarker or therapeutic potential.	[Krishnamoorthy, Srinivasan; Liu, Zhonghua; Zhu, Ruijuan; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX 77058 USA; [Hong, Ailing; Li, Tongbin; Zhou, Xiaochuan] LC Sci, Houston, TX USA	University of Houston System; University of Houston	Krishnamoorthy, S (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77058 USA.	ksrini10@gmail.com; xgao@uh.edu			NCI [4R33CA126209]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by R33 grant from NCI (4R33CA126209) to XG and XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bradley LM, 2008, J STEROID BIOCHEM, V109, P185, DOI 10.1016/j.jsbmb.2007.10.006; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; DeGnore JP, 1998, J AM SOC MASS SPECTR, V9, P1175, DOI 10.1016/S1044-0305(98)00088-9; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Finlayson CA, 2003, METABOLISM, V52, P1606, DOI 10.1016/S0026-0495(03)00311-1; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Gao XL, 2004, MOL DIVERS, V8, P177, DOI 10.1023/B:MODI.0000036233.58271.25; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Gong WM, 2008, NUCLEIC ACIDS RES, V36, pD679, DOI 10.1093/nar/gkm854; Hao Q, 2006, MOL PHARMACOL, V69, P1938, DOI 10.1124/mol.105.020115; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Krishnamoorthy S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002877; Lanzino M, 2008, CURR CANCER DRUG TAR, V8, P597, DOI 10.2174/156800908786241104; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paulo JA, 2013, J PROTEOMICS; Paulo JA, 2012, J PROTEOME RES, V11, P1897, DOI 10.1021/pr2011022; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Pellois JP, 2000, J COMB CHEM, V2, P355, DOI 10.1021/cc0000139; Pighi C, 2011, CELL ONCOL, V34, P141, DOI 10.1007/s13402-011-0019-7; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schumacher JA, 2007, J MOL DIAGN, V9, P169, DOI 10.2353/jmoldx.2007.060031; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Tzeng SR, 2000, PROTEIN SCI, V9, P2377, DOI 10.1110/ps.9.12.2377; Uen YH, 2013, J PROTEOMICS, V83, P197, DOI 10.1016/j.jprot.2013.03.007; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang JH, 2003, J BIOL CHEM, V278, P16797, DOI 10.1074/jbc.M211060200; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhou X, 2011, MICRORNA PROFILING U	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67634	10.1371/journal.pone.0067634	http://dx.doi.org/10.1371/journal.pone.0067634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826330	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000094
J	Lee, WS; Woo, EY; Kwon, J; Park, MJ; Lee, JS; Han, YH; Bae, IH				Lee, Woo Sang; Woo, Eun Young; Kwon, Junhye; Park, Myung-Jin; Lee, Jae-Seon; Han, Young-Hoon; Bae, In Hwa			Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; GLIOMA-CELLS; INVASION; CANCER; ACTIVATION; EXPRESSION; WNT; AKT; TRANSITION; FAMILY	Bcl-w a pro-survival member of the Bcl-2 protein family, is expressed in a variety of cancer types, including gastric and colorectal adenocarcinomas, as well as glioblastoma multiforme (GBM), the most common and lethal brain tumor type. Previously, we demonstrated that Bcl-w is upregulated in gastric cancer cells, particularly those displaying infiltrative morphology. These reports propose that Bcl-w is strongly associated with aggressive characteristic, such as invasive or mesenchymal phenotype of GBM. However, there is no information from studies of the role of Bcl-w in GBM. In the current study, we showed that Bcl-w is upregulated in human glioblastoma multiforme (WHO grade IV) tissues, compared with normal and glioma (WHO grade III) tissues. Bcl-w promotes the mesenchymal traits of glioblastoma cells by inducing vimentin expression via activation of transcription factors, beta-catenin, Twist1 and Snail in glioblastoma U251 cells. Moreover, Bcl-w induces invasiveness by promoting MMP-2 and FAK activation via the PI3K-p-Akt-p-GSK3 beta-beta-catenin pathway. We further confirmed that Bcl-w has the capacity to induce invasiveness in several human cancer cell lines. In particular, Bcl-w-stimulated beta-catenin is translocated into the nucleus as a transcription factor and promotes the expression of target genes, such as mesenchymal markers or MMPs, thereby increasing mesenchymal traits and invasiveness. Our findings collectively indicate that Bcl-w functions as a positive regulator of invasiveness by inducing mesenchymal changes and that trigger their aggressiveness of glioblastoma cells.	[Lee, Woo Sang; Woo, Eun Young; Park, Myung-Jin; Lee, Jae-Seon; Han, Young-Hoon; Bae, In Hwa] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Kwon, Junhye] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Sookmyung Women's University	Bae, IH (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea.	ihbae@kirams.re.kr						Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Bae IH, 2009, CANCER LETT, V277, P22, DOI 10.1016/j.canlet.2008.11.022; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Gibson L, 1996, ONCOGENE, V13, P665; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Han SP, 2011, CELL MOL NEUROBIOL, V31, P489, DOI 10.1007/s10571-010-9643-4; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Kamino M, 2011, CANCER SCI, V102, P540, DOI 10.1111/j.1349-7006.2010.01815.x; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim DK, 2001, J CELL SCI, V114, P4329; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Le DM, 2003, J NEUROSCI, V23, P4034; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liu C, 2011, CLIN EXP MED, V11, P105, DOI 10.1007/s10238-010-0110-9; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park MJ, 2002, CANCER RES, V62, P6318; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polakis P, 2000, GENE DEV, V14, P1837; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Varga I, 2010, CENT EUR NEUROSURG, V71, P173, DOI 10.1055/s-0030-1249698; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yue XA, 2010, BRAIN RES, V1366, P27, DOI 10.1016/j.brainres.2010.10.032; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354	40	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68030	10.1371/journal.pone.0068030	http://dx.doi.org/10.1371/journal.pone.0068030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826359	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000113
J	Li, G; Yang, QT; Zhu, YB; Wang, HR; Chen, XC; Zhang, XG; Lu, BF				Li, Gang; Yang, Qianting; Zhu, Yibei; Wang, Hong-Rui; Chen, Xinchun; Zhang, Xueguang; Lu, Binfeng			T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EOMESODERMIN; ADOPTIVE IMMUNOTHERAPY; COLORECTAL-CANCER; VIRAL-INFECTION; CUTTING EDGE; DIFFERENTIATION; METASTASIS; COMMITMENT; EXPRESSION; RESPONSES	Memory T cells are composed of effector, central, and memory stem cells. Previous studies have implicated that both T-bet and Eomes are involved in the generation of effector and central memory CD8 T cells. The exact role of these transcription factors in shaping the memory T cell pool is not well understood, particularly with memory stem T cells. Here, we demonstrate that both T-bet or Eomes are required for elimination of established tumors by adoptively transferred CD8 T cells. We also examined the role of T-bet and Eomes in the generation of tumor-specific memory T cell subsets upon adoptive transfer. We showed that combined T-bet and Eomes deficiency resulted in a severe reduction in the number of effector/central memory T cells but an increase in the percentage of CD62L(high)CD44(low) Sca-1(+) T cells which were similar to the phenotype of memory stem T cells. Despite preserving large numbers of phenotypic memory stem T cells, the lack of both of T-bet and Eomes resulted in a profound defect in antitumor memory responses, suggesting T-bet and Eomes are crucial for the antitumor function of these memory T cells. Our study establishes that T-bet and Eomes cooperate to promote the phenotype of effector/central memory CD8 T cell versus that of memory stem like T cells.	[Li, Gang; Zhang, Xueguang] Soochow Univ, Inst Med Biotechnol, Jiangsu Inst Clin Immunol, Stem Cell Res Lab Jiangsu Prov, Suzhou, Jiangsu, Peoples R China; [Yang, Qianting; Zhu, Yibei; Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Yang, Qianting; Chen, Xinchun] Guangdong Med Coll, Peoples Hosp 3, Shenzhen Key Lab Infect & Immun, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Guangdong, Peoples R China; [Zhu, Yibei] Soochow Univ, Coll Med, Dept Immunol, Suzhou, Jiangsu, Peoples R China; [Wang, Hong-Rui] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Guangdong Medical University; Soochow University - China; Xiamen University	Lu, BF (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.	Binfeng@pitt.edu		Wang, Hong-Rui/0000-0002-2916-8849	NSFC [2010692006, 30930085, 31170866, 81273208]; 973 project [2013CB530501]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Jiangsu natural science fund [BK2011289]; National Nature Science Foundation of China [81171535];  [1R21CA167229-01A1]; NATIONAL CANCER INSTITUTE [R21CA167229] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Jiangsu natural science fund; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is supported by 1R21CA167229-01A1 to BL. GL is partly supported by a scholarship from NSFC (#2010692006). This work is partly supported by NSFC key grant 30930085, the 973 project (No. 2013CB530501) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) (to XG. Zhang). Y Zhu is supported by NSFC grant 31170866, 81273208 and Jiangsu natural science fund BK2011289. QY and XC are supported by National Nature Science Foundation of China Grant No. 81171535.	Atreya I, 2007, GUT, V56, P1572, DOI 10.1136/gut.2006.117812; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chen LJ, 2012, CANC IMMUNOL IMMUNOT; Chen LJ, 2011, CANCER IMMUNOL IMMUN, V60, P1047, DOI 10.1007/s00262-011-1017-3; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kato K, 2010, BIOL BLOOD MARROW TR, V16, P751, DOI 10.1016/j.bbmt.2010.01.012; Lizee G, 2012, ANN REV MED; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	31	38	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67401	10.1371/journal.pone.0067401	http://dx.doi.org/10.1371/journal.pone.0067401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826287	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000321150000075
J	Malawista, SE; de Boisfleury, AC				Malawista, Stephen E.; de Boisfleury, Anne Chevance			Plunder of Human Blood Leukocytes Containing Ingested Material, by Other Leukocytes: Where Is the Fusagen That Allows Preservation of Membrane Integrity and Motile Function?	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES	In studying phagocytosis of zymosan particles by human blood monocytes in phase-contrast videomicroscopy, we found that monocytes loaded with zymosan particles became chemotactic for polymorphonuclear leukocytes (PMN) which closed on them and purloined their particle content. This despoliation usually occurred in monocytes that had begun to swell-prefiguring their death. The violent seizure of their contents by the aggressing PMN often tore the monocytes apart. However, some apparently healthy monocyte survived the removal of zymosan content by PMN or, more commonly, its removal by another monocyte. PMN-a much hardier cell in slide preparations-that were similarly loaded with zymosan particles, also attracted PMN. The latter could remove zymosan from the target cell without killing it. Thus, leukocytes were sacrificing significant portions of themselves without losing residual membrane integrity and motile function. Their behavior with respect to other particles (e. g., bacteria) will be of interest. We suggest that the membrane fusagen resides in the inner membrane leaflets when they are brought together in an extreme hourglass configuration. This event may be similar to the fragmentation of erythrocytes into intact pieces, the formation of cytokineplasts, the rear extrusion of content by migrating cells on surfaces, and the phagocytic process itself.	[Malawista, Stephen E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Malawista, Stephen E.; de Boisfleury, Anne Chevance] Hop La Pitie Salpetriere, Ctr Ecol Cellulaire, Paris, France	Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Malawista, SE (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	stephen.malawista@yale.edu						Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Brain N, 1969, NEW ENGL J MED, V281, P833; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; MALAWISTA SE, 1989, J CLIN INVEST, V83, P728, DOI 10.1172/JCI113939; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960	6	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65796	10.1371/journal.pone.0065796	http://dx.doi.org/10.1371/journal.pone.0065796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840370	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400014
J	Hoeke, L; Sharbati, J; Pawar, K; Keller, A; Einspanier, R; Sharbati, S				Hoeke, Lena; Sharbati, Jutta; Pawar, Kamlesh; Keller, Andreas; Einspanier, Ralf; Sharbati, Soroush			Intestinal Salmonella typhimurium Infection Leads to miR-29a Induced Caveolin 2 Regulation	PLOS ONE			English	Article							CELL-PROLIFERATION; EPITHELIAL-CELLS; FOCAL ADHESIONS; SHOW EVIDENCE; HOST-CELLS; MICE; EXPRESSION; INVASION; PATHOGENESIS; MECHANISMS	Background: Salmonella are able to modulate host cell functions facilitating both uptake and resistance to cellular host defence mechanisms. While interactions between bacterial modulators and cellular proteins have been the main focus of Salmonella research, relatively little is known about mammalian gene regulation in response to Salmonella infection. A major class of mammalian gene modulators consists of microRNAs. For our study we examined interactions of microRNAs and regulated mRNAs in mammalian intestinal Salmonella infections using a piglet model. Methodology/Principal Findings: After performing microRNA as well as mRNA specific microarray analysis of ileal samples from Salmonella infected as well as control piglets, we integrated expression analysis with target prediction identifying microRNAs that mainly regulate focal adhesion as well as actin cytoskeleton pathways. Particular attention was given to miR-29a, which was involved in most interactions including Caveolin 2. RT-qPCR experiments verified up-regulation of miR-29a after infection while its predicted target Caveolin 2 was significantly down-regulated as examined by transcript and protein detection. Reporter gene assays as well as RNAi experiments confirmed Caveolin 2 to be a miR-29a target. Knock-down of Caveolin 2 in intestinal epithelial cells resulted in retarded proliferation as well as increased bacterial uptake. In addition, our experiments showed that Caveolin 2 regulates the activation of the small Rho GTPase CDC42 but apparently not RAC1 in human intestinal cells. Conclusions/Significance: Our study outlines for the first time important regulation pathways in intestinal Salmonella infection pointing out that focal adhesion and organisation of actin cytoskeleton are regulated by microRNAs. Functional relevance is shown by miR-29a mediated Caveolin 2 regulation, modulating the activation state of CDC42. Further analysis of examined interactions may support the discovery of novel strategies impairing the uptake of intracellular pathogens.	[Hoeke, Lena; Sharbati, Jutta; Pawar, Kamlesh; Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany; [Keller, Andreas] Univ Saarland, Dept Human Genet, Homburg, Saar, Germany; [Keller, Andreas] Siemens AG, Healthcare Sect, Erlangen, Germany	Free University of Berlin; Saarland University; Siemens AG; Siemens Germany	Sharbati, S (corresponding author), Free Univ Berlin, Inst Vet Biochem, Berlin, Germany.	sharbati@zedat.fu-berlin.de	Pawar, Kamlesh Ganesh/M-8596-2019; Sharbati, Soroush/D-2548-2014; Keller, Andreas/ABB-6412-2021	Pawar, Kamlesh Ganesh/0000-0002-9767-0152; Keller, Andreas/0000-0002-5361-0895; Sharbati, Soroush/0000-0003-3338-7654	Deutsche Forschungsgemeinschaft [SH 465/1-1, SFB 852, B4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SH 465/1-1 and SFB 852 project B4.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berends BR, 1996, INT J FOOD MICROBIOL, V30, P37, DOI 10.1016/0168-1605(96)00990-7; Betts M.J., 2003, BIOINFORMA GENET, DOI DOI 10.1002/9780470059180.CH13; Boettcher JP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000457; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Almeida CJ, 2011, CELL CYCLE, V10, P2151, DOI 10.4161/cc.10.13.16234; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kum WWS, 2011, INFECT IMMUN, V79, P2554, DOI 10.1128/IAI.01235-10; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee S, 2011, INT J ONCOL, V38, P1395, DOI 10.3892/ijo.2011.958; Lim JS, 2009, BIOCHEM BIOPH RES CO, V390, P1322, DOI 10.1016/j.bbrc.2009.10.145; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu XY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-326; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Ma F, 2011, NAT IMMUNOL; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Nethe M, 2011, CELL ADHES MIGR, V5, P59, DOI 10.4161/cam.5.1.13702; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Orom U, 2012, CELL CYCLE, V11; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Shi J, 2006, MOL BIOL CELL, V17, P4698, DOI 10.1091/mbc.E06-06-0492; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Szabo I, 2009, APPL ENVIRON MICROB, V75, P2621, DOI 10.1128/AEM.01515-08; Uthe JJ, 2011, ANIM GENET, V42, P521, DOI 10.1111/j.1365-2052.2010.02171.x; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SO, 2009, CELL CYCLE, V8, P2070, DOI 10.4161/cc.8.13.8891; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xie LK, 2011, AM J PHYSIOL-CELL PH, V301, pC1161, DOI 10.1152/ajpcell.00486.2010; Zaas David W, 2009, Commun Integr Biol, V2, P535; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200	63	41	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67300	10.1371/journal.pone.0067300	http://dx.doi.org/10.1371/journal.pone.0067300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826261	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400130
J	Feulefack, JF; Luckert, MK; Mohapatra, S; Cash, SB; Alibhai, A; Kipp, W				Feulefack, Joseph F.; Luckert, Martin K.; Mohapatra, Sandeep; Cash, Sean B.; Alibhai, Arif; Kipp, Walter			Impact of Community-Based HIV/AIDS Treatment on Household Incomes in Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; POVERTY; TIME	Though health benefits to households in developing countries from antiretroviral treatment (ART) programs are widely reported in the literature, specific estimates regarding impacts of treatments on household incomes are rare. This type of information is important to governments and donors, as it is an indication of returns to their ART investments, and to better understand the role of HIV/AIDS in development. The objective of this study is to estimate the impact of a community-based ART program on household incomes in a previously underserved rural region of Uganda. A community-based ART program, based largely on labor contributions from community volunteers, was implemented and evaluated. All households with HIV/AIDS patients enrolled in the treatment programme (n = 134 households) were surveyed five times; once at the beginning of the treatment and every three months thereafter for a period of one year. Data were collected on household income from cash earnings and value of own production. The analysis, using ordinary least squares and quantile regressions, identifies the impact of the ART program on household incomes over the first year of the treatment, while controlling for heterogeneity in household characteristics and temporal changes. As a result of the treatment, health conditions of virtually all patients improved, and household incomes increased by approximately 30% to 40%, regardless of household income quantile. These increases in income, however, varied significantly depending on socio-demographic and socio-economic control variables. Overall, results show large and significant impacts of the ART program on household incomes, suggesting large returns to public investments in ART, and that treating HIV/AIDS is an important precondition for development. Moreover, development programs that invest in human capital and build wealth are important complements that can increase the returns to ART programs.	[Feulefack, Joseph F.; Luckert, Martin K.; Mohapatra, Sandeep] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada; [Cash, Sean B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Dept Food & Nutr Policy, Boston, MA 02111 USA; [Alibhai, Arif; Kipp, Walter] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Alberta; Tufts University; University of Alberta	Luckert, MK (corresponding author), Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada.	marty.luckert@ualberta.ca		Cash, Sean/0000-0002-7561-3392	Canadian Institutes of Health research (CIHR) [MOP-74586]	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by the Canadian Institutes of Health research (CIHR), grant number MOP-74586 www.cihr.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai A, 2010, CURR HIV RES, V8, P370, DOI 10.2174/157016210791330400; [Anonymous], 2004, WORLD HLTH REP; Barrett CB, 2006, WORLD DEV, V34, P1, DOI 10.1016/j.worlddev.2005.06.008; Barrett CB, 2006, J DEV STUD, V42, P248, DOI 10.1080/00220380500405394; Chhagan V, 2008, HEALTH SOCIOL REV, V17, P95, DOI 10.5172/hesr.451.17.1.95; d'Adda G, 2009, AFR DEV REV, V21, P180, DOI 10.1111/j.1467-8268.2009.00207.x; Dixon S., 2001, Journal of International Development, V13, P411, DOI 10.1002/jid.795; Greener R, 2000, S AFRICAN J EC, V68, P393; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kipp WE, 2009, AIDS CARE, V21, P118, DOI 10.1080/09540120802068761; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krishna A, 2006, J DEV STUD, V42, P346, DOI 10.1080/00220380500405634; Kwaramba P, 1997, SOCIOECONOMIC IMPACT; Lam D, 2005, 118 CSSR U CAP TOWN; Larson BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-240; Maher D, 2011, INT J CLIN PRACT, V65, P824, DOI 10.1111/j.1742-1241.2011.02697.x; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Muirhead D, 2006, 16 INT AIDS C; Omar MT, 2010, P GERM DEV EC C HANN; Parker DC, 2009, INT J ENV RES PUB HE, V6, P2113, DOI 10.3390/ijerph6082113; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Rubaihayo J, 2010, INFECT DIS REPORTS, V2; The World Bank Group, 2009, POV EQ; Theodore K, 2001, HIV AIDS CARIBBEAN E; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2006, REP GLOB AIDS EP; United Nations Development Programme, 2007, ZAMB HUM DEV REP 200; United Nations Joint Program on HIV/AIDS (UNAIDS), 2010, IS THIS FUT TREATM, P46; Yamano T, 2002, 5 TEG	30	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65625	10.1371/journal.pone.0065625	http://dx.doi.org/10.1371/journal.pone.0065625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840347	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800014
J	Cao, YX; Zhang, X; Shang, W; Xu, JJ; Wang, XH; Hu, XQ; Ao, YF; Cheng, HP				Cao, Yongxing; Zhang, Xin; Shang, Wei; Xu, Jiejia; Wang, Xianhua; Hu, Xiaoqing; Ao, Yingfang; Cheng, Heping			Proinflammatory Cytokines Stimulate Mitochondrial Superoxide Flashes in Articular Chondrocytes In Vitro and In Situ	PLOS ONE			English	Article							OSTEOARTHRITIS; METABOLISM; CARTILAGE; SURFACE	Objective: Mitochondria play important roles in many types of cells. However, little is known about mitochondrial function in chondrocytes. This study was undertaken to explore possible role of mitochondrial oxidative stress in inflammatory response in articular chondrocytes. Methods: Chondrocytes and cartilage explants were isolated from wild type or transgenic mice expressing the mitochondrial superoxide biosensor - circularly permuted yellow fluorescent protein (cpYFP). Cultured chondrocytes or cartilage explants were incubated in media containing interleukin-1 beta (10 ng/ml) or tumor necrosis factor-alpha (10 ng/ml) to stimulate an inflammatory response. Mitochondrial imaging was carried out by confocal and two-photon microscopy. Mitochondrial oxidative status was evaluated by "superoxide flash'' activity recorded with time lapse scanning. Results: Cultured chondrocytes contain abundant mitochondria that show active motility and dynamic morphological changes. In intact cartilage, mitochondrial abundance as well as chondrocyte density declines with distance from the surface. Importantly, sudden, bursting superoxide-producing events or "superoxide flashes'' occur at single-mitochondrion level, accompanied by transient mitochondrial swelling and membrane depolarization. The superoxide flash incidence in quiescent chondrocytes was similar to 4.5 and similar to 0.5 events/1000 mu m(2)* 100 s in vitro and in situ, respectively. Interleukin-1 beta or tumor necrosis factor-alpha stimulated mitochondrial superoxide flash activity by 2-fold in vitro and 5-fold in situ, without altering individual flash properties except for reduction in spatial size due to mitochondrial fragmentation. Conclusions: The superoxide flash response to proinflammatory cytokine stimulation in vitro and in situ suggests that chondrocyte mitochondria are a significant source of cellular oxidants and are an important previously under-appreciated mediator in inflammatory cartilage diseases.	[Cao, Yongxing; Zhang, Xin; Hu, Xiaoqing; Ao, Yingfang] Peking Univ, Inst Sports Med, Hosp 3, Beijing 100871, Peoples R China; [Shang, Wei; Xu, Jiejia; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Beijing 100871, Peoples R China	Peking University; Peking University	Ao, YF (corresponding author), Peking Univ, Inst Sports Med, Hosp 3, Beijing 100871, Peoples R China.	yingfang.ao@vip.sina.com	Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011	Heping, Cheng/0000-0002-9604-6702; Xu, Jiejia/0000-0003-3885-3546	National Basic Research Program of China [2013CB531200, 2011CB809102]; National Natural Science Foundation of China [81071474, 81171726]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531200 and 2011CB809102, URL: http://www.most.gov.cn) and the National Natural Science Foundation of China (81071474 and 81171726, URL: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Brennan FM, 1998, SPRINGER SEMIN IMMUN, V20, P133, DOI 10.1007/BF00832003; Cadenas E, 1998, FREE RADICAL RES, V28, P601, DOI 10.3109/10715769809065816; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; FERRELL WR, 1992, J PHYSIOL-LONDON, V449, P607, DOI 10.1113/jphysiol.1992.sp019104; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Heywood HK, 2008, BIOCHEM BIOPH RES CO, V373, P224, DOI 10.1016/j.bbrc.2008.06.011; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095; Li KT, 2009, BIOPHYS J, V96, p531A, DOI 10.1016/j.bpj.2008.12.2743; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Martin JA, 2012, OSTEOARTHR CARTILAGE, V20, P323, DOI 10.1016/j.joca.2012.01.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; OTTE P, 1991, Z RHEUMATOL, V50, P304; Ovchinnikov D, 2009, COLD SPRING HARB PRO; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; STOCKWELL RA, 1991, J ANAT, V175, P251; Takahashi T, 1998, ORAL SURG ORAL MED O, V85, P135, DOI 10.1016/S1079-2104(98)90415-2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675	37	29	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66444	10.1371/journal.pone.0066444	http://dx.doi.org/10.1371/journal.pone.0066444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840469	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200079
J	Dorresteijn, I; Hartel, T; Hanspach, J; von Wehrden, H; Fischer, J				Dorresteijn, Ine; Hartel, Tibor; Hanspach, Jan; von Wehrden, Henrik; Fischer, Joern			The Conservation Value of Traditional Rural Landscapes: The Case of Woodpeckers in Transylvania, Romania	PLOS ONE			English	Article							MIDDLE SPOTTED WOODPECKER; HOME-RANGE SIZE; DENDROCOPOS-MINOR; SPECIES RICHNESS; SCATTERED TREES; HABITAT AREA; FOREST; WESTERN; BIRDS; FRAGMENTATION	Land use change is a major threat to global biodiversity. Forest species face the dual threats of deforestation and intensification of forest management. In regions where forests are under threat, rural landscapes that retain structural components of mature forests potentially provide valuable additional habitat for some forest species. Here, we illustrate the habitat value of traditional wood pastures for a woodpecker assemblage of six species in southern Transylvania, Romania. Wood pastures are created by long-term stable silvo-pastoral management practices, and are composed of open grassland with scattered large, old trees. Because of their demanding habitat requirements, woodpeckers share habitat with many other bird species, and have been considered as possible indicator species for bird species diversity. We first compared woodpecker assemblages between forests and wood pastures. Second, we grouped features of wood pastures into three spatial contexts and addressed how these features related to the occurrence of three woodpecker species that are formally protected. Woodpecker species composition, but not the number of species, differed between forests and wood pastures, with the green woodpecker occurring more commonly in wood pastures, and the lesser spotted woodpecker more commonly in forests. Within wood pastures, the intermediate context (especially surrounding forest cover) best explained the presence of the grey-headed and middle spotted woodpecker. By contrast, variables describing local vegetation structure and characteristics of the surrounding landscape did not affect woodpecker occurrence in wood pastures. In contrast to many other parts of Europe, in which several species of woodpeckers have declined, the traditional rural landscape of Transylvania continues to provide habitat for several woodpecker species, both in forests and wood pastures. Given the apparent habitat value of wood pastures for woodpeckers we recommend wood pastures be explicitly considered in relevant policies of the European Union, namely the Habitats Directive and the EU Common Agricultural Policy.	[Dorresteijn, Ine; Hartel, Tibor; Hanspach, Jan; von Wehrden, Henrik; Fischer, Joern] Univ Luneburg, Fac Sustainabil, D-21335 Luneburg, Germany; [von Wehrden, Henrik] Univ Luneburg, Ctr Methods, D-21335 Luneburg, Germany; [Hartel, Tibor] Sapientia Univ, Dept Environm Sci, Cluj Napoca, Romania	Leuphana University Luneburg; Leuphana University Luneburg; Sapientia Hungarian University of Transylvania	Dorresteijn, I (corresponding author), Univ Luneburg, Fac Sustainabil, D-21335 Luneburg, Germany.	ine.dorresteijn@gmail.com	Tibor, Hartel/B-3440-2012; Fischer, Joern/W-5380-2019; Fischer, Joern/C-6625-2012	Fischer, Joern/0000-0003-3187-8978; Hanspach, Jan/0000-0002-6638-8699; Dorresteijn, Ine/0000-0001-9785-4982	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The project was funded by the Alexander von Humboldt Foundation through a Sofja Kovalevskaja Award to JF. The research stay of TH in Germany is funded by the Alexander von Humboldt foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder D, 2010, BIRD STUDY, V57, P100, DOI 10.1080/00063650903437511; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; ANGELSTAM P, 1994, ANN ZOOL FENN, V31, P157; Barrientos R, 2010, FOREST ECOL MANAG, V260, P595, DOI 10.1016/j.foreco.2010.05.015; Bauhus J, 2009, FOREST ECOL MANAG, V258, P525, DOI 10.1016/j.foreco.2009.01.053; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Blom S, 2012, 20 JORDBR, P20; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CONNER RN, 1991, WILSON BULL, V103, P446; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Goldberg E, 2007, J NAT CONSERV, V15, P109, DOI 10.1016/j.jnc.2007.04.001; HARTEL T., 2010, GOOD PRACTICE MANAGE; Horak J, 2013, J INSECT CONSERV, V17, P307, DOI 10.1007/s10841-012-9511-2; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Knorn J, 2012, BIOL CONSERV, V146, P204, DOI 10.1016/j.biocon.2011.12.020; Knorn J, 2009, REMOTE SENS ENVIRON, V113, P957, DOI 10.1016/j.rse.2009.01.010; Kosinski Z, 2007, POL J ECOL, V55, P519; Kumar R, 2010, J FIELD ORNITHOL, V81, P215, DOI 10.1111/j.1557-9263.2009.00267.x; Lammertink M, 2009, BIOL CONSERV, V142, P166, DOI 10.1016/j.biocon.2008.10.010; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Manning AD, 2009, J APPL ECOL, V46, P915, DOI 10.1111/j.1365-2664.2009.01657.x; Mikusinski G, 1998, CONSERV BIOL, V12, P200, DOI 10.1046/j.1523-1739.1998.96310.x; Mountford EP, 2003, FORESTRY, V76, P19, DOI 10.1093/forestry/76.1.19; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; Pasinelli G, 2000, BIOL CONSERV, V93, P227, DOI 10.1016/S0006-3207(99)00137-8; PETTERSSON B, 1985, HOLARCTIC ECOL, V8, P53; R Development Core Team, 2011, R LANG ENV STAT COMP; Roberge JM, 2008, BIOL CONSERV, V141, P997, DOI 10.1016/j.biocon.2008.01.010; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Robles H, 2007, FOREST ECOL MANAG, V242, P343, DOI 10.1016/j.foreco.2007.01.052; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; ROLSTAD J, 1995, ORNIS FENNICA, V72, P1; Rolstad J, 2000, OECOLOGIA, V124, P116, DOI 10.1007/s004420050031; Shurulinkov P, 2012, ACTA ZOOL BULGAR, V64, P43; Taboada A, 2006, FOREST ECOL MANAG, V237, P436, DOI 10.1016/j.foreco.2006.09.077; TJERNBERG M, 1993, ORNIS FENNICA, V70, P155; Tryjanowski P, 2011, ACTA ORNITHOL, V46, P1, DOI 10.3161/000164511X589857; Wiktander U, 2001, BIOL CONSERV, V100, P387, DOI 10.1016/S0006-3207(01)00045-3; WIKTANDER U, 1992, ORNIS FENNICA, V69, P113	45	35	39	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65236	10.1371/journal.pone.0065236	http://dx.doi.org/10.1371/journal.pone.0065236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840322	Green Published, Green Submitted, gold			2022-12-25	WOS:000322361200012
J	Fagundo, AB; de la Torre, R; Jimenez-Murcia, S; Aguera, Z; Pastor, A; Casanueva, FF; Granero, R; Banos, R; Botella, C; del Pino-Gutierrez, A; Fernandez-Real, JM; Fernandez-Garcia, JC; Fruhbeck, G; Gomez-Ambrosi, J; Menchon, JM; Moragrega, I; Rodriguez, R; Tarrega, S; Tinahones, FJ; Fernandez-Aranda, F				Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Pastor, Antoni; Casanueva, Felipe F.; Granero, Roser; Banos, Rosa; Botella, Cristina; del Pino-Gutierrez, Amparo; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Menchon, Jose M.; Moragrega, Ines; Rodriguez, Roser; Tarrega, Salome; Tinahones, Francisco J.; Fernandez-Aranda, Fernando			Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans	PLOS ONE			English	Article							ABSTINENT MARIJUANA USERS; MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; CANNABINOID RECEPTOR; NUCLEUS-ACCUMBENS; ANOREXIA-NERVOSA; DECISION-MAKING; SPATIAL MEMORY; CB1 RECEPTORS; BRAIN	Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Delta 9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognitive flexibility) in healthy subjects. One hundred and fifty seven subjects were included and assessed with the Wisconsin Card Sorting Test; Stroop Color and Word Test; and Iowa Gambling Task. All participants were female, aged between 18 and 60 years and spoke Spanish as their first language. Results showed a negative correlation between 2-AG and cognitive flexibility performance (r = -.37; p<.05). A positive correlation was found between AEA concentrations and both cognitive flexibility (r = .59; p,. 05) and decision making performance (r = .23; P<.05). There was no significant correlation between either 2-AG (r = -.17) or AEA (r = -.08) concentrations and inhibition response. These results show, in humans, a relevant modulation of the endocannabinoid system on prefrontal-dependent cognitive functioning. The present study might have significant implications for the underlying executive alterations described in some psychiatric disorders currently associated with endocannabinoids deregulation (namely drug abuse/dependence, depression, obesity and eating disorders). Understanding the neurobiology of their dysexecutive profile might certainly contribute to the development of new treatments and pharmacological approaches.	[Fagundo, Ana B.; Jimenez-Murcia, Susana; del Pino-Gutierrez, Amparo; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Casanueva, Felipe F.; Granero, Roser; Banos, Rosa; Botella, Cristina; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Moragrega, Ines; Rodriguez, Roser; Tinahones, Francisco J.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain; [de la Torre, Rafael; Pastor, Antoni] Hosp del Mar, Human Pharmacol & Clin Neurosci Res Grp, Neurosci Res Program, IMIM,Med Res Inst, Barcelona, Spain; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Pastor, Antoni] Univ Autonoma Barcelona, Dept Pharmacol, Sch Med, E-08193 Barcelona, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Div Endocrine, Complejo Hosp U Santiago, Santiago De Compostela, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, E-08193 Barcelona, Spain; [Banos, Rosa] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Botella, Cristina; Moragrega, Ines] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [del Pino-Gutierrez, Amparo] Univ Barcelona, Nursing Dept Publ Hlth Maternal & Child Hlth, Sch Nursing, Barcelona, Spain; [Fernandez-Real, Jose M.; Rodriguez, Roser] Hosp Dr Josep Trueta, Inst Invest Biomed Girona IdlBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria, Dept Endocrinol & Nutr, Malaga, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Dept Endocrinol & Nutr, Univ Navarra Clin, E-31080 Pamplona, Spain; [Menchon, Jose M.] Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Autonomous University of Barcelona; Universidade de Santiago de Compostela; Autonomous University of Barcelona; University of Valencia; Universitat Jaume I; University of Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	Botella, Cristina/F-9230-2010; JIMENEZ-MURCIA, SUSANA/L-9786-2014; BAÑOS, ROSA MARIA/C-6077-2011; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Larrea, Salomé Tárrega/AAE-2684-2020; Pastor, Antoni/AAD-4638-2020; Fernandez-Aranda, Fernando/L-9762-2014; AGÜERA, ZAIDA/K-9771-2014; Tárrega, Salomé/D-8876-2011; Granero, Roser/F-9492-2016; Granero, Roser/S-3529-2019; Fernandez-Garcia, Jose Carlos/B-5312-2013; de la Torre, Rafael/D-3561-2018; Tinahones, Francisco José/AAB-2882-2020; del Pino-Gutiérrez, Amparo/L-5347-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; Gómez-Ambrosi, Javier/D-2984-2017; Moragrega, Inés/EWO-1656-2022; Menchon, Jose/A-5242-2009	Botella, Cristina/0000-0001-8783-6959; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; BAÑOS, ROSA MARIA/0000-0003-0626-7665; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Larrea, Salomé Tárrega/0000-0002-5820-6795; Pastor, Antoni/0000-0003-3692-0696; Fernandez-Aranda, Fernando/0000-0002-2968-9898; AGÜERA, ZAIDA/0000-0003-4453-4939; Tárrega, Salomé/0000-0002-5820-6795; Granero, Roser/0000-0001-6308-3198; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; de la Torre, Rafael/0000-0002-6765-1866; del Pino-Gutiérrez, Amparo/0000-0002-2854-9850; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Fagundo, Ana Beatriz/0000-0003-1703-9457; Tinahones, Francisco J/0000-0001-6871-4403; Ines, Moragrega/0000-0002-2012-9763; Menchon, Jose/0000-0002-6231-6524	Fondo de Investigacion Sanitaria - FIS [PI081714, PI11/210]; AGAUR [2009SGR1554, 2009SGR718]	Fondo de Investigacion Sanitaria - FIS; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	Financial support was received from Fondo de Investigacion Sanitaria - FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718). Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva (JCI-2011-09248). CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton CH, 2011, ACTA PSYCHIAT SCAND, V124, P250, DOI 10.1111/j.1600-0447.2011.01687.x; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Burston JJ, 2010, BRIT J PHARMACOL, V161, P103, DOI 10.1111/j.1476-5381.2010.00870.x; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; De Vries TJ, 2005, TRENDS PHARMACOL SCI, V26, P420, DOI 10.1016/j.tips.2005.06.002; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1999, LIPIDS, V34, pS319, DOI 10.1007/BF02562332; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2000, CURR PHARM DESIGN, V6, P1361; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P229, DOI 10.1016/j.tips.2008.03.001; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Diana M, 1998, EUR J NEUROSCI, V10, P2825, DOI 10.1111/j.1460-9568.1998.00292.x; Egerton A, 2005, NEUROPSYCHOPHARMACOL, V30, P1895, DOI 10.1038/sj.npp.1300715; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Eldreth DA, 2004, NEUROIMAGE, V23, P914, DOI 10.1016/j.neuroimage.2004.07.032; Fagundo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043382; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gligorovic M, 2013, J INTELLECT DEV DISA; Golden C.J., 1978, STROOP COLOR WORD TE; Gruber SA, 2005, COGNITIVE BRAIN RES, V23, P107, DOI 10.1016/j.cogbrainres.2005.02.016; Hajos N, 2002, CHEM PHYS LIPIDS, V121, P73, DOI 10.1016/S0009-3084(02)00149-4; Heaton, 1981, WISCONSIN CARD SORTI; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; Hill MN, 2006, PSYCHOPHARMACOLOGY, V187, P245, DOI 10.1007/s00213-006-0421-4; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Klugmann Matthias, 2011, Front Behav Neurosci, V5, P37, DOI 10.3389/fnbeh.2011.00037; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Lafenetre P, 2009, NEUROPHARMACOLOGY, V57, P715, DOI 10.1016/j.neuropharm.2009.07.014; Lane SD, 2005, NEUROPSYCHOPHARMACOL, V30, P800, DOI 10.1038/sj.npp.1300620; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mathew RJ, 1999, ACTA PSYCHIAT SCAND, V100, P67, DOI 10.1111/j.1600-0447.1999.tb10916.x; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; Mato S, 2004, NEUROPHARMACOLOGY, V46, P716, DOI 10.1016/j.neuropharm.2003.11.004; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monteleone P, 2009, GENES BRAIN BEHAV, V8, P728, DOI 10.1111/j.1601-183X.2009.00518.x; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Pazos MR, 2008, CURR PHARM DESIGN, V14, P2317, DOI 10.2174/138161208785740108; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Pistis M, 2002, EUR J NEUROSCI, V15, P1795, DOI 10.1046/j.1460-9568.2002.02019.x; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Rubino T, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00064; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Sokolic L, 2011, BEHAV PHARMACOL, V22, P191, DOI 10.1097/FBP.0b013e328345c82b; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stefani MR, 2003, ANN NY ACAD SCI, V1003, P464, DOI 10.1196/annals.1300.064; Stefani MR, 2003, BEHAV NEUROSCI, V117, P728, DOI 10.1037/0735-7044.117.4.728; Stoving RK, 2009, J PSYCHIATR RES, V43, P671, DOI 10.1016/j.jpsychires.2008.09.007; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Tchanturia K, 2012, EUR EAT DISORD REV, V20, P169, DOI 10.1002/erv.1154; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V179, P863, DOI 10.1007/s00213-004-2121-2; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Verrico CD, 2003, SYNAPSE, V49, P61, DOI 10.1002/syn.10215; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P29, DOI 10.1016/0925-4927(96)02817-X; Whitlow CT, 2004, DRUG ALCOHOL DEPEN, V76, P107, DOI 10.1016/j.drugalcdep.2004.04.009; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	81	20	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66387	10.1371/journal.pone.0066387	http://dx.doi.org/10.1371/journal.pone.0066387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840456	gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200070
J	Pieper, R; Zhang, QS; Clark, DJ; Parmar, PP; Alami, H; Suh, MJ; Kuntumalla, S; Braisted, JC; Huang, ST; Tzipori, S				Pieper, Rembert; Zhang, Quanshun; Clark, David J.; Parmar, Prashanth P.; Alami, Hamid; Suh, Moo-Jin; Kuntumalla, Srilatha; Braisted, John C.; Huang, Shih-Ting; Tzipori, Saul			Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets	PLOS ONE			English	Article							ANAEROBIC SN-GLYCEROL-3-PHOSPHATE DEHYDROGENASE; RAW 264.7 MACROPHAGES; IN-VITRO; EXTRACELLULAR PROTEINS; SEROVAR TYPHIMURIUM; STATISTICAL-MODEL; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; YERSINIA-PESTIS; EXPRESSION	Background: Shiga toxin (Stx)-producing Escherichia coli cause severe intestinal infections involving colonization of epithelial Peyer's patches and formation of attachment/effacement (A/E) lesions. These lesions trigger leukocyte infiltration followed by inflammation and intestinal hemorrhage. Systems biology, which explores the crosstalk of Stx-producing Escherichia coli with the in vivo host environment, may elucidate novel molecular pathogenesis aspects. Methodology/Principal Findings: Enterohemorrhagic E. coli strain 86-24 produces Shiga toxin-2 and belongs to the serotype O157:H7. Bacterial cells were scrapped from stationary phase cultures (the in vitro condition) and used to infect gnotobiotic piglets via intestinal lavage. Bacterial cells isolated from the piglets' guts constituted the in vivo condition. Cell lysates were subjected to quantitative 2D gel and shotgun proteomic analyses, revealing metabolic shifts towards anaerobic energy generation, changes in carbon utilization, phosphate and ammonia starvation, and high activity of a glutamate decarboxylase acid resistance system in vivo. Increased abundance of pyridine nucleotide transhydrogenase (PntA and PntB) suggested in vivo shortage of intracellular NADPH. Abundance changes of proteins implicated in lipopolysaccharide biosynthesis (LpxC, ArnA, the predicted acyltransferase L7029) and outer membrane (OM) assembly (LptD, MlaA, MlaC) suggested bacterial cell surface modulation in response to activated host defenses. Indeed, there was evidence for interactions of innate immunity-associated proteins secreted into the intestines (GP340, REG3-gamma, resistin, lithostathine, and trefoil factor 3) with the bacterial cell envelope. Significance: Proteomic analysis afforded insights into system-wide adaptations of strain 86-24 to a hostile intestinal milieu, including responses to limited nutrients and cofactor supplies, intracellular acidification, and reactive nitrogen and oxygen species-mediated stress. Protein and lipopolysaccharide compositions of the OM were altered. Enhanced expression of type III secretion system effectors correlated with a metabolic shift back to a more aerobic milieu in vivo. Apparent pathogen pattern recognition molecules from piglet intestinal secretions adhered strongly to the bacterial cell surface.	[Pieper, Rembert; Clark, David J.; Parmar, Prashanth P.; Alami, Hamid; Suh, Moo-Jin; Kuntumalla, Srilatha; Braisted, John C.; Huang, Shih-Ting] J Craig Venter Inst, Rockville, MD USA; [Zhang, Quanshun; Tzipori, Saul] Tufts Univ, Div Infect Dis, Cummings Sch Vet Med, North Grafton, MA USA	J. Craig Venter Institute; Tufts University	Pieper, R (corresponding author), J Craig Venter Inst, Rockville, MD USA.	rpieper@jcvi.org	Suh, Moo-Jin/A-5436-2010	Suh, Moo-Jin/0000-0003-0003-393X; Clark, David/0000-0003-0527-8469	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [N01-AI-30050]; NIAID, NIH [N01-AI15447]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	At Tufts University, the work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) under contract number N01-AI-30050. At JCVI, the work was supported by the NIAID, NIH, under contract number N01-AI15447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; BUSCHMEIER B, 1985, FEMS MICROBIOL LETT, V29, P231, DOI 10.1111/j.1574-6968.1985.tb00868.x; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; FRANZON VL, 1990, INFECT IMMUN, V58, P529, DOI 10.1128/IAI.58.2.529-535.1990; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Golby P, 1998, J BACTERIOL, V180, P6586, DOI 10.1128/JB.180.24.6586-6596.1998; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; IOVANNA J, 1993, PANCREAS, V8, P597, DOI 10.1097/00006676-199309000-00011; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLEY JJ, 1984, J BIOL CHEM, V259, P2124; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; KURITZKES DR, 1984, J BACTERIOL, V157, P591, DOI 10.1128/JB.157.2.591-598.1984; Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; [Neidhardt FCU Neidhardt FCea], 1996, ESCHERICHIA COLI SAL, P13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; PAHEL G, 1979, P NATL ACAD SCI USA, V76, P4544, DOI 10.1073/pnas.76.9.4544; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Pieper R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026554; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Pieper R, 2009, PROTEOMICS, V9, P5029, DOI 10.1002/pmic.200900196; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; PODOLSKY DK, 1993, J BIOL CHEM, V268, P12230; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; REANEY SK, 1993, J GEN MICROBIOL, V139, P1523, DOI 10.1099/00221287-139-7-1523; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; SCHRYVERS A, 1981, J BIOL CHEM, V256, P9959; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Shi Liang, 2009, J Proteomics Bioinform, V2, P388; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; SIX S, 1994, J BACTERIOL, V176, P6470, DOI 10.1128/JB.176.21.6470-6478.1994; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; TZIPORI S, 1987, INFECT IMMUN, V55, P3117, DOI 10.1128/IAI.55.12.3117-3125.1987; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Wang HN, 2000, J BACTERIOL, V182, P5813, DOI 10.1128/JB.182.20.5813-5822.2000; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002; Yin XH, 2011, CAN J VET RES, V75, P81; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	104	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66462	10.1371/journal.pone.0066462	http://dx.doi.org/10.1371/journal.pone.0066462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840478	Green Submitted, gold, Green Published			2022-12-25	WOS:000322361200083
J	Ray, DK; Mueller, ND; West, PC; Foley, JA				Ray, Deepak K.; Mueller, Nathaniel D.; West, Paul C.; Foley, Jonathan A.			Yield Trends Are Insufficient to Double Global Crop Production by 2050	PLOS ONE			English	Article							FEEDING 9 BILLION; AGRICULTURAL INTENSIFICATION; SUSTAINABLE INTENSIFICATION; FOOD-PRODUCTION; WHEAT YIELDS; LAND; RICE; BIODIVERSITY; CHALLENGE; DECLINES	Several studies have shown that global crop production needs to double by 2050 to meet the projected demands from rising population, diet shifts, and increasing biofuels consumption. Boosting crop yields to meet these rising demands, rather than clearing more land for agriculture has been highlighted as a preferred solution to meet this goal. However, we first need to understand how crop yields are changing globally, and whether we are on track to double production by 2050. Using similar to 2.5 million agricultural statistics, collected for similar to 13,500 political units across the world, we track four key global crops-maize, rice, wheat, and soybean-that currently produce nearly two-thirds of global agricultural calories. We find that yields in these top four crops are increasing at 1.6%, 1.0%, 0.9%, and 1.3% per year, non-compounding rates, respectively, which is less than the 2.4% per year rate required to double global production by 2050. At these rates global production in these crops would increase by similar to 67%, similar to 42%, similar to 38%, and similar to 55%, respectively, which is far below what is needed to meet projected demands in 2050. We present detailed maps to identify where rates must be increased to boost crop production and meet rising demands.	[Ray, Deepak K.; Mueller, Nathaniel D.; West, Paul C.; Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ray, DK (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	dray@umn.edu	Mueller, Nathan D/E-5864-2010; Ray, Deepak K/F-7720-2012; Foley, Jonathan A/GRS-5522-2022; West, Paul C./J-1665-2015	Mueller, Nathan D/0000-0003-1857-5104; West, Paul C./0000-0001-9024-1657; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Institute on the Environment; National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program; NSF graduate fellowship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on the Environment; National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program; NSF graduate fellowship(National Science Foundation (NSF))	Research support was provided by a grant from the Gordon and Betty Moore Foundation, and by the Institute on the Environment, along with previous funding from National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program. This work also benefitted from contributions by General Mills, Mosaic, Cargill, Google, PepsiCo, and Kellogg to support stakeholder outreach and public engagement. N.D.M. was supported by a NSF graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2011, INT J AGR SUSTAIN, V9, P232; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; Eickhout B, 2006, AGR ECOSYST ENVIRON, V116, P4, DOI 10.1016/j.agee.2006.03.009; Fan S, 2007, DRAGON ELEPHANT AGR, P465; FAO, 2013, FOOD BAL SHEETS PART; Fao WFP. IFAD, 2014, STAT FOOD INS WORLD; Finger R, 2010, FOOD POLICY, V35, P175, DOI 10.1016/j.foodpol.2009.11.004; Fischer RAT, 2010, CROP SCI, V50, pS85, DOI 10.2135/cropsci2009.10.0564; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization [FAO], 2009, GLOBAL AGR 2050; Gibbs H, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/011007; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Gregory PJ, 2011, J EXP BOT, V62, P5233, DOI 10.1093/jxb/err232; Gustavsson J, 2011, INT C SAV FOOD INT D; Hafner S, 2003, AGR ECOSYST ENVIRON, V97, P275, DOI 10.1016/S0167-8809(03)00019-7; Heathcote AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053554; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Institution of Mechanical Engineers, 2013, GLOB FOOD WAST NOT W; Jaggard KW, 2010, PHILOS T R SOC B, V365, P2835, DOI 10.1098/rstb.2010.0153; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Lin M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024016; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Organisation for Economic Cooperation and Development (OECD), 2017, OECD EC SURV UK; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Supit I, 1997, AGR FOREST METEOROL, V88, P199, DOI 10.1016/S0168-1923(97)00037-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107	47	1619	1672	51	731	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66428	10.1371/journal.pone.0066428	http://dx.doi.org/10.1371/journal.pone.0066428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840465	Green Published, gold			2022-12-25	WOS:000322361200075
J	Mager, T; Braner, M; Kubsch, B; Hatahet, L; Alkoby, D; Rimon, A; Padan, E; Fendler, K				Mager, Thomas; Braner, Markus; Kubsch, Bastian; Hatahet, Lina; Alkoby, Dudu; Rimon, Abraham; Padan, Etana; Fendler, Klaus			Differential Effects of Mutations on the Transport Properties of the Na+/H+ Antiporter NhaA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-VIII-IX; DEPENDENT DIMERIZATION; CONFORMATIONAL-CHANGES; PH REGULATION; MEMBRANE; OLIGOMERIZATION; MECHANISM; SITE	Na+/H+ antiporters show a marked pH dependence, which is important for their physiological function in eukaryotic and prokaryotic cells. In NhaA, the Escherichia coli Na+/H+ antiporter, specific single site mutations modulating the pH profile of the transporter have been described in the past. To clarify the mechanism by which these mutations influence the pH dependence of NhaA, the substrate dependence of the kinetics of selected NhaA variants was electrophysiologically investigated and analyzed with a kinetic model. It is shown that the mutations affect NhaA activity in quite different ways by changing the properties of the binding site or the dynamics of the transporter. In the first case, pK and/or K-D(Na) are altered, and in the second case, the rate constants of the conformational transition between the inside and the outside open conformation are modified. It is shown that residues as far apart as 15-20 angstrom from the binding site can have a significant impact on the dynamics of the conformational transitions or on the binding properties of NhaA. The implications of these results for the pH regulation mechanism of NhaA are discussed.	[Mager, Thomas; Braner, Markus; Kubsch, Bastian; Hatahet, Lina; Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Alkoby, Dudu; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de		Mager, Thomas/0000-0002-9571-7033; Fendler, Klaus/0000-0002-5699-7060	Deutsche Forschungsgemeinschaft [SFB 807]; Israel Science Foundation [284/12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 807 (to K. F.) and Israel Science Foundation Grant 284/12 (to E. P.).	ADLER LW, 1977, J SUPRAMOL STR CELL, V7, P15, DOI 10.1002/jss.400070103; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Diab M, 2011, J MOL BIOL, V413, P604, DOI 10.1016/j.jmb.2011.08.046; Everberg H, 2006, J CHROMATOGR A, V1118, P244, DOI 10.1016/j.chroma.2006.03.123; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KLINGENBERG M, 1992, STUDY ENZYMES, P367; Kozachkov L, 2013, MOL MEMBR BIOL, V30, P90, DOI 10.3109/09687688.2012.693209; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M., 2002, PRACTICAL GUIDE MEMB, P179; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	32	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24666	24675		10.1074/jbc.M113.484071	http://dx.doi.org/10.1074/jbc.M113.484071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836890	Green Published, hybrid			2022-12-25	WOS:000330612300034
J	Ali, F; Khan, I; Samiulhaq; Shafie, S				Ali, Farhad; Khan, Ilyas; Samiulhaq; Shafie, Sharidan			Conjugate Effects of Heat and Mass Transfer on MHD Free Convection Flow over an Inclined Plate Embedded in a Porous Medium	PLOS ONE			English	Article							INFINITE VERTICAL PLATE; SLIP-FLOW; THERMAL-RADIATION; WALL TEMPERATURE; FLUID; SURFACE; SORET	The aim of this study is to present an exact analysis of combined effects of radiation and chemical reaction on the magnetohydrodynamic (MHD) free convection flow of an electrically conducting incompressible viscous fluid over an inclined plate embedded in a porous medium. The impulsively started plate with variable temperature and mass diffusion is considered. The dimensionless momentum equation coupled with the energy and mass diffusion equations are analytically solved using the Laplace transform method. Expressions for velocity, temperature and concentration fields are obtained. They satisfy all imposed initial and boundary conditions and can be reduced, as special cases, to some known solutions from the literature. Expressions for skin friction, Nusselt number and Sherwood number are also obtained. Finally, the effects of pertinent parameters on velocity, temperature and concentration profiles are graphically displayed whereas the variations in skin friction, Nusselt number and Sherwood number are shown through tables.	[Ali, Farhad; Khan, Ilyas; Samiulhaq; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia	Universiti Teknologi Malaysia	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia.	ridafie@yahoo.com	Ali, Farhad/Y-5301-2018; Khan, Ilyas/C-8770-2019; SHAFIE, SHARIDAN/A-2210-2013	Khan, Ilyas/0000-0002-2056-9371; SHAFIE, SHARIDAN/0000-0001-7795-2278				Ahmad N, 2012, J HEAT TRANSF, V134; Ahmed N., 2009, INT J APPL MATH MECH, V5, P87; Ali F, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.064402; [Anonymous], 2010, WORLD APPL SCI J; [Anonymous], 2011, INDIAN J SCI TECHNOL; Chandrakala P., 2010, INT J DYNAMICS FLUID, V6, P209; Cheng CY, 2008, INT COMMUN HEAT MASS, V35, P750, DOI 10.1016/j.icheatmasstransfer.2008.02.004; Cramer K.R., 1973, MAGNETO FLUID DYNAMI, P204; Guo ZX, 1999, INT J HEAT MASS TRAN, V42, P379, DOI 10.1016/S0017-9310(98)00145-8; Jingchun M, 2010, J MEMBRANE SCI, V430, P150; Kandasamy R, 2010, COMMUN NONLINEAR SCI, V15, P2109, DOI 10.1016/j.cnsns.2009.09.016; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; Makinde OD, 2011, CHEM ENG COMMUN, V198, P920, DOI 10.1080/00986445.2011.545296; Makinde OD, 2010, CAN J CHEM ENG, V88, P983, DOI 10.1002/cjce.20369; Makinde OD, 2012, Z NATURFORSCH A, V67, P239, DOI 10.5560/ZNA.2012-0014; Manivannan, 2011, INT J PURE APPL SCI, V3, P19; Mishra SR, 2013, INT J HEAT MASS TRAN, V57, P433, DOI 10.1016/j.ijheatmasstransfer.2012.10.053; Muthucumaraswamy R, 2006, THEOR APPL MECH, V33, P17, DOI 10.2298/TAM0601017M; Narahari Marneni, 2011, Turkish Journal of Engineering and Environmental Sciences, V35, P187, DOI 10.3906/muh-1101-15; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Narahari M., 2011, WORLD J MECH, V1, P176; Noor NFM, 2012, INT J HEAT MASS TRAN, V55, P2122, DOI 10.1016/j.ijheatmasstransfer.2011.12.015; Osman ANA, 2011, MATH PROBL ENGG, P1; Pal D, 2011, INT COMMUN HEAT MASS, V38, P463, DOI 10.1016/j.icheatmasstransfer.2010.12.039; Prasad VR, 2012, COMMUN NONLINEAR SCI, V17, P654, DOI 10.1016/j.cnsns.2011.04.033; Rajesh V, 2011, CHEM IND CHEM ENG Q, V17, P189, DOI 10.2298/CICEQ100829003R; Rajput U.S., 2011, APPL MATH SCI, V5, P149; Rajput U. S., 2012, INT J APPL MATH MECH, V8, P66; Samiulhaq, 2012, Z NATURFORSCH A, V67, P572, DOI 10.5560/ZNA.2012-0070; Samiulhaq, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.044401; Seth GS, 2011, HEAT MASS TRANSFER, V47, P551, DOI 10.1007/s00231-010-0740-1; Singh K.D., 2011, INT J APPL MECH ENG, V16, P277; Turkyilmazoglu M, 2013, COMPUT FLUIDS, V71, P426, DOI 10.1016/j.compfluid.2012.11.011; Turkyilmazoglu M, 2012, COMPUT FLUIDS, V70, P53, DOI 10.1016/j.compfluid.2012.01.009; Turkyilmazoglu M, 2012, INT J HEAT MASS TRAN, V55, P7635, DOI 10.1016/j.ijheatmasstransfer.2012.07.079; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2011, INT J MECH SCI, V53, P886, DOI 10.1016/j.ijmecsci.2011.07.012; Ziyauddin, 2010, INT J MATH MODELL SI, V3, P155	39	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65223	10.1371/journal.pone.0065223	http://dx.doi.org/10.1371/journal.pone.0065223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840321	Green Published, gold			2022-12-25	WOS:000321148400004
J	Benz, J; Reinstein, J; Meinhart, A				Benz, Juliane; Reinstein, Jochen; Meinhart, Anton			Structural Insights into the Effector - Immunity System Tae4/Tai4 from Salmonella typhimurium	PLOS ONE			English	Article							VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; SEQUENCE ALIGNMENTS; CYSTEINE PEPTIDASES; PROTEIN; MECHANISM; TSE1; CONSERVATION; SUPERFAMILY; REFINEMENT	Type-6-secretion systems of Gram-negative bacteria are widely distributed needle-like multi-protein complexes that are involved in microbial defense mechanisms. During bacterial competition these injection needles dispense effector proteins into the periplasm of competing bacteria where they induce degradation of the peptidoglycan scaffold and lead to cell lysis. Donor cells co-produce immunity proteins and shuttle them into their own periplasm to prevent accidental toxication by siblings. Recently, a plethora of previously unidentified hydrolases have been suggested to be peptidoglycan degrading amidases. These hydrolases are part of effector/immunity pairs that have been associated with bacterial warfare by type-6-secretion systems. The Tae4 and Tai4 operon encoded by Salmonella typhimurium is one of these newly discovered effector/immunity pairs. The Tae4 effector proteins induce cell lysis by cleaving the gamma-D-glutamyl-L-meso-diaminopimelic acid amide bond of acceptor stem muropeptides of the Gram-negative peptidoglycan. Although homologues of the Tae4/Tai4 system have been identified in various different pathogens, little is known about the functional mechanism of effector protein activity and their inhibition by the cognate immunity proteins. Here, we present the high-resolution crystal structure of the effector Tae4 of S. typhimurium in complex with its immunity protein Tai4. We show that Tae4 contains a classical NlpC/P60-peptidase core which is common to other effector proteins of the type-6-secretion system. However, Tae4 has unique structural features that are exclusively conserved within the family of Tae4 effectors and which are important for the substrate specificity. Most importantly, we show that although the overall structure of Tai4 is different to previously described immunity proteins, the essential mode of enzyme inhibition is conserved. Additionally, we provide evidence that inhibition in the Tae4/Tai4 heterotetramer relies on a central Tai4 dimer in order to acquire functionality.	[Benz, Juliane; Reinstein, Jochen; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg 1, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014		Chica and Heinz Schaller Foundation	Chica and Heinz Schaller Foundation	This work has been supported by the Chica and Heinz Schaller Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English G, 2012, MOL MICROBIOL; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALZKILL T, 1994, J BACTERIOL, V176, P563, DOI 10.1128/jb.176.3.563-568.1994; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Shang GJ, 2012, BIOCHEM J, V448, P201, DOI 10.1042/BJ20120668; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STORER AC, 1994, METHOD ENZYMOL, V244, P486; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036	40	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67362	10.1371/journal.pone.0067362	http://dx.doi.org/10.1371/journal.pone.0067362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826277	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000067
J	Gutierrez, T; Berry, D; Yang, TT; Mishamandani, S; McKay, L; Teske, A; Aitken, MD				Gutierrez, Tony; Berry, David; Yang, Tingting; Mishamandani, Sara; McKay, Luke; Teske, Andreas; Aitken, Michael D.			Role of Bacterial Exopolysaccharides (EPS) in the Fate of the Oil Released during the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							SEA HYDROTHERMAL-VENT; HYDROCARBON-DEGRADING BACTERIUM; SP-NOV.; HALOPHILIC BACTERIA; HALOMONAS-EURIHALINA; CRUDE-OIL; HYPERSALINE CONDITIONS; AROMATIC-HYDROCARBONS; FUNCTIONAL-PROPERTIES; EMULSIFYING ACTIVITY	Halomonas species are recognized for producing exopolysaccharides (EPS) exhibiting amphiphilic properties that allow these macromolecules to interface with hydrophobic substrates, such as hydrocarbons. There remains a paucity of knowledge, however, on the potential of Halomonas EPS to influence the biodegradation of hydrocarbons. In this study, the well-characterized amphiphilic EPS produced by Halomonas species strain TG39 was shown to effectively increase the solubilization of aromatic hydrocarbons and enhance their biodegradation by an indigenous microbial community from oil-contaminated surface waters collected during the active phase of the Deepwater Horizon oil spill. Three Halomonas strains were isolated from the Deepwater Horizon site, all of which produced EPS with excellent emulsifying qualities and shared high (97-100%) 16S rRNA sequence identity with strain TG39 and other EPS-producing Halomonas strains. Analysis of pyrosequence data from surface water samples collected during the spill revealed several distinct Halomonas phylotypes, of which some shared a high sequence identity (>= 97%) to strain TG39 and the Gulf spill isolates. Other bacterial groups comprising members with well-characterized EPS-producing qualities, such as Alteromonas, Colwellia and Pseudoalteromonas, were also found enriched in surface waters, suggesting that the total pool of EPS in the Gulf during the spill may have been supplemented by these organisms. Roller bottle incubations with one of the Halomonas isolates from the Deepwater Horizon spill site demonstrated its ability to effectively produce oil aggregates and emulsify the oil. The enrichment of EPS-producing bacteria during the spill coupled with their capacity to produce amphiphilic EPS is likely to have contributed to the ultimate removal of the oil and to the formation of oil aggregates, which were a dominant feature observed in contaminated surface waters.	[Gutierrez, Tony; Mishamandani, Sara; Aitken, Michael D.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Gutierrez, Tony] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Berry, David] Univ Vienna, Fac Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria; [Yang, Tingting; McKay, Luke; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Heriot Watt University; University of Vienna; University of North Carolina; University of North Carolina Chapel Hill	Gutierrez, T (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	Tony.Gutierrez@hw.ac.uk	Teske, Andreas/AAQ-9577-2021; Gutierrez, Tony/AAN-2479-2020; Gutierrez, Tony/D-6303-2013; Berry, David/C-8455-2011	Gutierrez, Tony/0000-0002-6127-8511; Gutierrez, Tony/0000-0002-6127-8511; Berry, David/0000-0002-8997-608X	European Community [PIOF-GA-2008-220129]; U.S. National Institute of Environmental Health Sciences [5 P42ES005948]; BP/Gulf of Mexico Research Initiative; NSF [NSF-OCE 1045115]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948] Funding Source: NIH RePORTER	European Community(European Commission); U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BP/Gulf of Mexico Research Initiative; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Marie Curie International Outgoing Fellowship (PIOF-GA-2008-220129) within the 7th European Community Framework Programme. Partial support was also provided through the U.S. National Institute of Environmental Health Sciences grant 5 P42ES005948, and through the BP/Gulf of Mexico Research Initiative to support consortium research entitled "Ecosystem Impacts of Oil and Gas Inputs to the Gulf (ECOGIG)" administered by the University of Mississippi. Andreas Teske, Tony Gutierrez and Luke McKay were also supported by NSF (RAPID Response: The microbial response to the Deepwater Horizon Oil Spill; NSF-OCE 1045115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi S, 2006, FEMS MICROBIOL LETT, V255, P108, DOI 10.1111/j.1574-6968.2005.00061.x; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Mata JA, 2006, RES MICROBIOL, V157, P827, DOI 10.1016/j.resmic.2006.06.004; Arahal DR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P811, DOI 10.1007/0-387-30746-x_28; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Barkay T, 1999, APPL ENVIRON MICROB, V65, P2697; BERTRAND JC, 1983, BIOTECHNOL LETT, V5, P567, DOI 10.1007/BF01184950; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; BLACKBURN SI, 1989, J PHYCOL, V25, P577, DOI 10.1111/j.1529-8817.1989.tb00264.x; Bouchotroch S, 2000, J IND MICROBIOL BIOT, V24, P374, DOI 10.1038/sj.jim.7000002; Bozzi L, 1996, INT J BIOL MACROMOL, V18, P9, DOI 10.1016/0141-8130(95)01038-6; Calvo C, 2002, APPL MICROBIOL BIOT, V60, P347, DOI 10.1007/s00253-002-1115-4; Calvo C, 1998, J IND MICROBIOL BIOT, V20, P205, DOI 10.1038/sj.jim.2900513; Cambon-Bonavita MA, 2002, J APPL MICROBIOL, V93, P310, DOI 10.1046/j.1365-2672.2002.01689.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dea ICM, 1986, FOOD HYDROCOLLOID, V1, P71, DOI 10.1016/S0268-005X(86)80009-1; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fingas M, 2003, MAR POLLUT BULL, V47, P369, DOI 10.1016/S0025-326X(03)00212-1; FORD T, 1991, APPL ENVIRON MICROB, V57, P1595, DOI 10.1128/AEM.57.6.1595-1601.1991; FRANCISCO DE, 1973, T AM MICROSC SOC, V92, P416, DOI 10.2307/3225245; Garcia MT, 2005, FEMS MICROBIOL ECOL, V54, P97, DOI 10.1016/j.femsec.2005.03.009; Garcia MT, 2004, INT J SYST EVOL MICR, V54, P1723, DOI 10.1099/ijs.0.63114-0; GRABER M, 1988, ENZYME MICROB TECH, V10, P198, DOI 10.1016/0141-0229(88)90067-1; Gutierrez T, 2007, J APPL MICROBIOL, V103, P1716, DOI 10.1111/j.1365-2672.2007.03407.x; Gutierrez T., 2013, ISME J IN PRESS; Gutierrez T, 2008, APPL ENVIRON MICROB, V74, P4867, DOI 10.1128/AEM.00316-08; Gutierrez T, 2007, APPL MICROBIOL BIOT, V76, P1017, DOI 10.1007/s00253-007-1091-9; Gutierrez T, 2009, BIOTECHNOL BIOENG, V103, P207, DOI 10.1002/bit.22218; Gyurcsik B, 2000, COORDIN CHEM REV, V203, P81, DOI 10.1016/S0010-8545(99)00183-6; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansell D.A., 2001, OCEANOGRAPHY, V14, P41, DOI DOI 10.5670/OCEANOG.2001.05; Hassler CS, 2011, MAR CHEM, V123, P88, DOI 10.1016/j.marchem.2010.10.003; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hinteregger C, 1997, BIOTECHNOL LETT, V19, P1099, DOI 10.1023/A:1018488410102; JACKSON GA, 1994, DEEP-SEA RES PT I, V41, P429, DOI 10.1016/0967-0637(94)90089-2; Janecka J, 2002, APPL ENVIRON MICROB, V68, P423, DOI 10.1128/AEM.68.1.423-426.2002; Jouault SC, 2001, BBA-GEN SUBJECTS, V1528, P141, DOI 10.1016/S0304-4165(01)00185-4; KAPLAN N, 1987, APPL ENVIRON MICROB, V53, P440, DOI 10.1128/AEM.53.2.440-446.1987; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kasai Y, 2002, ENVIRON MICROBIOL, V4, P141, DOI 10.1046/j.1462-2920.2002.00275.x; Katsivela E., 2003, WATER AIR SOIL POLL, V3, P103; Kaye JZ, 2004, INT J SYST EVOL MICR, V54, P499, DOI 10.1099/ijs.0.02799-0; KENNEDY AFD, 1987, BIOTECHNOL APPL BIOC, V9, P12; KIYOHARA H, 1982, APPL ENVIRON MICROB, V43, P454, DOI 10.1128/AEM.43.2.454-457.1982; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LANG S, 1993, BIOSURFACTANTS PRODU, P391; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Martinez-Checa F, 2002, APPL MICROBIOL BIOT, V58, P358, DOI 10.1007/s00253-001-0903-6; Marx JG, 2009, CAN J MICROBIOL, V55, P63, DOI 10.1139/W08-130; Melcher RJ, 2002, APPL ENVIRON MICROB, V68, P2858, DOI 10.1128/AEM.68.6.2858-2868.2002; Mihelcic James R., 1993, Biodegradation, V4, P141, DOI 10.1007/BF00695116; Mnif S, 2009, J APPL MICROBIOL, V107, P785, DOI 10.1111/j.1365-2672.2009.04251.x; Munoz JA, 2001, FOLIA MICROBIOL, V46, P297, DOI 10.1007/BF02815617; Nichols CAM, 2004, J APPL MICROBIOL, V96, P1057, DOI 10.1111/j.1365-2672.2004.02216.x; Niu HB, 2011, ENVIRON MODEL ASSESS, V16, P61, DOI 10.1007/s10666-010-9228-0; Paje MLF, 1997, MICROBIOL-UK, V143, P2975, DOI 10.1099/00221287-143-9-2975; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; PEARLMAN RS, 1984, J PHYS CHEM REF DATA, V13, P555, DOI 10.1063/1.555712; Pepi M, 2005, FEMS MICROBIOL ECOL, V53, P157, DOI 10.1016/j.femsec.2004.09.013; Poli A, 2007, SYST APPL MICROBIOL, V30, P31, DOI 10.1016/j.syapm.2006.03.003; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; QUESADA E, 1993, EXPERIENTIA, V49, P1037, DOI 10.1007/BF01929910; Quillaguaman J, 2004, INT J SYST EVOL MICR, V54, P721, DOI 10.1099/ijs.0.02800-0; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Roling WFM, 2004, APPL ENVIRON MICROB, V70, P2603, DOI 10.1128/AEM.70.5.2603-2613.2004; RONTANI JF, 1986, MAR CHEM, V20, P197, DOI 10.1016/0304-4203(86)90039-3; ROSENBERG E, 1979, APPL ENVIRON MICROB, V37, P409, DOI 10.1128/AEM.37.3.409-413.1979; Sanchez-Porro C, 2010, INT J SYST EVOL MICR, V60, P2768, DOI 10.1099/ijs.0.020628-0; Santschi P.H., 1998, BIOGEOCHEMISTRY GULF, P347; SCHULZ D, 1991, Z NATURFORSCH C, V46, P197; STUCKI G, 1987, APPL ENVIRON MICROB, V53, P292, DOI 10.1128/AEM.53.2.292-297.1987; Syutsubo K, 2001, ENVIRON MICROBIOL, V3, P371, DOI 10.1046/j.1462-2920.2001.00204.x; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; THOMAS JM, 1986, APPL ENVIRON MICROB, V52, P290, DOI 10.1128/AEM.52.2.290-296.1986; Thomas O, 2007, TECH INSTRUMENT, V27, P1; Tolstoguzov VB, 1991, FOOD HYDROCOLLOID, V4, P429; Tomlinson E, 1986, PARTITION COEFFICIEN, P101; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; VERDUGO P, 1993, ADV POLYM SCI, V110, P145; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; WHITEHOUSE BG, 1984, MAR CHEM, V14, P319, DOI 10.1016/0304-4203(84)90028-8; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; WODZINSKI RS, 1974, APPL MICROBIOL, V27, P1081, DOI 10.1128/AEM.27.6.1081-1084.1974; WODZINSKI RS, 1977, APPL ENVIRON MICROB, V33, P660, DOI 10.1128/AEM.33.3.660-665.1977; Wolfaardt G.M., 1999, MICROBIAL EXTRACELLU; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P6778, DOI 10.1016/j.biortech.2010.03.108; Zhao BS, 2009, CURR MICROBIOL, V58, P205, DOI 10.1007/s00284-008-9309-3; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	99	110	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67717	10.1371/journal.pone.0067717	http://dx.doi.org/10.1371/journal.pone.0067717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826336	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000096
J	Oenema, TA; Maarsingh, H; Smit, M; Groothuis, GMM; Meurs, H; Gosens, R				Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Groothuis, Geny M. M.; Meurs, Herman; Gosens, Reinoud			Bronchoconstriction Induces TGF-beta Release and Airway Remodelling in Guinea Pig Lung Slices	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MUSCARINIC RECEPTOR STIMULATION; OBSTRUCTIVE PULMONARY-DISEASE; TIOTROPIUM BROMIDE; MECHANICAL-STRESS; EPITHELIAL-CELLS; ASTHMA; EXPRESSION; MODEL	Airway remodelling, including smooth muscle remodelling, is a primary cause of airflow limitation in asthma. Recent evidence links bronchoconstriction to airway remodelling in asthma. The mechanisms involved are poorly understood. A possible player is the multifunctional cytokine TGF-beta, which plays an important role in airway remodelling. Guinea pig lung slices were used as an in vitro model to investigate mechanisms involved in bronchoconstriction-induced airway remodelling. To address this aim, mechanical effects of bronchoconstricting stimuli on contractile protein expression and TGF-beta release were investigated. Lung slices were viable for at least 48 h. Both methacholine and TGF-beta(1) augmented the expression of contractile proteins (sm-alpha-actin, sm-myosin, calponin) after 48 h. Confocal fluorescence microscopy showed that increased sm-myosin expression was enhanced in the peripheral airways and the central airways. Mechanistic studies demonstrated that methacholine-induced bronchoconstriction mediated the release of biologically active TGF-beta, which caused the increased contractile protein expression, as inhibition of actin polymerization (latrunculin A) or TGF-beta receptor kinase (SB431542) prevented the methacholine effects, whereas other bronchoconstricting agents (histamine and KCl) mimicked the effects of methacholine. Collectively, bronchoconstriction promotes the release of TGF-beta, which induces airway smooth muscle remodelling. This study shows that lung slices are a useful in vitro model to study mechanisms involved in airway remodelling.	[Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Dept Mol Pharmacol, Groningen, Netherlands; [Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Groothuis, Geny M. M.] Univ Groningen, Groningen Res Inst Pharm, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Oenema, TA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Dept Mol Pharmacol, Groningen, Netherlands.	t.a.oenema@rug.nl	Maarsingh, Harm/AAD-5642-2019	Gosens, Reinoud/0000-0002-5595-152X	Groningen Center for Drug Research; University of Groningen; NWO [40-00506-98-9021, 175-010-2009-023]	Groningen Center for Drug Research; University of Groningen; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Groningen Center for Drug Research and the University of Groningen. Part of the work has been performed at the University Medical Center Groningen Imaging and Microscopy Center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021 and 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Camoretti-Mercado B, 2000, J BIOL CHEM, V275; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Ceresa CC, 2009, AM J PHYSIOL-LUNG C, V296, pL1059, DOI 10.1152/ajplung.90445.2008; Chen G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-2; Goldsmith AM, 2007, AM J PHYSIOL-LUNG C, V292, pL99, DOI 10.1152/ajplung.00269.2006; Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; Gosens R, 2005, AM J RESP CRIT CARE, V171, P1096, DOI 10.1164/rccm.200409-1249OC; Gosens R, 2009, EUR RESPIR J, V34, P1436, DOI 10.1183/09031936.00045209; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Guyot C, 2010, LIVER INT, V30, P1529, DOI 10.1111/j.1478-3231.2010.02342.x; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Halayko AJ, 1999, AM J PHYSIOL-LUNG C, V276, pL197, DOI 10.1152/ajplung.1999.276.1.L197; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Kistemaker LEM, 2012, LIFE SCI, V91, P1126, DOI 10.1016/j.lfs.2012.02.021; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; MAGNAN A, 1994, THORAX, V49, P789, DOI 10.1136/thx.49.8.789; Oenema TA, 2012, AM J PHYSIOL-LUNG C, V303, pL589, DOI 10.1152/ajplung.00400.2011; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Ohta S, 2010, CLIN EXP ALLERGY, V40, P1266, DOI 10.1111/j.1365-2222.2010.03478.x; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; van de Bovenkamp M, 2005, TOXICOL SCI, V85, P632, DOI 10.1093/toxsci/kfi127; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Westra IM, 2013, XENOBIOTICA, V43, P98, DOI 10.3109/00498254.2012.723151; WIGGS BR, 1992, AM REV RESPIR DIS, V145, P1251, DOI 10.1164/ajrccm/145.6.1251; Wright D, 2013, PULM PHARMACOL THER, V26, P24, DOI 10.1016/j.pupt.2012.08.006	47	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65580	10.1371/journal.pone.0065580	http://dx.doi.org/10.1371/journal.pone.0065580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840342	Green Published, gold, Green Submitted			2022-12-25	WOS:000321424400007
J	Peck, LS; Souster, T; Clark, MS				Peck, Lloyd S.; Souster, Terri; Clark, Melody S.			Juveniles Are More Resistant to Warming than Adults in 4 Species of Antarctic Marine Invertebrates	PLOS ONE			English	Article							TEMPERATURE-SIZE RULE; THERMAL LIMITS; METABOLIC-RATE; CLIMATE-CHANGE; TRADE-OFFS; HISTORY; OXYGEN; OCEAN; ECTOTHERMS; POLAR	Juvenile stages are often thought to be less resistant to thermal challenges than adults, yet few studies make direct comparisons using the same methods between different life history stages. We tested the resilience of juvenile stages compared to adults in 4 species of Antarctic marine invertebrate over 3 different rates of experimental warming. The species used represent 3 phyla and 4 classes, and were the soft-shelled clam Laternula elliptica, the sea cucumber Cucumaria georgiana, the sea urchin Sterechinus neumayeri, and the seastar Odontaster validus. All four species are widely distributed, locally abundant to very abundant and are amongst the most important in the ecosystem for their roles. At the slowest rate of warming used (1 degrees C 3 days(-1)) juveniles survived to higher temperatures than adults in all species studied. At the intermediate rate (1 degrees C day(-1)) juveniles performed better in 3 of the 4 species, with no difference in the 4th, and at the fastest rate of warming (1 degrees C h(-1)) L. elliptica adults survived to higher temperatures than juveniles, but in C. georgiana juveniles survived to higher temperatures than adults and there were no differences in the other species. Oxygen limitation may explain the better performance of juveniles at the slower rates of warming, whereas the loss of difference between juveniles and adults at the fastest rate of warming suggests another mechanism sets the temperature limit here.	[Peck, Lloyd S.; Souster, Terri; Clark, Melody S.] British Antarctic Survey, Cambridge CB3 0ET, Cambs, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Peck, LS (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, Cambs, England.	l.peck@bas.ac.uk	Clark, Melody S/D-7371-2014	Clark, Melody S/0000-0002-3442-3824	Natural Environment Research Council of the UK, through the British Antarctic Survey; NERC [bas0100025, dml011000] Funding Source: UKRI; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish	Natural Environment Research Council of the UK, through the British Antarctic Survey; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by the Natural Environment Research Council of the UK, through the British Antarctic Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2009, EXP GERONTOL, V44, P307, DOI 10.1016/j.exger.2009.02.012; Angilletta MJ, 2003, AM NAT, V162, P332; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; Barnes RSF, 1988, INTRO MARINE ECOLOGY; Bayne BL, 2004, INTEGR COMP BIOL, V44, P425, DOI 10.1093/icb/44.6.425; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BREY T, 1991, POLAR BIOL, V11, P227; Brockington S, 2007, MAR ECOL PROG SER, V330, P139, DOI 10.3354/meps330139; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Clark MS, 2013, GLOBAL CHANGE BIOL, V19, P2251, DOI 10.1111/gcb.12197; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Dearborn JH, 1977, ADAPTATIONS ANTARCTI, P293; FOSTER BA, 1971, MAR BIOL, V8, P12, DOI 10.1007/BF00349341; GOSSELIN LA, 1995, MAR BIOL, V122, P625, DOI 10.1007/BF00350684; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Grange LJ, 2007, MAR BIOL, V153, P15, DOI 10.1007/s00227-007-0776-z; Huntsman AG, 1925, CONTR CAN BIOL, V2, P91; Husmann G, 2011, J EXP MAR BIOL ECOL, V398, P83, DOI 10.1016/j.jembe.2010.12.013; Janosik AM, 2011, POLAR BIOL, V34, P575, DOI 10.1007/s00300-010-0916-7; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Meredith MP, 2005, GEOPHYS RES; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Nielsen K, 1997, ANIMAL PHYSL; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; PEARSE JS, 1966, SCIENCE, V152, P1763, DOI 10.1126/science.152.3730.1763; PEARSE JS, 1991, AM ZOOL, V31, P65; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Peck LS, 2007, MAR BIOL, V150, P1191, DOI 10.1007/s00227-006-0428-8; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Peck LS, 2003, P ROY SOC B-BIOL SCI, V270, pS166, DOI 10.1098/rsbl.2003.0054; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Peck LS, 2000, GEOL SOC SPEC PUBL, V177, P441, DOI 10.1144/GSL.SP.2000.177.01.29; Philipp E, 2005, MECH AGEING DEV, V126, P610, DOI 10.1016/j.mad.2005.02.002; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, J EXP BIOL, V205, P2217; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P59; Richard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034655; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Stokes MD, 1996, ISRAEL J ZOOL, V42, pS67; Sulkin SD, 1996, CAN J FISH AQUAT SCI, V53, P2076, DOI 10.1139/cjfas-53-9-2076; Vernon H.M., 1900, J PHYSL, V25, P131; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	59	31	32	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66033	10.1371/journal.pone.0066033	http://dx.doi.org/10.1371/journal.pone.0066033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840393	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000321424400016
J	Rhodes, J; Dejsirilert, S; Maloney, SA; Jorakate, P; Kaewpan, A; Salika, P; Akarachotpong, T; Prapasiri, P; Naorat, S; Areerat, P; Ruayajin, A; Sawanpanyalert, P; Akarasewi, P; Peruski, LF; Baggett, HC				Rhodes, Julia; Dejsirilert, Surang; Maloney, Susan A.; Jorakate, Possawat; Kaewpan, Anek; Salika, Prasert; Akarachotpong, Thantapat; Prapasiri, Prabda; Naorat, Sathapana; Areerat, Peera; Ruayajin, Asadang; Sawanpanyalert, Pathom; Akarasewi, Pasakorn; Peruski, Leonard F., Jr.; Baggett, Henry C.			Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand: An Update on Incidence, Clinical Characteristics, Serotype Distribution, and Antimicrobial Susceptibility, 2005-2010	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; DISEASE; RESISTANCE; INFLUENZA; CHILDREN; BURDEN; IMPACT; ASIA	Background: Streptococcus pneumoniae is an important cause of morbidity and mortality in Southeast Asia, but regional data is limited. Updated burden estimates are critical as pneumococcal conjugate vaccine (PCV) is highly effective, but not yet included in the Expanded Program on Immunization of Thailand or neighboring countries. Methods: We implemented automated blood culture systems in two rural Thailand provinces as part of population-based surveillance for bacteremia. Blood cultures were collected from hospitalized patients as clinically indicated. Results: From May 2005- March 2010, 196 cases of pneumococcal bacteremia were confirmed in hospitalized patients. Of these, 57% had clinical pneumonia, 20% required mechanical ventilation, and 23% (n = 46) died. Antibiotic use before blood culture was confirmed in 25% of those with blood culture. Annual incidence of hospitalized pneumococcal bacteremia was 3.6 per 100,000 person-years; rates were higher among children aged <5 years at 11.7 and adults >= 65 years at 14.2, and highest among infants <1 year at 33.8. The median monthly case count was higher during December-March compared to the rest of the year 6.0 vs. 1.0 (p<0.001). The most common serotypes were 23F (16%) and 14 (14%); 61% (74% in patients <5 years) were serotypes in the 10-valent PCV (PCV 10) and 82% (92% in <5 years) in PCV 13. All isolates were sensitive to penicillin, but non-susceptibility was high for co-trimoxazole (57%), erythromycin (30%), and clindamycin (20%). Conclusions: We demonstrated a high pneumococcal bacteremia burden, yet underestimated incidence because we captured only hospitalized cases, and because pre-culture antibiotics were frequently used. Our findings together with prior research indicate that PCV would likely have high serotype coverage in Thailand. These findings will complement ongoing cost effectiveness analyses and support vaccine policy evaluation in Thailand and the region.	[Rhodes, Julia; Maloney, Susan A.; Jorakate, Possawat; Kaewpan, Anek; Salika, Prasert; Akarachotpong, Thantapat; Prapasiri, Prabda; Naorat, Sathapana; Peruski, Leonard F., Jr.; Baggett, Henry C.] Thailand Minist Publ Hlth, US Ctr Dis Control & Prevent Collaborat, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand; [Dejsirilert, Surang; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Ruayajin, Asadang] Sa Kaeo Prov Hlth Off, Sa Kaeo, Thailand; [Areerat, Peera] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand; [Akarasewi, Pasakorn] Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Rhodes, J (corresponding author), Thailand Minist Publ Hlth, US Ctr Dis Control & Prevent Collaborat, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand.	juliar@th.cdc.gov			Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP); GAVI Alliance	Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP); GAVI Alliance	Partial support was provided by the Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP), which was funded by the GAVI Alliance and based at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; [Anonymous], POP PROJ THAIL 2000; Baggett HC, 2012, EUR J CLIN MICROBIOL, V31, P753, DOI 10.1007/s10096-011-1370-3; Baggett HC, 2010, INT S PNEUM PNEUM DI; Baggett HC, 2009, CLIN INFECT DIS, V48, pS65, DOI 10.1086/596484; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; *CLSI, 2008, PERF STAND ANT SUS S; Dejsirilert S, 2010, 7 INT S PNEUM PNEUM; Dejsirilert Surang, 2009, J Med Assoc Thai, V92 Suppl 4, pS19; Department of Provincial Administration, POP IND AG; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; GAVI World Bank, 2012, CREAT MARK SAV LIV F; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mindy J., 2003, MANUAL LAB IDENTIFIC; Netsawang Supichaya, 2010, Journal of the Medical Association of Thailand, V93, pS6; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Sirinavin Sayomporn, 2003, International Journal of Infectious Diseases, V7, P183, DOI 10.1016/S1201-9712(03)90050-6; Siripongpreeda Natawan, 2010, Journal of the Medical Association of Thailand, V93, pS1; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Srifeungfung S, 2010, VACCINE, V28, P3440, DOI 10.1016/j.vaccine.2010.02.071; Srifuengfung Somporn, 2010, Journal of the Medical Association of Thailand, V93, pS27; Suwanpakdee Detchvijitr, 2010, Journal of the Medical Association of Thailand, V93, pS40; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Walter ND, 2009, NEW ENGL J MED, V361, P2584, DOI 10.1056/NEJMc0904844; Wongsawat Jurai, 2010, Journal of the Medical Association of Thailand, V93, pS53	32	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66038	10.1371/journal.pone.0066038	http://dx.doi.org/10.1371/journal.pone.0066038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840395	Green Published, gold			2022-12-25	WOS:000321424400017
J	Bai, XS; Saab, AS; Huang, WH; Hoberg, IK; Kirchhoff, F; Scheller, A				Bai, Xianshu; Saab, Aiman S.; Huang, Wenhui; Hoberg, Isolde K.; Kirchhoff, Frank; Scheller, Anja			Genetic Background Affects Human Glial Fibrillary Acidic Protein Promoter Activity	PLOS ONE			English	Article							ASTROCYTE-SPECIFIC TRANSCRIPTION; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; TRANSGENIC MICE; MESSENGER-RNA; C57BL/6J MICE; MOUSE-BRAIN; IN-VIVO; EXPRESSION; GFAP	The human glial fibrillary acidic protein (hGFAP) promoter has been used to generate numerous transgenic mouse lines, which has facilitated the analysis of astrocyte function in health and disease. Here, we evaluated the expression levels of various hGFAP transgenes at different ages in the two most commonly used inbred mouse strains, FVB/N (FVB) and C57BL/6N (B6N). In general, transgenic mice maintained on the B6N background displayed weaker transgene expression compared with transgenic FVB mice. Higher level of transgene expression in B6N mice could be regained by crossbreeding to FVB wild type mice. However, the endogenous murine GFAP expression was equivalent in both strains. In addition, we found that endogenous GFAP expression was increased in transgenic mice in comparison to wild type mice. The activities of the hGFAP transgenes were not age-dependently regulated. Our data highlight the importance of proper expression analysis when non-homologous recombination transgenesis is used.	[Bai, Xianshu; Saab, Aiman S.; Huang, Wenhui; Hoberg, Isolde K.; Kirchhoff, Frank; Scheller, Anja] Univ Saarland, Dept Mol Physiol, Homburg, Germany	Saarland University	Scheller, A (corresponding author), Univ Saarland, Dept Mol Physiol, Homburg, Germany.	anja.scheller@uks.eu	Kirchhoff, Frank/B-9335-2008; Huang, Wenhui/M-6227-2013; Scheller, Anja/B-8577-2018; Bai, Xianshu/ABY-7478-2022	Kirchhoff, Frank/0000-0002-2324-2761; Huang, Wenhui/0000-0001-9865-0375; Scheller, Anja/0000-0001-8955-2634; Bai, Xianshu/0000-0002-4758-1645; Saab, Aiman S./0000-0003-3886-8369	DFG [SPP 1172, SFB 894]; European Commission [FP7-202167 NeuroGLIA, FP7-People ITN-237956 EdU-Glia]	DFG(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by DFG SPP 1172, DFG SFB 894, European Commission FP7-202167 NeuroGLIA and FP7-People ITN-237956 EdU-Glia (http://www.eduglia.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESNARD F, 1991, J BIOL CHEM, V266, P18877; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Dobie K, 1997, TRENDS GENET, V13, P127, DOI 10.1016/S0168-9525(97)01097-4; ELDER GA, 1994, MOL BRAIN RES, V26, P177, DOI 10.1016/0169-328X(94)90089-2; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kim HJ, 2011, METHODS MOL BIOL, V793, P63, DOI 10.1007/978-1-61779-328-8_4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lee Y, 2006, GLIA, V53, P677, DOI 10.1002/glia.20320; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; LEWIS SA, 1985, J NEUROCHEM, V45, P913, DOI 10.1111/j.1471-4159.1985.tb04080.x; LI HS, 1992, ACTA OTO-LARYNGOL, V112, P956, DOI 10.3109/00016489209137496; LI HS, 1991, ACTA OTO-LARYNGOL, V111, P827, DOI 10.3109/00016489109138418; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MASOOD K, 1993, J NEUROCHEM, V61, P160, DOI 10.1111/j.1471-4159.1993.tb03551.x; Messing A, 2003, GLIA, V43, P87, DOI 10.1002/glia.10219; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Nolte C, 2001, GLIA, V33, P72; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Restrepo A, 2011, NEURO-ONCOLOGY, V13, P42, DOI 10.1093/neuonc/noq145; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Su M, 2004, NEUROCHEM RES, V29, P2075, DOI 10.1007/s11064-004-6881-1; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; TARDY M, 1989, J NEUROCHEM, V52, P162, DOI 10.1111/j.1471-4159.1989.tb10911.x; Weichman K, 1997, MOL CELL BIOL, V17, P5269, DOI 10.1128/MCB.17.9.5269; WILLOTT JF, 1993, J COMP NEUROL, V329, P402, DOI 10.1002/cne.903290310; Yoshida T, 1996, NEUROSCI LETT, V215, P107, DOI 10.1016/0304-3940(96)12966-9; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	61	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66873	10.1371/journal.pone.0066873	http://dx.doi.org/10.1371/journal.pone.0066873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826164	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400075
J	Carpinelli, MR; Manning, MG; Kile, BT; Rachel, AB				Carpinelli, Marina R.; Manning, Michael G.; Kile, Benjamin T.; Rachel, A. Burt			Two ENU-Induced Alleles of Atp2b2 Cause Deafness in Mice	PLOS ONE			English	Article							MEMBRANE CALCIUM-PUMP; SENSORY HAIR-CELLS; HEARING-LOSS; DEAFWADDLER MICE; POINT MUTATION; GENE; PMCA2; CADHERIN-23; MUTAGENESIS	Over 120 loci are known to cause inherited hearing loss in humans. The deafness gene has been identified for only half of these loci. With the aim of identifying some of the remaining deafness genes, we performed an ethylnitrosourea mutagenesis screen for deaf mice. We isolated two mutants with semi-dominant hearing loss, Deaf11 and Deaf13. Both contained causative mutations in Atp2b2, which encodes the plasma membrane calcium ATPase 2. The Atp2b2(Deaf11) mutation leads to a p. I1023S substitution in the tenth transmembrane domain. The Atp2b2(Deaf13) mutation leads to a p. R561S substitution in the catalytic core. Mice homozygous for these mutations display profound hearing loss. Heterozygotes display mild to moderate, progressive hearing loss.	[Carpinelli, Marina R.; Manning, Michael G.; Rachel, A. Burt] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Carpinelli, Marina R.; Manning, Michael G.] Univ Melbourne, HEARing Cooperat Res Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.; Rachel, A. Burt] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Carpinelli, MR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	marina.carpinelli@mcri.edu.au	Kile, Benjamin/GNP-3246-2022; Kile, Benjamin T/F-6593-2011; Burt, Rachel/I-7874-2012	Kile, Benjamin/0000-0002-8836-8947; Kile, Benjamin T/0000-0002-8836-8947; Burt, Rachel/0000-0001-8827-8266; Carpinelli, Marina/0000-0001-5115-7831	HEARing CRC; Australian Government's Cooperative Research Centres Program; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant; Garnet Passe and Rodney Williams Memorial Foundation	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant(Australian GovernmentDepartment of Industry, Innovation and Science); Garnet Passe and Rodney Williams Memorial Foundation	The authors acknowledge the financial support of the HEARing CRC (www.hearingcrc.org), established and supported under the Australian Government's Cooperative Research Centres Program; the Victorian State Government's Operational Infrastructure Support Program; the Australian Government's NHMRC IRIISS (www.nhmrc.gov.au); a National Collaborative Research Infrastructure Strategy grant to the Australian Phenomics Network (www.australianphenomics.org.au); and the Garnet Passe and Rodney Williams Memorial Foundation (www.gprwmf.org.au, fellowship to MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Berne RM, 2004, PHYSIOLOGY, P133; BODE VC, 1984, GENETICS, V108, P457; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; Carafoli E, 2011, SCI CHINA LIFE SCI, V54, P686, DOI 10.1007/s11427-011-4200-z; Carpinelli Marina R, 2012, Curr Protoc Mouse Biol, V2, P75, DOI 10.1002/9780470942390.mo110161; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Les EP, 1990, JAX NOTES; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Sun XY, 2008, GENE, V411, P94, DOI 10.1016/j.gene.2008.01.013; Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Tsai YS, 2006, MAMM GENOME, V17, P716, DOI 10.1007/s00335-005-0191-z; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1; Xu L, 2011, EXP ANIM TOKYO, V60, P71, DOI 10.1538/expanim.60.71; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67479	10.1371/journal.pone.0067479	http://dx.doi.org/10.1371/journal.pone.0067479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826306	Green Published, gold			2022-12-25	WOS:000321738400151
J	Liabeuf, S; Glorieux, G; Lenglet, A; Diouf, M; Schepers, E; Desjardins, L; Choukroun, G; Vanholder, R; Massy, ZA				Liabeuf, Sophie; Glorieux, Griet; Lenglet, Aurelie; Diouf, Momar; Schepers, Eva; Desjardins, Lucie; Choukroun, Gabriel; Vanholder, Raymond; Massy, Ziad A.		European Uremic Toxin EUTox Work G	Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; INDOXYL SULFATE; CRESOL; PROGRESSION; CRESYLSULPHATE; TOXICITY; MODERATE	Background: Uremic toxins are emerging as important, non-traditional cardiovascular risk factors in chronic kidney disease (CKD). P-cresol has been defined as a prototype protein-bound uremic toxin. Conjugation of p-cresol creates p-cresylsulfate (PCS) as the main metabolite and p-cresylglucuronide (PCG), at a markedly lower concentration. The objective of the present study was to evaluate serum PCG levels, determine the latter's association with mortality and establish whether the various protein-bound uremic toxins (i.e. PCS, PCG and indoxylsulfate (IS)) differed in their ability to predict mortality. Methodology/Principal Findings: We studied 139 patients (mean +/- SD age: 67 +/- 12; males: 60%) at different CKD stages (34.5% at CKD stages 2-3, 33.5% at stage 4-5 and 32% at stage 5D). A recently developed high-performance liquid chromatography method was used to assay PCG concentrations. Total and free PCG levels increased with the severity of CKD. During the study period (mean duration: 779 +/- 185 days), 38 patients died. High free and total PCG levels were correlated with overall and cardiovascular mortality independently of well-known predictors of survival, such as age, vascular calcification, anemia, inflammation and (in predialysis patients) the estimated glomerular filtration rate. In the same cohort, free PCS levels and free IS levels were both correlated with mortality. Furthermore, the respective predictive powers of three Cox multivariate models (free PCS+other risk factors, free IS+other risk factors and free PCS+other risk factors) were quite similar - suggesting that an elevated PCG concentration has much the same impact on mortality as other uremic toxins (such as PCS or IS) do. Conclusions: Although PCG is the minor metabolite of p-cresol, our study is the first to reveal its association with mortality. Furthermore, the free fraction of PCG appears to have much the same predictive power for mortality as PCS and IS do.	[Liabeuf, Sophie; Lenglet, Aurelie; Desjardins, Lucie; Choukroun, Gabriel; Massy, Ziad A.] Jules Verne Univ Picardy, INSERM, U1088, Amiens, France; [Liabeuf, Sophie; Lenglet, Aurelie; Diouf, Momar; Desjardins, Lucie; Massy, Ziad A.] Amiens Univ Hosp, Clin Res Ctr, Div Clin Pharmacol, Amiens, France; [Liabeuf, Sophie; Lenglet, Aurelie; Diouf, Momar; Desjardins, Lucie; Massy, Ziad A.] Jules Verne Univ Picardy, Amiens, France; [Glorieux, Griet; Schepers, Eva; Vanholder, Raymond] Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Choukroun, Gabriel] Amiens Univ Hosp, Div Nephrol Dialysis Transplantat, Amiens, France; [Massy, Ziad A.] Ambroise Pare Hosp, Div Nephrol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Ghent University; Ghent University Hospital; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Massy, ZA (corresponding author), Jules Verne Univ Picardy, INSERM, U1088, Amiens, France.	massy@u-picardie.fr	Gabriel, Choukroun/AAL-4969-2021; , liabeuf/AFB-7848-2022		Amiens University Hospital [PHRC:2006/0100]; EUTox Group	Amiens University Hospital; EUTox Group	This study was funded by a grant from Amiens University Hospital [PHRC:2006/0100 (March 27, 2006)] and supported also by EUTox Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa T, 2009, AM J KIDNEY DIS, V54, P459, DOI 10.1053/j.ajkd.2009.05.011; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Berge-Lefranc D, 2010, J PHYS CHEM B, V114, P1661, DOI 10.1021/jp9059517; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; de Loor H, 2005, CLIN CHEM, V51, P1535, DOI 10.1373/clinchem.2005.050781; De Smet R, 2003, CLIN CHEM, V49, P470, DOI 10.1373/49.3.470; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Iwasaki Y, 2006, NEPHROL DIAL TRANSPL, V21, P2768, DOI 10.1093/ndt/gfl311; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Liabeuf S, 2011, TOXINS, V3, P911, DOI 10.3390/toxins3070911; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; Massy ZA, 2009, SEMIN DIALYSIS, V22, P405, DOI 10.1111/j.1525-139X.2009.00590.x; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Meijers BK, 2009, AM J KIDNEY DIS; Nakamura T, 2004, KIDNEY BLOOD PRESS R, V27, P121, DOI 10.1159/000077536; Niwa T, 1997, MINER ELECTROL METAB, V23, P179; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Schulman G, 2006, AM J KIDNEY DIS, V47, P565, DOI 10.1053/j.ajkd.2005.12.036; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; VANHOLDER R, 1994, SEMIN NEPHROL, V14, P205; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; Zureik M, 2002, J HYPERTENS, V20, P85, DOI 10.1097/00004872-200201000-00013	34	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67168	10.1371/journal.pone.0067168	http://dx.doi.org/10.1371/journal.pone.0067168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826225	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400114
J	Sukhtankar, DD; Ko, MC				Sukhtankar, Devki D.; Ko, Mei-Chuan			Physiological Function of Gastrin-Releasing Peptide and Neuromedin B Receptors in Regulating Itch Scratching Behavior in the Spinal Cord of Mice	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; DORSAL-HORN NEURONS; INTRATHECAL MORPHINE; POSTCESAREAN ANALGESIA; RANDOMIZED-TRIALS; BOMBESIN; PRURITUS; RATS; RESPONSES; HISTAMINE	Pruritus (itch) is a severe side effect associated with the use of drugs as well as hepatic and hematological disorders. Previous studies in rodents suggest that bombesin receptor subtypes i.e. receptors for gastrin-releasing peptide (GRPr) and neuromedin B (NMBr) differentially regulate itch scratching. However, to what degree spinal GRPr and NMBr regulate scratching evoked by intrathecally administered bombesin-related peptides is not known. The first aim of this study was to pharmacologically compare the dose-response curves for scratching induced by intrathecally administered bombesin-related peptides versus morphine, which is known to elicit itch in humans. The second aim was to determine if spinal GRPr and NMBr selectively or generally mediate scratching behavior. Mice received intrathecal injection of bombesin (0.01-0.3 nmol), GRP (0.01-0.3nmol), NMB (0.1-1nmol) or morphine (0.3-3 nmol) and were observed for one hour for scratching activity. Bombesin elicited most profound scratching over one hour followed by GRP and NMB, whereas morphine failed to evoke scratching response indicating the insensitivity of mouse models to intrathecal opioid-induced itch. Intrathecal pretreatment with GRPr antagonist RC-3095 (0.03-0.1 nmol) produced a parallel rightward shift in the dose response curve of GRP-induced scratching but not NMB-induced scratching. Similarly, PD168368 (1-3 nmol) only attenuated NMB but not GRP-induced scratching. Individual or co-administration of RC-3095 and PD168368 failed to alter bombesin-evoked scratching. A higher dose of RC-3095 (0.3 nmol) generally suppressed scratching induced by all three peptides but also compromised motor function in the rotarod test. Together, these data indicate that spinal GRPr and NMBr independently drive itch neurotransmission in mice and may not mediate bombesin-induced scratching. GRPr antagonists at functionally receptor-selective doses only block spinal GRP-elicited scratching but the suppression of scratching at higher doses is confounded by motor impairment.	[Sukhtankar, Devki D.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Ko, Mei-Chuan] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA	University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center	Ko, MC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA.	kowake13@gmail.com	Ko, Mei-Chuan/C-9468-2009	Ko, Mei-Chuan/0000-0003-2436-4506	National Institute of Health, NIAMS [R01-AR-059193, R21-AR-064456]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059193, R21AR064456] Funding Source: NIH RePORTER	National Institute of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The current study is supported by National Institute of Health, NIAMS, Grants R01-AR-059193 and R21-AR-064456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Andoh T, 2011, PEPTIDES, V32, P2098, DOI 10.1016/j.peptides.2011.09.003; Bergasa NV, 2008, CLIN LIVER DIS, V12, P219, DOI 10.1016/j.cld.2007.11.009; BISHOP JF, 1986, PEPTIDES, V7, P835, DOI 10.1016/0196-9781(86)90103-8; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; COWAN A, 1985, LIFE SCI, V37, P135, DOI 10.1016/0024-3205(85)90416-3; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; GMEREK DE, 1988, ANN NY ACAD SCI, V525, P291, DOI 10.1111/j.1749-6632.1988.tb38614.x; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; GMEREK DE, 1983, PEPTIDES, V4, P907, DOI 10.1016/0196-9781(83)90089-X; Inan S, 2011, PEPTIDES, V32, P286, DOI 10.1016/j.peptides.2010.11.022; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Johnson MD, 1999, BRAIN RES, V839, P194, DOI 10.1016/S0006-8993(99)01708-4; Jones EA, 2002, QJM-INT J MED, V95, P547, DOI 10.1093/qjmed/95.8.547; KATZ R, 1980, NEUROPHARMACOLOGY, V19, P143, DOI 10.1016/0028-3908(80)90181-1; Ko MCH, 2000, ANESTHESIOLOGY, V92, P795, DOI 10.1097/00000542-200003000-00023; Ko MCH, 2004, J PHARMACOL EXP THER, V310, P169, DOI 10.1124/jpet.103.061101; Kozyrev N, 2012, J SEX MED, V9, P1303, DOI 10.1111/j.1743-6109.2012.02688.x; Kuraishi Y, 2000, J BIOMED SCI, V7, P248, DOI 10.1159/000025455; Lee H, 2003, BEHAV PHARMACOL, V14, P501, DOI 10.1097/00008877-200311000-00002; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; MASUI A, 1993, EUR J PHARMACOL, V238, P297, DOI 10.1016/0014-2999(93)90860-K; Meylan N, 2009, BRIT J ANAESTH, V102, P156, DOI 10.1093/bja/aen368; Palmer CM, 1999, ANESTHESIOLOGY, V90, P437, DOI 10.1097/00000542-199902000-00018; Patel Tejesh, 2010, Skin Therapy Lett, V15, P5; Patel T, 2010, EXPERT OPIN PHARMACO, V11, P1673, DOI 10.1517/14656566.2010.484420; Popping DM, 2012, PAIN, V153, P784, DOI 10.1016/j.pain.2011.11.028; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; Su PY, 2011, J PHARMACOL EXP THER, V337, P822, DOI 10.1124/jpet.111.178970; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tan-No K, 2008, NEUROPEPTIDES, V42, P239, DOI 10.1016/j.npep.2008.03.003; Tsai FF, 2010, ACTA ANAESTH SCAND, V54, P1265, DOI 10.1111/j.1399-6576.2010.02310.x; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wu HE, 2004, J PHARMACOL EXP THER, V310, P240, DOI 10.1124/jpet.104.065334; Yamada K, 2000, BRAIN RES, V870, P20, DOI 10.1016/S0006-8993(00)02395-7	42	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67422	10.1371/journal.pone.0067422	http://dx.doi.org/10.1371/journal.pone.0067422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826298	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400145
J	Treloar, KK; Simpson, MJ				Treloar, Katrina K.; Simpson, Matthew J.			Sensitivity of Edge Detection Methods for Quantifying Cell Migration Assays	PLOS ONE			English	Article							IN-VITRO; GROWTH; VITRONECTIN; INVASION; IMAGES; SKIN	Quantitative imaging methods to analyze cell migration assays are not standardized. Here we present a suite of two-dimensional barrier assays describing the collective spreading of an initially-confined population of 3T3 fibroblast cells. To quantify the motility rate we apply two different automatic image detection methods to locate the position of the leading edge of the spreading population after 24, 48 and 72 hours. These results are compared with a manual edge detection method where we systematically vary the detection threshold. Our results indicate that the observed spreading rates are very sensitive to the choice of image analysis tools and we show that a standard measure of cell migration can vary by as much as 25% for the same experimental images depending on the details of the image analysis tools. Our results imply that it is very difficult, if not impossible, to meaningfully compare previously published measures of cell migration since previous results have been obtained using different image analysis techniques and the details of these techniques are not always reported. Using a mathematical model, we provide a physical interpretation of our edge detection results. The physical interpretation is important since edge detection algorithms alone do not specify any physical measure, or physical definition, of the leading edge of the spreading population. Our modeling indicates that variations in the image threshold parameter correspond to a consistent variation in the local cell density. This means that varying the threshold parameter is equivalent to varying the location of the leading edge in the range of approximately 1-5% of the maximum cell density.	[Treloar, Katrina K.; Simpson, Matthew J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Treloar, Katrina K.; Simpson, Matthew J.] Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X	Australian Research Council [DP120100551]	Australian Research Council(Australian Research Council)	The authors appreciate the support of the Australian Research Council Discovery Grant Number DP120100551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU IE, 1979, P IEEE, V67, P753, DOI 10.1109/PROC.1979.11325; [Anonymous], 2011, PRINCIPLES DEV; Ashby WJ, 2012, INTEGR BIOL-UK, V4, P1338, DOI 10.1039/c2ib20154b; Bradie B, 2006, FRIENDLY INTRO NUMER; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Dixit VD, 2006, J BIOL CHEM, V281, P16681, DOI 10.1074/jbc.M600223200; Geback T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-75; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Guitera P, 2011, EXPERT REV ANTICANC, V11, P715, DOI [10.1586/era.11.43, 10.1586/ERA.11.43]; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kam Yoonseok, 2009, BMC Res Notes, V2, P130, DOI 10.1186/1756-0500-2-130; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Lee J, 2010, LANGMUIR, V26, P16672, DOI 10.1021/la103542y; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Mathworks, 2012, IM ACQ TOOLB US GUID; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Mete M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S23; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Okumura CYM, 2012, J MOL MED, V90, P1079, DOI 10.1007/s00109-012-0882-3; Research Services Branch National Institute of Health, 2012, IMAGEJ US GUID; Sadeghi HM, 1998, J REFRACT SURG, V14, P534; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Simpson MJ, 2012, APPL MATH MODEL, V36, P3323, DOI 10.1016/j.apm.2011.09.071; Simpson MJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051922; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Simpson MJ, 2010, PHYSICA A, V389, P3779, DOI 10.1016/j.physa.2010.05.020; Simpson MJ, 2005, MATH COMPUT SIMULAT, V70, P44, DOI 10.1016/j.matcom.2005.03.019; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Topman G, 2012, MED ENG PHYS, V34, P225, DOI 10.1016/j.medengphy.2011.07.014; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x; van Horssen R, 2011, J CELL PHYSIOL, V226, P288, DOI 10.1002/jcp.22330; Wang XJ, 2010, BIOCHEM BIOPH RES CO, V403, P264, DOI 10.1016/j.bbrc.2010.11.012; Weinberg RA, 2006, BIOL CANC; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zaritsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027593; Zordan MD, 2011, CYTOM PART A, V79A, P227, DOI 10.1002/cyto.a.21029	43	50	50	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67389	10.1371/journal.pone.0067389	http://dx.doi.org/10.1371/journal.pone.0067389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826283	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400139
J	Xia, RH; Song, XM; Wang, XJ; Li, J; Mao, L				Xia, Rong-Hui; Song, Xiao-Meng; Wang, Xiao-Jing; Li, Jiang; Mao, Li			The Combination of SMAD4 Expression and Histological Grade of Dysplasia Is a Better Predictor for the Malignant Transformation of Oral Leukoplakia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; PANCREATIC-CANCER; NECK-CANCER; HEAD; DPC4; MUCOSA; CLASSIFICATION; CHROMOSOME-18; PROGRESSION	Oral leukoplakia (OL) is the most common premalignancy in the oral cavity and can progress to oral squamous cell carcinoma (OSCC). SMAD4 is a tumor suppressor implicated in multiple cancer types including OSCC. To assess the role of SMAD4 in oral leukoplakia malignant transformation, the authors investigated SMAD4 expression patterns in OL and OSCC using a highly specific antibody and correlated the patterns with the risk of malignant transformation oral leukoplakia. Immunohistochemistry and a quantitative imaging system were used to measure SMAD4 expression in OL from 88 OL patients, including 22 who later went through malignant transformation, and their OSCC counterpart. Forty-three (48.9%) of the 88 OL patients had strong SMAD4 expression. SMAD4 expression had no significant correlation with patients' clinicopathological parameters. Interestingly, 17 (39.5%) of the 43 OL lesions with strong SMAD4 expression went through malignant transformation whereas only 5 (11.1%) of the 45 OL lesions with weak SMAD4 expression did so (p = 0.002). The SMAD4 expression in OL was much higher than that in their OSCC counterpart. Kaplan-Meier analysis revealed that the combination of SMAD4 expression and histological grade of dysplasia (p = 0.007) is a better predictor for the malignant transformation of oral leukoplakia. In the multivariate analysis, both SMAD4 expression and grade of dysplasia were identified as independent factors for OL malignant transformation risk (p = 0.013 and 0.021, respectively). It was concluded that high SMAD4 expression may be indicative of an early carcinogenic process in OL and serve as an independent biomarker in assessing malignant transformation risk in patients with OL, and the combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.	[Xia, Rong-Hui; Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Pathol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China; [Xia, Rong-Hui; Song, Xiao-Meng; Mao, Li] Univ Maryland, Sch Med, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Song, Xiao-Meng; Wang, Xiao-Jing] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Maxillofacial Head & Neck Oncol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China; Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore; Shanghai Jiao Tong University; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, J (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Pathol, Sch Med,Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China.	lijiang182000@yahoo.com; LMao@umaryland.edu	Mao, Li/C-7570-2011	Mao, Li/0000-0001-7263-3358	Chinese Nature Science Foundation [81272976, 30872905, 81072211]; Shanghai Leading Academic Discipline Project [S30206]; Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine [BXJ201029]	Chinese Nature Science Foundation; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine	This work was supported by Chinese Nature Science Foundation (81272976, 30872905 and 81072211), the Shanghai Leading Academic Discipline Project (S30206) and the Doctoral Innovation Foundation of Shanghai Jiao Tong University, School of Medicine (BXJ201029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Danielsson K, 2010, J ORAL PATHOL MED, V39, P639, DOI 10.1111/j.1600-0714.2010.00902.x; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 1996, CANCER RES, V56, P490; He SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-70; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Isaksson-Mettavainio M, 2012, INT J CANCER, V131, P779, DOI 10.1002/ijc.26473; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kim SK, 1996, CANCER RES, V56, P2519; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Osawa H, 2000, INT J ONCOL, V17, P723; Ottenhof NA, 2012, CELL ONCOL, V35, P119, DOI 10.1007/s13402-012-0072-x; Papadimitrakopoulou VA, 1998, CLIN CANCER RES, V4, P539; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Shi Q, 2012, MOL MED REP, V5, P89, DOI 10.3892/mmr.2011.600; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; van der Waal I, 2010, ORAL ONCOL, V46, P423, DOI 10.1016/j.oraloncology.2010.02.016; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; vanderWaal I, 1997, ORAL ONCOL, V33, P291, DOI 10.1016/S1368-8375(97)00002-X; Wang XM, 2009, MOL BIOL REP, V36, P861, DOI 10.1007/s11033-008-9256-x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wilentz RE, 2000, CANCER RES, V60, P2002; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie W, 2003, ONCOL RES, V14, P61, DOI 10.3727/000000003108748612	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66794	10.1371/journal.pone.0066794	http://dx.doi.org/10.1371/journal.pone.0066794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826135	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400052
J	Glaser, S; Obst, A; Koch, B; Henkel, B; Grieger, A; Felix, SB; Halank, M; Bruch, L; Bollmann, T; Warnke, C; Schaper, C; Ewert, R				Glaeser, Sven; Obst, Anne; Koch, Beate; Henkel, Beate; Grieger, Anita; Felix, Stephan B.; Halank, Michael; Bruch, Leonhard; Bollmann, Tom; Warnke, Christian; Schaeper, Christoph; Ewert, Ralf			Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis - The Predictive Value of Exercise Capacity and Gas Exchange Efficiency	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; LUNG; STANDARDIZATION; GUIDELINES; DIAGNOSIS; MORTALITY; IMPACT	Exercise capacity and survival of patients with IPF is potentially impaired by pulmonary hypertension. This study aims to investigate diagnostic and prognostic properties of gas exchange during exercise and lung function in IPF patients with or without pulmonary hypertension. In a multicentre setting, patients with IPF underwent right heart catheterization, cardiopulmonary exercise and lung function testing during their initial evaluation. Mortality follow up was evaluated. Seventy-three of 135 patients [82 males; median age of 64 (56; 72 years)] with IPF had pulmonary hypertension as assessed by right heart catheterization [median mean pulmonary arterial pressure 34 (27; 43) mmHg]. The presence of pulmonary hypertension was best predicted by gas exchange efficiency for carbon dioxide (cut off >= 152% predicted; area under the curve 0.94) and peak oxygen uptake (<= 56% predicted; 0.83), followed by diffusing capacity. Resting lung volumes did not predict pulmonary hypertension. Survival was best predicted by the presence of pulmonary hypertension, followed by peak oxygen uptake [HR 0.96 (0.93; 0.98)]. Pulmonary hypertension in IPF patients is best predicted by gas exchange efficiency during exercise and peak oxygen uptake. In addition to invasively measured pulmonary arterial pressure, oxygen uptake at peak exercise predicts survival in this patient population.	[Glaeser, Sven; Obst, Anne; Koch, Beate; Henkel, Beate; Grieger, Anita; Felix, Stephan B.; Bollmann, Tom; Warnke, Christian; Schaeper, Christoph; Ewert, Ralf] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany; [Halank, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany; [Bruch, Leonhard] BG Hosp, Trauma Hosp Berlin Assoc, Clin Internal Med, Berlin, Germany	Ernst Moritz Arndt Universitat Greifswald; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Glaser, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany.	sven.glaeser@uni-greifswald.de						ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Boutou AK, 2011, RESPIROLOGY, V16, P451, DOI 10.1111/j.1440-1843.2010.01909.x; Criee CP, 2011, RESP MED, V105, P959, DOI 10.1016/j.rmed.2011.02.006; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Fell CD, 2009, AM J RESP CRIT CARE, V179, P402, DOI 10.1164/rccm.200802-241OC; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Glaser S, 2012, EUR RESPIR J, V39, P29, DOI 10.1183/09031936.00009811; Glaser S, 2009, MED SCI SPORT EXER, V41, P967, DOI 10.1249/MSS.0b013e3181af696; Glaser S, 2009, RESP MED, V103, P317, DOI 10.1016/j.rmed.2008.08.005; Hansen J.E., 2011, PULMONARY FUNCTION T; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kimura M, 2012, PULMONARY HYPERTENSI; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minai OA, 2012, RESP MED, V106, P1613, DOI 10.1016/j.rmed.2012.07.013; Nadrous HF, 2005, CHEST, V128, P2393, DOI 10.1378/chest.128.4.2393; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; NELSON SB, 1990, CHEST, V97, P288, DOI 10.1378/chest.97.2.288; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Papakosta D, 2011, LUNG, V189, P391, DOI 10.1007/s00408-011-9304-5; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shorr AF, 2007, EUR RESPIR J, V30, P715, DOI 10.1183/09031936.00107206; Shorr AF, 2003, CHEST, V124, P922, DOI 10.1378/chest.124.3.922; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; Wasserman K, 2004, PRINCIPLES EXERCISE, V4th; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th	33	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65643	10.1371/journal.pone.0065643	http://dx.doi.org/10.1371/journal.pone.0065643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840349	Green Submitted, Green Published, gold			2022-12-25	WOS:000322342800015
J	Ma, AZ; Zhuang, XL; Wu, JM; Cui, MM; Lv, D; Liu, CZ; Zhuang, GQ				Ma, Anzhou; Zhuang, Xuliang; Wu, Junmei; Cui, Mengmeng; Lv, Di; Liu, Chunzhao; Zhuang, Guoqiang			Ascomycota Members Dominate Fungal Communities during Straw Residue Decomposition in Arable Soil	PLOS ONE			English	Article							LITTER DECOMPOSITION; PLANT RESIDUES; FOREST; NITROGEN; DIVERSITY; LIGNIN; IMPACT; CARBON; FERMENTATION; SUCCESSION	This study investigated the development of fungal community composition in arable soil during the degradation of straw residue. We explored the short-term responses of the fungal community over 28 days of decomposition in soil using culture-independent polymerase chain reaction in combination with a clone library and denaturing gradient gel electrophoresis (DGGE). Fungal cellobiohydrolase I (cbhI) genes in the soil were also characterized, and their diversity suggested the existence of a different cellulose decomposer. The DGGE profiles based on fungal internal transcribed spacer analysis showed different successions of fungal populations during residue decomposition. Members of Lecythophora and Sordariales were dominant in the early succession, while Hypocrea and Engyodontium were better adapted in the late succession. The succession of fungal communities might be related to changes of residue quality during decomposition. Collectively, sequences assigned to Ascomycota members were dominant at different stages of the fungal succession during decomposition, revealing that they were key drivers responsible for residue degradation in the arable soil tested.	[Ma, Anzhou; Zhuang, Xuliang; Wu, Junmei; Cui, Mengmeng; Zhuang, Guoqiang] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lv, Di] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Liu, Chunzhao] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Process Engineering, CAS	Zhuang, XL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	xlzhuang@rcees.ac.cn; gqzhuang@rcees.ac.cn	Zhuang, Guoqiang/M-4129-2018	Zhuang, Guoqiang/0000-0001-8755-7300	National Natural Science Foundation of China [41001151, 41173089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (41001151, 41173089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Artham T, 2010, BIOMACROMOLECULES, V11, P20, DOI 10.1021/bm9008099; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Bertrand I, 2009, BIORESOURCE TECHNOL, V100, P155, DOI 10.1016/j.biortech.2008.06.019; Blackwood CB, 2007, ENVIRON MICROBIOL, V9, P1306, DOI 10.1111/j.1462-2920.2007.01250.x; Dilly O, 2004, SOIL SCI PLANT NUTR, V50, P843, DOI 10.1080/00380768.2004.10408545; Dilly O, 2001, SOIL BIOL BIOCHEM, V33, P921, DOI 10.1016/S0038-0717(00)00239-X; Duong LM, 2008, FUNGAL DIVERS, V30, P23; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; GOMES J, 1989, APPL MICROBIOL BIOT, V31, P601, DOI 10.1007/BF00270803; Hadas A, 2004, SOIL BIOL BIOCHEM, V36, P255, DOI 10.1016/j.soilbio.2003.09.012; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; Jacobsen J, 2005, J MICROBIOL METH, V60, P63, DOI 10.1016/j.mimet.2004.08.013; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P8099, DOI 10.1016/j.biortech.2011.06.035; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lopez MJ, 2007, ENZYME MICROB TECH, V40, P794, DOI 10.1016/j.enzmictec.2006.06.012; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Ma AZ, 2008, ENZYME MICROB TECH, V42, P543, DOI 10.1016/j.enzmictec.2008.02.009; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; Nicolardot B, 2007, SOIL BIOL BIOCHEM, V39, P1631, DOI 10.1016/j.soilbio.2007.01.012; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Osono T, 2006, CAN J MICROBIOL, V52, P701, DOI 10.1139/W06-023; Osono T, 2009, FUNGAL DIVERS, V36, P101; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Ruan ZH, 2012, BIORESOURCE TECHNOL, V110, P198, DOI 10.1016/j.biortech.2012.01.053; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010	42	103	126	15	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66146	10.1371/journal.pone.0066146	http://dx.doi.org/10.1371/journal.pone.0066146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840414	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800036
J	Revelles, O; Millard, P; Nougayrede, JP; Dobrindt, U; Oswald, E; Letisse, F; Portais, JC				Revelles, Olga; Millard, Pierre; Nougayrede, Jean-Philippe; Dobrindt, Ulrich; Oswald, Eric; Letisse, Fabien; Portais, Jean-Charles			The Carbon Storage Regulator (Csr) System Exerts a Nutrient-Specific Control over Central Metabolism in Escherichia coli Strain Nissle 1917	PLOS ONE			English	Article							BINDING PROTEIN CSRA; ISOTOPE LABELING EXPERIMENTS; RNA MOLECULE CSRB; MOUSE INTESTINE; GLUCOSE-METABOLISM; CARBOHYDRATE-METABOLISM; GLYCOGEN BIOSYNTHESIS; MASS-SPECTROMETRY; K-12 MG1655; GENE CSRA	The role of the post-transcriptional carbon storage regulator (Csr) system in nutrient utilization and in the control of the central metabolism in E. coli reference commensal strain Nissle 1917 was investigated. Analysis of the growth capabilities of mutants altered for various components of the Csr system (csrA51, csrB, csrC and csrD mutations) showed that only the protein CsrA - the key component of the system - exerts a marked role in carbon nutrition. Attenuation of CsrA activity in the csrA51 mutant affects the growth efficiency on a broad range of physiologically relevant carbon sources, including compounds utilized by the Entner-Doudoroff (ED) pathway. Detailed investigations of the metabolomes and fluxomes of mutants and wild-type cells grown on carbon sources representative of glycolysis and of the ED pathway (glucose and gluconate, respectively), revealed significant re-adjusting of central carbon metabolism for both compounds in the csrA51 mutant. However, the metabolic re-adjusting observed on gluconate was strikingly different from that observed on glucose, indicating a nutrient-specific control of metabolism by the Csr system.	[Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, LISBP,INP, Toulouse, France; [Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] INRA, UMR792, Lab Ingn Syst Biol & Proc, F-31931 Toulouse, France; [Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] INRA, USC1360, F-31931 Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] CNRS, UMR5282, Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, D-48149 Munster, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munster	Portais, JC (corresponding author), Univ Toulouse, INSA, UPS, LISBP,INP, Toulouse, France.	portais@insa-toulouse.fr	Dobrindt, Ulrich/AEU-2378-2022; Nougayrede, Jean-Philippe/I-6362-2019	Dobrindt, Ulrich/0000-0001-9949-1898; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Portais, Jean-Charles/0000-0002-3480-0933; Fabien, Letisse/0000-0002-1490-0152; Oswald, Eric/0000-0002-3017-0081; Millard, Pierre/0000-0002-8136-9963	Institut National de la Recherche Agronomique; German Research Foundation [SFB1009, TP B05]	Institut National de la Recherche Agronomique; German Research Foundation(German Research Foundation (DFG))	The postdoctoral and PhD fellowships of OR and PM, respectively, were funded by the Institut National de la Recherche Agronomique [PM: Progran Young Researcher]. This work has benefited from the continuous support of the Region Midi-Pyrenees, the European Regional Development Fund, the French Ministry for Higher Education & Research, and SICOVAL, and the Institut National de la Recherche Agronomique. UD was supported by the German Research Foundation [SFB1009, TP B05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bailey JK, 2010, J CLIN MICROBIOL, V48, P3455, DOI 10.1128/JCM.00760-10; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHESTER VE, 1968, J GEN MICROBIOL, V51, P47, DOI 10.1099/00221287-51-1-49; COCAIGNBOUSQUET M, 1995, J APPL BACTERIOL, V79, P108, DOI 10.1111/j.1365-2672.1995.tb03131.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Hancock V, 2010, J MED MICROBIOL, V59, P392, DOI 10.1099/jmm.0.008672-0; Heux S, 2011, APPL ENVIRON MICROB, V77, P7040, DOI 10.1128/AEM.05838-11; Hobman JL, 2007, MOL MICROBIOL, V64, P881, DOI 10.1111/j.1365-2958.2007.05710.x; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; LIU MY, 1995, J BACTERIOL, V177, P2663, DOI 10.1128/jb.177.10.2663-2672.1995; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Massou S, 2007, PHYTOCHEMISTRY, V68, P2330, DOI 10.1016/j.phytochem.2007.03.011; Massou S, 2007, METAB ENG, V9, P252, DOI 10.1016/j.ymben.2007.03.001; McKee AE, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-79; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Murray EL, 2005, J BACTERIOL, V187, P991, DOI 10.1128/JB.187.3.991-1000.2005; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Pernestig AK, 2003, J BACTERIOL, V185, P843, DOI 10.1128/JB.185.3.843-853.2003; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Portais JC, 1999, EUR J BIOCHEM, V265, P473, DOI 10.1046/j.1432-1327.1999.00778.x; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Sokol S, 2012, BIOINFORMATICS, V28, P687, DOI 10.1093/bioinformatics/btr716; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Todar K, 2007, PATHOGENIC E COLI ON, P11; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001	56	37	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66386	10.1371/journal.pone.0066386	http://dx.doi.org/10.1371/journal.pone.0066386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840455	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800055
J	Scarpetta, S; de Candia, A				Scarpetta, Silvia; de Candia, Antonio			Neural Avalanches at the Critical Point between Replay and Non-Replay of Spatiotemporal Patterns	PLOS ONE			English	Article							NEURONAL AVALANCHES; LEARNING RULE; HIPPOCAMPAL REPLAY; PREFRONTAL CORTEX; CORTICAL NETWORKS; VISUAL-CORTEX; MODEL; SEQUENCES; MEMORY; RETRIEVAL	We model spontaneous cortical activity with a network of coupled spiking units, in which multiple spatio-temporal patterns are stored as dynamical attractors. We introduce an order parameter, which measures the overlap (similarity) between the activity of the network and the stored patterns. We find that, depending on the excitability of the network, different working regimes are possible. For high excitability, the dynamical attractors are stable, and a collective activity that replays one of the stored patterns emerges spontaneously, while for low excitability, no replay is induced. Between these two regimes, there is a critical region in which the dynamical attractors are unstable, and intermittent short replays are induced by noise. At the critical spiking threshold, the order parameter goes from zero to one, and its fluctuations are maximized, as expected for a phase transition (and as observed in recent experimental results in the brain). Notably, in this critical region, the avalanche size and duration distributions follow power laws. Critical exponents are consistent with a scaling relationship observed recently in neural avalanches measurements. In conclusion, our simple model suggests that avalanche power laws in cortical spontaneous activity may be the effect of a network at the critical point between the replay and non-replay of spatio-temporal patterns.	[Scarpetta, Silvia] Univ Salerno, Dipartimento Fis ER Caianiello, Fisciano, SA, Italy; [Scarpetta, Silvia] INFN Gr Coll Salerno, Fisciano, SA, Italy; [de Candia, Antonio] Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [de Candia, Antonio] CNR SPIN, Sez Napoli, Naples, Italy; [de Candia, Antonio] Complesso Univ Monte S Angelo, Sez Napoli, Ist Nazl Fis Nucl, Naples, Italy	University of Salerno; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	Scarpetta, S (corresponding author), Univ Salerno, Dipartimento Fis ER Caianiello, Fisciano, SA, Italy.	silvia@sa.infn.it	scarpetta, silvia/D-5217-2014; de Candia, Antonio/F-4024-2016; Scarpetta, Silvia/M-8591-2015	de Candia, Antonio/0000-0002-9869-1297; Scarpetta, Silvia/0000-0003-4189-0065	University of Naples "Federico II"; University of Salerno	University of Naples "Federico II"; University of Salerno	This work was supported by university public funds from the University of Naples "Federico II" and University of Salerno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2002, P NATL ACAD SCI USA, V99, P10132, DOI 10.1073/pnas.132651299; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borisyuk R, 2013, BIOSYSTEMS, V112, P214, DOI 10.1016/j.biosystems.2013.03.018; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W., 2002, SPIKING NEURON MODEL; Giacco F, 2011, FRONT ARTIF INTEL AP, V234, P265, DOI 10.3233/978-1-60750-972-1-265; Gilson M, 2012, PLOS COMPUT BIOL, V6, DOI [10.1371/journal.pcbi. 100258., DOI 10.1371/J0URNAL.PCBI.100258]; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Luczak A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00030; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marinaro M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041909; Marinaro M, 2003, NEUROCOMPUTING, V52-4, P89, DOI 10.1016/S0925-2312(02)00836-6; Marinaro M, 2007, MATH BIOSCI, V207, P322, DOI 10.1016/j.mbs.2006.10.001; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Scarpetta S, 2005, HIPPOCAMPUS, V15, P979, DOI 10.1002/hipo.20124; Scarpetta S, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/28006; Scarpetta S, 2002, NEURAL COMPUT, V14, P2371, DOI 10.1162/08997660260293265; Scarpetta S, 2001, ADV NEUR IN, V13, P152; Scarpetta S, 2012, J COMPUT NEUROSCI, P1; Scarpetta S., 2010, FRONTIERS SYNAPTIC N, V2, P1; Scarpetta S, 2013, BIOSYSTEMS, V112, P258, DOI 10.1016/j.biosystems.2013.03.017; Scarpetta S, 2011, FRONT ARTIF INTEL AP, V226, P218, DOI 10.3233/978-1-60750-692-8-218; Scarpetta S, 2008, LECT NOTES COMPUT SC, V5286, P38; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Segev R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011920; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012	54	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64162	10.1371/journal.pone.0064162	http://dx.doi.org/10.1371/journal.pone.0064162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840301	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800004
J	Cervelli, M; Bellavia, G; D'Amelio, M; Cavallucci, V; Moreno, S; Berger, J; Nardacci, R; Marcoli, M; Maura, G; Piacentini, M; Amendola, R; Cecconi, F; Mariottini, P				Cervelli, Manuela; Bellavia, Gabriella; D'Amelio, Marcello; Cavallucci, Virve; Moreno, Sandra; Berger, Joachim; Nardacci, Roberta; Marcoli, Manuela; Maura, Guido; Piacentini, Mauro; Amendola, Roberto; Cecconi, Francesco; Mariottini, Paolo			A New Transgenic Mouse Model for Studying the Neurotoxicity of Spermine Oxidase Dosage in the Response to Excitotoxic Injury	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; ORNITHINE-DECARBOXYLASE ACTIVITY; POLYAMINE RECOGNITION SITE; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; KAINIC ACID; RAT-BRAIN; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; HUNTINGTONS-DISEASE; CELLULAR FUNCTIONS	Spermine oxidase is a FAD-containing enzyme involved in polyamines catabolism, selectively oxidizing spermine to produce H2O2, spermidine, and 3-aminopropanal. Spermine oxidase is highly expressed in the mouse brain and plays a key role in regulating the levels of spermine, which is involved in protein synthesis, cell division and cell growth. Spermine is normally released by neurons at synaptic sites where it exerts a neuromodulatory function, by specifically interacting with different types of ion channels, and with ionotropic glutamate receptors. In order to get an insight into the neurobiological roles of spermine oxidase and spermine, we have deregulated spermine oxidase gene expression producing and characterizing the transgenic mouse model JoSMOrec, conditionally overexpressing the enzyme in the neocortex. We have investigated the effects of spermine oxidase overexpression in the mouse neocortex by transcript accumulation, immunohistochemical analysis, enzymatic assays and polyamine content in young and aged animals. Transgenic JoSMOrec mice showed in the neocortex a higher H2O2 production in respect to Wild-Type controls, indicating an increase of oxidative stress due to SMO overexpression. Moreover, the response of transgenic mice to excitotoxic brain injury, induced by kainic acid injection, was evaluated by analysing the behavioural phenotype, the immunodistribution of neural cell populations, and the ultrastructural features of neocortical neurons. Spermine oxidase overexpression and the consequently altered polyamine levels in the neocortex affects the cytoarchitecture in the adult and aging brain, as well as after neurotoxic insult. It resulted that the transgenic JoSMOrec mouse line is more sensitive to KA than Wild-Type mice, indicating an important role of spermine oxidase during excitotoxicity. These results provide novel evidences of the complex and critical functions carried out by spermine oxidase and spermine in the mammalian brain.	[Cervelli, Manuela; Bellavia, Gabriella; Moreno, Sandra; Mariottini, Paolo] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [D'Amelio, Marcello; Cavallucci, Virve; Cecconi, Francesco] Fdn Santa Lucia, IRCCS, Lab Mol Neuroembryol, Rome, Italy; [Berger, Joachim] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Nardacci, Roberta; Piacentini, Mauro] IRCCS L Spallanzani, Ist Nazl Malattie Infett, Rome, Italy; [Marcoli, Manuela; Maura, Guido] Univ Genoa, Ctr Eccellenza Ric Biomed CEBR, Sez Farmacol & Tossicol, Dipartimento Farm, Genoa, Italy; [Amendola, Roberto] Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Ctr Ric Casaccia 2, Sez Tossicol & Sci Biomed BAS BIOTECMED, Rome, Italy	Roma Tre University; IRCCS Santa Lucia; Monash University; IRCCS Lazzaro Spallanzani; University of Genoa; Italian National Agency New Technical Energy & Sustainable Economics Development	Cervelli, M (corresponding author), Univ Roma Tre, Dipartimento Biol, Rome, Italy.	cervelli@uniroma3.it	Piacentini, Mauro/I-2411-2016; Moreno, Sandra/D-4254-2014; Nardacci, Roberta/K-6555-2016; Cecconi, Francesco/K-3969-2016; Cervelli, Manuela/ABC-6913-2020; Berger, Joachim/N-2979-2019; Amendola, Roberto/AAM-2034-2020; OLIVERIO, MARCO/F-2229-2010	Piacentini, Mauro/0000-0003-2919-1296; Nardacci, Roberta/0000-0002-9209-1207; Cecconi, Francesco/0000-0002-5614-4359; Cervelli, Manuela/0000-0001-8535-8279; Berger, Joachim/0000-0002-7859-545X; OLIVERIO, MARCO/0000-0002-0316-4364; Bellavia, Gabriella/0000-0003-0431-0180; marcoli, manuela/0000-0003-3261-5264; D'Amelio, Marcello/0000-0001-6526-1832; moreno, sandra/0000-0002-1079-3222; Cavallucci, Virve/0000-0003-3082-6359	Universita Roma Tre	Universita Roma Tre	The financial support utilized for this work was mainly from the Universita Roma Tre, the year budget was below 10,000 Euro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALHONEN L, 1995, INT J CANCER, V63, P402, DOI 10.1002/ijc.2910630317; Amendola R, 2009, CURR CANCER DRUG TAR, V9, P118, DOI 10.2174/156800909787580935; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Cervelli M, 2009, INT J BIOCHEM CELL B, V41, P934, DOI 10.1016/j.biocel.2008.09.009; COYLE JT, 1987, CIBA F SYMP, V126, P186; DEVERA N, 1991, J NEUROCHEM, V57, P1; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doctrow S R, 1997, Adv Pharmacol, V38, P247; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; Fiori LM, 2011, INT J NEUROPSYCHOPH, V14, P595, DOI 10.1017/S1461145710001574; Fiori LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015146; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; HALONEN T, 1993, EUR J NEUROSCI, V5, P1233, DOI 10.1111/j.1460-9568.1993.tb00978.x; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOGAN B, 1983, NATURE, V306, P313, DOI 10.1038/306313a0; Iannicola C, 2000, J NEUROCHEM, V75, P830, DOI 10.1046/j.1471-4159.2000.0750830.x; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Janne J, 2005, J CELL MOL MED, V9, P865, DOI 10.1111/j.1582-4934.2005.tb00385.x; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; Kaasinen SK, 2003, EXP NEUROL, V183, P645, DOI 10.1016/S0014-4886(03)00186-9; Kaasinen SK, 2004, PHARM BIOCH BEHAV, V78, P3545; Kauppinen RA, 1995, PROG NEUROBIOL, V47, P545, DOI 10.1016/0301-0082(95)00037-2; Liu W, 2001, J NEUROCHEM, V79, P976, DOI 10.1046/j.1471-4159.2001.00650.x; LUKKARAINEN J, 1995, EUR J NEUROSCI, V7, P1840, DOI 10.1111/j.1460-9568.1995.tb00704.x; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; Lukkarinen JA, 1999, BRAIN RES, V826, P325, DOI 10.1016/S0006-8993(99)01327-X; Lukkarinen JA, 1998, EUR J NEUROSCI, V10, P2046, DOI 10.1046/j.1460-9568.1998.00216.x; MARTINEZ E, 1991, LIFE SCI, V48, P77, DOI 10.1016/0024-3205(91)90427-D; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PASCHEN W, 1991, BRAIN RES, V566, P354, DOI 10.1016/0006-8993(91)91726-H; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1990, J CEREBR BLOOD F MET, V10, P236, DOI 10.1038/jcbfm.1990.40; Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200; Rea G, 2004, IUBMB LIFE, V56, P167, DOI 10.1080/15216540410001673996; Schauwecker PE, 2003, MOL BRAIN RES, V112, P70, DOI 10.1016/S0169-328X(03)00048-2; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wang YL, 2005, BIOCHEM J, V386, P543, DOI 10.1042/BJ20041084; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yoshida M, 2010, BIOCHEM BIOPH RES CO, V391, P1234, DOI 10.1016/j.bbrc.2009.12.049; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; Zhu XY, 2001, BRAIN RES, V922, P293, DOI 10.1016/S0006-8993(01)03159-6	60	35	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64810	10.1371/journal.pone.0064810	http://dx.doi.org/10.1371/journal.pone.0064810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840306	Green Published, gold			2022-12-25	WOS:000322361200005
J	Naik, H; Tsai, MC; Fiedler-Kelly, J; Qiu, P; Vakilynejad, M				Naik, Himanshu; Tsai, Max C.; Fiedler-Kelly, Jill; Qiu, Ping; Vakilynejad, Majid			A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis	PLOS ONE			English	Article							HEALTHY-SUBJECTS; ANEMIA; ERYTHROPOIETIN; HEMODIALYSIS; MODEL	Peginesatide (OMONTYS (R)) is an erythropoiesis-stimulating agent that was indicated in the United States for the treatment of anemia due to chronic kidney disease in adult patients on dialysis prior to its recent marketing withdrawal by the manufacturer. The objective of this analysis was to develop a population pharmacokinetic and pharmacodynamic model to characterize the time-course of peginesatide plasma and hemoglobin concentrations following intravenous and subcutaneous administration. Plasma samples (n = 2,665) from 672 patients with chronic kidney disease (on or not on dialysis) and hemoglobin samples (n = 18,857) from 517 hemodialysis patients (subset of the 672 patients), were used for pharmacokinetic-pharmacodynamic model development in NONMEM VI. The pharmacokinetic profile of peginesatide was best described by a two-compartment model with first-order absorption and saturable elimination. The relationship between peginesatide and hemoglobin plasma concentrations was best characterized by a modified precursor-dependent lifespan indirect response model. The estimate of maximal stimulatory effect of peginesatide on the endogenous production rate of progenitor cells (Emax) was 0.54. The estimate of peginesatide drug concentration required for 50% of maximal response (EC50) estimates was 0.4 mu g/mL. Several significant (P<0.005) covariates affected simulated peginesatide exposure by <= 36%. Based upon <= 0.2 g/dL effects on simulated hemoglobin levels, none were considered clinically relevant.	[Naik, Himanshu; Tsai, Max C.; Vakilynejad, Majid] Takeda Global Res & Dev Inc, Pharmacometr, Deerfield, IL USA; [Fiedler-Kelly, Jill] Cognigen Corp, Pharmacometr Serv, Buffalo, NY USA; [Qiu, Ping] Takeda Global Res & Dev Inc, Clin Sci, Deerfield, IL USA		Vakilynejad, M (corresponding author), Takeda Global Res & Dev Inc, Pharmacometr, Deerfield, IL USA.	majid.vakilynejad@takeda.com			Takeda Global Research & Development Center, Inc.	Takeda Global Research & Development Center, Inc.	This study was supported by Takeda Global Research & Development Center, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Besarab A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-95; Boxenbaum H, 1998, J Pharm Pharm Sci, V1, P90; CDC, 2010, NAT CHRON KIDN DIS F; Chanu P, 2010, J CLIN PHARMACOL, V50, P507, DOI 10.1177/0091270009343931; Doshi S, 2010, J CLIN PHARMACOL, V50, p75S, DOI 10.1177/0091270010377201; Fishbane S, 2013, NEW ENGL J MED, V368, P307, DOI 10.1056/NEJMoa1203165; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Macdougall IC, 2011, CLIN J AM SOC NEPHRO, V6, P2579, DOI 10.2215/CJN.10831210; Mircera, 2007, MIRC METH POL GLYC E; National Kidney and Urologic Diseases Information Clearinghouse, 2011, KIDN UR DIS STAT US; Olsson-Gisleskog P, 2007, CLIN PHARMACOKINET, V46, P159, DOI 10.2165/00003088-200746020-00004; PDx-Pop, 2009, PDX POP TOOLS EXP PO; Peginesatide (OMONTYS&REG;) Prescribing Information, 2012, PEG OMONTYS PRESCR I, P60015; Roskos LK, 2006, J CLIN PHARMACOL, V46, P747, DOI 10.1177/0091270006288731; UEHLINGER DE, 1992, CLIN PHARMACOL THER, V51, P76, DOI 10.1038/clpt.1992.10; US Renal Data System, 2011, US REN DAT SYST 2011, V2; Woo S, 2008, J CLIN PHARMACOL, V48, P43, DOI 10.1177/0091270007309702; Woodburn KW, 2012, XENOBIOTICA, V42, P660, DOI 10.3109/00498254.2011.649310	19	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66422	10.1371/journal.pone.0066422	http://dx.doi.org/10.1371/journal.pone.0066422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840463	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200074
J	Berriman, ADC; Clancy, D; Clough, HE; Armstrong, D; Christley, RM				Berriman, Alexander D. C.; Clancy, Damian; Clough, Helen E.; Armstrong, Derek; Christley, Robert M.			Effectiveness of Simulated Interventions in Reducing the Estimated Prevalence of Salmonella in UK Pig Herds	PLOS ONE			English	Article							TYPHIMURIUM; CHOLERAESUIS; SWINE; EXCRETION; TRANSMISSION; VACCINATION; PERSISTENCE; SLAUGHTER; EFFICACY; LIVE	Salmonella spp are a major foodborne zoonotic cause of human illness. Consumption of pork products is believed to be a major source of human salmonellosis and Salmonella control throughout the food-chain is recommended. A number of on-farm interventions have been proposed, and some have been implemented in order to try to achieve Salmonella control. In this study we utilize previously developed models describing Salmonella dynamics to investigate the potential effects of a range of these on-farm interventions. As the models indicated that the number of bacteria shed in the faeces of an infectious animal was a key factor, interventions applied within a high-shedding scenario were also analysed. From simulation of the model, the probability of infection after Salmonella exposure was found to be a key driver of Salmonella transmission. The model also highlighted that minimising physiological stress can have a large effect but only when shedding levels are not excessive. When shedding was high, weekly cleaning and disinfection was not effective in Salmonella control. However it is possible that cleaning may have an effect if conducted more often. Furthermore, separating infectious animals, shedding bacteria at a high rate, from the rest of the population was found to be able to minimise the spread of Salmonella.	[Berriman, Alexander D. C.; Clough, Helen E.; Christley, Robert M.] Univ Liverpool, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England; [Clancy, Damian] Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England; [Armstrong, Derek] BPEX, Stoneleigh Pk, Warwick, England	University of Liverpool; University of Liverpool; Agriculture & Horticulture Development Board (AHDB)	Christley, RM (corresponding author), Univ Liverpool, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England.	robc@liverpool.ac.uk	Berriman, Alexander/D-1587-2014	Christley, Robert/0000-0001-9250-3032	Biotechnology and Biological Sciences Research Council (BBSRC); BPEX, Collaborative Award in Science and Engineering (CASE) studentship	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BPEX, Collaborative Award in Science and Engineering (CASE) studentship	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and BPEX, as part of a Collaborative Award in Science and Engineering (CASE) studentship (http://www.bbsrc.ac.uk/funding/studentships/case.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHVLA, 2011, INT REP EP STUD MULT; [Anonymous], 2012, ANN REPORT ZOONOSES; Berriman ADC, 2013, SEMISTOCHAS IN PRESS; Blanchard P., 2003, Pig Journal, V52, P182; Bolton DJ, 2003, J APPL MICROBIOL, V94, P1036, DOI 10.1046/j.1365-2672.2003.01938.x; British Pig Executive, 2007, PIG YB; Davies RH, 2004, J APPL MICROBIOL, V96, P750, DOI 10.1111/j.1365-2672.2004.02192.x; DEFRA, 2011, ZOON REP UK 2009; DEFRA, 2006, ZOON AB SURV FOODB P; DEFRA, 2008, BIOS GUID PREV SPREA; Denagamage TN, 2007, FOODBORNE PATHOG DIS, V4, P539, DOI 10.1089/fpd.2007.0013; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; EFSA, 2010, QUANT MICR RISK ASS; Erdman MM, 2005, JAVMA-J AM VET MED A, V227, P460, DOI 10.2460/javma.2005.227.460; Gray JT, 1996, APPL ENVIRON MICROB, V62, P141, DOI 10.1128/AEM.62.1.141-146.1996; GRAY JT, 1995, VET MICROBIOL, V47, P43, DOI 10.1016/0378-1135(95)00060-N; Gray JT, 1996, AM J VET RES, V57, P313; Gray JT, 2001, J FOOD PROTECT, V64, P945, DOI 10.4315/0362-028X-64.7.945; GUTZMANN F, 1976, AM J VET RES, V37, P649; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hill AA, 2008, EPIDEMIOL INFECT, V136, P320, DOI 10.1017/S0950268807008485; Ivanek R, 2004, J FOOD PROTECT, V67, P2403, DOI 10.4315/0362-028X-67.11.2403; Jensen A, 2005, SALMONELLA INFECT RI, P8793; Kranker S, 2003, J CLIN MICROBIOL, V41, P2282, DOI 10.1128/JCM.41.6.2282-2288.2003; Leek ABG, 2005, IRISH J AGR FOOD RES, V44, P247; Letellier A, 2000, CAN J VET RES, V64, P27; Lurette A, 2008, VET RES, V39, DOI 10.1051/vetres:2008026; MLC, 2006, BRIT PIG PROJ HOUS B; MORGAN IR, 1987, EPIDEMIOL INFECT, V98, P323, DOI 10.1017/S0950268800062075; Osterberg J, 2008, VET REC, V162, P580, DOI 10.1136/vr.162.18.580; Pires SM, 2011, EFSA ESTIMATIO UNPUB; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Potter Andrew, 2008, Animal Health Research Reviews, V9, P187, DOI 10.1017/S1466252308001606; ROBERTS MG, 2003, ENCY LIFE SUPPORT SY; Rostagno MH, 2011, VET REC, V169, P551, DOI 10.1136/vr.d7419; Schwarz P, 2011, VET RECORD, V169; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Soumpasis I, 2009, RISK ANAL, V29, P1521, DOI 10.1111/j.1539-6924.2009.01274.x; Swanenburg M, 2001, INT J FOOD MICROBIOL, V70, P243, DOI 10.1016/S0168-1605(01)00545-1; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; VLA, 2007, SALM LIV PROD GB 200; WILLIAMS LP, 1970, AM J PUBLIC HEALTH N, V60, P926, DOI 10.2105/AJPH.60.5.926; WILLIAMS RD, 1978, ANTIMICROB AGENTS CH, V14, P710, DOI 10.1128/AAC.14.5.710; Wong DMALF, 2002, LIVEST PROD SCI, V76, P215	45	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66054	10.1371/journal.pone.0066054	http://dx.doi.org/10.1371/journal.pone.0066054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840399	gold, Green Submitted, Green Published			2022-12-25	WOS:000321148400010
J	Cubi, R; Candalija, A; Ortega, A; Gil, C; Aguilera, J				Cubi, Roger; Candalija, Ana; Ortega, Arturo; Gil, Carles; Aguilera, Jose			Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress	PLOS ONE			English	Article							HEAVY-CHAIN; LIPID RAFTS; ACID SPHINGOMYELINASE; C-FRAGMENT; SYNAPTOTAGMIN-I; TERMINAL DOMAIN; RECEPTOR; KINASE; ACTIVATION; REQUIRES	Tetanus toxin (TeTx) is the protein, synthesized by the anaerobic bacteria Clostridium tetani, which causes tetanus disease. TeTx gains entry into target cells by means of its interaction with lipid rafts, which are membrane domains enriched in sphingomyelin and cholesterol. However, the exact mechanism of host membrane binding remains to be fully established. In the present study we used the recombinant carboxyl terminal fragment from TeTx (Hc-TeTx), the domain responsible for target neuron binding, showing that Hc-TeTx induces a moderate but rapid and sustained increase in the ceramide/sphingomyelin ratio in primary cultures of cerebellar granule neurons and in NGF-differentiated PC12 cells, as well as induces the formation of ceramide platforms in the plasma membrane. The mentioned increase is due to the promotion of neutral sphingomyelinase activity and not to the de novo synthesis, since GW4869, a specific neutral sphingomyelinase inhibitor, prevents neutral sphingomyelinase activity increase and formation of ceramide platforms. Moreover, neutral sphingomyelinase inhibition with GW4869 prevents Hc-TeTx-triggered signaling (Akt phosphorylation), as well as the protective effect of Hc-TeTx on PC12 cells subjected to oxidative stress, while siRNA directed against nSM2 prevents protection by Hc-TeTx of NSC-34 cells against oxidative insult. Finally, neutral sphingomyelinase activity seems not to be related with the internalization of Hc-TeTx into PC12 cells. Thus, the presented data shed light on the mechanisms triggered by TeTx after membrane binding, which could be related with the events leading to the neuroprotective action exerted by the Hc-TeTx fragment.	[Cubi, Roger; Candalija, Ana; Gil, Carles; Aguilera, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain; [Cubi, Roger; Candalija, Ana; Gil, Carles; Aguilera, Jose] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Catalunya, Spain; [Ortega, Arturo] Cinvestav IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Aguilera, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CIBERNED	Gil, C (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain.	carles.gil@uab.cat	Gil, Carles/AAI-9532-2020; Gil, Carles/C-7016-2008; Ortega, Arturo/A-2282-2008; Aguilera, Jose/N-6519-2015	Gil, Carles/0000-0003-2976-4146; Ortega, Arturo/0000-0002-9594-8114; Aguilera, Jose/0000-0002-9906-8034; Cubi, Roger/0000-0003-2762-9928; Candalija, Ana/0000-0002-5003-3789	Ministerio de Ciencia e Innovacion from the Spanish Government [BFU2009-10189, SAF2009-13626, SAF2008-00732]	Ministerio de Ciencia e Innovacion from the Spanish Government(Spanish Government)	This work was supported by grants BFU2009-10189, SAF2009-13626 and SAF2008-00732 from the Ministerio de Ciencia e Innovacion from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Albi E, 2004, BIOL CELL, V96, P657, DOI 10.1016/j.biolcel.2004.05.004; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bentley JK, 2007, J VIROL, V81, P1186, DOI 10.1128/JVI.02309-06; Bhuiyan MIH, 2010, BIOL PHARM BULL, V33, P11, DOI 10.1248/bpb.33.11; Chai Y, 2006, BIOCHEM BIOPH RES CO, V350, P307, DOI 10.1016/j.bbrc.2006.09.045; Chaib-Oukadour I, 2004, J NEUROCHEM, V90, P1227, DOI 10.1111/j.1471-4159.2004.02586.x; Chaib-Oukadour I, 2009, MOL CELL NEUROSCI, V41, P297, DOI 10.1016/j.mcn.2009.03.006; de Chaves EIP, 2006, BBA-BIOMEMBRANES, V1758, P1995, DOI 10.1016/j.bbamem.2006.09.018; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dreschers S, 2007, CELL PHYSIOL BIOCHEM, V20, P241, DOI 10.1159/000104170; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Gil C, 2003, BIOCHEM J, V373, P613, DOI 10.1042/BJ20030333; Gil C, 2001, BIOCHEM J, V356, P97, DOI 10.1042/0264-6021:3560097; Gil C, 1998, J NEUROCHEM, V70, P1636; Gil C, 2000, FEBS LETT, V481, P177, DOI 10.1016/S0014-5793(00)02002-0; Gomez-Munoz A, 2005, FEBS LETT, V579, P3744, DOI 10.1016/j.febslet.2005.05.067; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; HALPERN JL, 1993, J BIOL CHEM, V268, P11188; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hauck CR, 2000, FEBS LETT, V478, P260, DOI 10.1016/S0014-5793(00)01851-2; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lalli G, 2003, TRENDS MICROBIOL, V11, P431, DOI 10.1016/S0966-842X(03)00210-5; Mendieta L, 2009, NEUROSCI RES, V65, P98, DOI 10.1016/j.neures.2009.06.001; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Munro P, 2001, BIOCHEM BIOPH RES CO, V289, P623, DOI 10.1006/bbrc.2001.6031; Murphy SC, 2006, MOL MEMBR BIOL, V23, P81, DOI 10.1080/09687860500473440; Numakawa T, 2003, J BIOL CHEM, V278, P41259, DOI 10.1074/jbc.M304409200; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Riethmuller J, 2006, BBA-BIOMEMBRANES, V1758, P2139, DOI 10.1016/j.bbamem.2006.07.017; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Samet D, 1999, CHEM PHYS LIPIDS, V102, P65, DOI 10.1016/S0009-3084(99)00076-6; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Takahashi T, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/245090; Toivonen JM, 2010, TOXINS, V2, P2622, DOI 10.3390/toxins2112622; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; van der Meer-Janssen YPM, 2010, PROG LIPID RES, V49, P1, DOI 10.1016/j.plipres.2009.07.003; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	61	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68055	10.1371/journal.pone.0068055	http://dx.doi.org/10.1371/journal.pone.0068055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826362	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000116
J	Gu, W; Song, JY; Cao, Y; Sun, QW; Yao, H; Wu, QN; Chao, JG; Zhou, JJ; Xue, WD; Duan, JA				Gu, Wei; Song, Jingyuan; Cao, Yuan; Sun, Qingwen; Yao, Hui; Wu, Qinan; Chao, Jianguo; Zhou, Juanjuan; Xue, Wenda; Duan, Jinao			Application of the ITS2 Region for Barcoding Medicinal Plants of Selaginellaceae in Pteridophyta	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODE; SPECIES IDENTIFICATION; DERIVATIVES; TAMARISCINA; BIFLAVONES; EVOLUTION; SEQUENCES	Background: Selaginellaceae is a family of nonseed plants with special evolutionary significance. Plants of the family Selaginellaceae are similarly shaped and easily confused, complicating identification via traditional methods. This study explored, for the first time, the use of the DNA barcode ITS2 to identify medicinal plants of the Selaginellaceae family. Methodology/Principal Findings: In our study, 103 samples were collected from the main distribution areas in China; these samples represented 34 species and contained almost all of the medicinal plants of Selaginellaceae. The ITS2 region of the genome was amplified from these samples and sequenced using universal primers and reaction conditions. The success rates of the PCR amplification and sequencing were 100%. There was significant divergence between the interspecific and intraspecific genetic distances of the ITS2 regions, while the presence of a barcoding gap was obvious. Using the BLAST1 and nearest distance methods, our results proved that the ITS2 regions could successfully identify the species of all Selaginellaceae samples examined. In addition, the secondary structures of ITS2 in the helical regions displayed clear differences in stem loop number, size, position, and screw angle among the medicinal plants of Selaginellaceae. Furthermore, cluster analysis using the ITS2 barcode supported the relationship between the species of Selaginellaceae established by traditional morphological methods. Conclusion: The ITS2 barcode can effectively identify medicinal plants of Selaginellaceae. The results provide a scientific basis for the precise identification of plants of the family Selaginellaceae and the reasonable development of these resources. This study may broaden the application of DNA barcoding in the medicinal plant field and benefit phylogenetic investigations.	[Gu, Wei; Cao, Yuan; Wu, Qinan; Chao, Jianguo; Zhou, Juanjuan; Xue, Wenda; Duan, Jinao] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Song, Jingyuan; Yao, Hui] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Sun, Qingwen] Guiyang Coll Tradit Chinese Med, Dept Pharm, Guiyang, Peoples R China	Nanjing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Guizhou University of Traditional Chinese Medicine	Duan, JA (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	guwei9266@126.com	Yao, hui/AAM-2391-2021; Xue, Wenda/AAR-9273-2020	Xue, Wenda/0000-0001-9606-062X; Wu, Qinan/0000-0002-7836-0941	Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD [ysxk-2010]; National Natural Science Foundation of China [81102772]; Qing Lan Project; Fundamental Research Funds for the Central Universities [2012C02]	Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project(Jiangsu Polytech Institute); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD(ysxk-2010), the National Natural Science Foundation of China (No. 81102772), the Qing Lan Project, and the Fundamental Research Funds for the Central Universities (No. 2012C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Cao Y, 2010, FITOTERAPIA, V81, P253, DOI 10.1016/j.fitote.2009.09.007; Cao Y, 2010, BIOORG MED CHEM LETT, V20, P2456, DOI 10.1016/j.bmcl.2010.03.016; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Commission CP, 2010, PHARMACOPOEIA PEOPLE, P210; de Sa PGS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-187; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Federici S, 2013, BOT J LINN SOC, V171, P687, DOI 10.1111/boj.12034; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gayathri V, 2011, IMMUNOPHARM IMMUNOT, V33, P351, DOI 10.3109/08923973.2010.518617; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Korall P, 2004, MOL PHYLOGENET EVOL, V31, P852, DOI 10.1016/j.ympev.2003.10.014; Korall P, 2002, AM J BOT, V89, P506, DOI 10.3732/ajb.89.3.506; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Li GL, 2012, P NATL ACAD SCI USA, V109, P14711, DOI 10.1073/pnas.1204300109; Liu C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S4; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Marcon AB, 2005, ANN BOT-LONDON, V95, P271, DOI 10.1093/aob/mci022; Mishra PK, 2011, BRIT J NUTR, V106, P1154, DOI 10.1017/S0007114511001498; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Rai Padmalatha S, 2012, J Ayurveda Integr Med, V3, P136, DOI 10.4103/0975-9476.100177; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shakirov EV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00161; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Smith DR, 2009, PLANT MOL BIOL, V71, P627, DOI 10.1007/s11103-009-9545-3; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang YH, 2009, J NAT PROD, V72, P1151, DOI 10.1021/np9001515; Yang C, 2012, BEILSTEIN J ORG CHEM, V8, P1884, DOI 10.3762/bjoc.8.217; Yobi A, 2012, PLANT J, V72, P983, DOI 10.1111/tpj.12008; Zhang GG, 2012, PLANTA MED, V78, P390, DOI 10.1055/s-0031-1298175; Zhang YX, 2011, RAPID COMMUN MASS SP, V25, P2173, DOI 10.1002/rcm.5090; Zhang YP, 2011, J CHROMATOGR B, V879, P191, DOI 10.1016/j.jchromb.2010.12.004; Zheng XK, 2011, J ETHNOPHARMACOL, V133, P531, DOI 10.1016/j.jep.2010.10.028	46	46	69	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67818	10.1371/journal.pone.0067818	http://dx.doi.org/10.1371/journal.pone.0067818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826345	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000102
J	Huang, QB; Ma, X; Zhang, X; Liu, SW; Ai, Q; Shi, TP; Zhang, Y; Gao, Y; Fan, Y; Ni, D; Wang, BJ; Li, HZ; Zheng, T				Huang, Qing Bo; Ma, Xin; Zhang, Xu; Liu, Shang Wen; Ai, Qing; Shi, Tao Ping; Zhang, Yu; Gao, Yu; Fan, Yang; Ni, Dong; Wang, Bao Jun; Li, Hong Zhao; Zheng, Tao			Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; UP-REGULATION; STEM-CELLS; MICRORNAS; INVASION; VEGF; MICROVESICLES; EXPRESSION; BLOCKADE; ROLES	Background: Endothelial DLL4 plays an important role in controlling of tumor angiogenesis, which is required for tumor invasive growth and metastasis. However, the regulation of DLL4 in clear cell renal cell carcinoma (ccRCC) has not yet been systematically elucidated. Methodology: We performed bioinformatical analysis to explore miRNAs targeting DLL4. miR-30a was selected as a representative to validate its functional association in endothelial cell. Then, the expressions of DLL4 and mature miR-30a from 90 cases of ccRCC and 28 cases of nonmatched adjacent non-tumor tissues were measured by quantitative real-time PCR. Finally, the expression of miR-30a was correlated with DLL4 expression, tumor features (metastatic condition and microvessel density), and patient metastasis-free survival. The univariate and multivariate analyses were performed to select the risk factors associated with hematogenous metastasis, respectively. Principal Findings: miR-30a negatively regulated DLL4 and inhibited the proliferation and migration of endothelial cells. DLL4 was up-regulated in ccRCC and further increased in hematogenous metastatic cases, while miR-30a was down-regulated in tumor tissues and further decreased in hematogenous metastatic ccRCC (student down-regulated test, all p<0.05). Additionally, expression of miR-30a was inversely correlated with expression of DLL4 and microvessel density (linear correlation analysis, both p<0.05). Low-level miR-30a also indicated a higher probability of developing metastasis (log-rank test, p = 0.010). Most importantly, miR-30a expression was an independent predictor of ccRCC hematogenous metastasis by the univariate analysis and binary logistic regression model (both p<0.05). Conclusions: Down-regulated miR-30a in ccRCC was associated with tumor hematogenous metastasis through increasing microvessel density by targeting angiogenesis-specific DLL4.	[Huang, Qing Bo; Ma, Xin; Zhang, Xu; Ai, Qing; Shi, Tao Ping; Zhang, Yu; Gao, Yu; Fan, Yang; Ni, Dong; Wang, Bao Jun; Li, Hong Zhao; Zheng, Tao] Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China; [Liu, Shang Wen] Chinese PLA 303 Hosp, Dept Urol, Nanning, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China.	xzhang@foxmail.com	zhang, xu/GYE-3558-2022		National Nature Science Foundation [81100483]; Scientific Research Project for Health Industry [201002010]; National High Technology Research and Development Program ("863" Program), People's Republic of China [2012AA02101]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Project for Health Industry; National High Technology Research and Development Program ("863" Program), People's Republic of China(National High Technology Research and Development Program of China)	This work was supported by National Nature Science Foundation (No. 81100483), Scientific Research Project for Health Industry (No. 201002010) and the National High Technology Research and Development Program ("863" Program, No. 2012AA02101), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Ai Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Bukowski RM, 1997, CANCER-AM CANCER SOC, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Daubman S, 2010, CIRC RES, V106, P423, DOI 10.1161/RES.0b013e3181d61a0d; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu S, 2011, UROL ONCOL; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Santarpia L, 2010, ENDOCR-RELAT CANCER, V17, pF51, DOI 10.1677/ERC-09-0222; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zhang C, 2012, J HUAZHONG U SCI-MED, V32, P375, DOI 10.1007/s11596-012-0065-z; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	45	56	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67294	10.1371/journal.pone.0067294	http://dx.doi.org/10.1371/journal.pone.0067294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826258	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000057
J	Laido, G; Mangini, G; Taranto, F; Gadaleta, A; Blanco, A; Cattivelli, L; Marone, D; Mastrangelo, AM; Papa, R; De Vita, P				Laido, Giovanni; Mangini, Giacomo; Taranto, Francesca; Gadaleta, Agata; Blanco, Antonio; Cattivelli, Luigi; Marone, Daniela; Mastrangelo, Anna M.; Papa, Roberto; De Vita, Pasquale			Genetic Diversity and Population Structure of Tetraploid Wheats (Triticum turgidum L.) Estimated by SSR, DArT and Pedigree Data	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNIT; FREE-THRESHING HABIT; DURUM DESF. MACKEY; WILD EMMER WHEAT; LINKAGE DISEQUILIBRIUM; QUALITATIVE TRAITS; CULTIVARS; EVOLUTION; GERMPLASM; AFLP	Levels of genetic diversity and population genetic structure of a collection of 230 accessions of seven tetraploid Triticum turgidum L. subspecies were investigated using six morphological, nine seed storage protein loci, 26 SSRs and 970 DArT markers. The genetic diversity of the morphological traits and seed storage proteins was always lower in the durum wheat compared to the wild and domesticated emmer. Using Bayesian clustering (K = 2), both of the sets of molecular markers distinguished the durum wheat cultivars from the other tetraploid subspecies, and two distinct subgroups were detected within the durum wheat subspecies, which is in agreement with their origin and year of release. The genetic diversity of morphological traits and seed storage proteins was always lower in the improved durum cultivars registered after 1990, than in the intermediate and older ones. This marked effect on diversity was not observed for molecular markers, where there was only a weak reduction. At K >2, the SSR markers showed a greater degree of resolution than for DArT, with their identification of a greater number of groups within each subspecies. Analysis of DArT marker differentiation between the wheat subspecies indicated outlier loci that are potentially linked to genes controlling some important agronomic traits. Among the 211 loci identified under selection, 109 markers were recently mapped, and some of these markers were clustered into specific regions on chromosome arms 2BL, 3BS and 4AL, where several genes/quantitative trait loci (QTLs) are involved in the domestication of tetraploid wheats, such as the tenacious glumes (Tg) and brittle rachis (Br) characteristics. On the basis of these results, it can be assumed that the population structure of the tetraploid wheat collection partially reflects the evolutionary history of Triticum turgidum L. subspecies and the genetic potential of landraces and wild accessions for the detection of unexplored alleles.	[Laido, Giovanni; Cattivelli, Luigi; Marone, Daniela; Mastrangelo, Anna M.; Papa, Roberto; De Vita, Pasquale] Cereal Res Ctr, Consiglio Ric Sperimentaz Agr, Foggia, Italy; [Mangini, Giacomo; Taranto, Francesca; Gadaleta, Agata; Blanco, Antonio] Univ Bari, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universita degli Studi di Bari Aldo Moro	De Vita, P (corresponding author), Cereal Res Ctr, Consiglio Ric Sperimentaz Agr, Foggia, Italy.	pasquale.devita@entecra.it	Taranto, Francesca/V-1670-2018; Gadaleta, Agata/H-2627-2012; cattivelli, luigi/AAE-7046-2020; papa, roberto/F-9510-2014	Taranto, Francesca/0000-0002-7849-9038; Gadaleta, Agata/0000-0002-6312-249X; cattivelli, luigi/0000-0002-6067-4600; papa, roberto/0000-0001-9598-3131; BLANCO, ANTONIO/0000-0002-2222-1133; Mastrangelo, Anna Maria/0000-0002-3618-0301; Marone, Daniela/0000-0002-2365-6091; De Vita, Pasquale/0000-0002-9573-0510; Mangini, Giacomo/0000-0002-6600-2178	Ministry of Agricultural, Food and Forestry Policies (Italy)	Ministry of Agricultural, Food and Forestry Policies (Italy)	This works has been funded by the research project Esplora, Biomassval, RGV-FAO and Sicerme2 from the Ministry of Agricultural, Food and Forestry Policies (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiriano E, 2008, SPAN J AGRIC RES, V6, P599, DOI 10.5424/sjar/2008064-353; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Allard RW, 1996, EUPHYTICA, V92, P1, DOI 10.1007/BF00022822; Altintas S, 2008, PLANT BREEDING, V127, P9, DOI 10.1111/j.1439-0523.2007.01424.x; Autrique E, 1996, CROP SCI, V36, P735, DOI 10.2135/cropsci1996.0011183X003600030036x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; BOGGINI G, 1995, J CEREAL SCI, V22, P105, DOI 10.1016/0733-5210(95)90039-X; BRANLARD G, 1989, THEOR APPL GENET, V78, P353, DOI 10.1007/BF00265296; BUSHUK W, 1978, CAN J PLANT SCI, V58, P1019, DOI 10.4141/cjps78-155; Carmona S, 2010, BIOL PLANTARUM, V54, P69, DOI 10.1007/s10535-010-0010-6; COX TS, 1985, CROP SCI, V25, P1058, DOI 10.2135/cropsci1985.0011183X002500060039x; COX TS, 1990, THEOR APPL GENET, V79, P241, DOI 10.1007/BF00225958; DAMANIA AB, 1983, EUPHYTICA, V32, P877, DOI 10.1007/BF00042169; De Vita P, 2006, EUPHYTICA, V150, P195, DOI 10.1007/s10681-006-9107-6; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Dedkova OS, 2009, RUSS J GENET+, V45, P1082, DOI 10.1134/S1022795409090099; Digesu AM, 2009, J CEREAL SCI, V50, P210, DOI 10.1016/j.jcs.2009.05.002; Donini P, 2000, THEOR APPL GENET, V100, P912, DOI 10.1007/s001220051370; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Ellis RP, 1997, MOL BREEDING, V3, P359, DOI 10.1023/A:1009602321815; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YB, 2006, THEOR APPL GENET, V112, P1239, DOI 10.1007/s00122-006-0225-2; Fu YB, 2005, THEOR APPL GENET, V110, P1505, DOI 10.1007/s00122-005-1988-6; Fu YB, 2009, CROP SCI, V49, P161, DOI 10.2135/cropsci2008.03.0125; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; GRANER A, 1994, CROP SCI, V34, P1199, DOI 10.2135/cropsci1994.0011183X003400050010x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kuckuck H., 1979, Wheat Information Service, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFIANDRA D, 1985, CEREAL CHEM, V62, P314; Li QY, 2006, PLANT BREEDING, V125, P120, DOI 10.1111/j.1439-0523.2006.01173.x; Li W, 2006, RUSS J GENET+, V42, P311, DOI 10.1134/S1022795406030124; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; MACKEY J, 1988, BIOL ZBL, V107, P369; Manninen O, 1997, HEREDITAS, V126, P87, DOI 10.1111/j.1601-5223.1997.00087.x; MANTEL N, 1967, CANCER RES, V27, P209; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; Marone D, 2009, MOL BREEDING, V24, P25, DOI 10.1007/s11032-009-9268-9; MARTIN JM, 1991, CROP SCI, V31, P1131, DOI 10.2135/cropsci1991.0011183X003100050009x; Martos V, 2005, FIELD CROP RES, V91, P107, DOI 10.1016/j.fcr.2004.06.003; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; McIntosh R.A., 2006, CATALOGUE GENE SYMBO; Medini M, 2005, GENET RESOUR CROP EV, V52, P21, DOI 10.1007/s10722-005-0225-0; Mikel MA, 2008, CROP SCI, V48, P1399, DOI 10.2135/cropsci2008.01.0029; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Moragues M, 2006, GENET RESOUR CROP EV, V53, P993, DOI 10.1007/s10722-004-7367-3; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NietoTaladriz MT, 1997, THEOR APPL GENET, V95, P1155, DOI 10.1007/s001220050676; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Ozbek O, 2007, THEOR APPL GENET, V115, P19, DOI 10.1007/s00122-007-0536-y; PAN D, 2007, J PLANT SCI, V2, P416; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Pritchard JK, 2000, GENETICS, V155, P945; Riefolo C, 2011, CEREAL RES COMMUN, V39, P405, DOI 10.1556/CRC.39.2011.3.10; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; Ruiz M, 2012, CROP SCI, V52, P2262, DOI 10.2135/cropsci2012.02.0081; Russo MA, 2012, J PLANT INTERACT, V7, P290, DOI 10.1080/17429145.2011.640437; Schiemann E, 1948, WEIZEN ROGGEN GERSTE, P1; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Simonetti MC, 1999, GENET RESOUR CROP EV, V46, P267, DOI 10.1023/A:1008602009133; Sissons MJ, 2003, CEREAL CHEM, V80, P468, DOI 10.1094/CCHEM.2003.80.4.468; Soleiman VD, 2007, GENET RESOUR CROP EV, V54, P83, DOI 10.1007/s10722-005-1886-4; Soleimani VD, 2002, THEOR APPL GENET, V104, P350, DOI 10.1007/s001220100714; Sood S, 2009, THEOR APPL GENET, V119, P341, DOI 10.1007/s00122-009-1043-0; SOUZA E, 1989, CROP SCI, V29, P595, DOI 10.2135/cropsci1989.0011183X002900030008x; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thuillet AC, 2005, GENETICS, V169, P1589, DOI 10.1534/genetics.104.029553; TINKER NA, 1993, J HERED, V84, P238, DOI 10.1093/oxfordjournals.jhered.a111330; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Van Slageren MW, 1994, WAGENINGEN AGR U PAP; Wang SL, 2011, GENOME, V54, P273, DOI [10.1139/G10-119, 10.1139/g10-119]; Zhang LY, 2009, THEOR APPL GENET, V119, P43, DOI 10.1007/s00122-009-1015-4; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42	87	98	100	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67280	10.1371/journal.pone.0067280	http://dx.doi.org/10.1371/journal.pone.0067280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826256	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000056
J	Maier, M; Liebert, UG; Wittekind, C; Kaiser, T; Berg, T; Wiegand, J				Maier, Melanie; Liebert, Uwe G.; Wittekind, Christian; Kaiser, Thorsten; Berg, Thomas; Wiegand, Johannes			Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							VIRUS DNA QUANTIFICATION; TENOFOVIR DISOPROXIL FUMARATE; TIME PCR ASSAY; ENTECAVIR TREATMENT; VIRAL SUPPRESSION; LAMIVUDINE; INFECTION; PERFORMANCE; CIRRHOSIS; RESISTANCE	Background: Successful therapy of chronic hepatitis B with nucleos(t)ide analogues (NUCs) has been defined by undetectable HBV-DNA determined with conventional PCR (lower limit of detection (LLD) 60-80 IU/mL) in clinical registration trials. However, current EASL guidelines recommend highly sensitive real-time PCR (LLD<10-20 IU/mL) and define treatment response by HBV-DNA, 10 IU/mL. Aim: We evaluated frequency and relevance of minimal residual viremia (MRV) during long-term NUC-treatment in a real-life setting. Methods: Frozen serum samples (HBV-DNA negative by in-house PCR, LLD<73 IU/mL) were re-analyzed by real-time PCR (LLD<10 IU/mL, Abbott, Germany). MRV was defined by real time PCR positivity and conventional PCR negativity. Results: 237 samples of six HBsAg carriers and 27 NUC-treated CHB patients were analyzed (treatment period 28 (11-111) months, different treatment regimens with mono- or combination therapy). MRV was detected in 31/33 individuals (n = 160/237 serum samples) and more frequent in HBsAg carriers (95%) and HBeAg positive (87%) compared to HBeAg negative patients (53%) (p<0.0001, respectively). Five HBsAg carriers, five HBeAg positive, and four HBeAg negative individuals were continuously HBV-DNA positive. MRV was not significantly more often observed during NUC-monotherapies compared to combination therapies. Concomitant immunosuppressive therapy was present in nine cases and did not influence the results. Viral resistance occurred in three immunocompetent patients with adefovir or lamivudine monotherapy. Conclusions: MRV is frequently observed during long-term NUC-therapy. Adjustment of treatment with highly potent NUCs does not seem to be necessary in case of minimal residual viremia in a real-life setting.	[Maier, Melanie; Liebert, Uwe G.] Univ Klinikum Leipzig, Inst Virol, Leipzig, Germany; [Wittekind, Christian] Univ Klinikum Leipzig, Inst Pathol, Leipzig, Germany; [Kaiser, Thorsten] Univ Klinikum Leipzig, Inst Lab Med, Klin Chem & Mol Diagnost, Leipzig, Germany; [Berg, Thomas; Wiegand, Johannes] Univ Klinikum Leipzig, Dept Innere Med Dermatol & Neurol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Wiegand, J (corresponding author), Univ Klinikum Leipzig, Dept Innere Med Dermatol & Neurol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de		Berg, Thomas/0000-0003-0003-6241	Abbott, Wiesbaden, Germany	Abbott, Wiesbaden, Germany(Abbott Laboratories)	The project was funded by a research grant of Abbott, Wiesbaden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chevaliez S, 2008, J CLIN MICROBIOL, V46, P1716, DOI 10.1128/JCM.01248-07; Chevaliez S, 2010, J CLIN MICROBIOL, V48, P3641, DOI 10.1128/JCM.01306-10; Cornberg M, 2011, Z GASTROENTEROL, V49, P871, DOI 10.1055/s-0031-1273462; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Gordon SC, 2013, HEPATOLOGY, V58, P505, DOI 10.1002/hep.26277; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Ismail AM, 2011, J CLIN MICROBIOL, V49, P3215, DOI 10.1128/JCM.00915-11; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Locarnini S, 2005, SEMIN LIVER DIS, V25, P9, DOI 10.1055/s-2005-915645; Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2011, HEPATOLOGY, V54, p1011A; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; Yuen MF, 2011, AM J GASTROENTEROL, V106, P1264, DOI 10.1038/ajg.2011.45; Zoutendijk R, 2011, HEPATOLOGY, V54, P443, DOI 10.1002/hep.24406	23	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67481	10.1371/journal.pone.0067481	http://dx.doi.org/10.1371/journal.pone.0067481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826307	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000083
J	Zhang, ZJ; Fu, SN				Zhang, Zhi Jie; Fu, Siu Ngor			Shear Elastic Modulus on Patellar Tendon Captured from Supersonic Shear Imaging: Correlation with Tangent Traction Modulus Computed from Material Testing System and Test-Retest Reliability	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; ELASTOGRAPHY; STRENGTH	Characterization of the elastic properties of a tendon could enhance the diagnosis and treatment of tendon injuries. The purpose of this study was to examine the correlation between the shear elastic modulus on the patellar tendon captured from a Supersonic Shear Imaging (SSI) and the tangent traction modulus computed from a Material testing system (MTS) on 8 fresh patellar pig tendons (Experiment I). Test-retest reliability of the shear elastic modulus captured from the SSI was established in Experiment II on 22 patellar tendons of 11 healthy human subjects using the SSI. Spearman Correlation coefficients for the shear elastic modulus and tangent traction modulus ranged from 0.82 to 1.00 (all p<0.05) on the 8 tendons. The intra and inter-operator reliabilities were 0.98 (95% CI: 0.93-0.99) and 0.97 (95% CI: 0.93-0.98) respectively. The results from this study demonstrate that the shear elastic modulus of the patellar tendon measured by the SSI is related to the tangent traction modulus quantified by the MTS. The SSI shows good intra and inter-operator repeatability. Therefore, the present study shows that SSI can be used to assess elastic properties of a tendon.	[Zhang, Zhi Jie; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Peoples R China; [Zhang, Zhi Jie] Guangdong Prov Work Injury Rehabil Hosp, Dept Physiotherapy, Guangzhou, Guangdong, Peoples R China	Hong Kong Polytechnic University	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Peoples R China.	rsamyfu@inet.polyu.edu.hk	Zhang, Zhi Jie/AAR-1686-2020	FU, Amy/0000-0003-4405-015X				Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464; Carroll CC, 2008, J APPL PHYSIOL, V105, P1907, DOI 10.1152/japplphysiol.00059.2008; Domholdt E, 1993, PHYS THERAPY RES PRI, P153; Drakonaki EE, 2009, CLIN RADIOL, V64, P1196, DOI 10.1016/j.crad.2009.08.006; Hall TJ, 2003, ULTRASOUND MED BIOL, V29, P427, DOI 10.1016/S0301-5629(02)00733-0; Hansen P, 2006, CLIN BIOMECH, V21, P54, DOI 10.1016/j.clinbiomech.2005.07.008; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Maganaris CN, 2002, J BIOMECH, V35, P1019, DOI 10.1016/S0021-9290(02)00047-7; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074, DOI 10.2106/00004623-197658080-00006; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Thambyah A, 2000, CLIN BIOMECH, V15, P756, DOI 10.1016/S0268-0033(00)00047-4; TKACZUK H, 1968, ACTA ORTHOP SCAND, VS, P8; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	28	28	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68216	10.1371/journal.pone.0068216	http://dx.doi.org/10.1371/journal.pone.0068216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826378	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000132
J	Cooper, MJ; Cox, NJ; Zimmerman, EI; Dewar, BJ; Duncan, JS; Whittle, MC; Nguyen, TA; Jones, LS; Roy, SG; Smalley, DM; Kuan, PF; Richards, KL; Christopherson, RI; Jin, J; Frye, SV; Johnson, GL; Baldwin, AS; Graves, LM				Cooper, Matthew J.; Cox, Nathan J.; Zimmerman, Eric I.; Dewar, Brian J.; Duncan, James S.; Whittle, Martin C.; Nguyen, Thien A.; Jones, Lauren S.; Roy, Sreerupa Ghose; Smalley, David M.; Kuan, Pei Fen; Richards, Kristy L.; Christopherson, Richard I.; Jin, Jian; Frye, Stephen V.; Johnson, Gary L.; Baldwin, Albert S.; Graves, Lee M.			Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-TYROSINE KINASES; BCR-ABL; IMATINIB-RESISTANT; LYN KINASE; QUANTITATIVE-ANALYSIS; PROTEOMICS ANALYSIS; JNK ACTIVATION; MEK INHIBITION; IKK-ALPHA	Protein kinases play key roles in oncogenic signaling and are a major focus in the development of targeted cancer therapies. Imatinib, a BCR-Abl tyrosine kinase inhibitor, is a successful front-line treatment for chronic myelogenous leukemia (CML). However, resistance to imatinib may be acquired by BCR-Abl mutations or hyperactivation of Src family kinases such as Lyn. We have used multiplexed kinase inhibitor beads (MIBs) and quantitative mass spectrometry (MS) to compare kinase expression and activity in an imatinib-resistant (MYL-R) and -sensitive (MYL) cell model of CML. Using MIB/MS, expression and activity changes of over 150 kinases were quantitatively measured from various protein kinase families. Statistical analysis of experimental replicates assigned significance to 35 of these kinases, referred to as the MYL-R kinome profile. MIB/MS and immunoblotting confirmed the over-expression and activation of Lyn in MYL-R cells and identified additional kinases with increased (MEK, ERK, IKK alpha, PKC beta, NEK9) or decreased (Abl, Kit, JNK, ATM, Yes) abundance or activity. Inhibiting Lyn with dasatinib or by shRNA-mediated knockdown reduced the phosphorylation of MEK and IKK alpha. Because MYL-R cells showed elevated NF-kappa B signaling relative to MYL cells, as demonstrated by increased I kappa B alpha and IL-6 mRNA expression, we tested the effects of an IKK inhibitor (BAY 65-1942). MIB/MS and immunoblotting revealed that BAY 65-1942 increased MEK/ERK signaling and that this increase was prevented by co-treatment with a MEK inhibitor (AZD6244). Furthermore, the combined inhibition of MEK and IKK alpha resulted in reduced IL-6 mRNA expression, synergistic loss of cell viability and increased apoptosis. Thus, MIB/MS analysis identified MEK and IKK alpha as important downstream targets of Lyn, suggesting that co-targeting these kinases may provide a unique strategy to inhibit Lyn-dependent imatinib-resistant CML. These results demonstrate the utility of MIB/MS as a tool to identify dysregulated kinases and to interrogate kinome dynamics as cells respond to targeted kinase inhibition.	[Cooper, Matthew J.; Cox, Nathan J.; Zimmerman, Eric I.; Dewar, Brian J.; Duncan, James S.; Whittle, Martin C.; Nguyen, Thien A.; Jones, Lauren S.; Roy, Sreerupa Ghose; Smalley, David M.; Johnson, Gary L.; Graves, Lee M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Cooper, Matthew J.; Kuan, Pei Fen; Richards, Kristy L.; Johnson, Gary L.; Baldwin, Albert S.; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cooper, Matthew J.; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Kuan, Pei Fen] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Richards, Kristy L.] Univ N Carolina, Sch Med, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA; [Christopherson, Richard I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Jin, Jian; Frye, Stephen V.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	lmg@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; Graves, Lee/AAG-5470-2021; Kuan, Pei Fen/GRX-4622-2022; Christopherson, Richard/AAM-3115-2020; , Proteomics Core UNC/AAH-3777-2022; Core, Vector/CAF-4832-2022	Cox, Nathan/0000-0002-8573-5596	National Institutes of Health (NIH) [T32 AI07273, R01 GM101141, CA73756, CA75080]; NC TraCS; UCRF Team Science Innovation Award; University of North Carolina at Chapel Hill's Libraries; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756, T32CA071341, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101141, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC TraCS; UCRF Team Science Innovation Award; University of North Carolina at Chapel Hill's Libraries; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research support was provided by National Institutes of Health (NIH) grants T32 AI07273 (MJC), R01 GM101141 (LMG and GLJ), CA73756 (ASB) and CA75080 ASB), and by NC TraCS (LMG) (http://tracs.unc.edu) and the UCRF Team Science Innovation Award (LMG) (http://unclineberger.org/ucrf). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ault Patricia, 2007, Clin J Oncol Nurs, V11, P125, DOI 10.1188/07.CJON.125-129; Bantscheff M, 2007, PROTEOMICS BASED STR, V3, P1, DOI [10.1007/2789, DOI 10.1007/2789]; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bednarski BK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006992; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkopf SB, 2010, J PROTEOME RES, V9, P6033, DOI 10.1021/pr1008527; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Camarasa MV, 2005, J CELL BIOCHEM, V94, P98, DOI 10.1002/jcb.20278; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duncan EA, 2008, MOL CANCER THER, V7, P391, DOI 10.1158/1535-7163.MCT-07-0305; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Engler JR, 2010, LEUKEMIA, V24, P765, DOI 10.1038/leu.2010.16; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019169; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hayette S, 2011, LEUKEMIA RES, V35, P38, DOI 10.1016/j.leukres.2010.06.030; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2011, CELL CYCLE, V10, P250, DOI 10.4161/cc.10.2.14537; Hochhaus A, 2009, BEST PRACT RES CL HA, V22, P367, DOI 10.1016/j.beha.2009.05.004; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Inohara N, 2000, J BIOL CHEM, V275, P27823; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Ketley NJ, 2000, LEUKEMIA, V14, P620, DOI 10.1038/sj.leu.2401715; Lee F, 2008, INT J BIOCHEM CELL B, V40, P334, DOI 10.1016/j.biocel.2007.10.001; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mauro Michael J, 2006, Hematology Am Soc Hematol Educ Program, P219; Mian AA, 2009, LEUKEMIA, V23, P1614, DOI 10.1038/leu.2009.69; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nishioka C, 2010, LEUKEMIA, V24, P1631, DOI 10.1038/leu.2010.145; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; O'Hare T, 2008, JNCI-J NATL CANCER I, V100, P908, DOI 10.1093/jnci/djn204; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Pratilas CA, 2010, CLIN CANCER RES, V16, P3329, DOI 10.1158/1078-0432.CCR-09-3064; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ruvolo PP, 2011, J CELL BIOCHEM, V112, P1696, DOI 10.1002/jcb.23090; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Vondracek J, 2001, J LEUKOCYTE BIOL, V69, P794; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; Wang QZ, 2010, ACS CHEM BIOL, V5, P887, DOI 10.1021/cb100099h; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Wissing J, 2007, MOL CELL PROTEOMICS, V6, P537, DOI 10.1074/mcp.T600062-MCP200; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Wu ZX, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011635-1, 10.1074/mcp.M111.011635]; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhu FJ, 2009, OMICS, V13, P467, DOI 10.1089/omi.2009.0046; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	83	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66755	10.1371/journal.pone.0066755	http://dx.doi.org/10.1371/journal.pone.0066755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826126	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400044
J	Kurre, R; Kouzel, N; Ramakrishnan, K; Oldewurtel, ER; Maier, B				Kurre, Rainer; Kouzel, Nadzeya; Ramakrishnan, Kanimozhi; Oldewurtel, Enno R.; Maier, Berenike			Speed Switching of Gonococcal Surface Motility Correlates with Proton Motive Force	PLOS ONE			English	Article							IV PILI; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; BACILLUS-SUBTILIS; INTRACELLULAR PH; SUCCINIMIDYL ESTER; TWITCHING MOTILITY; MYXOCOCCUS-XANTHUS; NITRIC-OXIDE; MOTOR	Bacterial type IV pili are essential for adhesion to surfaces, motility, microcolony formation, and horizontal gene transfer in many bacterial species. These polymers are strong molecular motors that can retract at two different speeds. In the human pathogen Neisseria gonorrhoeae speed switching of single pili from 2 mu m/s to 1 mu m/s can be triggered by oxygen depletion. Here, we address the question how proton motive force (PMF) influences motor speed. Using pHluorin expression in combination with dyes that are sensitive to transmembrane Delta pH gradient or transmembrane potential Delta psi, we measured both components of the PMF at varying external pH. Depletion of PMF using uncouplers reversibly triggered switching into the low speed mode. Reduction of the PMF by approximate to 35 mV was enough to trigger speed switching. Reducing ATP levels by inhibition of the ATP synthase did not induce speed switching. Furthermore, we showed that the strictly aerobic Myxococcus xanthus failed to move upon depletion of PMF or oxygen, indicating that although the mechanical properties of the motor are conserved, its regulatory inputs have evolved differently. We conclude that depletion of PMF triggers speed switching of gonococcal pili. Although ATP is required for gonococcal pilus retraction, our data indicate that PMF is an independent additional energy source driving the high speed mode.	[Maier, Berenike] Univ Cologne, Dept Phys, D-50931 Cologne, Germany; Univ Cologne, Bioctr, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Maier, B (corresponding author), Univ Cologne, Dept Phys, D-50931 Cologne, Germany.	berenike.maier@uni-koeln.de	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927; Oldewurtel, Enno/0000-0002-2813-0259	Deutsche Forschungsgemeinschaft [MA3898, SFB 680]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft through MA3898 and SFB 680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand JF, 2009, FEMS MICROBIOL REV, V33, P593, DOI 10.1111/j.1574-6976.2009.00166.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Clark V. L., 2010, REGULATION FUNCTION; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crocker JC, 1996, PHYS REV LETT, V77, P1897, DOI 10.1103/PhysRevLett.77.1897; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; Falsetta ML, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00075; Falsetta ML, 2010, INFECT IMMUN, V78, P2320, DOI 10.1128/IAI.01312-09; Falsetta ML, 2009, INFECT IMMUN, V77, P3522, DOI 10.1128/IAI.00036-09; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Holz C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178104; Hong YS, 2009, APPL ENVIRON MICROB, V75, P2346, DOI 10.1128/AEM.02671-08; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kurre R, 2012, MOL MICROBIOL, V86, P857, DOI 10.1111/mmi.12022; Kurre R, 2012, BIOPHYS J, V102, P2556, DOI 10.1016/j.bpj.2012.04.020; Lissenden S, 2000, MOL MICROBIOL, V37, P839, DOI 10.1046/j.1365-2958.2000.02050.x; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Maier B, 2013, SOFT MATTER, V9, P5667, DOI 10.1039/c3sm50546d; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Opitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017088; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Philip AF, 2010, P NATL ACAD SCI USA, V107, P17986, DOI 10.1073/pnas.1004823107; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; Riondet C, 1997, BIOTECHNOL TECH, V11, P735, DOI 10.1023/A:1018492217623; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; SETTY OH, 1983, BIOPHYS J, V43, P371, DOI 10.1016/S0006-3495(83)84360-4; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; SHIOI J, 1984, J BIOL CHEM, V259, P983; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; SogaardAndersen L, 1996, P NATL ACAD SCI USA, V93, P2675, DOI 10.1073/pnas.93.7.2675; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Whitehead RN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-35; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	52	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67718	10.1371/journal.pone.0067718	http://dx.doi.org/10.1371/journal.pone.0067718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826337	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400169
J	Ma, YY; Zheng, SG; Wang, N; Duan, Y; Sun, XY; Jin, J; Zang, WQ; Li, M; Wang, YY; Zhao, GQ				Ma, Yunyun; Zheng, Shangen; Wang, Na; Duan, Yu; Sun, Xinyu; Jin, Jing; Zang, Wenqiao; Li, Min; Wang, Yuanyuan; Zhao, Guoqiang			Epidemiological Analysis of HTLV-1 and HTLV-2 Infection among Different Population in Central China	PLOS ONE			English	Article							VIRUS TYPE-I; T-CELL LEUKEMIA; SEXUALLY-TRANSMITTED INFECTIONS; NEUROLOGICAL DISEASE; CENTRAL-AFRICA; RISK-FACTORS; PREVALENCE; LYMPHOMA; TYPE-1; INDIVIDUALS	Background: HTLV-1 and HTLV-2 are retroviruses linked etiologically to various human diseases, and both of them can be transmitted by vertical route, sexual intercourse, blood transfusion and intravenous drug use. Recently, some HTLV-infected cases have been reported and this virus is mainly present in the Southeast coastal areas in China, but has not been studied for the people in Central China. Objectives: To know the epidemiologic patterns among different population samples in Central China and further identify risk factor for HTLV-1 and HTLV-2 infection. Methods: From January 2008 to December 2011, 5480 blood samples were screened for HTLV-1/2 antibodies by using enzyme immunoassay, followed by Western Blot. Results: The prevalence of HTLV-1 and HTLV-2 was found with infection rates 0.13% and 0.05% among all population samples for HTLV-1 and HTLV-2, respectively. The highest percentages of infection, 0.39% and 0.20%, were found in the high risk group, while only 0.06% and 0.03% in the blood donor group. There was only one case of HTLV-1 infection (0.11%) among patients with malignant hematological diseases. Of seven HTLV-1 positive cases, six were co-infected with HBV, two with HCV and one with HIV. Among three HTLV-2 positive individuals all were co-infected with HBV, one with HCV. Conclusions: HTLV-1 and HTLV-2 have been detected in the Central China at low prevalence, with the higher infection rate among high risk group. It was also found that co-infection of HTLV-1/2 with HIV and HBV occurred, presumably due to their similar transmission routes. HTLV-1/2 antibody screen among certain population would be important to prevent the spread of the viruses.	[Ma, Yunyun; Wang, Na; Zang, Wenqiao; Li, Min; Wang, Yuanyuan; Zhao, Guoqiang] Zhengzhou Univ, Basic Med Coll, Dept Immunol & Microbiol, Zhengzhou 450052, Henan, Peoples R China; [Ma, Yunyun; Jin, Jing] Henan Med Coll Staff & Workers, Dept Immunol & Microbiol, Zhengzhou, Henan, Peoples R China; [Zheng, Shangen] Wuhan Gen Hosp Guangzhou Mil, Dept Blood Transfus, Wuhan, Hubei, Peoples R China; [Duan, Yu] Zhengzhou Univ, Affiliated Hosp 1, Clin Lab, Zhengzhou 450052, Henan, Peoples R China; [Sun, Xinyu] Zhengzhou Cent Hosp, Dept Lab, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhao, GQ (corresponding author), Zhengzhou Univ, Basic Med Coll, Dept Immunol & Microbiol, Zhengzhou 450052, Henan, Peoples R China.	zhaogq@zzu.edu.cn						Andonov A, 2012, INFECT GENET EVOL, V12, P1822, DOI 10.1016/j.meegid.2012.07.015; Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126; Barrientos A, 2011, J MED VIROL, V83, P745, DOI 10.1002/jmv.22015; Berini CA, 2007, J MED VIROL, V79, P1914, DOI 10.1002/jmv.21036; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calattini S, 2009, J INFECT DIS, V199, P561, DOI 10.1086/596206; China Ministry of Health and joint UN programme on HIV/AIDS WHO, 2009, EST HIV AIDS EP CHIN; deCarvalho SMF, 1997, J ACQ IMMUN DEF SYND, V15, P238, DOI 10.1097/00042560-199707010-00008; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; FEIGAL E, 1991, J INFECT DIS, V164, P36, DOI 10.1093/infdis/164.1.36; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gilleece Y, 2005, CURR OPIN INFECT DIS, V18, P43, DOI 10.1097/00001432-200502000-00008; Giuliani M, 2000, SEX TRANSM DIS, V27, P87, DOI 10.1097/00007435-200002000-00006; HALL WW, 1994, SEMIN VIROL, V5, P165, DOI 10.1006/smvy.1994.1017; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; Kahn J, 2002, CLIN INFECT DIS, V35, P1382, DOI 10.1086/343044; KAPLAN JE, 1993, REV MED VIROL, V3, P137, DOI 10.1002/rmv.1980030304; KOENIG RE, 1992, AIDS RES HUM RETROV, V8, P221, DOI 10.1089/aid.1992.8.221; Lowis GW, 2002, ANN EPIDEMIOL, V12, P46, DOI 10.1016/S1047-2797(01)00231-9; Macdonald N, 2004, SEX TRANSM INFECT, V80, P492, DOI 10.1136/sti.2004.011197; MADELEINE MM, 1993, INT J CANCER, V54, P255, DOI 10.1002/ijc.2910540216; Mahieux R, 2009, PATHOL BIOL, V57, P161, DOI 10.1016/j.patbio.2008.02.015; Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4; Mauclere P, 2011, J INFECT DIS, V203, P1316, DOI 10.1093/infdis/jir031; Miyagi J, 2002, INT J HEMATOL, V75, P78, DOI 10.1007/BF02981984; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Shen YZ, 2013, HIV MED, V14, P167, DOI 10.1111/j.1468-1293.2012.01048.x; SHIMOTOHNO K, 1985, P NATL ACAD SCI USA, V82, P3101, DOI 10.1073/pnas.82.10.3101; SHIMOYAMA M, 1986, P NATL ACAD SCI USA, V83, P4524, DOI 10.1073/pnas.83.12.4524; van der Bij AK, 2005, SEX TRANSM INFECT, V81, P34, DOI 10.1136/sti.2003.007997; Van Dooren S, 2001, MOL BIOL EVOL, V18, P661, DOI 10.1093/oxfordjournals.molbev.a003846; Wang Hui-rong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P428; Wang JX, 2013, TRANSFUSION, V53, P1240, DOI 10.1111/j.1537-2995.2012.03940.x; Wang YC, 2005, J MED VIROL, V76, P613, DOI 10.1002/jmv.20405; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zanella L, 2012, J VIROL, V86, P12451, DOI 10.1128/JVI.02258-12; Zeng Y., 1985, Chinese Journal of Virology, V1, P344; Zhuo JC, 1995, CHINESE MED J-PEKING, V108, P902	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66795	10.1371/journal.pone.0066795	http://dx.doi.org/10.1371/journal.pone.0066795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826136	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400053
J	Sato, T; Tsujino, I; Ohira, H; Oyama-Manabe, N; Ito, YM; Noguchi, T; Yamada, A; Ikeda, D; Watanabe, T; Nishimura, M				Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Oyama-Manabe, Noriko; Ito, Yoichi M.; Noguchi, Teruo; Yamada, Asuka; Ikeda, Daisuke; Watanabe, Taku; Nishimura, Masaharu			Paradoxical Interventricular Septal Motion as a Major Determinant of Late Gadolinium Enhancement in Ventricular Insertion Points in Pulmonary Hypertension	PLOS ONE			English	Article							MYOCARDIAL DELAYED ENHANCEMENT; CARDIAC MAGNETIC-RESONANCE; PRESSURE-OVERLOAD; ARTERIAL-HYPERTENSION; HEART; MRI; VOLUME; MASS	Background: This study investigated the major clinical determinants of late gadolinium enhancement (LGE) at ventricular insertion points (VIPs) commonly seen in patients with pulmonary hypertension (PH). Methods: Forty-six consecutive PH patients (mean pulmonary artery pressure >= 25 mmHg at rest) and 21 matched controls were examined. Right ventricular (RV) morphology, function and LGE mass volume at VIPs were assessed by cardiac magnetic resonance (CMR). Radial motion of the left ventricular (LV) wall and interventricular septum (IVS) was assessed by speckle-tracking echocardiography. Paradoxical IVS motion index was then calculated. Univariate and multivariate regression analysis were conducted to characterize the relationship between LGE volume at VIPs and PH-related clinical indices, including the paradoxical IVS motion index. Results: Mean pulmonary arterial pressure (MPAP) of PH patients was 3869 mmHg. LGE at VIPs was observed in 42 of 46 PH patients, and the LGE volume was 2.02 mL (0.47-2.99 mL). Significant correlations with LGE volume at VIPs were observed for MPAP (r = 0.50) and CMR-derived parameters [RV mass index (r = 0.53), RV end-diastolic volume index (r = 0.53), RV ejection fraction (r = -0.56), and paradoxical IVS motion index (r = 0.77)]. In multiple regression analysis, paradoxical IVS motion index alone significantly predicted LGE volume at VIPs (p<0.001). Conclusions: LGE at VIPs seen in patients with PH appears to reflect altered IVS motion rather than elevated RV pressure or remodeling. Long-term studies would be of benefit to characterize the clinical relevance of LGE at VIPs.	[Sato, Takahiro; Tsujino, Ichizo; Ohira, Hiroshi; Yamada, Asuka; Ikeda, Daisuke; Watanabe, Taku] Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Oyama-Manabe, Noriko] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido 060, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Noguchi, Teruo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nishimura, Masaharu] Hokkaido Univ, Grad Sch Med, Dept Med 1, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; National Cerebral & Cardiovascular Center - Japan; Hokkaido University	Tsujino, I (corresponding author), Hokkaido Univ Hosp, Dept Med 1, Sapporo, Hokkaido 060, Japan.	itsujino@med.hokudai.ac.jp		Watanabe, Taku/0000-0002-3195-2413; Ito, Yoichi M./0000-0001-5073-0827				Blyth KG, 2005, EUR HEART J, V26, P1993, DOI 10.1093/eurheartj/ehi328; Bradlow WM, 2010, CIRC-CARDIOVASC IMAG, V3, P501, DOI 10.1161/CIRCIMAGING.109.919779; Dohi K, 2008, AM J CARDIOL, V101, P1206, DOI 10.1016/j.amjcard.2007.11.077; Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gaynor SL, 2005, AM J PHYSIOL-HEART C, V288, pH2140, DOI 10.1152/ajpheart.00566.2004; JESSUP M, 1987, AM HEART J, V113, P1114, DOI 10.1016/0002-8703(87)90921-5; Junqueira FP, 2009, BRIT J RADIOL, V82, P821, DOI 10.1259/bjr/28241773; Kroeker CAG, 2006, AM J PHYSIOL-HEART C, V290, pH2432, DOI 10.1152/ajpheart.01140.2005; Kroeker CAG, 2006, AM J PHYSIOL-HEART C, V291, pH2229, DOI 10.1152/ajpheart.00077.2006; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; Machin D, 1997, SAMPLE SIZE TABLES C; McCann GP, 2007, AM J ROENTGENOL, V188, P349, DOI 10.2214/AJR.05.1259; McCann GP, 2005, CIRCULATION, V112, pE268, DOI 10.1161/CIRCULATIONAHA.104.512848; McLure LER, 2009, EUR RESPIR J, V33, P1454, DOI 10.1183/09031936.00139907; RYAN T, 1985, J AM COLL CARDIOL, V5, P918, DOI 10.1016/S0735-1097(85)80433-2; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Sato T, 2012, INT J CARDIOL, V158, P156, DOI 10.1016/j.ijcard.2012.04.042; Sechtem U, 2007, HEART, V93, P1520, DOI 10.1136/hrt.2005.067355; Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114; Spottiswoode B, 2008, CARDIOVASC J AFR, V19, P208; TANAKA H, 1980, CIRCULATION, V62, P558, DOI 10.1161/01.CIR.62.3.558; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477	23	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66724	10.1371/journal.pone.0066724	http://dx.doi.org/10.1371/journal.pone.0066724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826118	Green Published, gold			2022-12-25	WOS:000321738400038
J	Rousset, F; Nguyen, MVC; Grange, L; Morel, F; Lardy, B				Rousset, Francis; Minh Vu Chuong Nguyen; Grange, Laurent; Morel, Francoise; Lardy, Bernard			Heme Oxygenase-1 Regulates Matrix Metalloproteinase MMP-1 Secretion and Chondrocyte Cell Death via Nox4 NADPH Oxidase Activity in Chondrocytes	PLOS ONE			English	Article							NF-KAPPA-B; NAD(P)H OXIDASE; GENE-EXPRESSION; CYTOCHROME B(558); CARBON-MONOXIDE; COLLAGENASE; INDUCTION; IDENTIFICATION; HYPERTROPHY; ACTIVATION	Interleukin-1 beta (IL-1 beta) activates the production of reactive oxygen species (ROS) and secretion of MMPs as well as chondrocyte apoptosis. Those events lead to matrix breakdown and are key features of osteoarthritis (OA). We confirmed that in human C-20/A4 chondrocytes the NADPH oxidase Nox4 is the main source of ROS upon IL-1 beta stimulation. Since heme molecules are essential for the NADPH oxidase maturation and activity, we therefore investigated the consequences of the modulation of Heme oxygenase-1 (HO-1), the limiting enzyme in heme catabolism, on the IL-1 beta signaling pathway and more specifically on Nox4 activity. Induction of HO-1 expression decreased dramatically Nox4 activity in C-20/A4 and HEK293 T-REx (TM) Nox4 cell lines. Unexpectedly, this decrease was not accompanied by any change in the expression, the subcellular localization or the maturation of Nox4. In fact, the inhibition of the heme synthesis by succinylacetone rather than heme catabolism by HO-1, led to a confinement of the Nox4/p22(phox) heterodimer in the endoplasmic reticulum with an absence of redox differential spectrum highlighting an incomplete maturation. Therefore, the downregulation of Nox4 activity by HO-1 induction appeared to be mediated by carbon monoxide (CO) generated from the heme degradation process. Interestingly, either HO-1 or CO caused a significant decrease in the expression of MMP-1 and DNA fragmentation of chondrocytes stimulated by IL-1 beta. These results all together suggest that a modulation of Nox4 activity via heme oxygenase-1 may represent a promising therapeutic tool in osteoarthritis.	[Rousset, Francis; Minh Vu Chuong Nguyen; Grange, Laurent; Morel, Francoise; Lardy, Bernard] Univ Grenoble 1, AGIM GREPI FRE CNRS 3405, Grenoble, France; [Grange, Laurent] CHU Hop Sud, Grenoble Teaching Hosp, Dept Rheumatol, Grenoble, France; [Lardy, Bernard] Ctr Hosp Univ, Inst Biol & Pathol, Lab Biochim Enzyme & Prot DBTP, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Rousset, F (corresponding author), Univ Grenoble 1, AGIM GREPI FRE CNRS 3405, Grenoble, France.	francisrousset@yahoo.fr	Rousset, Francis/AAA-6024-2021	Rousset, Francis/0000-0001-7747-179X	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble; Fondation Arthritis Courtin	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble; Fondation Arthritis Courtin	This work was supported by grants from the "Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris, the "UFR de Medecine, Universite Joseph Fourier, Grenoble the "Groupement des Entreprises Francaises dans la lutte contre le Cancer, delegation de Grenoble, the "Societe Francaise de Rhumatologie and the "Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble. FR is supported by grants from the Fondation Arthritis Courtin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Coustry F, 2012, AM J PATHOL, V180, P738, DOI 10.1016/j.ajpath.2011.10.033; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Grange L, 2006, ANTIOXID REDOX SIGN, V8, P1485, DOI 10.1089/ars.2006.8.1485; Guillen MI, 2008, RHEUMATOLOGY, V47, P1323, DOI 10.1093/rheumatology/ken264; Heraud F, 2000, ANN RHEUM DIS, V59, P959, DOI 10.1136/ard.59.12.959; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Koopman WJ, 2001, ARTHRITIS ALLIED CON, P226; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Megias J, 2008, J PHARMACOL EXP THER, V325, P56, DOI 10.1124/jpet.107.134650; Mendes AF, 2001, MEDIAT INFLAMM, V10, P209, DOI 10.1080/09629350120080401; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; MOREL F, 1985, EUR J BIOCHEM, V152, P669, DOI 10.1111/j.1432-1033.1985.tb09247.x; Morel F, 2007, B ACAD NAT MED PARIS, V191, P377, DOI 10.1016/S0001-4079(19)33082-1; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; Poole AR, 1997, MECH MODELS RHEUMATO, P163; POOLE AR, 2001, OSTEOARTHRITIS DIAGN, P29; Rodriguez AI, 2010, ARTERIOSCL THROM VAS, V30, P98, DOI 10.1161/ATVBAHA.109.197822; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Yang S, 2004, J CELL BIOCHEM, V92, P238, DOI 10.1002/jcb.20048; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001	43	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66478	10.1371/journal.pone.0066478	http://dx.doi.org/10.1371/journal.pone.0066478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840483	gold, Green Submitted, Green Published			2022-12-25	WOS:000322342800066
J	Sun, HY; Lou, XM; Shan, Q; Zhang, J; Zhu, X; Zhang, J; Wang, Y; Xie, YY; Xu, NZ; Liu, SQ				Sun, Huiying; Lou, Xiaomin; Shan, Qiang; Zhang, Ju; Zhu, Xu; Zhang, Jia; Wang, Yang; Xie, Yingying; Xu, Ningzhi; Liu, Siqi			Proteolytic Characteristics of Cathepsin D Related to the Recognition and Cleavage of Its Target Proteins	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; D EXPRESSION; B ACTIVITY; ATHEROSCLEROSIS; DEGRADATION; SPECIFICITY; MACROPHAGES; HEMOGLOBIN; HYDROLYSIS; TRANSITION	Cathepsin D (CD) plays an important role in both biological and pathological processes, although the cleavage characteristics and substrate selection of CD have yet to be fully explored. We employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify the CD cleavage sites in bovine serum albumin (BSA). We found that the hydrophobic residues at P1 were not only a preferential factor for CD cleavage but that the hydrophobicity at P1' also contributed to CD recognition. The concept of hydrophobic scores of neighbors (HSN) was proposed to describe the hydrophobic microenvironment of CD recognition sites. The survey of CD cleavage characteristics in several proteins suggested that the HSN was a sensitive indicator for judging the favorable sites in peptides for CD cleavage, with HSN values of 0.5-1.0 representing a likely threshold. Ovalbumin (OVA), a protein resistant to CD cleavage in its native state, was easily cleaved by CD after denaturation, and the features of the cleaved peptides were quite similar to those found in BSA, where a higher HSN value indicated greater cleavability. We further conducted two-dimensional gel electrophoresis (2DE) to find more proteins that were insensitive to CD cleavage in CD-knockdown cells. Based on an analysis of secondary and three-dimensional structures, we postulated that intact proteins with a structure consisting of all a-helices would be relatively accessible to CD cleavage.	[Sun, Huiying; Lou, Xiaomin; Shan, Qiang; Zhang, Ju; Zhu, Xu; Wang, Yang; Xie, Yingying; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Sun, Huiying; Shan, Qiang; Zhu, Xu; Wang, Yang; Xie, Yingying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Jia] Beijing Prot Innovat, Beijing, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, NZ (corresponding author), Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	xunzh@genomics.cn; siqiliu@genomics.cn			National Basic Research Program of China (973) [2010CB912703, 2011CB910704]; National Natural Science Foundation of China [30800568, 30901717]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973) (2010CB912703 and 2011CB910704) and the National Natural Science Foundation of China (30800568 and 30901717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelqvist H, 2012, ANN CLIN LAB SCI, V42, P231; Athauda SBP, 2002, PROTEIN PEPTIDE LETT, V9, P289, DOI 10.2174/0929866023408698; Bednarski E, 1996, J NEUROCHEM, V67, P1846, DOI 10.1046/j.1471-4159.1996.67051846.x; BEVER CT, 1995, J NEUROL SCI, V131, P71, DOI 10.1016/0022-510X(95)00039-5; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; COWAN R, 1990, Peptide Research, V3, P75; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Fonovic UP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053918; Fruitier I, 1998, BIOCHEM BIOPH RES CO, V246, P719, DOI 10.1006/bbrc.1998.8614; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Handley CJ, 2001, MATRIX BIOL, V20, P543, DOI 10.1016/S0945-053X(01)00168-8; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Hughes MC, 2000, MEAT SCI, V56, P165, DOI 10.1016/S0309-1740(00)00036-X; Impens F, 2012, BIOL CHEM, V393, P915, DOI 10.1515/hsz-2012-0168; Impens F, 2010, MOL CELL PROTEOMICS, V9, P2327, DOI 10.1074/mcp.M110.001271; Kaschina E, 2009, ATHEROSCLEROSIS, V205, P396, DOI 10.1016/j.atherosclerosis.2009.01.003; Kirana Chandra, 2012, Int J Proteomics, V2012, P245819, DOI 10.1155/2012/245819; Lombardi G, 2005, J IMMUNOL, V174, P7022, DOI 10.4049/jimmunol.174.11.7022; Melzer IM, 2012, CELL DEATH DIFFER, V19, P1435, DOI 10.1038/cdd.2012.17; Moller KK, 2012, J AGR FOOD CHEM, V60, P11421, DOI 10.1021/jf302890h; OFFERMANN MK, 1983, BIOCHEM J, V211, P529, DOI 10.1042/bj2110529; Ohri SS, 2007, CANCER BIOL THER, V6, P1081, DOI 10.4161/cbt.6.7.4325; Palashoff MH, 2008, THESIS; Pimenta DC, 2000, J PROTEIN CHEM, V19, P411, DOI 10.1023/A:1026432402259; Pimenta DC, 2001, BBA-PROTEIN STRUCT M, V1544, P113, DOI 10.1016/S0167-4838(00)00209-0; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sjoberg S, 2011, CLIN REV BONE MINER, V9, P138, DOI 10.1007/s12018-011-9098-2; TURKEWITZ AP, 1988, J BIOL CHEM, V263, P16309; Urbanelli L, 2008, NEUROBIOL AGING, V29, P12, DOI 10.1016/j.neurobiolaging.2006.09.005; VANNOORT JM, 1989, J BIOL CHEM, V264, P14159; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842	43	29	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65733	10.1371/journal.pone.0065733	http://dx.doi.org/10.1371/journal.pone.0065733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840360	gold, Green Published, Green Submitted			2022-12-25	WOS:000322342800018
J	Clarke, A; Morris, GJ; Fonseca, F; Murray, BJ; Acton, E; Price, HC				Clarke, Andrew; Morris, G. John; Fonseca, Fernanda; Murray, Benjamin J.; Acton, Elizabeth; Price, Hannah C.			A Low Temperature Limit for Life on Earth	PLOS ONE			English	Article							CELLULAR DESICCATION TOLERANCE; BIOLOGICAL ICE NUCLEATORS; ANTARCTIC NEMATODE; GLASS-FORMATION; COOLING RATE; DEGREES-C; SURVIVAL; FROZEN; VITRIFICATION; DROPLETS	There is no generally accepted value for the lower temperature limit for life on Earth. We present empirical evidence that free-living microbial cells cooling in the presence of external ice will undergo freeze-induced desiccation and a glass transition (vitrification) at a temperature between -10 degrees C and -26 degrees C. In contrast to intracellular freezing, vitrification does not result in death and cells may survive very low temperatures once vitrified. The high internal viscosity following vitrification means that diffusion of oxygen and metabolites is slowed to such an extent that cellular metabolism ceases. The temperature range for intracellular vitrification makes this a process of fundamental ecological significance for free-living microbes. It is only where extracellular ice is not present that cells can continue to metabolise below these temperatures, and water droplets in clouds provide an important example of such a habitat. In multicellular organisms the cells are isolated from ice in the environment, and the major factor dictating how they respond to low temperature is the physical state of the extracellular fluid. Where this fluid freezes, then the cells will dehydrate and vitrify in a manner analogous to free-living microbes. Where the extracellular fluid undercools then cells can continue to metabolise, albeit slowly, to temperatures below the vitrification temperature of free-living microbes. Evidence suggests that these cells do also eventually vitrify, but at lower temperatures that may be below -50 degrees C. Since cells must return to a fluid state to resume metabolism and complete their life cycle, and ice is almost universally present in environments at sub-zero temperatures, we propose that the vitrification temperature represents a general lower thermal limit to life on Earth, though its precise value differs between unicellular (typically above -20 degrees C) and multicellular organisms (typically below -20 degrees C). Few multicellular organisms can, however, complete their life cycle at temperatures below similar to-2 degrees C.	[Clarke, Andrew] British Antarctic Survey, Cambridge CB3 0ET, England; [Clarke, Andrew] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Morris, G. John; Acton, Elizabeth] Asymptote Ltd, St Johns Innovat Ctr, Cambridge, England; [Fonseca, Fernanda] INRA, F-78850 Thiverval Grignon, France; [Murray, Benjamin J.; Price, Hannah C.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of East Anglia; St Johns Innovation Centre - UK; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Leeds	Clarke, A (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	accl@bas.ac.uk	FONSECA, FERNANDA/HDN-9451-2022; Fonseca, Fernanda/AAR-9094-2020; Murray, Benjamin/C-1219-2010; Price, Hannah/G-1059-2015	FONSECA, FERNANDA/0000-0002-0315-6479; Fonseca, Fernanda/0000-0003-3394-182X; Murray, Benjamin/0000-0002-8198-8131; Price, Hannah/0000-0002-1608-1592	Institut National de la Recherche Agronomique; Natural Environment Research Council [NE/D009308/1, NE/H001050/1]; European Research Council [240449- ICE]; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011, NE/D009308/1, NE/H001050/1] Funding Source: UKRI	Institut National de la Recherche Agronomique; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.C. is retired but received emeritus support from the British Antarctic Survey, F. F. was supported by the Institut National de la Recherche Agronomique, and B.J.M. was supported by the Natural Environment Research Council (NE/D009308/1 and NE/H001050/1) and the European Research Council (240449- ICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels-Rausch T, 2012, REV MOD PHYS, V84, P885, DOI 10.1103/RevModPhys.84.885; Benner SA, 2010, ASTROBIOLOGY, V10, P1021, DOI 10.1089/ast.2010.0524; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Castell JD, 2005, LIFE ANCIENT ICE; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Christner BC, 2010, APPL MICROBIOL BIOT, V85, P481, DOI 10.1007/s00253-009-2291-2; Christner BC, 2008, P NATL ACAD SCI USA, V105, P18854, DOI 10.1073/pnas.0809816105; Chyba C.F., 2007, PLANETS LIFE EMERGIN, P388; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1986, J EXP BOT, V37, P1285, DOI 10.1093/jxb/37.9.1285; CLARKE KJ, 1985, PROTOPLASMA, V129, P120, DOI 10.1007/BF01279909; COLLINS M A, 1989, Food Microbiology (London), V6, P135, DOI 10.1016/S0740-0020(89)80021-8; Convey P, 2000, CRYO-LETT, V21, P327; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DIMMICK RL, 1979, APPL ENVIRON MICROB, V37, P924, DOI 10.1128/AEM.37.5.924-927.1979; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Farrell AH, 2004, J MOL EVOL, V59, P666, DOI 10.1007/s00239-004-2658-z; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Franks F, 2003, PHILOS T ROY SOC A, V361, P557, DOI 10.1098/rsta.2002.1141; Geiges O, 1996, ADV SPACE RES, V18, P109, DOI 10.1016/0273-1177(96)00006-3; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hansen LD, 2009, PURE APPL CHEM, V81, P1843, DOI 10.1351/PAC-CON-08-09-09; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2011, COMP BIOCHEM PHYS A, V160, P137, DOI 10.1016/j.cbpa.2011.05.032; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Hill KA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008002; HIRSH AG, 1985, PLANT PHYSIOL, V79, P41, DOI 10.1104/pp.79.1.41; HIRSH AG, 1987, CRYOBIOLOGY, V24, P214, DOI 10.1016/0011-2240(87)90024-1; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Jakosky BM, 2003, ASTROBIOLOGY, V3, P343, DOI 10.1089/153110703769016433; Kagoshima H, 2012, CRYOLETTERS, V33, P280; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Koop T, 2009, PHYS CHEM CHEM PHYS, V11, P10839, DOI 10.1039/b914289d; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Kostinski A, 2008, J ATMOS SCI, V65, P2961, DOI 10.1175/2008JAS2503.1; Leather S. R., 1993, ECOLOGY INSECT OVERW; Leopold A. C., 1986, MEMBRANES METABOLISM; LINDOW SE, 1982, PLANT PHYSIOL, V70, P1084, DOI 10.1104/pp.70.4.1084; Liu JJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001921; Mader HM, 2006, GEOLOGY, V34, P169, DOI 10.1130/G22096.1; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; McCafferty DJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1192; MILLER LK, 1978, CRYOBIOLOGY, V15, P345, DOI 10.1016/0011-2240(78)90046-9; MOROWITZ HJ, 1978, FDN BIOENERGETICS; Morris GJ, 2012, CRYOBIOLOGY, V64, P71, DOI 10.1016/j.cryobiol.2011.12.002; Murray AE, 2012, P NATL ACAD SCI USA, V109, P20626, DOI 10.1073/pnas.1208607109; Murray BJ, 2012, ATMOS CHEM PHYS, V12, P8575, DOI 10.5194/acp-12-8575-2012; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Panikova NS, 2006, SOIL BIOL BIOCHEM, V38, P785, DOI 10.1016/j.soilbio.2005.07.004; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Rapatz G. L., 1966, CRYOBIOLOGY, P147; Reid JP, 2007, INT REV PHYS CHEM, V26, P139, DOI 10.1080/01442350601081899; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Rohde RA, 2008, P NATL ACAD SCI USA, V105, P8667, DOI 10.1073/pnas.0803763105; Santl-Temkiv T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053550; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; Schroeter B., 1994, Cryptogamic Botany, V4, P233; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Sformo T, 2010, J EXP BIOL, V213, P502, DOI 10.1242/jeb.035758; Slade L., 1989, PROTEIN QUALITY EFFE, P9; Takenaka N, 2007, J PHYS CHEM A, V111, P8780, DOI 10.1021/jp0738356; Tanghe A, 2003, ADV APPL MICROBIOL, V53, P129, DOI 10.1016/S0065-2164(03)53004-0; TANSEY MR, 1972, P NATL ACAD SCI USA, V69, P2426, DOI 10.1073/pnas.69.9.2426; Tominaga H, 1981, HYDROBIOLOGIA, V82, P375; von Neumann J., 1951, GEN LOGICAL THEORY A; Weinzirl J, 1929, J DAIRY SCI, V12, P182; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wisniewski M., 2004, Journal of Crop Improvement, V10, P5, DOI 10.1300/J411v10n01_02; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	81	65	68	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66207	10.1371/journal.pone.0066207	http://dx.doi.org/10.1371/journal.pone.0066207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840425	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000322361200061
J	Yuan, XL; Wei, QY; Komaki, R; Liu, ZS; Yang, J; Tucker, SL; Xu, T; Heymach, JV; Lu, C; Cox, JD; Liao, ZX				Yuan, Xianglin; Wei, Qingyi; Komaki, Ritsuko; Liu, Zhensheng; Yang, Ju; Tucker, Susan L.; Xu, Ting; Heymach, John V.; Lu, Charles; Cox, James D.; Liao, Zhongxing			TGF beta 1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; THERAPY ONCOLOGY GROUP; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1 LEVEL; TGF-BETA; RADIATION-THERAPY; BRAIN METASTASES; BREAST-CANCER; RANDOMIZED-TRIAL; CARCINOMA	Purpose: Transforming growth factor (TGF)-beta 1 signaling is involved in cancer-cell metastasis. We investigated whether single nucleotide polymorphisms (SNPs) at TGF beta 1 were associated with overall survival (OS) and distant metastasis-free survival (DMFS) in patients with non-small cell lung cancer (NSCLC) treated with definitive radiotherapy, with or without chemotherapy. Methods: We genotyped TGF beta 1 SNPs at rs1800469 (C-509T), rs1800471 (G915C), and rs1982073 (T+29C) by polymerase chain reaction-restriction fragment length polymorphism in blood samples from 205 NSCLC patients who had had definitive radiotherapy at one institution in November 1998-January 2005. We also tested whether the TGF-beta 1 rs1982073 (T+29C) SNP affected the migration and invasion of A549 and PC9 lung cancer cells. Results: Median follow-up time for all patients was 17 months (range, 1-97 months; 39 months for patients alive at the time of analysis). Multivariate analysis showed that the TGF beta 1 rs1800469 CT/CC genotype was associated with poor OS (hazard ratio [HR] = 1.463 [95% confidence interval {CI} = 1.012-2.114], P = 0.043) and shorter DMFS (HR = 1.601 [95% CI = 1.042-2.459], P=0.032) and that the TGF beta 1 rs1982073 CT/CC genotype predicted poor DMFS (HR = 1.589 [95% CI = 1.009-2.502], P = 0.046) and poor brain MFS (HR = 2.567 [95% CI = 1.155-5.702], P = 0.021) after adjustment for age, sex, race, performance status, smoking status, tumor histology and volume, stage, receipt of concurrent radiochemotherapy, number of chemotherapy cycles, and radiation dose. Transfection with TGF beta 1+29C (vs. +29T) stimulated the migration and invasion of A549 and PC9 cells, suggesting that TGF beta 1+29C may be linked with increased metastatic potential. Conclusions: TGF beta 1 genotypes at rs1800469 and rs1982073 could be useful for predicting DMFS among patients with NSCLC treated with definitive radiation therapy. These findings require validation in larger prospective trials and thorough mechanistic studies.	[Yuan, Xianglin; Yang, Ju] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China; [Wei, Qingyi; Liu, Zhensheng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Komaki, Ritsuko; Xu, Ting; Cox, James D.; Liao, Zhongxing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Tucker, Susan L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Heymach, John V.; Lu, Charles] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liao, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	zliao@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	Cancer Center Support (Core) Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center Support (Core) Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Cancer Center Support (Core) Grant CA016672 to MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ampil F, 2007, LUNG CANCER, V57, P60, DOI 10.1016/j.lungcan.2007.02.006; Andre F, 2001, CANCER, V91, P2394, DOI 10.1002/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Byhardt RW, 1998, INT J RADIAT ONCOL, V42, P469, DOI 10.1016/S0360-3016(98)00251-X; Chen AM, 2007, CANCER-AM CANCER SOC, V109, P1668, DOI 10.1002/cncr.22565; Chorna I, 2005, EXP ONCOL, V27, P156; De Ruyck K, 2006, INT J RADIAT ONCOL, V65, P1240, DOI 10.1016/j.ijrobp.2006.03.047; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Dunning AM, 2003, CANCER RES, V63, P2610; Ewart-Toland A, 2004, CANCER EPIDEM BIOMAR, V13, P759; Fang Shu-Mei, 2005, Ai Zheng, V24, P305; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Fong YC, 2009, LUNG CANCER, V64, P13, DOI 10.1016/j.lungcan.2008.07.010; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kang Y, 2000, EXP LUNG RES, V26, P685, DOI 10.1080/01902140150216765; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mu L, 2008, BRIT J CANCER, V99, P1357, DOI 10.1038/sj.bjc.6604689; Nguyen TD, 2007, NEUROL CLIN, V25, P1173, DOI 10.1016/j.ncl.2007.07.011; Novakova-Jiresova A, 2004, RADIOTHER ONCOL, V71, P183, DOI 10.1016/j.radonc.2004.01.019; Penel N, 2001, LUNG CANCER, V33, P143, DOI 10.1016/S0169-5002(01)00202-1; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; Pottgen C, 2007, J CLIN ONCOL, V25, P4987, DOI 10.1200/JCO.2007.12.5468; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; Saji Hisashi, 2003, Ann Thorac Cardiovasc Surg, V9, P295; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843; Suardet L, 1996, INT J CANCER, V68, P126, DOI 10.1002/(SICI)1097-0215(19960927)68:1<126::AID-IJC22>3.0.CO;2-8; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsuchida K, 2006, MINI-REV MED CHEM, V6, P1255, DOI 10.2174/138955706778742759; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Yavuz AA, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-80; Yoon SM, 2005, INT J RADIAT ONCOL, V63, P885, DOI 10.1016/j.ijrobp.2005.07.951; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763; Zhao L, 2008, LUNG CANCER, V59, P232, DOI 10.1016/j.lungcan.2007.08.010	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65659	10.1371/journal.pone.0065659	http://dx.doi.org/10.1371/journal.pone.0065659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840350	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200029
J	Urano, Y; Ochiai, S; Noguchi, N				Urano, Yasuomi; Ochiai, Sachika; Noguchi, Noriko			Suppression of amyloid-beta production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking	FASEB JOURNAL			English	Article						oxysterol; vesicular transport; ER stress; Alzheimer's disease	ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; LIPID RAFTS; DEMENTED PATIENTS; GAMMA-SECRETASE; ER STRESS; CHOLESTEROL; BRAIN; PRESENILIN-1; PATHWAY	Cholesterol can be converted to 24S-hydroxycholesterol (24SOHC) by neuronal cholesterol 24-hydroxylase. In mouse models of Alzheimer's disease (AD), increasing 24SOHC levels reduced AD pathology. However, mechanisms underlying the effects of 24SOHC on amyloid- (A) production have remained unclear. Here we report that 24SOHC treatment reduces A production and increases endoplasmic reticulum (ER)-resident immature amyloid precursor protein (APP) levels in human neuroblastoma SH-SY5Y cells and CHO cells stably expressing human APP. Treatment with 1-10 M 24SOHC (equivalent to the concentrations detected in human brain homogenates) diminished A production (IC50=4.6 M for A(40)) without affecting secretase activities. To evaluate the intracellular APP transport, we established an in vitro vesicle formation assay. We found that APP budding via COPII vesicles was diminished by 70% in 24SOHC-treated cells. The proteomics and immunoblotting analysis revealed that 24SOHC induced the expression of glucose-regulated protein 78 (GRP78), an ER chaperone, through unfolded protein response pathways, and enhanced the formation of the APP/GRP78 complex. Knockdown of GRP78 diminished the inhibitory effects of 24SOHC on A production. These results suggest that 24SOHC down-regulates APP trafficking via enhancement of the complex formation of APP with up-regulated GRP78 in the ER, resulting in suppression of A production.Urano, Y., Ochiai, S., Noguchi, N. Suppression of amyloid- production by 24S-hydroxycholesterovia inhibition of intracellular amyloid precursor protein trafficking.	[Urano, Yasuomi; Ochiai, Sachika; Noguchi, Noriko] Doshisha Univ, Dept Med Life Syst, Fac Med & Life Sci, Kyoto 6100394, Japan	Doshisha University	Urano, Y (corresponding author), Doshisha Univ, Dept Med Life Syst, Fac Med & Life Sci, 1-3 Miyakodani, Kyoto 6100394, Japan.	yurano@mail.doshisha.ac.jp		Urano, Yasuomi/0000-0002-4901-1937	Takeda Science Foundation; Ministry of Education, Sports, Science, and Technology in Japan [21800075, 23700428]; Grants-in-Aid for Scientific Research [25830041] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Sports, Science, and Technology in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Edward Koo (University of California-San Diego, La Jolla, CA, USA) and Drs. Yasuo Ihara and Satoru Funamoto (Doshisha University, Kyoto, Japan) for providing reagents. The authors also thank Rie Yasuda, Maya Suetsugu, and Fumika Onoue for research support. This work was supported in part by the Takeda Science Foundation to Y.U. and a grant-in-aid for Research Activity Start-Up 21800075 and Young Scientists (B) 23700428 to Y.U. from the Ministry of Education, Sports, Science, and Technology in Japan.	Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bretillon L, 2000, NEUROSCI LETT, V293, P87, DOI 10.1016/S0304-3940(00)01466-X; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Huttunen HJ, 2007, J BIOL CHEM, V282, P28285, DOI 10.1074/jbc.M702951200; Huttunen HJ, 2009, FASEB J, V23, P3819, DOI 10.1096/fj.09-134999; Jeitner TM, 2011, CURR MED CHEM, V18, P1515; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kolsch H, 2004, NEUROSCI LETT, V368, P303, DOI 10.1016/j.neulet.2004.07.031; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Stensballe A, 2001, PROTEOMICS, V1, P955, DOI 10.1002/1615-9861(200108)1:8<955::AID-PROT955>3.0.CO;2-P; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zuliani G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-121	47	51	52	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4305	4315		10.1096/fj.13-231456	http://dx.doi.org/10.1096/fj.13-231456			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23839932				2022-12-25	WOS:000329747100039
J	Blanchetot, C; Verzijl, D; Mujic-Delic, A; Bosch, L; Rem, L; Leurs, R; Verrips, CT; Saunders, M; de Haard, H; Smit, MJ				Blanchetot, Christophe; Verzijl, Dennis; Mujic-Delic, Azra; Bosch, Leontien; Rem, Louise; Leurs, Rob; Verrips, C. Theo; Saunders, Michael; de Haard, Hans; Smit, Martine J.			Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DOMAIN ANTIBODY FRAGMENTS; HEAVY-CHAIN ANTIBODIES; IN-VIVO; DIFFERENTIAL EXPRESSION; ALLOGRAFT-REJECTION; MULTIPLE-SCLEROSIS; BINDING PROTEIN; T-LYMPHOCYTES	Chemokine receptors and their ligands play a prominent role in immune regulation but many have also been implicated in inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, allograft rejection after transplantation, and also in cancer metastasis. Most approaches to therapeutically target the chemokine system involve targeting of chemokine receptors with low molecular weight antagonists. Here we describe the selection and characterization of an unprecedented large and diverse panel of neutralizing Nanobodies (single domain camelid antibodies fragment) directed against several chemokines. We show that the Nanobodies directed against CCL2 (MCP-1), CCL5 (RANTES), CXCL11 (I-TAC), and CXCL12 (SDF-1 alpha) bind the chemokines with high affinity (at nanomolar concentration), thereby blocking receptor binding, inhibiting chemokine-induced receptor activation as well as chemotaxis. Together, we show that neutralizing Nanobodies can be selected efficiently for effective and specific therapeutic treatment against a wide range of immune and inflammatory diseases.	[Blanchetot, Christophe; Rem, Louise; Verrips, C. Theo; de Haard, Hans] Univ Utrecht, Dept Cellular Biol, NL-3584 CH Utrecht, Netherlands; [Blanchetot, Christophe; Rem, Louise; Verrips, C. Theo; de Haard, Hans] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Verzijl, Dennis; Mujic-Delic, Azra; Bosch, Leontien; Leurs, Rob; Smit, Martine J.] Vrije Univ Amsterdam, Div Med Chem, AIMMS, NL-1081 HV Amsterdam, Netherlands; [Saunders, Michael; de Haard, Hans] Ablynx NV, B-9052 Ghent, Belgium	Utrecht University; Utrecht University; Vrije Universiteit Amsterdam	de Haard, H (corresponding author), Univ Utrecht, Dept Cellular Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	hdehaard@argen-x.com; mj.smit@vu.nl	Leurs, Rob/AAC-8508-2022; Leurs, Rob/ABB-4299-2021	Leurs, Rob/0000-0003-1354-2848; Verzijl, Dennis/0000-0002-7716-9838; Blanchetot, christophe/0000-0001-9152-9978; Smit, Martine/0000-0003-2713-0238	Ablynx N.V.	Ablynx N.V.	This work was supported by Ablynx N.V.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; [Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Comerford L, 2005, IMMUNOL LETT, V96, P163, DOI 10.1016/j.imlet.2004.08.018; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Galzi J.-L., 2012, DRUG DISCOV TODAY, V9, pe245; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Jensen KK, 2003, J VIROL, V77, P624, DOI 10.1128/JVI.77.1.624-630.2003; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Kennedy KJ, 1998, J NEUROIMMUNOL, V92, P98, DOI 10.1016/S0165-5728(98)00187-8; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mulligan MS, 2000, EXP MOL PATHOL, V69, P167, DOI 10.1006/exmp.2000.2327; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nguyen VK, 2001, ADV IMMUNOL, V79, P261, DOI 10.1016/S0065-2776(01)79006-2; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Trinker M., 2012, DRUG DISCOV TODAY, V9, pe253; Tsui Ping, 2007, Human Antibodies, V16, P117; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Verzijl D, 2008, J PHARMACOL EXP THER, V325, P544, DOI 10.1124/jpet.107.134783; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	54	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25173	25182		10.1074/jbc.M113.467969	http://dx.doi.org/10.1074/jbc.M113.467969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23836909	Green Published, hybrid			2022-12-25	WOS:000330619000017
J	Spallotta, F; Tardivo, S; Nanni, S; Rosati, JD; Straino, S; Mai, A; Vecellio, M; Valente, S; Capogrossi, MC; Farsetti, A; Martone, J; Bozzoni, I; Pontecorvi, A; Gaetano, C; Colussi, C				Spallotta, Francesco; Tardivo, Silvia; Nanni, Simona; Rosati, Jessica D.; Straino, Stefania; Mai, Antonello; Vecellio, Matteo; Valente, Sergio; Capogrossi, Maurizio C.; Farsetti, Antonella; Martone, Julie; Bozzoni, Irene; Pontecorvi, Alfredo; Gaetano, Carlo; Colussi, Claudia			Detrimental Effect of Class-selective Histone Deacetylase Inhibitors during Tissue Regeneration following Hindlimb Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NITRIC-OXIDE; TRANSCRIPTION FACTOR; PROSTATE-CANCER; HDAC INHIBITORS; CLASS-I; ACTIVATION; DIFFERENTIATION; ANGIOGENESIS; MICE	Histone deacetylase inhibitors (DIs) are promising drugs for the treatment of several pathologies including ischemic and failing heart where they demonstrated efficacy. However, adverse side effects and cardiotoxicity have also been reported. Remarkably, no information is available about the effect of DIs during tissue regeneration following acute peripheral ischemia. In this study, mice made ischemic by femoral artery excision were injected with the DIs MS275 and MC1568, selective for class I and IIa histone deacetylases (HDACs), respectively. In untreated mice, soon after damage, class IIa HDAC phosphorylation and nuclear export occurred, paralleled by dystrophin and neuronal nitric-oxide synthase (nNOS) down-regulation and decreased protein phosphatase 2A activity. Between 14 and 21 days after ischemia, dystrophin and nNOS levels recovered, and class IIa HDACs relocalized to the nucleus. In this condition, the MC1568 compound increased the number of newly formed muscle fibers but delayed their terminal differentiation, whereas MS275 abolished the early onset of the regeneration process determining atrophy and fibrosis. The selective DIs had differential effects on the vascular compartment: MC1568 increased arteriogenesis whereas MS275 inhibited it. Capillarogenesis did not change. Chromatin immunoprecipitations revealed that class IIa HDAC complexes bind promoters of proliferation-associated genes and of class I HDAC1 and 2, high-lighting a hierarchical control between class II and I HDACs during tissue regeneration. Our findings indicate that class-selective DIs interfere with normal mouse ischemic hindlimb regeneration and suggest that their use could be limited by alteration of the regeneration process in peripheral ischemic tissues.	[Spallotta, Francesco; Rosati, Jessica D.; Vecellio, Matteo] Centro Cardiologico Monzino, Lab Biol Vascolare & Med Rigenerativa, I-20138 Milan, Italy; [Tardivo, Silvia; Straino, Stefania; Capogrossi, Maurizio C.] Ist Dermopatico Immacolata, Lab Patol Vascolare, I-00167 Rome, Italy; [Nanni, Simona; Pontecorvi, Alfredo; Colussi, Claudia] Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy; [Straino, Stefania] Explora Biotech, I-00131 Rome, Italy; [Mai, Antonello; Valente, Sergio] Univ Roma La Sapienza, Dipartimento Sci Chim, I-00185 Rome, Italy; [Farsetti, Antonella] CNR, Ist Biol Cellulare & Neurobiol, I-00143 Rome, Italy; [Nanni, Simona; Mai, Antonello; Colussi, Claudia] Natl Canc Inst Regina Elena, Dept Expt Oncol, I-00158 Rome, Italy; [Martone, Julie; Bozzoni, Irene] Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy; [Martone, Julie; Bozzoni, Irene] Univ Roma La Sapienza, Ist Biol & Patol Molecolare, I-00185 Rome, Italy; [Gaetano, Carlo] Goethe Univ, Div Cardiovascular Epigenet, Dept Cardiol, D-60325 Frankfurt, Germany	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Goethe University Frankfurt	Colussi, C (corresponding author), Univ Cattolica Sacro Cuore, Ist Patol Med, I-00168 Rome, Italy.	claudiacolussi@tiscali.it	Vecellio, Matteo Luca/HGB-6768-2022; Spallotta, Francesco/AAB-6261-2019; Tardivo, Silvia/K-2163-2018; Vecellio, Matteo Luca/AAA-9143-2022; Valente, Sergio/K-2198-2016; Mai, Antonello/AAC-2144-2019; Farsetti, Antonella/I-8710-2018; Rosati, Jessica Diana/AAK-6084-2020; Gaetano, Carlo/P-9997-2019; Colussi, Claudia/H-8609-2019; Rosati, Jessica Diana/H-2867-2016	Vecellio, Matteo Luca/0000-0002-8643-1316; Spallotta, Francesco/0000-0002-0466-6286; Tardivo, Silvia/0000-0001-7623-3407; Vecellio, Matteo Luca/0000-0002-8643-1316; Valente, Sergio/0000-0002-2241-607X; Farsetti, Antonella/0000-0002-8603-7925; Rosati, Jessica Diana/0000-0002-4483-386X; Gaetano, Carlo/0000-0002-5238-1832; Rosati, Jessica Diana/0000-0002-4483-386X; bozzoni, irene/0000-0002-3485-8537; MARTONE, Julie/0000-0001-7864-0516; Mai, Antonello/0000-0001-9176-2382; Colussi, Claudia/0000-0002-7727-8911				Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Karagiannis TC, 2010, AGING-US, V2, P659, DOI 10.18632/aging.100203; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Shah MH, 2006, CLIN CANCER RES, V12, P3997, DOI 10.1158/1078-0432.CCR-05-2689; Sneider EB, 2009, J CELL BIOCHEM, V108, P753, DOI 10.1002/jcb.22315; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Straino S, 2004, CIRCULATION, V110, P3341, DOI 10.1161/01.CIR.0000147776.50787.74; Troidl K, 2012, DIABETES-METAB RES, V28, P27, DOI 10.1002/dmrr.2232; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Xu Q, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00044; Yan JL, 2010, MOL THER, V18, P1482, DOI 10.1038/mt.2010.109; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zen AA, 2009, BIOCHEM SOC T, V37, P1221, DOI 10.1042/BST0371221; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22915	22929		10.1074/jbc.M113.484337	http://dx.doi.org/10.1074/jbc.M113.484337			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23836913	Green Published, hybrid			2022-12-25	WOS:000330598200004
J	Gaser, C; Franke, K; Kloppel, S; Koutsouleris, N; Sauer, H				Gaser, Christian; Franke, Katja; Kloeppel, Stefan; Koutsouleris, Nikolaos; Sauer, Heinrich		Alzheimer's Dis Neuroimaging Initi	BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CEREBROSPINAL-FLUID; CSF BIOMARKERS; BASE-LINE; INDIVIDUAL BRAINAGE; MCI PATIENTS; MRI; ATROPHY; DECLINE; PATTERN	Alzheimer's disease (AD), the most common form of dementia, shares many aspects of abnormal brain aging. We present a novel magnetic resonance imaging (MRI)-based biomarker that predicts the individual progression of mild cognitive impairment (MCI) to AD on the basis of pathological brain aging patterns. By employing kernel regression methods, the expression of normal brain-aging patterns forms the basis to estimate the brain age of a given new subject. If the estimated age is higher than the chronological age, a positive brain age gap estimation (BrainAGE) score indicates accelerated atrophy and is considered a risk factor for conversion to AD. Here, the BrainAGE framework was applied to predict the individual brain ages of 195 subjects with MCI at baseline, of which a total of 133 developed AD during 36 months of follow-up (corresponding to a pre-test probability of 68%). The ability of the BrainAGE framework to correctly identify MCI-converters was compared with the performance of commonly used cognitive scales, hippocampus volume, and state-of-the-art biomarkers derived from cerebrospinal fluid (CSF). With accuracy rates of up to 81%, BrainAGE outperformed all cognitive scales and CSF biomarkers in predicting conversion of MCI to AD within 3 years of follow-up. Each additional year in the BrainAGE score was associated with a 10% greater risk of developing AD (hazard rate: 1.10 [CI: 1.07-1.13]). Furthermore, the post-test probability was increased to 90% when using baseline BrainAGE scores to predict conversion to AD. The presented framework allows an accurate prediction even with multicenter data. Its fast and fully automated nature facilitates the integration into the clinical workflow. It can be exploited as a tool for screening as well as for monitoring treatment options.	[Gaser, Christian; Franke, Katja; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat, Struct Brain Mapping Grp, Jena, Germany; [Gaser, Christian] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Kloeppel, Stefan] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Dept Neurol, Freiburg, Germany; [Koutsouleris, Nikolaos] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Freiburg; University of Munich	Franke, K (corresponding author), Jena Univ Hosp, Dept Psychiat, Struct Brain Mapping Grp, Jena, Germany.	katja.franke@uni-jena.de	Franke, Katja/S-7577-2017; Gaser, Christian/F-5103-2010; Koutsouleris, Nikolaos/AAJ-7428-2020	Franke, Katja/0000-0003-1859-5738; Gaser, Christian/0000-0002-9940-099X; Kloppel, Stefan/0000-0001-6452-9964	BMBF grant [01EV0709]; ADNI (National Institutes of Health (NIH) grant [U01AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [P30AG010129, K01AG030514, U01AG024904] Funding Source: NIH RePORTER	BMBF grant(Federal Ministry of Education & Research (BMBF)); ADNI (National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by BMBF grant 01EV0709. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Data collection and sharing was funded by ADNI (National Institutes of Health (NIH) grant U01AG024904). ADNI itself is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the United States Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BENNETT KP, 2003, SIGKDD EXPLORATIONS, V2, P1; Bishop C.M., 2006, PATTERN RECOGNITION; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Duchesne S, 2009, NEUROIMAGE, V47, P1363, DOI 10.1016/j.neuroimage.2009.04.023; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Faul AC, 2002, ADV NEUR IN, V14, P383; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074; Franke K, 2012, NEUROIMAGE, V63, P1305, DOI 10.1016/j.neuroimage.2012.08.001; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gaser C., 2009, NEUROIMAGE, V1, pS121, DOI [10.1016/S1053-8119(09)71151-6, DOI 10.1016/S1053-8119(09)71151-6]; Ghosh S, 2008, ADV WATER RESOUR, V31, P132, DOI 10.1016/j.advwatres.2007.07.005; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Mangialasche F, 2013, J INTERNAL MED; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scholkopf B, 2001, LEARNING KERNELS SUP; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Spulber G, 2010, NEUROBIOL AGING, V31, P1601, DOI 10.1016/j.neurobiolaging.2008.08.018; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Teipel SJ, 2007, NEUROIMAGE, V38, P13, DOI 10.1016/j.neuroimage.2007.07.008; Tipping ME, 2000, ADV NEUR IN, V12, P652; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tipping Michael E., 2003, FAST MARGINAL LIKELI; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zheng Y. T., 2008, P 2008 INT C CONT BA, P161	73	245	248	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67346	10.1371/journal.pone.0067346	http://dx.doi.org/10.1371/journal.pone.0067346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826273	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000064
J	Mahboubi, H; Seganathy, E; Kong, D; Stochaj, U				Mahboubi, Hicham; Seganathy, Evangeline; Kong, Dekun; Stochaj, Ursula			Identification of Novel Stress Granule Components That Are Involved in Nuclear Transport	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; IMPORTIN ALPHA FAMILY; RNA-BINDING PROTEIN; 3 DISTINCT CLASSES; LOCALIZATION SIGNAL; PROCESSING BODIES; MESSENGER-RNA; IN-VITRO; EXPRESSION; PHOSPHORYLATION	Background: Importin-alpha 1 belongs to a subfamily of nuclear transport adaptors and participates in diverse cellular functions. Best understood for its role in protein transport, importin-alpha 1 also contributes to other biological processes. For instance, arsenite treatment causes importin-alpha 1 to associate with cytoplasmic stress granules (SGs) in mammalian cells. These stress-induced compartments contain translationally arrested mRNAs, small ribosomal subunits and numerous proteins involved in mRNA transport and metabolism. At present, it is not known whether members of all three importin-alpha subfamilies locate to SGs in response to stress. Results: Here, we demonstrate that the oxidant diethyl maleate (DEM), arsenite and heat shock, promote the formation of cytoplasmic SGs that contain nuclear transport factors. Specifically, importin-alpha 1, alpha 4 and alpha 5, which belong to distinct subfamilies, and importin-beta 1 were targeted by all of these stressors to cytoplasmic SGs, but not to P-bodies. Importin-alpha family members have been implicated in transcriptional regulation, which prompted us to analyze their ability to interact with poly(A)-RNA in growing cells. Our studies show that importin-alpha 1, but not alpha 4, alpha 5, importin-beta 1 or CAS, associated with poly(A)-RNA under nonstress conditions. Notably, this interaction was significantly reduced when cells were treated with DEM. Additional studies suggest that importin-alpha 1 is likely connected to poly(A)-RNA through an indirect interaction, as the adaptor did not bind homopolymer RNA specifically in vitro. Significance: Our studies establish that members of three importin-alpha subfamilies are bona fide SG components under different stress conditions. Furthermore, importin-alpha 1 is unique in its ability to interact with poly(A)-RNA in a stress-dependent fashion, and in vitro experiments indicate that this association is indirect. Collectively, our data emphasize that nuclear transport factors participate in a growing number of cellular activities that are modulated by stress.	[Mahboubi, Hicham; Seganathy, Evangeline; Kong, Dekun; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	Mahboubi, Hicham/E-4294-2015; stochaj, ursula/AAC-1865-2021	Mahboubi, Hicham/0000-0001-7643-0769; 	NSERC (Natural Sciences and Engineering Research Council of Canada); FQRNT (Fonds de recherche Nature et technologies Quebec); HSFC (Heart and Stroke Foundation of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT (Fonds de recherche Nature et technologies Quebec); HSFC (Heart and Stroke Foundation of Canada)	This research was supported by grants and fellowships from NSERC (Natural Sciences and Engineering Research Council of Canada; www.nserc-crsng.gc.ca), FQRNT (Fonds de recherche Nature et technologies Quebec; www.fqrnt.gouv.qc.ca) and HSFC (Heart and Stroke Foundation of Canada; www.hsf.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2009, SEMIN CELL DEV BIOL, V20, P576, DOI 10.1016/j.semcdb.2009.03.013; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fujimura K, 2010, BBA-MOL CELL RES, V1803, P865, DOI 10.1016/j.bbamcr.2010.03.020; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Holt JE, 2007, CURR GENOMICS, V8, P323, DOI 10.2174/138920207782446151; Itman C, 2009, SEMIN CELL DEV BIOL, V20, P607, DOI 10.1016/j.semcdb.2009.05.002; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kodicha M, 2012, J SIGNAL TRANSDUCT, V2012, P1; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Levin A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-112; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Mason DA, 2009, SEMIN CELL DEV BIOL, V20, P582, DOI 10.1016/j.semcdb.2009.02.006; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strom AC, 2001, GENOME BIOL, V2; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	59	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68356	10.1371/journal.pone.0068356	http://dx.doi.org/10.1371/journal.pone.0068356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826389	gold, Green Published, Green Submitted			2022-12-25	WOS:000321150000142
J	Nsoesie, EO; Beckman, RJ; Shashaani, S; Nagaraj, KS; Marathe, MV				Nsoesie, Elaine O.; Beckman, Richard J.; Shashaani, Sara; Nagaraj, Kalyani S.; Marathe, Madhav V.			A Simulation Optimization Approach to Epidemic Forecasting	PLOS ONE			English	Article							INFLUENZA-A H1N1; SEASONAL INFLUENZA; SURVEILLANCE; NETWORK; SCHOOLCHILDREN; HETEROGENEITY; VACCINATION; POPULATION; STRATEGIES; OUTBREAKS	Reliable forecasts of influenza can aid in the control of both seasonal and pandemic outbreaks. We introduce a simulation optimization (SIMOP) approach for forecasting the influenza epidemic curve. This study represents the final step of a project aimed at using a combination of simulation, classification, statistical and optimization techniques to forecast the epidemic curve and infer underlying model parameters during an influenza outbreak. The SIMOP procedure combines an individual-based model and the Nelder-Mead simplex optimization method. The method is used to forecast epidemics simulated over synthetic social networks representing Montgomery County in Virginia, Miami, Seattle and surrounding metropolitan regions. The results are presented for the first four weeks. Depending on the synthetic network, the peak time could be predicted within a 95% CI as early as seven weeks before the actual peak. The peak infected and total infected were also accurately forecasted for Montgomery County in Virginia within the forecasting period. Forecasting of the epidemic curve for both seasonal and pandemic influenza outbreaks is a complex problem, however this is a preliminary step and the results suggest that more can be achieved in this area.	[Nsoesie, Elaine O.; Beckman, Richard J.; Shashaani, Sara; Nagaraj, Kalyani S.; Marathe, Madhav V.] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Marathe, Madhav V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nsoesie, EO (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	onelaine@vbi.vt.edu	Shashaani, Sara/AAQ-7147-2020	Shashaani, Sara/0000-0001-8515-5877; Nsoesie, Elaine/0000-0001-9170-8714	NSF [OCI-0904844, CNS-1011769]; DTRA [HDTRA1-11-1-0016]; DTRA CNIMS [HDTRA1-11-D-0016-0001]; NIH MIDAS [2U01GM070694-09]; Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) [D12PC00337]; NSF SDCI [OCI-1032677]; Direct For Computer & Info Scie & Enginr [1032677] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); DTRA CNIMS; NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC); NSF SDCI(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been partially supported by NSF PetaApps Grant OCI-0904844, NSF NetSE Grant CNS-1011769, NSF SDCI Grant OCI-1032677, DTRA Grant HDTRA1-11-1-0016, DTRA CNIMS Contract HDTRA1-11-D-0016-0001 NIH MIDAS Grant 2U01GM070694-09 and by the Intelligence Advanced Research Projects Activity (IARPA) via Department of Interior National Business Center (DoI/NBC) contract number D12PC00337; the U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; Barrett CL, 2005, SCI AM, V292, P54, DOI 10.1038/scientificamerican0305-54; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Bera S, 2010, P INT MULT ENG COMP, V3; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Carrat F, 1998, J EPIDEMIOLOGY COMMU, P32; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Eubank S., 2010, Journal of Biological Dynamics, V4, P446, DOI 10.1080/17513751003778687; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Gates P, 2009, VACCINE, V27, P6669, DOI 10.1016/j.vaccine.2009.08.094; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Goldstein E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023380; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hastie T, 2009, ELEMENTS STAT 519 LE; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Huang Q Sue, 2007, N Z Med J, V120, pU2581; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nsoesie EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045414; Nsoesie Elaine O, 2011, STAT COMMUNICATIONS, V3; Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Taylor C, 2010, INT J INFECT DIS, V14, pE792, DOI 10.1016/j.ijid.2010.02.2267; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wilson N, 2009, EUROSURVEILLANCE, V14; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	50	25	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67164	10.1371/journal.pone.0067164	http://dx.doi.org/10.1371/journal.pone.0067164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826222	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000037
J	Barton, MD; Barton, HA				Barton, Michael D.; Barton, Hazel A.			Genomer - A Swiss Army Knife for Genome Scaffolding	PLOS ONE			English	Article							SOFTWARE	The increasing accessibility and reduced costs of sequencing has made genome analysis accessible to more and more researchers. Yet there remains a steep learning curve in the subsequent computational steps required to process raw reads into a database-deposited genome sequence. Here we describe "Genomer,'' a tool to simplify the manual tasks of finishing and uploading a genome sequence to a database. Genomer can format a genome scaffold into the common files required for submission to GenBank. This software also simplifies updating a genome scaffold by allowing a human-readable YAML format file to be edited instead of large sequence files. Genomer is written as a command line tool and is an effort to make the manual process of genome scaffolding more robust and reproducible. Extensive documentation and video tutorials are available at http://next.gs.	[Barton, Michael D.; Barton, Hazel A.] Univ Akron, Dept Biol, Akron, OH 44325 USA	University of Akron	Barton, MD (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	mail@michaelbarton.me.uk		Barton, Hazel/0000-0001-8585-9997; Barton, Michael/0000-0002-0064-2279	National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant [NIH 2P20 RR016481-09]; NIH R15 AREA Program grant [R15GM079775]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM079775] Funding Source: NIH RePORTER	National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant; NIH R15 AREA Program grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute for Health: IDeA Network of Biomedical Research Excellence (KY-INBRE) grant (NIH 2P20 RR016481-09) and the NIH R15 AREA Program grant (R15GM079775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MD, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-4; Beckloff Nicholas, 2012, Methods Mol Biol, V881, P471, DOI 10.1007/978-1-61779-827-6_16; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lopez-Fernandez H, 2011, NUCLEIC ACIDS RES, V39, pW562, DOI 10.1093/nar/gkr439; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matsumoto Yukihiro, RUBY PROGRAMMING LAN; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Tanaka N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-368; Torvalds L., GIT DISTRIBUTED REVI; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Wilkinson MD, 2002, BIOINFORMATICS, V18, P1398, DOI 10.1093/bioinformatics/18.10.1398	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66922	10.1371/journal.pone.0066922	http://dx.doi.org/10.1371/journal.pone.0066922			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826173	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400083
J	Smid, M; Dielis, AWJH; Spronk, HMH; Rumley, A; van Oerle, R; Woodward, M; ten Cate, H; Lowe, G				Smid, Machiel; Dielis, Arne W. J. H.; Spronk, Henri M. H.; Rumley, Ann; van Oerle, Rene; Woodward, Mark; ten Cate, Hugo; Lowe, Gordon			Thrombin Generation in the Glasgow Myocardial Infarction Study	PLOS ONE			English	Article							CORN TRYPSIN-INHIBITOR; TISSUE FACTOR; PLASMA; COAGULATION; SYSTEM; STABILITY; PROTEIN; DISEASE	Background: Thrombin is a key protease in coagulation also implicated in complex pathology including atherosclerosis. To address the role of thrombin in relation to myocardial infarction (MI) we explored thrombin generation analysis in plasma from patients and controls that had participated in the Glasgow MI Study (GLAMIS). Methods: Thrombin generation at 1 and 2 pM TF and with and without thrombomodulin (TM) was performed on plasmas from 356 subjects (171 cases, 185 age and sex matched controls) from GLAMIS collected between 3 and 9 months after the MI event. Results: Although thrombin generation was slightly delayed in cases (lag time increased from 3.3 to 3.6 min) at the highest trigger, the overall potential to generate thrombin was increased by 7% for the ETP and by 15% for the peak height (both at the 1 pM TF trigger) in cases. Addition of TM did not reveal differences. Furthermore, an increased thrombin generation was associated with MI [normalized ETP: adjusted OR for the highest percentile = 2.4 (95% CI 1.3-4.5) and normalized peak height: adjusted OR = 2.6 (1.3-5.0)] at the lowest trigger; normalized ETP and peak height being 2.1 (1.1-3.8) and 2.0 (1.0-4.1) at the higher 2 pM trigger. Conclusion: In GLAMIS, patients with a previous MI had an increased thrombin generation compared to controls. The absence of a clear difference in TM reduction suggests an unaltered anticoagulant activity in these patients. Further research is needed in order to unravel the underlying mechanisms of enhanced thrombin generation after MI.	[Smid, Machiel; Dielis, Arne W. J. H.; Spronk, Henri M. H.; van Oerle, Rene; ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, Maastricht, Netherlands; [Rumley, Ann; Lowe, Gordon] Univ Glasgow, Inst Cardiovasc & Med Studies, Glasgow, Lanark, Scotland; [Woodward, Mark] Univ Sydney, George Inst, Sydney, NSW 2006, Australia	Maastricht University; University of Glasgow; University of Sydney	ten Cate, H (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, Maastricht, Netherlands.	h.tencate@maastrichtuniversity.nl	Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015; Cate, Hugo ten/AAM-4000-2021	Woodward, Mark/0000-0001-9800-5296; Spronk, Henri/0000-0002-3858-334X; ten Cate, Hugo/0000-0001-7796-4463				Beijers HJBH, 2010, ARTERIOSCL THROM VAS, V30, P2639, DOI 10.1161/ATVBAHA.110.211946; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; BROZOVIC M, 1971, J CLIN PATHOL, V24, P690, DOI 10.1136/jcp.24.8.690; DAAE LNW, 1993, SCAND J CLIN LAB INV, V53, P19, DOI 10.3109/00365519309090694; Dargaud Y, 2007, BRIT J HAEMATOL, V139, P303, DOI 10.1111/j.1365-2141.2007.06785.x; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; KOERNER K, 1984, INFUS KLIN ERN, V11, P46; Lowe G, 2006, BR J HAEMATOL; Lowe GDO, 2003, J THROMB HAEMOST, V1, P2312, DOI 10.1046/j.1538-7836.2003.00467.x; Macchia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032894; Mobarrez F, 2011, THROMB HAEMOSTASIS, V106, P344, DOI 10.1160/TH10-12-0810; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Spronk HMH, 2008, THROMB HAEMOSTASIS, V100, P362, DOI 10.1160/TH08-03-0141; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Tobin WO, 2013, J NEUROL, V260, P590, DOI 10.1007/s00415-012-6684-2; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Van Veen JJ, 2008, BLOOD COAGUL FIBRIN, V19, P183, DOI 10.1097/MBC.0b013e3282f4bb47; Winckers K, 2011, J THROMB HAEMOST, V9, P2243, DOI 10.1111/j.1538-7836.2011.04497.x; Woodward M, 2006, BLOOD COAGUL FIBRIN, V17, P1, DOI 10.1097/01.mbc.0000195919.71950.f7	20	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66977	10.1371/journal.pone.0066977	http://dx.doi.org/10.1371/journal.pone.0066977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826181	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000321738400090
J	Yang, J; Wang, L; Yang, F; Luo, HM; Xu, LL; Lu, JL; Zeng, SQ; Zhang, ZH				Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong			mBeRFP, an Improved Large Stokes Shift Red Fluorescent Protein	PLOS ONE			English	Article							IN-VIVO; FRET; VARIANT; CYAN	Herein, we describe the generation of a monomeric large Stokes shift (LSS) red fluorescent protein, mBeRFP, with excitation and emission peaks at 446 and 615 nm, respectively. Compared with two previously reported LSS-RFPs (mKeima and LSS-mKate2), mBeRFP is approximately three times brighter. In addition, mBeRFP is characterized by improved photostability, rapid maturation, an extended lifetime, and a monomeric nature. Additionally, mBeRFP can be paired with the Alexa 647 dye as a FRET donor to detect caspase 3 activity. This FRET pair has an extremely dynamic range and a large Forster radius (approximately 6.5 nm). To demonstrate the applicability of mBeRFP for imaging in living cells, we performed dual-color imaging of mBeRFP and CFP simultaneously excited by a single excitation source, and we demonstrated that these fluorescent proteins allow the clear visualization of the dynamics of Bax during cancer cell apoptosis. Thus, mBeRFP appears to be particularly useful for cellular imaging applications.	[Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, ZH (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	czyzzh@mail.hust.edu.cn		Luo, Haiming/0000-0002-6226-5800; Yang, Jie/0000-0003-4346-9100	National Basic Research Program of China [2011CB910401]; Science Fund for Creative Research Group of China [61121004]; National Natural Science Foundation of China [30800208, 81172153]	National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No. 2011CB910401), Science Fund for Creative Research Group of China (Grant No.61121004), and National Natural Science Foundation of China (Grant No. 30800208, 81172153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawano H, 2008, NAT METHODS, V5, P373, DOI 10.1038/nmeth0508-373; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mayevsky A, 2011, J INNOV OPT HEAL SCI, V4, P337, DOI 10.1142/S1793545811001654; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Patterson GH, 2004, NAT BIOTECHNOL, V22, P1524, DOI 10.1038/nbt1204-1524; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Smith TA, 2012, J INNOV OPT HEAL SCI, V5, DOI 10.1142/S1793545812500253; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	23	28	29	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64849	10.1371/journal.pone.0064849	http://dx.doi.org/10.1371/journal.pone.0064849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840310	Green Published, gold, Green Submitted			2022-12-25	WOS:000322342800006
J	Fiorillo, AR; Tykoski, RS				Fiorillo, Anthony R.; Tykoski, Ronald S.			An Immature Pachyrhinosaurus perotorum (Dinosauria: Ceratopsidae) Nasal Reveals Unexpected Complexity of Craniofacial Ontogeny and Integument in Pachyrhinosaurus	PLOS ONE			English	Article							HORNED DINOSAURS; CENTROSAURINE; ALBERTA; ORNITHISCHIA; CANADA	A new specimen attributable to an immature individual of Pachyrhinosaurus perotorum (Dinosauria, Ceratopsidae) from the Kikak-Tegoseak Quarry in northern Alaska preserves a mix of features that provides refinement to the sequence of ontogenetic stages and transformations inferred for the development of the nasal boss in Pachyrhinosaurus. The new specimen consists of an incomplete nasal that includes the posterior part of the nasal horn, the dorsal surface between the horn and the left-side contacts for the prefrontal and frontal, and some of the left side of the rostrum posteroventral to the nasal horn. The combination of morphologies in the new specimen suggests either an additional stage of development should be recognized in the ontogeny of the nasal boss of Pachyrhinosaurus, or that the ontogenetic pathway of nasal boss development in P. perotorum was notably different from that of P. lakustai. Additionally, the presence of a distinct basal sulcus and the lateral palisade texture on the nasal horn of the specimen described here indicate that a thick, cornified horn sheath was present well before the formation of a dorsal cornified pad. A separate rugose patch on the nasal well posterior to the nasal horn is evidence for a cornified integumentary structure, most likely a thick cornified pad, on the posterior part of the nasal separate from the nasal horn prior to the onset of nasal boss formation in P. perotorum.	[Fiorillo, Anthony R.; Tykoski, Ronald S.] Perot Museum Nat & Sci, Dallas, TX USA		Fiorillo, AR (corresponding author), Perot Museum Nat & Sci, Dallas, TX USA.	anthony.fiorillo@perotmuseum.org		Fiorillo, Anthony/0000-0002-8998-0820	United States National Science Foundation [OPP 04245594]	United States National Science Foundation(National Science Foundation (NSF))	Field work was supported by the United States National Science Foundation award OPP 04245594 to Fiorillo (http://www.nsf.gov/awardsearch/showAward?AWD_ID=0424594&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conrad J. E., 1990, US GEOLOGICAL SURV C, V1990-C, P1; Currie Philip J., 2008, P1; CURRIE PJ, 1989, NAT HIST, V6, P60; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo Anthony R., 2010, P456; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; Langston W. Jr., 1967, Canadian Journal of Earth Sciences, V4, P171; McDonald AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022710; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson S.D., 2011, NEW PERSPECTIVES HOR, P405; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; STERNBERG C. M., 1950, NATION MUS CANADA MUS BULL, V118, P109	16	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65802	10.1371/journal.pone.0065802	http://dx.doi.org/10.1371/journal.pone.0065802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840371	Green Submitted, gold, Green Published			2022-12-25	WOS:000322361200037
J	Rawnsley, DR; Xiao, JP; Lee, JS; Liu, X; Mericko-Ishizuka, P; Kumar, V; He, J; Basu, A; Lu, MM; Lynn, FC; Pack, M; Gasa, R; Kahn, ML				Rawnsley, David R.; Xiao, Jiping; Lee, John S.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; He, Jie; Basu, Arindam; Lu, MinMin; Lynn, Francis C.; Pack, Michael; Gasa, Rosa; Kahn, Mark L.			The Transcription Factor Atonal homolog 8 Regulates Gata4 and Friend of Gata-2 during Vertebrate Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; HEART TUBE FORMATION; VASCULAR DEVELOPMENT; VENTRAL MORPHOGENESIS; CARDIAC MORPHOGENESIS; LUNG DEVELOPMENT; GENE-EXPRESSION; RIGHT VENTRICLE; FOG-2; ZEBRAFISH	GATA and Friend of GATA (FOG) form a transcriptional complex that plays a key role in cardiovascular development in both fish and mammals. In the present study we demonstrate that the basic helix-loop-helix transcription factor Atonal homolog 8 (Atoh8) is required for development of the heart in fish but not in mice. Genetic studies reveal that Atoh8 interacts specifically with Gata4 and Fog1 during development of the heart and swim bladder in the fish. Biochemical studies reveal that ATOH8, GATA4, and FOG2 associate in a single complex in vitro. In contrast to fish, ATOH8-deficient mice exhibit normal cardiac development and loss of ATOH8 does not alter cardiac development in Gata4(+/-) mice. This species difference in the role of ATOH8 is explained in part by LacZ and GFP reporter alleles that reveal restriction of Atoh8 expression to atrial but not ventricular myocardium in the mouse. Our findings identify ATOH8 as a novel regulator of GATA-FOG function that is required for cardiac development in the fish but not the mouse. Whether ATOH8 modulates GATA-FOG function at other sites or in more subtle ways in mammals is not yet known.	[Rawnsley, David R.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; He, Jie; Lu, MinMin; Pack, Michael; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Rawnsley, David R.; Liu, Xi; Mericko-Ishizuka, Patricia; Kumar, Vinayak; Lu, MinMin; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Basu, Arindam] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Xiao, Jiping] NYU, Dept Psychiat, New York, NY 10016 USA; [Lee, John S.] Bristol Myers Squibb Co, Hopewell, NJ 08525 USA; [Liu, Xi] Fourth Mil Med Univ, Xian 710032, Peoples R China; [Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 4H4, Canada; [Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 4H4, Canada; [Gasa, Rosa] Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Gasa, Rosa] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona 08017, Spain	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; New York University; Bristol-Myers Squibb; Air Force Military Medical University; University of British Columbia; University of British Columbia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Kahn, ML (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	markkahn@mail.med.upenn.edu		Kumar, Vinayak/0000-0002-1899-0386; Lynn, Francis/0000-0001-9318-1063	National Institutes of Health [T32 HL007971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grant T32 HL007971.	Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Barnett P, 2012, CURR TOP DEV BIOL, V100, P171, DOI 10.1016/B978-0-12-387786-4.00004-X; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Brien GL, 2009, SEMIN CELL DEV BIOL, V20, P835, DOI 10.1016/j.semcdb.2009.07.010; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023005; Conway SJ, 2010, PEDIATR CARDIOL, V31, P318, DOI 10.1007/s00246-009-9608-x; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; De Luca A, 2011, CLIN GENET, V80, P184, DOI 10.1111/j.1399-0004.2010.01523.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; Gore AV, 2011, DEVELOPMENT, V138, P4875, DOI 10.1242/dev.068460; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hashiguchi M, 2013, DEVELOPMENT, V140, P1970, DOI 10.1242/dev.088104; Her GM, 2004, GENESIS, V38, P26, DOI 10.1002/gene.10248; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Manuylov NL, 2009, THESCIENTIFICWORLDJO, V9, P575, DOI 10.1100/tsw.2009.75; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; PHILLIPS SEV, 1994, STRUCTURE, V2, P1, DOI 10.1016/S0969-2126(00)00002-2; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shu WG, 2002, DEVELOPMENT, V129, P4831; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Torday JS, 2007, INTEGR COMP BIOL, V47, P601, DOI 10.1093/icb/icm069; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945; Zaytouni T, 2011, ADV GENET, V76, P93, DOI 10.1016/B978-0-12-386481-9.00004-3; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	64	25	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24429	24440		10.1074/jbc.M113.463083	http://dx.doi.org/10.1074/jbc.M113.463083			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23836893	hybrid, Green Published			2022-12-25	WOS:000330612300013
J	Farrand, L; Byun, S; Kim, JY; Im-Aram, A; Lee, J; Lim, S; Lee, KW; Suh, JY; Lee, HJ; Tsang, BK				Farrand, Lee; Byun, Sanguine; Kim, Ji Young; Im-Aram, Akechai; Lee, Jihoon; Lim, Semi; Lee, Ki Won; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.			Piceatannol Enhances Cisplatin Sensitivity in Ovarian Cancer via Modulation of p53, X-linked Inhibitor of Apoptosis Protein (XIAP), and Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; CYTOCHROME-C; TUMOR XENOGRAFTS; DOWN-REGULATION; RESVERATROL; RESISTANCE; DRP1; CHEMOTHERAPY; ACTIVATION; THERAPY	Resistance to cisplatin (CDDP) in ovarian cancer (OVCA) arises from the dysregulation of tumor suppressors and survival signals. During genotoxic challenge, these factors can be influenced by secondary agents that facilitate the induction of apoptosis. Piceatannol is a natural metabolite of the stilbene resveratrol found in grapes and is converted from its parent compound by the enzyme CYP1BA1 p450. It has been hypothesized to exert specific effects against various cellular targets; however, its ability to influence CDDP resistance in cancer cells has not been investigated to date. Here, we show that piceatannol is a potent enhancer of CDDP sensitivity in OVCA, and this effect is achieved through the modulation of several major determinants of chemoresistance. Piceatannol enhances p53-mediated expression of the pro-apoptotic protein NOXA, increases XIAP degradation via the ubiquitin-proteasome pathway, and enhances caspase-3 activation. This response is associated with an increase in Drp1-dependent mitochondrial fission, leading to more effective induction of apoptosis. In vivo studies using a mouse model of OVCA reveal that a number of these changes occur in association with a greater overall reduction in tumor weight when mice are treated with both piceatannol and CDDP, in comparison to treatment with either agent alone. Taken together, these findings demonstrate the potential application of piceatannol to enhance CDDP sensitivity in OVCA, and it acts on p53, XIAP, and mitochondrial fission.	[Farrand, Lee; Byun, Sanguine; Kim, Ji Young; Im-Aram, Akechai; Lee, Jihoon; Lim, Semi; Lee, Ki Won; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Major Biomodulat, Seoul, South Korea; [Byun, Sanguine; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1N 6N5, Canada; [Byun, Sanguine; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Ottawa Hosp Gen Campus,3rd Floor,Rm W3107,501 Smy, Ottawa, ON K1H 8L6, Canada.	btsang@ohri.ca	Byun, Sanguine/AAR-5451-2021; Lee, Ki Won/M-4114-2018	Tsang, Benjamin K./0000-0003-1213-3946; Byun, Sanguine/0000-0003-3903-5887	World Class University Program through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology; Canadian Institutes of Health Research [M0P-126144]	World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by World Class University Program Grant R31-10056 through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology and Canadian Institutes of Health Research Grant M0P-126144.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Alas S, 2001, CANCER RES, V61, P5137; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; American Cancer Society, 2012, CANC FACTS FIG; Amiot MJ, 2013, BIOCHIMIE, V95, P1233, DOI 10.1016/j.biochi.2013.01.008; Asselin E, 2001, ENDOCRINOLOGY, V142, P2451, DOI 10.1210/en.142.6.2451; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Biggar RJ, 2012, CLIN CANCER RES, V18, P2133, DOI 10.1158/1078-0432.CCR-11-1389; Bras M, 2007, MOL CELL BIOL, V27, P7073, DOI 10.1128/MCB.02116-06; Brown JM, 1999, CANCER RES, V59, P1391; CANPOLAT C, 1994, CANCER, V74, P3059, DOI 10.1002/1097-0142(19941201)74:11<3059::AID-CNCR2820741125>3.0.CO;2-Z; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Covens A, 2002, GYNECOL ONCOL, V85, P71, DOI 10.1006/gyno.2001.6552; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Ghamande S, 2001, CANCER RES, V61, P7556; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Hesketh PJ, 2004, SUPPORT CARE CANCER, V12, P543, DOI 10.1007/s00520-003-0562-5; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Maggiolini M, 2005, J MOL ENDOCRINOL, V35, P269, DOI 10.1677/jme.1.01783; Nicholson SK, 2008, P NUTR SOC, V67, P42, DOI 10.1017/S0029665108006009; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Plumb JA, 2000, CANCER RES, V60, P6039; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rezk Youssef A, 2006, Am J Obstet Gynecol, V194, pe23, DOI 10.1016/j.ajog.2005.11.030; ROSE DP, 1986, CANCER-AM CANCER SOC, V58, P2363, DOI 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-#; Sasaki H, 2000, CANCER RES, V60, P5659; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Takahashi S, 2012, BRIT J NUTR, V107, P774, DOI 10.1017/S0007114511003588; Wolter F, 2002, J NUTR, V132, P298; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	60	74	76	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23740	23750		10.1074/jbc.M113.487686	http://dx.doi.org/10.1074/jbc.M113.487686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23833193	Green Published, hybrid			2022-12-25	WOS:000330611400014
J	Khan, GA; Berglund, B; Khan, KM; Lindgren, PE; Fick, J				Khan, Ghazanfar Ali; Berglund, Bjorn; Khan, Kashif Maqbool; Lindgren, Per-Eric; Fick, Jerker			Occurrence and Abundance of Antibiotics and Resistance Genes in Rivers, Canal and near Drug Formulation Facilities - A Study in Pakistan	PLOS ONE			English	Article							WATER TREATMENT-PLANT; PRODUCTION WASTE-WATER; SOLID-PHASE EXTRACTION; VETERINARY ANTIBIOTICS; AQUATIC ENVIRONMENT; DRINKING-WATER; INTEGRONS; BACTERIA; PHARMACEUTICALS; METAL	Antibiotic resistance (AR) is a global phenomenon that has severe epidemiological ramifications world-wide. It has been suggested that antibiotics that have been discharged into the natural aquatic environments after usage or manufacture can promote the occurrence of antibiotic resistance genes (ARG). These environmental ARGs could serve as a reservoir and be horizontally transferred to human-associated bacteria and thus contribute to AR proliferation. The aim of this study was to investigate the anthropogenic load of antibiotics in Northern Pakistan and study the occurrence of ARGs in selected samples from this region. 19 sampling sites were selected; including six rivers, one dam, one canal, one sewage drain and four drug formulation facilities. Our results show that five of the rivers have antibiotic levels comparable to surface water measurements in unpolluted sites in Europe and the US. However, high levels of antibiotics could be detected in the downstream river in close vicinity of the 10 million city Lahore, 1100, 1700 and 2700 ng L-1 for oxytetracycline, trimethoprim, and sulfamethoxazole respectively. Highest detected levels were at one of the drug formulation facilities, with the measured levels of 1100, 4100, 6200, 7300, 8000, 27000, 28000 and 49000 ng L 21 of erythromycin, lincomycin, ciprofloxacin, ofloxacin, levofloxacin, oxytetracycline, trimethoprim and sulfamethoxazole respectively. ARGs were also detected at the sites and the highest levels of ARGs detected, sulI and dfrA1, were directly associated with the antibiotics detected at the highest concentrations, sulfamethoxazole and trimethoprim. Highest levels of both antibiotics and ARGs were seen at a drug formulation facility, within an industrial estate with a low number of local residents and no hospitals in the vicinity, which indicates that the levels of ARGs at this site were associated with the environmental levels of antibiotics.	[Khan, Ghazanfar Ali; Fick, Jerker] Umea Univ, Dept Chem, Umea, Sweden; [Berglund, Bjorn; Lindgren, Per-Eric] Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Khan, Kashif Maqbool] Univ Punjab, Coll Pharm, Lahore, Pakistan; [Lindgren, Per-Eric] Cty Hosp Ryhov, Jonkoping, Sweden	Umea University; Linkoping University; University of Punjab	Khan, GA (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	ghazanfar.ali.khan@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022	Fick, Jerker/0000-0002-3949-7371	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS [210-2006-2132]; Foundation for Strategic Environmental Research (MISTRA)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS(Swedish Research Council Formas); Foundation for Strategic Environmental Research (MISTRA)	Research is funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS (contract no. 210-2006-2132) and in part by the Foundation for Strategic Environmental Research (MISTRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6; Cui CW, 2006, ENVIRON MONIT ASSESS, V121, P409, DOI 10.1007/s10661-005-9139-8; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Souza MJ, 2006, ECOTOXICOLOGY, V15, P379, DOI 10.1007/s10646-006-0068-2; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 1998, APPL ENVIRON MICROB, V64, P3499; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Harris SJ, 2012, HUM ECOL RISK ASSESS, V18, P767, DOI 10.1080/10807039.2012.688702; Hoerger Corinne C., 2009, Integrated Environmental Assessment and Management, V5, P331, DOI 10.1897/IEAM_2008-049.1; HOLM JV, 1995, ENVIRON SCI TECHNOL, V29, P1415, DOI 10.1021/es00005a039; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Khan GA, 2012, J PHARMACEUT BIOMED, V66, P24, DOI 10.1016/j.jpba.2012.02.011; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li D, 2008, WATER RES, V42, P307, DOI 10.1016/j.watres.2007.07.016; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Nikolaou A, 2007, ANAL BIOANAL CHEM, V387, P1225, DOI 10.1007/s00216-006-1035-8; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Segura PA, 2009, ENVIRON HEALTH PERSP, V117, P675, DOI 10.1289/ehp.11776; Sim WJ, 2011, CHEMOSPHERE, V82, P179, DOI 10.1016/j.chemosphere.2010.10.026; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Su HC, 2012, ENVIRON POLLUT, V169, P42, DOI 10.1016/j.envpol.2012.05.007; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zuhlke S, 2004, J CHROMATOGR A, V1050, P201, DOI [10.1016/j.chroma.2004.08.051, 10.1016/S0021-9673(04)01401-3]	48	145	152	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e62712	10.1371/journal.pone.0062712	http://dx.doi.org/10.1371/journal.pone.0062712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840297	Green Published, gold, Green Submitted			2022-12-25	WOS:000321148400001
J	Bianco, G; Botte, V; Dubroca, L; d'Alcala, MR; Mazzocchi, MG				Bianco, Giuseppe; Botte, Vincenzo; Dubroca, Laurent; d'Alcala, Maurizio Ribera; Mazzocchi, Maria Grazia			Unexpected Regularity in Swimming Behavior of Clausocalanus furcatus Revealed by a Telecentric 3D Computer Vision System	PLOS ONE			English	Article							PSEUDODIAPTOMUS-ANNANDALEI COPEPODA; PLANKTONIC COPEPODS; MOTILITY PATTERNS; FORAGING BEHAVIOR; CALANOID COPEPODS; FEEDING-BEHAVIOR; ZOOPLANKTON; MOTION	Planktonic copepods display a large repertoire of motion behaviors in a three-dimensional environment. Two-dimensional video observations demonstrated that the small copepod Clausocalanus furcatus, one the most widely distributed calanoids at low to medium latitudes, presented a unique swimming behavior that was continuous and fast and followed notably convoluted trajectories. Furthermore, previous observations indicated that the motion of C. furcatus resembled a random process. We characterized the swimming behavior of this species in three-dimensional space using a video system equipped with telecentric lenses, which allow tracking of zooplankton without the distortion errors inherent in common lenses. Our observations revealed unexpected regularities in the behavior of C. furcatus that appear primarily in the horizontal plane and could not have been identified in previous observations based on lateral views. Our results indicate that the swimming behavior of C. furcatus is based on a limited repertoire of basic kinematic modules but exhibits greater plasticity than previously thought.	[Bianco, Giuseppe; Botte, Vincenzo; Dubroca, Laurent; d'Alcala, Maurizio Ribera; Mazzocchi, Maria Grazia] Stn Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Bianco, G (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	Giuseppe.Bianco@biol.lu.se	Dubroca, Laurent/AAS-5187-2021; d'Alcala', Maurizio Ribera/B-7114-2012	Dubroca, Laurent/0000-0002-1861-0507; d'Alcala', Maurizio Ribera/0000-0002-5492-9961	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	This study is part of the Ph.D. thesis of G.B., University of Naples "Federico II", funded by the Stazione Zoologica Anton Dohrn. Funds for the video equipment were provided by the Center of Competence of Campania Region AMRA (Analisi e Monitoraggio del Rischio Ambientale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bagoien E, 2005, MAR ECOL PROG SER, V300, P129, DOI 10.3354/meps300129; Bradski G., 2008, LEARNING OPENCV COMP; BROWMAN HI, 1989, J PLANKTON RES, V11, P1075, DOI 10.1093/plankt/11.5.1075; BUNDY MH, 1993, B MAR SCI, V53, P15; BUSKEY EJ, 1984, MAR BIOL, V79, P165, DOI 10.1007/BF00951825; Dur G, 2011, J EXP MAR BIOL ECOL, V402, P1, DOI 10.1016/j.jembe.2011.02.039; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; Dur G, 2010, J PLANKTON RES, V32, P423, DOI 10.1093/plankt/fbp141; Fragopoulu N, 2001, CRUSTACEANA, V74, P49, DOI 10.1163/156854001505433; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Hanning T., 2011, HIGH PRECISION CAMER; Hartley R., 2003, MULTIPLE VIEW GEOMET, V2nd second; Jahne B., 2004, PRACTICAL HDB IMAGE; Kehayias G, 1996, ICES J MAR SCI, V53, P837, DOI 10.1006/jmsc.1996.0105; Ki&DEG;rboe T., 2008, MECHANISTIC APPROACH; Kiorboe T, 2005, LIMNOL OCEANOGR, V50, P1999, DOI 10.4319/lo.2005.50.6.1999; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Kundu P. K, 1990, FLUID MECH; Mazzocchi MG, 2011, J PLANKTON RES, V33, P1163, DOI 10.1093/plankt/fbr017; Mazzocchi MG, 1999, J PLANKTON RES, V21, P1501, DOI 10.1093/plankt/21.8.1501; Mazzocchi MG, 1998, J PLANKTON RES, V20, P331, DOI 10.1093/plankt/20.2.331; Murdoch D, 2001, P 2 INT WORKSH DISTR; Paffenhofer GA, 1998, J MARINE SYST, V15, P457, DOI 10.1016/S0924-7963(97)00037-7; Paffenhofer GA, 2006, MAR ECOL PROG SER, V317, P187, DOI 10.3354/meps317187; Pattenhofer GA, 2006, MAR ECOL-EVOL PERSP, V27, P99, DOI 10.1111/j.1439-0485.2006.00086.x; Peralba A, 2004, ICES J MAR SCI, V61, P645, DOI 10.1016/j.icesjms.2004.03.019; Press W., 1992, NUMERICAL RECIPES FO; R Core Team, 2012, R LANG ENV STAT COMP; Schmitt FG, 2001, PHYSICA A, V301, P375, DOI 10.1016/S0378-4371(01)00429-0; Schnack-Schiel SB, 2010, DEEP-SEA RES PT II, V57, P2064, DOI 10.1016/j.dsr2.2010.09.010; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Strickler JR, 1998, PHILOS T R SOC B, V353, P671, DOI 10.1098/rstb.1998.0233; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; TISELIUS P, 1990, MAR ECOL PROG SER, V66, P23, DOI 10.3354/meps066023; Uttieri M, 2008, MAR BIOL, V153, P925, DOI 10.1007/s00227-007-0864-0; VANDUREN LA, 1995, MAR ECOL PROG SER, V126, P153, DOI 10.3354/meps126153; Viitasalo M, 1998, MAR ECOL PROG SER, V175, P129, DOI 10.3354/meps175129; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Watanabe M., 1996, Computer Vision - ECCV '96. 4th Eurpean Conference on Computer Proceedings, P439; Wiggert JD, 2005, J PLANKTON RES, V27, P1013, DOI 10.1093/plankt/fbi090	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67640	10.1371/journal.pone.0067640	http://dx.doi.org/10.1371/journal.pone.0067640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826331	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000095
J	Diestel, U; Resch, M; Meinhardt, K; Weiler, S; Hellmann, TV; Mueller, TD; Nickel, J; Eichler, J; Muller, YA				Diestel, Uschi; Resch, Marcus; Meinhardt, Kathrin; Weiler, Sigrid; Hellmann, Tina V.; Mueller, Thomas D.; Nickel, Joachim; Eichler, Jutta; Muller, Yves A.			Identification of a Novel TGF-beta-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-beta-Receptor-3 (TGFR-3)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-TYPE-III; LIGAND-BINDING; BETAGLYCAN; POLYMERIZATION; SUPERFAMILY; CORECEPTOR; MEMBRANE; PROTEINS; INSIGHTS	The zona pellucida (ZP) domain is present in extracellular proteins such as the zona pellucida proteins and tectorins and participates in the formation of polymeric protein networks. However, the ZP domain also occurs in the cytokine signaling co-receptor transforming growth factor beta (TGF-beta) receptor type 3 (TGFR-3, also known as betaglycan) where it contributes to cytokine ligand recognition. Currently it is unclear how the ZP domain architecture enables this dual functionality. Here, we identify a novel major TGF-beta-binding site in the FG loop of the C-terminal subdomain of the murine TGFR-3 ZP domain (ZP-C) using protein crystallography, limited proteolysis experiments, surface plasmon resonance measurements and synthetic peptides. In the murine 2.7 angstrom crystal structure that we are presenting here, the FG-loop is disordered, however, well-ordered in a recently reported homologous rat ZP-C structure. Surprisingly, the adjacent external hydrophobic patch (EHP) segment is registered differently in the rat and murine structures suggesting that this segment only loosely associates with the remaining ZP-C fold. Such a flexible and temporarily-modulated association of the EHP segment with the ZP domain has been proposed to control the polymerization of ZP domain-containing proteins. Our findings suggest that this flexibility also extends to the ZP domain of TGFR-3 and might facilitate co-receptor ligand interaction and presentation via the adjacent FG-loop. This hints that a similar C-terminal region of the ZP domain architecture possibly regulates both the polymerization of extracellular matrix proteins and cytokine ligand recognition of TGFR-3.	[Diestel, Uschi; Resch, Marcus; Meinhardt, Kathrin; Weiler, Sigrid; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Erlangen, Germany; [Hellmann, Tina V.; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot 1, Julius von Sachs Inst Biowissensch, Wurzburg, Germany; [Nickel, Joachim] Univ Wurzburg, Lehrstuhl Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany; [Eichler, Jutta] Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany	University of Erlangen Nuremberg; University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016; Eichler, Jutta/H-7847-2018	Muller, Yves A/0000-0003-0519-8928; Eichler, Jutta/0000-0001-6683-9456; Mueller, Thomas/0000-0003-1862-7357	'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen; 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern; Collaborative Research Group SFB 769	'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen; 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern; Collaborative Research Group SFB 769	This work was supported by the 'Dr. Hertha und Helmut Schmauser-Stiftung', Erlangen, and the 'BioMedTec International Graduate School of Science' (BIGSS) within the Elitenetzwerk Bayern and the Collaborative Research Group SFB 769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Diestler DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.178101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Fivash M, 1998, CURR OPIN BIOTECH, V9, P97, DOI 10.1016/S0958-1669(98)80091-8; Franke R, 2007, ANGEW CHEM INT EDIT, V46, P1253, DOI 10.1002/anie.200603274; FUKUSHIMA D, 1993, J BIOL CHEM, V268, P22710; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaname S, 1996, BIOCHEM J, V315, P815, DOI 10.1042/bj3150815; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; Pepin MC, 1995, FEBS LETT, V377, P368, DOI 10.1016/0014-5793(95)01378-4; PEPIN MC, 1994, P NATL ACAD SCI USA, V91, P6997, DOI 10.1073/pnas.91.15.6997; PUETT D, 1977, MOL CELL BIOCHEM, V15, P109, DOI 10.1007/BF01793332; ROBINSON JP, 1973, ARCH BIOCHEM BIOPHYS, V159, P615, DOI 10.1016/0003-9861(73)90498-0; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	35	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67214	10.1371/journal.pone.0067214	http://dx.doi.org/10.1371/journal.pone.0067214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826237	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000045
J	Fouquet, C; Babayan, BM; Watilliaux, A; Bontempi, B; Tobin, C; Rondi-Reig, L				Fouquet, Celine; Babayan, Benedicte M.; Watilliaux, Aurelie; Bontempi, Bruno; Tobin, Christine; Rondi-Reig, Laure			Complementary Roles of the Hippocampus and the Dorsomedial Striatum during Spatial and Sequence-Based Navigation Behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NEURAL SYSTEMS-ANALYSIS; CAUDATE-NUCLEUS; DORSAL STRIATUM; BASAL GANGLIA; ELECTROPHYSIOLOGICAL EVIDENCE; ANTEROGRADE TRANSPORT; EPISODIC MEMORY; TEMPORAL-ORDER; CELL-ACTIVITY	We investigated the neural bases of navigation based on spatial or sequential egocentric representation during the completion of the starmaze, a complex goal-directed navigation task. In this maze, mice had to swim along a path composed of three choice points to find a hidden platform. As reported previously, this task can be solved by using two hippocampal-dependent strategies encoded in parallel i) the allocentric strategy requiring encoding of the contextual information, and ii) the sequential egocentric strategy requiring temporal encoding of a sequence of successive body movements associated to specific choice points. Mice were trained during one day and tested the following day in a single probe trial to reveal which of the two strategies was spontaneously preferred by each animal. Imaging of the activity-dependent gene c-fos revealed that both strategies are supported by an overlapping network involving the dorsal hippocampus, the dorsomedial striatum (DMS) and the medial prefrontal cortex. A significant higher activation of the ventral CA1 subregion was observed when mice used the sequential egocentric strategy. To investigate the potential different roles of the dorsal hippocampus and the DMS in both types of navigation, we performed region-specific excitotoxic lesions of each of these two structures. Dorsal hippocampus lesioned mice were unable to optimally learn the sequence but improved their performances by developing a serial strategy instead. DMS lesioned mice were severely impaired, failing to learn the task. Our data support the view that the hippocampus organizes information into a spatio-temporal representation, which can then be used by the DMS to perform goal-directed navigation.	[Fouquet, Celine; Babayan, Benedicte M.; Watilliaux, Aurelie; Tobin, Christine; Rondi-Reig, Laure] Univ Paris 06, CNRS, ENMVI Team, UMR7102, Paris, France; [Bontempi, Bruno] Univ Bordeaux 2, CNRS, Inst Malad Neurodegenerat, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Rondi-Reig, L (corresponding author), Univ Paris 06, CNRS, ENMVI Team, UMR7102, Paris, France.	laure.rondi@snv.jussieu.fr	Rondi-Reig, Laure/G-2816-2011; Rondi-Reig, Laure/M-6141-2016	Rondi-Reig, Laure/0000-0003-1006-0501	Fondation pour la Recherche Medicale, France [DEQ20120323730]; National Agency for Research, France [ANR-REG-07122001-01]; Region Ile de France; France Alzheimer [RAK09011DDA]	Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); National Agency for Research, France; Region Ile de France(Region Ile-de-France); France Alzheimer	This work was supported by the Fondation pour la Recherche Medicale DEQ20120323730, France, and National Agency for Research ANR-REG-07122001-01, France. CF was supported by a Region Ile de France PhD grant and France Alzheimer grants no RAK09011DDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Brown TI, 2012, NEUROIMAGE, V60, P1316, DOI 10.1016/j.neuroimage.2012.01.046; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 2011, NEUROBIOL LEARN MEM, V96, P95, DOI 10.1016/j.nlm.2011.06.002; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FERINO F, 1987, EXP BRAIN RES, V65, P421; Floresco SB, 2008, NEUROSCIENCE, V154, P877, DOI 10.1016/j.neuroscience.2008.04.004; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fouquet C, 2011, NEUROBIOL AGING, V32, P1881, DOI 10.1016/j.neurobiolaging.2009.11.001; Fouquet C, 2010, BEHAV BRAIN RES, V215, P172, DOI 10.1016/j.bbr.2010.05.054; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; Gruber AJ, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00050; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hoang LT, 2008, BEHAV NEUROSCI, V122, P9, DOI 10.1037/0735-7044.122.1.9; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Howland JG, 2008, HIPPOCAMPUS, V18, P251, DOI 10.1002/hipo.20396; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kennedy PJ, 2009, P NATL ACAD SCI USA, V106, P10805, DOI 10.1073/pnas.0903259106; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; KESNER RP, 1993, EXP BRAIN RES, V93, P462; Khamassi M, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00079; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Kobayashi T, 2003, NEUROSCIENCE, V117, P1025, DOI 10.1016/S0306-4522(02)00700-5; Kumaran D, 2006, NEURON, V49, P617, DOI 10.1016/j.neuron.2005.12.024; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MALDONADOIRIZARRY CS, 1995, BEHAV PHARMACOL, V6, P527; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Mizumori SJY, 2007, HIPPOCAMPUS, V17, P851, DOI 10.1002/hipo.20317; Mizumori SJY, 2009, BEHAV BRAIN RES, V199, P32, DOI 10.1016/j.bbr.2008.11.014; Mizumori SJY, 2000, MOL NEUROBIOL, V21, P57, DOI 10.1385/MN:21:1-2:057; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moussa R, 2011, LEARN MEMORY, V18, P444, DOI 10.1101/lm.2123811; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Penner MR, 2012, PROG NEUROBIOL, V96, P96, DOI 10.1016/j.pneurobio.2011.08.010; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rondi-Reig L, 2006, J NEUROSCI, V26, P4071, DOI 10.1523/JNEUROSCI.3408-05.2006; Rondi-Reig L, 2001, P NATL ACAD SCI USA, V98, P3543, DOI 10.1073/pnas.041620798; Rondi-Reig L, 2001, NEUROSCIENCE, V104, P207, DOI 10.1016/S0306-4522(01)00050-1; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Voermans NC, 2004, NEURON, V43, P427, DOI 10.1016/j.neuron.2004.07.009; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WHITE IM, 1993, BRAIN RES, V616, P71, DOI 10.1016/0006-8993(93)90194-R; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wiener SI, 1996, PROG NEUROBIOL, V49, P335, DOI 10.1016/0301-0082(96)00019-6; WIENER SI, 1993, J NEUROSCI, V13, P3802; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yeshenko O, 2004, BEHAV NEUROSCI, V118, P751, DOI 10.1037/0735-7044.118.4.751; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004	83	34	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67232	10.1371/journal.pone.0067232	http://dx.doi.org/10.1371/journal.pone.0067232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826243	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000047
J	Perez, SI; Tejedor, MF; Novo, NM; Aristide, L				Ivan Perez, S.; Tejedor, Marcelo F.; Novo, Nelson M.; Aristide, Leandro			Divergence Times and the Evolutionary Radiation of New World Monkeys (Platyrrhini, Primates): An Analysis of Fossil and Molecular Data	PLOS ONE			English	Article							MIDDLE MIOCENE; LA-VENTA; CLOCK; PHYLOGENIES; RODENTS; RATES; DIVERSIFICATION; SUBSTITUTION; DOLICHOCEBUS; SYSTEMATICS	The estimation of phylogenetic relationships and divergence times among a group of organisms is a fundamental first step toward understanding its biological diversification. The time of the most recent or last common ancestor (LCA) of extant platyrrhines is one of the most controversial among scholars of primate evolution. Here we use two molecular based approaches to date the initial divergence of the platyrrhine clade, Bayesian estimations under a relaxed-clock model and substitution rate plus generation time and body size, employing the fossil record and genome datasets. We also explore the robustness of our estimations with respect to changes in topology, fossil constraints and substitution rate, and discuss the implications of our findings for understanding the platyrrhine radiation. Our results suggest that fossil constraints, topology and substitution rate have an important influence on our divergence time estimates. Bayesian estimates using conservative but realistic fossil constraints suggest that the LCA of extant platyrrhines existed at ca. 29 Ma, with the 95% confidence limit for the node ranging from 27-31 Ma. The LCA of extant platyrrhine monkeys based on substitution rate corrected by generation time and body size was established between 21-29 Ma. The estimates based on the two approaches used in this study recalibrate the ages of the major platyrrhine clades and corroborate the hypothesis that they constitute very old lineages. These results can help reconcile several controversial points concerning the affinities of key early Miocene fossils that have arisen among paleontologists and molecular systematists. However, they cannot resolve the controversy of whether these fossil species truly belong to the extant lineages or to a stem platyrrhine clade. That question can only be resolved by morphology. Finally, we show that the use of different approaches and well supported fossil information gives a more robust divergence time estimate of a clade.	[Ivan Perez, S.; Aristide, Leandro] Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Antropoli, La Plata, Buenos Aires, Argentina; [Tejedor, Marcelo F.; Novo, Nelson M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut Province, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Perez, SI (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Antropoli, La Plata, Buenos Aires, Argentina.	iperez@fcnym.unlp.edu.ar	Aristide, Leandro/AES-1563-2022; Tejedor, Marcelo/AAU-4189-2021	Aristide, Leandro/0000-0001-9556-2783; Tejedor, Marcelo/0000-0003-3465-673X	FONCyT [PICT-2011-0307, PICT-2011-2520]	FONCyT(FONCyT)	Supported by grants from the FONCyT (PICT-2011-0307 to SIP and PICT-2011-2520 to MFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Aristide L, 2013, MOL PHYLOGENET EVOL; Babb PL, 2011, AM J PHYS ANTHROPOL, V146, P209, DOI 10.1002/ajpa.21567; Barroso CML, 1997, INT J PRIMATOL, V18, P651, DOI 10.1023/A:1026371408379; Benton Michael J., 2009, P35; Bertrand OC, 2012, AM MUS NOVIT, V3750; Bordas A. F., 1942, Physis Buenos Aires, V19, P265; Chiou KL, 2011, MOL PHYLOGENET EVOL, V59, P736, DOI 10.1016/j.ympev.2011.03.025; Delson E., 1984, P50; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fleagle JG, 2002, CAM S BIO EVOL ANTHR, V33, P161; Fleagle JG, 1983, MORPHOLOGIE EVOLUTIV, P141; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Fleagle JG, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P41; Flynn JJ, 1998, TRENDS ECOL EVOL, V13, P449, DOI 10.1016/S0169-5347(98)01457-8; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Gibb GC, 2013, P NATL ACAD SCI USA, V110, pE611, DOI 10.1073/pnas.1217134110; Goin FJ, 2010, BONES CLONES BIOMES; Groves CP, 2001, PRIMATE TAXONOMY; Hall T., 2004, BIOEDIT 7 0 0; Hartwig WC, 2002, CAM S BIO EVOL ANTHR, V33, P175; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HERSHKOVITZ P, 1970, Folia Primatologica, V12, P1, DOI 10.1159/000155278; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; IUCN, 2022, IUCN RED LIST THREAT; Perez SI, 2012, MOL PHYLOGENET EVOL, V65, P621, DOI 10.1016/j.ympev.2012.07.014; Kay RF, 2004, ANAT REC PART A, V281A, P1157, DOI 10.1002/ar.a.20121; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Kay RF, 1998, AM J PRIMATOL, V45, P317, DOI 10.1002/(SICI)1098-2345(1998)45:4<317::AID-AJP1>3.0.CO;2-Z; KAY RF, 1987, J HUM EVOL, V16, P173, DOI 10.1016/0047-2484(87)90075-3; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kay Richard F., 2010, P220; Kay RF, 2010, J HUM EVOL, V59, P218, DOI 10.1016/j.jhevol.2010.03.002; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; KRAGLIEVICH JL, 1951, REV MUSEO ARGENTINO, V2, P57; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lemey M., 2009, PHYLOGENETIC HDB PRA; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; LUCHTERHAND K, 1986, CR ACAD SCI II, V303, P1753; Madden Richard H., 1997, P499; Meldrum DJ, 1997, AM J PHYS ANTHROPOL, V102, P407, DOI 10.1002/(SICI)1096-8644(199703)102:3<407::AID-AJPA8>3.0.CO;2-R; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perkins ME, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P23; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Prufer K, 2013, P NATL ACAD SCI USA, V110, pE612, DOI 10.1073/pnas.1222027110; Rambaut A., 2007, TRACER V1 4; ROSENBERGER AL, 1991, INT J PRIMATOL, V12, P291, DOI 10.1007/BF02547590; Rosenberger AL, 2002, CAM S BIO EVOL ANTHR, V33, P151; ROSENBERGER AL, 1990, J HUM EVOL, V19, P209, DOI 10.1016/0047-2484(90)90017-6; ROSENBERGER AL, 1992, AM J PHYS ANTHROPOL, V88, P525, DOI 10.1002/ajpa.1330880408; ROSENBERGER AL, 1979, NATURE, V279, P416, DOI 10.1038/279416a0; Rosenberger AL, 2013, EVOLUTIONARY BIOL CO; Rosenberger AL, 2012, AM J PRIMATOL, V74, P692, DOI 10.1002/ajp.22037; Rosenberger AL, 2011, P ROY SOC B-BIOL SCI, V278, P67, DOI 10.1098/rspb.2010.1249; Rosenberger AL, 2010, J HUM EVOL, V59, P214, DOI 10.1016/j.jhevol.2010.03.003; Rosenberger Alfred L., 2009, P69, DOI 10.1007/978-0-387-78705-3_4; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; SETOGUCHI T, 1987, NATURE, V326, P692, DOI 10.1038/326692a0; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; STIRTON R. A., 1951, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V28, P315; TAJIMA F, 1993, GENETICS, V135, P599; Takai M, 2001, ANTHROPOL SCI, V109, P289, DOI 10.1537/ase.109.289; Takai M, 2000, AM J PHYS ANTHROPOL, V111, P263, DOI 10.1002/(SICI)1096-8644(200002)111:2<263::AID-AJPA10>3.3.CO;2-Y; TAKAI M, 1994, J HUM EVOL, V27, P329, DOI 10.1006/jhev.1994.1049; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; Tejedor Marcelo F., 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P251; Tejedor MF, 2006, P NATL ACAD SCI USA, V103, P5437, DOI 10.1073/pnas.0506126103; Tejedor MF, 2013, REV MUSEO L IN PRESS; Vucetich Maria Guiomar, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P625; Vucetich MG., 2010, PALEONTOLOGY GRAN BA, P189; Vucetich MG., 2010, PALEONTOLOGY GRAN BA, P202; Wiens John J., 2009, Journal of Biology (London), V8, P19, DOI 10.1186/jbiol112; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; WYSS AR, 1993, NATURE, V365, P434, DOI 10.1038/365434a0; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	89	55	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68029	10.1371/journal.pone.0068029	http://dx.doi.org/10.1371/journal.pone.0068029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826358	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000112
J	Madathil, SK; Carlson, SW; Brelsfoard, JM; Ye, P; D'Ercole, AJ; Saatman, KE				Madathil, Sindhu K.; Carlson, Shaun W.; Brelsfoard, Jennifer M.; Ye, Ping; D'Ercole, A. Joseph; Saatman, Kathryn E.			Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits following Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; IGF-I; FLUID-PERCUSSION; GLIAL SCAR; OLIGODENDROCYTE DEVELOPMENT; CASPASE-3 ACTIVATION; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) survivors often suffer from long-lasting cognitive impairment that stems from hippocampal injury. Systemic administration of insulin-like growth factor-1 (IGF-1), a polypeptide growth factor known to play vital roles in neuronal survival, has been shown to attenuate posttraumatic cognitive and motor dysfunction. However, its neuroprotective effects in TBI have not been examined. To this end, moderate or severe contusion brain injury was induced in mice with conditional (postnatal) overexpression of IGF-1 using the controlled cortical impact (CCI) injury model. CCI brain injury produces robust reactive astrocytosis in regions of neuronal damage such as the hippocampus. We exploited this regional astrocytosis by linking expression of hIGF-1 to the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter, effectively targeting IGF-1 delivery to vulnerable neurons. Following brain injury, IGF-1Tg mice exhibited a progressive increase in hippocampal IGF-1 levels which was coupled with enhanced hippocampal reactive astrocytosis and significantly greater GFAP levels relative to WT mice. IGF-1 overexpression stimulated Akt phosphorylation and reduced acute (1 and 3d) hippocampal neurodegeneration, culminating in greater neuron survival at 10d after CCI injury. Hippocampal neuroprotection achieved by IGF-1 overexpression was accompanied by improved motor and cognitive function in brain-injured mice. These data provide strong support for the therapeutic efficacy of increased brain levels of IGF-1 in the setting of TBI.	[Madathil, Sindhu K.; Carlson, Shaun W.; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40508 USA; [Ye, Ping; D'Ercole, A. Joseph] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill	Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40508 USA.	k.saatman@uky.edu	Madathil, Sindhu K/E-9407-2012; Carlson, Shaun/HCH-8617-2022	Carlson, Shaun/0000-0002-1413-5075	National Institutes of Health (NIH) [NS058484, NS072302, NS051220]; Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 7-20]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) NS058484, NS072302, and NS051220, and KSCHIRT 7-20 Kentucky Spinal Cord and Head Injury Research Trust fellowship to SKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; ANDERSSON IK, 1988, ACTA PHYSIOL SCAND, V132, P167, DOI 10.1111/j.1748-1716.1988.tb08314.x; Benito M, 1996, INT J BIOCHEM CELL B, V28, P499, DOI 10.1016/1357-2725(95)00168-9; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Cao Y, 2003, J CEREBR BLOOD F MET, V23, P739, DOI 10.1097/01.WCB.0000067720.12805.6F; Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002; CHERNAUSEK SD, 1993, J NEUROSCI RES, V34, P189, DOI 10.1002/jnr.490340206; Conte V., 2003, EUR J TRAUMA, V7, P335; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Delaney CL, 1999, J NEUROBIOL, V41, P540, DOI 10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Giralt A, 2010, GENE THER, V17, P1294, DOI 10.1038/gt.2010.71; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Goddard DR, 1999, J NEUROSCI RES, V57, P74, DOI 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O; Guan J, 2001, NEUROSCIENCE, V105, P299, DOI 10.1016/S0306-4522(01)00145-2; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hunsaker MR, 2008, BEHAV BRAIN RES, V188, P310, DOI 10.1016/j.bbr.2007.11.015; Karpova A, 2006, NEUROSCIENCE, V137, P833, DOI 10.1016/j.neuroscience.2005.10.012; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Lin SY, 2011, BRAIN RES, V1385, P246, DOI 10.1016/j.brainres.2011.02.013; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; McMorris FA, 1996, BRAIN PATHOL, V6, P313, DOI 10.1111/j.1750-3639.1996.tb00858.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun LY, 2006, ENDOCRINOLOGY, V147, P5480, DOI 10.1210/en.2006-0586; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801; Zhu W, 2009, J CEREBR BLOOD F MET, V29, P1528, DOI 10.1038/jcbfm.2009.75	74	71	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67204	10.1371/journal.pone.0067204	http://dx.doi.org/10.1371/journal.pone.0067204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826235	Green Published, gold, Green Submitted			2022-12-25	WOS:000321150000044
J	Trattner, B; Gravot, CM; Grothe, B; Kunz, L				Trattner, Barbara; Gravot, Celine Marie; Grothe, Benedikt; Kunz, Lars			Metabolic Maturation of Auditory Neurones in the Superior Olivary Complex	PLOS ONE			English	Article							CYTOCHROME-OXIDASE ACTIVITY; EXPERIENCE-DEPENDENT REFINEMENT; HYPERPOLARIZING GLYCINE ACTION; COINCIDENCE-DETECTOR NEURONS; GERBIL MERIONES-UNGUICULATUS; INTERAURAL TIME DIFFERENCES; BRAIN-STEM; ENERGY-METABOLISM; POSTNATAL-DEVELOPMENT; TRAPEZOID BODY	Neuronal activity is energetically costly, but despite its importance, energy production and consumption have been studied in only a few neurone types. Neuroenergetics is of special importance in auditory brainstem nuclei, where neurones exhibit various biophysical adaptations for extraordinary temporal precision and show particularly high firing rates. We have studied the development of energy metabolism in three principal nuclei of the superior olivary complex (SOC) involved in precise binaural processing in the Mongolian gerbil (Meriones unguiculatus). We used immunohistochemistry to quantify metabolic markers for energy consumption (Na+/K+-ATPase) and production (mitochondria, cytochrome c oxidase activity and glucose transporter 3 (GLUT3)). In addition, we calculated neuronal ATP consumption for different postnatal ages (P0-90) based upon published electrophysiological and morphological data. Our calculations relate neuronal processes to the regeneration of Na+ gradients perturbed by neuronal firing, and thus to ATP consumption by Na+/K+-ATPase. The developmental changes of calculated energy consumption closely resemble those of metabolic markers. Both increase before and after hearing onset occurring at P12-13 and reach a plateau thereafter. The increase in Na+/K+-ATPase and mitochondria precedes the rise in GLUT3 levels and is already substantial before hearing onset, whilst GLUT3 levels are scarcely detectable at this age. Based on these findings we assume that auditory inputs crucially contribute to metabolic maturation. In one nucleus, the medial nucleus of the trapezoid body (MNTB), the initial rise in marker levels and calculated ATP consumption occurs distinctly earlier than in the other nuclei investigated, and is almost completed by hearing onset. Our study shows that the mathematical model used is applicable to brainstem neurones. Energy consumption varies markedly between SOC nuclei with their different neuronal properties. Especially for the medial superior olive (MSO), we propose that temporally precise input integration is energetically more costly than the high firing frequencies typical for all SOC nuclei.	[Trattner, Barbara; Gravot, Celine Marie; Grothe, Benedikt; Kunz, Lars] Univ Munich, Div Neurobiol, Dept Biol 2, Martinsried, Germany; [Trattner, Barbara; Gravot, Celine Marie] Univ Munich, Grad Sch System Neurosci, Martinsried, Germany	University of Munich; University of Munich	Trattner, B (corresponding author), Univ Munich, Div Neurobiol, Dept Biol 2, Martinsried, Germany.	trattner@bio.lmu.de; lars.kunz@bio.lmu.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615	Graduate School of Systemic Neurosciences (GSN-LMU); Graduate School [1373]; DFG [CRC870/TPB13]	Graduate School of Systemic Neurosciences (GSN-LMU); Graduate School; DFG(German Research Foundation (DFG))	The authors thank the Graduate School of Systemic Neurosciences (GSN-LMU; http://www.gsn.uni-muenchen.de/index.html) and the Graduate School 1373 (DFG; http://www.dfg.de/en/index.jsp) for providing a grant to BT. This work was largely funded by the DFG (CRC870/TPB13; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chirila FV, 2007, J PHYSIOL-LONDON, V584, P167, DOI 10.1113/jphysiol.2007.137976; Crins TTH, 2011, J NEUROSCI, V31, P11706, DOI 10.1523/JNEUROSCI.1995-11.2011; CURTIS LM, 1993, EUR ARCH OTO-RHINO-L, V250, P265, DOI 10.1007/BF00186223; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; FINCK A, 1972, J COMP PHYSIOL PSYCH, V78, P375, DOI 10.1037/h0032373; Ford MC, 2009, J COMP NEUROL, V514, P92, DOI 10.1002/cne.21998; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; FRIAUF E, 1990, NEUROSCI LETT, V120, P58, DOI 10.1016/0304-3940(90)90167-8; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Grothe B, 1998, J NEUROSCI, V18, P6608; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hermann J, 2009, J NEUROPHYSIOL, V101, P20, DOI 10.1152/jn.90243.2008; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Horvath TL, 2009, TRENDS ENDOCRIN MET, V20, P78, DOI 10.1016/j.tem.2008.10.003; Howarth C, 2012, J CEREB BLOOD FLOW M; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Joshi I, 2004, J NEUROSCI, V24, P183, DOI 10.1523/JNEUROSCI.1074-03.2004; Kaiser A, 2011, J COMP NEUROL, V519, P2758, DOI 10.1002/cne.22650; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, EUR J NEUROSCI, V7, P1773, DOI 10.1111/j.1460-9568.1995.tb00697.x; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; KIL J, 1995, J COMP NEUROL, V353, P317, DOI 10.1002/cne.903530302; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Korf J, 2007, J NEUROCHEM, V103, P1697, DOI 10.1111/j.1471-4159.2007.04909.x; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Leino RL, 1997, J NEUROSCI RES, V49, P617; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; Lohrke S, 2005, EUR J NEUROSCI, V22, P2708, DOI 10.1111/j.1460-9568.2005.04465.x; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; MANTYCH GJ, 1992, ENDOCRINOLOGY, V131, P1270, DOI 10.1210/en.131.3.1270; MULLER M, 1990, EXP BRAIN RES, V81, P140; Nakamura PA, 2011, HEARING RES, V276, P70, DOI 10.1016/j.heares.2010.11.004; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; Nehlig A, 1997, DIABETES METAB, V23, P18; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PYSH JJ, 1970, BRAIN RES, V18, P325, DOI 10.1016/0006-8993(70)90332-X; Rautenberg PL, 2009, J COMP NEUROL, V517, P385, DOI 10.1002/cne.22166; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 2006, HEARING RES, V216, P100, DOI 10.1016/j.heares.2006.01.007; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1992, DEV BRAIN RES, V67, P47, DOI 10.1016/0165-3806(92)90024-Q; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Schuchmann S, 2005, EUR J NEUROSCI, V21, P2721, DOI 10.1111/j.1460-9568.2005.04109.x; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SOKOLOFF L, 1981, J CEREBR BLOOD F MET, V1, P7, DOI 10.1038/jcbfm.1981.4; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tollin DJ, 2008, J NEUROSCI, V28, P4848, DOI 10.1523/JNEUROSCI.5421-07.2008; Tollin DJ, 2002, J NEUROSCI, V22, P1468, DOI 10.1523/JNEUROSCI.22-04-01468.2002; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Tucci DL, 2002, JARO, V3, P89, DOI 10.1007/s101620010091; VANNUCCI RC, 1981, AM J PHYSIOL, V240, pR192, DOI 10.1152/ajpregu.1981.240.3.R192; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; Walcher J, 2011, J NEUROPHYSIOL; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; Werthat F, 2008, DEV NEUROBIOL, V68, P1454, DOI 10.1002/dneu.20660; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1978, BRAIN RES, V141, P185, DOI 10.1016/0006-8993(78)90629-7; WONGRILEY MTT, 1989, VISUAL NEUROSCI, V2, P483, DOI 10.1017/S0952523800012384; WOOLF NK, 1985, DEV BRAIN RES, V17, P131, DOI 10.1016/0165-3806(85)90138-5; WOOLF NK, 1984, HEARING RES, V13, P277, DOI 10.1016/0378-5955(84)90081-9; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; Youssoufian M, 2008, J COMP NEUROL, V506, P442, DOI 10.1002/cne.21566; ZhuO J, 2005, J BIOL CHEM, V280, P16038, DOI 10.1074/jbc.M500054200	105	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67351	10.1371/journal.pone.0067351	http://dx.doi.org/10.1371/journal.pone.0067351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826275	Green Submitted, Green Published, gold			2022-12-25	WOS:000321150000066
J	Huang, Y; Guo, XG; Ho, SYW; Shi, HT; Li, JT; Li, J; Cai, B; Wang, YZ				Huang, Yong; Guo, Xianguang; Ho, Simon Y. W.; Shi, Haitao; Li, Jiatang; Li, Jun; Cai, Bo; Wang, Yuezhao			Diversification and Demography of the Oriental Garden Lizard (Calotes versicolor) on Hainan Island and the Adjacent Mainland	PLOS ONE			English	Article							ENVIRONMENTAL NICHE MODELS; POPULATION-GROWTH; GEOGRAPHIC DISTRIBUTIONS; GENETIC DIFFERENTIATION; DNA POLYMORPHISM; PHYLOGEOGRAPHY; EVOLUTION; DISTANCE; HISTORY; SUBSTITUTION	The Oriental garden lizard (Calotes versicolor) is one of the few non-gekkonid lizards that are geographically widespread in the tropics. We investigated its population dynamics on Hainan Island and the adjacent mainland of China and Vietnam, focusing on the impact of cyclic upheaval and submergence of land bridges during the Pleistocene. Our Bayesian phylogenetic analysis reveals two mitochondrial lineages, A and B, which are estimated to have coalesced about 0.26 million years ago (95% credibility interval: 0.05-0.61 million years ago). Lineage A contains individuals mainly from central and southern Wuzhi Mountain on Hainan Island, whereas lineage B mainly comprises individuals from other sites on the island plus the adjacent mainland. The estimated coalescence times within lineages A (0.05 million years ago) and B (0.13 million years ago) fall within a period of cyclical land-bridge formation and disappearance in the Pleistocene. A spatial analysis of molecular variance identified two distinct population groupings: I, primarily containing lineage A, and II, mainly consisting of lineage B. However, haplotypes from lineages A and B occur sympatrically, suggesting that gene flow is ongoing. Neither Wuzhi Mountain nor Qiongzhou Strait and Gulf of Tonkin act as barriers to gene flow among C. versicolor populations. Analyses of the data using mismatch distributions and extended Bayesian skyline plots provide evidence of a relatively stable population size through time for Group I, and moderate population expansions and contractions during the end of the Pleistocene for Group II. We conclude that the phylogeographical patterns of C. versicolor are the combined product of Pleistocene sea-level oscillations and nonphysical barriers to gene flow.	[Huang, Yong; Guo, Xianguang; Li, Jiatang; Li, Jun; Cai, Bo; Wang, Yuezhao] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Huang, Yong] Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Shi, Haitao] Hainan Normal Univ, Coll Life Sci, Haikou, Hainan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Sydney; Hainan Normal University	Wang, YZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China.	arcib@cib.ac.cn	Guo, Xianguang/C-3282-2013; Ho, Simon YW/A-8417-2008; Li, Jia-Tang/AAC-7626-2020	Guo, Xianguang/0000-0001-7721-7388; Ho, Simon YW/0000-0002-0361-2307; 	National Natural Science Foundation of China [31272281, 31071892]; Knowledge Innovative Program of the Chinese Academy of Sciences [KSCX2-EW-Q-6, KSCX2-EW-J-22]; Basic Research Program of the National Science and Technology [2006FY110500-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Basic Research Program of the National Science and Technology	This work was supported by the National Natural Science Foundation of China (31272281, 31071892), Knowledge Innovative Program of the Chinese Academy of Sciences (KSCX2-EW-Q-6, KSCX2-EW-J-22), and Basic Research Program of the National Science and Technology (2006FY110500-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Boulenger G. A., 1912, REPTILIA BATRACHIA; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Darwin C., 1859, ORIGIN SPECIES MEANS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1997, GENETICS, V147, P915; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gunther A.C.L.G., 1864, REPTILES BRIT INDIA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; IBM Corp, 2010, IBM SPSS STAT WIND V; Irwin DE, 2002, EVOLUTION, V56, P2383; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; KOHN AJ, 1982, MAR ECOL PROG SER, V9, P147, DOI 10.3354/meps009147; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LH, 2010, MOL PHYLOGENET EVOL, V56, P601, DOI 10.1016/j.ympev.2010.04.032; Macdonald David W., 2001, P358; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Matyot Pat, 2004, Phelsuma, V12, P35; Nei M., 1987, MOL EVOLUTIONARY GEN; NEIGEL JE, 1993, GENETICS, V135, P1209; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Radder RS, 2006, CURR SCI INDIA, V91, P1354; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rutherford PL, 2003, J HERPETOL, V37, P98, DOI 10.1670/0022-1511(2003)037[0098:HUAMPO]2.0.CO;2; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; [施雅风 Shi Yafeng], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P687; Smith M.A., 1935, FAUNA BRIT INDIA INC, VII; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Su Z., 2006, QUATERNARY GLACIATIO; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; TAJIMA F, 1989, GENETICS, V123, P585; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Thuesen PA, 2008, J FISH BIOL, V72, P1174, DOI 10.1111/j.1095-8649.2007.01768.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei L, 2010, BIOL J LINN SOC, V99, P582, DOI 10.1111/j.1095-8312.2009.01387.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wright S, 1943, GENETICS, V28, P114; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zeng ZX, 1989, PHYS GEOGRAPHY HAINA; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhao E.M., 1999, FAUNA SINICA REPTILI; Zhao Huan-ting, 2007, Marine Geology & Quaternary Geology, V27, P33; Zug George R., 2006, Proceedings of the California Academy of Sciences, V57, P35	73	1	1	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e64754	10.1371/journal.pone.0064754	http://dx.doi.org/10.1371/journal.pone.0064754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840304	Green Published, Green Submitted, gold			2022-12-25	WOS:000321424400004
J	Ashour, AE; Jamal, S; Cheryan, VT; Muthu, M; Zoheir, KMA; Alafeefy, AM; Abd-Allah, AR; Levi, E; Tarca, AL; Polin, LA; Rishi, AK				Ashour, Abdelkader E.; Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Zoheir, Khairy M. A.; Alafeefy, Ahmed M.; Abd-Allah, Adel R.; Levi, Edi; Tarca, Adi L.; Polin, Lisa A.; Rishi, Arun K.			CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; P75 NEUROTROPHIN RECEPTOR; IN-VITRO; ACTIVATION; EXPRESSION; CYCLE; KINASE; LINES; TRKC	Medulloblastomas (MBs) constitute an aggressive class of intracranial pediatric tumors. Current multimodality treatments for MBs include surgery, ionizing radiation, and chemotherapy. Toxic side effects of therapies coupled with high incidence of recurrence and the metastatic spread warrant development of more effective, less toxic therapies for this disease. CARP-1/CCAR1 is a peri-nuclear phospho-protein that is a co-activator of the cell cycle regulatory anaphase promoting complex/cyclosome (APC/C) E3 ligase. CARP-1 functional mimetics (CFMs) are a novel class of small molecule compounds that interfere with CARP-1 binding with APC/C subunit APC-2, and suppress growth of a variety of cancer cells in part by promoting apoptosis. Here we investigated MB growth inhibitory potential of the CFMs and found that CFM-4 inhibits growth of MB cells in part by inducing CARP-1 expression, promoting PARP cleavage, activating pro-apoptotic stress-activated protein kinases (SAPK) p38 and JNK, and apoptosis. Gene-array-based analysis of the CFM-4-treated Daoy MB cells indicated down-regulation of a number of key cell growth and metastasis-promoting genes including cell motility regulating small GTP binding protein p21Rac1, and extracellular matrix metallopeptidase (MMP)-10. Moreover, CFM-4 treatment stimulated expression of a number of molecules such as neurotrophin (NTF) 3, and NF-kappa B signaling inhibitors ABIN1 and 2 proteins. Overexpression of NTF3 resulted in reduced MB cell viability while knock-down of NTF3 interfered with CFM-4-dependent loss of viability. CFMs also attenuated biological properties of the MB cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Together our data support anti-MB properties of CFM-4, and provide a proof-of-concept basis for further development of CFMs as potential anti-cancer agents for MBs.	[Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Levi, Edi; Rishi, Arun K.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA; [Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Jamal, Shazia; Cheryan, Vino T.; Muthu, Magesh; Polin, Lisa A.; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Ashour, Abdelkader E.; Zoheir, Khairy M. A.; Abd-Allah, Adel R.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Alafeefy, Ahmed M.] Salman Bin Abdulaziz Univ, Coll Pharm, Dept Pharmaceut Chem, Alkharj, Saudi Arabia; [Zoheir, Khairy M. A.] Natl Res Ctr, Dept Cell Biol, Cairo, Egypt	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; Prince Sattam Bin Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Rishi, AK (corresponding author), John D Dingell Vet Affairs Med Ctr, Detroit, MI USA.	Rishia@Karmanos.org	Alafeefy, Ahmed/AAB-3772-2019; Ashour, Abdelkader/ABH-8235-2020; Abdallah, Adel Rashad/AAA-4372-2022; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; Abdallah, Adel Rashad/0000-0002-6094-2847; muthu, magesh/0000-0003-3311-8120; Zoheir, Khairy/0000-0003-0896-4499; jamal, shazia/0000-0003-4555-9513; Levi, Edi/0000-0003-1809-2866	US Department of Veterans Affairs Merit Review grants; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [10-MED1188-02]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA140314] Funding Source: NIH RePORTER	US Department of Veterans Affairs Merit Review grants(US Department of Veterans Affairs); National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US Department of Veterans Affairs Merit Review grants (AKR), and a grant from the National Plan of Science, Technology and Innovation (Grant No. 10-MED1188-02), King Saud University, Riyadh, Saudi Arabia (AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bodey B, 2000, IN VIVO, V14, P667; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Doroshow JH, 2001, CANC CHEMOTHERAPY BI, P500; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JYH, 1999, CANCER RES, V59, P711; KOZMIK Z, 1995, P NATL ACAD SCI USA, V92, P5709, DOI 10.1073/pnas.92.12.5709; Kunkele A, 2012, NEURO-ONCOLOGY, V14, P859, DOI 10.1093/neuonc/nos115; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; MILLS JC, 1995, METHOD CELL BIOL, V46, P217; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Muragaki Y, 1997, J NEUROSCI, V17, P530; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Raaf John, 1944, ARCH NEUROL AND PSYCHIAT, V52, P163; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; Ranger A, 2010, J NEURO-ONCOL, V96, P181, DOI 10.1007/s11060-009-9962-9; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Shaw Leslie M., 2004, V294, P97; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Studebaker AW, 2010, NEURO-ONCOLOGY, V12, P1034, DOI 10.1093/neuonc/noq057; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Vince GH, 2001, J NEURO-ONCOL, V53, P99, DOI 10.1023/A:1012241031138; Washiyama K, 1996, AM J PATHOL, V148, P929; Webster NJG, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S1; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	50	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66733	10.1371/journal.pone.0066733	http://dx.doi.org/10.1371/journal.pone.0066733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826121	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400041
J	Clelland, CL; Read, LL; Panek, LJ; Nadrich, RH; Bancroft, C; Clelland, JD				Clelland, Catherine L.; Read, Laura L.; Panek, Laura J.; Nadrich, Robert H.; Bancroft, Carter; Clelland, James D.			Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DSM-IV DISORDERS; EARLY INTERVENTION; MAIN PITFALL; BLOOD; SCHIZOPHRENIA; MICROARRAY; ANTIDEPRESSANTS; CLASSIFICATION; UNDERDIAGNOSIS	There are currently no biological tests that differentiate patients with bipolar disorder (BPD) from healthy controls. While there is evidence that peripheral gene expression differences between patients and controls can be utilized as biomarkers for psychiatric illness, it is unclear whether current use or residual effects of antipsychotic and mood stabilizer medication drives much of the differential transcription. We therefore tested whether expression changes in first-episode, never-medicated BPD patients, can contribute to a biological classifier that is less influenced by medication and could potentially form a practicable biomarker assay for BPD. We employed microarray technology to measure global leukocyte gene expression in first-episode (n=3) and currently medicated BPD patients (n=26), and matched healthy controls (n=25). Following an initial feature selection of the microarray data, we developed a cross-validated 10-gene model that was able to correctly predict the diagnostic group of the training sample (26 medicated patients and 12 controls), with 89% sensitivity and 75% specificity (p<0.001). The 10-gene predictor was further explored via testing on an independent cohort consisting of three pairs of monozygotic twins discordant for BPD, plus the original enrichment sample cohort (the three never-medicated BPD patients and 13 matched control subjects), and a sample of experimental replicates (n=34). 83% of the independent test sample was correctly predicted, with a sensitivity of 67% and specificity of 100% (although this result did not reach statistical significance). Additionally, 88% of sample diagnostic classes were classified correctly for both the enrichment (p=0.015) and the replicate samples (p<0.001). We have developed a peripheral gene expression biomarker profile, that can classify healthy controls from patients with BPD receiving antipsychotic or mood stabilizing medication, which has both high sensitivity and specificity. Moreover, assay of three first-episode patients who had never received such medications, to first enrich the expression dataset for disease-related genes independent of medication effects, and then to test the 10-gene predictor, validates the peripheral biomarker approach for BPD.	[Clelland, Catherine L.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10027 USA; [Clelland, Catherine L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Read, Laura L.; Nadrich, Robert H.; Clelland, James D.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Read, Laura L.; Clelland, James D.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Nadrich, Robert H.] Bellevue Hosp Ctr, Dept Psychiat, New York, NY 10016 USA; [Bancroft, Carter] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Columbia University; Columbia University; New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research; Bellevue Hospital Center; Icahn School of Medicine at Mount Sinai	Clelland, CL (corresponding author), Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10027 USA.	cc2786@columbia.edu	Clelland, Catherine/AAZ-8551-2021		National Institutes of Health (NIH) from the National Institute of Mental Health (NIMH) [R21MH066883, R21MH067941]; National Center for Research Resources (NCRR) [1UL1 RR029893]; NCRR [KL2 RR024157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157, UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066883, R21MH067941] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Mental Health (NIMH); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Institutes of Health (NIH): Grant Numbers R21MH066883, and R21MH067941 from the National Institute of Mental Health (NIMH, to J. Clelland), Grant Number 1UL1 RR029893 from the National Center for Research Resources (NCRR), and Grant Number KL2 RR024157 (KL2 awardee C. Clelland), also from the NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official view of NIMH, NCRR or NIH.	Altamura AC, 2010, EUR ARCH PSY CLIN N, V260, P385, DOI 10.1007/s00406-009-0085-2; ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1130; Beech RD, 2010, BIPOLAR DISORD, V12, P813, DOI 10.1111/j.1399-5618.2010.00882.x; Berk M, 2007, MED J AUSTRALIA, V187, pS11; Berk M, 2011, BIPOLAR DISORD, V13, P87, DOI 10.1111/j.1399-5618.2011.00889.x; Berk M, 2010, J MENT HEALTH, V19, P113, DOI 10.3109/09638230903469111; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; BRB Array Tools, BRB ARR TOOLS; Brickman AL, 2002, PSYCHIATR SERV, V53, P349, DOI 10.1176/appi.ps.53.3.349; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Conus P, 2008, BIPOLAR DISORD, V10, P555, DOI 10.1111/j.1399-5618.2008.00610.x; Drzyzga L, 2006, BRAIN BEHAV IMMUN, V20, P532, DOI 10.1016/j.bbi.2006.02.002; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Duffy A, 2010, J AFFECT DISORDERS, V121, P127, DOI 10.1016/j.jad.2009.05.022; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Glangeaud-Freudenthal NMC, 2011, EUR PSYCHIAT, V26, P215, DOI 10.1016/j.eurpsy.2010.03.006; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gutierrez-Fernandez A, 2010, BIPOLAR DISORD, V12, P107, DOI 10.1111/j.1399-5618.2009.00776.x; Haack M, 1999, J PSYCHIATR RES, V33, P407, DOI 10.1016/S0022-3956(99)00021-7; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; Lit L, 2012, PHARMACOGENOMICS J, V12, P368, DOI 10.1038/tpj.2011.23; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pollmacher T, 2000, J PSYCHIATR RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; *R DEV COR TEAM, R LANG ENV STAT COMP; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Rybakowski JK, 2000, PHARMACOPSYCHIATRY, V33, P159; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Simon R, 2007, CANCER INFORM, V3, P11; Smith DJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c854; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608; Zimmerman M, 2010, EXPERT REV NEUROTHER, V10, P1019, DOI 10.1586/ERN.10.64; Zimmerman M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c855	57	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e69082	10.1371/journal.pone.0069082	http://dx.doi.org/10.1371/journal.pone.0069082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826396	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400181
J	Helmer, RA; Foreman, O; Dertien, JS; Panchoo, M; Bhakta, SM; Chilton, BS				Helmer, Rebecca A.; Foreman, Oded; Dertien, Janet S.; Panchoo, Marlyn; Bhakta, Suhani M.; Chilton, Beverly S.			Role of Helicase-Like Transcription Factor (Hltf) in the G2/M Transition and Apoptosis in Brain	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; JAK2 PHOSPHORYLATION; PASSENGER COMPLEX; SMC COMPLEXES; AURORA-B; DNA; CHROMATIN; GENE; PROLACTIN; REPLICATION	HLTF participates in transcription, chromatin remodeling, DNA damage repair, and tumor suppression. Aside from being expressed in mouse brain during embryonic and postnatal development, little is known about Hltf's functional importance. Splice variant quantification of wild-type neonatal (6-8 hour postpartum) brain gave a ratio of 5: 1 for Hltf isoform 1 (exons 1-25) to isoform 2 (exons 1-21 with exon 21 extended via a partial intron retention event). Western analysis showed a close correlation between mRNA and protein expression. Complete loss of Hltf caused encephalomalacia with increased apoptosis, and reduced viability. Sixty-four percent of Hltf null mice died, 48% within 12-24 hours of birth. An RNA-Seq snapshot of the neonatal brain transcriptome showed 341 of 20,000 transcripts were altered (p < 0.05) - 95 up regulated and 246 down regulated. MetaCore (TM) enrichment pathway analysis revealed Hltf regulates cell cycle, cell adhesion, and TGF-beta receptor signaling. Hltf's most important role is in the G2/M transition of the cell cycle (p = 4.672e-7) with an emphasis on transcript availability of major components in chromosome cohesion and condensation. Hltf null brains have reduced transcript levels for Rad21/Scc1, histone H3.3, Cap-E/Smc2, Cap-G/G2, and Aurora B kinase. The loss of Hltf in its yeast Rad5-like role in DNA damage repair is accompanied by down regulation of Cflar, a critical inhibitor of TNFRSF6-mediated apoptosis, and increased (p<0.0001) active caspase-3, an indicator of intrinsic triggering of apoptosis in null brains. Hltf also regulates Smad7/Bambi/Tgf-beta/Bmp5/Wnt10b signaling in brain. ChIP confirmed Hltf binding to consensus sequences in predicted (promoter Scgb3a1 gene) and previously unidentified (P-element on chromosome 7) targets. This study is the first to provide a comprehensive view of Hltf targets in brain. Moreover, it reveals how silencing Hltf disrupts cell cycle progression, and attenuates DNA damage repair.	[Helmer, Rebecca A.; Bhakta, Suhani M.; Chilton, Beverly S.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Foreman, Oded] Genentech Inc, San Francisco, CA USA; [Dertien, Janet S.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Panchoo, Marlyn] St Georges Univ, St Georges, Grenada	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Roche Holding; Genentech; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Chilton, BS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	beverly.chilton@ttuhsc.edu		Chilton, Beverly/0000-0002-8066-8697	TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program	TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program	The work was supported by TTUHSC (Texas Tech University Health Sciences Center) Preliminary Data Seed Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Carter SD, 2012, CRIT REV BIOCHEM MOL, V47, P1, DOI 10.3109/10409238.2011.614593; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chilton BS, 2008, BIOCHEM SOC T, V36, P632, DOI 10.1042/BST0360632; Clemessy M, 2012, J NEURO-ONCOL, V107, P29, DOI 10.1007/s11060-011-0715-1; Crockett S, 2011, NEUROREPORT, V22, P598, DOI 10.1097/WNR.0b013e3283494359; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Debauve G, 2008, CELL MOL LIFE SCI, V65, P591, DOI 10.1007/s00018-007-7392-4; Diaz-Martinez LA, 2007, PLOS ONE, V3, P1; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Fazzio TG, 2010, J CELL BIOL, V188, P491, DOI 10.1083/jcb.200908026; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Fukuoka T, 2006, ANTICANCER RES, V26, P3333; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gong XH, 1997, DEV BIOL, V183, P166, DOI 10.1006/dbio.1996.8486; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; HaywardLester A, 1996, MOL ENDOCRINOL, V10, P1335, DOI 10.1210/me.10.11.1335; He MX, 2013, AUTHOPHAGY, V9; Helmer RA, 2011, MOL CELL ENDOCRINOL, V338, P79, DOI 10.1016/j.mce.2011.03.009; Helmer RA, 2010, MOL CELL ENDOCRINOL, V325, P143, DOI 10.1016/j.mce.2010.05.010; Hewetson A, 2004, BIOL REPROD, V71, P1907, DOI 10.1095/biolreprod.104.031435; Hewetson A, 2003, J BIOL CHEM, V278, P40177, DOI 10.1074/jbc.M303921200; Hewetson A, 2002, MOL ENDOCRINOL, V16, P2101, DOI 10.1210/me.2002-0064; Hewetson A, 2008, MOL ENDOCRINOL, V22, P813, DOI 10.1210/me.2007-0432; Hibi K, 2003, INT J CANCER, V104, P433, DOI 10.1002/ijc.10985; Hussain NK, 2010, J NEUROSCI, V30, P14786, DOI 10.1523/JNEUROSCI.4124-10.2010; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Kang S, 2006, INT J CANCER, V118, P2168, DOI 10.1002/ijc.21609; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Leung WK, 2003, MOL CARCINOGEN, V37, P91, DOI 10.1002/mc.10124; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Longerich S, 2011, P NATL ACAD SCI USA, V108, P13881, DOI 10.1073/pnas.1110698108; Mahajan MC, 2002, BLOOD, V99, P348, DOI 10.1182/blood.V99.1.348; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Newman JJ, 2011, COLD SPRING HARB SYM, V75, P227; Prado Felix, 2012, Bioarchitecture, V2, P6; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Quenet D, 2012, CHROMOSOME RES, V20, P465, DOI 10.1007/s10577-012-9301-4; Resnick TD, 2009, GENETICS, V181, P875, DOI 10.1534/genetics.108.097741; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875; Sandhu S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-18; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Stellfox ME, 2013, CELL MOL LIFE SCI, V70, P387, DOI 10.1007/s00018-012-1048-8; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Weischenfeldt J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r35; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Zhang Q, 1997, GENE, V202, P31, DOI 10.1016/S0378-1119(97)00446-0	69	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66799	10.1371/journal.pone.0066799	http://dx.doi.org/10.1371/journal.pone.0066799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826137	Green Submitted, gold, Green Published			2022-12-25	WOS:000321738400054
J	Lambertucci, SA; Ruggiero, A				Lambertucci, Sergio A.; Ruggiero, Adriana			Cliffs Used as Communal Roosts by Andean Condors Protect the Birds from Weather and Predators	PLOS ONE			English	Article							VULTURE AEGYPIUS-MONACHUS; INFORMATION-CENTERS; POPULATION; CLIMATE; BEHAVIOR; SIZE; AGE; VARIABILITY; DISTURBANCE; SELECTION	The quality and availability of resources influence the geographical distribution of species. Social species need safe places to rest, meet, exchange information and obtain thermoregulatory benefits, but those places may also serve other important functions that have been overlooked in research. We use a large soaring bird that roosts communally in cliffs, the Andean condor (Vultur gryphus), as a model species to elucidate whether roost locations serve as a refuge from adverse weather conditions (climatic refuge hypothesis, CRH), and/or from predators or anthropogenic disturbances (threats refuge hypothesis, TRH). The CRH predicts that communal roosts will face in the opposite direction from where storms originate, and will be located in climatically stable, low precipitation areas. The TRH predicts that communal roosts will be large, poorly accessible cliffs, located far from human-made constructions. We surveyed cliffs used as communal roosts by condors in northwestern Patagonia, and compared them with alternative non-roosting cliffs to test these predictions at local and regional scales. We conclude that communal roosting places provide refuge against climate and disturbances such as, for instance, the threats of predators (including humans). Thus, it is not only the benefits gained from being aggregated per se, but the characteristics of the place selected for roosting that may both be essential for the survival of the species. This should be considered in management and conservation plans given the current scenario of global climate change and the increase in environmental disturbances.	[Lambertucci, Sergio A.; Ruggiero, Adriana] CONICET Univ Nacl Comahue, Lab Ecotono, INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Lambertucci, SA (corresponding author), CONICET Univ Nacl Comahue, Lab Ecotono, INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar		LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT) [PICT 38148]	Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT)	Funding provided by Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT) PICT 38148. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1999, LOGISTIC REGRESSION; BARTLETT RM, 1990, CAN J BOT, V68, P1931, DOI 10.1139/b90-254; Batschelet E, 1981, CIRCULAR STAT BIOL; Battin J, 2006, CONDOR, V108, P59, DOI 10.1650/0010-5422(2006)108[0059:CCATDA]2.0.CO;2; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Blanco G, 1999, ANIM BEHAV, V57, P1219, DOI 10.1006/anbe.1999.1103; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; CONOVER W. J, 1980, PRACTICAL NONPARAMET; De Martino E, 2009, ESTUDIO HOME RANGE E; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; EISERER LA, 1984, BIRD BEHAV, V5, P61; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Ellis DH, 2009, J RAPTOR RES, V43, P175, DOI 10.3356/JRR-08-110.1; Gelman A., 2007, DATA ANAL USING REGR; Hatchwell BJ, 2009, FUNCT ECOL, V23, P367, DOI 10.1111/j.1365-2435.2008.01511.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIRALDO F, 1990, BIRD STUDY, V37, P128, DOI 10.1080/00063659009477048; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; INDEC, 2002, CENS NAC AGR; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KOFORD CB, 1966, CALIFORNIA CONDOR; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2013, EMU, V113, P122, DOI 10.1071/MU12048; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Lambertucci SA, 2009, J RAPTOR RES, V43, P245, DOI 10.3356/JRR-08-108.1; Lambertucci SA, 2009, BIODIVERS CONSERV, V18, P2063, DOI 10.1007/s10531-008-9573-3; Larson D.W., 2000, CAMBRIDGE STUDIES EC; Margalida A, 2003, J RAPTOR RES, V37, P252; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; Moran-lopez R, 2006, BIOL CONSERV, V130, P169, DOI 10.1016/j.biocon.2005.12.011; Newton I., 1979, POPULATION ECOLOGY R; Onichimowska Anna., 2012, KONIEC GRY; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; PENNYCUICK CJ, 1984, IBIS, V126, P253, DOI 10.1111/j.1474-919X.1984.tb08005.x; Peters KA, 2007, J APPL ECOL, V44, P196, DOI 10.1111/j.1365-2664.2006.01248.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Saether BE, 2006, J ANIM ECOL, V75, P80, DOI 10.1111/j.1365-2656.2005.01023.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Zapata JA, 1999, J APPL ECOL, V36, P254, DOI 10.1046/j.1365-2664.1999.00396.x; Sarasola JH, 2005, J WILDLIFE DIS, V41, P643, DOI 10.7589/0090-3558-41.3.643; Sergio F, 2003, ANIM BEHAV, V66, P1109, DOI 10.1006/anbe.2003.2303; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Snyder NFR, 1986, NEST SITE BIOL CALIF, P228; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Tilman D., 1982, Monographs in Population Biology, pi; Walker RS, 2003, LANDSCAPE ECOL, V18, P187; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; WEATHERHEAD PJ, 1983, AM NAT, V121, P237, DOI 10.1086/284053; Williams R.N., 1984, Raptor Research, V18, P153; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x; Zar, 2011, BIOSTAT ANAL	59	24	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67304	10.1371/journal.pone.0067304	http://dx.doi.org/10.1371/journal.pone.0067304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826262	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400131
J	Li, P; Chen, XH; Su, LP; Li, CL; Zhi, QM; Yu, BQ; Sheng, H; Wang, JQ; Feng, RH; Cai, Q; Li, JF; Yu, YY; Yan, M; Liu, BY; Zhu, ZG				Li, Pu; Chen, Xuehua; Su, Liping; Li, Chenglong; Zhi, Qiaoming; Yu, Beiqin; Sheng, Hong; Wang, Junqing; Feng, Runhua; Cai, Qu; Li, Jianfang; Yu, Yingyan; Yan, Min; Liu, Bingya; Zhu, Zhenggang			Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MICRORNA EXPRESSION; CELL-PROLIFERATION; MIRNA SIGNATURE; CARCINOMA; METASTASIS; ESTABLISHMENT; ASSOCIATION; RESISTANCE; PROTEIN	MicroRNA has been recently recognized as playing a prominent role in tumorigenesis and metastasis. Here, we report that miR-338-3p was epigenetically silenced in gastric cancer, and its down-regulation was significantly correlated with gastric cancer clinicopathological features. Strikingly, restoring miR-338-3p expression in SGC-7901 gastric cancer cells inhibited proliferation, migration, invasion and tumorigenicity in vitro and in vivo, at least partly through inducing apoptosis. Furthermore, we demonstrate the oncogene SSX2IP is a target of miR-338-3p. We propose that miR-338-3p functions as a tumor suppressor in gastric cancer, and the methylation status of its CpG island could serve as a potential diagnostic marker for gastric cancer.	[Li, Pu; Chen, Xuehua; Su, Liping; Li, Chenglong; Zhi, Qiaoming; Yu, Beiqin; Sheng, Hong; Wang, Junqing; Feng, Runhua; Cai, Qu; Li, Jianfang; Yu, Yingyan; Yan, Min; Liu, Bingya; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Dept Surg, Shanghai Inst Digest Surg,Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	byliurj@sohu.com; zhenggang.zhu@yahoo.com	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762; /0000-0001-6874-9614	National Natural Science Foundation of China [30872476, 81072012, 81172324, 91229106, 30900670, 81272749]; Science and Technology Commission of Shanghai Municipality [10jc1411100, 09DZ1950100, 09DZ2260200, 11jc1407602, 101409042000]; Shanghai Key Discipline [S30204]; Key Projects in the National Science & Technology Pillar Program of China [2008BA152B03, 2011BA203191]; China Postdoctoral Science Foundation [2011M500796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Key Discipline; Key Projects in the National Science & Technology Pillar Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants from National Natural Science Foundation of China (numbers 30872476, 81072012, 81172324, 91229106, 30900670 and 81272749), Science and Technology Commission of Shanghai Municipality (numbers 10jc1411100, 09DZ1950100, 09DZ2260200, 11jc1407602 and 101409042000), Shanghai Key Discipline (S30204), and Key Projects in the National Science & Technology Pillar Program of China (numbers 2008BA152B03 and 2011BA203191), China Postdoctoral Science Foundation (number 2011M500796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; BARRANCO SC, 1983, CANCER RES, V43, P1703; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047563; De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058; Fabbri M, 2013, ADV EXP MED BIOL, V754, P137, DOI 10.1007/978-1-4419-9967-2_6; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Guinn B, 2009, BLOOD, V113, P1203, DOI 10.1182/blood-2008-09-178848; Guinn BA, 2008, BRIT J HAEMATOL, V140, P250, DOI 10.1111/j.1365-2141.2007.06892.x; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayashi Y, 2012, GUT; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim K, 2011, EPIGENETICS-US, V6, P740, DOI 10.4161/epi.6.6.15874; Kos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031022; Li CL, 2012, ONCOL REP, V27, P1960, DOI 10.3892/or.2012.1719; Li CL, 2012, CANCER LETT, V320, P189, DOI 10.1016/j.canlet.2012.02.030; Li P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-52; LIN CH, 1984, CHINESE MED J-PEKING, V97, P831; LU Y, 1986, Zhonghua Zhongliu Zazhi, V8, P241; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; O'Hara SP, 2009, GASTROENTEROLOGY, V136, P17, DOI 10.1053/j.gastro.2008.11.028; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; PARK JG, 1990, CANCER RES, V50, P2773; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Song JH, 2012, GASTROENTEROLOGY, V143, P35, DOI 10.1053/j.gastro.2012.05.003; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhang L, 2011, IMMUNOTHERAPY-UK, V3, P697, DOI [10.2217/IMT.11.50, 10.2217/imt.11.50]	43	59	62	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66782	10.1371/journal.pone.0066782	http://dx.doi.org/10.1371/journal.pone.0066782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826132	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400050
J	Suspene, R; Aynaud, MM; Vartanian, JP; Wain-Hobson, S				Suspene, Rodolphe; Aynaud, Marie-Ming; Vartanian, Jean-Pierre; Wain-Hobson, Simon			Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CYTOSINE DEAMINATION; MISMATCH REPAIR; FOREIGN DNA; NUCLEAR-DNA; VIF PROTEIN; IN-VIVO; HYPERMUTATION; HIV-1; RESTRICTION	Deamination of 5-methylcytidine (5MeC) in DNA results in a G: T mismatch unlike cytidine (C) deamination which gives rise to a G: U pair. Deamination of C was generally considered to arise spontaneously. It is now clear that human APOBEC3A (A3A), a polynucleotide cytidine deaminase (PCD) with specificity for single stranded DNA, can extensively deaminate human nuclear DNA. It is shown here that A3A among all human PCDs can deaminate 5-methylcytidine in a variety of single stranded DNA substrates both in vitro and in transfected cells almost as efficiently as cytidine itself. This ability of A3A to accommodate 5-methyl moiety extends to other small and physiologically relevant substituted cytidine bases such as 5-hydroxy and 5-bromocytidine. As 5MeCpG deamination hotspots characterize many genes associated with cancer it is plausible that A3A is a major player in the onset of cancer.	[Suspene, Rodolphe; Aynaud, Marie-Ming; Vartanian, Jean-Pierre; Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, Mol Retrovirol Unit, Paris, France.	simon.wain-hobson@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur; CNRS	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	The work was supported by grants from Institut Pasteur and the CNRS. The Molecular Retrovirology Unit is equipe labellisee par la Ligue pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Brooks PJ, 1996, J NEUROSCI, V16, P939; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chen ZQ, 2011, PHYS CHEM CHEM PHYS, V13, P6471, DOI 10.1039/c0cp02783a; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Labet V, 2010, J PHYS CHEM A, V114, P1826, DOI 10.1021/jp9049044; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	41	39	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e63461	10.1371/journal.pone.0063461	http://dx.doi.org/10.1371/journal.pone.0063461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840298	Green Published, Green Submitted, gold			2022-12-25	WOS:000322342800001
J	Carreras, C; Godley, BJ; Leon, YM; Hawkes, LA; Revuelta, O; Raga, JA; Tomas, J				Carreras, Carlos; Godley, Brendan J.; Leon, Yolanda M.; Hawkes, Lucy A.; Revuelta, Ohiana; Raga, Juan A.; Tomas, Jesus			Contextualising the Last Survivors: Population Structure of Marine Turtles in the Dominican Republic	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; MITOCHONDRIAL-DNA; HAWKSBILL TURTLES; CARETTA-CARETTA; CHELONIA-MYDAS; ERETMOCHELYS-IMBRICATA; CONSERVATION IMPLICATIONS; DERMOCHELYS-CORIACEA; MIGRATORY BEHAVIOR; GENETIC DIVERSITY	Nesting by three species of marine turtles persists in the Dominican Republic, despite historic threats and long-term population decline. We conducted a genetic survey of marine turtles in the Dominican Republic in order to link them with other rookeries around the Caribbean. We sequenced a 740(bp) fragment of the control region of the mitochondrial DNA of 92 samples from three marine turtle species [hawksbill (n = 48), green (n = 2) and leatherback (n = 42)], and incorporated published data from other nesting populations and foraging grounds. The leatherback turtle (Dermochelys coriacea) in the Dominican Republic appeared to be isolated from Awala-Yalimapo, Cayenne, Trinidad and St. Croix but connected with other Caribbean populations. Two distinct nesting populations of hawksbill turtles (Eremochelys imbricata) were detected in the Dominican Republic and exhibited interesting patterns of connectivity with other nesting sites and juvenile and adult male foraging aggregations. The green sea turtle (Chelonia mydas) has almost been extirpated from the Dominican Republic and limited inference could be made from our samples. Finally, results were compared with Lagrangian drifting buoys and published Lagrangian virtual particles that travelled through the Dominican Republic and Caribbean waters. Conservation implications of sink-source effects or genetic isolation derived from these complex inter-connections are discussed for each species and population.	[Carreras, Carlos; Godley, Brendan J.; Hawkes, Lucy A.; Tomas, Jesus] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Leon, Yolanda M.] Grp Jaragua, Santo Domingo, Dominican Rep; [Leon, Yolanda M.] Inst Tecnol Santo Domingo, Santo Domingo, Dominican Rep; [Revuelta, Ohiana; Raga, Juan A.; Tomas, Jesus] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain	University of Exeter; Instituto Tecnologico de Santo Domingo (INTEC); University of Valencia	Carreras, C (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, England.	carlos_c_h@hotmail.com	godley, brendan/O-1959-2019; Tomás, Jesús/AAA-4561-2019; godley, brendan j/A-6139-2009; Raga, Juan Antonio/L-7669-2014; Carreras, Carlos/B-6772-2012; Hawkes, Lucy/L-7407-2014	godley, brendan/0000-0003-3845-0034; godley, brendan j/0000-0003-3845-0034; Raga, Juan Antonio/0000-0003-2687-2539; Carreras, Carlos/0000-0002-2478-6445; Hawkes, Lucy/0000-0002-6696-1862; Tomas, Jesus/0000-0003-0120-7006	Spanish International Cooperation Agency (AECI) [A/2991/05, A/5641/06]; Spanish Ministry of Education and Sciences [CGL2006-02936-BOS]; General Foundation of the University of Valencia; European Union; NERC; Darwin Initiative; Biotechnology and Biological Sciences Research Council of the UK; 'Conselleria de Educacio' (Generalitat Valenciana) [Prometeo/2011/40]; Spanish Ministry of Sciences and Innovation [CGL2011-30413]	Spanish International Cooperation Agency (AECI); Spanish Ministry of Education and Sciences(Spanish Government); General Foundation of the University of Valencia; European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Darwin Initiative; Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 'Conselleria de Educacio' (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Sciences and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The present study is included as part of a conservation project funded by: the Spanish International Cooperation Agency (AECI, projects: A/2991/05 and A/5641/06), the Spanish Ministry of Education and Sciences (CGL2006-02936-BOS), the General Foundation of the University of Valencia, and the European Union (Marie Curie grants, FP6 & 7). BJG is supported by NERC and the Darwin Initiative. LAH is supported by the Biotechnology and Biological Sciences Research Council of the UK. JAR and JT are also supported by project Prometeo/2011/40 of 'Conselleria de Educacio' (Generalitat Valenciana) and project CGL2011-30413 of the Spanish Ministry of Sciences and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A, 2006, 26 ANN S SEA TURTL B, P179; Aucoin S, 2007, P GULF CARIBBEAN FIS, V60, P169; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Bass AL, 1996, MOL ECOL, V5, P321; Bass Anna L., 1999, Chelonian Conservation and Biology, V3, P195; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 1998, ECOL APPL, V8, P1; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Carreras C, 2007, CONSERV GENET, V8, P761, DOI 10.1007/s10592-006-9224-8; Carreras C, 2006, MAR BIOL, V149, P1269, DOI 10.1007/s00227-006-0282-8; Carreras C, 2011, J HERED, V102, P666, DOI 10.1093/jhered/esr089; Chacon-Chaverri D, 2007, CHELONIAN CONSERV BI, V6, P101, DOI 10.2744/1071-8443(2007)6[101:LSTNAG]2.0.CO;2; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; DiMatteo AD, 2009, SWOT DATABASE ONLINE; Dominguez TJ, 1994, P 14 ANN S SEA TURTL, P34; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Encalada SE, 1996, MOL ECOL, V5, P473; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feliz P, 2008, P 28 ANN SEA TURTL S, P247; FitzSimmons NN, 1997, GENETICS, V147, P1843; Fleming EH, 2001, SWIMMING TIDE RECENT; Formia A, 2006, CONSERV GENET, V7, P353, DOI 10.1007/s10592-005-9047-z; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Freake MJ, 2006, Q REV BIOL, V81, P327, DOI 10.1086/511528; Fu YX, 1997, GENETICS, V147, P915; Garofalo L, 2009, MAR BIOL, V156, P2085, DOI 10.1007/s00227-009-1239-5; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Goudet J, 1996, GENETICS, V144, P1933; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hawkes LA, 2012, MAR ECOL PROG SER, V461, P223, DOI 10.3354/meps09778; Hays GC, 1997, CAN J ZOOL, V75, P40, DOI 10.1139/z97-005; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Laurent L, 1998, MOL ECOL, V7, P1529, DOI 10.1046/j.1365-294x.1998.00471.x; Lee PLM, 2008, J EXP MAR BIOL ECOL, V356, P25, DOI 10.1016/j.jembe.2007.12.021; Leon YM, 2004, THESIS U RHODE ISLAN; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; Lohmann Kenneth J., 1997, P107; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; Luke K, 2004, MAR BIOL, V144, P799, DOI 10.1007/s00227-003-1241-2; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Molfetti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058061; Monzon-Arguello C, 2011, J EXP MAR BIOL ECOL, V407, P345, DOI 10.1016/j.jembe.2011.07.017; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Monzon-Arguello C, 2010, CONSERV GENET, V11, P1871, DOI 10.1007/s10592-010-0079-7; Monzon-Arguello C, 2010, J EXP MAR BIOL ECOL, V387, P9, DOI 10.1016/j.jembe.2010.03.004; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mortimer JA, 2007, MARINE TURTLE SPECIA; Mota JM, 2003, P 23 ANN S SEA TURTL, P197; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Okuyama T, 2005, ECOL APPL, V15, P315, DOI 10.1890/03-5063; Ordonez C, 2007, CHELONIAN CONSERV BI, V6, P122, DOI 10.2744/1071-8443(2007)6[122:CBPTMI]2.0.CO;2; Ottenwalder J. A., 1981, THESIS U AUTONOMA SA; Ottenwalder JA, 1996, CONSERVATION MANAGEM; Patino-Martinez J, 2008, BIOL CONSERV, V141, P1982, DOI 10.1016/j.biocon.2008.05.012; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Powell R, 2009, APPL HERPETOL, V6, P103, DOI 10.1163/157075409X427153; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Putman NF, 2012, MAR BIOL, V159, P2117, DOI 10.1007/s00227-012-1995-5; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Reuter A, 2006, TOURISTS TURTLES TRI; Revuelta O, 2012, ORYX, V46, P348, DOI 10.1017/S0030605311001529; Richardson PB, 2009, CHELONIAN CONSERV BI, V8, P192, DOI 10.2744/CCB-0871.1; Rolf DA, 1989, MOL BIOL EVOL, V6, P539; Ross J.P., 1983, P706; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shillinger George L., 2012, Marine Ecology Progress Series, V457, P163; Shillinger GL, 2012, P ROY SOC B-BIOL SCI, V279, P2391, DOI 10.1098/rspb.2011.2348; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Stam S, 1992, MARINE TURTLE NEWSLE, V57, P1921; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; Troeng S, 2007, CHELONIAN CONSERV BI, V6, P117, DOI 10.2744/1071-8443(2007)6[117:LTNTAT]2.0.CO;2; Van Dam Robert P., 2008, Endangered Species Research, V4, P85, DOI 10.3354/esr00044; Vargas SM, 2008, J HERED, V99, P215, DOI 10.1093/jhered/esm120; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wielgus J., 2010, COASTAL CAPITAL DOMI; ZAYKIN DV, 1993, J HERED, V84, P152, DOI 10.1093/oxfordjournals.jhered.a111304	106	13	13	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66037	10.1371/journal.pone.0066037	http://dx.doi.org/10.1371/journal.pone.0066037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840394	gold, Green Published			2022-12-25	WOS:000322361200051
J	Li, XM; Shen, QR; Zhang, DQ; Mei, XL; Ran, W; Xu, YC; Yu, GH				Li, Xiaoming; Shen, Qirong; Zhang, Dongqing; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui			Functional Groups Determine Biochar Properties (pH and EC) as Studied by Two-Dimensional C-13 NMR Correlation Spectroscopy	PLOS ONE			English	Article							DIFFERENT PYROLYTIC TEMPERATURES; STRUCTURAL-PROPERTIES; CARBON; ADSORPTION; SORPTION	While the properties of biochar are closely related to its functional groups, it is unclear under what conditions biochar develops its properties. In this study, two-dimensional (2D) C-13 nuclear magnetic resonance (NMR) correlation spectroscopy was for the first time applied to investigate the development of functional groups and establish their relationship with biochar properties. The results showed that the agricultural biomass carbonized to biochars was a dehydroxylation/dehydrogenation and aromatization process, mainly involving the cleavage of O-alkylated carbons and anomeric O-C-O carbons in addition to the production of fused-ring aromatic structures and aromatic C-O groups. With increasing charring temperature, the mass cleavage of O-alkylated groups and anomeric O-C-O carbons occurred prior to the production of fused-ring aromatic structures. The regression analysis between functional groups and biochar properties (pH and electrical conductivity) further demonstrated that the pH and electrical conductivity of rice straw derived biochars were mainly determined by fused-ring aromatic structures and anomeric O-C-O carbons, but the pH of rice bran derived biochars was determined by both fused-ring aromatic structures and aliphatic O-alkylated (HCOH) carbons. In summary, this work suggests a novel tool for characterising the development of functional groups in biochars.	[Li, Xiaoming; Shen, Qirong; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui] Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Li, Xiaoming; Shen, Qirong; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Dongqing] Baoshan Environm Protect Bur, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, GH (corresponding author), Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	yuguanghui@njau.edu.cn	Yu, Guanghui/H-4968-2013; Shen, Qirong/AAB-6531-2020	Yu, Guanghui/0000-0002-5699-779X; 	National Basic Research Program of China [2011CB100503]; National Natural Science Foundation of China [21007027]; 111 Project [B12009]; Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The work was funded by the National Basic Research Program of China (2011CB100503), the National Natural Science Foundation of China (21007027), the 111 Project (B12009), the Qing Lan Project of Jiangsu Province, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XY, 2012, ENERG FUEL, V26, P5983, DOI 10.1021/ef300947s; Cao XY, 2011, ENERG FUEL, V25, P388, DOI 10.1021/ef101342v; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Cheng HN, 2010, CARBON, V48, P2455, DOI 10.1016/j.carbon.2010.03.016; Freitas JCC, 1999, ENERG FUEL, V13, P53, DOI 10.1021/ef980075c; Hammes K, 2008, APPL GEOCHEM, V23, P2113, DOI 10.1016/j.apgeochem.2008.04.023; Harvey OR, 2011, ENVIRON SCI TECHNOL, V45, P5550, DOI 10.1021/es104401h; Keiluweit M, 2012, ENVIRON SCI TECHNOL, V46, P9333, DOI 10.1021/es302125k; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Knicker H, 2008, ORG GEOCHEM, V39, P935, DOI 10.1016/j.orggeochem.2008.03.021; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Manya JJ, 2012, ENVIRON SCI TECHNOL, V46, P7939, DOI 10.1021/es301029g; Mao JD, 2012, ENVIRON SCI TECHNOL, V46, P9571, DOI 10.1021/es301107c; Mao JD, 2002, INT J ENVIRON AN CH, V82, P183, DOI 10.1080/0306731029000953; Meyer S, 2011, ENVIRON SCI TECHNOL, V45, P9473, DOI 10.1021/es201792c; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Noda I., 2004, 2 DIMENSIONAL CORREL; Rutherford DW, 2012, BIOMASS BIOENERG, V46, P693, DOI 10.1016/j.biombioe.2012.06.026; Wang LP, 2012, BIORESOURCE TECHNOL, V105, P88, DOI 10.1016/j.biortech.2011.11.064; Yu GH, 2012, ENVIRON SCI TECHNOL, V46, P6102, DOI 10.1021/es3002212; Yu GH, 2011, ENVIRON SCI TECHNOL, V45, P9224, DOI 10.1021/es201483f; Zhang GX, 2011, ENVIRON POLLUT, V159, P2594, DOI 10.1016/j.envpol.2011.06.012	26	113	121	12	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65949	10.1371/journal.pone.0065949	http://dx.doi.org/10.1371/journal.pone.0065949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840381	Green Published, gold, Green Submitted			2022-12-25	WOS:000322361200043
J	Wu, X; Huang, LT; Wu, Z; Zhang, C; Jiang, DY; Bai, YT; Wang, Y; Chen, G				Wu, Xia; Huang, Lanting; Wu, Zheng; Zhang, Ce; Jiang, Dongyun; Bai, Yuting; Wang, Yun; Chen, Gong			Homeostatic Competition between Phasic and Tonic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC GABA(A) RECEPTORS; CEREBELLAR GRANULE CELLS; SUBUNIT MESSENGER-RNAS; GABAERGIC SYNAPSES; SYNAPTIC INHIBITION; PYRAMIDAL NEURONS; GAMMA-2 SUBUNIT; DELTA-SUBUNIT; RAT-BRAIN; TRAFFICKING	The GABA(A) receptors are the major inhibitory receptors in the brain and are localized at both synaptic and extrasynaptic membranes. Synaptic GABA(A) receptors mediate phasic inhibition, whereas extrasynaptic GABA(A) receptors mediate tonic inhibition. Both phasic and tonic inhibitions regulate neuronal activity, but whether they regulate each other is not very clear. Here, we investigated the functional interaction between synaptic and extrasynaptic GABA(A) receptors through various molecular manipulations. Overexpression of extrasynaptic alpha 6 beta 3 delta-GABA(A) receptors in mouse hippocampal pyramidal neurons significantly increased tonic currents. Surprisingly, the increase of tonic inhibition was accompanied by a dramatic reduction of the phasic inhibition, suggesting a possible homeostatic regulation of the total inhibition. Overexpressing the alpha 6 subunit alone induced an up-regulation of delta subunit expression and suppressed phasic inhibition similar to overexpressing the alpha 6 beta 3 delta subunits. Interestingly, blocking all GABA(A) receptors after overexpressing alpha 6 beta 3 delta receptors could not restore the synaptic GABAergic transmission, suggesting that receptor activation is not required for the homeostatic interplay. Furthermore, insertion of a gephyrin-binding-site (GBS) into the alpha 6 beta 3 delta subunits recruited alpha 6(GBS)beta 3 delta(GBS) receptors to postsynaptic sites but failed to rescue synaptic GABAergic transmission. Thus, it is not the positional effect of extrasynaptic alpha 6 beta 3 delta receptors that causes the down-regulation of phasic inhibition. Overexpressing alpha 5 beta 3 gamma 2 subunits similarly reduced synaptic GABAergic transmission. We propose a working model that both synaptic and extrasynaptic GABA(A) receptors may compete for limited receptor slots on the plasma membrane to maintain a homeostatic range of the total inhibition.	[Wu, Xia; Huang, Lanting; Wu, Zheng; Zhang, Ce; Jiang, Dongyun; Bai, Yuting; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Huang, Lanting; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Huang, Lanting; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fudan University; Fudan University	Chen, G (corresponding author), Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA.	gongchen@psu.edu	Wu, Zheng/H-3234-2019	Jiang, Dongyun/0000-0002-3496-6271; Chen JNU, Gong/0000-0002-1857-3670	National Institute of Health [MH083911, MH092740]; Natural Science Foundation of China [31129003]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH092740, R01MH083911] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Health Grants MH083911 and MH092740 (to G. C.). This work was also supported by Natural Science Foundation of China Grant 31129003 (to G. C. and Y. W.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Gonzalez MI, 2011, NEUROSCI LETT, V497, P218, DOI 10.1016/j.neulet.2011.02.052; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hines RM, 2012, CURR OPIN NEUROBIOL, V22, P552, DOI 10.1016/j.conb.2011.10.007; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jones A, 1997, J NEUROSCI, V17, P1350; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Krogsgaard-Larsen P, 2004, BIOCHEM PHARMACOL, V68, P1573, DOI 10.1016/j.bcp.2004.06.040; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Luscher B, 1997, MOL BRAIN RES, V51, P197, DOI 10.1016/S0169-328X(97)00242-8; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Meera P, 2011, J NEUROPHYSIOL, V106, P2057, DOI 10.1152/jn.00450.2011; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Schneider Gasser E. M., 2007, EUR J NEUROSCI, V25, P3287, DOI DOI 10.1111/J.1460-9568.2007.05558.X; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Sun CS, 2007, J NEUROSCI, V27, P12641, DOI 10.1523/JNEUROSCI.4141-07.2007; Sun YJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-21; Tia S, 1996, J NEUROSCI, V16, P3630; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Yu LMY, 2009, CURR OPIN NEUROBIOL, V19, P327, DOI 10.1016/j.conb.2009.07.002; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002; Zheng T, 1993, Brain Res Dev Brain Res, V75, P91	66	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25053	25065		10.1074/jbc.M113.491464	http://dx.doi.org/10.1074/jbc.M113.491464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23839941	hybrid, Green Published			2022-12-25	WOS:000330619000006
J	Bersuker, K; Hipp, MS; Calamini, B; Morimoto, RI; Kopito, RR				Bersuker, Kirill; Hipp, Mark S.; Calamini, Barbara; Morimoto, Richard I.; Kopito, Ron R.			Heat Shock Response Activation Exacerbates Inclusion Body Formation in a Cellular Model of Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; UNDERLIES; INDUCTION; STRESS; CELLS	The cellular heat shock response (HSR) protects cells from toxicity associated with defective protein folding, and this pathway is widely viewed as a potential pharmacological target to treat neurodegenerative diseases linked to protein aggregation. Here we show that the HSR is not activated by mutant huntingtin (HTT) even in cells selected for the highest expression levels and for the presence of inclusion bodies containing aggregated protein. Surprisingly, HSR activation by HSF1 overexpression or by administration of a small molecule activator lowers the concentration threshold at which HTT forms inclusion bodies in cells expressing aggregation-prone, polyglutamine-expanded fragments of HTT. These data suggest that the HSR does not mitigate inclusion body formation.	[Bersuker, Kirill; Hipp, Mark S.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Calamini, Barbara; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Stanford University; Northwestern University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	Kopito@stanford.edu	Hipp, Mark/AAA-4238-2022	Hipp, Mark/0000-0002-0497-3016	National Institutes of Health from the NINDS [5R01NS042842-10]; National Institutes of Health [2T32HG000044-16]; Deutsche Forschungsgemeinschaft; National Institutes of Health Training Grant in Signal Transduction and Cancer [T32 CA70085]; National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases [T32 AG000260]; NATIONAL CANCER INSTITUTE [T32CA070085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health Training Grant in Signal Transduction and Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS042842-10 from the NINDS (to R. R. K.).; The recipient of National Institutes of Health Predoctoral Grant 2T32HG000044-16.; Supported in part by a fellowship from the Deutsche Forschungsgemeinschaft. Present address: Dept. of Cellular Biochemistry, MaxPlanck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.; Supported by the National Institutes of Health Training Grant in Signal Transduction and Cancer (T32 CA70085) and the National Institutes of Health Training Grant in Drug Discovery in Age Related Diseases (T32 AG000260). Present address: Dept. of Neurobiology and Center for Drug Discovery, Duke University, Durham, NC 27704.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Calamini B, 2012, CURR TOP MED CHEM, V12, P2623; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Chafekar SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037929; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Riva L, 2012, J HUNTINGTONS DIS, V1, P33, DOI 10.3233/JHD-2012-120020; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298	22	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23633	23638		10.1074/jbc.C113.481945	http://dx.doi.org/10.1074/jbc.C113.481945			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23839939	Green Published, hybrid			2022-12-25	WOS:000330611400002
J	Candelario, J; Chachisvilis, M				Candelario, Jose; Chachisvilis, Mirianas			Activity of Bradykinin B-2 Receptor Is Regulated by Long-Chain Polyunsaturated Fatty Acids	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; FLUID SHEAR-STRESS; ENDOTHELIUM-DEPENDENT VASORELAXATION; PARATHYROID-HORMONE RECEPTOR; NITRIC-OXIDE SYNTHASE; EICOSAPENTAENOIC ACID; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; ALLOSTERIC MACHINES; LIVING CELLS	The molecular and cellular mechanisms by which long-chain polyunsaturated fatty acids (LCPUFA) exert their beneficial effects on cardiovascular health remain obscure. While both LCPUFA and bradykinin (BK) signaling pathway play a role in the cardiovascular system, any direct link between the two is yet to be established. Using picosecond time-resolved fluorescence microscopy and a genetically engineered bradykinin B-2 receptor (B2R) sensor (B2K-CC), we detected LCPUFA-induced conformational responses in the B2R similar to those caused by its cognate ligand, BK. The selective B2R antagonist (HOE-140) blocked the eicosapentaenoic acid (EPA, C20:5, n-3) induced conformational response of the B2K-CC. Further analysis suggests that LCPUFA are capable of direct, B2R-dependent activation of extracellular ligand-regulated kinases (ERK). From a wide range of fatty acids studied, varying in chain length, saturation, and position of double bonds, EPA, docosahexaenoic (DHA, C22:6, n-3), docosadienoic (DDA, C22: 2, n-6), and dihomo-gamma linoleic (DGLA, C20: 3, n-6) fatty acids caused the highest ERK phosphorylation. EPA or DHA dependent ERK phosphorylation was inhibited by the selective B2R antagonist. We show that LCPUFA stimulates downstream signaling by B2R such as B2R-dependent phosphorylation and expression regulation of endothelial nitric-oxide synthase (eNOS). Further analysis indicated that LCPUFA also alters levels of the eNOS transcription factor, kruppel-like factor 2 (KLF2). Moreover we show that EPA increases membrane fluidity on the same time scale as B2R conformational response, suggesting that partitioning of LCPUFA into bilayer is a primary step required for receptor activation. In summary our data show that LCPUFA activate B2R receptor at nanomolar concentrations suggesting a novel molecular mechanism by which fatty acids may affect the cardiovascular system.	[Candelario, Jose; Chachisvilis, Mirianas] La Jolla Bioengn Inst, San Diego, CA 92121 USA	La Jolla Bioengineering Institute	Chachisvilis, M (corresponding author), La Jolla Bioengn Inst, San Diego, CA 92121 USA.	mirianas@alumni.caltech.edu			National Institutes of Health [HL86943, HL86943-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to MC from the National Institutes of Health (HL86943 and HL86943-S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baylin A, 2003, CIRCULATION, V107, P1586, DOI 10.1161/01.CIR.0000058165.81208.C6; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Candelario J, 2012, CELLUALR MO IN PRESS; Candelario J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052583; Candelario J, 2012, CELL MOL BIOENG, V5, P277, DOI 10.1007/s12195-012-0232-0; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Engler M B, 1994, J Cardiovasc Risk, V1, P75, DOI 10.1097/00043798-199406000-00012; Engler MB, 2000, BRIT J PHARMACOL, V131, P1793, DOI 10.1038/sj.bjp.0703754; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; Figueroa CD, 2001, HYPERTENSION, V37, P110, DOI 10.1161/01.HYP.37.1.110; FRIEDMAN MH, 1975, CIRC RES, V36, P277, DOI 10.1161/01.RES.36.2.277; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 1999, LANCET, V354, P447; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Haidekker MA, 2001, CHEM BIOL, V8, P123, DOI 10.1016/S1074-5521(00)90061-9; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Kenakin T, 2004, RECEPTOR CHANNEL, V10, P51, DOI 10.1080/10606820490464316; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Kramarenko II, 2009, BIOCHEM PHARMACOL, V77, P269, DOI 10.1016/j.bcp.2008.09.027; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; LAWSON DL, 1991, EICOSANOIDS, V4, P217; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; ROBINSON DR, 1993, J LIPID RES, V34, P1423; Saito J, 1997, ATHEROSCLEROSIS, V131, P219, DOI 10.1016/S0021-9150(97)00048-8; SALEM N, 1986, DOCOSAHEXAENOIC ACID; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Starke-Peterkovic T, 2005, AM J PHYSIOL-REG I, V288, pR663, DOI 10.1152/ajpregu.00434.2004; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Thompson AA, 2011, METHODS, V55, P310, DOI 10.1016/j.ymeth.2011.10.011; TRIFILIEFF A, 1992, J PHARMACOL EXP THER, V263, P1377; Turchiello RF, 2000, BIOPOLYMERS, V54, P211, DOI 10.1002/1097-0282(200009)54:3<211::AID-BIP70>3.0.CO;2-P; VANMETER AR, 1994, MECH AGEING DEV, V75, P95, DOI 10.1016/0047-6374(94)90079-5; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; YIN K, 1991, BRIT J PHARMACOL, V102, P991, DOI 10.1111/j.1476-5381.1991.tb12289.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	67	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68151	10.1371/journal.pone.0068151	http://dx.doi.org/10.1371/journal.pone.0068151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826374	Green Submitted, gold, Green Published			2022-12-25	WOS:000321150000128
J	Gupta, P; Adkins, C; Lockman, P; Srivastava, SK				Gupta, Parul; Adkins, Chris; Lockman, Paul; Srivastava, Sanjay K.			Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; CANCER-CELLS; CRUCIFEROUS VEGETABLES; ANTITUMOR-ACTIVITY; CYCLE ARREST; EXPRESSION; SULFORAPHANE; ACTIVATION; INHIBITION	Breast tumor metastasis is a leading cause of cancer-related deaths worldwide. Breast tumor cells frequently metastasize to brain and initiate severe therapeutic complications. The chances of brain metastasis are further elevated in patients with HER2 overexpression. In the current study, we evaluated the anti-metastatic effects of phenethyl isothiocyanate (PEITC) in a novel murine model of breast tumor metastasis. The MDA-MB-231-BR (BR-brain seeking) breast tumor cells stably transfected with luciferase were injected into the left ventricle of mouse heart and the migration of cells to brain was monitored using a non-invasive IVIS bio-luminescent imaging system. In order to study the efficacy of PEITC in preventing the number of tumor cells migrating to brain, mice were given 10 mu mol PEITC by oral gavage for ten days prior to intra-cardiac injection of tumor cells labeled with quantum dots. To evaluate the tumor growth suppressive effects, 10 mmol PEITC was given to mice every day starting 14th day after intra-cardiac cell injection. Based on the presence of quantum dots in the brain section of control and treated mice, our results reveal that PEITC significantly prevented the metastasis of breast cancer cells to brain. Our results demonstrate that the growth of metastatic brain tumors in PEITC treated mice was about 50% less than that of control. According to Kaplan Meir's curve, median survival of tumor bearing mice treated with PEITC was prolonged by 20.5%. Furthermore as compared to controls, we observed reduced HER2, EGFR and VEGF expression in the brain sections of PEITC treated mice. To the best of our knowledge, our study for the first time demonstrates the anti-metastatic effects of PEITC in vivo in a novel breast tumor metastasis model and provides the rationale for further clinical investigation.	[Gupta, Parul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Gupta, Parul; Adkins, Chris; Lockman, Paul; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA; [Adkins, Chris; Lockman, Paul] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020; GUPTA, PARUL/AAF-1118-2019	Lockman, Paul/0000-0002-6995-9944	National Cancer Institute, National Institute of Health;  [CA106953];  [CA129038]; NATIONAL CANCER INSTITUTE [R01CA129038, R01CA106953] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 grants CA106953 and CA129038 (to S.K.S) awarded by the National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggs DA, 2010, AM J EPIDEMIOL, V172, P1268, DOI 10.1093/aje/kwq293; BOOGERD W, 1993, J NEURO-ONCOL, V15, P165, DOI 10.1007/BF01053937; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Brown JM, 1998, CANCER RES, V58, P1408; Brown KK, 2011, BBA-GEN SUBJECTS, V1810, P888, DOI 10.1016/j.bbagen.2011.06.004; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; Chang EL, 2003, ONCOLOGIST, V8, P398, DOI 10.1634/theoncologist.8-5-398; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Claffey KP, 1996, CANCER METAST REV, V15, P165, DOI 10.1007/BF00437469; Coleman RE, 2012, NAT REV CLIN ONCOL, V9, P76, DOI 10.1038/nrclinonc.2011.198; Conaway CC, 1999, DRUG METAB DISPOS, V27, P13; CONLEY FK, 1979, CANCER RES, V39, P1001; DAXENBICHLER ME, 1977, J ASSOC OFF ANA CHEM, V60, P950; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; Dieras V, 2011, B CANCER, V98, P385, DOI 10.1684/bdc.2011.1336; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Fidler IJ, 2010, MOL CELLS, V30, P93, DOI 10.1007/s10059-010-0133-9; Fokstuen T, 2000, BREAST CANCER RES TR, V62, P211, DOI 10.1023/A:1006486423827; Frisk G, 2012, BRIT J CANCER, V106, P1850, DOI 10.1038/bjc.2012.163; Gao N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.22; Gupta P, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-80; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jakubikova J, 2011, HAEMATOL-HEMATOL J, V96, P1170, DOI 10.3324/haematol.2010.029363; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong J, 2011, J KOREAN MED SCI, V26, P1569, DOI 10.3346/jkms.2011.26.12.1569; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Kandala PK, 2012, J BIOL CHEM; Kandala PK, 2012, ONCOTARGET, V3, P435; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Lassman AB, 2003, NEUROL CLIN, V21, P1, DOI 10.1016/S0733-8619(02)00035-X; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Lee SA, 2008, AM J CLIN NUTR, V87, P753, DOI 10.1093/ajcn/87.3.753; Li XQ, 2012, EUR J GYNAECOL ONCOL, V33, P178; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Liu XL, 2011, BIOCHEM BIOPH RES CO, V409, P577, DOI 10.1016/j.bbrc.2011.05.052; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nickerson NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030255; Nie F, 2012, CANCER-AM CANCER SOC, V118, P5198, DOI 10.1002/cncr.27553; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Padovani L, 2012, PROG NEUROL SURG, V25, P156, DOI 10.1159/000331189; PALMER S, 1985, PROG FOOD NUTR SCI, V9, P283; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; PATANAPHAN V, 1988, SOUTHERN MED J, V81, P1109, DOI 10.1097/00007611-198809000-00011; Pazaiti A, 2011, WOMENS HEALTH, V7, P181, DOI [10.2217/whe.11.5, 10.2217/WHE.11.5]; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; Tsao MN, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003869.pub3; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Wang XH, 2009, BIOCHEM PHARMACOL, V78, P261, DOI 10.1016/j.bcp.2009.04.010; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yang MD, 2010, ANTICANCER RES, V30, P2135; Yano S, 2000, CANCER RES, V60, P4959; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	59	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67278	10.1371/journal.pone.0067278	http://dx.doi.org/10.1371/journal.pone.0067278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826254	Green Published, Green Submitted, gold			2022-12-25	WOS:000321150000054
J	Mesquita, DN; Barbieri, MA; Goldani, HAS; Cardoso, VC; Goldani, MZ; Kac, G; Silva, AAM; Bettiol, H				Mesquita, Denise N.; Barbieri, Marco A.; Goldani, Helena A. S.; Cardoso, Viviane C.; Goldani, Marcelo Z.; Kac, Gilberto; Silva, Antonio A. M.; Bettiol, Heloisa			Cesarean Section Is Associated with Increased Peripheral and Central Adiposity in Young Adulthood: Cohort Study	PLOS ONE			English	Article							GUT MICROBIOTA; WAIST CIRCUMFERENCE; RIBEIRAO-PRETO; RISK-FACTORS; 1ST HOUR; OBESITY; BIRTH; DELIVERY; CHILDHOOD; HEALTH	Background: Cesarean section (CS) has been associated with obesity, measured by body mass index (BMI), in some studies. It has been hypothesized that this association, if causal, might be explained by changes in gut microbiota. However, little is known about whether CS is also associated with increased adiposity as measured by indicators other than BMI. Objective: To assess the association between CS and indicators of peripheral and central adiposity in young adults. Methods: The study was conducted on 2,063 young adults aged 23 to 25 years from the 1978/79Ribeirao Preto birth cohort, Sao Paulo, Brazil. CS was the independent variable. The anthropometric indicators of adiposity were: waist circumference (WC), waist-height ratio (WHtR), waist-hip ratio (WHR), tricipital skinfold (TSF), and subscapular skinfold (SSF). The association between CS and indicators of adiposity was investigated using a Poisson model, with robust adjustment of variance and calculation of incidence rate ratio (IRR) with 95% confidence interval (95% CI), and adjustment for birth variables. Results: Follow-up rate was 31.8%. The CS rate was 32%. Prevalences of increased WC, WHtR, WHR were 32.1%, 33.0% and 15.2%, respectively. After adjustment for birth variables, CS was associated with increased risk of adiposity when compared to vaginal delivery: 1.22 (95% CI 1.07; 1.39) for WC, 1.25 (95% CI 1.10; 1.42) for WHtR, 1.45 (95% CI 1.18; 1.79) for WHR, 1.36 (95% CI 1.04; 1.78) for TSF, and 1.43 (95% CI 1.08; 1.91) for SSF. Conclusion: Subjects born by CS had a higher risk for increased peripheral and central adiposity during young adult age compared to those born by vaginal delivery. The association of CS with adiposity was consistently observed for all indicators and was robust after adjustment for a variety of early life confounders.	[Mesquita, Denise N.; Barbieri, Marco A.; Cardoso, Viviane C.; Bettiol, Heloisa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Puericulture & Pediat, BR-14049 Ribeirao Preto, Brazil; [Goldani, Helena A. S.; Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Puericulture, Porto Alegre, RS, Brazil; [Kac, Gilberto] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Rio De Janeiro, Brazil; [Silva, Antonio A. M.] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Maranhao	Mesquita, DN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Puericulture & Pediat, BR-14049 Ribeirao Preto, Brazil.	dfisiomesquita@yahoo.com.br	Cardoso, Viviane/D-6254-2012; Silva, Antonio A M/B-5410-2009; Goldani, Helena/AAJ-8406-2021; Barbieri, Marco/J-2597-2014; Kac, Gilberto/H-6862-2012; Bettiol, Heloisa/B-4190-2013; Goldani, Marcelo Zubaran/U-8596-2019	Cardoso, Viviane/0000-0002-2677-5600; Silva, Antonio A M/0000-0003-4968-5138; Kac, Gilberto/0000-0001-8603-9077; Bettiol, Heloisa/0000-0001-8744-4373; 	Sao Paulo Research Foundation (FAPESP) [93/0525-0, 97/09517-1, 00/09508-7]; National Research Council (CNPq) [186/2009-3]; University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil	This study was supported by Sao Paulo Research Foundation (FAPESP, grants n. 93/0525-0, 97/09517-1, and 00/09508-7), National Research Council (CNPq, grant n. 186/2009-3), and University Hospital Research Foundation (FAEPA-HCFMRPUSP), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Almeida LEA, 1992, CAD SAUDE PUBLICA, V8, P90; Ashwell M, 1996, BRIT MED J, V312, P377; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barbieri MA, 2006, BRAZ J MED BIOL RES, V39, P1041, DOI 10.1590/S0100-879X2006000800007; Barbieri MA., 1989, CAD SAUDE PUBLICA, V5, P376; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Boccolini CS, 2011, REV SAUDE PUBL, V45, P69, DOI 10.1590/S0034-89102010005000051; CAMERON N, 1984, MEASUREMENT HUMAN GR, P182; Cardoso VC, 2007, BRAZ J MED BIOL RES, V40, P1165, DOI 10.1590/S0100-879X2006005000148; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Gomes UA, 1999, INT J EPIDEMIOL, V28, P687, DOI 10.1093/ije/28.4.687; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; JANOWITZ B, 1982, PUBLIC HEALTH, V96, P191, DOI 10.1016/S0033-3506(82)80063-2; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Li H-T, 2012, INT J OBESITY, P1; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Marques NM, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e66; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oliveira ZAR, 2007, BRAZ J MED BIOL RES, V40, P1245, DOI 10.1590/S0100-879X2006005000135; Organization WH, 1998, WELLB MEAS PRIM HLTH; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Utz RL, 2008, POLICE PERSPECTIVES, V4; VICTORA CG, 1990, ARCH DIS CHILD, V65, P632, DOI 10.1136/adc.65.6.632; Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760; White IR, 2011, STAT METHODS MED RES; World Health Organization, 2008, WAIST CIRCUMFERENCE; Zhou LS, 2011, EUR J PEDIATR, V170, P1401, DOI 10.1007/s00431-011-1416-7; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e66827	10.1371/journal.pone.0066827	http://dx.doi.org/10.1371/journal.pone.0066827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826150	gold, Green Submitted, Green Published			2022-12-25	WOS:000321150000013
J	Attig, L; Vige, A; Gabory, A; Karimi, M; Beauger, A; Gross, MS; Athias, A; Gallou-Kabani, C; Gambert, P; Ekstrom, TJ; Jais, JP; Junien, C				Attig, Linda; Vige, Alexandre; Gabory, Anne; Karimi, Moshen; Beauger, Aurore; Gross, Marie-Sylvie; Athias, Anne; Gallou-Kabani, Catherine; Gambert, Philippe; Ekstrom, Tomas J.; Jais, Jean-Philippe; Junien, Claudine			Dietary Alleviation of Maternal Obesity and Diabetes: Increased Resistance to Diet-Induced Obesity Transcriptional and Epigenetic Signatures	PLOS ONE			English	Article							HIGH-FAT DIET; GENE-EXPRESSION; METABOLIC SYNDROME; RAT; HYPOMETHYLATION; SUPPLEMENTATION; METHYLATION; MECHANISMS; EXPOSURE; GLUCOSE	According to the developmental origins of health and diseases (DOHaD), and in line with the findings of many studies, obesity during pregnancy is clearly a threat to the health and well-being of the offspring, later in adulthood. We previously showed that 20% of male and female inbred mice can cope with the obesogenic effects of a high-fat diet (HFD) for 20 weeks after weaning, remaining lean. However the feeding of a control diet (CD) to DIO mice during the periconceptional/gestation/lactation period led to a pronounced sex-specific shift (17% to 43%) from susceptibility to resistance to HFD, in the female offspring only. Our aim in this study was to determine how, in the context of maternal obesity and T2D, a CD could increase resistance on female fetuses. Transcriptional analyses were carried out with a custom-built mouse liver microarray and by quantitative RT-PCR for muscle and adipose tissue. Both global DNA methylation and levels of pertinent histone marks were assessed by LUMA and western blotting, and the expression of 15 relevant genes encoding chromatin-modifying enzymes was analyzed in tissues presenting global epigenetic changes. Resistance was associated with an enhancement of hepatic pathways protecting against steatosis, the unexpected upregulation of neurotransmission-related genes and the modulation of a vast imprinted gene network. Adipose tissue displayed a pronounced dysregulation of gene expression, with an upregulation of genes involved in lipid storage and adipocyte hypertrophy or hyperplasia in obese mice born to lean and obese mothers, respectively. Global DNA methylation, several histone marks and key epigenetic regulators were also altered. Whether they were themselves lean (resistant) or obese (sensitive), the offspring of lean and obese mice clearly differed in terms of several metabolic features and epigenetic marks suggesting that the effects of a HFD depend on the leanness or obesity of the mother.	[Attig, Linda; Gabory, Anne; Beauger, Aurore; Gross, Marie-Sylvie; Junien, Claudine] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Attig, Linda; Vige, Alexandre; Gabory, Anne; Beauger, Aurore; Gross, Marie-Sylvie; Gallou-Kabani, Catherine; Junien, Claudine] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Fac Med,INSERM U781, Paris, France; [Karimi, Moshen; Ekstrom, Tomas J.; Junien, Claudine] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Lab Med Epigenet, Stockholm, Sweden; [Athias, Anne] CHU Bocage, Sante STIC IFR100, Dijon, France; [Gambert, Philippe] Lab Biochim Med, Sante STIC IFR100, Dijon, France; [Jais, Jean-Philippe] Univ Paris 05, Hop Necker Enfants Malad, Serv Biostat & Informat Med, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Junien, C (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	claudine.junien@jouy.inra.fr	Ekström, Tomas/B-7764-2013	Gabory, Anne/0000-0002-0059-7375	Nestle; Fondation pour la Recherche Medicale; Association Francaise d'Etudes et de Recherche sur l'Obesite studentship; Swedish Cancer Society; INRA; INSERM (ATC-Nutrition, PRNH); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Arteres (FCA) [05-T4]; ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine [ANR-06-PNRA-022-01]; Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI [ISI IT-DIAB - 18/12/2008]; Fournier laboratory	Nestle(Nestle SA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise d'Etudes et de Recherche sur l'Obesite studentship; Swedish Cancer Society(Swedish Cancer Society); INRA; INSERM (ATC-Nutrition, PRNH)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Arteres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine(French National Research Agency (ANR)); Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI; Fournier laboratory	This work was supported by Nestle, the Fondation pour la Recherche Medicale and an Association Francaise d'Etudes et de Recherche sur l'Obesite studentship awarded to AV, a Fournier-Pharma studentship awarded to CGK, a grant from the Swedish Cancer Society awarded to TJE, and by grants from INRA, INSERM (ATC-Nutrition, PRNH), Association Francaise des Diabetiques, Institut Benjamin Delessert, the Fondation Coeur et Arteres (FCA No 05-T4), the ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et Nutrition Humaine, project ANR-06-PNRA-022-01, and Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab''OSEO-ISI (ISI IT-DIAB - 18/12/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interest. We received funding from two commercial sources, Fournier laboratory and Nestle as fellowship to C. Gallou-Kabani and A. Vige in 2004 and 2006 respectively. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beaudet AL, 2002, AM J HUM GENET, V70, P1389, DOI 10.1086/340969; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Fauque P, 2010, HUM MOL GENET; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gabory A, 2011, WORLD J DIABETES, V2, P164, DOI 10.4239/wjd.v2.i10.164; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gallou-Kabani C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1095, DOI 10.1152/ajpendo.00390.2006; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Joe MK, 2008, CELL SIGNAL; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Latour MG, 2002, AUTON NEUROSCI-BASIC, V95, P125, DOI 10.1016/S1566-0702(01)00390-3; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lin CH, 2001, CANCER RES, V61, P4238; Macfarlane DP, 2011, AM J PHYSIOL-ENDOC M, V300, pE402, DOI 10.1152/ajpendo.00331.2010; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miao F, 2008, J IMMUNOL, V180, P2264, DOI 10.4049/jimmunol.180.4.2264; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pembrey M., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P111; Pogribny IP, 2007, J NUTR, V137, p216S, DOI 10.1093/jn/137.1.216S; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Siebel AL, 2010, BIOCHEM PHARMACOL, V80, P1853, DOI 10.1016/j.bcp.2010.06.005; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Suzuki Hiromu, 2006, Asian Pac J Cancer Prev, V7, P177; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Uyama N, 2004, ANAT REC PART A, V280A, P808, DOI 10.1002/ar.a.20086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Verrier L, 2011, BIOL CELL, V103, P381, DOI 10.1042/BC20110028; Viens L, 1996, J LIPID RES, V37, P2179; Vige A, 2006, CYTOGENET GENOME RES, V113, P253, DOI 10.1159/000090840; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WATERLAND R, 2002, PUBLIC HLTH ISSUES I, V48, P317; Waterland RA, 2002, J NUTR, V132, P357, DOI 10.1093/jn/132.3.357; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	80	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66816	10.1371/journal.pone.0066816	http://dx.doi.org/10.1371/journal.pone.0066816			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826145	Green Published, Green Submitted, gold			2022-12-25	WOS:000321738400059
J	Auffinger, BM; Lall, RR; Dahdaleh, NS; Wong, AP; Lam, SK; Koski, T; Fessler, RG; Smith, ZA				Auffinger, Brenda M.; Lall, Rishi R.; Dahdaleh, Nader S.; Wong, Albert P.; Lam, Sandi K.; Koski, Tyler; Fessler, Richard G.; Smith, Zachary A.			Measuring Surgical Outcomes in Cervical Spondylotic Myelopathy Patients Undergoing Anterior Cervical Discectomy and Fusion: Assessment of Minimum Clinically Important Difference	PLOS ONE			English	Article							NECK-DISABILITY-INDEX; QUALITY-OF-LIFE; BACK PAIN QUESTIONNAIRE; INTRAINDIVIDUAL CHANGES; HEALTH-STATUS; ARTICLE; RELIABILITY; SENSITIVITY; VALIDITY; STATE	Object: The concept of minimum clinically important difference (MCID) has been used to measure the threshold by which the effect of a specific treatment can be considered clinically meaningful. MCID has previously been studied in surgical patients, however few studies have assessed its role in spinal surgery. The goal of this study was to assess the role of MCID in patients undergoing anterior cervical discectomy and fusion (ACDF) for cervical spondylotic myelopathy (CSM). Methods: Data was collected on 30 patients who underwent ACDF for CSM between 2007 and 2012. Preoperative and 1-year postoperative Neck Disability Index (NDI), Visual-Analog Scale (VAS), and Short Form-36 (SF-36) Physical (PCS) and Mental (MCS) Component Summary PRO scores were collected. Five distribution- and anchor-based approaches were used to calculate MCID threshold values average change, change difference, receiver operating characteristic curve (ROC), minimum detectable change (MDC) and standard error of measurement (SEM). The Health Transition Item of the SF-36 (HTI) was used as an external anchor. Results: Patients had a significant improvement in all mean physical PRO scores postoperatively (p<0.01) NDI (29.24 to 14.82), VAS (5.06 to 1.72), and PCS (36.98 to 44.22). The five MCID approaches yielded a range of values for each PRO: 2.00-8.78 for PCS, 2.06-5.73 for MCS, 4.83-13.39 for NDI, and 0.36-3.11 for VAS. PCS was the most representative PRO measure, presenting the greatest area under the ROC curve (0.94). MDC values were not affected by the choice of anchor and their threshold of improvement was statistically greater than the chance of error from unimproved patients. Conclusion: SF-36 PCS was the most representative PRO measure. MDC appears to be the most appropriate MCID method. When MDC was applied together with HTI anchor, the MCID thresholds were: 13.39 for NDI, 3.11 for VAS, 5.56 for PCS and 5.73 for MCS.	[Auffinger, Brenda M.; Lam, Sandi K.] Univ Chicago, Sect Neurol Surg, Chicago, IL 60637 USA; [Lall, Rishi R.; Dahdaleh, Nader S.; Wong, Albert P.; Koski, Tyler; Fessler, Richard G.; Smith, Zachary A.] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA	University of Chicago; Northwestern University	Smith, ZA (corresponding author), Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA.	zsmith@nmff.org		Lam, Sandi/0000-0003-3294-6637	Medtronic Inc.; Medtronic; Stryker; Depuy; Lanx Inc	Medtronic Inc.(Medtronic); Medtronic(Medtronic); Stryker; Depuy; Lanx Inc	RF receives educational grant support for research on spinal techniques from Medtronic Inc. However, he has no direct compensatory financial disclosures. The remaining authors have no direct compensatory financial disclosures. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; RF receives educational grant support from Medtronic, Stryker and Depuy for research on spinal techniques. Additionally he serves as a paid consultant for Lanx Inc for development of spinal surgery products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Beaton DE, 2001, J RHEUMATOL, V28, P400; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Gatchel RJ, 2010, SPINE J, V10, P321, DOI 10.1016/j.spinee.2009.10.015; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Kulkarni AV, 2006, J CLIN EPIDEMIOL, V59, P176, DOI 10.1016/j.jclinepi.2005.07.011; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; McDowell IN C, 1996, MEARURING HEATH GUID; MONTGOMERY DM, 1992, ORTHOP CLIN N AM, V23, P487; Parker SL, 2013, J NEUROSURG-SPINE, V18, P154, DOI 10.3171/2012.10.SPINE12312; Parker SL, 2012, J NEUROSURG-SPINE, V16, P471, DOI 10.3171/2012.1.SPINE11842; Parker SL, 2012, J NEUROSURG-SPINE, V16, P61, DOI 10.3171/2011.8.SPINE1194; Parker SL, 2011, J NEUROSURG-SPINE, V14, P598, DOI 10.3171/2010.12.SPINE10472; Pool JJM, 2007, SPINE, V32, P3047, DOI 10.1097/BRS.0b013e31815cf75b; Riddle DL, 1998, PHYS THER, V78, P1197, DOI 10.1093/ptj/78.11.1197; Stratford PW, 1998, PHYS THER, V78, P1186, DOI 10.1093/ptj/78.11.1186; van der Roer N, 2006, SPINE, V31, P578, DOI 10.1097/01.brs.0000201293.57439.47; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Vernon H, 2008, ARCH PHYS MED REHAB, V89, P1414, DOI 10.1016/j.apmr.2008.05.003; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wells G, 2001, J RHEUMATOL, V28, P406; Wilson HD, 2011, SPINE, V36, P474, DOI 10.1097/BRS.0b013e3181d41632; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	32	56	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67408	10.1371/journal.pone.0067408	http://dx.doi.org/10.1371/journal.pone.0067408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826290	Green Published, gold, Green Submitted			2022-12-25	WOS:000321738400140
J	Brown, JK; Lauer, KB; Ironmonger, EL; Inglis, NF; Bourne, TH; Critchley, HOD; Horne, AW				Brown, Jeremy K.; Lauer, Katarina B.; Ironmonger, Emily L.; Inglis, Neil F.; Bourne, Tom H.; Critchley, Hilary O. D.; Horne, Andrew W.			Shotgun Proteomics Identifies Serum Fibronectin as a Candidate Diagnostic Biomarker for Inclusion in Future Multiplex Tests for Ectopic Pregnancy	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; PLACENTAL GROWTH-FACTOR; MANAGEMENT; PLASMA; MARKER	Ectopic pregnancy (EP) is difficult to diagnose early and accurately. Women often present at emergency departments in early pregnancy with a 'pregnancy of unknown location' (PUL), and diagnosis and exclusion of EP is challenging due to a lack of reliable biomarkers. The objective of this study was to identify novel diagnostic biomarkers for EP. Shotgun proteomics, incorporating combinatorial-ligand library pre-fractionation, was used to interrogate pooled sera (n = 40) from women undergoing surgery for EP, termination of viable intrauterine pregnancy and management of non-viable intrauterine pregnancy. Western blot was used to validate results in individual sera. ELISAs were developed to interrogate sera from women with PUL (n = 120). Sera were collected at time of first symptomatic presentation and categorized according to pregnancy outcome. The main outcome measures were differences between groups and area under the receiver operating curve (ROC). Proteomics identified six biomarker candidates. Western blot detected significant differences in levels of two of these candidates. ELISA of sera from second cohort revealed that these differences were only significant for one of these candidates, fibronectin. ROC analysis of ability of fibronectin to discriminate EP from other pregnancy outcomes suggested that fibronectin has diagnostic potential (ROC 0.6439; 95% CI 0.5090 to 0.7788; P>0.05), becoming significant when 'ambiguous' medically managed PUL excluded from analysis (ROC 0.6538; 95% CI 0.5158 to 0.7918; P<0.05). Fibronectin may make a useful adjunct to future multiplex EP diagnostic tests.	[Brown, Jeremy K.; Lauer, Katarina B.; Ironmonger, Emily L.; Critchley, Hilary O. D.; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Inglis, Neil F.] Moredun Res Inst, Moredun Prote Facil, Penicuik, Midlothian, Scotland; [Bourne, Tom H.] Imperial Coll Natl Hlth Serv Trust, Queen Charlottes & Chelsea Hosp, London, England	University of Edinburgh; Moredun Research Institute; Imperial College London	Horne, AW (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	Bourne, Tom/I-6478-2012	Bourne, Tom/0000-0003-1421-6059; Lauer, Katharina Barbara/0000-0002-4347-7525; CRITCHLEY, HILARY/0000-0003-1913-4044; Horne, Andrew/0000-0002-9656-493X	United Kingdom Medical Research Council [MRC G0802808]; Medical Research Council [G1002033, G0802808] Funding Source: researchfish; MRC [G0802808, G1002033] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the United Kingdom Medical Research Council (MRC G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart K, 2011, EXPERT REV MOL DIAGN, V11, P759, DOI [10.1586/erm.11.72, 10.1586/ERM.11.72]; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Beer LA, 2011, METHODS MOL BIOL, V728, P3, DOI 10.1007/978-1-61779-068-3_1; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; Boschetti E, 2008, J PROTEOMICS, V71, P255, DOI 10.1016/j.jprot.2008.05.002; BUCK RH, 1988, FERTIL STERIL, V50, P752; Cabar FR, 2010, FERTIL STERIL, V94, P1595, DOI 10.1016/j.fertnstert.2009.10.036; Chen H, 2012, ARCH GYNECOL OBSTET, V285, P1231, DOI 10.1007/s00404-011-2137-x; Condous G, 2004, HUM REPROD, V19, P1900, DOI 10.1093/humrep/deh341; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Florio P, 2011, GYNECOL ENDOCRINOL, V27, P391, DOI 10.3109/09513590.2010.495430; Goldfinch GM, 2008, PROTEOMICS, V8, P1909, DOI 10.1002/pmic.200700531; Horne AW, 2008, J CLIN ENDOCR METAB, V93, P2375, DOI 10.1210/jc.2008-0136; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Horne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041442; Horne AW, 2011, J CLIN ENDOCR METAB, V96, pE104, DOI 10.1210/jc.2010-1403; Horne AW, 2010, ACTA OBSTET GYN SCAN, V89, P299, DOI 10.3109/00016340903568191; Iyibozkurt AC, 2010, CLIN EXP OBSTET GYN, V37, P217; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; MANTZAVINOS T, 1991, EUR J OBSTET GYN R B, V39, P117, DOI 10.1016/0028-2243(91)90074-U; Morelli SS, 2008, FERTIL STERIL, V90, P2068, DOI 10.1016/j.fertnstert.2007.10.063; Rasband W., 2006, IMAGEJ; Rausch ME, 2011, OBSTET GYNECOL, V117, P573, DOI 10.1097/AOG.0b013e31820b3c61; Rausch ME, 2011, FERTIL STERIL, V95, P1373, DOI 10.1016/j.fertnstert.2010.12.040; Sahraravand M, 2011, PLACENTA, V32, P999, DOI 10.1016/j.placenta.2011.10.005; Segal S, 2008, REPROD BIOMED ONLINE, V17, P789, DOI 10.1016/S1472-6483(10)60406-3; Sivalingam VN, 2011, J FAM PLAN REPROD H, V37, P231, DOI 10.1136/jfprhc-2011-0073; STERZIK K, 1989, INT J GYNECOL OBSTET, V28, P253, DOI 10.1016/0020-7292(89)90726-1; Varma R, 2012, CLIN EVID; Walker JJ, 2007, CLIN OBSTET GYNECOL, V50, P89, DOI 10.1097/GRF.0b013e31802f4f79; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397; Wiwanitkit V, 2011, FERTIL STERIL, V95, pE21, DOI 10.1016/j.fertnstert.2011.02.027	35	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66974	10.1371/journal.pone.0066974	http://dx.doi.org/10.1371/journal.pone.0066974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826180	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400089
J	Hirotsu, C; Tufik, S; Guindalini, C; Mazzotti, DR; Bittencourt, LR; Andersen, ML				Hirotsu, Camila; Tufik, Sergio; Guindalini, Camila; Mazzotti, Diego R.; Bittencourt, Lia R.; Andersen, Monica L.			Association Between Uric Acid Levels and Obstructive Sleep Apnea Syndrome in a Large Epidemiological Sample	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; CARDIOVASCULAR RISK-FACTORS; INDEPENDENT PREDICTOR; CREATININE RATIO; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS	Introduction: Recurrent hypoxia, which is associated with obstructive sleep apnea syndrome (OSAS), leads to an increase in the degradation of adenosine triphosphatase into xanthine, which in turn increases uric acid concentrations. Objective: The current study aimed to determine whether an association exists between OSAS and uric acid levels in the peripheral blood from a representative population of Sao Paulo (Brazil). Methods: A population-based survey adopting a probabilistic 3-stage cluster sample of Sao Paulo was used to represent the population according to gender, age, and socioeconomic class. A total of 1,042 volunteers underwent polysomnography recordings for OSAS diagnosis, blood pressure assessment, and biochemical blood analysis, and answered questionnaires. Results: Uric acid levels were correlated with most important risk factors for OSAS, such as AHI, desaturation time and index, minimum oxyhemoglobin saturation (SpO(2)), blood pressure, cholesterol, BMI, triglycerides and arousal, and with OSAS itself. Also, uric acid was increased in OSAS volunteers even after controlling for all confounders. Hyperuricemic volunteers presented lower mean and minimum SpO(2) and increased desaturation index. Importantly, minimum SpO(2) was a significant predictor of uric acid levels, which in turn was considered an independent predictor for OSAS in the binary logistic model. However, a ROC curve analysis for establishing cut-off points for uric acid levels as a biomarker of OSAS revealed moderate sensitivity and specificity. Conclusion: A strong association was found between uric acid levels and OSAS in a representative sample of the population of Sao Paulo. Although they do not qualify for a biomarker alone, uric acid levels may be involved in OSAS severity and should be considered in sleep apnea management in the future.	[Hirotsu, Camila; Tufik, Sergio; Guindalini, Camila; Mazzotti, Diego R.; Bittencourt, Lia R.; Andersen, Monica L.] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Andersen, ML (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	ml.andersen12@gmail.com	Andersen, Monica L/C-7616-2012; Mazzotti, Diego/C-3968-2012; Bittencourt, Lia/C-6551-2012; Mazzotti, Diego R./S-1886-2019	Andersen, Monica L/0000-0002-1894-6748; Bittencourt, Lia/0000-0001-7738-0927; Mazzotti, Diego R./0000-0003-3924-9199; Guindalini, Camila/0000-0002-6278-5881; Hirotsu, Camila/0000-0002-6760-0663	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [CEPID 98/14303-3, 10/50129-1]; CNPq	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (CEPID 98/14303-3 to ST; 10/50129-1 to CH). LRB, MLA and ST are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Bergamini C, 2009, EUR J HEART FAIL, V11, P444, DOI 10.1093/eurjhf/hfp042; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016/S0002-9149(01)02155-5; Bonora E, 1996, INT J OBESITY, V20, P975; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; BRAGHIROLI A, 1993, AM REV RESPIR DIS, V148, P173, DOI 10.1164/ajrccm/148.1.173; Brodov Y, 2010, AM J CARDIOL, V106, P1717, DOI 10.1016/j.amjcard.2010.07.046; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CHRISTENSEN EF, 1992, CHEST, V102, P556, DOI 10.1378/chest.102.2.556; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Desai MY, 2005, AM J CARDIOL, V95, P865, DOI 10.1016/j.amjcard.2004.12.013; Dopp JM, 2011, RESPIRATION, V82, P458, DOI 10.1159/000329341; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Duran M, 2012, ANGIOLOGY, V63, P448, DOI 10.1177/0003319711426868; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Garcia-Pachon E, 2007, LUNG, V185, P21, DOI 10.1007/s00408-006-0076-2; GEORGE CF, 1985, CLIN CHEST MED, V6, P595; Golbin Jason M, 2008, Proc Am Thorac Soc, V5, P200, DOI 10.1513/pats.200708-143MG; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; GRUM CM, 1985, CHEST, V88, P763, DOI 10.1378/chest.88.5.763; GUILLEMINAULT C, 1984, LANCET, V1, P126; HARKNESS RA, 1983, CLIN SCI, V64, P333, DOI 10.1042/cs0640333; Hira HS, 2012, ANN SAUDI MED, V32, P37, DOI 10.5144/0256-4947.2012.37; Iber C., 2007, AASM MANUAL SCORING; Ioachimescu AG, 2008, ARTHRITIS RHEUM-US, V58, P623, DOI 10.1002/art.23121; Jankowska EA, 2007, INT J CARDIOL, V115, P151, DOI 10.1016/j.ijcard.2005.10.033; JENSEN MH, 1980, BIOL NEONATE, V38, P40; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jubber AS, 2004, INT J CLIN PRACT, V58, P573, DOI 10.1111/j.1368-5031.2004.00166.x; Kaditis A, 2010, SLEEP MED, V11, P489, DOI 10.1016/j.sleep.2009.06.011; Karagiannis A, 2007, CIRC J, V71, P1120, DOI 10.1253/circj.71.1120; Kojima S, 2005, AM J CARDIOL, V96, P489, DOI 10.1016/j.amjcard.2005.04.007; Lavie Lena, 2012, Front Biosci (Elite Ed), V4, P1391; Lazzeri C, 2010, INT J CARDIOL, V138, P206, DOI 10.1016/j.ijcard.2008.06.024; Lippi G, 2008, BIOCHEM MEDICA, V18, P37; Liu Wenjun, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P1074; MCKEON JL, 1990, AM REV RESPIR DIS, V142, P8, DOI 10.1164/ajrccm/142.1.8; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Nagaya N, 1999, AM J RESP CRIT CARE, V160, P487, DOI 10.1164/ajrccm.160.2.9812078; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Patetsios P, 1996, ANN NY ACAD SCI, V800, P243, DOI 10.1111/j.1749-6632.1996.tb33318.x; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Plywaczewski Robert, 2005, Pneumonol Alergol Pol, V73, P254; Plywaczewski Robert, 2006, Pneumonol Alergol Pol, V74, P159; Puig JG, 1999, J HYPERTENS, V17, P869, DOI 10.1097/00004872-199917070-00001; RAIVIO KO, 1976, J PEDIATR-US, V88, P625, DOI 10.1016/S0022-3476(76)80023-6; Rechtschaffen A., 1968, MANUAL STANDARDIZED; REUNANEN A, 1982, ACTA MED SCAND, P49; Garcia AR, 2006, ARCH BRONCONEUMOL, V42, P492, DOI 10.1016/S1579-2129(06)60575-2; Sahebjami H, 1998, CHEST, V113, P1604, DOI 10.1378/chest.113.6.1604; Saito H, 2002, CHEST, V122, P1686, DOI 10.1378/chest.122.5.1686; Santos-Silva R, 2009, SLEEP MED, V10, P679, DOI 10.1016/j.sleep.2008.11.001; Sato F, 1997, CIRCULATION, V96, P274; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shimizu Y, 2002, CIRC J, V66, P571, DOI 10.1253/circj.66.571; SORLIE D, 1982, ACTA MED SCAND, V211, P281; Steiropoulos P, 2009, SLEEP, V32, P537, DOI 10.1093/sleep/32.4.537; Thomas JJ, 2012, CLIN EXP PHARM PHYSL; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Van Hoorenbeeck K, 2012, OBESITY, V20, P172, DOI 10.1038/oby.2011.282; Verhulst SL, 2007, CHEST, V132, P76, DOI 10.1378/chest.06-2930; Vijayan VK, 2012, EXPERT REV RESP MED, V6, P557, DOI [10.1586/ers.12.44, 10.1586/ERS.12.44]; World Medical Association Inc, 2009, J Indian Med Assoc, V107, P403; Wysocka E, 2013, ADV EXP MED BIOL, V756, P121, DOI 10.1007/978-94-007-4549-0_16; Yamazaki I, 1995, Nihon Kyobu Geka Gakkai Zasshi, V43, P26; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	69	37	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e66891	10.1371/journal.pone.0066891	http://dx.doi.org/10.1371/journal.pone.0066891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826169	Green Published, gold			2022-12-25	WOS:000321738400080
J	Jin, Y; Korol, SV; Jin, Z; Barg, S; Birnir, B				Jin, Yang; Korol, Sergiy V.; Jin, Zhe; Barg, Sebastian; Birnir, Bryndis			In Intact Islets Interstitial GABA Activates GABA(A) Receptors That Generate Tonic Currents in alpha-Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GAMMA-AMINOBUTYRIC-ACID; SYNAPTIC-LIKE MICROVESICLES; GLUCAGON-SECRETION; GLUTAMATE-DECARBOXYLASE; GLUCOSE-INHIBITION; ENDOCRINE PANCREAS; INSULIN-SECRETION; MOUSE; EXOCYTOSIS	In the rat islets gamma-aminobutyric acid (GABA) is produced by the beta-cells and, at least, the alpha-cells express the GABA(A) receptors (GABA(A) channels). In this study, we examined in intact islets if the interstitial GABA activated the GABA(A) receptors. We used the patch-clamp technique to record whole-cell and single-channel currents and single-cell RT-PCR to identify the cell-type we recorded from, in the intact rat islets. We further identified which GABAA receptor subunits were expressed. We determined the cell-type of 43 cells we recorded from and of these 49%, 28% and 7% were alpha, beta and delta-cells, respectively. In the remaining 16% of the cells, mRNA transcripts of more than one hormone gene were detected. The results show that in rat islets interstitial GABA activates tonic current in the alpha-cells but not in the beta-cells. Seventeen different GABA(A) receptor subunits are expressed with high expression of alpha 1, alpha 2, alpha 4, alpha 6, beta 3, gamma 1, delta, rho 1, rho 2 and rho 3 subunits whereas no expression was detected for alpha 5 or e subunits. The abundance of the GABA(A) receptor subunits detected suggests that a number of GABA(A) receptor subtypes are formed in the islets. The single-channel and tonic currents were enhanced by pentobarbital and inhibited by the GABA(A) receptor antagonist SR-95531. The single-channel conductance ranged from 24 to 105 pS. Whether the single-channel conductance is related to subtypes of the GABA(A) receptor or variable interstitial GABA concentrations remains to be determined. Our results reveal that GABA is an extracellular signaling molecule in rat pancreatic islets and reaches concentration levels that activate GABA(A) receptors on the glucagon-releasing alpha-cells.	[Jin, Yang; Korol, Sergiy V.; Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Barg, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Birnir, B (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Korol, Sergiy V./S-3442-2016; Barg, Sebastian/F-9523-2010; Jin, Zhe/C-5150-2008	Korol, Sergiy V./0000-0001-8279-2790; Barg, Sebastian/0000-0003-4661-5724; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266	Swedish Research Council; Swedish Diabetes Research Foundation; Ernfors Foundation; EXODIAB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Research Foundation; Ernfors Foundation; EXODIAB	The authors thank the Swedish Research Council, Swedish Diabetes Research Foundation, The Ernfors Foundation and EXODIAB for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Jin Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016188; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kash SF, 1999, HORM METAB RES, V31, P340, DOI 10.1055/s-2007-978750; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Leung YM, 2005, ENDOCRINOLOGY, V146, P4766, DOI 10.1210/en.2005-0803; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; MACDONALD RL, 1989, J PHYSIOL-LONDON, V410, P479, DOI 10.1113/jphysiol.1989.sp017545; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SANDLER S, 1987, ENDOCRINOLOGY, V121, P1424, DOI 10.1210/endo-121-4-1424; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; Smismans A, 1997, DIABETOLOGIA, V40, P1411, DOI 10.1007/s001250050843; SUNDLER F, 1977, CELL TISSUE RES, V178, P307; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; TANIGUCHI H, 1977, ARCH HISTOL JAPON, V40, P87, DOI 10.1679/aohc1950.40.Supplement_87; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; Wang C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1201, DOI 10.1152/ajpendo.00459.2006; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	40	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67228	10.1371/journal.pone.0067228	http://dx.doi.org/10.1371/journal.pone.0067228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826240	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400122
J	Perl, S; Perlman, J; Weitzel, RP; Phang, O; Hsieh, MM; Tisdale, J				Perl, Shira; Perlman, Jordan; Weitzel, R. P.; Phang, Oswald; Hsieh, Matthew M.; Tisdale, John			Addition of Rapamycin to Anti-CD3 Antibody Improves Long-Term Glycaemia Control in Diabetic NOD Mice	PLOS ONE			English	Article							T-CELLS; TYPE-1; TRIAL	Aims/Hypothesis: Non-Fc-binding Anti CD3 antibody has proven successful in reverting diabetes in the non-obese diabetes mouse model of type 1 diabetes and limited efficacy has been observed in human clinical trials. We hypothesized that addition of rapamycin, an mTOR inhibitor capable of inducing operational tolerance in allogeneic bone marrow transplantation, would result in improved diabetes reversal rates and overall glycemia. Methods: Seventy hyperglycemic non-obese diabetic mice were randomized to either a single injection of anti CD3 alone or a single injection of anti CD3 followed by 14 days of intra-peritoneal rapamycin. Mice were monitored for hyperglycemia and metabolic control. Results: Mice treated with the combination of anti CD3 and rapamycin had similar rates of diabetes reversal compared to anti CD3 alone (25/35 vs. 22/35). Mice treated with anti CD3 plus rapamycin had a significant improvement in glycemia control as exhibited by lower blood glucose levels in response to an intra-peritoneal glucose challenge; average peak blood glucose levels 30 min post intra-peritoneal injection of 2 gr/kg glucose were 6.9 mmol/L in the anti CD3 plus rapamycin group vs. 10 mmo/L in the anti CD3 alone (P<0.05). Conclusions/Interpretation: The addition of rapamycin to anti CD3 results in significant improvement in glycaemia control in diabetic NOD mice.	[Perl, Shira] NHLBI, Ctr Human Immunol, NIH, Bethesda, MD 20892 USA; [Perl, Shira; Perlman, Jordan; Weitzel, R. P.; Phang, Oswald; Hsieh, Matthew M.; Tisdale, John] NHLBI, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Perl, S (corresponding author), NHLBI, Ctr Human Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	perls@nhlbi.nih.gov			National Heart, Lung, and Blood Institute at the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL006009] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the intramural research program of the National Heart, Lung, and Blood Institute at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Bach JF, 2011, LANCET, V378, P459, DOI 10.1016/S0140-6736(11)60980-X; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Haller MJ, 2005, NEW ENGL J MED, V353, P2086; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Valle A, 2009, DIABETES, V58, P875, DOI 10.2337/db08-1432; Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143; Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173	11	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67189	10.1371/journal.pone.0067189	http://dx.doi.org/10.1371/journal.pone.0067189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826229	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400116
J	Praveen, P; Frohlich, H				Praveen, Paurush; Froehlich, Holger			Boosting Probabilistic Graphical Model Inference by Incorporating Prior Knowledge from Multiple Sources	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; BIOLOGICAL KNOWLEDGE; DATABASE; DISCOVERY; KEGG	Inferring regulatory networks from experimental data via probabilistic graphical models is a popular framework to gain insights into biological systems. However, the inherent noise in experimental data coupled with a limited sample size reduces the performance of network reverse engineering. Prior knowledge from existing sources of biological information can address this low signal to noise problem by biasing the network inference towards biologically plausible network structures. Although integrating various sources of information is desirable, their heterogeneous nature makes this task challenging. We propose two computational methods to incorporate various information sources into a probabilistic consensus structure prior to be used in graphical model inference. Our first model, called Latent Factor Model (LFM), assumes a high degree of correlation among external information sources and reconstructs a hidden variable as a common source in a Bayesian manner. The second model, a Noisy-OR, picks up the strongest support for an interaction among information sources in a probabilistic fashion. Our extensive computational studies on KEGG signaling pathways as well as on gene expression data from breast cancer and yeast heat shock response reveal that both approaches can significantly enhance the reconstruction accuracy of Bayesian Networks compared to other competing methods as well as to the situation without any prior. Our framework allows for using diverse information sources, like pathway databases, GO terms and protein domain data, etc. and is flexible enough to integrate new sources, if available.	[Praveen, Paurush; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr IT, Bonn, Germany	University of Bonn	Praveen, P (corresponding author), Univ Bonn, Bonn Aachen Int Ctr IT, Bonn, Germany.	praveen@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017	Fröhlich, Holger/0000-0002-5328-1243; Praveen, Paurush/0000-0003-1155-4140	B-IT Research School Grant	B-IT Research School Grant	PP is supported by a B-IT Research School Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Eyad Almasri P, 2008, P 4 INT S BIOINF RES; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Gao SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-359; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Imoto Seiya, 2006, Pac Symp Biocomput, P559; Imoto Seiya, 2002, Pac Symp Biocomput, P175; James K, 2009, LECT NOTES COMPUT SC, V5647, P31, DOI 10.1007/978-3-642-02879-3_4; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larsen P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-317; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Marbach D, 2012, NATURE METHODS, V9; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nariai N, 2004, PACIFIC S BIOCOMPUTI; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Tamada Yoshinori, 2005, Journal of Bioinformatics and Computational Biology, V3, P1295, DOI 10.1142/S0219720005001569; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weile J, 2012, BIOINFORMATICS; Werhli AV, 2007, STAT APPL GENET MOL, V6; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	38	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67410	10.1371/journal.pone.0067410	http://dx.doi.org/10.1371/journal.pone.0067410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826291	gold, Green Submitted, Green Published			2022-12-25	WOS:000321738400141
J	Suarez-Rubio, M; Wilson, S; Leimgruber, P; Lookingbill, T				Suarez-Rubio, Marcela; Wilson, Scott; Leimgruber, Peter; Lookingbill, Todd			Threshold Responses of Forest Birds to Landscape Changes around Exurban Development	PLOS ONE			English	Article							POPULATION-CHANGE; UNITED-STATES; RESIDENTIAL DEVELOPMENT; HABITAT FRAGMENTATION; RELATIVE IMPORTANCE; SPECIES RICHNESS; COMMUNITIES; PATTERNS; CONSERVATION; TRENDS	Low-density residential development (i.e., exurban development) is often embedded within a matrix of protected areas and natural amenities, raising concern about its ecological consequences. Forest-dependent species are particularly susceptible to human settlement even at low housing densities typical of exurban areas. However, few studies have examined the response of forest birds to this increasingly common form of land conversion. The aim of this study was to assess whether, how, and at what scale forest birds respond to changes in habitat due to exurban growth. We evaluated changes in habitat composition (amount) and configuration (arrangement) for forest and forest-edge species around North America Breeding Bird Survey (BBS) stops between 1986 and 2009. We used Threshold Indicator Taxa Analysis to detect change points in species occurrence at two spatial extents (400-m and 1-km radius buffer). Our results show that exurban development reduced forest cover and increased habitat fragmentation around BBS stops. Forest birds responded nonlinearly to most measures of habitat loss and fragmentation at both the local and landscape extents. However, the strength and even direction of the response changed with the extent for several of the metrics. The majority of forest birds' responses could be predicted by their habitat preferences indicating that management practices in exurban areas might target the maintenance of forested habitats, for example through easements or more focused management for birds within existing or new protected areas.	[Suarez-Rubio, Marcela] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA; [Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Lookingbill, Todd] Univ Richmond, Dept Geog & Environm, Richmond, VA 23173 USA	University System of Maryland; University of Maryland Center for Environmental Science; Environment & Climate Change Canada; Canadian Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Richmond	Suarez-Rubio, M (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA.	marcela.suarezrubio@boku.ac.at	Wilson, Scott/AAC-7144-2021; Leimgruber, Peter/O-1304-2015; NUNEZ-PENA, MARIA ISABEL/B-3883-2011; Suarez Pellicioni, Macarena/H-5527-2015; colome, angels/H-2522-2015	Leimgruber, Peter/0000-0002-3682-0153; Lookingbill, Todd/0000-0003-4946-6429; NUNEZ-PENA, MARIA ISABEL/0000-0002-3677-859X; Suarez Pellicioni, Macarena/0000-0002-9056-9561; Suarez-Rubio, Marcela/0000-0002-0596-2626; colome, angels/0000-0002-2976-1853	Appalachian Laboratory, University of Maryland Center for Environmental Science	Appalachian Laboratory, University of Maryland Center for Environmental Science	This work was supported by Appalachian Laboratory, University of Maryland Center for Environmental Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], BIRDS N AM ONLINE; ASKINS RA, 1995, SCIENCE, V267, P1956, DOI 10.1126/science.267.5206.1956; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Berger J. O., 2013, STAT DECISION THEORY; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; BURNLEY IH, 1995, J PLAN EDUC RES, V14, P245, DOI 10.1177/0739456X9501400402; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chace JF, 2003, LANDSCAPE URBAN PLAN, V64, P179, DOI 10.1016/S0169-2046(02)00220-7; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Dauphine N, 2009, IMPACTS FREE RANGING, P205; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; ENGELS TM, 1994, CONSERV BIOL, V8, P286, DOI 10.1046/j.1523-1739.1994.08010286.x; Engle David M., 1999, Great Plains Research, V9, P55; Erskine AJ, 1978, CANADIAN WILDLIFE SE, V42, P1; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans M, 2011, BIRDS N AM ONLINE; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fraterrigo JM, 2005, LANDSCAPE URBAN PLAN, V71, P263, DOI 10.1016/S0169-2046(04)00080-5; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd; Graber JW, 1985, BIOL NOTES; Greenlaw JS, 1996, E TOWHEE PIPILO ERYT; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; HAGAN JM, 1993, AUK, V110, P863; Halkin SL, 1999, BIRDS N AM ONLINE; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; HILL SR, 1988, AM MIDL NAT, V120, P313, DOI 10.2307/2426003; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hunt PD, 1998, CONSERV BIOL, V12, P1377, DOI 10.1046/j.1523-1739.1998.97005.x; Jones KB, 2000, ENVIRON MONIT ASSESS, V63, P159, DOI 10.1023/A:1006415029890; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kim KK, 2005, GROWTH CHANGE, V36, P273, DOI 10.1111/j.1468-2257.2005.00277.x; Krementz DG, 2000, WILSON BULL, V112, P243, DOI 10.1676/0043-5643(2000)112[0243:BSDAMO]2.0.CO;2; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lang JD, 2002, AUK, V119, P109, DOI 10.1642/0004-8038(2002)119[0109:WTMAHU]2.0.CO;2; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mancke RG, 2000, ECOL APPL, V10, P598, DOI 10.1890/1051-0761(2000)010[0598:BBDIWE]2.0.CO;2; Marzluff John M., 2001, P19; Matlack GR, 1997, J BIOGEOGR, V24, P281, DOI 10.1046/j.1365-2699.1997.00108.x; Mazerolle DF, 2004, CAN J ZOOL, V82, P1774, DOI 10.1139/Z04-175; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McGranahan D.A., 1999, NATURAL AMENITIES DR; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merenlender AM, 2009, LANDSCAPE URBAN PLAN, V92, P255, DOI 10.1016/j.landurbplan.2009.05.004; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; PETERJOHN PG, 1994, WILDLIFE SOC B, V22, P155; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; R Core Team, 2021, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robbins C.S., 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sauer JR, 1995, MONITORING BIRD POPU, P151; Sherry TW, 1997, BIRDS N AM; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith RJ, 2011, BIRDS N AM ONLINE; Smith WB, 2004, FOREST RESOURCES US; Soille P., 2013, MORPHOLOGICAL IMAGE; Struyk RJ, 1996, HOUSING STUD, V11, P233, DOI 10.1080/02673039608720854; Suarez-Rubio M, 2012, REMOTE SENS ENVIRON, V124, P360, DOI 10.1016/j.rse.2012.03.029; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Theobald DM, 2005, ECOL SOC, V10; U.S. NABCI Committee, 2009, STAT BIRDS; US Census Bureau, 2010, STAT COUNT QUICK FAC; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; van den Berg L, 2000, LANDSCAPE URBAN PLAN, V48, P169, DOI 10.1016/S0169-2046(00)00040-2; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wakamiya SW, 2012, NATURAL RESOURCE DAT; Weeks Jr HP, 2011, E PHOEBE SAYORNIS PH; Weldon Cooper Center, 2010, FIN 2008 PROV 2009 P; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	104	39	40	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67593	10.1371/journal.pone.0067593	http://dx.doi.org/10.1371/journal.pone.0067593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826325	Green Submitted, Green Published, gold			2022-12-25	WOS:000321738400161
J	Wang, Q; Cheng, XL; Zhang, DY; Gao, XJ; Zhou, L; Qin, XY; Xie, GY; Liu, K; Qin, Y; Liu, BL; Qin, MJ				Wang, Qi; Cheng, Xiao-Lan; Zhang, Dong-Yan; Gao, Xue-Jiao; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Liu, Kang; Qin, Yong; Liu, Bao-Lin; Qin, Min-Jian			Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance via Targeting ROS-Associated Inflammation and IRS-1 Pathway	PLOS ONE			English	Article							INDUCED DIABETIC-RAT; IN-VITRO; KAIKASAPONIN-III; PUERARIAE FLOS; DYSFUNCTION; TECTORIDIN; PURIFICATION; ISOFLAVONES; METABOLISM; FLOWERS	Tectorigenin is a plant isoflavonoid originally isolated from the dried flower of Pueraria thomsonii Benth. Although its anti-inflammatory and anti-hyperglycosemia effects have been well documented, the effect of tectorigenin on endothelial dysfunction insulin resistance involved has not yet been reported. Herein, this study aims to investigate the action of tectorigenin on amelioration of insulin resistance in the endothelium. Palmitic acid (PA) was chosen as a stimulant to induce ROS production in endothelial cells and successfully established insulin resistance evidenced by the specific impairment of insulin PI3K signaling. Tectorigenin effectively inhibited the ability of PA to induce the production of reactive oxygen species and collapse of mitochondrial membrane potential. Moreover, tectorigenin presented strong inhibition effect on ROS-associated inflammation, as TNF-alpha and IL-6 production in endothelial cells was greatly reduced with suppression of IKK beta/NF-kappa B phosphorylation and JNK activation. Tectorigenin also can inhibit inflammation-stimulated IRS-1 serine phosphorylation and restore the impaired insulin PI3K signaling, leading to a decreased NO production. These results demonstrated its positive regulation of insulin action in the endothelium. Meanwhile, tectorigenin down-regulated endothelin-1 and vascular cell adhesion molecule-1 overexpression, and restored the loss of insulin-mediated vasodilation in rat aorta. These findings suggested that tectorigenin could inhibit ROS-associated inflammation and ameliorated endothelial dysfunction implicated in insulin resistance through regulating IRS-1 function. Tectorigenin might have potential to be applied for the management of cardiovascular diseases involved in diabetes and insulin resistance.	[Wang, Qi; Cheng, Xiao-Lan; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Qin, Yong; Qin, Min-Jian] China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Dong-Yan] Henan Prov Peoples Hosp, Dept Pharm, Zhengzhou, Peoples R China; [Gao, Xue-Jiao] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China; [Liu, Kang; Liu, Bao-Lin] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Zhengzhou University; University of Macau; China Pharmaceutical University	Qin, MJ (corresponding author), China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	minjianqin@163.com	Qin, Minjian/D-3306-2017; TAO, Jun/I-2701-2014; Chen, Lung-Wen/J-5792-2015	Qin, Minjian/0000-0001-8539-7649; TAO, Jun/0000-0002-0936-4869; Chen, Lung-Wen/0000-0002-2311-7506	National Natural Science Foundation of China [81072976]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ11-0810]; Program for the Top Doctor Innovative Talents of China Pharmacuetical University [2011IIBPY03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province; Program for the Top Doctor Innovative Talents of China Pharmacuetical University	Support as provided by: National Natural Science Foundation of China (Grant No. 81072976), Research and Innovation Project for College Graduates of Jiangsu Province (CXZZ11-0810) and Program for the Top Doctor Innovative Talents of China Pharmacuetical University (2011IIBPY03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae EA, 1999, BIOL PHARM BULL, V22, P1314, DOI 10.1248/bpb.22.1314; Cao XL, 1999, J CHROMATOGR A, V855, P709, DOI 10.1016/S0021-9673(99)00715-3; Carmody RJ, 2000, CELL DEATH DIFFER, V7, P282, DOI 10.1038/sj.cdd.4400646; Choi J, 2004, J MED FOOD, V7, P31, DOI 10.1089/109662004322984671; Eringa EC, 2002, CARDIOVASC RES, V56, P464, DOI 10.1016/S0008-6363(02)00593-X; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Han T, 2012, FOOD CHEM TOXICOL, V50, P409, DOI 10.1016/j.fct.2011.10.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jung SH, 2002, ARCH PHARM RES, V25, P306, DOI 10.1007/BF02976631; Kamiya T, 2011, J HEALTH SCI, V57, P521, DOI 10.1248/jhs.57.521; Kearney MT, 2008, EXP PHYSIOL, V93, P158, DOI 10.1113/expphysiol.2007.039172; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Lee HU, 2005, J PHARMACOL SCI, V97, P541, DOI 10.1254/jphs.SCZ040467; Lee KT, 2000, ARCH PHARM RES, V23, P461, DOI 10.1007/BF02976573; Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037; NIIHO Y, 1989, YAKUGAKU ZASSHI, V109, P424, DOI 10.1248/yakushi1947.109.6_424; Pan CH, 2008, ARCH PHARM RES, V31, P1447, DOI 10.1007/s12272-001-2129-7; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Verma S, 2001, HYPERTENSION, V37, P328, DOI 10.1161/01.HYP.37.2.328; Wang Q, 2013, J PHARMACEUT BIOMED, V75, P25, DOI 10.1016/j.jpba.2012.11.009; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yuan D, 2009, J ASIAN NAT PROD RES, V11, P471, DOI 10.1080/10286020902819822; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang DY, 2013, J DIABETES, V5, P13, DOI 10.1111/1753-0407.12017; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619	29	69	72	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66417	10.1371/journal.pone.0066417	http://dx.doi.org/10.1371/journal.pone.0066417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23874802	Green Submitted, Green Published, gold			2022-12-25	WOS:000322361200072
J	Zhu, LH; Zhao, XC; Lai, LM; Wang, JJ; Jiang, LH; Ding, JZ; Liu, NX; Yu, YJ; Li, JS; Xiao, NW; Zheng, YR; Rimmington, GM				Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen; Zheng, Yuanrun; Rimmington, Glyn M.			Soil TPH Concentration Estimation Using Vegetation Indices in an Oil Polluted Area of Eastern China	PLOS ONE			English	Article							RED-EDGE; REFLECTANCE; LEAF; RESPONSES; FOREST; PREDICTION; PETROLEUM; RATIOS; RADAR; METAL	Assessing oil pollution using traditional field-based methods over large areas is difficult and expensive. Remote sensing technologies with good spatial and temporal coverage might provide an alternative for monitoring oil pollution by recording the spectral signals of plants growing in polluted soils. Total petroleum hydrocarbon concentrations of soils and the hyperspectral canopy reflectance were measured in wetlands dominated by reeds (Phragmites australis) around oil wells that have been producing oil for approximately 10 years in the Yellow River Delta, eastern China to evaluate the potential of vegetation indices and red edge parameters to estimate soil oil pollution. The detrimental effect of oil pollution on reed communities was confirmed by the evidence that the aboveground biomass decreased from 1076.5 g m(-2) to 5.3 g m(-2) with increasing total petroleum hydrocarbon concentrations ranging from 9.45 mg kg(-1) to 652 mg kg(-1). The modified chlorophyll absorption ratio index (MCARI) best estimated soil TPH concentration among 20 vegetation indices. The linear model involving MCARI had the highest coefficient of determination (R-2 = 0.73) and accuracy of prediction (RMSE = 104.2 mg kg(-1)). For other vegetation indices and red edge parameters, the R-2 and RMSE values ranged from 0.64 to 0.71 and from 120.2 mg kg(-1) to 106.8 mg kg(-1) respectively. The traditional broadband normalized difference vegetation index (NDVI), one of the broadband multispectral vegetation indices (BMVIs), produced a prediction (R-2 = 0.70 and RMSE = 110.1 mg kg(-1)) similar to that of MCARI. These results corroborated the potential of remote sensing for assessing soil oil pollution in large areas. Traditional BMVIs are still of great value in monitoring soil oil pollution when hyperspectral data are unavailable.	[Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Zheng, Yuanrun] Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Linhai; Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Research Academy of Environmental Sciences; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	Ding, Jinzhi/AAE-3421-2019; liming, lai/HGB-0743-2022; Xiao, Nengwen/ACW-1426-2022; Zhu, Linhai/B-8551-2011	Ding, Jinzhi/0000-0003-3664-2702; Zhu, Linhai/0000-0001-7064-9022; Xiao, NengWen/0000-0002-7482-135X	National Key Technology R&D Program of China [2008BAC43B01]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (2008BAC43B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Bannari A., 1995, REV VEG INDICES, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Baret F., 1989, P 12 CAN S REM SENS, V3, P1355; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Chaineau CH, 2003, WATER AIR SOIL POLL, V144, P419, DOI 10.1023/A:1022935600698; [陈建 CHEN Jian], 2011, [地理科学进展, Progress in Geography], V30, P585; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Clevers JGPW, 2004, INT J REMOTE SENS, V25, P3883, DOI 10.1080/01431160310001654473; COLWELL J E, 1974, Remote Sensing of Environment, V3, P175, DOI 10.1016/0034-4257(74)90003-0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Guyot G., 1988, J CHEM INF MODEL, P279; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Ji GD, 2004, ENVIRON INT, V30, P509, DOI 10.1016/j.envint.2003.10.003; Ji GD, 2007, ECOL ENG, V29, P272, DOI 10.1016/j.ecoleng.2006.04.002; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; Kooistra L, 2004, ENVIRON POLLUT, V127, P281, DOI 10.1016/S0269-7491(03)00266-5; Kooistra L, 2003, INT J REMOTE SENS, V24, P4995, DOI 10.1080/0143116031000080769; [刘五星 LIU Wuxing], 2007, [土壤, Soils], V39, P247; MAJOR DJ, 1990, INT J REMOTE SENS, V11, P727, DOI 10.1080/01431169008955053; Mason DC, 2012, IEEE T GEOSCI REMOTE, V50, P3041, DOI 10.1109/TGRS.2011.2178030; MILLER JR, 1990, INT J REMOTE SENS, V11, P1755, DOI 10.1080/01431169008955128; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Osuji LC, 2004, CHEM BIODIVERS, V1, P1569, DOI 10.1002/cbdv.200490117; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Pu RL, 2003, IEEE T GEOSCI REMOTE, V41, P916, DOI 10.1109/TGRS.2003.813555; Qiu GY, 1998, J HYDROL, V210, P93, DOI 10.1016/S0022-1694(98)00174-7; Ren L., 2000, AGROENVIRONMENTAL PR, V19, P360; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rosso PH, 2005, ENVIRON POLLUT, V137, P241, DOI 10.1016/j.envpol.2005.02.025; Rouse J.W., 1973, 3 EARTH RESOURCES TE, DOI DOI 10.1002/MRM.26868; SHIELDS PG, 1993, CANCER RES, V53, P3486; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; WOOLLEY JT, 1971, PLANT PHYSIOL, V47, P656, DOI 10.1104/pp.47.5.656; 许学工, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P111	51	91	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54028	10.1371/journal.pone.0054028	http://dx.doi.org/10.1371/journal.pone.0054028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342066	Green Submitted, gold, Green Published			2022-12-25	WOS:000313682700078
J	Niu, Q; Zhang, RK; Zhao, M; Zeng, SG; Huang, XB; Jiang, H; An, YF; Zhang, LW				Niu, Qian; Zhang, Ruke; Zhao, Min; Zeng, Sugen; Huang, Xunbei; Jiang, Hong; An, Youfang; Zhang, Luwen			Differences in Platelet Indices between Healthy Han Population and Tibetans in China	PLOS ONE			English	Article							HIGH-ALTITUDE; RISK-FACTOR; VOLUME; STROKE; ADAPTATION; REACTIVITY; HYPOXIA; DISEASE	Introduction: The present data on the evaluation of platelet (PLT) parameters in Chinese Han population and Tibetans are still limited. The objective of this study was to determine the differences in common PLT indices between Han population and Tibetans in China, through a large-scale investigation of healthy people. Methods: 2131 Han people from Chengdu Plain, 1099 Tibetans from Qinghai-Tibet Plateau and 956 Plateau Han migrants were included in this study. All the subjects were healthy people through the health screening. PLT indices were measured with Sysmex XE-2100 and XT-1800i blood cell automatic analyzer. Results: Compared with Han people in Chendu Plain, Tibetans had higher PLT count (P<0.01) but lower mean platelet volume (MPV), platelet distribution width (PDW) and platelet-large cell ratio (P-LCR) (P<0.01); while Plateau Han migrants had lower PLT count, MPV and P-LCR (P<0.05). When compared with Tibetans, Plateau Han migrants had lower levels of mean PLT count but higher PDW and P-LCR (P<0.05). Conclusions: There are ethnic differences in PLT indices between Chinese Han population and Tibetans. Based on this finding, it would be reasonable to conduct formal prospective studies to determine the clinical significance of these differences and to explore the effects of genetic background on these indices.	[Niu, Qian; Zhang, Ruke; Zeng, Sugen; Huang, Xunbei; Jiang, Hong] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China; [Zhao, Min] Peoples Hosp Tibet Autonomous Reg, Dept Lab Med, Lhasa, Peoples R China; [An, Youfang; Zhang, Luwen] Hosp Off Tibet Autonomous Reg Chengdu, Dept Lab Med, Chengdu, Peoples R China	Sichuan University	Jiang, H (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	jianghong6656@126.com		Zhao, Mei/0000-0003-3530-0233	Science and Technology Planning Project of Sichuan Province of China [2009SZ0157]; Science and Technology Project of Chengdu Government of Sichuan [12PPYB064SF-002]	Science and Technology Planning Project of Sichuan Province of China; Science and Technology Project of Chengdu Government of Sichuan	This study was supported by the Science and Technology Planning Project of Sichuan Province of China (Grant No. 2009SZ0157)(http://www.scst.gov.cn/info/), and the Science and Technology Project of Chengdu Government of Sichuan (Grant No. 12PPYB064SF-002)(http://www.cdst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Lorido JC, 2012, IRISH J MED SCI, V181, P179, DOI 10.1007/s11845-011-0755-8; Basset FA, 2006, EXP PHYSIOL, V91, P391, DOI 10.1113/expphysiol.2005.031682; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Dunleavy M, 2005, EXP PHYSIOL, V90, P411, DOI 10.1113/expphysiol.2004.029306; Gilmartin GS, 2008, AM J PHYSIOL-HEART C, V295, pH778, DOI 10.1152/ajpheart.00653.2007; Gupta N, 2012, SEMIN THROMB HEMOST, V38, P156, DOI 10.1055/s-0032-1301413; Ihara A, 2006, PATHOPHYSIOL HAEMO T, V35, P376, DOI 10.1159/000097692; Kamisli O, 2012, CLIN A IN PRESS 0719; Korkmaz L, 2012, ANATOL J CARDIOL, V12, P35, DOI 10.5152/akd.2012.007; Lehmann T, 2006, J APPL PHYSIOL, V100, P690, DOI 10.1152/japplphysiol.00991.2005; Ntaios G, 2008, ACTA HAEMATOL-BASEL, V119, P173, DOI 10.1159/000135658; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Suades R, 2012, THROMB HAEM IN PRESS, V108; Sucu M, 2010, CLIN APPL THROMB-HEM, V16, P563, DOI 10.1177/1076029609338046; Wang RT, 2011, PLATELETS, V22, P447, DOI 10.3109/09537104.2011.565431; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao YH, 2010, STROKE, V41, P2739, DOI 10.1161/STROKEAHA.110.586669	17	75	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67203	10.1371/journal.pone.0067203	http://dx.doi.org/10.1371/journal.pone.0067203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	24324824	gold, Green Published, Green Submitted			2022-12-25	WOS:000321738400118
J	Chen, XH; Yang, GX; Song, JH; Xu, H; Li, D; Goldsmith, J; Zeng, HY; Parsons-Wingerter, PA; Reinecker, HC; Kelly, CP				Chen, Xinhua; Yang, Guoxun; Song, Joo-Hye; Xu, Hua; Li, Dan; Goldsmith, Jeffrey; Zeng, Huiyan; Parsons-Wingerter, Patricia A.; Reinecker, Hans-Christian; Kelly, Ciaran P.			Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation	PLOS ONE			English	Article							DIFFICILE TOXIN-A; ANTIBIOTIC-ASSOCIATED DIARRHEA; ENDOTHELIAL GROWTH-FACTOR; SACCHAROMYCES-BOULARDII; BOWEL-DISEASE; ULCERATIVE-COLITIS; CHOLERA-TOXIN; PATHOGENESIS; PREVENTION; CELLS	Background and Aims: Saccharomyces boulardii (Sb) can protect against intestinal injury and tumor formation, but how this probiotic yeast controls protective mucosal host responses is unclear. Angiogenesis is an integral process of inflammatory responses in inflammatory bowel diseases (IBD) and required for mucosal remodeling during restitution. The aim of this study was to determine whether Sb alters VEGFR (vascular endothelial growth factor receptor) signaling, a central regulator of angiogenesis. Methods: HUVEC were used to examine the effects of Sb on signaling and on capillary tube formation (using the ECMatrix (TM) system). The effects of Sb on VEGF-mediated angiogenesis were examined in vivo using an adenovirus expressing VEGF-A(164) in the ears of adult nude mice (NuNu). The effects of Sb on blood vessel volume branching and density in DSS-induced colitis was quantified using VESsel GENeration (VESGEN) software. Results: 1) Sb treatment attenuated weight-loss (p<0.01) and histological damage (p<0.01) in DSS colitis. VESGEN analysis of angiogenesis showed significantly increased blood vessel density and volume in DSS-treated mice compared to control. Sb treatment significantly reduced the neo-vascularization associated with acute DSS colitis and accelerated mucosal recovery restoration of the lamina propria capillary network to a normal morphology. 2) Sb inhibited VEGF-induced angiogenesis in vivo in the mouse ear model. 3) Sb also significantly inhibited angiogenesis in vitro in the capillary tube assay in a dose-dependent manner (p<0.01). 4) In HUVEC, Sb reduced basal VEGFR-2 phosphorylation, VEGFR-2 phosphorylation in response to VEGF as well as activation of the downstream kinases PLC gamma and Erk1/2. Conclusions: Our findings indicate that the probiotic yeast S boulardii can modulate angiogenesis to limit intestinal inflammation and promote mucosal tissue repair by regulating VEGFR signaling.	[Chen, Xinhua; Yang, Guoxun; Xu, Hua; Li, Dan; Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Song, Joo-Hye; Reinecker, Hans-Christian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Goldsmith, Jeffrey] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA; [Zeng, Huiyan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; [Parsons-Wingerter, Patricia A.] John Glenn NASA Res Ctr, Cleveland, OH USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Aeronautics & Space Administration (NASA)	Chen, XH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	xchen1@bidmc.harvard.edu			NIH [PO1 DK 33506, DK-068181, DK-043351, AI-093588]; Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK068181, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Global Probiotic Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants PO1 DK 33506 (CPK, HCR), DK-068181, DK-043351 and AI-093588 (HCR), Crohn's & Colitis Foundation of America (Research Fellowship and Career Development Award, XC) and Global Probiotic Council (Young Investigator Award, XC). NASA and PPW have filed a United States patent application for the VESGEN software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandao RL, 1998, APPL ENVIRON MICROB, V64, P564; BUTS JP, 1990, DIGEST DIS SCI, V35, P251, DOI 10.1007/BF01536771; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chen XH, 2008, THERAPEUTIC MICROBIOLOGY: PROBIOTICS AND RELATED STRATEGIES, P51; Chen XH, 2009, GASTROENTEROLOGY, V137, P914, DOI 10.1053/j.gastro.2009.05.050; Chidlow JH, 2007, AM J PHYSIOL-GASTR L, V293, pG5, DOI 10.1152/ajpgi.00107.2007; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Czerucka D, 2002, MICROBES INFECT, V4, P733, DOI 10.1016/S1286-4579(02)01592-7; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Danese S, 2008, PATHOBIOLOGY, V75, P22, DOI 10.1159/000113791; Danese S, 2007, GUT, V56, P855, DOI 10.1136/gut.2006.114314; DIAS RS, 1995, BRAZ J MED BIOL RES, V28, P323; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Guslandi M, 2000, DIGEST DIS SCI, V45, P1462, DOI 10.1023/A:1005588911207; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; Guslandi M, 2011, J CLIN GASTROENTEROL, V45, P475, DOI 10.1097/MCG.0b013e318207f584; Guslandi M, 2010, J CLIN GASTROENTEROL, V44, P385, DOI 10.1097/MCG.0b013e3181cb4233; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Im E, 2009, AM J PHYSIOL-GASTR L, V297, pG999, DOI 10.1152/ajpgi.00204.2009; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kapsoritakis A, 2003, INT J COLORECTAL DIS, V18, P418, DOI 10.1007/s00384-003-0495-y; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; Nagy JA, 2008, METHOD ENZYMOL, V444, P43, DOI 10.1016/S0076-6879(08)02803-6; Papa A, 2008, DIGEST DIS, V26, P149, DOI 10.1159/000116773; Parsons-Wingerter P, INVEST OPHTHALMOL VI, V51, P498; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Sandor Z, 2006, BIOCHEM BIOPH RES CO, V350, P147, DOI 10.1016/j.bbrc.2006.09.021; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Sitohy B, CANC RES, V72, P1909; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sullivan A, 2002, INT J ANTIMICROB AG, V20, P313, DOI 10.1016/S0924-8579(02)00199-1; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; Vickerman MB, 2009, ANAT REC, V292, P320, DOI 10.1002/ar.20862	48	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e64227	10.1371/journal.pone.0064227	http://dx.doi.org/10.1371/journal.pone.0064227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23826208	Green Published, gold, Green Submitted			2022-12-25	WOS:000319036100060
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000314019100036
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600042
